FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Fonteles, CSR
   Ribeiro, EM
   Santos, MSA
   Leite, RFP
   Assuncao, GS
   Monteiro, AJ
   Pessoa, ALS
   Giacheti, CM
   Kerbage, SC
   Ribeiro, TR
   Cavalcanti, LPD
AF Roriz Fonteles, Cristiane Sa
   Ribeiro, Erlane Marques
   Aragao Santos, Marinisi Sales
   Pequeno Leite, Rebeka Ferreira
   Assuncao, Gabryela Sales
   Monteiro, Andre Jalles
   Santos Pessoa, Andre Luiz
   Giacheti, Celia Maria
   Kerbage, Saile Cavalcante
   Ribeiro, Thyciana Rodrigues
   de Goes Cavalcanti, Luciano Pamplona
TI Lingual Frenulum Phenotypes in Brazilian Infants With Congenital Zika
   Syndrome
SO CLEFT PALATE-CRANIOFACIAL JOURNAL
LA English
DT Article
DE microcephaly; Zika virus; lingual frenum; stomatognathic system
ID BREAST-FEEDING DIFFICULTIES; EHLERS-DANLOS-SYNDROME; POSTERIOR
   ANKYLOGLOSSIA; VIRUS-INFECTION; TONGUE-TIE; ASSOCIATION; MANAGEMENT;
   FRENOTOMY; DYSPHAGIA; OUTBREAK
AB Objective: The present study aimed to evaluate lingual frenulum in children affected by congenital Zika syndrome (CZS) and to analyze the association of lingual frenulum phenotypes with other variables.
   Design: This present work had a cross-sectional, descriptive study design.
   Setting: This study was carried out in Fortaleza (Brazil). The health professionals provided tertiary level of care. Data collection occurred during a multidisciplinary task force for evaluating infants affected by CZS in December 2 to 3, 2016.
   Patients: Fifty-four patients with CZS (1-12 months old; 32 girls and 22 boys) were recruited from a population of 70 infants.
   Interventions: A multidisciplinary group comprised of speech-language pathologist/audiologists and pediatric dentists evaluated all patients through an intraoral examination and a specific tongue maneuver protocol for infants.
   Main Outcome Measures: Lingual frenulum visibility was the primary outcome measure. Before initiating the study, we hypothesized that children with CZS had an absent lingual frenulum.
   Results: Lingual frenula were visible in 34 (63%) infants, whereas in 20 (37%) infants lingual frenula visibility required a specific maneuver to retract the tongue. Six of 20 infants presented posteriorly positioned lingual frenula that were visible after maneuver. Lingual frenula were covered by mucous tissue in 14 infants. Presence of posterior frenulum was associated with dysphagia (P = 0.038). However, the presence of dysphagia in a multivariate model did not associate with the presence of a posterior lingual frenulum (P = .069) or neurologic symptoms (P = .056).
   Conclusion: Children with CZS showed predominance of a posterior lingual frenula covered by an overlapping curtain-like mucous membrane.
C1 [Roriz Fonteles, Cristiane Sa; Monteiro, Andre Jalles; Ribeiro, Thyciana Rodrigues] Univ Fed Ceara, Dept Clin Dent, Rua Monsenhor Furtado 1273, BR-60430 Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane Marques; Aragao Santos, Marinisi Sales; Pequeno Leite, Rebeka Ferreira; Assuncao, Gabryela Sales; Santos Pessoa, Andre Luiz; Kerbage, Saile Cavalcante] Albert Sabin Childrens Hosp HIAS, Fortaleza, Ceara, Brazil.
   [Ribeiro, Erlane Marques] Christus Univ Ctr UNICHRISTUS, Fac Med, Fortaleza, Ceara, Brazil.
   [Giacheti, Celia Maria] Sao Paulo State Univ Julio de Mesquita Filho UNES, Dept Speech Language Pathol & Audiol, Sao Paulo, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Dept Community Hlth, Fortaleza, Ceara, Brazil.
RP Fonteles, CSR (corresponding author), Univ Fed Ceara, Dept Clin Dent, Rua Monsenhor Furtado 1273, BR-60430 Fortaleza, Ceara, Brazil.
EM cfontele@ufc.br
RI Giacheti, Celia M/I-4863-2012
OI Giacheti, Celia M/0000-0001-9691-4672
CR [Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BEIGHTON P, 1969, ANN RHEUM DIS, V28, P228, DOI 10.1136/ard.28.3.228
   Benoiton L, 2016, INT J PEDIATR OTORHI, V88, P13, DOI 10.1016/j.ijporl.2016.06.037
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cavalcanti LPG, 2017, REV MED UFC, V57, P52
   Chu MW, 2009, INT J PEDIATR OTORHI, V73, P881, DOI 10.1016/j.ijporl.2009.02.011
   De Felice C, 2001, LANCET, V357, P1500, DOI 10.1016/S0140-6736(00)04661-4
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dollberg S, 2014, BREASTFEED MED, V9, P286, DOI 10.1089/bfm.2014.0010
   Douglas PS, 2013, BREASTFEED MED, V8, P503, DOI 10.1089/bfm.2013.0103
   Fehrenbach MJ, 2002, ILLUSTRATED ANATOMY
   Ghaheri BA, 2017, LARYNGOSCOPE, V127, P1217, DOI 10.1002/lary.26306
   Haham A, 2014, BREASTFEED MED, V9, P438, DOI 10.1089/bfm.2014.0040
   Hazelbaker AK, 2010, TONGUE TIE MORPHOGEN
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hong P, 2010, INT J PEDIATR OTORHI, V74, P1003, DOI 10.1016/j.ijporl.2010.05.025
   Ingram J, 2015, ARCH DIS CHILD-FETAL, V100, pF344, DOI 10.1136/archdischild-2014-307503
   Kamal K, 2016, ANAESTHESIA, V71, P478, DOI 10.1111/anae.13427
   Knox I, 2010, NEOREVIEWS, V11, P513
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Machet L, 2010, AM J CLIN DERMATOL, V11, P269, DOI 10.2165/11530090-000000000-00000
   Marchesan IQ, 2014, TRATADO ESPECIALIDAD, P283
   Marcione Enajes Silva Soares, 2016, Rev. CEFAC, V18, P1042, DOI 10.1590/1982-0216201618522915
   Martinelli Roberta Lopes de Castro, 2013, Rev. CEFAC, V15, P599, DOI 10.1590/s1516-18462013005000032
   Mintz SM, 2005, ORAL SURG ORAL MED O, V99, P321, DOI 10.1016/j.tripleo.2004.08.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   O'Callahan C, 2013, INT J PEDIATR OTORHI, V77, P827, DOI 10.1016/j.ijporl.2013.02.022
   Parada C, 2015, CURR TOP DEV BIOL, V115, P31, DOI 10.1016/bs.ctdb.2015.07.023
   Pradhan S, 2012, INT J LASER DENT, V2, P41
   Pradhan S, 2013, INT J LASER DENT, V3, P19
   Pransky SM, 2015, INT J PEDIATR OTORHI, V79, P1714, DOI 10.1016/j.ijporl.2015.07.033
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Svystun O, 2017, INT J PEDIATR OTORHI, V99, P54, DOI 10.1016/j.ijporl.2017.05.024
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 36
TC 1
Z9 2
U1 0
U2 4
PU ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS
PI LAWRENCE
PA 810 EAST 10TH STREET, LAWRENCE, KS 66044 USA
SN 1055-6656
EI 1545-1569
J9 CLEFT PALATE-CRAN J
JI Cleft Palate-Craniofac. J.
PD NOV
PY 2018
VL 55
IS 10
BP 1391
EP 1398
DI 10.1177/1055665618766999
PG 8
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA GW4GX
UT WOS:000446871400007
PM 29613837
DA 2020-07-08
ER

PT J
AU Alcendor, DJ
AF Alcendor, Donald J.
TI Zika virus infection and implications for kidney disease
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Review
DE Zika virus; Kidney; Glomerulus; Viruria
ID BRAZIL; URINE; TRANSMISSION; RNA; PATHOGENESIS; SPECIMENS; EPIDEMIC;
   PODOCYTE; BIOLOGY; MODELS
AB High-level and persistent viruria observed in patients infected by Zika virus (ZIKV) has been well documented. However, renal pathology in acutely infected, immunocompetent patients remains subclinical. Moreover, the long-term impact of ZIKV infection, replication, and persistence in the renal compartment of adults and infants as well as immunosuppressed patients and solid organ transplant (SOT) recipients is unknown. Mechanisms involving host and viral factors that limit or control ZIKV pathogenesis in the renal compartment are important yet unexplored. The observation that long-term viral shedding occurs in the renal compartment in the absence of clinical disease requires further investigation. In this review, I explore Zika virus-induced renal pathology in animal models, the dynamics of virus shedding in urine, virus replication in glomerular cells, ZIKV infection in human renal transplantation, and the potential impact of long-term persistent ZIKV infection in the renal compartment.
C1 [Alcendor, Donald J.] Meharry Med Coll, Sch Med, Dept Microbiol Immunol & Physiol, Hubbard Hosp,Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd,5th Floor,Rm 5025, Nashville, TN 37208 USA.
RP Alcendor, DJ (corresponding author), Meharry Med Coll, Sch Med, Dept Microbiol Immunol & Physiol, Hubbard Hosp,Ctr AIDS Hlth Dispar Res, 1005 Dr DB Todd Jr Blvd,5th Floor,Rm 5025, Nashville, TN 37208 USA.
EM dalcendor@mmc.edu
OI Alcendor, Donald/0000-0002-4568-8158
FU Meharry Translational Research Center (MeTRC) from the National
   Institute on Minority Health and Health Disparities of the National
   Institutes of Health [5U54MD007593]; National Institute on Minority
   Health and Health Disparities of the National Institutes of Health
FX Research performed by D.J.A. reported in this publication was also
   supported by the Meharry Translational Research Center (MeTRC) (grant
   5U54MD007593) from the National Institute on Minority Health and Health
   Disparities of the National Institutes of Health.
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   Andrade DV, 2017, VIRUS RES, V17, P30462
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Barisoni L, 2003, AM J NEPHROL, V23, P353, DOI 10.1159/000072917
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Kublin JL, 2018, VIRUS RES, V254, P15, DOI 10.1016/j.virusres.2017.07.025
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nogueira ML, 2016, AM J TRANSPLANT, V17, P791
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002
   Peralta-Aros C, 2017, PEDIATR NEPHROL, V32, P897, DOI 10.1007/s00467-017-3588-5
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 48
TC 3
Z9 3
U1 0
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0946-2716
EI 1432-1440
J9 J MOL MED
JI J. Mol. Med.
PD NOV
PY 2018
VL 96
IS 11
BP 1145
EP 1151
DI 10.1007/s00109-018-1692-z
PG 7
WC Genetics & Heredity; Medicine, Research & Experimental
SC Genetics & Heredity; Research & Experimental Medicine
GA GY1KG
UT WOS:000448287300001
PM 30171265
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Jackman, JA
   Costa, VV
   Park, S
   Real, ALCV
   Park, JH
   Cardozo, PL
   Ferhan, AR
   Olmo, IG
   Moreira, TP
   Bambirra, JL
   Queiroz, VF
   Queiroz, CM
   Foureaux, G
   Souza, DG
   Ribeiros, FM
   Yoon, BK
   Wynendaele, E
   De Spiegeleer, B
   Teixeira, MM
   Cho, NJ
AF Jackman, Joshua A.
   Costa, Vivian V.
   Park, Soohyun
   Real, Ana Luiza C., V
   Park, Jae Hyeon
   Cardozo, Pablo L.
   Ferhan, Abdul Rahim
   Olmo, Isabella G.
   Moreira, Thaiane P.
   Bambirra, Jordana L.
   Queiroz, Victoria F.
   Queiroz-Junior, Celso M.
   Foureaux, Giselle
   Souza, Danielle G.
   Ribeiros, Fabiola M.
   Yoon, Bo Kyeong
   Wynendaele, Evelien
   De Spiegeleer, Bart
   Teixeira, Mauro M.
   Cho, Nam-Joon
TI Therapeutic treatment of Zika virus infection using a brain-penetrating
   antiviral peptide
SO NATURE MATERIALS
LA English
DT Article
ID HUMAN-ANTIBODIES; NERVOUS-SYSTEM; LIPID VESICLES; DENGUE; DISEASE; MICE
AB Zika virus is a mosquito-borne virus that is associated with neurodegenerative diseases, including Guillain-Barre syndrome' and congenital Zika syndrome(2). As Zika virus targets the nervous system, there is an urgent need to develop therapeutic strategies that inhibit Zika virus infection in the brain. Here, we have engineered a brain-penetrating peptide that works against Zika virus and other mosquito-borne viruses. We evaluated the therapeutic efficacy of the peptide in a lethal Zika virus mouse model exhibiting systemic and brain infection. Therapeutic treatment protected against mortality and markedly reduced clinical symptoms, viral loads and neuroinflammation, as well as mitigated microgliosis, neurodegeneration and brain damage. In addition to controlling systemic infection, the peptide crossed the blood-brain barrier to reduce viral loads in the brain and protected against Zikavirus-induced blood-brain barrier injury. Our findings demonstrate how engineering strategies can be applied to develop peptide therapeutics and support the potential of a brain-penetrating peptide to treat neurotropic viral infections.
C1 [Jackman, Joshua A.; Park, Soohyun; Park, Jae Hyeon; Ferhan, Abdul Rahim; Yoon, Bo Kyeong; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.
   [Costa, Vivian V.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Immunopharmacol Lab, Belo Horizonte, MG, Brazil.
   [Costa, Vivian V.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Ctr Drug Res & Dev Pharmaceut, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   [Costa, Vivian V.; Moreira, Thaiane P.; Bambirra, Jordana L.; Queiroz, Victoria F.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Res Grp Arboviral Dis, Belo Horizonte, MG, Brazil.
   [Real, Ana Luiza C., V; Cardozo, Pablo L.; Olmo, Isabella G.; Ribeiros, Fabiola M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Neurobiochem Lab, Belo Horizonte, MG, Brazil.
   [Moreira, Thaiane P.; Bambirra, Jordana L.; Queiroz, Victoria F.; Souza, Danielle G.] Univ Fed Minas Gerais, Dept Microbiol, Host Interact Microorganism Lab, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   [Queiroz-Junior, Celso M.; Foureaux, Giselle] Univ Fed Minas Gerais, Cardiac Biol Lab, Dept Morphol, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   [Wynendaele, Evelien; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat Grp, Ghent, Belgium.
   [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.
RP Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.; Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore.
EM njcho@ntu.edu.sg
RI Cho, Nam-Joon/A-3475-2019; Ribeiro, Fabiola/E-8831-2013; Teixeira, Mauro
   M/A-4587-2008; Queiroz-Junior, Celso/L-5438-2013; Cardozo, Pablo
   Leal/V-8093-2019; Olmo, Isabella Guimaraes/W-5050-2019; Costa, Vivian
   VVC/I-2499-2018; Cho, Nam-Joon/J-7816-2012
OI Ribeiro, Fabiola/0000-0001-7042-9433; Teixeira, Mauro
   M/0000-0002-6944-3008; Queiroz-Junior, Celso/0000-0002-7884-7709;
   Cardozo, Pablo Leal/0000-0001-5877-9393; Olmo, Isabella
   Guimaraes/0000-0002-0007-3280; Costa, Vivian VVC/0000-0002-0175-642X;
   Cho, Nam-Joon/0000-0002-8692-8955; Park, Soohyun/0000-0003-3261-7585;
   Ferhan, Abdul Rahim/0000-0003-3238-3125
FU National Research Foundation of SingaporeSingapore National Research
   Foundation [NRF-NRFF2011-01, NRF-CRP10-2012-07, NRF2015NRF-POC0001-19];
   National Medical Research Council of SingaporeNational Medical Research
   Council, Singapore [NMRC/CBRG/0005/2012]; Centre for Precision Biology
   at Nanyang Technological UniversityNanyang Technological University;
   National Institute of Science and Technology in Dengue and
   Host-microorganism Interaction (INCT dengue) - Brazilian National
   Science Council (CNPq, Brazil); Minas Gerais Foundation for Science
   (FAPEMIG, Brazil)Minas Gerais State Research Foundation (FAPEMIG);
   Financiadora de Estudos ePesquisa (Brazil) [FINEP 01.16.0050.00];
   Comissao de Apoio a Pessoal de Ensino Superior (CAPES, Brazil);  [PP
   SUS: APQ-03744-17]
FX This work was supported by the National Research Foundation of Singapore
   through an NRF Fellowship grant (NRF-NRFF2011-01), a Competitive
   Research Programme grant (NRF-CRP10-2012-07) and a Proof-of-Concept
   grant (NRF2015NRF-POC0001-19), the National Medical Research Council of
   Singapore (NMRC/CBRG/0005/2012) and the Centre for Precision Biology at
   Nanyang Technological University. This work also received support from
   the National Institute of Science and Technology in Dengue and
   Host-microorganism Interaction (INCT dengue), which is a programme
   sponsored by the Brazilian National Science Council (CNPq, Brazil) and
   the Minas Gerais Foundation for Science (FAPEMIG, Brazil). This work
   also received support from Financiadora de Estudos ePesquisa (FINEP
   01.16.0050.00, Brazil), PP SUS: APQ-03744-17 and Comissao de Apoio a
   Pessoal de Ensino Superior (CAPES, Brazil). I. Marcal, T. Colina, G. dos
   Santos and F. Assis are acknowledged for technical assistance with
   experiments. The authors also acknowledge G. Batista Menezes and M. Mota
   Antunes for help with the acquisition of confocal microscopy images.
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Badani H, 2014, BBA-BIOMEMBRANES, V1838, P2180, DOI 10.1016/j.bbamem.2014.04.015
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cho NJ, 2007, J AM CHEM SOC, V129, P10050, DOI 10.1021/ja0701412
   Cho NJ, 2010, NAT PROTOC, V5, P1096, DOI 10.1038/nprot.2010.65
   Cho NJ, 2009, ACS CHEM BIOL, V4, P1061, DOI 10.1021/cb900149b
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dallmeier K, 2016, CELL HOST MICROBE, V20, P420, DOI 10.1016/j.chom.2016.09.011
   DiResta G, 1990, BRAIN EDEMA 8, P34
   Fenyk-Melody JE, 2004, COMPARATIVE MED, V54, P378
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Foureaux G, 2013, INVEST OPHTH VIS SCI, V54, P4296, DOI 10.1167/iovs.12-11427
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garton M, 2018, P NATL ACAD SCI USA, V115, P1505, DOI 10.1073/pnas.1711837115
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213
   Iwasaki A, 2017, TRENDS MOL MED, V23, P227, DOI 10.1016/j.molmed.2017.01.004
   Jackman JA, 2016, J AM CHEM SOC, V138, P1406, DOI 10.1021/jacs.5b12491
   Jackman JA, 2015, SMALL, V11, P2372, DOI 10.1002/smll.201403638
   Jackman JA, 2014, LANGMUIR, V30, P2152, DOI 10.1021/la404582n
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauson AJ, 2015, J AM CHEM SOC, V137, P16144, DOI 10.1021/jacs.5b10595
   Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saiz J.- C., 2017, ANTIMICROB AGENTS CH, V61, pe00411
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054
   St John AL, 2013, ELIFE, V2
   Stalmans S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139652
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
NR 43
TC 18
Z9 18
U1 12
U2 52
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD NOV
PY 2018
VL 17
IS 11
BP 971
EP +
DI 10.1038/s41563-018-0194-2
PG 13
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA GX8IQ
UT WOS:000448029000012
PM 30349030
DA 2020-07-08
ER

PT J
AU Olson, D
   Rick, AM
   Krager, S
   Lamb, M
   Asturias, EJ
AF Olson, Daniel
   Rick, Anne-Marie
   Krager, Steven
   Lamb, Molly
   Asturias, Edwin J.
TI Vaccine Demand and Willingness-to-pay for Arbovirus Vaccines: A
   Cross-sectional Survey in Rural Guatemala
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE arbovirus; dengue; Zika; chikungunya; vaccine acceptability; vaccine
   attitudes
ID DENGUE VACCINE; CHIKUNGUNYA VIRUS; ACCEPTANCE; HESITANCY; INDONESIA;
   AMERICA; URBAN; ACEH
AB Background: Arboviruses including dengue (DENV), chikungunya (CHIKV) and Zika cause significant morbidity in Latin America. With multiple arbovirus vaccines in development, better understanding of community attitudes and acceptability for these vaccines is needed.
   Methods: In September 2016, a cross-sectional survey assessed arbovirus knowledge, attitudes, vaccine demand and willingness-to-pay (WTP) at the conclusion of a DENV/norovirus surveillance study in rural Guatemala with high arbovirus endemicity. Factors associated with vaccine demand and WTP were assessed with regression analysis.
   Results: Among 564 surveyed households, DENV knowledge was high. There was great concern for arboviruses, particularly CHIKV. Overall vaccine attitudes were positive with <5% identifying significant barriers, hesitancy or refusing previous vaccination. At 50% and 75% efficacy, 75% and 88% of respondents wanted arbovirus vaccines, respectively. DENV vaccine demand at 50% efficacy was associated with increased housing density, nonhealth postvaccination location, older children and medical source for information. For each vaccine, 52-55% of respondents were WTP $0-$3.40, while 16-17% were WTP $6.81. WTP at $3.40 and $6.81 levels for all vaccines was associated positively with parental education but negatively with good DENV knowledge. History of purchasing and identifying barriers to vaccines was associated with WTP $6.81.
   Conclusions: Demand for potential DENV, CHIKV and Zika vaccines is high at 50% and 75% efficacy in this Guatemalan community. Associated factors could be leveraged to optimize arbovirus vaccine implementation. Overall low WTP given current cost of Dengvaxia (Sanofi Pasteur, Lyon, France) suggests that government subsidization may be necessary in resource-poor regions, though a small private market may be supported.
C1 [Olson, Daniel; Rick, Anne-Marie; Lamb, Molly; Asturias, Edwin J.] Univ Colorado, Sch Publ Hlth, Ctr Global Hlth, Aurora, CO USA.
   [Olson, Daniel; Asturias, Edwin J.] Childrens Hosp Colorado, Div Pediat Infect Dis, Aurora, CO USA.
   [Olson, Daniel; Rick, Anne-Marie; Asturias, Edwin J.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA.
   [Krager, Steven; Lamb, Molly; Asturias, Edwin J.] Univ Colorado, Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA.
RP Olson, D; Asturias, EJ (corresponding author), Ctr Global Hlth, 13199 East Montview Blvd,Suite 310, Aurora, CO 80045 USA.
EM Olson@childrenscolorado.org; Edwin.asturias@ucdenver.edu
RI ; Asturias, Edwin/D-9842-2016
OI Rick, Anne-Marie/0000-0002-8166-1198; Asturias,
   Edwin/0000-0002-1275-0787
FU Takeda PharmaceuticalsTakeda Pharmaceutical Company Ltd
   [IISR-2014-100647]; National Institutes of Health (NIH)/National Center
   for Advancing Translational Sciences Colorado Clinical and Translational
   Science Institute [UL1 TR001082]; Children's Hospital of Colorado
   Research Scholar Award; NIH National Research Service AwardUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [T32 HP22240]; GlaxoSmithKline BiologicalsGlaxoSmithKline; Takeda
   Vaccines Inc.; Pantheryx Inc.
FX Supported by an Investigator-Initiated Sponsored Research Grant from
   Takeda Pharmaceuticals (grant number IISR-2014-100647); National
   Institutes of Health (NIH)/National Center for Advancing Translational
   Sciences Colorado Clinical and Translational Science Institute (grant
   number UL1 TR001082) to D.O.; and the Children's Hospital of Colorado
   Research Scholar Award to D.O. A.-M.R. is supported by NIH National
   Research Service Award T32 HP22240. Contents are the authors' sole
   responsibility and do not necessarily represent official National
   Institutes of Health view.; E.J.A. has served on an Advisory Board for
   Takeda Vaccines Inc. and is partially supported by research grants from
   GlaxoSmithKline Biologicals and Takeda Vaccines Inc. M.L. is partially
   supported by grants from GlaxoSmithKline Biologicals and Pantheryx Inc.
   D.O. is partially supported by a grant from Takeda Vaccines Inc. All
   authors have submitted the ICMJE Form for Disclosure of Potential
   Conflicts of Interest. Conflicts that the editors consider relevant to
   the content of the manuscript have been disclosed. The other authors
   have no conflicts of interest to disclose.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burchett HED, 2012, HEALTH POLICY PLANN, V27, pII5, DOI 10.1093/heapol/czs035
   Cáceres-Manrique Flor de María, 2009, Rev. salud pública, V11, P27
   Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/s0034-89102008000600003
   DelaFuente JP, 2016, PAED CHILD HEALT-CAN, V21, pE15, DOI 10.1093/pch/21.2.e15
   Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017
   Erasmus JH, 2016, J INFECT DIS, V214, pS488, DOI 10.1093/infdis/jiw271
   Garcia J, 2016, SEMANA EPIDEMIOLOGIC, P1
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadisoemarto PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002427
   Harapan H, 2017, ACTA TROP, V166, P249, DOI 10.1016/j.actatropica.2016.11.035
   Harapan H, 2016, ASIAN PAC J TROP MED, V9, P1092, DOI 10.1016/j.apjtm.2016.07.036
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Khan AA, 2015, VACCINE, V33, P5103, DOI 10.1016/j.vaccine.2015.08.014
   Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037
   Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Olson D, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx049
   Orozco M, 2015, SEMANA EPIDEMIOLOGIC, V28
   Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011
   Shapiro GK, 2018, VACCINE, V36, P660, DOI 10.1016/j.vaccine.2017.12.043
   Shuaib F, 2010, W INDIAN MED J, V59, P139
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2018, REV SAGE REC US DENG
   World Health Organization, DENG SEV DENG
   World Health Organization, SIT REP
   World Health Organization, VACC PIP TRACK DENG
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 36
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD NOV
PY 2018
VL 37
IS 11
BP 1184
EP 1189
DI 10.1097/INF.0000000000002169
PG 6
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA GX7SC
UT WOS:000447975400032
PM 30153226
DA 2020-07-08
ER

PT J
AU Morain, SR
   Eppes, CS
   Fisher, JW
   Bruce, CR
   Rac, M
   Aagaard, KM
   Lunstroth, R
   Fedson, S
   Dinesh, P
   Raphael, JL
AF Morain, Stephanie R.
   Eppes, Catherine S.
   Fisher, Joslyn W.
   Bruce, Courtenay R.
   Rac, Martha
   Aagaard, Kjersti M.
   Lunstroth, Rebecca
   Fedson, Savitri
   Dinesh, Pallavi
   Raphael, Jean L.
TI Stakeholder Insights from Zika Virus Infections in Houston, Texas, USA,
   2016-2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Review
ID UNITED-STATES
AB Responding to Zika virus infections in Houston, Texas, USA, presented numerous challenges across the health system. As the nation's fourth-largest city, in a subtropical region with high travel volume to Latin America and the Caribbean, Houston was an ideal location for studying experiences encountered by clinicians and public health officials as they responded to the Zika virus crisis. To identify the challenges encountered in the response and to explore strategies to improve future responses to emerging infectious diseases, we interviewed 38 key stakeholders who were clinical, scientific, operational, and public health leaders. From the responses, we identified 4 key challenges: testing, travel screening, patient demographics and immigration status, and insufficient collaboration (between public health officials and clinicians and among clinical providers). We also identified 5 strategic areas as potential solutions: improved electronic health record support, specialty centers and referral systems, standardized forms, centralized testing databases, and joint academic/public health task forces.
C1 [Morain, Stephanie R.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, One Baylor Plaza,Ste 310D, Houston, TX 77030 USA.
   [Eppes, Catherine S.; Fisher, Joslyn W.; Bruce, Courtenay R.; Rac, Martha; Aagaard, Kjersti M.; Fedson, Savitri; Dinesh, Pallavi; Raphael, Jean L.] Baylor Coll Med, Houston, TX 77030 USA.
   [Lunstroth, Rebecca] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA.
   [Bruce, Courtenay R.] Houston Methodist Hosp, Houston, TX USA.
RP Morain, SR (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, One Baylor Plaza,Ste 310D, Houston, TX 77030 USA.
EM stephanie.morain@bcm.edu
FU Texas Medical Center Health Policy Institute
FX This project was funded through a grant from the Texas Medical Center
   Health Policy Institute.
CR Arafat R, 2016, INT J INFECT DIS, V53, P72, DOI 10.1016/j.ijid.2016.11.182
   Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Boonstra A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-231
   Broome CV, 1998, EMERG INFECT DIS, V4, P358, DOI 10.3201/eid0403.980303
   Center for Disease Control and Prevention, 2015, PREGN WOM AN LAB EV
   Center for Disease Control and Prevention, 2015, CUM ZIK VIR DIS CAS
   Centers for Diease Control and Prevention, CDC UPD GUID PREGN W
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Fisher JW, 2009, WOMEN HEALTH ISS, V19, P3, DOI 10.1016/j.whi.2008.10.003
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Houston Airport System, MED KIT FACT SHEET
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Pan American Health Organization, 2015, ZIK CAS CONG SYNDR A
   Paules CI, 2017, ANN INTERN MED, V167, P805, DOI 10.7326/M17-2496
   Rac M, 2017, OBSTET GYNECOL, V129, p35S, DOI 10.1097/01.AOG.0000514332.47783.0f
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Saadi A, 2017, JAMA-J AM MED ASSOC, V318, P2079, DOI 10.1001/jama.2017.15714
   Texas Department of State Health Services, DONT GIV ZIK BIT CHA
   Van Beneden CA, 2016, MMWR-MORBID MORTAL W, V65, P75, DOI 10.15585/mmwr.su6503a11
   Wong AE, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.006
NR 21
TC 0
Z9 0
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2018
VL 24
IS 11
BP 2049
EP 2055
DI 10.3201/eid2411.172108
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GX4UO
UT WOS:000447732600011
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Delatorre, E
   Fernandez, J
   Bello, G
AF Delatorre, Edson
   Fernandez, Jorge
   Bello, Gonzalo
TI Investigating the Role of Easter Island in Migration of Zika Virus from
   South Pacific to AmericasNNN
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID OUTBREAK; BRAZIL
AB The role of Easter Island in the dissemination of Zika virus from the Pacific islands into the Americas remains unclear. We analyzed new Zika virus sequences from Eastern Island and found that Zika virus was independently disseminated from French Polynesia into the Americas and Easter Island at around the same time.
C1 [Delatorre, Edson; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Fernandez, Jorge] Publ Hlth Inst Chile, Santiago, Chile.
RP Delatorre, E (corresponding author), Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM delatorre.ioc@gmail.com
RI Delatorre, Edson/J-8330-2015; Bello, Gonzalo/E-6842-2013
OI Delatorre, Edson/0000-0002-5746-0820; 
FU Programa Nacional de Pos-Doutorado (PNPD)/CAPES in Brazil
FX E.D. is funded by a postdoctoral fellowship from the Programa Nacional
   de Pos-Doutorado (PNPD)/CAPES in Brazil.
CR Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
NR 10
TC 3
Z9 3
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2018
VL 24
IS 11
BP 2119
EP 2121
DI 10.3201/eid2411.180586
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GX4UO
UT WOS:000447732600033
PM 30334729
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Carvalho, AL
   Brites, C
   Taguchi, TB
   Pinho, SF
   Campos, G
   Lucena, R
AF de Carvalho, Alessandra Lemos
   Brites, Carlos
   Taguchi, Tania Barreto
   Pinho, Suely Fernandes
   Campos, Gubio
   Lucena, Rita
TI Congenital Zika Virus Infection with Normal Neurodevelopmental Outcome,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We describe a case of a 20-month-old girl with probable congenital Zika virus infection and normal neurodevelopment, despite microcephaly and abnormal neuroimaging. This case raises questions about early prognostic markers and draws attention to the need for investigation in suspected Zika cases, even if the child's early neurodevelopment is normal.
C1 [de Carvalho, Alessandra Lemos] SARAH Network Rehabil Hosp, Child Rehabil Ctr, Salvador Unit, Salvador, BA, Brazil.
   [Taguchi, Tania Barreto; Pinho, Suely Fernandes] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, Carlos; Campos, Gubio; Lucena, Rita] Univ Fed Bahia, Salvador, BA, Brazil.
RP de Carvalho, AL (corresponding author), SARAH Salvador Hosp, Av Tancredo Neves 2782, BR-41820900 Salvador, BA, Brazil.
EM alessandracarvalhoped@gmail.com
FU Coordination for the Improvement of Higher Education Personnel (CAPES),
   BrazilCAPES
FX No external funding was used for this study. G.C. received a "Zika fast
   track grant" provided by Coordination for the Improvement of Higher
   Education Personnel (CAPES), Brazil, to perform ELISA testing for Zika
   virus in the neonatal period. This institution had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of this manuscript. The other authors have no financial
   disclosures relevant to this article.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bayley N., 2005, BAYLEY SCALES INFANT
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
NR 10
TC 1
Z9 1
U1 0
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2018
VL 24
IS 11
BP 2128
EP 2130
DI 10.3201/eid2411.180883
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GX4UO
UT WOS:000447732600037
PM 30334734
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Campos, JLS
   Mongkolsapaya, J
   Screaton, GR
AF Campos, Jose Luis Slon
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
TI The immune response against flaviviruses
SO NATURE IMMUNOLOGY
LA English
DT Review
ID DENGUE VIRUS-INFECTION; WEST-NILE-VIRUS; CD8(+) T-CELLS;
   ANTIBODY-DEPENDENT ENHANCEMENT; JAPANESE ENCEPHALITIS-VIRUS; ORIGINAL
   ANTIGENIC SIN; ZIKA-VIRUS; STRUCTURAL BASIS; MONOCLONAL-ANTIBODIES;
   PROTECTIVE ROLE
AB Arthropod-borne flaviviruses are important human pathogens that cause a diverse range of clinical conditions, including severe hemorrhagic syndromes, neurological complications and congenital malformations. Consequently, there is an urgent need to develop safe and effective vaccines, a process requiring better understanding of the immunological mechanisms involved during infection. Decades of research suggest a paradoxical role of the immune response against flaviviruses: although the immune response is crucial for the control, clearance and prevention of infection, poor clinical outcomes are commonly associated with virus-specific immunity and immunopathogenesis. This relationship is further complicated by the high homology among viruses and the implication of cross-reactive immune responses in protection and pathogenesis. This Review examines the dual role of the adaptive immune response against flaviviruses, particularly emphasizing the most recent findings regarding cross-reactive T cell and antibody responses, and the effects that these concepts have on vaccine-development endeavors.
C1 [Campos, Jose Luis Slon; Mongkolsapaya, Juthathip] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
   [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford, England.
RP Screaton, GR (corresponding author), Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford, England.
EM gavin.screaton@medsci.ox.ac.uk
OI Screaton, Gavin/0000-0002-3549-4309; Slon Campos, Jose
   Luis/0000-0002-0012-5247
FU Wellcome Trust, UKWellcome Trust; Newton-Medical Research Council, UK;
   Wellcome TrustWellcome Trust
FX This work was supported by the Wellcome Trust, UK, and the
   Newton-Medical Research Council, UK. G.R.S. is supported as a Wellcome
   Trust Senior Investigator.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswas SM, 2009, J GEN VIROL, V90, P818, DOI 10.1099/vir.0.008045-0
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chuang YC, 2016, J IMMUNOL, V196, P1218, DOI 10.4049/jimmunol.1500057
   Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Crill WD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00334
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Ishikawa T, 2011, VACCINE, V29, P7444, DOI 10.1016/j.vaccine.2011.07.058
   Jain N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005329
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kohler S, 2012, EUR J IMMUNOL, V42, P2363, DOI 10.1002/eji.201142306
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   LINDENBACH BD, 2007, FIELDS VIROLOGY
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modis Y, 2014, CURR OPIN VIROL, V5, P34, DOI 10.1016/j.coviro.2014.01.009
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Phares TW, 2012, J VIROL, V86, P2416, DOI 10.1128/JVI.06797-11
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Qiu XD, 2018, NAT MICROBIOL, V3, P287, DOI 10.1038/s41564-017-0099-x
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SAGE Working Group on Dengue Vaccines and WHO Secretariat, 2016, SAGE M APR 2018
   Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006
   Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12
   Simmonds P., 2012, VIRUS TAXONOMY, P1003
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith SA, 2012, J VIROL, V86, P2665, DOI 10.1128/JVI.06335-11
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Talarico LB, 2017, EBIOMEDICINE, V20, P202, DOI 10.1016/j.ebiom.2017.04.033
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157
NR 125
TC 27
Z9 27
U1 2
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD NOV
PY 2018
VL 19
IS 11
BP 1189
EP 1198
DI 10.1038/s41590-018-0210-3
PG 10
WC Immunology
SC Immunology
GA GX3NT
UT WOS:000447632200014
PM 30333606
DA 2020-07-08
ER

PT J
AU Renner, M
   Flanagan, A
   Dejnirattisai, W
   Puttikhunt, C
   Kasinrerk, W
   Supasa, P
   Wongwiwat, W
   Chawansuntati, K
   Duangchinda, T
   Cowper, A
   Midgley, CM
   Malasit, P
   Huiskonen, JT
   Mongkolsapaya, J
   Screaton, GR
   Grimes, JM
AF Renner, Max
   Flanagan, Aleksandra
   Dejnirattisai, Wanwisa
   Puttikhunt, Chunya
   Kasinrerk, Watchara
   Supasa, Piyada
   Wongwiwat, Wiyada
   Chawansuntati, Kriangkrai
   Duangchinda, Thaneeya
   Cowper, Alison
   Midgley, Claire M.
   Malasit, Prida
   Huiskonen, Juha T.
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
   Grimes, Jonathan M.
TI Characterization of a potent and highly unusual minimally enhancing
   antibody directed against dengue virus
SO NATURE IMMUNOLOGY
LA English
DT Article
ID WEST-NILE-VIRUS; HUMAN NEUTRALIZING ANTIBODIES; ZIKA VIRUS; DEPENDENT
   ENHANCEMENT; ENVELOPE PROTEIN; MONOCLONAL-ANTIBODIES;
   ELECTRON-MICROSCOPY; CROSS-REACTIVITY; STRUCTURAL BASIS; DOMAIN-II
AB Dengue virus is a major pathogen, and severe infections can lead to life-threatening dengue hemorrhagic fever. Dengue virus exists as four serotypes, and dengue hemorrhagic fever is often associated with secondary heterologous infections. Antibody-dependent enhancement (ADE) may drive higher viral loads in these secondary infections and is purported to result from antibodies that recognize dengue virus but fail to fully neutralize it. Here we characterize two antibodies, 2C8 and 3H5, that bind to the envelope protein. Antibody 3H5 is highly unusual as it not only is potently neutralizing but also promotes little if any ADE, whereas antibody 2C8 has strong capacity to promote ADE. We show that 3H5 shows resilient binding in endosomal pH conditions and neutralizes at low occupancy. Immunocomplexes of 3H5 and dengue virus do not efficiently interact with Fc gamma receptors, which we propose is due to the binding mode of 3H5 and constitutes the primary mechanism of how ADE is avoided.
C1 [Renner, Max; Flanagan, Aleksandra; Huiskonen, Juha T.; Grimes, Jonathan M.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Dejnirattisai, Wanwisa; Supasa, Piyada; Wongwiwat, Wiyada; Cowper, Alison; Midgley, Claire M.; Mongkolsapaya, Juthathip; Screaton, Gavin R.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Puttikhunt, Chunya; Chawansuntati, Kriangkrai; Duangchinda, Thaneeya; Malasit, Prida] Mahidol Univ, Med Biotechnol Res Unit, Natl Ctr Genet Engn & Biotechnol, Fac Med,Siriraj Hosp, Bangkok, Thailand.
   [Puttikhunt, Chunya; Chawansuntati, Kriangkrai; Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Off Res & Dev, Dengue Hemorrhag Fever Res Unit, Fac Med,Siriraj Hosp, Bangkok, Thailand.
   [Kasinrerk, Watchara] Chiang Mai Univ, Biomed Technol Res Ctr, Natl Ctr Genet Engn & Biotechnol, Chiang Mai, Thailand.
   [Kasinrerk, Watchara] Chiang Mai Univ, Fac Associated Med Sci, Div Clin Immunol, Dept Med Technol, Chiang Mai, Thailand.
   [Grimes, Jonathan M.] Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England.
RP Grimes, JM (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England.; Mongkolsapaya, J; Screaton, GR (corresponding author), Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford, England.; Mongkolsapaya, J (corresponding author), Mahidol Univ, Off Res & Dev, Dengue Hemorrhag Fever Res Unit, Fac Med,Siriraj Hosp, Bangkok, Thailand.; Grimes, JM (corresponding author), Diamond Light Source Ltd, Div Sci, Didcot, Oxon, England.
EM juthathip.mongkolsapaya@well.ox.ac.uk; gavin.screaton@medsci.ox.ac.uk;
   jonathan@strubi.ox.ac.uk
RI Huiskonen, Juha T/C-3043-2008
OI Huiskonen, Juha T/0000-0002-0348-7323; Screaton,
   Gavin/0000-0002-3549-4309; Renner, Max/0000-0001-9885-8256
FU Wellcome Trust, UKWellcome Trust; Newton-Medical Research Council, UK
   [MR/NO12658/2]; National Institute for Health Research Oxford Biomedical
   Research Centre funding scheme; Thailand National Center for Genetic
   Engineering; and Biotechnology; Academy of FinlandAcademy of Finland;
   Office of the Higher Education Commission; Mahidol University under the
   National Research Universities Initiative; Research Chair Grant from the
   National Science and Technology Development Agency (NSTDA), Thailand;
   Faculty of Medicine Siriraj Hospital, Mahidol University
   [(IO)R015936005]; Wellcome TrustWellcome Trust [060208/Z/00/Z,
   093305/Z/10/Z, 075491/Z/04, 095541/Z/11/Z, 203224/Z/16/Z, 204703/Z/16/Z,
   080721/Z/06/Z]
FX This work was supported by the Wellcome Trust, UK; the Newton-Medical
   Research Council, UK (MR/NO12658/2); the National Institute for Health
   Research Oxford Biomedical Research Centre funding scheme; the Thailand
   National Center for Genetic Engineering; and Biotechnology, the Academy
   of Finland; the Office of the Higher Education Commission and Mahidol
   University under the National Research Universities Initiative; the
   Research Chair Grant from the National Science and Technology
   Development Agency (NSTDA), Thailand; and Faculty of Medicine Siriraj
   Hospital, Mahidol University, Grant Number (IO)R015936005. The OPIC
   electron microscopy facility was founded by a Wellcome Trust JIF award
   (060208/Z/00/Z) and is supported by a Wellcome Trust equipment grant
   (093305/Z/10/Z). The Wellcome Trust is also acknowledged for providing
   administrative support (Grant 075491/Z/04). G.R.S. is a Wellcome Trust
   senior investigator (095541/Z/11/Z and 203224/Z/16/Z). M.R. and A.F.
   were supported by Wellcome Trust fellowships (204703/Z/16/Z and
   080721/Z/06/Z). We thank A. Siebert for support with electron
   microscopy; T. Prommool and C. Tawilert for scale-up and purification of
   monoclonal antibodies; P. Keelapang for good advice on NT and ADE
   assays; and D. Bitto for assistance with cryo-EM sample preparation. We
   also thank the staff of the Diamond Light Source (proposal MX8423), and
   ESRF, K. Harlos, and T. Walter, for assistance with crystallization; and
   D. Stuart for scientific discussion.
CR Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Gallichotte EN, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006934
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   LOZZIO CB, 1973, J NATL CANCER I, V50, P535, DOI 10.1093/jnci/50.2.535
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   MORENS DM, 1987, MICROB PATHOGENESIS, V3, P231, DOI 10.1016/0882-4010(87)90056-8
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nettleship JE, 2008, PROTEIN EXPRES PURIF, V62, P83, DOI 10.1016/j.pep.2008.06.017
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   SIBER GR, 1993, J PEDIATR-US, V122, P204, DOI 10.1016/S0022-3476(06)80114-9
   Siegrist CA, 1998, VACCINE, V16, P1409, DOI 10.1016/S0264-410X(98)00100-5
   Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058
   Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023
   Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 63
TC 7
Z9 7
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD NOV
PY 2018
VL 19
IS 11
BP 1248
EP +
DI 10.1038/s41590-018-0227-7
PG 13
WC Immunology
SC Immunology
GA GX3NT
UT WOS:000447632200019
PM 30323338
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Nunes, RKV
   Martins, UN
   Brito, TB
   Nepel, A
   Costa, EV
   Barison, A
   Santos, RLC
   Cavalcanti, SCH
AF Nunes, Rafaela K. V.
   Martins, Ulisses N.
   Brito, Thaysnara B.
   Nepel, Angelita
   Costa, Emmanoel V.
   Barison, Andersson
   Santos, Roseli L. C.
   Cavalcanti, Socrates C. H.
TI Evaluation of (-)-borneol derivatives against the Zika vector, Aedes
   aegypti and a non-target species, Artemia sp.
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Dengue; Larvicidal activity; Microcephaly; Terpenes; QSAR; Borneol
   esters
ID STRUCTURE-TOXICITY RELATIONSHIPS; ESSENTIAL OILS; LARVICIDAL ACTIVITY;
   DIPTERA-CULICIDAE; MOSQUITO VECTORS; LARVAE; MONOTERPENES; DENGUE;
   DIFLUBENZURON; INSECTICIDES
AB Zika, dengue, and chikungunya are vector-borne diseases of pronounced concern transmitted by the mosquito Aedes aegypti Linn. (Diptera: Culicidae). The most important method to avoid outbreaks is to control mosquito spreading by the employment of insecticides and larvicides. Failure to control mosquito dispersal is mostly accounted to Ae. aegypti resistance to currently available larvicides and insecticides, encouraging the development of novel pesticides. In addition, the excessive use of larvicides poses serious threats to human health and the environment. Evaluation of natural products as larvicides in an attempt to overcome this situation is often found in the literature because products originated from nature are considered less toxic to non-target species and more eco-friendly. (-)-Borneol is a bicyclic monoterpene present in essential oils with moderate larvicidal activity. On account of these facts, it was of our interest to synthesize (-)-borneol ester derivatives aiming to study its structure-activity relationships against Ae. aegypti larvae. With the goal to estimate toxicity to a non-target species, evaluation of the lethal concentration 50% (LC50) on Artemia sp. (Artemiidae) and calculation of selectivity towards Ae. aegypti were carried out. The most potent derivative, (-)-Bornyl chloroacetate, exhibited the highest suitability index, demonstrating lower environmental toxicity than other borneol ester derivatives. A parabolic relationship between (-)-borneol esters larvicidal activity and partition coefficient (Log P) was achieved and a correlation equation obtained, validating the importance of lipophilicity to the larvicidal activity of these compounds.
C1 [Nunes, Rafaela K. V.; Martins, Ulisses N.; Brito, Thaysnara B.; Cavalcanti, Socrates C. H.] Univ Fed Sergipe, Med Chem Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
   [Nepel, Angelita; Barison, Andersson] Univ Fed Parana, Nucl Magnet Resonance Lab, Dept Chem, POB 19081, BR-81531990 Curitiba, PR, Brazil.
   [Costa, Emmanoel V.] Univ Fed Amazonas, Dept Chem, Inst Appl Sci, Manaus, Amazonas, Brazil.
   [Santos, Roseli L. C.] Univ Fed Sergipe, Parasitol Lab, Dept Morphol, BR-49100000 Sao Cristovao, SE, Brazil.
RP Cavalcanti, SCH (corresponding author), Univ Fed Sergipe, Med Chem Lab, Dept Pharm, BR-49100000 Sao Cristovao, SE, Brazil.
EM socratescavalcanti@yahoo.com.br
RI Santos, Roseli LC/F-1735-2015; Cavalcanti, Socrates/AAQ-7004-2020
OI Costa, Emmanoel/0000-0002-0153-822X
FU Brazilian National Scientific and Development Council (CNPq)
   [47601/2013-2]
FX The authors would like to acknowledge the Brazilian National Scientific
   and Development Council (CNPq) for supporting grant number 47601/2013-2.
   We also extend our gratefulness to Norberto Peporine Lopes and Jose
   Carlos Tomaz for mass spectra analyses.
CR Abe FR, 2014, J TOXICOL ENV HEAL A, V77, P37, DOI 10.1080/15287394.2014.865581
   Acerson MJ, 2015, TETRAHEDRON LETT, V56, P3277, DOI 10.1016/j.tetlet.2015.02.071
   Alencar EB, 2016, MED CHEM RES, V25, P2171, DOI 10.1007/s00044-016-1650-7
   Alves PB, 2007, J ESSENT OIL RES, V19, P89, DOI 10.1080/10412905.2007.9699236
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Catelan T. B. S., 2015, ADV INFECT DIS, V5, P48, DOI [10.4236/aid.2015.51005, DOI 10.4236/AID.2015.51005]
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cristani M, 2007, J AGR FOOD CHEM, V55, P6300, DOI 10.1021/jf070094x
   da Silva JJ, 2007, REV SOC BRAS MED TRO, V40, P612, DOI 10.1590/S0037-86822007000600002
   DEO P G, 1988, International Pest Control, V30, P118
   Finney D.T., 1971, PROBIT ANAL
   Marcelino PRF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187125
   Gamal Zakia A, 2012, J Egypt Soc Parasitol, V42, P1
   Gartenstein Simon, 2006, Australasian Journal of Ecotoxicology, V12, P83
   Gilliom J, 2017, 1291 US DEP INT US G, P1291
   Govindarajan M, 2018, ENVIRON SCI POLLUT R, V25, P10555, DOI 10.1007/s11356-018-1203-3
   Govindarajan M, 2018, ENVIRON SCI POLLUT R, V25, P10272, DOI 10.1007/s11356-017-8822-y
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   GROVER S, 1992, BIOCHEM BIOPH RES CO, V187, P1350, DOI 10.1016/0006-291X(92)90451-P
   Hansch C, 2009, EUR J MED CHEM, V44, P260, DOI 10.1016/j.ejmech.2008.02.040
   He K, 1997, PLANTA MED, V63, P158, DOI 10.1055/s-2006-957635
   KIVIRANTA J, 1993, ENVIRON TOXIC WATER, V8, P63, DOI 10.1002/tox.2530080107
   La Corte R, 2018, REV SOC BRAS MED TRO, V51, P284, DOI 10.1590/0037-8682-0449-2017
   Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019
   Lee SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23980-5
   Lewis DFV, 2004, XENOBIOTICA, V34, P501, DOI 10.1080/00498250410001691316
   Lopez MD, 2010, IND CROP PROD, V31, P284, DOI 10.1016/j.indcrop.2009.11.005
   Lu Y, 2013, ADV MATER RES-SWITZ, V726-731, P230, DOI 10.4028/www.scientific.net/AMR.726-731.230
   Lucia A, 2013, PARASITOL RES, V112, P4267, DOI 10.1007/s00436-013-3618-6
   Minguez L, 2016, ENVIRON SCI POLLUT R, V23, P4992, DOI 10.1007/s11356-014-3662-5
   Miron D, 2014, REV BRAS FARMACOGN, V24, P660, DOI 10.1016/j.bjp.2014.10.014
   Monnerat R., 2012, BIOASSAY, V7, P1, DOI DOI 10.14295/BA.V7.0.73
   Murugan K, 2007, BIORESOURCE TECHNOL, V98, P198, DOI 10.1016/j.biortech.2005.12.009
   Nanyonga S. K., 2013, African Journal of Pharmacy and Pharmacology, V7, P360
   Nascimento AMD, 2017, NEOTROP ENTOMOL, V46, P223, DOI 10.1007/s13744-016-0457-z
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Picollo MI, 2008, FITOTERAPIA, V79, P271, DOI 10.1016/j.fitote.2008.01.005
   Pirsaheb M, 2017, TOXIN REV, V36, P210, DOI 10.1080/15569543.2016.1269810
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Radwan M. A., 2008, International Journal of Tropical Insect Science, V28, P61, DOI 10.1017/S1742758408962366
   Rajeswary M, 2018, ENVIRON SCI POLLUT R, V25, P10307, DOI 10.1007/s11356-017-9093-3
   Rajkumar S, 2010, J ASIA-PAC ENTOMOL, V13, P107, DOI 10.1016/j.aspen.2010.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Shrivastava SR, 2017, ANN TROP MED PUBLIC, V10, P764, DOI 10.4103/1755-6783.213140
   Silva VB, 2017, J ARTHROPOD-BORNE DI, V11, P315
   Silva WJ, 2008, BIORESOURCE TECHNOL, V99, P3251, DOI 10.1016/j.biortech.2007.05.064
   Songa EA, 2016, TALANTA, V155, P289, DOI 10.1016/j.talanta.2016.04.046
   Stevenson PC, 2017, IND CROP PROD, V110, P2, DOI 10.1016/j.indcrop.2017.08.034
   Vanhaecke P., 1981, REPORT INTERCALIBRAT, V106, P359
   Vehovszky A, 2015, AQUAT TOXICOL, V167, P172, DOI 10.1016/j.aquatox.2015.08.009
   Santos VSV, 2017, J TOXICOL ENV HEAL A, V80, P155, DOI 10.1080/15287394.2016.1266721
   Volpe PLO, 1997, J BRAZIL CHEM SOC, V8, P1, DOI 10.1590/S0103-50531997000400005
   Weerasinghe AJ, 2015, INT J PHARM PHARM SC, V7, P459
   YOURNO J, 1981, BLOOD, V58, P939
NR 69
TC 1
Z9 1
U1 4
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD NOV
PY 2018
VL 25
IS 31
SI SI
BP 31165
EP 31174
DI 10.1007/s11356-018-2809-1
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GW8IQ
UT WOS:000447220700038
PM 30187415
DA 2020-07-08
ER

PT J
AU Souza, GK
   Schuquel, ITA
   Moura, VM
   Belloto, AC
   Chiavelli, LUR
   Ruiz, ALTG
   Shiozawa, L
   de Carvalho, JE
   Garcia, FP
   Kaplum, V
   Rodrigues, JHD
   Scariot, DB
   Delvecchio, R
   Machado-Ferreira, E
   Santana, R
   Soares, CAG
   Nakamura, CV
   Santin, SMD
   Pomini, AM
AF Souza, Gredson Keiff
   Albrecht Schuquel, Ivania Teresinha
   Moura, Vagner Marques
   Belloto, Andrezza Correia
   Rovigatti Chiavelli, Lucas Ulisses
   Tasca Gois Ruiz, Ana Lucia
   Shiozawa, Larissa
   de Carvalho, Joao Ernesto
   Garcia, Francielle Pelegrin
   Kaplum, Vanessa
   da Silva Rodrigues, Jean Henrique
   Scariot, Debora Botura
   Delvecchio, Rodrigo
   Machado-Ferreira, Erik
   Santana, Renato
   Gomes Soares, Carlos Augusto
   Nakamura, Celso Vataru
   de Oliveira Santin, Silvana Maria
   Pomini, Armando Mateus
TI X-ray structure of O-methyl-acrocol and anti-cancer, anti-parasitic,
   anti-bacterial and anti-Zika virus evaluations of the Brazilian palm
   tree Acrocomia totai (vol 109, pg 483, 2017)
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Correction
C1 [Souza, Gredson Keiff; Albrecht Schuquel, Ivania Teresinha; Moura, Vagner Marques; Belloto, Andrezza Correia; Rovigatti Chiavelli, Lucas Ulisses; de Oliveira Santin, Silvana Maria; Pomini, Armando Mateus] Univ Estadual Maringa, Dept Chem, Maringa, Parana, Brazil.
   [Tasca Gois Ruiz, Ana Lucia; Shiozawa, Larissa; de Carvalho, Joao Ernesto] Univ Estadual Campinas, CPQBA, Div Pharmacol & Toxicol, Sao Paulo, Brazil.
   [de Carvalho, Joao Ernesto] Univ Estadual Campinas, Fac Pharmaceut Sci, Sao Paulo, Brazil.
   [Garcia, Francielle Pelegrin; Kaplum, Vanessa; da Silva Rodrigues, Jean Henrique; Scariot, Debora Botura; Nakamura, Celso Vataru] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.
   [Delvecchio, Rodrigo; Machado-Ferreira, Erik; Santana, Renato; Gomes Soares, Carlos Augusto] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
RP Pomini, AM (corresponding author), Univ Estadual Maringa, Dept Chem, Maringa, Parana, Brazil.
EM ampomini@uem.br
RI de Oliveira Santin, Silvana Maria/AAD-8707-2019; Pomini, Armando
   M/P-1277-2018; Ruiz, Ana Lucia Tasca Gois/C-2249-2012; Garcia,
   Francielle Pelegrin/L-7691-2018; Souza, Gredson Keiff/G-2558-2016
OI Ruiz, Ana Lucia Tasca Gois/0000-0002-0844-8702; Garcia, Francielle
   Pelegrin/0000-0001-8966-9154; Souza, Gredson Keiff/0000-0001-9724-1131
CR Souza GK, 2017, IND CROP PROD, V109, P483, DOI 10.1016/j.indcrop.2017.08.066
NR 1
TC 0
Z9 0
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD NOV 1
PY 2018
VL 123
BP 808
EP 808
DI 10.1016/j.indcrop.2018.07.018
PG 1
WC Agricultural Engineering; Agronomy
SC Agriculture
GA GW6VZ
UT WOS:000447103900085
OA Bronze
DA 2020-07-08
ER

PT J
AU Vivekanandhan, P
   Deepa, S
   Kweka, EJ
   Shivakumar, MS
AF Vivekanandhan, Perumal
   Deepa, Selvaraj
   Kweka, Eliningaya J.
   Shivakumar, Muthugoundar Subramanian
TI Toxicity of Fusarium oxysporum-VKFO-01 Derived Silver Nanoparticles as
   Potential Inseciticide Against Three Mosquito Vector Species (Diptera:
   Culicidae)
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Fusarium oxysporum-VKFO-01; PCR; 18s rDNA; Phylogenetic analysis;
   Mosquito control; Silver nanoparticle
ID AEDES-AEGYPTI; BIOLOGICAL SYNTHESIS; BIOSYNTHESIS; FABRICATION; INDICA
AB Mosquitoes are important public health pest transmitting major diseases such as dengue, malaria, zika and chikungunya. In the current study, isolation and identification of an entomopathogenic fungus was confirmed using 18s rDNA sequencing analysis. Silver nanoparticles were synthesized using Fusarium oxysporum-VKFO-01 culture filtrate with silver nitrate and green synthesized AgNPs were tested on larvae of Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus. Fusarium oxysporum-VKFO-01 culture filtrate derived synthesized AgNPs were characterized using, UV-Vis spectroscopy, FT-IR, EDaX, XRD, SEM, TEM and AFM analysis. Larvicidal bioassay results show that strong mortality produced by F. oxysporum-VKFO-01 derived AgNPs. LC50 and LC90 values in An. stephensi, 69.985-401.639 mu g/ml; Ae. aegypti, 42.942-272.842 mu g/ml and Cx. quinquefasciatus, 97.557-706.962 mu g/ml respectively. The present study shows that F. oxysporum-VKFO-01 derived green AgNPs are very effective against An. stephensi, Ae. aegypti and Cx. quinquefasciatus mosquito larvae. Phylogenetic construction of 18s rDNA sequence was done for finding the taxonomic identification and the evolutionary steps of isolated Fusarium sp. Our evaluation highlighted those F. oxysporum-VKFO-01 culture filtrate mediated synthesized silver nanoparticles as a very effective green pesticide for control of mosquitoes.
C1 [Vivekanandhan, Perumal; Deepa, Selvaraj; Shivakumar, Muthugoundar Subramanian] Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem 636011, Tamil Nadu, India.
   [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, POB 3024, Arusha, Tanzania.
   [Kweka, Eliningaya J.] Catholic Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, POB 1464, Mwanza, Tanzania.
RP Shivakumar, MS (corresponding author), Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem 636011, Tamil Nadu, India.
EM skentomology@gmail.com
RI Shivakumar, Muthugounder S./AAD-6241-2019; Perumal,
   Vivekanandhan/H-2783-2017
OI Perumal, Vivekanandhan/0000-0002-3283-1306; Shivakumar, Muthugounder
   S/0000-0002-1910-5510
FU Periyar University [PU/AD-3/URF/16169/2016]
FX One author is grateful to Periyar University for providing financial
   support under University Research Fellowship Scheme (Ref No.
   PU/AD-3/URF/16169/2016). We also thank the Institute of Vector Control
   and Zoonoses (IVCZ), Hosur, Tamil Nadu for supplying mosquito larvae. We
   acknowledge the help rendered by Karunya University for EDaX, SEM and
   AFM analysis also thank to STIC (Sophisticated test and instrumentation
   center) Cochin, India for their help in TEM analysis.
CR Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Babu MMG, 2009, COLLOID SURFACE B, V74, P191, DOI 10.1016/j.colsurfb.2009.07.016
   Banu AN, 2014, PARASITOL RES, V113, P311, DOI 10.1007/s00436-013-3656-0
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   GARDNER JM, 1987, MYCOPATHOLOGIA, V97, P77, DOI 10.1007/BF00436841
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V162, P646, DOI 10.1016/j.jphotobiol.2016.07.036
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Karthik S, 2017, RSC ADV, V7, P41763, DOI 10.1039/c7ra05697d
   Ramkumar G, 2015, PARASITOL RES, V114, P2553, DOI 10.1007/s00436-015-4459-2
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   Shankar SS, 2004, NAT MATER, V3, P482, DOI 10.1038/nmat1152
   Soni N, 2015, INT J PHARMACEUT, V5, P398
   Soni N, 2013, ADV NANOPART, V2, P125, DOI DOI 10.4236/ANP.2013.22021
   Soni N, 2014, ANN MICROBIOL, V64, P1099, DOI 10.1007/s13213-013-0749-z
   Sowndarya P, 2017, ARTIF CELL NANOMED B, V45, P1490, DOI 10.1080/21691401.2016.1252383
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002
   Vivekanandhan P, 2018, PATHOG GLOB HEALTH, V112, P37, DOI 10.1080/20477724.2018.1438228
   Vivekanandhan P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030440
   Vivekanandhan P, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020388
   Wei XT, 2014, J CHEM TECHNOL BIOT, V89, P305, DOI 10.1002/jctb.4124
   World Health Organisation, 2010, GLOB INF SYST ALC HL
   World Health Organization (WHO), 2005, COMM DIS CONTR PREV
NR 30
TC 5
Z9 5
U1 0
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD NOV
PY 2018
VL 29
IS 6
BP 1139
EP 1149
DI 10.1007/s10876-018-1423-1
PG 11
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA GW2HU
UT WOS:000446704800026
DA 2020-07-08
ER

PT J
AU Karthiga, P
   Rajeshkumar, S
   Annadurai, G
AF Karthiga, Perumal
   Rajeshkumar, Shanmugam
   Annadurai, Gurusamy
TI Mechanism of Larvicidal Activity of Antimicrobial Silver Nanoparticles
   Synthesized Using Garcinia mangostana Bark Extract
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article
DE Aedes aegypti; AgNPs; Phyto-synthesis; Bark; Agarose gel electrophoresis
ID NONTARGET AQUATIC ORGANISMS; MOSQUITO-BORNE DISEASES; GREEN SYNTHESIS;
   LEAF EXTRACT; CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI;
   DIPTERA-CULICIDAE; AEDES-AEGYPTI; ZIKA VIRUS; MALARIA
AB In this present investigation, we used an inexpensive method for the synthesis of silver nanoparticles (AgNPs) using Garcinia mangostana bark. The phyto-assisted AgNPs further characterized using scanning electron microscope for morphology and the elemental composition was detected via energy dispersive X-ray analysis. The domain size was characterized with the help of X-ray diffraction and UV-Vis spectrophotometric analysis for surface plasmon resonance. The possible functional groups were identified with the help of Fourier transform infrared spectroscopy. Antibacterial properties of nanoparticles were evaluated against Escherichia coli, Bacillus subtilis, Staphylococcus aureus, Bacillus cereus and Klebsiella pneumoniae, using agar well diffusion method. Ultimately, the mosquitocidal activity of silver nanoparticles was assessed in the laboratory against fourth instar larvae of Aedes aegypti with LC50 of 5.93 mg L-1 which shows the potential larvicidal effect. To find out the mode of action for larvicidal activity, Agarose gel electrophoresis was carried out. We hypothesize that the toxicity of AgNPs against dengue vectors may be attributed to the small size of these AgNPs, which allows passage through the insect cuticle and into individual cells where they interfere with molting and other physiological processes.
C1 [Karthiga, Perumal] Manonmaniam Sundaranar Univ, Dept Chem, Tirunelveli 627012, TN, India.
   [Rajeshkumar, Shanmugam] SIMATS, Saveetha Dent Coll & Hosp, Madras 600077, TN, India.
   [Karthiga, Perumal; Annadurai, Gurusamy] Manonmaniam Sundaranar Univ, Sriparamakalyani Ctr Environm Sci, Alwarkurichi, TN, India.
RP Karthiga, P (corresponding author), Manonmaniam Sundaranar Univ, Dept Chem, Tirunelveli 627012, TN, India.; Rajeshkumar, S (corresponding author), SIMATS, Saveetha Dent Coll & Hosp, Madras 600077, TN, India.; Karthiga, P; Annadurai, G (corresponding author), Manonmaniam Sundaranar Univ, Sriparamakalyani Ctr Environm Sci, Alwarkurichi, TN, India.
EM karthibiotec@gmail.com; ssrajeshkumar@hotmail.com;
   annananoteam@gmail.com
RI Shanmugam, Rajeshkumar/M-1748-2017
OI Shanmugam, Rajeshkumar/0000-0001-7059-8894
CR Alaqad K, 2016, J ENV ANAL TOXICOL, DOI [10. 4172/2161-0525. 1000384, DOI 10.4172/2161-0525.1000384, 10.4172/2161-0525.1000384]
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Bindhu MR, 2015, SPECTROCHIM ACTA A, V135, P373, DOI 10.1016/j.saa.2014.07.045
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Das M K, 2003, J Vector Borne Dis, V40, P100
   Elumalai E. K., 2010, J PHARM SCI RES, V2, P549
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Himalayan B, 2000, FITOTERAPIA, V71, P553, DOI [10.1016/S0367-326X(00)00164-7, DOI 10.1016/S0367-326X(00)00164-7]
   Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Malarkodi C, 2017, FOOD CONTROL, V80, P11, DOI 10.1016/j.foodcont.2017.04.023
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   PEREZ C, 1990, Acta Biologiae et Medicinae Experimentalis, V15, P113
   Philip D, 2011, PHYSICA E, V43, P1318, DOI 10.1016/j.physe.2010.10.006
   Rajesh S, 2012, CARBOHYD POLYM, V96, P1, DOI [10.1007/s13204-012-0125-5, DOI 10.1007/S13204-012-0125-5]
   Rajeshkumar S, 2013, PHARM CHEM, V5, P224
   Rao P., 2014, INT J MULTIDISCIP CU, V2, P165
   Roopan SM, 2013, IND CROP PROD, V43, P631, DOI 10.1016/j.indcrop.2012.08.013
   Rudramurthy GR, 2016, MOLECULES, V21, DOI 10.3390/molecules21070836
   Shukla MK, 2012, BIORESOURCE TECHNOL, V107, P295, DOI 10.1016/j.biortech.2011.11.092
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Stevenson PC, 2017, IND CROP PROD, V110, P2, DOI 10.1016/j.indcrop.2017.08.034
   Vanaja M., 2013, Advances in Applied Science Research, V4, P50
   Vankar PS, 2011, APPL NANOSCI, DOI [10.1007/s13204-011-0051-y, DOI 10.1007/S13204-011-0051-Y]
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Veerasamy R, 2011, J SAUDI CHEM SOC, V15, P113, DOI 10.1016/j.jscs.2010.06.004
   Nguyen VQ, 2013, J NANOMATER, V2013, DOI 10.1155/2013/693486
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   World Health Organization, 2005, WHOCDSWHOPESGCDPP3
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 52
TC 4
Z9 4
U1 0
U2 17
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD NOV
PY 2018
VL 29
IS 6
BP 1233
EP 1241
DI 10.1007/s10876-018-1441-z
PG 9
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA GW2HU
UT WOS:000446704800037
DA 2020-07-08
ER

PT J
AU Zhao, YN
   Cao, XZ
   Guo, MZ
   Wang, XS
   Yu, T
   Ye, LQ
   Han, L
   Hei, L
   Tao, WY
   Tong, YM
   Xu, YF
   Zhong, J
AF Zhao, Yanan
   Cao, Xuezhi
   Guo, Mingzhe
   Wang, Xuesong
   Yu, Tao
   Ye, Liqing
   Han, Lin
   Hei, Lei
   Tao, Wanyin
   Tong, Yimin
   Xu, Yongfen
   Zhong, Jin
TI Neuralized E3 Ubiquitin Protein Ligase 3 Is an Inducible Antiviral
   Effector That Inhibits Hepatitis C Virus Assembly by Targeting Viral E1
   Glycoprotein
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE antiviral; E1; hepatitis C virus; NEURL3; virus assembly
ID INNATE IMMUNITY; PATTERN-RECOGNITION; HUMAN LIVER; IN-VITRO; INFECTION;
   REPLICATION; BINDING; PLAYS; INFLAMMATION; COMPLEXES
AB Hepatitis C virus (HCV) infection is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV can be sensed by host innate immunity to induce expression of interferons (IFNs) and a number of antiviral effectors. In this study, we found HCV infection induced the expression of neuralized E3 ubiquitin protein ligase 3 (NEURL3), a putative E3 ligase, in a manner that requires the involvement of innate immune sensing but is independent of the IFN action. Furthermore, we showed that NEURL3 inhibited HCV infection while it had little effect on other RNA viruses, including Zika virus (ZIKV), dengue virus (DENV), and vesicular stomatitis virus (VSV). Mechanistic studies demonstrated that NEURL3 inhibited HCV assembly by directly binding HCV envelope glycoprotein E1 to interfere with the E1/E2 heterodimerization, an important prerequisite for virion morphogenesis. Finally, we showed that knockout of NEURL3 significantly enhanced HCV infection. In summary, we identified NEURL3 as a novel inducible antiviral host factor that suppresses HCV assembly. Our results not only shed new insight into how host innate immunity acts against HCV but also revealed a new important biological function for NEURL3.
   IMPORTANCE The exact biological function of NEURL3, a putative E3 ligase, remains largely unknown. In this study, we found that NEURL3 could be upregulated upon HCV infection in a manner dependent on pattern recognition receptor-mediated innate immune response. NEURL3 inhibits HCV assembly by directly binding viral E1 envelope glycoprotein to disrupt its interaction with E2, an action that requires its Neuralized homology repeat (NHR) domain but not the RING domain. Furthermore, we found that NEURL3 has a pangenotypic anti-HCV activity and interacts with El of genotypes 2a, 1b, 3a, and 6a but does not inhibit other closely related RNA viruses, such as ZIKV, DENY, and VSV. To our knowledge, our study is the first report to demonstrate that NEURL3 functions as an antiviral host factor. Our results not only shed new insight into how host innate immunity acts against HCV, but also revealed a new important biological function for NEURL3.
C1 [Zhao, Yanan; Cao, Xuezhi; Guo, Mingzhe; Wang, Xuesong; Yu, Tao; Ye, Liqing; Han, Lin; Hei, Lei; Tao, Wanyin; Tong, Yimin; Xu, Yongfen; Zhong, Jin] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Viral Hepatitis, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
   [Zhao, Yanan; Guo, Mingzhe; Wang, Xuesong; Yu, Tao; Zhong, Jin] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Guo, Mingzhe; Ye, Liqing; Han, Lin; Zhong, Jin] ShanghaiTech Univ, Shanghai, Peoples R China.
RP Zhong, J (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Viral Hepatitis, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Zhong, J (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhong, J (corresponding author), ShanghaiTech Univ, Shanghai, Peoples R China.
EM jzhong@ips.ac.cn
RI Tao, Wanyin/AAR-9230-2020
OI Cao, Xuezhi/0000-0002-3602-4560
FU Chinese National 973 ProgramNational Basic Research Program of China
   [2015CB554300]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31670172, 31770189]; Strategic
   Priority Research Program of the Chinese Academy of SciencesChinese
   Academy of Sciences [XDPB03]; National Key Research and Development
   Program of China [2016YFC1200400]; National Sciences and Technology
   Major Projects for "Major New Drugs Innovation and Development"
   [2017ZX09101-005-001-005]
FX This study was supported by grants from the Chinese National 973 Program
   (2015CB554300), the National Natural Science Foundation of China
   (31670172), and the Strategic Priority Research Program of the Chinese
   Academy of Sciences (XDPB03) to J.Z., the National Key Research and
   Development Program of China (2016YFC1200400) and the National Sciences
   and Technology Major Projects for "Major New Drugs Innovation and
   Development" (2017ZX09101-005-001-005) to Y.X., and the National Natural
   Science Foundation of China (31770189) to Y.T. The funders had no role
   in study design, data collection and analysis, the decision to publish,
   or preparation of the manuscript. We declare no conflicts of interest.
CR Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097
   Amet T, 2014, CURR MOL MED, V14, P349, DOI 10.2174/1566524013666131118111719
   Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756
   Boldanova T, 2017, EMBO MOL MED, V9, P816, DOI 10.15252/emmm.201607006
   Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240
   Bukong TN, 2013, HEPATOLOGY, V58, P1569, DOI 10.1002/hep.26500
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007
   Chatel-Chaix L, 2011, J VIROL, V85, P11022, DOI 10.1128/JVI.00719-11
   Dafa-Berger A, 2012, VIROLOGY, V428, P98, DOI 10.1016/j.virol.2012.03.011
   Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345
   Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   DUBUISSON J, 1994, J VIROL, V68, P6147, DOI 10.1128/JVI.68.10.6147-6160.1994
   Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673
   Hadac EM, 2004, VIROLOGY, V329, P217, DOI 10.1016/j.virol.2004.08.036
   He FH, 2009, J MOL BIOL, V393, P478, DOI 10.1016/j.jmb.2009.08.020
   Hei L, 2017, HEPATOLOGY, V65, P1478, DOI 10.1002/hep.29050
   Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100
   Hu Y, 2005, BIOCHEM BIOPH RES CO, V333, P253, DOI 10.1016/j.bbrc.2005.05.102
   Ishibashi M, 2010, BIOCHEM BIOPH RES CO, V392, P397, DOI 10.1016/j.bbrc.2010.01.034
   Kwon YC, 2013, FEBS LETT, V587, P156, DOI 10.1016/j.febslet.2012.11.010
   Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16
   Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32
   Liu SL, 2017, CELL SIGNAL, V29, P62, DOI 10.1016/j.cellsig.2016.10.004
   Pan XB, 2013, ANTIVIR RES, V98, P54, DOI 10.1016/j.antiviral.2013.01.009
   Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373
   Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11
   SCHOEPP RJ, 1984, J CLIN MICROBIOL, V20, P1017, DOI 10.1128/JCM.20.5.1017-1019.1984
   Shi XZ, 2017, J MED VIROL, V89, P2173, DOI 10.1002/jmv.24867
   Smith JB, 2002, AM J PHYSIOL-LUNG C, V283, pL636, DOI 10.1152/ajplung.00496.2001
   Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tao WY, 2009, VIROLOGY, V395, P67, DOI 10.1016/j.virol.2009.09.006
   Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005
   Tong YM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01411
   Tong YM, 2017, J VIROL, V91, DOI 10.1128/JVI.02468-16
   Tsuchiya M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-74
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770
   Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066
   Wong MT, 2016, CELL MOL IMMUNOL, V13, P11, DOI 10.1038/cmi.2014.127
   Xiang Y, 2015, J VIROL, V89, P6805, DOI 10.1128/JVI.00587-15
   Xu WT, 2016, GENE, V592, P215, DOI 10.1016/j.gene.2016.07.062
   Xu YF, 2016, CURR OPIN IMMUNOL, V42, P98, DOI 10.1016/j.coi.2016.06.009
   Yan Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02399-16
   Yang C, 2016, CELL MOL IMMUNOL, V13, P94, DOI 10.1038/cmi.2014.131
   Yang DR, 2015, WORLD J GASTROENTERO, V21, P3786, DOI 10.3748/wjg.v21.i13.3786
   Zhao YL, 2014, J IMMUNOL, V193, P783, DOI 10.4049/jimmunol.1302563
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
   Zhou LY, 2016, WORLD J GASTROENTERO, V22, P1477, DOI 10.3748/wjg.v22.i4.1477
   Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608
NR 52
TC 2
Z9 2
U1 0
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2018
VL 92
IS 21
AR e01123-18
DI 10.1128/JVI.01123-18
PG 19
WC Virology
SC Virology
GA GW7HZ
UT WOS:000447139100017
PM 30111563
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lei, YF
   Takeda, K
   Yu, L
AF Lei, Yingfen
   Takeda, Kazuyo
   Yu, Li
TI Impaired heterologous protein-protein interaction is an essential cause
   for non-viability of WNV/DENV recombinants
SO VIROLOGY
LA English
DT Article
DE Chimeric flavivirus; Intergenic recombination; Protein-protein
   interactions
ID WEST-NILE-VIRUS; DEPENDENT RNA-POLYMERASE; NONSTRUCTURAL PROTEINS;
   NS2B-NS3 PROTEASE; ZIKA VIRUS; FLAVIVIRUS VACCINES; MOLECULAR-BIOLOGY;
   VIRAL REPLICATION; GENOMIC RNA; DENGUE
AB Flavivirus RNA replication starts at 3'-end, where it folds into a highly conserved stem-loop structure. We attempted to identify the viral non-structural proteins (NSPs) that might specifically interact with the 3'-stemloop (3'SL) through a genetic approach. WNV/DENV2 chimeric recombinants that contain Dengue2 (DENV2) gene(s) in West Nile virus (WNV) backbone were tested for replication competence. Three of seven recombinant viruses, containing the DENV2 NS1, NS2A, or NS4B gene and terminated with a mutated 3'SL (MutC 3'SL), were viable. Of these three, only those bearing the DENV2 NS1 and NS2A substitutions remained infectious when the MutC 3'SL was replaced by the wildtype WNV 3'SL. However, none of the seven chimeric recombinants bearing the DENV2 3'SL were viable. We then investigated the causes for failed replication of WNV/DENV2 chimeric recombinants. Proteolytic cleavage of NS polyproteins was defective by heterologous protease NS2B/3, but was efficient by homologous DENV2 NS2B/3 protease. Whereas, the heterologous polyproteins that contained DENV2 homologous protease were found to produce abnormal vesicles. WNV/DENV2 recombinants expressing the DENV2 homologous protease did not produce infectious virus either. We examined NS protein-protein interaction (PPI) and found that heterologous PPI (hPPI) between WNV and DENV2 NSPs were impaired to various degrees. Insufficient PPIs occurred mainly between heterologous NS2B and NS3; NS2B and NS4A; NS3 and NS5, correlating to those non-viability of substitution mutants. Our results indicate that impaired PPI may decrease protease activity and affect vesicle formation, and is the essential cause for non-viability of the WNV/DENV2 recombinants.
C1 [Lei, Yingfen] US FDA, Lab Mol Virol, Ctr Biol Evaluat & Res, 1401 Rockville Pike, Rockville, MD 20852 USA.
   [Lei, Yingfen] Fourth Mil Med Univ, Dept Microbiol, 17 Changle Xilu, Xian 710032, Shaanxi, Peoples R China.
   [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core Facil, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
   [Yu, Li] US FDA, Div Viral Prod, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Yu, L (corresponding author), US FDA, Bldg 72,Room 5332,White Oak Campus, Silver Spring, MD 20993 USA.
EM li.yu@fda.hhs.gov
FU FDA internal funding for flavivirus vaccine research
FX We appreciate Drs. Lewis Markoff, Barry Falgout, and Steven Rubin
   (Division of Viral Products, Office of Vaccines Research and Review,
   CBER/FDA) for review of the manuscript. The research funding came from
   FDA internal funding for flavivirus vaccine research.
CR Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   Chin R, 2013, INFECT DIS THER, V2, P145, DOI 10.1007/s40121-013-0018-2
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   FREDERICK MA, 1995, CURRENT PROTOCOLS MO
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murphy BR, 2004, LANCET, V364, P499, DOI 10.1016/S0140-6736(04)16801-3
   MURPHY FA, 1995, VIRUS TAXONOMY CLASS, P415
   Phong WY, 2011, BIOSCIENCE REP, V31, P399, DOI 10.1042/BSR20100142
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Seligman SJ, 2004, LANCET, V363, P2073, DOI 10.1016/S0140-6736(04)16459-3
   Seligman SJ, 2008, J INFECT DIS, V198, P794, DOI 10.1086/590915
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005
   Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035
   Yu L, 2017, VIROLOGY, V506, P130, DOI 10.1016/j.virol.2017.03.016
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14586
   Zuo ZL, 2009, J VIROL, V83, P1060, DOI 10.1128/JVI.01325-08
   Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1
NR 44
TC 0
Z9 0
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD NOV
PY 2018
VL 524
BP 140
EP 150
DI 10.1016/j.virol.2018.08.013
PG 11
WC Virology
SC Virology
GA GV8SM
UT WOS:000446415700014
PM 30195251
OA Other Gold
DA 2020-07-08
ER

PT J
AU Wu, WH
   Wang, J
   Yu, N
   Yan, JY
   Zhuo, ZH
   Chen, MY
   Su, XS
   Fang, MJ
   He, SZ
   Zhang, SY
   Zhang, YJ
   Ge, SX
   Xia, NS
AF Wu, Wenhui
   Wang, Jin
   Yu, Nan
   Yan, Juying
   Zhuo, Zhihao
   Chen, Mengyuan
   Su, Xiaosong
   Fang, Mujin
   He, Shuizhen
   Zhang, Shiyin
   Zhang, Yanjun
   Ge, Shengxiang
   Xia, Ningshao
TI Development of multiplex real-time reverse-transcriptase polymerase
   chain reaction assay for simultaneous detection of Zika, dengue, yellow
   fever, and chikungunya viruses in a single tube
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE chikungunya; dengue; multiplex real-time reverse-transcriptase
   polymerase chain reaction; yellow fever; Zika
ID RT-PCR; CHINA
AB Zika virus (ZIKV), dengue virus (DENV), chikungunya virus (CHIKV) and yellow fever virus (YFV) share the same mosquito vectors and have similar clinical manifestations early stage of infection. Therefore, simultaneously differentiating these viruses from each other is necessary. We developed a multiplex real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assay for the differentiation of these four viruses in a single tube. The linear range was established by regression analysis, and the R-2 value for each viruswas 0.98, and the 95% lower limit of detectionfor each virus was as follows (copies/reaction): ZIKV-Asian, 9; ZIKV-Africa, 15; CHIKV, 11; DENV-1, 19; DENV-2, 13; DENV-3, 24; DENV-4, 36; and YFV, 17. Meanwhile, our multiplex real-time RT-PCR has a good consistency with the commercial singleplex assay. In summary, the developed assay can be effectively used for the diagnosis of ZIKV, DENV, CHIKV, and YFV infections.
C1 [Wu, Wenhui; Wang, Jin; Zhuo, Zhihao; Chen, Mengyuan; Su, Xiaosong; Fang, Mujin; Zhang, Shiyin; Ge, Shengxiang; Xia, Ningshao] Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.
   [Wu, Wenhui; Wang, Jin; Zhuo, Zhihao; Chen, Mengyuan; Su, Xiaosong; Fang, Mujin; Zhang, Shiyin; Ge, Shengxiang; Xia, Ningshao] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Peoples R China.
   [Yu, Nan] Southern Med Univ, Zhujiang Hosp, Ctr Clin Lab Diag, Guangzhou, Guangdong, Peoples R China.
   [Yan, Juying; Zhang, Yanjun] Zhejiang Ctr Dis Control & Prevent, Hangzhou 310009, Zhejiang, Peoples R China.
   [He, Shuizhen] Xiamen Ctr Dis Control & Prevent, Xiamen, Peoples R China.
RP Zhang, YJ (corresponding author), Zhejiang Ctr Dis Control & Prevent, Hangzhou 310009, Zhejiang, Peoples R China.; Zhang, SY; Ge, SX (corresponding author), Univ Xiamen, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiangan South Rd, Xiamen 361102, Fujian, Peoples R China.
EM zhangshiyin@xmu.edu.cn; yjzhang@cdc.zj.cn; sxge@xmu.edu.cn
RI Ge, Shengxiang/Q-2256-2019
OI Ge, Shengxiang/0000-0002-7165-3004; Xia, Ningshao/0000-0003-0179-5266
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81501835]; Science and Technology Major Project of the Fujian
   Province [3502Z20171001-20170302]; Natural Science Foundation of the
   Fujian ProvinceNatural Science Foundation of Fujian Province
   [2017J05136]
FX Natural Science Foundation of China, Grant/Award Number: 81501835;
   Science and Technology Major Project of the Fujian Province, Grant/Award
   Number: 3502Z20171001-20170302; Natural Science Foundation of the Fujian
   Province, Grant/Award Number: 2017J05136
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Collins ND, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0566-9
   Domingo C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0877-0
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1019-1
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Luo L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0352-9
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8
   Qiaoli Z, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0042830PMID:22916166
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang BH, 2018, J INFECTION, V76, P106, DOI 10.1016/j.jinf.2017.09.002
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 26
TC 6
Z9 7
U1 0
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD NOV
PY 2018
VL 90
IS 11
BP 1681
EP 1686
DI 10.1002/jmv.25253
PG 6
WC Virology
SC Virology
GA GU8VF
UT WOS:000445620200002
PM 29979812
OA Bronze
DA 2020-07-08
ER

PT J
AU Bharati, M
   Saha, D
AF Bharati, Minu
   Saha, Dhiraj
TI Assessment of insecticide resistance in primary dengue vector, Aedes
   aegypti (Linn.) from Northern Districts of West Bengal, India
SO ACTA TROPICA
LA English
DT Article
DE Aedes aegypti; Insecticide resistance; Insecticide detoxifying enzyme;
   Dengue; Vector control
ID ALBOPICTUS SKUSE; TEMEPHOS RESISTANCE; ESTERASE-ACTIVITY; CULICIDAE;
   DIPTERA; SUSCEPTIBILITY; MALATHION; ISLANDS; IDENTIFICATION; POPULATIONS
AB Aedes mosquitoes are the major vectors transmitting several arboviral diseases such as dengue, zika and chikungunya worldwide. Northern districts of West Bengal is home to several epidemics vectored by mosquito including dengue infections, proper control of which depends on efficient vector control. However the onset of insecticide resistance has resulted in failure of vector control approaches. This study was carried out to unveil the level of insecticide resistance prevailing among the primary dengue vector in this dengue endemic region of India. It was observed that, field caught populations of Ae. aegypti were moderately to severely resistant to majority of the insecticide classes tested, Le. Organochlorine (DDT), Organophosphates (temephos, malathion), Synthetic Pyrethroids (deltamethrin, lambdacyhalothrin and permethrin) and carbamate (propoxur). In majority of the populations, metabolic detoxification seemed to play the underlying role behind the development of insecticide resistance. This study seems to be the first report revealing the pattern of insecticide resistance in Ae. aegypti from Northern West Bengal. Efficient disease management in this region can only be achieved through proper insecticide resistance management. This study may help the concerned authorities in the formulation of an effective vector control strategy throughout this region incorporating the knowledge gained through this study.
C1 [Bharati, Minu; Saha, Dhiraj] Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, PO North Bengal Univ, Siliguri 734013, W Bengal, India.
RP Saha, D (corresponding author), Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, PO North Bengal Univ, Siliguri 734013, W Bengal, India.
EM dhirajsaha.nbu@gmail.com
FU University Grants Commission (UGC)University Grants Commission, India
   [2121430414, 21/12/2014]
FX The authors express their sincere thanks to the Head, Department of
   Zoology, University of North Bengal, for providing laboratory facilities
   and funds from the departmental budget allocation. The authors also
   express their sincere appreciation to those scientists and authors upon
   whose concepts, hypotheses and scientific contributions the present work
   has been formulated, experimented and results discussed. Thanks are also
   expressed to the University of North Bengal for providing uninterrupted
   LAN (Local Area Network) that has helped immensely in searching and
   collecting related information. The first author expresses sincere
   gratitude to University Grants Commission (UGC) for providing financial
   assistance throughout this work through award letterSr. no. 2121430414,
   Ref no.: 21/12/2014 (ii) EU-V, Dated 03/06/2015.
CR Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Bharati Minu, 2018, Proceedings of the Zoological Society (Calcutta), V71, P239, DOI 10.1007/s12595-016-0193-8
   Bharati M, 2017, ACTA TROP, V170, P112, DOI 10.1016/j.actatropica.2017.02.029
   Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Choovattanapakorn N., 2017, Medical Entomology and Zoology, V68, P19
   Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   FIELD WN, 1984, J MED ENTOMOL, V21, P412, DOI 10.1093/jmedent/21.4.412
   GEORGHIOU GP, 1980, J ECON ENTOMOL, V73, P301, DOI 10.1093/jee/73.2.301
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Grigoraki L, 2016, INSECT BIOCHEM MOLEC, V74, P61, DOI 10.1016/j.ibmb.2016.05.007
   Gupta N, 2012, INDIAN J MED RES, V136, P373
   Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kamgang B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2408-x
   Karunaratne SHPP, 2001, B WORLD HEALTH ORGAN, V79, P1060
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lima-Catelani ARD, 2004, BIOCHEM GENET, V42, P69
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Mohsin Muhammad, 2016, International Journal of Mosquito Research, V3, P41
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   National Vector Borne Disease Control Programme, 2017, NVBDCP DENG
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Paiva MHS, 2016, GENOMICS, V107, P40, DOI 10.1016/j.ygeno.2015.11.004
   Philbert A, 2014, ADV ENTOMOL
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Ranson H, 2010, TROP NET, V1, P2078
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   Saha D., 2014, THESIS
   Selvi S, 2010, TROP BIOMED, V27, P534
   Sharma S. N., 2004, Journal of Communicable Diseases, V36, P177
   Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3
   Thavaselvam D., 1993, Indian Journal of Malariology, V30, P75
   Gambarra WPT, 2013, REV SOC BRAS MED TRO, V46, P178, DOI 10.1590/0037-8682-1727-2013
   Tyagi B.K., 2015, INT J MOSQ RES B, V2, P50
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
   WHO, 1998, TEST PROC INREMO
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315
   WORLD HEALTH ORGANIZATION, 2006, WHOCDSNTDWHOPESGCDPP
   Yadav K, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0754-0
   Yu S.J., 2008, TOXICOLOGY BIOCH INS
NR 48
TC 6
Z9 6
U1 2
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2018
VL 187
BP 78
EP 86
DI 10.1016/j.actatropica.2018.07.004
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GU0HX
UT WOS:000444931500013
PM 30026024
DA 2020-07-08
ER

PT J
AU Stoddard, PK
AF Stoddard, Philip K.
TI Managing Aedes aegypti populations in the first Zika transmission zones
   in the continental United States
SO ACTA TROPICA
LA English
DT Article
DE Bti; Naled; Miami; Miami Beach; Vector control
ID THURINGIENSIS VAR. ISRAELENSIS; URBAN CULEX-MOSQUITOS; BLOOD MEAL
   DIGESTION; APPLIED ULV AEROSOLS; SURVIVAL RATES; INSECTICIDE RESISTANCE;
   BEHAVIORAL-RESPONSES; APPARENT INFLUENCE; RISK-ASSESSMENT; EFFICACY
AB The African Zika virus swept across the Pacific, reaching the New World in 2014. In July, 2016, Miami-Dade County, Florida became the locus of the first mosquito-borne Zika transmission zones in the continental United States. Control efforts were guided by the Centers for Disease Control and Prevention, including aerial and truck sprays of adulticides and larvicides. To improve our understanding of how best to fight Zika transmission in an urban environment in the developed world, trap counts of adult Aedes (Stegomyia) aegypti (L.) mosquitoes from the treatment zones were analyzed to determine efficacy of the different insecticide treatments. Analysis revealed that application of four different ester pyrethroid and one non-ester pyrethroid had no statistically significant effect on mosquito counts. Aerial application of naled, a potent organophosphate adulticide, produced significant but short-lived drops in Ae. aegypti counts in the first two applications in the first active transmission zone (Wynwood), then lost some efficacy with subsequent application. In the other active transmission zone (Miami Beach), naled produced no measurable effect in the first three applications, and only a small, transient, and marginally significant reduction in the fourth application. Repeated application of the larvicidal bacterium Bti was accompanied by steady declines of Ae. aegypti populations in both sites. Zika transmission ceased in the first transmission zone, but expanded in the second transmission zone during this period. Specific recommendations are proposed for future treatments of urban mosquitoes.
C1 [Stoddard, Philip K.] Florida Int Univ, Dept Biol Sci, 11200 SW 8th St, Miami, FL 33199 USA.
RP Stoddard, PK (corresponding author), Florida Int Univ, Dept Biol Sci, 11200 SW 8th St, Miami, FL 33199 USA.
EM stoddard@fiu.edu
CR Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Boisvert M, 2000, BIOCONTROL SCI TECHN, V10, P517, DOI 10.1080/095831500750016361
   Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6
   Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280
   Clark G. G, 1989, P 5 S ARB RES AUSTR, P192
   CLARK GG, 1994, J AM MOSQUITO CONTR, V10, P119
   Clarke F, 2016, SUMMARY REPORT AERIA
   Connelly C. R, 2016, CO064 IFAS U FLOR FL
   Cornel Anthony J, 2016, F1000Res, V5, P194, DOI 10.12688/f1000research.8107.2
   Costa R, 1998, CURR OPIN NEUROBIOL, V8, P659, DOI 10.1016/S0959-4388(98)80096-2
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   ELIASON DA, 1990, J AM MOSQUITO CONTR, V6, P371
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   Field LM, 2003, BIOL J LINN SOC, V79, P107, DOI 10.1046/j.1095-8312.2003.00178.x
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Flechas J, 2016, AERIAL SPRAYING ZIKA
   Florida Dept. Health Miami-Dade County, 2016, ZIK VIR MIAM DAD COU
   FOCKS DA, 1987, AM J TROP MED HYG, V36, P639, DOI 10.4269/ajtmh.1987.36.639
   Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Graham AS, 2011, EMERG INFECT DIS, V17, P2074, DOI 10.3201/eid1711.110419
   GRATZ NG, 1993, MED VET ENTOMOL, V7, P1, DOI 10.1111/j.1365-2915.1993.tb00644.x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Health Alert Network, 2016, CDCHAN00394
   Health Alert Network, 2016, CDCHAN00393
   Health Alert Network, 2016, CDCHAN00398
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hoang TC, 2015, SCI TOTAL ENVIRON, V502, P252, DOI 10.1016/j.scitotenv.2014.09.027
   Hoang TC, 2015, CHEMOSPHERE, V120, P714, DOI 10.1016/j.chemosphere.2014.10.040
   Jacups SP, 2013, AM J TROP MED HYG, V88, P490, DOI 10.4269/ajtmh.12-0385
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kongmee M, 2004, J MED ENTOMOL, V41, P1055, DOI 10.1603/0022-2585-41.6.1055
   Kyriacou CP, 2008, TRENDS GENET, V24, P124, DOI 10.1016/j.tig.2007.12.003
   Likos A, 2016, LOCAL MOSQUITO BORNE
   Macdonald G., 1952, Tropical Diseases Bulletin, V49, P569
   McKenna M, 2016, NATL GEOGR
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Mongkalangoon P, 2009, J VECTOR ECOL, V34, P217, DOI [10.1111/j.1948-7134.2009.00029.x, 10.3376/038.034.0207]
   MOORE CG, 1990, J AM MOSQUITO CONTR, V6, P376
   MOUNT GA, 1978, MOSQ NEWS, V38, P54
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Oppold A, 2015, ECOTOX ENVIRON SAFE, V122, P45, DOI 10.1016/j.ecoenv.2015.06.036
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Potikasikorn J, 2005, AM J TROP MED HYG, V73, P343, DOI 10.4269/ajtmh.2005.73.343
   Pruszynski C. A, 2017, PLOS ONE, V12, DOI [10.1371/joumal.pone.0170079, DOI 10.1371/JOUMAL.PONE.0170079]
   Purdham R. S, 1986, J ASS NURSE ANESTHET, V53, P240
   Rahman MM, 2010, J ECON ENTOMOL, V103, P1347, DOI 10.1603/EC09171
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Russell TL, 2003, J ECON ENTOMOL, V96, P1786, DOI 10.1603/0022-0493-96.6.1786
   Smith DI, 2012, PLOS PATHOG, V8, DOI [10.1371/journal.ppat.1002588.e1002588, DOI 10.1371/JOURNAL.PPAT.1002588.E1002588]
   Sokol R. R, 1981, BIOMETRY
   Staletovich J, 2016, MIAMI BEACH NIGHT LI
   Tetreau G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-248
   Vasquez C, 2016, SYNOPSIS ZIKA RESPON
   Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zucker JR, 1996, EMERG INFECT DIS, V2, P37, DOI 10.3201/eid0201.960104
   Zuur Alain F., 2009, P1
NR 70
TC 7
Z9 7
U1 1
U2 48
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2018
VL 187
BP 108
EP 118
DI 10.1016/j.actatropica.2018.07.031
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GU0HX
UT WOS:000444931500017
PM 30075097
DA 2020-07-08
ER

PT J
AU Pomar, L
   Vouga, M
   Lambert, V
   Pomar, C
   Hcini, N
   Jolivet, A
   Benoist, G
   Rousset, D
   Matheus, S
   Malinger, G
   Panchaud, A
   Carles, G
   Baud, D
AF Pomar, Leo
   Vouga, Manon
   Lambert, Veronique
   Pomar, Celine
   Hcini, Najeh
   Jolivet, Anne
   Benoist, Guillaume
   Rousset, Dominique
   Matheus, Severine
   Malinger, Gustavo
   Panchaud, Alice
   Carles, Gabriel
   Baud, David
TI Maternal-fetal transmission and adverse perinatal outcomes in pregnant
   women infected with Zika virus: prospective cohort study in French
   Guiana
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID INTERIM GUIDANCE; TERRITORIES; MANAGEMENT; SPECTRUM; SEQUELAE; INFANTS;
   RISK
AB OBJECTIVES
   To estimate the rates of maternal-fetal transmission of Zika virus, adverse fetal/neonatal outcomes, and subsequent rates of asymptomatic/symptomatic congenital Zika virus infections up to the first week of life.
   DESIGN
   Cohort study with prospective data collection and subsequent review of fetal/neonatal outcomes.
   SETTINGS
   Referral centre for prenatal diagnosis of the French Guiana Western Hospital.
   PARTICIPANTS
   Pregnant women at any stage of pregnancy with a laboratory confirmed symptomatic or asymptomatic Zika virus infection during the epidemic period in western French Guiana. The cohort enrolled 300 participants and prospectively followed their 305 fetuses/newborns.
   MAIN OUTCOME MEASURES
   Rate of maternal-fetal transmission of Zika virus (amniotic fluid, fetal and neonatal blood, urine, cerebrospinal fluid, and placentas); clinical, biological, and radiological outcomes (blindly reviewed); and adverse outcomes defined as moderate signs potentially related to congenital Zika syndrome (CZS), severe complications compatible with CZS, or fetal loss. Associations between a laboratory confirmed congenital Zika virus infection and adverse fetal/neonatal outcomes were evaluated.
   RESULTS
   Maternal-fetal transmission was documented in 26% (76/291) of fetuses/newborns with complete data. Among the Zika virus positive fetuses/ newborns, 45% (34/76) presented with no signs/ complications at birth, 20% (15/76) with moderate signs potentially related to CZS, 21% (16/76) with severe complications compatible with CZS, and 14% (11/76) with fetal loss. Compared with the Zika virus positive fetuses/neonates, those that were identified as negative for Zika virus (215/291) were less likely to present with severe complications (5%; 10/215) or fetal loss (0.5%; 1/215; relative risk 6.9, 95% confidence interval 3.6 to 13.3). Association between a positive Zika virus test and any adverse fetal/ neonatal outcome was also significant (relative risk 4.4, 2.9 to 6.6). The population attributable fraction estimates that a confirmed congenital Zika virus infection contributes to 47% of adverse outcomes and 61% of severe adverse outcomes observed.
   CONCLUSION
   In cases of a known maternal Zika virus infection, approximately a quarter of fetuses will become congenitally infected, of which a third will have severe complications at birth or fetal loss. The burden of CZS might be lower than initially described in South America and may not differ from other congenital infections.
C1 [Pomar, Leo; Vouga, Manon; Pomar, Celine; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofoetal & Obstet Res Unit, Lausanne, Switzerland.
   [Pomar, Leo; Lambert, Veronique; Pomar, Celine; Hcini, Najeh; Carles, Gabriel] Ctr Hosp Ouest Guyanais Franck Joly, Dept Obstet & Gynaecol, St Laurent Du Maroni, France.
   [Jolivet, Anne] Ctr Hosp Ouest Guyanais Franck Joly, Publ Hlth Dept, St Laurent Du Maroni, France.
   [Jolivet, Anne] Sorbonne Univ, UPMC, Univ Paris 06, INSERM,Dept Social Epidemiol,UMRS 1136,IPLESP, Paris, France.
   [Benoist, Guillaume] Univ Caen Normandie, Ctr Hosp Univ Caen, Serv Gynecol Obstet & Med Reprod, Caen, Basse Normandie, France.
   [Rousset, Dominique; Matheus, Severine] Inst Pasteur French Guiana, Natl Reference Ctr Arboviruses, Lab Virol, Cayenne, France.
   [Malinger, Gustavo] Lis Matern Hosp, Div Ultrasound Obstet & Gynecol, Tel Aviv, Israel.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Sourasky Med Ctr, Tel Aviv, Israel.
   [Panchaud, Alice] Lausanne Univ Hosp, Serv Clin Pharmacol, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Lausanne, Switzerland.
   [Panchaud, Alice] CHU Vaudois, Serv Pharm, Lausanne, Switzerland.
RP Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofoetal & Obstet Res Unit, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Panchaud, Alice/S-6535-2019; Rousset, Dominique/S-5400-2019
OI Panchaud, Alice/0000-0001-6086-2401; Rousset,
   Dominique/0000-0002-1473-3147; benoist, guillaume/0000-0002-1415-6474;
   Baud, David/0000-0001-9914-6496; Jolivet, Anne/0000-0001-6233-1225
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Agence regionale de sante, 2016, EM VIR ZIK AUX ANT G
   Agence regionale de sante, 2016, SURV VIR ZIK AUX ANT
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Charrier R, 2017, SYNTHESE DEMOGRAPHIQ
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Oliveira CIF, 2013, J PEDIATR GENET, V2, P85, DOI 10.3233/PGE-13052
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Lambert V, 2017, ULTRASOUND OBSTET S1, V50, P19
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leruez-Ville M, 2017, BEST PRACT RES CL OB, V38, P97, DOI 10.1016/j.bpobgyn.2016.10.005
   LERUEZVILLE M, 2016, AM J OBSTET GYNECOL, V215
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, DOI 10.1002/uog.17510
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodo C, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.022
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Smith GCS, 2017, BEST PRACT RES CL OB, V38, P71, DOI 10.1016/j.bpobgyn.2016.08.002
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
NR 35
TC 27
Z9 27
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD OCT 31
PY 2018
VL 363
AR k4431
DI 10.1136/bmj.k4431
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA GZ6PY
UT WOS:000449564200005
PM 30381296
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Terzian, ACB
   Zini, N
   Sacchetto, L
   Rocha, RF
   Parra, MCP
   Del Sarto, JL
   Dias, ACF
   Coutinho, F
   Rayra, J
   da Silva, RA
   Costa, VV
   Fernandes, NCCDA
   Ressio, R
   Diaz-Delgado, J
   Guerra, J
   Cunha, MS
   Catao-Dias, JL
   Bittar, C
   Reis, AFN
   dos Santos, INP
   Ferreira, ACM
   Cruz, LEAA
   Rahal, P
   Ullmann, L
   Malossi, C
   de Araujo, JP
   Widen, S
   de Rezende, IM
   Mello, E
   Pacca, CC
   Kroon, EG
   Trindade, G
   Drumond, B
   Chiaravalloti-Neto, F
   Vasilakis, N
   Teixeira, MM
   Nogueira, ML
AF Terzian, Ana Carolina B.
   Zini, Nathalia
   Sacchetto, Livia
   Rocha, Rebeca Froes
   Pereira Parra, Maisa Carla
   Del Sarto, Juliana Lemos
   Fialho Dias, Ana Carolina
   Coutinho, Felipe
   Rayra, Jessica
   da Silva, Rafael Alves
   Costa, Vivian Vasconcelos
   Couto De Azevedo Fernandes, Natalia Coelho
   Ressio, Rodrigo
   Diaz-Delgado, Josue
   Guerra, Juliana
   Cunha, Mariana S.
   Catao-Dias, Jose Luiz
   Bittar, Cintia
   Negri Reis, Andreia Francesli
   Penha dos Santos, Izalco Nuremberg
   Marascalchi Ferreira, Andreia Cristina
   Arao Antonio Cruz, Lilian Elisa
   Rahal, Paula
   Ullmann, Leila
   Malossi, Camila
   de Araujo, Joao Pessoa, Jr.
   Widen, Steven
   de Rezende, Izabela Mauricio
   Mello, Erica
   Pacca, Carolina Colombelli
   Kroon, Erna Geessien
   Trindade, Giliane
   Drumond, Betania
   Chiaravalloti-Neto, Francisco
   Vasilakis, Nikos
   Teixeira, Mauro M.
   Nogueira, Mauricio Lacerda
TI Evidence of natural Zika virus infection in neotropical non-human
   primates in Brazil
SO SCIENTIFIC REPORTS
LA English
DT Article
ID YELLOW-FEVER; CALLITHRIX-JACCHUS; MODEL; IDENTIFICATION; TRANSMISSION;
   CHIKUNGUNYA; EMERGENCE; OUTBREAK; VIREMIA
AB In Africa, Old World Primates are involved in the maintenance of sylvatic circulation of ZIKV. However, in Brazil, the hosts for the sylvatic cycle remain unknown. We hypothesized that free-living NHPs might play a role in urban/periurban ZIKV dynamics, thus we undertook an NH P ZIKV investigation in two cities in Brazil. We identified ZIKV-positive NHPs and sequences obtained were phylogenetically related to the American lineage of ZIKV. Additionally, we inoculated four C. penicillata with ZIKV and our results demonstrated that marmosets had a sustained viremia. The natural and experimental infection of NHPs with ZIKV, support the hypothesis that NHPs may be a vertebrate host in the maintainance of ZIKV transmission/circulation in urban tropical settings. Further studies are needed to understand the role they may play in maintaining the urban cycle of the ZIKV and how they may be a conduit in establishing an enzootic transmission cycle in tropical Latin America.
C1 [Terzian, Ana Carolina B.; Zini, Nathalia; Pereira Parra, Maisa Carla; da Silva, Rafael Alves; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Sacchetto, Livia; de Rezende, Izabela Mauricio; Kroon, Erna Geessien; Trindade, Giliane; Drumond, Betania] Univ Fed Minas Gerais, Lab Virus, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Rocha, Rebeca Froes; Del Sarto, Juliana Lemos; Fialho Dias, Ana Carolina; Coutinho, Felipe; Rayra, Jessica; Costa, Vivian Vasconcelos; Teixeira, Mauro M.] Univ Fed Minas Gerais, Ctr Drug Res & Dev, Inst Ciencias Biol, Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Couto De Azevedo Fernandes, Natalia Coelho; Ressio, Rodrigo; Diaz-Delgado, Josue; Guerra, Juliana; Cunha, Mariana S.] IAL, Ave Dr Arnaldo,351-7 Andar,Sala 706, BR-01246000 Sao Paulo, SP, Brazil.
   [Catao-Dias, Jose Luiz] Univ Sao Paulo, FMVZ, LAPOCM, Lab Wildlife Comparat Pathol,Dept Pathol,Sch Vet, Ave Orlando Marques de Paiva 87, BR-05508270 Sao Paulo, SP, Brazil.
   [Bittar, Cintia; Rahal, Paula] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci, Dept Biol, Sao Jose Rio Preto IBILCE,UNESP, Rua Cristovao Colombo 2265, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
   [Negri Reis, Andreia Francesli; Penha dos Santos, Izalco Nuremberg; Marascalchi Ferreira, Andreia Cristina; Arao Antonio Cruz, Lilian Elisa] Epidemiol Surveillance Dept Sao Jose Do Rio Preto, Ave Romeu Strazzi 199, BR-15084010 Sao Jose Do Rio Preto, SP, Brazil.
   [Ullmann, Leila; Malossi, Camila; de Araujo, Joao Pessoa, Jr.] Sao Paulo State Univ Unesp, Inst Biotechnol, Alameda Tecomarias S-N, BR-18607440 Botucatu, SP, Brazil.
   [Widen, Steven] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Mello, Erica] Belo Horizonte Council, Ctr Controle Zoonoses, Rua Edna Quintel 173, BR-31270705 Belo Horizonte, MG, Brazil.
   [Pacca, Carolina Colombelli] Faceres Med Sch, Ave Anisio Haddad 6751, BR-15090305 Sao Jose Do Rio Preto, SP, Brazil.
   [Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Ave Dr Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Kroon, Erna/V-5444-2019; Nogueira, Mauricio L/B-7599-2012; Teixeira,
   Mauro M/A-4587-2008; Sacchetto, Livia/B-8841-2019; Rezende, Izabela
   Mauricio/AAL-5766-2020; Guerra, Juliana Mariotti/H-5310-2012; Rahal,
   Paula/D-3871-2012; CATAO-DIAS, JOSE LUIZ/C-4897-2012; Costa, Vivian
   VVC/I-2499-2018; Neto, Francisco Chiaravalloti/F-8006-2012; Bittar,
   Cintia/A-5042-2015; Fernandes, Natalia/H-4537-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Teixeira, Mauro
   M/0000-0002-6944-3008; Sacchetto, Livia/0000-0001-9716-6899; Rezende,
   Izabela Mauricio/0000-0003-2616-6300; Guerra, Juliana
   Mariotti/0000-0002-0326-7187; Rahal, Paula/0000-0001-5693-6148;
   CATAO-DIAS, JOSE LUIZ/0000-0003-2999-3395; Costa, Vivian
   VVC/0000-0002-0175-642X; Neto, Francisco
   Chiaravalloti/0000-0003-2686-8740; Bittar, Cintia/0000-0002-2048-4589;
   Fernandes, Natalia/0000-0003-4754-4200; Dantas Malossi,
   Camila/0000-0002-3841-2479
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1, 2015/12295-0,
   2014/23159-8]; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440593/2016-6]; INCT-Dengue; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES/Finance)
   [001]; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1U01AI115577]
FX We thank colleagues from Laboratorio de Virus and the team from
   Laboratorio de Zoonoses/Prefeitura de Belo Horizonte/MG. We thank Dr.
   Scott Weaver for critical reviewing of the manuscript. This work is
   supported by the Sao Paulo Research Foundation (FAPESP) via grants
   2013/21719-3 and 2016/15021-1 (MLN) and fellowships 2015/12295-0 (ACBT)
   and 2014/23159-8 (LSU). Additional support was provided by the FAPESP
   Zika Network, FAPEMIG (APQ01574-17), and CNPq (440593/2016-6) and
   INCT-Dengue. IMR and LS received fellowships from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES/Finance Code
   001). MLN and GST are CNPq Research Fellows. NV Zika work is supported
   by NIH grant 1U01AI115577 (NV).
CR Andrade EHP, 2016, AM J TROP MED HYG, V94, P1080, DOI 10.4269/ajtmh.15-0892
   [Anonymous], 2018, JORNAL BRASIL DESINF
   AUSUBEL FM, 2003, CURRENT PROTOCOLS MO
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   BrazilGovNews, 2017, BRAZILGOVNEWS
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007
   CHIU CY, 2017, SCI REP UK, V7
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004
   CONCEA, 2015, NORM CONCEA PROD MAN, P209
   Consoli R.A.G.B., 1998, PRINCIPAIS MOSQUITOS
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Mota MTD, 2016, BRAZ J MICROBIOL, V47, P38, DOI 10.1016/j.bjm.2016.10.008
   De Oliveira-Filho E. F, 2018, TRANSBOUND EMERG DIS, P1
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Dos Santos Marina Nogueira, 2014, Revista de Etologia, V13, P37
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Elias Colombo T, 2017, CLIN LAB VIROLOGICAL
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, BIORXIV, DOI [10.1101/049395, DOI 10.1101/049395]
   Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   FORATTINI O.P., 2002, CULICIDOLOGIA MED, V2
   Fragaszy D., 2004, COMPLETE CAPUCHIN BI
   Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Machado DC, 2012, INTERVIROLOGY, V55, P475, DOI 10.1159/000337166
   Mansfield K, 2003, COMPARATIVE MED, V53, P383
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Ministerio da Saude, 2017, INF ESP FEBR AM BRAS
   Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Omatsu T, 2012, J MED PRIMATOL, V41, P289, DOI 10.1111/j.1600-0684.2012.00552.x
   Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0
   Osuna CE, 2017, NAT MED, V23, P264, DOI 10.1038/nm0217-264b
   Rylands A. B., 2008, IUCN RED LIST THREAT
   SEFEROVIC M, 2018, SCI REP UK, V8
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasilakis N, 2008, AM J TROP MED HYG, V79, P128, DOI 10.4269/ajtmh.2008.79.128
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   WHO, 2017, DIS OUTBREAK NEWS
NR 64
TC 18
Z9 19
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 30
PY 2018
VL 8
AR 16034
DI 10.1038/s41598-018-34423-6
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY6SV
UT WOS:000448727000004
PM 30375482
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goldfarb, IT
   Jaffe, E
   James, K
   Lyerly, AD
AF Goldfarb, Ilona Telefus
   Jaffe, Elana
   James, Kaitlyn
   Lyerly, Anne Drapkin
TI Pregnant women's attitudes toward Zika virus vaccine trial participation
SO VACCINE
LA English
DT Article
DE Pregnancy; Zika virus; Vaccine research; Ethics
ID INFLUENZA; IMMUNIZATION
AB Introduction: As Zika virus infection during pregnancy can cause a range of congenital anomalies, pregnant women may be a target population for vaccination in future outbreaks. Their inclusion in vaccine trials is critical to ensure safe and effective vaccines in pregnancy. Though many vaccine candidates are in development, pregnant women's willingness to participate in Zika virus vaccine research is unknown. This study aims to describe pregnant women's attitudes toward Zika virus vaccine research participation, as well as perceived barriers to and facilitators of enrollment.
   Methods: Pregnant and recently postpartum women (n = 128) attending prenatal care at Massachusetts General Hospital completed surveys querying their willingness to participate in four hypothetical Zika virus vaccine trials and their motivations for participation. Demographics, information on prior Zika virus exposure, and vaccine acceptance were collected.
   Results: Most women (77%) accepted participation in at least one hypothetical Zika virus vaccine trial, and women were significantly more likely to accept prospective enrollment in an inactivated vaccine trial compared to a live-attenuated vaccine trial (p-value <0.0001) or a nucleic acid-based vaccine trial (p-value <0.0444). Important motivators for participation included evidence from research with pregnant and non-pregnant people, a desire to protect the baby from Zika, perceptions of vaccine safety, and provider recommendation.
   Conclusions: A majority of women in this cohort were willing to participate in a Zika virus vaccine trial while pregnant, however, differences in acceptance exist between vaccine platforms. The high value placed on evidence by participants highlights the importance of gathering and communicating pregnancy-specific data to potential research participants and their providers. Women's motivations for accepting research participation during pregnancy are important to inform the Zika virus vaccine research agenda, candidate prioritization, and trial design. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Goldfarb, Ilona Telefus] Massachusetts Gen Hosp, Dept Obstet & Gynecol, 55 Fruit St, Boston, MA 02114 USA.
   [Jaffe, Elana; Lyerly, Anne Drapkin] Univ N Carolina, Ctr Bioeth, Chapel Hill, NC USA.
   [Jaffe, Elana; Lyerly, Anne Drapkin] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA.
   [James, Kaitlyn] Massachusetts Gen Hosp, Deborah Kelly Ctr Outcomes Res, Dept Obstet & Gynecol, Boston, MA 02114 USA.
RP Goldfarb, IT (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, 55 Fruit St, Boston, MA 02114 USA.
EM igoldfarb@partners.org
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI108368]
FX This work was supported in part by the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health under award
   number R01AI108368. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health.
CR Alholm Z, 2017, OPEN FORUM INFECT DI, V4, DOI [10.1093/ofid/ofx163.1167, DOI 10.1093/OFID/OFX163.1167]
   Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Ding H, 2017, MMWR-MORBID MORTAL W, V66, P1016, DOI 10.15585/mmwr.mm6638a2
   Evans SC, 2015, INT J CLIN HLTH PSYC, V15, P160, DOI 10.1016/j.ijchp.2014.12.001
   Faden RR, 2017, VACCINE, V35, P6819, DOI 10.1016/j.vaccine.2017.09.065
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Fraiz LD, 2018, VACCINE, V36, P165, DOI 10.1016/j.vaccine.2017.11.021
   Goldfarb I, 2011, AM J OBSTET GYNECOL, V204, pS112, DOI 10.1016/j.ajog.2011.01.007
   Hombach J., UPDATE ZIKA VACCINES
   Lyerly AD, 2012, IRB ETHICS HUM RES, V34
   McQuaid F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010790
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Palmer S, 2016, J OBSTET GYNAECOL CA, V38, P945, DOI 10.1016/j.jogc.2016.04.100
   Ramirez R, 2015, FUTURES, V71, P70, DOI 10.1016/j.futures.2015.06.006
   Rodger MA, 2003, AM J PERINAT, V20, P69, DOI 10.1055/s-2003-38318
   Shavell VI, 2012, AM J OBSTET GYNECOL, V207, pS67, DOI 10.1016/j.ajog.2012.06.077
   Siedner MJ, 2018, LANCET PUBLIC HEALTH, V3, pE109, DOI 10.1016/S2468-2667(18)30029-X
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wiley KE, 2015, QUAL HEALTH RES, V25, P360, DOI 10.1177/1049732314551061
   Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046
   Wong LP, 2017, VACCINE, V35, P5912, DOI 10.1016/j.vaccine.2017.08.074
NR 22
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD OCT 29
PY 2018
VL 36
IS 45
BP 6711
EP 6717
DI 10.1016/j.vaccine.2018.09.042
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GZ5FH
UT WOS:000449444100019
PM 30268731
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wilk-da-Silva, R
   Diniz, MMCDL
   Marrelli, MT
   Wilke, ABB
AF Wilk-da-Silva, Ramon
   de Souza Leal Diniz, Morgana Michele Cavalcanti
   Marrelli, Mauro Toledo
   Bruno Wilke, Andre Barretto
TI Wing morphometric variability in Aedes aegypti (Diptera: Culicidae) from
   different urban built environments
SO PARASITES & VECTORS
LA English
DT Article
DE Wing geometric morphometrics; Urbanization; Dengue; Aedes aegypti
ID SAO-PAULO; IMMATURE MOSQUITOS; DENGUE VECTORS; DISEASE; GEOMETRY;
   TRANSMISSION; POPULATIONS; CHIKUNGUNYA; ISLANDS; BRAZIL
AB Background: Aedes aegypti is the main vector of the dengue, Zika and several other arboviruses. It is highly adapted to urbanized environments and can be found worldwide. Mosquito population control is considered the best strategy for fighting mosquito-borne diseases, making an understanding of their population dynamics vital for the development of more effective vector control programs. This study therefore sought to investigate how different levels of urbanization affect Aedes aegypti populations and modulate population structure in this species with the aid of wing geometric morphometrics.
   Methods: Specimens were collected from eleven locations in three areas with distinct levels of urbanization in the city of Sao Paulo, Brazil: conserved, intermediate and urbanized. The right wings of female mosquitoes collected were removed, and photographed and digitized. Canonical variate analysis and Mahalanobis distance were used to investigate the degree of wing-shape dissimilarity among populations. Thin-plate splines were calculated by regression analysis of Canonical Variation Analysis scores against wing-shape variation, and a cross-validated reclassification was performed for each individual; a neighbor-joining tree was then constructed.
   Results: Metapopulation and individual population analysis showed a clear segregation pattern in the Canonical Variation Analysis. Pairwise cross-validated reclassification yielded relatively high scores considering the microgeographical scale of the study and the fact that the study populations belong to the same species. The neighbor-joining tree showed that mosquitoes in the intermediate urban area segregated in the metapopulation and individual population analyses. Our findings show significant population structuring in Aedes aegypti mosquitoes in the areas studied. This is related to the different degrees of urbanization in the areas where the specimens were collected along with their geographical location.
   Conclusions: Urbanization processes in the study areas appear to play an important role in microevolutionary processes triggered by man-made modifications in the environment, resulting in a previously unknown population structuring pattern of major epidemiological importance.
C1 [Wilk-da-Silva, Ramon; de Souza Leal Diniz, Morgana Michele Cavalcanti; Marrelli, Mauro Toledo; Bruno Wilke, Andre Barretto] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.
   [Bruno Wilke, Andre Barretto] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
RP Marrelli, MT (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.
EM mmarelli@usp.br
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU State of Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/15313-4]; FAPESPFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/01172-5]
FX This study was supported by the State of Sao Paulo Research Foundation
   (FAPESP) (grant 2013/15313-4). RWS is the recipient of an MSc fellowship
   from FAPESP (2015/01172-5).
CR Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Wilke ABB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161643
   Cardo MV, 2015, J ASIA-PAC ENTOMOL, V18, P727, DOI 10.1016/j.aspen.2015.09.002
   Carvajal TM, 2016, J VECTOR DIS, V53, P127
   Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102
   Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1
   Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x
   Chintapalli RTV, 2016, J EXP BIOL, V219, P3945, DOI 10.1242/jeb.148254
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   Christe RD, 2016, INFECT GENET EVOL, V45, P434, DOI 10.1016/j.meegid.2016.10.007
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   de Carvalho GC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2348-5
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Forattini OP., 2002, CULICIDOLOGIA MED
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Gaspe MS, 2012, J MED ENTOMOL, V49, P504, DOI 10.1603/ME11176
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jian Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114301
   Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Matthys B, 2006, J VECTOR ECOL, V31, P319, DOI 10.3376/1081-1710(2006)31[319:UALUAC]2.0.CO;2
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002
   NATAL D, 1984, REV SAUDE PUBL, V18, P418, DOI 10.1590/S0034-89101984000500013
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y
   Rohlf F.J., 2006, TPSDIG DIGITIZE LAND
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Townroe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095325
   Vidal PO, 2012, MEM I OSWALDO CRUZ, V107, P1030, DOI 10.1590/S0074-02762012000800011
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   World Health Organization (WHO), 2012, DENG SEV DENG
NR 48
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 26
PY 2018
VL 11
DI 10.1186/s13071-018-3154-4
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GY2XL
UT WOS:000448407900002
PM 30367678
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Seferovic, M
   Sanchez-San Martin, C
   Tardif, SD
   Rutherford, J
   Castro, ECC
   Li, T
   Hodara, VL
   Parodi, LM
   Giavedoni, L
   Layne-Colon, D
   Tamhankar, M
   Yagi, S
   Martyn, C
   Reyes, K
   Suter, MA
   Aagaard, KM
   Chiu, CY
   Patterson, JL
AF Seferovic, Maxim
   Sanchez-San Martin, Claudia
   Tardif, Suzette D.
   Rutherford, Julienne
   Castro, Eumenia C. C.
   Li, Tony
   Hodara, Vida L.
   Parodi, Laura M.
   Giavedoni, Luis
   Layne-Colon, Donna
   Tamhankar, Manasi
   Yagi, Shigeo
   Martyn, Calla
   Reyes, Kevin
   Suter, Melissa A.
   Aagaard, Kjersti M.
   Chiu, Charles Y.
   Patterson, Jean L.
TI Experimental Zika Virus Infection in the Pregnant Common Marmoset
   Induces Spontaneous Fetal Loss and Neurodevelopmental Abnormalities (vol
   8, 6851, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Correction
C1 [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.
   [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Sanchez-San Martin, Claudia; Li, Tony; Martyn, Calla; Reyes, Kevin; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Tardif, Suzette D.; Hodara, Vida L.; Parodi, Laura M.; Giavedoni, Luis; Layne-Colon, Donna] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX 78245 USA.
   [Rutherford, Julienne] Univ Illinois, Dept Women Children & Family Hlth Sci, Chicago, IL 60612 USA.
   [Hodara, Vida L.; Parodi, Laura M.; Giavedoni, Luis; Tamhankar, Manasi; Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78245 USA.
   [Yagi, Shigeo] Calif Dept Publ Hlth, Richmond, CA 94804 USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA.
RP Aagaard, KM (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Baylor Coll Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.; Aagaard, KM (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Patterson, JL (corresponding author), Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78245 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA.
EM aagaardt@bcm.edu; charles.chiu@ucsf.edu; jpatters@txbiomed.org
CR Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
NR 1
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 26
PY 2018
VL 8
AR 16131
DI 10.1038/s41598-018-34068-5
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY3DG
UT WOS:000448426300001
PM 30367092
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shrivastava, S
   Puri, V
   Dilley, KA
   Ngouajio, E
   Shifflett, J
   Oldfield, LM
   Fedorova, NB
   Hu, LH
   Williams, T
   Durbin, A
   Amedeo, P
   Rashid, S
   Shabman, RS
   Pickett, BE
AF Shrivastava, Susmita
   Puri, Vinita
   Dilley, Kari A.
   Ngouajio, Erica
   Shifflett, Jessica
   Oldfield, Lauren M.
   Fedorova, Nadia B.
   Hu, Lihui
   Williams, Torrey
   Durbin, Alan
   Amedeo, Paolo
   Rashid, Sujatha
   Shabman, Reed S.
   Pickett, Brett E.
TI Whole genome sequencing, variant analysis, phylogenetics, and deep
   sequencing of Zika virus strains
SO SCIENTIFIC REPORTS
LA English
DT Article
ID STRONG PURIFYING SELECTION; POPULATION-DYNAMICS; MOSAIC STRUCTURE;
   RECOMBINATION; TRANSMISSION; MICRONESIA; INFECTION; INFERENCE; EPIDEMIC;
   OUTBREAK
AB The recent emergence of Zika virus (ZIKV) has been concentrated in the Caribbean, Southeastern United States, and South- and Central America; resulting in travel-based cases being reported around the globe. As multi-disciplinary collaborations are combatting the ZIKV outbreak, the need to validate the sequence of existing strains has become apparent. Here, we report high-quality sequence data for multiple ZIKV strains made publicly available through the National Institutes of Health- (NI H) funded biorepository, BEI Resources (www.beiresources.org ). Next-generation sequencing, 3' rapid amplification of cDNA ends (RACE), and viral genome annotation pipelines generated GenBank sequence records for 16 BEI Resources strains. Minor variants, consensus mutations, and consensus insertions/deletions were identified within the viral stocks using next-generation sequencing (NGS) and consensus changes were confirmed with Sanger sequencing. Bioinformatics analyses of the sequencing results confirm that the virus stocks available to the scientific research community through BEI Resources adequately represent the viral population diversity of ZIKV.
C1 [Shrivastava, Susmita; Puri, Vinita; Dilley, Kari A.; Ngouajio, Erica; Oldfield, Lauren M.; Fedorova, Nadia B.; Hu, Lihui; Amedeo, Paolo; Shabman, Reed S.; Pickett, Brett E.] J Craig Venter Inst, Rockville, MD 20850 USA.
   [Shifflett, Jessica; Rashid, Sujatha] ATCC, BEI Resources, Manassas, VA USA.
   [Williams, Torrey; Durbin, Alan] J Craig Venter Inst, La Jolla, CA USA.
   [Dilley, Kari A.] Sharp Edge Labs, Pittsburgh, PA USA.
   [Ngouajio, Erica] Univ Maryland, College Pk, MD 20742 USA.
   [Shabman, Reed S.] Amer Type Culture Collect, Manassas, VA USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.
EM bpickett@jcvi.org
OI Pickett, Brett/0000-0001-7930-8160
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110819, HHSN272201600013C]
FX We gratefully acknowledge Dr. Gene Tan for his input and insight into
   these sequencing experiments. This project has been funded in whole or
   part with federal funds from the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health, Department of Health
   and Human Services under Award Number U19AI110819. We also acknowledge
   the original depositors of viruses, which were then made available by
   BEI Resources. All BEI Resources reagents are made with federal funds
   from the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services under
   Contract Number HHSN272201600013C.
CR Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Anez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027459
   Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573
   Grinev A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004717
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003
   Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Organization W. H., 2016, ZIK SIT REP
   Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056
   Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   Rambaut A, 2014, TRACER V1 6
   SMITH JM, 1992, J MOL EVOL, V34, P126
   Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528
NR 38
TC 5
Z9 5
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 26
PY 2018
VL 8
AR 15843
DI 10.1038/s41598-018-34147-7
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY3BN
UT WOS:000448420700005
PM 30367096
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diop, F
   Vial, T
   Ferraris, P
   Wichit, S
   Bengue, M
   Hamel, R
   Talignani, L
   Liegeois, F
   Pompon, J
   Yssel, H
   Marti, G
   Misse, D
AF Diop, Fode
   Vial, Thomas
   Ferraris, Pauline
   Wichit, Sineewanlaya
   Bengue, Michele
   Hamel, Rodolphe
   Talignani, Ldic
   Liegeois, Florian
   Pompon, Julien
   Yssel, Hans
   Marti, Guillaume
   Misse, Dorothee
TI Zika virus infection modulates the metabolomic profile of microglial
   cells
SO PLOS ONE
LA English
DT Article
ID NERVOUS-SYSTEM; BRAIN; LYSOPHOSPHATIDYLCHOLINE; ACTIVATION; RECEPTOR;
   MACROPHAGES; MICRONESIA; ASYMMETRY; MECHANISM; ISCHEMIA
AB Zika virus (ZIKV) is an emerging arbovirus of the Flaviviridae family. Although infection with ZIKV generally leads to mild disease, its recent emergence in the Americas has been associated with an increase in the development of the Guillain-Barre syndrome in adults, as well as with neurological complications, in particular congenital microcephaly, in new-borns. To date, little information is available on neuroinflammation induced by ZIKV, notably in microglial cells in the context of their metabolic activity, a series of chemical transformations that are essential for their growth, reproduction, structural maintenance and environmental responses. Therefore, in the present study we investigated the metabolomic profile of ZIKV-infected microglia. Microglial cells were exposed to ZIKV at different time points and were analyzed by a Liquid Chromatography-High Resolution mass spectrometry-based metabolomic approach. The results show that ZIKV infection in microglia leads to modulation of the expression of numerous metabolites, including lysophospholipids, particulary Lysophosphatidylcholine, and phospholipids such as Phosphatidylcholine, Phosphatidylserine, Ceramide and Sphingomyelin, and carboxylicic acids as Undecanedioic and Dodecanedioic acid. Some of these metabolites are involved in neuronal differentiation, regulation of apoptosis, virion architecture and viral replication. ZIKV infection was associated with concomitant secretion of inflammatory mediators linked with central nervous system inflammation such as IL-6, TNF-alpha, IL-beta, iNOS and NO. It also resulted in the upregulation of the expression of the gene encoding CX3CR1, a chemokine receptor known to regulate functional synapse plasticity and signaling between microglial cells. These findings highlight an important role for microglia and their metabolites in the process of neuroinflammation that occurs during ZIKV pathogenesis.
C1 [Diop, Fode; Ferraris, Pauline; Bengue, Michele; Hamel, Rodolphe; Talignani, Ldic; Liegeois, Florian; Pompon, Julien; Misse, Dorothee] Univ Montpellier, CNRS, IRD, MIVEGEC UMR 224, Montpellier, France.
   [Vial, Thomas; Marti, Guillaume] Univ Toulouse, IRD, PHARMADEV UMR 152, Toulouse, France.
   [Wichit, Sineewanlaya] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Salaya, Nakhon Pathom, Thailand.
   [Yssel, Hans] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Ctr Immunol & Malad Infect,Inserm,U1135,UPMC, Paris, France.
RP Misse, D (corresponding author), Univ Montpellier, CNRS, IRD, MIVEGEC UMR 224, Montpellier, France.
EM dorothee.misse@ird.fr
RI Yvert, Blaise/E-9052-2016; Ferraris, Pauline/F-9077-2017; Hamel,
   Rodolphe/AAG-1714-2020; Marti, Guillaume/B-4395-2016
OI Yvert, Blaise/0000-0002-8850-7935; Ferraris,
   Pauline/0000-0002-8796-3074; Hamel, Rodolphe/0000-0001-8603-7039; Marti,
   Guillaume/0000-0002-6321-9005; Vial, Thomas/0000-0003-3347-7342
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-14-CE14-0029, ANR-15-CE15-00029]; European Union's Horizon 2020
   research and innovation programme under ZIKAlliance [734548];
   Infectiopole Sud foundation
FX This work was supported by grants from the Agence Nationale de la
   Recherche (grants ANR-14-CE14-0029 and ANR-15-CE15-00029), the European
   Union's Horizon 2020 research and innovation programme under ZIKAlliance
   grant agreement No. 734548. Fode Diop was supported by a fellowship from
   the Infectiopole Sud foundation.
CR Alexander JJ, 1998, NEUROCHEM RES, V23, P227, DOI 10.1023/A:1022441211177
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Arnoux I, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/689404
   Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459
   Besnard M, 2014, EURO SURVEILL B EUR, V19
   Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001
   Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   De Simone R, 2002, J NEUROPATH EXP NEUR, V61, P237, DOI 10.1093/jnen/61.3.237
   Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Glinton KE, 2018, MOL GENET METAB, V123, P309, DOI 10.1016/j.ymgme.2017.12.009
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105
   JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307
   Muramatsu R, 2015, J BIOL CHEM, V290, P11515, DOI 10.1074/jbc.M114.587253
   Nishiyama K, 2018, INT IMMUNOPHARMACOL, V55, P205, DOI 10.1016/j.intimp.2017.12.003
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.3.CO;2-N
   Pagani F, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00111, 10.3389/fncel.2015.00111]
   Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560
   Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0
   SUN GY, 1984, J NEUROCHEM, V43, P1081, DOI 10.1111/j.1471-4159.1984.tb12847.x
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tsugawa H, 2016, ANAL CHEM, V88, P7946, DOI 10.1021/acs.analchem.6b00770
   Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393
   Werneburg S, 2017, CURR OPIN NEUROBIOL, V47, P138, DOI 10.1016/j.conb.2017.10.002
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113
   Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063
NR 50
TC 7
Z9 7
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 25
PY 2018
VL 13
IS 10
AR e0206093
DI 10.1371/journal.pone.0206093
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GY3GT
UT WOS:000448438400044
PM 30359409
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Amin, ND
   Pasca, SP
AF Amin, Neal D.
   Pasca, Sergiu P.
TI Building Models of Brain Disorders with Three-Dimensional Organoids
SO NEURON
LA English
DT Review
ID PLURIPOTENT STEM-CELLS; ZIKA VIRUS-INFECTION; AUTISM SPECTRUM DISORDERS;
   HUMAN CEREBRAL ORGANOIDS; MILLER-DIEKER-SYNDROME; OUTER RADIAL GLIA;
   NEUROPSYCHIATRIC DISORDERS; BIPOLAR DISORDER; CORTICAL DEVELOPMENT;
   NEURAL PROGENITORS
AB Disorders of the nervous system are challenging to study and treat due to the relative inaccessibility of functional human brain tissue for research. Stem cell-derived 3D human brain organoids have the potential to recapitulate features of the human brain with greater complexity than 2D models and are increasingly being applied to model diseases affecting the central nervous system. Here, we review the use of human brain organoids to investigate neurological and psychiatric (neuropsychiatric) disorders and how this technology may ultimately advance our biological understanding of these conditions.
C1 [Amin, Neal D.; Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
RP Pasca, SP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.
EM spasca@stanford.edu
OI Pasca, Sergiu/0000-0002-3216-3248
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Alda M, 2015, MOL PSYCHIATR, V20, P661, DOI 10.1038/mp.2015.4
   Allende ML, 2018, J LIPID RES, V59, P550, DOI 10.1194/jlr.M081323
   [Anonymous], 2017, LANCET NEUROL, V16, P857, DOI 10.1016/S1474-4422(17)30338-1
   Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017
   Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021
   Ben-David U, 2017, NAT GENET, V49, P1567, DOI 10.1038/ng.3967
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923
   Bian S, 2018, NAT METHODS, V15, P631, DOI 10.1038/s41592-018-0070-7
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Birnbaum R, 2017, NAT REV NEUROSCI, V18, P727, DOI 10.1038/nrn.2017.125
   Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y
   Bley AE, 2011, PEDIATRICS, V128, pE1233, DOI 10.1542/peds.2011-0078
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027
   Braun U, 2018, NEURON, V97, P14, DOI 10.1016/j.neuron.2017.11.007
   Bredenoord AL, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9414
   Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915
   Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chandler CH, 2013, TRENDS GENET, V29, P358, DOI 10.1016/j.tig.2013.01.009
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Curatolo P, 2015, LANCET NEUROL, V14, P733, DOI 10.1016/S1474-4422(15)00069-1
   Dakic V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12779-5
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dehaene-Lambertz G, 2015, NEURON, V88, P93, DOI 10.1016/j.neuron.2015.09.026
   Demjaha A, 2012, SCHIZOPHRENIA BULL, V38, P209, DOI 10.1093/schbul/sbr100
   Deng WL, 2018, STEM CELL REP, V10, P2005, DOI 10.1016/j.stemcr.2018.05.012
   Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034
   Drouin-Ouellet J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00530
   Drummond E, 2017, ACTA NEUROPATHOL, V133, P155, DOI 10.1007/s00401-016-1662-x
   Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626
   Dulla K, 2018, MOL THER-NUCL ACIDS, V12, P730, DOI 10.1016/j.omtn.2018.07.010
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Farahany NA, 2018, NATURE, V556, P429, DOI 10.1038/d41586-018-04813-x
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023
   Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954
   Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003
   Gordon JA, 2016, NAT NEUROSCI, V19, P1385, DOI 10.1038/nn.4419
   Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593
   Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2
   Hoffman GE, 2019, MOL PSYCHIATR, V24, P49, DOI 10.1038/s41380-018-0029-1
   Hornykiewicz O, 2010, J NEUROL, V257, pS249, DOI 10.1007/s00415-010-5741-y
   Huh CJ, 2016, ELIFE, V5, DOI [10.7554/elife.18648, 10.7554/eLife.18648]
   Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135
   Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Insel TR, 2013, NEURON, V80, P561, DOI 10.1016/j.neuron.2013.09.041
   Jennings C, 2016, NAT NEUROSCI, V19, P1123, DOI 10.1038/nn.4362
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403
   Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Kuwahara A, 2017, METHODS MOL BIOL, V1597, P17, DOI 10.1007/978-1-4939-6949-4_2
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lavazza A, 2018, J MED ETHICS, V44, P606, DOI 10.1136/medethics-2017-104555
   Lawson CA, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S85354
   Lee CT, 2017, NEUROPSYCHOPHARMACOL, V42, P774, DOI 10.1038/npp.2016.156
   Lewitus E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00424
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008
   Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014
   Lord C, 2018, LANCET, V392, P508, DOI 10.1016/S0140-6736(18)31129-2
   Lu JF, 2016, NAT BIOTECHNOL, V34, P89, DOI 10.1038/nbt.3435
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008
   Marthiens V, 2010, J CELL SCI, V123, P1613, DOI 10.1242/jcs.054312
   Martin KR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15816
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mertens J, 2015, CELL STEM CELL, V17, P705, DOI 10.1016/j.stem.2015.09.001
   Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526
   Mitchell PB, 2000, B WORLD HEALTH ORGAN, V78, P515
   Moon HM, 2013, WIRES DEV BIOL, V2, P229, DOI 10.1002/wdev.67
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005
   Nicodemus KK, 2010, HUM GENET, V127, P441, DOI 10.1007/s00439-009-0782-y
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ogura T, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162214
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021
   Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157
   Pham MT, 2018, NEUROREPORT, V29, P588, DOI 10.1097/WNR.0000000000001014
   Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009
   Rice GI, 2015, J CLIN IMMUNOL, V35, P235, DOI 10.1007/s10875-015-0147-3
   Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x
   Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x
   SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]
   Seo J, 2017, J NEUROSCI, V37, P9917, DOI 10.1523/JNEUROSCI.0621-17.2017
   Shimada H, 2017, CELL REP, V20, P384, DOI 10.1016/j.celrep.2017.06.045
   Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Smoller JW, 2019, MOL PSYCHIATR, V24, P409, DOI 10.1038/s41380-017-0010-4
   Soliman MA, 2017, MOL PSYCHIATR, V22, P1241, DOI 10.1038/mp.2017.40
   Srikanth P, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0122-x
   Srikanth P, 2015, CELL REP, V12, P1414, DOI 10.1016/j.celrep.2015.07.061
   State MW, 2012, SCIENCE, V337, P1301, DOI 10.1126/science.1224989
   Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240
   Taber KH, 2010, ANNU REV MED, V61, P121, DOI 10.1146/annurev.med.051408.105018
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015
   Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009
   Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Vahdatpour C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3339/fnins.2016.00450
   Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2
   Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Wang YQ, 2018, LAB CHIP, V18, P851, DOI 10.1039/c7lc01084b
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye F, 2017, NEURON, V96, P1204, DOI 10.1016/j.neuron.2017.11.034
   Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu YJ, 2017, INTEGR BIOL-UK, V9, P968, DOI 10.1039/c7ib00105c
   Zong H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020610
NR 154
TC 57
Z9 59
U1 12
U2 39
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD OCT 24
PY 2018
VL 100
IS 2
BP 389
EP 405
DI 10.1016/j.neuron.2018.10.007
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA GY1KR
UT WOS:000448288900009
PM 30359604
OA Bronze
DA 2020-07-08
ER

PT J
AU Liao, YH
   Fan, ZJ
   Dens, HP
   Yang, Y
   Lin, JY
   Zhao, ZY
   Tan, QQ
   Li, B
   Huang, X
AF Liao, Yuhui
   Fan, Zhijin
   Dens, Huaping
   Yang, Yang
   Lin, Jingyan
   Zhao, Zhaoyan
   Tan, Qingqin
   Li, Bin
   Huang, Xi
TI Zika Virus Liquid Biopsy: A Dendritic Ru(bpy)(3)(2+)-Polymer-Amplified
   ECL Diagnosis Strategy Using a Drop of Blood
SO ACS CENTRAL SCIENCE
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; SEXUAL TRANSMISSION; RNA; INFECTION;
   PROTECTION; ANTIBODIES; DISEASE; SWITCH; ASSAY
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that leads to devastating consequences for fetal development. However, accurate diagnosis of ZIKV is made difficult by the fact that most infected patients are asymptomatic or present with symptoms similar to those of other febrile illnesses. Thus, the development of a simple, accurate, highly sensitive, and reliable method for the biomedical analysis and diagnosis of ZIKV is needed. Herein, a novel ZIKV liquid biopsy system was constructed via a dendritic Ru(bpy)(3)(2+)-polymer-amplified electro-chemiluminescence (ECL) strategy. This system accomplished amplification-free analysis of ZIKV using a drop of blood, and simultaneously achieved a high sensitivity of 500 copies and superior specificity. This strategy adopted the humoral biomarker as the diagnostic index, which greatly simplified the analysis process, and established a nondestructive detection mode. Furthermore, the performance index for biomedical analysis of clinical ZIKV samples was investigated, and the results indicated that the dendritic Ru(bpy)(3)(2+)-polymer-amplified ECL strategy reliably responded to ZIKV from the body fluid (blood, saliva, and urine). Hence, this system suitably met the strict clinical requirements for ZIKV detection and thus has the potential to serve as a new paradigm for the biomedical analysis and diagnosis of ZIKV.
C1 [Liao, Yuhui; Fan, Zhijin; Dens, Huaping; Zhao, Zhaoyan; Tan, Qingqin; Li, Bin; Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Hosp 5, Program Infect & Immun, Guangzhou 510120, Guangdong, Peoples R China.
   [Liao, Yuhui; Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou Women & Childrens Med Ctr, Dept Internal Med, Guangzhou 510120, Guangdong, Peoples R China.
   [Huang, Xi] Guangzhou Med Univ, Coll Basic Med Sci, Sinofrench Hoffmann Inst Immunol, Guangzhou 510000, Guangdong, Peoples R China.
   [Liao, Yuhui; Zhao, Zhaoyan; Tan, Qingqin; Li, Bin; Huang, Xi] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510120, Guangdong, Peoples R China.
   [Huang, Xi] Jilin Univ, Hosp 1, Changchun 130021, Jilin, Peoples R China.
   [Liao, Yuhui; Yang, Yang; Lin, Jingyan; Huang, Xi] Shenzhen Third Peoples Hosp, State Key Discipline Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
RP Huang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Hosp 5, Program Infect & Immun, Guangzhou 510120, Guangdong, Peoples R China.; Huang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou Women & Childrens Med Ctr, Dept Internal Med, Guangzhou 510120, Guangdong, Peoples R China.; Huang, X (corresponding author), Guangzhou Med Univ, Coll Basic Med Sci, Sinofrench Hoffmann Inst Immunol, Guangzhou 510000, Guangdong, Peoples R China.; Huang, X (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510120, Guangdong, Peoples R China.; Huang, X (corresponding author), Jilin Univ, Hosp 1, Changchun 130021, Jilin, Peoples R China.; Huang, X (corresponding author), Shenzhen Third Peoples Hosp, State Key Discipline Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
EM huangxi6@mail.sysu.edu.cn
RI Fan, Zhijin/T-2752-2018
OI Fan, Zhijin/0000-0003-0018-4949; Liao, Yuhui/0000-0003-4702-9516
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470877, 81261160323]; National Key Research and
   Development Program of China [2016YFC1200105]; National Science and
   Technology Key Projects for Major Infectious Diseases [2017ZX10302301,
   2013ZX10003001]; Science and Technology Planning Project of Guangzhou
   [201704020226, 2016A020250001, 201604020006]; Guangdong Natural Science
   FoundationNational Natural Science Foundation of Guangdong Province
   [2015A030311009]
FX This work was supported by grants from the National Natural Science
   Foundation of China (31470877, 81261160323), the National Key Research
   and Development Program of China (2016YFC1200105), the National Science
   and Technology Key Projects for Major Infectious Diseases
   (2017ZX10302301 and 2013ZX10003001), the Science and Technology Planning
   Project of Guangzhou (201704020226, 2016A020250001, and 201604020006),
   and the Guangdong Natural Science Foundation (2015A030311009).
CR Baptista T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2194
   Barragan F, 2011, J AM CHEM SOC, V133, P14098, DOI 10.1021/ja205235m
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Collot M, 2018, J AM CHEM SOC, V140, P5401, DOI 10.1021/jacs.7b12817
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Hage DS, 2018, CLIN CHEM, V64, P991, DOI 10.1373/clinchem.2017.282699
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hori Y, 2018, J AM CHEM SOC, V140, P1686, DOI 10.1021/jacs.7b09713
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kim H, 2017, NUCLEIC ACIDS RES, V45, pD475, DOI 10.1093/nar/gkw1095
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Lin S, 2015, CHEM SCI, V6, P4284, DOI 10.1039/c5sc01320h
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 49
TC 5
Z9 5
U1 5
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2374-7943
EI 2374-7951
J9 ACS CENTRAL SCI
JI ACS Central Sci.
PD OCT 24
PY 2018
VL 4
IS 10
BP 1403
EP 1411
DI 10.1021/acscentsci.8b00471
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX8QG
UT WOS:000448053200016
PM 30410978
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xiao, PP
   Han, JC
   Zhang, Y
   Li, CH
   Guo, XF
   Wen, SB
   Tan, MY
   Li, YQ
   Wang, MP
   Liu, H
   Ren, JQ
   Zhou, HN
   Lu, HJ
   Jin, NY
AF Xiao, Pengpeng
   Han, Jicheng
   Zhang, Ying
   Li, Chenghui
   Guo, Xiaofang
   Wen, Shubo
   Tan, Mingyao
   Li, Yiquan
   Wang, Maopeng
   Liu, Hao
   Ren, Jingqiang
   Zhou, Hongning
   Lu, Huijun
   Jin, Ningyi
TI Metagenomic Analysis of Flaviviridae in Mosquito Viromes Isolated From
   Yunnan Province in China Reveals Genes From Dengue and Zika Viruses
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE metagenomic analysis; mosquito; virome; virus detection; phylogenetic
   analysis
ID JAPANESE ENCEPHALITIS-VIRUS; DISCOVERY; OUTBREAK; ASSAY; PCR
AB More than 6,000 mosquitoes of six species from six sites were collected and tested for their virome using metagenomics sequencing and bioinformatic analysis. The identified viral sequences belonged to more than 50 viral families. The results were veri fied by PCR of selected viruses in all mosquitoes, followed by phylogenetic analysis. In the present study, we identified the partial dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV) sequences in mosquitoes. Metagenomic analysis and the PCR amplification revealed three DENV sequences, one of which encodes a partial envelope protein. Two ZIKV sequences both encoding partial nonstructural protein 3 and one JEV sequence encoding the complete envelope protein were identified. There was variability in the viral titers of the newly isolated virus JEV-China/YN2016-1 of different passage viruses. The newly identified Zika virus gene from ZIKV-China/YN2016-1 was an Asian genotype and shared the highest nucleotide sequence identity (97.1%) with a ZIKV sequence from Thailand isolated in 2004. Phylogenetic analysis of ZIKV-China/YN2016-1 and ZIKV-China/YN2016-2 with known Flavivirus genes indicated that ZIKV has propagated in Yunnan province, China.
C1 [Xiao, Pengpeng; Han, Jicheng; Li, Chenghui; Li, Yiquan; Jin, Ningyi] Yanbian Univ, Med Coll, Yanji, Peoples R China.
   [Xiao, Pengpeng; Han, Jicheng; Li, Chenghui; Wen, Shubo; Tan, Mingyao; Li, Yiquan; Wang, Maopeng; Liu, Hao; Ren, Jingqiang; Lu, Huijun; Jin, Ningyi] Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China.
   [Zhang, Ying] Jilin Univ, Coll Vet Med, Coll Anim Sci, Changchun, Jilin, Peoples R China.
   [Guo, Xiaofang; Zhou, Hongning] Yunnan Inst Parasit Dis, Simao, Peoples R China.
   [Tan, Mingyao; Lu, Huijun] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.
   [Wang, Maopeng] Wenzhou Univ, Inst Virol, Wenzhou, Peoples R China.
   [Liu, Hao] Foshan Univ, Sch Life Sci & Engn, Foshan, Peoples R China.
   [Ren, Jingqiang] Inst Special Econ Anim & Plant Sci, Div Econ Anim Epidem, Changchun, Jilin, Peoples R China.
RP Jin, NY (corresponding author), Yanbian Univ, Med Coll, Yanji, Peoples R China.; Lu, HJ; Jin, NY (corresponding author), Acad Mil Med Sci, Inst Mil Vet, Changchun, Jilin, Peoples R China.; Lu, HJ (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.
EM human_lu@126.com; ningyik@126.com
RI WANG, Maopeng/P-4109-2014
OI WANG, Maopeng/0000-0001-8203-6645
FU National Program on Key Research Project of China [2016YFD0500401,
   2017YFD0501803]; Special Fund for Agro-scientific Research in the Public
   Interest [201203082]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31272573]; Yunnan
   Academician Workstation [2018IC151]; National Natural Science
   FoundationNational Natural Science Foundation of China [3180130343]
FX This work was supported by the National Program on Key Research Project
   of China [grant numbers 2016YFD0500401, 2017YFD0501803], the Special
   Fund for Agro-scientific Research in the Public Interest [grant number
   201203082], the National Natural Science Foundation of China [grant
   number 31272573], the Yunnan Academician Workstation [grant number
   2018IC151], and the National Natural Science Foundation [grant number
   3180130343].
CR Almeida RS, 2005, VET MICROBIOL, V105, P131, DOI 10.1016/j.vetmic.2004.11.004
   Alquezar-Planas DE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02468
   Atoni E, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010030
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Carissimo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153881
   Cholleti H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162751
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Ergunay K, 2017, ARCH VIROL, V162, P1903, DOI 10.1007/s00705-017-3314-4
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Feng Yun, 2015, Bing Du Xue Bao, V31, P51
   Fisher RG, 2015, J CLIN VIROL, V62, P48, DOI 10.1016/j.jcv.2014.11.014
   Frey KG, 2016, EVOL BIOINFORM, V12, P1, DOI 10.4137/EBO.S38518
   Guo XF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-70
   He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950
   Houghton M, 2009, J HEPATOL, V51, P939, DOI 10.1016/j.jhep.2009.08.004
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   KRAH DL, 1991, BIOLOGICALS, V19, P223, DOI 10.1016/1045-1056(91)90039-M
   Li H, 2015, BIOMED ENVIRON SCI, V28, P374, DOI 10.3967/bes2015.052
   Li JF, 2015, GENET MOL RES, V14, P8733, DOI 10.4238/2015.July.31.22
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Motooka D, 2015, METHODS MOL BIOL, V1236, P125, DOI 10.1007/978-1-4939-1743-3_11
   NI HL, 1994, J GEN VIROL, V75, P1505, DOI 10.1099/0022-1317-75-6-1505
   Pham TNQ, 2005, J GEN VIROL, V86, P657, DOI 10.1099/vir.0.80624-0
   Ritchie SA, 2007, VECTOR-BORNE ZOONOT, V7, P497, DOI 10.1089/vbz.2006.0643
   Shi CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129845
   Shi JD, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-121
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Wang BH, 2016, INFECT GENET EVOL, V37, P1, DOI 10.1016/j.meegid.2015.10.022
   Wang J, 2012, GENET MOL RES, V11, P1909, DOI 10.4238/2012.July.19.10
   Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499
   Xia H, 2018, VIROL SIN, V33, P59, DOI 10.1007/s12250-018-0015-4
   Xiong Yiquan, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P1822
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710
NR 43
TC 3
Z9 3
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD OCT 24
PY 2018
VL 8
AR 359
DI 10.3389/fcimb.2018.00359
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GX9GX
UT WOS:000448109900001
PM 30406038
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Camp, B
   Mandivarapu, JK
   Ramamurthy, N
   Wingo, J
   Bourgeois, AG
   Cao, XJ
   Sunderraman, R
AF Camp, Blake
   Mandivarapu, Jaya Krishna
   Ramamurthy, Nagashayan
   Wingo, James
   Bourgeois, Anu G.
   Cao, Xiaojun
   Sunderraman, Rajshekhar
TI A new cross-platform architecture for epi-info software suite
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 6th Workshop on Computational Advances in Molecular Epidemiology (CAME)
CY AUG 20, 2017
CL Boston, MA
DE Cross-platform; Form-design; Analytics; Pubic-health; NoSQL; Electron;
   Data-collection
AB Background: The Epi-Info software suite, built and maintained by the Centers for Disease Control and Prevention (CDC), is widely used by epidemiologists and public health researchers to collect and analyze public health data, especially in the event of outbreaks such as Ebola and Zika. As it exists today, Epi-Info Desktop runs only on the Windows platform, and the larger Epi-Info Suite of products consists of separate codebases for several different devices and use-cases. Software portability has become increasingly important over the past few years as it offers a number of obvious benefits. These include reduced development time, reduced cost, and simplified system architecture. Thus, there is a blatant need for continued research. Specifically, it is critical to fully understand any underlying negative performance issues which arise from platform-agnostic systems. Such understanding should allow for improved design, and thus result in substantial mitigation of reduced performance. In this paper, we present a viable cross-platform architecture for Epi-Info which solves many of these problems.
   Results: We have successfully generated executables for Linux, Mac, and Windows from a single code-base, and we have shown that performance need not be completely sacrificed when building a cross-platform application. This has been accomplished by using Electron as a wrapper for an AngularJS app, a Python analytics module, and a local, browser-based NoSQL database.
   Conclusions: Promising results warrant future research. Specifically, the design allows for cross-platform form-design, data-collection, offline/online modes, scalable storage, automatic local-to-remote data sync, and fast analytics which rival more traditional approaches.
C1 [Camp, Blake; Mandivarapu, Jaya Krishna; Ramamurthy, Nagashayan; Wingo, James; Bourgeois, Anu G.; Cao, Xiaojun; Sunderraman, Rajshekhar] Georgia State Univ, Dept Comp Sci, 25 Pk Pl, Atlanta, GA 30303 USA.
RP Camp, B (corresponding author), Georgia State Univ, Dept Comp Sci, 25 Pk Pl, Atlanta, GA 30303 USA.
EM bcamp2@gsu.edu
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [200-2016-91969]
FX Research was partially funded by the CDC under contract number
   200-2016-91969. Publication costs are covered by the Department of
   Computer Science, Georgia State University.
CR Dean AG, 1995, THESIS
   Maponga BA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-567
   Marshall CA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2991-3
   Scotch Matthew, 2006, Int J Health Geogr, V5, P39, DOI 10.1186/1476-072X-5-39
NR 4
TC 0
Z9 0
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD OCT 22
PY 2018
VL 19
SU 11
AR 359
DI 10.1186/s12859-018-2334-8
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA GX7IR
UT WOS:000447941700005
PM 30343662
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bartlett, LJ
   Carlson, CJ
   Boots, M
AF Bartlett, Lewis J.
   Carlson, Colin J.
   Boots, Mike
TI Identifying regions of risk to honey bees from Zika vector control in
   the USA
SO JOURNAL OF APICULTURAL RESEARCH
LA English
DT Article
DE Zika virus; Apis mellifera; pesticide; vector control; honey bee;
   pollinator
ID WEST NILE VIRUS; ADULT MOSQUITO MANAGEMENT; UNITED-STATES;
   ENVIRONMENTAL-CONDITIONS; POLLINATION SERVICES; INFECTIOUS-DISEASES;
   NONTARGET INSECTS; CLIMATE-CHANGE; PESTICIDES; CROPS
AB Managed honey bees are a crucial component of many countries' agricultural systems. Critically, it is now well established that honey bees are faced with multiple threats, and therefore, it is important that we determine and mitigate new threats. The emergence of Zika virus has introduced the new threat of insecticidal mosquito control leading to honey bee losses, with demand from beekeepers for a comprehensive risk assessment to help mitigate losses. Here, we present novel estimates of county-level honey bee colony densities across the USA and combine these new data with different projections of Zika virus suitability to assess the magnitude of this risk. We find that up to 13% of colonies can reasonably be expected to experience elevated risk of damaging pesticide exposure, according to interpretation of current Zika virus projections. We show a significant positive correlation between areas of Zika suitability and honey bee colony density. Increased risk of colony loss to pesticides are found in the South-East, Gulf Coast, Florida, and the California Central Valley. We highlight certain states which are better placed to mitigate threats, recommending other states look towards these schemes to protect apiculture from both government and commercial pesticide application.
C1 [Bartlett, Lewis J.] Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, England.
   [Carlson, Colin J.] Univ Maryland, Natl Socioenvironm Synth Ctr, Annapolis, MD USA.
   [Carlson, Colin J.] Georgetown Univ, Dept Biol, Washington, DC 20057 USA.
   [Boots, Mike] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
RP Bartlett, LJ (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, England.
EM l.bartlett@exeter.ac.uk
CR Albrigo L.G., 2002, P FLORIDA STATE HORT, V115, P27
   Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021
   Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112
   Bouzid M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005176
   Breidenbaugh MS, 2010, ENVIRON ENTOMOL, V39, P591, DOI 10.1603/EN09087
   Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767
   Brittain C, 2013, GLOBAL CHANGE BIOL, V19, P540, DOI 10.1111/gcb.12043
   Brosi BJ, 2017, NAT ECOL EVOL, V1, P1250, DOI 10.1038/s41559-017-0246-z
   Burgett M, 2010, AM BEE J, V150, P35
   Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Caron D. M., 2013, HONEY BEE BIOL BEEKE, p133?158
   CDC, 2016, INT CDC REC ZIK VECT
   CDC, 2016, AER SPRAYING MOSQ CO
   Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x
   Clemson University, 2016, NON FOLL UP PEST US
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Dai PL, 2010, ENVIRON TOXICOL CHEM, V29, P644, DOI 10.1002/etc.67
   Davis RS, 2007, INTEGR ENVIRON ASSES, V3, P373, DOI 10.1002/ieam.5630030308
   Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Dolezal AG, 2016, J ECON ENTOMOL, V109, P41, DOI 10.1093/jee/tov301
   Duprey Z, 2008, J AM MOSQUITO CONTR, V24, P42, DOI 10.2987/5559.1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   FWS, 2016, END THREAT WILDL PLA
   Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Harriott N, 2016, PESTICIDES YOU, V36, P9
   Ho SS, 2007, PUBLIC OPIN QUART, V71, P671, DOI 10.1093/poq/nfm041
   Hoang TC, 2011, ENVIRON TOXICOL CHEM, V30, P997, DOI 10.1002/etc.462
   Hodges A, 2001, AM BEE J, V141, P361
   Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405
   Ingram EM, 2015, CHEMOSPHERE, V135, P272, DOI 10.1016/j.chemosphere.2015.04.022
   Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018
   Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414
   Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721
   Klein S, 2017, TRENDS ECOL EVOL, V32, P268, DOI 10.1016/j.tree.2016.12.009
   Knapp JL, 2017, J APPL ECOL, V54, P1171, DOI 10.1111/1365-2664.12813
   Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113
   Levin M. D., 1983, Bulletin of the Entomological Society of America, V29, P50
   MABA, 2016, METR ATL BEEK ASS BE
   Matthews G, 2011, INTEGRATED VECTOR MA
   Matthews G. A., 2003, Pesticide Outlook, V14, P210, DOI 10.1039/b311469b
   Matthews GA, 2000, PEST MANAG SCI, V56, P974, DOI 10.1002/1526-4998(200011)56:11<974::AID-PS231>3.0.CO;2-4
   Matthews Graham A., 2008, Environmentalist, V28, P19, DOI 10.1007/s10669-007-9039-2
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004
   Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588
   Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007
   Rader R, 2013, GLOBAL CHANGE BIOL, V19, P3103, DOI 10.1111/gcb.12264
   Rader R, 2012, J APPL ECOL, V49, P126, DOI 10.1111/j.1365-2664.2011.02066.x
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031
   Rumkee JCO, 2017, ENVIRON SCI TECHNOL, V51, P6908, DOI 10.1021/acs.est.6b04206
   Russ RV, 1999, AM BEE J, V139, P607
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009
   Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482
   Schleier JJ, 2010, ECOTOXICOLOGY, V19, P1140, DOI 10.1007/s10646-010-0497-9
   Schleier JJ, 2010, ARCH ENVIRON CON TOX, V58, P105, DOI 10.1007/s00244-009-9353-4
   Schmidt CW, 2016, ENVIRON HEALTH PERSP, V124, pA157, DOI 10.1289/ehp.124-A157
   Schoups G, 2005, P NATL ACAD SCI USA, V102, P15352, DOI 10.1073/pnas.0507723102
   Simone-Finstrom M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32023
   Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01
   US Census Bureau D I D, 2015, COUNT TOT DAT POP PO
   USDA NASS, 2013, US HON PROD 1 PERC
   USDA NASS, 2017, JAN 1 HON BEE COL 8
   USDA NASS, 2017, US HON PROD 3 PERC O
   vanEngelsdorp Dennis, 2012, American Entomologist, V58, P116
   vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011
   Zhong H, 2003, ARCH ENVIRON CON TOX, V45, P216, DOI 10.1007/s00244-002-0185-8
NR 81
TC 1
Z9 1
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0021-8839
EI 2078-6913
J9 J APICULT RES
JI J. Apic. Res.
PD OCT 20
PY 2018
VL 57
IS 5
BP 709
EP 719
DI 10.1080/00218839.2018.1494914
PG 11
WC Entomology
SC Entomology
GA GY3EA
UT WOS:000448429100014
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Turner, J
   Krishna, R
   van't Hof, AE
   Sutton, ER
   Matzen, K
   Darby, AC
AF Turner, Joe
   Krishna, Ritesh
   van't Hof, Arjen E.
   Sutton, Elizabeth R.
   Matzen, Kelly
   Darby, Alistair C.
TI The sequence of a male-specific genome region containing the sex
   determination switch in Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE M locus; Nix; Sex determination; Chromosome evolution; Genomics; BAC;
   PacBio
ID Y-CHROMOSOME; ZIKA VIRUS; MOSQUITO; EVOLUTION; INSIGHTS; DENGUE
AB Background: Aedes aegypti is the principal vector of several important arboviruses. Among the methods of vector control to limit transmission of disease are genetic strategies that involve the release of sterile or genetically modified non-biting males, which has generated interest in manipulating mosquito sex ratios. Sex determination in Re. aegypti is controlled by a non-recombining Y chromosome-like region called the M locus, yet characterisation of this locus has been thwarted by the repetitive nature of the genome. In 2015, an M locus gene named Nix was identified that displays the qualities of a sex determination switch.
   Results: With the use of a whole-genome bacterial artificial chromosome (BAC) library, we amplified and sequenced a similar to 200 kb region containing the male-determining gene Nix. In this study, we show that Nix is comprised of two exons separated by a 99 kb intron primarily composed of repetitive DNA, especially transposable elements.
   Conclusions: Nix, an unusually large and highly repetitive gene, exhibits features in common with Y chromosome genes in other organisms. We speculate that the lack of recombination at the M locus has allowed the expansion of repeats in a mariner characteristic of a sex-limited chromosome, in accordance with proposed models of sex chromosome evolution in insects.
C1 [Turner, Joe; Krishna, Ritesh; van't Hof, Arjen E.; Darby, Alistair C.] Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Crown St, Liverpool L69 7ZB, Merseyside, England.
   [Turner, Joe; Sutton, Elizabeth R.; Matzen, Kelly] Oxitec Ltd, 71 Innovat Dr,Milton Pk, Abingdon OX14 4RQ, Oxon, England.
   [Krishna, Ritesh] IBM Res UK, STFC Daresbury Lab, Warrington WA4 4AD, Cheshire, England.
   [van't Hof, Arjen E.] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Sutton, Elizabeth R.] Univ Oxford, Dept Zool, South Parks Rd, Oxford OX1 3PS, England.
   [Sutton, Elizabeth R.] Sistemic, West Scotland Sci Pk, Glasgow G20 0SP, Lanark, Scotland.
RP Darby, AC (corresponding author), Univ Liverpool, Inst Integrat Biol, Ctr Genom Res, Crown St, Liverpool L69 7ZB, Merseyside, England.
EM joe.turner2@liverpool.ac.uk; acdarby@liverpool.ac.uk
RI Darby, Alistair/I-6485-2012; Turner, Joe/F-7636-2017
OI Darby, Alistair/0000-0002-3786-6209; Matzen, Kelly/0000-0002-1167-7397;
   Turner, Joe/0000-0003-3138-1427
FU UK Biotechnology and Biological Sciences Research Council
   (BBSRC)Biotechnology and Biological Sciences Research Council (BBSRC)
   [BB/M503460/1]; BBSRCBiotechnology and Biological Sciences Research
   Council (BBSRC) [BB/M001512/1]
FX This work was funded by UK Biotechnology and Biological Sciences
   Research Council (BBSRC) PhD training grant BB/M503460/1 (JT & ACD) and
   BBSRC grant BB/M001512/1 (KM & ACD).
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Artieri CG, 2014, MOL BIOL EVOL, V31, P2879, DOI 10.1093/molbev/msu226
   Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366
   Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biedler JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033933
   Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998
   CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119
   Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697
   Charlesworth D, 2010, GENETICS, V186, P9, DOI 10.1534/genetics.110.117697
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Clements A.N, 1992, BIOL MOSQUITOES
   CRAIG GB, 1960, SCIENCE, V132, P1887, DOI 10.1126/science.132.3443.1887
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fontaine A, 2017, GENOME BIOL EVOL, V9, P2322, DOI 10.1093/gbe/evx171
   Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015
   Hall AB, 2016, P NATL ACAD SCI USA, V113, pE2114, DOI 10.1073/pnas.1525164113
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hall AB, 2014, GENOME BIOL EVOL, V6, P179, DOI 10.1093/gbe/evu002
   Kaiser VB, 2010, ANNU REV GENET, V44, P91, DOI 10.1146/annurev-genet-102209-163600
   Hoang KP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1331-x
   Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351
   Marais GAB, 2008, CURR BIOL, V18, P545, DOI 10.1016/j.cub.2008.03.023
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   Matthews BJ, 2017, BIORXIV
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   NEWTON ME, 1978, GENETICA, V48, P137, DOI 10.1007/BF00127510
   Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651
   Toups MA, 2010, GENETICS, V186, P763, DOI 10.1534/genetics.110.118794
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
NR 35
TC 1
Z9 1
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 20
PY 2018
VL 11
AR 549
DI 10.1186/s13071-018-3090-3
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GX5EB
UT WOS:000447764100001
PM 30342535
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Clancy, CS
   Van Wettere, AJ
   Morrey, JD
   Julander, JG
AF Clancy, Chad S.
   Van Wettere, Arnaud J.
   Morrey, John D.
   Julander, Justin G.
TI Coitus-Free Sexual Transmission of Zika Virus in a Mouse Model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EXTRACELLULAR ORGANELLES PROSTASOMES; SEMINAL PLASMA;
   REPRODUCTIVE-TRACT; INFECTION; PROGESTERONE; SEMEN; CELLS; MICE;
   SPERMATOZOA; COMPONENTS
AB Zika virus (ZIKV) is an arboviral infection that may be sexually transmitted. The present study aims to determine if accessory sex glands are a potential source of infectious virus and important in sexual transmission. Male interferon type I receptor knockout (Ifnar(-/-)) mice were challenged subcutaneously with a Puerto Rican ZIKV isolate. Reproductive tissues were harvested seven days after viral challenge and artificial insemination fluid derived from epididymis or homogenized accessory sex glands (seminal plasma) was obtained. Naive interferon type I and II receptor knockout (AG129) females were pretreated with progesterone, and inoculated intravaginally with either epididymal flush or seminal plasma from ZIKV-infected males. ZIKV RNA was demonstrated in the artificial insemination fluid and ZIKV antigen was detected in epididymal epithelial cells but not within seminiferous tubules at the time of artificial insemination fluid collection. Peripheral viremia, demonstrated by ZIKV RNA in whole blood samples of females from each challenge group was observed. Infectious virus was present in both epididymal fluid and seminal plasma. These studies provide evidence of passage of virus from epididymal flush and seminal plasma to naive females via artificial insemination and provides a model for the study of sexual transmission of ZIKV.
C1 [Clancy, Chad S.; Van Wettere, Arnaud J.] Utah State Univ, Sch Vet Med, Dept Anim Dairy & Vet Sci, Utah Vet Diagnost Lab, Logan, UT 84322 USA.
   [Clancy, Chad S.; Morrey, John D.; Julander, Justin G.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.
RP Julander, JG (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.
EM Justin.julander@usu.edu
OI Clancy, Chad/0000-0002-5354-9270
FU Public Health Service (PHS)United States Public Health Service
   [5R33AI101483]; Virology Branch, National Institute of Allergy and
   Infectious Diseases (NIAID), National Institutes of Health
   [HHSN272201000039I/HHSN27200004]
FX The work was supported by Public Health Service (PHS) grant 5R33AI101483
   and contract HHSN272201000039I/HHSN27200004 to J.D.M. from the Virology
   Branch, National Institute of Allergy and Infectious Diseases (NIAID),
   National Institutes of Health.
CR Aalberts M, 2014, REPRODUCTION, V147, pR1, DOI 10.1530/REP-13-0358
   ANDERSON DJ, 1982, J IMMUNOL, V128, P535
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339
   Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen PJ, 1998, J REPROD IMMUNOL, V40, P63, DOI 10.1016/S0165-0378(98)00035-7
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   KELLY RW, 1991, CLIN EXP IMMUNOL, V86, P550
   Mann PC, 2012, TOXICOL PATHOL, V40, P7, DOI 10.1177/0192623312438738
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Research Council, 2011, THE NATIONAL, V66
   Ochsenkuhn R, 2006, J REPROD IMMUNOL, V71, P57, DOI 10.1016/j.jri.2006.01.002
   Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138
   Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3
   Salam AP, 2018, LANCET INFECT DIS, V18, P144, DOI 10.1016/S1473-3099(18)30020-3
   SKIBINSKI G, 1992, AM J REPROD IMMUNOL, V28, P97, DOI 10.1111/j.1600-0897.1992.tb00767.x
   Szekeres-Bartho J, 2001, INT IMMUNOPHARMACOL, V1, P1037, DOI 10.1016/S1567-5769(01)00035-2
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Xu YP, 2011, J REPROD IMMUNOL, V91, P17, DOI 10.1016/j.jri.2011.06.101
NR 34
TC 4
Z9 4
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 18
PY 2018
VL 8
AR 15379
DI 10.1038/s41598-018-33528-2
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX2ZV
UT WOS:000447591000036
PM 30337585
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, KY
   Zhang, Q
   Pastore-Piontti, A
   Chinazzi, M
   Mistry, D
   Dean, NE
   Rojas, DP
   Merler, S
   Poletti, P
   Rossi, L
   Halloran, ME
   Longini, IM
   Vespignani, A
AF Sun, Kaiyuan
   Zhang, Qian
   Pastore-Piontti, Ana
   Chinazzi, Matteo
   Mistry, Dina
   Dean, Natalie E.
   Rojas, Diana Patricia
   Merler, Stefano
   Poletti, Piero
   Rossi, Luca
   Halloran, M. Elizabeth
   Longini, Ira M., Jr.
   Vespignani, Alessandro
TI Quantifying the risk of local Zika virus transmission in the contiguous
   US during the 2015-2016 ZIKV epidemic
SO BMC MEDICINE
LA English
DT Article
DE Zika virus; Risk assessment; Computational modeling
ID AEDES-ALBOPICTUS; UNITED-STATES; METEOROLOGICAL VARIABLES;
   STEGOMYIA-AEGYPTI; BIRTH-DEFECTS; DENGUE; TEMPERATURE; ABUNDANCE;
   POPULATIONS; CULICIDAE
AB Background: Local mosquito-borne Zika virus (ZIKV) transmission has been reported in two counties in the contiguous United States (US), prompting the issuance of travel, prevention, and testing guidance across the contiguous US. Large uncertainty, however, surrounds the quantification of the actual risk of ZIKV introduction and autochthonous transmission across different areas of the US.
   Methods: We present a framework for the projection of ZIKV autochthonous transmission in the contiguous US during the 2015-2016 epidemic using a data-driven stochastic and spatial epidemic model accounting for seasonal, environmental, and detailed population data. The model generates an ensemble of travel-related case counts and simulates their potential to have triggered local transmission at the individual level in the 2015-2016 ZIKV epidemic.
   Results: We estimate the risk of ZIKV introduction and local transmission at the county level and at the 0.025 degrees x 0.025 degrees cell level across the contiguous US. We provide a risk measure based on the probability of observing local transmission in a specific location during a ZIKV epidemic modeled after the epidemic observed during the years 2015-2016. The high spatial and temporal resolution of the model allows us to generate statistical estimates of the number of ZIKV introductions leading to local transmission in each location. We find that the risk was spatially heterogeneously distributed and concentrated in a few specific areas that account for less than 1% of the contiguous US population. Locations in Texas and Florida that have actually experienced local ZIKV transmission were among the places at highest risk according to our results. We also provide an analysis of the key determinants for local transmission and identify the key introduction routes and their contributions to ZIKV transmission in the contiguous US.
   Conclusions: This framework provides quantitative risk estimates, fully captures the stochasticity of ZIKV introduction events, and is not biased by the under-ascertainment of cases due to asymptomatic cases. It provides general information on key risk determinants and data with potential uses in defining public health recommendations and guidance about ZIKV risk in the US.
C1 [Sun, Kaiyuan; Zhang, Qian; Pastore-Piontti, Ana; Chinazzi, Matteo; Mistry, Dina; Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.
   [Dean, Natalie E.; Rojas, Diana Patricia; Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL 32611 USA.
   [Merler, Stefano; Poletti, Piero] Bruno Kessler Fdn, I-38123 Trento, Italy.
   [Rossi, Luca; Vespignani, Alessandro] Inst Sci Interchange Fdn, I-10126 Turin, Italy.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
RP Vespignani, A (corresponding author), Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA.; Vespignani, A (corresponding author), Inst Sci Interchange Fdn, I-10126 Turin, Italy.
EM a.vespignani@neu.edu
RI Mistry, Dina/AAR-4654-2020; merler, stefano/I-3557-2017; Rojas, Diana
   Patricia/AAC-2469-2019
OI Mistry, Dina/0000-0002-1598-1388; merler, stefano/0000-0002-5117-0611;
   Rojas, Diana Patricia/0000-0003-0241-6416; Chinazzi,
   Matteo/0000-0002-5955-1929; Vespignani, Alessandro/0000-0003-3419-4205
FU Models of Infectious Disease Agent Study, National Institute of General
   Medical Sciences [U54GM111274]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI102939-05]
FX This work was supported by the Models of Infectious Disease Agent Study,
   National Institute of General Medical Sciences Grant U54GM111274 and the
   NIH supplement Grant R01 AI102939-05.
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Ajelli M, 2017, ACTA TROP, V176, P332, DOI 10.1016/j.actatropica.2017.08.026
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Allard A, PLOS PATHOG, V13
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   [Anonymous], 2016, WORLD AIR TRANSP AIR
   Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Centers for Disease Control and Prevention, 2017, GUID AR LOC ZIK VIR
   Centers for Disease Control and Prevention, 2017, ADV PEOPL LIV TRAV B
   Centers for Disease Control and Prevention, 2017, ZIK VIR CTR DIS CONT
   Centers for Disease Control and Prevention, 2017, ADV PEOPL LIV TRAV S
   Centers for Disease Control and Protection, 2017, EST RANG AED AEG AED
   CIESIN, 2017, GLOB POP COUNT GRID, DOI [10. 7927/H4CC0XNV, DOI 10.7927/H4CC0XNV]
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fox SJ, 2018, DOWNGRADING DIS TRAN, DOI [10. 1101/265942, DOI 10.1101/265942]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gomes AF, 2012, CAD SAUDE PUBLICA, V28, P2189, DOI 10.1590/S0102-311X2012001100018
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Keegan LT, 2017, J INFECT DIS, V216, pS884, DOI 10.1093/infdis/jix437
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee BY, 2017, PLOS NEGLECT TROP D, V11
   Li MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166211
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Luciano T, 2003, J AM MOSQUITO CONTR, V19, P100
   Marini G, 2017, EURO SURVEILL, V22
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Monaghan AJ, 2016, PLOS CURR OUTBREAKS, DOI [10. 1371/currents. outbreaks. 50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.0UTBREAKS.50DFC7F46798675FC63E7D7DA563DA76, 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76]
   Nordhaus W.D., 2016, GLOBAL GRIDDED GEOGR
   Pan American Health Organization, 2017, ZIK VIR INF PAN AM H
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Russell SP, 2017, PLOS CURRENTS OUTBRE, DOI [10. 1371/currents. outbreaks. cd76717676629d47704170ecbdb5f820, DOI 10.1371/CURRENTS.0UTBREAKS.CD76717676629D47704170ECBDB5F820]
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO, 2017, ZIK VIR COMPL 2016 P
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 60
TC 4
Z9 4
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD OCT 18
PY 2018
VL 16
AR 195
DI 10.1186/s12916-018-1185-5
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA GX5DN
UT WOS:000447762000001
PM 30336778
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Pleet, ML
   Branscome, H
   DeMarino, C
   Pinto, DO
   Zadeh, MA
   Rodriguez, M
   Sariyer, IK
   El-Hage, N
   Kashanchi, F
AF Pleet, Michelle L.
   Branscome, Heather
   DeMarino, Catherine
   Pinto, Daniel O.
   Zadeh, Mohammad Asad
   Rodriguez, Myosotys
   Sariyer, Ilker Kudret
   El-Hage, Nazira
   Kashanchi, Fatah
TI Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE autophagy; exosome; extracellular vesicle; virus; infectious disease;
   secretory autophagy
ID HERPES-SIMPLEX-VIRUS; HEPATITIS-C VIRUS; EPSTEIN-BARR-VIRUS; NF-KAPPA-B;
   UNCONVENTIONAL SECRETION; DENGUE VIRUS; EXTRACELLULAR VESICLES; NEURONAL
   AUTOPHAGY; CYTOSOLIC PROTEINS; INHIBITS AUTOPHAGY
AB Autophagy, a highly conserved process, serves to maintain cellular homeostasis in response to an extensive variety of internal and external stimuli. The classic, or canonical, pathway of autophagy involves the coordinated degradation and recycling of intracellular components and pathogenic material. Proper regulation of autophagy is critical to maintain cellular health, as alterations in the autophagy pathway have been linked to the progression of a variety of physiological and pathological conditions in humans, namely in aging and in viral infection. In addition to its canonical role as a degradative pathway, a more unconventional and non-degradative role for autophagy has emerged as an area of increasing interest. This process, known as secretory autophagy, is gaining widespread attention as many viruses are believed to use this pathway as a means to release and spread viral particles. Moreover, secretory autophagy has been found to intersect with other intracellular pathways, such as the biogenesis and secretion of extracellular vesicles (EVs). Here, we provide a review of the current landscape surrounding both degradative autophagy and secretory autophagy in relation to both aging and viral infection. We discuss their key features, while describing their interplay with numerous different viruses (i.e. hepatitis B and C viruses, Epstein-Barr virus, SV40, herpesviruses, HIV, chikungunya virus, dengue virus, Zika virus, Ebola virus, HTLV, Rift Valley fever virus, poliovirus, and influenza A virus), and compare secretory autophagy to other pathways of extracellular vesicle release. Lastly, we highlight the need for, and emphasize the importance of, more thorough methods to study the underlying mechanisms of these pathways to better advance our understanding of disease progression.
C1 [Pleet, Michelle L.; Branscome, Heather; DeMarino, Catherine; Pinto, Daniel O.; Zadeh, Mohammad Asad; Kashanchi, Fatah] George Mason Univ, Mol Virol Lab, Sch Syst Biol, Manassas, VA 20110 USA.
   [Rodriguez, Myosotys; El-Hage, Nazira] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
   [Sariyer, Ilker Kudret] Temple Univ, Dept Neurosci, Ctr Neurobiol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
RP Kashanchi, F (corresponding author), George Mason Univ, Mol Virol Lab, Sch Syst Biol, Manassas, VA 20110 USA.
EM fkashanc@gmu.edu
RI Sariyer, Ilker/AAE-7677-2020
OI Pinto, Daniel/0000-0002-1716-0217
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI078859,
   AI074410, AI127351-01, AI043894, NS099029]; National Institutes of
   Health (NIH)-National Institute on Drug Abuse (NIDA) grants [R01
   DA036154, R21 DA041287]
FX This work was supported by National Institutes of Health (NIH) Grants
   AI078859, AI074410, AI127351-01, AI043894, and NS099029 (to FK) and by
   the National Institutes of Health (NIH)-National Institute on Drug Abuse
   (NIDA) grants R01 DA036154 and R21 DA041287 (to NE-H).
CR Abels ER, 2016, CELL MOL NEUROBIOL, V36, P301, DOI 10.1007/s10571-016-0366-z
   Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07
   Alexander DE, 2008, AUTOPHAGY, V4, P101, DOI 10.4161/auto.5222
   Alirezaei M, 2008, AUTOPHAGY, V4, P963, DOI 10.4161/auto.6805
   Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6
   Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016
   Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894
   Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403
   Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556
   Bhattacharya A, 2015, INT REV IMMUNOL, V34, P382, DOI 10.3109/08830185.2014.999156
   Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111
   Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732
   Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014
   Bouley SJ, 2014, VIROLOGY, V456, P87, DOI 10.1016/j.virol.2014.03.009
   Bruno AP, 2014, CELL CYCLE, V13, P3640, DOI 10.4161/15384101.2014.952959
   Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098
   Budida R, 2017, EUR J IMMUNOL, V47, P1819, DOI 10.1002/eji.201646908
   Burman JL, 2012, P NATL ACAD SCI USA, V109, P10438, DOI 10.1073/pnas.1120688109
   Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305
   Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770
   Chaumorcel M, 2012, J VIROL, V86, P2571, DOI 10.1128/JVI.05746-11
   Chen L, 2015, BIOCHEM BIOPH RES CO, V465, P739, DOI 10.1016/j.bbrc.2015.08.070
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Cheney L., 2017, OPEN FORUM INFECT S1, V4, pS208, DOI [10.1093/ofid/ofx163.407, DOI 10.1093/OFID/OFX163.407]
   Cheng H, 2012, PROTEIN CELL, V3, P581, DOI 10.1007/s13238-012-2047-0
   Cheng LS, 2017, CLIN SCI, V131, P381, DOI [10.1042/CS20160704, 10.1042/cs20160704]
   Cheung YT, 2011, J CELL MOL MED, V15, P244, DOI 10.1111/j.1582-4934.2009.00990.x
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI 10.1056/NEJMra1205406
   Chuang SY, 2014, BIOMED RES INT, DOI 10.1155/2014/297293
   Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326
   Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458
   Cuervo AM, 2014, CURR OPIN IMMUNOL, V29, P97, DOI 10.1016/j.coi.2014.05.006
   DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2
   de Duve C, 1964, POSTGRAD MED J, V40, P557
   de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187
   Decuypere JP, 2011, J AGING RES, V2011, P1, DOI DOI 10.4061/2011/920178
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   DeMarino C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25943-2
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008
   Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006
   DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8
   Dinkins C, 2015, IMMUNOL CELL BIOL, V93, P11, DOI 10.1038/icb.2014.88
   Doring T, 2018, J VIROL, V92, DOI 10.1128/JVI.01513-17
   Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388
   Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398
   Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154
   DUVE CD, 1955, BIOCHEM J, V60, P604
   Eekels JJM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-69
   Eitan E, 2016, AGEING RES REV, V32, P65, DOI 10.1016/j.arr.2016.05.001
   Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174
   Ene L, 2011, J Med Life, V4, P432
   Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158
   Fields J, 2015, J NEUROSCI, V35, P1921, DOI 10.1523/JNEUROSCI.3207-14.2015
   Fleming A, 2014, PATHOG DIS, V71, P107, DOI 10.1111/2049-632X.12135
   Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697
   Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005
   Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   GORDON PB, 1988, BIOCHEM BIOPH RES CO, V151, P40, DOI 10.1016/0006-291X(88)90556-6
   Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422
   Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9
   Hosseini Hamideh Mahmoodzadeh, 2013, Inflammation & Allergy Drug Targets, V12, P29
   Huang WJ, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.20719
   Hung CH, 2014, J VIROL, V88, P12133, DOI 10.1128/JVI.02033-14
   Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111
   Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286
   Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Isola AL, 2017, CURR NEUROPHARMACOL, V15, P157, DOI 10.2174/1570159X14666160825160421
   Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001
   Jackson WT, 2015, VIROLOGY, V479, P450, DOI 10.1016/j.virol.2015.03.042
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Jarvela T, 2012, CELL HEALTH CYTOSKEL, V4, P37, DOI 10.2147/CHC.S21849
   Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659
   Jiang S, 2013, J INNATE IMMUN, V5, P471, DOI 10.1159/000346707
   Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0
   Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51
   Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036
   Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249
   Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347
   Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113
   Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006
   Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025
   Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09
   Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070
   Lazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034169
   Lee DY, 2008, ONCOGENE, V27, P2833, DOI 10.1038/sj.onc.1210946
   Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x
   Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107
   Lussignol M, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120372
   Lussignol M, 2013, J VIROL, V87, P859, DOI 10.1128/JVI.01158-12
   Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149
   Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Matecic M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000921
   McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10
   Meiffren G, 2010, AUTOPHAGY, V6, P299, DOI 10.4161/auto.6.2.11132
   Merabova N, 2015, J CELL PHYSIOL, V230, P831, DOI 10.1002/jcp.24811
   Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141
   Mouna L, 2016, AUTOPHAGY, V12, P327, DOI 10.1080/15548627.2015.1125071
   Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020
   Munz C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00269
   Mutsafi Y, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030139
   Nakatogawa H, 2015, AUTOPHAGY, V11, P2377, DOI 10.1080/15548627.2015.1106665
   NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993
   Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895
   Nardacci R, 2014, AUTOPHAGY, V10, P1167, DOI 10.4161/auto.28678
   Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426
   Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617
   Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   OJHA CR, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9070176
   Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001
   Panyasrivanit M, 2009, AUTOPHAGY, V5, P434, DOI 10.4161/auto.5.3.7925
   Papandreou ME, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600175
   Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371
   Paul P, 2016, ADV VIRUS RES, V95, P149, DOI 10.1016/bs.aivir.2016.02.002
   Petkova DS, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050123
   Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015
   Pleet ML, 2018, J INFECT DIS, V218, pS365, DOI 10.1093/infdis/jiy472
   Pleet ML, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01765
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Pratt ZL, 2012, J VIROL, V86, P4380, DOI 10.1128/JVI.06966-11
   Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044
   Raab-Traub N, 2017, NAT REV MICROBIOL, V15, P559, DOI 10.1038/nrmicro.2017.60
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362
   Ren T, 2015, ONCOGENE, V34, P373, DOI 10.1038/onc.2013.552
   Richards AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003046
   Richetta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003599
   Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622
   Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0
   Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045
   ROZIERES A, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9120359
   Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166
   Sagnier S, 2015, J VIROL, V89, P615, DOI 10.1128/JVI.02174-14
   Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003
   Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021
   Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527
   Sampey GC, 2016, J BIOL CHEM, V291, P1251, DOI 10.1074/jbc.M115.662171
   Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421
   Santos-Llamas A, 2018, ARCH TOXICOL, V92, P2109, DOI 10.1007/s00204-018-2200-5
   Saribas AS, 2015, CELL CYCLE, V14, P2899, DOI 10.1080/15384101.2015.1069927
   Sariyer IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045000
   Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007
   Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107
   Siracusano G, 2016, SCI REP-UK, V6, DOI 10.1038/srep31302
   Soria FN, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00026
   Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979
   Su MF, 2014, J BIOL CHEM, V289, P8029, DOI 10.1074/jbc.M113.515361
   Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11
   Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299
   Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176
   Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019
   Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581
   Tang SW, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-92
   Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019
   Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30
   Tian YJ, 2011, J VIROL, V85, P13453, DOI 10.1128/JVI.06064-11
   Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E
   Wang JH, 2013, CELL SIGNAL, V25, P2797, DOI 10.1016/j.cellsig.2013.09.010
   Wang LY, 2015, BIOL CHEM, V396, P1215, DOI 10.1515/hsz-2015-0172
   Wen HJ, 2010, J VIROL, V84, P7448, DOI 10.1128/JVI.00024-10
   White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490
   Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084
   Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740
   Zhirnov OP, 2013, J VIROL, V87, P13107, DOI 10.1128/JVI.02148-13
   Zhou DJ, 2011, J INFECT DIS, V203, P1647, DOI 10.1093/infdis/jir163
   Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524
NR 194
TC 6
Z9 6
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD OCT 18
PY 2018
VL 8
AR 362
DI 10.3389/fcimb.2018.00362
PG 17
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GX2ZB
UT WOS:000447588800001
PM 30406039
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schiela, B
   Bernklau, S
   Malekshahi, Z
   Deutschmann, D
   Koske, I
   Banki, Z
   Thielens, NM
   Wurzner, R
   Speth, C
   Weiss, G
   Stiasny, K
   Steinmann, E
   Stoiber, H
AF Schiela, Britta
   Bernklau, Sarah
   Malekshahi, Zahra
   Deutschmann, Daniela
   Koske, Iris
   Banki, Zoltan
   Thielens, Nicole M.
   Wuerzner, Reinhard
   Speth, Cornelia
   Weiss, Guenter
   Stiasny, Karin
   Steinmann, Eike
   Stoiber, Heribert
TI Active Human Complement Reduces the Zika Virus Load via Formation of the
   Membrane-Attack Complex
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE complement; Zika virus; C1q; IgM; MAC; lysis
ID WEST-NILE-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; LECTIN PATHWAY
   ACTIVATION; MANNOSE-BINDING LECTIN; INFLUENZA-VIRUS; NATURAL IGM;
   INFECTION; NEUTRALIZATION; ANTIBODIES; CELLS
AB Although neglected in the past, the interest on Zika virus (ZIKV) raised dramatically in the last several years. The rapid spread of the virus in Latin America and the association of the infection with microcephaly in newborns or Guillain-Barre Syndrome in adults prompted the WHO to declare the ZIKV epidemic to be an international public health emergency in 2016. As the virus gained only limited attention in the past, investigations on interactions of ZIKV with human complement are limited. This prompted us to investigate the stability of the virus to human complement. At low serum concentrations (10%) which refers to complement concentrations found on mucosal surfaces, the virus was relatively stable at 37 degrees C, while at high complement levels (50% serum concentration) ZIKV titers were dramatically reduced, although the virus remained infectious for about 4-5min under these conditions. The classical pathway was identified as the main actor of complement activation driven by IgM antibodies. In addition, direct binding of C1q to both envelope and NS1 proteins was observed. Formation of the MAC on the viral surface and thus complement-mediated lysis and not opsonization seems to be essential for the reduction of viral titers.
C1 [Schiela, Britta; Bernklau, Sarah; Malekshahi, Zahra; Deutschmann, Daniela; Koske, Iris; Banki, Zoltan; Stoiber, Heribert] Med Univ Innsbruck, Div Virol, Innsbruck, Austria.
   [Thielens, Nicole M.] Univ Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France.
   [Wuerzner, Reinhard; Speth, Cornelia] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria.
   [Weiss, Guenter] Med Univ Innsbruck, Dept Internal Med 2, Innsbruck, Austria.
   [Stiasny, Karin] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [Steinmann, Eike] Ruhr Univ Bochum, Dept Mol & Med Virol, Bochum, Germany.
RP Stoiber, H (corresponding author), Med Univ Innsbruck, Div Virol, Innsbruck, Austria.
EM Heribert.stoiber@i-med.ac.at
RI Thielens, Nicole M/F-2512-2013
OI Thielens, Nicole M/0000-0002-7354-0302; Steinmann,
   Eike/0000-0002-3654-9965; Stiasny, Karin/0000-0002-1902-8674; Banki,
   Zoltan/0000-0002-3826-5800
FU FWF, Vienna AustriaAustrian Science Fund (FWF) [W1253-B24]; FWFAustrian
   Science Fund (FWF) [P26117-B20]
FX This study was supported by the FWF, Vienna Austria (HOROS doctoral
   Program, W1253-B24) to HS and RW. CS was supported by the FWF (Project
   Nr. P26117-B20).
CR Avirutnan P, 2008, VACCINE, V26, pI100, DOI 10.1016/j.vaccine.2008.11.061
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250
   Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271
   BEEBE DP, 1981, J IMMUNOL, V126, P1562
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Choi YS, 2008, J EXP MED, V205, P3053, DOI 10.1084/jem.20080979
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   DESPREZ RM, 1975, INFECT IMMUN, V11, P1235, DOI 10.1128/IAI.11.6.1235-1243.1975
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Douradinha B, 2014, VIRUS RES, V179, P231, DOI 10.1016/j.virusres.2013.11.007
   Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849
   Fragnoud R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1271-7
   Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154
   Huber G, 2011, CURR OPIN HIV AIDS, V6, P419, DOI 10.1097/COH.0b013e3283495a26
   Huerta V, 2016, J PROTEOMICS, V131, P205, DOI 10.1016/j.jprot.2015.11.003
   Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005
   Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388
   Mehlhop E, 2009, VIROLOGY, V393, P11, DOI 10.1016/j.virol.2009.08.019
   Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Parej K, 2013, MOL IMMUNOL, V54, P415, DOI 10.1016/j.molimm.2013.01.009
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Seiler P, 1998, J VIROL, V72, P2253, DOI 10.1128/JVI.72.3.2253-2258.1998
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   SPEAR GT, 1993, J VIROL, V67, P53, DOI 10.1128/JVI.67.1.53-59.1993
   SPEAR GT, 1990, J VIROL, V64, P5869, DOI 10.1128/JVI.64.12.5869-5873.1990
   Tesfay MZ, 2014, J VIROL, V88, P6148, DOI 10.1128/JVI.00074-14
   Thielens NM, 2002, IMMUNOBIOLOGY, V205, P563, DOI 10.1078/0171-2985-00155
   VASANTHA S, 1988, VIROLOGY, V167, P433
NR 40
TC 5
Z9 5
U1 1
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD OCT 17
PY 2018
VL 9
AR 2177
DI 10.3389/fimmu.2018.02177
PG 9
WC Immunology
SC Immunology
GA GX1OP
UT WOS:000447487600001
PM 30386325
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, CF
   Deng, YQ
   Zu, SL
   Quanquin, N
   Shang, JZ
   Tian, M
   Ji, X
   Zhang, NN
   Dong, HL
   Xu, YP
   Zhao, LZ
   Zhang, FC
   Li, XF
   Wu, AP
   Cheng, GH
   Qin, CF
AF Li, Chunfeng
   Deng, Yong-Qiang
   Zu, Shulong
   Quanquin, Natalie
   Shang, Jingzhe
   Tian, Min
   Ji, Xue
   Zhang, Na-Na
   Dong, Hao-Long
   Xu, Yan-Peng
   Zhao, Ling-Zhai
   Zhang, Fu-Chun
   Li, Xiao-Feng
   Wu, Aiping
   Cheng, Genhong
   Qin, Cheng-Feng
TI Zika virus shedding in the stool and infection through the anorectal
   mucosa in mice
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID SEXUALLY-TRANSMITTED INFECTION; TEMBUSU VIRUS; MOUSE MODEL;
   TRANSMISSION; LEADS; IDENTIFICATION; STATES; CHINA
AB Zika virus (ZIKV) has elicited global concern due to its unique biological features, unusual transmission routes, and unexpected clinical outcomes. Although ZIKV transmission through anal intercourse has been reported in humans, it remains unclear if ZIKV is detectable in the stool, if it can infect the host through the anal canal mucosa, and what the pathogenesis of such a route of infection might be in the mouse model. Herein, we demonstrate that ZIKV RNA can be recovered from stools in multiple mouse models, as well as from the stool of a ZIKV patient. Remarkably, intra- anal (i.a.) inoculation with ZIKV leads to efficient infection in both Ifnar1(-/-) and immunocompetent mice, characterized by extensive viral replication in the blood and multiple organs, including the brain, small intestine, testes, and rectum, as well as robust humoral and innate immune responses. Moreover, i.a. inoculation of ZIKV in pregnant mice resulted in transplacental infection and delayed fetal development. Overall, our results identify the anorectal mucosa as a potential site of ZIKV infection in mice, reveal the associated pathogenesis of i.a. infection, and highlight the complexity of ZIKV transmission through anal intercourse.
C1 [Li, Chunfeng; Shang, Jingzhe; Wu, Aiping; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Shang, Jingzhe; Wu, Aiping; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Deng, Yong-Qiang; Tian, Min; Ji, Xue; Zhang, Na-Na; Dong, Hao-Long; Xu, Yan-Peng; Li, Xiao-Feng; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Li, Chunfeng; Shang, Jingzhe; Wu, Aiping; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Deng, Yong-Qiang; Zhao, Ling-Zhai; Zhang, Fu-Chun; Qin, Cheng-Feng] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Zu, Shulong] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China.
   [Zu, Shulong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Quanquin, Natalie; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
RP Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM gcheng@mednet.ucla.edu; qincf@bmi.ac.cn
RI Li, Chunfeng/S-3185-2019; Qin, Cheng-Feng/I-6839-2019
OI Li, Chunfeng/0000-0001-8883-9078; Qin, Cheng-Feng/0000-0002-0632-2807
FU NSFC Excellent Young Scientist award [81522025]; Innovative Research
   Group [81621005]; Newton Advanced Fellowship from the UK Academy of
   Medical Sciences [81661130162]; CAMS Initiative Innovative Medicine
   [2016-I2M-1-005]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [U170220023, 81772176, 31670883,
   91542201, 81590765, 31500145]; Major Project for "Significant New Drugs
   Innovation and Development" [2015ZX09102023]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI140718, AI069120, AI056154, AI078389 502]; MOST
   (China)Ministry of Science and Technology, China [2016YFD0500304];
   Guangzhou Science and Technology Program for Public Wellbeing
   [201704020229]; PUMC Youth Fund [3332016125]
FX We thank Dr. Pengcheng Pu (Institute of Biophysics, Chinese Academy of
   Science) and all members of our team for helpful discussions. C-.F.Q.
   was supported by the NSFC Excellent Young Scientist award (81522025),
   the Innovative Research Group (81621005), and the Newton Advanced
   Fellowship from the UK Academy of Medical Sciences (81661130162). This
   work was supported by the CAMS Initiative Innovative Medicine (No.
   2016-I2M-1-005), the National Natural Science Foundation of China
   (U170220023, 81772176, 31670883, 91542201, 81590765, and 31500145),
   Major Project for "Significant New Drugs Innovation and Development"
   (2015ZX09102023), NIH R01 AI140718, AI069120, AI056154 and AI078389 502
   grants, MOST (China, 2016YFD0500304), and the Guangzhou Science and
   Technology Program for Public Wellbeing (No. 201704020229). C.L. was
   supported by the PUMC Youth Fund (No. 3332016125).
CR Balfe Myles, 2010, BMC Res Notes, V3, P229, DOI 10.1186/1756-0500-3-229
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Denison HJ, 2017, AUST NZ J PUBL HEAL, V41, P432, DOI 10.1111/1753-6405.12680
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157
   Kustec T, 2016, ZDRAV VARST, V55, P174, DOI 10.1515/sjph-2016-0022
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Wang QX, 2014, AVIAN DIS, V58, P616, DOI 10.1637/10795-021114-Reg
   Wang YQ, 2017, GENOM PROTEOM BIOINF, V15, P14, DOI 10.1016/j.gpb.2017.01.001
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang NN, 2016, HUM VACC IMMUNOTHER, V12, P3107, DOI 10.1080/21645515.2016.1219004
NR 41
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 17
PY 2018
VL 7
AR 169
DI 10.1038/s41426-018-0170-6
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GX3PW
UT WOS:000447639500001
PM 30333476
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nasseri, B
   Soleimani, N
   Rabiee, N
   Kalbasi, A
   Karimi, M
   Hamblin, MR
AF Nasseri, Behzad
   Soleimani, Neda
   Rabiee, Navid
   Kalbasi, Alireza
   Karimi, Mahdi
   Hamblin, Michael R.
TI Point-of-care microfluidic devices for pathogen detection
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Review
DE Microfluidics-based assays; Point-of-care devices; Smart-phone based
   sensors; Low resource environments; Micropattern soft lithography;
   Lab-on-a-chip diagnosis; Infectious microorganisms; Biomarkers of
   infection
ID ON-A-CHIP; HEPATITIS-B-VIRUS; ENHANCED RAMAN-SCATTERING; TOTAL ANALYSIS
   SYSTEMS; ESCHERICHIA-COLI; CAPILLARY-ELECTROPHORESIS; RAPID DETECTION;
   MYCOBACTERIUM-TUBERCULOSIS; VIBRIO-CHOLERAE; ULTRASENSITIVE DETECTION
AB The rapid diagnosis of pathogens is crucial in the early stages of treatment of diseases where the choice of the correct drug can be critical. Although conventional cell culture-based techniques have been widely utilized in clinical applications, newly introduced optical-based, microfluidic chips are becoming attractive. The advantages of the novel methods compared to the conventional techniques comprise more rapid diagnosis, lower consumption of patient sample and valuable reagents, easy application, and high reproducibility in the detection of pathogens. The miniaturized channels used in microfluidic systems simulate interactions between cells and reagents in microchannel structures, and evaluate the interactions between biological moieties to enable diagnosis of microorganisms. The overarching goal of this review is to provide a summary of the development of microfluidic biochips and to comprehensively discuss different applications of microfluidic biochips in the detection of pathogens. New types of microfluidic systems and novel techniques for viral pathogen detection (e.g. HIV, HVB, ZIKV) are covered. Next generation techniques relying on high sensitivity, specificity, lower consumption of precious reagents, suggest that rapid generation of results can be achieved via optical based detection of bacterial cells. The introduction of smartphones to replace microscope based observation has substantially improved cell detection, and allows facile data processing and transfer for presentation purposes.
C1 [Nasseri, Behzad; Soleimani, Neda] Shahid Beheshti Univ, Dept Microbiol, Fac Life Sci & Biotechnol, Tehran, Iran.
   [Nasseri, Behzad; Soleimani, Neda] Shahid Beheshti Univ, Dept Microbial Biotechnol, Fac Life Sci & Biotechnol, Tehran, Iran.
   [Nasseri, Behzad; Soleimani, Neda] Shahid Beheshti Univ, Dept Nanobiotechnol, Fac Life Sci & Biotechnol, Tehran, Iran.
   [Nasseri, Behzad] Hacettepe Univ, Chem Engn Dept, TR-06800 Ankara, Turkey.
   [Nasseri, Behzad] Hacettepe Univ, Bioengn Div, TR-06800 Ankara, Turkey.
   [Rabiee, Navid] Shahid Beheshti Univ, Dept Chem, Tehran, Iran.
   [Kalbasi, Alireza] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
   [Karimi, Mahdi] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran.
   [Karimi, Mahdi] Iran Univ Med Sci, Fac Adv Technol Med, Dept Med Nanotechnol, Tehran, Iran.
   [Karimi, Mahdi; Hamblin, Michael R.] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.
   [Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA.
   [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Hamblin, MR (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.; Karimi, M (corresponding author), Iran Univ Med Sci, Hemmat Highway, Tehran, Tehran Province, Iran.
EM b_nasseri@sbu.ac.ir; N_soleimani@sbu.ac.ir; nrabiee94@gmail.com;
   alireza_kalbasi@dfci.harvard.edu; m_karimy2006@yahoo.com;
   Hamblin@helix.mgh.harvard.edu
RI Rabiee, Navid/K-4407-2019; Hamblin, Michael R/H-2758-2019; Rabiee,
   Mohammad/L-9865-2018
OI Rabiee, Navid/0000-0002-6945-8541; Hamblin, Michael
   R/0000-0001-6431-4605; Rabiee, Mohammad/0000-0003-1180-8729
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI050875, R21 AI121700]
CR [Anonymous], ANAL CHEM, V69, P373
   Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e
   Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h
   Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408
   Chiu DT, 2017, CHEM-US, V2, P201, DOI 10.1016/j.chempr.2017.01.009
   Chung HJ, 2013, NAT NANOTECHNOL, V8, P369, DOI [10.1038/nnano.2013.70, 10.1038/NNANO.2013.70]
   Cohen J., 2016, SCIENCE
   de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]
   Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200
   Dina NE, 2017, ANALYST, V142, P1782, DOI [10.1039/c7an00106a, 10.1039/C7AN00106A]
   Dittrich PS, 2006, ANAL CHEM, V78, P3887, DOI 10.1021/ac0605602
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Duval D, 2012, LAB CHIP, V12, P1987, DOI [10.1039/c2lc40054e, 10.1039/c21c40054e]
   Ertl P, 2004, ANAL CHEM, V76, P3749, DOI 10.1021/ac035282a
   FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641
   Fiscus SA, 2006, PLOS MED, V3, P1743, DOI 10.1371/journal.pmed.0030417
   Fitzgerald JE, 2017, TRENDS BIOTECHNOL, V35, P33, DOI 10.1016/j.tibtech.2016.08.005
   Foudeh AM, 2012, LAB CHIP, V12, P3249, DOI 10.1039/c2lc40630f
   Funes-Huacca M, 2012, LAB CHIP, V12, P4269, DOI 10.1039/c2lc40391a
   Fykse EM, 2007, APPL ENVIRON MICROB, V73, P1457, DOI 10.1128/AEM.01635-06
   Gaits F., 2003, SCI STKE, V2003
   Gau JJ, 2001, BIOSENS BIOELECTRON, V16, P745, DOI 10.1016/S0956-5663(01)00216-0
   Gervais L, 2011, ADV MATER, V23, pH151, DOI 10.1002/adma.201100464
   Ghazani AA, 2013, NANOMED-NANOTECHNOL, V9, P1009, DOI 10.1016/j.nano.2013.03.011
   Godber B, 2005, CLIN CHEM, V51, P1962, DOI 10.1373/clinchem.2005.053249
   Gomez-Sjoberg R, 2005, J MICROELECTROMECH S, V14, P829, DOI 10.1109/JMEMS.2005.845444
   Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   Guan XA, 2010, BIOMED MICRODEVICES, V12, P683, DOI 10.1007/s10544-010-9421-6
   Hanscheid T, 1999, CLIN LAB HAEMATOL, V21, P235, DOI 10.1046/j.1365-2257.1999.00220.x
   HARRISON DJ, 1992, ANAL CHEM, V64, P1926, DOI 10.1021/ac00041a030
   Hart RW, 2011, ORAL DIS, V17, P745, DOI 10.1111/j.1601-0825.2011.01808.x
   Haun JB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002048
   Hochstetier S., 2005, GOOGLE PATENTS
   Hoppmann EP, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2286076
   Hossain SMZ, 2012, ANAL BIOANAL CHEM, V403, P1567, DOI 10.1007/s00216-012-5975-x
   Huang G., 2017, SCI REP, V7
   Huq A, 1996, J FOOD PROTECT, V59, P96, DOI 10.4315/0362-028X-59.1.96
   Ionescu-Zanetti C, 2005, P NATL ACAD SCI USA, V102, P9112, DOI 10.1073/pnas.0503418102
   Issadore D, 2011, LAB CHIP, V11, P2282, DOI 10.1039/c1lc20177h
   Janasek D, 2006, NATURE, V442, P374, DOI 10.1038/nature05059
   Jarvius J, 2006, NAT METHODS, V3, P725, DOI 10.1038/NMETH916
   Jayamohan H., 2017, ARXIV170308583
   Jiang XY, 2003, J AM CHEM SOC, V125, P5294, DOI 10.1021/ja034566+
   Jokerst JC, 2012, ANAL CHEM, V84, P2900, DOI 10.1021/ac203466y
   Joung HA, 2014, BIOSENS BIOELECTRON, V53, P330, DOI 10.1016/j.bios.2013.10.004
   Kang T, 2010, NANO LETT, V10, P1189, DOI 10.1021/nl1000086
   Kaur H, 2000, Indian J Med Sci, V54, P432
   Ke C, 2004, SENSOR ACTUAT B-CHEM, V102, P308, DOI 10.1016/j.snb.2004.04.083
   Kim DK, 2011, ANAL CHEM, V83, P6215, DOI 10.1021/ac2007762
   Kim E, 1996, J AM CHEM SOC, V118, P5722, DOI 10.1021/ja960151v
   Kim G, 2015, BIOSENS BIOELECTRON, V67, P243, DOI 10.1016/j.bios.2014.08.023
   Ko H, 2014, ADV MATER, V26, P2335, DOI 10.1002/adma.201305014
   KOCH WH, 1993, APPL ENVIRON MICROB, V59, P556, DOI 10.1128/AEM.59.2.556-560.1993
   Kong RYC, 2002, WATER RES, V36, P2802, DOI 10.1016/S0043-1354(01)00503-6
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Kramer MF, 2004, J FOOD PROTECT, V67, P46, DOI 10.4315/0362-028X-67.1.46
   Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6
   Laksanasopin T., 2015, SCIENCE, V7, P1
   Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711
   Lee H, 2009, ANGEW CHEM INT EDIT, V48, P5657, DOI 10.1002/anie.200901791
   Lee SJ, 2008, SENSOR ACTUAT B-CHEM, V132, P443, DOI 10.1016/j.snb.2007.10.035
   Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406
   Lee WG, 2007, LAB CHIP, V7, P516, DOI 10.1039/b614912j
   Lei KF, 2012, JALA-J LAB AUTOM, V17, P330, DOI 10.1177/2211068212454853
   Li PCH, 1997, ANAL CHEM, V69, P1564, DOI 10.1021/ac9606564
   Li YB, 2006, J RAPID METH AUT MIC, V14, P96, DOI 10.1111/j.1745-4581.2006.00034.x
   Liong M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2745
   Liu GL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2031935
   Liu RH, 2006, J ASS LAB AUTOM, V11, P360
   Liu RH, 2006, ANAL CHEM, V78, P4184, DOI 10.1021/ac060450v
   Liu SR, 1999, ANAL CHEM, V71, P566, DOI 10.1021/ac980783v
   Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x
   Malic L, 2009, BIOSENS BIOELECTRON, V24, P2218, DOI 10.1016/j.bios.2008.11.031
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manganelli R, 1999, MOL MICROBIOL, V31, P715, DOI 10.1046/j.1365-2958.1999.01212.x
   Manz A., 1997, SOL STAT SENS ACT 19
   Mason HY, 2003, BIOSENS BIOELECTRON, V18, P521, DOI 10.1016/S0956-5663(03)00010-1
   McNerney R, 2011, NAT REV MICROBIOL, V9, P204, DOI 10.1038/nrmicro2521
   Mocan T, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0260-y
   Moller-Kristensen M, 2007, J INVEST DERMATOL, V127, P1524, DOI 10.1038/sj.jid.5700748
   Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Mujika M, 2009, BIOSENS BIOELECTRON, V24, P1253, DOI 10.1016/j.bios.2008.07.024
   Mukhopadhyay R, 2007, ANAL CHEM, V79, P7249, DOI 10.1021/ac071972t
   Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005
   Myers KM, 2006, MOL CELL PROBE, V20, P71, DOI 10.1016/j.mcp.2005.09.006
   Na W, 2018, BIOSENS BIOELECTRON, V108, P9, DOI 10.1016/j.bios.2018.02.040
   Navarro-Noya Y, 2012, BRAZ J MICROBIOL, V43, P283, DOI [10.1590/S1517-83822012000100033, 10.1590/S1517-838220120001000033]
   O'Sullivan CE, 2002, J CLIN MICROBIOL, V40, P1723, DOI 10.1128/JCM.40.5.1723-1727.2002
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017
   Park TS, 2013, LAB CHIP, V13, P4832, DOI 10.1039/c3lc50976a
   Peng S, 2006, J AM CHEM SOC, V128, P10676, DOI 10.1021/ja063969h
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pohlmann C, 2014, ANALYST, V139, P1063, DOI 10.1039/c3an02059b
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Psaltis AJ, 2007, LARYNGOSCOPE, V117, P1302, DOI 10.1097/MLG.0b013e31806009b0
   Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060
   Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3
   Radke SM, 2004, IEEE SENS J, V4, P434, DOI 10.1109/JSEN.2004.830300
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920
   Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q
   Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118
   SalimiMoosavi H, 1997, J AM CHEM SOC, V119, P8716, DOI 10.1021/ja971735f
   SalmanOgli A, 2016, CURR APPL PHYS, V16, P1498, DOI 10.1016/j.cap.2016.08.021
   Salmanogli A., 2017, SENS ACTUATORS A
   SalmanOgli A, 2017, J LUMIN, V190, P386, DOI 10.1016/j.jlumin.2017.05.083
   Salmanogli A, 2017, SENSOR ACTUAT A-PHYS, V262, P87, DOI 10.1016/j.sna.2017.05.013
   Shanmukh S, 2008, ANAL BIOANAL CHEM, V390, P1551, DOI 10.1007/s00216-008-1851-0
   Shao HL, 2012, THERANOSTICS, V2, P55, DOI 10.7150/thno.3465
   Shelby JP, 2003, P NATL ACAD SCI USA, V100, P14618, DOI 10.1073/pnas.2433968100
   Silley P, 1996, J APPL BACTERIOL, V80, P233, DOI 10.1111/j.1365-2672.1996.tb03215.x
   Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256
   Sin MLY, 2013, IEEE NANOTECHNOL MAG, V7, P31, DOI 10.1109/MNANO.2012.2237331
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stokes DL, 2001, FRESEN J ANAL CHEM, V369, P295, DOI 10.1007/s002160000660
   Streets AM, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4789751
   Tamarm O, 2003, BIOSENS BIOELECTRON, V18, P755, DOI 10.1016/S0956-5663(03)00022-8
   Tani H, 2004, ANAL CHEM, V76, P6693, DOI 10.1021/ac049401d
   Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757
   Tawil N, 2012, BIOSENS BIOELECTRON, V37, P24, DOI 10.1016/j.bios.2012.04.048
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Tram K, 2014, ANGEW CHEM INT EDIT, V53, P12799, DOI 10.1002/anie.201407021
   UNAIDS, 2017, END AIDS PROGR 90 90
   Varshney M, 2007, BIOSENS BIOELECTRON, V22, P2408, DOI 10.1016/j.bios.2006.08.030
   Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q
   Wan Y, 2014, J MATER CHEM B, V2, P4818, DOI 10.1039/c4tb00288a
   Wang F, 2012, J BIOMED NANOTECHNOL, V8, P786, DOI 10.1166/jbn.2012.1446
   Wang J.-H., 2012, MICR SYST MEMS 2012
   Wang L, 2008, ANAL CHIM ACTA, V610, P97, DOI 10.1016/j.aca.2007.12.048
   Wang S., 2010, P SPIE
   Wang Y, 2012, ANAL CHEM, V84, P8345, DOI 10.1021/ac301904x
   Wang YZ, 2017, INT J NANOMED, V12, P4789, DOI 10.2147/IJN.S137338
   Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616
   Whitesides G., 2006, NATURE
   Wilson A.D., 2016, NANOBIOSENS DIS DIAG, V5, P15, DOI DOI 10.2147/NDD.S66278
   WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010
   Wu JD, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-017-0014-0
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xiang Q, 2006, BIOSENS BIOELECTRON, V21, P2006, DOI 10.1016/j.bios.2005.09.019
   Yadavalli VK, 2004, ANAL CHIM ACTA, V507, P123, DOI 10.1016/j.aca.2003.12.029
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yang M, 2013, SENSORS-BASEL, V13, P6865, DOI 10.3390/s130506865
   Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031
   Yi CQ, 2006, ANAL BIOANAL CHEM, V384, P1259, DOI 10.1007/s00216-005-0252-x
   Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028
   Yoo SM, 2016, TRENDS BIOTECHNOL, V34, P7, DOI 10.1016/j.tibtech.2015.09.012
   Yoo SM, 2015, TALANTA, V132, P112, DOI 10.1016/j.talanta.2014.09.003
   Yoo SM, 2010, MOL CELL PROBE, V24, P44, DOI 10.1016/j.mcp.2009.09.003
   Zhang H, 2010, BIOSENS BIOELECTRON, V25, P2402, DOI 10.1016/j.bios.2010.02.032
   Zhi X, 2014, BIOSENS BIOELECTRON, V54, P372, DOI 10.1016/j.bios.2013.11.025
   Zhou JH, 2012, ANAL BIOANAL CHEM, V402, P1601, DOI 10.1007/s00216-011-5585-z
   Zourob M, 2005, BIOSENS BIOELECTRON, V21, P293, DOI 10.1016/j.bios.2004.10.013
NR 157
TC 40
Z9 42
U1 59
U2 240
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD OCT 15
PY 2018
VL 117
BP 112
EP 128
DI 10.1016/j.bios.2018.05.050
PG 17
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA GR0GH
UT WOS:000442191900015
PM 29890393
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ojha, CR
   Rodriguez, M
   Lapierre, J
   Karuppan, MKM
   Branscome, H
   Kashanchi, F
   El-Hage, N
AF Ojha, Chet Raj
   Rodriguez, Myosotys
   Lapierre, Jessica
   Karuppan, Mohan Kumar Muthu
   Branscome, Heather
   Kashanchi, Fatah
   El-Hage, Nazira
TI Complementary Mechanisms Potentially Involved in the Pathology of Zika
   Virus
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE Zika virus; toll-like receptor; autophagy; apoptosis; unfolded protein
   response
ID INNATE IMMUNE-RESPONSE; RECEPTOR TYROSINE KINASE; STRESS GRANULE
   FORMATION; TOLL-LIKE RECEPTOR-3; DENGUE VIRUS; WEST-NILE;
   ENDOPLASMIC-RETICULUM; NEURAL PROGENITORS; VIRAL-INFECTION; HOST-DEFENSE
AB Zika virus (ZIKV) has emerged as a global health threat due to its neuro-teratogenic effect and wide range of transmission routes. Most recently, ZIKV infection has been linked with both autoimmune disorders in adults and neurodevelopmental disorders in newborns. Researchers are exploring potential cellular and molecular mechanisms underlying the neuro-teratogenicity and related consequences by using various in vitro cell culture methods and in vivo animal models. Though some of the putative viral entry receptors have been identified for ZIKV entry into the target cells, the exact mechanism of ZIKV entry or induced pathology are still not clear. Some of the important host cellular pathways including the toll-like receptor (TLR), autophagy, apoptosis and unfolded protein response (UPR) pathways are considered potential mechanism(s) for ZIKV induced neuroinflammation and for neurodevelopmental disorders. Since there is still a dire need for efficient treatment and vaccine to prevent ZIKV mediated disorders, a better understanding of the interaction between virus and host cellular pathways could pave the way for development of targeted therapeutic intervention. In this review, we are focusing on the recent advances and current knowledge regarding the interaction of ZIKV with abovementioned pathways so as to provide basic understanding to execute further research that could aid in the development of novel therapeutic strategy.
C1 [Ojha, Chet Raj; Rodriguez, Myosotys; Lapierre, Jessica; Karuppan, Mohan Kumar Muthu; El-Hage, Nazira] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
   [Branscome, Heather; Kashanchi, Fatah] George Mason Univ, Sch Syst Biol, Mol Virol Lab, Manassas, VA USA.
RP El-Hage, N (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
EM nelhage@fiu.edu
OI Ojha, Chet Raj/0000-0002-6816-8892
FU National Institutes of Health (NIH)-National Institute on Drug Abuse
   (NIDA)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) [DA036154]; Florida Department of Health [7ZK09]; Florida
   International University graduate school
FX We gratefully acknowledge the support of the National Institutes of
   Health (NIH)-National Institute on Drug Abuse (NIDA) grant DA036154 and
   Florida Department of Health grant 7ZK09 to NE-H. We also acknowledge
   the presidential award given to CO from Florida International University
   graduate school.
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Alberts B., 2002, MOL BIOL CELL
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Althaus CL, PLOS MED, V13
   Amaral JD, 2010, DISCOV MED, V9, P145
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Anderson P, 2002, J CELL SCI, V115, P3227
   Ayala Alfred, 2007, Novartis Found Symp, V280, P37
   Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Camenisch TD, 1999, J IMMUNOL, V162, P3498
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao B, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86654
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722
   Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcia M, 2017, EUR CYTOKINE NETW, V28, P41, DOI 10.1684/ecn.2017.0394
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Heslop HE, 2013, HEMATOL-AM SOC HEMAT, P342, DOI 10.1182/asheducation-2013.1.342
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Jung CY, 2018, ANTICANCER RES, V38, P279, DOI 10.21873/anticanres.12219
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kimani SG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43908
   Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009
   Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346
   Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Narayanan R., 2018, MOJ PROTEOMICS BIOIN, V3, P1, DOI [10.15406/mojpb.2016.03.00084, DOI 10.15406/MOJPB.2016.03.00084]
   OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016
   Ojha CR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070176
   Okamoto T, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9090243
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM, V12, P371, DOI 10.1007/s11481-017-9743-8
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rankin EB, 2016, CANCERS, V8, DOI 10.3390/cancers8110103
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207
   Sautto G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/450963
   Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200
   Shibutani ST, 2015, NAT IMMUNOL, V16, P1014, DOI 10.1038/ni.3273
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777
   Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.14
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
NR 126
TC 4
Z9 4
U1 0
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD OCT 15
PY 2018
VL 9
AR 2340
DI 10.3389/fimmu.2018.02340
PG 12
WC Immunology
SC Immunology
GA GW8UI
UT WOS:000447256100001
PM 30374352
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, J
   Beier, JC
   Cantrell, RS
   Cosner, C
   Fuller, DO
   Guan, YT
   Zhang, GY
   Ruan, SG
AF Chen, Jing
   Beier, John C.
   Cantrell, Robert Stephen
   Cosner, Chris
   Fuller, Douglas O.
   Guan, Yongtao
   Zhang, Guoyan
   Ruan, Shigui
TI Modeling the importation and local transmission of vector-borne diseases
   in Florida: The case of Zika outbreak in 2016
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Mathematical modeling; Mosquito-borne diseases; Chikungunya; Dengue;
   Zika; Transmission dynamics; Sensitive analysis
ID VIRUS OUTBREAK; REPRODUCTION NUMBER; POPULATION-DYNAMICS; DENGUE
   EPIDEMICS; HUMAN MOVEMENT; CHIKUNGUNYA; PERSISTENCE; EMERGENCE;
   IMMUNITY; ISLAND
AB Chikungunya, dengue, and Zika viruses are all transmitted by Aedes aegypti and Aedes albopictus mosquito species, had been imported to Florida and caused local outbreaks. We propose a deterministic model to study the importation and local transmission of these mosquito-borne diseases. The purpose is to model and mimic the importation of these viruses to Florida via travelers, local infections in domestic mosquitoes by imported travelers, and finally non-travel related transmissions to local humans by infected local mosquitoes. As a case study, the model will be used to simulate the accumulative Zika cases in Florida. Since the disease system is driven by a continuing input of infections from outside sources, orthodox analytic methods based on the calculation of the basic reproduction number are inadequate to describe and predict their behavior. Via steady-state analysis and sensitivity analysis, effective control and prevention measures for these mosquito-borne diseases are tested. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Chen, Jing] Nova Southeastern Univ, Halmos Coll Nat Sci & Oceanog, Ft Lauderdale, FL 33314 USA.
   [Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Cantrell, Robert Stephen; Cosner, Chris; Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA.
   [Fuller, Douglas O.] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33146 USA.
   [Guan, Yongtao] Univ Miami, Dept Management Sci, Coral Gables, FL 33124 USA.
   [Zhang, Guoyan] Florida Dept Hlth, Epidemiol Dis Control & Immunizat Serv, 8600 NW 17th St,Suite 200, Miami, FL 33126 USA.
RP Ruan, SG (corresponding author), Univ Miami, Dept Math, Coral Gables, FL 33124 USA.
EM ruan@math.miami.edu
RI Ruan, Shigui/AAF-9165-2020
OI Ruan, Shigui/0000-0002-6348-8205
FU Center for Disease Control and Prevention [1U01CK000510-01]; National
   Science FoundationNational Science Foundation (NSF) [DMS-1412454];
   Convergence Research Groups Program of College of Arts and Sciences at
   the University of Miami
FX This research was partially supported by the Center for Disease Control
   and Prevention grant (1U01CK000510-01) "Southeastern Regional Center of
   Excellence in Vector-Borne Diseases: The Gateway Program", National
   Science Foundation (DMS-1412454), and the Convergence Research Groups
   Program of College of Arts and Sciences at the University of Miami. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR American Mosquito Control Association, 2016, MOSQ BORN DIS
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CDC, 2018, ZIK VIR
   Center for Disease Control and Prevention (CDC), 2016, 2014 FIN DAT US
   Center for Disease Control and Prevention (CDC), 2016, PREP RESP CHIKUNG VI
   Centers for Disease Control, 2016, CHIK VIR US
   Centers for Disease Control and Prevention (CDC), 2016, DENGUE
   Chen J, 2016, DISCRETE CONT DYN-B, V21, P2423, DOI 10.3934/dcdsb.2016054
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Chowell G, 2013, MATH BIOSCI ENG, V10, P1455, DOI 10.3934/mbe.2013.10.1455
   Cosner C, 2009, J THEOR BIOL, V258, P550, DOI 10.1016/j.jtbi.2009.02.016
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Diekmann O., 2009, J ROYAL SOC INTERFAC, V7
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Florida Department of Health (FDH), 2017, CHIK FEV CHIK
   Florida Department of Health (FDH), 2016, DENG FEV
   Florida Department of Health (FDH), 2018, ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao D, 2014, ANAL MODELING SPATIA, P109
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gao DZ, 2012, SIAM J APPL MATH, V72, P819, DOI 10.1137/110850761
   Garrett L, 1996, FOREIGN AFF, V75, P66, DOI 10.2307/20047468
   GILOTRA SK, 1967, AM J EPIDEMIOL, V86, P379, DOI 10.1093/oxfordjournals.aje.a120748
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   KEENER JP, 1973, ARCH RATION MECH AN, V50, P159, DOI 10.1007/BF00703966
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Linares S., 2007, JPN J INFECT DIS, V60, P408
   Liu P, 2007, J FUNCT ANAL, V251, P573, DOI 10.1016/j.jfa.2007.06.015
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Mack S., 2016, WRLN
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO [Pan American Health Organization], 2011, PREP RESP CHIK VIR I
   Pan American Health Organization (PAHO), 2018, ZIK VIR INF
   Pan American Health Organization (PAHO), 2018, CHIK
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918
   Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   United States Census Bureau (USCB), 2013, 2013 HIST POP DAT
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Verma Priyanka, 2018, Current Immunology Reviews, V14, P31, DOI 10.2174/1573395514666180417143739
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 75
TC 2
Z9 2
U1 1
U2 42
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD OCT 14
PY 2018
VL 455
BP 342
EP 356
DI 10.1016/j.jtbi.2018.07.026
PG 15
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA GT2WN
UT WOS:000444361100033
PM 30053386
DA 2020-07-08
ER

PT J
AU Cheng, YC
   Tjaden, NB
   Jaeschke, A
   Luhken, R
   Ziegler, U
   Thomas, SM
   Beierkuhnlein, C
AF Cheng, Yanchao
   Tjaden, Nils Benjamin
   Jaeschke, Anja
   Luehken, Renke
   Ziegler, Ute
   Thomas, Stephanie Margarete
   Beierkuhnlein, Carl
TI Evaluating the risk for Usutu virus circulation in Europe: comparison of
   environmental niche models and epidemiological models
SO INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS
LA English
DT Article
DE Usutu; Maxent; SEIR; Vector-borne disease; Risk map; Europe; Basic
   reproduction number; R-0; ENM
ID WEST-NILE-VIRUS; INFECTIOUS-DISEASES; CLIMATE-CHANGE; SELECTING
   THRESHOLDS; GLOBAL DISTRIBUTION; SPECIES OCCURRENCE; ZIKA VIRUS; WORLD
   MAP; TRANSMISSION; GERMANY
AB Background: Usutu virus (USUV) is a mosquito-borne flavivirus, reported in many countries of Africa and Europe, with an increasing spatial distribution and host range. Recent outbreaks leading to regional declines of European common blackbird (Turdus merula) populations and a rising number of human cases emphasize the need for increased awareness and spatial risk assessment.
   Methods: Modelling approaches in ecology and epidemiology differ substantially in their algorithms, potentially resulting in diverging model outputs. Therefore, we implemented a parallel approach incorporating two commonly applied modelling techniques: (1) Maxent, a correlation-based environmental niche model and (2) a mechanistic epidemiological susceptible-exposed-infected-removed (SEIR) model. Across Europe, surveillance data of USUV-positive birds from 2003 to 2016 was acquired to train the environmental niche model and to serve as test cases for the SEIR model. The SEIR model is mainly driven by daily mean temperature and calculates the basic reproduction number R-0. The environmental niche model was run with long-term bio-climatic variables derived from the same source in order to estimate climatic suitability.
   Results: Large areas across Europe are currently suitable for USUV transmission. Both models show patterns of high risk for USUV in parts of France, in the Pannonian Basin as well as northern Italy. The environmental niche model depicts the current situation better, but with USUV still being in an invasive stage there is a chance for under-estimation of risk. Areas where transmission occurred are mostly predicted correctly by the SEIR model, but it mostly fails to resolve the temporal dynamics of USUV events. High R-0 values predicted by the SEIR model in areas without evidence for real-life transmission suggest that it may tend towards over-estimation of risk.
   Conclusions: The results from our parallel-model approach highlight that relying on a single model for assessing vector-borne disease risk may lead to incomplete conclusions. Utilizing different modelling approaches is thus crucial for risk-assessment of under-studied emerging pathogens like USUV.
C1 [Cheng, Yanchao; Tjaden, Nils Benjamin; Jaeschke, Anja; Thomas, Stephanie Margarete; Beierkuhnlein, Carl] Univ Bayreuth, Dept Biogeog, Univ Str 30, D-95447 Bayreuth, Germany.
   [Luehken, Renke] World Hlth Org Collaborating Ctr Arbovirus & Hemo, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Ziegler, Ute] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Sudufer 10, D-17493 Greifswald, Germany.
   [Beierkuhnlein, Carl] Bayreuth Ctr Ecol & Environm Res, BayCEER, Bayreuth, Germany.
RP Cheng, YC (corresponding author), Univ Bayreuth, Dept Biogeog, Univ Str 30, D-95447 Bayreuth, Germany.
EM yanchao1.cheng@uni-bayreuth.de
OI Thomas, Stephanie Margarete/0000-0003-0507-2006; Luhken,
   Renke/0000-0002-1984-839X
FU Federal Ministry of Education and Research of Germany (BMBF)Federal
   Ministry of Education & Research (BMBF) [01EI1702A, 01KL1601]; China
   Scholarship CouncilChina Scholarship Council [201506040059]; German
   Research Foundation (DFG)German Research Foundation (DFG); University of
   Bayreuth
FX This work was partly funded by the Federal Ministry of Education and
   Research of Germany (BMBF), Grant Nos. 01EI1702A and 01KL1601. Yanchao
   Cheng is funded by China Scholarship Council, No. 201506040059. This
   publication was funded by the German Research Foundation (DFG) and the
   University of Bayreuth in the funding programme Open Access Publishing.
CR Allering L, 2012, EUROSURVEILLANCE, V17, P2
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854
   Barbic L, 2013, VECTOR-BORNE ZOONOT, V13, P772, DOI 10.1089/vbz.2012.1236
   Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borstler J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1597-z
   Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200
   Brugger K, 2009, PREV VET MED, V88, P24, DOI 10.1016/j.prevetmed.2008.06.023
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cianci D, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0001-0
   Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015
   Cramer W, 2001, CLIMATE CHANGE 2001
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Durand B, 2016, EPIDEMIOL INFECT, V144, P1857, DOI 10.1017/S095026881600011X
   Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x
   Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x
   Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Escribano-Romero E, 2015, VET MICROBIOL, V176, P365, DOI 10.1016/j.vetmic.2015.02.005
   Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122
   Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5
   HOFSTRA N, 2008, J GEOPHYS RES-ATMOS, V113, DOI DOI 10.1029/2008JD010100
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Kang DS, 2017, VECTOR BIOL J, V2, P1, DOI [10.4172/2473-4810.1000116, DOI 10.4172/2473-4810.1000116]
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096
   Liu CR, 2016, ECOL EVOL, V6, P337, DOI 10.1002/ece3.1878
   Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058
   Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x
   Luhken R, 2017, EMERG INFECT DIS, V23, P1991, DOI 10.3201/eid2312.171257
   Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8
   Moller AP, 2014, OECOLOGIA, V175, P1019, DOI 10.1007/s00442-014-2953-3
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Munoz J, 2011, J MED ENTOMOL, V48, P956, DOI 10.1603/ME11016
   Ng V, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP669, 10.1289/ehp669]
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799
   Pautasso A, 2016, VECTOR-BORNE ZOONOT, V16, P292, DOI 10.1089/vbz.2015.1851
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Percivalle E, 2017, VECTOR-BORNE ZOONOT, V17, P658, DOI 10.1089/vbz.2017.2126
   Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Poidinger M, 1996, VIROLOGY, V218, P417, DOI 10.1006/viro.1996.0213
   R Core Team, R LANG ENV STAT COMP
   Reiczigel J, 2010, STOCH ENV RES RISK A, V24, P455, DOI 10.1007/s00477-009-0333-z
   Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Roiz D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-333
   Rubel F, 2008, PREV VET MED, V85, P166, DOI 10.1016/j.prevetmed.2008.01.006
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Samy AM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003250
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Tamas B, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.72
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tjaden NB, 2018, TRENDS PARASITOL, V34, P227, DOI 10.1016/j.pt.2017.11.006
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Vittecoq M, 2013, VECTOR-BORNE ZOONOT, V13, P610, DOI 10.1089/vbz.2012.1166
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367, DOI 10.1080/00034983.1964.11686258
   Wu T, 2017, AMBIO, V46, P18, DOI 10.1007/s13280-016-0809-2
   Ziegler U, 2016, VET MICROBIOL, V192, P60, DOI 10.1016/j.vetmic.2016.06.007
   Ziegler U, 2015, VECTOR-BORNE ZOONOT, V15, P481, DOI 10.1089/vbz.2014.1746
NR 82
TC 5
Z9 5
U1 3
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-072X
J9 INT J HEALTH GEOGR
JI Int. J. Health Geogr.
PD OCT 12
PY 2018
VL 17
AR 35
DI 10.1186/s12942-018-0155-7
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GY2ZL
UT WOS:000448413800001
PM 30314528
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bastos, MM
   Coelho, FC
AF Bastos, Marcio M.
   Coelho, Flavio Codeco
TI Estimating under-observation and the full size of the 2016 Zika epidemic
   in Rio de Janeiro
SO PLOS ONE
LA English
DT Article
ID BASIC REPRODUCTION NUMBER; SEXUAL TRANSMISSION; VIRUS; COLOMBIA; HISTORY
AB The 2015-16 Zika epidemic spread quickly from north to south in Brazil. Two striking features were the much higher incidence in young adult women due to sexual transmission, and the serious congenital malformations and miscarriages associated to Zika infection in pregnant women. In this paper we use case reporting data along with live-birth records to reconstruct the full size of the epidemic through a Bayesian probabilistic graph model representing the Zika transmission probabilities of observation (case reporting) and of birth loss (through miscarriage or abortion). We find that the probability of observing (reporting) a Zika case is different between men and women and ranges between 10 to 13%. From these estimates we reconstruct the full size of the Zika epidemic in Rio de Janeiro in 2015-16.
C1 [Bastos, Marcio M.; Coelho, Flavio Codeco] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, RJ, Brazil.
RP Bastos, MM (corresponding author), Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, RJ, Brazil.
EM marciomacielbastos@hotmail.com
RI Coelho, Flavio/L-1089-2018
OI Coelho, Flavio/0000-0003-3868-4391
FU Fundacao Getulio Vargas
FX This project has received financial support in the form of a scholarship
   to Marcio Bastos from Fundacao Getulio Vargas, and equipment in the form
   of a TESLA GPU card from NVIDIA. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bastos L., 2016, BIORXIV, DOI DOI 10.1101/055475
   Betancourt M, 2015, CURRENT TRENDS BAYES, V79, P30, DOI DOI 10.1201/B18502-5)
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Coelho FC, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00317
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coelho FC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18455
   Coimbra BM, 2017, BIORXIV
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A
   Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hoffman MD, 2014, J MACH LEARN RES, V15, P1593
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 18
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 12
PY 2018
VL 13
IS 10
AR e0205001
DI 10.1371/journal.pone.0205001
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GX0UN
UT WOS:000447427300019
PM 30312300
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sacchetto, L
   Zauli, DAG
   Costa, GB
   Guagliardo, SAJ
   Alvim, LB
   Marinho, FLD
   Abrahao, JS
   Trindade, GD
   Kroon, EG
   Mateo, ECC
   Drumond, BP
AF Sacchetto, Livia
   Gomes Zauli, Danielle Alves
   Costa, Galileu Barbosa
   Guagliardo, Sarah Anne J.
   Alvim, Luige Biciati
   de Oliveira Marinho, Feliciana Lage
   Abrahao, Jonatas Santos
   Trindade, Giliane de Souza
   Kroon, Erna Geessien
   Cueva Mateo, Elvis Cristian
   Drumond, Betania Paiva
TI Screening for Zika virus RNA in sera of suspected cases: a retrospective
   cross-sectional study
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Cross-sectional study; Epidemiology; Brazil; Dengue virus;
   Chikungunya virus
ID CASE SERIES; BRAZIL; INFECTION; OUTBREAK
AB Background: Zika virus (ZIKV) became a global human health concern owing to its rapid spread worldwide and its association with congenital and neurological disorders. The current epidemiological profile of arboviruses in Brazil is characterized by widespread co-circulation of Dengue virus, Chikungunya virus, and ZIKV throughout the country. These viruses cause acute diseases frequently with overlapping symptoms, which could result in an inaccurate diagnosis based solely on clinical and epidemiological grounds. Here we conducted a screening for ZIKV RNA in serum samples from patients across Brazil with suspected ZIKV infection.
   Methods: Using RT-qPCR, we investigated ZIKV RNA in 3001 serum samples. Samples were passively acquired through a private laboratory network, between December 2015 and August 2016, from 27 Brazilian Federative Units. We performed descriptive statistics on demographic variables including sex, age, and geographic location.
   Results: ZIKV was detected in 11.4% (95%CI = 10.3-12.6%) of the sera. ZIKV RNA was detected in sera collected throughout the country, but during the analyzed period, RNA was more frequently detected in samples from the Southeast, Midwest, and North regions (3.9 to 5.8 times higher) when compared to the Northeast and South regions.
   Conclusions: These data reinforce the importance of laboratory diagnosis, surveillance systems, and further epidemiological studies to understand the dynamics of outbreaks and diseases associated with ZIKV and other arboviruses.
C1 [Sacchetto, Livia; Costa, Galileu Barbosa; Abrahao, Jonatas Santos; Trindade, Giliane de Souza; Kroon, Erna Geessien; Drumond, Betania Paiva] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gomes Zauli, Danielle Alves; Alvim, Luige Biciati; de Oliveira Marinho, Feliciana Lage; Cueva Mateo, Elvis Cristian] Inst Hermes Pardini, Vespasiano, MG, Brazil.
   [Costa, Galileu Barbosa; Guagliardo, Sarah Anne J.] US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA USA.
   [Guagliardo, Sarah Anne J.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Drumond, Betania Paiva] Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol, Juiz De Fora, MG, Brazil.
RP Drumond, BP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Bloco F4,Sala 258,Ave Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.; Drumond, BP (corresponding author), Univ Fed Juiz de Fora, Programa Posgrad Ciencias Biol, Juiz De Fora, MG, Brazil.
EM betaniadrumond@ufmg.br
RI Sacchetto, Livia/B-8841-2019; Costa, Galileu Barbosa/M-5768-2019; Kroon,
   Erna/V-5444-2019
OI Sacchetto, Livia/0000-0001-9716-6899; Barbosa Costa,
   Galileu/0000-0001-7360-6722
FU Hermes Pardini Institute; Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-01703-14]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; Pro-Reitoria de Pesquisa da Universidade Federal
   de Minas Gerais;  [MCTIC/FNDCT-CNPq/ MEC-CAPES/MS-Decit-14/2016]
FX The study was supported by Hermes Pardini Institute, Fundacao de Amparo
   a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01703-14],
   MCTIC/FNDCT-CNPq/ MEC-CAPES/MS-Decit-14/2016, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Pro-Reitoria
   de Pesquisa da Universidade Federal de Minas Gerais. Livia Sacchetto is
   fellow from CAPES. Giliane de Souza Trindade, Jonatas Santos Abrahao and
   Erna Geessien Kroon are CNPq researchers.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bioclin QUIBASA, 2017, BIOG ZIK VIR PCR
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention, 2016, CHIK
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centres for Disease Control and Prevention, DENGUE
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Ministerio da Saude Brasil, 2016, PROC SER AD VIG FEBR
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, 2016, ZIK VIR
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EPIDEMIOLOGICO, V48
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2017, B EP
   Secretaria de Vigilancia em Saude Ministerio da Saude Brasil, 2016, B EPIDEMIOLOGICO, V47
   Smith DR, 2017, CRIT REV MICROBIOL, V43, P405, DOI [10.1080/1040841X.2016.1230974, 10.1080/1040841x.2016.1230974]
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 0
Z9 0
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD OCT 11
PY 2018
VL 15
AR 155
DI 10.1186/s12985-018-1070-z
PG 8
WC Virology
SC Virology
GA GW9EK
UT WOS:000447284700001
PM 30305112
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lustig, Y
   Sofer, D
   Bucris, ED
   Mendelson, E
AF Lustig, Yaniv
   Sofer, Danit
   Bucris, Efrat Dahan
   Mendelson, Ella
TI Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus
   Cross-Reactivity
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE WNV; surveillance; one health; diagnosis; Zika; West Nile; mosquitoes;
   flavivirus
ID IMMUNOGLOBULIN-M ANTIBODIES; ZIKA VIRUS; UNITED-STATES; MOSQUITO
   SURVEILLANCE; CULEX-PIPIENS; BLOOD-DONORS; NEUROINVASIVE DISEASE;
   CENTRAL MACEDONIA; IGG ANTIBODIES; FEVER OUTBREAK
AB West Nile Virus (WNV) is an arthropod-borne flavivirus whose zoonotic cycle includes both mosquitoes and birds as amplifiers and humans and horses as dead-end hosts. In recent years WNV has been spreading globally and is currently endemic in Africa, The Middle East, India, Australia, central and southern Europe, and the Americas. Integrated surveillance schemes and environmental data aim to detect viral circulation and reduce the risk of infection for the human population emphasizing the critical role for One Health principles in public health. Approximately 20% of WNV infected patients develop West Nile Fever while in less than 1%, infection results in West Nile Neurological Disease. Currently, the diagnosis of WNV infection is primarily based on serology, since molecular identification of WNV RNA is unreliable due to the short viremia. The recent emergence of Zika virus epidemic in America and Asia has added another layer of complexity to WNV diagnosis due to significant cross-reactivity between several members of the Flaviviridae family such as Zika, dengue, Usutu, and West Nile viruses. Diagnosis is especially challenging in persons living in regions with flavivirus co-circulation as well as in travelers from WNV endemic countries traveling to Zika or dengue infected areas or vise-versa. Here, we review the recent studies implementing WNV surveillance of mosquitoes and birds within the One Health initiative. Furthermore, we discuss the utility of novel molecular methods, alongside traditional molecular and serological methods, in WNV diagnosis and epidemiological research.
C1 [Lustig, Yaniv; Sofer, Danit; Bucris, Efrat Dahan; Mendelson, Ella] Minist Hlth, Sheba Med Ctr, Cent Virol Lab, Ramat Gan, Israel.
   [Mendelson, Ella] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel.
RP Lustig, Y (corresponding author), Minist Hlth, Sheba Med Ctr, Cent Virol Lab, Ramat Gan, Israel.
EM Yaniv.lustig@sheba.health.gov.il
FU Central Virology Laboratory
FX This work was supported by internal sources of the Central Virology
   Laboratory.
CR Alba A, 2014, ZOONOSES PUBLIC HLTH, V61, P181, DOI 10.1111/zph.12048
   Andreadis TG, 2001, EMERG INFECT DIS, V7, P670
   Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137
   Angelini P, 2010, EUROSURVEILLANCE, V15, P11
   Anis E, 2014, J INFECTION, V68, P170, DOI 10.1016/j.jinf.2013.10.009
   Arnold Carrie, 2012, Lancet Neurol, V11, P1023, DOI 10.1016/S1474-4422(12)70278-8
   Autorino GL, 2002, EMERG INFECT DIS, V8, P1372, DOI 10.3201/eid0812.020234
   Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barker CM, 2009, J VECTOR ECOL, V34, P276, DOI [10.3376/038.034.0214, 10.1111/j.1948-7134.2009.00036.x]
   Barker CM, 2003, AM J TROP MED HYG, V68, P508, DOI 10.4269/ajtmh.2003.68.508
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]
   Bassal R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179774
   BERNKOPF H, 1953, J INFECT DIS, V93, P207, DOI 10.1093/infdis/93.3.207
   Bin H, 2001, ANN NY ACAD SCI, V951, P127
   Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007
   Bouzalas IG, 2016, TRANSBOUND EMERG DIS, V63, pE219, DOI 10.1111/tbed.12334
   Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Busch MP, 2006, EMERG INFECT DIS, V12, P395, DOI 10.3201/eid1203.051287
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029
   Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Casadella M, 2017, VIRUS RES, V239, P69, DOI 10.1016/j.virusres.2016.10.019
   Castillo-Olivares J, 2004, VET RES, V35, P467, DOI 10.1051/vetres:2004022
   Chaintoutis SC, 2016, ACTA TROP, V163, P26, DOI 10.1016/j.actatropica.2016.07.018
   Chen CC, 2013, INT J ENV RES PUB HE, V10, P3033, DOI 10.3390/ijerph10073033
   Chuang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046882
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Costa AN, 2011, EUROSURVEILLANCE, V16, P2
   Danis K, 2011, EUROSURVEILLANCE, V16, P2
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022
   Davis Justin K, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.90e80717c4e67e1a830f17feeaaf85de
   DeGroote JP, 2012, VECTOR-BORNE ZOONOT, V12, P657, DOI 10.1089/vbz.2011.0786
   Deurenberg RH, 2017, J BIOTECHNOL, V243, P16, DOI 10.1016/j.jbiotec.2016.12.022
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Ergunay K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2087-7
   Ergunay K, 2015, EMERG INFECT DIS, V21, P352, DOI 10.3201/eid2102.141135
   Ergunay K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003028
   Ergunay K, 2013, VECTOR-BORNE ZOONOT, V13, P744, DOI 10.1089/vbz.2012.1288
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Figuerola J, 2007, EMERG INFECT DIS, V13, P1915, DOI 10.3201/eid1312.070343
   FLATAU E, 1981, ISRAEL J MED SCI, V17, P1057
   Gaibani P, 2013, NEW MICROBIOL, V36, P81
   Gamino V, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-39
   Garcia-Bocanegra I, 2012, VET MICROBIOL, V160, P341, DOI 10.1016/j.vetmic.2012.06.027
   Garcia-Bocanegra I, 2011, EMERG INFECT DIS, V17, P2397, DOI 10.3201/eid1712.110651
   Giordano BV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183568
   Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006
   Gossner CM, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.18.30526
   Gyure KA, 2009, J NEUROPATH EXP NEUR, V68, P1053, DOI 10.1097/NEN.0b013e3181b88114
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Harrigan RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015437
   Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hoper D, 2016, REV SCI TECH OIE, V35, P83, DOI 10.20506/rst.35.1.2419
   Inojosa WO, 2012, INFECTION, V40, P557, DOI 10.1007/s15010-012-0263-4
   Jimenez-Clavero MA, 2010, VET REC, V167, P379, DOI 10.1136/vr.c3155
   Kalaycioglu H, 2012, EUROSURVEILLANCE, V17, P12
   KATZ G, 1989, ISRAEL J MED SCI, V25, P39
   Kolodziejek J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0021-5
   Kulkarni MA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.33
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Ladbury GAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080432
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Lerner Henrik, 2015, Infection Ecology & Epidemiology, V5, P25300, DOI 10.3402/iee.v5.25300
   Liu RS, 2006, MATH BIOSCI ENG, V3, P145
   Lopez G, 2008, VECTOR-BORNE ZOONOT, V8, P615, DOI 10.1089/vbz.2007.0200
   Lopez-Ruiz N, 2018, EUROSURVEILLANCE, V23, P17
   Lustig Y, 2017, CLIN MICROBIOL INFEC, V23, P986, DOI 10.1016/j.cmi.2017.04.023
   Lustig Y, 2017, INT J INFECT DIS, V64, P20, DOI 10.1016/j.ijid.2017.08.011
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Lustig Y, 2016, J INFECT DIS, V213, P1107, DOI 10.1093/infdis/jiv556
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Maidana NA, 2009, J THEOR BIOL, V258, P403, DOI 10.1016/j.jtbi.2008.12.032
   Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309
   Mallya S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3052-6
   May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10
   Montgomery SP, 2006, TRANSFUSION, V46, P2038, DOI 10.1111/j.1537-2995.2006.01030.x
   Morelli MC, 2010, CLIN INFECT DIS, V51, pE34, DOI 10.1086/655146
   Mulatti P, 2013, ZOONOSES PUBLIC HLTH, V60, P375, DOI 10.1111/zph.12013
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray KO, 2013, AM J TROP MED HYG, V89, P996, DOI 10.4269/ajtmh.13-0232
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Napoli C, 2013, INT J ENV RES PUB HE, V10, P7180, DOI 10.3390/ijerph10127180
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Orshan L, 2008, J MED ENTOMOL, V45, P939, DOI 10.1603/0022-2585(2008)45[939:MVOWNF]2.0.CO;2
   Pai A, 2008, TRANSFUSION, V48, P2184, DOI 10.1111/j.1537-2995.2008.01861.x
   Papa A, 2015, HIPPOKRATIA, V19, P34
   Papa A, 2010, EUROSURVEILLANCE, V15
   Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]
   Papa A, 2011, J MED VIROL, V83, P1857, DOI 10.1002/jmv.22190
   Paternoster G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188156
   Paternoster G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00236
   Patsoula E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2450682
   Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Pervanidou D, 2014, EUROSURVEILLANCE, V19, P28, DOI 10.2807/1560-7917.ES2014.19.13.20758
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pezzotti P, 2011, EUROSURVEILLANCE, V16, P10
   Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241
   Pierro A, 2011, VECTOR-BORNE ZOONOT, V11, P1605, DOI 10.1089/vbz.2011.0616
   Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219
   Poh KC, 2018, J MED ENTOMOL, V55, P1062, DOI 10.1093/jme/tjy051
   Prince HE, 2005, J CLIN MICROBIOL, V43, P4316, DOI 10.1128/JCM.43.9.4316-4320.2005
   Rabel PO, 2011, EURO SURVEILL, V16
   Ramamurthy Mageshbabu, 2017, VirusDisease, V28, P349, DOI 10.1007/s13337-017-0415-3
   Rappole JH, 2003, J APPL MICROBIOL, V94, p47S
   Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Rizzo C, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.37.30340
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Rosa R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-269
   Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10
   Salama M, 2019, TRAVEL MED INFECT DI, V28, P41, DOI 10.1016/j.tmaid.2018.07.008
   Sanchez-Gomez A, 2017, ACTA TROP, V169, P163, DOI 10.1016/j.actatropica.2017.02.022
   Seino KK, 2007, CLIN VACCINE IMMUNOL, V14, P1465, DOI 10.1128/CVI.00249-07
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Steiner I, 2013, NEUROLOGY, V81, P1441, DOI 10.1212/WNL.0b013e3182a840ad
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stiasny K, 2013, EUROSURVEILLANCE, V18, P26, DOI 10.2807/1560-7917.ES2013.18.43.20614
   Tesh RB, 2004, EMERG INFECT DIS, V10, P1649, DOI 10.3201/eid1009.040203
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Valiakos G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096935
   Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925
   Vrioni G, 2014, VECTOR-BORNE ZOONOT, V14, P52, DOI 10.1089/vbz.2013.1369
   Weinberger M, 2001, EMERG INFECT DIS, V7, P686, DOI 10.3201/eid0704.010416
   White DJ, 2001, EMERG INFECT DIS, V7, P643
   Williams SH, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00311-18
   Wilson MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14058
   Zana B, 2016, J VECTOR DIS, V53, P379
   Zhang W, 2009, TRANSFUS MED REV, V23, P146, DOI 10.1016/j.tmrv.2008.12.008
   Zheng H, 2014, Can Commun Dis Rep, V40, P173
   Ziermann R, 2008, EXPERT REV MOL DIAGN, V8, P239, DOI 10.1586/14737159.8.3.239
NR 145
TC 10
Z9 12
U1 2
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 11
PY 2018
VL 9
AR 2421
DI 10.3389/fmicb.2018.02421
PG 10
WC Microbiology
SC Microbiology
GA GW5VH
UT WOS:000447008200001
PM 30369916
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Valdez, LD
   Sibona, GJ
   Condat, CA
AF Valdez, L. D.
   Sibona, G. J.
   Condat, C. A.
TI Impact of rainfall on Aedes aegypti populations
SO ECOLOGICAL MODELLING
LA English
DT Article
DE Aedes; Rainfall; Mosquito abundance; Mathematical modeling; Taiwan
ID STEGOMYIA AEGYPTI; ALBOPICTUS DIPTERA; CULICIDAE LARVAE; ZIKA VIRUS;
   DENGUE; VECTOR; CLIMATE; TEMPERATURE; SURVIVAL; TRENDS
AB Aedes aegypti is the main vector of multiple diseases, such as dengue, Zika, and chikungunya. Due to modifications in weather patterns, its geographical range is continuously evolving. Temperature is a key factor for its expansion into regions with cool winters, but rainfall can also have a strong impact on the colonization of these regions, since larvae emerging after a rainfall are likely to die at temperatures below 10 degrees C. As climate change is expected to affect rainfall regimes, with a higher frequency of heavy storms and an increase in drought-affected areas, it is important to understand how different rainfall scenarios may shape Ae. aegypti's range. We develop a model for the population dynamics of Ae. aegypti, coupled with a rainfall model to study the effect of the temporal distribution of rainfall on mosquito abundance. Using a fracturing process, we then investigate the effect of a higher variability in the daily rainfall. As an example, we show that rainfall distribution is necessary to explain the geographic range of Ae. aegypti in Taiwan, an island characterized by rainy winters in the north and dry winters in the south. We also predict that a higher variability in the rainfall time distribution will decrease the maximum abundance of Ae. aegypti during the summer. An increase in daily rainfall variability will likewise enhance its extinction probability. Finally, we obtain a nonlinear relationship between dry season duration and extinction probability. These findings can have a significant impact on our ability to predict disease outbreaks.
C1 [Valdez, L. D.; Sibona, G. J.; Condat, C. A.] Univ Nacl Cordoba, Fac Matemat Astron Fis & Computac, Ciudad Univ, RA-5000 Cordoba, Argentina.
   [Valdez, L. D.; Sibona, G. J.; Condat, C. A.] Consejo Nacl Invest Cient & Tecn, Inst Fis Enrique Gaviola, Ciudad Univ, RA-5000 Cordoba, Argentina.
   [Valdez, L. D.] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.
RP Valdez, LD (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.
EM lvaldez@famaf.unc.edu.ar
RI Sibona, Gustavo J/O-3989-2018; Sibona, Gustavo J/B-3161-2012
OI Sibona, Gustavo/0000-0003-3013-159X
FU SECyT-UNCSecretaria de Ciencia y Tecnologia (SECYT) [103/15, 313/16];
   CONICETConsejo Nacional de Investigaciones Cientificas y Tecnicas
   (CONICET) [PIP 11220150100644]
FX This work was supported by SECyT-UNC (projects 103/15 and 313/16) and
   CONICET (PIP 11220150100644). We also thank Mgter. Laura Lopez for
   useful discussions.
CR BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499
   Barmak DH, 2014, EPIDEMIOL INFECT, V142, P545, DOI 10.1017/S0950268813001301
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2
   Chen C. S., 1988, YUSHANIA, V5, P1
   Chen CS, 2003, MON WEATHER REV, V131, P1323, DOI 10.1175/1520-0493(2003)131<1323:TRCOT>2.0.CO;2
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   Finley BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094920
   Garzon MJ, 2013, J VECTOR ECOL, V38, P339, DOI 10.1111/j.1948-7134.2013.12049.x
   GILLETT J. D., 1955, Bulletin of Entomological Research, V46, P241, DOI 10.1017/S0007485300030881
   GILLETT JD, 1977, PROC R SOC SER B-BIO, V196, P223, DOI 10.1098/rspb.1977.0038
   Goddard J., 2016, PHYS GUIDE ARTHROPOD
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   HAN SH, 1981, CHINESE MED J, V28, P193
   HATCHETT SP, 1946, PUBLIC HEALTH REP, V61, P1234, DOI 10.2307/4585803
   Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a
   Ho HM, 2005, ATMOS ENVIRON, V39, P5839, DOI 10.1016/j.atmosenv.2005.06.034
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Hu WB, 2006, ECOL MODEL, V196, P505, DOI 10.1016/j.ecolmodel.2006.02.028
   Hwang JS, 1991, CHINESE J ENTOMOL SP, V6, P105
   Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447
   Kress A, 2016, J VECTOR ECOL, V41, P142, DOI 10.1111/jvec.12206
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Modarres R, 2007, J ARID ENVIRON, V70, P344, DOI 10.1016/j.jaridenv.2006.12.024
   MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225
   Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110
   Norrant C, 2006, THEOR APPL CLIMATOL, V83, P89, DOI 10.1007/s00704-005-0163-y
   Gimenez JO, 2015, J MED ENTOMOL, V52, P879, DOI 10.1093/jme/tjv107
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rakesh Katyal, 1996, Dengue Bulletin, V20, P78
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Romanenko V.A., 1961, P UKRAINIAN HYDROMET, V3, P12
   Romeo Aznar V., 2013, ECOL MODEL, V253, P44, DOI DOI 10.1016/J.EC0LM0DE1.2012.12.004
   ROZEBOOM L. E., 1939, Proceedings of the Oklahoma Academy of Science, V19, P81
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tsuda Y, 2001, ENVIRON ENTOMOL, V30, P855, DOI 10.1603/0046-225X-30.5.855
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Valdez LD, 2017, J THEOR BIOL, V421, P28, DOI 10.1016/j.jtbi.2017.03.024
   Valipour M, 2014, J APPL WATER ENG RES, V2, P33, DOI 10.1080/23249676.2014.923790
   Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114
   Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 51
TC 2
Z9 2
U1 1
U2 69
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-3800
EI 1872-7026
J9 ECOL MODEL
JI Ecol. Model.
PD OCT 10
PY 2018
VL 385
BP 96
EP 105
DI 10.1016/j.ecolmodel.2018.07.003
PG 10
WC Ecology
SC Environmental Sciences & Ecology
GA GR8KX
UT WOS:000442973900010
OA Green Published
DA 2020-07-08
ER

PT J
AU Xie, XP
   Kum, DPB
   Xia, HJ
   Luo, HL
   Shan, C
   Zou, J
   Muruato, AE
   Medeiros, DBA
   Nunes, BTD
   Dallmeier, K
   Rossi, SL
   Weaver, SC
   Neyts, J
   Wang, T
   Vasconcelos, PFC
   Shi, PY
AF Xie, Xuping
   Kum, Dieudonne B.
   Xia, Hongjie
   Luo, Huanle
   Shan, Chao
   Zou, Jing
   Muruato, Antonio E.
   Medeiros, Daniele B. A.
   Nunes, Bruno T. D.
   Dallmeier, Kai
   Rossi, Shannan L.
   Weaver, Scott C.
   Neyts, Johan
   Wang, Tian
   Vasconcelos, Pedro F. C.
   Shi, Pei-Yong
TI A Single-Dose Live-Attenuated Zika Virus Vaccine with Controlled
   Infection Rounds that Protects against Vertical Transmission
SO CELL HOST & MICROBE
LA English
DT Article
ID CAPSID PROTEIN; DNA VACCINE; IMMUNOGENICITY; IMMUNITY; CONSULTATION;
   CANDIDATES; MOLECULES; DELETIONS; PHASE-1; SAFETY
AB Zika virus (ZIKV) infection of the mother during pregnancy causes devastating Zika congenital syndrome in the offspring. A ZIKV vaccine with optimal safety and immunogenicity for use in pregnant women is critically needed. Toward this goal, we have developed a single-dose live-attenuated vaccine candidate that infects cells with controlled, limited infection rounds. The vaccine contains a 9-amino-acid deletion in the viral capsid protein and replicates to titers of > 10(6) focus-forming units (FFU)/mL in cells expressing the full-length capsid protein. Immunization of A129 mice with one dose (10(5) FFU) did not produce viremia, but elicited protective immunity that completely prevented viremia, morbidity, and mortality after challenge with an epidemic ZIKV strain (10(6) PFU). A single-dose vaccination also fully prevented infection of pregnant mice and maternal-to-fetal transmission. Intracranial injection of the vaccine (10(4) FFU) to 1-day-old mice did not cause any disease or death, underscoring the safety of this vaccine candidate.
C1 [Xie, Xuping; Xia, Hongjie; Shan, Chao; Zou, Jing; Muruato, Antonio E.; Medeiros, Daniele B. A.; Nunes, Bruno T. D.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Kum, Dieudonne B.; Dallmeier, Kai; Neyts, Johan] Univ Leuven, KU Leuven, Rega Inst Med Res, Dept Microbiol & Immunol,Lab Virol & Chemoth, Leuven, Belgium.
   [Medeiros, Daniele B. A.; Nunes, Bruno T. D.; Vasconcelos, Pedro F. C.] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Para, Brazil.
   [Vasconcelos, Pedro F. C.] Para State Univ, Dept Pathol, Belem, Para, Brazil.
   [Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Neyts, Johan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Xie, XP; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
EM xuxie@utmb.edu; peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019; Xia, Hongjie/M-9241-2019; Vasconcelos,
   Pedro/AAH-3142-2019; Neyts, Johan/U-8267-2017
OI Xia, Hongjie/0000-0002-2520-7038; Neyts, Johan/0000-0002-0033-7514; Kum,
   Dieudonne Buh/0000-0001-8251-8230
FU Kleberg Foundation Award; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI127744, AI120942];
   CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [U01CK000512]
FX We thank Maki Wakamiya, Jiaren Sun, Yuejin Liang, W. Sam Fagg, Shelton
   Bradrick, Mariano Garcia-Blanco, and other colleagues at University of
   Texas Medical Branch for helpful discussions and support. The P.-Y.S.
   lab was supported by a Kleberg Foundation Award and NIH grant AI127744.
   This research was also partially supported by NIH grant AI120942 to
   S.C.W. and by Cooperative Agreement Number U01CK000512 to S.C.W., funded
   by the CDC.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang DC, 2008, NAT BIOTECHNOL, V26, P571, DOI 10.1038/nbt1400
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Hombach J, 2007, VACCINE, V25, P4130, DOI 10.1016/j.vaccine.2007.02.079
   Kofler RM, 2004, P NATL ACAD SCI USA, V101, P1951, DOI 10.1073/pnas.0307145101
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Peng MH, 2018, ANTIVIR RES, V154, P87, DOI 10.1016/j.antiviral.2018.04.013
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schlick P, 2010, VACCINE, V28, P5903, DOI 10.1016/j.vaccine.2010.06.045
   Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08
   Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Widman DG, 2008, VACCINE, V26, P2762, DOI 10.1016/j.vaccine.2008.03.009
   Widman DG, 2009, VACCINE, V27, P5550, DOI 10.1016/j.vaccine.2009.07.016
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004
NR 54
TC 16
Z9 17
U1 1
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD OCT 10
PY 2018
VL 24
IS 4
BP 487
EP +
DI 10.1016/j.chom.2018.09.008
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GW4MJ
UT WOS:000446888300008
PM 30308155
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Miterko, LN
   Lackey, EP
   Heck, DH
   Sillitoe, RV
AF Miterko, Lauren N.
   Lackey, Elizabeth P.
   Heck, Detlef H.
   Sillitoe, Roy V.
TI Shaping Diversity Into the Brain's Form and Function
SO FRONTIERS IN NEURAL CIRCUITS
LA English
DT Review
DE neuron; glia; folding; layering; connectivity; topography; patterning
ID ZIKA VIRUS; PATTERNED EXPRESSION; GENE-EXPRESSION; CEREBRAL-CORTEX;
   SONIC HEDGEHOG; BERGMANN GLIA; AXON GUIDANCE; RADIAL GLIA; CELL;
   CEREBELLUM
AB The brain contains a large diversity of unique cell types that use specific genetic programs to control development and instruct the intricate wiring of sensory, motor, and cognitive brain regions. In addition to their cellular diversity and specialized connectivity maps, each region's dedicated function is also expressed in their characteristic gross external morphologies. The folds on the surface of the cerebral cortex and cerebellum are classic examples. But, to what extent does structure relate to function and at what spatial scale? We discuss the mechanisms that sculpt functional brain maps and external morphologies. We also contrast the cryptic structural defects in conditions such as autism spectrum disorders to the overt microcephaly after Zika infections, taking into consideration that both diseases disrupt proper cognitive development. The data indicate that dynamic processes shape all brain areas to fit into jigsaw-like patterns. The patterns in each region reflect circuit connectivity, which ultimately supports local signal processing and accomplishes multi-areal integration of information processing to optimize brain functions.
C1 [Miterko, Lauren N.; Lackey, Elizabeth P.; Sillitoe, Roy V.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Miterko, Lauren N.; Sillitoe, Roy V.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
   [Miterko, Lauren N.; Lackey, Elizabeth P.; Sillitoe, Roy V.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.
   [Lackey, Elizabeth P.; Sillitoe, Roy V.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.
   [Heck, Detlef H.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.
RP Sillitoe, RV (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Sillitoe, RV (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.; Sillitoe, RV (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Sillitoe, RV (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.
EM sillitoe@bcm.edu
OI Heck, Detlef/0000-0003-2438-4064
FU Baylor College of Medicine (BCM) and Texas Children's Hospital; Hamill
   Foundation; BCM IDDRC Grant from the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development [U54HD083092]; National
   Institutes of Neurological Disorders and Stroke (NINDS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS089664, R01NS100874]; National Institutes of Mental Health
   (NIMH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH112143]
FX RS was supported by funds from Baylor College of Medicine (BCM) and
   Texas Children's Hospital, the Hamill Foundation, BCM IDDRC Grant
   U54HD083092 from the Eunice Kennedy Shriver National Institute of Child
   Health and Human Development (The IDDRC Neuropathology Sub-Core
   contributed to the tissue staining), and the National Institutes of
   Neurological Disorders and Stroke (NINDS) R01NS089664 and R01NS100874.
   DH and RS were supported by National Institutes of Mental Health (NIMH)
   R01MH112143.
CR ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4
   Altman J, 1997, DEV CEREBELLAR SYSTE
   Antoine MW, 2018, BIORXIV, DOI [10.1101/317693, DOI 10.1101/317693]
   Apps R, 2018, CEREBELLUM, V17, P654, DOI 10.1007/s12311-018-0952-3
   Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698
   Arbib M. A., 1998, NEURAL ORG STRUCTURE
   BARRON DH, 1950, J EXP ZOOL, V113, P553, DOI 10.1002/jez.1401130304
   Blaess S, 2008, DEVELOPMENT, V135, P2093, DOI 10.1242/dev.015990
   Bloem B, 2017, ELIFE, V6, DOI 10.7554/eLife.32353
   Bolk L, 1906, CEREBELLUM SAUGETIER
   Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003
   Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002
   BRODMANN K, 1909, VERGLEICHENDE LOKALI
   Caligiore D, 2017, CEREBELLUM, V16, P203, DOI 10.1007/s12311-016-0763-3
   Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025
   Carlisi CO, 2017, BIOL PSYCHIAT, V82, P83, DOI 10.1016/j.biopsych.2016.10.006
   Catania KC, 2012, CURR OPIN NEUROBIOL, V22, P251, DOI 10.1016/j.conb.2011.11.014
   Cerminara NL, 2015, NAT REV NEUROSCI, V16, P79, DOI 10.1038/nrn3886
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Christian KM, 2018, NAT MED, V24, P258, DOI 10.1038/nm.4510
   Cooperrider J, 2014, J NEUROSCI, V34, P9040, DOI 10.1523/JNEUROSCI.0953-14.2014
   Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dahlem K, 2016, J NEUROPHYSIOL, V115, P2280, DOI 10.1152/jn.00763.2015
   Dominici C, 2017, NATURE, V545, P350, DOI 10.1038/nature22331
   DREAZEN E, 1989, J ULTRAS MED, V8, P155
   ECCLES J, 1965, PERSPECT BIOL MED, V8, P289
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Fox C. A., 1967, CEREBELLUM
   Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029181
   Gebre SA, 2012, BRAIN STRUCT FUNCT, V217, P165, DOI 10.1007/s00429-011-0339-4
   GILBERT PFC, 1974, BRAIN RES, V70, P1, DOI 10.1016/0006-8993(74)90208-X
   Golden CEM, 2018, CURR OPIN NEUROBIOL, V48, P106, DOI 10.1016/j.conb.2017.11.006
   Govek EE, 2018, ISCIENCE, V1, P35, DOI 10.1016/j.isci.2018.01.004
   Guy J, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00054
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104
   Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683
   Hevner RF, 2006, MOL NEUROBIOL, V33, P33, DOI 10.1385/MN:33:1:033
   Hikishima K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00148-1
   Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028
   Hollis ER, 2016, NAT NEUROSCI, V19, P697, DOI 10.1038/nn.4282
   Homman-Ludiye J, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00079
   Horn KM, 2010, J NEUROSCI, V30, P9411, DOI 10.1523/JNEUROSCI.0440-10.2010
   Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607
   HUBEL DH, 1979, SCI AM, V241, P150, DOI 10.1038/scientificamerican0979-150
   Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462
   Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0
   KAAS JH, 1982, CONTRIBUTIONS SENSOR, V7, P201
   Kaas JH, 2013, WIRES COGN SCI, V4, P33, DOI 10.1002/wcs.1206
   Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799
   Karzbrun E, 2018, NAT PHYS, V14, P515, DOI 10.1038/s41567-018-0046-7
   Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614
   Kremer MC, 2017, GLIA, V65, P606, DOI 10.1002/glia.23115
   LARRAMEN.LM, 1967, SCIENCE, V156, P967, DOI 10.1126/science.156.3777.967
   LARSELL O, 1970, COMP ANATOMY HISTOLO
   Le Gros Clark W., 1945, DEFORMATION PATTERNS
   Legue E, 2015, DEVELOPMENT, V142, P1661, DOI 10.1242/dev.120287
   Li H, 2011, ANN NY ACAD SCI, V1225, P119, DOI 10.1111/j.1749-6632.2011.06024.x
   Li KR, 2014, J NEUROSCI, V34, P922, DOI 10.1523/JNEUROSCI.3476-13.2014
   Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493
   Long KR, 2018, NEURON, V99, P702, DOI 10.1016/j.neuron.2018.07.013
   Ma S, 2012, J NEUROSCI, V32, P14979, DOI 10.1523/JNEUROSCI.1282-12.2012
   Manto M, 2008, CEREBELLUM, V7, P505, DOI 10.1007/s12311-008-0063-7
   MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820
   Marzban H, 2011, CEREBELLUM, V10, P422, DOI 10.1007/s12311-010-0208-3
   Matsumoto N, 2017, ELIFE, V6, DOI 10.7554/eLife.29285
   Mayer C, 2016, NEURON, V92, P45, DOI 10.1016/j.neuron.2016.09.035
   McAfee S. S., 2017, BIORXIV, DOI [10.1101/173849, DOI 10.1101/173849]
   Meng Y, 2018, HUM BRAIN MAPP, V39, P3625, DOI 10.1002/hbm.24199
   Miterko L. N., 2018, HDB CEREBELLUM CEREB, P43
   Mota B, 2015, SCIENCE, V349, P74, DOI 10.1126/science.aaa9101
   MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408
   Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008
   O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010
   Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004
   Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003
   Ozol KO, 1997, HISTOL HISTOPATHOL, V12, P171
   PENFIELD W, 1968, P ROY SOC MED, V61, P831, DOI 10.1177/003591576806100839
   Peng J, 2018, NEURON, V97, P326, DOI 10.1016/j.neuron.2017.12.028
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Rakic P, 2009, TRENDS NEUROSCI, V32, P291, DOI 10.1016/j.tins.2009.01.007
   Reeber SL, 2018, CEREBELLUM, V17, P392, DOI 10.1007/s12311-014-0571-6
   RICHMAN DP, 1975, SCIENCE, V189, P18
   Riddle K, 2017, BRAIN IMAGING BEHAV, V11, P541, DOI 10.1007/s11682-016-9534-5
   Ronan L, 2015, BRAIN STRUCT FUNCT, V220, P2475, DOI 10.1007/s00429-014-0961-z
   Ronan L, 2014, CEREB CORTEX, V24, P2219, DOI 10.1093/cercor/bht082
   Roy A, 2015, ELIFE, V4, DOI 10.7554/eLife.12703
   Ruigrok TJH, 2011, CEREBELLUM, V10, P464, DOI 10.1007/s12311-010-0164-y
   Ryan KE, 2017, DEV BIOL, V432, P165, DOI 10.1016/j.ydbio.2017.09.036
   Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140
   Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X
   SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11
   SHERRY DF, 1992, TRENDS NEUROSCI, V15, P298, DOI 10.1016/0166-2236(92)90080-R
   Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237
   Sillitoe RV, 2010, J NEUROSCI, V30, P10015, DOI 10.1523/JNEUROSCI.0653-10.2010
   Sillitoe RV, 2008, J NEUROSCI, V28, P12150, DOI 10.1523/JNEUROSCI.2059-08.2008
   Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4
   Smith RS, 2018, NEURON, V99, P905, DOI 10.1016/j.neuron.2018.07.052
   Stoodley CJ, 2017, NAT NEUROSCI, V20, P1744, DOI 10.1038/s41593-017-0004-1
   Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039
   Sudarov A, 2011, J NEUROSCI, V31, P11055, DOI 10.1523/JNEUROSCI.0479-11.2011
   Sudarov A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-26
   Sultan KT, 2016, NEURON, V92, P31, DOI 10.1016/j.neuron.2016.09.033
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Tan GH, 2018, CELL RES, V28, P90, DOI 10.1038/cr.2017.128
   Tatavarty V., 2018, BIORXIV, DOI [10.1101/36, DOI 10.1101/36]
   Thawani A, 2018, CELL REP, V23, P692, DOI 10.1016/j.celrep.2018.03.080
   Uesaka N, 2014, SCIENCE, V344, P1020, DOI 10.1126/science.1252514
   Van Essen DC, 2018, BRAIN BEHAV EVOLUT, V91, P158, DOI 10.1159/000489943
   VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0
   Varadarajan SG, 2017, NEURON, V94, P790, DOI 10.1016/j.neuron.2017.03.007
   Voogd J, 1997, PROG BRAIN RES, V114, P21
   Wadiche JI, 2005, NAT NEUROSCI, V8, P1329, DOI 10.1038/nn1539
   Wang L, 2016, NAT NEUROSCI, V19, P888, DOI 10.1038/nn.4307
   Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807
   Wang YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10481
   Wangler MF, 2017, GENETICS, V207, P9, DOI 10.1534/genetics.117.203067
   Wasser CR, 2017, J BIOL CHEM, V292, P1330, DOI 10.1074/jbc.R116.766782
   Welker W., 1990, Cerebral Cortex, V8B, P3
   Welsh JP, 2002, ADV NEUROL, V89, P331
   White JJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14912
   White JJ, 2014, J NEUROSCI, V34, P8231, DOI 10.1523/JNEUROSCI.0122-14.2014
   White JJ, 2013, WIRES DEV BIOL, V2, P149, DOI 10.1002/wdev.65
   White JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4042
   Wojcinski A, 2017, NAT NEUROSCI, V20, P1361, DOI 10.1038/nn.4621
   Xiao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105633
   Zhou HY, 2014, ELIFE, V3, DOI 10.7554/eLife.02811
NR 132
TC 4
Z9 4
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5110
J9 FRONT NEURAL CIRCUIT
JI Front. Neural Circuits
PD OCT 10
PY 2018
VL 12
AR 83
DI 10.3389/fncir.2018.00083
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA GW4TY
UT WOS:000446915800001
PM 30364100
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Erasmus, JH
   Khandhar, AP
   Guderian, J
   Granger, B
   Archer, J
   Archer, M
   Gage, E
   Fuerte-Stone, J
   Larson, E
   Lin, S
   Kramer, R
   Coler, RN
   Fox, CB
   Stinchcomb, DT
   Reed, SG
   Van Hoeven, N
AF Erasmus, Jesse H.
   Khandhar, Amit P.
   Guderian, Jeff
   Granger, Brian
   Archer, Jacob
   Archer, Michelle
   Gage, Emily
   Fuerte-Stone, Jasmine
   Larson, Elise
   Lin, Susan
   Kramer, Ryan
   Coler, Rhea N.
   Fox, Christopher B.
   Stinchcomb, Dan T.
   Reed, Steven G.
   Van Hoeven, Neal
TI A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA
   Provides Single, Low-Dose Protection against Zika
SO MOLECULAR THERAPY
LA English
DT Article
ID VIRUS-INFECTION; CATIONIC NANOEMULSION; NONVIRAL DELIVERY;
   GENE-TRANSFER; TLR4 AGONIST; DNA VACCINE; EFFICACY; IMMUNOGENICITY;
   NANOPARTICLES; THERAPEUTICS
AB Since the first demonstration of in vivo gene expression from an injected RNA molecule almost two decades ago, 1 the field of RNA-based therapeutics is now taking significant strides, with many cancer and infectious disease targets entering clinical trials. 2 Critical to this success has been advances in the knowledge and application of delivery formulations. Currently, various lipid nanoparticle (LNP) platforms are at the forefront, 3 but the encapsulation approach underpinning LNP formulations offsets the synthetic and rapid-response nature of RNA vaccines. 4 Second, limited stability of LNP formulated RNA precludes stockpiling for pandemic readiness. 5 Here, we show the development of a two-vialed approach wherein the delivery formulation, a highly stable nanostructured lipid carrier (NLC), can be manufactured and stockpiled separate from the target RNA, which is admixed prior to administration. Furthermore, specific physicochemical modifications to the NLC modulate immune responses, either enhancing or diminishing neutralizing antibody responses. We have combined this approach with a replicating viral RNA (rvRNA) encoding Zika virus (ZIKV) antigens and demonstrated a single dose as low as 10 ng can completely protect mice against a lethal ZIKV challenge, representing what might be the most potent approach to date of any Zika vaccine.
C1 [Erasmus, Jesse H.; Khandhar, Amit P.; Guderian, Jeff; Granger, Brian; Archer, Jacob; Archer, Michelle; Gage, Emily; Fuerte-Stone, Jasmine; Larson, Elise; Lin, Susan; Kramer, Ryan; Coler, Rhea N.; Fox, Christopher B.; Stinchcomb, Dan T.; Reed, Steven G.; Van Hoeven, Neal] Infect Dis Res Inst, 1616 Eastlake Ave E,Suite 400, Seattle, WA 98102 USA.
   [Gage, Emily; Coler, Rhea N.; Reed, Steven G.; Van Hoeven, Neal] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Coler, Rhea N.; Van Hoeven, Neal] PAI Life Sci Inc, Seattle, WA USA.
RP Erasmus, JH; Khandhar, AP (corresponding author), Infect Dis Res Inst, 1616 Eastlake Ave E,Suite 400, Seattle, WA 98102 USA.
EM jesse.erasmus@idri.org; amit.khandhar@idri.org
OI Khandhar, Amit/0000-0003-4049-1855
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5R21AI128992, 1F32AI136371]; Nanopass
   Technologies, Ltd.
FX pWe thank Y. Levin, E. Kochba, and M. Barkan at Nanopass Technologies,
   Ltd. for providing the Micronjet600 needle for ID immunizations as well
   as for participating in productive discussions and S. Larsen for
   critical reading of this manuscript and helpful discussions. Support for
   this work came from NIH 5R21AI128992 and from Nanopass Technologies,
   Ltd. J.H.E. is a Washington Research Foundation postdoctoral fellow and
   is funded by NIH 1F32AI136371. Finally, we wish to dedicate this work to
   the memory of the late Dr. Dan Stinchcomb, who was instrumental in
   orchestrating this multidisciplinary team and providing valuable input,
   direction, and mentorship. He was dedicated to improving global health,
   and his contributions will be greatly missed.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Ball RL, 2017, INT J NANOMED, V12, P305, DOI 10.2147/IJN.S123062
   Barefoot B, 2008, VACCINE, V26, P6108, DOI 10.1016/j.vaccine.2008.09.007
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797
   Bogers WM, 2015, J INFECT DIS, V211, P947, DOI 10.1093/infdis/jiu522
   Brazzoli M, 2016, J VIROL, V90, P332, DOI 10.1128/JVI.01786-15
   Brito LA, 2014, MOL THER, V22, P2118, DOI 10.1038/mt.2014.133
   Calabro S, 2013, VACCINE, V31, P3363, DOI 10.1016/j.vaccine.2013.05.007
   Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DeFrancesco L, 2017, NAT BIOTECHNOL, V35, P193, DOI 10.1038/nbt.3812
   Desbien AL, 2015, EUR J IMMUNOL, V45, P407, DOI 10.1002/eji.201444543
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   DWARKI VJ, 1993, METHOD ENZYMOL, V217, P644
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109
   Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54
   Hume HKC, 2017, VACCINE, V35, P4480, DOI 10.1016/j.vaccine.2017.02.069
   Kaczmarek JC, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0450-0
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kanasty RL, 2012, MOL THER, V20, P513, DOI 10.1038/mt.2011.294
   Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497
   Kim TW, 2002, J CONTROL RELEASE, V82, P455, DOI 10.1016/S0168-3659(02)00138-4
   Knudsen ML, 2014, J VIROL, V88, P12438, DOI 10.1128/JVI.02223-14
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lechardeur D, 2006, HUM GENE THER, V17, P882, DOI 10.1089/hum.2006.17.882
   Lehto T, 2016, ADV DRUG DELIVER REV, V106, P172, DOI 10.1016/j.addr.2016.06.008
   Leitner WW, 2003, NAT MED, V9, P33, DOI 10.1038/nm813
   Li JH, 2017, ANGEW CHEM INT EDIT, V56, P13709, DOI 10.1002/anie.201707466
   Liao F., 2015, ADV GENET, V2, P1
   Ljungberg K, 2015, EXPERT REV VACCINES, V14, P177, DOI 10.1586/14760584.2015.965690
   Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014
   Maruggi G, 2017, VACCINE, V35, P361, DOI 10.1016/j.vaccine.2016.11.040
   Maurer T, 2007, METHODS, V41, P48, DOI 10.1016/j.ymeth.2006.06.017
   Misquith A, 2014, COLLOID SURFACE B, V113, P312, DOI 10.1016/j.colsurfb.2013.09.006
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Muller RH, 2016, PERCUTANEOUS PENETRA, P161
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Myhr AI, 2017, CURR ISSUES MOL BIOL, V22, P79, DOI 10.21775/cimb.022.079
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen DN, 2012, P NATL ACAD SCI USA, V109, pE797, DOI 10.1073/pnas.1121423109
   Nguyen DN, 2009, MOL THER, V17, P1555, DOI 10.1038/mt.2009.147
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630
   Pepini T, 2017, J IMMUNOL, V198, P4012, DOI 10.4049/jimmunol.1601877
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Plotkin S, 2017, VACCINE, V35, P4064, DOI 10.1016/j.vaccine.2017.06.003
   Pradhan D, 2017, INTERDISCIP SCI, V9, P468, DOI 10.1007/s12539-017-0238-3
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rietwyk S, 2017, ACS NANO, V11, P7572, DOI 10.1021/acsnano.7b04734
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schott JW, 2016, MOL THER, V24, P1513, DOI 10.1038/mt.2016.143
   Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Wilhelmsen CL, 2000, COMPARATIVE MED, V50, P374
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Xie X, 2017, MBIO, V8, P1
NR 65
TC 7
Z9 7
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD OCT 3
PY 2018
VL 26
IS 10
BP 2507
EP 2522
DI 10.1016/j.ymthe.2018.07.010
PG 16
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA GX5CL
UT WOS:000447758800019
PM 30078765
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Yousseu, FBS
   Nemg, FBS
   Ngouanet, SA
   Mekanda, FMO
   Demanou, M
AF Yousseu, Francine Berlange Sado
   Nemg, Fredy Brice Simo
   Ngouanet, Sandra Ateutchia
   Mekanda, Franck Martin Obam
   Demanou, Maurice
TI Detection and serotyping of dengue viruses in febrile patients
   consulting at the New-Bell District Hospital in Douala, Cameroon
SO PLOS ONE
LA English
DT Article
ID CHIKUNGUNYA-VIRUS; ARBOVIRAL INFECTIONS; ANGOLA; SEROPREVALENCE;
   OUTBREAK
AB Arboviruses are a major public health problem worldwide and are predominantly present in intertropical areas. Chikungunya, dengue and zika viruses have been implicated in recent epidemics in Asia, America and Africa. In Cameroon, data on these viruses are fragmentary. The purpose of this study was to determine the frequency of detection of these three viruses in febrile patients in Douala, Cameroon. A cross-sectional and descriptive study was conducted from March to April 2017 at the New-Bell District Hospital in Douala. Blood samples were collected from febrile patients and tested for malaria infections using Rapid Diagnostic test. Plasma harvested was later analyzed for the presence of chikungunya, dengue and zika viruses by a Trioplex real-time RT-PCR at Centre Pasteur of Cameroon. A total of 114 participants were included, of which 63.2% were females, reflecting a sex ratio (female/male) of 1.7. The median age was 26 years, range [0.25-81]. Eight (7%) of the 114 participants were infected with Dengue virus (DENV) among which 5 were identified as serotype 1. No cases of infection by either Zika virus or Chikungunya virus were detected. Three cases of dengue-malaria co-infection (13%) were recorded. No association was found between socio-demographic factors and dengue infection. The phylogenetic analysis of the partial envelope E gene showed that all the five DENV serotype 1 samples belonged to sub-type V, similarly to strains from West African countries, particularly those from Nigeria, Senegal and Cote d'Ivoire. This study showed the circulation of DENV serotype 1 in febrile patients and raises the alarm for the establishment of a sustained surveillance system to detect cases and prevent potential outbreaks in Cameroon. The existence of dengue-malaria co-infections suggests that surveillance of arboviruses should not be limited to febrile, non-malarial cases.
C1 [Yousseu, Francine Berlange Sado; Nemg, Fredy Brice Simo; Mekanda, Franck Martin Obam; Demanou, Maurice] CPC, Natl Reference Lab Chikungunya & Dengue, Dept Virol, Yaounde, Centre, Cameroon.
   [Yousseu, Francine Berlange Sado; Ngouanet, Sandra Ateutchia] Univ Dschang, Dept Biomed Sci, Dschang, West, Cameroon.
RP Demanou, M (corresponding author), CPC, Natl Reference Lab Chikungunya & Dengue, Dept Virol, Yaounde, Centre, Cameroon.
EM demanou@pasteur-yaounde.org
OI Demanou, Maurice/0000-0002-9275-0874
CR Abreu C, 2016, J CLIN VIROL, V79, P77, DOI 10.1016/j.jcv.2016.04.011
   Achonduh-Atijegbe OA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1996-y
   Ageep AK, 2006, SAUDI MED J, V27, P1711
   [Anonymous], CDC TRIOPL REAL TIM
   Ayorinde AF, 2016, J INFECT PUBLIC HEAL, V9, P52, DOI 10.1016/j.jiph.2015.06.009
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950
   Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128
   Epelboin L, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax028
   Esposito S, 2012, EUR J CLIN MICROBIOL, V31, P3251, DOI 10.1007/s10096-012-1692-9
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Gulati S, 2012, SCAND J INFECT DIS, V44, P522, DOI 10.3109/00365548.2012.669044
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932
   Mamoudou D, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.1.8442
   Masson E, 2018, FIEVRE JAUNE DENGUE
   Maurice D, 2015, VIROL SIN, V30, P470, DOI 10.1007/s12250-015-3663-7
   Monamele GC, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.227.15316
   Ndip LM, 2004, EMERG INFECT DIS, V10, P432, DOI 10.3201/eid1003.020713
   Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005
   Parreira R, 2014, EUROSURVEILLANCE, V19, P7
   Parreira R, 2014, J INFECT DEV COUNTR, V8, P1210, DOI 10.3855/jidc.4910
   Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500
   Rodhain F, 1996, B SOC PATHOL EXOT, V89, P87
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   WHO, WEEKL B OUTBR OTH EM
NR 32
TC 7
Z9 7
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 3
PY 2018
VL 13
IS 10
AR e0204143
DI 10.1371/journal.pone.0204143
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV7VQ
UT WOS:000446342400043
PM 30281633
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU O'Reilly, KM
   Lowe, R
   Edmunds, WJ
   Mayaud, P
   Kucharski, A
   Eggo, RM
   Funk, S
   Bhatia, D
   Khan, K
   Kraemer, MUG
   Wilder-Smith, A
   Rodrigues, LC
   Brasil, P
   Massad, E
   Jaenisch, T
   Cauchemez, S
   Brady, OJ
   Yakob, L
AF O'Reilly, Kathleen M.
   Lowe, Rachel
   Edmunds, W. John
   Mayaud, Philippe
   Kucharski, Adam
   Eggo, Rosalind M.
   Funk, Sebastian
   Bhatia, Deepit
   Khan, Kamran
   Kraemer, Moritz U. G.
   Wilder-Smith, Annelies
   Rodrigues, Laura C.
   Brasil, Patricia
   Massad, Eduardo
   Jaenisch, Thomas
   Cauchemez, Simon
   Brady, Oliver J.
   Yakob, Laith
TI Projecting the end of the Zika virus epidemic in Latin America: a
   modelling analysis
SO BMC MEDICINE
LA English
DT Article
DE Zika virus; Epidemic; Mathematical modelling; Latin America and the
   Caribbean; Connectivity
ID VECTOR-BORNE TRANSMISSION; INFECTION; BRAZIL; RISK; DYNAMICS; OUTBREAK;
   NUMBER; SIZE
AB Background: Zika virus (ZIKV) emerged in Latin America and the Caribbean (LAC) region in 2013, with serious implications for population health in the region. In 2016, the World Health Organization declared the ZIKV outbreak a Public Health Emergency of International Concern following a cluster of associated neurological disorders and neonatal malformations. In 2017, Zika cases declined, but future incidence in LAC remains uncertain due to gaps in our understanding, considerable variation in surveillance and the lack of a comprehensive collation of data from affected countries.
   Methods: Our analysis combines information on confirmed and suspected Zika cases across LAC countries and a spatio-temporal dynamic transmission model for ZIKV infection to determine key transmission parameters and projected incidence in 90 major cities within 35 countries. Seasonality was determined by spatio-temporal estimates of Aedes aegypti vectorial capacity. We used country and state-level data from 2015 to mid-2017 to infer key model parameters, country-specific disease reporting rates, and the 2018 projected incidence. A 10-fold cross-validation approach was used to validate parameter estimates to out-of-sample epidemic trajectories.
   Results: There was limited transmission in 2015, but in 2016 and 2017 there was sufficient opportunity for wide-spread ZIKV transmission in most cities, resulting in the depletion of susceptible individuals. We predict that the highest number of cases in 2018 would present within some Brazilian States (Sao Paulo and Rio de Janeiro), Colombia and French Guiana, but the estimated number of cases were no more than a few hundred. Model estimates of the timing of the peak in incidence were correlated (p < 0.05) with the reported peak in incidence. The reporting rate varied across countries, with lower reporting rates for those with only confirmed cases compared to those who reported both confirmed and suspected cases.
   Conclusions: The findings suggest that the ZIKV epidemic is by and large over within LAC, with incidence projected to be low in most cities in 2018. Local low levels of transmission are probable, but the estimated rate of infection suggests that most cities have a population with high levels of herd immunity.
C1 [O'Reilly, Kathleen M.; Wilder-Smith, Annelies; Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [O'Reilly, Kathleen M.; Lowe, Rachel; Edmunds, W. John; Kucharski, Adam; Eggo, Rosalind M.; Funk, Sebastian; Brady, Oliver J.; Yakob, Laith] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel; Edmunds, W. John; Kucharski, Adam; Eggo, Rosalind M.; Funk, Sebastian; Rodrigues, Laura C.; Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain.
   [Mayaud, Philippe] London Sch Hyg & Trop Med, Dept Clin Res, London, England.
   [Bhatia, Deepit; Khan, Kamran] Univ Toronto, Div Infect Dis, Toronto, ON, Canada.
   [Bhatia, Deepit; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Oxford, England.
   [Wilder-Smith, Annelies] Umea Univ, Dept Med & Publ Hlth, Umea, Sweden.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Massad, Eduardo] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Heidelberg Univ, Dept Infect Dis, Dept Infect Dis & Parasitol, Heidelberg, Germany.
   [Cauchemez, Simon] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Cauchemez, Simon] CNRS, URA3012, Paris, France.
   [Cauchemez, Simon] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France.
RP O'Reilly, KM (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.; O'Reilly, KM (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
EM kathleen.oreilly@lshtm.ac.uk
RI O'Reilly, Kathleen/H-9170-2019; Yakob, Laith/AAD-4521-2019; Bhatia,
   Deepit/AAC-1444-2020
OI O'Reilly, Kathleen/0000-0002-4892-8022; Yakob,
   Laith/0000-0001-8639-4511; MAYAUD, Philippe/0000-0001-5730-947X; Lowe,
   Rachel/0000-0003-3939-7343; Eggo, Rosalind M/0000-0002-0362-6717;
   Bhatia, Deepit/0000-0001-8168-6873; Funk, Sebastian/0000-0002-2842-3406
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant [734548]; ZikaPLAN Grant [734584]; Royal Society
   Dorothy Hodgkin FellowshipRoyal Society of London; Sir Henry Dale
   Fellowship; Royal SocietyRoyal Society of London [206250/Z/17/Z]; Sir
   Henry Wellcome Fellowship; Wellcome TrustWellcome Trust [206250/Z/17/Z,
   206471/Z/17/Z]; Laboratoire d'Excellence Integrative Biology of Emerging
   Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of Infectious
   Disease Agent Study of the National Institute of General Medical
   Sciences; AXA Research Fund; Branco Weiss Fellowship - Society in
   Science; National Institute of Child Health and Human DevelopmentUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [T32HD040128]; National Library of
   Medicine of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM) [R01LM010812, R01LM011965]
FX This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant Agreement no.
   734548 and ZikaPLAN Grant Agreement No 734584. RL was funded by a Royal
   Society Dorothy Hodgkin Fellowship. AK was funded by a Sir Henry Dale
   Fellowship jointly funded by the Wellcome Trust and the Royal Society
   (grant Number 206250/Z/17/Z). OJB was funded by a Sir Henry Wellcome
   Fellowship funded by the Wellcome Trust (grant number 206471/Z/17/Z). SC
   was funded by the Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program (grant ANR-10-LABX-62-IBEID), the
   Models of Infectious Disease Agent Study of the National Institute of
   General Medical Sciences, and the AXA Research Fund. MUGK is supported
   by The Branco Weiss Fellowship - Society in Science, administered by the
   ETH Zurich and acknowledges funding from a Training Grant from the
   National Institute of Child Health and Human Development (T32HD040128)
   and the National Library of Medicine of the National Institutes of
   Health (R01LM010812, R01LM011965). The funders had no role in in the
   design of the study, the collection, analysis and interpretation of
   data, or in writing the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Andronico A, 2017, AM J EPIDEMIOL, V16, P1
   Asher J., 2017, BIORXIV, DOI [10.1101/187591, DOI 10.1101/187591]
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   Butler D, 2017, NATURE, V545, P396, DOI 10.1038/545396a
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Mallet H, 2015, B INFORM SANIT EPIDE
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Nelson B, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.ac6d0f8c9c35e88825c1a1147697531c, DOI 10.1371/CURRENTS.OUTBREAKS.AC6D0F8C9C35E88825C1A1147697531C]
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Roberts MG, 2013, J MATH BIOL, V66, P1463, DOI 10.1007/s00285-012-0540-y
   Rodriguez-Barraquer I, 2016, BIORXIV, DOI [10.1101/041095, DOI 10.1101/041095]
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Sinan B., SISTEMA INFORM AGRAV
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172
   WHO, 2017, ZIK SIT REP
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   World Health Organization, 2017, WHO VACC PIP TRACK Z
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 55
TC 17
Z9 17
U1 2
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD OCT 3
PY 2018
VL 16
AR 180
DI 10.1186/s12916-018-1158-8
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV6DT
UT WOS:000446198400001
PM 30285863
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Martin, TC
   Visconti, A
   Spector, TD
   Falchi, M
AF Martin, Tiphaine C.
   Visconti, Alessia
   Spector, Tim D.
   Falchi, Mario
TI Conducting metagenomic studies in microbiology and clinical research
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Metagenomics; Human microbiome; Microbiology and clinical research; Next
   generation sequencing
ID HUMAN GUT MICROBIOME; INTESTINAL MICROBIOTA; QUALITY-CONTROL; ZIKA
   VIRUS; ANTIBIOTIC-RESISTANCE; STORAGE-CONDITIONS; FECAL MICROBIOTA;
   GENE-EXPRESSION; REAL-TIME; GENOMES
AB Owing to the increased cost-effectiveness of high-throughput technologies, the number of studies focusing on the human microbiome and its connections to human health and disease has recently surged. However, best practices in microbiology and clinical research have yet to be clearly established. Here, we present an overview of the challenges and opportunities involved in conducting a metagenomic study, with a particular focus on data processing and analytical methods.
C1 [Martin, Tiphaine C.; Visconti, Alessia; Spector, Tim D.; Falchi, Mario] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.
   [Martin, Tiphaine C.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA.
RP Spector, TD; Falchi, M (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.
EM tim.spector@kcl.ac.uk; alessia.visconti@kcl.ac.uk;
   tiphaine.martin@kcl.ac.uk; mario.falchi@kcl.ac.uk
RI Visconti, Alessia/N-1845-2019
OI Visconti, Alessia/0000-0003-4144-2019; Martin,
   Tiphaine/0000-0001-9990-1455
FU Wellcome TrustWellcome Trust; MRCMedical Research Council UK (MRC);
   National Institute for Health Research (NIHR)National Institute for
   Health Research (NIHR); Biomedical Research Centre based at Guy's and St
   Thomas' NHS Foundation Trust; King's College London
FX TwinsUK was funded by the Wellcome Trust and MRC. The study also
   receives support from the National Institute for Health Research (NIHR)-
   funded BioResource, Clinical Research Facility and Biomedical Research
   Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership
   with King's College London.
CR Afiahayati, 2015, DNA RES, V22, P69, DOI 10.1093/dnares/dsu041
   Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18
   AlFaleh K, 2012, EVID BASED CHILD HLT, V7, P1807, DOI DOI 10.1002/ebch.1881
   Almeida M, 2015, METAGENOMICS MICROBI, P55
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Amir A, 2017, MSYSTEMS, V2, P1
   Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x
   Andrews S, 2010, FASTQC QUALITY CONTR
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI 10.1016/j.chom.2015.04.004
   Bag S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26775
   Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x
   Bashiardes S, 2016, BIOINFORM BIOL INSIG, V10, P19, DOI 10.4137/BBI.S34610
   Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911
   Bhattacharya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142038
   Bohlin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-464
   Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Bourgeois S, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0255-y
   Bowers RM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2063-6
   Brown BL, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix007
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Burriesci MS, 2012, BIOINFORMATICS, V28, P1324, DOI 10.1093/bioinformatics/bts123
   Bushnell B, 2015, BBMAP SHORT READ ALI
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Carmody RN, 2014, J CLIN INVEST, V124, P4173, DOI 10.1172/JCI72335
   Carr R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105776
   Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808
   Chang Q, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-118
   Chen C, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-8
   Chen SF, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1469-3
   Chevreux B, 1999, COMP SCI BIOL P GER, V99, P45, DOI DOI 10.1.1.23/7465
   Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350
   Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486
   Davenport ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090731
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   de Bruijn N, 1946, COMMUNICATION
   de la Bastide M, 2007, CURRENT PROTOCOLS BI, V11
   De La Cochetiere MF, 2008, MICROB ECOL, V56, P395, DOI 10.1007/s00248-007-9356-5
   Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103
   Droge J, 2012, BRIEF BIOINFORM, V13, P646, DOI 10.1093/bib/bbs031
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Dudhagara P, 2015, GENOM PROTEOM BIOINF, V13, P296, DOI 10.1016/j.gpb.2015.10.003
   Ebbert MTW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1097-3
   EISEMAN B, 1958, SURGERY, V44, P854
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Forslund K, 2014, BIOESSAYS, V36, P316, DOI 10.1002/bies.201300143
   Forster SC, 2016, NUCLEIC ACIDS RES, V44, pD604, DOI 10.1093/nar/gkv1216
   Francesco V., 2011, EMBNET J, V17, P46, DOI [10.14806/ej.17.1.208, DOI 10.14806/EJ.17.1.208]
   Frank JA, 2016, SCI REP, V6, P1
   Ghurye Jay S., 2016, Yale Journal of Biology and Medicine, V89, P353
   Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037
   Gordon A., 2010, FASTX TOOLKIT
   Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632
   Grassl N, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0293-0
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Haider B, 2014, BIOINFORMATICS, V30, P2717, DOI 10.1093/bioinformatics/btu395
   Handelsman J, 2009, MICROB BIOTECHNOL, V2, P138, DOI 10.1111/j.1751-7915.2009.00090_8.x
   Hoff KJ, 2009, NUCLEIC ACIDS RES, V37, pW101, DOI 10.1093/nar/gkp327
   Hsiao KC, 2017, LANCET CHILD ADOLESC
   Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861
   Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07
   Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112
   Jonsson V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2386-y
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322
   Karlsson FH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003706
   Koonin EV, 2003, SEQUENCEEVOLUTIONFUN, P25
   Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008
   Koren S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r101
   Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x
   Krueger F, 2012, TRIMGALORE
   Kuleshov V, 2016, NAT BIOTECHNOL, V34, P64, DOI 10.1038/nbt.3416
   Kultima JR, 2016, BIOINFORMATICS, V32, P2520, DOI 10.1093/bioinformatics/btw183
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133
   Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112
   Luo CW, 2015, NAT BIOTECHNOL, V33, P1045, DOI 10.1038/nbt.3319
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521
   Markowitz VM, 2013, NUCLEIC ACIDS RES, V42, pD568
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052
   McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2
   Mende DR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00143
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mohammed MH, 2011, BIOINFORMATICS, V27, P22, DOI 10.1093/bioinformatics/btq608
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001
   MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3
   Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678
   Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187
   Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027
   O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189
   Onate FP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1406-7
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Osborn DA, 2013, PREBIOTICS INFANTS P
   Ospina R, 2012, COMPUT STAT DATA AN, V56, P1609, DOI 10.1016/j.csda.2011.10.005
   Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2
   Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480
   Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5
   Proal AD, 2009, AUTOIMMUN REV, V8, P677, DOI 10.1016/j.autrev.2009.02.016
   Pumbwe L, 2007, J ANTIMICROB CHEMOTH, V60, P1288, DOI 10.1093/jac/dkm363
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quigley EMM, 2017, NAT REV GASTRO HEPAT, V14, P315, DOI 10.1038/nrgastro.2017.29
   Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083
   Richter DC, 2007, BIOINFORMATICS, V23, P1573, DOI 10.1093/bioinformatics/btm153
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3
   Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z
   SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2
   Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229
   Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]
   Shaw AG, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0186-x
   Shoaie S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00086
   Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139
   Sinha R, 2016, CANCER EPIDEM BIOMAR, V25, P407, DOI 10.1158/1055-9965.EPI-15-0951
   Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834
   Statnikov A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-11
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI DOI 10.1089/GST.1995.1.9
   Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739
   Szajewska H, 2017, PEDIATR RES, V81, P752, DOI 10.1038/pr.2017.5
   Taub MA, 2010, GENOME MED, V2, DOI 10.1186/gm208
   Tennessen K, 2015, ISME J, V10, P1
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   The Huttenhower Lab, 2017, KNEADDATA
   Tigchelaar EF, 2016, GUT, V65, P540, DOI 10.1136/gutjnl-2015-310328
   Treangen TJ, 2011, CURR PROTOC BIOINFOR, V11, P11, DOI DOI 10.1002/0471250953.BI1108S33
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136
   Underwood MA, 2009, J PEDIATR GASTR NUTR, V48, P216, DOI 10.1097/MPG.0b013e31818de195
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618
   Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x
   Visconti A, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy072
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Walker AW, 2016, ADV EXP MED BIOL, V902, P5, DOI 10.1007/978-3-319-31248-4_2
   Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1
   WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190
   WHITTAKER RH, 1960, ECOL MONOGR, V30, P280
   Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x
   Wilke A, 2016, NUCLEIC ACIDS RES, V44, pD590, DOI 10.1093/nar/gkv1322
   Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002
   Wingett S., 2011, FASTQ SCREEN
   Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Wu C, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0302-3
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992
   Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209
   Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124361
   Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhao N, 2015, AM J HUM GENET, V96, P797, DOI 10.1016/j.ajhg.2015.04.003
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
   Zhou Qian, 2014, Genomics Proteomics & Bioinformatics, V12, P52, DOI 10.1016/j.gpb.2014.01.002
   Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275
   Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918
NR 185
TC 3
Z9 5
U1 5
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD OCT
PY 2018
VL 102
IS 20
BP 8629
EP 8646
DI 10.1007/s00253-018-9209-9
PG 18
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GU8QD
UT WOS:000445604600003
PM 30078138
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Bonilla-Aldana, DK
   Bonilla-Aldana, JC
   Mondragon-Cardona, A
AF Rodriguez-Morales, Alfonso J.
   Katterine Bonilla-Aldana, D.
   Camilo Bonilla-Aldana, Juan
   Mondragon-Cardona, Alvaro
TI Chikungunya and Zika in Huila: Mapping their Incidence in a Neglected
   Area of Colombia
SO ARCHIVES OF MEDICAL RESEARCH
LA English
DT Letter
C1 [Rodriguez-Morales, Alfonso J.; Katterine Bonilla-Aldana, D.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira, Risaralda, Colombia.
   [Katterine Bonilla-Aldana, D.] Fdn Univ Autonoma Amer, Grp Invest Sanidad Anim, Pereira, Risaralda, Colombia.
   [Camilo Bonilla-Aldana, Juan] Univ Surcolombiana, Neiva, Huila, Colombia.
   [Mondragon-Cardona, Alvaro] Univ Surcolombiana, Hosp Univ Hernando Moncaleano Perdomo, Dept Internal Med, Neiva, Huila, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res & Incubator Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
OI Bonilla-Aldana, D. Katterine/0000-0002-9412-2556
CR Escalera-Antezana JP, 2018, ARCH MED RES, V49, P288, DOI 10.1016/j.arcmed.2018.09.002
   Murillo-Zamora E, 2018, ARCH MED RES, V49, P65, DOI 10.1016/j.arcmed.2018.04.008
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Thahir-Silva Shehana, 2018, Infez Med, V26, P178
NR 4
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0188-4409
EI 1873-5487
J9 ARCH MED RES
JI Arch. Med. Res.
PD OCT
PY 2018
VL 49
IS 7
BP 512
EP 513
DI 10.1016/j.arcmed.2019.01.009
PG 2
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HV5XJ
UT WOS:000466058100012
PM 30799053
DA 2020-07-08
ER

PT J
AU Murillo-Zamora, E
   Mendoza-Cano, O
   Guzman-Esquivel, J
AF Murillo-Zamora, Efren
   Mendoza-Cano, Oliver
   Guzman-Esquivel, Jose
TI Response to: Chikungunya and Zika in Huila: Mapping their Incidence in a
   Neglected Area of Colombia
SO ARCHIVES OF MEDICAL RESEARCH
LA English
DT Letter
C1 [Murillo-Zamora, Efren] Inst Mexicano Seguro Social, Unidad Med Familiar 19, Dept Epidemiol, Colima, Colima, Mexico.
   [Murillo-Zamora, Efren] Univ Colima, Fac Med, Programa Doctorado Ciencias Med, Colima, Colima, Mexico.
   [Mendoza-Cano, Oliver] Univ Colima, Fac Ingn Civil, Coquimatlan, Colima, Mexico.
   [Guzman-Esquivel, Jose] Univ Colima, Fac Med, Colima, Colima, Mexico.
   [Guzman-Esquivel, Jose] Inst Mexicano Seguro Social, Unidad Invest Epidemiol Clin, Colima, Colima, Mexico.
RP Mendoza-Cano, O (corresponding author), Univ Colima, Fac Ingn Civil, Coquimatlan, Colima, Mexico.
EM oliver@ucol.mx
RI Mendoza-Cano, Oliver/C-9317-2018; Esquivel, Jose Guzman/N-2853-2015
OI Mendoza-Cano, Oliver/0000-0001-9614-4946; Esquivel, Jose
   Guzman/0000-0002-6727-0051; Murillo-Zamora, Efren/0000-0002-1118-498X
CR Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Vanlerberghe V, 2017, REV PANAM SALUD PUBL, V41, DOI 10.26633/RPSP.2017.16
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0188-4409
EI 1873-5487
J9 ARCH MED RES
JI Arch. Med. Res.
PD OCT
PY 2018
VL 49
IS 7
BP 514
EP 514
DI 10.1016/j.arcmed.2019.01.010
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HV5XJ
UT WOS:000466058100013
PM 30850187
DA 2020-07-08
ER

PT J
AU Patel, I
   Attarabeen, O
   Camacho, F
   Kummer, M
   Dykes, D
   Arbogast, Z
   Srivastava, P
   Parihar, A
   Sharma, R
   Guy, J
   Ha, D
   Gunaseelan, S
   Dhingra, S
   Balkrishnan, R
   Rodriguez-Cintron, F
   Maldonado-Davila, W
AF Patel, I
   Attarabeen, O.
   Camacho, F.
   Kummer, M.
   Dykes, D.
   Arbogast, Z.
   Srivastava, P.
   Parihar, A.
   Sharma, R.
   Guy, J.
   Ha, D.
   Gunaseelan, S.
   Dhingra, S.
   Balkrishnan, R.
   Rodriguez-Cintron, F.
   Maldonado-Davila, W.
TI KNOWLEDGE, ATTITUDE AND PRACTICES ABOUT ZIKA VIRUS AMONG PHARMACY
   STUDENTS IN THE UNITED STATES (US) AND INDIA: A CROSS SECTIONAL STUDY
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Patel, I; Attarabeen, O.; Kummer, M.; Dykes, D.; Arbogast, Z.] Marshall Univ, Huntington, WV USA.
   [Camacho, F.; Balkrishnan, R.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Srivastava, P.] Dr APJ Abdul Kalam Tech Univ, Varanasi, Uttar Pradesh, India.
   [Parihar, A.] Bhupal Nobles Inst Pharmaceut Sci, Udaipur, RJ, India.
   [Sharma, R.] Touro Coll & Univ Syst, New York, NY USA.
   [Guy, J.] Univ Findlay, Findlay, OH USA.
   [Ha, D.] Keck Grad Inst, Claremont, CA USA.
   [Gunaseelan, S.] Texas A&M Univ, Kingsville, TX USA.
   [Dhingra, S.] Univ West Indies, St Augustine, Trinidad Tobago.
   [Rodriguez-Cintron, F.; Maldonado-Davila, W.] Univ Puerto Rico, San Juan, PR 00936 USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD OCT
PY 2018
VL 21
SU 3
MA PIN118
BP S240
EP S240
DI 10.1016/j.jval.2018.09.1435
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA HN1ZN
UT WOS:000459985602213
OA Bronze
DA 2020-07-08
ER

PT J
AU Bhagat, R
   Prajapati, B
   Narwal, S
   Agnihotri, N
   Adlakha, YK
   Sen, J
   Mani, S
   Seth, P
AF Bhagat, Reshma
   Prajapati, Bharat
   Narwal, Sonia
   Agnihotri, Nitin
   Adlakha, Yogita K.
   Sen, Jonaki
   Mani, Shyamala
   Seth, Pankaj
TI Zika virus E protein alters the properties of human fetal neural stem
   cells by modulating microRNA circuitry
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article
ID PROGENITOR CELLS; PRECURSOR CELLS; DIFFERENTIATION; PROLIFERATION;
   NEUROGENESIS; BRAIN; INFECTION; APOPTOSIS; NOTCH2; ACTIVATION
AB Zika virus (ZV) infects neural stem cells (NSCs) and causes quiescence in NSCs, reducing the pool of brain cells, leading to microcephaly. Despite conscientious efforts, the molecular mechanisms for ZV-mediated effects on NSCs lack clarity. This study aimed to explore the underlying mechanisms for ZV-mediated induction of quiescence in the primary cultures of human fetal neural stem cells (fNSCs). We demonstrate that expression of ZV envelope (E) protein displays maximum quiescence in human fNSCs by accumulating cells in the G0/G1 phase of the cell cycle as compared to other non-structural proteins, viz. NS2A, NS4A and NS4B. E protein induces immature differentiation by induction of pro-neuronal genes in proliferating fNSCs, induces apoptosis in differentiating fNSCs 3 days post differentiation, and disrupts migration of cells from differentiating neurospheres. In utero electroporation of mouse brain with E protein shows drastic downregulation of proliferating cells in ventricular and subventricular zone regions. Global microRNA sequencing suggests that E protein modulates miRNA circuitry. Among differentially expressed miRNAs, we found 14 upregulated and 11 downregulated miRNAs. Mir-204-3p and mir-1273g-3p directly regulate NOTCH2 and PAX3 expression, respectively, by binding to their 3'UTR. Bioinformatic analysis using GO analysis for the targets of differentially expressed miRNAs revealed enrichment of cell cycle and developmental processes. Furthermore, WNT, CCKR, PDGF, EGF, p53, and NOTCH signaling pathways were among the top enriched pathways. Thus, our study provides evidence for the involvement of ZV E protein and novel insights into the molecular mechanism through identification of miRNA circuitry.
C1 [Bhagat, Reshma; Prajapati, Bharat; Narwal, Sonia; Adlakha, Yogita K.; Seth, Pankaj] Natl Brain Res Ctr, Neurovirol Sect, Dept Cellular & Mol Neurosci, Gurgaon, Haryana, India.
   [Agnihotri, Nitin; Sen, Jonaki] Indian Inst Technol Kanpur, Dept Biol Sci & Bioengn, Kanpur, Uttar Pradesh, India.
   [Mani, Shyamala] Curadev Pharma Pvt Ltd, B87 Sect 83, Noida, Uttar Pradesh, India.
   [Mani, Shyamala] Hop Robert Debre, INSERM, U1141, Paris, France.
RP Seth, P (corresponding author), Natl Brain Res Ctr, Neurovirol Sect, Dept Cellular & Mol Neurosci, Gurgaon, Haryana, India.
EM pseth.nbrc@gov.in
OI Seth, Pankaj/0000-0003-1021-7839
FU CSIR, New Delhi, IndiaCouncil of Scientific & Industrial Research (CSIR)
   - India; CEFIPRA [490-302]; NBRC core funds; Biotechnology Information
   System Network (BTISNET) grant, DBT, India
FX Technical assistance from Mr. DL Meena and Mr. Naushad Alam of NBRC,
   India, is acknowledged. Ms. Bindu Singh and Ms. Priyanka S Kshtriya
   helped in initial assays. Junior and Senior Research Fellowship to Ms.
   Reshma Bhagat from CSIR, New Delhi, India, is greatly acknowledged.
   Expression vectors for the four ZV proteins were kind gift from Dr.
   Shyamala Mani, IISc, India (These were possible due to financial support
   from CEFIPRA (490-302) awarded to P. Gressens (INSERM) and S. Mani).
   Financial support for the study from NBRC core funds to PS is greatly
   acknowledged. The authors also wish to acknowledge the support of the
   facilities provided under the Biotechnology Information System Network
   (BTISNET) grant, DBT, India, and Distributed Information Centre at NBRC,
   Manesar, India.
CR Adams BD, 2015, CANCER RES, V75, P5206, DOI 10.1158/0008-5472.CAN-15-1989
   Aloia AL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/509306
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Chen Z, 2016, J VIROL, V90, P3722, DOI 10.1128/JVI.03242-15
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Filippis L, 2012, STEM CELL TRANSL MED, V1, P298, DOI 10.5966/sctm.2011-0045
   dos Santos CND, 2000, VIROLOGY, V274, P292, DOI 10.1006/viro.2000.0457
   Eskild A, 2005, BJOG-INT J OBSTET GY, V112, P1620, DOI 10.1111/j.1471-0528.2005.00764.x
   Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008
   Fatima M, 2016, CELL DEATH DIFFER, V23, P776, DOI 10.1038/cdd.2015.138
   Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020
   Garcia-Gutierrez P, 2014, J CELL SCI, V127, P2554, DOI 10.1242/jcs.147462
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Huang JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34740
   Ishido M, 2010, J HEALTH SCI, V56, P175, DOI 10.1248/jhs.56.175
   Jacques TS, 1998, DEVELOPMENT, V125, P3167
   Jung CG, 2004, FASEB J, V18, P1237, DOI 10.1096/fj.03-0927fje
   Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9
   Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002
   Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009
   KOZAK RA, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100297
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Malik S, 2014, J NEUROIMMUNE PHARM, V9, P340, DOI 10.1007/s11481-014-9523-7
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292
   Mishra M, 2010, J NEUROVIROL, V16, P355, DOI 10.3109/13550284.2010.513028
   Niu XM, 2016, FEBS LETT, V590, P2709, DOI 10.1002/1873-3468.12309
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Ouyang XX, 2016, INT J MED SCI, V13, P195, DOI 10.7150/ijms.13996
   Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104
   Pitto L, 2010, CELL CYCLE, V9, P434, DOI 10.4161/cc.9.3.10762
   REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7
   Sakata-Yanagimoto M, 2015, METHODS MOL BIOL, V1220, P79, DOI 10.1007/978-1-4939-1568-2_6
   Saxena M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.147157
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6
   Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tchorz JS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.65
   Thounaojam MC, 2014, J VIROL, V88, P4798, DOI 10.1128/JVI.02979-13
   Veroni C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0353-1
   WHO, 2017, WHO ZIK SIT REP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yamaguchi Y, 2015, CURR TOP DEV BIOL, V114, P159, DOI 10.1016/bs.ctdb.2015.07.016
   Zou Y, 2016, MOL MED REP, V14, P3517, DOI 10.3892/mmr.2016.5688
NR 63
TC 8
Z9 7
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD OCT
PY 2018
VL 25
IS 10
BP 1837
EP 1854
DI 10.1038/s41418-018-0163-y
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA HL2XB
UT WOS:000458571600001
PM 30050059
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhang, YL
   Zhang, HJ
   Ma, WQ
   Liu, KF
   Zhao, M
   Zhao, YZ
   Lu, XC
   Zhand, FP
   Li, XD
   Gao, GF
   Liu, WJ
AF Zhang, Yongli
   Zhang, Hangjie
   Ma, Wenqiang
   Liu, Kefang
   Zhao, Min
   Zhao, Yingze
   Lu, Xuancheng
   Zhand, Fuping
   Li, Xiangdong
   Gao, George F.
   Liu, William J.
TI Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged
   Organs of Infected Ifnar1(-/-) Mice
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology and Infection; Issue 140; Zika virus; antigen-specific T
   cell; vaccination; immunoprivileged organs; tetramer
ID CTL
AB The Zika virus (ZIKV) can induce inflammation in immunoprivileged organs (e.g., the brain and testis), leading to the Guillain-Barre syndrome and damaging the testes. During an infection with the ZIKV, immune cells have been shown to infiltrate into the tissues. However, the cellular mechanisms that define the protection and/or immunopathogenesis of these immune cells during a ZIKV infection are still largely unknown. Herein, we describe methods to evaluate the virus-specific T-cell functionality in these immunoprivileged organs of ZIKV-infected mice. These methods include a) a ZIKV infection and vaccine inoculation in Ifnar1(-/-) mice; b) histopathology, immunofluorescence, and immunohistochemistry assays to detect the virus infection and inflammation in the brain, testes, and spleen; c) the preparation of a tetramer of ZIKV-derived T-cell epitopes; d) the detection of ZIKV-specific T cells in the monocytes isolated from the brain, testes, and spleen. Using these approaches, it is possible to detect the antigen-specific T cells that have infiltrated into the immunoprivileged organs and to evaluate the functions of these T cells during the infection: potential immune protection via virus clearance and/or immunopathogenesis to exacerbate the inflammation. These findings may also help to clarify the contribution of T cells induced by the immunization against ZIKV.
C1 [Zhang, Yongli; Liu, Kefang; Gao, George F.; Liu, William J.] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China.
   [Zhang, Yongli; Zhang, Hangjie; Liu, Kefang; Zhao, Yingze; Gao, George F.; Liu, William J.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.
   [Ma, Wenqiang; Li, Xiangdong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.
   [Zhao, Min; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
   [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent, Lab Anim Ctr, Beijing, Peoples R China.
   [Zhand, Fuping; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
RP Gao, GF; Liu, WJ (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Peoples R China.; Gao, GF; Liu, WJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Med Virol & Viral Dis, Beijing, Peoples R China.; Li, XD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
EM xiangdongli@cau.edu.cn; gaof@im.ac.cn; liujun@ivdc.chinacdc.cn
FU National Key Research and Development Program of China [2017YFC1200202];
   Major Special Projects for Infectious Disease Research of China
   [2016ZX10004222-003]; National Natural Science Foundation of China
   Innovative Research Group [81621091]
FX The authors thank Gary Wong for the English revision. This work was
   supported by the National Key Research and Development Program of China
   (grant 2017YFC1200202), the Major Special Projects for Infectious
   Disease Research of China (grant 2016ZX10004222-003). George F. Gao is a
   leading principal investigator of the National Natural Science
   Foundation of China Innovative Research Group (grant 81621091).
CR Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Evilsizor MN, 2015, JOVE-J VIS EXP, V99, P52293
   Govindarajan S, 2015, JOVE-J VIS EXP, DOI 10.3791/53256
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jama BP, 2014, JOVE-J VIS EXP, DOI 10.3791/52257
   Legoux FP, 2012, JOVE-J VIS EXP, DOI 10.3791/4420
   Li HT, 2005, J IMMUNOL, V174, P195, DOI 10.4049/jimmunol.174.1.195
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marques ETA, 2018, LANCET, V391, P516, DOI 10.1016/S0140-6736(17)33107-0
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658
   Shang T, 2011, ENDOCRINOLOGY, V152, P2827, DOI 10.1210/en.2011-0031
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110
   Xu K, 2018, J VIROLOGY J
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao M, 2017, SCI CHINA LIFE SCI, V60, P1307, DOI 10.1007/s11427-017-9241-3
   Zhou MH, 2006, J IMMUNOL, V177, P2138, DOI 10.4049/jimmunol.177.4.2138
NR 26
TC 1
Z9 1
U1 2
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD OCT
PY 2018
IS 140
AR e58110
DI 10.3791/58110
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HI4WM
UT WOS:000456452800111
PM 30394402
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ragas, J
AF Ragas, Jose
TI Zika: from the Brazilian backlands to global threat
SO HISTORIA CIENCIAS SAUDE-MANGUINHOS
LA English
DT Book Review
C1 [Ragas, Jose] Pontificia Univ Catolica Chile, Inst Hist, Santiago, Chile.
RP Ragas, J (corresponding author), Pontificia Univ Catolica Chile, Inst Hist, Santiago, Chile.
EM jose.ragas@uc.cl
CR Diniz D., 2017, ZIKA BRAZILIAN BACKL
NR 1
TC 1
Z9 1
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0104-5970
EI 1678-4758
J9 HIST CIENC SAUDE-MAN
JI Hist. Cienc. Saude-Manguinhos
PD OCT-DEC
PY 2018
VL 25
IS 4
BP 1185
EP 1187
DI 10.1590/S0104-59702018000500016
PG 3
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA HG5WA
UT WOS:000455049500025
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus Infection Among Pregnant Women and Their Neonates in New York
   City, January 2016-June 2017
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitt 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Dept Community Med, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitt 1 Med Acad Ctr, Bangkok, Thailand.
CR Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/AOG.0000000000002737, 10.1097/aog.0000000000002737]
NR 1
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD OCT
PY 2018
VL 132
IS 4
BP 1067
EP 1067
DI 10.1097/AOG.0000000000002907
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HF2BQ
UT WOS:000454041500053
PM 30247349
DA 2020-07-08
ER

PT J
AU Gruba, N
   Martinez, JIR
   Grzywa, R
   Wysocka, M
   Skorenski, M
   Dabrowska, A
   Lecka, M
   Suder, P
   Sienczyk, M
   Pyrc, K
   Lesner, A
AF Gruba, Natalia
   Martinez, Jose Ignacio Rodriguez
   Grzywa, Renata
   Wysocka, Madalena
   Skorenski, Marcin
   Dabrowska, Agnieszka
   Lecka, Maria
   Suder, Piotr
   Sienczyk, Marcin
   Pyrc, Krzysztof
   Lesner, Adam
TI One Step Beyond: Design of Substrates Spanning Primed Positions of Zika
   Virus NS2B-NS3 Protease
SO ACS MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Zika virus; NS2B-NS3 protease; internally quenched peptides; peptide
   library; combinatorial chemistry
ID LIGAND DOCKING; INHIBITORS
AB Although the mosquito-borne Zika virus was discovered in the late 1940s of the 20th century, for years it was neglected, as the disease in humans was rare and relatively mild. Viral NS2B-NS3 protease is essential for virus replication, and except for maturation of viral proteins, it also modulates the infection microenvironment to facilitate virus invasion. Here, we report the combinatorial chemistry approach for the synthesis of internally quenched substrates of the Zika virus NS2B-NS3 protease that were optimized in prime positions of the peptide chain. Final substrate ABZ-ValLys-Lys-Arg-Ala-Ala-Trp-Tyr(3-NO2)-NH2 displays an excellent kinetic parameter (k(cat)/K-M reaching nearly 1.26 X 10(8) AV X s(-1)), which is over 10 times greater than previously reported (7.7 X 106 M-1 X s(-1)) substrate. Moreover, it was found to be selective over West Nile virus protease.
C1 [Gruba, Natalia; Wysocka, Madalena; Lesner, Adam] Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland.
   [Martinez, Jose Ignacio Rodriguez; Dabrowska, Agnieszka; Pyrc, Krzysztof] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Gronostajowa 7, PL-30387 Krakow, Poland.
   [Grzywa, Renata; Skorenski, Marcin; Lecka, Maria; Sienczyk, Marcin] Wroclaw Univ Sci & Technol, Fac Chem, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
   [Dabrowska, Agnieszka; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7A, PL-30387 Krakow, Poland.
   [Suder, Piotr] AGH Univ Sci & Technol, Adama Mickiewicza 30, PL-30059 Krakow, Poland.
RP Lesner, A (corresponding author), Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland.
EM adam.lesner@ug.edu.pl
OI Suder, Piotr/0000-0003-4511-1241; Rodriguez Martinez, Jose
   Ignacio/0000-0002-3379-9686; Gruba, Natalia/0000-0003-3281-9945
FU Ministry of Science and Higher Education Iuventus Plus Programme [IP2012
   0556 72]; Polish National Science Center [UMO-2017/01/X/ST5/00106,
   UMO-2016/21/B/NZ6/01307]; Wroclaw University of Science and Technology
   [0401/0195/17]
FX The work was funded in part by Ministry of Science and Higher Education
   Iuventus Plus Programme (IP2012 0556 72) and Polish National Science
   Center (UMO-2017/01/X/ST5/00106 (to N.G.) and (UMO-2016/21/B/NZ6/01307)
   (to K.P.)). M.S. and R.G. are grateful for support from Wroclaw
   University of Science and Technology (Statute Funds 0401/0195/17).
CR FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
   HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0
   ICTV. International comittee on taxonomy of viruses, 2014, VIRUS TAXONOMY
   Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9
   Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   ten Brink T, 2010, J COMPUT AID MOL DES, V24, P935, DOI 10.1007/s10822-010-9385-x
NR 19
TC 4
Z9 4
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-5875
J9 ACS MED CHEM LETT
JI ACS Med. Chem. Lett.
PD OCT
PY 2018
VL 9
IS 10
BP 1025
EP 1029
DI 10.1021/acsmedchemlett.8b00316
PG 9
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GX1JH
UT WOS:000447471800015
PM 30344911
OA Green Published
DA 2020-07-08
ER

PT J
AU Walper, SA
   Aragones, GL
   Sapsford, KE
   Brown, CW
   Rowland, CE
   Breger, JC
   Medintz, IL
AF Walper, Scott A.
   Aragones, Guillermo Lasarte
   Sapsford, Kim E.
   Brown, Carl W., III
   Rowland, Clare E.
   Breger, Joyce C.
   Medintz, Igor L.
TI Detecting Biothreat Agents: From Current Diagnostics to Developing
   Sensor Technologies
SO ACS SENSORS
LA English
DT Review
DE biothreat; bacteria; virus; toxin; biosensor; FDA; diagnostic; assay;
   pandemic; Ebola
ID STAPHYLOCOCCAL-ENTEROTOXIN-B; REAL-TIME PCR; BACILLUS-ANTHRACIS SPORES;
   RESONANCE ENERGY-TRANSFER; MEDIATED ISOTHERMAL AMPLIFICATION;
   LINKED-IMMUNOSORBENT-ASSAY; LABEL-FREE DETECTION; OF-CARE DIAGNOSTICS;
   PERFORMANCE LIQUID-CHROMATOGRAPHY; ACTIVE BOTULINUM NEUROTOXIN
AB Although a fundamental understanding of the pathogenicity of most biothreat agents has been elucidated and available treatments have increased substantially over the past decades, they still represent a significant public health threat in this age of (bio)terrorism, indiscriminate warfare, pollution, climate change, unchecked population growth, and globalization. The key step to almost all prevention, protection, prophylaxis, post-exposure treatment, and mitigation of any bioagent is early detection. Here, we review available methods for detecting bioagents including pathogenic bacteria and viruses along with their toxins. An introduction placing this subject in the historical context of previous naturally occurring outbreaks and efforts to weaponize selected agents is first provided along with definitions and relevant considerations. An overview of the detection technologies that find use in this endeavor along with how they provide data or transduce signal within a sensing configuration follows. Current "gold" standards for biothreat detection/diagnostics along with a listing of relevant FDA approved in vitro diagnostic devices is then discussed to provide an overview of the current state of the art. Given the 2014 outbreak of Ebola virus in Western Africa and the recent 2016 spread of Zika virus in the Americas, discussion of what constitutes a public health emergency and how new in vitro diagnostic devices are authorized for emergency use in the U.S. are also included. The majority of the Review is then subdivided around the sensing of bacterial, viral, and toxin biothreats with each including an overview of the major agents in that class, a detailed cross-section of different sensing methods in development based on assay format or analytical technique, and some discussion of related microfluidic lab-on-a-chip/point-of-care devices. Finally, an outlook is given on how this field will develop from the perspective of the biosensing technology itself and the new emerging threats they may face.
C1 [Walper, Scott A.; Aragones, Guillermo Lasarte; Brown, Carl W., III; Rowland, Clare E.; Breger, Joyce C.; Medintz, Igor L.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Code 6900, Washington, DC 20375 USA.
   [Aragones, Guillermo Lasarte; Brown, Carl W., III] George Mason Univ, Coll Sci, Fairfax, VA 22030 USA.
   [Sapsford, Kim E.] US FDA, OMPT CDRH OIR DMD Bacterial Resp & Med Countermea, Silver Spring, MD 20993 USA.
   [Rowland, Clare E.] CNR, Washington, DC 20036 USA.
RP Medintz, IL (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Code 6900, Washington, DC 20375 USA.
EM igor.medintz@nrl.navy.mil
RI Aragones, Guillermo Lasarte/AAC-8735-2019; Walper, Scott/A-5110-2018
OI Aragones, Guillermo Lasarte/0000-0003-3502-9367; Walper,
   Scott/0000-0002-9436-3456
FU National Institute of Food and Agriculture, U.S. Department of
   AgricultureUnited States Department of Agriculture (USDA)
   [2016-67021-25038]
FX S.A.W., J.C.B., and I.L.M. acknowledge ONR, NRL, the NRL NSI, and the
   National Institute of Food and Agriculture, U.S. Department of
   Agriculture, under award number 2016-67021-25038. C.E.R. acknowledges a
   National Research Council Research Associateship through NRL. K.E.S.
   acknowledges DMD and Y. Shea, M. Soboleski, R. Heipertz, T. Lowe, and J.
   Ross for their review and comments on selected sections included herein.
   S.A.W. acknowledges the OSD Applied Research to Advance Science &
   Technology (ARAP) program.
CR Abdelhamid HN, 2012, ANAL CHIM ACTA, V751, P94, DOI 10.1016/j.aca.2012.09.012
   Acquah C, 2016, CRIT REV BIOTECHNOL, V36, P1010, DOI 10.3109/07388551.2015.1083940
   Adhikari M, 2015, ANAL CHEM, V87, P11660, DOI 10.1021/acs.analchem.5b00702
   Adkins JA, 2017, ANAL CHEM, V89, P3613, DOI 10.1021/acs.analchem.6b05009
   Agasti SS, 2010, ADV DRUG DELIVER REV, V62, P316, DOI 10.1016/j.addr.2009.11.004
   Ahmed A, 2014, CLIN MICROBIOL REV, V27, P631, DOI 10.1128/CMR.00120-13
   Ahmed SR, 2016, BIOTECHNOL BIOENG, V113, P2298, DOI 10.1002/bit.25982
   Ai KL, 2009, ANGEW CHEM INT EDIT, V48, P304, DOI 10.1002/anie.200804231
   Al-Agamy M. H. M., 2011, Research Journal of Microbiology, V6, P193, DOI 10.3923/jm.2011.193.245
   Alam SI, 2012, ANAL CHEM, V84, P10500, DOI 10.1021/ac3028678
   Alarcon SH, 2006, TALANTA, V69, P1031, DOI 10.1016/j.talanta.2005.12.024
   Algar WR, 2017, J AM CHEM SOC, V139, P363, DOI 10.1021/jacs.6b11042
   Algar WR, 2014, J MATER CHEM B, V2, P7816, DOI 10.1039/c4tb00985a
   Algar WR, 2014, COORDIN CHEM REV, V263, P65, DOI 10.1016/j.ccr.2013.07.015
   Algar WR, 2012, ANAL CHEM, V84, P10136, DOI 10.1021/ac3028068
   Algar WR, 2012, J AM CHEM SOC, V134, P1876, DOI 10.1021/ja210162f
   Algar WR, 2011, ANAL CHEM, V83, P8826, DOI 10.1021/ac201331r
   Algar WR, 2011, BIOCONJUGATE CHEM, V22, P825, DOI 10.1021/bc200065z
   Aliberti A, 2016, ANALYST, V141, P1250, DOI 10.1039/c5an02001h
   Allen UD, 2016, PEDIATR TRANSPLANT, V20, P124, DOI 10.1111/petr.12610
   Almaviva S, 2015, LECT NOTES ELECTR EN, V319, P19, DOI 10.1007/978-3-319-09617-9_4
   Alvarez M, 2010, ANALYST, V135, P827, DOI 10.1039/b908503n
   Amani J, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.17473
   American Society for Microbiology, SENT LEV CLIN LAB PR
   Amini A., 2017, BMC INFECT DIS, V17, P19
   Amini K, 2015, REV ENVIRON SCI BIO, V14, P23, DOI 10.1007/s11157-014-9351-5
   Amoako KK, 2013, INT J FOOD MICROBIOL, V165, P319, DOI 10.1016/j.ijfoodmicro.2013.05.028
   Amoako KK, 2012, J MICROBIOL METH, V90, P228, DOI 10.1016/j.mimet.2012.05.012
   Anderson G. P., 2000, P SOC PHOTO-OPT INS, V4206
   Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010
   Anderson GP, 2004, SENS LETT, V2, P18, DOI 10.1166/sl.2004.029
   Anderson GP, 2000, BIOSENS BIOELECTRON, V14, P771, DOI 10.1016/S0956-5663(99)00053-6
   ANDERSON GP, 2000, P 1 C POINT DET CHEM
   Angione SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073497
   [Anonymous], 2016, FED REGISTER, V81, P2805
   [Anonymous], 1996, NATO HDB MED ASP NBC
   [Anonymous], 2011, TARO LEAF BLIGHT HAW
   [Anonymous], 2009, PAND INFL PREP RESP
   Appell M, 2016, J AOAC INT, V99, P861, DOI 10.5740/jaoacint.16-0113
   Arduini F, 2016, TALANTA, V150, P440, DOI 10.1016/j.talanta.2015.12.048
   Arvanitis M, 2014, CLIN MICROBIOL REV, V27, P490, DOI 10.1128/CMR.00091-13
   Ashley J, 2013, BIOSENS BIOELECTRON, V48, P126, DOI 10.1016/j.bios.2013.04.009
   Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a
   Aslan K, 2010, J MED CHEM BIOL RADI, V8, P1
   AUSUBEL FM, 1995, CURRENT PROTOCOLS MO
   Aydin S, 2015, PEPTIDES, V72, P4, DOI 10.1016/j.peptides.2015.04.012
   Ayyadurai S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-285
   Babrak L, 2016, TOXINS, V8, DOI 10.3390/toxins8010013
   BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983
   Badea M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160021
   Bahadir EB, 2016, ARTIF CELL NANOMED B, V44, P248, DOI 10.3109/21691401.2014.942456
   Bahadir EB, 2015, ANAL BIOCHEM, V478, P107, DOI 10.1016/j.ab.2015.03.011
   Bakker E, 2002, ANAL CHEM, V74, p420A, DOI 10.1021/ac022086f
   Bakthavathsalam P, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-8
   Balali-Mood M, 2014, ENCY TOXICOLOGY, P427, DOI [10.1016/B978-0-12-386454-3.00632-1, DOI 10.1016/B978-0-12-386454-3.00632-1]
   Baldwin CD, 2009, DIAGN MICR INFEC DIS, V63, P403, DOI 10.1016/j.diagmicrobio.2008.12.012
   Bamrungsap S, 2014, MICROCHIM ACTA, V181, P223, DOI 10.1007/s00604-013-1106-4
   Banada PP, 2009, BIOSENS BIOELECTRON, V24, P1685, DOI 10.1016/j.bios.2008.08.053
   Bao KD, 2012, BIOMED CHROMATOGR, V26, P1049, DOI 10.1002/bmc.1742
   Barlaan EA, 2005, J MICROBIOL METH, V61, P399, DOI 10.1016/j.mimet.2005.01.002
   Barnes LS, 2011, J INORG BIOCHEM, V105, P1580, DOI 10.1016/j.jinorgbio.2011.08.020
   Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278
   Baron S., 1996, MED MICROBIOLOGY
   dos Santos MB, 2013, BIOSENS BIOELECTRON, V45, P174, DOI 10.1016/j.bios.2013.01.009
   Barry John M., 2004, GREAT INFLUENZA STOR
   Basile K, 2018, EXPERT REV MOL DIAGN, V18, P75, DOI 10.1080/14737159.2018.1419065
   Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997
   Becker H., 2015, P SOC PHOTO-OPT INS
   Bennetts M., 2016, SUNDAY TIMES
   Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006
   Benton BJ, 1998, TOXICON, V36, P571, DOI 10.1016/S0041-0101(97)00158-X
   Berg B, 2015, ACS NANO, V9, P7857, DOI 10.1021/acsnano.5b03203
   Bergantin JH, 2010, ANAL LETT, V43, P476, DOI 10.1080/00032710903402317
   Berkenpas E, 2006, BIOSENS BIOELECTRON, V21, P2255, DOI 10.1016/j.bios.2005.11.005
   Bhaduri A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/bioinformatics/bts100
   Bhaduri P, 2012, WATER ENVIRON RES, V84, P786, DOI 10.2175/106143012X13407275694608
   Bhatta D, 2011, BIOSENS BIOELECTRON, V30, P78, DOI 10.1016/j.bios.2011.08.031
   Bhunia AK, 2014, FUTURE MICROBIOL, V9, P935, DOI [10.2217/FMB.14.61, 10.2217/fmb.14.61]
   Bhunia SK, 2013, SCI REP-UK, V3, DOI 10.1038/srep01473
   Bigna JJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015748
   Blanco-Canosa JB, 2014, COORDIN CHEM REV, V263, P101, DOI 10.1016/j.ccr.2013.08.030
   Boeneman K, 2013, ACS NANO, V7, P3778, DOI 10.1021/nn400702r
   Bogomolova A, 2010, SENSORS FOR CHEMICAL AND BIOLOGICAL APPLICATIONS, P333, DOI 10.1201/9781420005042-c13
   Bonanni A, 2010, ANALYST, V135, P1765, DOI 10.1039/c000532k
   Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017214
   Boyer AE, 2015, ANAL BIOANAL CHEM, V407, P2847, DOI 10.1007/s00216-015-8509-5
   Branch DW, 2004, BIOSENS BIOELECTRON, V19, P849, DOI 10.1016/j.bios.2003.08.020
   Breger JC, 2017, NANOSCALE, V9, P10447, DOI 10.1039/c7nr03362a
   Breger JC, 2017, NANO FUTURES, V1, DOI 10.1088/2399-1984/aa6561
   Breger JC, 2015, ACS NANO, V9, P8491, DOI 10.1021/acsnano.5b03459
   Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019
   Brinkworth CS, 2009, ANAL CHEM, V81, P1529, DOI 10.1021/ac802240f
   Brooks CE, 2010, VET MICROBIOL, V144, P226, DOI 10.1016/j.vetmic.2009.12.030
   Brown CW, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201700181
   Brown CW, 2015, CHEMBIOCHEM, V16, P725, DOI 10.1002/cbic.201402615
   Brown CW, 2014, ANGEW CHEM INT EDIT, V53, P7183, DOI 10.1002/anie.201402691
   Bruins M, 2013, TUBERCULOSIS, V93, P232, DOI 10.1016/j.tube.2012.10.002
   Bruno JG, 1999, BIOSENS BIOELECTRON, V14, P457, DOI 10.1016/S0956-5663(99)00028-7
   Bruno JG, 2009, J FLUORESC, V19, P427, DOI 10.1007/s10895-008-0429-8
   Bu XD, 2016, TRAC-TREND ANAL CHEM, V82, P22, DOI 10.1016/j.trac.2016.04.025
   Buchapudi KR, 2011, ANALYST, V136, P1539, DOI 10.1039/c0an01007c
   Buckhout-White S, 2016, RSC ADV, V6, P97587, DOI 10.1039/c6ra23079b
   Buckhout-White S, 2014, RSC ADV, V4, P48860, DOI 10.1039/c4ra10580j
   Bunyakul N, 2015, SENSORS-BASEL, V15, P547, DOI 10.3390/s150100547
   Burgula Y, 2007, J RAPID METH AUT MIC, V15, P146, DOI 10.1111/j.1745-4581.2007.00078.x
   Busman M, 2015, FOOD CONTROL, V47, P592, DOI 10.1016/j.foodcont.2014.08.003
   Busman M, 2014, FOOD ADDIT CONTAM A, V31, P932, DOI 10.1080/19440049.2014.900572
   Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a
   Byrne B, 2009, SENSORS-BASEL, V9, P4407, DOI 10.3390/s90604407
   Cable ML, 2009, J AM CHEM SOC, V131, P9562, DOI 10.1021/ja902291v
   Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578
   Callahan JH, 2006, ANAL CHEM, V78, P1789, DOI 10.1021/ac051292v
   Campbell GA, 2006, ANAL CHEM, V78, P2328, DOI 10.1021/ac0517491
   Campbell GA, 2006, BIOSENS BIOELECTRON, V21, P1684, DOI 10.1016/j.bios.2005.08.001
   Campbell GA, 2007, SENSOR ACTUAT B-CHEM, V127, P376, DOI 10.1016/j.snb.2007.04.038
   Campbell GA, 2007, SENSOR ACTUAT B-CHEM, V126, P354, DOI 10.1016/j.snb.2007.03.021
   Campbell K, 2007, ANAL CHEM, V79, P5906, DOI 10.1021/ac070342o
   Campbell K, 2009, J CHROMATOGR B, V877, P4079, DOI 10.1016/j.jchromb.2009.10.023
   Campos AR, 2016, J PHYS CHEM C, V120, P20961, DOI 10.1021/acs.jpcc.6b03027
   Capua I, 2003, AVIAN PATHOL, V32, P47, DOI 10.1080/0307945021000070714
   Cardoso DR, 2011, CIENC SAUDE COLETIVA, V16, P821, DOI 10.1590/S1413-81232011000700013
   Carey JR, 2011, J AM CHEM SOC, V133, P7571, DOI 10.1021/ja201634d
   Carus WS, 2015, HEALTH SECUR, V13, P219, DOI 10.1089/hs.2014.0092
   CDC, DENG LAB GUID DIAGN
   *CDCP, LAB RESP NETW PARTN
   Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266
   Cent. Dis. Control Prev, 2004, JAMA-J AM MED ASSOC, V291, P173
   Centers for Disease Control and Prevention, SEAS INFL VACC EFF
   Centers for Disease Control and Prevention, INFL FLU
   Centers for Disease Control and Prevention, BIOS MICR BIOM LAB B
   Centers for Disease Control and Prevention, A HIST OF ANTHR
   Centers for Disease Control and Prevention, 2016, MULT OUTBR SHIG TOX
   Centers for Disease Control and Prevention (CDC) Department of Health and Human Services (HHS), 2012, Fed Regist, V77, P61083
   Centers for Disease Control and Prevention Department of Health and Human Services, 2017, FED REGISTER, V82, P6278
   Centers for Disease Control CDC and Prevention, 2014, 2014 EB OUTBR W AFR
   Chambers JP, 2008, CURR ISSUES MOL BIOL, V10, P1
   Chan CPY, 2013, ANNU REV ANAL CHEM, V6, P191, DOI 10.1146/annurev-anchem-062012-092641
   Chan KY, 2013, BIOSENS BIOELECTRON, V41, P532, DOI 10.1016/j.bios.2012.09.016
   Chang BY, 2010, ANNU REV ANAL CHEM, V3, P207, DOI 10.1146/annurev.anchem.012809.102211
   Chao J, 2016, BIOSENS BIOELECTRON, V76, P68, DOI 10.1016/j.bios.2015.07.007
   Charles PT, 2006, ANAL CHIM ACTA, V578, P2, DOI 10.1016/j.aca.2006.04.083
   Chatrathi MP, 2007, BIOSENS BIOELECTRON, V22, P2932, DOI 10.1016/j.bios.2006.12.013
   Chauvet R, 2017, APPL SPECTROSC REV, V52, P123, DOI 10.1080/05704928.2016.1209760
   Chen AC, 2013, CHEM SOC REV, V42, P5425, DOI 10.1039/c3cs35518g
   Chen AC, 2013, ANAL METHODS-UK, V5, P2158, DOI 10.1039/c3ay40155c
   Chen CH, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/43/435102
   Chen H, 2015, CHEM COMMUN, V51, P5036, DOI 10.1039/c5cc00757g
   Chen HX, 2013, MICROCHIM ACTA, V180, P431, DOI 10.1007/s00604-013-0943-5
   Chen HY, 2014, ANAL BIOANAL CHEM, V406, P5157, DOI 10.1007/s00216-014-7934-1
   Chen HW, 2014, J MICROBIOL METH, V107, P176, DOI 10.1016/j.mimet.2014.07.039
   Chen HJ, 2013, CHEM SOC REV, V42, P2679, DOI 10.1039/c2cs35367a
   Chen JH, 2012, FOOD CONTROL, V25, P555, DOI 10.1016/j.foodcont.2011.11.039
   Chen LY, 2018, ACS SENSORS, V3, P27, DOI 10.1021/acssensors.7b00816
   Chen LY, 2015, SENSORS-BASEL, V15, P8852, DOI 10.3390/s150408852
   Chen S, 2016, SENSOR ACTUAT B-CHEM, V235, P563, DOI 10.1016/j.snb.2016.05.118
   Chen Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333, 10.1371/journal.pone.0018139]
   Chen Y, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.26
   Chenau J, 2014, ANAL CHEM, V86, P6144, DOI 10.1021/ac501371r
   Chenau J, 2011, ANAL CHEM, V83, P8675, DOI 10.1021/ac2020992
   Cheng XH, 2009, ANAL BIOANAL CHEM, V393, P487, DOI 10.1007/s00216-008-2514-x
   Cheung SF, 2015, JALA-J LAB AUTOM, V20, P316, DOI 10.1177/2211068215577197
   Cho H, 2014, BIOSENS BIOELECTRON, V54, P667, DOI 10.1016/j.bios.2013.11.058
   Cho IH, 2014, ANNU REV ANAL CHEM, V7, P65, DOI 10.1146/annurev-anchem-071213-020249
   Cho IH, 2013, INT J FOOD MICROBIOL, V164, P70, DOI 10.1016/j.ijfoodmicro.2013.02.025
   Choi JR, 2016, ANALYST, V141, P2930, DOI 10.1039/c5an02532j
   Choi JR, 2016, BIOSENS BIOELECTRON, V79, P98, DOI 10.1016/j.bios.2015.12.005
   Chou CC, 2012, SENSORS-BASEL, V12, P16660, DOI 10.3390/s121216660
   Chou TC, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-52
   Christensen DR, 2006, CLIN CHEM, V52, P141, DOI 10.1373/clinchem.2005.052522
   Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412
   Chu M. C., 2001, BASIC LAB PROTOCOL P
   Ciaurriz P, 2017, BEILSTEIN J NANOTECH, V8, P244, DOI 10.3762/bjnano.8.27
   Cirino NM, 2004, EXPERT REV MOL DIAGN, V4, P841, DOI 10.1586/14737159.4.6.841
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Clark RF, 1999, UNDERSEA HYPERBAR M, V26, P175
   Claussen JC, 2013, NANOSCALE, V5, P12156, DOI 10.1039/c3nr03655c
   Clementi M, 2015, NEW MICROBIOL, V38, P437
   Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j
   Coleman R, 2016, TOXICON, V119, P64, DOI 10.1016/j.toxicon.2016.05.009
   College of American Pathologists, LAB PREP EX LPX
   Collins AM, 2018, IMMUNOGENETICS, V70, P143, DOI 10.1007/s00251-017-1049-8
   Comer PJ, 2004, J RISK RES, V7, P523, DOI 10.1080/1366987032000123865
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   CONDIT RC, 2001, FIELDS VIROLOGY
   Cook Noble David, 1998, BORN DIE DIS NEW WOR
   Cooper KL, 2011, SENSORS-BASEL, V11, P3004, DOI 10.3390/s110303004
   Cornett E. M., 2012, ANGEW CHEM, V124, P9209
   Cortina ME, 2016, BIOSENS BIOELECTRON, V80, P24, DOI 10.1016/j.bios.2016.01.021
   Cotten M, 2014, J VIROL, V88, P11056, DOI 10.1128/JVI.01333-14
   Courtney B, 2014, BIOSECUR BIOTERROR, V12, P239, DOI 10.1089/bsp.2014.0046
   Cowcher DP, 2013, ANAL CHEM, V85, P3297, DOI 10.1021/ac303657k
   Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498
   Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]
   Creran B, 2014, ACS APPL MATER INTER, V6, P19525, DOI 10.1021/am505689g
   Crivianu-Gaita V, 2015, BIOSENS BIOELECTRON, V70, P167, DOI 10.1016/j.bios.2015.03.032
   Croddy E, 2001, MIL MED, V166, P837
   Croddy E, 2005, WEAPONS MASS DESTRUC
   Cui HC, 2013, ANALYST, V138, P7188, DOI 10.1039/c3an01112g
   Cui XK, 2017, CHEM SCI, V8, P3628, DOI 10.1039/c6sc03720h
   Cui ZQ, 2011, NANOSCALE, V3, P2454, DOI 10.1039/c1nr10218d
   Cao C, 2011, SMALL, V7, P1701, DOI 10.1002/smll.201100294
   Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781
   D'Agata Roberta, 2012, Artif DNA PNA XNA, V3, P45, DOI 10.4161/adna.21383
   Dai SL, 2017, BIOSENS BIOELECTRON, V91, P538, DOI 10.1016/j.bios.2017.01.009
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Datar R, 2009, MRS BULL, V34, P449, DOI 10.1557/mrs2009.121
   Davies AR, 2010, MED J AUSTRALIA, V192, P356, DOI 10.5694/j.1326-5377.2010.tb03545.x
   Davis R, 2012, J APPL MICROBIOL, V112, P743, DOI 10.1111/j.1365-2672.2011.05215.x
   Davis R, 2010, J APPL MICROBIOL, V109, P2019, DOI 10.1111/j.1365-2672.2010.04832.x
   Davis R., 2010, APPL MICROBIOL, V2, P1582
   Davis R, 2011, INT J FOOD MICROBIOL, V150, P140, DOI 10.1016/j.ijfoodmicro.2011.07.024
   Davis R, 2010, J FOOD SCI, V75, pM340, DOI 10.1111/j.1750-3841.2010.01686.x
   Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4
   Dayan-Kenigsberg J, 2008, J IMMUNOL METHODS, V336, P251, DOI 10.1016/j.jim.2008.05.007
   De Crozals G, 2016, NANO TODAY, V11, P435, DOI 10.1016/j.nantod.2016.07.002
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   de Rooij MMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151281
   Dea S, 2000, J VIROL METHODS, V87, P109, DOI 10.1016/S0166-0934(00)00158-0
   Delehanty JB, 2012, ANAL CHIM ACTA, V750, P63, DOI 10.1016/j.aca.2012.05.032
   Delehanty JB, 2011, J AM CHEM SOC, V133, P10482, DOI 10.1021/ja200555z
   Dembek Z. F., 2011, USAMRIIDS MED MANAGE
   Dembek ZF, 2007, MED ASPECTS BIOL WAR
   Demirev PA, 2008, J MASS SPECTROM, V43, P1441, DOI 10.1002/jms.1474
   Deng H, 2013, CHEM COMMUN, V49, P51, DOI 10.1039/c2cc37037a
   Deng MJ, 2011, MOL BIOL REP, V38, P1941, DOI 10.1007/s11033-010-0315-8
   Deng ZT, 2007, J PHYS CHEM B, V111, P12024, DOI 10.1021/jp074609z
   Denkbas E. B., 2012, NATO SCI PEACE SECUR
   Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763
   DENNIS DT, 1999, PLAGUE MANUAL EPIDEM
   Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805
   Diaz SA, 2017, J MATER CHEM B, V5, P7907, DOI 10.1039/c7tb01654a
   Diaz SA, 2017, ACS NANO, V11, P5884, DOI 10.1021/acsnano.7b01624
   Dickers Kirsten J., 2003, Toxicological Reviews, V22, P137, DOI 10.2165/00139709-200322030-00002
   Dierig A, 2015, PEDIATR INFECT DIS J, V34, P97, DOI 10.1097/INF.0000000000000601
   Dietzsch M, 2012, PROC SPIE, V8367, DOI 10.1117/12.920473
   DiEuliis D, 2018, PROTEIN CELL, V9, P239, DOI 10.1007/s13238-017-0493-4
   Ding SW, 2015, CURR OPIN BIOTECH, V34, P242, DOI 10.1016/j.copbio.2015.04.005
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Doria G, 2012, SENSORS-BASEL, V12, P1657, DOI 10.3390/s120201657
   Dostalova S., 2015, J METALLOMICS NANOTE, V1, P37
   Dover JE, 2009, J MICROBIOL METH, V78, P10, DOI 10.1016/j.mimet.2009.04.008
   Drexler JF, 2014, ANTIVIR RES, V101, P45, DOI 10.1016/j.antiviral.2013.10.013
   Drzymala SS, 2015, ANAL BIOANAL CHEM, V407, P3489, DOI 10.1007/s00216-015-8541-5
   Duan DM, 2015, BIOSENS BIOELECTRON, V74, P134, DOI 10.1016/j.bios.2015.05.025
   Duan N, 2016, ANAL METHODS-UK, V8, P1390, DOI [10.1039/C5AY02608C, 10.1039/c5ay02608c]
   Duan N, 2015, MICROCHIM ACTA, V182, P917, DOI 10.1007/s00604-014-1406-3
   Duan N, 2013, ANAL CHIM ACTA, V804, P151, DOI 10.1016/j.aca.2013.09.047
   Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876
   Duchesne L, 2018, J VIRAL HEPATITIS, V25, P108, DOI 10.1111/jvh.12827
   Dugan L, 2012, J MICROBIOL METH, V90, P280, DOI 10.1016/j.mimet.2012.05.022
   Duggan AT, 2016, CURR BIOL, V26, P3407, DOI 10.1016/j.cub.2016.10.061
   Dulay SB, 2014, BIOSENS BIOELECTRON, V59, P342, DOI 10.1016/j.bios.2014.03.024
   Dungchai W, 2008, TALANTA, V77, P727, DOI 10.1016/j.talanta.2008.07.014
   Dunning FM, 2012, APPL ENVIRON MICROB, V78, P7687, DOI 10.1128/AEM.01664-12
   Dupuis A, 2008, PROTEOMICS, V8, P4633, DOI 10.1002/pmic.200800326
   Duriez E, 2008, J PROTEOME RES, V7, P4154, DOI 10.1021/pr8003437
   Duriez E, 2016, J MASS SPECTROM, V51, P183, DOI 10.1002/jms.3747
   Dutse SW, 2011, SENSORS-BASEL, V11, P5754, DOI 10.3390/s110605754
   Dweik M, 2012, TALANTA, V94, P84, DOI 10.1016/j.talanta.2012.02.056
   Dwivedi HP, 2010, APPL MICROBIOL BIOT, V87, P2323, DOI 10.1007/s00253-010-2728-7
   Dwyer CL, 2015, CHEM MATER, V27, P6490, DOI 10.1021/acs.chemmater.5b02870
   Dybwad M, 2013, APPL ENVIRON MICROB, V79, P5372, DOI 10.1128/AEM.01724-13
   Dzantiev BB, 2014, TRAC-TREND ANAL CHEM, V55, P81, DOI 10.1016/j.trac.2013.11.007
   Ecker D. J., 2006, JALA, V11, P341
   Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918
   Edelstein RL, 2000, BIOSENS BIOELECTRON, V14, P805, DOI 10.1016/S0956-5663(99)00054-8
   Edwards KA, 2006, ANAL BIOANAL CHEM, V384, P73, DOI 10.1007/s00216-005-0090-x
   Eliuk S, 2015, ANNU REV ANAL CHEM, V8, P61, DOI 10.1146/annurev-anchem-071114-040325
   Emilsson GM, 2002, CELL MOL LIFE SCI, V59, P596, DOI 10.1007/s00018-002-8452-4
   Emrich CA, 2002, ANAL CHEM, V74, P5076, DOI 10.1021/ac020236g
   Emrich CA, 2007, ANAL CHEM, V79, P7360, DOI 10.1021/ac0711485
   Engstrom A, 2012, J CLIN MICROBIOL, V50, P2026, DOI 10.1128/JCM.06664-11
   Ertekin O, 2016, TOXINS, V8, DOI 10.3390/toxins8050148
   Eulberg D, 2003, CHEMBIOCHEM, V4, P979, DOI 10.1002/cbic.200300663
   Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11
   Evans JT, 2009, J ANTIMICROB CHEMOTH, V63, P295, DOI 10.1093/jac/dkn506
   Evich M, 2017, HETEROCYCL COMMUN, V23, P155, DOI 10.1515/hc-2017-0056
   Fagerquist CK, 2011, ACS SYM SER, V1065, P99
   Faltin B, 2013, CLIN CHEM, V59, P1567, DOI 10.1373/clinchem.2013.205211
   Fan FX, 2015, FOODBORNE PATHOG DIS, V12, P778, DOI 10.1089/fpd.2015.1950
   Fan FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124507
   Fan Z. H., 2009, TRANSD 2009 INT SOL
   Fang SB, 2009, J MICROBIOL METH, V77, P225, DOI 10.1016/j.mimet.2009.02.008
   Farquharson S, 2014, ANALYST, V139, P6366, DOI 10.1039/c4an01163e
   Fatah A.A., 2001, INTRO BIOL AGENT DET
   Fauci AS, 2012, SCIENCE, V336, P1522, DOI 10.1126/science.1224305
   Fedele CG, 2006, J CLIN MICROBIOL, V44, P4464, DOI 10.1128/JCM.00276-06
   Felder E, 2012, TOXINS, V4, P633, DOI 10.3390/toxins4090633
   Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314
   Feltis BN, 2008, BIOSENS BIOELECTRON, V23, P1131, DOI 10.1016/j.bios.2007.11.005
   Feng S, 2014, ACS NANO, V8, P3069, DOI 10.1021/nn500614k
   Fenner F, 1988, SMALLPOX ITS ERADICA
   Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004
   Ferracci G, 2011, ANAL BIOCHEM, V410, P281, DOI 10.1016/j.ab.2010.11.045
   Ferrier DC, 2015, BIOSENS BIOELECTRON, V68, P798, DOI 10.1016/j.bios.2015.01.031
   Fetter L, 2015, CHEM COMMUN, V51, P15137, DOI 10.1039/c5cc05933j
   Figueiredo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07865
   Filippov A A., 2013, J BIOTERRORISM BIODE, V01
   Fischer N, 2007, CURR OPIN CHEM BIOL, V11, P316, DOI 10.1016/j.cbpa.2007.05.017
   Fode-Vaughan KA, 2003, LETT APPL MICROBIOL, V37, P239, DOI 10.1046/j.1472-765X.2003.01386.x
   Fonfria ES, 2007, ANAL CHEM, V79, P6303, DOI 10.1021/ac070362q
   Foreman MR, 2015, ADV OPT PHOTONICS, V7, P168, DOI 10.1364/AOP.7.000168
   Fornara A, 2008, NANO LETT, V8, P3423, DOI 10.1021/nl8022498
   Fournier PE, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0114-2
   Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219
   Fraga M, 2014, ANAL CHIM ACTA, V850, P57, DOI 10.1016/j.aca.2014.08.030
   Franciosa G, 2004, APPL ENVIRON MICROB, V70, P4170, DOI 10.1128/AEM.70.7.4170-4176.2004
   Franzini RM, 2011, BIOCONJUGATE CHEM, V22, P1869, DOI 10.1021/bc2003567
   Fredriksson SA, 2005, ANAL CHEM, V77, P1545, DOI 10.1021/ac048756u
   FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900
   Fu J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/15/155502
   Fu L., 2006, MRS ONLINE P LIBR, V951
   Fu SJ, 2011, APPL BIOCHEM BIOTECH, V163, P845, DOI 10.1007/s12010-010-9088-8
   Fu X, 2016, BIOSENS BIOELECTRON, V78, P530, DOI 10.1016/j.bios.2015.11.099
   Fu ZY, 2013, METHODS, V64, P260, DOI 10.1016/j.ymeth.2013.08.003
   Fu ZY, 2013, SENSOR ACTUAT B-CHEM, V182, P633, DOI 10.1016/j.snb.2013.03.033
   Fukushi S, 2018, J VIROL METHODS, V251, P22, DOI 10.1016/j.jviromet.2017.10.008
   Fursova KK, 2016, RUSS J BIOORG CHEM+, V42, P294, DOI 10.1134/S1068162016020035
   Galvani AP, 2003, P NATL ACAD SCI USA, V100, P15276, DOI 10.1073/pnas.2435085100
   Gan SD, 2013, J INVEST DERMATOL, V133, pE10, DOI 10.1038/jid.2013.287
   Ganesan V, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/lcdr/2014/9191.5086
   Gao D, 2013, LAB CHIP, V13, P3309, DOI 10.1039/c3lc50449b
   Garber EAE, 2005, J FOOD PROTECT, V68, P1294, DOI 10.4315/0362-028X-68.6.1294
   Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948
   Garcia-Moraleja A, 2015, FOOD RES INT, V72, P247, DOI 10.1016/j.foodres.2015.02.030
   Gardner C. W., 2008, P SOC PHOTO-OPT INS
   Garrigue I, 2016, J CLIN VIROL, V80, P74, DOI 10.1016/j.jcv.2016.04.017
   Gartner C., 2015, P SOC PHOTO-OPT INS
   Gautam R, 2015, CURR SCI INDIA, V108, P341
   Gaylord ST, 2015, ANAL CHEM, V87, P6570, DOI 10.1021/acs.analchem.5b00322
   Ge YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069941
   Gee JE, 2004, J CLIN MICROBIOL, V42, P3649, DOI [10.1128/JCM.42.8.3649-3654.2004, 10.1128/jcm.42.8.3649-3654.2004]
   Gee JE, 2003, J CLIN MICROBIOL, V41, P4647, DOI 10.1128/JCM.41.10.4647-4654.2003
   Geissler D, 2014, INORG CHEM, V53, P1824, DOI 10.1021/ic4017883
   Gemmill KB, 2015, CHEM MATER, V27, P6222, DOI 10.1021/acs.chemmater.5b03181
   Gemmill KB, 2013, BIOCONJUGATE CHEM, V24, P269, DOI 10.1021/bc300644p
   Geng P, 2008, ELECTROCHIM ACTA, V53, P4663, DOI 10.1016/j.electacta.2008.01.037
   Geng T, 2006, SENSORS-BASEL, V6, P796, DOI 10.3390/s6080796
   Georgiev V., 2009, INFECT DIS, V2, P221
   Ghosh N, 2013, INDIAN J MICROBIOL, V53, P48, DOI 10.1007/s12088-012-0334-3
   Ghosh N, 2013, DIAGN MICR INFEC DIS, V77, P14, DOI 10.1016/j.diagmicrobio.2013.05.006
   Gilchrist CA, 2015, CLIN MICROBIOL REV, V28, P541, DOI 10.1128/CMR.00075-13
   Giltner CL, 2013, J CLIN MICROBIOL, V51, P618, DOI 10.1128/JCM.02565-12
   Gnanam Annie J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS55, DOI 10.1016/S0035-9203(08)70015-4
   Gorzer I, 2010, J VIROL, V84, P7195, DOI 10.1128/JVI.00475-10
   Goftman VV, 2016, BIOSENS BIOELECTRON, V79, P476, DOI 10.1016/j.bios.2015.12.079
   Goji N, 2015, J MICROBIOL METH, V109, P167, DOI 10.1016/j.mimet.2014.12.003
   Golberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086341
   Goldman BI, 2016, ARCH PATHOL LAB MED, V140, P503, DOI 10.5858/arpa.2015-0428-LE
   Goldman ER, 2009, SENSORS-BASEL, V9, P542, DOI 10.3390/s90100542
   Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053
   Goldman ER, 2004, ANAL CHEM, V76, P684, DOI 10.1021/ac035083r
   Goldman ER, 2002, J AM CHEM SOC, V124, P6378, DOI 10.1021/ja0125570
   Gomez A, 2014, ANAL CHEM, V86, P11992, DOI 10.1021/ac5018748
   Gooding JJ, 2006, ANAL CHIM ACTA, V559, P137, DOI 10.1016/j.aca.2005.12.020
   GOPINATH PG, 2015, J MED BIOL ENG, V4, P307
   Gopinath SCB, 2014, BIOSENS BIOELECTRON, V60, P332, DOI 10.1016/j.bios.2014.04.014
   Goryacheva IY, 2016, COMP ANAL C, V72, P5, DOI 10.1016/bs.coac.2016.03.007
   Graham DL, 2004, TRENDS BIOTECHNOL, V22, P455, DOI 10.1016/j.tibtech.2004.06.006
   Grate JW, 2010, TRAC-TREND ANAL CHEM, V29, P1137, DOI 10.1016/j.trac.2010.07.005
   Gravel JF, 2014, MICROFLUID NANOFLUID, V16, P1075, DOI 10.1007/s10404-013-1273-y
   Grenda T, 2014, B VET I PULAWY, V58, P393, DOI 10.2478/bvip-2014-0061
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400
   Grimes CA, 2011, SENSORS-BASEL, V11, P2809, DOI 10.3390/s110302809
   Grimwade JE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02352
   Gronewold TMA, 2007, ANAL CHIM ACTA, V603, P119, DOI 10.1016/j.aca.2007.09.056
   Gross B, 2017, ANAL CHEM, V89, P57, DOI 10.1021/acs.analchem.6b04344
   Gross J.H., 2004, MASS SPECTROMETRY TX
   Grossi G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01072-8
   Gu HW, 2006, CHEM COMMUN, P941, DOI 10.1039/b514130c
   Guan JG, 2004, J BIOSCI BIOENG, V97, P219, DOI 10.1016/s1389-1723(04)70195-4
   Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002
   Gulig Paul A., 2008, P755, DOI 10.1007/978-0-387-75113-9_28
   Guntupalli R, 2007, J MICROBIOL METH, V70, P112, DOI 10.1016/j.mimet.2007.04.001
   Guntupalli R, 2007, BIOSENS BIOELECTRON, V22, P1474, DOI 10.1016/j.bios.2006.06.037
   Guo Q, 2013, INT J TUBERC LUNG D, V17, P1008, DOI 10.5588/ijtld.12.0519
   Guo XF, 2012, ANAL CHEM, V84, P241, DOI 10.1021/ac202419u
   Guo Y, 2015, ANALYST, V140, P551, DOI 10.1039/c4an01463d
   Hadjinicolaou AV, 2009, J MICROBIOL METH, V78, P45, DOI 10.1016/j.mimet.2009.04.005
   Hahn MA, 2005, ANAL CHEM, V77, P4861, DOI 10.1021/ac050641i
   Hahn MA, 2008, ANAL CHEM, V80, P864, DOI 10.1021/ac7018365
   Halliwell J, 2013, TOXINS, V5, P1381, DOI 10.3390/toxins5081381
   Hampl J, 2001, ANAL BIOCHEM, V288, P176, DOI 10.1006/abio.2000.4902
   Han SR, 2013, J MICROBIOL BIOTECHN, V23, P878, DOI 10.4014/jmb.1212.12033
   Hannis JC, 2008, J CLIN MICROBIOL, V46, P1220, DOI 10.1128/JCM.02158-07
   Hao RZ, 2011, BIOSENS BIOELECTRON, V26, P3398, DOI 10.1016/j.bios.2011.01.010
   Hao RZ, 2009, BIOSENS BIOELECTRON, V24, P1330, DOI 10.1016/j.bios.2008.07.071
   Harkup K., 2015, A IS ARSENIC POISONS
   Harz A, 2009, CYTOM PART A, V75A, P104, DOI 10.1002/cyto.a.20682
   HASHIMOTO K, 1990, MICROBIAL TOXINS IN FOODS AND FEEDS, P575
   Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/NNM.13.86, 10.2217/nnm.13.86]
   Hatano B, 2010, JPN J INFECT DIS, V63, P36
   Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12
   Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5
   He F, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-330
   He LL, 2011, CHEM SCI, V2, P1579, DOI 10.1039/c1sc00201e
   He LL, 2011, J FOOD SCI, V76, pN49, DOI 10.1111/j.1750-3841.2011.02196.x
   He XX, 2011, ANALYST, V136, P4183, DOI 10.1039/c1an15413c
   He YP, 2015, FOOD MICROBIOL, V47, P28, DOI 10.1016/j.fm.2014.11.004
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362
   Hernychova L, 2008, ANAL CHEM, V80, P7097, DOI 10.1021/ac800788k
   Hestvik G, 2015, EPIDEMIOL INFECT, V143, P2137, DOI 10.1017/S0950268814002398
   Hibi K, 2006, ANAL CHIM ACTA, V573, P158, DOI 10.1016/j.aca.2006.03.022
   Hickert S, 2016, MYCOTOXIN RES, V32, P7, DOI 10.1007/s12550-015-0233-7
   Hickert S, 2015, MYCOTOXIN RES, V31, P109, DOI 10.1007/s12550-015-0221-y
   HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0
   Hildebrandt N, 2017, CHEM REV, V117, P536, DOI 10.1021/acs.chemrev.6b00030
   Hildebrandt N, 2014, COORDIN CHEM REV, V273, P125, DOI 10.1016/j.ccr.2014.01.020
   Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015
   Hillson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132850
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hines HB, 2005, APPL ENVIRON MICROB, V71, P4478, DOI 10.1128/AEM.71.8.4478-4486.2005
   Hintsche R., 1997, FRONTIERS BIOSENSORS
   Ho YP, 2010, CLIN CHEM, V56, P525, DOI 10.1373/clinchem.2009.138867
   Hotzer B, 2012, SMALL, V8, P2297, DOI 10.1002/smll.201200109
   Hoffmann B, 2009, VET MICROBIOL, V139, P1, DOI 10.1016/j.vetmic.2009.04.034
   Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Hong SC, 2011, SENSOR ACTUAT B-CHEM, V156, P271, DOI 10.1016/j.snb.2011.04.032
   Hong WY, 2010, J MICROBIOL METH, V83, P133, DOI 10.1016/j.mimet.2010.08.005
   Horsmon J., 2008, P 26 ARM SCI C ORL F
   Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182
   Houldcroft CJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01317
   Houpikian P, 2002, EMERG INFECT DIS, V8, P122
   Hsing IM, 2007, ELECTROANAL, V19, P755, DOI 10.1002/elan.200603785
   Hu J, 2013, LAB CHIP, V13, P4352, DOI 10.1039/c3lc50672j
   Hu JT, 2015, RSC ADV, V5, P16036, DOI 10.1039/c4ra17327a
   Hu JT, 2014, RSC ADV, V4, P43998, DOI 10.1039/c4ra06001f
   Hu YH, 2014, ANAL CHEM, V86, P8785, DOI 10.1021/ac502008k
   Huan TN, 2009, BIOSENS BIOELECTRON, V25, P469, DOI 10.1016/j.bios.2009.08.002
   Huang CJ, 2011, ANAL CHEM, V83, P674, DOI 10.1021/ac102773r
   Huang JL, 2010, BIOSENS BIOELECTRON, V25, P1204, DOI 10.1016/j.bios.2009.10.036
   Huang S, 2008, BIOTECHNOL BIOENG, V101, P1014, DOI 10.1002/bit.21995
   Huang S, 2009, IEEE Sensors Journal, V9, P1091, DOI 10.1109/JSEN.2009.2025850
   Huang Yi, 2014, Virologica Sinica, V29, P372, DOI 10.1007/s12250-014-3512-0
   Huang Y, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102375
   Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141545
   Huff K, 2012, MICROB BIOTECHNOL, V5, P607, DOI 10.1111/j.1751-7915.2012.00349.x
   Hurtle W, 2003, J CLIN MICROBIOL, V41, P4758, DOI 10.1128/JCM.41.10.4758-4766.2003
   Hurtle W, 2003, J CLIN MICROBIOL, V41, P3273, DOI 10.1128/JCM.41.7.3273-3283.2003
   Hurtle W, 2002, BIOTECHNIQUES, V33, P386, DOI 10.2144/02332rr05
   Hushegyi A, 2015, CHEM COMMUN, V51, P7474, DOI 10.1039/c5cc00922g
   Hushegyi A, 2016, BIOSENS BIOELECTRON, V79, P644, DOI 10.1016/j.bios.2015.12.102
   Hussain MM, 2013, CLIN BIOCHEM, V46, P633, DOI 10.1016/j.clinbiochem.2012.12.020
   Huybrechts B, 2015, ARCH TOXICOL, V89, P1993, DOI 10.1007/s00204-014-1358-8
   Hwang J, 2016, RSC ADV, V6, P48445, DOI 10.1039/c6ra05446c
   Hwang J, 2016, NANOSCALE, V8, P11418, DOI 10.1039/c5nr07243c
   Inglis TJJ, 2015, J CLIN MICROBIOL, V53, P1009, DOI 10.1128/JCM.03644-14
   International Union of Pure and Applied Chemistry (IUPAC), 2014, COMP CHEM TERM GOLD, P166
   Ionescu RE, 2007, ENZYME MICROB TECH, V40, P403, DOI 10.1016/j.enzmictec.2006.07.010
   Ionescu RE, 2007, ANAL CHEM, V79, P8662, DOI 10.1021/ac0707129
   Ivnitski D, 1999, BIOSENS BIOELECTRON, V14, P599, DOI 10.1016/S0956-5663(99)00039-1
   Jacob D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039928
   Jamshaid T, 2016, TRAC-TREND ANAL CHEM, V79, P344, DOI 10.1016/j.trac.2015.10.022
   Jang HB, 2011, ANAL CHEM, V83, P1717, DOI 10.1021/ac102846q
   Jang I, 2015, ANAEROBE, V35, P48, DOI 10.1016/j.anaerobe.2015.07.001
   Jang JH, 2010, MAR DRUGS, V8, P1049, DOI 10.3390/md8041049
   Janse I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-86
   Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P4004, DOI 10.1002/1521-3773(20001117)39:22<4004::AID-ANIE4004>3.0.CO;2-2
   Jantra J, 2011, J ENVIRON SCI HEAL A, V46, P560, DOI 10.1080/10934529.2011.562810
   Janzen TW, 2015, J FOOD PROTECT, V78, P355, DOI 10.4315/0362-028X.JFP-14-216
   Jaton K, 2013, New Microbes New Infect, V1, P6, DOI 10.1002/2052-2975.8
   Jelden KC, 2016, J CLIN MICROBIOL, V54, P1031, DOI 10.1128/JCM.02905-15
   Jen HC, 2008, J CHROMATOGR B, V871, P95, DOI 10.1016/j.jchromb.2008.06.030
   Jen HC, 2014, J FOOD DRUG ANAL, V22, P178, DOI 10.1016/j.jfda.2013.09.005
   Jeng K, 2013, J CLIN MICROBIOL, V51, P3300, DOI 10.1128/JCM.01443-13
   Jenko KL, 2014, ANALYST, V139, P5093, DOI [10.1039/C4AN01270D, 10.1039/c4an01270d]
   Jennings TL, 2011, ACS NANO, V5, P5579, DOI 10.1021/nn201050g
   Jian-Umpunkul P, 2012, J VIROL METHODS, V185, P24, DOI 10.1016/j.jviromet.2012.05.021
   Jiang TT, 2009, CHEM COMMUN, P1972, DOI 10.1039/b818853j
   Jing WW, 2014, ANAL CHEM, V86, P5815, DOI 10.1021/ac500578h
   Johnson BJ, 2014, NANO TODAY, V9, P102, DOI 10.1016/j.nantod.2014.02.005
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Joo J, 2012, ANALYST, V137, P3609, DOI 10.1039/c2an35369e
   Joriczyk-Matysiak E., 2014, BIOMED RES INT, V2014
   Joshi SG, 2012, J PHARMACOL TOX MET, V65, P8, DOI 10.1016/j.vascn.2011.11.002
   Joshi S, 2016, ANALYST, V141, P1307, DOI 10.1039/c5an02512e
   Joung CK, 2013, BIOSENS BIOELECTRON, V44, P210, DOI 10.1016/j.bios.2013.01.024
   Ju Q, 2016, ANALYST, V141, P2838, DOI 10.1039/c6an00129g
   Julich S, 2014, PROC SPIE, V9107, DOI 10.1117/12.2049859
   Jung BY, 2005, J FOOD PROTECT, V68, P2140, DOI 10.4315/0362-028X-68.10.2140
   Jung CC, 2003, IEEE SENS J, V3, P352, DOI 10.1109/JSEN.2003.815775
   Justino CIL, 2015, TRAC-TREND ANAL CHEM, V68, P2, DOI 10.1016/j.trac.2015.03.006
   Kadota T, 2010, ANAL CHIM ACTA, V673, P173, DOI 10.1016/j.aca.2010.05.028
   Kahraman M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798640
   Kaiser J, 2005, SCIENCE, V310, P28, DOI 10.1126/science.310.5745.28
   Goncalves LCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073701
   Price TE., 2017, FED REGISTER, V82, P17569
   del Rio JS, 2014, BIOSENS BIOELECTRON, V54, P674, DOI 10.1016/j.bios.2013.11.035
   Strategic and Technical Advisory Group for Tuberculosis (STAG-TB), 2009, 9 M
   The Blue Ribbon Study Panel on Biodefense, 2015, NATL BLUEPRINT BIODE
   U. S. Food & Drug Administration Department of Health and Human Services, 2014, FED REGISTER, V79, P9226
   U. S. Food & Drug Administration Department of Health and Human Services, 2017, FED REGISTER, V82, P50144
   US Food and Drug Administration, DEV ADV COMPR REG AS
   WHO, INFL SEAS
   World Health Organization, EB VACC THER DIAGN
   World Health Organization, 2015, WHOMERSRA151
   Worldwide Threat Assessment of the US Intelligence Community, 2016, WORLDW THREAT ASS US
   Serrano AB, 2015, TOXINS, V7, P3554, DOI 10.3390/toxins7093554
   Ediage EN, 2015, FOOD CHEM, V177, P397, DOI 10.1016/j.foodchem.2015.01.060
   Fei Liu, 2007, Sensing and Instrumentation for Food Quality and Safety, V1, P161, DOI 10.1007/s11694-007-9021-1
   Kalasinsky KS, 2007, ANAL CHEM, V79, P2658, DOI 10.1021/ac0700575
   Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027
   Kalb SR, 2015, TOXINS, V7, P3497, DOI 10.3390/toxins7093497
   Kalb SR, 2015, J AGR FOOD CHEM, V63, P1133, DOI 10.1021/jf505482b
   Kalb SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012237
   Kaleta EJ, 2011, J CLIN MICROBIOL, V49, P345, DOI 10.1128/JCM.00936-10
   Kalidasan K, 2013, MOL BIOSYST, V9, P618, DOI 10.1039/c3mb25527a
   Kamal IH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-145
   Kandpal Lalit Mohan, 2014, Journal of Biosystems Engineering, V39, P215
   Kang SI, 2015, COMP IMMUNOL MICROB, V40, P1, DOI 10.1016/j.cimid.2015.03.001
   Kara P, 2008, ELECTROANAL, V20, P2629, DOI 10.1002/elan.200804368
   Karaseva NA, 2013, KEY ENG MATER, V543, P515, DOI 10.4028/www.scientific.net/KEM.543.515
   Karger A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-229
   Karsunke XYZ, 2009, ANAL BIOANAL CHEM, V395, P1623, DOI 10.1007/s00216-009-2905-7
   Kaushik A, 2008, ELECTROCHEM COMMUN, V10, P1364, DOI 10.1016/j.elecom.2008.07.007
   Kautter D. A., 1992, COMPENDIUM METHODS M
   Keer JT, 2003, J MICROBIOL METH, V53, P175, DOI 10.1016/S0167-7012(03)00025-3
   Keller PM, 2016, J CLIN MICROBIOL, V54, P816, DOI 10.1128/JCM.03250-15
   Kelly H, 2011, B WORLD HEALTH ORGAN, V89, P540, DOI [10.2471/BLT.11.088815, 10.2471/BLT.11.089086]
   Kennedy D, 2017, CURR ISSUES MOL BIOL, V23, P21, DOI 10.21775/cimb.023.021
   Khalid N, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1381
   Khan I, 2013, TRANSBOUND EMERG DIS, V60, P204, DOI 10.1111/j.1865-1682.2012.01342.x
   Khanam F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002316
   Khnouf R, 2015, SENSOR ACTUAT B-CHEM, V221, P723, DOI 10.1016/j.snb.2015.06.077
   Kim GY, 2010, ANAL CHIM ACTA, V677, P90, DOI 10.1016/j.aca.2010.07.046
   Kim JS, 2009, ANAL CHEM, V81, P5426, DOI 10.1021/ac9005827
   Kim JE, 2015, J HAZARD MATER, V298, P188, DOI 10.1016/j.jhazmat.2015.05.041
   Kim JH, 2012, LAB CHIP, V12, P1437, DOI [10.1039/c2lc21131, 10.1039/c2lc21131a]
   Kim S, 2005, J APPL MICROBIOL, V99, P411, DOI 10.1111/j.1365-2672.2005.02621.x
   Kim S, 2015, TALANTA, V140, P183, DOI 10.1016/j.talanta.2015.03.044
   King A.M.Q., 2012, VIRUS TAXONOMY CLASS
   Kirmizis D., 2012, APPL QUANTUM DOTS FL
   Kitamura Y, 2016, YAKUGAKU ZASSHI, V136, P1491, DOI 10.1248/yakushi.16-00180
   Klaubert B, 2009, J CHROMATOGR B, V877, P1084, DOI 10.1016/j.jchromb.2009.02.053
   Klemm R., 2014, P SOC PHOTO-OPT INS
   Kleo K, 2012, ANAL BIOANAL CHEM, V404, P843, DOI 10.1007/s00216-012-6172-7
   Kleo K, 2011, ANAL BIOCHEM, V418, P260, DOI 10.1016/j.ab.2011.07.016
   KNIPE DM, 2001, FIELDS VIROLOGY
   Ko J, 2015, J HAZARD MATER, V285, P11, DOI 10.1016/j.jhazmat.2014.11.018
   Ko SH, 2006, BIOSENS BIOELECTRON, V21, P1283, DOI 10.1016/j.bios.2005.05.017
   Koch S, 2000, BIOSENS BIOELECTRON, V14, P779, DOI 10.1016/S0956-5663(99)00051-2
   Koets M, 2009, BIOSENS BIOELECTRON, V24, P1893, DOI 10.1016/j.bios.2008.09.023
   Kokkinos PA, 2014, FOOD ANAL METHOD, V7, P512, DOI 10.1007/s12161-013-9748-8
   Kondas AV, 2015, J CLIN MICROBIOL, V53, P1406, DOI 10.1128/JCM.03613-14
   Kongkapan J, 2016, J VET MED SCI, V78, P259, DOI 10.1292/jvms.15-0317
   KONIG B, 1993, ANAL LETT, V26, P1567, DOI 10.1080/00032719308021481
   Kosoy M, 2017, VECTOR-BORNE ZOONOT, V17, P635, DOI 10.1089/vbz.2017.2142
   Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868
   Kowalczewska M, 2011, GENOME MED, V3, DOI 10.1186/gm266
   Koziel M, 2013, DIAGN MICR INFEC DIS, V75, P46, DOI 10.1016/j.diagmicrobio.2012.09.007
   Krahling V, 2016, MED MICROBIOL IMMUN, V205, P173, DOI 10.1007/s00430-015-0438-6
   Kramer MF, 2004, J FOOD PROTECT, V67, P46, DOI 10.4315/0362-028X-67.1.46
   Kreuzer MP, 2002, TOXICON, V40, P1267, DOI 10.1016/S0041-0101(02)00132-0
   Krokhin O, 2003, MOL CELL PROTEOMICS, V2, P346, DOI 10.1074/mcp.M300048-MCP200
   Kuang H, 2013, INT J MOL SCI, V14, P8603, DOI 10.3390/ijms14048603
   Kugeler KJ, 2015, EMERG INFECT DIS, V21, P16, DOI 10.3201/eid2101.140564
   Kulagina NV, 2007, SENSORS-BASEL, V7, P2808, DOI 10.3390/s7112808
   Kulagina NV, 2005, ANAL CHEM, V77, P6504, DOI 10.1021/ac050639r
   Kundu S, 2013, CLIN INFECT DIS, V57, P407, DOI 10.1093/cid/cit287
   Kuroda M, 2012, J CLIN MICROBIOL, V50, P1810, DOI 10.1128/JCM.06715-11
   Kurono S, 2001, ANAL LETT, V34, P2439, DOI 10.1081/AL-100107525
   Kutter E., 2004, BACTERIOPHAGES BIOL
   Kutter JP, 2012, J CHROMATOGR A, V1221, P72, DOI 10.1016/j.chroma.2011.10.044
   Kwon D, 2015, ANAL CHIM ACTA, V883, P61, DOI 10.1016/j.aca.2015.04.044
   Kwon SJ, 2014, ANAL CHEM, V86, P2279, DOI 10.1021/ac500262d
   La Belle JT, 2009, ELECTROANAL, V21, P2267, DOI 10.1002/elan.200904666
   La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107
   Labib M, 2013, ANALYST, V138, P1865, DOI 10.1039/c3an36771a
   Labib M, 2012, ANAL CHEM, V84, P8966, DOI 10.1021/ac302902s
   Labib M, 2009, ANAL BIOANAL CHEM, V393, P1539, DOI 10.1007/s00216-008-2559-x
   Ladd J, 2008, SENSOR ACTUAT B-CHEM, V130, P129, DOI 10.1016/j.snb.2007.07.140
   Lange K, 2008, ANAL BIOANAL CHEM, V391, P1509, DOI 10.1007/s00216-008-1911-5
   Lagally ET, 2001, ANAL CHEM, V73, P565, DOI 10.1021/ac001026b
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE
   LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343
   Lan YB, 2008, J BIONIC ENG, V5, P239, DOI 10.1016/S1672-6529(08)60030-X
   Larson MA, 2013, PROTEOM CLIN APPL, V7, P416, DOI 10.1002/prca.201200092
   Larsson GL, 2017, CELL ONCOL, V40, P521, DOI 10.1007/s13402-017-0331-y
   Lasch P, 2008, ANAL CHEM, V80, P2026, DOI 10.1021/ac701822j
   Lasch P, 2010, ANAL CHEM, V82, P8464, DOI 10.1021/ac101036s
   Lassman ME, 2007, ANAL LETT, V40, P1864, DOI 10.1080/00032710701384659
   Lassman ME, 2016, CLIN CHIM ACTA, V459, P155, DOI 10.1016/j.cca.2016.05.027
   Laupland KB, 2013, CAN J INFECT DIS MED, V24, P125, DOI 10.1155/2013/101630
   Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036
   Le Marechal C, 2016, ANAEROBE, V38, P7, DOI 10.1016/j.anaerobe.2015.10.014
   LeClaire R. D., 2005, BIOL WEAPONS DEFENSE, P41
   Lederberg J, 1992, EMERGING INFECT MICR
   Lee CK, 2012, J CLIN VIROL, V55, P239, DOI 10.1016/j.jcv.2012.07.008
   Lee CC, 2015, ANAL CHEM, V87, P5410, DOI 10.1021/acs.analchem.5b00810
   Lee W, 2014, ANAL CHEM, V86, P6683, DOI 10.1021/ac501436d
   Lee YJ, 2012, BIOCHEM BIOPH RES CO, V417, P414, DOI 10.1016/j.bbrc.2011.11.130
   Lee Y, 2017, ADV MATER TECHNOL-US, V2, DOI 10.1002/admt.201700053
   Lei KF, 2015, ANAL CHIM ACTA, V883, P37, DOI 10.1016/j.aca.2015.02.071
   Leipold MD, 2011, ANAL BIOCHEM, V419, P1, DOI 10.1016/j.ab.2011.07.035
   Leirs K, 2016, ANAL CHEM, V88, P8450, DOI 10.1021/acs.analchem.6b00502
   Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06
   Leonardi GP, 2013, J VIROL METHODS, V189, P379, DOI 10.1016/j.jviromet.2013.02.008
   Ler SG, 2006, J CHROMATOGR A, V1133, P1, DOI 10.1016/j.chroma.2006.08.078
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leski TA, 2015, EMERG INFECT DIS, V21, P609, DOI 10.3201/eid2104.141469
   Leung A, 2007, SENSOR ACTUAT B-CHEM, V125, P688, DOI 10.1016/j.snb.2007.03.010
   Leung KSY, 2011, MAR DRUGS, V9, P2291, DOI 10.3390/md9112291
   Leveque C, 2014, BIOSENS BIOELECTRON, V57, P207, DOI 10.1016/j.bios.2014.02.015
   Leveque C, 2013, BIOSENS BIOELECTRON, V49, P276, DOI 10.1016/j.bios.2013.05.032
   LEVINE S, 1953, J BACTERIOL, V65, P10, DOI 10.1128/JB.65.1.10-15.1953
   Lewis S., 2014, ANN M AM SOC CLIN PA
   Li CY, 2016, ANAL CHEM, V88, P4432, DOI 10.1021/acs.analchem.6b00065
   Li D, 2013, J Appl Microbiol, V115, P1159, DOI 10.1111/jam.12310
   Li DJ, 2011, ANAL CHIM ACTA, V687, P89, DOI 10.1016/j.aca.2010.12.018
   Li F, 2010, ANAL CHEM, V82, P3399, DOI 10.1021/ac100325f
   Li Q, 2013, ANAL CHEM, V85, P9087, DOI 10.1021/ac4016616
   Li XL, 2016, ANAL LETT, V49, P2405, DOI 10.1080/00032719.2016.1151888
   Lian DS, 2016, CLIN CHEM LAB MED, V54, P707, DOI 10.1515/cclm-2015-0096
   Liebana S, 2009, BIOSENS BIOELECTRON, V25, P510, DOI 10.1016/j.bios.2009.07.022
   Liebes Y, 2009, SENSOR ACTUAT B-CHEM, V140, P568, DOI 10.1016/j.snb.2009.04.050
   Ligler FS, 2007, ANAL SCI, V23, P5, DOI 10.2116/analsci.23.5
   Ligler FS, 2003, ANAL BIOANAL CHEM, V377, P469, DOI 10.1007/s00216-003-1992-0
   Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005
   Limonard GJM, 2012, FEMS IMMUNOL MED MIC, V64, P57, DOI 10.1111/j.1574-695X.2011.00890.x
   Lin CY, 2017, ANAL CHIM ACTA, V963, P112, DOI 10.1016/j.aca.2017.01.031
   Lin FYH, 2005, CLIN DIAGN LAB IMMUN, V12, P418, DOI 10.1128/CDLI.12.3.418-425.2005
   LIN JY, 1970, NATURE, V227, P292, DOI 10.1038/227292a0
   Lin R, 2015, LAB CHIP, V15, P1488, DOI 10.1039/c4lc01370k
   Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13
   Lin W. C., 2009, C LAS EL PAC RIM SHA
   Lin YH, 2008, BIOSENS BIOELECTRON, V23, P1832, DOI 10.1016/j.bios.2008.02.030
   Lindstrom M, 2006, CLIN MICROBIOL REV, V19, P298, DOI 10.1128/CMR.19.2.298-314.2006
   Lisowski P, 2013, CHROMATOGRAPHIA, V76, P1201, DOI 10.1007/s10337-013-2413-y
   Liu AP, 2013, EUR FOOD RES TECHNOL, V237, P323, DOI 10.1007/s00217-013-1995-9
   Liu F, 2010, ANAL CHEM, V82, P7758, DOI 10.1021/ac101666y
   Liu HM, 2016, CHEMOSPHERE, V150, P176, DOI 10.1016/j.chemosphere.2016.02.032
   Liu J, 2013, CHINESE J ANAL CHEM, V41, P500, DOI 10.3724/SP.J.1096.2013.20854
   Liu Jinny L, 2016, Biotechnol Rep (Amst), V10, P56, DOI 10.1016/j.btre.2016.03.001
   Liu P, 2011, J VIROL, V85, P11291, DOI 10.1128/JVI.00823-11
   Liu QT, 2015, TALANTA, V136, P114, DOI 10.1016/j.talanta.2014.12.020
   Liu QT, 2015, J CHROMATOGR B, V988, P175, DOI 10.1016/j.jchromb.2015.02.022
   Liu T, 2014, SENSOR ACTUAT B-CHEM, V196, P161, DOI 10.1016/j.snb.2014.02.003
   Liu WY, 2014, MICROCHIM ACTA, V181, P1415, DOI 10.1007/s00604-014-1286-6
   Liu XH, 2014, ANAL CHEM, V86, P2345, DOI 10.1021/ac402626g
   Liu YS, 2007, LAB CHIP, V7, P603, DOI 10.1039/b702408h
   Liu YS, 2013, CHEM SOC REV, V42, P6924, DOI 10.1039/c3cs60060b
   Liu YJ, 2015, ANALYST, V140, P3989, DOI 10.1039/c5an00407a
   Liu Y, 2017, ACS NANO, V11, P9614, DOI 10.1021/acsnano.7b04898
   Liu ZJ, 2012, ANAL CHIM ACTA, V735, P23, DOI 10.1016/j.aca.2012.05.008
   Liu ZY, 2016, INT J MOL MED, V38, P951, DOI 10.3892/ijmm.2016.2678
   Llandro J, 2010, MED BIOL ENG COMPUT, V48, P977, DOI 10.1007/s11517-010-0649-3
   Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014
   Longjam Neeta, 2011, Vet Med Int, V2011, P905768, DOI 10.4061/2011/905768
   Lonsdale CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062726
   Louie RF, 2009, DISASTER MED PUBLIC, V3, pS193, DOI [10.1097/DMP.0b013e3181979a06, 10.1097/DMP.0b013e3181be6dc4]
   Loutfi A, 2015, J FOOD ENG, V144, P103, DOI 10.1016/j.jfoodeng.2014.07.019
   Loveless BM, 2010, MOL CELL PROBE, V24, P154, DOI 10.1016/j.mcp.2010.01.003
   Lowe W, 2014, CURR ISSUES MOL BIOL, V16, P23
   Lu L, 2016, ELECTROCHIM ACTA, V213, P89, DOI 10.1016/j.electacta.2016.07.096
   Lu L, 2013, BIOSENS BIOELECTRON, V42, P492, DOI 10.1016/j.bios.2012.10.060
   Lu T, 2011, P NATL ACAD SCI USA, V108, P5976, DOI 10.1073/pnas.1017962108
   Luan K, 2018, ANAL CHEM, V90, P3600, DOI 10.1021/acs.analchem.8b00050
   Lubin AA, 2006, ANAL CHEM, V78, P5671, DOI 10.1021/ac0601819
   Lucena R, 2011, J CHROMATOGR A, V1218, P620, DOI 10.1016/j.chroma.2010.10.069
   Luka G, 2015, SENSORS-BASEL, V15, P30011, DOI 10.3390/s151229783
   Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x
   Luo CH, 2012, ELECTROANAL, V24, P1186, DOI 10.1002/elan.201100700
   Luo QP, 2009, VET MICROBIOL, V137, P24, DOI 10.1016/j.vetmic.2008.12.009
   Luo R, 2014, SENSOR ACTUAT B-CHEM, V198, P87, DOI 10.1016/j.snb.2014.02.104
   Ma SY, 2015, ANAL CHIM ACTA, V895, P54, DOI 10.1016/j.aca.2015.09.004
   Ma XY, 2014, ANAL LETT, V47, P2048, DOI 10.1080/00032719.2014.898152
   Maalouf R, 2007, ANAL CHEM, V79, P4879, DOI 10.1021/ac070085n
   Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   Magro L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00758-9
   Mailloux S, 2015, ANGEW CHEM INT EDIT, V54, P6562, DOI 10.1002/anie.201411148
   Mairhofer J, 2009, SENSORS-BASEL, V9, P4804, DOI 10.3390/s90604804
   Majchrzykiewicz-Koehorst JA, 2015, J VIROL METHODS, V213, P75, DOI 10.1016/j.jviromet.2014.11.014
   Makam SS, 2013, WORLD J MICROB BIOT, V29, P2379, DOI 10.1007/s11274-013-1406-1
   Maneeprakorn W, 2016, RSC ADV, V6, P112079, DOI 10.1039/c6ra24418a
   Mao X, 2009, ANAL CHEM, V81, P1660, DOI 10.1021/ac8024653
   Mar E, 2000, GENET TEST, V4, P393, DOI 10.1089/109065700750065153
   Maragos CM, 2015, FOOD ADDIT CONTAM A, V32, P1164, DOI 10.1080/19440049.2015.1036383
   Maraldo D, 2007, ANAL CHEM, V79, P7636, DOI 10.1021/ac070589l
   Reyes-Gallardo EM, 2015, BIOANALYSIS, V7, P1723, DOI [10.4155/BIO.15.93, 10.4155/bio.15.93]
   Mariani S, 2014, ANAL BIOANAL CHEM, V406, P2303, DOI 10.1007/s00216-014-7647-5
   Marks James D, 2004, Anesthesiol Clin North Am, V22, P509, DOI 10.1016/j.atc.2004.05.010
   Marley E, 2015, FOOD ADDIT CONTAM A, V32, P2131, DOI 10.1080/19440049.2015.1100331
   Marquette CA, 2006, ANAL BIOANAL CHEM, V385, P546, DOI 10.1007/s00216-006-0439-9
   Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872
   Mashayekhi F, 2010, ANAL BIOANAL CHEM, V398, P2955, DOI 10.1007/s00216-010-4213-7
   Massart S, 2014, VIRUS RES, V188, P90, DOI 10.1016/j.virusres.2014.03.029
   Massey M, 2017, ACS SENSORS, V2, P1205, DOI 10.1021/acssensors.7b00355
   Massey M, 2015, CURR OPIN BIOTECH, V34, P30, DOI 10.1016/j.copbio.2014.11.006
   MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288
   Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7
   Maurer HH, 2016, ARCH TOXICOL, V90, P2161, DOI 10.1007/s00204-016-1764-1
   Mavrouli MD, 2011, VIRAL IMMUNOL, V24, P221, DOI 10.1089/vim.2010.0137
   Mayboroda O, 2016, ANAL BIOANAL CHEM, V408, P671, DOI 10.1007/s00216-015-9177-1
   Mazuet C, 2012, J CLIN MICROBIOL, V50, P4091, DOI 10.1128/JCM.02392-12
   McCall B, 2011, TUBERCULOSIS, V91, pS54, DOI 10.1016/j.tube.2011.10.011
   McGovern JP, 2008, ANALYST, V133, P649, DOI 10.1039/b715948j
   McGrath SC, 2011, ANAL CHEM, V83, P2897, DOI 10.1021/ac102571f
   McKillen J, 2007, J VIROL METHODS, V140, P155, DOI 10.1016/j.jviromet.2006.11.018
   Mechaly A, 2013, ANAL BIOANAL CHEM, V405, P3965, DOI 10.1007/s00216-013-6752-1
   Mechery SJ, 2006, CHEM-ASIAN J, V1, P384, DOI 10.1002/asia.200600009
   Medina MB, 2005, J RAPID METH AUT MIC, V13, P37, DOI 10.1111/j.1745-4581.2005.00005.x
   Medintz I, 1996, J BACTERIOL, V178, P2245, DOI 10.1128/jb.178.8.2245-2254.1996
   Medintz I. L., 2013, FRET FORSTER RESONAN
   Medintz I, 2006, NAT MATER, V5, P842, DOI 10.1038/nmat1776
   Medintz IL, 2009, ANAL CHEM, V81, P4831, DOI 10.1021/ac900412j
   Medintz IL, 2005, ANAL CHEM, V77, P365, DOI 10.1021/ac048485n
   Medintz IL, 2004, ANAL CHEM, V76, P5620, DOI 10.1021/ac049419o
   Medintz IL, 2004, ANAL LETT, V37, P191, DOI 10.1081/AL-120027785
   Medintz IL, 2001, ELECTROPHORESIS, V22, P3845, DOI 10.1002/1522-2683(200110)22:18<3845::AID-ELPS3845>3.0.CO;2-0
   Medintz IL, 2001, J CHROMATOGR A, V924, P265, DOI 10.1016/S0021-9673(01)00852-4
   Medintz IL, 2000, GENOME RES, V10, P1211, DOI 10.1101/gr.10.8.1211
   Mei Q, 2006, ANAL CHEM, V78, P7659, DOI 10.1021/ac0610006
   Meisel S, 2012, APPL ENVIRON MICROB, V78, P5575, DOI 10.1128/AEM.00637-12
   Men JS, 2010, ANAL BIOCHEM, V401, P211, DOI 10.1016/j.ab.2010.02.033
   Meneely JP, 2010, TALANTA, V81, P630, DOI 10.1016/j.talanta.2009.12.055
   Metzgar D, 2013, VIRULENCE, V4, P752, DOI 10.4161/viru.26652
   Meyer MHF, 2007, J MAGN MAGN MATER, V311, P259, DOI 10.1016/j.jmmm.2006.10.1175
   Mirnejad R, 2013, ASIAN PAC J TROP MED, V6, P453, DOI 10.1016/S1995-7645(13)60073-5
   Mirski T, 2014, ANN AGR ENV MED, V21, P224, DOI 10.5604/1232-1966.1108581
   Misra R. S., 2008, ASIAN AUSTR J PLANT, V2, P55
   Mnyambwa NP, 2017, EUR J CLIN MICROBIOL, V36, P2021, DOI 10.1007/s10096-017-3027-3
   Moczydlowski EG, 2013, TOXICON, V63, P165, DOI 10.1016/j.toxicon.2012.11.026
   Moll N, 2007, BIOSENS BIOELECTRON, V22, P2145, DOI 10.1016/j.bios.2006.09.032
   Montagut Y, 2011, BIOSENSORS - EMERGING MATERIALS AND APPLICATIONS, P153
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Morgner F, 2011, SENSORS-BASEL, V11, P9667, DOI 10.3390/s111009667
   Morris BA, 2005, BIOPHYS CHEM, V113, P67, DOI 10.1016/j.bpc.2004.07.041
   Morris LGT, 2017, JAMA ONCOL, V3, P244, DOI 10.1001/jamaoncol.2016.1790
   Morvan JM, 1999, MICROBES INFECT, V1, P1193, DOI 10.1016/S1286-4579(99)00242-7
   Mostafa S, 2011, IEEE ELECTR DEVICE L, V32, P408, DOI 10.1109/LED.2010.2098015
   Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050
   Mouffouk F, 2011, BIOSENS BIOELECTRON, V26, P3517, DOI 10.1016/j.bios.2011.01.037
   Mudanyali O, 2012, LAB CHIP, V12, P2678, DOI [10.1039/c21c40235a, 10.1039/c2lc40235a]
   Muhammad-Tahir Z, 2005, IEEE SENS J, V5, P757, DOI 10.1109/JSEN.2005.846377
   Mujika M, 2009, BIOSENS BIOELECTRON, V24, P1253, DOI 10.1016/j.bios.2008.07.024
   Mukhopadhyay B, 2009, TETRAHEDRON LETT, V50, P886, DOI 10.1016/j.tetlet.2008.12.029
   Mukundan H, 2012, TUBERCULOSIS, V92, P407, DOI 10.1016/j.tube.2012.05.009
   Mulvaney SP, 2009, BIOSENS BIOELECTRON, V24, P1109, DOI 10.1016/j.bios.2008.06.010
   Muratovic AZ, 2015, TOXINS, V7, P3637, DOI 10.3390/toxins7093637
   Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449
   Myers JK, 2001, NAT STRUCT BIOL, V8, P552, DOI 10.1038/88626
   Nagaraj S, 2016, INT J FOOD MICROBIOL, V237, P136, DOI 10.1016/j.ijfoodmicro.2016.08.009
   Naimushin AN, 2002, BIOSENS BIOELECTRON, V17, P573, DOI 10.1016/S0956-5663(02)00014-3
   Nakayama E, 2010, CLIN VACCINE IMMUNOL, V17, P1723, DOI 10.1128/CVI.00170-10
   Nam YR, 2015, J VIROL METHODS, V214, P15, DOI 10.1016/j.jviromet.2014.10.021
   Namiesnik J, 2000, CRIT REV ANAL CHEM, V30, P221, DOI 10.1080/10408340091164243
   Nandi S, 2015, ANALYST, V140, P4232, DOI 10.1039/c5an00471c
   Narayanan J, 2015, BIOSENS BIOELECTRON, V69, P249, DOI 10.1016/j.bios.2015.02.039
   NAUMANN D, 1991, NATURE, V351, P81, DOI 10.1038/351081a0
   Nayak S, 2017, ANAL CHEM, V89, P102, DOI 10.1021/acs.analchem.6b04630
   Neill JD, 2014, J VIROL METHODS, V201, P68, DOI 10.1016/j.jviromet.2014.02.016
   Nelson DL, 2016, LEHNINGER PRINCIPLES
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005
   Ngom B, 2010, ANAL BIOANAL CHEM, V397, P1113, DOI 10.1007/s00216-010-3661-4
   NICOLAOU KC, 1995, J AM CHEM SOC, V117, P10252, DOI 10.1021/ja00146a010
   Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102
   NIESSEN WMA, 1995, J CHROMATOGR A, V703, P37, DOI 10.1016/0021-9673(94)01198-N
   Niikura M, 2001, J CLIN MICROBIOL, V39, P3267, DOI 10.1128/JCM.39.9.3267-3271.2001
   Nikitin PI, 2007, J MAGN MAGN MATER, V311, P445, DOI 10.1016/j.jmmm.2006.10.1180
   Nishi K, 2015, SENSORS-BASEL, V15, P25831, DOI 10.3390/s151025831
   Niu MC, 2016, MICROCHIM ACTA, V183, P2677, DOI 10.1007/s00604-016-1930-4
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   O'Leary MA, 2004, TOXICON, V44, P549, DOI 10.1016/j.toxicon.2004.07.008
   Ostin A, 2007, ANAL CHEM, V79, P6271, DOI 10.1021/ac0701740
   Oh E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35538
   Oh S, 2018, ACS APPL MATER INTER, V10, P12534, DOI 10.1021/acsami.8b02735
   Oh S, 2013, BIOSENS BIOELECTRON, V41, P758, DOI 10.1016/j.bios.2012.09.069
   Oh WK, 2011, BIOSENS BIOELECTRON, V29, P172, DOI 10.1016/j.bios.2011.08.013
   Ohk SH, 2013, FOOD MICROBIOL, V33, P166, DOI 10.1016/j.fm.2012.09.013
   Okafor C, 2014, SENSORS-BASEL, V14, P19128, DOI 10.3390/s141019128
   Ong KG, 2006, IEEE SENS J, V6, P514, DOI 10.1109/JSEN.2006.874450
   Ou W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-32
   Ou W, 2011, J VIROL METHODS, V174, P99, DOI 10.1016/j.jviromet.2011.04.003
   Owen JA, 2013, KUBY IMMUNOLOGY
   Owen TW, 2007, SENSOR ACTUAT B-CHEM, V126, P691, DOI 10.1016/j.snb.2007.04.028
   Ozdemir MS, 2013, ANAL CHEM, V85, P4770, DOI 10.1021/ac400514u
   Pachucki CT, 2004, J CLIN MICROBIOL, V42, P2796, DOI 10.1128/JCM.42.6.2796-2798.2004
   Pahlow S, 2015, ADV DRUG DELIVER REV, V89, P105, DOI 10.1016/j.addr.2015.04.006
   Pal S, 2009, BIOSENS BIOELECTRON, V24, P1437, DOI 10.1016/j.bios.2008.08.020
   Palaniyappan A, 2012, POULTRY SCI, V91, P636, DOI 10.3382/ps.2011-01916
   Pan Q, 2005, ANTIMICROB AGENTS CH, V49, P4052, DOI 10.1128/AAC.49.10.4052-4060.2005
   Pandey SK, 2012, MOL BIOSYST, V8, P1853, DOI 10.1039/c2mb25048a
   Paniel N, 2013, METHODS, V64, P229, DOI 10.1016/j.ymeth.2013.07.001
   Panning M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-77
   Papadopoulou E, 2015, ANAL CHEM, V87, P1605, DOI 10.1021/ac503063c
   Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570
   Pardee K, 2016, CELL, V167, P248, DOI 10.1016/j.cell.2016.09.013
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park J, 2013, ACS NANO, V7, P9416, DOI 10.1021/nn4042078
   Park MK, 2012, FOOD CONTROL, V26, P539, DOI 10.1016/j.foodcont.2012.01.061
   Patel MK, 2013, J NANOSCI NANOTECHNO, V13, P1671, DOI 10.1166/jnn.2013.7123
   Patocka J., 2001, ASA NEWSL, V85, P20
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   Patterson AS, 2013, APPL ENVIRON MICROB, V79, P2302, DOI 10.1128/AEM.03882-12
   Pedrero M, 2012, ELECTROANAL, V24, P470, DOI 10.1002/elan.201100528
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Pekdemir ME, 2012, ANALYST, V137, P4834, DOI 10.1039/c2an35471c
   Pennacchio A, 2014, OPT MATER, V36, P1670, DOI 10.1016/j.optmat.2013.12.045
   Perez-Sancho M, 2013, RES VET SCI, V95, P489, DOI 10.1016/j.rvsc.2013.05.002
   Peruski AH, 2003, CLIN DIAGN LAB IMMUN, V10, P506, DOI 10.1128/CDLI.10.4.506-513.2003
   Petryayeva E, 2016, ANAL BIOANAL CHEM, V408, P2913, DOI 10.1007/s00216-015-9300-3
   Petryayeva E, 2015, ANALYST, V140, P4037, DOI 10.1039/c5an00475f
   Petryayeva E, 2015, RSC ADV, V5, P22256, DOI 10.1039/c4ra15036h
   Petryayeva E, 2013, APPL SPECTROSC, V67, P215, DOI 10.1366/12-06948
   Piatek AS, 1998, NAT BIOTECHNOL, V16, P359, DOI 10.1038/nbt0498-359
   Pierce CY, 2007, ANAL CHIM ACTA, V583, P23, DOI 10.1016/j.aca.2006.09.065
   Piyasena ME, 2014, LAB CHIP, V14, P1044, DOI 10.1039/c3lc51152a
   Pohanka M, 2007, FOLIA MICROBIOL, V52, P325, DOI 10.1007/BF02932086
   Pohanka M, 2005, ANAL LETT, V38, P411, DOI 10.1081/AL-200047764
   Pohanka M, 2009, FOLIA MICROBIOL, V54, P263, DOI 10.1007/s12223-009-0046-1
   Pohanka M, 2007, ELECTROANAL, V19, P2507, DOI 10.1002/elan.200704003
   Pohanka M, 2007, TALANTA, V71, P981, DOI 10.1016/j.talanta.2006.05.074
   Pollack A, 2002, NY TIMES
   Porter MD, 2008, CHEM SOC REV, V37, P1001, DOI 10.1039/b708461g
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Postinikova E, 2008, PHYTOPATHOLOGY, V98, P1156, DOI 10.1094/PHYTO-98-11-1156
   POUPARD JA, 1992, ANN NY ACAD SCI, V666, P9, DOI 10.1111/j.1749-6632.1992.tb38020.x
   Premasiri WR, 2016, ANAL BIOANAL CHEM, V408, P4631, DOI 10.1007/s00216-016-9540-x
   Priest JR, 2017, CURR OPIN PEDIATR, V29, P513, DOI 10.1097/MOP.0000000000000532
   Primmerman C. A., 2000, Lincoln Laboratory Journal, V12, P3
   Qin DL, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/89364
   Qu Q, 2009, J MICROBIOL METH, V79, P121, DOI 10.1016/j.mimet.2009.07.015
   Qu S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000629
   Rahi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18060
   Rahimi E., 2013, Comparative Clinical Pathology, V22, P181, DOI 10.1007/s00580-011-1383-4
   Rajwa B, 2010, CYTOM PART A, V77A, P1103, DOI 10.1002/cyto.a.20978
   Raman C.V., 1929, Proceedings of the Royal Society of London, V122, P23, DOI 10.1098/rspa.1929.0002
   Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005
   Raphael BH, 2012, J MICROBIOL METH, V90, P267, DOI 10.1016/j.mimet.2012.05.020
   Ravan H, 2013, ANAL BIOCHEM, V439, P102, DOI 10.1016/j.ab.2013.04.014
   Ray PP, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0828-y
   Rebuffo-Scheer CA, 2008, ANAL BIOANAL CHEM, V390, P1629, DOI 10.1007/s00216-008-1834-1
   Regan JF, 2008, ANAL CHEM, V80, P7422, DOI 10.1021/ac801125x
   Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1016/S0168-6445(02)00091-8
   Reintjes R, 2002, EMERG INFECT DIS, V8, P69, DOI 10.3201/eid0801.010131
   Ren J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0283-5
   Ren QQ, 2015, J NANOMATER, V2015, DOI 10.1155/2015/534070
   REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9
   Rhouati A, 2013, TOXINS, V5, P1988, DOI 10.3390/toxins5111988
   Ricciardi C, 2013, BIOSENS BIOELECTRON, V40, P233, DOI 10.1016/j.bios.2012.07.029
   Rich RL, 2007, J MOL RECOGNIT, V20, P300, DOI 10.1002/jmr.862
   Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920
   Riedel Stefan, 2004, Proc (Bayl Univ Med Cent), V17, P400
   Rios-Corripio MA, 2016, ANAL LETT, V49, P1862, DOI 10.1080/00032719.2015.1128944
   Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641
   Robb CS, 2015, TRAC-TREND ANAL CHEM, V67, P100, DOI 10.1016/j.trac.2015.01.003
   Rocha-Gaso MI, 2009, SENSORS-BASEL, V9, P5740, DOI [10.3390/s9095740, 10.3390/s90705740]
   Roda A, 2012, ANAL BIOANAL CHEM, V402, P69, DOI 10.1007/s00216-011-5455-8
   Rodriguez NM, 2015, ANAL CHEM, V87, P7872, DOI 10.1021/acs.analchem.5b01594
   Rodriguez P, 2012, FOOD CHEM, V132, P1103, DOI 10.1016/j.foodchem.2011.11.081
   Rodriguez-Lazaro D, 2004, FEMS MICROBIOL LETT, V237, P119, DOI [10.1016/j.femsle.2004.06.024, 10.1111/j.1574-6968.2004.tb09686.x]
   Rodriguez-Orozco AR, 2010, MINI-REV MED CHEM, V10, P1393
   Rohde A, 2015, FOOD MICROBIOL, V46, P395, DOI 10.1016/j.fm.2014.09.002
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295
   Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985
   Rowe CA, 1999, ANAL CHEM, V71, P3846, DOI 10.1021/ac981425v
   Rowe-Taitt CA, 2000, BIOSENS BIOELECTRON, V14, P785, DOI 10.1016/S0956-5663(99)00052-4
   Rowe-Taitt CA, 2000, BIOSENS BIOELECTRON, V15, P579, DOI 10.1016/S0956-5663(00)00122-6
   Rowland CE, 2016, MATER TODAY, V19, P464, DOI 10.1016/j.mattod.2016.02.018
   Ruan CM, 2003, ANAL CHEM, V75, P6494, DOI 10.1021/ac034562n
   Sachdeva A, 2014, J SCI FOOD AGR, V94, P707, DOI 10.1002/jsfa.6310
   Sajjanar B, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3043-0
   Sakurai A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116715
   Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753
   Salinas-Castillo A, 2013, CHEM COMMUN, V49, P1103, DOI 10.1039/c2cc36450f
   Salmain M, 2012, SENSOR ACTUAT B-CHEM, V173, P148, DOI 10.1016/j.snb.2012.06.052
   Salmain M, 2011, BIOSENS BIOELECTRON, V29, P140, DOI 10.1016/j.bios.2011.08.007
   Samanta A, 2015, NANOSCALE, V7, P7603, DOI 10.1039/c5nr00828j
   Samorodnitsky E, 2015, J MOL DIAGN, V17, P64, DOI 10.1016/j.jmoldx.2014.09.009
   Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489
   Sampath R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036528
   Santos IC, 2016, ANALYST, V141, P2827, DOI 10.1039/c6an00131a
   Sanvicens N, 2011, ANAL BIOANAL CHEM, V399, P2755, DOI 10.1007/s00216-010-4624-5
   Sanvicens N, 2009, TRAC-TREND ANAL CHEM, V28, P1243, DOI 10.1016/j.trac.2009.08.002
   Sapsford KE, 2004, ANAL CHEM, V76, P433, DOI 10.1021/ac035122z
   Sapsford KE, 2008, MATER TODAY, V11, P38, DOI 10.1016/S1369-7021(08)70018-X
   Sapsford KE, 2006, ANGEW CHEM INT EDIT, V45, P4562, DOI 10.1002/anie.200503873
   Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v
   Sapsford KE, 2011, SENSORS-BASEL, V11, P7879, DOI 10.3390/s110807879
   Sapsford KE, 2011, ACS NANO, V5, P2687, DOI 10.1021/nn102997b
   Sapsford KE, 2009, ANAL BIOANAL CHEM, V394, P499, DOI 10.1007/s00216-009-2730-z
   SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006
   Sattarahmady N, 2015, BIOCHEM ENG J, V97, P1, DOI 10.1016/j.bej.2015.01.010
   Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243
   Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635
   Schep LJ, 2009, ENVIRON INT, V35, P1267, DOI 10.1016/j.envint.2009.08.004
   Scherer JR, 2001, BIOTECHNIQUES, V31, P1150, DOI 10.2144/01315rr04
   Schmid O, 2005, J MED MICROBIOL, V54, P1205, DOI 10.1099/jmm.0.46223-0
   Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909
   Schmitt P, 2005, EPIDEMIOL INFECT, V133, P759, DOI 10.1017/S0950268805003742
   Schoch-Spana M, 2000, CLIN INFECT DIS, V31, P1409, DOI 10.1086/317493
   Schofield David A, 2012, Bacteriophage, V2, P105
   Schroeder K, 2010, MOL CELL PROBE, V24, P110, DOI 10.1016/j.mcp.2009.10.008
   Schumacher WC, 2008, APPL ENVIRON MICROB, V74, P5220, DOI 10.1128/AEM.00369-08
   Schumacher WC, 2009, ADV POWDER TECHNOL, V20, P438, DOI 10.1016/j.apt.2009.03.006
   Schwahn AB, 2010, ANAL CHEM, V82, P4584, DOI 10.1021/ac100594j
   Scotcher MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011047
   SCOTT GH, 1990, ANN NY ACAD SCI, V590, P291, DOI 10.1111/j.1749-6632.1990.tb42235.x
   Seidel M, 2014, ANAL BIOANAL CHEM, V406, P5589, DOI 10.1007/s00216-014-7968-4
   Seiner DR, 2013, J APPL MICROBIOL, V114, P992, DOI 10.1111/jam.12107
   Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]
   Seo Y, 2016, NANOSCALE, V8, P1944, DOI 10.1039/c5nr06230f
   Sergueev KV, 2012, ADV EXP MED BIOL, V954, P135, DOI 10.1007/978-1-4614-3561-7_17
   Setlow P, 2006, J APPL MICROBIOL, V101, P514, DOI 10.1111/j.1365-2672.2005.02736.x
   Seyer A, 2012, ANAL CHEM, V84, P5103, DOI 10.1021/ac300880x
   Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017
   Shah J, 2003, ELECTROANAL, V15, P157, DOI 10.1002/elan.200390019
   Sharma N, 2013, CLIN VACCINE IMMUNOL, V20, P9, DOI 10.1128/CVI.00516-12
   Sharma P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135986
   Sharp PA, 2005, SCIENCE, V310, P17, DOI 10.1126/science.310.5745.17
   Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x
   Shehata AA, 2012, J VIROL METHODS, V180, P18, DOI 10.1016/j.jviromet.2011.12.004
   Shen W, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/1/015004
   Shen ZH, 2007, ANAL CHEM, V79, P2312, DOI 10.1021/ac061986j
   Shende C., 2016, J ANAL BIOANAL TECH, V7, P302
   Shim WB, 2014, ANAL BIOANAL CHEM, V406, P859, DOI 10.1007/s00216-013-7497-6
   Shivakiran MS, 2016, APPL MICROBIOL BIOT, V100, P893, DOI 10.1007/s00253-015-7151-7
   Shlyapnikov YM, 2012, ANAL CHEM, V84, P5596, DOI 10.1021/ac300567f
   Shriver-Lake LC, 2005, IEEE SENS J, V5, P751, DOI 10.1109/JSEN.2005.848121
   Shriver-Lake LC, 2013, ANAL BIOANAL CHEM, V405, P5611, DOI 10.1007/s00216-013-6980-4
   Si Y, 2016, BIOSENS BIOELECTRON, V75, P320, DOI 10.1016/j.bios.2015.08.028
   Sikazwe CT, 2016, J VIROL METHODS, V235, P65, DOI 10.1016/j.jviromet.2016.05.014
   Simon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054947
   Simpson JM, 2005, BIOSENS BIOELECTRON, V21, P881, DOI 10.1016/j.bios.2005.02.012
   Sin MLY, 2014, EXPERT REV MOL DIAGN, V14, P225, DOI 10.1586/14737159.2014.888313
   Singh A, 2013, SENSORS-BASEL, V13, P1763, DOI 10.3390/s130201763
   Singh AK, 2009, ACS NANO, V3, P1906, DOI 10.1021/nn9005494
   Singh A, 2015, BIOELECTROCHEMISTRY, V105, P7, DOI 10.1016/j.bioelechem.2015.03.005
   Singh A, 2016, BIOSENS BIOELECTRON, V83, P162, DOI 10.1016/j.bios.2016.04.054
   Singh AK, 2014, MBIO, V5, DOI 10.1128/mBio.01019-13
   Singh D, 2012, AGRICULTURE-BASEL, V2, P182, DOI 10.3390/agriculture2030182
   Singh DK, 2014, J HAZARD MATER, V265, P89, DOI 10.1016/j.jhazmat.2013.11.041
   Singh E, 2017, ACS APPL MATER INTER, V9, P34544, DOI 10.1021/acsami.7b07063
   Singh P, 2016, SENSOR ACTUAT B-CHEM, V229, P110, DOI 10.1016/j.snb.2016.01.118
   Singh VV, 2016, ELECTROANAL, V28, P920, DOI 10.1002/elan.201501088
   Singhal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00791
   Skoog DA, 2006, PRINCIPLES INSTRUMEN
   Skottman T, 2007, EUR J CLIN MICROBIOL, V26, P207, DOI 10.1007/s10096-007-0262-z
   Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112
   Smartt AE, 2012, ANAL BIOANAL CHEM, V402, P3127, DOI 10.1007/s00216-011-5555-5
   Smirnova DV, 2017, PHOTOCHEM PHOTOBIOL, V93, P436, DOI 10.1111/php.12656
   Sohrabi M, 2014, J CLIN MICROBIOL, V52, P4239, DOI 10.1128/JCM.01819-14
   Song LN, 2006, ANAL CHEM, V78, P1023, DOI 10.1021/ac051417w
   Sorokulova IB, 2005, J MICROBIOL METH, V63, P55, DOI 10.1016/j.mimet.2005.02.019
   Sospedra I, 2012, J CHROMATOGR A, V1238, P54, DOI 10.1016/j.chroma.2012.03.022
   Sospedra I, 2011, ANAL BIOANAL CHEM, V400, P1525, DOI 10.1007/s00216-011-4906-6
   Souf S., 2016, BIOSCI HORIZ, V9, phzw010, DOI [10.1093/biohorizons/hzw010., DOI 10.1093/BIOHORIZONS/HZW010]
   Spehar-Deleze AM, 2015, ANAL BIOANAL CHEM, V407, P6657, DOI 10.1007/s00216-015-8831-y
   Spencer KA, 2007, VACCINE, V25, P5653, DOI 10.1016/j.vaccine.2007.02.053
   Srinivasan B, 2009, ANGEW CHEM INT EDIT, V48, P2764, DOI 10.1002/anie.200806266
   Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003
   Steiniger SCJ, 2007, MOL IMMUNOL, V44, P2749, DOI 10.1016/j.molimm.2006.11.011
   Stelzer-Braid S, 2008, J CLIN VIROL, V43, P241, DOI 10.1016/j.jcv.2008.06.012
   Stern D, 2016, BIOSENS BIOELECTRON, V78, P111, DOI 10.1016/j.bios.2015.11.020
   Stiles PL, 2008, ANNU REV ANAL CHEM, V1, P601, DOI 10.1146/annurev.anchem.1.031207.112814
   Stobiecka M, 2015, CHEM PAP, V69, P62, DOI 10.1515/chempap-2015-0026
   Stockel S, 2016, J RAMAN SPECTROSC, V47, P89, DOI 10.1002/jrs.4844
   Stockel S, 2015, ANAL BIOANAL CHEM, V407, P787, DOI 10.1007/s00216-014-7906-5
   Su HC, 2013, ANALYST, V138, P3026, DOI 10.1039/c3an00026e
   Su HC, 2012, SENSOR ACTUAT B-CHEM, V161, P298, DOI 10.1016/j.snb.2011.10.035
   Su L, 2015, OPTOELECTRON LETT, V11, P157, DOI 10.1007/s11801-015-4216-x
   Subramanian A, 2006, BIOSENS BIOELECTRON, V21, P998, DOI 10.1016/j.bios.2005.03.007
   Sun J, 2013, WOODH PUBL SER BIOM, V61, P527, DOI 10.1533/9780857097040.4.527
   Sun WS, 2015, J CHROMATOGR A, V1387, P42, DOI 10.1016/j.chroma.2015.01.071
   Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014
   Suresh S, 2010, TALANTA, V81, P703, DOI 10.1016/j.talanta.2010.01.007
   Suttisunhakul V, 2016, J CLIN MICROBIOL, V54, P1259, DOI 10.1128/JCM.02856-15
   Svraka S, 2010, J GEN VIROL, V91, P2846, DOI 10.1099/vir.0.024612-0
   Sy M, 2016, CHEM COMMUN, V52, P5080, DOI 10.1039/c6cc00922k
   SYKES PJ, 1992, BIOTECHNIQUES, V13, P444
   Szkola A, 2014, ANALYST, V139, P5885, DOI [10.1039/c4an00345d, 10.1039/C4AN00345D]
   Szkola A, 2013, ANAL CHIM ACTA, V787, P211, DOI 10.1016/j.aca.2013.05.028
   Szlag VM, 2016, ACS SENSORS, V1, P842, DOI 10.1021/acssensors.6b00209
   Tachibana H, 2015, BIOSENS BIOELECTRON, V74, P725, DOI 10.1016/j.bios.2015.07.009
   Taevernier L, 2014, J PHARMACEUT BIOMED, V100, P50, DOI 10.1016/j.jpba.2014.07.021
   Taitt CR, 2015, WOODHEAD PUBL FOOD S, V262, P195, DOI 10.1016/B978-0-85709-801-6.00008-3
   Taitt CR, 2008, SENSORS-BASEL, V8, P8361, DOI 10.3390/s8128361
   Taitt CR, 2005, BIOSENS BIOELECTRON, V20, P2470, DOI 10.1016/j.bios.2004.10.026
   Tallent SM, 2013, APPL ENVIRON MICROB, V79, P1422, DOI 10.1128/AEM.02743-12
   Tamborrini M, 2006, ANGEW CHEM INT EDIT, V45, P6581, DOI 10.1002/anie.200602048
   Tang JJ, 2016, ACS APPL MATER INTER, V8, P2449, DOI 10.1021/acsami.5b12860
   Tang YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088267
   Tang Y, 2016, BIOSENS BIOELECTRON, V86, P255, DOI 10.1016/j.bios.2016.06.063
   Tao L, 2016, MICROCHIM ACTA, V183, P2163, DOI 10.1007/s00604-016-1849-9
   Taubenberger JK, 2012, MBIO, V3, DOI 10.1128/mBio.00201-12
   Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230
   Tavakoli A, 2017, FUTURE VIROL, V12, P141, DOI 10.2217/fvl-2016-0096
   Tawil N, 2014, ANALYST, V139, P1224, DOI 10.1039/c3an01989f
   Taylor AD, 2008, SENSOR ACTUAT B-CHEM, V130, P120, DOI 10.1016/j.snb.2007.07.136
   Taylor AD, 2006, BIOSENS BIOELECTRON, V22, P752, DOI 10.1016/j.bios.2006.03.012
   Taylor AD, 2011, J SENSORS, V2011, DOI [10.1155/2011/601704, 10.1155/2011/307542]
   Tekin HC, 2013, LAB CHIP, V13, P4711, DOI 10.1039/c3lc50477h
   Temur E, 2012, ANAL CHEM, V84, P10600, DOI 10.1021/ac301924f
   Thi Hoa Nguyen, 2012, Advances in Natural Sciences: Nanoscience & Nanotechnology, V3, DOI 10.1088/2043-6262/3/3/035014
   Tram DTN, 2016, BIOTECHNOL ADV, V34, P1275, DOI 10.1016/j.biotechadv.2016.09.003
   Teng J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01426
   Tennant SM, 2015, CLIN INFECT DIS, V61, pS241, DOI 10.1093/cid/civ726
   Tenzin, 2012, ZOONOSES PUBLIC HLTH, V59, P451, DOI 10.1111/j.1863-2378.2012.01489.x
   Thiramanas R, 2016, MICROCHIM ACTA, V183, P389, DOI 10.1007/s00604-015-1657-7
   Thomson E, 2016, J CLIN MICROBIOL, V54, P2470, DOI 10.1128/JCM.00330-16
   Tims TB, 2004, J MICROBIOL METH, V59, P127, DOI 10.1016/j.mimet.2004.02.016
   Tiwari A, 2014, TROP ANIM HEALTH PRO, V46, P1519, DOI 10.1007/s11250-014-0664-8
   Tlili C, 2013, ANAL CHEM, V85, P4893, DOI 10.1021/ac302699x
   Tolba M, 2012, ANALYST, V137, P5749, DOI 10.1039/c2an35988j
   Tolosa J, 2016, CHEMOSPHERE, V145, P402, DOI 10.1016/j.chemosphere.2015.11.085
   Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536
   Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212
   Tran H, 2008, TOXICON, V52, P582, DOI 10.1016/j.toxicon.2008.07.008
   Trilla A, 2008, CLIN INFECT DIS, V47, P668, DOI 10.1086/590567
   Trilling AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026754
   Tsai TT, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/044404
   Tsai YH, 2006, J CHROMATOGR B, V832, P75, DOI 10.1016/j.jchromb.2005.12.036
   Tsilia V, 2012, ANAL BIOANAL CHEM, V404, P1691, DOI 10.1007/s00216-012-6254-6
   Tsui CKM, 2011, IMA FUNGUS, V2, P177, DOI 10.5598/imafungus.2011.02.02.09
   Tudos AJ, 2003, J AGR FOOD CHEM, V51, P5843, DOI 10.1021/jf030244d
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392
   Tuorinsky S.D., 2008, MED ASPECTS CHEM WAR
   Turnbull PCB, 1999, J APPL MICROBIOL, V87, P237, DOI 10.1046/j.1365-2672.1999.00876.x
   Turner KB, 2016, EXPERT OPIN DRUG DEL, V13, P561, DOI 10.1517/17425247.2016.1133583
   Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303
   Umeda K, 2010, MICROBIOL IMMUNOL, V54, P308, DOI 10.1111/j.1348-0421.2010.00213.x
   Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008
   Vaclavik L, 2010, TALANTA, V82, P1950, DOI 10.1016/j.talanta.2010.08.029
   Valadez AM, 2009, SENSORS-BASEL, V9, P5810, DOI 10.3390/s90705810
   Valerio E, 2010, TOXINS, V2, P2359, DOI 10.3390/toxins2102359
   Valizadeh A, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-480
   van Baar BLM, 2004, J CHROMATOGR A, V1035, P97, DOI 10.1016/j.chroma.2004.02.047
   van Baar BLM, 2002, J CHROMATOGR A, V970, P95, DOI 10.1016/S0021-9673(02)00508-3
   van der Merwe RG, 2014, ANALYST, V139, P2617, DOI 10.1039/c4an00208c
   Vandamm JP, 2014, J CLIN MICROBIOL, V52, P2998, DOI 10.1128/JCM.00316-14
   Vater A, 2015, DRUG DISCOV TODAY, V20, P147, DOI 10.1016/j.drudis.2014.09.004
   Vega VA, 2015, J AOAC INT, V98, P806, DOI 10.5740/jaoacint.14-241
   Veigas B, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/41/415101
   Velumani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020737
   Velusamy V, 2010, BIOTECHNOL ADV, V28, P232, DOI 10.1016/j.biotechadv.2009.12.004
   Vemula SV, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040096
   Verma MS, 2015, BIOTECHNOL ADV, V33, P666, DOI 10.1016/j.biotechadv.2015.03.003
   Viboud C, 2010, PLOS CURR, V2, DOI DOI 10.1371/CURRENTS.RRN1153
   Vinayaka AC, 2010, ANAL BIOANAL CHEM, V397, P1445, DOI 10.1007/s00216-010-3683-y
   Vincent AT, 2017, J MICROBIOL METH, V138, P60, DOI 10.1016/j.mimet.2016.02.016
   Visser M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0539-x
   Viswanathan S, 2012, TALANTA, V94, P315, DOI 10.1016/j.talanta.2012.03.049
   Vivekananda J, 2006, LAB INVEST, V86, P610, DOI 10.1038/labinvest.3700417
   Voiculescu I, 2012, BIOSENS BIOELECTRON, V33, P1, DOI 10.1016/j.bios.2011.12.041
   Vranish JN, 2018, LANGMUIR, V34, P2901, DOI 10.1021/acs.langmuir.7b02588
   Vyas SS, 2015, BIOSENS BIOELECTRON, V70, P254, DOI 10.1016/j.bios.2015.03.045
   Waiwijit U, 2012, IEEE C ELEC DEVICES
   Walper SA, 2013, ANTIBODIES, V2, P152, DOI 10.3390/antib2010152
   Walper SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032801
   Wan J., 2005, IEEE SENSORS 2005
   Wan JH, 2007, SENSOR ACTUAT B-CHEM, V127, P559, DOI 10.1016/j.snb.2007.05.017
   Wan Y, 2014, BIOSENS BIOELECTRON, V55, P289, DOI 10.1016/j.bios.2013.11.080
   Wan Y, 2011, BIOSENS BIOELECTRON, V26, P1959, DOI 10.1016/j.bios.2010.08.008
   Wang CG, 2010, SMALL, V6, P283, DOI 10.1002/smll.200901596
   Wang DB, 2015, BIOSENS BIOELECTRON, V67, P608, DOI 10.1016/j.bios.2014.09.067
   Wang DB, 2013, BIOSENS BIOELECTRON, V42, P661, DOI 10.1016/j.bios.2012.10.088
   Wang DB, 2009, ANALYST, V134, P738, DOI 10.1039/b813038h
   Wang DX, 2014, ANAL CHEM, V86, P10847, DOI 10.1021/ac502948v
   Wang DX, 2011, ANAL BIOCHEM, V412, P67, DOI 10.1016/j.ab.2011.01.025
   Wang F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/fpd.2012.1448
   Wang H, 2007, J RAPID METH AUT MIC, V15, P67, DOI 10.1111/j.1745-4581.2007.00075.x
   Wang L, 2007, BIOCONJUGATE CHEM, V18, P297, DOI 10.1021/bc060255n
   Wang Q, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00149
   Wang QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064465
   Wang RJ, 2015, ANAL METHODS-UK, V7, P1701, DOI [10.1039/C4AY02880E, 10.1039/c4ay02880e]
   Wang WB, 2016, ACS APPL MATER INTER, V8, P15591, DOI 10.1021/acsami.6b02905
   Wang XP, 2015, FOOD CHEM, V173, P897, DOI 10.1016/j.foodchem.2014.10.056
   Wang YX, 2013, BIOSENS BIOELECTRON, V49, P492, DOI 10.1016/j.bios.2013.05.061
   Wang YX, 2012, SENSORS-BASEL, V12, P3449, DOI 10.3390/s120303449
   Wang Y, 2017, ACS APPL MATER INTER, V9, P31446, DOI 10.1021/acsami.7b08736
   Wang YQ, 2013, CHEM REV, V113, P1391, DOI 10.1021/cr300120g
   Wang ZP, 2011, LUMINESCENCE, V26, P136, DOI 10.1002/bio.1196
   Wei H, 2007, SENSOR ACTUAT B-CHEM, V127, P525, DOI 10.1016/j.snb.2007.05.012
   Wei H, 2007, SENSOR ACTUAT B-CHEM, V123, P204, DOI 10.1016/j.snb.2006.08.010
   Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102
   Weingart OG, 2012, SENSORS-BASEL, V12, P2324, DOI 10.3390/s120202324
   Weller SA, 2012, J MED MICROBIOL, V61, P1546, DOI 10.1099/jmm.0.049007-0
   Wen CY, 2013, ANAL CHEM, V85, P1223, DOI 10.1021/ac303204q
   Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7
   Wibowo MH, 2017, J VIROL METHODS, V249, P181, DOI 10.1016/j.jviromet.2017.08.014
   Wilcox J, 2015, J CHROMATOGR A, V1400, P91, DOI 10.1016/j.chroma.2015.04.053
   Wild D., 2013, IMMUNOASSAY HDB
   Wilkes JG, 2012, FOOD MICROBIOL, V30, P281, DOI 10.1016/j.fm.2011.11.002
   Windham WR, 2012, J NEAR INFRARED SPEC, V20, P547, DOI 10.1255/jnirs.1004
   Wiriyachaiporn N, 2015, MICROCHIM ACTA, V182, P85, DOI 10.1007/s00604-014-1303-9
   Wittig MB, 2006, DEUT TIERARZTL WOCH, V113, P323
   Wojciechowski J, 2010, SENSORS-BASEL, V10, P3351, DOI 10.3390/s100403351
   Wolfbeis OS, 2004, ANAL CHEM, V76, P3269, DOI 10.1021/ac040049d
   Wolper SA, 2014, ANAL BIOCHEM, V447, P64, DOI 10.1016/j.ab.2013.10.031
   Woodbury RL, 2002, J PROTEOME RES, V1, P233, DOI 10.1021/pr025506q
   Wu CF, 2013, ANGEW CHEM INT EDIT, V52, P3086, DOI 10.1002/anie.201205133
   Wu F, 2016, BIOSENS BIOELECTRON, V77, P464, DOI 10.1016/j.bios.2015.10.002
   Wu HY, 2013, SENSORS-BASEL, V13, P8551, DOI 10.3390/s130708551
   Wu LY, 2013, TALANTA, V106, P360, DOI 10.1016/j.talanta.2012.12.053
   Wu WH, 2014, ACS APPL MATER INTER, V6, P16974, DOI 10.1021/am5045828
   Wuthiekanun V, 2005, CLIN DIAGN LAB IMMUN, V12, P555, DOI 10.1128/CDLI.12.4.555-556.2005
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Xiao JY, 2011, NANOSCALE, V3, P1383, DOI 10.1039/c0nr00814a
   Xing YS, 2013, ANALYST, V138, P3457, DOI 10.1039/c3an00100h
   Xu J, 2007, J COMPUT THEOR NANOS, V4, P1219, DOI 10.1166/jctn.2007.001
   Xu SH, 2017, ANAL CHEM, V89, P1617, DOI 10.1021/acs.analchem.6b03711
   Xue P, 2011, MICROCHIM ACTA, V174, P167, DOI 10.1007/s00604-011-0604-5
   Yakes BJ, 2016, TALANTA, V156, P55, DOI 10.1016/j.talanta.2016.05.008
   Yakes BJ, 2014, ANAL CHEM, V86, P9251, DOI 10.1021/ac502271y
   Yakes BJ, 2011, SENSOR ACTUAT B-CHEM, V156, P805, DOI 10.1016/j.snb.2011.02.043
   Yakes BJ, 2011, J AGR FOOD CHEM, V59, P839, DOI 10.1021/jf103779k
   Yakes BJ, 2010, MAR DRUGS, V8, P565, DOI 10.3390/md8030565
   Yan XD, 2006, CURR ANAL CHEM, V2, P297, DOI 10.2174/157341106777698251
   Yang DT, 2016, TALANTA, V146, P457, DOI 10.1016/j.talanta.2015.09.006
   Yang LL, 2010, ANAL CHEM, V82, P1109, DOI 10.1021/ac902524a
   Yang LJ, 2006, ANALYST, V131, P394, DOI 10.1039/b510888h
   Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8
   Yang SP, 2015, J AGR FOOD CHEM, V63, P8592, DOI 10.1021/acs.jafc.5b03281
   Yang YY, 2017, ANAL CHEM, V89, P71, DOI 10.1021/acs.analchem.6b04581
   Yanik AA, 2010, NANO LETT, V10, P4962, DOI 10.1021/nl103025u
   Yea C, 2011, J VIROL METHODS, V172, P72, DOI 10.1016/j.jviromet.2010.12.024
   Yeo SJ, 2017, BIOSENS BIOELECTRON, V94, P677, DOI 10.1016/j.bios.2017.03.068
   Yeung SHI, 2008, CLIN CHEM, V54, P1080, DOI 10.1373/clinchem.2007.102319
   Yin WW, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-23
   Ymeti A, 2007, NANO LETT, V7, P394, DOI 10.1021/nl062595n
   Yoon JY, 2012, SENSORS-BASEL, V12, P10713, DOI 10.3390/s120810713
   Yoon J, 2017, J VIROL METHODS, V243, P15, DOI 10.1016/j.jviromet.2017.01.013
   Yu CH, 2010, FOOD ADDIT CONTAM A, V27, P89, DOI 10.1080/02652030903207250
   Yu HW, 2012, ANAL CHIM ACTA, V750, P191, DOI 10.1016/j.aca.2012.05.017
   Yu YY, 2017, J VIROL METHODS, V247, P58, DOI 10.1016/j.jviromet.2017.05.014
   Yuan HX, 2014, ADV MATER, V26, P6978, DOI 10.1002/adma.201400379
   Yue GZ, 2016, COORDIN CHEM REV, V311, P75, DOI 10.1016/j.ccr.2015.11.009
   Zahavy E, 2012, ADV EXP MED BIOL, V733, P23, DOI 10.1007/978-94-007-2555-3_3
   Zarei M, 2017, TRAC-TREND ANAL CHEM, V91, P26, DOI 10.1016/j.trac.2017.04.001
   Zeng Y, 2016, MICROCHIM ACTA, V183, P741, DOI 10.1007/s00604-015-1715-1
   Zengin A, 2015, J MATER CHEM B, V3, P306, DOI 10.1039/c4tb00290c
   Zhang CH, 2016, ANAL CHEM, V88, P7447, DOI 10.1021/acs.analchem.6b00944
   Zhang DX, 2018, ANAL CHEM, V90, P5512, DOI 10.1021/acs.analchem.8b00399
   Zhang H, 2015, BIOSENS BIOELECTRON, V71, P186, DOI 10.1016/j.bios.2015.04.034
   Zhang J, 2004, ANAL SCI, V20, P585, DOI 10.2116/analsci.20.585
   Zhang PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105305
   Zhang WY, 2017, ELECTROANAL, V29, P1206, DOI 10.1002/elan.201600748
   Zhang XJ, 2014, J APPL BIOMED, V12, P63, DOI 10.1016/j.jab.2014.02.005
   Zhang YY, 2016, APPL SURF SCI, V378, P375, DOI 10.1016/j.apsusc.2016.04.001
   Zhang Y, 2007, ANAL BIOCHEM, V364, P122, DOI 10.1016/j.ab.2007.02.031
   Zhao R, 2014, J MICROELECTROMECH S, V23, P1054, DOI 10.1109/JMEMS.2014.2345666
   Zhao SY, 2012, INT J MOL SCI, V13, P13704, DOI 10.3390/ijms131013704
   Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.0404806101
   Zhao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21342
   Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428
   Zheng J, 2011, ANAL CHIM ACTA, V702, P149, DOI 10.1016/j.aca.2011.06.045
   Zheng JK, 2017, TALANTA, V162, P552, DOI 10.1016/j.talanta.2016.10.052
   Zheng LT, 2017, BIOSENS BIOELECTRON, V91, P46, DOI 10.1016/j.bios.2016.12.037
   Zhong QP, 2011, ADV MATER RES-SWITZ, V236-238, P2820, DOI 10.4028/www.scientific.net/AMR.236-238.2820
   Zhou B, 2002, P NATL ACAD SCI USA, V99, P5241, DOI 10.1073/pnas.082121599
   Zhou DD, 2016, MICROCHIM ACTA, V183, P2753, DOI 10.1007/s00604-016-1919-z
   Zhou LX, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/193963
   Zhou Y, 2007, J MED COLL PLA, V22, P347, DOI DOI 10.1016/S1000-
   Zhu HY, 2008, ANALYST, V133, P356, DOI 10.1039/b716834a
   Zhu HY, 2012, ANALYST, V137, P2541, DOI 10.1039/c2an35071h
   Zhu PX, 2011, BIOSENS BIOELECTRON, V30, P337, DOI 10.1016/j.bios.2011.09.029
   Zhu T, 2010, LAB CHIP, V10, P1557, DOI 10.1039/b925968f
   Zhu ZL, 2015, BIOSENS BIOELECTRON, V65, P320, DOI 10.1016/j.bios.2014.10.059
   Zou NX, 2007, EXP BIOL MED, V232, P550
NR 1166
TC 29
Z9 29
U1 12
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD OCT
PY 2018
VL 3
IS 10
BP 1894
EP 2024
DI 10.1021/acssensors.8b00420
PG 261
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA GZ0DR
UT WOS:000449030300002
PM 30080029
OA Bronze
DA 2020-07-08
ER

PT J
AU Aragao, CF
   Cruz, ACR
   Neto, JPN
   Monteiro, HAD
   da Silva, EVP
   da Silva, SP
   Andrade, ATD
   Tadei, WP
   Pinheiro, VCS
AF Aragao, Carine Fortes
   Ribeiro Cruz, Ana Cecilia
   Nunes Neto, Joaquim Pinto
   de Oliveira Monteiro, Hamilton Antonio
   Pinto da Silva, Eliana Vieira
   da Silva, Sandro Patroca
   dos Santos Andrade, Aylane Tamara
   Tadei, Wanderli Pedro
   Soares Pinheiro, Valeria Cristina
TI Circulation of Chikungunya virus in Aedes aegypti in Maranhao, Northeast
   Brazil
SO ACTA TROPICA
LA English
DT Article
DE Aedes aegypti; Chikungunya virus; Natural infection
ID ALBOPICTUS; MOSQUITOS; VECTOR; FIELD
AB The simultaneous circulation of Dengue virus (DENV), Chikungunya virus (CHIKV) and Zika virus (ZIKV) arboviruses have placed Brazil among the main worldwide endemic areas. Brazilian Northeast region concentrates the highest incidence of infections caused by CHIKV and ZIKV. In Maranhao, the second biggest northeastern state, there are cases of human infections caused by these three arboviruses and presence of Aedes aegypti and Aedes albopictus vectors. In this context, this study aimed to investigate the circulation of CHIKV, DENV and ZIKV in Ae. aegypti and Ae. albopictus mosquitoes collected in urban areas of Barra do Gorda, Caxias, Codo, Sao Luis and Sao Mateus do Maranhao municipalities in the state of Maranhao through Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR) technique. 428 Ae. aegypti and 1 Ae. albopictus were collected, which formed 44 pools. Three of these showed positive results for CHIKV: AR832767 (five Ae. aegypti female collected in Caxias), AR832784 and AR832785 (both composed of 20 Ae. aegypti female collected in Sao Mateus do Maranhao). This study consolidates information about CHIKV circulation in state of Maranhao, as well as the role of Ae. aegypti in the transmission of CHIKV in urban area.
C1 [Aragao, Carine Fortes] Univ Fed Para, Inst Ciencias Biol, Programa Posgrad Biol Agentes Infecciosos & Paras, Belem, Para, Brazil.
   [Ribeiro Cruz, Ana Cecilia; Nunes Neto, Joaquim Pinto; de Oliveira Monteiro, Hamilton Antonio; Pinto da Silva, Eliana Vieira; da Silva, Sandro Patroca] Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Ananindeua, PA, Brazil.
   [dos Santos Andrade, Aylane Tamara; Soares Pinheiro, Valeria Cristina] Univ Estadual Maranhao, Lab Entomol Med, Dept Quim & Biol, Ctr Estudos Super Caxias, Caxias, MA, Brazil.
   [Tadei, Wanderli Pedro] Inst Nacl de Pesquisas da Amazonia, Lab Malaria & Dengue, Manaus, Amazonas, Brazil.
RP Pinheiro, VCS (corresponding author), Univ Estadual Maranhao, Ctr Estudos Super Caxias, Praca Duque Caxias S-N, BR-65604380 Caxias, Maranhao, Brazil.
EM vc_pinheiro@hotmail.com
RI Pinheiro, Valeria Cristina Soares/W-8389-2019; Cruz, Ana Cecilia
   Ribeiro/V-9276-2019; Neto, Joaquim Pinto Nunes/Y-5703-2019; Tadei,
   Wanderli/N-4486-2018
OI Tadei, Wanderli/0000-0002-0612-3285; PINTO NUNES NETO,
   JOAQUIM/0000-0001-5981-0065; Fortes Aragao, Carine/0000-0003-2721-6496
FU Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e
   Tecnologico do Maranhao / Pesquisa para o SUS: Gestao Compartilhada em
   Saude (PPSUS - FAPEMA/MS-DECIT/CNPq/SES) [03392/13]; Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [427416/2016-7];
   Secretaria de Estado da Saude do Maranhao and Instituto Evandro Chagas /
   Ministerio da Saude
FX This work was supported by Fundacao de Amparo a Pesquisa e ao
   Desenvolvimento Cientifico e Tecnologico do Maranhao / Pesquisa para o
   SUS: Gestao Compartilhada em Saude (PPSUS - FAPEMA/MS-DECIT/CNPq/SES)
   [processe No 03392/13], Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq) [processe No 427416/2016-7], Secretaria de Estado
   da Saude do Maranhao and Instituto Evandro Chagas / Ministerio da Saude.
CR Andrade A.T.d.S., 2018, AVANCOS CIENCIAS BIO, P135
   [Anonymous], 2017, B EPIDEMIOLOGICO, V48
   Auguste AJ, 2009, VIROLOGY, V392, P123, DOI 10.1016/j.virol.2009.06.038
   Bezerra J. M. T., 2013, Open Tropical Medicine Journal, V6, P5, DOI 10.2174/1874315301306010005
   Brazil. Ministerio da Satide (MS, 2017, LEV RAP IND INF PEL
   Brazil. Ministerio da Saude (MS, 2015, FEBR CHIK MAN CLIN, P28
   Brazil Ministerio da Saude (MS, 2014, B EPIDEMIOLOGICO, V45
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Donalisio Maria Rita, 2015, Rev. bras. epidemiol., V18, P283, DOI 10.1590/1980-5497201500010022
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Forattini O., 2002, CULICIDOLOGIA MED, V2, P860
   Forattini O.P, 1965, ENTOMOLOGIA MED, V3, P416
   Forattini O. P., 1962, ENTOMOLOGIA MED, V1, P662
   Forattini O.P, 1965, ENTOMOLOGIA MEDICA, V2, P506
   Gonçalves Neto Vicente Silva, 2004, Cad. Saúde Pública, V20, P1427, DOI 10.1590/S0102-311X2004000500039
   Griffin DE, 2013, FIELDS VIROLOGY, P651
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   KUHN RJ, 2013, FIELDS VIROLOGY, V1, P629
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lane J, 1953, NEOTROPICAL CULICIDA, V2, P1112
   Lane J., 1953, NEOTROPICAL CULICIDA, V1, P548
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Ministerio da Saude (MS), 2016, B EPIDEMIOLOGICO, V47
   MS-Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   NASCI RS, 1981, MOSQ NEWS, V41, P808
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Soares-da-Silva J, 2012, REV SOC BRAS MED TRO, V45, P174, DOI 10.1590/S0037-86822012000200007
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   World Health Organization, 2017, CHIK
NR 32
TC 3
Z9 3
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD OCT
PY 2018
VL 186
BP 1
EP 4
DI 10.1016/j.actatropica.2018.06.022
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GQ2LP
UT WOS:000441486800001
PM 29932932
DA 2020-07-08
ER

PT J
AU Grazel, R
   Harris-Haman, P
AF Grazel, Regina
   Harris-Haman, Pamela
TI Zika Virus Infection A Vector-Borne Threat to Pregnant Women and Infants
SO ADVANCES IN NEONATAL CARE
LA English
DT Article
DE congenital Zika infection; infants; pregnancy; Zika virus; ZIKV
ID UPDATE INTERIM GUIDANCE; US TERRITORIES; BIRTH-DEFECTS; UNITED-STATES;
   MANAGEMENT; EXPOSURE; HEALTH; MILK
AB Background: Zika virus (ZIKV) is an emergent flavivirus, transmitted predominately by Aedes genus mosquitos that recently reached the Americas and was soon implicated in an increase in microcephaly and other serious birth defects.
   Purpose: This report provides updated information and recommendations on testing, screening, and care for pregnant women and infants affected by ZIKV.
   Methods: Current published recommendations from the Centers for Disease Control and Prevention, the World Health Organization, and the American Academy of Pediatrics were reviewed and included in this report.
   Results: Although largely a self-limiting disease usually without symptoms, pregnant women and their fetuses are at greatest risk. Maternal transmission of ZIKV to the fetus can lead to congenital Zika infection with potentially devastating sequelae to the infant. The available evidence suggests that infection during the first trimester of pregnancy, in which the fetus' central nervous system is being formed, is associated with higher risk of brain abnormalities and perinatal loss.
   Implications for Practice: Uncertainties remain about the course of the disease, and the full spectrum of effects of the virus on the developing infant is not yet understood. Infants with congenital Zika syndrome need coordinated follow-up and long-term specialty care, as well as support for the family.
   Implications for Research: There is no known cure for ZIKV infection and no vaccine is currently available. The full spectrum of developmental disabilities and other adverse early childhood outcomes associated with congenital ZIKV infection needs to be studied.
C1 [Grazel, Regina] Amer Acad Pediat, East Windsor, NJ USA.
   [Grazel, Regina] Crit Congenital Heart Defects Screening Program, New Jersey Dept Hlth, Trenton, NJ USA.
   [Grazel, Regina] Zika Infant Surveillance, Trenton, NJ USA.
   [Harris-Haman, Pamela] Thomas Jefferson Sch Nursing, Philadelphia, PA USA.
   [Harris-Haman, Pamela] Duke Johnson & Johnson Nurse Leadership, Div Community Hlth, Durham, NC USA.
   [Harris-Haman, Pamela] Geisinger Holy Spirit Hosp, Middletown, PA USA.
RP Harris-Haman, P (corresponding author), 115 Providence Circle, Middletown, PA 17057 USA.
EM pahhnnp@aol.com
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   [Anonymous], 2018, 2018 REP COMM INF DI
   [Anonymous], ZIK AND PREGN
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   *CDCP, POT RANG US
   Centers for Disease Control and Prevention, OUTC PREGN LAB EV PO
   Centers for Disease Control and Prevention, 2016, MED REL FLOR INV LIN
   Centers for Disease Control and Prevention, HLTH CAR PROV
   Centers for Disease Control and Prevention, WOM THEIR PARTN TRYI
   Centre for Disease Control and Prevention, TYP ZIK VIR TESTS
   Coelho A. V. C, 2017, INT J MOL SCI, V18
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pfaender S, 2017, VIRUS RES, V228, P58, DOI 10.1016/j.virusres.2016.11.025
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, DOI [10. 15585/mmwr. num6521e1, DOI 10.15585/MMWR.NUM6521E1]
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Washburn L, ZIK RAIS BAB MICR
   Wu J, 2016, CHINESE MED J-PEKING, V129, P2347, DOI 10.4103/0366-6999.190672
   Zorrilla Carmen D, 2016, Obstet Gynecol Int J, V5, DOI 10.15406/ogij.2016.05.00180
NR 35
TC 4
Z9 4
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1536-0903
EI 1536-0911
J9 ADV NEONAT CARE
JI Adv. Neonatal Care
PD OCT
PY 2018
VL 18
IS 5
BP 350
EP 359
DI 10.1097/ANC.0000000000000557
PG 10
WC Nursing
SC Nursing
GA HB2OJ
UT WOS:000450880500007
PM 30239403
DA 2020-07-08
ER

PT J
AU Soriano, V
   del Romero, J
AF Soriano, Vicente
   del Romero, Jorge
TI Rebound in Sexually Transmitted Infections Following the Success of
   Antiretrovirals for HIV/AIDS
SO AIDS REVIEWS
LA English
DT Review
DE HIV; Pre-exposure prophylaxis; Post-exposure prophylaxis; Treatment as
   prevention; Risk compensation; Chlamydia gonorrhea; Trichomonas;
   Syphilis; Papillomavirus; Mycoplasma genitalium; Herpes simplex; Men
   having sex with men
ID VIRUS TYPE-1 INFECTION; FOR-DISEASE-CONTROL; ACUTE HEPATITIS-C;
   PREEXPOSURE PROPHYLAXIS; HUMAN-PAPILLOMAVIRUS; HIV-INFECTION; HIGH-RISK;
   MYCOPLASMA-GENITALIUM; EUROPEAN GUIDELINE; ZIKA VIRUS
AB Nearly 1 million people become infected every day with any of the four major curable sexually transmitted infections (STIs), namely trichomoniasis, chlamydia, gonorrhea, and syphilis. Despite huge global incidence, STIs remain as neglected diseases. The success of antiretrovirals for halting progression to AIDS in HIV-infected individuals and for stopping HIV transmission to uninfected contacts, either as pre- or post-exposure-prophylaxis, has to lead to increased risky sexual behaviors through risk compensation. Recent epidemics and outbreaks of STIs among men having sex with men reflect the global loss of fear to HIV/AIDS. The-alarming rising rates of STIs worldwide have been fueled by: (1) rapid spread of drug resistance, that is, for Neisseria gonorrhoeae and Mycoplasma genitalium; (2) unprecedented impact of recreational drugs (chemsex) and internet (apps, websites) for facilitating exposure to multiple sex partners; and (3) growing rates of sexual violence and commercial sex, associated with wars, refugees, migrations, traveling, and sexual tourism. Moreover, there is an increasing appreciation of sexual transmission for other agents, including human T-lymphotropic virus type 1, hepatitis A and C viruses, Zika, and Ebola. For addressing this new scenario for STIs, an expert panel workshop was arranged in Madrid, Spain in May 2018. This review summarizes the discussions at the meeting.
C1 [Soriano, Vicente] UNIR Hlth Sci Sch, Dept Med, Madrid, Spain.
   [Soriano, Vicente] La Paz Univ Hosp, Infect Dis Unit, Madrid, Spain.
   [del Romero, Jorge] Ctr Sanitario Sandoval, Sexually Transmitted Infect Unit, Madrid, Spain.
RP Soriano, V (corresponding author), UNIR Hlth Sci Sch, Almansa 101, Madrid 28040, Spain.
EM vicente.soriano@unir.net
RI Soriano, Vicente/O-5730-2018
OI Soriano, Vicente/0000-0002-4624-5199
CR Abara W, 2014, SEX TRANSM INFECT, V90, P596, DOI 10.1136/sextrans-2014-051545
   Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI 10.1093/cid/cit665
   Alaei K, 2016, AIDS, V30, P2753, DOI 10.1097/QAD.0000000000001262
   Bachmann LH, 2015, CLIN INFECT DIS, V61, pS763, DOI 10.1093/cid/civ755
   Bakker I, 2018, SEX HEALTH, V15, P173, DOI 10.1071/SH17139
   Ballesteros J, 2016, REV ESP DROG, V4, P47
   Barreiro P, 2007, HUM REPROD, V22, P2353, DOI 10.1093/humrep/dem226
   Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd
   Barreiro P, 2017, AIDS REV, V19, P114
   Barreiro P, 2016, ANTIVIR THER, V21, P489, DOI 10.3851/IMP3038
   Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P2525, DOI 10.1001/jama.2016.16776
   Boesecke C, 2015, LIVER INT, V35, P2384, DOI 10.1111/liv.12848
   Cachay ER, 2014, AIDS REV, V16, P90
   Cachay ER, 2013, AIDS REV, V15, P122
   Chen XY, 2013, LANCET INFECT DIS, V13, P877, DOI 10.1016/S1473-3099(13)70109-9
   Clifford GM, 2017, CLIN INFECT DIS, V64, P1228, DOI 10.1093/cid/cix135
   Cone MM, 2013, GASTROENTEROL CLIN N, V42, P877, DOI 10.1016/j.gtc.2013.09.003
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3
   de Mendoza C, 2017, AIDS, V31, P1653, DOI [10.1097/QAD.0000000000001527, 10.1097/qad.0000000000001527]
   de Mendoza C, 2012, AIDS REV, V14, P279
   Del Romero J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004398
   di Giacomo E, JAMA PEDIAT
   Englander E, 2018, JAMA PEDIATR, V172, P317, DOI 10.1001/jamapediatrics.2017.5682
   Fernandez-Montero JV, 2016, AIDS REV, V18, P222
   Fernandez-Montero JV, 2017, AIDS REV, V19, P212
   Fletcher JB, 2018, J PSYCHOACTIVE DRUGS, V50, P206, DOI 10.1080/02791072.2018.1447173
   Friedman B, 2016, CLIN MICROBIOL INFEC, V22, P768, DOI 10.1016/j.cmi.2016.07.030
   Gamez-Guadix M, 2015, SEX RES SOC POLICY, V12, P145, DOI 10.1007/s13178-015-0186-9
   Gaydos C, 2014, EXPERT REV ANTI-INFE, V12, P657, DOI 10.1586/14787210.2014.880651
   Ghanem KG, 2015, CLIN INFECT DIS, V61, pS818, DOI 10.1093/cid/civ714
   Gonzalez-Baeza A, 2018, AIDS PATIENT CARE ST, V32, P112, DOI 10.1089/apc.2017.0263
   Hallfors DD, 2004, AM J PREV MED, V27, P224, DOI 10.1016/j.amepre.2004.06.001
   Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4
   Hanson J, 2005, ANN EPIDEMIOL, V15, P13, DOI 10.1016/j.annepidem.2004.05.001
   Hoornenborg E, 2018, AIDS, V32, P1527, DOI [10.1097/qad.0000000000001874, 10.1097/QAD.0000000000001874]
   Horner P, 2018, J EUR ACAD DERMATOL, V32, P1845, DOI 10.1111/jdv.15146
   Jensen JS, 2017, LANCET INFECT DIS, V17, P795, DOI 10.1016/S1473-3099(17)30364-X
   Justman JE, 2018, NEW ENGL J MED, V378, P1859, DOI 10.1056/NEJMp1801934
   Kann L, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6708a1
   Kann L, 2016, MMWR-MORBID MORTAL W, V65, P106, DOI 10.15585/mmwr.mm6505a2
   Karnes JB, 2014, AM FAM PHYSICIAN, V90, P312
   Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006
   Keygnaert I, 2015, REPROD HEALTH MATTER, V23, P45, DOI 10.1016/j.rhm.2015.11.002
   King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70
   Kojima N, 2016, AIDS, V30, P2251, DOI 10.1097/QAD.0000000000001185
   Korhonen C, 2018, AIDS, V32, P1507, DOI [10.1097/QAD.0000000000001847, 10.1097/qad.0000000000001847]
   Lankenau SE, 2007, DRUG ALCOHOL DEPEN, V87, P183, DOI 10.1016/j.drugalcdep.2006.08.015
   Lautenschlager S, 2017, INT J STD AIDS, V28, P324, DOI 10.1177/0956462416687913
   LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981
   Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Magidson JF, 2014, J PSYCHOSOM RES, V76, P322, DOI 10.1016/j.jpsychores.2013.12.009
   Menezes CB, 2016, MICROB CELL, V3, P404, DOI 10.15698/mic2016.09.526
   Milam J, J ACQUIR IMMUNE DEFI
   Mohammed H, 2018, SEX TRANSM INFECT, V94, P553, DOI 10.1136/sextrans-2017-053273
   Mohammed H, 2016, EMERG INFECT DIS, V22, P88, DOI 10.3201/eid2201.151331
   Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273
   Molina JM, 2018, LANCET INFECT DIS, V18, P308, DOI [10.1016/s1473-3099(17)30725-9, 10.1016/S1473-3099(17)30725-9]
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray PJ, 2014, PEDIATRICS, V134, pE302, DOI 10.1542/peds.2014-1024
   Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304
   Nguyen Trang Quyen, 2018, Sex Transm Dis, V45, pS55, DOI 10.1097/OLQ.0000000000000870
   Nunes D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171303
   O'Byrne P, 2016, CAN FAM PHYSICIAN, V62, P554
   O'Farrell N, 2016, INT J STD AIDS, V27, P605, DOI 10.1177/0956462416633626
   O'Leary D, 2014, LINACRE Q, V81, P12, DOI 10.1179/2050854913Y.0000000015
   Orisatoki R O, 2009, Niger J Med, V18, P143
   Oser C, 2008, ADDICT RES THEORY, V16, P289, DOI 10.1080/16066350801983723
   Paiva A, 2017, J MED VIROL, V89, P1287, DOI 10.1002/jmv.24745
   Park IU, 2015, CLIN INFECT DIS, V61, pS849, DOI 10.1093/cid/civ813
   Piyaraj P, 2018, LANCET HIV, V5, pE379, DOI 10.1016/S2352-3018(18)30065-1
   Protogerou C, 2014, AIDS BEHAV, V18, P1847, DOI 10.1007/s10461-014-0807-y
   Rajasingham R, 2012, AIDS PATIENT CARE ST, V26, P36, DOI 10.1089/apc.2011.0153
   Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6
   Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148
   Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135
   Romero L, 2017, COCHRANE DB SYST REV, V12
   Ruiz-Sancho A, 2007, HIV CLIN TRIALS, V8, P98, DOI 10.1310/hct0802-98
   Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212
   Satake M, 2016, LANCET INFECT DIS, V16, P1246, DOI 10.1016/S1473-3099(16)30252-3
   Sewell J, 2018, SEX TRANSM INFECT, V94, P494, DOI 10.1136/sextrans-2017-053439
   Siguier M, 2018, ACS INFECT DIS, V4, P660, DOI 10.1021/acsinfecdis.8b00043
   Sonnenberg P, 2015, INT J EPIDEMIOL, V44, P1982, DOI 10.1093/ije/dyv194
   Soriano V, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060293
   Soriano V, 2016, LIVER INT, V36, P763, DOI 10.1111/liv.12858
   Soriano V, 2013, NAT REV GASTRO HEPAT, V10, P568, DOI 10.1038/nrgastro.2013.165
   Stamm LV, 2016, MICROB CELL, V3, P363, DOI 10.15698/mic2016.09.523
   Suay-Garcia B, 2017, EUR J CLIN MICROBIOL, V36, P1065, DOI 10.1007/s10096-017-2931-x
   Sulak P.J., 2005, FEMALE PATIENT, V30, P29
   Tam S, 2018, ORAL ONCOL, V82, P91, DOI 10.1016/j.oraloncology.2018.04.005
   Tomkins A, PERSPECT PUBLIC HLTH
   Torrone EA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002511
   Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182
   Tsevat DG, 2017, AM J OBSTET GYNECOL, V216, P1, DOI 10.1016/j.ajog.2016.08.008
   Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/S1473-3099(17)30310-9, 10.1016/s1473-3099(17)30310-9]
   Uzoigwe CE, 2017, LANCET GLOB HEALTH, V5, pE30, DOI 10.1016/S2214-109X(16)30307-2
   Fernandez-Montero JV, 2012, AIDS REV, V14, P54
   Nguyen VK, 2018, AIDS, V32, P523, DOI 10.1097/QAD.0000000000001718
   Watanabe T., 2018, CURRENT STATUS HTLV, P29
   WHO, 2017, REP SEX TRANSM INF
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Zaza S, 2016, JAMA-J AM MED ASSOC, V316, P2355, DOI 10.1001/jama.2016.11683
   Zeiler A, 2014, LINACRE Q, V81, P372, DOI 10.1179/0024363914Z.00000000088
NR 104
TC 10
Z9 10
U1 3
U2 8
PU PERMANYER PUBL
PI BARCELONA
PA MALLORCA, 310, BARCELONA, 08037, SPAIN
SN 1139-6121
EI 1698-6997
J9 AIDS REV
JI Aids Rev.
PD OCT-DEC
PY 2018
VL 20
IS 4
BP 187
EP 204
DI 10.24875/AIDSRev.18000034
PG 18
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA HE3DF
UT WOS:000453231000002
PM 30548023
DA 2020-07-08
ER

PT J
AU Bernatchez, JA
   Yang, ZH
   Coste, M
   Li, J
   Beck, S
   Liu, Y
   Clark, AE
   Zhu, Z
   Luna, LA
   Sohl, CD
   Purse, BW
   Li, RS
   Siqueira-Neto, JL
AF Bernatchez, Jean A.
   Yang, Zunhua
   Coste, Michael
   Li, Jerry
   Beck, Sungjun
   Liu, Yan
   Clark, Alex E.
   Zhu, Zhe
   Luna, Lucas A.
   Sohl, Christal D.
   Purse, Byron W.
   Li, Rongshi
   Siqueira-Neto, Jair L.
TI Development and Validation of a Phenotypic High-Content Imaging Assay
   for Assessing the Antiviral Activity of Small-Molecule Inhibitors
   Targeting Zika Virus
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE Zika virus; antiviral agents; high-throughput screening; cellular
   imaging
ID POTENTIAL ANTIBIOTIC AGENTS; DEPENDENT RNA-POLYMERASE; MARINOPYRROLE
   DERIVATIVES; DRUG DISCOVERY; LETHAL MUTAGENESIS; INFECTION; ANALOGS;
   REPLICATION; NUCLEOSIDE; SOFOSBUVIR
AB Zika virus (ZIKV) has been linked to the development of microcephaly in newborns, as well as Guillain-Barre syndrome. There are currently no drugs available to treat ZIKV infection, and accordingly, there is an unmet medical need for the discovery of new therapies. High-throughput drug screening efforts focusing on indirect readouts of cell viability are prone to a higher frequency of false positives in cases where the virus is viable in the cell but the cytopathic effect (CPE) is reduced or delayed. Here, we describe a fast and label-free phenotypic high-content imaging assay to detect cells affected by the virus-induced CPE using automated imaging and analysis. Protection from the CPE correlates with a decrease in viral antigen production, as observed by immunofluorescence. We trained our assay using a collection of nucleoside analogues with activity against ZIKV; the previously reported antiviral activities of 2'-C-methylribonucleosides and ribavirin against the Zika virus in Vero cells were confirmed using our developed method. To validate the ability of our assay to reveal new anti-ZIKV compounds, we profiled a novel library of 24 natural product derivatives and found compound 1 to be an inhibitor of the ZIKV-induced cytopathic effect; the activity of the compound was confirmed in human fetal neural stem cells (NSCs). The described technique can be easily leveraged as a primary screening assay for profiling of the activities of large compound libraries against ZIKV and can be expanded to other ZIKV strains and other cell lines displaying morphological changes upon ZIKV infection.
C1 [Bernatchez, Jean A.; Beck, Sungjun; Clark, Alex E.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Bernatchez, Jean A.; Siqueira-Neto, Jair L.] Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA.
   [Yang, Zunhua; Li, Jerry; Liu, Yan; Li, Rongshi] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
   [Coste, Michael; Luna, Lucas A.; Sohl, Christal D.; Purse, Byron W.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA.
   [Clark, Alex E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Zhu, Zhe] Stanford Consortium Regenerat Med, La Jolla, CA USA.
   [Zhu, Zhe] Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.
RP Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA.; Li, RS (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
EM rongshili@unmc.edu; jairlage@uscd.edu
RI Zhu, Zhe/H-6009-2019; Purse, Byron W./M-6438-2019; ,
   Zunhua/AAQ-6242-2020; Siqueira-Neto, Jair L/D-6040-2012
OI Zhu, Zhe/0000-0002-5385-948X; , Zunhua/0000-0001-6520-5371;
   Siqueira-Neto, Jair L/0000-0001-9574-8174; Bernatchez,
   Jean/0000-0002-8309-1627
FU Clinical and Translational (CTRI) pilot grant [UL1TR001442]; San Diego
   State University; Nebraska Research Initiative (NRI); University of
   Nebraska Medical Center
FX This research was partially supported by Clinical and Translational
   (CTRI) pilot grant UL1TR001442. B.W.P., M.C., L.A.L., and C.D.S. thank
   San Diego State University for financial support. The design and
   synthesis of a library of natural product derivatives were partially
   supported by the Nebraska Research Initiative (NRI) and start-up funds
   to R.L. from the University of Nebraska Medical Center.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albrecht T, 1996, MED MICROBIOLOGY
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonnac LF, 2013, J MED CHEM, V56, P9403, DOI 10.1021/jm400653j
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cahard D, 2004, MINI-REV MED CHEM, V4, P371
   Cheng CW, 2013, MAR DRUGS, V11, P2927, DOI 10.3390/md11082927
   Cheng CW, 2010, J COMB CHEM, V12, P541, DOI 10.1021/cc100052j
   Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Graci JD, 2008, FUTURE VIROL, V3, P553, DOI 10.2217/17460794.3.6.553
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Li R, 2016, US patent, Patent No. [62,309,685, 62309685]
   Li R, 2016, Synthesis of pyrrolomycins as antibiofilm agents. Patent Cooperation Treaty International Application, Patent No. [WO 2016-US42423, 2016]
   Li R, 2017, Patent Cooperation Treaty International Application, Patent No. [WO2017011725, 2017011725]
   Li R, 2018, US patent, Patent No. [9,868,474, 9868474]
   Li R, 2015, US patent, Patent No. 62193192
   Li R., 2016, US Patent, Patent No. [9,340,501, 9340501, 9340501B2]
   Li R, 2016, US patent, Patent No. [62,299,588, 62299588]
   Li R, 2015, US patent, Patent No. [62,219,289, 62219289]
   Li RS, 2016, MED RES REV, V36, P169, DOI 10.1002/med.21359
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Liu Y, 2014, MAR DRUGS, V12, P2458, DOI 10.3390/md12052458
   Liu Y, 2012, MAR DRUGS, V10, P953, DOI 10.3390/md10040953
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111
   Muggia F, 2012, EXPERT OPIN INV DRUG, V21, P403, DOI 10.1517/13543784.2012.666236
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Potisopon S, 2017, ANTIVIR RES, V140, P25, DOI 10.1016/j.antiviral.2016.12.021
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shim J, 2003, ANTIVIR RES, V58, P243, DOI 10.1016/S0166-3542(03)00007-X
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang ZH, 2016, EUR J MED CHEM, V124, P129, DOI 10.1016/j.ejmech.2016.08.017
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 46
TC 9
Z9 9
U1 0
U2 19
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD OCT
PY 2018
VL 62
IS 10
AR e00725-18
DI 10.1128/AAC.00725-18
PG 11
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA GU6GH
UT WOS:000445405500020
PM 30061280
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Romette, JL
   Prat, CM
   Gould, EA
   de Lamballerie, X
   Charrel, R
   Coutard, B
   Fooks, AR
   Bardsley, M
   Carroll, M
   Drosten, C
   Drexler, JF
   Gunther, S
   Klempa, B
   Pinschewer, D
   Klimkait, T
   Avsic-Zupanc, T
   Capobianchi, MR
   Dicaro, A
   Ippolito, G
   Nitsche, A
   Koopmans, M
   Reusken, C
   Gorbalenya, A
   Raoul, H
   Bourhy, H
   Mettenleiter, T
   Reiche, S
   Batten, C
   Sabeta, C
   Paweska, JT
   Eropkin, M
   Zverev, V
   Hu, Z
   Mac Cullough, S
   Mirazimi, A
   Pradel, F
   Lieutaud, P
AF Romette, J. L.
   Prat, C. M.
   Gould, E. A.
   de Lamballerie, X.
   Charrel, R.
   Coutard, B.
   Fooks, A. R.
   Bardsley, M.
   Carroll, M.
   Drosten, C.
   Drexler, J. F.
   Guenther, S.
   Klempa, B.
   Pinschewer, D.
   Klimkait, T.
   Avsic-Zupanc, T.
   Capobianchi, M. R.
   Dicaro, A.
   Ippolito, G.
   Nitsche, A.
   Koopmans, M.
   Reusken, C.
   Gorbalenya, A.
   Raoul, H.
   Bourhy, H.
   Mettenleiter, T.
   Reiche, S.
   Batten, C.
   Sabeta, C.
   Paweska, J. T.
   Eropkin, M.
   Zverev, V
   Hu, Z.
   Mac Cullough, S.
   Mirazimi, A.
   Pradel, F.
   Lieutaud, P.
TI The European Virus Archive goes global: A growing resource for research
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Virus archive; Virus collection; EU infrastructure
ID ZIKA VIRUS
AB The European Virus Archive (EVA) was created in 2008 with funding from the FP7-EU Infrastructure Programme, in response to the need for a coordinated and readily accessible collection of viruses that could be made available to academia, public health organisations and industry. Within three years, it developed from a consortium of nine European laboratories to encompass associated partners in Africa, Russia, China, Turkey, Germany and Italy. In 2014, the H2020 Research and Innovation Framework Programme (INFRAS projects) provided support for the transformation of the EVA from a European to a global organization (EVAg). The EVAg now operates as a non-profit consortium, with 26 partners and 20 associated partners from 21 EU and non-EU countries. In this paper, we outline the structure, management and goals of the EVAg, to bring to the attention of researchers the wealth of products it can provide and to illustrate how end-users can gain access to these resources. Organisations or individuals who would like to be considered as contributors are invited to contact the EVAg coordinator, Jean-Louis Romette, at jean-louis.romette@univmed.fr.
C1 [Romette, J. L.; Prat, C. M.; Gould, E. A.; de Lamballerie, X.; Charrel, R.; Lieutaud, P.] Aix Marseille Univ, UVE, IRD 190, INSERM 1207,IHU Mediterranee Infect, Marseille, France.
   [Coutard, B.] Architectures & Fonct Macromol Biol, Marseille, France.
   [Fooks, A. R.; Bardsley, M.] Anim & Plant Hlth Agcy, Weybridge, Surrey, England.
   [Carroll, M.] Dept Hlth Special Pathogens Lab, Porton Down, England.
   [Drosten, C.; Drexler, J. F.] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, D-10117 Berlin, Germany.
   [Drosten, C.; Drexler, J. F.] Berlin Inst Hlth, Inst Virol, D-10117 Berlin, Germany.
   [Guenther, S.] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany.
   [Klempa, B.] Slovak Acad Sci, Inst Virol, Biomed Res Ctr, Bratislava, Slovakia.
   [Pinschewer, D.; Klimkait, T.] Univ Bales, Dept Pathol & Immunol, Basel, Switzerland.
   [Avsic-Zupanc, T.] Inst Microbiol & Immunol, Ljubljana, Slovenia.
   [Capobianchi, M. R.; Dicaro, A.; Ippolito, G.] Ist Nazl Malattie Infett Roma, UOC, Rome, Italy.
   [Nitsche, A.] Robert Koch Inst, Berlin, Germany.
   [Koopmans, M.; Reusken, C.] Erasmus MC, Rotterdam, Netherlands.
   [Gorbalenya, A.] Leiden Univ, Med Ctr, Leiden, Netherlands.
   [Raoul, H.] INSERM, Lab Merieux, Lyon, France.
   [Bourhy, H.] Inst Pasteur, Paris, France.
   [Mettenleiter, T.; Reiche, S.] Friedrich Loeffler Inst, Greifswald, Germany.
   [Batten, C.] Pirbright Inst, Pirbright, England.
   [Sabeta, C.] Onderstepoort Vet Inst, Praetoria, South Africa.
   [Paweska, J. T.] Natl Inst Communicable Dis, Johannesburg, South Africa.
   [Eropkin, M.] Res Inst Influenza, St Petersburg, Russia.
   [Zverev, V] Mechnikov Sci Res Inst Vaccines & Sera, Moscow, Russia.
   [Hu, Z.] Wuhan Inst Virol, Wuhan, Hubei, Peoples R China.
   [Mac Cullough, S.] Australian Anim Hlth Lab, Geelong, Vic, Australia.
   [Mac Cullough, S.] Australia Dis, Johannesburg, South Africa.
   [Mirazimi, A.] Folkhalsomyndigheten, Stockholm, Sweden.
   [Pradel, F.] Fdn Merieux, Reseau GABRIEL, Lyon, France.
RP Romette, JL (corresponding author), Aix Marseille Univ, UVE, IRD 190, INSERM 1207,IHU Mediterranee Infect, Marseille, France.
EM jean-louis.romette@univ-amu.fr
RI McCullough, Sam/H-7987-2013; Mettenleiter, h. c. Thomas C./U-1016-2019;
   Zverev, Vitaly/V-5171-2019; Koopmans, Marion/Y-9170-2019; Gorbalenya,
   Alexander E/J-4818-2012; Klempa, Boris/N-3096-2019; Klempa,
   Boris/J-8876-2012; Di Caro, Antonino/K-6854-2016
OI McCullough, Sam/0000-0002-2757-2733; Zverev, Vitaly/0000-0001-5808-2246;
   Koopmans, Marion/0000-0002-5204-2312; Gorbalenya, Alexander
   E/0000-0002-4967-7341; Klempa, Boris/0000-0002-6931-1224; Klempa,
   Boris/0000-0002-6931-1224; Di Caro, Antonino/0000-0001-6027-3009; PERNO,
   CARLO FEDERICO/0000-0002-0825-5388; Drexler, Jan
   Felix/0000-0002-3509-0232; Ippolito, Giuseppe/0000-0002-1076-2979;
   Pradel, Florence/0000-0002-1023-0796; Charrel, Remi/0000-0002-7675-8251;
   AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Gunther,
   Stephan/0000-0002-6562-0230; Zverev, Vitalii/0000-0002-0017-1892;
   Klimkait, Thomas/0000-0003-4945-6511
FU European Virus Archive global (EVAg) project from the European Union's
   Horizon 2020 research and innovation programme [653316]
FX This publication was supported by the European Virus Archive global
   (EVAg) project that has received funding from the European Union's
   Horizon 2020 research and innovation programme under grant agreement No
   653316.
CR Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Fischer C, 2017, BRAZIL EMERG INFECT, V23
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gould EA, 2012, ANTIVIR RES, V95, P167, DOI 10.1016/j.antiviral.2012.05.005
   Haddock E, 2018, NAT MICROBIOL, V3, P556, DOI 10.1038/s41564-018-0141-7
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   WHO, 2018, WHOMERSLAB151REV1
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 11
TC 8
Z9 8
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2018
VL 158
BP 127
EP 134
DI 10.1016/j.antiviral.2018.07.017
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GV5LP
UT WOS:000446144000014
PM 30059721
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Luthra, P
   Naidoo, J
   Pietzsch, CA
   De, S
   Khadka, S
   Anantpadma, M
   Williams, CG
   Edwards, MR
   Davey, RA
   Bukreyev, A
   Ready, JM
   Basler, CF
AF Luthra, Priya
   Naidoo, Jacinth
   Pietzsch, Colette A.
   De, Sampriti
   Khadka, Sudip
   Anantpadma, Manu
   Williams, Caroline G.
   Edwards, Megan R.
   Davey, Robert A.
   Bukreyev, Alexander
   Ready, Joseph M.
   Basler, Christopher F.
TI Inhibiting pyrimidine biosynthesis impairs Ebola virus replication
   through depletion of nucleoside pools and activation of innate immune
   responses
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID DOUBLE-STRANDED-RNA; MARBURG-VIRUS; VP35 PROTEIN; DIHYDROOROTATE
   DEHYDROGENASE; INTERFERON ANTAGONISM; ANTIVIRAL RESPONSE; BREQUINAR
   SODIUM; INFECTION; TRANSCRIPTION; KARYOPHERIN
AB Specific host pathways that may be targeted therapeutically to inhibit the replication of Ebola virus (EBOV) and other emerging viruses remain incompletely defined. A screen of 200,000 compounds for inhibition of an EBOV minigenome (MG) assay that measures the function of the viral polymerase complex identified as hits several compounds with an amino-tetrahydrocarbazole scaffold. This scaffold was structurally similar to GSK983, a compound previously described as having broad-spectrum antiviral activity due to its impairing de novo pyrimidine biosynthesis through inhibition of dihydroorotate dehydrogenase (DHODH). We generated compound SW835, the racemic version of GSK983 and demonstrated that SW835 and brequinar, another DHODH inhibitor, potently inhibit the MG assay and the replication of EBOV, vesicular stomatitis virus (VSV) and Zika (ZIKV) in vitro. Nucleoside and deoxynucleoside supplementation studies demonstrated that depletion of pyrimidine pools contributes to antiviral activity of these compounds. As reported for other DHODH inhibitors, SW835 and brequinar also induced expression of interferon stimulated genes (ISGs). ISG induction was demonstrated to occur without production of IFN alpha/beta and independently of the IFN alpha receptor and was not blocked by EBOV-encoded suppressors of IFN signaling pathways. Furthermore, we demonstrated that transcription factor IRF1 is required for this ISG induction, and that IRF1 induction requires the DNA damage response kinase ATM. Therefore, de novo pyrimidine biosynthesis is critical for the replication of EBOV and other RNA viruses and inhibition of this pathway activates an ATM and IRF1-dependent innate immune response that subverts EBOV immune evasion functions.
C1 [Luthra, Priya; De, Sampriti; Khadka, Sudip; Williams, Caroline G.; Edwards, Megan R.; Basler, Christopher F.] Georgia State Univ, Ctr Microbial Pathogenesis, Inst Biomed Sci, Atlanta, GA 30303 USA.
   [Naidoo, Jacinth; Ready, Joseph M.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA.
   [Pietzsch, Colette A.; Bukreyev, Alexander] Univ Texas Med Branch, Dept Pathol, Galveston Natl Lab, Galveston, TX 77555 USA.
   [Bukreyev, Alexander] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston Natl Lab, Galveston, TX 77555 USA.
   [Anantpadma, Manu; Davey, Robert A.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78295 USA.
   [Anantpadma, Manu; Davey, Robert A.] Boston Univ, Sch Med, Dept Microbiol, NEIDL, Boston, MA 02118 USA.
RP Basler, CF (corresponding author), Georgia State Univ, Ctr Microbial Pathogenesis, Inst Biomed Sci, Atlanta, GA 30303 USA.
EM cbasler@gsu.edu
RI Anantpadma, Manu/AAF-6819-2020; Basler, Christopher/AAG-8346-2019
OI Anantpadma, Manu/0000-0001-5796-532X; Basler,
   Christopher/0000-0003-4195-425X; khadka, sudip/0000-0002-5551-0417;
   Davey, Robert/0000-0001-9168-2892
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI109664, P01AI120943,
   R01AI125453]; Welch FoundationThe Welch Foundation [I-1612]
FX This work was supported by NIH grant U19AI109664 to CFB, AB and JMR, by
   NIH grants P01AI120943 (Amarasinghe) to CFB and RAD and R01AI125453 to
   CFB and RAD, by the Welch Foundation (I-1612) to JMR. CFB is an Georgia
   Research Alliance Eminent Scholar in Microbial Pathogenesis. We thank
   Michelle Meyer for help with the EBOV assays performed at UTMB.
CR Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1
   Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297
   Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003
   Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108
   Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05
   CHEN SF, 1992, CANCER RES, V52, P3521
   Cheung NN, 2017, J GEN VIROL, V98, P946, DOI 10.1099/jgv.0.000758
   Chung D, 2015, J ANTIMICROB AGENTS, V1
   Chung DH, 2016, ANTIMICROB AGENTS CH, V60, P4552, DOI 10.1128/AAC.00282-16
   CRAMER DV, 1992, TRANSPLANTATION, V53, P303, DOI 10.1097/00007890-199202010-00009
   Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC
   Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]
   Edwards MR, 2015, ACS INFECT DIS, V1, P380, DOI 10.1021/acsinfecdis.5b00053
   Feagins AR, 2015, J INFECT DIS, V212, pS219, DOI 10.1093/infdis/jiv010
   Feagins AR, 2014, J VIROL, V88, P14440, DOI 10.1128/JVI.02069-14
   Grandin C, 2016, ANTIVIR RES, V125, P58, DOI 10.1016/j.antiviral.2015.11.006
   Gudmundsson KS, 2009, BIOORG MED CHEM LETT, V19, P4110, DOI 10.1016/j.bmcl.2009.06.001
   Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07
   Harvey R, 2009, ANTIVIR RES, V82, P1, DOI 10.1016/j.antiviral.2008.12.015
   Hayden FG, 2017, J INFECT DIS, V215, P167, DOI 10.1093/infdis/jiw496
   Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jasenosky LD, 2010, ANTIMICROB AGENTS CH, V54, P3007, DOI 10.1128/AAC.00138-10
   Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106
   Khiar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02776-z
   Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200
   Leung DW, 2010, NAT STRUCT MOL BIOL, V17, P165, DOI 10.1038/nsmb.1765
   Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0
   Lubaki NM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006031
   Lucas-Hourani M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00383-17, 10.1128/aac.00383-17]
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Luthra P, 2018, ANTIVIR RES, V150, P193, DOI 10.1016/j.antiviral.2017.12.019
   Luthra P, 2017, MBIO, V8, DOI [10.1128/mBio.00368-17, 10.1128/mbio.00368-17]
   Luthra P, 2015, J VIROL, V89, P5148, DOI 10.1128/JVI.03652-14
   Luthra P, 2013, CELL HOST MICROBE, V14, P74, DOI 10.1016/j.chom.2013.06.010
   Mateo M, 2010, J VIROL, V84, P1169, DOI 10.1128/JVI.01372-09
   Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524
   Muhlberger E, 2007, FUTURE VIROL, V2, P205, DOI 10.2217/17460794.2.2.205
   Muhlberger E, 1999, J VIROL, V73, P2333
   Ortiz-Riano E, 2014, J VIROL, V88, P878, DOI 10.1128/JVI.02275-13
   Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981
   Prins KC, 2010, J VIROL, V84, P3004, DOI 10.1128/JVI.02459-09
   Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07
   Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05
   Reis RAG, 2017, ARCH BIOCHEM BIOPHYS, V632, P175, DOI 10.1016/j.abb.2017.06.019
   Rhein BA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005263
   Rougeron V, 2015, J CLIN VIROL, V64, P111, DOI 10.1016/j.jcv.2015.01.014
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004
   Smee Donald F., 2012, Antiviral Chemistry & Chemotherapy, V22, P263, DOI 10.3851/IMP2105
   Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015
   Spengler JR, 2016, EMERG INFECT DIS, V22, P956, DOI [10.3201/eid2206.160021, 10.32032/eid2206.160021]
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   Valmas C, 2011, J VIROL, V85, P4309, DOI 10.1128/JVI.02575-10
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Wang YJ, 2016, ANTIMICROB AGENTS CH, V60, P2834, DOI 10.1128/AAC.02700-15
   Willis N, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-13
   Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008
   Yeh S, 2015, NEW ENGL J MED, V373, P1982, DOI 10.1056/NEJMc1510459
   Yen B, 2014, J VIROL, V88, P12500, DOI 10.1128/JVI.02163-14
   Yen BC, 2016, J VIROL, V90, P5108, DOI 10.1128/JVI.00191-16
   Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113
NR 63
TC 15
Z9 16
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2018
VL 158
BP 288
EP 302
DI 10.1016/j.antiviral.2018.08.012
PG 15
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GV5LP
UT WOS:000446144000030
PM 30144461
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ribeiro, MR
   Moreli, JB
   Marques, RE
   Papa, MP
   Meuren, LM
   Rahal, P
   de Arruda, LB
   Oliani, AH
   Oliani, DCMV
   Oliani, SM
   Narayanan, A
   Nogueira, ML
AF Ribeiro, Milene Rocha
   Moreli, Jusciele Brogin
   Marques, Rafael Elias
   Papa, Michelle Premazzi
   Meuren, Lana Monteiro
   Rahal, Paula
   de Arruda, Luciana Barros
   Oliani, Antonio Helio
   Mos Vaz Oliani, Denise Cristina
   Oliani, Sonia Maria
   Narayanan, Aarthi
   Nogueira, Mauricio Lacerda
TI Zika-virus-infected human full-term placental explants display
   pro-inflammatory responses and undergo apoptosis
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID CHORIONIC-GONADOTROPIN; 1ST TRIMESTER; TROPHOBLAST; FETAL; INVASION;
   CELLS; COMPLICATIONS; TRANSMISSION; EXPRESSION; PROTECTION
AB Zika virus (ZIKV) is a flavivirus that has been highly correlated with the development of neurological disorders and other malformations in newborns and stillborn fetuses after congenital infection. This association is supported by the presence of ZIKV in the fetal brain and amniotic fluid, and findings suggest that infection of the placental barrier is a critical step for fetal ZIKV infection in utero. Therefore, relevant models to investigate the interaction between ZIKV and placental tissues are essential for understanding the pathogenesis of Zika syndrome. In this report, we demonstrate that explant tissue from full-term human placentas sustains a productive ZIKV infection, though the results depend on the strain. Viral infection was found to be associated with pro-inflammatory cytokine expression and apoptosis of the infected tissue, and these findings confirm that placental explants are targets of ZIKV replication. We propose that human placental explants are useful as a model for studying ZIKV infection ex vivo.
C1 [Ribeiro, Milene Rocha; Rahal, Paula; Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Sch Biosci Humanities & Exact Sci, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil.
   [Moreli, Jusciele Brogin] Fed Univ Sao Paulo UNIFESP, Sao Paulo, SP, Brazil.
   [Marques, Rafael Elias] Natl Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.
   [Papa, Michelle Premazzi; Meuren, Lana Monteiro; de Arruda, Luciana Barros] Fed Univ Rio de Janeiro UFRJ, Paulo de Goes Dept Microbiol, Rio De Janeiro, Brazil.
   [Narayanan, Aarthi] George Mason Univ, Fairfax, VA 22030 USA.
   [Ribeiro, Milene Rocha; Oliani, Antonio Helio; Mos Vaz Oliani, Denise Cristina; Nogueira, Mauricio Lacerda] Sao Jose do Rio Preto Sch Med FAMERP, Dept Dermatol Infect & Parasit Dis, Virol Res Lab, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, Dept Dermatol Infect & Parasit Dis, Virol Res Lab, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Rahal, Paula/D-3871-2012; Arruda, Luciana B/N-9086-2013; OLIANI,
   ANTONIO/O-1673-2019; Nogueira, Mauricio L/B-7599-2012; Marques, Rafael
   Elias/R-4890-2016; Oliani, Sonia Maria/E-3476-2012
OI Rahal, Paula/0000-0001-5693-6148; Nogueira, Mauricio
   L/0000-0003-1102-2419; Marques, Rafael Elias/0000-0002-6949-0947;
   Oliani, Antonio Helio/0000-0003-1242-4364; Moreli,
   Jusciele/0000-0002-0945-9462; Oliani, Sonia Maria/0000-0003-0918-2130
FU Brazilian National Institute of Science and Technology for Dengue
   Studies (INCT em Dengue); Sao Paulo Research Foundation (FAPESP)Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21719-3];
   Brazilian National Research Council (CAPES)National Council for
   Scientific and Technological Development (CNPq)CAPES
FX The authors gratefully acknowledge the Brazilian National Institute of
   Science and Technology for Dengue Studies (INCT em Dengue), the Sao
   Paulo Research Foundation (FAPESP; Grant No. 2013/21719-3 to MLN) and
   the Brazilian National Research Council (CAPES) for their financial
   support.
CR Aliota M. T., 2016, PLOS NEGLECT TROP D, V10, DOI DOI 10.1371/JOURNAL.PNTD.0004750
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chutinimitkul S, 2005, J VIROL METHODS, V129, P8, DOI 10.1016/j.jviromet.2005.05.006
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Derricott H, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12725
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fettke F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00495
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcia-Ruiz G, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0111-3
   Girard S, 2014, AM J REPROD IMMUNOL, V72, P422, DOI 10.1111/aji.12274
   Giugliano S, 2015, J IMMUNOL, V195, P3737, DOI 10.4049/jimmunol.1500409
   Gomes CP, 2013, AM J REPROD IMMUNOL, V69, P545, DOI 10.1111/aji.12088
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899
   Hamming OJ, 2013, EMBO J, V32, P3055, DOI 10.1038/emboj.2013.232
   Heazell AEP, 2008, REPROD SCI, V15, P1034, DOI 10.1177/1933719108322438
   Helige C, 2008, HUM REPROD, V23, P2282, DOI 10.1093/humrep/den198
   Itinteang T, 2011, J CLIN PATHOL, V64, P870, DOI 10.1136/jclinpath-2011-200191
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   KURMAN RJ, 1984, INT J GYNECOL PATHOL, V3, P101, DOI 10.1097/00004347-198403010-00009
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lash GE, 2006, FASEB J, V20, P2512, DOI 10.1096/fj.06-6616com
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee HC, 2014, J BIOL CHEM, V289, P5310, DOI 10.1074/jbc.M113.536102
   Leisser C, 2006, MOL HUM REPROD, V12, P601, DOI 10.1093/molehr/gal066
   LIBRACH CL, 1994, J BIOL CHEM, V269, P17125
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   McEwan M, 2009, CYTOKINE GROWTH F R, V20, P241, DOI 10.1016/j.cytogfr.2009.05.004
   Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200
   Otun HA, 2011, J REPROD IMMUNOL, V88, P1, DOI 10.1016/j.jri.2010.10.003
   Pacanowski M, 2012, JAMA-J AM MED ASSOC, V307, P1921, DOI 10.1001/jama.2012.3516
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pontillo A, 2013, REPROD SCI, V20, P563, DOI 10.1177/1933719112459240
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth I, 1996, J EXP MED, V184, P539, DOI 10.1084/jem.184.2.539
   Roth I, 1999, DEV BIOL, V205, P194, DOI 10.1006/dbio.1998.9122
   Siwetz M, 2016, LAB INVEST, V96, P428, DOI 10.1038/labinvest.2015.159
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vargas-Rojas MI, 2016, J MATERN-FETAL NEO M, V29, P1642, DOI 10.3109/14767058.2015.1057811
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   VICOVAC L, 1995, PLACENTA, V16, P41, DOI 10.1016/0143-4004(95)90080-2
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilczynski JR, 2003, EUR J OBSTET GYN R B, V109, P8, DOI 10.1016/S0301-2115(02)00350-0
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 72
TC 5
Z9 5
U1 1
U2 7
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD OCT
PY 2018
VL 163
IS 10
BP 2687
EP 2699
DI 10.1007/s00705-018-3911-x
PG 13
WC Virology
SC Virology
GA GT7UM
UT WOS:000444735000006
PM 29876782
OA Green Published
DA 2020-07-08
ER

PT J
AU Krystosik, AR
   Curtis, A
   LaBeaud, AD
   Davalos, DM
   Pacheco, R
   Buritica, P
   Alvarez, AA
   Bhatta, MP
   Palacios, JHR
   James, MA
AF Krystosik, Amy R.
   Curtis, Andrew
   LaBeaud, A. Desiree
   Davalos, Diana M.
   Pacheco, Robinson
   Buritica, Paola
   Alvarez, Alvaro A.
   Bhatta, Madhav P.
   Rojas Palacios, Jorge Humberto
   James, Mark A.
TI Neighborhood Violence Impacts Disease Control and Surveillance: Case
   Study of Cali, Colombia from 2014 to 2016
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE arboviral surveillance; neighborhood violence; clinical diagnosis;
   laboratory specificity; spatial clustering; community health
ID CHIKUNGUNYA VIRUS-INFECTIONS; DENGUE VIRUS; AEDES-AEGYPTI; RISK-FACTORS;
   ZIKA; HEALTH; COINFECTION; OUTBREAK; ILLNESS; FEVER
AB Arboviruses are responsible for a large burden of disease globally and are thus subject to intense epidemiological scrutiny. However, a variable notably absent from most epidemiological analyses has been the impact of violence on arboviral transmission and surveillance. Violence impedes surveillance and delivery of health and preventative services and affects an individual's health-related behaviors when survival takes priority. Moreover, low and middle-income countries bear a disproportionately high burden of violence and related health outcomes, including vector borne diseases. To better understand the epidemiology of arboviral outbreaks in Cali, Colombia, we georeferenced chikungunya (CHIKV), dengue (DENV), and Zika (ZIKV) viral cases from The National System of Surveillance in Public Health between October 2014 and April 2016. We extracted homicide data from the municipal monthly reports and kernel density of homicide distribution from IdeasPaz. Crucially, an overall higher risk of homicide is associated with increased risk of reported DENV, lower rates of acute testing, and higher rates of lab versus clinical discordance. In the context of high violence as a potential barrier to access to preventive health services, a community approach to improve health and peace should be considered.
C1 [Krystosik, Amy R.; LaBeaud, A. Desiree] Stanford Univ, Dept Pediat, Div Infect Dis, Grant Bldg,S 374,300 Pasteur Dr, Stanford, CA 94305 USA.
   [Krystosik, Amy R.; Bhatta, Madhav P.; James, Mark A.] Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44240 USA.
   [Curtis, Andrew] Kent State Univ, Dept Geog, GIS Hlth & Hazards Lab, Kent, OH 44240 USA.
   [Davalos, Diana M.; Pacheco, Robinson] Univ Icesi, Dept Publ Hlth & Community Med, Cali 760031, Colombia.
   [Pacheco, Robinson; Buritica, Paola] Univ Libre, Grp Invest Epidemiol & Serv, Cali 760031, Colombia.
   [Alvarez, Alvaro A.] Caucaseco Sci Res Ctr, Cali 760031, Colombia.
   [Alvarez, Alvaro A.] Stanford Univ, Sch Med Res IRT, 3172 Porter Dr, Stanford, CA 94305 USA.
   [Rojas Palacios, Jorge Humberto] Secretaria Salud Cali, Cali 760031, Colombia.
RP Krystosik, AR (corresponding author), Stanford Univ, Dept Pediat, Div Infect Dis, Grant Bldg,S 374,300 Pasteur Dr, Stanford, CA 94305 USA.; Krystosik, AR (corresponding author), Kent State Univ, Coll Publ Hlth, Dept Biostat Environm Hlth Sci & Epidemiol, Kent, OH 44240 USA.
EM akrystos@stanford.edu; acurti13@kent.edu; dlabeaud@stanford.edu;
   dmdavalos@icesi.edu.co; robinson.pacheco.73@gmail.com;
   p3107@hotmail.com; alvaro1@stanford.edu; mbhatta@kent.edu;
   jorge.rojas@cali.gov.co; mjames22@kent.edu
RI Curtis, Andrew/U-8674-2019
OI Krystosik, Amy/0000-0001-7944-8876
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   [Anonymous], 2009, VERS 8 0
   Armitage N.M., 2016, PLAN DECENAL SALUD P
   Bender J., MOST VIOLENT CITIES
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Braveman P, 2014, PUBLIC HEALTH REP, V129, P19, DOI 10.1177/00333549141291S206
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, GEOGR DISTR CHIK VIR
   Centre for Disease Control and Prevention, FACTS MICR
   Chang AY, 2014, HEALTH HUM RIGHTS, V16, P93
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004073
   Cleves D, 2016, J PEDIATR SURG, V51, P1341, DOI 10.1016/j.jpedsurg.2016.01.008
   Cruz MM, 2017, J IMMUNOL, V198
   DeGroote JP, 2012, GEOGR COMPASS, V6, P645, DOI 10.1111/gec3.12003
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Departamento Administrativo de Planeacion, 2016, CAL EN CIFR, P244
   Dickin SK, 2014, APPL GEOGR, V46, P71, DOI 10.1016/j.apgeog.2013.11.003
   Dickin SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063584
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   El Pais, 2015, CAD 20 HECT CAL EST
   El Tiempo, VEN MIGR MAS GRAND H
   El Tiempo, 89 VEN CENS QUIER QU
   Fine P, 2013, LANCET, V381, P1302, DOI 10.1016/S0140-6736(13)60771-0
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Globovision, COL ANN END CHIK EP
   Goicolea I, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1397909
   Grajales J, 2011, J PEASANT STUD, V38, P771, DOI 10.1080/03066150.2011.607701
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grossi-Soyster EN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005998
   Guadagno RE, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00734
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Harrington J, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/756832
   Hawthorne TL, 2013, GEOFORUM, V50, P97, DOI 10.1016/j.geoforum.2013.08.002
   Heath CJ, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofx234
   Jones CH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-846
   Khormi HM, 2011, SCI TOTAL ENVIRON, V409, P4713, DOI 10.1016/j.scitotenv.2011.08.028
   Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208
   Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995
   Kwan M.-P, 2012, ANN GIS, V18, P245, DOI DOI 10.1080/19475683.2012.727867
   Kwan MP, 2013, ANN ASSOC AM GEOGR, V103, P1078, DOI 10.1080/00045608.2013.792177
   Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P891, DOI 10.1080/00045608.2012.687348
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Lian CW, 2006, TROP BIOMED, V23, P85
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Malik A, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5902-x
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Mattar S, 2017, J INFECT PUBLIC HEAL, V10, P507, DOI 10.1016/j.jiph.2016.09.014
   Matzopoulos R, 2008, INT J INJ CONTROL SA, V15, P177, DOI 10.1080/17457300802396487
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ministerio de Salud y Proteccion Social, CAS CHIK MUN
   Ministerio de Salud y Proteccion Social, 2015, MINSALUD CONF 1 NEW
   Minsterio de Relaciones Exteriores, 2018, RAD VEN COL
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   Morales-Perez A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4300-1
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   National Institutes of Health of Colombia, 2016, WEEKL EP B
   Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997
   Ngugi HN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2271-9
   Tuan NM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003638
   Norris A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149074
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   O'Meara WP, 2014, PUBLIC HEALTH, V128, P993, DOI 10.1016/j.puhe.2014.08.010
   Olliaro P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005967
   Ortíz Yamileth, 2007, rev.fac.med., V55, P31
   Padmanabha H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144451
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Paulo CO, 2017, IDCases, V9, P30, DOI 10.1016/j.idcr.2017.03.015
   PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x
   Prates MO, 2014, STAT MED, V33, P2634, DOI 10.1002/sim.6143
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Roques P, 2011, J INFECT DIS, V203, P141, DOI 10.1093/infdis/jiq026
   RStudio Team, 2016, RSTUDIO INT DEV R
   Runge-Ranzinger S, 2008, TROP MED INT HEALTH, V13, P1022, DOI 10.1111/j.1365-3156.2008.02112.x
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Sanna M, 2017, ASIAN PAC J TROP MED, V10, P275, DOI 10.1016/j.apjtm.2017.03.009
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Schirmer P., 2017, ONLINE J PUBLIC HLTH, V9, pe098
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Secretaria de Salud Municipal, 2018, WORK DOC 2018 TABL 1
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Slutkin G., 2018, CONTAGION VIOLENCE, V2013, P94
   Slutkin Gary, 2018, AMA J Ethics, V20, P47, DOI 10.1001/journalofethics.2018.20.1.nlit1-1801
   Slutkin Gary, 2018, AMA J Ethics, V20, P516, DOI 10.1001/journalofethics.2018.20.5.corr2-1805
   Slutkin G, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0025
   Slutkin Gary, 2016, Health Prog, V97, P5
   United Nations Office for the Coordination of Humanitarian Affairs Colombia, 2018, HUM NEEDS OV COL, P40
   United Nations Office for the Coordination of Humanitarian Affairs Colombia, 2015, HUM NEEDS OV COL, P32
   Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5
   Velasco JM, 2015, AM J TROP MED HYG, V93, P1318, DOI 10.4269/ajtmh.15-0332
   Luque RV, 2017, UNIV PSYCHOL, V16, DOI 10.11144/Javeriana.upsy16-3.icca
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   World Bank Group, 2015, DOING BUS COL, V2015
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2015, GLOB ACT PLAN CONTR, P1, DOI DOI 10.1016/S0968-8080(12)40660-7
   World Health Organization, 2002, WORLD REPORT VIOLENC, P360
   Yaseen HM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-249
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zhu GG, 2018, SCI TOTAL ENVIRON, V622, P252, DOI 10.1016/j.scitotenv.2017.11.314
NR 117
TC 3
Z9 3
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2018
VL 15
IS 10
AR 2144
DI 10.3390/ijerph15102144
PG 20
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GY7TQ
UT WOS:000448818100086
PM 30274270
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matusali, G
   Houzet, L
   Satie, AP
   Mahe, D
   Aubry, F
   Couderc, T
   Frouard, J
   Bourgeau, S
   Bensalah, K
   Lavoue, S
   Joguet, G
   Bujan, L
   Cabie, A
   Avelar, G
   Lecuit, M
   Le Tortorec, A
   Dejucq-Rainsford, N
AF Matusali, Giulia
   Houzet, Laurent
   Satie, Anne-Pascale
   Mahe, Dominique
   Aubry, Florence
   Couderc, Therese
   Frouard, Julie
   Bourgeau, Salome
   Bensalah, Karim
   Lavoue, Sylvain
   Joguet, Guillaume
   Bujan, Louis
   Cabie, Andre
   Avelar, Gleide
   Lecuit, Marc
   Le Tortorec, Anna
   Dejucq-Rainsford, Nathalie
TI Zika virus infects human testicular tissue and germ cells
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID SEXUAL TRANSMISSION; PERITUBULAR CELLS; HUMAN TESTIS; SEMEN;
   INTERFERONS; RESPONSES; RNA; EXPRESSION; PROTEINS; ORCHITIS
AB Zika virus (ZIKV) is a teratogenic mosquito-borne flavivirus that can be sexually transmitted from man to woman. The finding of high viral loads and prolonged viral shedding in semen suggests that ZIKV replicates within the human male genital tract, but its target organs are unknown. Using ex vivo infection of organotypic cultures, we demonstrated here that ZIKV replicates in human testicular tissue and infects a broad range of cell types, including germ cells, which we also identified as infected in semen from ZIKV-infected donors. ZIKV had no major deleterious effect on the morphology and hormonal production of the human testis explants. Infection induced a broad antiviral response but no IFN upregulation and minimal proinflammatory response in testis explants, with no cytopathic effect. Finally, we studied ZIKV infection in mouse testis and compared it to human infection. This study provides key insights into how ZIKV may persist in semen and alter semen parameters, as well as a valuable tool for testing antiviral agents.
C1 [Matusali, Giulia; Houzet, Laurent; Satie, Anne-Pascale; Mahe, Dominique; Aubry, Florence; Frouard, Julie; Bourgeau, Salome; Le Tortorec, Anna; Dejucq-Rainsford, Nathalie] Univ Rennes, Inserm, EHESP, Irset,UMR S1085, Rennes, France.
   [Couderc, Therese; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Couderc, Therese; Lecuit, Marc] Inserm U1117, Paris, France.
   [Bensalah, Karim] CHU Rennes, Serv Urol, Rennes, France.
   [Lavoue, Sylvain] CHU Rennes, Unite Coordinat Hosp Prelevements Organes & Tissu, Rennes, France.
   [Joguet, Guillaume] CHU Pointe A Pitre, Ctr Caribeen Med Reprod CECOS, Pointe a Pitre, France.
   [Bujan, Louis] Univ Paul Sabatier Toulouse III, Hop Paule de Viguier, CHU Toulouse, CECOS,Res Grp Human Fertil EA 3694, Toulouse, France.
   [Cabie, Andre] CHU Martinique, Inserm Ctr Invest Clin 1424, Fort De France, France.
   [Cabie, Andre] CHU Martinique, Serv Malad Infect, Fort De France, France.
   [Avelar, Gleide] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil.
   [Lecuit, Marc] Paris Descartes Univ, Dept Infect Dis & Trop Med, Necker Enfants Malad Univ Hosp, Paris, France.
RP Dejucq-Rainsford, N (corresponding author), IRSET Inserm U1085, 9 Ave Pr Leon Bernard, F-35000 Rennes, France.
EM nathalie.dejucq-rainsford@univ-rennes1.fr
RI MAHE, Dominique MD/I-7316-2015; Lecuit, Marc/M-4126-2019; matusali,
   giulia/N-7201-2015; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Lecuit,
   Marc/J-4073-2013
OI Lecuit, Marc/0000-0002-4491-1063; matusali, giulia/0000-0002-2948-4243;
   Lecuit, Marc/0000-0002-4491-1063; Cabie, Andre/0000-0003-0117-3061;
   Dejucq-Rainsford, Nathalie/0000-0002-1788-2690; Bujan,
   Louis/0000-0003-1540-0536
FU European UnionEuropean Union (EU) [733176, 734584, 734548]; LabEx IBEID;
   Institut Pasteur; InsermInstitut National de la Sante et de la Recherche
   Medicale (Inserm); REACTing; CAPES-COFECUBCAPES; Agence de la
   biomedecine; Agence regionale de sante Guadeloupe; French Ministry of
   Health (Soutien exceptionnel a la recherche et a l'innovation); European
   Virus Archive Goes Global (EVAg) project from the European Union
   [653316]
FX This project received funding from the European Union's Horizon 2020
   research and innovation program under grant agreement no. 733176,
   ZikaPLAN (grant agreement no. 734584), and ZIKAlliance (grant agreement
   734548) and was funded in part by LabEx IBEID, Institut Pasteur, and
   Inserm. GM received support from REACTing. GA and NDR received funding
   from CAPES-COFECUB. GJ and LB received funding from Agence de la
   biomedecine and Agence regionale de sante Guadeloupe for the collection
   of semen from infected men. AC received funding from the French Ministry
   of Health (Soutien exceptionnel a la recherche et a l'innovation) and
   support from REACTing. Experiments were conducted in part on L3, MRic,
   and H2P2 platforms at Biosit federative structure (Universite de Rennes,
   CNRS, Inserm, Biosit [Biologie, Sante, Innovation Technologique de
   Rennes] - UMS 3480, US_S 018). This publication was supported by the
   European Virus Archive Goes Global (EVAg) project, which has received
   funding from the European Union's Horizon 2020 research and innovation
   program under grant agreement 653316. We thank Xavier Montagutelli for
   help with animal experiments and Laurianne Lesne and Christele Desdoits
   for assistance in hormonal assays.
CR ADAMOPOULOS DA, 1978, BRIT MED J, V1, P1177, DOI 10.1136/bmj.1.6121.1177
   Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Cheng CY, 2010, MOL CELL ENDOCRINOL, V315, P49, DOI 10.1016/j.mce.2009.08.004
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Dejucq N, 1998, J REPROD IMMUNOL, V41, P291, DOI 10.1016/S0165-0378(98)00065-5
   Dejucq N, 1998, ENDOCRINOLOGY, V139, P3081, DOI 10.1210/en.139.7.3081
   Dejucq N, 1997, J CELL BIOL, V139, P865, DOI 10.1083/jcb.139.4.865
   Deleage C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-017-0387-9
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Epelboin S, 2017, HUM REPROD UPDATE, V23, P629, DOI 10.1093/humupd/dmx024
   Evenson DP, 2000, J ANDROL, V21, P739
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guerin B, 2005, THERIOGENOLOGY, V63, P556, DOI 10.1016/j.theriogenology.2004.09.030
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hasan M, 2013, NAT IMMUNOL, V14, P61, DOI 10.1038/ni.2475
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Houzet L, 2018, J VIROL, V92, DOI 10.1128/JVI.00133-18
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kristensen DM, 2018, P NATL ACAD SCI USA, V115, pE715, DOI 10.1073/pnas.1715035115
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lalle E, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.18.18-00197
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Tortorec A, 2008, HUM REPROD, V23, P2095, DOI 10.1093/humrep/den207
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matusali G, 2015, J VIROL, V89, P5772, DOI 10.1128/JVI.03628-14
   Mayerhofer A, 2013, REPRODUCTION, V145, pR107, DOI 10.1530/REP-12-0497
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799
   Potter SJ, 2017, REPRODUCTION, V153, pR151, DOI 10.1530/REP-16-0588
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018
   Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191
   Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689
   Satie AP, 2011, J BIOL CHEM, V286, P23280, DOI 10.1074/jbc.M111.229120
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schoggins JW, 2018, NAT COMMUN, V9, P414
   Sergerie M, 2007, FERTIL STERIL, V88, DOI 10.1016/j.fertnstert.2006.12.045
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Strange DP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0080-7
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xia Y, 2012, ARCH GERONTOL GERIAT, V55, P116, DOI 10.1016/j.archger.2011.05.005
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
   Young JC, 2011, INT J ANDROL, V34, pE204, DOI 10.1111/j.1365-2605.2011.01170.x
   2010, ANDROLOGY, P1
NR 73
TC 20
Z9 20
U1 1
U2 10
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD OCT 1
PY 2018
VL 128
IS 10
BP 4697
EP 4710
DI 10.1172/JCI121735
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GV4IZ
UT WOS:000446063600046
PM 30063220
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Weiler, A
   Aliota, M
   Weger-Lucarelli, J
   Semler, M
   Barry, G
   Dudley, D
   Newman, C
   O'Connor, S
   O'Connor, D
   Ebel, G
   Friedrich, T
AF Weiler, Andrea
   Aliota, Matthew
   Weger-Lucarelli, James
   Semler, Matthew
   Barry, Gabrielle
   Dudley, Dawn
   Newman, Christina
   O'Connor, Shelby
   O'Connor, David
   Ebel, Gregory
   Friedrich, Thomas
TI Resources for non-human primate models of Zika virus
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Weiler, Andrea; Semler, Matthew; Barry, Gabrielle; O'Connor, David; Friedrich, Thomas] WNPRC, Madison, WI USA.
   [Aliota, Matthew; Friedrich, Thomas] UW Madison Pathobiol Sci, Madison, WI USA.
   [Weger-Lucarelli, James; Ebel, Gregory] Colorado State Univ, Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Semler, Matthew; Dudley, Dawn; Newman, Christina; O'Connor, Shelby; O'Connor, David] UW Madison Cellular & Mol Pathol, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2018
VL 47
IS 5
SI SI
MA 54
BP 350
EP 350
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA GU8UQ
UT WOS:000445618600117
DA 2020-07-08
ER

PT J
AU Paniz-Mondolfi, AE
   Giraldo, J
   Rodriguez-Morales, AJ
   Pacheco, O
   Lombo-Lucero, GY
   Plaza, JD
   Adami-Teppa, FJ
   Carrillo, A
   Hernandez-Pereira, CE
   Blohm, GM
AF Paniz-Mondolfi, Alberto E.
   Giraldo, Jose
   Rodriguez-Morales, Alfonso J.
   Pacheco, Oriana
   Lombo-Lucero, German Y.
   Plaza, Juan D.
   Adami-Teppa, Fabio J.
   Carrillo, Alejandra
   Hernandez-Pereira, Carlos E.
   Blohm, Gabriela M.
TI Alice in Wonderland syndrome: a novel neurological presentation of Zika
   virus infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Alice in Woderland syndrome; Viral; Metamorphopsia
ID ENCEPHALITIS
AB Zika virus (ZIKV) is a flavivirus endemic in Africa and Southern Asian countries, which has recently emerged in unprecedented epidemic proportions around the world. Although ZIKV infection is often asymptomatic or distinguished by non-specific influenza-like symptoms, an increase in its pathogenicity and biological behavior has been the hallmark of the current pandemic. Increasing evidence suggests that neurotropic strains of ZIKV have evolved from less pathogenic strains of the virus. Neurological manifestations of ZIKV infection include a spectrum of congenital and non-congenital clinical entities, however visual somatosensory perceptual disorders have not been recorded to date. Herein, we report a case of a 15-year-old female who presented with a constellation of perceptual symptoms (metamorphopsia, telopsia, and pelopsia) following acute ZIKV infection. Although such symptoms may have originated from direct viral injury, a post-ZIKV autoimmune reaction to previously unexposed neuronal surface antigens or through molecular mimicry cannot be excluded. The development of Alice in Wonderland syndrome in our patient highlights the ever-increasing expanding spectrum of neurological symptoms associated to ZIKV infection.
C1 [Paniz-Mondolfi, Alberto E.] Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Infect Dis & Trop Med, Barquisimeto 3023, Lara, Venezuela.
   [Paniz-Mondolfi, Alberto E.] Inst Estudios Avanzados IDEA, Lab Senalizac Celular & Bioquim Parasitos, Caracas, Venezuela.
   [Paniz-Mondolfi, Alberto E.] Inst Venezolano Seguros Sociales IVSS, Directorate Hlth, Caracas, Venezuela.
   [Giraldo, Jose] Hosp Int Barquisimeto, Dept Ophtalmol & Neuroophtalmol, Barquisimeto, Venezuela.
   [Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Colombia.
   [Pacheco, Oriana; Lombo-Lucero, German Y.; Adami-Teppa, Fabio J.; Hernandez-Pereira, Carlos E.] Venezuelan Sci Incubator, Infect Dis Res Incubator & Zoonosis & Emerging Pa, Cabudare 3023, Lara, Venezuela.
   [Pacheco, Oriana; Lombo-Lucero, German Y.; Plaza, Juan D.; Carrillo, Alejandra; Hernandez-Pereira, Carlos E.] Univ Centroccidental Lisandro Alvarado, Coll Med, Hlth Sci Dept, Barquisimeto 3001, Lara, Venezuela.
   [Plaza, Juan D.; Carrillo, Alejandra] Univ Nacl Expt Francisco de Miranda, Coll Med, Hlth Sci Dept, Punto Fijo, Falcon, Venezuela.
   [Adami-Teppa, Fabio J.] Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Radiol, Div Neuroradiol, Barquisimeto 3001, Venezuela.
   [Blohm, Gabriela M.] Univ Florida, Coll Liberal Arts & Sci, Dept Biol, Gainesville, FL 32611 USA.
   [Blohm, Gabriela M.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
RP Paniz-Mondolfi, AE (corresponding author), Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Infect Dis & Trop Med, Barquisimeto 3023, Lara, Venezuela.; Paniz-Mondolfi, AE (corresponding author), Inst Estudios Avanzados IDEA, Lab Senalizac Celular & Bioquim Parasitos, Caracas, Venezuela.; Paniz-Mondolfi, AE (corresponding author), Inst Venezolano Seguros Sociales IVSS, Directorate Hlth, Caracas, Venezuela.
EM alberto.paniz-mondolfi@yale.edu
CR Araujo AQC, 2006, LANCET NEUROL, V5, P1068, DOI 10.1016/S1474-4422(06)70628-7
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Farooq O, 2017, PEDIATR NEUROL, V77, P5, DOI 10.1016/j.pediatrneurol.2017.08.008
   Fine EJ, 2013, PROG BRAIN RES, V206, P143, DOI 10.1016/B978-0-444-63364-4.00025-9
   Galli J, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0556-y
   Getts DR, 2013, IMMUNOL REV, V255, P197, DOI 10.1111/imr.12091
   Linnoila JJ, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000245
   Lobigs M, 1996, IMMUNOL REV, V152, P5, DOI 10.1111/j.1600-065X.1996.tb00908.x
   Lucchese G, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12608
   Mastria G, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8243145
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   O'Toole P, 2017, BRAIN DEV-JPN, V39, P470, DOI 10.1016/j.braindev.2017.01.004
   Omata T, 2016, PEDIATR INT, V58, P1057, DOI 10.1111/ped.13039
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Tuzun E, 2007, NEUROLOGIST, V13, P261, DOI 10.1097/NRL.0b013e31813e34a5
   Weidenfeld A, 2011, CHILD NERV SYST, V27, P893, DOI 10.1007/s00381-011-1400-6
NR 16
TC 2
Z9 2
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2018
VL 24
IS 5
BP 660
EP 663
DI 10.1007/s13365-018-0645-1
PG 4
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA HB8HF
UT WOS:000451327900017
PM 30105501
DA 2020-07-08
ER

PT J
AU Basile, AJ
   Goodman, C
   Horiuchi, K
   Sloan, A
   Johnson, BW
   Kosoy, O
   Laven, J
   Panella, AJ
   Sheets, I
   Medina, F
   Mendoza, EJ
   Epperson, M
   Maniatis, P
   Semenova, V
   Steward-Clark, E
   Wong, E
   Biggerstaff, BJ
   Lanciotti, R
   Drebot, M
   Safronetz, D
   Schiffer, J
AF Basile, Alison Jane
   Goodman, Christin
   Horiuchi, Kalanthe
   Sloan, Angela
   Johnson, Barbara W.
   Kosoy, Olga
   Laven, Janeen
   Panella, Amanda J.
   Sheets, Isabel
   Medina, Freddy
   Mendoza, Emelissa J.
   Epperson, Monica
   Maniatis, Panagiotis
   Semenova, Vera
   Steward-Clark, Evelene
   Wong, Emily
   Biggerstaff, Brad J.
   Lanciotti, Robert
   Drebot, Michael
   Safronetz, David
   Schiffer, Jarad
TI Multi-laboratory comparison of three commercially available Zika IgM
   enzyme-linked immunosorbent assays
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika; Dengue; Virus; Kits; ELISA; Enzyme-linked immunosorbent assay;
   Commercial; IgM; IgG; Immunoglobulin M; Immunoglobulin G; Comparison;
   Nonstructural protein 1; NS1; Envelope E
ID VIRUS IGM; DENGUE; SPECIFICITY; ANTIBODIES; INFECTION; SENSITIVITY;
   MICRONESIA; REACTIVITY; OUTBREAK; ANTIGEN
C1 [Basile, Alison Jane; Goodman, Christin; Horiuchi, Kalanthe; Sloan, Angela; Kosoy, Olga; Laven, Janeen; Panella, Amanda J.; Sheets, Isabel; Biggerstaff, Brad J.; Lanciotti, Robert] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 30333 USA.
   [Sloan, Angela; Mendoza, Emelissa J.; Drebot, Michael; Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Epperson, Monica; Maniatis, Panagiotis; Semenova, Vera; Steward-Clark, Evelene; Wong, Emily; Schiffer, Jarad] Ctr Dis Control & Prevent, Div Bacterial Dis, Microbial Pathogenesis & Immune Response Lab, Atlanta, GA USA.
   [Medina, Freddy] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, San Juan, PR USA.
RP Basile, AJ (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 30333 USA.
EM ajj1@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Beaty B, 1995, DIAGNOSTIC PROCEDURE, P189
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao Lormeau V.-M., 2014, EMERG INFECT DIS, V20, P1085
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Khawar W, 2017, CUREUS, V9, DOI 10.7759/cureus.1099
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Paz-Bailey G., 2017, PERSISTENCE ZIKA VIR
   Prince HE, 2013, J CLIN LAB ANAL, V27, P27, DOI 10.1002/jcla.21557
   R Core Team, 2017, R LANG ENV STAT COMP
   Robinson JS, 2010, AM J TROP MED HYG, V83, P1146, DOI 10.4269/ajtmh.2010.10-0212
   Russell BJ, 2007, J VIROL METHODS, V145, P62, DOI 10.1016/j.jviromet.2007.05.008
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   TSAI TF, 1987, J CLIN MICROBIOL, V25, P370, DOI 10.1128/JCM.25.2.370-376.1987
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   de Souza VAUF, 2007, J CLIN VIROL, V39, P230, DOI 10.1016/j.jcv.2007.04.005
   Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 4
Z9 4
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2018
VL 260
BP 26
EP 33
DI 10.1016/j.jviromet.2018.06.018
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA GQ9AD
UT WOS:000442057400005
PM 29964076
OA Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Pan, T
   Peng, ZL
   Tan, LK
   Zou, F
   Zhou, N
   Liu, BF
   Liang, LT
   Chen, CC
   Liu, J
   Wu, LY
   Liu, GY
   Peng, ZQ
   Liu, WW
   Ma, XC
   Zhang, JS
   Zhu, X
   Liu, T
   Li, MF
   Huang, X
   Tao, L
   Zhang, YW
   Zhang, H
AF Pan, Ting
   Peng, Zhilin
   Tan, Likai
   Zou, Fan
   Zhou, Nan
   Liu, Bingfeng
   Liang, Liting
   Chen, Cancan
   Liu, Jun
   Wu, Liyang
   Liu, Guangyan
   Peng, Zhiqin
   Liu, Weiwei
   Ma, Xiancai
   Zhang, Junsong
   Zhu, Xun
   Liu, Ting
   Li, Mengfeng
   Huang, Xi
   Tao, Liang
   Zhang, Yiwen
   Zhang, Hui
TI Nonsteroidal Anti-inflammatory Drugs Potently Inhibit the Replication of
   Zika Viruses by Inducing the Degradation of AXL
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE AXL; NSAID; ZIKV; ubiquitination
ID SEXUAL TRANSMISSION; INFECTION; HSP90; CELLS; IDENTIFICATION; RECEPTORS;
   MECHANISM; KINASES; BIOLOGY; ENTRY
AB Zika virus (ZIKV) is genetically and biologically related to other Flaviviridae family members and has disseminated to many countries. It is associated with severe consequences, including the abnormal development of the neural system in fetuses and neurological diseases in adults. Therefore, the development of anti-ZIKV drugs is of paramount importance. Screening of generic drugs revealed that several nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin, ibuprofen, naproxen, acetaminophen, and lornoxicam, potently inhibited the entry of Zika virus Env/HIV-1-pseudotyped viruses. They also significantly inhibited the replication of wild-type ZIKV both in cell lines and in primary human fetal endothelial cells. Interestingly, the NSAIDs exerted this inhibitory effect by potently reducing the expression of AXL, the entry cofactor of ZIKV. Further studies showed that the NSAIDs downregulated the prostaglandin E2/prostaglandin E receptor 2 (EP2)/cAMP/protein kinase A (PKA) signaling pathway and reduced PKA-dependent CDC37 phosphorylation and the interaction between CDC37 and HSP90, which subsequently facilitated CHIP/ubiquitination/proteasomemediated AXL degradation. Taken together, our results highlight a new mechanism of action of antiviral agents which may assist in designing a convenient strategy for treating ZIKV-infected patients.
   IMPORTANCE Zika virus (ZIKV) infection, which causes congenital malformations, including microcephaly and other neurological disorders, has attracted global attention. We observed that several NSAIDs significantly inhibited ZIKV infection. Based on our observations, we propose a novel mechanism of action of antiviral compounds which involves the blockade of virus entry via degradation of the entry cofactor. Furthermore, NSAIDs can be practically used for preventing ZIKV infection in pregnant women, as certain NSAIDs, including ibuprofen and acetaminophen, are considered clinically safe.
C1 [Pan, Ting; Peng, Zhilin; Tan, Likai; Zou, Fan; Zhou, Nan; Liu, Bingfeng; Liang, Liting; Chen, Cancan; Liu, Jun; Wu, Liyang; Liu, Guangyan; Peng, Zhiqin; Liu, Weiwei; Ma, Xiancai; Zhang, Junsong; Liu, Ting; Huang, Xi; Zhang, Yiwen; Zhang, Hui] Sun Yet Sen Univ, Inst Human Virol, Guangzhou, Guangdong, Peoples R China.
   [Pan, Ting; Peng, Zhilin; Tan, Likai; Zou, Fan; Zhou, Nan; Liu, Bingfeng; Liang, Liting; Chen, Cancan; Liu, Jun; Wu, Liyang; Liu, Guangyan; Peng, Zhiqin; Liu, Weiwei; Ma, Xiancai; Zhang, Junsong; Zhu, Xun; Liu, Ting; Li, Mengfeng; Huang, Xi; Zhang, Yiwen; Zhang, Hui] Sun Yet Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.
   [Pan, Ting; Peng, Zhilin; Tan, Likai; Zou, Fan; Zhou, Nan; Liu, Bingfeng; Liang, Liting; Chen, Cancan; Liu, Jun; Wu, Liyang; Liu, Guangyan; Peng, Zhiqin; Liu, Weiwei; Ma, Xiancai; Zhang, Junsong; Zhang, Yiwen; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou, Guangdong, Peoples R China.
   [Zhu, Xun; Li, Mengfeng; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.
   [Liu, Ting; Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou, Guangdong, Peoples R China.
   [Tao, Liang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.
RP Zhang, YW; Zhang, H (corresponding author), Sun Yet Sen Univ, Inst Human Virol, Guangzhou, Guangdong, Peoples R China.; Zhang, YW; Zhang, H (corresponding author), Sun Yet Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.; Zhang, YW; Zhang, H (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou, Guangdong, Peoples R China.; Zhang, H (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.
EM zhangyiwen_83@163.com; zhangh92@mail.sysu.edu.cn
OI Ma, Xiancai/0000-0002-4934-4221; Pan, Ting/0000-0002-7106-7312
FU National Special Research Program of China for Important Infectious
   Diseases [2018ZX10302103, 2017ZX10202102]; Important Key Program of the
   Natural Science Foundation of China [81730060]; International
   Collaboration Program of the Natural Science Foundation of China; U.S.
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [81561128007]; Joint-Innovation Program
   in Healthcare for Special Scientific Research Projects of Guangzhou
   [201803040002]; Introduction of Innovative R&D Team Program of Guangdong
   Province [2009010058]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31500740]; Natural
   Science Foundation of GuangdongNational Natural Science Foundation of
   Guangdong Province [2015A030310442]; Science and Technology Planning
   Project of Guangzhou [201704020226]; Pearl River S&T Nova Program of
   Guangzhou [201806010118]; National Science and Technology Major Project
   [2018ZX10101004003001]
FX This work was supported by the National Special Research Program of
   China for Important Infectious Diseases (2018ZX10302103 and
   2017ZX10202102), the Important Key Program of the Natural Science
   Foundation of China (81730060), the International Collaboration Program
   of the Natural Science Foundation of China and the U.S. NIH
   (81561128007), the Joint-Innovation Program in Healthcare for Special
   Scientific Research Projects of Guangzhou (201803040002), and the
   Introduction of Innovative R&D Team Program of Guangdong Province
   (2009010058) to H.Z. This work was also supported by the National
   Natural Science Foundation of China (no. 31500740), the Natural Science
   Foundation of Guangdong (2015A030310442), the Science and Technology
   Planning Project of Guangzhou (201704020226), and the Pearl River S&T
   Nova Program of Guangzhou (201806010118) to T.P. This work was also
   supported by the National Science and Technology Major Project
   (2018ZX10101004003001) to J.Z.
CR Apaja PM, 2014, PHYSIOLOGY, V29, P265, DOI 10.1152/physiol.00058.2013
   Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200
   Birrell MA, 2011, BRIT J PHARMACOL, V164, P1845, DOI 10.1111/j.1476-5381.2011.01494.x
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao Z, 2016, ONCOTARGET, V7, P29864, DOI 10.18632/oncotarget.8219
   Clark P, 2008, J PHARMACOL EXP THER, V325, P425, DOI 10.1124/jpet.107.134510
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eckl JM, 2015, J BIOL CHEM, V290, P30843, DOI 10.1074/jbc.M115.693150
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ganesh K, 2012, J IMMUNOL, V189, P2563, DOI 10.4049/jimmunol.1102762
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   KARNITZ LM, 2007, SCI STKE, V2007, ppe22, DOI DOI 10.1126/STKE.3852007PE22
   Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422
   Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200
   Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X
   Marx J, 2013, ROSENS EMERGENCY MED
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363
   Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang JS, 2016, J VIROL, V90, P3966, DOI 10.1128/JVI.03137-15
   Zhou N, 2016, J BIOL CHEM, V291, P9218, DOI 10.1074/jbc.M116.716100
NR 48
TC 8
Z9 8
U1 2
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2018
VL 92
IS 20
AR UNSP e01018-18
DI 10.1128/JVI.01018-18
PG 18
WC Virology
SC Virology
GA GU9LW
UT WOS:000445668400021
PM 30068645
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Puggioni, G
   Pintus, D
   Melzi, E
   Meloni, G
   Rocchigiani, AM
   Maestrale, C
   Manunta, D
   Savini, G
   Dattena, M
   Oggiano, A
   Palmarini, M
   Ligios, C
AF Puggioni, Giantonella
   Pintus, Davide
   Melzi, Eleonora
   Meloni, Giorgio
   Rocchigiani, Angela Maria
   Maestrale, Caterina
   Manunta, Daniela
   Savini, Giovanni
   Dattena, Maria
   Oggiano, Annalisa
   Palmarini, Massimo
   Ligios, Ciriaco
TI Testicular Degeneration and Infertility following Arbovirus Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE arbovirus; bluetongue virus; infertility; sheep
ID BLUETONGUE VIRUS-INFECTION; EPIZOOTIC HEMORRHAGIC-DISEASE; I INTERFERON;
   ZIKA VIRUS; TESTOSTERONE CONCENTRATIONS; PLASMA TESTOSTERONE; GENOME
   SEGMENT; LEYDIG-CELLS; DENGUE; SPERMATOGENESIS
AB Arboviruses can cause a variety of clinical signs, including febrile illness, arthritis, encephalitis, and hemorrhagic fever. The recent Zika epidemic highlighted the possibility that arboviruses may also negatively affect the male reproductive tract. In this study, we focused on bluetongue virus (BTV), the causative agent of bluetongue and one of the major arboviruses of ruminants. We show that rams that recovered from bluetongue displayed signs of testicular degeneration and azoospermia up to 100 days after the initial infection. Importantly, testicular degeneration was induced in rams experimentally infected with either a high (BTV-1(IT2006))- or a low (BTV-1(IT2013))-virulence strain of BTV. Rams infected with the low-virulence BTV strain displayed testicular lesions in the absence of other major clinical signs. Testicular lesions in BTV-infected rams were due to viral replication in the endothelial cells of the peritubular areas of the testes, resulting in stimulation of a type I interferon response, reduction of testosterone biosynthesis by Leydig cells and destruction of Sertoli cells and the blood-testis barrier in more severe cases. Hence, BTV induces testicular degeneration and disruption of spermatogenesis by replicating solely in the endothelial cells of the peritubular areas unlike other gonadotropic viruses. This study shows that a naturally occurring arboviral disease can cause testicular degeneration and affect male fertility at least temporarily.
   IMPORTANCE During the recent Zika epidemic, it has become apparent that arboviruses could potentially cause reproductive health problems in male patients. Little is known regarding the effects that arboviruses have on the male reproductive tract. Here, we studied bluetongue virus (BTV), an arbovirus of ruminants, and its effects on the testes of rams. We show that BTV was able to induce testicular degeneration in naturally and experimentally infected rams. Testicular degeneration was caused by BTV replication in the endothelial cells of the peritubular area surrounding the seminiferous tubules (the functional unit of the testes) and was associated with a localized type I interferon response, destruction of the cells supporting the developing germinal cells (Sertoli cells), and reduction of testosterone synthesis. As a result of BTV infection, rams became azoospermic. This study highlights that problems in the male reproductive tract caused by arboviruses could be more common than previously thought.
C1 [Puggioni, Giantonella; Pintus, Davide; Meloni, Giorgio; Rocchigiani, Angela Maria; Maestrale, Caterina; Manunta, Daniela; Oggiano, Annalisa; Ligios, Ciriaco] Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy.
   [Melzi, Eleonora; Palmarini, Massimo] Univ Glasgow, Ctr Virus Res, MRC, Glasgow, Lanark, Scotland.
   [Savini, Giovanni] Ist Zooprofilatt Sperimentale Abruzzo & Molise, OIE Reference Lab BTV, Teramo, Italy.
   [Dattena, Maria] AGRIS, Dipartimento Ric Nelle Prod Anim, Olmedo, Italy.
   [Melzi, Eleonora] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA.
RP Ligios, C (corresponding author), Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy.
EM ciriaco.ligios@izs-sardegna.it
OI Puggioni, Giantonella/0000-0001-9013-8203; Melzi,
   Eleonora/0000-0002-1520-735X; Palmarini, Massimo/0000-0001-7007-4070
FU Italian Ministry of HealthMinistry of Health, Italy [RC IZS SA 01/13];
   Wellcome TrustWellcome Trust [206369/Z/17/Z]
FX This study was funded by the Italian Ministry of Health (grant RC IZS SA
   01/13) and by the Wellcome Trust (investigator award 206369/Z/17/Z).
CR Abecia JA, 2017, REPROD DOMEST ANIM, V52, P851, DOI 10.1111/rda.12988
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   BERGH A, 1990, INT J ANDROL, V13, P463, DOI 10.1111/j.1365-2605.1990.tb01053.x
   Bergstein-Galan TG, 2017, THERIOGENOLOGY, V96, P69, DOI 10.1016/j.theriogenology.2017.04.001
   Caporale M, 2014, J VIROL, V88, P10399, DOI 10.1128/JVI.01641-14
   Chauveau E, 2013, J VIROL, V87, P8241, DOI 10.1128/JVI.00678-13
   Chauveau E, 2012, J VIROL, V86, P11789, DOI 10.1128/JVI.00430-12
   Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019
   Coviello AD, 2004, J ANDROL, V25, P931
   Creasy D. M., 2018, FUNDAMENTALS TOXICOL, P459
   Depping R, 2004, BIOL REPROD, V71, P331, DOI 10.1095/biolreprod.104.027797
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106
   Ergun S, 1997, ADV EXP MED BIOL, V424, P163
   Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7
   Fox KA, 2015, J WILDLIFE DIS, V51, P166, DOI 10.7589/2014-03-067
   Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165
   Ge R, 2008, ADV EXP MED BIOL, V636, P255, DOI 10.1007/978-0-387-09597-4_14
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905
   Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957
   Holstein Adolf-Friedrich, 2003, Reprod Biol Endocrinol, V1, P107, DOI 10.1186/1477-7827-1-107
   Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   KATONGOLE CB, 1974, J ENDOCRINOL, V60, P101, DOI 10.1677/joe.0.0600101
   Kirschvink N, 2009, VET J, V182, P244, DOI 10.1016/j.tvjl.2008.06.008
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Goffic R, 2003, J VIROL, V77, P3297, DOI 10.1128/JVI.77.5.3297-3300.2003
   Lelli R., 2003, Veterinaria Italiana, V39, P5
   Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005
   Lorusso A, 2018, INFECT GENET EVOL, V59, P63, DOI 10.1016/j.meegid.2018.01.025
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   MacLachlan NJ, 2008, VET PATHOL, V45, P310, DOI 10.1354/vp.45-3-310
   Maclachlan NJ, 2015, REV SCI TECH OIE, V34, P341, DOI 10.20506/rst.34.2.2361
   Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003
   Maclachlan NJ, 2017, CURR OPIN VIROL, V27, P31, DOI 10.1016/j.coviro.2017.10.002
   Maclachlan NJ, 2011, PREV VET MED, V102, P107, DOI 10.1016/j.prevetmed.2011.04.005
   MACLACHLAN NJ, 1985, AM J VET RES, V46, P1238
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Mellor PS, 2009, BIOL ANIM INFECT, P1
   Melzi E, 2016, P NATL ACAD SCI USA, V113, pE6238, DOI 10.1073/pnas.1610012113
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Muller U, 2010, VET J, V186, P402, DOI 10.1016/j.tvjl.2009.09.017
   Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009
   Nomikou K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005056
   ODonnell L, 1996, BIOL REPROD, V55, P895, DOI 10.1095/biolreprod55.4.895
   OIE, 2014, MANUAL DIAGNOSTIC TE
   OSBURN BI, 1994, COMP IMMUNOL MICROB, V17, P189, DOI 10.1016/0147-9571(94)90042-6
   PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977
   Patel A, 2014, VIRUS RES, V182, P5, DOI 10.1016/j.virusres.2013.12.017
   PURVIS K, 1974, J ENDOCRINOL, V61, P241, DOI 10.1677/joe.0.0610241
   Rasmussen LD, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-75
   Ratinier M, 2016, J VIROL, V90, P5427, DOI 10.1128/JVI.00422-16
   Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   SAMAL SK, 1987, J GEN VIROL, V68, P2319, DOI 10.1099/0022-1317-68-9-2319
   Satie AP, 2011, J BIOL CHEM, V286, P23280, DOI 10.1074/jbc.M111.229120
   Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086
   Shaw AE, 2013, J VIROL, V87, P543, DOI 10.1128/JVI.02266-12
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Sigfrid L, 2018, CLIN MICROBIOL INFEC, V24, P229, DOI 10.1016/j.cmi.2017.05.029
   Slenczka W, 2007, J INFECT DIS, V196, pS131, DOI 10.1086/520551
   Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9
   STOTT JL, 1987, J VIROL, V61, P2670, DOI 10.1128/JVI.61.9.2670-2674.1987
   Ulusoy E, 2004, ARCH ANDROLOGY, V50, P379, DOI 10.1080/01485010490474823
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133
   Vitour D, 2014, VIRUS RES, V182, P59, DOI 10.1016/j.virusres.2013.10.027
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weidemann W, 2002, CARDIOVASC DRUG REV, V20, P175
   Welsh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013632
   Weng Q, 2005, EXP ANIM TOKYO, V54, P451, DOI 10.1538/expanim.54.451
   Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399
   Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38
NR 79
TC 3
Z9 3
U1 2
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2018
VL 92
IS 19
AR e01131-18
DI 10.1128/JVI.01131-18
PG 17
WC Virology
SC Virology
GA GT3VA
UT WOS:000444430700027
PM 30021901
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Sin, SH
   Eason, AB
   Bigi, R
   Kim, Y
   Kang, S
   Tan, K
   Seltzer, TA
   Venkataramanan, R
   An, H
   Dittmer, DP
AF Sin, Sang-Hoon
   Eason, Anthony B.
   Bigi, Rachele
   Kim, Yongbaek
   Kang, Sunah
   Tan, Kelly
   Seltzer, Tischan A.
   Venkataramanan, Raman
   An, Hyowon
   Dittmer, Dirk P.
TI Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells
   Hyperresponsive to Secondary Infections
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE KSHV; Kaposi's sarcoma; mouse model; primary effusion lymphoma;
   rapamycin
ID PRIMARY EFFUSION LYMPHOMA; MULTICENTRIC CASTLEMAN DISEASE; ZIKA
   VIRUS-INFECTION; FC-GAMMA-RIIB; IN-VIVO; NUCLEAR ANTIGEN; IMMUNE
   ACTIVATION; TRANSGENIC MICE; DNA-SEQUENCES; HIV-INFECTION
AB Kaposi's sarcoma-associated herpesvirus (KSHV) induces B cell hyperplasia and neoplasia, such as multicentric Castleman's disease (MCD) and primary effusion lymphoma (PEL). To explore KSHV-induced B cell reprogramming in vivo, we expressed the KSHV latency locus, inclusive of all viral microRNAs (miRNAs), in B cells of transgenic mice in the absence of the inhibitory Fc gamma RIIB receptor. The BALB/c strain was chosen as this is the preferred model to study B cell differentiation. The mice developed hyperglobulinemia, plasmacytosis, and B lymphoid hyperplasia. This phenotype was ameliorated by everolimus, which is a rapamycin derivative used for the treatment of mantle cell lymphoma. KSHV latency mice exhibited hyperresponsiveness to the T-dependent (TD) antigen mimic anti-CD40 and increased incidence of pristane-induced inflammation. Lastly, the adaptive immunity against a secondary infection with Zika virus (ZIKV) was markedly enhanced. These phenotypes are consistent with KSHV lowering the activation threshold of latently infected B cells, which may be beneficial in areas of endemicity, where KSHV is acquired in childhood and infections are common.
   IMPORTANCE Kaposi's sarcoma-associated herpesvirus (KSHV) establishes latency in B cells and is stringently linked to primary effusion lymphoma (PEL) and the premalignant B cell hyperplasia multicentric Castleman's disease (MCD). To investigate potential genetic background effects, we expressed the KSHV miRNAs in BALB/c transgenic mice. BALB/c mice are the preferred strain for B cell hybridoma development because of their propensity to develop predictable B cell responses to antigen. The BALB/c latency mice exhibited a higher incidence of B cell hyperplasia as well as sustained hyperglobulinemia. The development of neutralizing antibodies against ZIKV was augmented in BALB/c latency mice. Hyperglobulinemia was dampened by everolimus, a derivative of rapamycin, suggesting a role for mTOR inhibitors in managing immune activation, which is hallmark of KSHV infection as well as HIV infection.
C1 [Sin, Sang-Hoon; Eason, Anthony B.; Bigi, Rachele; Kang, Sunah; Tan, Kelly; Seltzer, Tischan A.; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Program Global Oncol, Chapel Hill, NC 27515 USA.
   [Sin, Sang-Hoon; Eason, Anthony B.; Bigi, Rachele; Kang, Sunah; Tan, Kelly; Seltzer, Tischan A.; Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Program Virol, Chapel Hill, NC 27515 USA.
   [Sin, Sang-Hoon; Eason, Anthony B.; Bigi, Rachele; Kang, Sunah; Tan, Kelly; Seltzer, Tischan A.; Dittmer, Dirk P.] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27515 USA.
   [Kim, Yongbaek] Seoul Natl Univ, Coll Vet Med, Lab Vet Clin Pathol, Seoul, South Korea.
   [Venkataramanan, Raman] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA.
   [An, Hyowon] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC 27515 USA.
RP Sin, SH (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Program Global Oncol, Chapel Hill, NC 27515 USA.; Sin, SH (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Program Virol, Chapel Hill, NC 27515 USA.; Sin, SH (corresponding author), Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27515 USA.
EM sang-hoon_sin@med.unc.edu
OI Tan, Kelly/0000-0003-4289-3188; Bigi, Rachele/0000-0001-5660-475X;
   dittmer, dirk/0000-0003-4968-5656; Eason, Anthony/0000-0002-6723-7999
FU NCI Center Core Support grant [5P30CA016086-41, CA16086, P30 CA016086];
   NIH Public Health Service grants [P01 CA019014, R01 DE018304]
FX The UNC LCCC Animal Histopathology Core is supported in part by an NCI
   Center Core Support grant (5P30CA016086-41) to the UNC LCCC. The LCCC
   Animal Studies Core is supported in part by an NCI Center Core Support
   grant (CA16086) to the UNC Lineberger Comprehensive Cancer Center. The
   UNC Flow Cytometry Core Facility is supported in part by an NCI Center
   Core Support grant (P30 CA016086) to the UNC LCCC. D.P.D. and S.H.S.
   received support from NIH Public Health Service grants P01 CA019014 and
   R01 DE018304.
CR Anders PM, 2018, J CLIN INVEST, V128, P2519, DOI 10.1172/JCI97053
   ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0
   ANDERSSON J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410
   Ballon G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004581
   Barr TA, 2003, IMMUNOLOGY, V109, P87, DOI 10.1046/j.1365-2567.2003.01634.x
   Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762
   Bergquam EP, 1999, J VIROL, V73, P7874, DOI 10.1128/JVI.73.9.7874-7876.1999
   Boss IW, 2011, J VIROL, V85, P9877, DOI 10.1128/JVI.05558-11
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Bride KL, 2016, BLOOD, V127, P17, DOI 10.1182/blood-2015-07-657981
   Carbone A, 2015, INT J CANCER, V137, P251, DOI 10.1002/ijc.28923
   Carlring J, 2012, BLOOD, V119, P2056, DOI 10.1182/blood-2011-05-355461
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Coleman CB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003916
   COUTINHO A, 1974, J EXP MED, V139, P74, DOI 10.1084/jem.139.1.74
   Damania B, 2000, J VIROL, V74, P2721, DOI 10.1128/JVI.74.6.2721-2730.2000
   de Sanjose S, 2009, J INFECT DIS, V199, P1449, DOI 10.1086/598523
   Dittmer DP, 2016, J CLIN INVEST, V126, P3165, DOI 10.1172/JCI84418
   Fajgenbaum DC, 2017, BLOOD, V129, P1646, DOI 10.1182/blood-2016-10-746933
   Fakhari FD, 2006, J CLIN INVEST, V116, P735, DOI 10.1172/JCI26190
   FEINSTEIN AR, 1956, ANN INTERN MED, V44, P899, DOI 10.7326/0003-4819-44-5-899
   Fernandez D, 2006, ARTHRITIS RHEUM-US, V54, P2983, DOI 10.1002/art.22085
   Getahun A, 2017, J EXP MED, V214, P931, DOI 10.1084/jem.20160972
   GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0
   Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992
   Greenfield EA, 2015, ANTIBODIES LAB MANUA, P201
   Jeong JH, 2002, J VIROL, V76, P11024, DOI 10.1128/JVI.76.21.11024-11032.2002
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Knox TA, 2008, JAIDS-J ACQ IMM DEF, V49, P358, DOI 10.1097/QAI.0b013e31818c7efe
   Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999
   Krown SE, 2012, JAIDS-J ACQ IMM DEF, V59, P447, DOI 10.1097/QAI.0b013e31823e7884
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee BH, 2012, CLIN REV ALLERG IMMU, V42, P35, DOI 10.1007/s12016-011-8288-5
   Li FB, 2014, J IMMUNOL, V192, P3021, DOI 10.4049/jimmunol.1302934
   MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494
   Martin C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170504
   Matar CG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004858
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Mukherjee S, 2009, J TRANSPLANT, V2009, DOI 10.1155/2009/701464
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988
   O'Hara AJ, 2008, BLOOD, V111, P2347, DOI 10.1182/blood-2007-08-104463
   O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8
   Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079
   Polizzotto MN, 2016, CLIN INFECT DIS, V62, P730, DOI 10.1093/cid/civ996
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Prevel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074450
   Reddy SS, 2016, MBIO, V7, DOI 10.1128/mBio.00723-16
   Rekow MM, 2016, VIROLOGY, V492, P140, DOI 10.1016/j.virol.2016.02.022
   Richman LP, 2014, CANCER IMMUNOL RES, V2, P19, DOI 10.1158/2326-6066.CIR-13-0152
   Riva G, 2012, BLOOD, V120, P4150, DOI 10.1182/blood-2012-04-421412
   Roy D, 2013, CANCER RES, V73, P2235, DOI 10.1158/0008-5472.CAN-12-1851
   Salinas E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006865
   SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341
   Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092
   Sin SH, 2016, J VIROL, V90, P2150, DOI 10.1128/JVI.02456-15
   Sin SH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005135
   Sin SH, 2013, J VIROL, V87, P11908, DOI 10.1128/JVI.01620-13
   Sin SH, 2013, BLOOD, V121, P2952, DOI 10.1182/blood-2012-03-415620
   Sin SH, 2010, J VIROL, V84, P10653, DOI 10.1128/JVI.00848-10
   Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07
   Sodhi A, 2006, CANCER CELL, V10, P133, DOI 10.1016/j.ccr.2006.05.026
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831
   Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496
   SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547
   Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0
   Terrell S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006543
   Vogel SN, 1999, J IMMUNOL, V162, P5666
   VOGEL SN, 1994, INFECT IMMUN, V62, P4454, DOI 10.1128/IAI.62.10.4454-4459.1994
   White AL, 2014, CURR TOP MICROBIOL, V382, P355, DOI 10.1007/978-3-319-07911-0_16
   White AL, 2011, J IMMUNOL, V187, P1754, DOI 10.4049/jimmunol.1101135
   Wu SJ, 2009, J CLIN VIROL, V44, P81, DOI 10.1016/j.jcv.2008.08.015
   Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94
   Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429
NR 76
TC 2
Z9 2
U1 1
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD OCT
PY 2018
VL 92
IS 19
AR e01138-18
DI 10.1128/JVI.01138-18
PG 16
WC Virology
SC Virology
GA GT3VA
UT WOS:000444430700028
PM 30021906
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Frantz, PN
   Teeravechyan, S
   Tangy, F
AF Frantz, Phanramphoei N.
   Teeravechyan, Samaporn
   Tangy, Frederic
TI Measles-derived vaccines to prevent emerging viral diseases
SO MICROBES AND INFECTION
LA English
DT Article
DE Measles vector; Emerging diseases; Vaccines
ID RESPIRATORY SYNDROME CORONAVIRUS; ANTIBODY-DEPENDENT ENHANCEMENT;
   CELLULAR IMMUNE-RESPONSES; VIRUS-LIKE PARTICLES; NIPAH VIRUS; ZIKA
   VIRUS; NEUTRALIZING ANTIBODIES; SARS CORONAVIRUS; LETHAL CHALLENGE;
   SECRETED FORM
AB Infectious disease epidemics match wars and natural disasters in their capacity to threaten lives and damage economies. Like SARS previously and Zika recently, the Ebola crisis in 2015 showed how vulnerable the world is to these epidemics, with over 11,000 people dying in the outbreak. In addition to causing immense human suffering, these epidemics particularly affect low- and middle-income countries. Many of these deadly infectious diseases that have epidemic potential can become global health emergencies in the absence of effective vaccines. But very few vaccines against these threats have been developed to create proven medical products. The measles vaccine is an efficient, live attenuated, replicating virus that has been safely administered to 2 billion children over the last 40 years, affording life-long protection after a single dose. Taking advantage of these characteristics, this attenuated virus was transformed into a versatile chimeric or recombinant vaccine vector with demonstrated proof-of-principle in humans and a preclinical track record of rapid adaptability and effectiveness for a variety of pathogens. Clinical trials have shown the safety and immunogenicity of this vaccine platform in individuals with preexisting immunity to measles. This review describes the potential of this platform to develop new vaccines against emerging viral diseases. (C) 2018 Published by Elsevier Masson SAS on behalf of Institut Pasteur.
C1 [Frantz, Phanramphoei N.; Tangy, Frederic] Inst Pasteur, CNRS UMR 3965, Dept Virol, Viral Genom & Vaccinat Unit, Paris, France.
   [Frantz, Phanramphoei N.; Teeravechyan, Samaporn] Natl Sci & Technol Dev Agcy, Virol & Cell Technol Lab, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand.
RP Tangy, F (corresponding author), Inst Pasteur, CNRS UMR 3965, Dept Virol, Viral Genom & Vaccinat Unit, Paris, France.
EM ftangy@pasteur.fr
OI Tangy, Frederic/0000-0002-5937-5654; Teeravechyan,
   Samaporn/0000-0003-0776-9552
FU Institut Pasteur; CNRSCentre National de la Recherche Scientifique
   (CNRS); Marie Sklodowska-Curie fellowship (H2020-MSCA-IF-2015)
FX This work was supported by institutional grants from Institut Pasteur
   and CNRS. Phanramphoei Frantz was supported by a Marie Sklodowska-Curie
   fellowship (H2020-MSCA-IF-2015).
CR Ali R, 2001, EMERG INFECT DIS, V7, P759
   [Anonymous], 2017, ANN REV LIST PRIOR D
   [Anonymous], 2010, ON HLTH APPR CONTR Z
   Bradfute SB, 2008, J IMMUNOL, V180, P4058, DOI 10.4049/jimmunol.180.6.4058
   Brandler S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000096
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Brandler S, 2012, J INFECT DIS, V206, P212, DOI 10.1093/infdis/jis328
   Brandler S, 2010, VACCINE, V28, P6730, DOI 10.1016/j.vaccine.2010.07.073
   Bredenbeek PJ, 2006, VIROLOGY, V345, P299, DOI 10.1016/j.virol.2005.12.001
   Broder CC, 2013, ANTIVIR RES, V100, P8, DOI 10.1016/j.antiviral.2013.06.012
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993
   Cantarella G, 2009, VACCINE, V27, P3385, DOI 10.1016/j.vaccine.2009.01.061
   Combredet C, 2003, J VIROL, V77, P11546, DOI 10.1128/JVI.77.21.11546-11554.2003
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   del Valle JR, 2007, J VIROL, V81, P10597, DOI 10.1128/JVI.00923-07
   Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Escriou N, 2014, VIROLOGY, V452, P32, DOI 10.1016/j.virol.2014.01.002
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Faburay B, 2017, CURRENT STATUS RIFT, P5
   Faburay B, 2014, VECTOR-BORNE ZOONOT, V14, P746, DOI 10.1089/vbz.2014.1650
   FISHERHOCH SP, 1989, P NATL ACAD SCI USA, V86, P317, DOI 10.1073/pnas.86.1.317
   Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082
   Geisbert TW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000225
   Geisbert TW, 2005, PLOS MED, V2, P537, DOI 10.1371/journal.pmed.0020183
   Guerbois M, 2009, VIROLOGY, V388, P191, DOI 10.1016/j.virol.2009.02.047
   Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HARRINGTON DG, 1980, AM J VET RES, V41, P1559
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Homaira N, 2007, EPIDEMIOLOGY INFECT, V138, P1630
   Jahrling PB, 2007, J INFECT DIS, V196, pS400, DOI 10.1086/520587
   Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412
   Kanapathipillai R, 2014, NEW ENGL J MED, V371, P2249, DOI 10.1056/NEJMp1412166
   Ki M, 2015, EPIDEMIOL HLTH, V2015, P37, DOI DOI 10.4178/EPIH/E2015033
   Kieny MP, 2016, LANCET, V388, P460, DOI 10.1016/S0140-6736(16)31152-7
   Le Duc J.W., 2016, VIRAL PATHOGENESIS B, V16, P215
   Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006
   Liniger M, 2008, VACCINE, V26, P2164, DOI 10.1016/j.vaccine.2008.01.057
   Liniger M, 2009, VACCINE, V27, P3299, DOI 10.1016/j.vaccine.2009.01.057
   Lo MK, 2014, ANTIVIR RES, V101, P26, DOI 10.1016/j.antiviral.2013.10.012
   Lorin C, 2005, THERAPIE, V60, P227, DOI 10.2515/therapie:2005029
   Lorin C, 2004, J VIROL, V78, P146, DOI 10.1128/JVI.78.1.146-157.2004
   Lorin C, 2012, N-S ARCH PHARMACOL, V385, P1211, DOI 10.1007/s00210-012-0793-4
   Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15
   Mire CE, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-353
   Mura M, 2017, J VIROL, V91, DOI 10.1128/JVI.00643-17
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Osorio JE, 2015, VACCINE, V33, P7112, DOI 10.1016/j.vaccine.2015.11.022
   Prescott J, 2015, VACCINE, V33, P2823, DOI 10.1016/j.vaccine.2015.03.089
   RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x
   Rahman MA, 2008, VECTOR-BORNE ZOONOT, V2012, P65, DOI DOI 10.1089/VBZ.2011.0656
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   RANDALL RAYMOND, 1962, JOUR IMMUNOL, V89, P660
   Rewar S, 2014, ANN GLOB HEALTH, V80, P444, DOI 10.1016/j.aogh.2015.02.005
   Rezza G, 2015, HUM VACC IMMUNOTHER, V11, P1258, DOI 10.1080/21645515.2015.1021528
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stebbings R, 2013, VACCINE, V31, P6079, DOI 10.1016/j.vaccine.2013.09.072
   Stebbings R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050397
   Tangy F, 2005, VIRAL IMMUNOL, V18, P317, DOI 10.1089/vim.2005.18.317
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06
   WHO, 2017, ZIK SIT REP
   World Bank, 2014, EC IMP 2014 EB EP SH
   Yamaji Y, 2014, VACCINE, V32, P4529, DOI 10.1016/j.vaccine.2014.06.024
   Yoneda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058414
   Zuniga A, 2013, HUM VACC IMMUNOTHER, V9, P607, DOI 10.4161/hv.23242
NR 72
TC 6
Z9 6
U1 5
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD OCT-NOV
PY 2018
VL 20
IS 9-10
BP 493
EP 500
DI 10.1016/j.micinf.2018.01.005
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA HA5ME
UT WOS:000450315700007
PM 29410084
OA Green Published
DA 2020-07-08
ER

PT J
AU Ziv, O
   Gabryelska, MM
   Lun, ATL
   Gebert, LFR
   Sheu-Gruttadauria, J
   Meredith, LW
   Liu, ZY
   Kwok, CK
   Qin, CF
   MacRae, IJ
   Goodfellow, I
   Marioni, JC
   Kudla, G
   Miska, EA
AF Ziv, Omer
   Gabryelska, Marta M.
   Lun, Aaron T. L.
   Gebert, Luca F. R.
   Sheu-Gruttadauria, Jessica
   Meredith, Luke W.
   Liu, Zhong-Yu
   Kwok, Chun Kit
   Qin, Cheng-Feng
   MacRae, Ian J.
   Goodfellow, Ian
   Marioni, John C.
   Kudla, Grzegorz
   Miska, Eric A.
TI COMRADES determines in vivo RNA structures and interactions
SO NATURE METHODS
LA English
DT Article
ID SECONDARY STRUCTURE; DIFFERENTIAL EXPRESSION; READ ALIGNMENT; CODING
   REGION; REVEALS; GENOME; VIRUS; TRANSCRIPTOME; REPLICATION; CYCLIZATION
AB The structural flexibility of RNA underlies fundamental biological processes, but there are no methods for exploring the multiple conformations adopted by RNAs in vivo. We developed cross-linking of matched RNAs and deep sequencing (COMRADES) for in-depth RNA conformation capture, and a pipeline for the retrieval of RNA structural ensembles. Using COMRADES, we determined the architecture of the Zika virus RNA genome inside cells, and identified multiple site-specific interactions with human noncoding RNAs.
C1 [Ziv, Omer; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.
   [Ziv, Omer; Miska, Eric A.] Univ Cambridge, Dept Genet, Cambridge, England.
   [Gabryelska, Marta M.; Kudla, Grzegorz] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.
   [Lun, Aaron T. L.; Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.
   [Gebert, Luca F. R.; Sheu-Gruttadauria, Jessica; MacRae, Ian J.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.
   [Meredith, Luke W.; Goodfellow, Ian] Univ Cambridge, Dept Pathol, Cambridge, England.
   [Liu, Zhong-Yu; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Kwok, Chun Kit] City Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China.
   [Marioni, John C.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England.
   [Marioni, John C.; Miska, Eric A.] Wellcome Sanger Inst, Cambridge, England.
   [Liu, Zhong-Yu] Sun Yat Sen Univ, Sch Med Shenzhen, Guangzhou, Guangdong, Peoples R China.
RP Ziv, O; Miska, EA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England.; Ziv, O; Miska, EA (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.; Kudla, G (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Miska, EA (corresponding author), Wellcome Sanger Inst, Cambridge, England.
EM omer.ziv@gurdon.cam.ac.uk; gkudla@gmail.com; eric.miska@gurdon.cam.ac.uk
RI Qin, Cheng-Feng/I-6839-2019; Lun, Aaron T. L./J-3807-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Lun, Aaron T.
   L./0000-0002-3564-4813; Marioni, John/0000-0001-9092-0852; Gabryelska,
   Marta/0000-0002-4433-282X; Ziv, Omer/0000-0002-3044-5006; Goodfellow,
   Ian/0000-0002-9483-510X; KWOK, Chun Kit/0000-0001-9175-8543; Meredith,
   Luke/0000-0002-3802-8290; Kudla, Grzegorz/0000-0002-7924-2744
FU Cancer Research UKCancer Research UK [C13474/A18583, C6946/A14492,
   A17197]; Wellcome TrustWellcome Trust [104640/Z/14/Z, 092096/Z/10/Z,
   207507, 207498/Z/17/Z]; Human Frontier Science Program (HFSP)Human
   Frontier Science Program [LT000558/2015]; European Molecular Biology
   Organization (EMBO)European Molecular Biology Organization (EMBO)
   [ALTF1622-2014]; Blavatnik Family Foundation; UK Medical Research
   CouncilMedical Research Council UK (MRC); EMBL; NIGMSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM104475, R01GM115649]; City University of Hong KongCity University
   of Hong Kong [9610363, 7200520]; Croucher Foundation [9500030]; Hong
   Kong RGCHong Kong Research Grants Council [9048103, 9054020]; NSFC
   (Excellent Young Scientist Fund) [81522025]; Academy of Medical
   Sciences, UK (Newton Advanced Fellowship)
FX The authors thank A. Kohl (Centre for Virus Research, University of
   Glasgow, Glasgow, UK) and L.J. Pena and R.F. Franca (Fiocruz Recife,
   Pernambuco, Brazil) for providing the PE243 ZIKV RNA used to generate
   the virus stock. We thank Y. Galanty and F.M. Martinez for assisting
   with CRISPR-Cas9 knockout; T.D. Domenico and W. Matsushima for
   collapsing UMIs; G. Sanguinetti for suggesting the RNA-folding strategy;
   A.M. Sharkey and L. Gardner (University of Cambridge, Cambridge, UK) for
   providing the JEG-3 cells; S. Moss for assisting with risk assessment;
   M.S. Diamond, T. Sweeney, A. Firth, D. Jordan, A. Zeisel, and members of
   the Miska group for their comments; and C. Flandoli for illustrations.
   This work was supported by Cancer Research UK (C13474/A18583 and
   C6946/A14492 to E.A.M.; award no. A17197 to J.C.M.), the Wellcome Trust
   (104640/Z/14/Z and 092096/Z/10/Z to E.A.M.; 207507 to G.K. and M.M.G.;
   Senior Fellowship in Basic Biomedical Science 207498/Z/17/Z to I.G.),
   the Human Frontier Science Program (HFSP; LT000558/2015 to O.Z.), the
   European Molecular Biology Organization (EMBO; ALTF1622-2014 to O.Z.),
   the Blavatnik Family Foundation (postdoctoral fellowship to O.Z.), the
   UK Medical Research Council (G. K. and M.M.G.), EMBL (core funding to
   J.C.M.), NIGMS (grants R01GM104475 and R01GM115649 to I.J.M., L.F.R.G.,
   and J.S.-G.), City University of Hong Kong (projects 9610363 and 7200520
   to C.K.K.), the Croucher Foundation (project 9500030 to C. K. K.), the
   Hong Kong RGC (projects 9048103 and 9054020 to C.K.K.), the NSFC
   (Excellent Young Scientist Fund 81522025 to C.-F.Q.), and the Academy of
   Medical Sciences, UK (Newton Advanced Fellowship to C.-F.Q.).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Aw JGA, 2016, MOL CELL, V62, P603, DOI 10.1016/j.molcel.2016.04.028
   Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325
   Guo YE, 2014, MOL CELL BIOL, V34, P3780, DOI 10.1128/MCB.00871-14
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   Kwok CK, 2016, NAT METHODS, V13, P841, DOI 10.1038/nmeth.3965
   Kwok CK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3971
   Lai D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks241
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Liu ZY, 2016, ELIFE, V5, DOI 10.7554/eLife.17636
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lu ZP, 2016, CELL, V165, P1267, DOI 10.1016/j.cell.2016.04.028
   Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19
   Lun ATL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0683-0
   Lun ATL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku351
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1
   Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920
   Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024
   Ramani V, 2015, NAT BIOTECHNOL, V33, P980, DOI 10.1038/nbt.3289
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040
   Sharma E, 2016, MOL CELL, V62, P618, DOI 10.1016/j.molcel.2016.04.030
   Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116
   Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263
   Sugimoto Y, 2015, NATURE, V519, P491, DOI 10.1038/nature14280
   Travis AJ, 2014, METHODS, V65, P263, DOI 10.1016/j.ymeth.2013.10.015
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   Ziv O., PROTOC EXCH
NR 42
TC 20
Z9 22
U1 4
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD OCT
PY 2018
VL 15
IS 10
BP 785
EP +
DI 10.1038/s41592-018-0121-0
PG 7
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA GY7UD
UT WOS:000448820100024
PM 30202058
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Stanelle-Bertram, S
   Walendy-Gnirss, K
   Speiseder, T
   Thiele, S
   Asante, IA
   Dreier, C
   Kouassi, NM
   Preuss, A
   Pilnitz-Stolze, G
   Muller, U
   Thanisch, S
   Richter, M
   Scharrenberg, R
   Kraus, V
   Dork, R
   Schau, L
   Herder, V
   Gerhauser, I
   Pfankuche, VM
   Kaufer, C
   Waltl, I
   Moraes, T
   Sellau, J
   Hoenow, S
   Schmidt-Chanasit, J
   Jansen, S
   Schattling, B
   Ittrich, H
   Bartsch, U
   Renne, T
   Bartenschlager, R
   Arck, P
   Cadar, D
   Friese, MA
   Vapalahti, O
   Lotter, H
   Benites, S
   Rolling, L
   Gabriel, M
   Baumgartner, W
   Morellini, F
   Holter, SM
   Amarie, O
   Fuchs, H
   de Angelis, MH
   Loscher, W
   de Anda, FC
   Gabriel, G
AF Stanelle-Bertram, Stephanie
   Walendy-Gnirss, Kerstin
   Speiseder, Thomas
   Thiele, Swantje
   Asante, Ivy Asantewaa
   Dreier, Carola
   Kouassi, Nancy Mounogou
   Preuss, Annette
   Pilnitz-Stolze, Gundula
   Mueller, Ursula
   Thanisch, Stefanie
   Richter, Melanie
   Scharrenberg, Robin
   Kraus, Vanessa
   Doerk, Ronja
   Schau, Lynn
   Herder, Vanessa
   Gerhauser, Ingo
   Pfankuche, Vanessa Maria
   Kaeufer, Christopher
   Waltl, Inken
   Moraes, Thais
   Sellau, Julie
   Hoenow, Stefan
   Schmidt-Chanasit, Jonas
   Jansen, Stephanie
   Schattling, Benjamin
   Ittrich, Harald
   Bartsch, Udo
   Renne, Thomas
   Bartenschlager, Ralf
   Arck, Petra
   Cadar, Daniel
   Friese, Manuel A.
   Vapalahti, Olli
   Lotter, Hanna
   Benites, Sany
   Rolling, Lane
   Gabriel, Martin
   Baumgaertner, Wolfgang
   Morellini, Fabio
   Hoelter, Sabine M.
   Amarie, Oana
   Fuchs, Helmut
   de Angelis, Martin Hrabe
   Loescher, Wolfgang
   de Anda, Froylan Calderon
   Gabriel, Guelsah
TI Male offspring born to mildly ZIKV-infected mice are at risk of
   developing neurocognitive disorders in adulthood
SO NATURE MICROBIOLOGY
LA English
DT Article
ID MORRIS WATER MAZE; VIRUS-INFECTION; BRAIN; TESTOSTERONE; PREGNANCY;
   LEADS; EXPOSURE; GROWTH
AB Congenital Zika virus (ZIKV) syndrome may cause fetal microcephaly in -1% of affected newborns. Here, we investigate whether the majority of clinically inapparent newborns might suffer from long-term health impairments not readily visible at birth. Infection of immunocompetent pregnant mice with high-dose ZIKV caused severe offspring phenotypes, such as fetal death, as expected. By contrast, low-dose (LD) maternal ZIKV infection resulted in reduced fetal birth weight but no other obvious phenotypes. Male offspring born to LD ZIKV-infected mothers had increased testosterone (TST) levels and were less likely to survive in utero infection compared to their female littermates. Males also presented an increased number of immature neurons in apical and basal hippocampal dendrites, while female offspring had immature neurons in basal dendrites only. Moreover, male offspring with high but not very high (storm) TST levels were more likely to suffer from learning and memory impairments compared to females. Future studies are required to understand the impact of TST on neuropathological and neurocognitive impairments in later life. In summary, increased sex-specific vigilance is required in countries with high ZIKV prevalence, where impaired neurodevelopment may be camouflaged by a healthy appearance at birth.
C1 [Stanelle-Bertram, Stephanie; Walendy-Gnirss, Kerstin; Speiseder, Thomas; Thiele, Swantje; Asante, Ivy Asantewaa; Dreier, Carola; Kouassi, Nancy Mounogou; Preuss, Annette; Pilnitz-Stolze, Gundula; Mueller, Ursula; Thanisch, Stefanie; Gabriel, Guelsah] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.
   [Richter, Melanie; Scharrenberg, Robin; de Anda, Froylan Calderon] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg ZNMH, Neuronal Dev, Hamburg, Germany.
   [Kraus, Vanessa; Doerk, Ronja; Schau, Lynn; Morellini, Fabio] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg ZNMH, Res Grp Behav Biol, Hamburg, Germany.
   [Herder, Vanessa; Gerhauser, Ingo; Pfankuche, Vanessa Maria; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Germany.
   [Herder, Vanessa; Pfankuche, Vanessa Maria; Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany.
   [Kaeufer, Christopher; Waltl, Inken; Loescher, Wolfgang] Univ Vet Med, Dept Pharmacol Toxicol & Pharm, Hannover, Germany.
   [Moraes, Thais; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.
   [Sellau, Julie; Hoenow, Stefan; Schmidt-Chanasit, Jonas; Jansen, Stephanie; Cadar, Daniel; Lotter, Hanna; Gabriel, Martin] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Schmidt-Chanasit, Jonas; Gabriel, Guelsah] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany.
   [Schattling, Benjamin; Friese, Manuel A.] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sclerosis, Hamburg, Germany.
   [Ittrich, Harald] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.
   [Bartsch, Udo] Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany.
   [Renne, Thomas] Univ Med Ctr Hamburg Eppendorf, Inst Clin & Lab Chem, Hamburg, Germany.
   [Arck, Petra] Univ Med Ctr Hamburg Eppendorf, Dept Obstet & Fetal Med, Hamburg, Germany.
   [Vapalahti, Olli] Univ Helsinki, Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki, Finland.
   [Benites, Sany; Rolling, Lane] Trop Pathol & Infect Dis Assoc, Cuzco, Peru.
   [Hoelter, Sabine M.; Amarie, Oana] Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.
   [Hoelter, Sabine M.; Amarie, Oana; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany.
   [de Angelis, Martin Hrabe] Tech Univ Munich, Sch Life Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany.
   [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany.
   [Gabriel, Guelsah] Univ Lubeck, Ctr Struct & Cell Biol Med, Lubeck, Germany.
   [Gabriel, Guelsah] Univ Vet Med, Hannover, Germany.
RP Gabriel, G (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.; Gabriel, G (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany.; Gabriel, G (corresponding author), Univ Lubeck, Ctr Struct & Cell Biol Med, Lubeck, Germany.; Gabriel, G (corresponding author), Univ Vet Med, Hannover, Germany.
EM guelsah.gabriel@leibniz-hpi.de
RI Herder, Vanessa/AAG-6647-2020; Waltl, Inken/N-7537-2019; de Angelis,
   Martin Hrabe/F-5531-2012; Holter-Koch, Sabine/N-5868-2014
OI de Angelis, Martin Hrabe/0000-0002-7898-2353; Herder,
   Vanessa/0000-0003-4814-1382; Sellau, Julie/0000-0001-9921-4823;
   Holter-Koch, Sabine/0000-0003-4878-5241; Calderon de Anda,
   Froylan/0000-0003-2743-7774; Cadar, Daniel/0000-0002-8063-2766;
   Scharrenberg, Robin/0000-0001-7825-894X; Friese, Manuel
   A./0000-0001-6380-2420; Vapalahti, Olli/0000-0003-2270-6824
FU Free and Hanseatic City of Hamburg; Federal Ministry of Health; German
   Research Center for Infection (DZIF); Niedersachsen Research Network on
   Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of
   Lower Saxony, Germany; German Federal Ministry of Education and
   ResearchFederal Ministry of Education & Research (BMBF) [01KX1012];
   Deutsche Forschungsgemeinschaft (DFG) GrantGerman Research Foundation
   (DFG) [FOR 2419, CA1495/1-1, CA 1495/4-1]; ERA-NET Neuron Grant
   (Bundesministerium fur Bildung und Forschung, BMBF) [01EW1410 ZMNH AN
   B1]; Landesforschungsforderung Hamburg (Z-AN LF); University Medical
   Center Hamburg-Eppendorf (UKE); Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [BA 1505/8-1]
FX The Heinrich Pette Institute, Leibniz Institute for Experimental
   Virology is supported by the Free and Hanseatic City of Hamburg and the
   Federal Ministry of Health. This study was supported by the Federal
   Ministry of Health (G.G.), the German Research Center for Infection
   (DZIF) (G.G.), the Niedersachsen Research Network on Neuroinfectiology
   (N-RENNT) of the Ministry of Science and Culture of Lower Saxony,
   Germany (W.B., W.L.) and the German Federal Ministry of Education and
   Research (Infrafrontier grant 01KX1012) (M.H.A.). F.C.d.A. is supported
   by Deutsche Forschungsgemeinschaft (DFG) Grant (FOR 2419, CA1495/1-1 and
   CA 1495/4-1), ERA-NET Neuron Grant (Bundesministerium fur Bildung und
   Forschung, BMBF, 01EW1410 ZMNH AN B1), Landesforschungsforderung Hamburg
   (Z-AN LF) and University Medical Center Hamburg-Eppendorf (UKE). R.B. is
   supported by the Deutsche Forschungsgemeinschaft (BA 1505/8-1). We are
   grateful for the excellent technical contribution of all staff at the
   technology platform small animal models of the Heinrich Pette Institute,
   Leibniz Institute for Experimental Virology, Hamburg and the technical
   staff of the Department of Pathology, University of Veterinary Medicine,
   Hannover. We thank T. Andreas from the Department of Obstetrics and
   Fetal Medicine at the University Medical Center Hamburg-Eppendorf for
   his excellent technical support with the preparation of pregnant mice.
   We thank P. Pruunsild and H. Bading, Department of Neurobiology,
   Interdisciplinary Center for Neurosciences at Heidelberg University for
   providing human NPCs. We thank U. Markert, Department of Obstetrics,
   Placenta-Lab, University Hospital Jena for providing the human placental
   cells.
CR Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489
   Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45
   Barbazanges A, 1996, J NEUROSCI, V16, P3943
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012
   Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133
   Croy B. A., 2014, GUIDE INVESTIGATION
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Engels G, 2017, CELL HOST MICROBE, V21, P321, DOI 10.1016/j.chom.2017.02.020
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Groticke I, 2008, EXP NEUROL, V213, P71, DOI 10.1016/j.expneurol.2008.04.036
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   He S, 2016, J MATERN-FETAL NEO M, V29, P1999, DOI 10.3109/14767058.2015.1072159
   Holter Sabine M, 2015, Curr Protoc Mouse Biol, V5, P331, DOI 10.1002/9780470942390.mo150068
   Holter Sabine M, 2015, Curr Protoc Mouse Biol, V5, P291, DOI 10.1002/9780470942390.mo150010
   Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105
   Leuner B, 2004, MOL NEUROBIOL, V29, P117, DOI 10.1385/MN:29:2:117
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Maliqueo M, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00152
   Manikkam M, 2004, ENDOCRINOLOGY, V145, P790, DOI 10.1210/en.2003-0478
   MEIKLE DB, 1986, J REPROD FERTIL, V78, P587, DOI 10.1530/jrf.0.0780587
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540
   Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34
   Mui AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192435
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Paxinos G., 2012, PAXINOS FRANKLINS MO
   Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541
   Risher WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107591
   RUSSELL PK, 1967, JPN J MED SCI BIOL, VS 20, P103
   Sabuncu MR, 2016, P NATL ACAD SCI USA, V113, pE5749, DOI 10.1073/pnas.1604378113
   Shors TJ, 2002, P NATL ACAD SCI USA, V99, P13955, DOI 10.1073/pnas.202199999
   Solano ME, 2016, PLACENTA, V39, P7, DOI 10.1016/j.placenta.2015.12.017
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9
   Nguyen TV, 2017, PSYCHONEUROENDOCRINO, V76, P206, DOI 10.1016/j.psyneuen.2016.12.005
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 52
TC 5
Z9 5
U1 2
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD OCT
PY 2018
VL 3
IS 10
BP 1161
EP +
DI 10.1038/s41564-018-0236-1
PG 17
WC Microbiology
SC Microbiology
GA GY0RD
UT WOS:000448228400014
PM 30202017
OA Green Published
DA 2020-07-08
ER

PT J
AU Kading, RC
   Golnar, AJ
   Hamer, SA
   Hamer, GL
AF Kading, Rebekah C.
   Golnar, Andrew J.
   Hamer, Sarah A.
   Hamer, Gabriel L.
TI Advanced surveillance and preparedness to meet a new era of invasive
   vectors and emerging vector-borne diseases
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; VALLEY FEVER VIRUS; UNITED-STATES; ZIKA; SPREAD; RISK;
   OUTBREAK; LESSONS; TICKS; EBOLA
C1 [Kading, Rebekah C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Golnar, Andrew J.; Hamer, Gabriel L.] Texas A&M Univ, Coll Agr & Life Sci, Dept Entomol, College Stn, TX USA.
   [Hamer, Sarah A.] Texas A&M Univ, Coll Vet Med & Biomed Sci, College Stn, TX USA.
RP Kading, RC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM rebekah.kading@colostate.edu
FU Department of Homeland Security (DHS) Science and Technology Directorate
   (ST)United States Department of Homeland Security (DHS)
   [HSHQDC-17-C-B0003]
FX All authors were supported by the Department of Homeland Security (DHS)
   Science and Technology Directorate (S&T) under agreement
   #HSHQDC-17-C-B0003. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barker CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002515
   Bell BP, 2016, MMWR-MORBID MORTAL W, V65, P4, DOI 10.15585/mmwr.su6503a2
   Burkle FM, 2016, DISASTER MED PUBLIC, V10, P296, DOI 10.1017/dmp.2016.27
   Cabezas-Cruz A, 2018, MICROBES INFECT, V20, P441, DOI 10.1016/j.micinf.2017.12.015
   Centers for Disease Control, 2018, TYP ZIK VIR TESTS
   Centers for Disease Control (CDC), 2014, ENH EB SCREEN START
   Cohen EB, 2015, APPL ENVIRON MICROB, V81, P8366, DOI 10.1128/AEM.02656-15
   Defense Advanced Research Projects Agency (DARPA), 2018, PREV EM PATH THREATS
   Department of Homeland Security (DHS), 2014, PHILL CBP INT 2 1 NA
   Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092
   Global Health Security Agenda, IMPL GLOB HLTH SEC A
   Golnar AJ, 2018, TRANSBOUND EMERG DIS, V65, P85, DOI 10.1111/tbed.12608
   Golnar AJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003163
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hadler JL, 2014, MMWR-MORBID MORTAL W, V63, P281
   Hamer GL, 2016, J MED ENTOMOL, V53, P485, DOI 10.1093/jme/tjw020
   Hoffman SJ, 2018, AM J PUBLIC HEALTH, V108, P329, DOI [10.2105/ajph.2017.304245, 10.2105/AJPH.2017.304245]
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Kanawha County Farm Bureau, 2018, DISC DANG NONN TICK
   Keirans JE, 2001, J MED ENTOMOL, V38, P850, DOI 10.1603/0022-2585-38.6.850
   Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   MOORE CG, 1988, J AM MOSQUITO CONTR, V4, P356
   Oliveira ARS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2354-7
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pellerin C., 2016, DOD NEWS        0310
   Peterson AT, 2015, J VECTOR ECOL, V40, P191, DOI 10.1111/jvec.12151
   Peyton EL, 1999, J AM MOSQUITO CONTR, V15, P238
   Salyer SJ, 2017, EMERG INFECT DIS, V23, pS57, DOI 10.3201/eid2313.170418
   Schaffner F., 2012, GUIDELINES SURVEILLA
   Schlegelmilch J, J BUSINESS CONTINUIT, V9, P112
   Sifferlin A., 2018, TIME MAGAZINE
   Smith KM, 2017, VET MED SCI, V3, P71, DOI 10.1002/vms3.57
   Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007
   US Department of Transportation (USDOT), 2017, AIRCR DIS REQ
   USAID (U. S. Agency for International Development), 2016, EM PAND THREATS
   Winters AM, 2008, AM J TROP MED HYG, V78, P654, DOI 10.4269/ajtmh.2008.78.654
NR 37
TC 1
Z9 1
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006761
DI 10.1371/journal.pntd.0006761
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100025
PM 30359392
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, WR
   Soares-da-Silva, J
   Ferreira, FAD
   Rodrigues, B
   Tadei, WP
   Zequi, JAC
AF da Silva, William Ribeiro
   Soares-da-Silva, Joelma
   da Silva Ferreira, Francisco Augusto
   Rodrigues, Brandao
   Tadei, Wanderli Pedro
   Cyrino Zequi, Joao Antonio
TI Oviposition of Aedes aegypti Linnaeus, 1762 and Aedes albopictus Skuse,
   1894 (Diptera: Culicidae) under laboratory and field conditions using
   ovitraps associated to different control agents, Manaus, Amazonas,
   Brazil
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Chikungunya; Control; Dengue; Insecticides; Zika
ID THURINGIENSIS VAR. ISRAELENSIS; BACILLUS-THURINGIENSIS;
   CULEX-QUINQUEFASCIATUS; LETHAL OVITRAP; DENGUE VECTORS; UNITED-STATES;
   MOSQUITO; SPINOSAD; RESISTANCE; INFUSIONS
AB The aim of this study was to analyze the effectiveness of different control agents of Aedes aegypti and Aedes albopictus associated with ovitraps under laboratory and field conditions. Five treatments were used: grass infusion +Bacillus thuringiensis israelensis (gI + Bti), grass infusion +Saccharopolyspora spinosa (gI + Ss), grass infusion + Pyriproxyfen (gI + P), distilled water + Toxorhynchites haemorrhoidalis (dW + Th), and grass infusion (gI) (control). The highest mean number of eggs of both species were obtained with grass infusion in the laboratory. Among control agents, the lowest mean of A. aegypti eggs occurred with gI + Ss and the lowest mean of A. albopictus eggs occurred with dW + Th. There was no difference between treatments in A. aegypti (P= 0.4320) and A. albopictus (P= 0.7179). In the field, the highest mean number of eggs for both species were obtained with gI + Ss, and the lowest values were obtained with gI + P (P= 0.0124). The treatments can be applied to both the surveillance and the control, but ovitraps with biological larvicide Bti were more effective and safer considering the number of eggs laid and selectivity of pathogens for mosquitoes. (C) 2018 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [da Silva, William Ribeiro; da Silva Ferreira, Francisco Augusto; Rodrigues, Brandao; Tadei, Wanderli Pedro] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Entomol, Lab Controle Biol & Biotecnol Malaria & Dengue, Manaus, AM, Brazil.
   [Soares-da-Silva, Joelma] Univ Fed Maranhao, Curso Ciencias Nat, Campus 7, Maranhao, MA, Brazil.
   [Cyrino Zequi, Joao Antonio] Univ Estadual Londrina, Dept Biol Anim & Vegetal, Lab Entomol Med, Londrina, PR, Brazil.
RP Zequi, JAC (corresponding author), Univ Estadual Londrina, Dept Biol Anim & Vegetal, Lab Entomol Med, Londrina, PR, Brazil.
EM joaozequi@gmail.com
RI Tadei, Wanderli/N-4486-2018
OI Tadei, Wanderli/0000-0002-0612-3285
FU Laboratory of Biological Control and Biotechnology of Malaria and Dengue
   of the National Institute of Research of the Amazon; Foundation for
   Research Support of the State of Amazonas; National Council for the
   Scientific and Technological DevelopmentNational Council for Scientific
   and Technological Development (CNPq)
FX The authors thank the team of the Laboratory of Biological Control and
   Biotechnology of Malaria and Dengue of the National Institute of
   Research of the Amazon, Foundation for Research Support of the State of
   Amazonas, and National Council for the Scientific and Technological
   Development for their financial support.
CR Alahmed Azzam Mohammed, 2012, Journal of King Saud University Science, V24, P55, DOI 10.1016/j.jksus.2010.12.001
   Allan SA, 1995, J CHEM ECOL, V21, P1847, DOI 10.1007/BF02033681
   Avendanha J, 2007, MINAS GERAIS REV I A, V66, P207
   BAILEY DL, 1983, MOSQ NEWS, V43, P33
   Beech CJ, 2009, ASIA PAC J MOL BIOL, V17, P99
   Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x
   Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrieri M, 2009, J AM MOSQUITO CONTR, V25, P149, DOI 10.2987/08-5852.1
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Cetin H, 2005, J VECTOR ECOL, V30, P151
   CHADEE DD, 1990, ENTOMOL EXP APPL, V57, P295, DOI 10.1007/BF00355029
   Chism BD, 2003, MED VET ENTOMOL, V17, P211, DOI 10.1046/j.1365-2915.2003.00433.x
   Claro Depoli Priscila Aparecida, 2016, EntomoBrasilis, V9, P51, DOI 10.12741/ebrasilis.v9i1.509
   Clements A.N, 1999, BIOL MOSQUITOES DEV
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Ferreira FAD, 2015, REV BRAS ENTOMOL, V59, P234, DOI 10.1016/j.rbe.2015.03.013
   da Silva VC, 2006, REV SAUDE PUBL, V40, P1106, DOI [10.1590/S0034-89102006000700021, 10.1590/s0034-89102006000700021]
   Darbro JM, 2011, BIOCONTROL SCI TECHN, V21, P1027, DOI 10.1080/09583157.2011.597913
   Dias LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173689
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Fischer S, 2017, B ENTOMOL RES, V107, P225, DOI [10.1017/s0007485316000869, 10.1017/S0007485316000869]
   FORATTINI O.P., 2002, CULICIDOLOGIA MEDICA
   GILL SS, 1995, MEM I OSWALDO CRUZ, V90, P69, DOI 10.1590/S0074-02761995000100016
   Gomes A. C., 2002, INFORM EPIDEMIOLOGIC, V11, P79
   GOMES AC, 1998, INF EPIDEMIOL SUS, V7, P49
   Gubler D, 2005, REV PANAM SALUD PUBL, V17, P221
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Jahan N, 2013, PAK J ZOOL, V45, P305
   Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146
   Koeppen N.W, 1948, CLIMATOLOGIA COM EST
   Leon W., 2001, REV PERU MED EXP SAL, V18, P77
   Lopes Jose, 1999, Revista Brasileira de Zoologia, V16, P821, DOI 10.1590/S0101-81751999000300018
   Marina CF, 2011, PEST MANAG SCI, V67, P114, DOI [10.1002/ps.2043, 10.1002/pros.21278]
   Martins VP, 2013, ENTOMOTROPICA, V28, P75
   Medeiros E. D. S., 2013, AFR J BIOTECHNOL, V12, P836
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Moulton JK, 2000, PEST MANAG SCI, V56, P842, DOI 10.1002/1526-4998(200010)56:10<842::AID-PS212>3.0.CO;2-H
   Nunes LS, 2011, BIOTA AMAZONIA, V1, P26
   Alarcon EP, 2014, BIOMEDICA, V34, P409, DOI [10.7705/biomedica.v34i3.2134, 10.1590/S0120-41572014000300011]
   Calvo EP, 2016, BIOMEDICA, V36, P35, DOI 10.7705/biomedica.v36i0.2982
   Perich MJ, 2003, MED VET ENTOMOL, V17, P205, DOI 10.1046/j.1365-2915.2003.00427.x
   Phasomkusolsil S, 2014, SE ASIAN J TROP MED, V45, P40
   PINHEIRO Valéria Cristina Soares, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P245, DOI 10.1590/S0036-46652002000500002
   Quiroz-Martinez H, 2012, J AM MOSQUITO CONTR, V28, P47, DOI 10.2987/11-6175.1
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Regis LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067682
   Rehan A, 2014, CROP PROT, V56, P10, DOI 10.1016/j.cropro.2013.10.013
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Rinkevich FD, 2009, INSECT MOL BIOL, V18, P233, DOI 10.1111/j.1365-2583.2009.00873.x
   Rossati Antonella, 2015, Recenti Progressi in Medicina, V106, P125, DOI 10.1701/1806.19702
   Sant'ana AL, 2006, J MED ENTOMOL, V43, P214, DOI 10.1603/0022-2585(2006)043[0214:COGIAO]2.0.CO;2
   Santos Roseli La Corte dos, 2003, Rev. Saúde Pública, V37, P671, DOI 10.1590/s0034-89102003000500019
   Soares-da-Silva J, 2017, ACTA TROP, V176, P197, DOI 10.1016/j.actatropica.2017.08.006
   Soares-da-Silva J, 2012, REV SOC BRAS MED TRO, V45, P174, DOI 10.1590/S0037-86822012000200007
   Soares-da-Silvaa J, 2015, REV BRAS ENTOMOL, V59, P1, DOI 10.1016/j.rbe.2015.02.001
   Solis-Valdez CB, 2015, SOUTHWEST ENTOMOL, V40, P575, DOI 10.3958/059.040.0316
   Stoops CA, 2005, J VECTOR ECOL, V30, P41
   Su TY, 2014, J MED ENTOMOL, V51, P421, DOI 10.1603/ME13173
   Su TY, 2014, J MED ENTOMOL, V51, P428, DOI 10.1603/ME13207
   Su TY, 2012, J AM MOSQUITO CONTR, V28, P263, DOI 10.2987/12-6245R.1
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   WHO (World Health Organization), 1984, TDRBCVSWG7843 WHO, P33
   WRBU, 2018, MOSQ ID RES
   ZEQUI JAC, 2015, INT J MOSQ RES A, V2, P5
NR 67
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD OCT-DEC
PY 2018
VL 62
IS 4
BP 304
EP 310
DI 10.1016/j.rbe.2018.08.001
PG 7
WC Entomology
SC Entomology
GA HC6PJ
UT WOS:000451923500009
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hagen, L
   Keller, T
   Neely, S
   DePaula, N
   Robert-Cooperman, C
AF Hagen, Loni
   Keller, Thomas
   Neely, Stephen
   DePaula, Nic
   Robert-Cooperman, Claudia
TI Crisis Communications in the Age of Social Media: A Network Analysis of
   Zika-Related Tweets
SO SOCIAL SCIENCE COMPUTER REVIEW
LA English
DT Article
DE Zika; health emergency management; social network analysis; Twitter;
   crisis informatics
ID TWITTER; MANAGEMENT; COMMUNITY
AB While emerging technologies such as social media have demonstrated value for crisis communications, significant question remains regarding how these tools can be most effectively leveraged to facilitate the flow of valid information under crisis conditions. In an effort to address these issues, this article examines the use of Twitter during the 2015-2016 Zika virus outbreak in the United States. Particular attention is paid to network structures within the Zika conversation and how different actors and communities contribute to the flow of information throughout the broader Twitter community. Public-facing organizations can benefit from a deeper understanding of the nature and structure of spontaneously occurring communities on social media as well as the types of content that they create and circulate. As such, these findings have significant implications for the development of effective social media strategies during natural disasters and public health emergencies. In particular, this analysis identifies several predominant themes communicated through Zika-related tweets as well as a number of distinct communities and influential actors. The findings suggest that respected political actors, public institutions, as well as those with valid scientific credentials can help to facilitate the flow of accurate and vital information across disparate communities.
C1 [Hagen, Loni] Univ S Florida, Sch Information, Tampa, FL USA.
   [Neely, Stephen] Univ S Florida, Sch Publ Affairs, Tampa, FL USA.
   [Robert-Cooperman, Claudia] Univ S Florida, Hlth Sci Program, Tampa, FL USA.
   [Keller, Thomas] Georgia Inst Technol, Atlanta, GA 30332 USA.
   [DePaula, Nic] SUNY Albany, Albany, NY 12222 USA.
RP Hagen, L (corresponding author), Univ S Florida, 4202 E Fowler Ave CIS2031, Tampa, FL 33620 USA.
EM lonihagen@usf.edu
OI DePaula, Nicolau/0000-0001-5467-8480
CR Acar Adam, 2011, International Journal of Web Based Communities, V7, P392, DOI 10.1504/IJWBC.2011.041206
   American Red Cross, 2012, SOC MED DIS EM
   [Anonymous], 2013, CBS NEWS
   Barbera P, 2015, PSYCHOL SCI, V26, P1531, DOI 10.1177/0956797615594620
   Barbera P, 2015, POLIT ANAL, V23, P76, DOI 10.1093/pan/mpu011
   Bastian M., 2009, P INT AAAI C WEBL SO, V8, P361, DOI DOI 10.1136/QSHC.2004.010033
   Bernier S., 2013, SOCIAL MEDIA DISASTE
   Bird D, 2012, AUST J EMERG MANAG, V27, P27
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002
   Borgatti SP, 2011, SAGE HDB SOCIAL NETW, P417, DOI DOI 10.4135/9781446294413.N28
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249
   Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X
   Burke M, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P945
   Canright Geoffrey S., 2006, ComPlexUs, V3, P131, DOI 10.1159/000094195
   Caverlee James, 2008, Joint Conference on Digital Libraries (JCDL 2008), P104, DOI 10.1145/1378889.1378908
   Choi S, 2014, NEW MEDIA SOC, V16, P129, DOI 10.1177/1461444813487956
   Conover M. D., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P192, DOI 10.1109/PASSAT/SocialCom.2011.34
   Conrado SP, 2016, J DECIS SYST, V25, P171, DOI 10.1080/12460125.2016.1187396
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Dapena K., 2017, DAILY FLORIDA ZIKA V
   Easley David, 2010, NETWORKS CROWDS MARK
   Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002
   Franceschet M, 2011, COMMUN ACM, V54, P92, DOI 10.1145/1953122.1953146
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Gimenez-Garca J. M., 2016, PROFILES 2016 3 INT
   Golbeck J, 2013, ANAL SOCIAL WEB
   Gottfried J., 2016, NEWS USE SOCIAL MEDI
   Graham MW, 2015, PUBLIC RELAT REV, V41, P386, DOI 10.1016/j.pubrev.2015.02.001
   Groshek J, 2013, SOC SCI COMPUT REV, V31, P563, DOI 10.1177/0894439313490401
   Guskin E, 2012, HURRICANE SANDY TWIT
   Henn S., 2013, SOCIAL MEDIAS RUSH J
   Hitlin P., 2016, HLTH ISSUES TOPPED L
   Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092
   Hughes A. L., 2008, P 5 INT ISRAM C CIT
   Hughes AL, 2012, J HOMEL SECUR EMERG, V9
   Hughes AL, 2015, J HOMEL SECUR EMERG, V12, P679, DOI 10.1515/jhsem-2014-0080
   Hughes AL, 2009, INT J EMERG MANAG, V6, P248, DOI 10.1504/IJEM.2009.031564
   Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679
   Jin Y, 2014, COMMUN RES, V41, P74, DOI 10.1177/0093650211423918
   Kapucu N, 2010, DISASTER PREV MANAG, V19, P452, DOI 10.1108/09653561011070376
   Kim KS, 2014, J ACAD LIBR, V40, P171, DOI 10.1016/j.acalib.2014.03.001
   Krippendorff K., 2012, CONTENT ANAL INTRO I
   Lachlan KA, 2016, COMPUT HUM BEHAV, V54, P647, DOI 10.1016/j.chb.2015.05.027
   Latonero M., 2011, INT J INFORM SYSTEMS, V3, P1, DOI DOI 10.4018/JISCRM.2011100101
   Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225
   Madden M., 2011, 65 ONLINE ADULTUSE
   McSweeney P. J, 2009, GEPHI NETWORK STAT
   Mendoza M., 2010, P 1 WORKSH SOC MED A, V10, P71, DOI DOI 10.1145/1964858.1964869
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Mergel Ines, 2012, Information Polity, V17, P281, DOI 10.3233/IP-2012-000281
   Mitchell A, 2013, TWITTER NEWS CONSUME
   Nelson L. D., 2009, ELECT NEWS, V3, P176, DOI DOI 10.1080/19312430903300046
   Newman M, 2008, MATH NETWORKS
   Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103
   Palen L, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P727
   Pechta LE, 2010, J HOMEL SECUR EMERG, V7
   Perrin A., 2015, SOCIAL MEDIA USAGE 2
   R Core Team, 2015, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rene P. L., 2016, PA TIMES
   Rogers E. M., 1995, DIFFUSION INNOVATION
   Simon T, 2015, INT J INFORM MANAGE, V35, P609, DOI 10.1016/j.ijinfomgt.2015.07.001
   Simon T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104136
   Smith M., 2014, MAPPING TWITTER TOPI
   Spence P. R., 2005, LESSONS LEARNED PROT, P70
   Starbird K, 2015, HUM ECOL RISK ASSESS, V21, P605, DOI 10.1080/10807039.2014.947866
   Steelman TA, 2014, ADMIN SOC, V46, P707, DOI 10.1177/0095399712469198
   Stewart MC, 2016, COMPUT HUM BEHAV, V54, P639, DOI 10.1016/j.chb.2015.07.009
   Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242
   Cool CT, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/WPSAR.2015.6.2.HYN_013, 10.5365/wpsar.2015.6.2.HYN_013]
   Webb H, 2016, ACM T INFORM SYST, V34, DOI 10.1145/2893478
   Whelan E, 2013, INFORM SYST J, V23, P197, DOI 10.1111/j.1365-2575.2011.00384.x
   Xu WW, 2015, QUAL QUANT, V49, P1361, DOI 10.1007/s11135-014-0051-6
   Yates D, 2011, INT J INFORM MANAGE, V31, P6, DOI 10.1016/j.ijinfomgt.2010.10.001
   Yoo E, 2016, J OPER MANAG, V45, P123, DOI 10.1016/j.jom.2016.05.007
   Yun GW, 2016, INT J MED INFORM, V91, P67, DOI 10.1016/j.ijmedinf.2016.04.009
NR 79
TC 9
Z9 9
U1 17
U2 58
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0894-4393
EI 1552-8286
J9 SOC SCI COMPUT REV
JI Soc. Sci. Comput. Rev.
PD OCT
PY 2018
VL 36
IS 5
BP 523
EP 541
DI 10.1177/0894439317721985
PG 19
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science; Social Sciences, Interdisciplinary
SC Computer Science; Information Science & Library Science; Social Sciences
   - Other Topics
GA GT4SS
UT WOS:000444495100002
DA 2020-07-08
ER

PT J
AU Mercorelli, B
   Palu, G
   Loregian, A
AF Mercorelli, Beatrice
   Palu, Giorgio
   Loregian, Arianna
TI Drug Repurposing for Viral Infectious Diseases: How Far Are We?
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID EAST RESPIRATORY SYNDROME; ZIKA VIRUS-INFECTION; BROAD-SPECTRUM
   ANTIVIRALS; SMALL-MOLECULE INHIBITORS; STRUCTURE-BASED DISCOVERY;
   FDA-APPROVED DRUGS; EBOLA-VIRUS; SYNDROME CORONAVIRUS; DENGUE VIRUS;
   INFLUENZA-A
AB Despite the recent advances in controlling some viral pathogens, most viral infections still lack specific treatment. Indeed, the need for effective therapeutic strategies to combat 'old', emergent, and re-emergent viruses is not paralleled by the approval of new antivirals. In the past years, drug repurposing combined with innovative approaches for drug validation, and with appropriate animal models, significantly contributed to the identification of new antiviral molecules and targets for therapeutic intervention. In this review, we describe the main strategies of drug repurposing in antiviral discovery, discuss the most promising candidates that could be repurposed to treat viral infections, and analyze the possible caveats of this trendy strategy of drug discovery.
C1 [Mercorelli, Beatrice; Palu, Giorgio; Loregian, Arianna] Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
RP Loregian, A (corresponding author), Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
EM arianna.loregian@unipd.it
OI LOREGIAN, ARIANNA/0000-0002-8900-861X
FU University of Padua [PDA141311]; Associazione Italiana per la Ricerca
   sul Cancro (AIRC)Associazione Italiana per la Ricerca sul Cancro (AIRC)
   [IG 18855]
FX The research in our laboratory was supported by the University of Padua
   (Progetto di Ricerca di Ateneo 2014, grant PDA141311 to A.L.; STARS-CoG
   'FINDER' to B.M.) and Associazione Italiana per la Ricerca sul Cancro
   (AIRC, grant no. IG 18855).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
   Arend KC, 2017, MOL CELL PROTEOMICS, V16, pS263, DOI 10.1074/mcp.M116.065375
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Bao J, 2016, ANGEW CHEM INT EDIT, V55, P3438, DOI 10.1002/anie.201511361
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bixler Sandra L, 2017, Curr Treat Options Infect Dis, V9, P299, DOI 10.1007/s40506-017-0130-z
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Coleman CM, 2016, J VIROL, V90, P8924, DOI 10.1128/JVI.01429-16
   Colson P, 2016, INT J ANTIMICROB AG, V48, P349, DOI 10.1016/j.ijantimicag.2016.07.004
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Coussens NP, 2017, PHARMACOL REV, V69, P479, DOI 10.1124/pr.117.013755
   de Wilde AH, 2017, VIRUS RES, V228, P7, DOI 10.1016/j.virusres.2016.11.011
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Droebner K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02130
   Dyall J, 2017, DRUGS, V77, P1935, DOI 10.1007/s40265-017-0830-1
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Gardner TJ, 2015, ANTIVIR RES, V113, P49, DOI 10.1016/j.antiviral.2014.10.011
   Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107
   Haffizulla J, 2014, LANCET INFECT DIS, V14, P609, DOI 10.1016/S1473-3099(14)70717-0
   Hampson L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147917
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Hu YM, 2017, ANTIVIR RES, V145, P103, DOI 10.1016/j.antiviral.2017.07.016
   Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862
   Hung IFN, 2017, CHEST, V151, P1069, DOI 10.1016/j.chest.2016.11.012
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Jones LH, 2017, NAT REV DRUG DISCOV, V16, P285, DOI 10.1038/nrd.2016.244
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kapoor A, 2012, ANTIMICROB AGENTS CH, V56, P4891, DOI 10.1128/AAC.00898-12
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lai JH, 2017, BIOCHEM PHARMACOL, V129, P14, DOI 10.1016/j.bcp.2017.01.005
   Lejal N, 2013, ANTIMICROB AGENTS CH, V57, P2231, DOI 10.1128/AAC.02335-12
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liu GD, 2017, TRENDS MOL MED, V23, P820, DOI 10.1016/j.molmed.2017.07.002
   Loregian A, 2014, CELL MOL LIFE SCI, V71, P3659, DOI 10.1007/s00018-014-1615-2
   Loregian A, 2013, TRENDS MICROBIOL, V21, P261, DOI 10.1016/j.tim.2013.03.006
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   McKimm-Breschkin JL, 2018, ANTIVIR RES, V149, P118, DOI 10.1016/j.antiviral.2017.11.013
   Mercorelli B, 2018, ANTIVIR RES, V150, P130, DOI 10.1016/j.antiviral.2017.12.014
   Mercorelli B, 2016, CELL CHEM BIOL, V23, P340, DOI 10.1016/j.chembiol.2015.12.012
   Mercorelli B, 2011, PHARMACOL THERAPEUT, V131, P309, DOI 10.1016/j.pharmthera.2011.04.007
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mukhopadhyay R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005717
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107
   Ponroy N, 2015, J MED VIROL, V87, P141, DOI 10.1002/jmv.23998
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Salata C, 2015, PATHOG DIS, V71, P280
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Strating JRPM, 2015, CELL REP, V10, P600, DOI 10.1016/j.celrep.2014.12.054
   Strittmatter SM, 2014, NAT MED, V20, P590, DOI 10.1038/nm.3595
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015
   Sweiti H, 2017, CURR THER RES CLIN E, V84, P10, DOI 10.1016/j.curtheres.2017.01.007
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   van de Klundert MAA, 2016, J VIRAL HEPATITIS, V23, P191, DOI 10.1111/jvh.12479
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Wang YZ, 2016, ANTIVIR RES, V125, P1, DOI 10.1016/j.antiviral.2015.11.003
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yan ZP, 2014, MBIO, V5, DOI 10.1128/mBio.01318-14
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zheng W, 2018, BRIT J PHARMACOL, V175, P181, DOI 10.1111/bph.13895
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 75
TC 33
Z9 33
U1 14
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD OCT
PY 2018
VL 26
IS 10
BP 865
EP 876
DI 10.1016/j.tim.2018.04.004
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GT9BX
UT WOS:000444835500007
PM 29759926
OA Green Published
DA 2020-07-08
ER

PT J
AU Rossi, SL
   Ebel, GD
   Shan, C
   Shi, PY
   Vasilakis, N
AF Rossi, Shannan L.
   Ebel, Gregory D.
   Shan, Chao
   Shi, Pei-Yong
   Vasilakis, Nikos
TI Did Zika Virus Mutate to Cause Severe Outbreaks?
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID SEXUAL TRANSMISSION; BORNE TRANSMISSION; SINGLE MUTATION; NEW-YORK;
   EMERGENCE; AMERICA; ENHANCEMENT; COMPETENCE; INFECTION; AFRICAN
AB Zika virus (ZIKV) has challenged the assumed knowledge regarding the pathobiology of flaviviruses. Despite causing sporadic and mild disease in the 50 years since its discovery, Zika virus has now caused multiple outbreaks in dozens of countries worldwide. Moreover, the disease severity in recent outbreaks, with neurological disease in adult and devastating congenital malformations in fetuses, was not previously seen. One hypothesis is that the virus has acquired mutations that have increased its virulence. Indeed, mutations in other arboviruses, such as West Nile virus (WNV), chikungunya virus (CHIKV), and Venezuelan equine encephalitis virus (VEEV), have enhanced outbreaks. This possibility, as well as alternative hypotheses, are explored here.
C1 [Rossi, Shannan L.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
RP Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Rossi, SL (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM slrossi@utmb.edu
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U01 AI115577,
   AI067380, AI125996]; Joint Vaccine Accquisition Program
   [W911QY-15-1-0014]; CDC grant for the Western Gulf Center of Excellence
   for Vector-Borne Diseases; Kleberg Foundation Award; UTMB
   [CTSAUL1TR-001439]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI127744]
FX We kindly thank Christopher Roundy for his proofreading help. This work
   was supported in part by the US National Institutes of Health grants U01
   AI115577 for NV, AI067380 and AI125996 for GDE, and the Joint Vaccine
   Accquisition ProgramW911QY-15-1-0014 for SR. P-YS and CS were supported
   by a CDC grant for the Western Gulf Center of Excellence for
   Vector-Borne Diseases, Kleberg Foundation Award, UTMB CTSAUL1TR-001439,
   and NIH grant AI127744.
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2002, J VIROL, V76, P1718, DOI 10.1128/JVI.76.4.1718-1730.2002
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P1260, DOI 10.3201/eid2308.170479
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lourenco Jose, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Wang D, 2017, SCI REP, V7
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 69
TC 7
Z9 7
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD OCT
PY 2018
VL 26
IS 10
BP 877
EP 885
DI 10.1016/j.tim.2018.05.007
PG 9
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GT9BX
UT WOS:000444835500008
PM 29903417
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Sager, G
   Gabaglio, S
   Sztul, E
   Belov, GA
AF Sager, Garrett
   Gabaglio, Samuel
   Sztul, Elizabeth
   Belov, George A.
TI Role of Host Cell Secretory Machinery in Zika Virus Life Cycle
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; flaviviruses; virion maturation; secretory pathway; membrane
   trafficking
ID BORNE ENCEPHALITIS-VIRUS; RECOMBINANT SUBVIRAL PARTICLES; NONSTRUCTURAL
   PROTEIN NS2A; DENGUE VIRUS; ENVELOPE PROTEIN; 3-DIMENSIONAL
   ARCHITECTURE; ULTRASTRUCTURAL CHARACTERIZATION; REPLICATION SITES;
   CAPSID PROTEIN; CORE PROTEIN
AB The high human cost of Zika virus infections and the rapid establishment of virus circulation in novel areas, including the United States, present an urgent need for countermeasures against this emerging threat. The development of an effective vaccine against Zika virus may be problematic because of the cross reactivity of the antibodies with other flaviviruses leading to antibody-dependent enhancement of infection. Moreover, rapidly replicating positive strand RNA viruses, including Zika virus, generate large spectrum of mutant genomes (quasi species) every replication round, allowing rapid selection of variants resistant to drugs targeting virus-specific proteins. On the other hand, viruses are ultimate cellular parasites and rely on the host metabolism for every step of their life cycle, thus presenting an opportunity to manipulate host processes as an alternative approach to suppress virus replication and spread. Zika and other flaviviruses critically depend on the cellular secretory pathway, which transfers proteins and membranes from the ER through the Golgi to the plasma membrane, for virion assembly, maturation and release. In this review, we summarize the current knowledge of interactions of Zika and similar arthropod-borne flaviviruses with the cellular secretory machinery with a special emphasis on virus-specific changes of the secretory pathway. Identification of the regulatory networks and effector proteins required to accommodate the trafficking of virions, which represent a highly unusual cargo for the secretory pathway, may open an attractive and virtually untapped reservoir of alternative targets for the development of superior anti-viral drugs.
C1 [Sager, Garrett; Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.
   [Gabaglio, Samuel; Belov, George A.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA.
RP Sztul, E (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.; Belov, GA (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA.
EM gsager56@uab.edu; samuelgv@terpmail.umd.edu; esztul@uab.edu;
   gbelov@umd.edu
RI Belov, George/B-4625-2008
OI Belov, George/0000-0002-0892-1731
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM122802]
CR Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Alcala AC, 2018, J VIROL, V92, DOI 10.1128/JVI.00275-18
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Belov GA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000216
   BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559
   Beznoussenko GV, 2002, ANAT RECORD, V268, P226, DOI 10.1002/ar.10157
   Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Burlaud-Gaillard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093573
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Chen ZN, 2011, MICROBES INFECT, V13, P143, DOI 10.1016/j.micinf.2010.10.011
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   Farhat R, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12804
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Fox Rebecca M, 2015, Front Biol (Beijing), V10, P28
   Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062
   Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068
   Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09
   Gu F, 2001, CELL MOL LIFE SCI, V58, P1067, DOI 10.1007/PL00000922
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hammel I, 2010, J CELL MOL MED, V14, P1904, DOI 10.1111/j.1582-4934.2010.01071.x
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hoffmann HH, 2017, CELL HOST MICROBE, V22, P460, DOI 10.1016/j.chom.2017.09.002
   Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Klinger CM, 2016, MOL BIOL EVOL, V33, P1528, DOI 10.1093/molbev/msw034
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lanke KHW, 2009, J VIROL, V83, P11940, DOI 10.1128/JVI.01244-09
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0
   Lewy TG, 2017, YALE J BIOL MED, V90, P291
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li MY, 2015, CELL REP, V10, P1496, DOI 10.1016/j.celrep.2015.02.021
   Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070
   Liu J, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0071-8
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Mutsafi Y, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030139
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   NICHOLS BA, 1971, J CELL BIOL, V50, P498, DOI 10.1083/jcb.50.2.498
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Roby JA, 2013, J VIROL, V87, P13063, DOI 10.1128/JVI.01552-13
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Santiana M, 2018, CELL HOST MICROBE, V24, P208, DOI 10.1016/j.chom.2018.07.006
   Santos AJM, 2016, J CELL BIOL, V213, P343, DOI 10.1083/jcb.201603072
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SREENIVASAN V, 1993, J VIROL METHODS, V45, P1, DOI 10.1016/0166-0934(93)90135-E
   Szul T, 2011, PHYSIOLOGY, V26, P348, DOI 10.1152/physiol.00017.2011
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007
   Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   Triyatni M, 2016, WORLD J HEPATOL, V8, P796, DOI 10.4254/wjh.v8.i19.796
   Troupin A, 2016, J IMMUNOL, V197, P4382, DOI 10.4049/jimmunol.1600846
   van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Verheije MH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000088
   Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang H, 2017, OSTEOPOROSIS INT, V28, P1473, DOI 10.1007/s00198-016-3866-2
NR 123
TC 8
Z9 9
U1 4
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2018
VL 10
IS 10
AR 559
DI 10.3390/v10100559
PG 18
WC Virology
SC Virology
GA GY7UL
UT WOS:000448821200047
PM 30326556
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Towers, VS
   Goldsmith, M
   Goldsmith, P
AF Towers, Victoria S.
   Goldsmith, Melissa
   Goldsmith, Patricia
TI Zika Virus Patient Education Recommendations
SO ADVANCES IN NEONATAL CARE
LA English
DT Article
DE fetal teratogens; neonatal; neonatal intensive care; Zika; Zika virus
ID INFECTION; INFANTS
AB Background: A growing threat to maternal-fetal health, the most recent and largest outbreak of the Zika virus disease has introduced the devastating fetal effects of microcephaly and other central nervous system deficits.
   Purpose; This brief outlines a history of Zika virus disease, its known effects, best practice recommendations for providers to educate patients, and information for individuals on how to protect themselves.
   Methods/Search Strategy: A search of the literature using the databases PubMed, UptoDate, and CINAHL was conducted for articles published between 2009 and 2016. Key informant interviews with clinical genetics and public health professionals were conducted.
   Findings/Results: The proposed best practice recommendations for education regarding the Zika virus disease and appropriate prevention and treatment methods are outlined.
   Implications for Practice: As the Zika virus continues to spread and further research is conducted regarding its teratogenic effects, the need for concise and effective education is critical to raise awareness, decrease the potential for maternal exposure, and reduce fetal risks.
   Implications for Research: Therefore, the need for appropriate recognition, treatment, management, and prevention of the Zika virus disease prompts the necessity for further education and high-quality level research to be conducted and utilized.
C1 [Towers, Victoria S.] Mayo Clin, 81 Grande Isle Ave SW, Rochester, MN 55902 USA.
   [Towers, Victoria S.; Goldsmith, Melissa; Goldsmith, Patricia] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA.
RP Towers, VS (corresponding author), Mayo Clin, 81 Grande Isle Ave SW, Rochester, MN 55902 USA.
EM vtowers@email.arizona.edu
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, ZIK CAS US
   Centers for Disease Control and Prevention, CDC ISS UPD ZIK REC
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   Gozlan M, MEDSCAPE INFECT DIS
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Public Health England, ZIK VIR GUILL BARR S
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Society of Maternal and Fetal Medicine, ULTR SCREEN FET MICR
   Sun LH, WASHINGTON POST
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   WHO, ZIK VIR
   World Health Organization, 2016, ZIK VIR ZIKV VACC TA
NR 20
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1536-0903
EI 1536-0911
J9 ADV NEONAT CARE
JI Adv. Neonatal Care
PD OCT
PY 2018
VL 18
IS 5
BP 360
EP 365
DI 10.1097/ANC.0000000000000548
PG 6
WC Nursing
SC Nursing
GA HB2OJ
UT WOS:000450880500008
PM 30239404
DA 2020-07-08
ER

PT J
AU Chen, H
   Wu, YQ
   Fang, YL
   Liao, P
   Zhao, KC
   Deng, Y
   He, NY
AF Chen, Hui
   Wu, Yanqi
   Fang, Yile
   Liao, Pei
   Zhao, Kangchen
   Deng, Yan
   He, Nongyue
TI Integrated and Automated, Sample-In to Result-Out, System for
   Nanotechnology-Based Detection of Infectious Pathogens
SO NANOSCIENCE AND NANOTECHNOLOGY LETTERS
LA English
DT Article
DE Automated Detection; Human Adenovirus (ADV); Influenza A Virus H3;
   Japanese Encephalitis Virus (JEV)
ID OF-CARE TESTS; JAPANESE ENCEPHALITIS; VIRUS-INFECTION; UNITED-STATES;
   ZIKA VIRUS; MORTALITY; DISEASES; INFLUENZA; DISCOVERY; EPIDEMIC
AB An integrated and automated, sample-in to result-out, system for nanotechnology-based nucleic acid detection, was designed and used for real-time identification of pathogens from different types of samples, including feces, sputum, and serum. In order to assess the performance of this novel system, generated results were compared with the results of the assays on the same samples, conducted by the staff of Jiangsu Provincial Center for Disease Control and Prevention (CDC) under a controlled environment, using Tianlong automated extraction and LightCycler detection. The results have documented that the two detection platforms generated essentially identical real-time fluorescence curves for different sample types and different viruses. Compared with the Tianlong automated extraction and LightCycler detection, which separately perform the nucleic acid extraction and real-time fluorescence PCR, the integrated and automated system with closed cartridge carries out the entire detection procedure in a closed box, avoiding any chances of contamination and ensuring the safety of the personnel.
C1 [Chen, Hui; Deng, Yan; He, Nongyue] Hunan Univ Technol, Hunan Key Lab Biomed Nanomat & Devices, Econ Forest Cultivat & Utilizat, Collaborat Innovat Ctr Hunan Prov 2011, Zhuzhou 412007, Peoples R China.
   [Wu, Yanqi] Shenzhen Aikkete Biotechnol Co Ltd, Shenzhen 518055, Peoples R China.
   [Chen, Hui; Fang, Yile; Liao, Pei; He, Nongyue] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Zhao, Kangchen] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing 210003, Peoples R China.
RP Chen, H; He, NY (corresponding author), Hunan Univ Technol, Hunan Key Lab Biomed Nanomat & Devices, Econ Forest Cultivat & Utilizat, Collaborat Innovat Ctr Hunan Prov 2011, Zhuzhou 412007, Peoples R China.; Wu, YQ (corresponding author), Shenzhen Aikkete Biotechnol Co Ltd, Shenzhen 518055, Peoples R China.; Chen, H; He, NY (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
FU NSFCNational Natural Science Foundation of China [61701176]; Shenzhen
   Science and Technology Projects [CKCY2017042609200989]; Natural Science
   Foundation of Hunan Province of ChinaNatural Science Foundation of Hunan
   Province [2018JJ3130]; National Key Research and Development Program of
   China [2017YFA0205301]; China Postdoctoral Science FoundationChina
   Postdoctoral Science Foundation [2016T90403]; Hunan Key Research Project
   [2017SK2174]; Economical Forest Cultivation and Utilization of 2011
   Collaborative Innovation Center in Hunan Province [(2013) 448]
FX We thank the participants and volunteers who took part in this work or
   offered help especially the Jiangsu Provincial Center for Disease
   Control and Prevention. This research was financially supported by NSFC
   (Grant No. 61701176), the Shenzhen Science and Technology Projects
   (Grant No. CKCY2017042609200989), Natural Science Foundation of Hunan
   Province of China (Grant No. 2018JJ3130), the National Key Research and
   Development Program of China (Grant No. 2017YFA0205301), China
   Postdoctoral Science Foundation (Grant No. 2016T90403), Hunan Key
   Research Project (Grant No. 2017SK2174), and the Economical Forest
   Cultivation and Utilization of 2011 Collaborative Innovation Center in
   Hunan Province [(2013) 448].
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Arkwright PD, 2005, EPIDEMIOL INFECT, V133, P979, DOI 10.1017/S0950268805004516
   Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61
   Bharucha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194412
   Bi P, 2003, INTERN MED J, V33, P152, DOI 10.1046/j.1445-5994.2003.00354.x
   Bullman S, 2017, ANNU REV PATHOL-MECH, V12, P217, DOI 10.1146/annurev-pathol-012615-044305
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P621
   Chen H, 2017, J BIOMED NANOTECHNOL, V13, P1619, DOI 10.1166/jbn.2017.2478
   Chen H, 2016, NANOSCI NANOTECH LET, V8, P1118, DOI 10.1166/nnl.2016.2278
   Christaki E, 2015, VIRULENCE, V6, P554, DOI 10.1080/21505594.2015.1040975
   Clerc O, 2010, CLIN MICROBIOL INFEC, V16, P1054, DOI 10.1111/j.1469-0691.2010.03281.x
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Cook James, 2017, F1000Res, V6, P90, DOI 10.12688/f1000research.10152.1
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Deaton A, 2008, J ECON PERSPECT, V22, P53, DOI 10.1257/jep.22.2.53
   Des Jarlais DC, 2016, AIDS, V30, P815, DOI 10.1097/QAD.0000000000001039
   Dowdle Ingenta W. R., 1999, B WORLD HEALTH ORGAN, V77, P820
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   Fettig J, 2014, INFECT DIS CLIN N AM, V28, P323, DOI 10.1016/j.idc.2014.05.001
   Findlater A, 2018, TRENDS PARASITOL, V34, P772, DOI 10.1016/j.pt.2018.07.004
   Fricker Manuel, 2008, J Infect Public Health, V1, P72, DOI 10.1016/j.jiph.2008.10.005
   Ge YY, 2017, INT J NANOMED, V12, P2645, DOI 10.2147/IJN.S132670
   Gopinath SCB, 2014, BIOSENS BIOELECTRON, V60, P332, DOI 10.1016/j.bios.2014.04.014
   Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188
   Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381
   Janssen S, 2014, INFECTION, V42, P281, DOI 10.1007/s15010-013-0568-y
   Kagaayi J, 2016, CURR HIV-AIDS REP, V13, P187, DOI 10.1007/s11904-016-0318-8
   Kaner J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0194-4
   Khanal S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010030
   Kitange HM, 1996, BRIT MED J, V312, P216, DOI 10.1136/bmj.312.7025.216
   Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868
   Lee CY, 2014, J MED VIROL, V86, P2128, DOI 10.1002/jmv.23940
   Lipkin WI, 2013, NAT REV MICROBIOL, V11, P133, DOI 10.1038/nrmicro2949
   LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152
   Lo TQ, 2017, ANNU REV MED, V68, P359, DOI 10.1146/annurev-med-052915-015604
   Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923
   Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014
   McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480
   Morens D. M., 2012, MBIO, V3
   Navidad JF, 2013, J CLIN MICROBIOL, V51, P3018, DOI 10.1128/JCM.00896-13
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Parnell S, 2012, J THEOR BIOL, V305, P30, DOI 10.1016/j.jtbi.2012.03.009
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Perlman S., 2013, MBIO, V4
   Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002
   Turtle L, 2018, NAT REV NEUROL, V14, P298, DOI 10.1038/nrneurol.2018.30
   Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002
   Wenzel RP, 2005, ARCH MED RES, V36, P610, DOI 10.1016/j.arcmed.2005.03.040
   Wong SSY, 2005, J NEUROVIROL, V11, P455, DOI 10.1080/13550280500187724
   Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1
   Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8
NR 53
TC 38
Z9 38
U1 5
U2 9
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1941-4900
EI 1941-4919
J9 NANOSCI NANOTECH LET
JI Nanosci. Nanotechnol. Lett.
PD OCT
PY 2018
VL 10
IS 10
BP 1423
EP 1428
DI 10.1166/nnl.2018.2802
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA HB1OV
UT WOS:000450794500015
DA 2020-07-08
ER

PT J
AU Prael, FJ
   Chen, R
   Li, ZL
   Reed, CW
   Lindsley, CW
   Weaver, CD
   Swale, DR
AF Prael, Francis J., III
   Chen, Rui
   Li, Zhilin
   Reed, Carson W.
   Lindsley, Craig W.
   Weaver, C. David
   Swale, Daniel R.
TI Use of chemical probes to explore the toxicological potential of the
   K+/Cl- cotransporter (KCC) as a novel insecticide target to control the
   primary vector of dengue and Zika virus, Aedes aegypti
SO PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
DE Vector biology; Insecticide; Potassium; Insect nervous system;
   Thallium-flux; Insecticide discovery
ID K-CL COTRANSPORTER; MALPIGHIAN TUBULES UMT; ANOPHELES-GAMBIAE; FLUID
   SECRETION; RESISTANCE; CHLORIDE; STRAIN; NEUROTRANSMISSION;
   SUSCEPTIBILITY; INHIBITION
AB The majority of commercialized insecticides target the insect nervous system and therefore, neural proteins are well-validated targets for insecticide development. Considering that only a few neural targets are exploited for insecticidal action and the development of insecticide resistance has reduced the efficacy of current insecticidal classes, we sought to test the toxicological potential of the potassium-chloride cotransporter (KCC). In mammals, KCC proteins have seminal roles in shaping GABAergic signaling and inhibitory neurotransmission, thus ion transport through KCC is critical for proper neurotransmission. Therefore, we hypothesized that mosquito KCC represents a putative insecticide target site and that pharmacological inhibition of KCC constructs in Aedes aegypti will be lethal. To test this hypothesis, we developed a robust, cell-based fluorescence assay that enables in vitro characterization of small-molecules against Ae. aegypti KCC and performed a proof-of-concept study employing well characterized mammalian KCC modulators to determine the toxicological potential of Ae. aegypti KCC. The selective inhibitor of mammalian KCC, termed VU0463271, was found to be a potent inhibitor Ae. aegypti KCC and microinjection induced lethality in a concentration-dependent manner to susceptible and pyrethroid resistant strains. Importantly, an analog of VU0463271 was shown to be > 40-fold less potent and did not induce toxicity, suggesting that the observed physiological effects and mortality are likely due to KCC inhibition. This proof-of-concept study suggests that Ae. aegypti KCC represents a putative target site for mos-quitocide design that can mitigate the current mechanisms of insecticide resistance.
C1 [Prael, Francis J., III; Reed, Carson W.; Lindsley, Craig W.; Weaver, C. David] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA.
   [Chen, Rui; Li, Zhilin; Swale, Daniel R.] Louisiana State Univ, AgCtr, Dept Entomol, Baton Rouge, LA 70803 USA.
   [Prael, Francis J., III; Reed, Carson W.; Lindsley, Craig W.; Weaver, C. David] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.
   [Reed, Carson W.; Lindsley, Craig W.; Weaver, C. David] Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA.
RP Swale, DR (corresponding author), LSU, Dept Entomol, 404 Life Sci Bldg, Baton Rouge, LA 70803 USA.
EM dswale@agcenter.lsu.edu
FU LSU AgCenter; Louisiana Board of Regents [LEQSF (2016-2019)-RD-A-26]
FX The co-author, Dr. Dave Weaver, was responsible for developing the cell
   line expressing Ae. aegypti KCC, studies that determined the in vitro
   potency of inhibitors to Ae. aegypti KCC, and oversaw the writing of
   those portions of the manuscript. Therefore, Dr. Weaver is the
   corresponding author for these methods, data, and data interpretation.
   The authors thank Brendan Dutter for synthesis of Thallos-AM and the
   staff of the Vanderbilt High-throughput Screening Facility for their
   assistance. We thank the Louisiana Board of Regents (LEQSF
   (2016-2019)-RD-A-26; PI Swale) and start-up funds provided to Swale by
   LSU AgCenter for the financial support for this research.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003
   Bloomquist JR, 2014, ACS SYM SER, V1172, P71
   Chamma I, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00005
   Delpire E, 2012, BIOORG MED CHEM LETT, V22, P4532, DOI 10.1016/j.bmcl.2012.05.126
   Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106
   Flores CE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00327
   Francis SAM, 2017, INSECTS, V8, DOI 10.3390/insects8010002
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Gamez AD, 2012, J INSECT PHYSIOL, V58, P543, DOI 10.1016/j.jinsphys.2011.12.008
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Gutierrez AM, 2004, J MEMBRANE BIOL, V202, P105, DOI 10.1007/s00232-004-0723-6
   Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006
   Hubner CA, 2014, EMBO REP, V15, P732, DOI 10.15252/embr.201439039
   Ingabire CM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2046-y
   Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X
   Islam RM, 2015, METHODSX, V2, P19, DOI 10.1016/j.mex.2014.12.002
   Larson NR, 2017, NEUROTOXICOLOGY, V60, P214, DOI 10.1016/j.neuro.2016.05.021
   Linton SM, 1999, J EXP BIOL, V202, P1561
   Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36
   Mutunga JM, 2015, PESTIC BIOCHEM PHYS, V121, P116, DOI 10.1016/j.pestbp.2015.03.001
   Nuss AB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003515
   Piermarini PM, 2011, AM J PHYSIOL-REG I, V301, pR1318, DOI 10.1152/ajpregu.00223.2011
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Raphemot R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110772
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Sokhna C, 2013, CLIN MICROBIOL INFEC, V19, P902, DOI 10.1111/1469-0691.12314
   Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014
   Swale DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36954
   Tanis JE, 2009, J NEUROSCI, V29, P9943, DOI 10.1523/JNEUROSCI.1989-09.2009
   Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656
   Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004
   Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429
NR 39
TC 3
Z9 3
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0048-3575
EI 1095-9939
J9 PESTIC BIOCHEM PHYS
JI Pest. Biochem. Physiol.
PD OCT
PY 2018
VL 151
SI SI
BP 10
EP 17
DI 10.1016/j.pestbp.2018.03.019
PG 8
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA GZ2UP
UT WOS:000449244200003
PM 30704707
OA Other Gold
DA 2020-07-08
ER

PT J
AU Bidokhti, MRM
   Dutta, D
   Madduri, LSV
   Woollard, SM
   Norgren, R
   Giavedoni, L
   Byrareddy, SN
AF Bidokhti, Mehdi R. M.
   Dutta, Debashis
   Madduri, Lepakshe S., V
   Woollard, Shawna M.
   Norgren, Robert, Jr.
   Giavedoni, Luis
   Byrareddy, Siddappa N.
TI SIV/SHIV-Zika co-infection does not alter disease pathogenesis in adult
   non-pregnant rhesus macaque model
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VIRUS
AB Due to the large geographical overlap of populations exposed to Zika virus (ZIKV) and human immunodeficiency virus (HIV), understanding the disease pathogenesis of co-infection is urgently needed. This warrants the development of an animal model for HIV-ZIKV co infection. In this study, we used adult non-pregnant macaques that were chronically infected with simian immunodeficiency virus/chimeric simian human immunodeficiency virus (SIV/SHIV) and then inoculated with ZIKV. Plasma viral loads of both SIV/SHIV and ZIKV co infected animals revealed no significant changes as compared to animals that were infected with ZIKV alone or as compared to SIV/SHIV infected animals prior to ZIKV inoculation. ZIKV tissue clearance of co-infected animals was similar to animals that were infected with ZIKV alone. Furthermore, in co-infected macaques, there was no statistically significant difference in plasma cytokines/chemokines levels as compared to prior to ZIKV inoculation. Collectively, these findings suggest that co-infection may not alter disease pathogenesis, thus warranting larger HIV-ZIKV epidemiological studies in order to validate these findings.
C1 [Bidokhti, Mehdi R. M.; Dutta, Debashis; Madduri, Lepakshe S., V; Woollard, Shawna M.; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Norgren, Robert, Jr.; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.
   [Giavedoni, Luis] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
RP Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
EM sid.byrareddy@unmc.edu
RI Dutta, Debashis/L-4685-2019
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI113883, R21AI11415]; Nebraska
   Neuroscience Alliance Endowed Fund Award; University of Nebraska Food
   for Health Seed Grant
FX This study was supported in part by NIH R01AI113883, R21AI11415 and
   Nebraska Neuroscience Alliance Endowed Fund Award to SNB; University of
   Nebraska Food for Health Seed Grant Award to SNB and RN. The granters or
   funders had no role in designing this study.
CR Barreiro P, 2016, AIDS REV, V18, P112
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dutta D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196942
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014
   Joao EAC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200168
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Rothan HA, 2019, MOL NEUROBIOL, V56, P2551, DOI 10.1007/s12035-018-1263-x
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Sherman KE, 2018, JAIDS-J ACQ IMM DEF, V78, pE35, DOI 10.1097/QAI.0000000000001718
   Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Takahashi Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003929
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Villamil-Gomez WE, 2018, J FORMOS MED ASSOC, V117, P856, DOI 10.1016/j.jfma.2018.05.019
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Woollard SM OO, 2018, PATHOGENS, V7, DOI [10.3390/pathogens7030000, DOI 10.3390/PATHOGENS7030000]
NR 25
TC 3
Z9 3
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006811
DI 10.1371/journal.pntd.0006811
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100035
PM 30359380
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Colmant, AMG
   Hall-Mendelin, S
   Ritchie, SA
   Bielefeldt-Ohmann, H
   Harrison, JJ
   Newton, ND
   O'Brien, CA
   Cazier, C
   Johansen, CA
   Hobson-Peters, J
   Hall, RA
   van den Hurk, AF
AF Colmant, Agathe M. G.
   Hall-Mendelin, Sonja
   Ritchie, Scott A.
   Bielefeldt-Ohmann, Helle
   Harrison, Jessica J.
   Newton, Natalee D.
   O'Brien, Caitlin A.
   Cazier, Chris
   Johansen, Cheryl A.
   Hobson-Peters, Jody
   Hall, Roy A.
   van den Hurk, Andrew F.
TI The recently identified flavivirus Bamaga virus is transmitted
   horizontally by Culex mosquitoes and interferes with West Nile virus
   replication in vitro and transmission in vivo
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; PAPUA-NEW-GUINEA;
   AEDES-ALBOPICTUS; VECTOR COMPETENCE; DENGUE-VIRUS;
   MONOCLONAL-ANTIBODIES; PERSISTENT INFECTION; SINDBIS VIRUS;
   SUPERINFECTION EXCLUSION
AB Arthropod-borne flaviviruses such as yellow fever (YFV), Zika and dengue viruses continue to cause significant human disease globally. These viruses are transmitted by mosquitoes when a female imbibes an infected blood-meal from a viremic vertebrate host and expectorates the virus into a subsequent host. Bamaga virus (BgV) is a flavivirus recently discovered in Culex sitiens subgroup mosquitoes collected from Cape York Peninsula, Australia. This virus phylogenetically clusters with the YFV group, but is potentially restricted in most vertebrates. However, high levels of replication in an opossum cell line (OK) indicate a potential association with marsupials. To ascertain whether BgV could be horizontally transmitted by mosquitoes, the vector competence of two members of the Cx. sitiens subgroup, Cx. annulirostris and Cx. sitiens, for BgV was investigated. Eleven to thirteen days after imbibing an infectious blood-meal, infection rates were 11.3% and 18.8% for Cx. annulirostris and Cx. sitiens, respectively. Cx. annulirostris transmitted the virus at low levels (5.6% had BgV-positive saliva overall); Cx. sitiens did not transmit the virus. When mosquitoes were injected intrathoracially with BgV, the infection and transmission rates were 100% and 82%, respectively, for both species. These results provided evidence for the first time that BgV can be transmitted horizontally by Cx. annulirostris, the primary vector of pathogenic zoonotic flaviviruses in Australia. We also assessed whether BgV could interfere with replication in vitro, and infection and transmission in vivo of super-infecting pathogenic Culex-associated flaviviruses. BgV significantly reduced growth of Murray Valley encephalitis and West Nile (WNV) viruses in vitro. While prior infection with BgV by injection did not inhibit WNV super-infection of Cx. annulirostris, significantly fewer BgV-infected mosquitoes could transmit WNV than mock-injected mosquitoes. Overall, these data contribute to our understanding of flavivirus ecology, modes of transmission by Australian mosquitoes and mechanisms for super-infection interference.
C1 [Colmant, Agathe M. G.; Bielefeldt-Ohmann, Helle; Harrison, Jessica J.; Newton, Natalee D.; O'Brien, Caitlin A.; Hobson-Peters, Jody; Hall, Roy A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
   [Hall-Mendelin, Sonja; van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Publ Hlth Virol, Forens & Sci Serv, Coopers Plains, Qld, Australia.
   [Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Qld, Australia.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia.
   [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton Campus, Gatton, Qld, Australia.
   [Cazier, Chris] Queensland Univ Technol, Fac Hlth, Tech Serv, Biosci Div, Gardens Point Campus, Brisbane, Qld, Australia.
   [Johansen, Cheryl A.] PathWest Lab Med WA, Nedlands, WA, Australia.
   [Johansen, Cheryl A.] Univ Western Australia, Sch Biomed Sci, Nedlands, WA, Australia.
RP Hall, RA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.; van den Hurk, AF (corresponding author), Queensland Govt, Dept Hlth, Publ Hlth Virol, Forens & Sci Serv, Coopers Plains, Qld, Australia.
EM roy.hall@uq.edu.au; Andrew.VanDenHurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019
OI van den Hurk, Andrew/0000-0001-6262-831X; Newton,
   Natalee/0000-0002-5617-8639; Colmant, Agathe/0000-0002-2004-4073
FU Australian Government Research Training Program ScholarshipAustralian
   GovernmentDepartment of Industry, Innovation and Science; Funding
   initiatives for mosquito management in Western Australia (FIMMWA),
   Western Australian Health Department
FX The Australian Government Research Training Program Scholarship
   (https://www.education.gov.au/research-training-program) funded Ph.D.
   students AMGC, JJH and CAO. This research was supported by the Funding
   initiatives for mosquito management in Western Australia (FIMMWA),
   Western Australian Health Department,
   (https://ww2.health.wa.gov.au/Articles/F_I/Funding-initiatives-for-mosqu
   ito-management-in-Western-Australia), awarded to SHM, HBO, CAJ, JHP,
   RAH. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   AITKEN THG, 1977, AM J TROP MED HYG, V26, P985, DOI 10.4269/ajtmh.1977.26.985
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Berge T., 1975, INT CATALOGUE ARBOVI
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   CHEN WJ, 1993, J MED ENTOMOL, V30, P524, DOI 10.1093/jmedent/30.3.524
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Colmant AMG, 2016, J GEN VIROL, V97, P1087, DOI 10.1099/jgv.0.000430
   DOHERTY R. L., 1963, AUSTRALIAN J SCI, V26, P183
   Frost MJ, 2012, EMERG INFECT DIS, V18, P792, DOI 10.3201/eid1805.111720
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   IGARASHI A, 1979, NATURE, V280, P690, DOI 10.1038/280690a0
   Jansen CC, 2013, INT J ENV RES PUB HE, V10, P3735, DOI 10.3390/ijerph10083735
   Jansen CC, 2008, VECTOR-BORNE ZOONOT, V8, P805, DOI 10.1089/vbz.2008.0037
   Johansen CA, 2000, AM J TROP MED HYG, V62, P631, DOI 10.4269/ajtmh.2000.62.631
   Kanthong N, 2008, DEV COMP IMMUNOL, V32, P1063, DOI 10.1016/j.dci.2008.02.008
   Kanthong N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-14
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   KUNO G, 1982, INTERVIROLOGY, V18, P45, DOI 10.1159/000149303
   Lutomiah JL, 2011, J MED ENTOMOL, V48, P1197, DOI 10.1603/ME11062
   Macdonald J, 2010, EVOL BIOINFORM, V6, P91
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Moore PR, 2007, J AM MOSQUITO CONTR, V23, P383, DOI 10.2987/5598.1
   Muturi EJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0667-y
   Nicholson J, 2014, J MED ENTOMOL, V51, P661, DOI 10.1603/ME13204
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   O'Guinn ML, 2013, AM J TROP MED HYG, V89, P1023, DOI 10.4269/ajtmh.13-0160
   Pesko K, 2009, VECTOR-BORNE ZOONOT, V9, P281, DOI 10.1089/vbz.2007.0281
   Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   RIEDEL B, 1977, J VIROL, V23, P554, DOI 10.1128/JVI.23.3.554-561.1977
   Ritchie SA, 2007, VECTOR-BORNE ZOONOT, V7, P497, DOI 10.1089/vbz.2006.0643
   Ritchie SA, 2013, J MED ENTOMOL, V50, P185, DOI 10.1603/ME12112
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Sudeep AB, 2015, INDIAN J MED RES, V142, P44, DOI 10.4103/0971-5916.176618
   Thibodeaux BA, 2009, CLIN VACCINE IMMUNOL, V16, P679, DOI 10.1128/CVI.00354-08
   Turell MJ, 2006, J MED ENTOMOL, V43, P296, DOI 10.1603/0022-2585(2006)043[0296:LTOJEA]2.0.CO;2
   van den Hurk AF, 2003, MED VET ENTOMOL, V17, P403, DOI 10.1111/j.1365-2915.2003.00458.x
   van den Hurk AF, 2003, J MED ENTOMOL, V40, P82, DOI 10.1603/0022-2585-40.1.82
   Van den Hurk AF, 2001, AM J TROP MED HYG, V64, P125, DOI 10.4269/ajtmh.2001.64.125
   Van Den Hurk AF, 2006, AM J TROP MED HYG, V75, P21, DOI 10.4269/ajtmh.2006.75.21
   van den Hurk AF, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0586-3
   ZHANG PF, 1993, J GEN VIROL, V74, P1703, DOI 10.1099/0022-1317-74-8-1703
NR 58
TC 2
Z9 2
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006886
DI 10.1371/journal.pntd.0006886
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100070
PM 30356234
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Estep, AS
   Sanscrainte, ND
   Waits, CM
   Bernard, SJ
   Lloyd, AM
   Lucas, KJ
   Buckner, EA
   Vaidyanathan, R
   Morreale, R
   Conti, LA
   Becnel, JJ
AF Estep, Alden S.
   Sanscrainte, Neil D.
   Waits, Christy M.
   Bernard, Sarah J.
   Lloyd, Aaron M.
   Lucas, Keira J.
   Buckner, Eva A.
   Vaidyanathan, Rajeev
   Morreale, Rachel
   Conti, Lisa A.
   Becnel, James J.
TI Quantification of permethrin resistance and kdr alleles in Florida
   strains of Aedes aegypti (L.) and Aedes albopictus (Skuse)
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SODIUM-CHANNEL GENE; DIPTERA-CULICIDAE; INSECTICIDE RESISTANCE;
   PYRETHROID RESISTANCE; MUTATIONS; MECHANISMS; SUSCEPTIBILITY; MOSQUITOS;
   VECTOR; CULEX
AB Recent outbreaks of locally transmitted dengue and Zika viruses in Florida have placed more emphasis on integrated vector management plans for Aedes aegypti (L.) and Aedes albopictus Skuse. Adulticiding, primarily with pyrethroids, is often employed for the immediate control of potentially arbovirus-infected mosquitoes during outbreak situations. While pyrethroid resistance is common in Ae. aegypti worldwide and testing is recommended by CDC and WHO, resistance to this class of products has not been widely examined or quantified in Florida. To address this information gap, we performed the first study to quantify both pyrethroid resistance and genetic markers of pyrethroid resistance in Ae. aegypti and Ae. albopictus strains in Florida. Using direct topical application to measure intrinsic toxicity, we examined 21 Ae. aegyptistrains from 9 counties and found permethrin resistance (resistance ratio (RR) = 6-61-fold) in all strains when compared to the susceptible ORLI952 control strain. Permethrin resistance in five strains of Ae. albopictus was very low (RR<1.6) even when collected from the same containers producing resistant Ae. aegypti. Characterization of two sodium channel kdralleles associated with pyrethroid-resistance showed widespread distribution in 62 strains of Ae. aegypti. The 1534 phenylalanine to cysteine (F1534C) single nucleotide polymorphism SNP was fixed or nearly fixed in all strains regardless of RR. We observed much more variation in the 1016 valine to isoleucine (V10161) allele and observed that an increasing frequency of the homozygous V10161 allele correlates strongly with increased RR (Pearson corr = 0.905). In agreement with previous studies, we observed a very low frequency of three kdrgenotypes, IIFF, VIFF, and IIFC. In this study, we provide a statewide examination of pyrethroid resistance, and demonstrate that permethrin resistance and the genetic markers for resistance are widely present in FL Ae. aegypti. Resistance testing should be included in an effective management program.
C1 [Estep, Alden S.; Waits, Christy M.; Bernard, Sarah J.] Navy Entomol Ctr Excellence, CMAVE Detachment, Gainesville, FL 32601 USA.
   [Sanscrainte, Neil D.; Becnel, James J.] ARS, Mosquito & Fly Res Unit, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA.
   [Lloyd, Aaron M.] Pasco Cty Mosquito Control Dist, Odessa, FL USA.
   [Lucas, Keira J.] Collier Mosquito Control Dist, Naples, FL USA.
   [Buckner, Eva A.] Manatee Mosquito Control Dist, Palmetto, FL USA.
   [Vaidyanathan, Rajeev] Clarke Inc, St Charles, IL USA.
   [Morreale, Rachel] Lee Cty Mosquito Control, Lehigh Acres, FL USA.
   [Conti, Lisa A.] Florida Dept Agr & Consumer Serv, Tallahassee, FL USA.
   [Buckner, Eva A.] Florida Med Entomol Lab, Vero Beach, FL USA.
RP Estep, AS (corresponding author), Navy Entomol Ctr Excellence, CMAVE Detachment, Gainesville, FL 32601 USA.
EM alden.estep@ars.usda.gov
OI Sanscrainte, Neil/0000-0002-0891-5278; Estep, Alden/0000-0002-8281-3229
FU Deployed Warfighters Protection Program; University of Florida, Emerging
   Pathogens Institute
FX Funding for laboratory studies was provided by the Deployed Warfighters
   Protection Program, managed by the Armed Forces Pest Management Board.
   Funding for specimen collections was provided by local mosquito control
   programs and/or the CDC Southeast Vector Center of Excellence, Gateway
   Program based at the University of Florida, Emerging Pathogens
   Institute. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Agramonte NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005954
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Chang F, 2014, J AGR FOOD CHEM, V62, P476, DOI 10.1021/jf4045843
   Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214
   Connelly CR, 2018, PESTICIDE RESISTANCE, DOI [10.1371/journal.pone.0101992, DOI 10.1371/JOURNAL.PONE.0101992]
   Cornel AJ, 2016, F1000RES, V5
   Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Georghiou G. P., 1990, ACS SYM SER, P18
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jamroz RC, 1998, INSECT BIOCHEM MOLEC, V28, P1031, DOI 10.1016/S0965-1748(98)00094-0
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Komalamisra N, 2009, SE ASIAN J TROP MED, V40, P1221
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Richards SL, 2017, J MED ENTOMOL, V54, P682, DOI 10.1093/jme/tjw231
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund DM, 1990, PESTICIDE RESISTANCE, P58
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Waits CM, 2017, FLA ENTOMOL, V100, P571, DOI 10.1653/024.100.0313
   WHO, 2016, MON MAN INS RES AED
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   World Health Organization, 2009, GUID EFF TEST INS IN
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 38
TC 7
Z9 7
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006544
DI 10.1371/journal.pntd.0006544
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100006
PM 30356237
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Katzelnick, LC
   Escoto, AC
   McElvany, BD
   Chavez, C
   Salje, H
   Luo, WS
   Rodriguez-Barraquer, I
   Jarman, R
   Durbin, AP
   Diehl, SA
   Smith, DJ
   Whitehead, SS
   Cummings, DAT
AF Katzelnick, Leah C.
   Escoto, Ana Coello
   McElvany, Benjamin D.
   Chavez, Christian
   Salje, Henrik
   Luo, Wensheng
   Rodriguez-Barraquer, Isabel
   Jarman, Richard
   Durbin, Anna P.
   Diehl, Sean A.
   Smith, Derek J.
   Whitehead, Stephen S.
   Cummings, Derek A. T.
TI Viridot: An automated virus plaque (immunofocus) counter for the
   measurement of serological neutralizing responses with application to
   dengue virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID REDUCTION NEUTRALIZATION; VACCINE; ANTIBODIES; INFECTION;
   IMMUNOGENICITY; SEROTYPES; HEALTHY
AB The gold-standard method for quantifying neutralizing antibody responses to many viruses, including dengue virus (DENV), is the plaque reduction neutralization test (PRNT, also called the immunofocus reduction neutralization test). The PRNT conducted on 96-well plates is high-throughput and requires a smaller volume of antiserum than on 6- or 24-well plates, but manual plaque counting is challenging and existing automated plaque counters are expensive or difficult to optimize. We have developed Viridot (Viridot package), a program for R with a user interface in shiny, that counts viral plaques of a variety of phenotypes, estimates neutralizing antibody titers, and performs other calculations of use to virologists. The Viridot plaque counter includes an automatic parameter identification mode (misses <10 plaques/well for 87% of diverse DENV strains [n = 1521]) and a mode that allows the user to fine-tune the parameters used for counting plaques. We compared standardized manual and Viridot plaque counting methods applied to the same wells by two analyses and found that Viridot plaque counts were as similar to the same analyst's manual count (Lin's concordance correlation coefficient, rho(c) = 0.99 [95% confidence interval: 0.99-1.00]) as manual counts between analysts (rho(c) = 0.99 [95% CI: 0.98-0.99]). The average ratio of neutralizing antibody titers based on manual counted plaques to Viridot counted plaques was 1.05 (95% CI: 0.98-1.14), similar to the average ratio of antibody titers based on manual plaque counts by the two analysts (1.06 [95% CI: 0.84-1.34]). Across diverse DENV and ZIKV strains (n = 14), manual and Viridot plaque counts were mostly consistent (range of rho(c) = 0.74 to 1.00) and the average ratio of antibody titers based on manual and Viridot counted plaques was close to 1 (0.94 [0.86-1.02]). Thus, Viridot can be used for plaque counting and neutralizing antibody titer estimation of diverse DENV strains and potentially other viruses on 96-well plates as well as for formalization of plaque-counting rules for standardization across experiments and analysts.
C1 [Katzelnick, Leah C.; Escoto, Ana Coello; Chavez, Christian; Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Katzelnick, Leah C.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [McElvany, Benjamin D.; Diehl, Sean A.] Univ Vermont, Larner Coll Med, Vaccine Testing Ctr, Dept Med Infect Dis, Burlington, VT 05405 USA.
   [Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.
   [Salje, Henrik; Rodriguez-Barraquer, Isabel; Cummings, Derek A. T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Luo, Wensheng; Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA.
   [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, Sch Med, San Francisco, CA 94117 USA.
   [Jarman, Richard] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England.
   [Whitehead, Stephen S.] Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Bethesda, MD 20892 USA.
   [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
RP Katzelnick, LC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Katzelnick, LC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM leah.katzelnick@berkeley.edu
RI Whitehead, Stephen/AAG-2787-2019; Diehl, Sean/AAE-2779-2020
OI Diehl, Sean/0000-0001-9700-235X; Coello Escoto, Ana/0000-0002-9634-5091;
   Rodriguez-Barraquer, Isabel/0000-0001-6784-1021
FU Intramural Research Program of the NIH, National Institute of Allergy
   and Infectious Diseases, National Institutes of Health [R01AI114703-01];
   Bill and Melinda Gates FoundationGates Foundation [OPP1104710]
FX This research was supported in part by the Intramural Research Program
   of the NIH, National Institute of Allergy and Infectious Diseases,
   National Institutes of Health Grant R01AI114703-01 (to DATC), and Bill
   and Melinda Gates Foundation grant OPP1104710 (to APD). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andrade P, 2018, METHODS MOL BIOL, V1808, P151, DOI 10.1007/978-1-4939-8567-8_13
   Chang W, 2017, WEB APPL FRAMEWORK R
   CONDIT RC, 2007, FIELDS VIROLOGY, P25
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P785, DOI 10.1038/ni0715-785a
   DULBECCO R, 1956, VIROLOGY, V2, P162, DOI 10.1016/0042-6822(56)90017-4
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   MORENS DM, 1985, MICROBIOL IMMUNOL, V29, P1197, DOI 10.1111/j.1348-0421.1985.tb00909.x
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046
   Pedersen TL, 2016, R PACKAGE VERSION 0
   R Core Team, 2016, R LANG ENV STAT COMP
   Rasband W.S., IMAGEJ
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021
   Rowell J, 2018, VACCINE, V36, P1008, DOI 10.1016/j.vaccine.2017.11.065
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119
   Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125
   Warnes GR, 2015, R PACKAGE VERSION 3
   WHO, 2007, GUID PLAQ RED NEUTR
   Ziegler CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005501
   Zielinska E, 2005, VIROL J, V2, P1, DOI [10.1186/1743-422X-2-1, DOI 10.1186/1743-422X-2-1]
NR 35
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006862
DI 10.1371/journal.pntd.0006862
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100055
PM 30356267
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, YH
   Tseng, CK
   Lin, CK
   Wei, CK
   Lee, JC
   Young, KC
AF Wu, Yu-Hsuan
   Tseng, Chin-Kai
   Lin, Chun-Kuang
   Wei, Chih-Ku
   Lee, Jin-Ching
   Young, Kung-Chia
TI ICR suckling mouse model of Zika virus infection for disease modeling
   and drug validation
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE; PATHOGENESIS; REPLICATION; COLOMBIA; BRAIN; MICE
AB Background
   Zika virus (ZIKV) infection causes diseases ranging from acute self-limiting febrile illness to life-threatening Guillain Barre Syndrome and other neurological disorders in adults. Cumulative evidence suggests an association between ZIKV infection and microcephaly in newborn infants. Given the host-range restrictions of the virus, a susceptible animal model infected by ZIKV must be developed for evaluation of vaccines and antivirals. In this study, we propose a convenient mouse model for analysis of neurological disorders caused by ZIKV.
   Methodology
   Six-day-old immunocompetent ICR suckling mice were used in the experiment. Different inoculum virus concentrations, challenge routes, and challenge times were assessed. Viremic dissemination was determined in the liver, spleen, kidney, and brain through Western blot assay, plaque assay, absolute quantification real-time PCR, and histological observation. Azithromycin, a well-characterized anti-ZIKV compound, was used to evaluate the ICR suckling mouse model for antiviral testing.
   Conclusions
   Signs of illness and neurological disease and high mortality rate were observed in mice injected with ZIKV intracerebrally (10(2) to 10(5)) and intraperitoneally (10(3) to 10(5)). Viremic dissemination was observed in the liver, spleen, kidney, and brain. ZIKV transmitted, rapid replicated, and induced monocyte infiltration into the brain approximately 5 to 6 days post inoculum. Azithromycin conferred protection against ZIKV-caused neurological and life-threatening diseases. The developed model of ZIKV infection and disease can be used for screening drugs against ZIKV and discovering the underlying mechanism of ZIKV pathogenesis.
C1 [Wu, Yu-Hsuan; Tseng, Chin-Kai; Young, Kung-Chia] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan.
   [Lin, Chun-Kuang] Natl Sun Yat Sen Univ, Coll Marine Sci, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan.
   [Wei, Chih-Ku; Lee, Jin-Ching] Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan.
   [Lee, Jin-Ching] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.
   [Lee, Jin-Ching] Kaohsiung Med Univ, Res Ctr Nat Prod & Drug Dev, Kaohsiung, Taiwan.
   [Lee, Jin-Ching] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.
   [Young, Kung-Chia] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.
RP Young, KC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ, Coll Life Sci, Dept Biotechnol, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ, Res Ctr Nat Prod & Drug Dev, Kaohsiung, Taiwan.; Lee, JC (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.; Young, KC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.
EM jclee@kmu.edu.tw; t7908077@mail.ncku.edu.tw
OI Wu, Yu-Hsuan/0000-0002-2175-3867
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [MOST104-2320-B-037-025-MY3, MOST 107-2311-B-037 -005
   -MY3]; KMU-KMUH Co-Project of Key Research Grant from Kaohsiung Medical
   University of Taiwan [KMU-DK107011, KMU-DK108010]; National Sun Yat-Sen
   University-KUM Joint Research Project of Taiwan [NSYSU-KMU 107-I003];
   Industry-University Service Research Project from Kaohsiung Medical
   University of Taiwan [S106002]
FX This work was supported by Ministry of Science and Technology of Taiwan
   under Grant (MOST104-2320-B-037-025-MY3 and MOST 107-2311-B-037 -005
   -MY3) (https://www.most.gov.tw/), KMU-KMUH Co-Project of Key Research
   Grant (KMU-DK107011 and KMU-DK108010) from Kaohsiung Medical University
   of Taiwan(https://www.kmu.edu.tw/), National Sun Yat-Sen University-KUM
   Joint Research Project of Taiwan (NSYSU-KMU 107-I003)
   (http://www.nsysu.edu.tw/bin/home.php), and Industry-University Service
   Research Project from Kaohsiung Medical University of Taiwan
   (S106002)(https://www.kmu.edu.tw/). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Bauler TJ, 2017, AM J PATHOL, V187, P187, DOI 10.1016/j.ajpath.2016.09.002
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Iannetta M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01152-17
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lai YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07308-3
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee JC, 2015, ANTIVIR RES, V116, P1, DOI 10.1016/j.antiviral.2015.01.002
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Lin CK, 2017, SCI REP-UK, V7, DOI 10.1038/srep44701
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM, V12, P371, DOI 10.1007/s11481-017-9743-8
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schaefer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148259
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tang XAN, 2010, J NEUROSCI METH, V190, P240, DOI 10.1016/j.jneumeth.2010.05.004
   Tseng CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098904
   Tseng CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32176
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Willison HJ, 2005, J PERIPHER NERV SYST, V10, P94, DOI 10.1111/j.1085-9489.2005.0010202.x
   Yu JH, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070165
   Yu JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45171
NR 47
TC 5
Z9 6
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2018
VL 12
IS 10
AR e0006848
DI 10.1371/journal.pntd.0006848
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ3WJ
UT WOS:000449318100049
PM 30356305
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sassetti, M
   Ze-Ze, L
   Franco, J
   da Cunha, J
   Gomes, A
   Tome, A
   Alves, MJ
AF Sassetti, Madalena
   Ze-Ze, Libia
   Franco, Joao
   da Cunha, Jose
   Gomes, Antonio
   Tome, Ana
   Alves, Maria-Joao
TI First case of confirmed congenital Zika syndrome in continental Africa
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Angola; congenital Zika syndrome; microcephaly; Portugal; Zika virus
ID VIRUS-INFECTION; PREGNANCY OUTCOMES; TERRITORIES; EPIDEMIC; INFANTS
AB Background: Zika virus has been responsible for recent outbreaks in the western hemisphere with known neurological complications such as microcephaly. This complication has not been previously documented in continental Africa.
   Methods: Neurological evaluation of the newborn was performed after birth, at one and two months of age. The mother and the newborn sera samples were tested by immunofluorescent assay (IFA; immunoglobulin G [IgG] and IgM) for Zika virus and the presence of Zika virus ribonucleic acid (RNA) was checked by qualitative real-time reverse transcription polymerase chain reaction (RT-PCR) in placenta, blood and urine samples.
   Results: We report on a newborn, born in Portugal, with microcephaly with confirmed congenital Zika virus infection (Asian Lineage) imported from Angola with typical clinical and imaging findings.
   Conclusions: To our knowledge this is the first report that shows the circulation of the Asian Lineage in Angola and the first report of a congenital Zika syndrome in continental Africa.
C1 [Sassetti, Madalena; Franco, Joao; da Cunha, Jose; Gomes, Antonio] Hosp Garcia Orta, Dept Paediat, Av Torrado Silva, P-2805267 Almada, Portugal.
   [Ze-Ze, Libia; Alves, Maria-Joao] Natl Inst Hlth Dr Ricardo Jorge, Ctr Vectors & Infect Dis Res, Av Liberdade 5, P-2965575 Aguas De Moura, Portugal.
   [Ze-Ze, Libia] Biosyst & Integrat Sci Inst BioISI, Edificio TecLabs,Campus FCUL, P-1749016 Lisbon, Portugal.
   [Tome, Ana] Hosp Garcia Orta, Dept Obstet & Gynecol, Av Torrado Silva, P-2805267 Almada, Portugal.
RP Sassetti, M (corresponding author), Hosp Garcia Orta, Dept Paediat, Av Torrado Silva, P-2805267 Almada, Portugal.
EM madalena.sassetti.ac@gmail.com
OI Alves, Maria Joao/0000-0003-0065-9000; Ze-Ze, Libia/0000-0001-7258-1439
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   WHO, WEEKL B OUTBR OTH EM
NR 16
TC 8
Z9 8
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD OCT
PY 2018
VL 112
IS 10
BP 458
EP 462
DI 10.1093/trstmh/try074
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HA0PR
UT WOS:000449910400005
PM 30053235
OA Bronze
DA 2020-07-08
ER

PT J
AU Tsui, I
   Moreira, MEL
   Rossetto, JD
   Vasconcelos, Z
   Gaw, SL
   Neves, LM
   Zin, OA
   Haefeli, L
   Silveira, JCB
   Gomes, SC
   Adachi, K
   Pone, MVD
   Pone, SM
   Pereira, JP
   Belfort, R
   Arumugaswami, V
   Brasil, P
   Nielsen-Saines, K
   Zin, AA
AF Tsui, Irena
   Lopes Moreira, Maria Elisabeth
   Rossetto, Julia D.
   Vasconcelos, Zilton
   Gaw, Stephanie L.
   Neves, Luiza M.
   Zin, Olivia A.
   Haefeli, Lorena
   Barros Silveira Filho, Joel Carlos
   Gomes, Saint Clair, Jr.
   Adachi, Kristina
   da Silva Pone, Marcos Vinicius
   Pone, Sheila Moura
   Pereira, Jose Paulo, Jr.
   Belfort, Rubens
   Arumugaswami, Vaithilingaraja
   Brasil, Patricia
   Nielsen-Saines, Karin
   Zin, Andrea A.
TI Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus
   Exposure
SO PEDIATRICS
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; OPHTHALMIC MANIFESTATIONS; MACULAR
   ATROPHY; INFECTION; STATES
AB OBJECTIVES:To characterize ophthalmic manifestations of confirmed or suspected antenatal Zika virus (ZIKV) exposure.METHODS:Infants with antenatal ZIKV exposure were referred for evaluation during the 2015-2016 Rio de Janeiro outbreak. Mothers with symptomatic ZIKV infection during pregnancy and/or infants with microcephaly or other findings that were suggestive of suspected antenatal exposure were tested with reverse transcriptase polymerase chain reaction (RT-PCR). Complete eye examinations were performed by pediatric ophthalmologists between January 2016 and February 2017. The main outcome measure was eye abnormalities in RT-PCR-positive and suspected (ie, not tested or RT-PCR-negative) antenatal ZIKV cases.RESULTS:Of 224 infants, 189 had RT-PCR testing performed. Of 189 patients, 156 had positive RT-PCR results in their blood, urine, and/or placenta. Of 224 infants, 90 had central nervous system (CNS) abnormalities, including microcephaly (62 infants). Eye abnormalities were present in 57 of 224 (25.4%) infants. Optic nerve (44 of 57; 77.2%) and retina abnormalities (37 of 57; 64.9%) were the most common. The group with suspected ZIKV infection (68 infants) had proportionally more eye (36.8% vs 20.5%; P = .022) and CNS abnormalities (68.3% vs 28.1%; P = .008), likely because of referral patterns. Eye abnormalities consistent with ZIKV infection were clinically comparable in both RT-PCR-positive and unconfirmed groups, including 4 RT-PCR-positive infants of 5 without any CNS abnormalities.CONCLUSIONS:Similar eye manifestations were identified regardless of laboratory confirmation. Well-appearing infants were also found to have eye abnormalities. Therefore, all infants born after ZIKV outbreaks should be universally screened for eye abnormalities.
C1 [Tsui, Irena; Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Opthalmol, Retina Div, Los Angeles, CA USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA.
   [Lopes Moreira, Maria Elisabeth; Rossetto, Julia D.; Vasconcelos, Zilton; Neves, Luiza M.; Haefeli, Lorena; Gomes, Saint Clair, Jr.; da Silva Pone, Marcos Vinicius; Zin, Andrea A.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; Pereira, Jose Paulo, Jr.; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Neves, Luiza M.; Zin, Olivia A.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil.
   [Barros Silveira Filho, Joel Carlos] Univ Unigranrio, Dept Ophthalmol, Rio De Janeiro, Brazil.
   [Belfort, Rubens] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.
RP Zin, AA (corresponding author), Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, Brazil.
EM andreazin@iff.fiocruz.br
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; da Silva Pone, Marcos
   Vinicius/N-1285-2019; Junior, Clair Gomes/F-7579-2012; Junior, Clair
   Gomes/W-8940-2019; Vasconcelos, Zilton/AAD-5784-2019
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Junior, Clair
   Gomes/0000-0002-1554-943X; Junior, Clair Gomes/0000-0002-1554-943X;
   Vasconcelos, Zilton/0000-0002-2193-2224; da Silva Pone, Marcos
   Vinicius/0000-0002-5152-2242; Moura Pone, Sheila/0000-0002-6246-8915
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [441098/2016-9]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI AI128697]; National Eye InstituteUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [R21EY028318-01];
   Research to Prevent BlindnessResearch to Prevent Blindness (RPB);
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
FX Supported by the Brazilian National Council for Scientific and
   Technological Development (grant 441098/2016-9), the National Institute
   of Allergy and Infectious Diseases (grant AI AI128697), and the National
   Eye Institute (grant R21EY028318-01). Dr Tsui was supported in part by a
   Research to Prevent Blindness unrestricted grant given to the Jules
   Stein Eye Institute. Funded by the National Institutes of Health (NIH).
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, PREV COMB DENG CHIUN
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Freitas BD, 2017, OPHTHALMOLOGY, V124, P1876, DOI 10.1016/j.ophtha.2017.06.009
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Rifkin LM, 2016, JAMA OPHTHALMOL, V134, P1427, DOI 10.1001/jamaophthalmol.2016.4299
   Secretaria Municipal de Saude, PREF RIO DE JAN
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 35
TC 5
Z9 5
U1 0
U2 0
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD OCT
PY 2018
VL 142
IS 4
AR e20181104
DI 10.1542/peds.2018-1104
PG 8
WC Pediatrics
SC Pediatrics
GA GZ0EU
UT WOS:000449034300029
PM 30213843
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Goodfellow, FT
   Willard, KA
   Wu, X
   Scoville, S
   Stice, SL
   Brindley, MA
AF Goodfellow, Forrest T.
   Willard, Katherine A.
   Wu, Xian
   Scoville, Shelley
   Stice, Steven L.
   Brindley, Melinda A.
TI Strain-Dependent Consequences of Zika Virus Infection and Differential
   Impact on Neural Development
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; neural progenitor cells; neurons
ID MOUSE-BRAIN; STEM-CELLS; LONG-TERM; FETAL; PROGENITORS; REPLICATION;
   APOPTOSIS
AB Maternal infection with Zika virus (ZIKV) during pregnancy can result in neonatal abnormalities, including neurological dysfunction and microcephaly. Experimental models of congenital Zika syndrome identified neural progenitor cells as a target of viral infection. Neural progenitor cells are responsible for populating the developing central nervous system with neurons and glia. Neural progenitor dysfunction can lead to severe birth defects, namely, lissencephaly, microcephaly, and cognitive deficits. For this study, the consequences of ZIKV infection in human pluripotent stem cell-derived neural progenitor (hNP) cells and neurons were evaluated. ZIKV isolates from Asian and African lineages displayed lineage-specific replication kinetics, cytopathic effects, and impacts on hNP function and neuronal differentiation. The currently circulating ZIKV isolates exhibit a unique profile of virulence, cytopathic effect, and impaired cellular functions that likely contribute to the pathological mechanism of congenital Zika syndrome. The authors found that infection with Asian-lineage ZIKV isolates impaired the proliferation and migration of hNP cells, and neuron maturation. In contrast, the African-lineage infections resulted in abrupt and extensive cell death. This work furthers the understanding of ZIKV-induced brain pathology.
C1 [Goodfellow, Forrest T.; Wu, Xian; Stice, Steven L.] Univ Georgia, Coll Agr & Environm Sci, Regenerat Biosci Ctr, Dept Anim & Dairy Sci, Athens, GA 30602 USA.
   [Willard, Katherine A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
   [Scoville, Shelley] ArunA Biomed, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis,Dept Populat Hlth, Athens, GA 30602 USA.
RP Stice, SL (corresponding author), Univ Georgia, Coll Agr & Environm Sci, Regenerat Biosci Ctr, Dept Anim & Dairy Sci, Athens, GA 30602 USA.; Brindley, MA (corresponding author), Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis,Dept Populat Hlth, Athens, GA 30602 USA.
EM forrestgoodfellow@gmail.com; katherine.willard@duke.edu;
   xian.wu@nih.gov; sscoville@arunabio.com; sstice@uga.edu;
   mbrindle@uga.edu
OI Brindley, Melinda/0000-0002-4929-8085; Willard,
   Katherine/0000-0002-0044-2664
FU University of Georgia
FX This research received no external funding; the project was supported by
   funds from the University of Georgia.
CR Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Bertipaglia C, 2018, SEMIN CELL DEV BIOL, V82, P57, DOI 10.1016/j.semcdb.2017.11.033
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bizzotto S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00030
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870
   Gomme EA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002971
   Goodfellow FT, 2016, ADV FUNCT MATER, V26, P3899, DOI 10.1002/adfm.201504444
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Harrill JA, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0099-9
   Harrill JA, 2010, NEUROTOXICOLOGY, V31, P277, DOI 10.1016/j.neuro.2010.02.003
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ivanov VN, 2014, APOPTOSIS, V19, P399, DOI 10.1007/s10495-013-0925-4
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu J.S., 2012, JASPERS BASIC MECH E
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu X, 2017, TOXICOL SCI, V157, P410, DOI 10.1093/toxsci/kfx056
   Wu X, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0107-4
   Yi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175744
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Young A, 2011, NEUROSCIENCE, V192, P793, DOI 10.1016/j.neuroscience.2011.04.039
   Young A, 2010, J NEUROSCI RES, V88, P3222, DOI 10.1002/jnr.22499
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
NR 56
TC 7
Z9 7
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2018
VL 10
IS 10
AR 550
DI 10.3390/v10100550
PG 15
WC Virology
SC Virology
GA GY7UL
UT WOS:000448821200038
PM 30304805
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marquez-Jurado, S
   Nogales, A
   Avila-Perez, G
   Iborra, FJ
   Martinez-Sobrido, L
   Almazan, F
AF Marquez-Jurado, Silvia
   Nogales, Aitor
   Avila-Perez, Gines
   Iborra, Francisco J.
   Martinez-Sobrido, Luis
   Almazan, Fernando
TI An Alanine-to-Valine Substitution in the Residue 175 of Zika Virus NS2A
   Protein Affects Viral RNA Synthesis and Attenuates the Virus In Vivo
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; Full-length cDNA infectious clones; Bacterial artificial
   chromosome; NS2A protein
ID BACTERIAL ARTIFICIAL CHROMOSOME; INFECTIOUS CDNA-CLONE;
   ESCHERICHIA-COLI; NONSTRUCTURAL PROTEINS; DENGUE VIRUS; DNA;
   RECOMBINATION; REPLICON; VITRO; GENE
AB The recent outbreaks of Zika virus (ZIKV), its association with Guillain-Barre syndrome and fetal abnormalities, and the lack of approved vaccines and antivirals, highlight the importance of developing countermeasures to combat ZIKV disease. In this respect, infectious clones constitute excellent tools to accomplish these goals. However, flavivirus infectious clones are often difficult to work with due to the toxicity of some flavivirus sequences in bacteria. To bypass this problem, several alternative approaches have been applied for the generation of ZIKV clones including, among others, in vitro ligation, insertions of introns and using infectious subgenomic amplicons. Here, we report a simple and novel DNA-launched approach based on the use of a bacterial artificial chromosome (BAC) to generate a cDNA clone of Rio Grande do Norte Natal ZIKV strain. The sequence was identified from the brain tissue of an aborted fetus with microcephaly. The BAC clone was fully stable in bacteria and the infectious virus was efficiently recovered in Vero cells through direct delivery of the cDNA clone. The rescued virus yielded high titers in Vero cells and was pathogenic in a validated mouse model (A129 mice) of ZIKV infection. Furthermore, using this infectious clone we have generated a mutant ZIKV containing a single amino acid substitution (A175V) in the NS2A protein that presented reduced viral RNA synthesis in cell cultures, was highly attenuated in vivo and induced fully protection against a lethal challenge with ZIKV wild-type. This BAC approach provides a stable and reliable reverse genetic system for ZIKV that will help to identify viral determinants of virulence and facilitate the development of vaccine and therapeutic strategies.
C1 [Marquez-Jurado, Silvia; Iborra, Francisco J.; Almazan, Fernando] Campus Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, Madrid 28049, Spain.
   [Nogales, Aitor; Avila-Perez, Gines; Martinez-Sobrido, Luis] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.
RP Almazan, F (corresponding author), Campus Univ Autonoma Madrid, CSIC, CNB, Dept Mol & Cell Biol, 3 Darwin St, Madrid 28049, Spain.; Martinez-Sobrido, L (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA.
EM smarquez@cnb.csic.es; aitor_nogales@urmc.rochester.edu;
   Gines_Perez@urmc.rochester.edu; fjiborra@cnb.csic.es;
   luis_martinez@urmc.rochester.edu; falmazan@cnb.csic.es
RI Almazan, Fernando/K-8781-2015; Marquez-Jurado, Silvia/K-8072-2015
OI Almazan, Fernando/0000-0002-5752-8469; iborra,
   francisco/0000-0002-0692-3696; Marquez-Jurado,
   Silvia/0000-0003-4592-9756; Martinez-Sobrido, Luis/0000-0001-7084-0804;
   NOGALES, AITOR/0000-0002-2424-7900
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [BFU2016-79127-R]; National Institute of Health (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [1R21AI120500]
FX This research was funded by the Spanish Ministry of Economy and
   Competitiveness (MINECO) (grant number BFU2016-79127-R) to F.A. and
   F.J.I. and the National Institute of Health (NIH) (grant number
   1R21AI120500) to L.M.-S. and F.A.
CR Almazan F, 2000, P NATL ACAD SCI USA, V97, P5516, DOI 10.1073/pnas.97.10.5516
   Almazan F, 2006, J VIROL, V80, P10900, DOI 10.1128/JVI.00385-06
   Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   [Anonymous], FAV
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Balint A, 2012, J VIROL, V86, P6258, DOI 10.1128/JVI.00189-12
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dubensky TW, 1996, J VIROL, V70, P508, DOI 10.1128/JVI.70.1.508-519.1996
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V317, P246, DOI 10.1001/jama.2016.20447
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Jamsai D, 2003, GENOMICS, V82, P68, DOI 10.1016/S0888-7543(03)00100-9
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Munster M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070368
   Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3
   National Research Council, 2011, GUIDE CARE USE LAB A
   Nogales A, 2017, VIROLOGY, V500, P1, DOI 10.1016/j.virol.2016.10.008
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rossi SL, 2007, VIROLOGY, V364, P184, DOI 10.1016/j.virol.2007.02.009
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   St-Jean JR, 2006, J VIROL, V80, P3670, DOI 10.1128/JVI.80.7.3670-3674.2006
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Usme-Ciro JA, 2014, VIRUS RES, V180, P12, DOI 10.1016/j.virusres.2013.12.001
   Wang K, 1997, BIOTECHNIQUES, V23, P992, DOI 10.2144/97236bm04
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417
NR 67
TC 9
Z9 9
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2018
VL 10
IS 10
AR 547
DI 10.3390/v10100547
PG 21
WC Virology
SC Virology
GA GY7UL
UT WOS:000448821200035
PM 30301244
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Setoh, YX
   Peng, NY
   Nakayama, E
   Amarilla, AA
   Prow, NA
   Suhrbier, A
   Khromykh, AA
AF Setoh, Yin Xiang
   Peng, Nias Y.
   Nakayama, Eri
   Amarilla, Alberto A.
   Prow, Natalie A.
   Suhrbier, Andreas
   Khromykh, Alexander A.
TI Fetal Brain Infection Is Not a Unique Characteristic of Brazilian Zika
   Viruses
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; pregnancy; fetal infection; congenital Zika syndrome; Asian
   lineage
ID AEDES-AEGYPTI MOSQUITOS; MICE; TRANSMISSION; REPLICATION; EPIDEMIC;
   AMERICA
AB The recent emergence of Zika virus (ZIKV) in Brazil was associated with an increased number of fetal brain infections that resulted in a spectrum of congenital neurological complications known as congenital Zika syndrome (CZS). Herein, we generated de novo from sequence data an early Asian lineage ZIKV isolate (ZIKV-MY; Malaysia, 1966) not associated with microcephaly and compared the in vitro replication kinetics and fetal brain infection in interferon alpha/beta receptor 1 knockout (IFNAR1(-/-)) dams of this isolate and of a Brazilian isolate (ZIKV-Natal; Natal, 2015) unequivocally associated with microcephaly. The replication efficiencies of ZIKV-MY and ZIKV-Natal in A549 and Vero cells were similar, while ZIKV-MY replicated more efficiently in wild-type (WT) and IFNAR(-/-) mouse embryonic fibroblasts. Viremias in IFNAR1(-/-) dams were similar after infection with ZIKV-MY or ZIKV-Natal, and importantly, infection of fetal brains was also not significantly different. Thus, fetal brain infection does not appear to be a unique feature of Brazilian ZIKV isolates.
C1 [Setoh, Yin Xiang; Peng, Nias Y.; Amarilla, Alberto A.; Khromykh, Alexander A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
   [Nakayama, Eri; Prow, Natalie A.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld 4006, Australia.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.
RP Khromykh, AA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.; Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld 4006, Australia.
EM y.setoh@uq.edu.au; y.g.peng@uq.net.au;
   Eri.Nakayama@qimrberghofer.edu.au; a.amarillaortiz@uq.edu.au;
   Natalie.Prow@qimrberghofer.edu.au;
   andreas.suhrbier@qimrberghofer.edu.au; alexander.khromykh@uq.edu.au
RI Setoh, Yin Xiang/K-4503-2012; Peng, Yong Gao/J-9329-2017; Khromykh,
   Alexander/X-7200-2018
OI Setoh, Yin Xiang/0000-0002-1683-3555; Peng, Yong
   Gao/0000-0002-7488-5441; AMARILLA ORTIZ, Alberto/0000-0002-6640-3377;
   Khromykh, Alexander/0000-0001-6206-6935
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia
   [APP1144950]; Advance Queensland Research Fellowship from the Queensland
   Government, Australia; Daiichi Sankyo Foundation of Life Science, Japan
FX This research was funded by the National Health and Medical Research
   Council (NHMRC) of Australia, grant number APP1144950. A.A.K. and A.S.
   are Research Fellows with the NHMRC. N.A.P. was supported by an Advance
   Queensland Research Fellowship from the Queensland Government,
   Australia. E.N. was supported in part by the Daiichi Sankyo Foundation
   of Life Science, Japan.
CR Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
NR 35
TC 8
Z9 8
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2018
VL 10
IS 10
AR 541
DI 10.3390/v10100541
PG 10
WC Virology
SC Virology
GA GY7UL
UT WOS:000448821200029
PM 30282919
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, S
   Kumar, A
AF Singh, Sneha
   Kumar, Ashok
TI Ocular Manifestations of Emerging Flaviviruses and the Blood-Retinal
   Barrier
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; eye; zika virus; blood-retinal barrier; ocular; innate
   response
ID ZIKA VIRUS-INFECTION; KYASANUR-FOREST-DISEASE; DENGUE VIRUS; JAPANESE
   ENCEPHALITIS; ISCHEMIC MACULOPATHY; IMMUNE-MECHANISMS; FEVER;
   PATHOGENESIS; CYTOKINE; FUTURE
AB Despite flaviviruses remaining the leading cause of systemic human infections worldwide, ocular manifestations of these mosquito-transmitted viruses are considered relatively uncommon in part due to under-reporting. However, recent outbreaks of Zika virus (ZIKV) implicated in causing multiple ocular abnormalities, such as conjunctivitis, retinal hemorrhages, chorioretinal atrophy, posterior uveitis, optic neuritis, and maculopathies, has rejuvenated a significant interest in understanding the pathogenesis of flaviviruses, including ZIKV, in the eye. In this review, first, we summarize the current knowledge of the major flaviviruses (Dengue, West Nile, Yellow Fever, and Japanese Encephalitis) reported to cause ocular manifestations in humans with emphasis on recent ZIKV outbreaks. Second, being an immune privilege organ, the eye is protected from systemic infections by the presence of blood-retinal barriers (BRB). Hence, we discuss how flaviviruses modulate retinal innate response and breach the protective BRB to cause ocular or retinal pathology. Finally, we describe recently identified infection signatures of ZIKV and discuss whether these system biology-predicted genes or signaling pathways (e.g., cellular metabolism) could contribute to the pathogenesis of ocular manifestations and assist in the development of ocular antiviral therapies against ZIKV and other flaviviruses.
C1 [Singh, Sneha; Kumar, Ashok] Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48201 USA.
   [Kumar, Ashok] Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA.
RP Kumar, A (corresponding author), Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48201 USA.; Kumar, A (corresponding author), Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA.
EM gq8860@wayne.edu; akuma@med.wayne.edu
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R21AI135583,
   R01EY026964, R01 EY027381, P30EY004068]; Research to Prevent Blindness
   Inc.Research to Prevent Blindness (RPB)
FX Research in our laboratory is supported in parts by National Institute
   of Health (NIH) Grants (R21AI135583, R01EY026964, and R01 EY027381 to
   A.K.), NIH Core Grant P30EY004068 (to Linda D. Hazlett), and an
   unrestricted grant from Research to Prevent Blindness Inc. (to Kresge
   Eye Institute, Wayne State University).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abroug F, 2006, MAYO CLIN PROC, V81, P12, DOI 10.4065/81.1.12
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Alshekhlee A, 2006, ARCH NEUROL-CHICAGO, V63, P1324, DOI 10.1001/archneur.63.9.1324
   [Anonymous], 1983, Indian J Ophthalmol, V31, P700
   Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Ben Yahia S, 2009, INT J MED SCI, V6, P114
   Beral L, 2008, OPHTHALMOLOGY, V115, P1524
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Birlutiu Victoria, 2014, J Med Case Rep, V8, P232, DOI 10.1186/1752-1947-8-232
   Boo YL, 2016, TZU CHI MED J, V28, P157, DOI 10.1016/j.tcmj.2015.09.007
   Callender DM, 2019, GLOB PUBLIC HEALTH, V14, P445, DOI 10.1080/17441692.2018.1512144
   Campbell M, 2013, ADV EXP MED BIOL, V763, P70
   Carr JM, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3164375
   Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446
   Chan DPL, 2006, EMERG INFECT DIS, V12, P285
   Chee E, 2009, AM J OPHTHALMOL, V148, P910, DOI 10.1016/j.ajo.2009.06.030
   Chin MS, 2001, INVEST OPHTH VIS SCI, V42, P2338
   Contreras D., 2017, MODELING ZIKA VIRUS, DOI [10.1101/128405, DOI 10.1101/128405]
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Cruz-Villegas V, 2003, RETINA-J RET VIT DIS, V23, P576, DOI 10.1097/00006982-200308000-00031
   de Andrade Gabriel Costa, 2017, Int J Retina Vitreous, V3, P4, DOI 10.1186/s40942-016-0057-4
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   de Silva AM, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029371
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diaz-Coranguez M, 2017, VISION RES, V139, P123, DOI 10.1016/j.visres.2017.05.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donnio A, 2010, CAN J OPHTHALMOL, V45, P183, DOI 10.1139/i09-207
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Fang ST, 2006, EYE, V20, P1439, DOI 10.1038/sj.eye.6702301
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Fronk AH, 2016, J TISSUE ENG, V7, DOI 10.1177/2041731416650838
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Garg S, 2005, SURV OPHTHALMOL, V50, P3, DOI 10.1016/j.survophthal.2004.10.001
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Igarashi A, 2002, CURR TOP MICROBIOL, V267, P139
   ISHII T, 1977, ACTA NEUROPATHOL, V38, P181, DOI 10.1007/BF00688063
   Jampol LM, 2015, JAMA OPHTHALMOL, V133, P1105, DOI 10.1001/jamaophthalmol.2015.2400
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Khairallah M, 2006, OPHTHAL SURG LAS IM, V37, P240, DOI 10.3928/15428877-20060501-11
   Khairallah M, 2004, OPHTHALMOLOGY, V111, P2065, DOI 10.1016/j.ophtha.2004.03.032
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kumar A, 2016, CELL MICROBIOL, V18, P1815, DOI 10.1111/cmi.12625
   Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lim WK, 2004, OPHTHALMOLOGY, V111, P2057, DOI 10.1016/j.ophtha.2004.03.038
   LUDWIG GV, 1993, IN VITRO CELL DEV-AN, V29A, P296, DOI 10.1007/BF02633958
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Mangione Julia N A, 2014, Trop Med Health, V42, P137, DOI 10.2149/tmh.2014-09
   Mankouri J, 2011, REV MED VIROL, V21, P205, DOI 10.1002/rmv.687
   de Aragao REM, 2010, ARQ BRAS OFTALMOL, V73, P175, DOI 10.1590/S0004-27492010000200015
   MATHUR A, 1992, INT J EXP PATHOL, V73, P603
   Merle H, 2018, J FR OPHTALMOL, V41, pE235, DOI 10.1016/j.jfo.2018.05.002
   Merle H, 2017, JAMA OPHTHALMOL, V135, P284, DOI 10.1001/jamaophthalmol.2016.5689
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Momma Y, 2003, INVEST OPHTH VIS SCI, V44, P2026, DOI 10.1167/iovs.02-0980
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mourya DT, 2012, J VIROL METHODS, V186, P49, DOI 10.1016/j.jviromet.2012.07.019
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495
   PERCOPO CM, 1990, J IMMUNOL, V145, P4101
   Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   RAO R L, 1958, J Indian Med Assoc, V31, P113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Sanna A, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.36.1800471
   Saranappa SBS, 2012, INDIAN PEDIATR, V49, P760, DOI 10.1007/s13312-012-0142-1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Seet RCS, 2007, J CLIN VIROL, V38, P101, DOI 10.1016/j.jcv.2006.11.002
   Shah SZ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00149
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Sirisena Nadeera, 2017, VirusDisease, V28, P341, DOI 10.1007/s13337-017-0401-9
   Sivakumar RR, 2013, OPHTHALMOLOGY, V120, P1820, DOI 10.1016/j.ophtha.2013.02.006
   SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Tabbara K, 2012, ANN SAUDI MED, V32, P530, DOI 10.5144/0256-4947.2012.30.4.1105
   Taylor AW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00037
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Voigt U, 2001, KLIN MONATSBL AUGENH, V218, P688, DOI 10.1055/s-2001-18392
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   WORK T H, 1957, Indian J Med Sci, V11, P619
   WORK TH, 1959, AM J PUBLIC HEALTH N, V49, P869, DOI 10.2105/AJPH.49.7.869
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P1701, DOI 10.1167/iovs.06-0697
   Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194
   Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu S, 2017, ANTIVIR RES, V145, P70, DOI 10.1016/j.antiviral.2017.07.012
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 129
TC 14
Z9 14
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD OCT
PY 2018
VL 10
IS 10
AR 530
DI 10.3390/v10100530
PG 20
WC Virology
SC Virology
GA GY7UL
UT WOS:000448821200018
PM 30274199
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leonhard, SE
   Munts, AG
   van der Eijk, AA
   Jacobs, BC
AF Leonhard, Sonja E.
   Munts, Alexander G.
   van der Eijk, Annemiek A.
   Jacobs, Bart C.
TI Acute-onset chronic inflammatory demyelinating polyneuropathy after Zika
   virus infection
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Editorial Material
ID GUILLAIN-BARRE-SYNDROME
C1 [Leonhard, Sonja E.] Erasmus Univ, Dept Neurol, Med Ctr, NL-3000CB Rotterdam, Netherlands.
   [Munts, Alexander G.] Spaarne Gasthuis Hosp, Dept Neurol, Haarlem, Netherlands.
   [van der Eijk, Annemiek A.] Erasmus Univ, Dept Virosci, Med Ctr, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus Univ, Dept Neurol & Immunol, Med Ctr, Rotterdam, Netherlands.
RP Leonhard, SE (corresponding author), Erasmus Univ, Dept Neurol, Med Ctr, NL-3000CB Rotterdam, Netherlands.
EM s.leonhard@erasmusmc.nl
OI Leonhard, Sonja/0000-0003-4832-6926
FU European UnionEuropean Union (EU) [734584]
FX The study was funded by a grant from the European Union (Horizon 2020,
   ZikaPLAN Grant Agreement No. 734584).
CR Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x
   World Health Organization, 2017, ZIK SIT REP 10 MARCH
NR 5
TC 3
Z9 4
U1 0
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD OCT
PY 2018
VL 89
IS 10
BP 1118
EP +
DI 10.1136/jnnp-2017-317346
PG 2
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA GZ0AE
UT WOS:000449016200179
PM 29175895
DA 2020-07-08
ER

PT J
AU Bamford, CGG
   Aranday-Cortes, E
   Filipe, IC
   Sukumar, S
   Mair, D
   Filipe, AD
   Mendoza, JL
   Garcia, KC
   Fan, S
   Tishkoff, SA
   McLauchlan, J
AF Bamford, Connor G. G.
   Aranday-Cortes, Elihu
   Filipe, Ines Cordeiro
   Sukumar, Swathi
   Mair, Daniel
   Filipe, Ana da Silva
   Mendoza, Juan L.
   Garcia, K. Christopher
   Fan, Shaohua
   Tishkoff, Sarah A.
   McLauchlan, John
TI A polymorphic residue that attenuates the antiviral potential of
   interferon lambda 4 in hominid lineages
SO PLOS PATHOGENS
LA English
DT Article
ID HEPATITIS-C VIRUS; GENETIC-VARIATION; STIMULATED GENES; RNA REPLICATION;
   INFECTION; CHIMPANZEES; GENOME; EXPRESSION; CLEARANCE; COMPLEX
AB As antimicrobial signalling molecules, type III or lambda interferons (IFN lambda s) are critical for defence against infection by diverse pathogens, including bacteria, fungi and viruses. Counter-intuitively, expression of one member of the family, IFN lambda 4, is associated with decreased clearance of hepatitis C virus (HCV) in the human population; by contrast, a natural frameshift mutation that abrogates IFN lambda 4 production improves HCV clearance. To further understand how genetic variation between and within species affects IFN lambda 4 function, we screened a panel of all known extant coding variants of human IFN lambda 4 for their antiviral potential and identify three that substantially affect activity: P70S, L79F and K154E. The most notable variant was K154E, which was found in African Congo rainforest 'Pygmy' hunter-gatherers. K154E greatly enhanced in vitro activity in a range of antiviral (HCV, Zika virus, influenza virus and encephalomyocarditis virus) and gene expression assays. Remarkably, E154 is the ancestral residue in mammalian IFN lambda 4s and is extremely well conserved, yet K154 has been fixed throughout evolution of the hominid genus Homo, including Neanderthals. Compared to chimpanzee IFN lambda 4, the human orthologue had reduced activity due to amino acid K154. Comparison of published gene expression data from humans and chimpanzees showed that this difference in activity between K154 and E154 in IFN lambda 4 correlates with differences in antiviral gene expression in vivo during HCV infection. Mechanistically, our data show that the human-specific K154 negatively affects IFN lambda 4 activity through a novel means by reducing its secretion and potency. We thus demonstrate that attenuated activity of IFN lambda 4 is conserved among humans and postulate that differences in IFN lambda 4 activity between species contribute to distinct host-specific responses to-and outcomes of-infection, such as HCV infection. The driver of reduced IFN lambda 4 antiviral activity in humans remains unknown but likely arose between 6 million and 360,000 years ago in Africa.
C1 [Bamford, Connor G. G.; Aranday-Cortes, Elihu; Filipe, Ines Cordeiro; Sukumar, Swathi; Mair, Daniel; Filipe, Ana da Silva; McLauchlan, John] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Mendoza, Juan L.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.
   [Mendoza, Juan L.; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.
   [Fan, Shaohua; Tishkoff, Sarah A.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA.
   [Fan, Shaohua; Tishkoff, Sarah A.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.
RP McLauchlan, J (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
EM john.mclauchlan@glasgow.ac.uk
RI Aranday-Cortes, Elihu/G-3706-2012
OI Aranday-Cortes, Elihu/0000-0003-2637-2307; Mair,
   Daniel/0000-0001-7169-9080; Filipe, Ines/0000-0001-6052-3506; Bamford,
   Connor/0000-0003-4895-1983
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K01CA175127,
   1R01DK104339-0, 1R01GM113657-01]; UK Medical Research CouncilMedical
   Research Council UK (MRC) [MC_UU_12014/1]
FX JLM is supported by National Institutes of Health (https://www.nih.gov/)
   award K01CA175127. SF and SAT were supported by National Institutes of
   Health (https://www.nih.gov/) grants 1R01DK104339-0 and 1R01GM113657-01.
   This work was funded by the UK Medical Research Council
   (https://mrc.ukri.org/) (MC_UU_12014/1). The funders had no role in
   study design, datacollection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393
   Ansari MA, 2017, NAT GENET, V49, P666, DOI 10.1038/ng.3835
   Bassett SE, 1998, J VIROL, V72, P2589, DOI 10.1128/JVI.72.4.2589-2599.1998
   Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004
   Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001
   Boldanova T, 2017, EMBO MOL MED, V9, P816, DOI 10.15252/emmm.201607006
   Bukh J, 2004, HEPATOLOGY, V39, P1469, DOI 10.1002/hep.20268
   Cohen TS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003682
   Cowton VM, 2016, J VIROL, V90, P7456, DOI 10.1128/JVI.00685-16
   Dill MT, 2012, GASTROENTEROLOGY, V143, P777, DOI 10.1053/j.gastro.2012.05.044
   Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dorningues P, 2015, J GEN VIROL, V96, P3236, DOI 10.1099/jgv.0.000283
   Dyla E, 2013, EMBO J, V32, P3055, DOI [10.1038/EMBOJ.2013.232, DOI 10.1038/EMBOJ.2013.232]
   Dyla E, 2014, NAT COMMUN, V5, P5699, DOI [10.1038/ncommns669, DOI 10.1038/NCOMMNS669]
   Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422
   Espinosa V, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5357
   Foupouapouognigni Y, 2011, J CLIN MICROBIOL, V49, P737, DOI 10.1128/JCM.01475-10
   Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021
   Gad HH, 2009, J BIOL CHEM, V284, P20869, DOI 10.1074/jbc.M109.002923
   Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025
   Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   Hong MA, 2016, J EXP MED, V213, P2539, DOI 10.1084/jem.20160437
   Jones DM, 2010, J GEN VIROL, V91, P2238, DOI 10.1099/vir.0.022210-0
   Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009
   Lanford RE, 2007, HEPATOLOGY, V46, P999, DOI 10.1002/hep.21776
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lu YF, 2015, VIROLOGY, V476, P334, DOI 10.1016/j.virol.2014.12.020
   Luangsay S, 2015, J HEPATOL, V63, P1077, DOI 10.1016/j.jhep.2015.06.022
   Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964
   Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680
   Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052
   Mendoza JL, 2017, IMMUNITY, V46, P379, DOI 10.1016/j.immuni.2017.02.017
   Miknis ZJ, 2010, J MOL BIOL, V404, P650, DOI 10.1016/j.jmb.2010.09.068
   Mohamed M, 2009, J VIROL, V83, P7612, DOI 10.1128/JVI.02080-08
   Mulangu S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1607-y
   Nanda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003442
   Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100
   Njouom R, 2003, J MED VIROL, V71, P219, DOI 10.1002/jmv.10473
   O'Brien TR, 2015, J HEPATOL, V63, P1103, DOI 10.1016/j.jhep.2015.06.035
   Obajemu AA, 2017, J IMMUNOL, V199, P3808, DOI 10.4049/jimmunol.1700807
   Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915
   Paquin A, 2016, J INTERF CYTOK RES, V36, P30, DOI 10.1089/jir.2015.0096
   Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897
   Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789
   Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200
   Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001
   Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103
   Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Ray SC, 2000, J VIROL, V74, P3058, DOI 10.1128/JVI.74.7.3058-3066.2000
   Robinson MW, 2015, LIVER INT, V35, P2256, DOI 10.1111/liv.12830
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086
   Sheahan T, 2014, CELL HOST MICROBE, V15, P190, DOI 10.1016/j.chom.2014.01.007
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199
   Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299
   Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463
   Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Walker CM, 1997, SPRINGER SEMIN IMMUN, V19, P85, DOI 10.1007/BF00945027
   Yu C, 2010, J VIROL, V84, P11264, DOI 10.1128/JVI.01205-10
NR 72
TC 5
Z9 5
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD OCT
PY 2018
VL 14
IS 10
AR e1007307
DI 10.1371/journal.ppat.1007307
PG 35
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GY9PA
UT WOS:000448978700017
PM 30308076
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Batool, K
   Alam, I
   Zhao, GH
   Wang, JX
   Xu, J
   Yu, XQ
   Huang, EJ
   Guan, X
   Zhang, LL
AF Batool, Khadija
   Alam, Intikhab
   Zhao, Guohui
   Wang, Junxiang
   Xu, Jin
   Yu, Xiaoqiang
   Huang, Enjiong
   Guan, Xiong
   Zhang, Lingling
TI C-Type Lectin-20 Interacts with ALP1 Receptor to Reduce Cry Toxicity in
   Aedes aegypti
SO TOXINS
LA English
DT Article
DE Aedes aegypti; C-type lectin; Bacillus thuringiensis Cry11A; alkaline
   phosphatase; toxicity
ID THURINGIENSIS SUBSP ISRAELENSIS; ALKALINE-PHOSPHATASE;
   MOLECULAR-CLONING; ANOPHELES-GAMBIAE; CRYSTAL-STRUCTURE; INNATE
   IMMUNITY; BINDING PROTEIN; CRY11AA TOXIN; MIDGUT; EXPRESSION
AB Aedes aegypti is a crucial vector for human diseases, such as yellow fever, dengue, chikungunya, and Zika viruses. Today, a major challenge throughout the globe is the insufficient availability of antiviral drugs and vaccines against arboviruses, and toxins produced by Bacillus thuringiensis (Bt) are still used as biological agents for mosquito control. The use of Cry toxins to kill insects mainly depends on the interaction between Cry toxins and important toxin receptors, such as alkaline phosphatase (ALP). In this study, we investigated the function of A. aegypti C-type lectin-20 (CTL-20) in the tolerance of Cry toxins. We showed that recombinant CTL-20 protein interacted with both Cry11Aa and ALP1 by the Far-Western blot and ELISA methods, and CTL-20 bound to A. aegypti larval brush border membrane vesicles (BBMVs). Binding affinity of CTL-20 to ALP1 was higher than that of Cry11Aa to ALP1. Furthermore, the survival rate of A. aegypti larvae fed with Cry11Aa toxin mixed with recombinant CTL-20 fusion protein was significantly increased compared with that of the control larvae fed with Cry11Aa mixed with thioredoxin. Our novel results suggest that midgut proteins like CTLs may interfere with interactions between Cry toxins and toxin receptors by binding to both Cry toxins and receptors to alter Cry toxicity.
C1 [Batool, Khadija; Zhao, Guohui; Wang, Junxiang; Xu, Jin; Yu, Xiaoqiang; Guan, Xiong; Zhang, Lingling] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Coll Life Sci, Key Lab Biopesticides & Chem Biol,MOE, Fuzhou 350002, Fujian, Peoples R China.
   [Alam, Intikhab] Fujian Agr & Forestry Univ, Coll Crop Sci, Minist Educ, Key Lab Genet Breeding & Comprehens Utilizat Crop, Fuzhou 350002, Fujian, Peoples R China.
   [Yu, Xiaoqiang] Univ Missouri, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.
   [Huang, Enjiong] Fujian Int Travel Healthcare Ctr, Fuzhou 350001, Fujian, Peoples R China.
RP Zhang, LL (corresponding author), Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Coll Life Sci, Key Lab Biopesticides & Chem Biol,MOE, Fuzhou 350002, Fujian, Peoples R China.
EM khadijabatoolali@gmail.com; intikhabalam2013@gmail.com;
   Zhaogh1019@outlook.com; junxiangwang@outlook.com; xujinfafu@outlook.com;
   yux@umkc.edu; enjiong@163.com; guanxfafu@126.com;
   linglingzhang@fafu.edu.cn
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI117808]; National
   Natural Science Foundation of China [NSFC]National Natural Science
   Foundation of China [31301724]; foreign cooperative project of Fujian
   province [2018I0023]; Science and Technology Project of Fuzhou
   [2018-G-70]; Open Project Funds of State Key Laboratory for early
   development of microbial resources; Special Fund for Scientific and
   Technological Innovation of Fujian Agriculture and Forestry University
   [CXZX2017136, CXZX2017306, CXZX2017214, KF2015064-65]
FX This work was funded by National Institute of Health [grant number
   AI117808]; National Natural Science Foundation of China [NSFC, grant
   number 31301724]; the foreign cooperative project of Fujian province
   [2018I0023]; Science and Technology Project of Fuzhou [grant number
   2018-G-70]; Open Project Funds of State Key Laboratory for early
   development of microbial resources; and the Special Fund for Scientific
   and Technological Innovation of Fujian Agriculture and Forestry
   University [grant number CXZX2017136, CXZX2017306, CXZX2017214 and
   KF2015064-65].
CR Aliota MT, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-463
   Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   CARROLL J, 1993, EUR J BIOCHEM, V214, P771, DOI 10.1111/j.1432-1033.1993.tb17979.x
   Chai LQ, 2008, DEV COMP IMMUNOL, V32, P71, DOI 10.1016/j.dci.2007.04.006
   Chen JW, 2017, PEPTIDES, V98, P78, DOI 10.1016/j.peptides.2017.05.011
   Chen JW, 2013, INSECT BIOCHEM MOLEC, V43, P1201, DOI 10.1016/j.ibmb.2013.09.007
   Chen JW, 2009, INSECT BIOCHEM MOLEC, V39, P688, DOI 10.1016/j.ibmb.2009.08.003
   CHILCOTT CN, 1988, J GEN MICROBIOL, V134, P2551
   Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007
   Christophers S., 1960, AEDES AEGYPTI L YELL
   DAI SM, 1993, INSECT BIOCHEM MOLEC, V23, P273, DOI 10.1016/0965-1748(93)90008-G
   Darboux I, 2001, INSECT BIOCHEM MOLEC, V31, P981, DOI 10.1016/S0965-1748(01)00046-7
   Despres L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-926
   DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0
   Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517
   Fernandez LE, 2009, BIOCHEMISTRY-US, V48, P8899, DOI 10.1021/bi900979b
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guo ZJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005124
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218
   Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021
   Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128
   Johnson S, 2003, J ENVIRON SCI HEAL B, V38, P451, DOI 10.1081/PFC-120021665
   Lee SB, 2014, INSECT BIOCHEM MOLEC, V54, P112, DOI 10.1016/j.ibmb.2014.09.004
   LERECLUS D, 1995, BIO-TECHNOL, V13, P67, DOI 10.1038/nbt0195-67
   Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009
   Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P60, DOI 10.1053/j.spid.2004.09.013
   Mayer S, 2017, HISTOCHEM CELL BIOL, V147, P223, DOI 10.1007/s00418-016-1523-7
   Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296
   Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46
   Poncet S, 1997, APPL ENVIRON MICROB, V63, P4413, DOI 10.1128/AEM.63.11.4413-4420.1997
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Rao XJ, 2015, INSECT BIOCHEM MOLEC, V62, P75, DOI 10.1016/j.ibmb.2014.12.006
   Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200
   Shi XZ, 2012, AMINO ACIDS, V42, P2383, DOI 10.1007/s00726-011-0980-5
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474
   Tuiskunen-Back A., 2013, INFECT ECOL EPIDEMIO, V3, P19839, DOI [10.3402/iee.v3i0.1983924003364, DOI 10.3402/IEE.V3I0.19839]
   Wang PX, 2014, J BIOTECHNOL, V171, P1, DOI 10.1016/j.jbiotec.2013.11.023
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
   Xia XF, 2018, DEV COMP IMMUNOL, V83, P70, DOI 10.1016/j.dci.2017.11.020
   Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x
   Zhang LL, 2017, J AGR FOOD CHEM, V65, P10884, DOI 10.1021/acs.jafc.7b04427
   Zhang LL, 2010, MICROBIOL RES, V165, P133, DOI 10.1016/j.micres.2009.03.002
NR 53
TC 3
Z9 3
U1 1
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6651
J9 TOXINS
JI Toxins
PD OCT
PY 2018
VL 10
IS 10
AR 390
DI 10.3390/toxins10100390
PG 11
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA GY7UG
UT WOS:000448820400011
PM 30257487
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Caswell, RJ
   Manavi, K
AF Caswell, R. J.
   Manavi, K.
TI Emerging sexually transmitted viral infections: 2. Review of Zika virus
   disease
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Review
DE Viral disease; Zika virus
ID GUILLAIN-BARRE-SYNDROME; UPDATE INTERIM GUIDANCE; UNITED-STATES; CASE
   SERIES; TRANSMISSION; BRAZIL; JANUARY; DENGUE; COMPLICATIONS;
   ASSOCIATION
AB A sudden increase in the number of newborn infants with microcephaly in Brazil in 2015 brought Zika virus (ZIKV), a less-known infection, to public attention. The rapid increase in the number of cases across the Americas and the devastating complications of infection with ZIKV highlighted the gravity of the situation. Within a relatively short period of time, our knowledge of this infection has significantly increased. This includes the realisation that ZIKV can be sexually transmitted. The aim of the present article is to provide a concise summary on this novel sexually transmitted infection linked to human birth defects and Guillain-Barre Syndrome. According to World Health Organization, individuals living outside areas of ZIKV mosquito transmission where one or both partners have been exposed to ZIKV should abstain from sex or have sex with condoms for at least six months after the last day of possible exposure.
C1 [Caswell, R. J.; Manavi, K.] Queen Elizabeth Hosp Birmingham, Dept HIV & Genitourinary Med, Birmingham, W Midlands, England.
RP Manavi, K (corresponding author), Queen Elizabeth Hosp Birmingham, Dept GU Med, 3rd Floor,East Block,Heritage Bldg,Metchley Dr, Birmingham B15 2TH, W Midlands, England.
EM kaveh.manavi@uhb.nhs.uk
CR Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centre for Disease Control and Prevention, ZIK VIR ZIK INF CHIL
   Centres for Disease Control and Prevention, 2016, ZIK VIR DIAGN TEST C
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Orantes LD, 2020, NEUROLOGIA, V35, P160, DOI 10.1016/j.nrl.2017.07.019
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Report S, 2017, ZIK VIR MICR GUILL B
   Resiere D, 2018, J CLIN VIROL, V98, P8, DOI 10.1016/j.jcv.2017.11.002
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2017, PREV POT SEX TRANSM
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
NR 83
TC 1
Z9 1
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD OCT
PY 2018
VL 29
IS 12
BP 1238
EP 1246
DI 10.1177/0956462418779465
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GY1EZ
UT WOS:000448268900011
PM 29945539
DA 2020-07-08
ER

PT J
AU Zou, J
   Xie, XP
   Luo, HL
   Shan, C
   Muruato, AE
   Weaver, SC
   Wang, T
   Shi, PY
AF Zou, Jing
   Xie, Xuping
   Luo, Huanle
   Shan, Chao
   Muruato, Antonio E.
   Weaver, Scott C.
   Wang, Tian
   Shi, Pei-Yong
TI A single-dose plasmid-launched live-attenuated Zika vaccine induces
   protective immunity
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; DNA vaccine; live-attenuated vaccine; flavivirus
ID DNA VACCINE; NEUTRALIZING ANTIBODIES; INITIATES REPLICATION;
   ENCEPHALITIS-VIRUS; CLINICAL-TRIALS; IN-VITRO; MICE; IMMUNOGENICITY;
   INFECTION; AMERICA
AB Background: Vaccines are the most effective means to fight and eradicate infectious diseases. Live-attenuated vaccines (LAV) usually have the advantages of single dose, rapid onset of immunity, and durable protection. DNA vaccines have the advantages of chemical stability, ease of production, and no cold chain requirement. The ability to combine the strengths of LAV and DNA vaccines may transform future vaccine development by eliminating cold chain and cell culture with the potential for adventitious agents.
   Methods: A DNA-launched LAV was developed for ZIKV virus (ZIKV), a pathogen that recently caused a global public health emergency. The cDNA copy of a ZIKV LAV genome was engineered into a DNA plasmid. The DNA-LAV plasmid was delivered into mice using a clinically proven device TriGrid (TM) to launch the replication of LAV.
   Findings: A single-dose immunization as low as 0.5 mu g of DNA-LAV plasmid conferred 100% seroconversion in A129 mice. All seroconverted mice developed sterilizing immunity, as indicated by no detectable infectious viruses and no increase of neutralizing antibody titers after ZIKV challenge. The immunization also elicited robust T cell responses. In pregnant mice, the DNA-LAV vaccination fully protected against ZIKV-induced disease and maternal-to-fetal transmission. High levels of neutralizing activities were detected in fetal serum, indicating maternal-to-fetal humoral transfer. In male mice, a single-dose vaccination completely prevented testis infection, injury, and oligospermia.
   Interpretation: The remarkable simplicity and potency of ZIKV DNA-LAV warrant further development of this vaccine candidate. The DNA-LAV approach may serve as a universal vaccine platform for other plus-sense RNA viruses. (C) 2018 The Authors. Published by Elsevier B.V.
C1 [Zou, Jing; Xie, Xuping; Shan, Chao; Muruato, Antonio E.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, IN 77555 USA.
   [Luo, Huanle; Muruato, Antonio E.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, IN USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, IN USA.
   [Weaver, Scott C.; Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, IN USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, Galveston, IN USA.
   [Weaver, Scott C.; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol Mol Biophys, Galveston, IN USA.
   [Wang, Tian; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pathol, Galveston, IN USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, IN USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, IN 77555 USA.
EM peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019
FU McLaughlin Endowment at University of Texas Medical Branch; Novartis
   Institutes for BioMedical Research; University of Texas STARs Award;
   Kleberg Foundation Award; UTMB CTSAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR-001439];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI127744, AI099123, AI120942]; UTMB
   Sealy Institute for Vaccine Sciences Pilot Grant; Centers for Disease
   Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [U01CK000512]
FX J.Z. and X.X. were awarded with postdoctoral fellowships from the
   McLaughlin Endowment at University of Texas Medical Branch and the
   Novartis Institutes for BioMedical Research, respectively. P.-Y.S. lab
   was supported by a University of Texas STARs Award, a Kleberg Foundation
   Award, UTMB CTSA UL1TR-001439, and NIH grant AI127744. T.W. lab was
   supported by NIH grant AI099123 and UTMB Sealy Institute for Vaccine
   Sciences Pilot Grant. This research was also partially supported by NIH
   grant AI120942 to S.C.W. and by Cooperative Agreement Number U01CK000512
   to S.C.W., funded by the Centers for Disease Control and Prevention. Its
   contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the Centers for Disease
   Control and Prevention or the Department of Health and Human Services.
CR Abbink P, 2017, SCI TRANSL MED, P420
   Abbink P, 2018, NAT REV MICROBIOL
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barzon L, 2016, INFECT DYNAMICS TRAV, V21
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Cheeseman HM, 2018, HUM GENE THER
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850
   Dupuy LC, 2011, CLIN VACCINE IMMUNOL, V18, P707, DOI 10.1128/CVI.00030-11
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Ghaffarifar F, 2018, DRUG TODAY, V54, P315, DOI 10.1358/dot.2018.54.5.2807864
   Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nicastri E., 2016, EURO SURVEILL, V21
   Nickols B, 2017, VIROLOGY, V512, P66, DOI 10.1016/j.virol.2017.09.005
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tebas P, 2017, N ENGL J MED
   Tretyakova I, 2014, VIROLOGY, V468, P28, DOI 10.1016/j.virol.2014.07.050
   Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114
   Tretyakova I, 2013, VACCINE, V31, P1019, DOI 10.1016/j.vaccine.2012.12.050
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502
   Xie X, 2017, MBIO, V8, P1
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
NR 46
TC 12
Z9 12
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD OCT
PY 2018
VL 36
BP 92
EP 102
DI 10.1016/j.ebiom.2018.08.056
PG 11
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA GX4GD
UT WOS:000447685300017
PM 30201444
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, XY
   Chen, C
   Tian, HL
   Chi, H
   Mu, ZY
   Zhang, TQ
   Yang, KL
   Zhao, Q
   Liu, XH
   Wang, ZF
   Ji, XY
   Yang, HT
AF Yang, Xiaoyun
   Chen, Cheng
   Tian, Hongliang
   Chi, Heng
   Mu, Zhongyu
   Zhang, Tianqing
   Yang, Kailin
   Zhao, Qi
   Liu, Xiaohua
   Wang, Zefang
   Ji, Xiaoyun
   Yang, Haitao
TI Mechanism of ATP hydrolysis by the Zika virus helicase
SO FASEB JOURNAL
LA English
DT Article
DE drug design; structure; mutagenesis
ID NS3 PROTEIN; INSIGHTS; DESIGN; DOMAIN
AB During its life cycle, Zika virus (ZIKV), an arthropod-borne flavivirus that is associated with Guillain-Barre syndrome and causes microencephaly in fetuses and newborn children, encodes a critical and indispensable helicase domain that has 5-triphosphatase activity and performs ATP hydrolysis to generate energy and thus, sustains unwinding of double-stranded RNA during ZIKV genome replication. Of these processes, ATP hydrolysis represents the most basic event; however, its dynamic mechanisms remain largely unknown, impeding the further understanding of the function of ZIKV helicase and the ongoing anti-ZIKV drug design. In this work, we determined the crystal structure of ZIKV helicase in complex with ADP-AlF3-Mn2+ and ADP-Mn2+ separately. The structural analysis indicates that these structures represent the intermediate state and posthydrolysis state, respectively, of the ATP hydrolysis process of ZIKV helicase. These findings, together with our earlier work, which identified the prehydrolysis state of ZIKV helicase, lead to a proposal of the ATP hydrolysis cycle for ZIKV helicase. On this basis, we used site-directed mutagenesis combined with an enzymatic study to identify successfully residues that are critical for the ATPase activity of ZIKV helicase; this will provide new ideas to understand the function for the key enzyme of ZIKV.Yang, X., Chen, C., Tian, H., Chi, H., Mu, Z., Zhang, T., Yang, K., Zhao, Q., Liu, X., Wang, Z., Ji, X., Yang, H. Mechanism of ATP hydrolysis by the Zika virus helicase.
C1 [Yang, Xiaoyun; Chen, Cheng; Tian, Hongliang; Chi, Heng; Mu, Zhongyu; Zhang, Tianqing; Liu, Xiaohua; Wang, Zefang; Yang, Haitao] Tianjin Univ, 92 Weijin Rd, Tianjin 300072, Peoples R China.
   [Yang, Xiaoyun; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.
   [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.
RP Wang, ZF; Yang, HT (corresponding author), Tianjin Univ, 92 Weijin Rd, Tianjin 300072, Peoples R China.
EM zefangwang@tju.edu.cn; yanght@tju.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31528006]; National Key Basic Research Program of
   China (973 Program)National Basic Research Program of China
   [2015CB859800, 2014CB542800]; National Key Research Program of China
   [2016YFD0500300]
FX The authors thank the staff at Beamline BL18U1 of the Shanghai
   Synchrotron Radiation Facility (SSRF) for data collection. Atomic
   coordinates and structure factors have been deposited in the Research
   Collaboratory for Structural Bioinformatics (RCSB) PDB IDs: 5Y6M and
   5Y6N. This work was supported by the National Natural Science Foundation
   of China (31528006), the National Key Basic Research Program of China
   (973 Program) (2015CB859800 and 2014CB542800), and the National Key
   Research Program of China (2016YFD0500300). The authors declare no
   conflicts of interest.
CR Abdelhaleem M, 2010, METHODS MOL BIOL, V587, P1, DOI 10.1007/978-1-60327-355-8_1
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011
   Isaguliants MG, 2003, IMMUNOL LETT, V88, P1, DOI 10.1016/S0165-2478(03)00051-8
   Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Silveira GF, 2016, CLIN EXP IMMUNOL, V183, P114, DOI 10.1111/cei.12701
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
NR 27
TC 4
Z9 5
U1 2
U2 11
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD OCT
PY 2018
VL 32
IS 10
BP 5250
EP 5257
DI 10.1096/fj.201701140R
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GX7RI
UT WOS:000447972500005
PM 29913559
DA 2020-07-08
ER

PT J
AU Williamson, KE
AF Williamson, K. Eliza
TI Care in the time of Zika: notes on the 'afterlife' of the epidemic in
   Salvador (Bahia), Brazil (vol 22, pg 685, 2018)
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Correction
DE Zika; Time; Disability; Maternity; Anthropology
CR Williamson KE, 2018, INTERFACE-BOTUCATU, V22, P685, DOI 10.1590/1807-57622017.0856
NR 1
TC 0
Z9 0
U1 0
U2 0
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PD OCT-DEC
PY 2018
VL 22
IS 67
BP 1299
EP 1299
DI 10.1590/1807-57622018.0218
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GX4CN
UT WOS:000447674700029
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zhang, LD
   Chen, CJ
   Dai, L
   Zhang, L
   Xu, KQ
   Song, YZ
   Xia, XS
   Han, QQ
   Chen, Q
   Zhang, JY
AF Zhang, Liding
   Chen, Congjie
   Dai, Li
   Zhang, Li
   Xu, Keqing
   Song, Yuzhu
   Xia, Xueshan
   Han, Qinqin
   Chen, Qiang
   Zhang, Jinyang
TI Efficient Capture and Detection of Zika Virion by Polyclonal Antibody
   Against Prokaryotic Recombinant Envelope Protein
SO JUNDISHAPUR JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Zika Virus; E Protein; Polyclonal Antibodies; IC-LAMP
ID DOMAIN-III PROTEIN; DENGUE VIRUS TYPE-4; MASS GATHERINGS;
   IMMUNOGENICITY; PURIFICATION; PREPAREDNESS; EXPRESSION; OUTBREAK;
   AMERICA
AB Background: The outbreak of Zika virus (ZIKV) in many countries caused alarming numbers of babies born with microcephalus and severe neurologic disorders, however, the methods for the detection of the ZIKV are limited at present.
   Objectives: The aim of this study was to produce polyclonal antibody against full length envelop protein of ZIKV (ZIKV-E protein) in prokaryotic system and to evaluate its efficacy to capture ZIKV virion.
   Methods: The recombinant full length ZIKV-E protein was purified and then used as an immunogen to vaccinate BALB/c mice to produce polyclonal antibody. Protein A/G coated magnetic beads were coated with the polyclonal antibody to capture the ZIKV virion in the culture medium of Vero cells infected with ZIKV. The products of immunoprecipitation were further used for Western Blot, Loop-mediated isothermal amplification (LAMP), and PCR assay.
   Results: Western Blot and indirect immunofluorescence analysis showed that the mouse polyclonal antibody could react specifically with the native E protein in Vero cells infected with ZIKV. The results of Western Blot, Immunocaptured-LAMP (IC-LAMP), and Immunocaptured-PCR (IC-PCR) showed that polyclonal antibody of ZIKV-E recombinant protein can capture ZIKV virion specifically, however, the polyclonal antibody against the ZIKV-NS1, Shigella, and Salmonella without such a function.
   Conclusions: These findings may provide the basis for the development of the rapid diagnostic kits such as, IC-PCR, IC-LAMP, and sandwich ELISA. The serum virion capture activity elicited by prokaryotic expressed recombinant ZIKV-E protein may also provide a basis for further preparation of neutralizing antibody and protein subunit vaccine candidate against ZIKV.
C1 [Zhang, Liding; Chen, Congjie; Dai, Li; Zhang, Li; Xu, Keqing; Song, Yuzhu; Xia, Xueshan; Han, Qinqin; Chen, Qiang; Zhang, Jinyang] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.
RP Zhang, JY (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.
EM jyzhang@kmust.edu.cn
RI Zhang, Jinyang/S-9625-2019
OI Zhang, Jinyang/0000-0001-7533-998X
FU Kunming University of Science and Technology; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81860625]; Applied Basic Research Projects of Yunnan Province
   [2018FB128]
FX This work was supported by the 2017 Year Undergraduate Student
   Innovation & Carve Out Training Program Granting Project of Kunming
   University of Science and Technology, National Natural Science
   Foundation of China (Grant No. 81860625), and Applied Basic Research
   Projects of Yunnan Province (2018FB128)
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Babu JP, 2008, VACCINE, V26, P4655, DOI 10.1016/j.vaccine.2008.07.006
   Bhavani KG, 2017, J PHARMACEUT BIOMED, V132, P156, DOI 10.1016/j.jpba.2016.09.025
   Cao L, 2016, J THORAC DIS, V8, P3160, DOI 10.21037/jtd.2016.11.94
   Cao XL, 2017, PROTEIN EXPRES PURIF, V130, P81, DOI 10.1016/j.pep.2016.09.013
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Jaiswal S, 2004, PROTEIN EXPRES PURIF, V33, P80, DOI 10.1016/j.pep.2003.09.009
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Ma TF, 2016, VACCINE, V34, P2157, DOI 10.1016/j.vaccine.2016.03.030
   Mayer Marcus, 2004, Methods Mol Med, V94, P239
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ramakrishnan C, 2017, CHEM BIOL DRUG DES, V89, P772, DOI 10.1111/cbdd.12901
   Raviprakash K, 2000, VACCINE, V18, P2426, DOI 10.1016/S0264-410X(99)00570-8
   Rawal Gautam, 2016, J Family Med Prim Care, V5, P523, DOI 10.4103/2249-4863.197256
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Tripathi NK, 2008, J BIOTECHNOL, V134, P278, DOI 10.1016/j.jbiotec.2008.02.001
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Yavropoulou MP, 2016, HORM-INT J ENDOCRINO, V15, P551, DOI 10.14310/horm.2002.1710
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zhang LD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00094
NR 28
TC 4
Z9 4
U1 0
U2 8
PU AHVAZ JUNDISHAPUR UNIV MED SCI
PI AHVAZ
PA PO BOX 6357-33118, AHVAZ, 00000, IRAN
SN 2008-3645
EI 2008-4161
J9 JUNDISHAPUR J MICROB
JI Jundishapur J. Microbiol.
PD OCT
PY 2018
VL 11
IS 10
AR e68858
DI 10.5812/jjm.68858
PG 8
WC Microbiology
SC Microbiology
GA GX6AJ
UT WOS:000447838300003
OA Other Gold
DA 2020-07-08
ER

PT J
AU Fatima, M
   Khan, MS
   Rashid, H
   Mehmood, A
   Kanwal, S
   Rasheed, MA
   Jamil, F
AF Fatima, Musrrat
   Khan, Muhammad Saad
   Rashid, Hamid
   Mehmood, Asim
   Kanwal, Sumaira
   Rasheed, Muhammad Asif
   Jamil, Farrukh
TI Structure Based Virtual Screening and Molecular Docking Studies for
   Identification of Allosteric Inhibitors against Zika Virus Protease
   NS2B-NS3
SO PAKISTAN JOURNAL OF ZOOLOGY
LA English
DT Article
DE Zika virus; NS2B-NS3; Protease; Inhibitors; Virtual screening; Docking
ID PSEUDOGENES; DYNAMICS
AB Zika virus (ZIKV) has gained research interests after its recent outbreak in Brazil and America in 2015, where it affected millions of people. Studies have shown its role in developing microcephaly and GBS Syndrome. There is a need to develop drugs against ZIKV. Here we uses pharmacoinformatics techniques to identify potential inhibitors against ZIKV protease NS2B-NS3, which has a well-known role in the viral replication. By using three dimensional structure of the NS2B-NS3, an allosteric site has been identified in the protein. Moreover, the identified site is used for structure-based virtual screening. After screening 100,000 compounds, 14 compounds are selected, which fulfilled different already established drug likeliness parameters such as rule of five and nontoxic nature. These 14 compounds are used for pharmacophore modeling, and Zinc natural compounds database (ZND) is screened against the developed pharmacophore. The compounds with the highest pharmacophore fit scores are screened and docked on the identified allosteric site of NS2B-NS3. Analysis of the data showed two compounds (ZINC00845171, ZINC08782519) as potential inhibitors for NS2B-NS3 of ZIKV.
C1 [Fatima, Musrrat; Khan, Muhammad Saad; Rashid, Hamid; Mehmood, Asim; Kanwal, Sumaira; Rasheed, Muhammad Asif; Jamil, Farrukh] COMSATS Univ Islamabad, Dept Biosci, Sahiwal Campus, Punjab, Pakistan.
RP Jamil, F (corresponding author), COMSATS Univ Islamabad, Dept Biosci, Sahiwal Campus, Punjab, Pakistan.
EM farrukhccb@gmail.com
RI kanwal, sumaira/Z-2057-2019
FU Higher Education Commission (HEC) of PakistanHigher Education Commission
   of Pakistan
FX We gratefully acknowledge Higher Education Commission (HEC) of Pakistan
   for grants to this study.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a
   Colman E, 2012, NEW ENGL J MED, V367, P1577, DOI 10.1056/NEJMp1211277
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Jamil F, 2018, PAK J ZOOL, V50, P1565, DOI 10.17582/journal.pjz/2018.50.4.sc9
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Mukhametov A, 2014, J MOL GRAPH MODEL, V52, P103, DOI 10.1016/j.jmgm.2014.06.008
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Rana N, 2017, PAK J ZOOL, V49, P1261, DOI 10.17582/journal.pjz/2017.49.4.1261.1265
   Robert Kiss M.S., 2012, J CHEMINFORMATICS, P17, DOI [10.1186/1758-2946-4-S1-P17, DOI 10.1186/1758-2946-4-S1-P17]
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tariq F, 2016, PAK J ZOOL, V48, P1805
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
NR 28
TC 1
Z9 2
U1 0
U2 2
PU ZOOLOGICAL SOC PAKISTAN
PI LAHORE
PA UNIV PUNJAB, NEW CAMPUS, C/O DEPT ZOOLOGY, LAHORE, PAKISTAN
SN 0030-9923
J9 PAK J ZOOL
JI Pak. J. Zool.
PD OCT
PY 2018
VL 50
IS 5
BP 1709
EP 1715
DI 10.17582/journal.pjz/2018.50.5.1709.1715
PG 7
WC Zoology
SC Zoology
GA GX3AI
UT WOS:000447592500014
OA Other Gold
DA 2020-07-08
ER

PT J
AU Gondim, KC
   Atella, GC
   Pontes, EG
   Majerowicz, D
AF Gondim, Katia C.
   Atella, Georgia C.
   Pontes, Emerson G.
   Majerowicz, David
TI Lipid metabolism in insect disease vectors
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Review
DE Hematophagy; Lipid metabolism; Lipid transport; Vector insects
ID YELLOW-FEVER MOSQUITO; PANSTRONGYLUS-MEGISTUS HEMIPTERA; STEROL CARRIER
   PROTEIN-2; ACETYL-COA CARBOXYLASE; AEDES-AEGYPTI DIPTERA;
   RECEPTOR-MEDIATED ENDOCYTOSIS; LIPOPHORIN BINDING-SITES;
   PERIPLANETA-AMERICANA L; BUGS RHODNIUS-PROLIXUS; INSULIN-LIKE PEPTIDES
AB More than a third of the world population is at constant risk of contracting some insect-transmitted disease, such as Dengue fever, Zika virus disease, malaria, Chagas' disease, African trypanosomiasis, and others. Independent of the life cycle of the pathogen causing the disease, the insect vector hematophagous habit is a common and crucial trait for the transmission of all these diseases. This lifestyle is unique, as hematophagous insects feed on blood, a diet that is rich in protein but relatively poor in lipids and carbohydrates, in huge amounts and low frequency. Another unique feature of these insects is that blood meal triggers essential metabolic processes, as molting and oogenesis and, in this way, regulates the expression of various genes that are involved in these events. In this paper, we review current knowledge of the physiology and biochemistry of lipid metabolism in insect disease vectors, comparing with classical models whenever possible. We address lipid digestion and absorption, hemolymphatic transport, and lipid storage by the fat body and ovary. In this context, both de novo fatty acid and triacylglycerol synthesis are discussed, including the related fatty acid activation process and the intracellular lipid binding proteins. As lipids are stored in order to be mobilized later on, e.g. for flight activity or survivorship, lipolysis and beta-oxidation are also considered. All these events need to be finely regulated, and the role of hormones in this control is summarized. Finally, we also review information about infection, when vector insect physiology is affected, and there is a crosstalk between its immune system and lipid metabolism. There is not abundant information about lipid metabolism in vector insects, and significant current gaps in the field are indicated, as well as questions to be answered in the future.
C1 [Gondim, Katia C.; Atella, Georgia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, RJ, Brazil.
   [Pontes, Emerson G.] Univ Fed Rural Rio de Janeiro, Inst Quim, Dept Bioquim, Seropedica, RJ, Brazil.
   [Majerowicz, David] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, Rio De Janeiro, RJ, Brazil.
RP Gondim, KC; Majerowicz, D (corresponding author), Ave Carlos Chagas Filho,373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM katia@bioqmed.ufrj.br; majerowicz@pharma.ufrj.br
RI Atella, Georgia/AAK-7897-2020; Pontes, Emerson/P-9347-2016; Gondim,
   Katia C./AAN-4059-2020; Majerowicz, David/S-6136-2019
OI Majerowicz, David/0000-0001-7916-5315
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   BrazilCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), BrazilNational Council for Scientific
   and Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), BrazilCAPES; Instituto Nacional de
   Ciencia e Tecnologia em Entomologia Molecular (INCT-EM), Brazil
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ), Brazil, Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil, and
   Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular
   (INCT-EM), Brazil.
CR Alabaster A, 2011, INSECT BIOCHEM MOLEC, V41, P946, DOI 10.1016/j.ibmb.2011.09.004
   Alves CR, 2007, EXP PARASITOL, V116, P44, DOI 10.1016/j.exppara.2006.11.012
   Alves-Bezerra M, 2017, BBA-MOL CELL BIOL L, V1862, P324, DOI 10.1016/j.bbalip.2016.12.004
   Alves-Bezerra M, 2016, BBA-MOL CELL BIOL L, V1861, P650, DOI 10.1016/j.bbalip.2016.04.007
   Alves-Bezerra M, 2016, INSECT BIOCHEM MOLEC, V69, P51, DOI 10.1016/j.ibmb.2015.06.013
   Alves-Bezerra M, 2012, BBA-MOL CELL BIOL L, V1821, P1462, DOI 10.1016/j.bbalip.2012.08.002
   Alves-Bezerra M, 2010, INSECT BIOCHEM MOLEC, V40, P119, DOI 10.1016/j.ibmb.2010.01.002
   Arrese EL, 1999, J LIPID RES, V40, P556
   Arrese EL, 1996, ARCH INSECT BIOCHEM, V31, P325, DOI 10.1002/(SICI)1520-6327(1996)31:3&lt;325::AID-ARCH7&gt;3.0.CO;2-W
   Arrese EL, 2001, J LIPID RES, V42, P225
   Arrese EL, 2008, ARCH BIOCHEM BIOPHYS, V473, P42, DOI 10.1016/j.abb.2008.02.036
   Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356
   ATELLA GC, 1992, ARCH INSECT BIOCHEM, V19, P133, DOI 10.1002/arch.940190206
   ATELLA GC, 1995, ARCH INSECT BIOCHEM, V30, P337, DOI 10.1002/arch.940300404
   Atella GC, 2002, J EXP BIOL, V205, P3623
   Atella GC, 2000, ARCH INSECT BIOCHEM, V43, P99, DOI 10.1002/(SICI)1520-6327(200003)43:3&lt;99::AID-ARCH1&gt;3.0.CO;2-3
   Atella GC, 2006, INSECT BIOCHEM MOLEC, V36, P375, DOI 10.1016/j.ibmb.2006.01.019
   Atella GC, 2009, ACTA TROP, V109, P159, DOI 10.1016/j.actatropica.2008.10.004
   Attardo GM, 2012, INSECT BIOCHEM MOLEC, V42, P360, DOI 10.1016/j.ibmb.2012.01.007
   Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695
   Barber MC, 2005, BBA-MOL CELL BIOL L, V1733, P1, DOI 10.1016/j.bbalip.2004.12.001
   Baumann AA, 2013, MOL CELL ENDOCRINOL, V372, P30, DOI 10.1016/j.mce.2013.02.019
   BECKETT EB, 1990, PARASITOL RES, V76, P606, DOI 10.1007/BF00932571
   BEENAKKERS AMT, 1988, INSECT BIOCHEM, V18, P1, DOI 10.1016/0020-1790(88)90029-7
   Benoit JB, 2015, ANNU REV ENTOMOL, V60, P351, DOI 10.1146/annurev-ento-010814-020834
   Benoit JB, 2011, J INSECT PHYSIOL, V57, P1553, DOI 10.1016/j.jinsphys.2011.08.009
   BILLINGSLEY PF, 1983, CAN J ZOOL, V61, P2574, DOI 10.1139/z83-339
   Bittencourt-Cunha PR, 2013, MEM I OSWALDO CRUZ, V108, P494, DOI 10.1590/S0074-0276108042013016
   Bolsoni-Lopes A, 2015, ARCH ENDOCRIN METAB, V59, P335, DOI 10.1590/2359-3997000000067
   Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105
   Caccia S, 2012, J INSECT PHYSIOL, V58, P621, DOI 10.1016/j.jinsphys.2011.12.019
   Calderon-Fernandez GM, 2017, J MED ENTOMOL, V54, P1531, DOI 10.1093/jme/tjx151
   Canavoso LE, 2004, INSECT BIOCHEM MOLEC, V34, P845, DOI 10.1016/j.ibmb.2004.05.008
   Canavoso LE, 2004, J LIPID RES, V45, P456, DOI 10.1194/jlr.M300242-JLR200
   Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23
   Canavoso LE, 2003, MEM I OSWALDO CRUZ, V98, P909, DOI 10.1590/S0074-02762003000700009
   Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5
   CAPURRO MD, 1994, COMP BIOCHEM PHYS B, V108, P35, DOI 10.1016/0305-0491(94)90161-9
   Cavagnari BM, 2000, J MED ENTOMOL, V37, P938, DOI 10.1603/0022-2585-37.6.938
   Cheon HM, 2006, J BIOL CHEM, V281, P8426, DOI 10.1074/jbc.M510957200
   Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6
   CHINO H, 1981, INSECT BIOCHEM, V11, P491, DOI 10.1016/0020-1790(81)90085-8
   CHINO H, 1964, SCIENCE, V143, P359, DOI 10.1126/science.143.3604.359
   CHINO H, 1971, INSECT BIOCHEM, V1, P337, DOI 10.1016/0020-1790(71)90051-5
   Ciudad L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-53
   CLARK AJ, 1959, J BIOL CHEM, V234, P2578
   Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005
   Coelho HSL, 1997, ARCH INSECT BIOCHEM, V35, P301, DOI 10.1002/(SICI)1520-6327(199705)35:3<301::AID-ARCH4>3.0.CO;2-W
   Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1
   Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w
   Conners EE, 2016, ACTA TROP, V156, P68, DOI 10.1016/j.actatropica.2016.01.002
   Corassa RB, 2017, PERSPECT PUBLIC HEAL, V137, P289, DOI 10.1177/1757913916671160
   Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600
   Cucunawangsih, 2017, VIROL RES TREAT, V8
   Dantuma NP, 1996, J LIPID RES, V37, P1345
   Dantuma NP, 1999, J LIPID RES, V40, P973
   Dantuma NP, 1997, J LIPID RES, V38, P254
   Defferrari MS, 2016, INSECT BIOCHEM MOLEC, V70, P148, DOI 10.1016/j.ibmb.2015.12.009
   Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023
   DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09
   DOWNER RGH, 1985, INSECT BIOCHEM, V15, P627, DOI 10.1016/0020-1790(85)90124-6
   Dyer DH, 2009, MOL CELL BIOCHEM, V326, P67, DOI 10.1007/s11010-008-0007-z
   Entringer PF, 2013, MEM I OSWALDO CRUZ, V108, P836, DOI 10.1590/0074-0276130129
   Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006
   Faergeman NJ, 1997, BIOCHEM J, V323, P1
   FERNANDOWARNAKULASURIYA GJP, 1988, INSECT BIOCHEM, V18, P211, DOI 10.1016/0020-1790(88)90025-X
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   FICHERA LE, 1982, COMP BIOCHEM PHYS B, V72, P71, DOI 10.1016/0305-0491(82)90012-8
   Folly E, 2003, BIOCHEM BIOPH RES CO, V310, P555, DOI 10.1016/j.bbrc.2003.09.038
   FORD PS, 1994, J MED ENTOMOL, V31, P435, DOI 10.1093/jmedent/31.3.435
   FRIEND WG, 1965, CAN J ZOOLOG, V43, P125, DOI 10.1139/z65-010
   Fruttero LL, 2017, J INSECT PHYSIOL, V96, P82, DOI 10.1016/j.jinsphys.2016.10.014
   Fruttero LL, 2014, INSECT BIOCHEM MOLEC, V52, P1, DOI 10.1016/j.ibmb.2014.06.002
   Fruttero LL, 2011, J INSECT PHYSIOL, V57, P475, DOI 10.1016/j.jinsphys.2011.01.009
   Fruttero LL, 2009, INSECT BIOCHEM MOLEC, V39, P322, DOI 10.1016/j.ibmb.2009.01.009
   Fu Q, 2011, INSECT MOL BIOL, V20, P541, DOI 10.1111/j.1365-2583.2011.01087.x
   Fu Q, 2015, J MED ENTOMOL, V52, P1124, DOI 10.1093/jme/tjv101
   Gade G, 2003, GEN COMP ENDOCR, V132, P10, DOI 10.1016/S0016-6480(03)00159-X
   Gade G, 2002, COMP BIOCHEM PHYS B, V132, P117, DOI 10.1016/S1096-4959(01)00541-3
   GEERING K, 1975, J INSECT PHYSIOL, V21, P1251, DOI 10.1016/0022-1910(75)90095-5
   Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094
   Glatz JFC, 2015, PROSTAG LEUKOTR ESS, V93, P45, DOI 10.1016/j.plefa.2014.07.011
   Goh KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029576
   GOLDRING JPD, 1994, COMP BIOCHEM PHYS B, V108, P27
   Golodne DM, 2001, INSECT BIOCHEM MOLEC, V31, P563, DOI 10.1016/S0965-1748(00)00161-2
   Gondim KC, 2000, INSECT BIOCHEM MOLEC, V30, P405, DOI 10.1016/S0965-1748(00)00014-X
   GONDIM KC, 1989, J INSECT PHYSIOL, V35, P19, DOI 10.1016/0022-1910(89)90032-2
   GONDIM KC, 1989, INSECT BIOCHEM, V19, P153, DOI 10.1016/0020-1790(89)90086-3
   Gonzalez MS, 1999, LIPIDS, V34, P1199, DOI 10.1007/s11745-999-0472-7
   Gopalapillai R, 2006, J LIPID RES, V47, P1005, DOI 10.1194/jlr.M500462-JLR200
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541
   Grillo LAM, 2003, INSECT BIOCHEM MOLEC, V33, P429, DOI 10.1016/S0965-1748(03)00007-9
   Grillo LAM, 2007, INSECT BIOCHEM MOLEC, V37, P579, DOI 10.1016/j.ibmb.2007.03.002
   Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003
   Gulia-Nuss M, 2012, J EXP BIOL, V215, P3758, DOI 10.1242/jeb.074617
   Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401
   Guo XR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-102
   Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410
   HOFFMAN AGD, 1979, LIPIDS, V14, P893, DOI 10.1007/BF02533502
   HOFFMAN AGD, 1979, INSECT BIOCHEM, V9, P129, DOI 10.1016/0020-1790(79)90041-6
   Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722
   HURD H, 1995, PARASITOL TODAY, V11, P411, DOI 10.1016/0169-4758(95)80021-2
   Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700
   JUAREZ P, 1989, COMP BIOCHEM PHYS B, V93, P763, DOI 10.1016/0305-0491(89)90043-6
   Kamoshida Y, 2012, BIOCHEM BIOPH RES CO, V421, P203, DOI 10.1016/j.bbrc.2012.03.135
   KATASE H, 1982, BIOCHIM BIOPHYS ACTA, V710, P341
   Kaufmann C, 2006, INSECT BIOCHEM MOLEC, V36, P466, DOI 10.1016/j.ibmb.2006.03.009
   Kaufmann C, 2009, INSECT BIOCHEM MOLEC, V39, P770, DOI 10.1016/j.ibmb.2009.09.002
   KAWOOYA JK, 1988, J BIOL CHEM, V263, P8748
   KAWOOYA JK, 1986, J BIOL CHEM, V261, P3588
   Kim BY, 2015, COMP BIOCHEM PHYS B, V182, P6, DOI 10.1016/j.cbpb.2014.11.010
   Krebs KC, 2003, INSECT MOL BIOL, V12, P51, DOI 10.1046/j.1365-2583.2003.00386.x
   Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299
   Kumar BA, 2011, PARASITOL RES, V108, P377, DOI 10.1007/s00436-010-2075-8
   Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011
   Lan Q, 2004, J LIPID RES, V45, P1468, DOI 10.1194/jlr.M400003-JLR200
   LANE NJ, 1979, J CELL SCI, V39, P355
   LANGLEY PA, 1981, INSECT BIOCHEM, V11, P225, DOI 10.1016/0020-1790(81)90100-1
   Lee CS, 2003, INSECT BIOCHEM MOLEC, V33, P761, DOI 10.1016/S0965-1748(03)00066-3
   LEHANE MJ, 1977, J INSECT PHYSIOL, V23, P945, DOI 10.1016/0022-1910(77)90121-4
   Leyria J, 2014, ARCH INSECT BIOCHEM, V87, P148, DOI 10.1002/arch.21186
   Ling L, 2017, P NATL ACAD SCI USA, V114, pE8017, DOI 10.1073/pnas.1710970114
   Lukashevich ED, 2003, PALEONTOL J+, V37, P153
   Machado EA, 1996, ARCH INSECT BIOCHEM, V31, P185, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;185::AID-ARCH6&gt;3.0.CO;2-Z
   Majerowicz D, 2017, GENE, V596, P27, DOI 10.1016/j.gene.2016.09.045
   Majerowicz D, 2016, INSECT BIOCHEM MOLEC, V72, P41, DOI 10.1016/j.ibmb.2016.03.002
   Majerowicz D, 2013, ARCH INSECT BIOCHEM, V82, P129, DOI 10.1002/arch.21080
   Marco HG, 2013, PEPTIDES, V41, P21, DOI 10.1016/j.peptides.2012.09.032
   Marinotti O, 2006, COMP BIOCHEM PHYS B, V144, P101, DOI 10.1016/j.cbpb.2006.01.012
   Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112
   NAGASAWA H, 1984, SCIENCE, V226, P1344, DOI 10.1126/science.226.4680.1344
   Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3
   Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001
   Nirmala X, 2005, INSECT MOL BIOL, V14, P95, DOI 10.1111/j.1365-2583.2005.00535.x
   Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   OCHANDA JO, 1991, COMP BIOCHEM PHYS B, V99, P811, DOI 10.1016/0305-0491(91)90146-5
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103
   Ohnishi A, 2005, J BIOL CHEM, V280, P4111, DOI 10.1074/jbc.M413429200
   Ohnishi A, 2009, J BIOL CHEM, V284, P5128, DOI 10.1074/jbc.M806072200
   Oliveira GA, 2006, ARCH INSECT BIOCHEM, V62, P164, DOI 10.1002/arch.20132
   OLIVEIRA PL, 1986, J INSECT PHYSIOL, V32, P859, DOI 10.1016/0022-1910(86)90101-0
   Oryan A, 2018, BIOCHEM BIOPH RES CO, V497, P550, DOI 10.1016/j.bbrc.2018.02.088
   Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297
   Parvy JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002925
   Patel R, 2004, INSECT BIOCHEM MOLEC, V34, P1269, DOI 10.1016/j.ibmb.2004.08.008
   Patel RT, 2006, ARCH INSECT BIOCHEM, V63, P73, DOI 10.1002/arch.20143
   Patel RT, 2005, J BIOL CHEM, V280, P22624, DOI 10.1074/jbc.M413128200
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pennington James E, 2002, J Insect Sci, V2, P15
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pontes EG, 2002, INSECT BIOCHEM MOLEC, V32, P1409, DOI 10.1016/S0965-1748(02)00061-9
   Pontes EG, 2008, J INSECT PHYSIOL, V54, P790, DOI 10.1016/j.jinsphys.2008.02.003
   PRASAD SV, 1986, J BIOL CHEM, V261, P7174
   RENSHAW M, 1995, MED VET ENTOMOL, V9, P381, DOI 10.1111/j.1365-2915.1995.tb00009.x
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594
   Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784
   Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016
   Rodriguez-Vazquez M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005356
   Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434
   ROWLAND M, 1988, PARASITOLOGY, V97, P221, DOI 10.1017/S003118200005842X
   Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004
   Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258
   Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233
   RYAN RO, 1986, BIOCHEM BIOPH RES CO, V136, P260, DOI 10.1016/0006-291X(86)90903-4
   Sakudoh T, 2010, J BIOL CHEM, V285, P7739, DOI 10.1074/jbc.M109.074435
   Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3
   Santos R, 2011, ARCH INSECT BIOCHEM, V77, P1, DOI 10.1002/arch.20414
   Sawabe K, 2000, J MED ENTOMOL, V37, P726, DOI 10.1603/0022-2585-37.5.726
   Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3
   SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6
   Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005
   Schwedes CC, 2012, J INSECT PHYSIOL, V58, P293, DOI 10.1016/j.jinsphys.2012.01.013
   Seo SJ, 2003, J BIOL CHEM, V278, P41954, DOI 10.1074/jbc.M308200200
   Sieber MH, 2012, CELL METAB, V15, P122, DOI 10.1016/j.cmet.2011.11.011
   Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010
   Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011
   Sim C, 2013, INSECT MOL BIOL, V22, P1, DOI 10.1111/j.1365-2583.2012.01166.x
   Sim C, 2009, PHYSIOL GENOMICS, V39, P202, DOI 10.1152/physiolgenomics.00095.2009
   SMITH AF, 1992, J BIOL CHEM, V267, P380
   SPATES GE, 1990, ARCH INSECT BIOCHEM, V14, P1, DOI 10.1002/arch.940140102
   Stroppa MM, 2013, AM J TROP MED HYG, V88, P1146, DOI 10.4269/ajtmh.12-0464
   Sun JX, 2000, INSECT BIOCHEM MOLEC, V30, P1161, DOI 10.1016/S0965-1748(00)00093-X
   Takken W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-345
   Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001
   Telang A, 2013, J INSECT PHYSIOL, V59, P283, DOI 10.1016/j.jinsphys.2012.11.006
   TROY S, 1975, COMP BIOCHEM PHYS B, V50, P457, DOI 10.1016/0305-0491(75)90258-8
   TSUCHIDA K, 1990, J BIOL CHEM, V265, P5761
   TSUCHIDA K, 1988, INSECT BIOCHEM, V18, P263, DOI 10.1016/0020-1790(88)90090-X
   Tufail M, 2009, INSECT MOL BIOL, V18, P281, DOI 10.1111/j.1365-2583.2009.00865.x
   Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007
   Van der Horst DJ, 2010, J INSECT PHYSIOL, V56, P844, DOI 10.1016/j.jinsphys.2010.02.015
   Van Hoof D, 2005, INSECT BIOCHEM MOLEC, V35, P117, DOI 10.1016/j.ibmb.2004.09.009
   Van Hoof D, 2002, J CELL SCI, V115, P4001, DOI 10.1242/jcs.00113
   VANDERHORST DJ, 1981, INSECT BIOCHEM, V11, P717, DOI 10.1016/0020-1790(81)90064-0
   VANHANDEL E, 1993, J INSECT PHYSIOL, V39, P831, DOI 10.1016/0022-1910(93)90115-8
   VANHEUSDEN MC, 1991, J LIPID RES, V32, P1789
   VANHEUSDEN MC, 1989, J BIOL CHEM, V264, P17287
   VanHeusden MC, 1997, ARCH INSECT BIOCHEM, V34, P301, DOI 10.1002/(SICI)1520-6327(1997)34:3<301::AID-ARCH5>3.0.CO;2-X
   Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044
   Voght SP, 2007, CELL METAB, V5, P195, DOI 10.1016/j.cmet.2007.01.011
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   WARD JP, 1982, J INSECT PHYSIOL, V28, P527, DOI 10.1016/0022-1910(82)90033-6
   WELLS MA, 1987, J BIOL CHEM, V262, P4172
   Wen DH, 2016, DEV COMP IMMUNOL, V65, P124, DOI 10.1016/j.dci.2016.07.001
   Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003
   Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013
   Xu X, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003108
   Yao YZ, 2014, CURR BIOL, V24, P1786, DOI 10.1016/j.cub.2014.06.045
   Yu XL, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.10101
   Zandawala M, 2015, INSECT MOL BIOL, V24, P264, DOI 10.1111/imb.12157
   Zdybicka-Barabas A, 2015, PEPTIDES, V68, P105, DOI 10.1016/j.peptides.2014.12.013
   Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014
   Ziegler R, 1997, EUR J ENTOMOL, V94, P385
   Ziegler R, 2001, J INSECT PHYSIOL, V47, P623, DOI 10.1016/S0022-1910(00)00158-X
NR 218
TC 5
Z9 5
U1 3
U2 35
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD OCT
PY 2018
VL 101
BP 108
EP 123
DI 10.1016/j.ibmb.2018.08.005
PG 16
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA GX2LH
UT WOS:000447550000011
PM 30171905
DA 2020-07-08
ER

PT J
AU Jash, A
   Govero, J
   Diamond, MS
   Rich, JN
   Chheda, MG
AF Jash, Arijita
   Govero, Jennifer
   Diamond, Michael S.
   Rich, Jeremy N.
   Chheda, Milan G.
TI Developing Zika Virus as a New Treatment for Glioblastoma
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 15-18, 2018
CL Chicago, IL
SP Child Neurol Soc
C1 [Jash, Arijita; Govero, Jennifer; Diamond, Michael S.; Chheda, Milan G.] Washington Univ, Sch Med, St Louis, MO USA.
   [Rich, Jeremy N.] Univ Calif San Diego, San Diego, CA 92103 USA.
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2018
VL 84
SU 22
MA M298
BP S227
EP S227
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GV9ZK
UT WOS:000446520900448
DA 2020-07-08
ER

PT J
AU Mochida, G
   Nakayama, T
   Guise, A
   Fujimura, K
   Meziani, A
   Cheng, L
   Vaughan, D
   Kodani, A
   Gonzalez, D
   Durbin, A
   Bosch, I
   Teixeira, M
   Gehrke, L
   Steen, J
AF Mochida, G.
   Nakayama, T.
   Guise, A.
   Fujimura, K.
   Meziani, A.
   Cheng, L.
   Vaughan, D.
   Kodani, A.
   Gonzalez, D.
   Durbin, A.
   Bosch, I
   Teixeira, M.
   Gehrke, L.
   Steen, J.
TI A New Mouse Model of Congenital Zika Virus Infection Reveals
   Neurodevelopmental Pathways Disrupted in Congenital Zika Syndrome
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 15-18, 2018
CL Chicago, IL
SP Child Neurol Soc
DE Infections/Neuroimmunology; Rare Diseases
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2018
VL 84
SU 22
MA PL2-1
BP S310
EP S311
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GV9ZK
UT WOS:000446520900520
DA 2020-07-08
ER

PT J
AU Mulkey, S
   Vezina, G
   Bulas, D
   Fourzali, Y
   Morales, A
   Arroyave-Wessel, M
   Swisher, C
   Christante, C
   Russo, S
   Kousa, Y
   Msall, M
   Cure, C
   DeBiasi, R
   du Plessis, A
AF Mulkey, S.
   Vezina, G.
   Bulas, D.
   Fourzali, Y.
   Morales, A.
   Arroyave-Wessel, M.
   Swisher, C.
   Christante, C.
   Russo, S.
   Kousa, Y.
   Msall, M.
   Cure, C.
   DeBiasi, R.
   du Plessis, A.
TI Six-month Neurodevelopmental Outcomes of Apparently Normal Newborns from
   Zika Virus Positive Pregnancies
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 15-18, 2018
CL Chicago, IL
SP Child Neurol Soc
DE Infections/Neuroimmunology; Neonatal Neurology; Cognitive/Behavioral
   Disorders
RI Youssef A Kousa/AAR-3064-2020
OI Youssef A Kousa/0000-0001-6049-8144
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2018
VL 84
SU 22
MA 86
BP S362
EP S363
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GV9ZK
UT WOS:000446520900619
DA 2020-07-08
ER

PT J
AU Rodriguez, J
   Diaz, M
   Montalvo, A
   Gonzalez, J
AF Rodriguez, J.
   Diaz, M.
   Montalvo, A.
   Gonzalez, J.
TI Case Series: Congenital Zika Virus Infection Associated with Epileptic
   Spasms
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Child-Neurology-Society (CNS)
CY OCT 15-18, 2018
CL Chicago, IL
SP Child Neurol Soc
DE Rare Diseases; Neonatal Neurology; Epilepsy
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2018
VL 84
SU 22
MA 167
BP S401
EP S401
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GV9ZK
UT WOS:000446520900700
DA 2020-07-08
ER

PT J
AU Reuter, JD
   Nelson, SL
AF Reuter, Jon D.
   Nelson, Suzanne L.
TI Hematologic Parameters and Viral Status for Zika, Chikungunya,
   Bluetongue, and Epizootic Hemorrhagic Disease in White-tailed Deer
   (Odocoileus virginianus) on St. John, US Virgin Islands
SO JOURNAL OF WILDLIFE DISEASES
LA English
DT Article
DE BTV; EHDV; hematology; St. John; USVI; virus
ID VIRUS; INFESTATIONS; MEDETOMIDINE; MICROPLUS; IXODIDAE; SEROTYPE;
   CATTLE; ACARI
AB A population of white-tailed deer (Odocoileus virginianus) resides throughout the island of St. John, US Virgin Islands, predominately in the Virgin Islands National Park. Adult deer (n = 23), ranging from 1 yr to 8 yr old, were assessed to characterize body condition and health. Serologic samples were screened for important viral pathogens in the area, including Zika, chikungunya, bluetongue, and epizootic hemorrhagic disease viruses. Samples were collected in July 2016; males were in velvet and all females were in diestrus. Deer had recovered from a severe drought the previous year but were generally healthy, with a low-level but high incidence of tick parasitism. Marked statistically significant changes in hematocrit and hemoglobin levels were associated with the effects of the anesthetic mixture used for capture. No other statistically significant differences were observed. Serum from four deer induced reduction in Zika virus plaques, suggesting possible exposure. No serum was reactive for chikungunya virus. Bluetongue and epizootic hemorrhagic disease antibodies were present in 50% of the sampled deer, but no clinical signs associated with disease were observed during the study period. These data will be valuable for future dynamic health assessment and may help assess changes to the population, such as those induced by climate change, infectious disease, or other demographic events.
C1 [Reuter, Jon D.] Univ Colorado, Dept Psychol & Neurosci, Off Anim Resources, 2860 Wilderness Pl, Boulder, CO 80301 USA.
   [Nelson, Suzanne L.] Univ Colorado, Dept Integrat Physiol, 354 UCB, Boulder, CO 80309 USA.
   [Nelson, Suzanne L.] US Fish & Wildlife Serv, 510 Desmond Dr SE, Lacey, WA 98503 USA.
RP Reuter, JD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Off Anim Resources, 2860 Wilderness Pl, Boulder, CO 80301 USA.
EM jon.reuter@colorado.edu
FU Friends of the Virgin Islands National Park
FX Funding for the study was provided by Friends of the Virgin Islands
   National Park. We thank Thomas Kelley and Alan Shane McKinley from the
   Virgin Islands National Park; Laura Palminteri and staff at Canines,
   Cats, and Critters; Richard Bowen at Colorado State University; and
   Celine Vetter at the University of Colorado Boulder for facilitation and
   support. We also thank the field crew of Darrin Masters, Kaitie Apple,
   Jake DePom-polo, Ben Wilkins, Maggie Johnson, and Madison Malone.
CR BUBENIK GA, 1987, J WILDLIFE MANAGE, V51, P57, DOI 10.2307/3801630
   Cain A, 2003, GUIDE AGE DETERMINAT
   Drolet BS, 2013, VET MICROBIOL, V166, P347, DOI 10.1016/j.vetmic.2013.05.027
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   GREINER EC, 1990, J MED ENTOMOL, V27, P1071, DOI 10.1093/jmedent/27.6.1071
   GRUBB P, 2005, MAMMAL SPECIES WORLD, P637
   Miller BF, 2009, J WILDLIFE DIS, V45, P457, DOI 10.7589/0090-3558-45.2.457
   Nelson SL, 2017, J MED ENTOMOL, V54, P1440, DOI 10.1093/jme/tjx112
   OKELLY JC, 1970, AUST J BIOL SCI, V23, P681, DOI 10.1071/BI9700681
   Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626
   Seal US, 1981, DIS PARASITES WHITE, P19
   Seaman G. A., 1966, Caribbean Journal of Science, V6, P33
   Szabo MPJ, 2003, J MED ENTOMOL, V40, P268, DOI 10.1603/0022-2585-40.3.268
   Wilson DV, 2004, VET ANAESTH ANALG, V31, P102, DOI 10.1111/j.1467-2987.2004.00152.x
   WOLKERS J, 1994, VET QUART, V16, P7, DOI 10.1080/01652176.1994.9694406
   World Organization for Animal Health, 2017, MAN DIAGN TESTS VACC
   Wu Xiao, 2015, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V34, P116, DOI 10.1089/mab.2014.0065
NR 17
TC 1
Z9 1
U1 0
U2 12
PU WILDLIFE DISEASE ASSOC, INC
PI LAWRENCE
PA 810 EAST 10TH ST, LAWRENCE, KS 66044-8897 USA
SN 0090-3558
EI 1943-3700
J9 J WILDLIFE DIS
JI J. Wildl. Dis.
PD OCT
PY 2018
VL 54
IS 4
BP 843
EP 847
DI 10.7589/2017-12-315
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA GW2AN
UT WOS:000446684500024
PM 29792759
DA 2020-07-08
ER

PT J
AU Sherman, KE
   Rouster, SD
   Kong, LX
   Aliota, MT
   Blackard, JT
   Dean, GE
AF Sherman, Kenneth E.
   Rouster, Susan D.
   Kong, Ling X.
   Aliota, Matthew T.
   Blackard, Jason T.
   Dean, Gary E.
TI Zika Virus Replication in Hepatocyte Cell Lines
SO HEPATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver
   Meeting
CY NOV 09-13, 2018
CL San Francisco, CA
SP Amer Assoc Study Liver Dis
C1 [Sherman, Kenneth E.; Rouster, Susan D.; Kong, Ling X.; Blackard, Jason T.] Univ Cincinnati, Dept Med, Cincinnati, OH 45221 USA.
   [Aliota, Matthew T.] Univ Wisconsin, Madison, WI USA.
   [Dean, Gary E.] Univ Cincinnati, Dept Med, Mol Genet, Cincinnati, OH 45221 USA.
FU AbbVieAbbott Laboratories; BMSBristol-Myers Squibb; GileadGilead
   Sciences; MerckMerck & Company; MedImmuneAstraZeneca
FX Kenneth E. Sherman - AbbVie: Grant/Research Support; BMS: Grant/Research
   Support; Gilead: Grant/Research Support; Merck: Grant/Research Support;
   Abbott Laboratories: Advisory Committee or Review Panel; Shionogi:
   Advisory Committee or Review Panel; MedImmune: Grant/Research Support;
   MedPace (DSMB): Advisory Committee or Review Panel; Watermark (DSMB for
   Allerga
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2018
VL 68
SU 1
MA 1229
BP 713A
EP 714A
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA GV3TU
UT WOS:000446020502023
DA 2020-07-08
ER

PT J
AU Valentine, GC
   Seferovic, MD
   Fowler, SW
   Major, AM
   Gorchakov, R
   Berry, R
   Swennes, AG
   Murray, KO
   Suter, MA
   Aagaard, KM
AF Valentine, Gregory C.
   Seferovic, Maxim D.
   Fowler, Stephanie W.
   Major, Angela M.
   Gorchakov, Rodion
   Berry, Rebecca
   Swennes, Alton G.
   Murray, Kristy O.
   Suter, Melissa A.
   Aagaard, Kjersti M.
TI Timing of gestational exposure to Zika virus is associated with
   postnatal growth restriction in a murine model
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article; Proceedings Paper
CT 38th Annual Pregnancy Meeting of the Society-for-Maternal-Fetal-Medicine
   (SMFM)
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
DE congenital infection; growth restriction; ZIKV
ID MOUSE MODEL; INFECTION; INFANTS; BRAZIL; RISK; TISSUE; BIRTH
AB BACKGROUND: Vertical transmission of Zika virus leads to infection of neuroprogenitor cells and destruction of brain parenchyma. Recent evidence suggests that the timing of infection as well as host factors may affect vertical transmission. As a result, congenital Zika virus infection may only become clinically apparent in the postnatal period.
   OBJECTIVE: We sought to develop an outbred mouse model of Zika virus vertical transmission to determine if the timing of gestational Zika virus exposure yields phenotypic differences at birth and through adolescence. We hypothesized that later gestational inoculations would only become apparent in adolescence.
   STUDY DESIGN: To better recapitulate human exposures, timed pregnant Swiss-Webster dams (n = 15) were subcutaneously inoculated with 1 x 10(4) plaque-forming units of first passage contemporary Zika virus HN16 strain or a mock injection on embryonic day 4, 8, or 12 with bioactive antiinterferon alpha receptor antibody administered in days preceding and proceeding inoculation. The antibody was given to prevent the robust type I interferon signaling cascade that make mice inherently resistant to Zika virus infection. At birth and adolescence (6 weeks of age) offspring were assessed for growth, brain weight, and biparietal head diameters, and Zika virus viral levels by reverse transcription-polymerase chain reaction or in situ hybridization.
   RESULTS: Pups of Zika virus-infected dams infected at embryonic days 4 and 8 but not 12 were growth restricted (P<.003). Brain weights were significantly smaller at birth (P=.01) for embryonic day 8 Zika viruseexposed offspring. At 6 weeks of age, biparietal diameters were smaller for all Zika viruseexposed males and females (P<.05), with embryonic day 8eexposed males smallest by biparietal diameter and growth-restriction measurements (weight >2 SD, P=.0007). All pups and adolescent mice were assessed for Zika virus infection by reverse transcription-polymerase chain reaction. Analysis of all underweight pups reveled 1 to be positive for neuronal Zika virus infection by in situ hybridization, while a second moribund animal was diffusely positive at 8 days of age by Zika virus infectivity throughout the brain, kidneys, and intestine.
   CONCLUSION: These findings demonstrate that postnatal effects of infection occurring at single time points continue to be detrimental to offspring in the postnatal period in a subset of littermates and subject to a window of gestational susceptibility coinciding with placentation. This model recapitulates frequently encountered clinical scenarios in nonendemic regions, including the majority of the United States, where travel-related exposure occurs in short and welldefined windows of gestation. Our low rate of infection and relatively rare evidence of congenital Zika syndrome parallels human population-based data.
C1 [Valentine, Gregory C.] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.
   [Seferovic, Maxim D.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.
   [Gorchakov, Rodion; Berry, Rebecca; Murray, Kristy O.] Baylor Coll Med, Dept Pediat, Sect Pediat Trop Med, Houston, TX 77030 USA.
   [Fowler, Stephanie W.; Swennes, Alton G.] Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA.
   [Major, Angela M.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Texas Childrens Hosp, Houston, TX 77030 USA.
RP Aagaard, KM (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.
EM aagaardt@bcm.edu
OI Valentine, Gregory/0000-0002-3055-2987
FU Evangelina Whitlock grant
FX This study was supported in part by the Evangelina Whitlock grant
   provided to G.C.V. The funders had no role in developing the study
   design, data collection, and/or analysis, decision to publish, or
   preparation of the manuscript.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Chen FH, 2010, DEV DYNAM, V239, P1941, DOI 10.1002/dvdy.22319
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Santos VS, 2017, AM J TROP MED HYG, V97, P151, DOI 10.4269/ajtmh.16-1021
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sutherland AE, 2016, SEMIN CELL DEV BIOL, V55, P89, DOI 10.1016/j.semcdb.2016.01.033
   Valentine G, 2016, EXPERT REV ANTI-INFE, V14, P1127, DOI 10.1080/14787210.2016.1245614
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808
   World Health Organization, WHO STAT 1 M INT HLT
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 38
TC 5
Z9 5
U1 0
U2 3
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD OCT
PY 2018
VL 219
IS 4
AR 403.e1-e9
DI 10.1016/j.ajog.2018.06.005
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GV2CK
UT WOS:000445892700026
PM 29902449
OA Other Gold
DA 2020-07-08
ER

PT J
AU Nikolay, A
   Leon, A
   Schwamborn, K
   Genzel, Y
   Reichl, U
AF Nikolay, Alexander
   Leon, Arnaud
   Schwamborn, Klaus
   Genzel, Yvonne
   Reichl, Udo
TI Process intensification of EB66 (R) cell cultivations leads to
   high-yield yellow fever and Zika virus production
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE EB66((R)); Yellow fever virus; Zika virus; Flavivirus; Perfusion;
   Capacitance probe
ID DENSITY CULTIVATIONS; INFLUENZA VACCINES; PERFUSION CULTURES; LINE; MVA;
   OPTIMIZATION; SYSTEM; ATF
AB A live-attenuated, human vaccine against mosquito-borne yellow fever virus has been available since the 1930s. The vaccine provides long-lasting immunity and consistent mass vaccination campaigns counter viral spread. However, traditional egg-based vaccine manufacturing requires about 12months and vaccine supplies are chronically close to shortages. In particular, for urban outbreaks, vaccine demand can be covered rarely by global stockpiling. Thus, there is an urgent need for an improved vaccine production platform, ideally transferable to other flaviviruses including Zika virus. Here, we present a proof-of-concept study regarding cell culture-based yellow fever virus 17D (YFV) and wild-type Zika virus (ZIKV) production using duck embryo-derived EB66 (R) cells. Based on comprehensive studies in shake flasks, 1-L bioreactor systems were operated with scalable hollow fiber-based tangential flow filtration (TFF) and alternating tangential flow filtration (ATF) perfusion systems for process intensification. EB66 (R) cells grew in chemically defined medium to cell concentrations of 1.6x10(8) cells/mL. Infection studies with EB66 (R)-adapted virus led to maximum YFV titers of 7.3x10(8)PFU/mL, which corresponds to about 10 million vaccine doses for the bioreactor harvest. For ZIKV, titers of 1.0x10(10)PFU/mL were achieved. Processes were automated successfully using a capacitance probe to control perfusion rates based on on-line measured cell concentrations. The use of cryo-bags for direct inoculation of production bioreactors facilitates pre-culture preparation contributing to improved process robustness. In conclusion, this platform is a powerful option for next generation cell culture-based flavivirus vaccine manufacturing.
C1 [Nikolay, Alexander; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [Leon, Arnaud; Schwamborn, Klaus] Valneva SE, 6 Rue Alain Bombard, F-44800 St Herblain, France.
   [Reichl, Udo] Otto von Guericke Univ, Univ Pl 2, D-39106 Magdeburg, Germany.
RP Genzel, Y (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
EM genzel@mpi-magdeburg.mpg.de
OI Nikolay, Alexander/0000-0003-4475-9556
FU Max Planck SocietyMax Planck Society
FX Open access funding provided by Max Planck Society.
CR Brown Stephen W, 2010, PDA J Pharm Sci Technol, V64, P419
   Calisher CH, 2016, EMERG INFECT DIS, V22, P1859, DOI 10.3201/eid2210.160875
   Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106
   Clincke MF, 2013, BIOTECHNOL PROGR, V29, P754, DOI 10.1002/btpr.1704
   Diamond MS, 2018, NAT REV IMMUNOL, V18, P89, DOI 10.1038/nri.2017.132
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Dowd JE, 2003, CYTOTECHNOLOGY, V42, P35, DOI 10.1023/A:1026192228471
   Frensing T, 2014, APPL MICROBIOL BIOT, V98, P8999, DOI 10.1007/s00253-014-5933-y
   Gallo-Ramirez LE, 2015, EXPERT REV VACCINES, V14, P1181, DOI 10.1586/14760584.2015.1067144
   Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016
   Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2
   Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]
   HARRIS CM, 1987, ENZYME MICROB TECH, V9, P181, DOI 10.1016/0141-0229(87)90075-5
   Jordan I, 2009, VACCINE, V27, P748, DOI 10.1016/j.vaccine.2008.11.066
   Konstantinov K, 2006, ADV BIOCHEM ENG BIOT, V101, P75, DOI 10.1007/10_016
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leon A, 2016, VACCINE, V34, P5878, DOI 10.1016/j.vaccine.2016.10.043
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023
   Nikolay A, 2018, VACCINE, V36, P3140, DOI 10.1016/j.vaccine.2017.03.018
   Pau MG, 2001, VACCINE, V19, P2716, DOI 10.1016/S0264-410X(00)00508-9
   Petiot E, 2017, J BIOTECHNOL, V242, P19, DOI 10.1016/j.jbiotec.2016.11.010
   Petiot E, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-84
   Seth G, 2013, BIOTECHNOL BIOENG, V110, P1376, DOI 10.1002/bit.24808
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Vazquez-Ramirez D, 2018, VACCINE, V36, P3124, DOI 10.1016/j.vaccine.2017.10.112
   WHO, 2016, YELL FEV GLOB VACC S
   WHO, 2016, GLOB STRAT EL YELL F
   Wilder-Smith A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax008
NR 33
TC 7
Z9 7
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD OCT
PY 2018
VL 102
IS 20
BP 8725
EP 8737
DI 10.1007/s00253-018-9275-z
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GU8QD
UT WOS:000445604600010
PM 30091043
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Lim, MQ
   Kumaran, EAP
   Tan, HC
   Lye, DC
   Leo, YS
   Ooi, EE
   MacAry, PA
   Bertoletti, A
   Rivino, L
AF Lim, Mei Qiu
   Kumaran, Emmanuelle A. P.
   Tan, Hwee Cheng
   Lye, David C.
   Leo, Yee Sin
   Ooi, Eng Eong
   MacAry, Paul A.
   Bertoletti, Antonio
   Rivino, Laura
TI Cross-Reactivity and Anti-viral Function of Dengue Capsid and
   NS3-Specific Memory T Cells Toward Zika Virus
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE dengue virus (DENV); Zika virus (ZIKV); T cells; cross-reactive immune
   response; heterologous immunity; anti-viral response
ID ORIGINAL ANTIGENIC SIN; PROTECTIVE ROLE; RESPONSES; CD4(+); INFECTION;
   NS3; EPITOPES; IMMUNITY; CLONES
AB Zika virus (ZIKV), a flavivirus with homology to dengue virus (DENV), is spreading to areas of DENV hyper-endemicity. Heterologous T cell immunity, whereby virus-specific memory T cells are activated by variant peptides derived from a different virus, can lead to enhanced viral clearance or diminished protective immunity and altered immunopathology. In mice, CD8+ T cells specific for DENV provide in vivo protective efficacy against subsequent ZIKV infection. In humans, contrasting studies report complete absence or varying degrees of DENV/ZIKV T cell cross-reactivity. Moreover, the impact of cross-reactive T cell recognition on the anti-viral capacity of T cells remains unclear. Here, we show that DENV-specific memory T cells display robust cross-reactive recognition of ZIKV NS3 ex vivo and after in vitro expansion in respectively n = 7/10 and n = 9/9 dengue-immune individuals tested. In contrast, cross-reactivity toward ZIKV capsid is low or absent. Cross-reactive recognition of DENV or ZIKV NS3 peptides elicits similar production of the anti-viral effector mediators IFN-gamma, TNF-, and CD107a. We identify 9 DENV/ZIKV cross-reactive epitopes, 7 of which are CD4+ and 2 are CD8+ T cell epitopes. We also show that cross-reactive CD4+ and CD8+ T cells targeting novel NS3 epitopes display anti-viral effector potential toward ZIKV-infected cells, with CD8+ T cells mediating direct lyses of these cells. Our results demonstrate that DENV NS3-specific memory T cells display anti-viral effector capacity toward ZIKV, suggesting a potential beneficial effect in humans of pre-existing T cell immunity to DENV upon ZIKV infection.
C1 [Lim, Mei Qiu; Tan, Hwee Cheng; Ooi, Eng Eong; Bertoletti, Antonio; Rivino, Laura] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Kumaran, Emmanuelle A. P.; Ooi, Eng Eong; MacAry, Paul A.] Natl Univ Singapore, Life Sci Inst, Immunol Programme, Dept Microbiol & Immunol, Singapore, Singapore.
   [Lye, David C.; Leo, Yee Sin] Tan Tock Seng Hosp, Communicable Dis Ctr, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Lye, David C.; Leo, Yee Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Lye, David C.; Leo, Yee Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Leo, Yee Sin] NCID, Singapore, Singapore.
   [Bertoletti, Antonio] Singapore Agcy Sci Technol & Res A STAR, Singapore Immunol Network, Singapore, Singapore.
RP Rivino, L (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
EM laura.rivino@duke-nus.edu.sg
OI Ooi, Eng Eong/0000-0002-0520-1544; Lye, David/0000-0003-0324-0205;
   Rivino, Laura/0000-0001-6213-9794; Kumaran,
   Emmanuelle/0000-0003-3074-0125
FU Cooperative Basic Research Grant-New Investigator Grant of the Singapore
   National Medical Research Council [CBRG-NIG R-913-301-289-213]; Open
   Fund-Individual Research Grant of the Singapore National Medical
   Research Council [OF-IRG R-913-301-439-213]; Duke-NUS Medical School
   Khoo Bridge Funding Award [Duke-NUS-KBrFA/2017/0005]; Singapore
   Translational Research (STaR) Investigator Award [NMRC/STaR/013/2012]
FX This work was funded by: a Cooperative Basic Research Grant-New
   Investigator Grant (CBRG-NIG R-913-301-289-213), an Open Fund-Individual
   Research Grant (OF-IRG R-913-301-439-213) of the Singapore National
   Medical Research Council and a Duke-NUS Medical School Khoo Bridge
   Funding Award (Duke-NUS-KBrFA/2017/0005) to LR; a Singapore
   Translational Research (STaR) Investigator Award (NMRC/STaR/013/2012) to
   AB. We would like to thank all subjects for consenting to participate in
   this study. We also thank Kamini Kunasegaran and Reshmi Giri for
   technical assistance.
CR Aihara H, 1998, J VIROL, V72, P8032, DOI 10.1128/JVI.72.10.8032-8036.1998
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727
   Culshaw A, 2017, NAT IMMUNOL, V18, P1228, DOI 10.1038/ni.3850
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Klenerman P, 1998, NATURE, V394, P482
   KURANE I, 1995, J GEN VIROL, V76, P2243, DOI 10.1099/0022-1317-76-9-2243
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Okamoto Y, 1998, J GEN VIROL, V79, P697, DOI 10.1099/0022-1317-79-4-697
   Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Selin LK, 2004, SEMIN IMMUNOL, V16, P335, DOI 10.1016/j.smim.2004.08.014
   Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08
   Tharakaraman K, 2018, CELL HOST MICROBE, V23, P618, DOI 10.1016/j.chom.2018.04.004
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zivny J, 1999, J IMMUNOL, V163, P2754
NR 41
TC 12
Z9 12
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD OCT 1
PY 2018
VL 9
AR 2225
DI 10.3389/fimmu.2018.02225
PG 14
WC Immunology
SC Immunology
GA GV4JX
UT WOS:000446066300001
PM 30327651
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Livingstone-Banks, J
AF Livingstone-Banks, Jonathan
TI The case for a meta-nosological investigation of pragmatic disease
   definition and classification
SO JOURNAL OF EVALUATION IN CLINICAL PRACTICE
LA English
DT Article
DE disease definition; disease taxonomy; meta-nosology; metaphysics;
   nosology; philosophy of medicine
ID ZIKA VIRUS
AB Nosology is the science of defining and classifying diseases. Meta-nosology is the study of how we do this, on what principles nosological practices are based, the quality of the resulting medical taxonomy, and primarily whether/how diseases can be defined better than they are now. In modern Western medicine, there are a wide variety of ways in which diseases are defined and categorized. Examples include by the symptoms they present with (syndromic), their underlying causes (etiological), the biological mechanisms involved (pathogenetic), available treatments, historical precedent, and through diagnostic exclusion. Here, I explore the hypothesis that how we define diseases has an impact on how (and how effectively) we research and treat them. I explore the philosophical implications of this thesis and suggest a direction that the underlying metaphysics of disease definition might follow. I conclude that further research is warranted into whether our current disease definitions could be improved upon.
C1 [Livingstone-Banks, Jonathan] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.
RP Livingstone-Banks, J (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.
EM jonathan.livingstone-banks@phc.ox.ac.uk
OI Livingstone-Banks, Jonathan/0000-0002-3757-5591
CR [Anonymous], 2013, FACTS ESS TREM
   [Anonymous], 1992, ICD 10 CLASS MENT BE
   [Anonymous], 2017, ZIKA VIRUS STUDY PRO
   Banks J, 2014, ANTIREALIST ESSENTIA
   Bingham AM, 2016, CDC MORBIDITY MORTAL, V65
   Blackburn S., 1993, ESSAYS QUASIREALISM
   BOORSE C, 1977, PHILOS SCI, V44, P542, DOI 10.1086/288768
   BOYD R, 1991, PHILOS STUD, V61, P127, DOI 10.1007/BF00385837
   Brochhausen M, 2016, ROUTLEDGE COMPANION
   DUPRE J, 1993, DISORDER THINGS META
   Ereshefsky M, 2009, STUD HIST PHI PART C, V40, P221, DOI 10.1016/j.shpsc.2009.06.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kendig C, 2016, NATURAL KINDS CLASSI
   Lewis David, 1969, CONVENTION PHILOS ST
   Locke J., 1689, ESSAY HUMAN UNDERSTA
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   MARGOLIS J, 1976, J MED PHILOS, V1, P238, DOI 10.1093/jmp/1.3.238
   Reznek L., 1987, NATURE DIS
   Sidelle A, 1998, NOUS, V32, P423, DOI 10.1111/0029-4624.00133
   Sidelle A., 1989, NECESSITY ESSENCE IN
   Simon J, 2016, ROUTLEDGE COMPANION
NR 21
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1356-1294
EI 1365-2753
J9 J EVAL CLIN PRACT
JI J. Eval. Clin. Pract.
PD OCT
PY 2018
VL 24
IS 5
SI SI
BP 1013
EP 1018
DI 10.1111/jep.13012
PG 6
WC Health Care Sciences & Services; Medical Informatics; Medicine, General
   & Internal
SC Health Care Sciences & Services; Medical Informatics; General & Internal
   Medicine
GA GU8US
UT WOS:000445618800016
PM 30066390
OA Bronze
DA 2020-07-08
ER

PT J
AU Van Rompay, K
AF Van Rompay, Koen
TI Jumping from HIV into Zika: Research into high gear
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Van Rompay, Koen] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2018
VL 47
IS 5
SI SI
MA 500
BP 324
EP 324
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA GU8UQ
UT WOS:000445618600053
DA 2020-07-08
ER

PT J
AU Dudley, D
   Newman, CM
   Mohr, EL
   Aliota, MT
   Nguyen, SM
   Antony, KM
   Kohn, S
   Simmons, HA
   Weiler, AM
   Semler, MR
   Mohns, MS
   Breitbach, ME
   Stewart, LM
   Koenig, M
   Wolfe, B
   Salamat, MS
   Teixeira, LBC
   Zeng, XK
   Wiepz, GJ
   Thoong, TH
   Barry, GL
   Weisgrau, KL
   Vosler, LJ
   Rasheed, MN
   Graham, ME
   Block, L
   Post, J
   Hayes, JM
   Schultz-Darken, N
   Schotzko, ML
   Eudailey, JA
   Kuhn, J
   Permar, SR
   Rakasz, EG
   Capuano, S
   Tarantal, AF
   Osorio, JE
   O'Connor, SL
   Friedrich, TC
   Golos, TG
   O'Connor, DH
AF Dudley, Dawn
   Newman, Christina M.
   Mohr, Emma L.
   Aliota, Matthew T.
   Nguyen, Sydney M.
   Antony, Kathleen M.
   Kohn, Sarah
   Simmons, Heather A.
   Weiler, Andrea M.
   Semler, Matthew R.
   Mohns, Mariel S.
   Breitbach, Meghan E.
   Stewart, Laurel M.
   Koenig, Michelle
   Wolfe, Bryce
   Salamat, M. Shahriar
   Teixeira, Leandro B. C.
   Zeng, Xiankun
   Wiepz, Gregory J.
   Thoong, Troy H.
   Barry, Gabrielle L.
   Weisgrau, Kim L.
   Vosler, Logan J.
   Rasheed, Mustafa N.
   Graham, Michael E.
   Block, Lindsey
   Post, Jennifer
   Hayes, Jennifer M.
   Schultz-Darken, Nancy
   Schotzko, Michele L.
   Eudailey, Josh A.
   Kuhn, Jens
   Permar, Sallie R.
   Rakasz, Eva G.
   Capuano, Saverio, III
   Tarantal, Alice F.
   Osorio, Jorge E.
   O'Connor, Shelby L.
   Friedrich, Thomas C.
   Golos, Thaddeus G.
   O'Connor, David H.
TI Nonhuman primate models for Zika virus infection
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Dudley, Dawn; Newman, Christina M.; Semler, Matthew R.; Mohns, Mariel S.; Breitbach, Meghan E.; Stewart, Laurel M.; Koenig, Michelle; Wolfe, Bryce; Salamat, M. Shahriar; Rasheed, Mustafa N.; Graham, Michael E.; Block, Lindsey; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
   [Mohr, Emma L.] Univ Wisconsin Madison, Dept Pediat, Madison, WI USA.
   [Aliota, Matthew T.; Friedrich, Thomas C.] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI USA.
   [Nguyen, Sydney M.; Antony, Kathleen M.; Golos, Thaddeus G.] Univ Wisconsin Madison, Dept Obstet & Gynecol, Madison, WI USA.
   [Kohn, Sarah] Univ Wisconsin Madison, Dept Radiol, Madison, WI USA.
   [Simmons, Heather A.; Weiler, Andrea M.; Thoong, Troy H.; Barry, Gabrielle L.; Weisgrau, Kim L.; Vosler, Logan J.; Post, Jennifer; Hayes, Jennifer M.; Schultz-Darken, Nancy; Schotzko, Michele L.; Kuhn, Jens; Rakasz, Eva G.; Capuano, Saverio, III; Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Teixeira, Leandro B. C.] Univ Wisconsin Madison, Sch Vet Med, Madison, WI USA.
   [Zeng, Xiankun; Osorio, Jorge E.] NIAID, Integrated Res Facil Ft Detrick, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Wiepz, Gregory J.; Golos, Thaddeus G.] Univ Wisconsin Madison, Dept Comparat Biosci, Madison, WI USA.
   [Eudailey, Josh A.; Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27706 USA.
   [Eudailey, Josh A.; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27706 USA.
   [Tarantal, Alice F.] Univ Calif Davis, Dept Pediat, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Tarantal, Alice F.] Univ Calif Davis, Dept Cell Biol & Human Anat, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
RI Rakasz, Eva G/H-9197-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2018
VL 47
IS 5
SI SI
MA 506
BP 326
EP 327
PG 2
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA GU8UQ
UT WOS:000445618600059
DA 2020-07-08
ER

PT J
AU Berry, N
   Ferguson, D
   Ham, C
   Hall, J
   Jenkins, A
   Giles, E
   Rose, N
   Hewson, R
   Dowell, S
   Kempster, S
   Almonds, N
AF Berry, Neil
   Ferguson, Deborah
   Ham, Claire
   Hall, Jo
   Jenkins, Adrian
   Giles, Elaine
   Rose, Nicola
   Hewson, Roger
   Dowell, Stuart
   Kempster, Sarah
   Almonds, Neil
TI Infection dynamics and persistence of Zika virus in new and old world
   non-human primates
SO JOURNAL OF MEDICAL PRIMATOLOGY
LA English
DT Meeting Abstract
C1 [Berry, Neil; Ferguson, Deborah; Ham, Claire; Hall, Jo; Jenkins, Adrian; Giles, Elaine; Rose, Nicola; Kempster, Sarah; Almonds, Neil] NIBSC, Ridge, Herts, England.
   [Hewson, Roger; Dowell, Stuart] PHE Porton, Porton Down, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0047-2565
EI 1600-0684
J9 J MED PRIMATOL
JI J. Med. Primatol.
PD OCT
PY 2018
VL 47
IS 5
SI SI
MA 507
BP 327
EP 327
PG 1
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA GU8UQ
UT WOS:000445618600060
DA 2020-07-08
ER

PT J
AU Tao, X
   de Mello, CPP
   Kim, TH
   Vicchiarelli, M
   Bulitta, JB
   Kaushikc, A
   Brown, AN
AF Tao, Xun
   de Mello, Camilly P. Pires
   Kim, Tae Hwan
   Vicchiarelli, Michael
   Bulitta, Jurgen B.
   Kaushikc, Ajeet
   Brown, Ashley N.
TI Clinical regimens of Favipiravir (FAV) inhibit Zika virus (ZIKV)
   replication in the Hollow Fiber Infection Model (HFIM)
SO JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
LA English
DT Meeting Abstract
C1 [Tao, Xun; Kim, Tae Hwan; Bulitta, Jurgen B.] Univ Florida, Coll Pharm, Dept Pharmaceut, Ctr Pharmacomet & Syst Pharmacol, Orlando, FL USA.
   [de Mello, Camilly P. Pires; Vicchiarelli, Michael; Brown, Ashley N.] Univ Florida, Coll Med, Dept Med, Inst Therapeut Innovat, Orlando, FL USA.
   [Kaushikc, Ajeet] Florida Int Univ, Herbert Wertheim Coll Med, Inst Neuroimmune Pharmacol, Ctr Personalized Nanomed,Dept Immunol, Miami, FL 33199 USA.
RI Bulitta, Jurgen B/P-3355-2018
OI Bulitta, Jurgen B/0000-0001-7352-3097
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1567-567X
EI 1573-8744
J9 J PHARMACOKINET PHAR
JI J. Pharmacokinet. Pharmacodyn.
PD OCT
PY 2018
VL 45
SU 1
MA W-065
BP S119
EP S119
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GU5YT
UT WOS:000445374700263
DA 2020-07-08
ER

PT J
AU Pal, S
   Ganesan, K
   Eswaran, S
AF Pal, Shreya
   Ganesan, Keerthiga
   Eswaran, Sambasivan
TI Chemical Crosslinking-Mass Spectrometry (CXL-MS) for Proteomics,
   Antibody-Drug Conjugates (ADCs) and Cryo-Electron Microscopy (cryo-EM)
SO IUBMB LIFE
LA English
DT Review
DE chemical crosslinkers; proteomics; antibody-drug conjugates; cryo-EM
ID STRUCTURAL BIOLOGY; PROTEIN STRUCTURES; RESOLUTION; VISUALIZATION;
   COMPLEX; CHEMISTRY; SOFTWARE; IMAGE
AB Chemical crosslinking-mass spectrometry (CXL-MS) has emerged as a powerful tool in structural biology to elucidate protein-protein interactions. This review throws light on the advent of these technologies incorporating chemical crosslinking in proteomics, structural biology and extended to studies and applications of antibody-drug conjugates (ADCs). Monoclonal ASCs are known to target their specific receptors, where the drug could be released for vastly improved therapeutic effect. Cryo-electron microscopy (cryo-EM) is being referred to as the revolution of the century as it can help attain almost atomic resolution, while preserving the biological samples at near-native state and has been recognized by the Nobel award 2017. CXL-MS and appropriate bioinformatics tools in combination with cryo-EM reveal better 3D information about dynamic interactions in proteins, interactive domains and motifs, among others in ADCs and in viruses like Zika virus, Rota virus, Dengue virus and also spliceosomes at resolutions, especially below 3 angstrom. (c) 2018 IUBMB Life, 70(10):947-960, 2018
C1 [Pal, Shreya] Amity Univ Haryana, Manesar, Haryana, India.
   [Ganesan, Keerthiga] SASTRA Deemed Be Univ, Thanjavur, Tamil Nadu, India.
   [Eswaran, Sambasivan] Reg Ctr Biotechnol, NCR Biotech Sci Cluster, 3rd Milestone,Faridabad Gurgaon Expressway, Faridabad 121001, Haryana, India.
RP Eswaran, S (corresponding author), Reg Ctr Biotechnol, NCR Biotech Sci Cluster, 3rd Milestone,Faridabad Gurgaon Expressway, Faridabad 121001, Haryana, India.
EM samba.eswaran@rcb.res.in
CR Agarwal P, 2015, BIOCONJUGATE CHEM, V26, P176, DOI 10.1021/bc5004982
   AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955
   Aramayo RJ, 2018, NAT STRUCT MOL BIOL, V25, P37, DOI 10.1038/s41594-017-0003-7
   Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022
   Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576
   Beniac D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46374
   Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107
   Campbell MG, 2015, ELIFE, V4, DOI 10.7554/eLife.06380
   Chari RVJ, 2014, ANGEW CHEM INT EDIT, V53, P3796, DOI 10.1002/anie.201307628
   Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106
   Courcelles M, 2017, J PROTEOME RES, V16, P2645, DOI 10.1021/acs.jproteome.7b00205
   Dihazi GH, 2003, RAPID COMMUN MASS SP, V17, P2005, DOI 10.1002/rcm.1144
   Dvornek NC, 2015, J STRUCT BIOL, V190, P200, DOI 10.1016/j.jsb.2015.03.009
   Faruqi AR, 2006, NUCL INSTRUM METH A, V566, P770, DOI 10.1016/j.nima.2006.07.013
   Fioramonte M, 2018, ANAL CHEM, V90, P6043, DOI 10.1021/acs.analchem.7b05135
   Franken LE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00718-x
   Gaur M, 2012, MONATSH CHEM, V143, P283, DOI 10.1007/s00706-011-0652-x
   Grant TJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00011.1
   Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890
   Hage C, 2017, ANGEW CHEM INT EDIT, V56, P14551, DOI 10.1002/anie.201708273
   Henderson R, 2015, ARCH BIOCHEM BIOPHYS, V581, P19, DOI 10.1016/j.abb.2015.02.036
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Hryc CF, 2011, CURR OPIN VIROL, V1, P110, DOI 10.1016/j.coviro.2011.05.019
   Huisgen Rolf, 1963, ANGEW CHEM INT EDIT, V2, P565, DOI DOI 10.1002/ANIE.196305651
   Kang K, 2017, PROTEOME SCI, V15, DOI 10.1186/s12953-017-0121-5
   Kannan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065610
   Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212
   Kaushal PS, 2015, P NATL ACAD SCI USA, V112, pE2736, DOI 10.1073/pnas.1507224112
   Khoshouei M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16099
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kosinski J, 2015, J STRUCT BIOL, V189, P177, DOI 10.1016/j.jsb.2015.01.014
   Leitner A, 2016, TRENDS BIOCHEM SCI, V41, P20, DOI 10.1016/j.tibs.2015.10.008
   Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040
   Nogales E, 2015, MOL CELL, V58, P677, DOI 10.1016/j.molcel.2015.02.019
   Panowski S, 2013, MABS, V6, P34, DOI DOI 10.4161/MABS.2702224423619
   Patra M, 2016, CHEM SOC REV, V45, P6415, DOI 10.1039/c5cs00784d
   Perkins GA, 2009, METHOD ENZYMOL, V456, P29, DOI 10.1016/S0076-6879(08)04402-9
   Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]
   Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]
   Sanghai ZA, 2018, NATURE, V556, P126, DOI 10.1038/nature26156
   Scapin G., 2017, MICROSC MICROANAL, V23, P1186
   Schmidt C, 2017, CURR OPIN STRUC BIOL, V46, P157, DOI 10.1016/j.sbi.2017.10.005
   Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108
   Sigworth FJ, 2016, MICROSCOPY-JPN, V65, P57, DOI 10.1093/jmicro/dfv370
   Sinz A, 2015, PROTEIN SCI, V24, P1193, DOI 10.1002/pro.2696
   Tan D, 2016, ELIFE, V5, DOI 10.7554/eLife.12509
   Thakur S. K., 2017, J ANAL BIOANAL TECH, V8
   Thompson RF, 2016, METHODS, V100, P3, DOI 10.1016/j.ymeth.2016.02.017
   Tian YL, 2017, J AM CHEM SOC, V139, P6078, DOI 10.1021/jacs.7b02615
   van Zundert GCP, 2015, STRUCTURE, V23, P949, DOI 10.1016/j.str.2015.03.014
   Wakankar A, 2011, MABS-AUSTIN, V3, P161, DOI 10.4161/mabs.3.2.14960
   Yu GM, 2016, STRUCTURE, V24, P1984, DOI 10.1016/j.str.2016.09.008
   Zhang X., 2015, SCI REP, V5, P1, DOI DOI 10.1038/srep09713
   Zhang XY, 2018, ANAL CHEM, V90, P1195, DOI 10.1021/acs.analchem.7b03789
   Zhang XM, 2012, ADV ENG FORUM, V5, P20, DOI 10.4028/www.scientific.net/AEF.5.20
NR 55
TC 2
Z9 2
U1 6
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD OCT
PY 2018
VL 70
IS 10
BP 947
EP 960
DI 10.1002/iub.1916
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GU6TQ
UT WOS:000445449500001
PM 30176115
OA Bronze
DA 2020-07-08
ER

PT J
AU Fontaine, A
   de Laval, F
   Belleoud, D
   Briolant, S
   Matheus, S
AF Fontaine, Albin
   de Laval, Franck
   Belleoud, Didier
   Briolant, Sebastien
   Matheus, Severine
TI Duration of Zika Viremia in Serum
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
C1 [Fontaine, Albin; Briolant, Sebastien] Inst Rech Biomed Armees, Unite Parasitol & Entomol, Dept Malad Infect, Marseille, France.
   [Fontaine, Albin; Briolant, Sebastien] Aix Marseille Univ, UMR Vecteurs Infect Trop & Mediterraneennes VITRO, Mediterranee Infect, IRD,AP HM,SSA,IHU, Marseille, France.
   [de Laval, Franck] Mil Ctr Epidemiol & Publ Hlth, Marseille, France.
   [de Laval, Franck; Belleoud, Didier; Briolant, Sebastien] French Armed Forces Hlth Serv French Guiana, Cayenne, French Guiana.
   [de Laval, Franck] Aix Marseille Univ, UMR Sci Econ & Sociales Sante & Traitement Inform, Mediterranee Infect, CNRS,INSERM,IRD,SSA,IHU, Marseille, France.
   [Matheus, Severine] Inst Pasteur, Lab Virol, 23 Ave Pasteur,BP 6010, Cayenne 97306, French Guiana.
RP Matheus, S (corresponding author), Inst Pasteur, Lab Virol, 23 Ave Pasteur,BP 6010, Cayenne 97306, French Guiana.
EM smatheus@pasteur-cayenne.fr
RI Fontaine, Albin/K-4345-2019
OI Fontaine, Albin/0000-0001-6869-6516
FU Direction du Service de Sante des Armees [2016RC10]; European Virus
   Archive goes Global project through Horizon 2020 of the European Union
   [653316]
FX This work was supported by the Direction du Service de Sante des Armees
   [grant number 2016RC10] and by the European Virus Archive goes Global
   project through a grant from Horizon 2020 of the European Union [grant
   number 653316].
CR Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Paz-Bailey G, 2017, N ENGL J MED
   R Core Team, 2017, R LANG ENV STAT COMP
NR 7
TC 5
Z9 5
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 1
PY 2018
VL 67
IS 7
BP 1143
EP 1144
DI 10.1093/cid/ciy261
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GU6BX
UT WOS:000445387500024
PM 29617955
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barzon, L
   Percivalle, E
   Pacenti, M
   Rovida, F
   Zavattoni, M
   Del Bravo, P
   Cattelan, AM
   Palu, G
   Baldanti, F
AF Barzon, Luisa
   Percivalle, Elena
   Pacenti, Monia
   Rovida, Francesca
   Zavattoni, Maurizio
   Del Bravo, Paola
   Cattelan, Anna Maria
   Palu, Giorgio
   Baldanti, Fausto
TI Duration of Zika Viremia in Serum Reply
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
ID VIRUS-INFECTION; WHOLE-BLOOD; MONOCYTES; TARGET
C1 [Barzon, Luisa; Palu, Giorgio] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
   [Barzon, Luisa; Pacenti, Monia; Palu, Giorgio] Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
   [Percivalle, Elena; Rovida, Francesca; Zavattoni, Maurizio; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Pavia, Italy.
   [Del Bravo, Paola] Verona Univ Hosp, Infect Dis Unit, Verona, Italy.
   [Cattelan, Anna Maria] Padova Univ Hosp, Infect Dis Unit, Padua, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Rovida, Francesca/K-7984-2016; percivalle, elena/K-7994-2016; CATTELAN,
   ANNA MARIA/AAL-3654-2020; Barzon, Luisa/K-7961-2016; Baldanti,
   Fausto/J-4924-2018
OI Rovida, Francesca/0000-0003-2345-2790; percivalle,
   elena/0000-0002-3355-1410; CATTELAN, ANNA MARIA/0000-0003-2869-2945;
   Barzon, Luisa/0000-0003-0720-8456; Baldanti, Fausto/0000-0002-3358-8969
CR Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Fontaine A, 2018, CLIN INFECT DIS, V67, P1143, DOI 10.1093/cid/ciy261
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Paz-Bailey G, 2018, NEW ENGL J MED, V66, P1173
NR 7
TC 1
Z9 1
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 1
PY 2018
VL 67
IS 7
BP 1144
EP 1145
DI 10.1093/cid/ciy262
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GU6BX
UT WOS:000445387500025
PM 29617958
OA Bronze
DA 2020-07-08
ER

PT J
AU Gopalakrishnan, R
   Sukumaran, D
   Thakare, VB
   Garg, P
   Singh, R
AF Gopalakrishnan, Reji
   Sukumaran, D.
   Thakare, Vikas B.
   Garg, Prabhat
   Singh, Ram
TI A review on test methods for insecticidal fabrics and the need for
   standardisation
SO PARASITOLOGY RESEARCH
LA English
DT Review
DE Insecticidal fabrics; Permethrin; Disease vector; Personal protection;
   Test methods
ID IMPREGNATED MILITARY UNIFORMS; VECTOR-BORNE DISEASES; PERSONAL
   PROTECTION; CONTACT TOXICITY; AEDES-AEGYPTI; BED NETS; PERMETHRIN;
   MALARIA; LEISHMANIASIS; AFGHANISTAN
AB Insecticidal fabrics are effective personal protective measures against disease vectors and unlike bed nets, these fabrics can provide protection from day-biting mosquitoes and in outdoor environments. The rapid geographical expansion of day-biting mosquitoes and their role in disease transmission necessitate technological interventions, which can be effectively used during the daytime. There is a renewed interest in insecticidal fabrics mainly due to the recent outbreaks and geographical spread of dengue and chikungunya and with the emerging threat of Zika virus infection. Insecticidal fabrics are useful for protection from night-biting mosquitoes and also in situations were sleeping under a bed net is not possible. They are also effective against other biting arthropods like ticks, mites, tsetse flies, sand flies and body lice. Although long-lasting insecticidal fabrics factory-treated with permethrin are now commercially available for military and civilian use, there are no international guidelines for testing their efficacy. The different methods employed so far for testing bioefficacy, washing and quantification of permethrin are compiled in this review. The future prospects and challenges ahead for long-lasting insecticidal fabrics are discussed in the context of the increased threat from day-biting mosquitoes and the diseases transmitted by them. The review focuses on the need for standardisation of the test methods for ensuring adequate bioefficacy and safety to the user. The differences between long-lasting insecticidal nets and long-lasting insecticidal fabrics are elaborated, and the need for a separate registration and licencing procedure for long-lasting insecticidal fabrics is highlighted. A test procedure for insecticidal fabrics is described, which could be used until internationally accepted guidelines are available.
C1 [Gopalakrishnan, Reji; Sukumaran, D.; Thakare, Vikas B.; Garg, Prabhat; Singh, Ram] Def Res & Dev Estab, Gwalior 474002, India.
RP Gopalakrishnan, R (corresponding author), Def Res & Dev Estab, Gwalior 474002, India.
EM gkreji@drde.drdo.in
RI SUKUMARAN, DEVANATHAN/L-6343-2019
FU Defence Research and Development Establishment, Gwalior
FX We would like to thank the Director, Defence Research and Development
   Establishment, Gwalior for his guidance and support during the study.
CR AFPMB, 2009, ARM FORC PEST MAN BO
   [Anonymous], 2009, GUID EFF TEST MOSQ R
   Appel KE, 2008, INT J HYG ENVIR HEAL, V211, P88, DOI 10.1016/j.ijheh.2007.10.005
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Bhatt RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-189
   Cecilia Dayaraj, 2014, WHO South East Asia J Public Health, V3, P22, DOI 10.4103/2224-3151.206879
   Dhiman S, 2011, INDIAN J MED RES, V133, P665
   EAMSILA C, 1994, J AM MOSQUITO CONTR, V10, P515
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   Faulde M, 2009, ACTA TROP, V110, P28, DOI 10.1016/j.actatropica.2008.12.005
   Faulde M, 2016, PARASITOL RES, V115, P1573, DOI 10.1007/s00436-015-4892-2
   Faulde MK, 2010, PARASITOL RES, V106, P957, DOI 10.1007/s00436-010-1749-6
   Faulde MK, 2003, J MED ENTOMOL, V40, P935, DOI 10.1603/0022-2585-40.6.935
   Frances SP, 2003, J AM MOSQUITO CONTR, V19, P275
   Frances SP, 2014, J MED ENTOMOL, V51, P1220, DOI 10.1603/ME14084
   Fryauff DJ, 1996, J AM MOSQUITO CONTR, V12, P84
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gopalakrishnan R, 2014, INT J ENVIRON SCI TE, V11, P1855, DOI 10.1007/s13762-013-0337-6
   Gopalakrishnan R, 2014, INDIAN J MED RES, V140, P314
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   GUPTA RK, 1989, J AM MOSQUITO CONTR, V5, P176
   HARBACH RE, 1990, J AM MOSQUITO CONTR, V6, P641
   Karacic S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166399
   Kenea O, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1668-9
   Khoobdel M., 2005, International Journal of Environmental Science and Technology, V2, P161
   Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Macedo PA, 2007, J TOXICOL ENV HEAL A, V70, P1758, DOI 10.1080/15287390701459049
   MCCAIN WC, 2007, INSECT REPELLENTS PR, P261
   Most B, 2017, PARASITOL RES, V116, P677, DOI 10.1007/s00436-016-5333-6
   Mutebi J, 2017, PROTECTION MOSQUITOE
   NEN, 2018, 83332018 NEN
   Pages F, 2010, CLIN MICROBIOL INFEC, V16, P209, DOI 10.1111/j.1469-0691.2009.03132.x
   Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134
   Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81
   Rossbach B, 2010, TOXICOL LETT, V192, P50, DOI 10.1016/j.toxlet.2009.06.863
   Rowland M, 1999, T ROY SOC TROP MED H, V93, P465, DOI 10.1016/S0035-9203(99)90341-3
   Rozendaal J.A., 1997, VECTOR CONTROL METHO
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247
   SCHRECK CE, 1982, J ECON ENTOMOL, V75, P1059, DOI 10.1093/jee/75.6.1059
   Sheikh K, 2016, SCI AM, V315, P19, DOI 10.1038/scientificamerican0816-19
   Shim E, 2017, AM J TROP MED HYG, V96, P1227, DOI 10.4269/ajtmh.16-0810
   SOTO J, 1995, CLIN INFECT DIS, V21, P599, DOI 10.1093/clinids/21.3.599
   Sukumaran D, 2014, PARASITOL RES, V113, P1739, DOI 10.1007/s00436-014-3819-7
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   USEPA, 2017, REP TREAT CLOTH
   Vaughn MF, 2011, VECTOR-BORNE ZOONOT, V11, P869, DOI 10.1089/vbz.2010.0158
   Wanzira H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1360-0
   WHO, 2006, GUID TEST MOSQ AD IN
   WHO, 2013, GUID EFF TEST SPAT R
   WHO, 2013, GUID LAB FIELD TEST
   World Health Organization, 2016, TEST PROC INREMO
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Wunsche H, 2017, MOTH VECTOR PROOFING
NR 55
TC 2
Z9 2
U1 2
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD OCT
PY 2018
VL 117
IS 10
BP 3067
EP 3080
DI 10.1007/s00436-018-6061-x
PG 14
WC Parasitology
SC Parasitology
GA GU3ES
UT WOS:000445159500003
PM 30151634
DA 2020-07-08
ER

PT J
AU Yang, H
   Eder, A
   Yogurtcu, O
   Chancey, C
   Forshee, R
AF Yang, Hong
   Eder, Anne
   Yogurtcu, Osman
   Chancey, Caren
   Forshee, Richard
TI Risk Assessment of Zika Virus Minipool Nucleic Acid Testing in Outbreak
   Scenarios
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 13-16, 2018
CL Boston, MA
SP AABB
C1 [Yang, Hong; Eder, Anne; Yogurtcu, Osman; Chancey, Caren; Forshee, Richard] US FDA, CBER, Rockville, MD 20857 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2018
VL 58
SU 2
SI SI
MA BBC9-MN3-2
BP 18A
EP 19A
PG 2
WC Hematology
SC Hematology
GA GT4LP
UT WOS:000444475900026
DA 2020-07-08
ER

PT J
AU Russell, WA
   Stramer, SL
   Busch, MP
   Custer, B
AF Russell, W. Alton
   Stramer, Susan L.
   Busch, Michael P.
   Custer, Brian
TI The Cost-Effectiveness of Implementing Minipool Nucleic Acid Testing for
   Zika Virus
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 13-16, 2018
CL Boston, MA
SP AABB
C1 [Russell, W. Alton] Stanford Univ, Stanford, CA 94305 USA.
   [Stramer, Susan L.] Amer Red Cross, Washington, DC 20006 USA.
   [Busch, Michael P.; Custer, Brian] Blood Syst Res Inst, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2018
VL 58
SU 2
SI SI
MA BBC26-MN3-
BP 20A
EP 21A
PG 2
WC Hematology
SC Hematology
GA GT4LP
UT WOS:000444475900030
DA 2020-07-08
ER

PT J
AU Grinev, A
   Assis, F
   Volkova, E
   Sippert, E
   Fares-Gusmao, R
   Ok, S
   Rocha, B
   Chancey, C
   Rios, M
AF Grinev, Andriyan
   Assis, Felipe
   Volkova, Evgeniya
   Sippert, Emilia
   Fares-Gusmao, Rafaelle
   Ok, Suzan
   Rocha, Bruno
   Chancey, Caren
   Rios, Maria
TI Genetic Variability of Zika Virus Isolated from US Blood Donors, 2016
SO TRANSFUSION
LA English
DT Meeting Abstract
CT AABB Annual Meeting
CY OCT 13-16, 2018
CL Boston, MA
SP AABB
C1 [Grinev, Andriyan; Assis, Felipe; Volkova, Evgeniya; Sippert, Emilia; Fares-Gusmao, Rafaelle; Ok, Suzan; Rocha, Bruno; Chancey, Caren; Rios, Maria] US FDA, CBER, Rockville, MD 20857 USA.
RI Sippert, Emilia Angela/B-3033-2013
OI Sippert, Emilia Angela/0000-0002-6341-3879
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD OCT
PY 2018
VL 58
SU 2
SI SI
MA BBC13-MN3-
BP 21A
EP 21A
PG 1
WC Hematology
SC Hematology
GA GT4LP
UT WOS:000444475900031
DA 2020-07-08
ER

PT J
AU Chen, S
   Xu, Q
   Buchenberger, J
   Bagavathi, A
   Fair, G
   Shaikh, S
   Krishnan, S
AF Chen, Shi
   Xu, Qian
   Buchenberger, John
   Bagavathi, Arunkumar
   Fair, Gabriel
   Shaikh, Samira
   Krishnan, Siddharth
TI Dynamics of Health Agency Response and Public Engagement in Public
   Health Emergency: A Case Study of CDC Tweeting Patterns During the 2016
   Zika Epidemic
SO JMIR PUBLIC HEALTH AND SURVEILLANCE
LA English
DT Article
DE Centers for Disease Control and Prevention; public engagement; Twitter;
   time series analysis; Zika epidemic; social media; twitter;
   infodemiology; infoveillance
AB Background: Social media have been increasingly adopted by health agencies to disseminate information, interact with the public, and understand public opinion. Among them, the Centers for Disease Control and Prevention (CDC) is one of the first US government health agencies to adopt social media during health emergencies and crisis. It had been active on Twitter during the 2016 Zika epidemic that caused 5168 domestic noncongenital cases in the United States.
   Objective: The aim of this study was to quantify the temporal variabilities in CDC's tweeting activities throughout the Zika epidemic, public engagement defined as retweeting and replying, and Zika case counts. It then compares the patterns of these 3 datasets to identify possible discrepancy among domestic Zika case counts, CDC's response on Twitter, and public engagement in this topic.
   Methods: All of the CDC-initiated tweets published in 2016 with corresponding retweets and replies were collected from 67 CDC-associated Twitter accounts. Both univariate and multivariate time series analyses were performed in each quarter of 2016 for domestic Zika case counts, CDC tweeting activities, and public engagement in the CDC-initiated tweets.
   Results: CDC sent out >84.0% (5130/6104) of its Zika tweets in the first quarter of 2016 when Zika case counts were low in the 50 US states and territories (only 560/5168, 10.8% cases and 662/38,885, 1.70% cases, respectively). While Zika case counts increased dramatically in the second and third quarters, CDC efforts on Twitter substantially decreased. The time series of public engagement in the CDC-initiated tweets generally differed among quarters and from that of original CDC tweets based on autoregressive integrated moving average model results. Both original CDC tweets and public engagement had the highest mutual information with Zika case counts in the second quarter. Furthermore, public engagement in the original CDC tweets was substantially correlated with and preceded actual Zika case counts.
   Conclusions: Considerable discrepancies existed among CDC's original tweets regarding Zika, public engagement in these tweets, and actual Zika epidemic. The patterns of these discrepancies also varied between different quarters in 2016. CDC was much more active in the early warning of Zika, especially in the first quarter of 2016. Public engagement in CDC's original tweets served as a more prominent predictor of actual Zika epidemic than the number of CDC's original tweets later in the year.
C1 [Chen, Shi; Buchenberger, John] Univ N Carolina, Dept Publ Hlth Sci, 9021 Univ City Blvd, Charlotte, NC 28223 USA.
   [Xu, Qian] Elon Univ, Sch Commun, Elon, NC USA.
   [Bagavathi, Arunkumar; Fair, Gabriel; Shaikh, Samira; Krishnan, Siddharth] Univ N Carolina, Dept Comp Sci, Charlotte, NC USA.
RP Chen, S (corresponding author), Univ N Carolina, Dept Publ Hlth Sci, 9021 Univ City Blvd, Charlotte, NC 28223 USA.
EM schen56@uncc.edu
OI Fair, Gabriel/0000-0002-0560-9558; Xu, Qian/0000-0002-2354-0208
CR ADEBAYO G, 2017, COMMUNICATION, V2
   Avery E, 2010, J PUBLIC RELAT RES, V22, P336, DOI 10.1080/10627261003614427
   Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018
   Avery EJ, 2009, HEALTH COMMUN, V24, P327, DOI 10.1080/10410230902889365
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672
   Centers for Disease Control and Prevention. Cumulative Zika Virus Disease Case Counts in the United States, 2018, CUMZIK VIR DIS CAS C
   Chapman B, 2014, PERSPECT PUBLIC HEAL, V134, P225, DOI 10.1177/1757913914538015
   Diga M, 2009, PUBLIC RELAT REV, V35, P440, DOI 10.1016/j.pubrev.2009.07.003
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Guidry JPD, 2017, PUBLIC RELAT REV, V43, P477, DOI 10.1016/j.pubrev.2017.04.009
   Hadi T, 2017, HEALTH SECUR, V15, P440, DOI 10.1089/hs.2017.0031
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   Harris JK, 2017, J PUBLIC HEALTH MAN, V23, P577, DOI 10.1097/PHH.0000000000000516
   Hartley DM, 2014, MILBANK Q, V92, P34, DOI 10.1111/1468-0009.12039
   He C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7861
   Hu Y, 2017, PUBLIC RELAT REV, V43, P461, DOI 10.1016/j.pubrev.2017.03.002
   Joob B, 2016, AM J INFECT CONTROL, V44, P1756, DOI 10.1016/j.ajic.2016.08.019
   Kass-Hout TA, 2013, BRIT MED BULL, V108, P5, DOI 10.1093/bmb/ldt028
   Kendra RL, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4220
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Muppalla R, 2017, P ANN INT IEEE EMBS, P1194, DOI 10.1109/EMBC.2017.8037044
   Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416
   Naslund JA, 2017, ADDICT BEHAV, V73, P81, DOI 10.1016/j.addbeh.2017.05.002
   Paul MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103408
   Rabarison Kristina M, 2017, JMIR Public Health Surveill, V3, pe34, DOI 10.2196/publichealth.7181
   Rossmann C, 2018, RISK ANAL, V38, P357, DOI 10.1111/risa.12841
   Santillana M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004513
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Sharpe J Danielle, 2016, JMIR Public Health Surveill, V2, pe161
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527
   World Health Organization, 2017, HLTH IS FUNDAMENTAL
NR 34
TC 0
Z9 0
U1 2
U2 2
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2369-2960
J9 JMIR PUBLIC HLTH SUR
JI JMIR Public Health Surveill.
PD OCT-DEC
PY 2018
VL 4
IS 4
BP 73
EP 85
AR UNSP e10827
DI 10.2196/10827
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA VJ0RQ
UT WOS:000526815900006
PM 30467106
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giovanetti, M
   de Jesus, JG
   de Maia, ML
   Junior, JX
   Amarante, MFC
   Viana, P
   Barreto, FK
   de Cerqueira, EM
   Santos, NP
   Falcao, MB
   Costa, MCM
   Faical, AVB
   de Melo, ALA
   Amorim, LS
   de Siqueira, IC
   Macarenhas, DL
   de Filippis, AMB
   Faria, NR
   Acosta, AX
   Alcantara, LCJ
AF Giovanetti, M.
   Goes de Jesus, J.
   Lima de Maia, M.
   Junior, J. X.
   Castro Amarante, M. F.
   Viana, P.
   Khouri Barreto, F.
   de Cerqueira, E. M.
   Pedreira Santos, N.
   Barreto Falcao, M.
   Machado Costa, M. C.
   Barros Faical, A. V.
   Andrade de Melo, A. L.
   Santos Amorim, L.
   de Siqueira, I. C.
   Macarenhas, D. L.
   Bispo de Filippis, A. M.
   Faria, N. Rodrigues
   Xavier Acosta, A.
   Junior Alcantara, L. C.
TI Genetic evidence of Zika virus in mother's breast milk and body fluids
   of a newborn with severe congenital defects
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Giovanetti, M.; Goes de Jesus, J.; Junior, J. X.; Castro Amarante, M. F.; Viana, P.; Khouri Barreto, F.; Santos Amorim, L.; Junior Alcantara, L. C.] Inst Goncalo Moniz Salvador, Lab Patol Expt, Salvador, BA, Brazil.
   [Giovanetti, M.; Bispo de Filippis, A. M.; Junior Alcantara, L. C.] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Lima de Maia, M.; de Cerqueira, E. M.] Univ Estadual Feira de Santana, Salvador, BA, Brazil.
   [Lima de Maia, M.; Pedreira Santos, N.; Barreto Falcao, M.; Machado Costa, M. C.; Andrade de Melo, A. L.; Macarenhas, D. L.] Secretaria Saude Feira Santana, Salvador, BA, Brazil.
   [Barreto Falcao, M.; Xavier Acosta, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Faria, N. Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
RP Alcantara, LCJ (corresponding author), Fiocruz MS, Fundac Oswaldo Cruz, Rio De Janeiro, Brazil.
EM lalcan@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Giovanetti,
   Marta/AAK-7408-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Xavier,
   Joilson/0000-0003-3916-2018; Alcantara, Luiz/0000-0002-6769-9931
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX Supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). All authors report no conflicts of interest
   relevant to this article.
CR de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dupont-Rouzeyrol M, 2016, LANCET LOND ENGL, V387, P1051
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 5
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD OCT
PY 2018
VL 24
IS 10
BP 1111
EP 1112
DI 10.1016/j.cmi.2018.06.008
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GU0EY
UT WOS:000444923000026
PM 29906587
OA Bronze
DA 2020-07-08
ER

PT J
AU Subissi, L
   Dub, T
   Besnard, M
   Mariteragi-Helle, T
   Nhan, T
   Lutringer-Magnin, D
   Barboza, P
   Gurry, C
   Brindel, P
   Nilles, EJ
   Baud, D
   Merianos, A
   Musso, D
   Glynn, JR
   Dupuis, G
   Cao-Lormeau, VM
   Giard, M
   Mallet, HP
AF Subissi, Lorenzo
   Dub, Timothee
   Besnard, Marianne
   Mariteragi-Helle, Teheipuaura
   Nhan, Tuxuan
   Lutringer-Magnin, Delphine
   Barboza, Philippe
   Gurry, Celine
   Brindel, Pauline
   Nilles, Eric J.
   Baud, David
   Merianos, Angela
   Musso, Didier
   Glynn, Judith R.
   Dupuis, Gilles
   Cao-Lormeau, Van-Mai
   Giard, Marine
   Mallet, Henri-Pierre
TI Zika Virus Infection during Pregnancy and Effects on Early Childhood
   Development, French Polynesia, 2013-2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFANTS; BRAZIL; WOMEN; SEROPREVALENCE; TRANSMISSION; DENGUE
AB Congenital Zika virus syndrome consists of a large spectrum of neurologic abnormalities seen in infants infected with Zika virus in utero. However, little is known about the effects of Zika virus intrauterine infection on the neurocognitive development of children born without birth defects. Using a case-control study design, we investigated the temporal association of a cluster of congenital defects with Zika virus infection. In a nested study, we also assessed the early childhood development of children recruited in the initial study as controls who were born without known birth defects,. We found evidence for an association of congenital defects with both maternal Zika virus seropositivity (time of infection unknown) and symptomatic Zika virus infection during pregnancy. Although the early childhood development assessment found no excess burden of developmental delay associated with maternal Zika virus infection, larger, longer-term studies are needed.
C1 [Subissi, Lorenzo; Barboza, Philippe; Gurry, Celine; Brindel, Pauline] WHO, Geneva, Switzerland.
   [Dub, Timothee] Inst Pasteur, Paris, France.
   [Besnard, Marianne; Lutringer-Magnin, Delphine] French Polynesia Hosp Ctr, Pirae, French Polynesi, France.
   [Mariteragi-Helle, Teheipuaura; Nhan, Tuxuan; Musso, Didier; Cao-Lormeau, Van-Mai] Inst Louis Malarde, Papeete, French Polynesi, France.
   [Nilles, Eric J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Nilles, Eric J.] Harvard Humanitarian Initiat, Boston, MA USA.
   [Nilles, Eric J.; Merianos, Angela] WHO, Manila, Philippines.
   [Baud, David] Univ Hosp, Lausanne, Switzerland.
   [Musso, Didier] Aix Marseille Univ, AP HM, IRD, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Glynn, Judith R.] London Sch Hyg & Trop Med, London, England.
   [Dupuis, Gilles] Univ Quebec, Montreal, PQ, Canada.
   [Dupuis, Gilles] Ctr Liaison Intervent & Prevent Psychosociales, Montreal, PQ, Canada.
   [Giard, Marine; Mallet, Henri-Pierre] Bur Veille Sanit, Direct Sante, BP 611, F-98713 Papeete, French Polynesi, France.
RP Giard, M (corresponding author), Bur Veille Sanit, Direct Sante, BP 611, F-98713 Papeete, French Polynesi, France.
EM marine.giard@sante.gov.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018; Musso, Didier/AAO-8178-2020; Musso,
   Didier/P-7809-2016; Subissi, Lorenzo/A-6553-2017
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Nilles,
   Eric/0000-0001-7044-5257; Baud, David/0000-0001-9914-6496; Subissi,
   Lorenzo/0000-0001-5147-575X
FU World Health Organization Western Pacific Regional Office
FX We thank Arnaud Fontanet for stimulating discussions and for critical
   review of the statistical analyses. We thank Guylaine Aurili, Nathalie
   Guerin, Ethel Taurua, Priscillia Bompard, Poerava Chapman, and Ludivine
   Marcelis for help collecting the data; Marie-Francoise Merlenghi and the
   Centre d'Action Medico-Sociale Precoce (CAMSP) for help in the choice of
   the ECD assessment tool and for pediatric evaluation of children with
   suspected delayed development; and Laura El-Hachem for providing
   training on the ECD assessment tool. We also thank Francois Laudon,
   Laure Yen Kai Sun, Jean-Marc Segalin, Evelyne Lecalvez, and Sylvie
   Rolland for logistics support. We thank Patrick Drury, Aneta Dujanovic,
   and the Global Outbreak Alert and Response Network (GOARN), as well as
   the World Health Organization Western Pacific Regional Office, for
   supervision and financial support. We thank Caroline Fuhrer and Rocio
   Escobar for generating the map.
CR Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baud D, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5319
   Bayley N., 2005, BAYLEY SCALES INFANT
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hollingshead A., 1975, 4 FACTOR INDEX SOCIA
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ismail LC, 2013, BJOG-INT J OBSTET GY, V120, P42, DOI 10.1111/1471-0528.12125
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   King NJC, 2017, TRENDS MICROBIOL, V25, P701, DOI 10.1016/j.tim.2017.05.005
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   WHO, 2017, ZIK SIT REP
NR 37
TC 10
Z9 12
U1 1
U2 12
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2018
VL 24
IS 10
BP 1850
EP 1858
DI 10.3201/eid2410.172079
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GT8PR
UT WOS:000444801900008
PM 30226164
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baylis, SA
   Blumel, J
AF Baylis, Sally A.
   Bluemel, Johannes
TI External Quality Assessment for Zika Virus Molecular Diagnostic Testing,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID INACTIVATION
C1 [Baylis, Sally A.; Bluemel, Johannes] Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
RP Baylis, SA (corresponding author), Paul Ehrlich Inst, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
EM Sally.Baylis@pei.de
CR Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P674, DOI 10.1089/vbz.2015.1795
   Park SL, 2016, J VIROL METHODS, V234, P152, DOI 10.1016/j.jviromet.2016.04.004
NR 5
TC 0
Z9 0
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2018
VL 24
IS 10
BP 1966
EP 1966
DI 10.3201/eid2410.180360
PG 1
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GT8PR
UT WOS:000444801900037
PM 30226168
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calvet, GA
   Brasil, P
   Siqueira, AM
   Zogbi, HE
   Goncalves, BD
   Santos, AD
   Lupi, O
   de Souza, RV
   Rodrigues, CDD
   Bressan, CD
   Wakimoto, MD
   de Araujo, ES
   dos Santos, IC
   Georg, I
   Nogueira, RMR
   Veloso, VG
   de Filippis, AMB
AF Calvet, Guilherme Amaral
   Brasil, Patricia
   Siqueira, Andre Machado
   Zogbi, Heruza Einsfeld
   Goncalves, Bianca de Santis
   Santos, Aline da Silva
   Lupi, Otilia
   de Souza, Rogerio Valls
   dos Santos Rodrigues, Cintia Damasceno
   Bressan, Clarisse da Silveira
   Wakimoto, Mayumi Duarte
   de Araujo, Eliane Saraiva
   dos Santos, Ingrid Cardoso
   Georg, Ingebourg
   Ribeiro Nogueira, Rita Maria
   Veloso, Valdilea Goncalves
   Bispo de Filippis, Ana Maria
TI Zika Virus Infection and Differential Diagnosis in a Cohort of
   HIV-Infected Patients
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Article
DE Zika; ZIKV; arboviruses; HIV; Brazil
ID RIO-DE-JANEIRO; PARVOVIRUS B19; DENGUE; LEISHMANIASIS; COINFECTION;
   PREVALENCE; EPIDEMIC; DISEASES; SAMPLES; URINE
AB Background: Zika virus (ZIKV) emergence in South America revealed the lack of knowledge regarding clinical manifestations in HIV-infected individuals.
   Objectives: We described the clinical characteristics, laboratory manifestations, differential diagnosis, and outcome of ZIKV infection in a large, single-center cohort of HIV-infected patients.
   Methods: HIV-infected patients aged 18 years and older with clinical suspected arboviral disease from an ongoing cohort were followed from February 2015 through December 2015. Acute serum samples were tested for ZIKV, dengue virus (DENY), and chikungunya virus by real-time reverse transcriptase polymerase chain reaction, anti-DENV immunoglobulin (IgM/IgG, and syphilis assays; convalescent samples were tested for anti-DENV IgM/IgG; and urine samples were tested for ZIKV by real-time reverse transcriptase polymerase chain reaction. ZIKV disease was defined according to the Pan American Health Organization (PAHO) guidelines.
   Results: Of 101 patients, ZIKV was confirmed in 43 cases and suspected in 34, and another diagnosis was assumed for 24 patients (dengue, secondary/latent syphilis, respiratory infections, human parvovirus B19, adverse drug reaction, musculoskeletal disorders, and acute gastroenteritis). ZIKV-confirmed and ZIKV-suspected patients reported similar signs and symptoms. Pruritic rash was the most common symptom, followed by myalgia, nonpurulent conjunctivitis, arthralgia, prostration, and headache. In the short-term follow-up [median 67.5 days (interquartile range: 32-104.5)], CD4 cell count (Z = -0.831, P = 0.406) and HIV viral load (Z= -0.447, P = 0.655) did not change significantly after ZIKV infection. There were no hospitalizations, complications, or deaths.
   Conclusions: Among HIV-infected patients with suspected arboviral disease, 42.6% were ZIKV-infected. CD4 cell counts and HIV viral load were not different after ZIKV infection. Differential diagnosis with other diseases and adverse drug reaction should be evaluated.
C1 [Calvet, Guilherme Amaral; Brasil, Patricia; Siqueira, Andre Machado; Zogbi, Heruza Einsfeld; Lupi, Otilia; de Souza, Rogerio Valls; Bressan, Clarisse da Silveira; Wakimoto, Mayumi Duarte; dos Santos, Ingrid Cardoso] Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Rio De Janeiro, Brazil.
   [Calvet, Guilherme Amaral; Brasil, Patricia; Siqueira, Andre Machado; Zogbi, Heruza Einsfeld; Lupi, Otilia; de Souza, Rogerio Valls; Bressan, Clarisse da Silveira; Wakimoto, Mayumi Duarte; dos Santos, Ingrid Cardoso] Fiocruz MS, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Goncalves, Bianca de Santis; Santos, Aline da Silva; dos Santos Rodrigues, Cintia Damasceno; de Araujo, Eliane Saraiva; Ribeiro Nogueira, Rita Maria; Bispo de Filippis, Ana Maria] Fiocruz MS, Oswaldo Cruz Inst, Flavivirus Lab, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Georg, Ingebourg] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Immunodiagnost Sect, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Veloso, Valdilea Goncalves] Fiocruz MS, STD AIDS Clin Res Lab, Evandro Chagas Natl Inst Infect Dis, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
RP Calvet, GA (corresponding author), Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Acute Febrile Illnesses Lab, Oswaldo Cruz Fdn, Ave Brasil,4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br
RI Calvet, Guilherme/G-6959-2013
OI Calvet, Guilherme/0000-0002-3545-5238
FU Departamento de Ciencia e Tecnologia [DECIT/25000.072811/2016-17];
   Ministerio da Saude do Brasil; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel SuperiorCAPES [CAPES/88887.116627/2016-01]; European Union's
   Horizon 2020 program [734857]; Faperj (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-18/2015TXB]
FX Supported by Departamento de Ciencia e Tecnologia
   (DECIT/25000.072811/2016-17), Ministerio da Saude do Brasil, grants from
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/88887.116627/2016-01), the European Union's Horizon 2020 program
   under grant agreement ZIKACTION No. 734857, and Faperj (Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) grant no.
   E-18/2015TXB.
CR Pereira RFA, 2014, MEM I OSWALDO CRUZ, V109, P168, DOI [10.1590/0074-0276140312, 10.1590/0074-02760130312]
   Anema A, 2005, CAN MED ASSOC J, V172, P1434, DOI 10.1503/cmaj.050511
   Berg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088257
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chen XP, 2003, CHINESE MED J-PEKING, V116, P1810
   DiazGranados CA, 2009, LANCET INFECT DIS, V9, P324, DOI 10.1016/S1473-3099(09)70088-X
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446
   Gonzalez D, 2009, J INFECT DEV COUNTR, V3, P318
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guerra JAO, 2011, AM J TROP MED HYG, V85, P524, DOI 10.4269/ajtmh.2011.11-0075
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81
   Hook EW, 2017, LANCET, V389, P1550, DOI 10.1016/S0140-6736(16)32411-4
   Joob Beuy, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS568
   Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180
   Karp CL, 2007, CLIN INFECT DIS, V45, P1208, DOI 10.1086/522181
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   de Azevedo KML, 2012, MEM I OSWALDO CRUZ, V107, P356, DOI 10.1590/S0074-02762012000300010
   Martins-Melo FR, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/534649
   Mendes WDS, 2006, AM J TROP MED HYG, V74, P905
   Moreira RI, 2011, JAIDS-J ACQ IMM DEF, V57, pS171, DOI 10.1097/QAI.0b013e31821e9d59
   Pan American Health Organization/World Health Organization Regional Office for the Americas, 2017, REG ZIK EP UPD AM
   Pang JX, 2015, AM J TROP MED HYG, V92, P1156, DOI 10.4269/ajtmh.15-0031
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Shimelis T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0919-7
   Siong Wong Chia, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P260
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   UNAIDS, GLOB AIDS UPD 2017
   van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556
   Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Yunihastuti E, 2014, ASIA PAC ALLERGY, V4, P54, DOI 10.5415/apallergy.2014.4.1.54
NR 44
TC 2
Z9 2
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD OCT 1
PY 2018
VL 79
IS 2
BP 237
EP 243
DI 10.1097/QAI.0000000000001777
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GT6QR
UT WOS:000444643300017
PM 29912006
DA 2020-07-08
ER

PT J
AU Kinchen, VJ
   Cox, AL
   Bailey, JR
AF Kinchen, Valerie J.
   Cox, Andrea L.
   Bailey, Justin R.
TI Can Broadly Neutralizing Monoclonal Antibodies Lead to a Hepatitis C
   Virus Vaccine?
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID HYPERVARIABLE REGION 1; E2 ENVELOPE GLYCOPROTEIN; CHRONIC HCV INFECTION;
   T-CELL RESPONSES; STRUCTURAL BASIS; UNITED-STATES; CD81 BINDING; ZIKA
   VIRUS; CHIMPANZEES; ESCAPE
AB While licensed vaccines elicit protective antibody responses against a variety of viral infections, an effective vaccine for hepatitis C virus (HCV) has remained elusive. The extraordinary genetic diversity of HCV and the ability of the virus to evade the immune response have hindered vaccine development efforts. However, recent studies have greatly expanded the number of well characterized broadly neutralizing human monoclonal antibodies (bNAbs) against HCV. These bNAbs target relatively conserved HCV epitopes, prevent HCV infection in animal models, and are associated with spontaneous clearance of human HCV infection. In this review, recent high-resolution bNAb epitope mapping and structural analysis of bNAb epitope complexes that may serve as a guide for vaccine development are discussed along with major obstacles.
C1 [Kinchen, Valerie J.; Cox, Andrea L.; Bailey, Justin R.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
   [Cox, Andrea L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.
RP Bailey, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
EM jballey7@jhmi.edu
OI Cox, Andrea/0000-0002-9331-2462; Kinchen, Valerie/0000-0003-2317-9990
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI127469, U19 AI088791]
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Bailey JR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92872
   Bailey JR, 2015, J CLIN INVEST, V125, P437, DOI 10.1172/JCI78794
   Bailey JR, 2012, J VIROL, V86, P12582, DOI 10.1128/JVI.01440-12
   Bjoro K, 1999, QJM-INT J MED, V92, P433, DOI 10.1093/qjmed/92.8.433
   Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022
   Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09
   Carlsen THR, 2014, HEPATOLOGY, V60, P1551, DOI 10.1002/hep.27298
   Chang KM, 2001, HEPATOLOGY, V33, P267, DOI 10.1053/jhep.2001.21162
   CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294
   Chung RT, 2013, AM J TRANSPLANT, V13, P1047, DOI 10.1111/ajt.12083
   de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512
   Deng L, 2013, P NATL ACAD SCI USA, V110, P7418, DOI 10.1073/pnas.1305306110
   Diepolder HM, 1996, J MOL MED-JMM, V74, P583, DOI 10.1007/s001090050062
   Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080
   Durbin Anna P, 2016, J Infect Dis, V214, P832, DOI 10.1093/infdis/jiw067
   El-Diwany R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006235
   Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07
   FARCI P, 1994, P NATL ACAD SCI USA, V91, P7792, DOI 10.1073/pnas.91.16.7792
   Fauvelle C, 2016, GASTROENTEROLOGY, V150, P206, DOI 10.1053/j.gastro.2015.09.014
   Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999
   Franco S, 2014, GASTROENTEROLOGY, V147, P599, DOI 10.1053/j.gastro.2014.05.010
   Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109
   Gopal R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006735
   Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a
   Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000
   Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973
   Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227
   Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x
   Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104
   Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104
   KAO JH, 1995, J INFECT DIS, V172, P261, DOI 10.1093/infdis/172.1.261
   Keck ZY, 2008, J VIROL, V82, P6067, DOI 10.1128/JVI.00252-08
   Keck ZY, 2016, HEPATOLOGY, V64, P1922, DOI 10.1002/hep.28850
   Keck ZY, 2016, J VIROL, V90, P3112, DOI 10.1128/JVI.02458-15
   Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653
   Keck ZY, 2009, J VIROL, V83, P6149, DOI 10.1128/JVI.00248-09
   Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kong L, 2016, P NATL ACAD SCI USA, V113, P12768, DOI 10.1073/pnas.1609780113
   Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876
   Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12
   Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109
   Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lagging LM, 2002, LIVER, V22, P136, DOI 10.1034/j.1600-0676.2002.01623.x
   Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Law JLM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059776
   Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698
   Li YL, 2015, J BIOL CHEM, V290, P10117, DOI 10.1074/jbc.M115.643528
   Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101
   Mankowski MC, 2018, P NATL ACAD SCI USA, V115, pE82, DOI 10.1073/pnas.1718441115
   MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992
   McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618
   Meola A, 2015, J VIROL, V89, P2170, DOI 10.1128/JVI.02190-14
   Merat SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165047
   Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07
   Morin TJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002895
   Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013
   Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017
   Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005
   Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104
   Pierce BG, 2017, J VIROL, V91, DOI 10.1128/JVI.01032-17
   Pierce BG, 2016, P NATL ACAD SCI USA, V113, pE6946, DOI 10.1073/pnas.1614942113
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Potter JA, 2012, J VIROL, V86, P12923, DOI 10.1128/JVI.02052-12
   Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10
   Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999
   Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133
   Rodrigo C, 2017, INFECT GENET EVOL, V49, P88, DOI 10.1016/j.meegid.2017.01.006
   Rollier C, 2004, J VIROL, V78, P187, DOI 10.1128/JVI.78.1.187-196.2004
   Sabo MC, 2011, J VIROL, V85, P7005, DOI 10.1128/JVI.00586-11
   Shimizu YK, 1996, VIROLOGY, V223, P409, DOI 10.1006/viro.1996.0497
   SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053
   Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218
   Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643
   Swann RE, 2016, J VIROL, V90, P4530, DOI 10.1128/JVI.02669-15
   Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Vietheer PT, 2017, HEPATOLOGY, V65, P1117, DOI 10.1002/hep.28989
   Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008
   World Health Organization, 2017, GLOB HEP REP
   Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029
   Youn JW, 2005, HEPATOLOGY, V42, P1429, DOI 10.1002/hep.20934
   Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106
   zur Wiesch JS, 2012, J EXP MED, V209, P61, DOI 10.1084/jem.20100388
NR 89
TC 10
Z9 11
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD OCT
PY 2018
VL 26
IS 10
BP 854
EP 864
DI 10.1016/j.tim.2018.04.002
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GT9BX
UT WOS:000444835500006
PM 29703495
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Piltci-Loeb, R
   Kraemer, J
   Lin, KW
   Stoto, MA
AF Piltci-Loeb, Rachael
   Kraemer, John
   Lin, Kenneth W.
   Stoto, Michael A.
TI Public Health Surveillance for Zika Virus: Data Interpretation and
   Report Validity
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID UNITED-STATES; INFLUENZA-A; AUGUST 2016; CARE; KNOWLEDGE; DISEASES;
   EPIDEMIOLOGY; TRANSMISSION; BEHAVIORS; ATTITUDES
AB Zika virus provides an example For which public health surveillance is based primarily on health care provider notifications to health departments of potential cases. This case-based surveillance is commonly used to understand the spread of disease in a population.
   However, case-based surveillance is often biased whether testing is done and which tests are used and the accuracy of the results depend on a variety of Factors including test availability, patient demand, perceptions of transmission, and patient and provider awareness, leading to surveillance artifacts that can provide misleading information on the spread of a disease in a population and have significant public health practice implications.
   To better understand this challenge, we First summarize the process that health departments use to generate surveillance reports, then describe Factors inFluencing testing and reporting patterns at the patient, provider, and contextual level. We then describe public health activities, including active surveillance, that influence both patient and provider behavior as well as surveillance reports, and conclude with a discussion about the interpretation of surveillance data and approaches that could improve the validity of surveillance reports.
C1 [Piltci-Loeb, Rachael] NYU, Coll Global Publ Hlth, New York, NY USA.
   [Kraemer, John; Stoto, Michael A.] Georgetown Univ, Dept Hlth Syst Adm, Washington, DC USA.
   [Lin, Kenneth W.] Georgetown Univ, Med Ctr, Dept Family Med, Washington, DC 20007 USA.
RP Piltci-Loeb, R (corresponding author), 715 Broadway, New York, NY 10003 USA.
EM rpl5@nyu.edu
CR Abramson D., 2016, US PUBLICS PERCEPTIO
   [Anonymous], 2016, ZIK VIR GAPS AM KNOW
   [Anonymous], 2016, MOSQ SURV CONTR ASS
   Armstrong D, 2013, INT J EPIDEMIOL, V42, P1617, DOI 10.1093/ije/dyt114
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Branswell H., 2017, STAT NEWS       0501
   Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff
   Centers for Disease Control and Prevention, ZIK VIR DIS ZIK VIR
   Chang D., 2016, MIAMI HERALD
   Cheng C, 2006, J APPL SOC PSYCHOL, V36, P222, DOI 10.1111/j.0021-9029.2006.00059.x
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Chorba T L, 1990, MMWR Recomm Rep, V39, P1
   Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530
   DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93
   Fill MMA, 2017, J PUBLIC HEALTH MAN, V23, P581, DOI 10.1097/PHH.0000000000000492
   Florida Department ofAgriculture and Consumer Services, 2016, FLORIDA TREND   1018
   Gidado S, 2015, PLOS CURR, V7
   Goldfarb IT, 2017, JAMA-J AM MED ASSOC, V318, P2075, DOI 10.1001/jama.2017.15680
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Harvard Opinion Research Program, 2016, MAN US FAM CONS PREG
   James L, 2008, CLIN INFECT DIS, V46, P1264, DOI 10.1086/533445
   Jiang XY, 2009, INT J BEHAV MED, V16, P58, DOI 10.1007/s12529-008-9005-5
   Last JM, 2013, INT J EPIDEMIOL, V42, P1608, DOI 10.1093/ije/dyt113
   Last JM, 2013, INT J EPIDEMIOL, V42, P1613, DOI 10.1093/ije/dyt112
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lin K, J AM BOARD FAM MED
   Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7
   Rabin Roni Caryn, 2016, NY TIMES
   Raphael M., 2017, COMMUNICATION   0425
   Roush S, 1999, JAMA-J AM MED ASSOC, V282, P164, DOI 10.1001/jama.282.2.164
   Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271
   Stern J., 2014, VANITY FAIR
   Stoto MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040984
   VOSS S, 1992, BRIT MED J, V304, P755, DOI 10.1136/bmj.304.6829.755
   Wahnich A, 2018, EMERG INFECT DIS, V24, P827, DOI 10.3201/eid2405.170764
   2018, AM J PUMIC HEALTH, V108, P1358, DOI DOI 10.2105/ATPH.2018.304525
NR 36
TC 2
Z9 2
U1 0
U2 7
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD OCT
PY 2018
VL 108
IS 10
BP 1358
EP 1362
DI 10.2105/AJPH.2018.304525
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GT3NT
UT WOS:000444410800041
PM 30138063
DA 2020-07-08
ER

PT J
AU Jacquot, C
   Delaney, M
AF Jacquot, Cyril
   Delaney, Meghan
TI Efforts Toward Elimination of Infectious Agents in Blood Products
SO JOURNAL OF INTENSIVE CARE MEDICINE
LA English
DT Review
DE transfusion; blood supply safety; blood donor testing; septic
   transfusion reaction; pathogen reduction technology
ID SEPTIC TRANSFUSION REACTIONS; FRESH-FROZEN PLASMA; PATHOGEN
   INACTIVATION; APHERESIS PLATELETS; ZIKA VIRUS; BACTERIAL-CONTAMINATION;
   COST-EFFECTIVENESS; UNITED-STATES; CYTOMEGALOVIRUS; TRANSMISSION
AB The US blood supply has never been safer. This level of safety depends on a multifaceted approach including blood donor screening, sensitive infectious disease testing, and good manufacturing practice. However, risks remain for transfusion-transmitted infections due to bacterial contamination of platelets and emerging diseases. Thus, ongoing improvements in screening and testing are required. Newer pathogen reduction technologies have shown promise in further ameliorating the safety of the blood supply.
C1 [Jacquot, Cyril; Delaney, Meghan] Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Div Lab Med, Sheikh Zayed Campus Adv Childrens Med, Washington, DC 20010 USA.
   [Jacquot, Cyril; Delaney, Meghan] Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Div Hematol, Sheikh Zayed Campus Adv Childrens Med, Washington, DC 20010 USA.
   [Jacquot, Cyril; Delaney, Meghan] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Jacquot, Cyril; Delaney, Meghan] George Washington Univ, Sch Med & Hlth Sci, Dept Pathol, Washington, DC 20052 USA.
RP Delaney, M (corresponding author), Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Div Lab Med, Sheikh Zayed Campus Adv Childrens Med, Washington, DC 20010 USA.; Delaney, M (corresponding author), Childrens Natl Hlth Syst, Ctr Canc & Blood Disorders, Div Hematol, Sheikh Zayed Campus Adv Childrens Med, Washington, DC 20010 USA.
EM mdelaney2@childrensnational.org
OI Jacquot, Cyril/0000-0003-1281-0644
CR AABB, 2016, STANDARDS BLOOD BANK
   ADLER SP, 1983, REV INFECT DIS, V5, P977
   Alvarez M, 2016, TRANSFUSION, V56, P831, DOI 10.1111/trf.13409
   Amato M, 2017, VOX SANG, V112, P47, DOI 10.1111/vox.12456
   AMMANN AJ, 1983, LANCET, V1, P956
   [Anonymous], 2016, CER CORP MON INT
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Butler C, 2013, COCHRANE DB SYST REV, V28
   Canadian Agency for Drugs and Technologies in Health (CADTH), 2010, CADTH TECHNOL OVERV, V1, pe0106
   Cap AP, 2016, TRANSFUSION, V56, pS6, DOI 10.1111/trf.13393
   Cardo LJ, 2007, TRANSFUS APHER SCI, V37, P131, DOI 10.1016/j.transci.2007.07.002
   CHAMBERS RW, 1969, TRANSFUSION, V9, P32, DOI 10.1111/j.1537-2995.1969.tb04909.x
   Ciaravino V, 2003, TRANSFUSION, V43, P1481, DOI 10.1046/j.1537-2995.2003.00544.x
   Custer B, 2017, Vox Sang, V112, P526, DOI 10.1111/vox.12538
   Dumont LJ, 2010, TRANSFUSION, V50, P589, DOI 10.1111/j.1537-2995.2009.02460.x
   Dunbar NM, 2016, TRANSFUSION, V56, P1262, DOI 10.1111/trf.13577
   Eder AF, 2007, TRANSFUSION, V47, P1134, DOI 10.1111/j.1537-2995.2007.01248.x
   Food and Drug Administration, 2016, FOOD DRUG ADM MON IN
   Food and Drug Administration, 2017, FOOD DRUG ADM MON IN
   Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606
   Goodrich RP, 2006, TRANSFUS APHER SCI, V35, P5, DOI 10.1016/j.transci.2006.01.007
   Hauser L, 2014, BLOOD, V123, P796, DOI 10.1182/blood-2013-09-524348
   Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e
   Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362
   Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944
   Hubbard T, 2016, TRANSFUSION, V56, P41, DOI 10.1111/trf.13261
   Irsch J, 2015, TRANSFUS APHER SCI, V52, P240, DOI 10.1016/j.transci.2015.02.013
   Kaiser-Guignard J, 2014, BLOOD REV, V28, P235, DOI 10.1016/j.blre.2014.07.005
   Katz L, 2013, TRANSFUSION MED HEMO
   Li J, 2004, VOX SANG, V87, P82, DOI 10.1111/j.1423-0410.2004.00548.x
   Li JW, 2017, TRANSFUSION, V57, P2321, DOI 10.1111/trf.14216
   Murphy WG, 2011, TRANSFUS APHER SCI, V45, P69, DOI 10.1016/j.transci.2011.06.005
   Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Octapharma, 2017, OCT MON INT
   PASS RF, 2001, FIELDS VIROLOGY, V2, P2675
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   Perez-Pujol S, 2005, TRANSFUSION, V45, P911, DOI 10.1111/j.1537-2995.2005.04350.x
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Popovski MA, 2012, TRANSFUSION REACTION
   Preiksaitis JK, 2000, TRANSFUS MED REV, V14, P112, DOI 10.1016/S0887-7963(00)80003-6
   Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x
   Rentas F, 2007, TRANSFUSION, V47, P240, DOI 10.1111/j.1537-2995.2007.01094.x
   Riedler GF, 2003, VOX SANG, V85, P88, DOI 10.1046/j.1423-0410.2003.00329.x
   Salunkhe V, 2015, TRANSFUS APHER SCI, V52, P19, DOI 10.1016/j.transci.2014.12.016
   Schmidt M, 2015, TRANSFUSION, V55, P2104, DOI 10.1111/trf.13171
   Seghatchian J, 2012, TRANSFUS APHER SCI, V46, P221, DOI 10.1016/j.transci.2012.01.008
   Shirley DAT, 2017, PEDIATR CLIN N AM, V64, P937, DOI 10.1016/j.pcl.2017.03.012
   Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154
   Stansbury LG, 2009, TRANSFUS MED REV, V23, P232, DOI 10.1016/j.tmrv.2009.03.007
   Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173
   Stramer SL, 2017, TECHNICAL MANUAL AM, P161
   Stramer SL, 2013, TRANSFUSION, V53, P2449, DOI 10.1111/trf.12213
   Sullivan KD, 2015, CLIN J ONCOL NURS, V19, P516, DOI 10.1188/15.CJON.516-520
   Thiele T, 2011, TRANSFUSION, V51, P2620, DOI 10.1111/j.1537-2995.2011.03203.x
   Tonnetti L, 2010, TRANSFUSION, V50, P1019, DOI 10.1111/j.1537-2995.2009.02538.x
   Vamvakas EC, 2005, TRANSFUS MED REV, V19, P181, DOI 10.1016/j.tmrv.2005.02.002
   Webert KE, 2008, TRANSFUS MED REV, V22, P1, DOI 10.1016/j.tmrv.2007.09.001
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Wu YY, 2010, TRANSFUSION, V50, P776, DOI 10.1111/j.1537-2995.2009.02486.x
   Ziemann M, 2007, TRANSFUSION, V47, P1972, DOI 10.1111/j.1537-2995.2007.01420.x
NR 61
TC 5
Z9 5
U1 1
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0885-0666
EI 1525-1489
J9 J INTENSIVE CARE MED
JI J. Intensive Care Med.
PD OCT
PY 2018
VL 33
IS 10
BP 543
EP 550
DI 10.1177/0885066618756589
PG 8
WC Critical Care Medicine
SC General & Internal Medicine
GA GT4QV
UT WOS:000444490200001
PM 29562814
DA 2020-07-08
ER

PT J
AU Abbink, P
   Stephenson, KE
   Barouch, DH
AF Abbink, Peter
   Stephenson, Kathryn E.
   Barouch, Dan H.
TI Zika virus vaccines
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID MESSENGER-RNA VACCINES; DNA VACCINE; PLACENTAL DEVELOPMENT;
   IMMUNE-RESPONSES; CELL TROPISM; INFECTION; IMMUNOGENICITY; PROTECTION;
   CHALLENGE; SAFETY
AB The recent epidemic of Zika virus (ZIKV) in the Americas has revealed the devastating consequences of ZIKV infection, particularly in pregnant women. Congenital Zika syndrome, characterized by malformations and microcephaly in neonates as well as developmental challenges in children, highlights the need for the development of a safe and effective vaccine. Multiple vaccine candidates have been developed and have shown promising results in both animal models and phase I clinical trials. However, important challenges remain for the clinical development of these vaccines. In this Progress article, we discuss recent preclinical studies and lessons learned from first-in-human clinical trials with ZIKV vaccines.
C1 [Abbink, Peter; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.
   [Stephenson, Kathryn E.; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Boston, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Barouch, Dan/Y-3918-2019
OI Abbink, Peter/0000-0003-1978-088X
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [UM1 AI126603, UM1 AI124377]
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2018, J VIROL, V92, DOI 10.1128/JVI.01924-17
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Austin SK, 2014, VIRUSES-BASEL, V6, P1015, DOI 10.3390/v6031015
   Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880
   Barouch DH, 2013, J INFECT DIS, V207, P248, DOI 10.1093/infdis/jis671
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Beasley DWC, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.13
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Combredet C, 2003, J VIROL, V77, P11546, DOI 10.1128/JVI.77.21.11546-11554.2003
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durkin M., 2017, DEV MED CHILD NEUROL, V59, P13
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feasey NA, 2017, LANCET, V390, P2419, DOI 10.1016/S0140-6736(17)32407-8
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hokey David A, 2014, Mycobact Dis, V4, pe128
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larena M, 2013, J VIROL, V87, P4395, DOI 10.1128/JVI.03144-12
   Larocca RA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf7643
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lauer KB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00298-16
   Ledgerwood JE, 2015, NEW ENGL J MED, V373, P776, DOI 10.1056/NEJMc1505499
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Lissauer D, 2016, BJOG-INT J OBSTET GY, V123, P1258, DOI 10.1111/1471-0528.14071
   Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Memoli MJ, 2015, CLIN INFECT DIS, V60, P693, DOI 10.1093/cid/ciu924
   Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1
   Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Reichmuth AM, 2016, THER DELIV, V7, P319, DOI 10.4155/tde-2016-0006
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Shah SK, 2017, ETHICAL CONSIDERATIO
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ulmer JB, 1996, IMMUNOLOGY, V89, P59, DOI 10.1046/j.1365-2567.1996.d01-718.x
   Ura T, 2014, VACCINES, V2, P624, DOI 10.3390/vaccines2030624
   US FDA, 2015, PROD DEV AN RUL GUID
   Valladeau J, 1999, EUR J IMMUNOL, V29, P2695, DOI 10.1002/(SICI)1521-4141(199909)29:09<2695::AID-IMMU2695>3.0.CO;2-Q
   van Ballegooijen M, 2003, JAIDS-J ACQ IMM DEF, V34, P214, DOI 10.1097/00126334-200310010-00012
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van Wouwe J. P., 2018, PLOS ONE, V13
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winslow RL, 2017, JAMA-J AM MED ASSOC, V317, P1074, DOI 10.1001/jama.2016.20644
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Xu MH, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0003-3
   Yousafzai MT, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00395
NR 103
TC 32
Z9 32
U1 5
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD OCT
PY 2018
VL 16
IS 10
BP 594
EP 600
DI 10.1038/s41579-018-0039-7
PG 7
WC Microbiology
SC Microbiology
GA GT5VM
UT WOS:000444578100007
PM 29921914
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Congenital Zika syndrome in non-endemic regions
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Letter
DE Congenital; infection; Zika
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Mehrjardi MZ, 2018, J PERINAT MED, V46, P687, DOI 10.1515/jpm-2017-0191
   Wiwanitkit V, 2017, JPN J RADIOL, V35, P40, DOI 10.1007/s11604-016-0595-6
   Wiwanitkit V, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.03.017
NR 4
TC 1
Z9 1
U1 0
U2 7
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD OCT
PY 2018
VL 46
IS 7
BP 819
EP 819
DI 10.1515/jpm-2017-0403
PG 1
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GT1LJ
UT WOS:000444231300021
PM 29451864
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
AF Mehrjardi, Mohammad Zare
TI Reply to: Congenital Zika syndrome in non-endemic regions: A
   neuroimaging pattern-based approach
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Letter
DE Brain calcification; congenital Zika syndrome; microcephaly;
   pattern-based approach; prenatal screening; Zika virus
ID VIRUS-INFECTION
C1 [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Sch Med, Shohada Tajrish Hosp, Dept Radiol,Tajrish SQ, Tehran 1989934148, Iran.
   [Mehrjardi, Mohammad Zare] Climax Radiol Educ Fdn, Div Clin Res, Sect Fetal Imaging, Tehran, Iran.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Shohada Tajrish Hosp, Dept Radiol,Tajrish SQ, Tehran 1989934148, Iran.; Mehrjardi, MZ (corresponding author), Climax Radiol Educ Fdn, Div Clin Res, Sect Fetal Imaging, Tehran, Iran.
EM zare@sbmu.ac.ir
RI Zare Mehrjardi, Mohammad/G-8980-2017
OI Zare Mehrjardi, Mohammad/0000-0001-5793-5323
CR Ximenes ASFC, 2019, J MATERN-FETAL NEO M, V32, P493, DOI 10.1080/14767058.2017.1384459
   Joob B, 2018, J PERINAT MED, V46, P819, DOI 10.1515/jpm-2017-0403
   Mehrjardi MZ, 2018, J PERINAT MED, V46, P687, DOI 10.1515/jpm-2017-0191
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
NR 7
TC 0
Z9 0
U1 0
U2 6
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD OCT
PY 2018
VL 46
IS 7
BP 820
EP 821
DI 10.1515/jpm-2018-0081
PG 2
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GT1LJ
UT WOS:000444231300022
PM 29958184
DA 2020-07-08
ER

PT J
AU Morsy, S
   Dang, TN
   Kamel, MG
   Zayan, AH
   Makran, OM
   Elhady, M
   Hirayama, K
   Huy, NT
AF Morsy, S.
   Dang, T. N.
   Kamel, M. G.
   Zayan, A. H.
   Makran, O. M.
   Elhady, M.
   Hirayama, K.
   Huy, N. T.
TI Prediction of Zika-confirmed cases in Brazil and Colombia using Google
   Trends
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Brazil; Colombia; Google Trends; prediction; Zika
ID TIME-SERIES REGRESSION; VIRUSES; DENGUE; CHIKUNGUNYA; EPIDEMIC; MODEL
AB Zika virus infection in humans has been linked to severe neurological sequels and foetal malformations. The rapidly evolving epidemics and serious complications made the frequent updates of Zika virus mandatory. Web search query has emerged as a low-cost real-time surveillance system to anticipate infectious diseases' outbreaks. Hence, we developed a prediction model that could predict Zika-confirmed cases based on Zika search volume in Google Trends. We extracted weekly confirmed Zika cases of two epidemic countries, Brazil and Colombia. We got the weekly Zika search volume in the two countries from Google Trends. We used standard time-series regression (TSR) to predict the weekly confirmed Zika cases based on the Zika search volume (Zika query). The basis TSR model - using 1-week lag of Zika query and using 1-week lag of Zika cases as a control for autocorrelation was the best for predicting Zika cases in Brazil and Colombia because it balanced the performance of the model and the advance time in the prediction. Our results showed that we could use Google search queries to predict Zika cases 1 week earlier before the outbreak. These findings are important to help healthcare authorities evaluate the outbreak and take necessary precautions.
C1 [Morsy, S.] Tanta Univ, Fac Med, Med Biochem & Mol Biol Dept, Tanta, Egypt.
   [Morsy, S.; Dang, T. N.; Kamel, M. G.; Zayan, A. H.; Makran, O. M.; Elhady, M.] Online Res Club, Nagasaki, Japan.
   [Dang, T. N.] Univ Med & Pharm, Ho Chi Minh City, Vietnam.
   [Kamel, M. G.] Menia Univ, Fac Med, Al Minya 61519, Egypt.
   [Zayan, A. H.] Menoufia Univ, Fac Med, Menoufia, Egypt.
   [Makran, O. M.] October 6 Univ, Fac Med, 6th October City, Egypt.
   [Elhady, M.] Al Azhar Univ, Dept Pediat, Fac Med Girls, Cairo 11651, Egypt.
   [Hirayama, K.] Nagasaki Univ, Dept Immunogenet, Inst Trop Med NEKKEN, Leading Grad Sch Program, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
   [Hirayama, K.; Huy, N. T.] Nagasaki Univ, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
   [Huy, N. T.] Ton Duc Thang Univ, Evidence Based Med Res Grp, Ho Chi Minh City 70000076000, Vietnam.
   [Huy, N. T.] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City 70000076000, Vietnam.
   [Huy, N. T.] Nagasaki Univ, Dept Clin Prod Dev, Inst Trop Med NEKKEN, Leading Grad Sch Program, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
RP Huy, NT (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.; Huy, NT (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City 70000076000, Vietnam.; Huy, NT (corresponding author), Nagasaki Univ, Dept Clin Prod Dev, Inst Trop Med NEKKEN, Leading Grad Sch Program, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM nguyentienhuy@tdt.edu.vn
RI Morsy, Sara/AAP-5378-2020; Elhady, Marwa/J-2525-2019; Elsayed, Omar
   Mohamed Makram Mohamed/O-7012-2018; Zayan, Ahmad/O-8731-2018; Huy,
   Nguyen Tien/B-2573-2010; Kamel, Mohamed Gomaa/S-3342-2018
OI Morsy, Sara/0000-0002-2477-1139; Elhady, Marwa/0000-0002-7785-3736;
   Elsayed, Omar Mohamed Makram Mohamed/0000-0001-8361-9068; Zayan,
   Ahmad/0000-0003-2581-0459; Huy, Nguyen Tien/0000-0002-9543-9440; Kamel,
   Mohamed Gomaa/0000-0001-9848-2965
CR [Anonymous], 2013, CONTRIBUTIONS TSMODE
   Bendix Carstensen MPELMH, 2018, EP PACK STAT AN EP R
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Phung D, 2015, ACTA TROP, V141, P88, DOI 10.1016/j.actatropica.2014.10.005
   Huff A, 2016, INT J INFECT DIS, V53, P97, DOI 10.1016/j.ijid.2016.11.245
   Imai C, 2015, ENVIRON RES, V142, P319, DOI 10.1016/j.envres.2015.06.040
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Mitchell C, 2017, PAHO WHO COUNTRIES T
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rohatgi A., 2018, WEBPLOTDIGITIZER 4 1
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sanchez JD, 2016, PAHO WHO ZIKA RESOUR
   Team BB, 2017, BBMLE TOOLS GEN MAX
   Team RC, 2017, LANG ENV STAT COMP
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 20
TC 7
Z9 7
U1 7
U2 24
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2018
VL 146
IS 13
BP 1625
EP 1627
DI 10.1017/S0950268818002078
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GS3QS
UT WOS:000443535400004
PM 30056812
OA Bronze
DA 2020-07-08
ER

PT J
AU Thompson, CN
   Lee, CT
   Immerwahr, S
   Resnick, S
   Culp, G
   Greene, SK
AF Thompson, C. N.
   Lee, C. T.
   Immerwahr, S.
   Resnick, S.
   Culp, G.
   Greene, S. K.
TI Sampling considerations for a potential Zika virus urosurvey in New York
   City
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Local transmission; sampling; urosurvey; Zika virus
ID SUBSTANTIATE FREEDOM; INFECTION; DISEASE; FLORIDA
AB In 2016, imported Zika virus (ZIKV) infections and the presence of a potentially competent mosquito vector (Aedes albopictus) implied that ZIKV transmission in New York City (NYC) was possible. The NYC Department of Health and Mental Hygiene developed contingency plans for a urosurvey to rule out ongoing local transmission as quickly as possible if a locally acquired case of confirmed ZIKV infection was suspected. We identified tools to (1) rapidly estimate the population living in any given 150-m radius (i.e. within the typical flight distance of an Aedes mosquito) and (2) calculate the sample size needed to test and rule out the further local transmission. As we expected near-zero ZIKV prevalence, methods relying on the normal approximation to the binomial distribution were inappropriate. Instead, we assumed a hypergeometric distribution, 10 missed cases at maximum, a urine assay sensitivity of 92.6% and 100% specificity. Three suspected example risk areas were evaluated with estimated population sizes of 479-4,453, corresponding to a minimum of 133-1244 urine samples. This planning exercise improved our capacity for ruling out local transmission of an emerging infection in a dense, urban environment where all residents in a suspected risk area cannot be feasibly sampled.
C1 [Thompson, C. N.; Lee, C. T.; Greene, S. K.] New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, Long Isl City, NY 11101 USA.
   [Lee, C. T.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, Atlanta, GA USA.
   [Immerwahr, S.; Culp, G.] New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, Long Isl City, NY USA.
   [Resnick, S.] New York City Dept Hlth & Mental Hyg, Bur IT Informat, Long Isl City, NY USA.
RP Thompson, CN (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, Long Isl City, NY 11101 USA.
EM cthompson2@health.nyc.gov
OI Greene, Sharon/0000-0002-3509-2377
FU Intramural CDC HHS [CC999999]
CR Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bajwa W, 2016, COMPREHENSIVE MOSQUI
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0
   Centers for Disease Control and Prevention, 2016, INT CDC REC ZIK VECT
   Centers for Disease Control and Prevention, 2017, ZIK CAS US
   Chan T-C, 2018, ANN C INT SOC DIS SU
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Greene SK, 2017, ANN C COUNC STAT TER
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kopacka I, 2015, COMPREHENSIVE R ARCH
   Korn E.L., 1998, SURV METHODOL, V24, P193
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Melissa Global Intelligence, 2014, MEL GLOB INT CUST AD
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   NCSS LLC, 2014, PASS 13 POW AN SAMPL
   New York City Department of City Planning, 2010, NYC PLANN DAT MAPS
   New York City Department of City Planning, 2017, NYC PLANN DAT MAPS
   New York City Department of Health and Mental Hygiene, 2017, HLTH TOP ZIK VIR
   New York City Department of Information Technology and Telecommunications, 2018, NYC OP DAT
   Obenauer PJ, 2009, J MED ENTOMOL, V46, P900, DOI 10.1603/033.046.0424
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   United States Food and Drug Administration, 2016, EM SIT MED DEV
   US Centers for Disease Control and Prevention, 2017, OV ZIK VIR TEST
   Wahnich A, 2016, ONLINE J PUBLIC HLTH, V9, pe115
   Wang WZ, 2015, J AM STAT ASSOC, V110, P1491, DOI 10.1080/01621459.2014.966191
   WHO (World Health Organization), 2017, ZIKA VIR CLASS TABL
   WHO (World Health Organization) Regional Office for Europe, 2016, VECT SURV CONTR UPD
   Ziller M, 2002, PREV VET MED, V52, P333, DOI 10.1016/S0167-5877(01)00245-8
NR 36
TC 1
Z9 1
U1 0
U2 14
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD OCT
PY 2018
VL 146
IS 13
BP 1628
EP 1634
DI 10.1017/S0950268818002236
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GS3QS
UT WOS:000443535400005
PM 30086802
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU dos Santos, IM
   Agra, JPG
   de Carvalho, TGC
   Maia, GLD
   de Alencar, EB
AF dos Santos, Ieda Maria
   Gomes Agra, Joao Pedro
   Cavalcante de Carvalho, Thiego Gustavo
   de Azevedo Maia, Gabriela Lemos
   de Alencar Filho, Edilson Beserra
TI Classical and 3D QSAR studies of larvicidal monoterpenes against Aedes
   aegypti: new molecular insights for the rational design of more active
   compounds
SO STRUCTURAL CHEMISTRY
LA English
DT Article
DE Monoterpenes; Larvicidal activity; Classical QSAR; 3D-QSAR; Ordered
   predictors selector
ID DESCRIPTORS; DYNAMICS; QSPR; SELECTION
AB Monoterpenes are compounds found on essential oils of diverse plants, with biological activities such as repellent, insecticidal and larvicidal against some organism and microorganism species. Dengue, Chikungunya, and Zika are important public health problems caused by viruses, which are transmitted by the bite of Aedes aegypti mosquitoes. One of the most common strategies to combat these diseases is the control of the vector proliferation, by physical and chemical methods. Thus, the design, synthesis, and test of the compounds with larvicidal profile have emerged as an important research line. In this paper, we present the use of computational approaches to provide robust, predictive, and conveniently interpretable quantitative structure-activity relationships models, involving a series of 55 monoterpenes and structurally related compounds, which presented larvicidal activity against females of Aedes aegypti, expressed by IC50. Through the proposition and analysis of 2D and 3D molecular descriptors, consistent and easily understood molecular bases about larvicidal activity are provided, for the proposition of new molecules with more active profile. Theoretical geometry optimization of the 55 compounds was performed using the PM6 semiempirical Hamiltonian, followed by B3LYP/6-31+G(d) level of theory, using Gaussian 09W (R) package. A set of classical descriptors was obtained from Dragon (R) software for each compound and submitted to a variable selection procedure, using the Ordered Predictors Selector (OPS) algorithm, considering larvicidal (pIC(50)) activities previously reported. Then, a 3D quantitative structure-activity relationship (QSAR) investigation was performed by Open3DQSAR program, using the same values of activity, for the investigation of sterical and electrostatic molecular fields. For classical QSAR, five descriptors were selected as the most important, providing a robust and predictive QSAR model via multiple linear regression (MLR). In addition, a good 3D-QSAR model was found, with a clear interpretation of the physical sense of the fields, according to the classical model. Molecules with more elongated structures contain a six-membered ring with 1,4 substitution pattern, highest lipophilicity, less volume on a central moiety, and lateral hydrophobic chain at six-membered ring, tend to be more actives.
C1 [dos Santos, Ieda Maria; de Azevedo Maia, Gabriela Lemos; de Alencar Filho, Edilson Beserra] Fed Univ San Francisco Valley, Postgrad Program Hlth & Biol Sci, Petrolina, PE, Brazil.
   [Gomes Agra, Joao Pedro; Cavalcante de Carvalho, Thiego Gustavo; de Azevedo Maia, Gabriela Lemos; de Alencar Filho, Edilson Beserra] Fed Univ San Francisco Valley, Coll Pharm, Petrolina, PE, Brazil.
   [de Alencar Filho, Edilson Beserra] Fed Univ San Francisco Valley, Postgrad Program Nat Resources Semiarid, Petrolina, PE, Brazil.
RP de Alencar, EB (corresponding author), Fed Univ San Francisco Valley, Postgrad Program Hlth & Biol Sci, Petrolina, PE, Brazil.; de Alencar, EB (corresponding author), Fed Univ San Francisco Valley, Coll Pharm, Petrolina, PE, Brazil.; de Alencar, EB (corresponding author), Fed Univ San Francisco Valley, Postgrad Program Nat Resources Semiarid, Petrolina, PE, Brazil.
EM edilson.beserra@univasf.edu.br
RI de Azevedo Maia, Gabriela Lemos/Q-6839-2017; Alencar Filho, Edilson
   B./D-8775-2016
OI de Azevedo Maia, Gabriela Lemos/0000-0002-6878-4644; Alencar Filho,
   Edilson B./0000-0002-1000-0114; Agra Gomes, Joao
   Pedro/0000-0002-7664-0990
FU Foundation of Support to the Science and Technology of the State of
   Pernambuco - FACEPE; National Council for Scientific and Technological
   Development - CNPQNational Council for Scientific and Technological
   Development (CNPq); Coordination of Improvement of Higher Level
   Personnel - CAPESCAPES; Federal University of San Francisco Valley
   UNIVASF
FX The authors are grateful to the Foundation of Support to the Science and
   Technology of the State of Pernambuco - FACEPE, National Council for
   Scientific and Technological Development - CNPQ, Coordination of
   Improvement of Higher Level Personnel - CAPES, and Federal University of
   San Francisco Valley UNIVASF for the financial support and National
   High-performance Processing Center of Federal University of Ceara -
   CENAPAD-UFC for some computational facilities as Gaussian 09W package.
CR Alencar EB, 2017, J MOL STRUCT, V1133, P338, DOI 10.1016/j.molstruc.2016.12.035
   Alencar EB, 2016, MED CHEM RES, V25, P2171, DOI 10.1007/s00044-016-1650-7
   Alencar EB, 2014, MED CHEM RES, V23, P5328, DOI 10.1007/s00044-014-1077-y
   Bielinska-Waz D, 2014, STRUCT CHEM, V25, P29, DOI 10.1007/s11224-013-0229-x
   Brunk E, 2015, CHEM REV, V115, P6217, DOI 10.1021/cr500628b
   Cherkasov A, 2014, J MED CHEM, V57, P4977, DOI 10.1021/jm4004285
   Consonni V, 2002, J CHEM INF COMP SCI, V42, P682, DOI 10.1021/ci015504a
   da Silva GNS, 2016, PEST MANAG SCI, V72, P1883, DOI 10.1002/ps.4221
   de Oliveira DB, 2001, QUANT STRUCT-ACT REL, V19, P599
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Filho EBA, 2012, J MOL STRUCT, V1022, P72, DOI 10.1016/j.molstruc.2012.04.051
   Frisch M.J., 2009, GAUSSIAN 09 REVISION
   Huang P, 2008, ANNU REV PHYS CHEM, V59, P261, DOI 10.1146/annurev.physchem.59.032607.093528
   Jabeen I, 2013, J COMPUT AID MOL DES, V27, P161, DOI 10.1007/s10822-013-9635-9
   Jagiello K, 2016, J NANOPART RES, V18, DOI 10.1007/s11051-016-3564-1
   Jagiello K, 2014, STRUCT CHEM, V25, P997, DOI 10.1007/s11224-014-0419-1
   Kiralj R, 2009, J BRAZIL CHEM SOC, V20, P770, DOI 10.1590/S0103-50532009000400021
   Kode srl, 2018, DRAGON SOFTWARE MOL
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   Lauria A, 2010, CURR MED CHEM, V17, P3142, DOI 10.2174/092986710792232021
   Martins JPA, 2013, QUIM NOVA, V36, P554, DOI 10.1590/S0100-40422013000400013
   MORIGUCHI I, 1992, CHEM PHARM BULL, V40, P127
   OECD, 2007, GUID DOC VAL QUANT S
   Oliveira BG, 2016, CRYSTALS, V6, DOI 10.3390/cryst6050056
   Oliveira BG, 2009, J MOL MODEL, V15, P421, DOI 10.1007/s00894-008-0422-9
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   Teofilo RF, 2009, J CHEMOMETR, V23, P32, DOI 10.1002/cem.1192
   Todeschni R, 2010, BOOK SERIES METHODS, V41, DOI [10.1002/9783527628766, DOI 10.1002/9783527628766]
   Tosco P, 2011, J MOL MODEL, V17, P201, DOI 10.1007/s00894-010-0684-x
   Tse JS, 2002, ANNU REV PHYS CHEM, V53, P249, DOI 10.1146/annurev.physchem.53.090401.105737
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Veras LD, 2010, J BRAZIL CHEM SOC, V21, P872, DOI 10.1590/S0103-50532010000500015
   Vinzi VE, 2013, WILEY INTERDISCIP RE, V5, P1, DOI 10.1002/wics.1239
NR 35
TC 4
Z9 4
U1 6
U2 31
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-0400
EI 1572-9001
J9 STRUCT CHEM
JI Struct. Chem.
PD OCT
PY 2018
VL 29
IS 5
BP 1287
EP 1297
DI 10.1007/s11224-018-1110-8
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Crystallography
SC Chemistry; Crystallography
GA GR4WJ
UT WOS:000442621000005
DA 2020-07-08
ER

PT J
AU Santos, MCD
   Nascimento, YM
   Monteiro, JD
   Alves, BEB
   Melo, MF
   Paiva, AAP
   Pereira, HWB
   Medeiros, LG
   Morais, IC
   Neto, JCF
   Fernandes, JV
   Araujo, JMG
   Lima, KMG
AF Santos, Marfran C. D.
   Nascimento, Yasmin M.
   Monteiro, Joelma D.
   Alves, Brenda E. B.
   Melo, Marilia F.
   Paiva, Anne A. P.
   Pereira, Hannaly W. B.
   Medeiros, Leandro G.
   Morais, Ingryd C.
   Fagundes Neto, Joao Ciro
   Fernandes, Jose V.
   Araujo, Joselio M. G.
   Lima, Kassio M. G.
TI ATR-FTIR spectroscopy with chemometric algorithms of multivariate
   classification in the discrimination between healthy vs. dengue vs.
   chikungunya vs. zika clinical samples (vol 10, pg 1280, 2018)
SO ANALYTICAL METHODS
LA English
DT Correction
C1 [Santos, Marfran C. D.; Lima, Kassio M. G.] Univ Fed Rio Grande do Norte, Biol Chem & Chemometr, Inst Chem, BR-59072970 Natal, RN, Brazil.
   [Nascimento, Yasmin M.; Monteiro, Joelma D.; Alves, Brenda E. B.; Melo, Marilia F.; Paiva, Anne A. P.; Pereira, Hannaly W. B.; Medeiros, Leandro G.; Fagundes Neto, Joao Ciro; Fernandes, Jose V.; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Lab Mol Biol Infect Dis & Canc, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Nascimento, Yasmin M.; Monteiro, Joelma D.; Alves, Brenda E. B.; Melo, Marilia F.; Paiva, Anne A. P.; Pereira, Hannaly W. B.; Medeiros, Leandro G.; Morais, Ingryd C.; Fagundes Neto, Joao Ciro; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Virol Lab, Inst Trop Med, BR-59072970 Natal, RN, Brazil.
RP Lima, KMG (corresponding author), Univ Fed Rio Grande do Norte, Biol Chem & Chemometr, Inst Chem, BR-59072970 Natal, RN, Brazil.
EM kassiolima@gmail.com
OI Fernandes, Jose Verissimo/0000-0002-5169-6496
CR Santos MCD, 2018, ANAL METHODS-UK, V10, P1280, DOI 10.1039/c7ay02784b
NR 1
TC 0
Z9 0
U1 1
U2 2
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9660
EI 1759-9679
J9 ANAL METHODS-UK
JI Anal. Methods
PD SEP 28
PY 2018
VL 10
IS 36
BP 4472
EP 4473
DI 10.1039/c8ay90116c
PG 2
WC Chemistry, Analytical; Food Science & Technology; Spectroscopy
SC Chemistry; Food Science & Technology; Spectroscopy
GA GY2VF
UT WOS:000448401300013
OA Other Gold
DA 2020-07-08
ER

PT J
AU Mahawaththa, MC
   Lee, MD
   Giannoulis, A
   Adams, LA
   Feintuch, A
   Swarbrick, JD
   Graham, B
   Nitsche, C
   Goldfarb, D
   Otting, G
AF Mahawaththa, Mithun C.
   Lee, Michael D.
   Giannoulis, Angeliki
   Adams, Luke A.
   Feintuch, Akiva
   Swarbrick, James D.
   Graham, Bim
   Nitsche, Christoph
   Goldfarb, Daniella
   Otting, Gottfried
TI Small neutral Gd(III) tags for distance measurements in proteins by
   double electron-electron resonance experiments
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID VIRUS NS2B-NS3 PROTEASE; IN-CELL EPR; ZIKA VIRUS; SPIN LABELS;
   PSEUDOCONTACT SHIFTS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FLAVIVIRAL
   PROTEASES; MEDICINAL CHEMISTRY; STRUCTURAL BASIS
AB Spin labels containing a Gd(III) ion have become important for measuring nanometer distances in proteins by double electron-electron resonance (DEER) experiments at high EPR frequencies. The distance resolution and sensitivity of these measurements strongly depend on the Gd(III) tag used. Here we report the performance of two Gd(III) tags, propargyl-DO3A and C11 in DEER experiments carried out at W-band (95 GHz). Both tags are small, uncharged and devoid of bulky hydrophobic pendants. The propargyl-DO3A tag is designed for conjugation to the azide-group of an unnatural amino acid. The C11 tag is a new tag designed for attachment to a single cysteine residue. The tags delivered narrower distance distributions in the E. coli aspartate/glutamate binding protein and the Zika virus NS2B-NS3 protease than previously established Gd(III) tags. The improved performance is consistent with the absence of specific hydrophobic or charge-charge interactions with the protein. In the case of the Zika virus NS2B-NS3 protease, unexpectedly broad Gd(III)-Gd(III) distance distributions observed with the previously published charged C9 tag, but not the C11 tag, illustrate the potential of tags to perturb a labile protein structure and the importance of different tags. The results obtained with the C11 tag demonstrate the closed conformation in the commonly used linked construct of the Zika virus NS2B-NS3 protease, both in the presence and absence of an inhibitor.
C1 [Mahawaththa, Mithun C.; Nitsche, Christoph; Otting, Gottfried] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
   [Lee, Michael D.; Adams, Luke A.; Swarbrick, James D.; Graham, Bim] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.
   [Giannoulis, Angeliki; Feintuch, Akiva; Goldfarb, Daniella] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.
RP Otting, G (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.; Goldfarb, D (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.
EM Daniella.Goldfarb@weizmann.ac.il; Gottfried.Otting@anu.edu.au
RI Otting, Gottfried/H-8413-2014; Don, Mithun Mahawaththage/N-9503-2019
OI Otting, Gottfried/0000-0002-0563-0146; Lee, Michael/0000-0001-7055-0903;
   Adams, Luke/0000-0002-8481-9819; Goldfarb, daniella/0000-0001-5714-7159
FU Australian Research CouncilAustralian Research Council; Israel Science
   Foundation (ISF)Israel Science Foundation [334/14]; Alexander von
   Humboldt FoundationAlexander von Humboldt Foundation
FX Financial support by the Australian Research Council, including a
   Laureate Fellowship to G. O., is gratefully acknowledged. D. G.
   acknowledges the support of the Israel Science Foundation (ISF grant No.
   334/14). This research was made possible in part by the historic
   generosity of the Harold Perlman Family (D. G.). D. G. holds the Erich
   Klieger Professorial Chair in Chemical Physics. C. N. thanks the
   Alexander von Humboldt Foundation for a Feodor Lynen Fellowship and
   Professor Christian D. Klein for project support.
CR Abdelkader EH, 2015, CHEM COMMUN, V51, P15898, DOI 10.1039/c5cc07121f
   Abdelkader EH, 2015, J PHYS CHEM LETT, V6, P5016, DOI 10.1021/acs.jpclett.5b02451
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Barthelmes D, 2015, J BIOMOL NMR, V63, P275, DOI 10.1007/s10858-015-9984-x
   Chen WN, 2016, J AM CHEM SOC, V138, P4539, DOI 10.1021/jacs.6b00416
   Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w
   Cohen MR, 2016, PHYS CHEM CHEM PHYS, V18, P12847, DOI 10.1039/c6cp00829a
   Dalaloyan A, 2015, PHYS CHEM CHEM PHYS, V17, P18464, DOI 10.1039/c5cp02602d
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Edwards DT, 2014, STRUCTURE, V22, P1677, DOI 10.1016/j.str.2014.09.008
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Feintuch A, 2015, METHOD ENZYMOL, V563, P415, DOI 10.1016/bs.mie.2015.07.006
   Garbuio L, 2013, J PHYS CHEM B, V117, P3145, DOI 10.1021/jp401806g
   Ghimire H, 2009, BIOCHEMISTRY-US, V48, P5782, DOI 10.1021/bi900781u
   Goldfarb D, 2008, J MAGN RESON, V194, P8, DOI 10.1016/j.jmr.2008.05.019
   Goldfarb D, 2014, PHYS CHEM CHEM PHYS, V16, P9685, DOI 10.1039/c3cp53822b
   Graham B, 2011, BIOCONJUGATE CHEM, V22, P2118, DOI 10.1021/bc200353c
   Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0
   Hu YL, 2008, J MOL BIOL, V382, P99, DOI 10.1016/j.jmb.2008.06.091
   Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9
   Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213
   Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001
   Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716
   Kaminker I, 2012, PHYS CHEM CHEM PHYS, V14, P4355, DOI 10.1039/c2cp40219j
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Loh CT, 2013, BIOCONJUGATE CHEM, V24, P260, DOI 10.1021/bc300631z
   Lueders P, 2011, J PHYS CHEM LETT, V2, P604, DOI 10.1021/jz200073h
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Manukovsky N, 2017, J CHEM PHYS, V147, DOI 10.1063/1.4994084
   Martorana A, 2014, J AM CHEM SOC, V136, P13458, DOI 10.1021/ja5079392
   Mascali FC, 2016, ANGEW CHEM INT EDIT, V55, P11041, DOI 10.1002/anie.201603653
   Matalon E, 2013, ANGEW CHEM INT EDIT, V52, P11831, DOI 10.1002/anie.201305574
   Matalon E, 2013, J PHYS CHEM B, V117, P2280, DOI 10.1021/jp310056h
   Mukai T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09699
   Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w
   Nitsche C, 2017, CHEM COMMUN, V53, P10894, DOI 10.1039/c7cc06155b
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Polyhach Y, 2007, J MAGN RESON, V185, P118, DOI 10.1016/j.jmr.2006.11.012
   Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h
   Potapov A, 2010, J AM CHEM SOC, V132, P9040, DOI 10.1021/ja1015662
   Prokopiou G, 2018, INORG CHEM, V57, P5048, DOI 10.1021/acs.inorgchem.8b00133
   Qi M, 2014, J AM CHEM SOC, V136, P15366, DOI 10.1021/ja508274d
   Reginsson GW, 2012, J MAGN RESON, V216, P175, DOI 10.1016/j.jmr.2012.01.019
   Song Y, 2011, J MAGN RESON, V210, P59, DOI 10.1016/j.jmr.2011.02.010
   Stanton-Cook M., PYPARATOOLS SOFTWARE
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531
   Thonon D, 2007, CONTRAST MEDIA MOL I, V2, P24, DOI 10.1002/cmmi.121
   Vanasschen C, 2011, INORG CHEM, V50, P8946, DOI 10.1021/ic2010997
   Vigier FM, 2014, PHYS CHEM CHEM PHYS, V16, P19218, DOI 10.1039/c4cp02275k
   Welegedara AP, 2017, CHEM-EUR J, V23, P11694, DOI 10.1002/chem.201702521
   Wu ZY, 2017, J PHYS CHEM LETT, V8, P5277, DOI 10.1021/acs.jpclett.7b01739
   Yagi H, 2011, J AM CHEM SOC, V133, P10418, DOI 10.1021/ja204415w
   Yan LM, 2016, TETRAHEDRON, V72, P8578, DOI 10.1016/j.tet.2016.11.036
   Yang Y, 2017, PHYS CHEM CHEM PHYS, V19, P26944, DOI 10.1039/c7cp04311b
   Yang Y, 2017, ANGEW CHEM INT EDIT, V56, P2914, DOI 10.1002/anie.201611051
   Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 64
TC 6
Z9 6
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD SEP 28
PY 2018
VL 20
IS 36
BP 23535
EP 23545
DI 10.1039/c8cp03532f
PG 11
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA GX0AI
UT WOS:000447370600038
PM 30183028
DA 2020-07-08
ER

PT J
AU Sanchez-San Martin, C
   Li, T
   Bouquet, J
   Streithorst, J
   Yu, GX
   Paranjpe, A
   Chiu, CY
AF Sanchez-San Martin, Claudia
   Li, Tony
   Bouquet, Jerome
   Streithorst, Jessica
   Yu, Guixia
   Paranjpe, Aditi
   Chiu, Charles Y.
TI Differentiation enhances Zika virus infection of neuronal brain cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN NEUROBLASTOMA-CELLS; RETINOIC ACID; SH-SY5Y; FEVER; INHIBITION;
   EXPRESSION; NIGERIA; GROWTH; LINE
AB Zika virus (ZIKV) is an emerging, mosquito-borne pathogen associated with a widespread 2015-2016 epidemic in the Western Hemisphere and a proven cause of microcephaly and other fetal brain defects in infants born to infected mothers. ZIKV infections have been also linked to other neurological illnesses in infected adults and children, including Guillain-Barre syndrome (GBS), acute flaccid paralysis (AFP) and meningoencephalitis, but the viral pathophysiology behind those conditions remains poorly understood. Here we investigated ZIKV infectivity in neuroblastoma SH-SY5Y cells, both undifferentiated and following differentiation with retinoic acid. We found that multiple ZIKV strains, representing both the prototype African and contemporary Asian epidemic lineages, were able to replicate in SH-SY5Y cells. Differentiation with resultant expression of mature neuron markers increased infectivity in these cells, and the extent of infectivity correlated with degree of differentiation. New viral particles in infected cells were visualized by electron microscopy and found to be primarily situated inside vesicles; overt damage to the Golgi apparatus was also observed. Enhanced ZIKV infectivity in a neural cell line following differentiation may contribute to viral neuropathogenesis in the developing or mature central nervous system.
C1 [Li, Tony; Bouquet, Jerome; Streithorst, Jessica; Yu, Guixia; Paranjpe, Aditi; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.
   [Sanchez-San Martin, Claudia; Li, Tony; Bouquet, Jerome; Streithorst, Jessica; Yu, Guixia; Paranjpe, Aditi; Chiu, Charles Y.] UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94107 USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94107 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.; Chiu, CY (corresponding author), UCSF, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94107 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94107 USA.
EM charles.chiu@ucsf.edu
OI Bouquet, Jerome/0000-0001-8077-6025; Chiu, Charles/0000-0003-2915-2094
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-HL105704, R21-AI129455]; Abbott
   Laboratories, Inc.Abbott Laboratories
FX We would like to acknowledge Marion Lanteri (Blood Systems Research
   Institute), Lark Coffey (Blood Systems Research Institute), Raul Andino
   (UCSF), Shigeo Yagi (California Department of Public Health) and Joseph
   DeRisi (UCSF) for sharing reagents. Data for this study were acquired at
   the Nikon Imaging Center at UCSF. This study was also supported NIH
   grants R01-HL105704 and R21-AI129455, and award from Abbott
   Laboratories, Inc. to CYC. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363
   Akond Z, 2018, BIOINFORMATION, V14, P153, DOI 10.6026/97320630014153
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Craig AT, 2017, B WORLD HEALTH ORGAN, V95, P69, DOI 10.2471/BLT.16.171892
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Debruyne DN, 2016, ONCOGENE, V35, P3681, DOI 10.1038/onc.2015.434
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Du XL, 2015, MOL MED REP, V12, P953, DOI 10.3892/mmr.2015.3482
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gordon J, 2013, METHODS MOL BIOL, V1078, P1, DOI 10.1007/978-1-62703-640-5_1
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Huhtamo E, 2014, VIROLOGY, V464, P320, DOI 10.1016/j.virol.2014.07.015
   Janesick A, 2015, CELL MOL LIFE SCI, V72, P1559, DOI 10.1007/s00018-014-1815-9
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Khwanraj K, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/734703
   LAMONICA N, 1989, J VIROL, V63, P2357, DOI 10.1128/JVI.63.5.2357-2360.1989
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lopez-Carballo G, 2002, J BIOL CHEM, V277, P25297, DOI 10.1074/jbc.M201869200
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611
   Madi Deepak, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS70, DOI 10.12980/APJTB.4.2014C1006
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nair S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36179
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   ROSS RA, 1983, J NATL CANCER I, V71, P741
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103
   Winkelmann Evandro R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7404.1
   Xu J, 2012, MOL BIOL REP, V39, P789, DOI 10.1007/s11033-011-0800-8
   Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381
NR 49
TC 4
Z9 4
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 28
PY 2018
VL 8
AR 14543
DI 10.1038/s41598-018-32400-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV2DF
UT WOS:000445895400030
PM 30266962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paz-Bailey, G
   Rosenberg, ES
   Doyle, K
   Munoz-Jordan, J
   Santiago, GA
   Klein, L
   Perez-Padilla, J
   Medina, FA
   Waterman, SH
   Adams, LE
   Lozier, MJ
   Bertran-Pasarell, J
   Gubern, CG
   Alvarado, LI
   Sharp, TM
AF Paz-Bailey, Gabriela
   Rosenberg, Eli S.
   Doyle, Kate
   Munoz-Jordan, Jorge
   Santiago, Gilberto A.
   Klein, Liore
   Perez-Padilla, Janice
   Medina, Freddy A.
   Waterman, Stephen H.
   Adams, Laura E.
   Lozier, Matthew J.
   Bertran-Pasarell, Jorge
   Garcia Gubern, Carlos
   Alvarado, Luisa, I
   Sharp, Tyler M.
TI Persistence of Zika Virus in Body Fluids-Final Report
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; FEMALE GENITAL-TRACT; UNITED-STATES;
   INFECTION; SEMEN; PREVENTION; TRAVELERS; DISEASE; SALIVA; URINE
AB BACKGROUND
   To estimate the frequency and duration of detectable Zika virus (ZIKV) RNA in human body fluids, we prospectively assessed a cohort of recently infected participants in Puerto Rico.
   METHODS
   We evaluated samples obtained from 295 participants (including 94 men who provided semen specimens) in whom ZIKV RNA was detected on reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay in urine or blood at an enhanced arboviral clinical surveillance site. We collected serum, urine, saliva, semen, and vaginal secretions weekly for the first month and at 2, 4, and 6 months. All specimens were tested by means of RT-PCR, and serum was tested with the use of anti-ZIKV IgM enzyme-linked immunosorbent assay. Among the participants with ZIKV RNA in any specimen at week 4, collection continued every 2 weeks thereafter until all specimens tested negative. We used parametric Weibull regression models to estimate the time until the loss of ZIKV RNA detection in each body fluid and reported the findings in medians and 95th percentiles.
   RESULTS
   The medians and 95th percentiles for the time until the loss of ZIKV RNA detection were 15 days (95% confidence interval [CI], 14 to 17) and 41 days (95% CI, 37 to 44), respectively, in serum; 11 days (95% CI, 9 to 12) and 34 days (95% CI, 30 to 38) in urine; and 42 days (95% CI, 35 to 50) and 120 days (95% CI, 100 to 139) in semen. Less than 5% of participants had detectable ZIKV RNA in saliva or vaginal secretions.
   CONCLUSIONS
   The prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. In 95% of the men in this study, ZIKV RNA was cleared from semen after approximately 4 months.
C1 [Paz-Bailey, Gabriela; Munoz-Jordan, Jorge; Santiago, Gilberto A.; Perez-Padilla, Janice; Medina, Freddy A.; Waterman, Stephen H.; Adams, Laura E.; Lozier, Matthew J.; Sharp, Tyler M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Doyle, Kate] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis Sexually Transm, Atlanta, GA USA.
   [Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Albany, NY USA.
   [Klein, Liore] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Bertran-Pasarell, Jorge] Auxilio Mutuo Hosp, San Juan, PR 00919 USA.
   [Garcia Gubern, Carlos; Alvarado, Luisa, I] Ponce Hlth Sci Univ, Sch Med, St Lukes Episcopal Hosp Consortium, Ponce, PR USA.
RP Paz-Bailey, G (corresponding author), Ctr Dis Control & Prevent, 1324 Calle Canada, San Juan, PR 00920 USA.
EM gmb5@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX Funded by the Centers for Disease Control and Prevention.
CR [Anonymous], 2017, GUID US LAB TEST ZIK
   [Anonymous], 2016, ZIK VIR EM AUTH EM U
   [Anonymous], 2016, ZIK VIR EM US AUTH E
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Feldmann H, 2018, NEW ENGL J MED, V378, P1440, DOI 10.1056/NEJMe1803212
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T., 2016, EURO SURVEILL, V21
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Hunsperger EA, 2016, J INFECT DIS, V214, P836, DOI 10.1093/infdis/jiw103
   Iannetta M, 2017, EURO SURVEILL, V22
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Medina FA, 2018, J INFECT DIS
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Perez S, 2016, EURO SURVEILL, V21
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
NR 53
TC 150
Z9 150
U1 7
U2 55
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD SEP 27
PY 2018
VL 379
IS 13
BP 1234
EP 1243
DI 10.1056/NEJMoa1613108
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV1KS
UT WOS:000445835100008
PM 28195756
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Calvez, E
   O'Connor, O
   Pol, M
   Rousset, D
   Faye, O
   Richard, V
   Tarantola, A
   Dupont-Rouzeyrol, M
AF Calvez, Elodie
   O'Connor, Olivia
   Pol, Morgane
   Rousset, Dominique
   Faye, Oumar
   Richard, Vincent
   Tarantola, Arnaud
   Dupont-Rouzeyrol, Myrielle
TI Differential transmission of Asian and African Zika virus lineages by
   Aedes aegypti from New Caledonia
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID WEST-NILE-VIRUS; CHIKUNGUNYA VIRUS; ARBOVIRUS INFECTION; VECTOR;
   COMPETENCE; FITNESS
AB Zika virus (ZIKV) is a Flavivirus that is transmitted to humans by Aedes mosquitoes. ZIKV is divided into two phylogenetic lineages, African and Asian. In the Asian lineage, Pacific and American clades have been linked to the recent worldwide outbreak of ZIKV. The aim of this study was to measure the vector competence of Aedes aegypti for seven ZIKV strains belonging to both lineages. We demonstrate that Ae. aegypti from New Caledonia (NC), South Pacific region, is a low-competence vector for Asian ZIKV (< 10% transmission efficiency). No significant differences were observed in vector competence with respect to the sampling date and collection site of Asian ZIKV strains used (2014 and 2015 for New Caledonia, Pacific clade, and 2016 for French Guiana, American clade). The ability of the New Caledonian Ae. aegypti to transmit ZIKV is significantly greater for the earlier viral isolates belonging to the African lineage (> 37% transmission efficiency after 9 days post- infection) compared to recent ZIKV isolates from African (10% transmission efficiency) and Asian lineages (< 10% transmission efficiency). The results of this study demonstrate that Ae. aegypti from NC can become infected and replicate different ZIKV strains belonging to all lineages. Our data emphasize the importance of studying the interaction between vectors and their arboviruses according to each local geographic context. This approach will improve our understanding of arbovirus transmission to prevent their emergence and improve health surveillance.
C1 [Calvez, Elodie; O'Connor, Olivia; Dupont-Rouzeyrol, Myrielle] Inst Pasteur Nouvelle Caledonie, URE Dengue & Autres Arboviroses, Reseau Int, Inst Pasteur, Noumea, New Caledonia.
   [Pol, Morgane] Inst Pasteur Nouvelle Caledonie, URE Entomol Med, Reseau Int, Inst Pasteur, Noumea, New Caledonia.
   [Rousset, Dominique] Inst Pasteur, Lab Virol, Ctr Natl Reference Arbovirus, Reseau Int,Inst Pasteur, Cayenne, French Guiana.
   [Faye, Oumar] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Reseau Int, Inst Pasteur, Dakar, Senegal.
   [Richard, Vincent] Inst Pasteur Nouvelle Caledonie, Reseau Int, Inst Pasteur, Noumea, New Caledonia.
   [Tarantola, Arnaud] Inst Pasteur Nouvelle Caledonie, Unite Epidemiol, Reseau Int, Inst Pasteur, Noumea, New Caledonia.
RP Dupont-Rouzeyrol, M (corresponding author), Inst Pasteur Nouvelle Caledonie, URE Dengue & Autres Arboviroses, Reseau Int, Inst Pasteur, Noumea, New Caledonia.
EM mdupont@pasteur.nc
RI Faye, Oumar/T-7168-2019; Tarantola, Arnaud/D-2149-2015; Rousset,
   Dominique/S-5400-2019
OI Tarantola, Arnaud/0000-0002-6946-7958; Rousset,
   Dominique/0000-0002-1473-3147; O'CONNOR, Olivia/0000-0002-8108-8408
FU Actions Concertees Inter Pasteuriennes (ZikAe project) [ACIP A-15-2014];
   European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant [734548]
FX We thank Catherine Inizan for participating in ZIKV stock production and
   for revising the manuscript. We thank Cyrille Goarant for the rabbit
   blood samples. This work was supported by the Actions Concertees Inter
   Pasteuriennes (ZikAe project, ACIP A-15-2014) and partly by the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   Grant Agreement no. 734548.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   [Anonymous], 2016, R LANG ENV STAT COMP
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Boyer S, 2018, MICROBES INFECT, V23
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Calvez E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006637
   Calvez E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2319-x
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Fansiri T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003621
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FAYE O, 2014, PLOS NEGLECT TROP D, V8, P5624
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Igor ADP, 2016, EMERG INFECT DIS, V22, P1438, DOI [10.3201/eid2208.160496, DOI 10.3201/EID2208.160496]
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Lambrechts L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2437
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Mourya DT, 2000, INDIAN J MED RES, V111, P157
   Myles KM, 2003, J VIROL, V77, P8872, DOI 10.1128/JVI.77.16.8872-8881.2003
   PERRY WJ, 1950, AM J TROP MED, V30, P103
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Scholle F, 2004, J VIROL, V78, P11605, DOI 10.1128/JVI.78.21.11605-11614.2004
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vogels CBF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.82
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 60
TC 14
Z9 14
U1 1
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 26
PY 2018
VL 7
AR 159
DI 10.1038/s41426-018-0166-2
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GW1LL
UT WOS:000446640100001
PM 30254274
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Acosta-Ampudia, Y
   Monsalve, DM
   Rodriguez, Y
   Pacheco, Y
   Anaya, JM
   Ramirez-Santana, C
AF Acosta-Ampudia, Yeny
   Monsalve, Diana M.
   Rodriguez, Yhojan
   Pacheco, Yovana
   Anaya, Juan-Manuel
   Ramirez-Santana, Carolina
TI Mayaro: an emerging viral threat?
SO EMERGING MICROBES & INFECTIONS
LA English
DT Review
ID ACUTE FEBRILE ILLNESS; HUMAN-DISEASE AGENT; VIRUS-INFECTION; AMAZON
   BASIN; RAIN-FOREST; MOUSE MODEL; ALPHAVIRUSES; ARBOVIRUS; BRAZIL; FEVER
AB Mayaro virus (MAYV), an enveloped RNA virus, belongs to the Togaviridae family and Alphavirus genus. This arthropod-borne virus (Arbovirus) is similar to Chikungunya (CHIKV), Dengue (DENV), and Zika virus (ZIKV). The term "ChikDenMaZika syndrome" has been coined for clinically suspected arboviruses, which have arisen as a consequence of the high viral burden, viral co-infection, and co-circulation in South America. In most cases, MAYV disease is nonspecific, mild, and self-limited. Fever, arthralgia, and maculopapular rash are among the most common symptoms described, being largely indistinguishable from those caused by other arboviruses. However, severe manifestations of the infection have been reported, such as chronic polyarthritis, neurological complications, hemorrhage, myocarditis, and even death. Currently, there are no specific commercial tools for the diagnosis of MAYV, and the use of serological methods can be affected by cross-reactivity and the window period. A diagnosis based on clinical and epidemiological data alone is still premature. Therefore, new entomological research is warranted, and new highly specific molecular diagnostic methods should be developed. This comprehensive review is intended to encourage public health authorities and scientific communities to actively work on diagnosing, preventing, and treating MAYV infection.
C1 [Acosta-Ampudia, Yeny; Monsalve, Diana M.; Rodriguez, Yhojan; Pacheco, Yovana; Anaya, Juan-Manuel; Ramirez-Santana, Carolina] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota 111221, Colombia.
RP Ramirez-Santana, C (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Bogota 111221, Colombia.
EM heily.ramirez@urosario.edu.co
RI Pacheco Nieva, Yovana/J-2932-2018; Acosta-Ampudia, Yeny/J-2401-2016;
   Monsalve, Diana M./J-2374-2016; Ramirez-Santana, Carolina/J-2363-2016
OI Pacheco Nieva, Yovana/0000-0002-0722-546X; Acosta-Ampudia,
   Yeny/0000-0001-8491-9134; Monsalve, Diana M./0000-0002-1145-1312;
   Ramirez-Santana, Carolina/0000-0003-2137-4899
FU Universidad del Rosario, Bogota, Colombia [ABN011]
FX The authors are grateful to the members of the Center for Autoimmune
   Diseases Research (CREA) for fruitful discussions. This work was
   supported by the Universidad del Rosario (ABN011), Bogota, Colombia.
CR Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Amorim R, 2017, ARCH VIROL, V162, P1577, DOI 10.1007/s00705-017-3261-0
   Anantapreecha S, 2007, JPN J INFECT DIS, V60, P267
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Assuncao-Miranda I, 2013, BIOMED RES INT, DOI 10.1155/2013/973516
   Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   BUCKLEY SM, 1972, B WORLD HEALTH ORGAN, V46, P451
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   Camini FC, 2017, VIRUS RES, V236, P1, DOI 10.1016/j.virusres.2017.04.017
   Carney RM, 2011, EMERG INFECT DIS, V17, P1445, DOI 10.3201/eid1708.100411
   Carvalho CAM, 2017, PEERJ, V5, DOI 10.7717/peerj.3245
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Cavalheiro MG, 2016, AN ACAD BRAS CIENC, V88, P1485, DOI 10.1590/0001-3765201620150685
   Chen Z., 2013, JBI DATABASE SYST RE, V11, P56
   Coimbra Terezinha Lisieux M., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P221, DOI 10.1590/S0036-46652007000400005
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Thoisy B, 2003, EMERG INFECT DIS, V9, P1326
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   FIGUEIREDO LTM, 1989, MEM I OSWALDO CRUZ, V84, P303, DOI 10.1590/S0074-02761989000300003
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Friedrich-Janicke B, 2014, EMERG INFECT DIS, V20, P1255, DOI 10.3201/eid2007.140043
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   GREISERWILKE I, 1989, J GEN VIROL, V70, P743, DOI 10.1099/0022-1317-70-3-743
   GROOT H, 1961, AM J TROP MED HYG, V10, P397, DOI 10.4269/ajtmh.1961.10.397
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hassing RJ, 2010, J INFECTION, V61, P343, DOI 10.1016/j.jinf.2010.06.009
   Heise MT, 2000, J VIROL, V74, P9294, DOI 10.1128/JVI.74.19.9294-9299.2000
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Izurieta RO, 2011, J GLOB INFECT DIS, V3, P317, DOI 10.4103/0974-777X.91049
   Jacups SP, 2011, J MED ENTOMOL, V48, P453, DOI 10.1603/ME10193
   Juarez D, 2013, J VIROL METHODS, V187, P185, DOI 10.1016/j.jviromet.2012.09.026
   Junt T, 1999, EPIDEMIOL INFECT, V123, P511, DOI 10.1017/S0950268899003180
   KARBAAT J, 1964, TROP GEOGR MED, V16, P370
   LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   LEDUC JW, 1981, AM J TROP MED HYG, V30, P682, DOI 10.4269/ajtmh.1981.30.682
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   Mackay IM, 2016, MICROBES INFECT, V18, P724, DOI 10.1016/j.micinf.2016.10.007
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Masclee GMC, 2014, GASTROENTEROLOGY, V147, P784, DOI 10.1053/j.gastro.2014.06.007
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   MCGILL PE, 1995, BAILLIERE CLIN RHEUM, V9, P145
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Napoleao-Pego P, 2014, J HUM VIROL RETROVIR, V1, P18
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Okamoto KW, 2012, J THEOR BIOL, V309, P47, DOI 10.1016/j.jtbi.2012.05.020
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Receveur M. C., 2010, EUROSURVEILLANCE, V15, P18
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Santiago FW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004104
   SCHAEFFER M, 1959, AM J TROP MED HYG, V8, P372, DOI 10.4269/ajtmh.1959.8.372
   Slegers CAD, 2014, J CLIN VIROL, V60, P317, DOI 10.1016/j.jcv.2014.04.020
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   SRIHONGSE S, 1973, MIL MED, V138, P422
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Talarmin A, 1998, AM J TROP MED HYG, V59, P452, DOI 10.4269/ajtmh.1998.59.452
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Taylor SF, 2005, SOUTH MED J, V98, P484, DOI 10.1097/01.SMJ.0000145879.14102.F4
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
   Theilacker C, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-369
   Torres JR, 2004, EMERG INFECT DIS, V10, P1304
   Waggoner JJ, 2018, J CLIN VIROL, V98, P1, DOI 10.1016/j.jcv.2017.11.006
   Wang E, 2006, J CLIN MICROBIOL, V44, P4000, DOI 10.1128/JCM.00175-06
   Weise WJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002969
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 79
TC 23
Z9 23
U1 1
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 26
PY 2018
VL 7
AR 163
DI 10.1038/s41426-018-0163-5
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GW1LL
UT WOS:000446640100005
PM 30254258
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Touret, F
   Gilles, M
   Klitting, R
   Aubry, F
   de Lamballerie, X
   Nougairede, A
AF Touret, Franck
   Gilles, Magali
   Klitting, Raphaelle
   Aubry, Fabien
   de Lamballerie, Xavier
   Nougairede, Antoine
TI Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D
   attenuated backbone
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID TETRAVALENT DENGUE VACCINE; T-CELL RESPONSES; MICE; INFECTION; SAFETY;
   IMMUNOGENICITY; ENCEPHALITIS; PROTECTION; DISEASE; MODELS
AB Zika virus (ZIKV) has recently become dispersed throughout the tropics and sub-tropics, causing epidemics associated with congenital disease and neurological complications. There is currently no commercial vaccine for ZIKV. In this study, we describe the initial development of a chimeric virus containing the prM/E proteins of a ZIKV epidemic strain incorporated into a yellow fever 17-D attenuated backbone. Using the versatile and rapid ISA (Infectious Subgenomic Amplicons) reverse genetics method, we compared different constructs and confirmed the need to modify the cleavage site between the pre-peptide and prM protein. Genotypic characterization of the chimeras indicated that the emergence of compensatory mutations in the E protein was required to restore viral replicative fitness. Using an immunocompromised mouse model, we demonstrated that mice infected with the chimeric virus produced levels of neutralizing antibodies that were close to those observed following infection with ZIKV. Furthermore, pre-immunized mice were protected against viscerotropic and neuroinvasive disease following challenge with a heterologous ZIKV strain. These data provide a sound basis for the future development of this ZIKV vaccine candidate.
C1 [Touret, Franck; Gilles, Magali; Klitting, Raphaelle; Aubry, Fabien; de Lamballerie, Xavier; Nougairede, Antoine] Aix Marseille Univ, IHU Mediterranee Infect, Inserm 1207, IRD 190,UVE, Marseille, France.
RP Touret, F; Nougairede, A (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, Inserm 1207, IRD 190,UVE, Marseille, France.
EM franck.touret@hotmail.fr; antoine.nougairede@univ-amu.fr
OI Touret, Franck/0000-0002-4734-2249
FU French "Agence Nationale de la Recherche"French National Research Agency
   (ANR) [ANR-14-CE14-0001]; European Virus Archive goes global project
   (EVAg; European Union-Horizon 2020 programme) [653316]
FX We thank Ernest A. Gould from the UMR UVE (Marseille, France) for his
   valuable review of the manuscript. We also thank Geraldine Piorkowski
   and Karine Barthelemy from the UMR UVE (Marseille, France) for
   performing viral sequencing. This work was supported by the French
   "Agence Nationale de la Recherche" (grant agreement no.
   ANR-14-CE14-0001) and the European Virus Archive goes global project
   (EVAg; European Union-Horizon 2020 programme under grant agreement no.
   653316; http://www.european-virusarchive.com/).
CR Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Atieh T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14522-6
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Bradley MP, 2017, COMPARATIVE MED, V67, P242
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chin R, 2013, INFECT DIS THER, V2, P145, DOI 10.1007/s40121-013-0018-2
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Delang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31819
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Minor PD, 2015, VIROLOGY, V479, P379, DOI 10.1016/j.virol.2015.03.032
   Monath TP, 2015, VACCINE, V33, P62, DOI 10.1016/j.vaccine.2014.10.004
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   Monath TP, 2002, VACCINE, V20, P1004, DOI 10.1016/S0264-410X(01)00457-1
   Monath TP, 2002, J VIROL, V76, P1932, DOI 10.1128/JVI.76.4.1932-1943.2002
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Touret F, 2014, MBIO, V5, DOI 10.1128/mBio.01529-14
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 43
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD SEP 26
PY 2018
VL 7
AR 161
DI 10.1038/s41426-018-0161-7
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GW1LL
UT WOS:000446640100003
PM 30254297
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Van Hoeven, N
   Wiley, S
   Gage, E
   Fiore-Gartland, A
   Granger, B
   Gray, S
   Fox, C
   Clements, DE
   Parks, DE
   Winram, S
   Stinchcomb, DT
   Reed, SG
   Coler, RN
AF Van Hoeven, Neal
   Wiley, Steven
   Gage, Emily
   Fiore-Gartland, Andrew
   Granger, Brian
   Gray, Sean
   Fox, Christopher
   Clements, David E.
   Parks, D. Elliot
   Winram, Scott
   Stinchcomb, Dan T.
   Reed, Steven G.
   Coler, Rhea N.
TI A combination of TLR-4 agonist and saponin adjuvants increases antibody
   diversity and protective efficacy of a recombinant West Nile Virus
   antigen
SO NPJ VACCINES
LA English
DT Article
ID HIGHLY POTENT; UNITED-STATES; VACCINE; PROTEIN; IMMUNOGENICITY;
   INFECTION; IDENTIFICATION; MECHANISMS; RESPONSES; IMMUNITY
AB Members of the Flaviviridae family are the leading causes of mosquito-borne viral disease worldwide. While dengue virus is the most prevalent, the recent Zika virus outbreak in the Americas triggered a WHO public health emergency, and yellow fever and West Nile viruses (WNV) continue to cause regional epidemics. Given the sporadic nature of flaviviral epidemics both temporally and geographically, there is an urgent need for vaccines that can rapidly provide effective immunity. Protection from flaviviral infection is correlated with antibodies to the viral envelope (E) protein, which encodes receptor binding and fusion functions. TLR agonist adjuvants represent a promising tool to enhance the protective capacity of flavivirus vaccines through dose and dosage reduction and broadening of antiviral antibody responses. This study investigates the ability to improve the immunogenicity and protective capacity of a promising clinical-stage WNV recombinant E-protein vaccine (WN-80E) using a novel combination adjuvant, which contains a potent TLR-4 agonist and the saponin QS21 in a liposomal formulation (SLA-LSQ). Here, we show that, in combination with WN-80E, optimized SLA-LSQ is capable of inducing long-lasting immune responses in preclinical models that provide sterilizing protection from WNV challenge, reducing viral titers following WNV challenge to undetectable levels in Syrian hamsters. We have investigated potential mechanisms of action by examining the antibody repertoire generated post-immunization. SLA-LSQ induced a more diverse antibody response to WNV recombinant E-protein antigen than less protective adjuvants. Collectively, these studies identify an adjuvant formulation that enhances the protective capacity of recombinant flavivirus vaccines.
C1 [Van Hoeven, Neal; Gage, Emily; Granger, Brian; Fox, Christopher; Stinchcomb, Dan T.; Reed, Steven G.; Coler, Rhea N.] Infect Dis Res Inst, 1616 Eastlake Ave E,Suite 400, Seattle, WA 98102 USA.
   [Van Hoeven, Neal; Gage, Emily; Fox, Christopher; Reed, Steven G.; Coler, Rhea N.] Univ Washington, Dept Global Hlth, Pathobiol Program, Seattle, WA 98195 USA.
   [Wiley, Steven] Imdaptive Inc, 3010 Northwest 56th St, Seattle, WA 98107 USA.
   [Fiore-Gartland, Andrew] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave, Seattle, WA 98109 USA.
   [Gray, Sean; Coler, Rhea N.] PAI Life Sci Inc, 1616 Eastlake Ave,Suite 250, Seattle, WA 98102 USA.
   [Clements, David E.; Parks, D. Elliot] Hawaii Biotech Inc, 99-193 Aiea Hts Dr, Aiea, HI 96701 USA.
   [Winram, Scott] Leidos Inc, 11951 Freedom Dr, Reston, VA 20190 USA.
RP Van Hoeven, N (corresponding author), Infect Dis Res Inst, 1616 Eastlake Ave E,Suite 400, Seattle, WA 98102 USA.; Van Hoeven, N (corresponding author), Univ Washington, Dept Global Hlth, Pathobiol Program, Seattle, WA 98195 USA.
EM neal.vanhoeven@idri.org
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272201300029C]
FX The project described has been funded in whole or in part with Federal
   funds from the National Institute of Allergy and Infectious Diseases,
   National Institutes of Health, Department of Health and Human Services,
   under Contract No. HHSN272201300029C.
CR Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008
   Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384
   Brandler S, 2012, J INFECT DIS, V206, P212, DOI 10.1093/infdis/jis328
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Carter D, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.63
   CDC, 2013, W NIL VIR FIN MAPS D
   Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699
   Coller B. A, 2012, United States patent application, Patent No. [US20120141520A1, 20120141520]
   Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Desbien AL, 2016, J IMMUNOL, V197, P4351, DOI 10.4049/jimmunol.1600993
   Desbien AL, 2015, EUR J IMMUNOL, V45, P407, DOI 10.1002/eji.201444543
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Gershman MD, 2017, MMWR-MORBID MORTAL W, V66, P457, DOI 10.15585/mmwr.mm6617e2
   Gray SA, 2016, ANTIVIR RES, V131, P100, DOI 10.1016/j.antiviral.2016.04.001
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204
   Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200
   Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087
   Kim DY, 2014, P NATL ACAD SCI USA, V111, P10708, DOI 10.1073/pnas.1408677111
   Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Marty-Roix R, 2016, J BIOL CHEM, V291, P1123, DOI 10.1074/jbc.M115.683011
   McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156
   Muraki Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0282-8
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12
   Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409
   Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Van Hoeven N, 2017, SCI REP-UK, V7, DOI 10.1038/srep46426
   Van Hoeven N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149610
   Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208
   Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310
   Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135
   Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064
NR 50
TC 0
Z9 0
U1 0
U2 7
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD SEP 26
PY 2018
VL 3
AR 39
DI 10.1038/s41541-018-0077-1
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GV7AK
UT WOS:000446273200001
PM 30302281
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Blom, K
   Cuapio, A
   Sandberg, JT
   Varnaite, R
   Michaelsson, J
   Bjorkstrom, NK
   Sandberg, JK
   Klingstrom, J
   Lindquist, L
   Russ, SG
   Ljunggren, HG
AF Blom, Kim
   Cuapio, Angelica
   Sandberg, J. Tyler
   Varnaite, Renata
   Michaelsson, Jakob
   Bjorkstrom, Niklas K.
   Sandberg, Johan K.
   Klingstrom, Jonas
   Lindquist, Lars
   Russ, Sara Gredmark
   Ljunggren, Hans-Gustaf
TI Cell-Mediated Immune Responses and Immunopathogenesis of Human
   Tick-Borne Encephalitis Virus-Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE cell-mediated immunity; flavivirus; NK cells; T cells; tick-borne
   encephalitis; tick-borne encephalitis virus; viral immunopathogenesis
ID NATURAL-KILLER-CELLS; BLOOD-BRAIN-BARRIER; CD8(+) T-CELLS;
   ANTIBODY-DEPENDENT ENHANCEMENT; CENTRAL-NERVOUS-SYSTEM; WEST NILE VIRUS;
   TERM-FOLLOW-UP; DENGUE VIRUS; NK CELLS; ZIKA VIRUS
AB Tick-borne encephalitis virus (TBEV) is a flavivirus that belongs to the Flaviviridae family. TBEV is transmitted to humans primarily from infected ticks. The virus causes tick-borne encephalitis (TBE), an acute viral disease that affects the central nervous system (CNS). Infection can lead to acute neurological symptoms of significant severity due to meningitis or meningo(myelo) encephalitis. TBE can cause long-term suffering and has been recognized as an increasing public health problem. TBEV-affected areas currently include large parts of central and northern Europe as well as northern Asia. Infection with TBEV triggers a humoral as well as a cell-mediated immune response. In contrast to the well-characterized humoral antibody-mediated response, the cell-mediated immune responses elicited to natural TBEV-infection have been poorly characterized until recently. Here, we review recent progress in our understanding of the cell-mediated immune response to human TBEV-infection. A particular emphasis is devoted to studies of the response mediated by natural killer (NK) cells and CD8T cells. The studies described include results revealing the temporal dynamics of the T cell-as well as NK cell-responses in relation to disease state and functional characterization of these cells. Additionally, we discuss specific immunopathological aspects of TBEV-infection in the CNS.
C1 [Blom, Kim; Cuapio, Angelica; Sandberg, J. Tyler; Varnaite, Renata; Michaelsson, Jakob; Bjorkstrom, Niklas K.; Sandberg, Johan K.; Klingstrom, Jonas; Russ, Sara Gredmark; Ljunggren, Hans-Gustaf] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden.
   [Lindquist, Lars; Russ, Sara Gredmark] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.
   [Lindquist, Lars] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.
RP Blom, K; Ljunggren, HG (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden.
EM kim.blom@ki.se; hans-gustaf.ljunggren@ki.se
RI Bjorkstrom, Niklas/N-2919-2017
OI Bjorkstrom, Niklas/0000-0002-0967-076X; Blom, Kim/0000-0002-5286-3735;
   Sandberg, John Tyler/0000-0001-6747-6933; Klingstrom,
   Jonas/0000-0001-9076-1441; Sandberg, Johan/0000-0002-6275-0750
FU Swedish Research CouncilSwedish Research Council; Swedish Foundation for
   Strategic ResearchSwedish Foundation for Strategic Research; Karolinska
   InstitutetKarolinska Institutet; Stockholm County CouncilStockholm
   County Council
FX The authors were founded by the Swedish Research Council, the Swedish
   Foundation for Strategic Research, Karolinska Institutet and the
   Stockholm County Council.
CR Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030
   Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802
   Andersson CR, 2010, VACCINE, V28, P2827, DOI 10.1016/j.vaccine.2010.02.001
   Appay V, 2004, SEMIN IMMUNOL, V16, P205, DOI 10.1016/j.smim.2004.02.007
   Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   AVSICZUPANC T, 1995, CLIN DIAGN VIROL, V4, P51, DOI 10.1016/0928-0197(94)00062-Y
   Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x
   Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031
   Beran J, 2014, VACCINE, V32, P4275, DOI 10.1016/j.vaccine.2014.06.028
   Bily T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10745
   Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189
   BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605
   Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762
   Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675
   Blom K, 2017, J INTERN MED, V282, P206, DOI 10.1111/joim.12638
   Blom K, 2016, J IMMUNOL, V197, P2762, DOI 10.4049/jimmunol.1600950
   Blom K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004622
   Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234
   Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265
   CALISHER CH, 1988, ACTA VIROL, V32, P469
   Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395
   Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118
   Cichocki F, 2016, CURR TOP MICROBIOL, V395, P63, DOI 10.1007/82_2015_487
   Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9
   Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4
   Donoso Mantke O, 2011, EUROSURVEILLANCE, P16
   ECDC, 2012, EP SIT TICK BORN ENC
   Ehrlich HJ, 2003, VACCINE, V22, P217, DOI 10.1016/S0264-410X(03)00563-2
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fauriat C, 2010, BLOOD, V115, P2167, DOI 10.1182/blood-2009-08-238469
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746
   Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54
   Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230
   Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058
   Gunther G, 1997, CLIN DIAGN VIROL, V8, P17, DOI 10.1016/S0928-0197(97)00273-0
   Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3
   Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012
   Heinz FX, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.es2015.20.13.21077
   Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458
   HEINZ FXC, 2000, FAMILY FLAVIVIRIDAE
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Holzmann H, 2003, VACCINE, V21, pS36, DOI 10.1016/S0264-410X(02)00819-8
   Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003673
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Kaech SM, 2001, NAT IMMUNOL, V2, P415
   Kohl I, 1996, EUR J EPIDEMIOL, V12, P373, DOI 10.1007/BF00145300
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kulakowska A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0193-4
   Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002
   Lehrer Axel T, 2011, J Bioterror Biodef, V2011, P3
   Lim DSL, 2014, J IMMUNOL, V193, P5065, DOI 10.4049/jimmunol.1302240
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x
   Loew-Baselli A, 2006, VACCINE, V24, P5256, DOI 10.1016/j.vaccine.2006.03.061
   Loew-Baselli A, 2011, VACCINE, V29, P7307, DOI 10.1016/j.vaccine.2011.07.089
   Lotric-Furlan S, 2017, J INTERN MED, V282, P142, DOI 10.1111/joim.12625
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Marquardt N, 2015, J IMMUNOL, V195, P3262, DOI 10.4049/jimmunol.1401811
   Martin R, 2014, CURR TOP MICROBIOL, V378, P149, DOI 10.1007/978-3-319-05879-5_7
   McAuley AJ, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0009-5
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   McMinn PC, 1997, J GEN VIROL, V78, P2711, DOI 10.1099/0022-1317-78-11-2711
   Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Silva JRN, 2011, VACCINE, V29, P6327, DOI 10.1016/j.vaccine.2011.05.019
   Negi N, 2018, INT REV IMMUNOL, V37, P57, DOI 10.1080/08830185.2017.1357719
   O'Sullivan TE, 2015, IMMUNITY, V43, P634, DOI 10.1016/j.immuni.2015.09.013
   Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953
   Petitdemange C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002268
   PHILLPOTTS RJ, 1985, J GEN VIROL, V66, P1831, DOI 10.1099/0022-1317-66-8-1831
   Plotkin S.A., 2012, VACCINES
   PuchhammerStockl E, 1995, CLIN DIAGN VIROL, V4, P321, DOI 10.1016/0928-0197(95)00022-4
   Randolph SE, 2010, EUROSURVEILLANCE, V15, P24
   Roos MTL, 2000, J INFECT DIS, V182, P451, DOI 10.1086/315737
   Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   SCHNEIDER H, 1931, WIEN KLIN WOCHENSCHR, V44, P350
   Schondorf I, 2007, VACCINE, V25, P1470, DOI 10.1016/j.vaccine.2006.10.028
   Schuler M, 2014, EUROSURVEILLANCE, V19, P39, DOI 10.2807/1560-7917.ES2014.19.13.20756
   Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033
   Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707
   Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stegmann KA, 2012, J INFECT DIS, V205, P1351, DOI 10.1093/infdis/jis210
   Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069
   Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722
   Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500
   Taba P, 2017, EUR J NEUROL, V24, P1214, DOI 10.1111/ene.13356
   Tomazic J, 1997, ACTA NEUROL SCAND, V95, P29, DOI 10.1111/j.1600-0404.1997.tb00064.x
   TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582
   Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   World Health Organization, 2017, TICK BORNE ENCEPHALI
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zeman P, 2010, TICKS TICK-BORNE DIS, V1, P129, DOI 10.1016/j.ttbdis.2010.05.003
   Zhang MJ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-3
NR 119
TC 6
Z9 6
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 26
PY 2018
VL 9
AR 2174
DI 10.3389/fimmu.2018.02174
PG 10
WC Immunology
SC Immunology
GA GU9JC
UT WOS:000445660600001
PM 30319632
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Laureti, M
   Narayanan, D
   Rodriguez-Andres, J
   Fazakerley, JK
   Kedzierski, L
AF Laureti, Mathilde
   Narayanan, Divya
   Rodriguez-Andres, Julio
   Fazakerley, John K.
   Kedzierski, Lukasz
TI Flavivirus Receptors: Diversity, Identity, and Cell Entry
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE flaviviruses; Japanese encephalitis virus; Zika virus (ZIKV); dengue
   virus; yellow fever virus; entry receptor
ID JAPANESE ENCEPHALITIS-VIRUS; NEURAL PROGENITOR CELLS; WEST-NILE;
   DC-SIGN; INFECTION ENHANCEMENT; CEREBRAL ORGANOIDS; LIPID RAFTS;
   VIMENTIN; BRAIN; IDENTIFICATION
AB Flaviviruses are emerging and re-emerging arthropod-borne pathogens responsible for significant mortality and morbidity worldwide. The genus comprises more than seventy small, positive-sense, single-stranded RNA viruses, which are responsible for a spectrum of human and animal diseases ranging in symptoms from mild, in fluenza-like infection to fatal encephalitis and haemorrhagic fever. Despite genomic and structural similarities across the genus, infections by different flaviviruses result in disparate clinical presentations. This review focusses on two haemorrhagic flaviviruses, dengue virus and yellow fever virus, and two neurotropic flaviviruses, Japanese encephalitis virus and Zika virus. We review current knowledge on host-pathogen interactions, virus entry strategies and tropism.
C1 [Laureti, Mathilde; Narayanan, Divya; Rodriguez-Andres, Julio; Fazakerley, John K.; Kedzierski, Lukasz] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
   [Laureti, Mathilde; Narayanan, Divya; Rodriguez-Andres, Julio; Fazakerley, John K.; Kedzierski, Lukasz] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia.
RP Kedzierski, L (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kedzierski, L (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia.
EM lukaszk@unimelb.edu.au
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465
   Alhoot MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034060
   Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410
   Aoki C, 2006, J BIOCHEM, V139, P607, DOI 10.1093/jb/mvj067
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Burudi EME, 1999, GLIA, V25, P44, DOI 10.1002/(SICI)1098-1136(19990101)25:1<44::AID-GLIA5>3.0.CO;2-C
   Cabrera-Hernandez A, 2007, J MED VIROL, V79, P386, DOI 10.1002/jmv.20786
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-35
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Che PL, 2013, VIROLOGY, V446, P303, DOI 10.1016/j.virol.2013.08.009
   Chee HY, 2004, BIOCHEM BIOPH RES CO, V320, P11, DOI 10.1016/j.bbrc.2004.05.124
   Chen CJ, 2014, J VIROL, V88, P1150, DOI 10.1128/JVI.02738-13
   Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Chiang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30648
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Chuang CK, 2015, J GEN VIROL, V96, P793, DOI 10.1099/jgv.0.000015
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Das S, 2011, VIRUS RES, V160, P404, DOI 10.1016/j.virusres.2011.06.001
   Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x
   Das S, 2010, J NEUROCHEM, V115, P537, DOI 10.1111/j.1471-4159.2010.06951.x
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fan WC, 2017, RES VET SCI, V111, P67, DOI 10.1016/j.rvsc.2016.12.007
   Fernandez-Garcia MD, 2016, MBIO, V7, DOI 10.1128/mBio.01956-15
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124
   Gao F, 2010, BIOCHEM BIOPH RES CO, V391, P952, DOI 10.1016/j.bbrc.2009.11.172
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   GOLLINS SW, 1984, J GEN VIROL, V65, P1261, DOI 10.1099/0022-1317-65-8-1261
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hoving JC, 2014, CELL MICROBIOL, V16, P185, DOI 10.1111/cmi.12249
   Hung CY, 2011, J GEN VIROL, V92, P2803, DOI 10.1099/vir.0.033993-0
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kalita J, 2000, J NEUROL SCI, V174, P3, DOI 10.1016/S0022-510X(99)00318-4
   Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002
   Khan AG, 2010, J VIROL, V84, P3984, DOI 10.1128/JVI.01693-09
   KIMURAKURODA J, 1993, ARCH VIROL, V130, P477, DOI 10.1007/BF01309676
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Kumar S, 2009, BRAIN RES, V1268, P135, DOI 10.1016/j.brainres.2009.02.051
   Lannes N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0931-5
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Li F, 2015, J VIROL, V89, P5602, DOI 10.1128/JVI.00143-15
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Liu CC, 2017, J VIROL, V91, DOI [10.1128/JVI.01113-17, 10.1128/jvi.01113-17]
   Liu P, 2017, TRAFFIC, V18, P218, DOI 10.1111/tra.12469
   Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200
   Lo YL, 2016, PLOS ONE, V1, DOI 10.1371/journal.pone.0166474
   Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mandl JN, 2011, J IMMUNOL, V186, P6406, DOI 10.4049/jimmunol.1001191
   Martin CSS, 2004, J VIROL, V78, P2310, DOI 10.1128/JVI.78.5.2310-2318.2004
   MATHUR A, 1988, BRIT J EXP PATHOL, V69, P423
   Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Ly MHP, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2894-7
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Mukhtar M, 2002, VIROLOGY, V297, P78, DOI 10.1006/viro.2002.1376
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   Myint KSA, 1999, AM J TROP MED HYG, V60, P338, DOI 10.4269/ajtmh.1999.60.338
   Nagata N, 2015, J NEUROPATH EXP NEUR, V74, P250, DOI 10.1097/NEN.0000000000000166
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   Nain M, 2016, REV MED VIROL, V26, P129, DOI 10.1002/rmv.1868
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Noisakran S, 2010, ADV VIROL, V2010, DOI 10.1155/2010/164878
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Vega-Almeida TO, 2013, ARCH VIROL, V158, P1189, DOI 10.1007/s00705-012-1596-0
   Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002
   Prieto AL, 2000, J COMP NEUROL, V425, P295
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0006191
   Ren JP, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-83
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sapkal GN, 2007, AM J TROP MED HYG, V77, P1139, DOI 10.4269/ajtmh.2007.77.1139
   Seligman SJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-27
   SHARMA S, 1991, CLIN EXP IMMUNOL, V85, P85, DOI 10.1111/j.1365-2249.1991.tb05687.x
   Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002
   Simanjuntak Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00651
   Simon LV, 2018, STATPEARLS
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Srisutthisamphan K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22639-5
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   SUCHARIT S, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P611
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829
   THEIN S, 1993, J MED VIROL, V40, P102, DOI 10.1002/jmv.1890400205
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013
   Todorich B, 2008, J NEUROCHEM, V107, P1495, DOI 10.1111/j.1471-4159.2008.05678.x
   Tripathi NK, 2011, BIOTECHNOL J, V6, P604, DOI 10.1002/biot.201000399
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   Wang KZ, 2016, INT J BIOL SCI, V12, P872, DOI 10.7150/ijbs.15641
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2018, DENG SEV DENG
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Wu YP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-128
   Xu QQ, 2016, FUTURE MICROBIOL, V11, P1227, DOI 10.2217/fmb-2016-0002
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0
NR 168
TC 16
Z9 17
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 26
PY 2018
VL 9
AR 2180
DI 10.3389/fimmu.2018.02180
PG 11
WC Immunology
SC Immunology
GA GU9JF
UT WOS:000445660900001
PM 30319635
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Drews, E
   Adam, A
   Htoo, P
   Townsley, E
   Mathew, A
AF Drews, Elena
   Adam, Awadalkareem
   Htoo, Phone
   Townsley, Elizabeth
   Mathew, Anuja
TI Upregulation of HLA-E by dengue and not Zika viruses
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Article
DE dengue fever; HLA-E; natural killer; NKG2a
ID HEMORRHAGIC-FEVER; ENDOTHELIAL-CELLS; EXPRESSION; ASSOCIATION;
   INFECTION; RESPONSES; CYTOKINE; INNATE; MICA
AB Introduction. The most severe form of dengue virus (DENV) illness, dengue haemorrhagic fever, is characterised by plasma leakage and increased vascular permeability. Objectives. Given the critical role that endothelial cells play in the pathogenesis of DENV, we wanted to determine whether infection with DENV altered the expression of MHC class I related genes including HLA-E. Results. In this study, we provide evidence that HLA-E but not MICA/8 or HLA-G is upregulated by all four serotypes of DENV in an endothelial cell line human microvascular endothelial cells (HMEC)-1. In contrast, Zika virus (ZIKV), a related flavivirus, where plasma leakage is not a major manifestation of disease, did not upregulate HLA-E. We found modest levels of soluble HLA-E in supernatants from DENV but not ZIKV-infected cells. Coculture experiments found minimal activation of natural killer (NK) cells in the presence of both uninfected and infected HMEC-1 cells. HLA-E induced by DENV infection could not dampen the degranulation of activated NK cells by interacting with its ligand NKG2a. Conclusions. Our results suggest that while DENV infection induces HLA-E, the high MHC class I expression on uninfected and infected HMEC-1 cells may dominate the diverse signals generated between inhibitory and activating receptors on NK cells and ligands on target cells.
C1 [Drews, Elena; Townsley, Elizabeth; Mathew, Anuja] Univ Massachusetts, Med Sch, Div Infect Dis & Immunol, Worcester, MA 01605 USA.
   [Adam, Awadalkareem; Htoo, Phone; Mathew, Anuja] Univ Rhode Isl, Inst Immunol & Informat, Dept Cell & Mol Biol, Room 334B,80 Washington St, Providence, RI 02903 USA.
RP Mathew, A (corresponding author), Univ Rhode Isl, Inst Immunol & Informat, Dept Cell & Mol Biol, Room 334B,80 Washington St, Providence, RI 02903 USA.
EM mathewa@uri.edu
RI Mathew, Anuja/V-6711-2019
OI Mathew, Anuja/0000-0002-6752-009X; Drews, Elena/0000-0003-0607-4003
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI113479]
FX This manuscript is supported by grant R21AI113479 from the NIH/NIAID.
CR BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519
   Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213
   Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006
   Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12
   Freud AG, 2017, IMMUNITY, V47, P820, DOI 10.1016/j.immuni.2017.10.008
   Garcia G, 2011, HUM IMMUNOL, V72, P904, DOI 10.1016/j.humimm.2011.06.010
   Gavlovsky PJ, 2016, HUM IMMUNOL, V77, P1084, DOI 10.1016/j.humimm.2016.02.007
   Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072
   Iwaszko M, 2011, ARCH IMMUNOL THER EX, V59, P353, DOI 10.1007/s00005-011-0137-y
   Joosten SA, 2016, J IMMUNOL RES, DOI 10.1155/2016/2695396
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Libraty DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098509
   Maki G, 2001, J HEMATOTH STEM CELL, V10, P369, DOI 10.1089/152581601750288975
   Nightingale ZD, 2008, J LEUKOCYTE BIOL, V84, P1028, DOI 10.1189/jlb.0208105
   Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499
   Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319
   Shwetank, 2014, IMMUNOL LETT, V162, P94, DOI 10.1016/j.imlet.2014.07.010
   Shwetank, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079197
   Siren J, 2004, J GEN VIROL, V85, P2357, DOI 10.1099/vir.0.80105-0
   Srikiatkhachorn A, 2007, PEDIATR INFECT DIS J, V26, P283, DOI 10.1097/01.inf.0000258612.26743.10
   Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1
   Sullivan LC, 2008, TISSUE ANTIGENS, V72, P415, DOI 10.1111/j.1399-0039.2008.01138.x
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Townsley E, 2016, CLIN EXP IMMUNOL, V183, P419, DOI 10.1111/cei.12722
   Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818
   Zidi I, 2016, HLA, V87, P153, DOI 10.1111/tan.12767
NR 26
TC 4
Z9 4
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PD SEP 25
PY 2018
VL 7
IS 9
AR e1039
DI 10.1002/cti2.1039
PG 8
WC Immunology
SC Immunology
GA GV6WJ
UT WOS:000446258800001
PM 30263117
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thornton, J
AF Thornton, Jacqui
TI Mothers of Zika babies make a splash
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
NR 1
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD SEP 25
PY 2018
VL 362
AR k4037
DI 10.1136/bmj.k4037
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV6LX
UT WOS:000446223700006
PM 30254069
DA 2020-07-08
ER

PT J
AU de Noronha, L
   Zanluca, C
   Burger, M
   Suzukawa, AA
   Azevedo, M
   Rebutini, PZ
   Novadzki, IM
   Tanabe, LS
   Presibella, MM
   dos Santos, CND
AF de Noronha, Lucia
   Zanluca, Camila
   Burger, Marion
   Suzukawa, Andreia Akemi
   Azevedo, Marina
   Rebutini, Patricia Z.
   Novadzki, Iolanda Maria
   Tanabe, Laurina Setsuko
   Presibella, Mayra Marinho
   Duarte dos Santos, Claudia Nunes
TI Zika Virus Infection at Different Pregnancy Stages: Anatomopathological
   Findings, Target Cells and Viral Persistence in Placental Tissues
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; vertical transmission; placenta; anatomopathological
   analysis; Hofbauer cells; morphometric analysis
ID HOFBAUER CELLS; PATHOLOGY; BRAZIL; REPLICATION; MICRONESIA; ASSAY
AB Zika virus (ZIKV) infection in humans has been associated with congenital malformations and other neurological disorders, such as Guillain-Barre syndrome. The mechanism(s) of ZIKV intrauterine transmission, the cell types involved, the most vulnerable period of pregnancy for severe outcomes from infection and other physiopathological aspects are not completely elucidated. In this study, we analyzed placental samples obtained at the time of delivery from a group of 24 women diagnosed with ZIKV infection during the first, second or third trimesters of pregnancy. Villous immaturity was the main histological finding in the placental tissues, although placentas without alterations were also frequently observed. Significant enhancement of the number of syncytial sprouts was observed in the placentas of women infected during the third trimester, indicating the development of placental abnormalities after ZIKV infection. Hyperplasia of Hofbauer cells (HCs) was also observed in these third-trimester placental tissues, and remarkably, HCs were the only ZIKV-positive fetal cells found in the placentas studied that persisted until birth, as revealed by immunohistochemical (IHC) analysis. Thirty-three percent of women infected during pregnancy delivered infants with congenital abnormalities, although no pattern correlating the gestational stage at infection, the IHC positivity of HCs in placental tissues and the presence of congenital malformations at birth was observed. Placental tissue analysis enabled us to confirm maternal ZIKV infection in cases where serum from the acute infection phase was not available, which reinforces the importance of this technique in identifying possible causal factors of birth defects. The results we observed in the samples from naturally infected pregnant women may contribute to the understanding of some aspects of the pathophysiology of ZIKV.
C1 [de Noronha, Lucia; Azevedo, Marina; Rebutini, Patricia Z.] Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.
   [Zanluca, Camila; Suzukawa, Andreia Akemi; Duarte dos Santos, Claudia Nunes] Fundacao Oswald Cruz, Lab Virol Mol, Inst Carlos Chagas, Curitiba, Parana, Brazil.
   [Burger, Marion; Novadzki, Iolanda Maria; Tanabe, Laurina Setsuko] Secretaria Saude Estado Parana, Curitiba, Parana, Brazil.
   [Presibella, Mayra Marinho] Lab Cent Estado Parana, Curitiba, Parana, Brazil.
RP de Noronha, L (corresponding author), Pontificia Univ Catolica Parana, Lab Patol Expt, Curitiba, Parana, Brazil.; dos Santos, CND (corresponding author), Fundacao Oswald Cruz, Lab Virol Mol, Inst Carlos Chagas, Curitiba, Parana, Brazil.
EM lnno.noronha@gmail.com; claudia.dossantos@fiocruz.br
RI Rebutini, Patricia Z/I-5283-2017; Santos, Claudia Duarte
   dos/P-4868-2019; noronha, lucia/F-6339-2015
OI Rebutini, Patricia Z/0000-0002-7364-6844; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; noronha, lucia/0000-0003-0310-7164; Zanluca,
   Camila/0000-0001-7350-9105
FU Fiocruz; CNPqNational Council for Scientific and Technological
   Development (CNPq) [439968/2016-0]; CapesCAPES [481-2016
   (88887.116626/2016-01)]; Fundacao AraucariaFundacao Araucaria [CP
   04/2016]; CNPq fellowshipNational Council for Scientific and
   Technological Development (CNPq)
FX Fiocruz, CNPq (439968/2016-0), Capes Zika Fast Track 481-2016
   (88887.116626/2016-01), and Fundacao Araucaria (CP 04/2016). CD and LN
   have a CNPq fellowship.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   [Anonymous], 2017, ZIK MAC ELISA
   Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baurakiades E, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-101
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759
   International Comittee on Taxonomy of Viruses (ICTV), 2017, VIR TAX 2016 REL
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Khan S, 2000, BIOL REPROD, V62, P1075, DOI 10.1095/biolreprod62.4.1075
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Loukeris K, 2010, PEDIATR DEVEL PATHOL, V13, P305, DOI 10.2350/09-08-0692-OA.1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore K., 2014, DEV HUMAN CLIN ORIEN, P48
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Tang ZH, 2011, AM J REPROD IMMUNOL, V66, P336, DOI 10.1111/j.1600-0897.2011.01006.x
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   World Health Organization (WHO), 2017, ZIK SIT REP 2017
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 8
Z9 8
U1 3
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 25
PY 2018
VL 9
AR 2266
DI 10.3389/fmicb.2018.02266
PG 11
WC Microbiology
SC Microbiology
GA GU8JT
UT WOS:000445586100001
PM 30337910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carlin, AF
   Vizcarra, EA
   Branche, E
   Viramontes, KM
   Suarez-Amaran, L
   Ley, K
   Heinz, S
   Benner, C
   Shresta, S
   Glass, CK
AF Carlin, Aaron F.
   Vizcarra, Edward A.
   Branche, Emilie
   Viramontes, Karla M.
   Suarez-Amaran, Lester
   Ley, Klaus
   Heinz, Sven
   Benner, Christopher
   Shresta, Sujan
   Glass, Christopher K.
TI Deconvolution of pro- and antiviral genomic responses in Zika
   virus-infected and bystander macrophages
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; macrophage; immune evasion; genomics; transcription
ID TRANSCRIPTION FACTORS; SEXUAL TRANSMISSION; DENGUE VIRUS; I INTERFERON;
   RNA; ENHANCEMENT; INHIBITION; EVASION; PROTEIN; PATHOGENESIS
AB Genome-wide investigations of host-pathogen interactions are often limited by analyses of mixed populations of infected and uninfected cells, which lower sensitivity and accuracy. To overcome these obstacles and identify key mechanisms by which Zika virus (ZIKV) manipulates host responses, we developed a system that enables simultaneous characterization of genome-wide transcriptional and epigenetic changes in ZIKV-infected and neighboring uninfected primary human macrophages. We demonstrate that transcriptional responses in ZIKV-infected macrophages differed radically from those in uninfected neighbors and that studying the cell population as a whole produces misleading results. Notably, the uninfected population of macrophages exhibits the most rapid and extensive changes in gene expression, related to type I IFN signaling. In contrast, infected macrophages exhibit a delayed and attenuated transcriptional response distinguished by preferential expression of IFNB1 at late time points. Biochemical and genomic studies of infected macrophages indicate that ZIKV infection causes both a targeted defect in the type I IFN response due to degradation of STAT2 and reduces RNA polymerase II protein levels and DNA occupancy, particularly at genes required for macrophage identity. Simultaneous evaluation of transcriptomic and epigenetic features of infected and uninfected macrophages thereby reveals the coincident evolution of dominant proviral or antiviral mechanisms, respectively, that determine the outcome of ZIKV exposure.
C1 [Carlin, Aaron F.; Suarez-Amaran, Lester; Heinz, Sven; Benner, Christopher; Shresta, Sujan; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
   [Vizcarra, Edward A.; Branche, Emilie; Viramontes, Karla M.; Ley, Klaus; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
RP Shresta, S; Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.; Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
EM sujan@lji.org; ckglass@ucsd.edu
OI Heinz, Sven/0000-0002-4665-1007; Benner,
   Christopher/0000-0002-4618-0719; Glass, Christopher/0000-0003-4344-3592
FU National Institute of Diabetes and Digestive and Kidney
   Diseases/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01 DK091183, PPG DK074868];
   National Institute of Allergy and Infectious Diseases/NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI116813, R21NS100477, R21AI127988]; Interactive Fund Grant from
   Kyowa Kirin Pharmaceutical Research; NIH KL2 Grant of the Clinical and
   Translational Science Awards (CTSA) Program [1KL2TR001444]; Career Award
   for Medical Scientists from the Burroughs Wellcome FundBurroughs
   Wellcome Fund
FX We thank Dr. Aravinda de Silva (University of North Carolina School of
   Medicine, Chapel Hill) for providing dengue-immune sera. This research
   was supported by National Institute of Diabetes and Digestive and Kidney
   Diseases/NIH Grants R01 DK091183 and PPG DK074868 (to C.K.G.), National
   Institute of Allergy and Infectious Diseases/NIH Grants R01AI116813,
   R21NS100477, and R21AI127988 and an Interactive Fund Grant from Kyowa
   Kirin Pharmaceutical Research (to S.S.), and NIH KL2 Grant 1KL2TR001444
   of the Clinical and Translational Science Awards (CTSA) Program and a
   Career Award for Medical Scientists from the Burroughs Wellcome Fund (to
   A.F.C.).
CR Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45
   CRAWFORD N, 1981, CELL, V27, P555, DOI 10.1016/0092-8674(81)90397-4
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07
   Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012
   Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Harwig A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100309
   Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lin CW, 2008, VIRUS RES, V137, P49, DOI 10.1016/j.virusres.2008.05.015
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   R Development Core Team, 2013, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Thomas D, 2004, J BIOL CHEM, V279, P31471, DOI 10.1074/jbc.M400938200
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785
   Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2017, ZIK SIT REP
   Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 57
TC 8
Z9 8
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 25
PY 2018
VL 115
IS 39
BP E9172
EP E9181
DI 10.1073/pnas.1807690115
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU7XK
UT WOS:000445545200018
PM 30206152
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Tan, ZY
   Zhang, WP
   Sun, JH
   Fu, ZQ
   Ke, XL
   Zheng, CS
   Zhang, Y
   Li, PH
   Liu, Y
   Hu, QX
   Wang, HZ
   Zheng, ZH
AF Tan, Zhongyuan
   Zhang, Wanpo
   Sun, Jianhong
   Fu, Zuquan
   Ke, Xianliang
   Zheng, Caishang
   Zhang, Yuan
   Li, Penghui
   Liu, Yan
   Hu, Qinxue
   Wang, Hanzhong
   Zheng, Zhenhua
TI ZIKV infection activates the IRE1-XBP1 and ATF6 pathways of unfolded
   protein response in neural cells
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
DE Zika virus; Neural cell; Neuropathogenesis; ER stress; Unfolded protein
   response
ID ENDOPLASMIC-RETICULUM STRESS; HEPATITIS-C VIRUS; XBP1 MESSENGER-RNA; ER
   STRESS; ENTEROVIRUS 71; VIRAL REPLICATION; FLAVIVIRUS; PATHOGENESIS;
   INHIBITION; DISEASE
AB Background: Many viruses depend on the extensive membranous network of the endoplasmic reticulum (ER) for their translation, replication, and packaging. Certain membrane modifications of the ER can be a trigger for ER stress, as well as the accumulation of viral protein in the ER by viral infection. Then, unfolded protein response (UPR) is activated to alleviate the stress. Zika virus (ZIKV) is a mosquito-borne flavivirus and its infection causes microcephaly in newborns and serious neurological complications in adults. Here, we investigated ER stress and the regulating model of UPR in ZIKV-infected neural cells in vitro and in vivo.
   Methods: Mice deficient in type I and II IFN receptors were infected with ZIKV via intraperitoneal injection and the nervous tissues of the mice were assayed at 5 days post-infection. The expression of phospho-IRE1, XBP1, and ATF6 which were the key markers of ER stress were analyzed by immunohistochemistry assay in vivo. Additionally, the nuclear localization of XBP1s and ATF6n were analyzed by immunohistofluorescence. Furthermore, two representative neural cells, neuroblastoma cell line (SK-N-SH) and astrocytoma cell line (CCF-STTG1), were selected to verify the ER stress in vitro. The expression of BIP, phospho-elF2 alpha, phospho-IRE1, and ATF6 were analyzed through western blot and the nuclear localization of XBP1s was performed by confocal immunofluorescence microscopy. RT-qPCR was also used to quantify the mRNA level of the UPR downstream genes in vitro and in vivo.
   Results: ZIKV infection significantly upregulated the expression of ER stress markers in vitro and in vivo. Phospho-IRE1 and XBP1 expression significantly increased in the cerebellum and mesocephalon, while ATF6 expression significantly increased in the mesocephalon. ATF6n and XBP1s were translocated into the cell nucleus. The levels of BIP, ATF6, phospho-elf2 alpha, and spliced xbpl also significantly increased in vitro. Furthermore, the downstream genes of UPR were detected to investigate the regulating model of the UPR during ZIKV infection in vitro and in vivo. The transcriptional levels of atf4, gadd34, chop, and edem-1 in vivo and that of gadd34 and chop in vitro significantly increased.
   Conclusion: Findings in this study demonstrated that ZIKV infection activates ER stress in neural cells. The results offer clues to further study the mechanism of neuropathogenesis caused by ZIKV infection.
C1 [Tan, Zhongyuan; Sun, Jianhong; Ke, Xianliang; Zheng, Caishang; Zhang, Yuan; Li, Penghui; Liu, Yan; Wang, Hanzhong; Zheng, Zhenhua] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
   [Tan, Zhongyuan; Li, Penghui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Zhang, Wanpo; Fu, Zuquan] Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Hubei, Peoples R China.
   [Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.
RP Wang, HZ; Zheng, ZH (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
EM wanghz@wh.iov.cn; zhengzh@wh.iov.cn
OI Hu, Qinxue/0000-0002-4594-9215
FU National Key R&D Program of China [2016YFD0500406]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [81471953]; Youth Innovation Promotion Association of CAS
   [2016302]
FX This work was supported by the National Key R&D Program of China
   (2016YFD0500406 to HanzhongWang), the National Natural Science
   Foundation of China (NSFC) (NO. 81471953 to ZhenhuaZheng), and Youth
   Innovation Promotion Association of CAS (2016302 to Zhenhua Zheng).
CR Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Amici C, 2015, CELL MICROBIOL, V17, P1391, DOI 10.1111/cmi.12446
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0
   Booth L, 2016, J CELL PHYSIOL, V231, P2286, DOI 10.1002/jcp.25431
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Choy MS, 2015, CELL REP, V11, P1885, DOI 10.1016/j.celrep.2015.05.043
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gallagher CM, 2016, ELIFE, V5
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62
   Gu XW, 2016, MOL CELL ENDOCRINOL, V434, P48, DOI 10.1016/j.mce.2016.06.012
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976
   Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270
   Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149
   Isler JA, 2005, J VIROL, V79, P6890, DOI 10.1128/JVI.79.11.6890-6899.2005
   Jheng JR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00388
   Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Khajavi M, 2008, NEURON, V57, P329, DOI 10.1016/j.neuron.2008.01.017
   Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liu Y, 2016, J VIROL, V90, P10472, DOI 10.1128/JVI.01756-16
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Mercado G, 2016, BRAIN RES, V1648, P626, DOI 10.1016/j.brainres.2016.04.042
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oishi N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.108
   Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Yang W, 2016, J CEREBR BLOOD F MET, V36, P2044, DOI 10.1177/0271678X16674488
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zheng ZH, 2011, J IMMUNOL, V187, P2202, DOI 10.4049/jimmunol.1100285
NR 53
TC 12
Z9 12
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD SEP 21
PY 2018
VL 15
AR 275
DI 10.1186/s12974-018-1311-5
PG 16
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA GU4CG
UT WOS:000445228100002
PM 30241539
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Marquez-Escobar, VA
   Banuelos-Hernandez, B
   Rosales-Mendoza, S
AF Araceli Marquez-Escobar, Veronica
   Banuelos-Hernandez, Bernardo
   Rosales-Mendoza, Sergio
TI Expression of a Zika virus antigen in microalgae: Towards mucosal
   vaccine development
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Oral vaccine; Schizochytrium sp.; Microalgae; Algevir system; Mucosal
   immunogen; Subunit vaccine
ID SEXUAL TRANSMISSION; CLINICAL-TRIALS; BRAZIL; IMMUNOGENICITY;
   MICRONESIA; PROTECTION; PROTEINS; OUTBREAK; EPITOPES; PHASE-1
AB Zika virus (ZIKV) infection has extended rapidly all over the world in the last decades affecting humans of all ages, inducing severe illness such as the autoimmune Guillain-Barre syndrome as well as fetal neurodevelopmental defects. Despite the epidemiological importance of ZIKV, today there are no commercially available drugs or vaccines to combat or prevent this infection. Microalgae are attractive hosts to produce and deliver vaccines, with some candidates under preclinical evaluation. Herein, algae-based expression was assessed for the production of a new vaccine candidate against ZIKV called ZK. The Algevir technology was applied to express an antigenic protein called ZK comprising the B subunit of the heat labile Escherichia coli enterotoxin along with 3 epitopes from the ZIKV envelope glycoprotein. Efficient expression of the ZK antigen was achieved in Schizochytrium sp. with yields of up to 365 mu g g(-1) microalgae fresh weight. Upon oral administration in mice, the microalgae-made ZK protein elicited significant humoral responses at a higher magnitude to those induced upon subcutaneous immunization. The algae-made ZK vaccine represents a promising candidate to formulate attractive vaccines against ZIKV.
C1 [Araceli Marquez-Escobar, Veronica; Banuelos-Hernandez, Bernardo; Rosales-Mendoza, Sergio] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Lab Biofarmaceut Recombinantes, San Luis Potosi, Mexico.
   [Araceli Marquez-Escobar, Veronica; Banuelos-Hernandez, Bernardo; Rosales-Mendoza, Sergio] Univ Autonoma San Luis Potosi, Ctr Invest Ciencias Salud & Biomed, Secc Biotecnol, San Luis Potosi, Mexico.
RP Rosales-Mendoza, S (corresponding author), Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Ave Dr Manuel Nava 6, San Luis Potosi 78210, SLP, Mexico.
EM rosales.s@uaslp.mx
RI Banuelos-Hernandez, Bernardo/P-8851-2019
OI Banuelos-Hernandez, Bernardo/0000-0003-4399-0887
FU Consejo Nacional de Ciencia y Tecnologia, CONACYT/MexicoConsejo Nacional
   de Ciencia y Tecnologia (CONACyT) [INFR-2016-271182, 256063]
FX This work was supported by Consejo Nacional de Ciencia y Tecnologia,
   CONACYT/Mexico (grant INFR-2016-271182 and 256063 to SRM). And by
   Programa para el Desarrollo Profesional Docente (PRODEP), to VAME for
   postdoctoral stay.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Badawi MM, 2016, AM J BIOMED RES, V4, P46
   Banuelos-Hernandez B, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01100
   Bayne ACV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061790
   Beltran-Lopez JI, 2016, PLANT CELL REP, V35, P1133, DOI 10.1007/s00299-016-1946-6
   Bosch D, 2010, EXPERT REV VACCINES, V9, P835, DOI 10.1586/erv.10.83
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CANGELOSI GA, 1991, METHOD ENZYMOL, V204, P384
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x
   Gregory JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037179
   Hempel F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028424
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   JEFFERSON RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI DOI 10.1007/BF02667740
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Ma YP, 2016, EXPERT REV VACCINES, V15, P1361, DOI 10.1080/14760584.2016.1182868
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mathieu-Rivet E, 2013, MOL CELL PROTEOMICS, V12, P3160, DOI 10.1074/mcp.M113.028191
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monreal-Escalante E, 2016, PLANTA, V243, P675, DOI 10.1007/s00425-015-2431-0
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Orellana-Escobedo L, 2015, PLANT CELL REP, V34, P425, DOI 10.1007/s00299-014-1720-6
   Ramos-Martinez EM, 2017, PLANT BIOTECHNOL J, V15, P1214, DOI 10.1111/pbi.12710
   Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349
   Rios-Huerta R, 2017, PLANT CELL REP, V36, P355, DOI 10.1007/s00299-016-2088-6
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 47
TC 6
Z9 6
U1 2
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD SEP 20
PY 2018
VL 282
BP 86
EP 91
DI 10.1016/j.jbiotec.2018.07.025
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GQ0BM
UT WOS:000441281200011
PM 30031093
DA 2020-07-08
ER

PT J
AU Mediouni, S
   Jablonski, JA
   Tsuda, S
   Richard, A
   Kessing, C
   Andrade, MV
   Biswas, A
   Even, Y
   Tellinghuisen, T
   Choe, H
   Cameron, M
   Stevenson, M
   Valente, ST
AF Mediouni, S.
   Jablonski, J. A.
   Tsuda, S.
   Richard, A.
   Kessing, C.
   Andrade, M. V.
   Biswas, A.
   Even, Y.
   Tellinghuisen, T.
   Choe, H.
   Cameron, M.
   Stevenson, M.
   Valente, S. T.
TI Potent suppression of HIV-1 cell attachment by Kudzu root extract
SO RETROVIROLOGY
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; INTEGRIN
   ALPHA(4)BETA(7); ENVELOPE GLYCOPROTEIN; REVERSE-TRANSCRIPTASE; FUSION
   INHIBITOR; DRUG-RESISTANCE; T-CELLS; DC-SIGN; INFECTION
AB There is a constant need to improve antiretrovirals against HIV since therapy is limited by cost, side effects and the emergence of drug resistance. Kudzu is a climbing vine from which the root extract (Pueraria lobata), rich in isoflavones and saponins, has long been used in traditional Chinese medicine for a variety of purposes, from weight loss to alcoholism prevention. Here we show that Kudzu root extract significantly inhibits HIV-1 entry into cell lines, primary human CD4(+)T lymphocytes and macrophages, without cell-associated toxicity. Specifically, Kudzu inhibits the initial attachment of the viral particle to the cell surface, a mechanism that depends on the envelope glycoprotein gp120 but is independent from the HIV-1 cell receptor CD4 and co-receptors CXCR4/CCR5. This activity seems selective to lentiviruses since Kudzu inhibits HIV-2 and simian immunodeficiency virus, but does not interfere with Hepatitis C, Influenza, Zika Brazil and adenovirus infection. Importantly, depending on the dose, Kudzu can act synergistically or additively with the current antiretroviral cocktails against HIV-1 and can block viruses resistant to the fusion inhibitor Enfuvirtide. Together our results highlight Kudzu's root extract value as a supplement to current antiretroviral therapy against HIV.
C1 [Mediouni, S.; Jablonski, J. A.; Tsuda, S.; Richard, A.; Kessing, C.; Biswas, A.; Tellinghuisen, T.; Choe, H.; Valente, S. T.] Scripps Res Inst, Dept Immunol & Microbiol, 130 Scripps Way,3C1, Jupiter, FL 33458 USA.
   [Cameron, M.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA.
   [Even, Y.] Botanists Beach Farm, Jupiter, FL USA.
   [Andrade, M. V.; Stevenson, M.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
   [Tellinghuisen, T.] Roche, Basel, Switzerland.
RP Valente, ST (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, 130 Scripps Way,3C1, Jupiter, FL 33458 USA.
EM svalente@scripps.edu
FU Scripps Research Institute
FX This work was supported with funding from The Scripps Research
   Institute.
CR Abram ME, 2014, J VIROL, V88, P7589, DOI 10.1128/JVI.00302-14
   Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566
   Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003
   Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001
   Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200
   Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106
   Clapham PR, 1999, MOL MEMBR BIOL, V16, P49, DOI 10.1080/096876899294751
   Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195
   Didigu CA, 2012, VIRUSES-BASEL, V4, P309, DOI 10.3390/v4020309
   Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005
   Du G, 2010, J CHROMATOGR A, V1217, P705, DOI 10.1016/j.chroma.2009.12.017
   Duffalo ML, 2003, ANN PHARMACOTHER, V37, P1448, DOI 10.1345/aph.1D143
   Fellinger CH, 2017, J VIROL, V91, DOI 10.1128/JVI.00847-17
   Fessel WJ, 2011, ANTIVIR RES, V92, P484, DOI 10.1016/j.antiviral.2011.09.010
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003
   Hardy N, 2004, PHARMACOTHERAPY, V24, P198, DOI 10.1592/phco.24.2.198.33141
   Hunt JS, 2009, PHARMACOTHERAPY, V29, P295, DOI 10.1592/phco.29.3.295
   Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000
   Li Guohui, 2010, Zhongguo Zhong Yao Za Zhi, V35, P3156
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Liu BR, 2015, J NAT PROD, V78, P294, DOI 10.1021/np5009416
   Moore JP, 1998, NATURE, V393, P630, DOI 10.1038/31359
   Mousseau G, 2015, MBIO, V6, DOI 10.1128/mBio.00465-15
   Mousseau G, 2012, CELL HOST MICROBE, V12, P97, DOI 10.1016/j.chom.2012.05.016
   Nunez N.V.A., 2010, J NANOBIOTECHNOL, V8
   Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09
   Penetar DM, 2015, DRUG ALCOHOL DEPEN, V153, P194, DOI 10.1016/j.drugalcdep.2015.05.025
   Poveda E, 2005, AIDS REV, V7, P139
   Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Ren J, 2002, P NATL ACAD SCI USA, V99, P14410, DOI 10.1073/pnas.222366699
   Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907
   Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001
   Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771
   Sato Y, 2015, MAR DRUGS, V13, P3454, DOI 10.3390/md13063454
   SCHULZ TF, 1990, J VIROL, V64, P5177, DOI 10.1128/JVI.64.10.5177-5182.1990
   Tallarida RJ, 2016, CURR PROTOC PHARM, V72, P9
   Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000
   Thenin-Houssier S, 2016, ANTIMICROB AGENTS CH, V60, P2195, DOI 10.1128/AAC.02574-15
   Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200
   Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180
   Witvrouw M, 2004, ANTIVIR THER, V9, P57
   Zhang Z, 2013, J CLIN PHARMACOL, V53, P787, DOI 10.1002/jcph.96
   Zhong Y, 2012, J FOOD SCI, V77, pE280, DOI 10.1111/j.1750-3841.2012.02887.x
   Zhou YX, 2014, PHYTOTHER RES, V28, P961, DOI 10.1002/ptr.5083
NR 46
TC 5
Z9 7
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD SEP 20
PY 2018
VL 15
AR 64
DI 10.1186/s12977-018-0446-x
PG 18
WC Virology
SC Virology
GA GU2ZT
UT WOS:000445142900001
PM 30236131
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rauch, S
   Jasny, E
   Schmidt, KE
   Petsch, B
AF Rauch, Susanne
   Jasny, Edith
   Schmidt, Kim E.
   Petsch, Benjamin
TI New Vaccine Technologies to Combat Outbreak Situations
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE viral vector vaccine; DNA vaccine; mRNA vaccine; pandemics; vaccine
   development
ID MESSENGER-RNA VACCINES; EBOLA-VIRUS DISEASE; T-CELL RESPONSES;
   ANTIGEN-PRESENTING CELLS; PLACEBO-CONTROLLED TRIAL; ACUTE RESPIRATORY
   SYNDROME; ATTENUATED MEASLES-VIRUS; I CLINICAL-TRIAL; VESICULAR
   STOMATITIS; DNA VACCINES
AB Ever since the development of the first vaccine more than 200 years ago, vaccinations have greatly decreased the burden of infectious diseases worldwide, famously leading to the eradication of small pox and allowing the restriction of diseases such as polio, tetanus, diphtheria, and measles. A multitude of research efforts focuses on the improvement of established and the discovery of new vaccines such as the HPV (human papilloma virus) vaccine in 2006. However, radical changes in the density, age distribution and traveling habits of the population worldwide as well as the changing climate favor the emergence of old and new pathogens that bear the risk of becoming pandemic threats. In recent years, the rapid spread of severe infections such as HIV, SARS, Ebola, and Zika have highlighted the dire need for global preparedness for pandemics, which necessitates the extremely rapid development and comprehensive distribution of vaccines against potentially previously unknown pathogens. What is more, the emergence of antibiotic resistant bacteria calls for new approaches to prevent infections. Given these changes, established methods for the identification of new vaccine candidates are no longer sufficient to ensure global protection. Hence, new vaccine technologies able to achieve rapid development as well as large scale production are of pivotal importance. This review will discuss viral vector and nucleic acid-based vaccines (DNA and mRNA vaccines) as new approaches that might be able to tackle these challenges to global health.
C1 [Rauch, Susanne; Jasny, Edith; Schmidt, Kim E.; Petsch, Benjamin] CureVac AG, Tubingen, Germany.
RP Rauch, S (corresponding author), CureVac AG, Tubingen, Germany.
EM susanne.rauch@curevac.com
RI Petsch, Benni/AAL-7767-2020
CR Aberle JH, 2005, J VIROL, V79, P15107, DOI 10.1128/JVI.79.24.15107-15113.2005
   Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15
   Afkhami S, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.30
   Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85
   Alberer M, 2017, LANCET, V390, P1511, DOI 10.1016/S0140-6736(17)31665-3
   Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051
   Armengol G, 2004, MOL BIOTECHNOL, V27, P109, DOI 10.1385/MB:27:2:109
   Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880
   Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035
   Baldo A, 2016, HUM VACC IMMUNOTHER, V12, P1102, DOI 10.1080/21645515.2015.1122146
   Baldo A, 2013, CURR GENE THER, V13, P385
   Bialkowski L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22509
   Bogers WM, 2015, J INFECT DIS, V211, P947, DOI 10.1093/infdis/jiu522
   Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349
   Brazzoli M, 2016, J VIROL, V90, P332, DOI 10.1128/JVI.01786-15
   Brito LA, 2015, ADV GENET, V89, P179, DOI 10.1016/bs.adgen.2014.10.005
   Carralot JP, 2004, CELL MOL LIFE SCI, V61, P2418, DOI 10.1007/s00018-004-4255-0
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chahal JS, 2016, P NATL ACAD SCI USA, V113, pE4133, DOI 10.1073/pnas.1600299113
   Chen NH, 2017, IUBMB LIFE, V69, P297, DOI 10.1002/iub.1625
   Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0
   Clarke DK, 2016, VACCINE, V34, P6597, DOI 10.1016/j.vaccine.2016.06.071
   Condit RC, 2016, VACCINE, V34, P6610, DOI 10.1016/j.vaccine.2016.04.060
   Corr M, 1996, J EXP MED, V184, P1555, DOI 10.1084/jem.184.4.1555
   Crank MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123969
   Daniel DP, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14465
   Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810
   de Bruyn G, 2010, CURR OPIN HIV AIDS, V5, P404, DOI 10.1097/COH.0b013e32833d1fca
   De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Edwards DK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-016-1111-6
   Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Fausther-Bovendo H, 2014, HUM VACC IMMUNOTHER, V10, P2875, DOI 10.4161/hv.29594
   Fotin-Mleczek M, 2012, J GENE MED, V14, P428, DOI 10.1002/jgm.2605
   Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8
   Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a
   Frey SE, 2015, VACCINE, V33, P5225, DOI 10.1016/j.vaccine.2015.06.075
   Fu TM, 1997, MOL MED, V3, P362, DOI 10.1007/BF03401683
   GALLIE DR, 1995, GENE, V165, P233, DOI 10.1016/0378-1119(95)00521-7
   GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109
   Gilbert JA, 2018, LANCET RESP MED, V6, P94, DOI 10.1016/S2213-2600(17)30466-6
   Granstein RD, 2000, J INVEST DERMATOL, V114, P632, DOI 10.1046/j.1523-1747.2000.00929.x
   Grant-Klein RJ, 2012, HUM VACC IMMUNOTHER, V8, P1703, DOI 10.4161/hv.21873
   Green CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008748
   Gsell PS, 2017, LANCET INFECT DIS, V17, P1276, DOI 10.1016/S1473-3099(17)30541-8
   Guan S, 2017, GENE THER, V24, P133, DOI 10.1038/gt.2017.5
   Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006
   Halstead SB, 2018, HUM VACC IMMUNOTHER, V14, P2158, DOI 10.1080/21645515.2018.1445448
   Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024
   Humphreys IR, 2018, IMMUNOLOGY, V153, P1, DOI 10.1111/imm.12829
   Iavarone C, 2017, EXPERT REV VACCINES, V16, P871, DOI 10.1080/14760584.2017.1355245
   Iwasaki A, 1997, J IMMUNOL, V159, P11
   Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175
   Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732
   Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Kallen KJ, 2013, HUM VACC IMMUNOTHER, V9, P2263, DOI 10.4161/hv.25181
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200
   Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7
   Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695
   Kauffman KJ, 2016, J CONTROL RELEASE, V240, P227, DOI 10.1016/j.jconrel.2015.12.032
   Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067
   Kibuuka H, 2015, LANCET, V385, P1545, DOI 10.1016/S0140-6736(14)62385-0
   Klug B, 2016, VACCINE, V34, P6617, DOI 10.1016/j.vaccine.2016.02.015
   Koff WC, 2013, SCIENCE, V340, DOI 10.1126/science.1232910
   Kofler RM, 2004, P NATL ACAD SCI USA, V101, P1951, DOI 10.1073/pnas.0307145101
   Kowalczyk A, 2016, VACCINE, V34, P3882, DOI 10.1016/j.vaccine.2016.05.046
   Kreiter S, 2010, CANCER RES, V70, P9031, DOI 10.1158/0008-5472.CAN-10-0699
   Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180
   Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431
   Lambricht L, 2016, EXPERT OPIN DRUG DEL, V13, P295, DOI 10.1517/17425247.2016.1121990
   Lauer KB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00298-16
   LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477
   Lazzaro S, 2015, IMMUNOLOGY, V146, P312, DOI 10.1111/imm.12505
   Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037
   Ledgerwood JE, 2017, NEW ENGL J MED, V376, P928, DOI [10.1056/NEJMoa1410863, 10.1056/nejmoa1410863]
   Lee CS, 2017, GENES DIS, V4, P43, DOI 10.1016/j.gendis.2017.04.001
   Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303
   Li L, 2016, EXPERT REV VACCINES, V15, P313, DOI 10.1586/14760584.2016.1124762
   Liang F, 2017, MOL THER, V25, P2635, DOI 10.1016/j.ymthe.2017.08.006
   Liebowitz D, 2015, LANCET INFECT DIS, V15, P1041, DOI 10.1016/S1473-3099(15)00266-2
   Lindgren G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01539
   Loomis RJ, 2015, VACCINES-BASEL, V3, P429, DOI 10.3390/vaccines3020429
   Lundstrom K, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040039
   Lutz J, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0032-6
   Magini D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161193
   Manam S, 2000, INTERVIROLOGY, V43, P273, DOI 10.1159/000053994
   Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06
   Martins KA, 2016, EXPERT REV VACCINES, V15, P1101, DOI 10.1080/14760584.2016.1187566
   Marzi A, 2016, J INFECT DIS, V214, pS360, DOI 10.1093/infdis/jiw218
   Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920
   McLean KA, 2016, VACCINE, V34, P5410, DOI 10.1016/j.vaccine.2016.08.019
   Medaglini D, 2017, CURR OPIN VIROL, V23, P88, DOI 10.1016/j.coviro.2017.03.008
   Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042
   Meyer M, 2018, J INFECT DIS, V217, P451, DOI 10.1093/infdis/jix592
   Midoux P, 2015, EXPERT REV VACCINES, V14, P221, DOI 10.1586/14760584.2015.986104
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Muhlebach MD, 2017, VIRUS GENES, V53, P733, DOI 10.1007/s11262-017-1486-3
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nabel GJ, 2013, NEW ENGL J MED, V368, P551, DOI 10.1056/NEJMra1204186
   O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850
   Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759
   Ovsyannikova IG, 2003, CLIN DIAGN LAB IMMUN, V10, P411, DOI 10.1128/CDLI.10.3.411-416.2003
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007
   Pardi Norbert, 2013, Methods Mol Biol, V969, P29, DOI 10.1007/978-1-62703-260-5_2
   Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724
   Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498
   Pepini T, 2017, J IMMUNOL, V198, P4012, DOI 10.4049/jimmunol.1601877
   Perri S, 2003, J VIROL, V77, P10394, DOI 10.1128/JVI.77.19.10394-10403.2003
   Peters W, 2013, VACCINE, V31, P1752, DOI 10.1016/j.vaccine.2013.01.023
   Petricciani J, 2014, BIOLOGICALS, V42, P223, DOI 10.1016/j.biologicals.2014.07.003
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Plotkin S, 2017, VACCINE, V35, P4064, DOI 10.1016/j.vaccine.2017.06.003
   Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075
   Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755
   Qiu P, 1996, GENE THER, V3, P262
   Ramanathan A, 2016, NUCLEIC ACIDS RES, V44, P7511, DOI 10.1093/nar/gkw551
   Ramezanpour B, 2016, VACCINE, V34, P6436, DOI 10.1016/j.vaccine.2016.06.059
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12288, DOI 10.1073/pnas.1402981111
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   Reichmuth AM, 2016, THER DELIV, V7, P319, DOI 10.4155/tde-2016-0006
   Reperant LA, 2017, VACCINE, V35, P4470, DOI 10.1016/j.vaccine.2017.04.082
   Richardson JS, 2010, HUM VACCINES, V6, P439, DOI 10.4161/hv.6.6.11097
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   ROSS J, 1985, BLOOD, V66, P1149
   Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003
   Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008
   Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511
   Schalk JAC, 2006, HUM VACCINES, V2, P45, DOI 10.4161/hv.2.2.2620
   Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656
   Schlake T, 2012, RNA BIOL, V9, P1319, DOI 10.4161/rna.22269
   Schnee M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004746
   Selmi A, 2016, CANCER IMMUNOL IMMUN, V65, P1075, DOI 10.1007/s00262-016-1869-7
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Steitz J, 2006, CANCER IMMUNOL IMMUN, V55, P246, DOI 10.1007/s00262-005-0042-5
   Stepinski J, 2001, RNA, V7, P1486
   Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177
   Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108
   Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876
   Tan WG, 2013, J VIROL, V87, P1359, DOI 10.1128/JVI.02055-12
   Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103
   van den Pol AN, 2013, J VIROL, V87, P1019, DOI 10.1128/JVI.01106-12
   Vanderzanden L, 1998, VIROLOGY, V246, P134, DOI 10.1006/viro.1998.9176
   VENKATESAN S, 1980, J BIOL CHEM, V255, P903
   Venkatraman N, 2017, VACCINE, V35, P6208, DOI 10.1016/j.vaccine.2017.09.028
   Vivinus S, 2001, EUR J BIOCHEM, V268, P1908, DOI 10.1046/j.1432-1327.2001.02064.x
   Vogel AB, 2018, MOL THER, V26, P446, DOI 10.1016/j.ymthe.2017.11.017
   Walters AA, 2014, GENE THER, V21, P645, DOI 10.1038/gt.2014.37
   Wang M, 2018, VACCINE, V36, P683, DOI 10.1016/j.vaccine.2017.12.046
   Wang YX, 2017, HUM VACC IMMUNOTHER, V13, P153, DOI 10.1080/21645515.2016.1225637
   Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213
   Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3
   Williams JA, 2013, VACCINES, V1, P225, DOI 10.3390/vaccines1030225
   Wold WSM, 2013, CURR GENE THER, V13, P421
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037
   Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016
   Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0
   Zohra FT, 2007, BIOCHEM BIOPH RES CO, V358, P373, DOI 10.1016/j.bbrc.2007.04.059
   Zuniga A, 2007, VACCINE, V25, P2974, DOI 10.1016/j.vaccine.2007.01.064
NR 181
TC 27
Z9 27
U1 7
U2 43
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 19
PY 2018
VL 9
AR 1963
DI 10.3389/fimmu.2018.01963
PG 24
WC Immunology
SC Immunology
GA GU1QG
UT WOS:000445040100001
PM 30283434
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yockey, LJ
   Iwasaki, A
AF Yockey, Laura J.
   Iwasaki, Akiko
TI Interferons and Proinflammatory Cytokines in Pregnancy and Fetal
   Development
SO IMMUNITY
LA English
DT Review
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; INDUCED PRETERM BIRTH;
   NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; ZIKA VIRUS; MATERNAL
   OBESITY; T-CELLS; INFLAMMATORY RESPONSE; COMPLEMENT ACTIVATION; EMBRYO
   IMPLANTATION
AB Successful pregnancy requires carefully-coordinated communications between the mother and fetus. Immune cells and cytokine signaling pathways participate as mediators of these communications to promote healthy pregnancy. At the same time, certain infections or inflammatory conditions in pregnant mothers cause severe disease and have detrimental impacts on the developing fetus. In this review, we examine evidence for the role of maternal and fetal immune responses affecting pregnancy and fetal development, both under homeostasis and following infection. We discuss immune responses that are necessary to promote healthy pregnancy and those that lead to congenital disorders and pregnancy complications, with a particular emphasis on the role of interferons and cytokines. Understanding the contributions of the immune system in pregnancy and fetal development provides important insights into the pathogenesis underlying maternal and fetal diseases and sheds insights on possible targets for therapy.
C1 [Yockey, Laura J.; Iwasaki, Akiko] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.
   [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
RP Iwasaki, A (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM akiko.iwasaki@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI054359, R01EB000487, R01AI127429,
   R21AI131284];  [T32GM007205];  [F30 HD094717]
FX The authors received funding from the NIH AI054359, R01EB000487,
   R01AI127429, and R21AI131284 (to A.I.). A.I. is an Investigator of the
   Howard Hughes Medical Institute. L.J.Y. was supported in part by
   T32GM007205 and F30 HD094717. BioRender was used to make Figures 1 and
   2. Due to space constraint, we regret our inability to cite all relevant
   studies.
CR Aaltonen R, 2005, OBSTET GYNECOL, V106, P802, DOI 10.1097/01.AOG.0000178750.84837.ed
   Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001
   Ahn J, 2015, BIOCHEM BIOPH RES CO, V466, P52, DOI 10.1016/j.bbrc.2015.08.104
   Albertsson AM, 2018, AM J PATHOL, V188, P757, DOI 10.1016/j.ajpath.2017.11.012
   Altmae S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169223
   Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037
   Ambrosi A, 2014, EXP CELL RES, V325, P2, DOI 10.1016/j.yexcr.2014.01.003
   Andrade D, 2015, ARTHRITIS RHEUMATOL, V67, P977, DOI 10.1002/art.39029
   Aplin JD, 2017, J CELL SCI, V130, P15, DOI 10.1242/jcs.175943
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937
   Aye ILMH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116186
   Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37
   Barboza R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08299-x
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485
   Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495
   Boyle AK, 2017, J REPROD IMMUNOL, V119, P62, DOI 10.1016/j.jri.2016.11.008
   Brito-Zeron P, 2015, NAT REV RHEUMATOL, V11, P301, DOI 10.1038/nrrheum.2015.29
   Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774
   Bundhun PK, 2017, J AUTOIMMUN, V79, P17, DOI 10.1016/j.jaut.2017.02.009
   Burd I, 2010, J NEUROSCI RES, V88, P1872, DOI 10.1002/jnr.22368
   Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288
   Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR
   Care AS, 2013, J CLIN INVEST, V123, P3472, DOI 10.1172/JCI60561
   Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001
   Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042
   Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578
   Chavan AR, 2016, PLACENTA, V40, P40, DOI 10.1016/j.placenta.2016.02.012
   Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314
   Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002
   Cohen D, 2011, J PATHOL, V225, P502, DOI 10.1002/path.2893
   Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011
   Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cross SN, 2017, J IMMUNOL, V199, P2885, DOI 10.4049/jimmunol.1700870
   Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
   Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Devakumar D., 2017, LANCET INFECT DIS, V18, P1
   DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112
   Dosch NC, 2016, J PEDIATR-US, V172, P20, DOI 10.1016/j.jpeds.2016.02.023
   Ealy AD, 2001, ENDOCRINOLOGY, V142, P2906, DOI 10.1210/en.142.7.2906
   Edlow AG, 2017, PRENATAL DIAG, V37, P95, DOI 10.1002/pd.4932
   Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x
   Feyaerts D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03191-0
   Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332
   Fried M, 2017, CLIN INFECT DIS, V65, P1729, DOI 10.1093/cid/cix623
   Fu BQ, 2017, IMMUNITY, V47, P1100, DOI 10.1016/j.immuni.2017.11.018
   Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817
   Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3
   Goeden N, 2016, J NEUROSCI, V36, P6041, DOI 10.1523/JNEUROSCI.2534-15.2016
   Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8
   Gonzalez JM, 2013, J REPROD IMMUNOL, V97, P112, DOI 10.1016/j.jri.2012.07.008
   Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024
   Green MP, 2005, BIOL REPROD, V73, P1087, DOI 10.1095/biolreprod.105.043406
   Griffith OW, 2017, P NATL ACAD SCI USA, V114, pE6566, DOI 10.1073/pnas.1701129114
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hogmalm A, 2014, AM J PHYSIOL-LUNG C, V306, pL23, DOI 10.1152/ajplung.00154.2013
   Holst RM, 2009, OBSTET GYNECOL, V114, P268, DOI 10.1097/AOG.0b013e3181ae6a08
   Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588
   Huppertz B, 2014, PROG BIOPHYS MOL BIO, V114, P33, DOI 10.1016/j.pbiomolbio.2013.11.007
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jennewein MF, 2017, SEMIN IMMUNOPATHOL, V39, P605, DOI 10.1007/s00281-017-0653-x
   KALLIALA I, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J4511
   Kim MY, 2018, ANN RHEUM DIS, V77, P549, DOI 10.1136/annrheumdis-2017-212224
   Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910
   Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001
   Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009
   Kroener L, 2016, SEMIN REPROD MED, V34, P27, DOI 10.1055/s-0035-1570029
   Lee AJ, 2013, J LEUKOCYTE BIOL, V93, P905, DOI 10.1189/jlb.0912442
   Lei J, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12798
   Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216
   Lin HF, 1997, DEVELOPMENT, V124, P2463
   Liu S, 2017, J REPROD IMMUNOL, V124, P44, DOI 10.1016/j.jri.2017.10.045
   Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9
   Mahany EB, 2018, ENDOCRINOLOGY, V159, P1718, DOI 10.1210/en.2017-03053
   Mccoy AM, 2017, AM J PATHOL, V187, P2635, DOI 10.1016/j.ajpath.2017.08.013
   Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022
   Meuwissen MEC, 2016, J EXP MED, V213, P1163, DOI 10.1084/jem.20151529
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore K.L., 2017, DEV HUMAN, P457
   Moore KA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0877-6
   Moser G, 2017, PLACENTA, V56, P19, DOI 10.1016/j.placenta.2017.02.007
   Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x
   Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353
   Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084
   Niikura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185392
   Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095
   Oger S, 2002, J CLIN ENDOCR METAB, V87, P5524, DOI 10.1210/jc.2002-020575
   Ostensen M, 2013, CURR OPIN RHEUMATOL, V25, P591, DOI 10.1097/BOR.0b013e328363ebf7
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Pan American Health Organization (PAHO) World Health Organization (WHO), 2017, ZIK SUSP CONF CAS RE
   Park HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138114
   Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016
   Pazos M, 2012, IMMUNOL RES, V54, P254, DOI 10.1007/s12026-012-8303-9
   Pendeloski KPT, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12674
   Perdu S, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85560
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Persson M, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2563
   Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90
   Rinaldi SF, 2017, MOL HUM REPROD, V23, P708, DOI 10.1093/molehr/gax038
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Roberts KA, 2011, PLACENTA, V32, P247, DOI 10.1016/j.placenta.2010.12.023
   Roberts RM, 2007, CYTOKINE GROWTH F R, V18, P403, DOI 10.1016/j.cytogfr.2007.06.010
   Robertson SA, 2018, J REPROD IMMUNOL, V125, P80, DOI 10.1016/j.jri.2017.12.003
   Robertson SA, 2010, ENDOCRINOLOGY, V151, P3996, DOI 10.1210/en.2010-0063
   Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816
   Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18
   Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062
   Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007
   Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005
   Rozner AE, 2016, AM J REPROD IMMUNOL, V76, P364, DOI 10.1111/aji.12564
   Rudolph MD, 2018, NAT NEUROSCI, V21, P765, DOI 10.1038/s41593-018-0128-y
   Saccone G, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.026
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072
   Santos TD, 2017, J REPROD IMMUNOL, V123, P78, DOI 10.1016/j.jri.2017.09.007
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013
   Senegas A, 2009, INT J PARASITOL, V39, P481, DOI 10.1016/j.ijpara.2008.08.009
   Siewiera J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003257
   Simoes R., 2016, REV ASSOC MED BRAS, V62, P106
   Simon A, 2012, J ASSIST REPROD GEN, V29, P1227, DOI 10.1007/s10815-012-9861-4
   Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089
   Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007
   STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0
   Sullivan KD, 2016, ELIFE, V5, DOI 10.7554/eLife.16220
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008
   TAUBENECK MW, 1995, J NUTR, V125, P908
   Tessier DR, 2015, AM J REPROD IMMUNOL, V74, P1, DOI 10.1111/aji.12345
   Thaxton JE, 2013, J IMMUNOL, V190, P3639, DOI 10.4049/jimmunol.1203488
   Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788
   Thekkeveedu RK, 2017, RESP MED, V132, P170, DOI 10.1016/j.rmed.2017.10.014
   Tong M, 2015, HUM REPROD UPDATE, V21, P97, DOI 10.1093/humupd/dmu049
   Tribe RM, 2003, BIOL REPROD, V68, P1842, DOI 10.1095/biolreprod.102.011403
   van der Zwan A, 2018, P NATL ACAD SCI USA, V115, P385, DOI 10.1073/pnas.1713957115
   van Egmond A, 2016, J REPROD IMMUNOL, V113, P1, DOI 10.1016/j.jri.2015.09.073
   Vinet E, 2015, ARTHRITIS RHEUMATOL, V67, P3201, DOI 10.1002/art.39320
   Vinet E, 2015, CIRCULATION, V131, P149, DOI 10.1161/CIRCULATIONAHA.114.010027
   Wahid HH, 2015, ENDOCRINOLOGY, V156, P3828, DOI [10.1210/en.2015-1089, 10.1210/EN.2015-1089]
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004
   Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401
   Wilson RM, 2015, PEDIAT ALLERG IMM-UK, V26, P344, DOI 10.1111/pai.12387
   Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200
   Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214
   Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Yellon SM, 2017, BIOL REPROD, V96, P13, DOI 10.1095/biolreprod.116.142844
   Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zenclussen AC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00321
   Zhao L, 2008, TOXICOL SCI, V103, P149, DOI 10.1093/toxsci/kfn027
   Zhao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082713
NR 168
TC 29
Z9 29
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD SEP 18
PY 2018
VL 49
IS 3
BP 397
EP 412
DI 10.1016/j.immuni.2018.07.017
PG 16
WC Immunology
SC Immunology
GA GU0AK
UT WOS:000444909600009
PM 30231982
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Chen, Y
   Liu, T
   Zhang, Z
   Chen, M
   Rong, L
   Ma, L
   Yu, B
   Wu, D
   Zhang, P
   Zhu, X
   Huang, X
   Zhang, H
   Li, YP
AF Chen, Yiyi
   Liu, Ting
   Zhang, Zhenzhen
   Chen, Mingxiao
   Rong, Liang
   Ma, Ling
   Yu, Bolan
   Wu, De
   Zhang, Ping
   Zhu, Xun
   Huang, Xi
   Zhang, Hui
   Li, Yi-Ping
TI Novel genetically stable infectious clone for a Zika virus clinical
   isolate and identification of RNA elements essential for virus
   production
SO VIRUS RESEARCH
LA English
DT Article
DE Flavivirus; Reverse genetics system; Mutation; RNA-RNA interaction;
   Escherichia coli promoter; Genetically stable
ID JAPANESE-ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; CDNA-CLONES; FULL-LENGTH;
   GENOMIC CHARACTERIZATION; BRAIN; MODEL
AB Zika virus (ZIKV) is an Aedes mosquitoes-transmitted flavivirus, and its infection may cause severe neurological diseases. A genetically stable infectious clone is essential for ZIKV research, however the toxicity and instability of the viral cDNA in bacteria potentially due to its bacterial promoter activity are major challenges. Here, we constructed a full-length cDNA clone for isolate ZG01 by introducing non-coding changes T1865C/A1868G to reduce the bacterial promoter activity. Wild-type and recombinant ZG01 were highly attenuated in Vero cells, thus we serially passaged wild-type ZG01 through neonatal mice and Vero cells to generate high-titer virus, from which four mutations (4m, C2178T/G2913A/T4991C/T10561C) were identified. Addition of 4m greatly enhanced the infectivity, as ZG01_4m released ZIKV of 10(7.0)-10(7.5) plaque-forming unit (PFU)/ml in infected Vero and A549 cells. ZG01_4m resembled the infectivity of high-titer ZG01 in vitro and in vivo. Notably, ZG01_4m plasmid was genetically stable after multiple rounds of transformation-purification in bacteria. Using ZG01_4m, we identified a potential RNA-RNA interaction between 5'UTR and 3'UTR and demonstrated that the nucleotides involved were essential for ZIKV production. The genetically stable ZG01 cDNA clone provides a reliable tool for the study of this important virus, and the strategy used here is feasible for the development of reverse genetics systems for other ZIKV isolates and related flaviviruses.
C1 [Chen, Yiyi; Zhang, Zhenzhen; Chen, Mingxiao; Rong, Liang; Ma, Ling; Zhu, Xun; Zhang, Hui; Li, Yi-Ping] Sun Yat Sen Univ, Minist Educ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China.
   [Chen, Yiyi; Liu, Ting; Zhang, Zhenzhen; Chen, Mingxiao; Rong, Liang; Ma, Ling; Zhang, Ping; Zhu, Xun; Zhang, Hui; Li, Yi-Ping] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China.
   [Liu, Ting; Zhang, Ping] Sun Yat Sen Univ, Minist Educ, Zhongshan Sch Med, Dept Immunol, Guangzhou 510080, Guangdong, Peoples R China.
   [Yu, Bolan] Guangzhou Med Univ, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China.
   [Wu, De] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Guangdong, Peoples R China.
   [Huang, Xi] Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Hosp 5, Guangzhou 510080, Guangdong, Peoples R China.
   [Li, Yi-Ping] Sun Yat Sen Univ, Affiliated Hosp 5, Program Pathobiol, Guangzhou, Guangdong, Peoples R China.
   [Li, Yi-Ping] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China.
RP Li, YP (corresponding author), Sun Yat Sen Univ, Res Bldg,North Campus 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM lyiping@mail.sysu.edu.cn
RI Li, Yi-Ping/A-4832-2011
OI Li, Yi-Ping/0000-0003-2360-9516
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470263]; National Basic Research Program of China
   (973 program)National Basic Research Program of China [2015CB554301];
   Science and Technology Planning Project of Guangdong Province, China
   [2016A020219003, 2017A050506017, 2017A050501012]; Fundamental Research
   Funds for the Central Universities, ChinaFundamental Research Funds for
   the Central Universities [15ykjc06a]; Key Lab for Major Obstetric
   Diseases of Guangdong Province, China [J1803003]; 111 Project, China
   [B12003, B13037]
FX This study was supported by research grants from the National Natural
   Science Foundation of China (grant number 31470263); National Basic
   Research Program of China (973 program) (grant number 2015CB554301);
   Science and Technology Planning Project of Guangdong Province, China
   (grant numbers 2016A020219003, 2017A050506017, and 2017A050501012); The
   Fundamental Research Funds for the Central Universities, China (grant
   number 15ykjc06a); Key Lab for Major Obstetric Diseases of Guangdong
   Province, China (grant number J1803003); and the 111 Project, China
   (grant numbers B12003 and B13037).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Blaney JE, 2006, VIRAL IMMUNOL, V19, P10, DOI 10.1089/vim.2006.19.10
   Blaney JE, 2004, AM J TROP MED HYG, V71, P811, DOI 10.4269/ajtmh.2004.71.811
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   KAPOOR M, 1995, GENE, V162, P175, DOI 10.1016/0378-1119(95)00332-Z
   LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mandl CW, 1997, J GEN VIROL, V78, P1049, DOI 10.1099/0022-1317-78-5-1049
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   PLETNEV AG, 1992, P NATL ACAD SCI USA, V89, P10532, DOI 10.1073/pnas.89.21.10532
   Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997
   Pu SY, 2014, J GEN VIROL, V95, P1493, DOI 10.1099/vir.0.064915-0
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7
   RICE C M, 1989, New Biologist, V1, P285
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Salamov V.S.A., 2011, METAGENOMICITAPP, P61
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000
   Yu JH, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070165
   Yudhaputri FA, 2017, VIROLOGY, V510, P248, DOI 10.1016/j.virol.2017.07.026
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0
   Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11
NR 62
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD SEP 15
PY 2018
VL 257
BP 14
EP 24
DI 10.1016/j.virusres.2018.08.016
PG 11
WC Virology
SC Virology
GA GX9AI
UT WOS:000448090500003
PM 30144463
DA 2020-07-08
ER

PT J
AU Zheng, YY
   Liu, QX
   Wu, YX
   Ma, L
   Zhang, ZZ
   Liu, T
   Jin, SH
   She, YC
   Li, YP
   Cui, J
AF Zheng, Yanyan
   Liu, Qingxiang
   Wu, Yaoxing
   Ma, Ling
   Zhang, Zhenzhen
   Liu, Tao
   Jin, Shouheng
   She, Yuanchu
   Li, Yi-Ping
   Cui, Jun
TI Zika virus elicits inflammation to evade antiviral response by cleaving
   cGAS via NS1-caspase-1 axis
SO EMBO JOURNAL
LA English
DT Article
DE antiviral immunity; inflammasome; type I interferon signaling; Zika
   virus
ID INNATE IMMUNITY; SELECTIVE AUTOPHAGY; ACTIVATION; CASPASE-1;
   INFLAMMASOMES; PATHOGENESIS; RECOGNITION; SPECIFICITY; INFECTIONS;
   INHIBITORS
AB Viral infection triggers host innate immune responses, which primarily include the activation of type I interferon (IFN) signaling and inflammasomes. Here, we report that Zika virus (ZIKV) infection triggers NLRP3 inflammasome activation, which is further enhanced by viral non-structural protein NS1 to benefit its replication. NS1 recruits the host deubiquitinase USP8 to cleave K11-linked poly-ubiquitin chains from caspase-1 at Lys134, thus inhibiting the proteasomal degradation of caspase-1. The enhanced stabilization of caspase-1 by NS1 promotes the cleavage of cGAS, which recognizes mitochondrial DNA release and initiates type I IFN signaling during ZIKV infection. NLRP3 deficiency increases type I IFN production and strengthens host resistance to ZIKV in vitro and in vivo. Taken together, our work unravels a novel antagonistic mechanism employed by ZIKV to suppress host immune response by manipulating the interplay between inflammasome and type I IFN signaling, which might guide the rational design of therapeutics in the future.
C1 [Zheng, Yanyan; Liu, Qingxiang; Wu, Yaoxing; Liu, Tao; Jin, Shouheng; She, Yuanchu; Cui, Jun] Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Gene Funct & Regulat, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.
   [Ma, Ling; Zhang, Zhenzhen; Li, Yi-Ping] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Key Lab Trop Dis Control,Minist Educ, Guangzhou, Guangdong, Peoples R China.
   [Li, Yi-Ping] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Infect Dis, Zhuhai, Peoples R China.
RP Cui, J (corresponding author), Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Gene Funct & Regulat, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Key Lab Trop Dis Control,Minist Educ, Guangzhou, Guangdong, Peoples R China.; Li, YP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 5, Dept Infect Dis, Zhuhai, Peoples R China.
EM lyiping@mail.sysu.edu.cn; cuij5@mail.sysu.edu.cn
RI Li, Yi-Ping/A-4832-2011
OI Li, Yi-Ping/0000-0003-2360-9516; CUI, JUN/0000-0002-8000-3708
FU National Key Basic Research Program of ChinaNational Basic Research
   Program of China [2015CB859800, 2014CB910800, 2015CB554301]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [31522018, 91629101, 31470263, 31700150]; Science and
   Technology Planning Project of Guangdong Province, China
   [2016A020219003]
FX We thank Dr. Matthew Evans (Icahn School of Medicine at Mount Sinai, New
   York) for providing ZIKV strain MR766; Dr. Andrew Yueh (National Health
   Research Institutes, Taiwan) for providing DENV strain 16681. This work
   was supported by National Key Basic Research Program of China
   (2015CB859800, 2014CB910800, 2015CB554301), National Natural Science
   Foundation of China (31522018, 91629101, 31470263, 31700150), and
   Science and Technology Planning Project of Guangdong Province, China
   (2016A020219003).
CR Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Barral PM, 2009, VIROLOGY, V391, P171, DOI 10.1016/j.virol.2009.06.045
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45
   Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025
   Cheong WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126456
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jabir MS, 2014, CELL HOST MICROBE, V15, P214, DOI 10.1016/j.chom.2014.01.010
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Komune N, 2011, J VIROL, V85, P13019, DOI 10.1128/JVI.05942-11
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016
   Lee H, 2018, EXPERT OPIN THER PAT, V28, P47, DOI 10.1080/13543776.2017.1378426
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007
   Parekh FK, 2010, AM J TROP MED HYG, V83, P973, DOI 10.4269/ajtmh.2010.09-0445
   Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shrivastava G, 2016, IMMUNOL RES, V64, P1101, DOI 10.1007/s12026-016-8873-z
   Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011
   Winkler S, 2015, SEMIN IMMUNOPATHOL, V37, P419, DOI 10.1007/s00281-015-0494-4
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
NR 49
TC 21
Z9 22
U1 3
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD SEP 14
PY 2018
VL 37
IS 18
AR e99347
DI 10.15252/embj.201899347
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GT8QO
UT WOS:000444804700010
PM 30065070
OA Green Published
DA 2020-07-08
ER

PT J
AU Cohen, J
AF Cohen, Jon
TI INFECTIOUS DISEASE Steep drop in Zika cases undermines vaccine trial
SO SCIENCE
LA English
DT News Item
NR 0
TC 4
Z9 4
U1 0
U2 3
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD SEP 14
PY 2018
VL 361
IS 6407
BP 1055
EP 1056
DI 10.1126/science.361.6407.1055
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT4YU
UT WOS:000444513300013
PM 30213891
DA 2020-07-08
ER

PT J
AU Scaturro, P
   Stukalov, A
   Haas, DA
   Cortese, M
   Draganova, K
   Plaszczyca, A
   Bartenschlager, R
   Gotz, M
   Pichlmair, A
AF Scaturro, Pietro
   Stukalov, Alexey
   Haas, Darya A.
   Cortese, Mirko
   Draganova, Kalina
   Plaszczyca, Anna
   Bartenschlager, Ralf
   Goetz, Magdalena
   Pichlmair, Andreas
TI An orthogonal proteomic survey uncovers novel Zika virus host factors
SO NATURE
LA English
DT Article
ID PROTEIN; PHOSPHOPROTEOMICS; DIFFERENTIATION; ENRICHMENT; PLATFORM;
   GENOME; KINASE; CELLS
AB Zika virus (ZIKV) has recently emerged as a global health concern owing to its widespread diffusion and its association with severe neurological symptoms and microcephaly in newborns(1). However, the molecular mechanisms that are responsible for the pathogenicity of ZIKV remain largely unknown. Here we use human neural progenitor cells and the neuronal cell line SK-N-BE2 in an integrated proteomics approach to characterize the cellular responses to viral infection at the proteome and phosphoproteome level, and use affinity proteomics to identify cellular targets of ZIKV proteins. Using this approach, we identify 386 ZIKV-interacting proteins, ZIKV-specific and pan-flaviviral activities as well as host factors with known functions in neuronal development, retinal defects and infertility. Moreover, our analysis identified 1,216 phosphorylation sites that are specifically up-or downregulated after ZIKV infection, indicating profound modulation of fundamental signalling pathways such as AKT, MAPK-ERK and ATM-ATR and thereby providing mechanistic insights into the proliferation arrest elicited by ZIKV infection. Functionally, our integrative study identifies ZIKV host-dependency factors and provides a comprehensive framework for a system-level understanding of ZIKV-induced perturbations at the levels of proteins and cellular pathways.
C1 [Scaturro, Pietro; Stukalov, Alexey; Haas, Darya A.; Pichlmair, Andreas] Max Planck Inst Biochem, Innate Immun Lab, Martinsried, Germany.
   [Scaturro, Pietro; Stukalov, Alexey; Pichlmair, Andreas] Tech Univ Munich, Inst Virol, Sch Med, Munich, Germany.
   [Cortese, Mirko; Plaszczyca, Anna; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.
   [Draganova, Kalina; Goetz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, Neuherberg, Germany.
   [Draganova, Kalina; Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany.
   [Bartenschlager, Ralf] German Ctr Infect Res DZIF, Heidelberg Partner Site, Heidelberg, Germany.
   [Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Synergy, Excellence Cluster Syst Neurol, Munich, Germany.
   [Pichlmair, Andreas] German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.
RP Scaturro, P; Pichlmair, A (corresponding author), Max Planck Inst Biochem, Innate Immun Lab, Martinsried, Germany.; Scaturro, P; Pichlmair, A (corresponding author), Tech Univ Munich, Inst Virol, Sch Med, Munich, Germany.; Pichlmair, A (corresponding author), German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.
EM pietro.scaturro@tum.de; andreas.pichlmair@tum.de
OI Scaturro, Pietro/0000-0001-9098-3087; Cortese, Mirko/0000-0003-1786-4211
FU ERC starting grant [StG 311339]; Max-Planck free-floater program; German
   Research FoundationGerman Research Foundation (DFG) [PI1084/2, PI1084/3,
   PI1084/4, TRR 237, TRR179]; Federal Ministry for Education and Research
   (ERA-Net grant ERASe); Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [BA1505/8-1]; Horizon 2020: Marie Sklodowska-Curie ETN
   "ANTIVIRALS" [642434]; DFGGerman Research Foundation (DFG) [SFB871];
   advanced ERC grant ChroNeuroRepair
FX We thank D. Mauceri, F. Sacco and L. Chatel-Chaix for discussions and R.
   Hornberger, I. Paron, K. Mayr and G. Sowa for technical assistance. The
   work in the authors' laboratory was funded by an ERC starting grant (StG
   311339, iVIP), the Max-Planck free-floater program, the German Research
   Foundation (PI1084/2, PI1084/3, PI1084/4, TRR 237 and TRR179) and the
   Federal Ministry for Education and Research (ERA-Net grant ERASe) all to
   A.Pi. R.B. was supported by the Deutsche Forschungsgemeinschaft
   (BA1505/8-1). A. Pl. was supported by the Horizon 2020: Marie
   Sklodowska-Curie ETN "ANTIVIRALS" (grant agreement 642434 to R.B.). M.G.
   was supported by the DFG (SFB871) and the advanced ERC grant
   ChroNeuroRepair.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Gebhardt A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9192
   Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111
   Havlicek S, 2014, HUM MOL GENET, V23, P2527, DOI 10.1093/hmg/ddt644
   Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267
   Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091
   Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327
   Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05
   Li HM, 2008, MOL BIOL CELL, V19, P4804, DOI 10.1091/mbc.E08-03-0294
   Li H, 2009, STEM CELLS, V27, P1244, DOI 10.1002/stem.55
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Ochrietor JD, 2004, DEV NEUROSCI-BASEL, V26, P380, DOI 10.1159/000082280
   Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115
   Paul D, 2015, J GEN VIROL, V96, P1696, DOI 10.1099/vir.0.000111
   Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104
   Radke J, 2015, BBA-MOL BASIS DIS, V1852, P2262, DOI 10.1016/j.bbadis.2015.05.007
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Slomnicki LP, 2016, MOL CELL PROTEOMICS, V15, P2055, DOI 10.1074/mcp.M115.051920
   Soderholm S, 2016, MOL CELL PROTEOMICS, V15, P3203, DOI 10.1074/mcp.M116.057984
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Wojcechowskyj JA, 2013, CELL HOST MICROBE, V13, P613, DOI 10.1016/j.chom.2013.04.011
   Yamashita N, 2012, J NEUROSCI, V32, P1360, DOI 10.1523/JNEUROSCI.5563-11.2012
NR 38
TC 30
Z9 31
U1 10
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD SEP 13
PY 2018
VL 561
IS 7722
BP 253
EP +
DI 10.1038/s41586-018-0484-5
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT3XQ
UT WOS:000444437900046
PM 30177828
DA 2020-07-08
ER

PT J
AU Khaiboullina, S
   Uppal, T
   Martynova, E
   Rizvanov, A
   Baranwal, M
   Verma, SC
AF Khaiboullina, Svetalana
   Uppal, Timsy
   Martynova, Ekaterina
   Rizvanov, Albert
   Baranwal, Manoj
   Verma, Subhash C.
TI History of ZIKV Infections in India and Management of Disease Outbreaks
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika virus (ZIKV); epidemiology; emerging infections; India; ADEs; Aedes
   aegypti
ID ANTIBODY-DEPENDENT ENHANCEMENT; VIRUS-INFECTION; AEDES-AEGYPTI;
   DENGUE-VIRUS; CROSS-REACTIVITY; GENE DRIVE; BRAZIL; MOSQUITO; PACIFIC;
   ISLAND
AB Zika virus (ZIKV) is an emerging arbovirus infection endemic in multiple countries spread from Asia, Africa to the Americas and Europe. Previously known to cause rare and fairly benign human infections, ZIKV has become a major international public health emergency after being linked to unexpected neurological complications, that includes fetal brain damage/death and microcephaly in babies born to infected mothers and Guillain-Barre syndrome (GBS) in adults. It appears that a single genetic mutation in the ZIKV genome, likely acquired during explosive ZIKV outbreak in French Polynesia (2013), made virus causing mild disease to target fetus brain. The Aedes mosquitoes are found to be the main carrier of ZIKV, passing the virus to humans. Originally isolated from patients in Africa in 1954 (African lineage), virus disseminated to Southeast Asia (Asian lineage), establishing new endemic foci, including one in India. Numerous cases of ZIKV infection have been reported in several locations in India and neighboring countries like Pakistan and Bangladesh since mid of the last century, suggesting that the virus reached this part of Asia soon after it was first discovered in Uganda in 1947. Although, the exact means by which ZIKV was introduced to India remains unknown, it appears that the ZIKV strain circulating in India possibly belongs to the "Asian lineage," which has not yet been associated with microcephaly and other neurological disorders. However, there still exists a threat that the contemporary ZIKV virulent strain from South America, carrying a mutation can return to Asia, posing a potential crisis to newborns and adult patients. Currently there is no specific vaccine or antiviral medication to combat ZIKV infection, thus, vector control and continuous monitoring of potential ZIKV exposure is essential to prevent the devastating consequences similar to the ones experienced in Brazil. However, the major obstacle faced by Indian healthcare agencies is that most cases of ZIKV infection have been reported in rural areas that lack access to rapid diagnosis of infection. In this review, we attempt to present a comprehensive analysis of what is currently known about the ZIKV infection in India and the neighboring countries.
C1 [Khaiboullina, Svetalana; Uppal, Timsy; Verma, Subhash C.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.
   [Khaiboullina, Svetalana; Martynova, Ekaterina; Rizvanov, Albert] Kazan Fed Univ, Sci & Educ Ctr Pharmaceut, Dept Exploratory Res, Kazan, Russia.
   [Baranwal, Manoj] Thapar Inst Engn & Technol, Dept Biotechnol, Patiala, Punjab, India.
RP Verma, SC (corresponding author), Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.
EM scverma@medicine.nevada.edu
RI Rizvanov, Albert/H-4486-2013; Baranwal, Manoj/W-9186-2019; Khaiboullina,
   Svetlana/M-4793-2016
OI Rizvanov, Albert/0000-0002-9427-5739; Baranwal,
   Manoj/0000-0002-6581-9346; Uppal, Timsy/0000-0001-6264-4635;
   Khaiboullina, Svetlana/0000-0002-5064-570X
FU Russian Government Program of Competitive Growth; Ministry of Education
   and Science of Russian FederationMinistry of Education and Science,
   Russian Federation [20.5175.2017/6.7]; Nevada INBRE grant
FX Kazan Federal University was supported by the Russian Government Program
   of Competitive Growth. AR was supported by state assignment
   20.5175.2017/6.7 of the Ministry of Education and Science of Russian
   Federation. The work was supported by the Nevada INBRE grant.
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bhattacharya S, 2005, PERSPECTIVES ENV HLT, P53
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carrio A, 2015, SENSORS-BASEL, V15, P29569, DOI 10.3390/s151129569
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chakraborty S, 1986, B CAL SCH TROP MED, V34, P15
   Choi JR, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201600920
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Moreno MD, 2017, GUT, V66, P250, DOI 10.1136/gutjnl-2015-310148
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2016, MOSQ MAPS NEW INF AR
   European Centre for Disease Prevention and Control, 2016, EP UPD OUT ZIK VIR C
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hammond AM, 2017, PATHOG GLOB HEALTH, V111, P412, DOI 10.1080/20477724.2018.1438880
   James P., 2016, COMMITTEE GENE DRIVE
   Kalra N. L, 1997, PREVALENCE AEDES AEG
   Kouri G, 1998, EMERG INFECT DIS, V4, P89
   Kumari R, 2011, TROP MED INT HEALTH, V16, P949, DOI 10.1111/j.1365-3156.2011.02789.x
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   Magambo KA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19040
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Mohamed M, 2017, VIRCHOWS ARCH, V471, P631, DOI 10.1007/s00428-017-2207-y
   Mukhopadhyay A. K., 1978, B CAL SCH TROP MED, V26, P5
   Muraduzzaman AKM, 2017, ASIAN PAC J TROP MED, V10, P925, DOI 10.1016/j.apjtm.2017.08.015
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Public Health England, 2017, CLIN ADV ZIK ASS PRE
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Reiter P., 1997, SURVEILLANCE CONTROL
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Russell JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23641-7
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sapkal GN, 2018, J INFECTION, V76, P314, DOI 10.1016/j.jinf.2017.09.020
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2016, ZIK SIT REP NEUR SYN
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   Zander C, 2016, DENMARK REPORTS 1 CA
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 84
TC 5
Z9 5
U1 1
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD SEP 12
PY 2018
VL 9
AR 2126
DI 10.3389/fmicb.2018.02126
PG 8
WC Microbiology
SC Microbiology
GA GT3IM
UT WOS:000444395200001
PM 30258421
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zambrana, JV
   Carrillo, FB
   Burger-Calderon, R
   Collado, D
   Sanchez, N
   Ojeda, S
   Monterrey, JC
   Plazaola, M
   Lopez, B
   Arguello, S
   Elizondo, D
   Aviles, W
   Coloma, J
   Kuan, G
   Balmaseda, A
   Gordon, A
   Harris, E
AF Victor Zambrana, Jose
   Carrillo, Fausto Bustos
   Burger-Calderon, Raquel
   Collado, Damaris
   Sanchez, Nery
   Ojeda, Sergio
   Carey Monterrey, Jairo
   Plazaola, Miguel
   Lopez, Brenda
   Arguello, Sonia
   Elizondo, Douglas
   Aviles, William
   Coloma, Josefina
   Kuan, Guillermina
   Balmaseda, Angel
   Gordon, Aubree
   Harris, Eva
TI Seroprevalence, risk factor, and spatial analyses of Zika virus
   infection after the 2016 epidemic in Managua, Nicaragua
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; seroprevalence; cohort; risk factor; spatial analysis
ID SPECIFICITY; CHILDREN; COHORT; BRAZIL
AB In 2015, a Zika epidemic in Brazil began spreading throughout the Americas. Zika virus (ZIKV) entered Managua, Nicaragua, in January 2016 and caused an epidemic that peaked in July-September 2016. ZIKV seropositivity was estimated among participants of pediatric (n = 3,740) and household (n = 2,147) cohort studies, including an adult-only subset from the household cohort (n = 1,074), in Managua. Seropositivity was based on a highly sensitive and specific assay, the Zika NS1 blockade-of-binding ELISA, which can be used in dengue endemic populations. Overall seropositivity for the pediatric (ages 214), household (ages 2-80), and adult (ages 15-80) cohorts was 36, 46, and 56%, respectively. Trend, risk factor, and contour mapping analyses demonstrated that ZIKV seroprevalence increased nonlinearly with age and that body surface area was statistically associated with increasing seroprevalence in children. ZIKV seropositivity was higher in females than in males across almost all ages, with adjusted prevalence ratios in children and adults of 1.11 (95% CI: 1.02-1.21) and 1.14 (95% CI: 1.01-1.28), respectively. No household-level risk factors were statistically significant in multivariate analyses. A spatial analysis revealed a 10-15% difference in the risk of ZIKV infections across our 3-km-wide study site, suggesting that ZIKV infection risk varies at small spatial scales. To our knowledge, this is the largest ZIKV seroprevalence study reported in the Americas, and the only one in Central America and in children to date. It reveals a high level of immunity against ZIKV in Managua as a result of the 2016 epidemic, making a second large Zika epidemic unlikely in the near future.
C1 [Victor Zambrana, Jose; Burger-Calderon, Raquel; Collado, Damaris; Sanchez, Nery; Ojeda, Sergio; Carey Monterrey, Jairo; Plazaola, Miguel; Lopez, Brenda; Arguello, Sonia; Elizondo, Douglas; Aviles, William; Balmaseda, Angel] Sustainable Sci Inst, Managua 14007, Nicaragua.
   [Carrillo, Fausto Bustos; Burger-Calderon, Raquel; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Carrillo, Fausto Bustos] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.
   [Kuan, Guillermina] Minist Hlth, Hlth Ctr Socrates Flores Vivas, Managua 12014, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua 16064, Nicaragua.
   [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
RI Gordon, Aubree/X-1113-2019; Zambrana, Jose Victor/Q-3214-2019
OI Gordon, Aubree/0000-0002-9352-7877; Zambrana, Jose
   Victor/0000-0003-0107-6173; COLLADO GARCIA, DAMARIS
   LISANGELES/0000-0002-0878-3260; Bustos Carrillo,
   Fausto/0000-0002-7263-5625
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01AI106695, R01AI099631,
   R01AI121721]
FX We thank Davide Corti at Humabs Biomed SA, subsidiary of Vir
   Biotechnology, Inc., for his generous donation of biotinylated ZKA35
   monoclonal antibody. We thank the outstanding study team of the
   Nicaraguan Pediatric Dengue Cohort Study and the Household Influenza
   Cohort Study at the Centro de Salud Socrates Flores Vivas (Nicaraguan
   Ministry of Health), the Laboratorio Nacional de Virologia at the Centro
   Nacional de Diagnostico y Referencia (Nicaraguan Ministry of Health),
   and the Sustainable Sciences Institute, as well as the study
   participants and their families. We also thank the Nicaraguan Ministry
   of Health for providing surveillance data for the Zika cases in Managua
   that were tested and confirmed by rRT-PCR. This work was supported by
   the National Institute of Allergy and Infectious Diseases of the
   National Institutes of Health via Grants P01AI106695 (to E.H.),
   R01AI099631 (to A.B.), and R01AI121721 (to A.G.).
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Arostegui J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4296-6
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010
   de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Direccion General de Vigilancia para la Salud Ministerio del Poder Ciudadano para la Salud de Nicaragua Managua Nicaragua, 2017, Rev Panam Salud Publica, V41, pe59
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gordon A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1256-6
   Haque U, 2016, ACTA TROP, V162, P5, DOI 10.1016/j.actatropica.2016.06.010
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Hastie T, 1986, STAT SCI, V1, P297, DOI DOI 10.1214/SS/1177013604
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nicaragua Ministry of Health, 2016, EPIDEMIOLOGICAL B, V52
   Pan American Health Organization, 2018, PAHO ZIK CUM CAS
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP NIC
   Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x
   PORT GR, 1980, B ENTOMOL RES, V70, P133, DOI 10.1017/S0007485300009834
   ProMED-PORT, 2015, DOENC DESC BRAS 02 B
   R Core Team, 2017, R LANG ENV STAT COMP
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales Alfonso J, 2017, Infez Med, V25, P241
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vito Michele Rosario M, 2018, R NEWS, V8, P20
   WHO/Institut Pasteur/ISARIC/CONSISE, 2017, STAND PROT CROSS SEC
   Wood S. N., 2017, GEN ADDITIVE MODELS
   Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374
   Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759
NR 52
TC 19
Z9 19
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 11
PY 2018
VL 115
IS 37
BP 9294
EP 9299
DI 10.1073/pnas.1804672115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT1SZ
UT WOS:000444257200072
PM 30150394
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Koblischke, M
   Stiasny, K
   Aberle, SW
   Malafa, S
   Tsouchnikas, G
   Schwaiger, J
   Kundi, M
   Heinz, FX
   Aberle, JH
AF Koblischke, Maximilian
   Stiasny, Karin
   Aberle, Stephan W.
   Malafa, Stefan
   Tsouchnikas, Georgios
   Schwaiger, Julia
   Kundi, Michael
   Heinz, Franz X.
   Aberle, Judith H.
TI Structural Influence on the Dominance of Virus-Specific CD4 T Cell
   Epitopes in Zika Virus Infection (vol 9, 1196, 2018)
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Correction
DE Zika virus; flavivirus; CD4 T cell; immunodominance; epitope; Zika
   patients
C1 [Koblischke, Maximilian; Stiasny, Karin; Aberle, Stephan W.; Malafa, Stefan; Tsouchnikas, Georgios; Schwaiger, Julia; Heinz, Franz X.; Aberle, Judith H.] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria.
RP Aberle, JH (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM judith.aberle@meduniwien.ac.at
OI Aberle, Judith H/0000-0003-1197-3935; Malafa, Stefan/0000-0002-0222-9832
CR Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
NR 1
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 11
PY 2018
VL 9
AR 2083
DI 10.3389/fimmu.2018.02083
PG 1
WC Immunology
SC Immunology
GA GT2NJ
UT WOS:000444331200004
PM 30254648
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bharati, M
   Saha, D
AF Bharati, Minu
   Saha, Dhiraj
TI Multiple insecticide resistance mechanisms in primary dengue vector,
   Aedes aegypti (Linn.) from dengue endemic districts of sub-Himalayan
   West Bengal, India
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI; ANOPHELES-GAMBIAE; CROSS-RESISTANCE; IDENTIFICATION;
   ALBOPICTUS; IMPACT; GENE; DDT
AB Background
   Mosquitoes belonging to genus Aedes are the prime vectors of several arboviral diseases such as Dengue, Zika and Chikungunya worldwide. Every year numerous cases of dengue infections occur throughout the world, proper control of which depends on efficient vector control. However the onset of insecticide resistance has resulted in failure of vector control approaches.
   Principal findings
   This study was carried out to unveil the degree of prevailing insecticide resistance along with its underlying mechanisms among the primary dengue vector in dengue endemic districts of West Bengal, India through standard WHO protocol. It was observed that, the majority of the tested populations were found to possess resistance to more than one insecticide. In adult bioassay, the toxicity levels of the six tested insecticides was found to decrease in the following order: deltamethrin > lambdacyhalothrin > malathion > propoxur > permethrin > DDT. In larval bioassay, one of the tested populations was found to possess moderate resistance against temephos, mortality percentage 92.5% and 79.8% for WHO (0.0200 ppm) and National Vector Borne disease Programme, India recommended dose (0.0125 ppm) respectively. Carboxylesterases were found to be involved in conferring resistance as revealed in synergistic and quantitative assay against temephos in North Dinajpur (NDP) population and malathion in Alipurduar (APD) and Darjeeling (DAR) populations. Similar correlations were also observed in the majority of the tested populations between reduced susceptibilities against pyrethroid insecticides and Cytochrome P450S activity.
   Conclusion
   Efficient disease management in this region can only be achieved through proper integrated vector management along with tools to minimize insecticide resistance. This study may help the concerned authorities in the formulation of an effective vector control strategy throughout this region incorporating the knowledge gained through this study.
C1 [Bharati, Minu; Saha, Dhiraj] Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, PO North Bengal Univ, Siliguri, W Bengal, India.
RP Saha, D (corresponding author), Univ North Bengal, Dept Zool, Insect Biochem & Mol Biol Lab, PO North Bengal Univ, Siliguri, W Bengal, India.
EM dhirajsaha.nbu@gmail.com
CR Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Bharati Minu, 2018, Proceedings of the Zoological Society (Calcutta), V71, P239, DOI 10.1007/s12595-016-0193-8
   Bharati M, 2017, ACTA TROP, V170, P112, DOI 10.1016/j.actatropica.2017.02.029
   Bisset JA, 2013, J MED ENTOMOL, V50, P352, DOI 10.1603/ME12064
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Chatterjee M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006192
   Choovattanapakorn N., 2017, Medical Entomology and Zoology, V68, P19
   Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P203, DOI 10.2987/11-6198R.1
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   Gupta N, 2012, INDIAN J MED RES, V136, P373
   Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Karunaratne SHPP, 2001, B WORLD HEALTH ORGAN, V79, P1060
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   National Vector Borne Disease Control Programme, 2017, NVBDCP DENG
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Paiva MHS, 2016, GENOMICS, V107, P40, DOI 10.1016/j.ygeno.2015.11.004
   Philbert A., 2014, ADV ENTOMOL, V2, P120, DOI DOI 10.4236/ae.2014.23019
   Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Ranson H, 2010, TROP NET, V1, P2078
   Sharma S. N., 2004, Journal of Communicable Diseases, V36, P177
   Tyagi B.K., 2015, INT J MOSQ RES B, V2, P50
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
   WHO, 2006, GUID TEST MOSQ AD IN
   WHO, 1998, TEST PROC INREMO
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
NR 36
TC 6
Z9 6
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 10
PY 2018
VL 13
IS 9
AR e0203207
DI 10.1371/journal.pone.0203207
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT7DK
UT WOS:000444681100012
PM 30199543
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vouga, M
   Musso, D
   Goorhuis, A
   Freedman, DO
   Baud, D
AF Vouga, Manon
   Musso, Didier
   Goorhuis, Abraham
   Freedman, David O.
   Baud, David
TI Updated Zika virus recommendations are needed
SO LANCET
LA English
DT Letter
C1 [Vouga, Manon; Baud, David] Univ Lausanne Hosp, Dept Woman Mother Child, Maternofetal & Obstet Res Unit Obstetr Serv, CH-1011 Lausanne, Switzerland.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Musso, Didier] Aix Marseille Univ, AP HM, IRD, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Goorhuis, Abraham] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Ctr Trop Med & Travel Med,Dept Infect Dis, Amsterdam, Netherlands.
   [Freedman, David O.] Univ Alabama Birmingham, William C Gorgas Ctr Geog Med, Div Infect Dis, Birmingham, AL USA.
RP Baud, D (corresponding author), Univ Lausanne Hosp, Dept Woman Mother Child, Maternofetal & Obstet Res Unit Obstetr Serv, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496; Freedman, David O./0000-0002-5642-5257
CR European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Musso D, 2018, CLIN MICROBIOL INFEC, V24, P566, DOI 10.1016/j.cmi.2018.03.007
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   WHO, 2016, INT GUID
NR 5
TC 5
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD SEP 8
PY 2018
VL 392
IS 10150
BP 818
EP 819
DI 10.1016/S0140-6736(18)31827-0
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GT0KV
UT WOS:000444130000022
PM 30146329
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, BJ
   Liao, HM
   Liu, HB
   Tsai, S
   Zhang, J
   Hung, GC
   Chin, PJ
   Gao, YM
   Lo, SC
AF Li, Bingjie
   Liao, Hsiao-Mei
   Liu, Hebing
   Tsai, Shien
   Zhang, Jing
   Hung, Guo-Chiuan
   Chin, Pei-Ju
   Gao, Yamei
   Lo, Shyh-Ching
TI Comparative genomics, infectivity and cytopathogenicity of Zika viruses
   produced by acutely and persistently infected human hematopoietic cell
   lines
SO PLOS ONE
LA English
DT Article
ID WEST-NILE-VIRUS; BLOOD MONONUCLEAR-CELLS; CONFERS RESISTANCE; 2K
   PEPTIDE; STRAINS; PROTEIN; NS4A; TRANSMISSION; FLAVIVIRUS; MUTATION
AB Zika virus (ZIKV), an arthropod-borne virus, has emerged as a major human pathogen. Prolonged or persistent ZIKV infection of human cells and tissues may serve as a reservoir for the virus and present serious challenges to the safety of public health. Human hematopoietic cell lines with different developmental properties revealed differences in susceptibility and outcomes to ZIKV infection. In three separate studies involving the prototypic MR 766 ZIKV strain and the human monocytic leukemia U937 cell line, ZIKV initially developed only a low-grade infection at a slow rate. After continuous culture for several months, persistently ZIKV-infected cell lines were observed with most, if not all, cells testing positive for ZIKV antigen. The infected cultures produced ZIKV RNA (v-RNA) and infectious ZIKVs persistently ("persistent ZIKVs") with distinct infectivity and pathogenicity when tested using various kinds of host cells. When the genomes of ZIKVs from the three persistently infected cell lines were compared with the genome of the prototypic MR 766 ZIKV strain, distinct sets of mutations specific to each cell line were found. Significantly, all three "persistent ZIKVs" were capable of infecting fresh U937 cells with high efficiency at rapid rates, resulting in the development of a new set of persistently ZIKV-infected U937 cell lines. The genomes of ZIKVs from the new set of persistently ZIKV-infected U937 cell lines were further analyzed for their different mutations. The 2nd generation of persistent ZIKVs continued to possess most of the distinct sets of mutations specific to the respective 1st generation of persistent ZIKVs. We anticipate that the study will contribute to the understanding of the fundamental biology of adaptive mutations and selection during viral persistence. The persistently ZIKV-infected human cell lines that we developed will also be useful to investigate critical molecular pathways of ZIKV persistence and to study drugs or countermeasures against ZIKV infections and transmission.
C1 [Li, Bingjie; Liao, Hsiao-Mei; Liu, Hebing; Tsai, Shien; Zhang, Jing; Hung, Guo-Chiuan; Chin, Pei-Ju; Lo, Shyh-Ching] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies,Ctr Biol Evaluat & Re, Silver Spring, MD 20993 USA.
   [Gao, Yamei] US FDA, Lab Pediat & Resp Viral Dis, Div Viral Prod, Off Vaccines Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA.
RP Lo, SC (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Tissues & Adv Therapies,Ctr Biol Evaluat & Re, Silver Spring, MD 20993 USA.
EM shyhching.lo@fda.hhs.gov
OI , Pei-Ju/0000-0001-8892-7465
FU FDA Modernizing Science grant; FDA Zika supplement fund; Protein and
   Nucleic Acid Laboratory under Facility for Biotechnology Resources,
   Center for Biologics Evaluation and Research, Food and Drug
   Administration
FX This work was supported in part by the FDA Modernizing Science grant and
   FDA Zika supplement fund. The funders had no role in study design, data
   collection and interpretation or preparation of the manuscript for
   publication.; The viral RNA genome sequencing was supported by the
   Protein and Nucleic Acid Laboratory under Facility for Biotechnology
   Resources, Center for Biologics Evaluation and Research, Food and Drug
   Administration.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Burkhalter KL, 2018, J MED ENTOMOL, V55, P717, DOI 10.1093/jme/tjy005
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Campbell CL, 2014, VIROLOGY, V464, P228, DOI 10.1016/j.virol.2014.07.009
   Carossino M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2852-4
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Ding XH, 2005, AM J TROP MED HYG, V73, P803, DOI 10.4269/ajtmh.2005.73.803
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   Feng GH, 2002, CHINESE MED J-PEKING, V115, P1324
   Giersing BK, 2019, VACCINE, V37, P7315, DOI 10.1016/j.vaccine.2016.10.090
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Jean Michel M, 2017, EMERG INFECT DIS, V23, DOI [10.1007/s00705-006-0903-z, DOI 10.1007/S00705-006-0903-Z]
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Saxena V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002275
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Stanley E., 2009, Morbidity and Mortality Weekly Report, V58, P1263
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang SM, 2004, BLOOD, V104, P4252, DOI 10.1182/blood-2004-04-1245
   Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003
NR 39
TC 4
Z9 4
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 7
PY 2018
VL 13
IS 9
AR e0203331
DI 10.1371/journal.pone.0203331
PG 28
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT0BU
UT WOS:000444093600060
PM 30192813
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stauft, CB
   Shen, SH
   Song, YT
   Gorbatsevych, O
   Asare, E
   Futcher, B
   Mueller, S
   Payne, A
   Brecher, M
   Kramer, L
   Wimmer, E
AF Stauft, Charles B.
   Shen, Sam H.
   Song, Yutong
   Gorbatsevych, Oleksandr
   Asare, Emmanuel
   Futcher, Bruce
   Mueller, Steffen
   Payne, Anne
   Brecher, Matthew
   Kramer, Laura
   Wimmer, Eckard
TI Extensive recoding of dengue virus type 2 specifically reduces
   replication in primate cells without gain-of-function in Aedes aegypti
   mosquitoes
SO PLOS ONE
LA English
DT Article
ID CODON-PAIR BIAS; INFLUENZA-VIRUS; STRAIN 16681; ATTENUATION; POLIOVIRUS;
   GENOME; VACCINE; RNA; DEOPTIMIZATION; CDNA
AB Dengue virus (DENV), an arthropod-borne ("arbovirus") virus, causes a range of human maladies ranging from self-limiting dengue fever to the life-threatening dengue shock syndrome and proliferates well in two different taxa of the Animal Kingdom, mosquitoes and primates. Mosquitoes and primates show taxonomic group-specific intolerance to certain codon pairs when expressing their genes by translation. This is called "codon pair bias". By necessity, dengue viruses evolved to delicately balance this fundamental difference in their open reading frames (ORFs). We have undone the evolutionarily conserved genomic balance in the DENV2 ORF sequence and specifically shifted the encoding preference away from primates. However, this recoding of DENV2 raised concerns of 'gain-of-function,' namely whether recoding could inadvertently increase fitness for replication in the arthropod vector. Using mosquito cell lines and two strains of Aedes aegypti we did not observe any increase in fitness in DENV2 variants codon pair deoptimized for humans. This ability to disrupt and control DENV2' s host preference has great promise towards developing the next generation of synthetic vaccines not only for DENV but for other emerging arboviral pathogens such as chikungunya virus and Zika virus.
C1 [Stauft, Charles B.; Shen, Sam H.; Song, Yutong; Gorbatsevych, Oleksandr; Asare, Emmanuel; Futcher, Bruce; Mueller, Steffen; Wimmer, Eckard] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.
   [Stauft, Charles B.; Mueller, Steffen; Wimmer, Eckard] Codagenix Inc, Farmingdale, NY 11735 USA.
   [Payne, Anne; Brecher, Matthew; Kramer, Laura] New York State Dept Hlth, Wadsworth Ctr, Slingerlands, NY USA.
   [Kramer, Laura] SUNY Albany, Sch Publ Hlth, Albany, NY USA.
RP Wimmer, E (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.; Wimmer, E (corresponding author), Codagenix Inc, Farmingdale, NY 11735 USA.
EM eckard.wimmer@stonybrook.edu
OI Gorbatsevych, Oleksandr/0000-0002-2159-1490; Brecher,
   Matthew/0000-0003-1151-2290
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [5R01AI110792,
   5R21AI126048]
FX This work was supported by the National Institute of Health (NIH)
   Research Project (R01) grant for project #5R01AI110792 entitled
   "Tailoring virulence of dengue virus in mammals and mosquitoes." Our
   work was also funded by another National Institute of Health (NIH)
   Exploratory/Developmental Grant (R21) for project #5R21AI126048.
CR Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Broadbent AJ, 2016, VACCINE, V34, P563, DOI 10.1016/j.vaccine.2015.11.054
   Buchan R, 2005, BMC BIOINFORMATICS, V6, pP4, DOI [10.1186/1471-2105-6-S3-P4, DOI 10.1186/1471-2105-6-S3-P4]
   Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09
   Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000
   Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184
   Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Coffin JM, 2008, NEW ENGL J MED, V359, P2283, DOI 10.1056/NEJMcibr0805820
   Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fields B.N., 2013, FIELDS VIROLOGY
   Futcher B, 2015, P NATL ACAD SCI USA, V112, pE3635, DOI 10.1073/pnas.1507710112
   GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0
   Jin H, 2004, J VIROL, V78, P995, DOI 10.1128/JVI.78.2.995-998.2004
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Klitting R, 2018, BIORXIV, DOI [10.1101/256610, DOI 10.1101/256610]
   KUNO G, 1982, INTERVIROLOGY, V18, P45, DOI 10.1159/000149303
   Le Nouen C, 2017, P NATL ACAD SCI USA, V114, pE386, DOI 10.1073/pnas.1619242114
   Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636
   Mueller S, 2009, CHEM BIOL, V16, P337, DOI 10.1016/j.chembiol.2009.03.002
   National Academies of Sciences E Affairs P and G Committee on Science T Management C on DUR of CO for F, 2017, MAN DUAL US RES CONC
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Ni YY, 2014, VIROLOGY, V450, P132, DOI 10.1016/j.virol.2013.12.009
   Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172
   Paul AV, 2000, VIROLOGY, V272, P72, DOI 10.1006/viro.2000.0354
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427
   Schaeffer E, 2015, J INVEST DERMATOL, V135, P1743, DOI 10.1038/jid.2014.525
   Segundo FDS, 2016, J VIROL, V90, P1298, DOI 10.1128/JVI.02167-15
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Shen SH, 2006, REV CELL BIOL MOL ME, DOI [10.1002/3527600906.mcb.20120059/abstract, DOI 10.1002/3527600906.MCB.20120059/ABSTRACT]
   Simmen MW, 2008, GENOMICS, V92, P33, DOI 10.1016/j.ygeno.2008.03.009
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Singh KRP, 1971, ARTHROPOD CELL CULTU, P127, DOI [10.1007/978-3-642-65224-0_20, DOI 10.1007/978-3-642-65224-0_20]
   Song YT, 2017, P NATL ACAD SCI USA, V114, pE8731, DOI 10.1073/pnas.1714385114
   Stauft CB, 2018, SYNTHETIC VIRUSES EL, DOI [10.1002/9780470015902.a0027771/abstract, DOI 10.1002/9780470015902.A0027771/ABSTRACT]
   Stauft CB, 2017, SYNTHETIC VIRUSES EL
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Toyoda H, 2007, CANCER RES, V67, P2857, DOI 10.1158/0008-5472.CAN-06-3713
   Toyoda H, 2011, INT J ONCOL, V38, P81, DOI 10.3892/ijo_00000826
   Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392
   Wang BY, 2015, MBIO, V6, DOI 10.1128/mBio.00237-15
   Wikan N, 2009, J VIROL METHODS, V157, P227, DOI 10.1016/j.jviromet.2008.12.019
   Wimmer E, 2006, EMBO REP, V7, pS3, DOI 10.1038/sj.embor.7400728
   Wimmer E, 2011, ANNU REV MICROBIOL, V65, P583, DOI 10.1146/annurev-micro-090110-102957
   Wimmer E, 2009, NAT BIOTECHNOL, V27, P1163, DOI 10.1038/nbt.1593
   Yang C, 2013, P NATL ACAD SCI USA, V110, P9481, DOI 10.1073/pnas.1307473110
   Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044
NR 60
TC 4
Z9 4
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 7
PY 2018
VL 13
IS 9
AR e0198303
DI 10.1371/journal.pone.0198303
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GT0BU
UT WOS:000444093600003
PM 30192757
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Murthy, BP
   Vagi, S
   Desamu-Thorpe, R
   Avchen, R
AF Murthy, Bhavini Patel
   Vagi, Sara
   Desamu-Thorpe, Rodel
   Avchen, Rachel
TI Assessment of State, Local, and Territorial Zika Planning and
   Preparedness Activities - United States, June 2016-July 2017
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID VIRUS-INFECTION; PREGNANCY
C1 [Murthy, Bhavini Patel] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Murthy, Bhavini Patel; Vagi, Sara; Desamu-Thorpe, Rodel; Avchen, Rachel] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
RP Murthy, BP (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Murthy, BP (corresponding author), CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
EM bmurthy@cdc.gov
FU Zika response; CDC's State Coordination Task Force; Data Collation and
   Integration for Public Health Event Response Team; Public Health
   Emergency Preparedness specialists
FX The 53 jurisdictions funded to support the Zika response; CDC's State
   Coordination Task Force; the Data Collation and Integration for Public
   Health Event Response Team; Public Health Emergency Preparedness
   specialists.
CR CDC, 2016, ZAP SUMM ARCH PLANN
   CDC, 2016, EST RANG AED ALB AED
   CDC, 2016, PHPR FUND ZIK PREP R
   CDC, 2016, FUND GUID STAT LOC H
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 6
TC 1
Z9 1
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD SEP 7
PY 2018
VL 67
IS 35
BP 969
EP 973
DI 10.15585/mmwr.mm6735a2
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GS8WV
UT WOS:000443996300001
PM 30188883
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Li, Y
   Loh, YR
   Hung, AW
   Kang, CB
AF Li, Yan
   Loh, Ying Ru
   Hung, Alvin W.
   Kang, CongBao
TI Characterization of molecular interactions between Zika virus protease
   and peptides derived from the C-terminus of NS2B
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Zika virus; Protease; Protease inhibitor; NMR spectroscopy; Protein
   dynamics
ID WEST-NILE-VIRUS; DENGUE VIRUS; STRUCTURAL-CHARACTERIZATION; NS3
   PROTEASE; MEMBRANE TOPOLOGY; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; NS4B
   PROTEIN; INHIBITORS; COMPLEX
AB Zika virus (ZIKV) protease is a two-component complex in which NS3 contains the catalytic triad and NS2B cofactor region is important for protease folding and activity. A protease construct-eZiPro without the transmembrane domains of NS2B was designed. Structural study on eZiPro reveals that the Thr-GlyLys-Arg (TGKR) sequence at the C-terminus of NS2B binds to the active site after cleavage. The bZiPro construct only contains NS2B cofactor region and the N-terminus of NS3 without any artificial linker or protease cleavage site, giving rise to an empty pocket accessible to substrate and inhibitor binding. Herein, we demonstrate that the TGKR sequence of NS2B in eZiPro is dynamic. Peptides from NS2B with various lengths exhibit different binding affinities to bZiPro. TGKR binding to the active site in eZiPro does not affect protease binding to small-molecule compounds. Our results suggest that eZiPro will also be useful for evaluating small-molecule protease inhibitors. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Li, Yan; Loh, Ying Ru; Hung, Alvin W.; Kang, CongBao] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
RP Kang, CB (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
EM cbkang@etc.a-star.edu.sg
RI Li, Yan/G-4642-2013; Kang, Congbao/AAP-7572-2020
OI Li, Yan/0000-0003-1963-839X; Kang, Congbao/0000-0002-9886-9374
FU A*STAR JCO grantAgency for Science Technology & Research (ASTAR)
   [1431AFG102/1331A028]
FX We thank the support from A*STAR JCO grant (1431AFG102/1331A028).
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089
   Huang QW, 2013, PROTEIN EXPRES PURIF, V92, P156, DOI 10.1016/j.pep.2013.09.015
   Huang QW, 2011, PROTEIN EXPRES PURIF, V80, P169, DOI 10.1016/j.pep.2011.08.008
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Y, 2016, ANGEW CHEM INT EDIT, V55, P12068, DOI 10.1002/anie.201606609
   Li Y, 2015, FEBS LETT, V589, P2683, DOI 10.1016/j.febslet.2015.07.044
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Liew LSY, 2016, PROTEIN EXPRES PURIF, V121, P141, DOI 10.1016/j.pep.2016.02.001
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shannon AE, 2016, PROTEIN EXPRES PURIF, V119, P124, DOI 10.1016/j.pep.2015.11.022
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Yildiz M., 2013, ACS CHEM BIOL, V17, P76
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 40
TC 5
Z9 6
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 5
PY 2018
VL 503
IS 2
BP 691
EP 696
DI 10.1016/j.bbrc.2018.06.062
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GR5VY
UT WOS:000442711200044
PM 29908184
DA 2020-07-08
ER

PT J
AU Tao, ZY
   Cao, RY
   Yan, YZ
   Huang, GC
   Lv, K
   Li, W
   Geng, YH
   Zhao, L
   Wang, AP
   He, QH
   Yang, JJ
   Fan, SY
   Huang, MH
   Guo, HY
   Zhong, W
   Liu, M
AF Tao, Zeyu
   Cao, Ruiyuan
   Yan, Yunzheng
   Huang, Guocheng
   Lv, Kai
   Li, Wei
   Geng, Yunhe
   Zhao, Lei
   Wang, Apeng
   He, Qinghao
   Yang, Jingjing
   Fan, Shiyong
   Huang, Menghao
   Guo, Huiyuan
   Zhong, Wu
   Liu, Mingliang
TI Design, synthesis and in vitro anti-Zika virus evaluation of novel
   Sinefungin derivatives
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Anti-Zika virus; Sinefungin; EPZ004777; Structure-activity
   relationships; Methyltransferases
ID METHYLTRANSFERASE; METHYLATION; DISCOVERY; PROTEIN; A9145
AB We report herein the design and synthesis of a series of novel Sinefungin (SIN) derivatives, based on the structures of SIN and its analogue EPZ004777. Our results reveal that target compounds 1ad-af, 1ba-bb and 1bf-bh show better activity (IC50 = 4.56-20.16 mu M) than EPZ004777 (IC50 = 35.19 mu M). Surprisingly, SIN was founded to be not as active (IC50 > 50 mu M) as we and other research groups predicted. Interestingly, the intermediates 9a-b and 11b display potent anti-ZIKV potency (IC50 = 6.33-29.98 mu M), and compound 9a also exhibits acceptable cytotoxicity (CC50 > 200 mu M), suggesting their promising potential to be leads for further development. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Tao, Zeyu; Huang, Guocheng; Lv, Kai; Geng, Yunhe; Wang, Apeng; Guo, Huiyuan; Liu, Mingliang] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.
   [Tao, Zeyu; Huang, Guocheng; Lv, Kai; Geng, Yunhe; Wang, Apeng; Guo, Huiyuan; Liu, Mingliang] Peking Union Med Coll, Beijing 100050, Peoples R China.
   [Cao, Ruiyuan; Yan, Yunzheng; Li, Wei; Zhao, Lei; He, Qinghao; Yang, Jingjing; Fan, Shiyong; Zhong, Wu] Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Emergence Drugs, Beijing 100850, Peoples R China.
   [Huang, Menghao] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.
RP Lv, K; Liu, M (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.; Lv, K; Liu, M (corresponding author), Peking Union Med Coll, Beijing 100050, Peoples R China.
EM lvkailk@hotmail.com; lmllyx@126.com
RI Huang, Menghao/I-3104-2019
OI Huang, Menghao/0000-0002-2389-8680
FU NSFCNational Natural Science Foundation of China [81502923, 81773631,
   81302702]; National S&T Major Special Project on Major New Drug
   Innovations [2018ZX09711001-007-002]
FX This work was financially supported by NSFC (81502923, 81773631,
   81302702), National S&T Major Special Project on Major New Drug
   Innovations (2018ZX09711001-007-002).
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076900
   Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009
   DUBE DK, 1983, AM J TROP MED HYG, V32, P31, DOI 10.4269/ajtmh.1983.32.31
   GORDEE RS, 1973, J ANTIBIOT, V26, P466, DOI 10.7164/antibiotics.26.466
   HAMILL RL, 1973, J ANTIBIOT, V26, P463, DOI 10.7164/antibiotics.26.463
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Koppolu V, 2018, J NEUROVIROL, V24, P255, DOI 10.1007/s13365-018-0614-8
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   PUGH CSG, 1982, BIOCHEMISTRY-US, V21, P1535, DOI 10.1021/bi00536a011
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   WHO, HIST ZIK VIR
   Xia HJ, 2018, ACS INFECT DIS, V4, P656, DOI 10.1021/acsinfecdis.8b00004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zingg JM, 1996, NUCLEIC ACIDS RES, V24, P3267, DOI 10.1093/nar/24.16.3267
NR 18
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD SEP 5
PY 2018
VL 157
BP 994
EP 1004
DI 10.1016/j.ejmech.2018.08.057
PG 11
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GX1LY
UT WOS:000447480000071
PM 30170321
DA 2020-07-08
ER

PT J
AU Sevvana, M
   Long, F
   Miller, AS
   Klose, T
   Buda, G
   Sun, L
   Kuhn, RJ
   Rossmann, MG
AF Sevvana, Madhumati
   Long, Feng
   Miller, Andrew S.
   Klose, Thomas
   Buda, Geeta
   Sun, Lei
   Kuhn, Richard J.
   Rossmann, Michael G.
TI Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at
   3.1 angstrom Resolution
SO STRUCTURE
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; WEST-NILE-VIRUS; DENGUE VIRUS; CRYOELECTRON
   MICROSCOPY; FAB FRAGMENTS; MATURATION; IMMATURE; ANTIBODY;
   NEUTRALIZATION; COMPLEX
AB Among the several arthropod-borne human flaviviral diseases, the recent outbreak of Zika virus (ZIKV) has caused devastating birth defects and neurological disorders, challenging the world with another major public health concern. We report here the refined structure of the mature ZIKV at a resolution of 3.1 angstrom as determined by cryo-electron microscopic single-particle reconstruction. The improvement in the resolution, compared with previous enveloped virus structures, was the result of optimized virus preparation methods and data processing techniques. The glycoprotein interactions and surface properties of ZIKV were compared with other mosquito-borne flavivirus structures. The largest structural differences and sequence variations occur at the glycosylation loop associated with receptor binding. Probable drug binding pockets were identified on the viral surface. These results also provide a structural basis for the design of vaccines against ZIKV.
C1 [Sevvana, Madhumati; Long, Feng; Miller, Andrew S.; Klose, Thomas; Buda, Geeta; Sun, Lei; Kuhn, Richard J.; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Sun, Lei] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai, Peoples R China.
   [Sun, Lei] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China.
RP Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
EM mr@purdue.edu
RI Sevvana, Madhumati/S-3297-2019
OI Sevvana, Madhumati/0000-0003-4992-6296
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI076331, AI073755]
FX The work described here was supported by NIH grant AI076331 to M.G.R.
   and R.J.K. and NIH grant AI073755 awarded to Michael S. Diamond (PI,
   Washington University in St. Louis) with a subaward to M.G.R. and R.J.K.
   We thank the Purdue Cryo-EM facility for their help and support and
   Yingyuan Sun (Nick) and Qianglin Fang for help with cryo-EM data
   collection. We are also grateful to the Purdue Rosen Center for Advanced
   Computing for research computing support. We thank S. Saif Hasan for
   discussions about the manuscript. We thank S. Kelly for help in
   preparing this manuscript.
CR Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   De La Guardia C, 2014, BIOMED RES INT, DOI 10.1155/2014/825039
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Fuzik T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02882-0
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Guo F, 2014, METHODS MOL BIOL, V1117, P401, DOI 10.1007/978-1-62703-776-1_19
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Mukherjee S, 2016, VIROLOGY, V497, P33, DOI 10.1016/j.virol.2016.06.022
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008
   Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013
   ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Suss J., 2008, EUROSURVEILLANCE, V13, P18916, DOI DOI 10.2807/ESE.13.26.18916-EN
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Wang ZQ, 2013, J VIROL, V87, P8909, DOI 10.1128/JVI.00472-13
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xiao CA, 2007, J STRUCT BIOL, V158, P182, DOI 10.1016/j.jsb.2006.10.013
   Yang JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000428
   Yu GM, 2016, J STRUCT BIOL, V195, P207, DOI 10.1016/j.jsb.2016.06.003
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
NR 75
TC 18
Z9 18
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD SEP 4
PY 2018
VL 26
IS 9
BP 1169
EP +
DI 10.1016/j.str.2018.05.006
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA GS3ZA
UT WOS:000443567100003
PM 29958768
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Graciaa, DS
   Collins, MH
   Wu, HM
AF Graciaa, Daniel S.
   Collins, Matthew H.
   Wu, Henry M.
TI Zika in 2018: Advising Travelers Amid Changing Incidence
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID VIRUS-INFECTION; WOMEN; CARE
C1 [Graciaa, Daniel S.] Emory Univ, Sch Med, Dept Family & Prevent Med, 1841 Clifton Rd,5th Floor, Atlanta, GA 30322 USA.
   [Collins, Matthew H.; Wu, Henry M.] Emory Univ, Sch Med, Atlanta, GA USA.
   [Collins, Matthew H.; Wu, Henry M.] Emory TravelWell Ctr, Med Off Tower 7,550 Peachtree St NE, Atlanta, GA 30308 USA.
RP Graciaa, DS (corresponding author), Emory Univ, Sch Med, Dept Family & Prevent Med, 1841 Clifton Rd,5th Floor, Atlanta, GA 30322 USA.
EM dsgraci@emory.edu
OI Graciaa, Daniel/0000-0002-9484-8488
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Centers for Disease Control and Prevention, 2018, ZIK VIR 2017 CAS COU
   Goldfarb IT, 2017, JAMA-J AM MED ASSOC, V318, P2075, DOI 10.1001/jama.2017.15680
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lammert S, 2017, EMERG INFECT DIS, V23, P324, DOI 10.3201/eid2302.161292
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
NR 10
TC 4
Z9 4
U1 0
U2 0
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD SEP 4
PY 2018
VL 169
IS 5
BP 337
EP +
DI 10.7326/M18-1112
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA GS2MV
UT WOS:000443385100015
PM 30014144
DA 2020-07-08
ER

PT J
AU Dabaja, MZ
   Lima, ED
   de Oliveira, DN
   Guerreiro, TM
   Melo, CFOR
   Morishita, KN
   Lancellotti, M
   Ruiz, ALTG
   Goulart, G
   Duarte, DA
   Catharino, RR
AF Dabaja, Mohamed Ziad
   Lima, Estela de Oliveira
   de Oliveira, Diogo Noin
   Guerreiro, Tatiane Melina
   Odir Rodrigues Melo, Carlos Fernando
   Morishita, Karen Noda
   Lancellotti, Marcelo
   Tasca Gois Ruiz, Ana Lucia
   Goulart, Gisele
   Duarte, Diego Andreazzi
   Catharino, Rodrigo Ramos
TI Metabolic alterations induced by attenuated Zika virus in glioblastoma
   cells
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Zika virus; Outer membrane vesicle; Prototype; Mass spectrometry; Cancer
   research
ID NF-KAPPA-B; ANTICANCER DRUG SCREEN; NITRIC-OXIDE SYNTHASE;
   TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; LYSOPHOSPHATIDIC ACID;
   IN-VIVO; METHIONINE SYNTHASE; HYDROGEN-PEROXIDE; FOLIC-ACID
AB Background: Zika virus (ZIKV) has recently become a major matter of concern since its association with microcephaly cases in newborns was determined. From then on, ZIKV has been untiringly studied, and several scientific data have shown the virus' tropism to neural cells. Previous studies have proposed that ZIKV induced glioblastoma cells death, suggesting that ZIKV and ZIKV-associated molecules might induce intracellular biochemical alterations, and thereby be alternatives for neural cancer management. In this sense, the present contribution presents a prospective approach for glioblastomas management: producing a ZIKV-based therapy that stimulates glioblastoma control. We developed an attenuated ZIKV prototype based on bacterial outer membrane vesicles (OMV). The attenuated ZIKV was applied on glioblastoma cells, where cytopathic and cytostatic effects were evaluated. Glioblastoma cells, with and without treatment, were submitted to mass spectrometry analysis.
   Results: Microscopic analysis showed cytopathic effects induced by ZIKV prototype on glioblastoma cells after 24 and 48 h post-treatment. DNA fragmentation assay and TNF-alpha expression were indicative that ZVp induced cell damage and death. The metabolomics investigation elected 5 different biomarkers that might be associated with cell cytopathic effects, highlighting intracellular biochemical modifications induced by the attenuated ZIKV. The remarkable evidence of cell death in glioblastoma stimulated further studies that rendered a preliminary screening with other tumor cell lineages, though anti-proliferative activity test. Among the 11 tumors evaluated, prostate and ovarian tumors were the most affected by ZIKV prototype, and other 6 cell lines also presented cytostatic effects.
   Conclusions: Results ultimately demonstrated that this prototype not only emerges as a potential alternative for glioblastoma management, but may also be an important tool against other important tumors.
C1 [Dabaja, Mohamed Ziad; Lima, Estela de Oliveira; de Oliveira, Diogo Noin; Guerreiro, Tatiane Melina; Odir Rodrigues Melo, Carlos Fernando; Morishita, Karen Noda; Catharino, Rodrigo Ramos] Univ Estadual Campinas, UNICAMP, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
   [Lancellotti, Marcelo] Univ Estadual Campinas, UNICAMP, Sch Pharmaceut Sci, Lab Biotechnol, Campinas, SP, Brazil.
   [Tasca Gois Ruiz, Ana Lucia; Goulart, Gisele] Univ Estadual Campinas, UNICAMP, Fac Pharmaceut Sci, BR-13081970 Campinas, SP, Brazil.
   [Duarte, Diego Andreazzi] Univ Estadual Campinas, UNICAMP, Fac Med Sci, Renal Pathophysiol Lab, Campinas, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Pharmaceut Sci, Innovare Biomarkers Lab, Campinas, SP, Brazil.
EM rrc@g.unicamp.br
RI Ruiz, Ana Lucia Tasca Gois/C-2249-2012; de Oliveira, Diogo
   Noin/C-3939-2013; Lima, Estela/W-5105-2019; de Oliveira Lima,
   Estela/G-7375-2015
OI Ruiz, Ana Lucia Tasca Gois/0000-0002-0844-8702; de Oliveira, Diogo
   Noin/0000-0002-2725-476X; Lima, Estela/0000-0003-0479-0364; de Oliveira
   Lima, Estela/0000-0003-0479-0364; Melo, Carlos/0000-0003-0334-1065
FU OCRC (Obesity Comorbidities Research Center) CEPID: CMPO - Centro
   Multidisciplinar de Pesquisa em Obesidade e Doencas Associadas (FAPESP)
   [13/07607-8]; National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [134522/2016-8]; Coordination for the Improvement of Higher Level
   Personnel (CAPES)CAPES [PNPD: 1578388, PROEX: 1489740]; Sao Paulo
   Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [11/50400-0, 15/06809-1, 18/14657-5, 16/17066-2];
   Plano Nacional de Enfrentamento ao Aedes aegypti e a Microcefalia
   [Brazilian Plan for Fighting Aedes aegypti and Microcephaly]
   [88887.137889/2017-00]
FX This work was supported by the OCRC (Obesity Comorbidities Research
   Center) CEPID: CMPO - Centro Multidisciplinar de Pesquisa em Obesidade e
   Doencas Associadas (FAPESP number: 13/07607-8); the National Council for
   Scientific and Technological Development (134522/2016-8) for the
   fellowship from MZD; the Coordination for the Improvement of Higher
   Level Personnel (CAPES) for the fellowships from EOL (PNPD: 1578388) and
   TMG (PROEX: 1489740); by Sao Paulo Research Foundation (FAPESP, Process
   Nos. 11/50400-0, 15/06809-1 and 18/14657-5 for RRC, and 16/17066-2 for
   CFORM); and by Plano Nacional de Enfrentamento ao Aedes aegypti e a
   Microcefalia [Brazilian Plan for Fighting Aedes aegypti and
   Microcephaly] for the fellowship under process No. 88887.137889/2017-00
   for DNO.
CR Alves D, 2013, J VACCINES VACCIN, DOI [10.4172/2157-7560.1000196, DOI 10.4172/2157-7560.1000196]
   Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522
   Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628
   BANERJEE RV, 1990, FASEB J, V4, P1450
   BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X
   BOYER CS, 1995, BIOCHEM PHARMACOL, V50, P753, DOI 10.1016/0006-2952(95)00195-6
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault S, 2007, AM J PHYSIOL-REG I, V292, pR1174, DOI 10.1152/ajpregu.00619.2006
   CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666
   Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000
   CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danishpajooh IO, 2001, J BIOL CHEM, V276, P27296, DOI 10.1074/jbc.M104043200
   DAS AK, 1989, LIPIDS, V24, P329, DOI 10.1007/BF02535172
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dean Wendy, 2005, Birth Defects Res C Embryo Today, V75, P98, DOI 10.1002/bdrc.20037
   Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Dong YZ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2754756
   ELIAS L, 1991, LEUKEMIA, V5, P879
   Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084
   FADOK VA, 1992, J IMMUNOL, V148, P2207
   GU XX, 1991, ANAL BIOCHEM, V196, P311, DOI 10.1016/0003-2697(91)90472-6
   GUO HY, 1993, CANCER RES, V53, P5676
   JAMES SJ, 1992, CARCINOGENESIS, V13, P2471, DOI 10.1093/carcin/13.12.2471
   JAMES SJ, 1994, CELL PROLIFERAT, V27, P395, DOI 10.1111/j.1365-2184.1994.tb01471.x
   Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1
   KOPROWSKI H, 1993, P NATL ACAD SCI USA, V90, P3024, DOI 10.1073/pnas.90.7.3024
   Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lima ED, 2018, J MASS SPECTROM, V53, P257, DOI 10.1002/jms.4058
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757
   Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801
   NATARAJAN V, 1993, J BIOL CHEM, V268, P930
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589
   Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236
   Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7
   Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422
   Roman WA, 2017, REV BRAS FARMACOGN, V27, P592, DOI 10.1016/j.bjp.2017.05.007
   Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287
   Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048
   Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590
   Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459
   WRIGHT SC, 1992, J CELL BIOCHEM, V48, P344, DOI 10.1002/jcb.240480403
   Xia J, 2016, CURR PROTOC BIOINFOR, V55
   Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Zeyaullah M, 2012, PATHOL ONCOL RES, V18, P771, DOI 10.1007/s12253-012-9548-2
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 60
TC 1
Z9 1
U1 1
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD SEP 4
PY 2018
VL 8
AR 47
DI 10.1186/s13578-018-0243-1
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GS4PP
UT WOS:000443631100001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Giel-Moloney, M
   Goncalvez, AP
   Catalan, J
   Lecouturier, V
   Girerd-Chambaz, Y
   Diaz, F
   Maldonado-Arocho, F
   Gomila, RC
   Bernard, MC
   Oomen, R
   Delagrave, S
   Burdin, N
   Kleanthous, H
   Jackson, N
   Heinrichs, J
   Pugachev, KV
AF Giel-Moloney, Maryann
   Goncalvez, Ana P.
   Catalan, John
   Lecouturier, Valerie
   Girerd-Chambaz, Yves
   Diaz, Fernando
   Maldonado-Arocho, Francisco
   Gomila, Raul C.
   Bernard, Marie-Clotilde
   Oomen, Ray
   Delagrave, Simon
   Burdin, Nicolas
   Kleanthous, Harold
   Jackson, Nicolas
   Heinrichs, Jon
   Pugachev, Konstantin V.
TI Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a
   live-attenuated Zika virus vaccine
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TICK-BORNE ENCEPHALITIS; WEST-NILE-VIRUS; FLAVIVIRUS VACCINES;
   PROTECTIVE EFFICACY; NEURAL PROGENITORS; ADULT VOLUNTEERS; CANDIDATE;
   IMMUNOGENICITY; CLEAVAGE; PROTEIN
AB Zika virus (ZIKV) is an emerging mosquito-borne pathogen representing a global health concern. It has been linked to fetal microcephaly and other birth defects and neurological disorders in adults. Sanofi Pasteur has engaged in the development of an inactivated ZIKV vaccine, as well as a live chimeric vaccine candidate ChimeriVax-Zika (CYZ) that could become a preferred vaccine depending on future ZIKV epidemiology. This report focuses on the CYZ candidate that was constructed by replacing the pre-membrane and envelope (prM-E) genes in the genome of live attenuated yellow fever 17D vaccine virus (YF 17D) with those from ZIKV yielding a viable CYZ chimeric virus. The replication rate of CYZ in the Vero cell substrate was increased by using a hybrid YF 17D-ZIKV signal sequence for the prM protein. CYZ was highly attenuated both in mice and in human in vitro models (human neuroblastoma and neuronal progenitor cells), without the need for additional attenuating modifications. It exhibited significantly reduced viral loads in organs compared to a wild-type ZIKV and a complete lack of neuroinvasion following inoculation of immunodeficient A129 mice. A single dose of CYZ elicited high titers of ZIKV-specific neutralizing antibodies in both immunocompetent and A129 mice and protected animals from ZIKV challenge. The data indicate that CYZ is a promising vaccine candidate against ZIKV.
C1 [Giel-Moloney, Maryann; Goncalvez, Ana P.; Catalan, John; Diaz, Fernando; Maldonado-Arocho, Francisco; Gomila, Raul C.; Oomen, Ray; Delagrave, Simon; Kleanthous, Harold; Pugachev, Konstantin V.] Sanofi Pasteur, Res & Dev, Cambridge, MA 02139 USA.
   [Lecouturier, Valerie; Girerd-Chambaz, Yves; Bernard, Marie-Clotilde; Burdin, Nicolas; Jackson, Nicolas] Sanofi Pasteur, Res & Dev, Marcy Letoile, France.
   [Heinrichs, Jon] Sanofi Pasteur, Res & Dev, Swiftwater, PA USA.
   [Diaz, Fernando] VL46 Inc, Cambridge, MA USA.
   [Maldonado-Arocho, Francisco] Kanyos Bio, Cambridge, MA USA.
RP Pugachev, KV (corresponding author), Sanofi Pasteur, Res & Dev, Cambridge, MA 02139 USA.
EM konstantin.pugachev@sanofi.com
FU Sanofi Pasteur
FX The authors are grateful to Sanofi Pasteur colleagues N. Mantel, V.
   Barban, F. Boudet, E. Oloo, T. Strugnell, J. Hamberger, H. Hernandez, T.
   Vogel, G. Ravel, E. Danve-Chery, E. Richier, E. Navarro-Sanchez, C.
   Sellin, F. Noriega, G. Anez, L. Baglyos, J.L. Clavel, M. L'Azou, M.
   Bonaparte, V. Delore, P. Commander, L. Gerentes, A. Kieffer, C. Auduc,
   A. Khromava, S. Gailhardou, F. Verdier, J. Moser, C.J. Wei, N.
   Darricarrere, R. Rudicell, B. Small, G. Zealey, A. Rumyantsev and C.
   Lewin for helpful discussions and/or experimental contributions, staff
   of animal research facilities at Sanofi Pasteur Cambridge and
   Marcy-l'Etoile sites for assistance with mice, and Dr. Robert Tesh,
   World Reference Center for Emerging Viruses and Arboviruses (WRCEVA),
   UTMB, Galveston, TX for providing several ZIKV strains. This work was
   funded by Sanofi Pasteur.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   [Anonymous], 2016, EPIDEMIOLOGICAL UPDA
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durbin AP, 2005, J INFECT DIS, V191, P710, DOI 10.1086/427780
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gubler D., 2007, FIELDS VIROLOGY, V1, P1153
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Monath TP, 2005, BIOLOGICALS, V33, P131, DOI 10.1016/j.biologicals.2005.03.009
   Monath TP, 2013, VACCINES, P870, DOI 10.1016/B978-1-4557-0090-5.00043-4.
   MONATH TP, 1996, FIELDS VIROLOGY, P961
   Pierce KK, 2017, J INFECT DIS, V215, P52, DOI 10.1093/infdis/jiw501
   PLETNEV AG, 1992, P NATL ACAD SCI USA, V89, P10532, DOI 10.1073/pnas.89.21.10532
   Pugachev K., 2009, NEW GENERATION VACCI, P557
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006
   Rumyantsev AA, 2013, P NATL ACAD SCI USA, V110, P13103, DOI 10.1073/pnas.1306245110
   Rumyantsev AA, 2011, VACCINE, V29, P5184, DOI 10.1016/j.vaccine.2011.05.032
   Rurayantsev AA, 2006, VACCINE, V24, P133, DOI 10.1016/j.vaccine.2005.07.067
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Thomas SJ, 2017, NEW ENGL J MED, V376, P1883, DOI 10.1056/NEJMcibr1701402
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 49
TC 7
Z9 7
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 4
PY 2018
VL 8
AR 13206
DI 10.1038/s41598-018-31375-9
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3TA
UT WOS:000443543700016
PM 30181550
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vouga, M
   Baud, D
   Jolivet, E
   Najioullah, F
   Monthieux, A
   Schaub, B
AF Vouga, Manon
   Baud, David
   Jolivet, Eugenie
   Najioullah, Fatiha
   Monthieux, Alice
   Schaub, Bruno
TI Congenital Zika virus syndrome. . .what else? Two case reports of severe
   combined fetal pathologies
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Congenital Zika syndrome; Parvovirus B19; Trisomy 18; Microcephaly;
   Fetal anemia
ID WOMEN
AB Background: Zika virus (ZIKV) has recently emerged as a teratogenic infectious agent associated with severe fetal cerebral anomalies. Other microorganisms (TORCH agents) as well as genetic disorders and toxic agents may lead to similar anomalies. In case of fetal anomalies, the exact etiology might be difficult to establish, especially in ZIKV endemic countries. As the risks associated with maternal infection remain unclear adequate parental counseling is difficult.
   Case presentation: We present two cases of severe fetal pathologies managed in our multidisciplinary center during the ZIKV outbreak in Martinique, a French Caribbean Island. Both fetuses had congenital ZIKV infection confirmed by RT-PCR. While one case presented with significant cerebral anomalies, the other one presented with hydrops fetalis. A complete analysis revealed that the fetal lesions observed resulted from a combination of ZIKV congenital infection and a genetic disorder (trisomy 18) in case 1 or congenital Parvovirus B19 infection in case 2.
   Conclusions: We highlight the difficulties related to adequate diagnosis in case of suspected ZIKV congenital syndrome. Additional factors may contribute to or cause fetal pathology, even in the presence of a confirmed ZIKV fetal infection. An exact diagnosis is mandatory to draw definitive conclusions. We further emphasize that, similarly to other congenital infections, it is very likely that not all infected fetuses will become symptomatic.
C1 [Vouga, Manon; Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Jolivet, Eugenie; Monthieux, Alice; Schaub, Bruno] Univ Hosp Martinique, Unit Obstet & Gynecol, Maison Femme Mere & Enfant, Multidisciplinary Ctr Prenatal Diag Martinique, Fort De France, Martinique, France.
   [Jolivet, Eugenie; Schaub, Bruno] Univ Hosp Martinique, Maison Femme Mere & Enfant, Registre Malformat Antilles REMALAN, Fort De France, Martinique, France.
   [Najioullah, Fatiha] Univ Hosp Martinique, Serv Virol, Fort De France, Martinique, France.
   [Baud, David] CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
RP Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.; Baud, D (corresponding author), CHU Vaudois, Dept Obstet & Gynecol, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
OI Baud, David/0000-0001-9914-6496
CR Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cire Antilles Guyane, 2016, SIT EP VIR ZIK ANT G
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pomar L, 2017, ULTRASOUND OBSTET GY
   Porat S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0204-7
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schaub B, 2017, LANCET INFECT DIS
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
NR 14
TC 1
Z9 1
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD SEP 3
PY 2018
VL 18
AR 356
DI 10.1186/s12884-018-1998-4
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GS7AV
UT WOS:000443852600002
PM 30176812
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castro, T
   Sabalza, M
   Barber, C
   Abrams, W
   Da Costa, AC
   Milagres, FAD
   Braz-Silva, PH
   Malamud, D
   Gallottini, M
AF Castro, Talita
   Sabalza, Maite
   Barber, Cheryl
   Abrams, William
   Da Costa, Antonio Charlys
   De Padua Milagres, Flavio Augusto
   Braz-Silva, Paulo Henrique
   Malamud, Daniel
   Gallottini, Marina
TI Rapid diagnosis of Zika virus through saliva and urine by Loop-mediated
   isothermal amplification (LAMP)
SO JOURNAL OF ORAL MICROBIOLOGY
LA English
DT Article
DE Flavivirus; virology; polymerase chain reaction; RNA; infection; Dengue;
   saliva; LAMP; Zika
AB Background: Zika virus (ZIKV) is a single-stranded RNA virus and member of the Flaviviridae family. Recent studies have reported that saliva can be an important alternative to detect ZIKV. Saliva requires less processing than blood greatly simplifying the assay. Loop-mediated Isothermal Amplification (LAMP) is a rapid assay that detects nucleic acids, including ZIKV RNA.
   Aim: The aim of this study was to evaluate the efficacy of saliva and urine to diagnose ZIKV infection in subjects during the acute phase, through ZIKV RNA detection by LAMP.
   Method: A total of 131 samples (68 saliva and 63 urine samples) from 69 subjects in the acute phase of ZIKV infection, and confirmed positive for ZIKV by blood analysis through real time-PCR, were collected and analyzed by Reverse Transcriptase Loop-mediated Isothermal Amplification (RT-LAMP).
   Results: From the 68 saliva samples, 45 (66.2%) were positive for ZIKV with an average time to positivity (Tp) of 13.5min, and from the 63 urine samples, 25 (39.7%) were positive with the average Tp of 15.8min. Saliva detected more samples (p=0.0042) and had faster Tp (p=0.0176) as compared with urine.
   Conclusion: Saliva proved to be a feasible alternative to diagnose ZIKV infection during the acute phase by LAMP.
C1 [Castro, Talita; Braz-Silva, Paulo Henrique; Gallottini, Marina] Univ Sao Paulo, Sch Dent, Stomatol Dept, Sao Paulo, SP, Brazil.
   [Sabalza, Maite; Barber, Cheryl; Abrams, William; Malamud, Daniel] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA.
   [Da Costa, Antonio Charlys; Braz-Silva, Paulo Henrique] Univ Sao Paulo, Inst Trop Med, Lab Med Res, Sao Paulo, SP, Brazil.
   [De Padua Milagres, Flavio Augusto] Secretary Hlth Tocantins, Epidemiol Surveillance & Infect Dis, Palmas, TO, Brazil.
   [De Padua Milagres, Flavio Augusto] Fed Univ Tocantins, Palmas, TO, Brazil.
RP Castro, T (corresponding author), Univ Sao Paulo, Sch Dent, Stomatol Dept, Sao Paulo, SP, Brazil.
EM talita.correa@usp.br
RI Abrams, William R/A-5782-2008; Braz-Silva, Paulo Henrique/O-4344-2014;
   da-Costa, Antonio Charlys/G-1548-2010; milagres, flavio/Q-2403-2019
OI Braz-Silva, Paulo Henrique/0000-0002-1842-9521; da-Costa, Antonio
   Charlys/0000-0001-5516-5177; Malamud, Daniel/0000-0002-9094-4122;
   Milagres, Flavio/0000-0002-6889-8772
FU National Institute of Dental and Craniofacial ResearchUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [U01 DE017855, DE024456]; CAPES/PDSE [88881.132005/2016-01];
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/00021-9]
FX This work was supported by the National Institute of Dental and
   Craniofacial Research [U01 DE017855]; National Institute of Dental and
   Craniofacial Research [DE024456]; CAPES/PDSE [88881.132005/2016-01];
   FAPESP [2017/00021-9].
CR Barzon L, 2016, EUROSURVEILLANCE, V2016, P10
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Malamud Daniel, 2011, Dent Clin North Am, V55, P159, DOI 10.1016/j.cden.2010.08.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 24
TC 2
Z9 2
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
EI 2000-2297
J9 J ORAL MICROBIOL
JI J. Oral Microbiology
PD SEP 3
PY 2018
VL 10
IS 1
AR 1510712
DI 10.1080/20002297.2018.1510712
PG 6
WC Microbiology
SC Microbiology
GA GS7QZ
UT WOS:000443899200001
PM 30202506
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Eder, M
   Cortes, F
   Filha, NTD
   de Franca, GVA
   Degroote, S
   Braga, C
   Ridde, V
   Martelli, CMT
AF Eder, Marcus
   Cortes, Fanny
   de Siqueira Filha, Noemia Teixeira
   Araujo de Franca, Giovanny Vinicius
   Degroote, Stephanie
   Braga, Cynthia
   Ridde, Valery
   Turchi Martelli, Celina Maria
TI Scoping review on vector-borne diseases in urban areas: transmission
   dynamics, vectorial capacity and co-infection
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Review
DE Arboviruses; Disease vectors; Coinfection; Urban population;
   Epidemiology; Review
ID MALARIA TRANSMISSION; RISK-FACTORS; PLASMODIUM-FALCIPARUM;
   ENVIRONMENTAL-FACTORS; DENGUE VIRUS; ZIKA VIRUS; SAO-PAULO; OUTBREAK;
   URBANIZATION; INFECTION
AB Background: Transmission dynamics, vectorial capacity, and co-infections have substantial impacts on vector-borne diseases (VBDs) affecting urban and suburban populations. Reviewing key factors can provide insight into priority research areas and offer suggestions for potential interventions.
   Main body: Through a scoping review, we identify knowledge gaps on transmission dynamics, vectorial capacity, and co-infections regarding VBDs in urban areas. Peer-reviewed and grey literature published between 2000 and 2016 was searched. We screened abstracts and full texts to select studies. Using an extraction grid, we retrieved general data, results, lessons learned and recommendations, future research avenues, and practice implications. We classified studies by VBD and country/continent and identified relevant knowledge gaps. Of 773 articles selected for full-text screening, 50 were included in the review: 23 based on research in the Americas, 15 in Asia, 10 in Africa, and one each in Europe and Australia. The largest body of evidence concerning VBD epidemiology in urban areas concerned dengue and malaria. Other arboviruses covered included chikungunya and West Nile virus, other parasitic diseases such as leishmaniasis and trypanosomiasis, and bacterial rickettsiosis and plague. Most articles retrieved in our review combined transmission dynamics and vectorial capacity; only two combined transmission dynamics and co-infection. The review identified significant knowledge gaps on the role of asymptomatic individuals, the effects of co-infection and other host factors, and the impacts of climatic, environmental, and socioeconomic factors on VBD transmission in urban areas. Limitations included the trade-off from narrowing the search strategy (missing out on classical modelling studies), a lack of studies on co-infections, most studies being only descriptive, and few offering concrete public health recommendations. More research is needed on transmission risk in homes and workplaces, given increasingly dynamic and mobile populations. The lack of studies on co-infection hampers monitoring of infections transmitted by the same vector.
   Conclusions: Strengthening VBD surveillance and control, particularly in asymptomatic cases and mobile populations, as well as using early warning tools to predict increasing transmission, were key strategies identified for public health policy and practice.
C1 [Eder, Marcus] Publ Hlth England Sierra Leone Country Off, Freetown, Sierra Leone.
   [Eder, Marcus; Braga, Cynthia; Turchi Martelli, Celina Maria] Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Inst IAM, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50 Recife, PE, Brazil.
   [Cortes, Fanny] Univ Pernambuco UPE, Recife, PE, Brazil.
   [de Siqueira Filha, Noemia Teixeira] Univ Liverpool Liverpool Sch Trop Med, London, England.
   [Araujo de Franca, Giovanny Vinicius] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil.
   [Degroote, Stephanie; Ridde, Valery] Univ Montreal, Sch Publ Hlth ESPUM, Montreal, PQ, Canada.
   [Ridde, Valery] Univ Paris 05, Univ Paris Sorbonne Cites, ERL INSERM SAGESUD, IRD,French Inst Res Sustainable Dev,CEPED, Paris, France.
RP Martelli, CMT (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ, Aggeu Magalhaes Inst IAM, Ave Prof Moraes Rego S-N,Cidade Univ, BR-50 Recife, PE, Brazil.
EM turchicm@gmail.com
RI Ridde, Valery/AAD-2736-2019; Braga, Maria Cynthia/A-8204-2013; Araujo de
   Franca, Giovanny Vinicius/L-7385-2018
OI Ridde, Valery/0000-0001-9299-8266; Braga, Maria
   Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Araujo de Franca, Giovanny
   Vinicius/0000-0002-7530-2017; Degroote, Stephanie/0000-0002-7942-7992
FU VERDAS Consortium
FX VERDAS Consortium.
CR Ali M, 2003, USE GEOGRAPHIC INFOR, P634
   Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1
   Amaku M, 2016, EPIDEMIOL INFECT, V144, P3435, DOI 10.1017/S0950268816001448
   Anders KL, 2015, HOUSEHOLDS FOCI DENG
   ANDERSON R M, 1991
   Araujo R V, 2015, SAO PAULO URBAN HEAT, P146
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Carver S, 2008, INT J INFECT DIS, V12, P528, DOI 10.1016/j.ijid.2008.02.008
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Correa PRL, 2005, REV SAUDE PUBL, V39, P33, DOI 10.1590/S0034-89102005000100005
   Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019
   Camargo-Neves Vera Lucia Fonseca de, 2003, Rev. Soc. Bras. Med. Trop., V36, P27, DOI 10.1590/S0037-86822003000700009
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   de Souza CE, 2015, REV SOC BRAS MED TRO, V48, P11, DOI 10.1590/0037-8682-0281-2014
   Dev V, 2004, AM J TROP MED HYG, V71, P451, DOI 10.4269/ajtmh.2004.71.451
   Dhiman RC, 2013, ALTITUDE TEMPERATURE, P220
   Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008
   Ebenezer A, 2016, J VECTOR DIS, V53, P46
   El Sayed BB, 2000, ACTA TROP, V75, P163, DOI 10.1016/S0001-706X(99)00098-4
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fouque F, 2004, EPIDEMIOLOGICAL ENTO, P41
   Girod R, 2011, ANN TROP MED PARASIT, V105, P107, DOI 10.1179/136485911X12899838683322
   Godsey MS, 2012, AM J TROP MED HYG, V87, P1125, DOI 10.4269/ajtmh.2012.11-0700
   Gould LH, 2005, OUTBREAK YELLOW FEVE, P1247
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012
   Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Ho K, 2011, EPIDEMIOLOGY CONTROL, P263
   Hoffmann TC, 2014, BMJ, V348
   Ivan E, 2012, ACTA TROP, V124, P179, DOI 10.1016/j.actatropica.2012.08.004
   Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118
   Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008
   Lee Y, 2009, ANN ACAD MED SINGAP, V38, P840
   Martinez-Vega RA, 2015, PLOS NEGLECT TROP D, V9, P1
   Medrano-Mercado N, 2008, MEM I OSWALDO CRUZ, V103, P423, DOI 10.1590/S0074-02762008000500003
   Mendez F, 2006, AM J TROP MED HYG, V74, P678, DOI 10.4269/ajtmh.2006.74.678
   Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x
   Muller DA, 2001, ACTA TROP, V78, P155, DOI 10.1016/S0001-706X(01)00067-5
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nielsen CF, 2008, AM J TROP MED HYG, V78, P53, DOI 10.4269/ajtmh.2008.78.53
   Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   Perkins TA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P99, DOI 10.1079/9781845939649.0099
   Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662
   Pham HV, 2009, INT J EPIDEMIOL, V38, P1634, DOI 10.1093/ije/dyp244
   Reiner RC, 2014, P NATL ACAD SCI US
   Reiter P, 2003, TEXAS LIFESTYLE LIMI, P86
   Rezza G, 2007, INFECT CHIKUNGUNYA V, P1840
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, P1, DOI DOI 10.1371/journal.pntd.0001370
   Salazar PM, 2007, REV PANAM SALUD PUBL, V22, P75, DOI 10.1590/S1020-49892007000700001
   Salomon OD, 2006, MEM I OSWALDO CRUZ, V101, P295, DOI 10.1590/S0074-02762006000300013
   Sanchez L, 2006, AEDES AEGYPTI LARVAL, P800
   Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755
   Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3
   Seidahmed OME, 2012, SPATIAL TEMPORAL PAT
   Sissoko MS, 2015, AM J TROP MED HYG, V93, P790, DOI 10.4269/ajtmh.14-0765
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Struchiner CJ, 2015, PLOS ONE, P1
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Teixeira MG, 2015, NEW EPIDEMIOLOGIC PR, P220
   Thomaz Soccol V, 2009, NEW FOCUS CUTANEOUS, P308
   Uranw S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-21
   Vasconcelos PFC, 2001, EPIDEMIC JUNGLE YELL, P598
   Wertheim HFL, 2012, ATLAS HUM INFECT DIS, P33
   Wilson ML, 2015, INT CTR EXCELL MAL S, V3, P110, DOI DOI 10.4269/AJTMH.14-0834
   World Health Organization, 2016, WORLD MALARIA REPORT
   World Health Organization, 2016, JOINT EXT EV TOOL IN
   World Health Organization, 2017, NEGL TROP DIS FACT S
   World Health Organization, 2016, VECT BORN DIS
   World Health Organization, 2014, WHO GLOB HLTH EXP AT
   Woyessa A, 2004, ETHIOP J HEALTH DEV, V18, P2, DOI DOI 10.4314/ejhd.v18i1.9858
   Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014
   Yang T, 2009, EPIDEMIOLOGY VECTOR, P148
   Ye Y, 2010, GLOB HEAL ACTIO 0107, V2
   Zhang Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-544
   Zhao XQ, 2013, MARINE MICROBIOLOGY: BIOACTIVE COMPOUNDS AND BIOTECHNOLOGICAL APPLICATIONS, P267
NR 81
TC 9
Z9 9
U1 0
U2 30
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-5162
EI 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD SEP 3
PY 2018
VL 7
AR 90
DI 10.1186/s40249-018-0475-7
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GS4WW
UT WOS:000443658500001
PM 30173661
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Tang, B
   Huo, X
   Xiao, YN
   Ruan, SG
   Wu, JH
AF Tang, Biao
   Huo, Xi
   Xiao, Yanni
   Ruan, Shigui
   Wu, Jianhong
TI A conceptual model for optimizing vaccine coverage to reduce
   vector-borne infections in the presence of antibody-dependent
   enhancement
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Zika; Dengue; Antibody dependent enhancement; Optimized vaccination
   strategies; Mathematical modelling
ID ZIKA VIRUS OUTBREAK; DENGUE VIRUS; REPRODUCTION NUMBER; EPIDEMIC;
   TRANSMISSION; PATHOGENESIS; IMMUNITY; PATTERN; RISKS
AB Background: Many vector-borne diseases co-circulate, as the viruses from the same family are also transmitted by the same vector species. For example, Zika and dengue viruses belong to the same Flavivirus family and are primarily transmitted by a common mosquito species Aedes aegypti. Zika outbreaks have also commonly occurred in dengue-endemic areas, and co-circulation and co-infection of both viruses have been reported. As recent immunological cross-reactivity studies have confirmed that convalescent plasma following dengue infection can enhance Zika infection, and as global efforts of developing dengue and Zika vaccines are intensified, it is important to examine whether and how vaccination against one disease in a large population may affect infection dynamics of another disease due to antibody-dependent enhancement.
   Methods: Through a conceptual co-infection dynamics model parametrized by reported dengue and Zika epidemic and immunological cross-reactivity characteristics, we evaluate impact of a hypothetical dengue vaccination program on Zika infection dynamics in a single season when only one particular dengue serotype is involved.
   Results: We show that an appropriately designed and optimized dengue vaccination program can not only help control the dengue spread but also, counter-intuitively, reduce Zika infections. We identify optimal dengue vaccination coverages for controlling dengue and simultaneously reducing Zika infections, as well as the critical coverages exceeding which dengue vaccination will increase Zika infections.
   Conclusion: This study based on a conceptual model shows the promise of an integrative vector-borne disease control strategy involving optimal vaccination programs, in regions where different viruses or different serotypes of the same virus co-circulate, and convalescent plasma following infection from one virus (serotype) can enhance infection against another virus (serotype). The conceptual model provides a first step towards well-designed regional and global vector-borne disease immunization programs.
C1 [Tang, Biao; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Shaanxi, Peoples R China.
   [Tang, Biao; Huo, Xi; Wu, Jianhong] York Univ, Ctr Dis Modelling, Lab Ind & Appl Math, Toronto, ON M3J 1P3, Canada.
   [Huo, Xi; Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33146 USA.
RP Wu, JH (corresponding author), York Univ, Ctr Dis Modelling, Lab Ind & Appl Math, Toronto, ON M3J 1P3, Canada.
EM wujh@mathstat.yorku.ca
RI Ruan, Shigui/AAF-9165-2020; Tang, Biao/N-4129-2019
OI Ruan, Shigui/0000-0002-6348-8205; Tang, Biao/0000-0002-0418-5773
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [11571273, 11631012]; Fundamental Research
   Funds for the Central UniversitiesFundamental Research Funds for the
   Central Universities [08143042]; National Science FoundationNational
   Science Foundation (NSF) [DMS-1412454]; Canada Research Chair
   ProgramCanada Research Chairs; Natural Sciences and Engineering Research
   Council of CanadaNatural Sciences and Engineering Research Council of
   Canada; International Development Research Center (Ottawa, Canada)
   [104519-010]
FX This project was partially supported by the National Natural Science
   Foundation of China (NSFC, 11571273, 11631012 (YX)), the Fundamental
   Research Funds for the Central Universities (08143042 (YX)), National
   Science Foundation (DMS-1412454 (SR)), the Canada Research Chair
   Program, the Natural Sciences and Engineering Research Council of Canada
   (JW), and the International Development Research Center (Ottawa, Canada,
   104519-010).
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Majumder MS, 2016, B WORLD HEALTH ORGAN, V10, P1, DOI DOI 10.2471/BLT.16.171009)
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Massad E, 2014, LANCET INFECT DIS, V14, P552, DOI 10.1016/S1473-3099(14)70807-2
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Valentine G, 2016, EXPERT REV ANTI-INFE, V14, P1127, DOI 10.1080/14787210.2016.1245614
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   World Health Organization (WHO), UPD QUEST ANSW REL D
   World Health Organization (WHO), QUEST ANSW DENG VACC
   Zhang Q, 2016, BIORXIV, DOI [10.1101/066456, DOI 10.1101/066456]
NR 47
TC 1
Z9 1
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD SEP 3
PY 2018
VL 15
AR 13
DI 10.1186/s12976-018-0085-x
PG 19
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GS3OB
UT WOS:000443528000001
PM 30173664
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gomez, EJ
   Perez, FA
   Ventura, D
AF Gomez, Eduardo J.
   Perez, Fernanda Aguilar
   Ventura, Deisy
TI What explains the lacklustre response to Zika in Brazil? Exploring
   institutional, economic and health system context
SO BMJ GLOBAL HEALTH
LA English
DT Article
AB By early-2016, the international community began to pressure Brazil for a stronger policy response to Zika. In contrast to what was seen in the past, however, these international pressures did not elicit such a response. In this article, we explore why this was the case, reviewing the government's policy response and the broader political and economic context shaping this response. The authors used single case study analysis and qualitative sources, such as books, journal articles, and government policy reports to support their empirical claims. We found that despite increased international pressures from the WHO, domestic political factors and economic recession hampered the government's ability to strengthen its health systems response to Zika. Consequently, those states most afflicted by Zika have seen policy initiatives that lack sufficient funding, administrative and human resource capacity. This study revealed that despite a government's deep foreign policy history of positively responding to international pressures through a stronger policy response to health epidemics, a sudden change in government, rising political instability, and economic recession can motivate governments to abandon this foreign policy tradition and undermine its response to new public health threats.
C1 [Gomez, Eduardo J.] Kings Coll London, Dept Int Dev, London, England.
   [Perez, Fernanda Aguilar] Univ Sao Paulo, Inst Int Relat, Sao Paulo, Brazil.
   [Ventura, Deisy] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil.
RP Gomez, EJ (corresponding author), Kings Coll London, Dept Int Dev, London, England.
EM eduardo.gomez@kcl.ac.uk
OI Ventura, Deisy/0000-0001-8237-2470
CR [Anonymous], 2016, MINISTRY HLTH ESTIMA
   [Anonymous], 2016, INT HLTH REG
   [Anonymous], 2016, GUARDIAN
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Brazilian Ministry of Health, 2017, MIN SAUD DEST 135 2
   Brazilian Ministry of Health, 2016, R 65 MILLH PESQ VIR
   Brazilian Ministry of Health, 2016, MIN SAUD FIN PREG CO
   Brazilian Ministry of Health-Department of Health Surveillance, 2017, B EPIDEMIOLOGICO, V48
   Brazilian Ministry of Health-Department of Health Surveillance, 2017, B EPIDEMIOLOGICO
   Brazilian Ministry of Health-Department of Health Surveillance, 2017, B EPIDEMIOLOGICO, P48
   Chade J, 2016, NAO EXISTE JUSTIFICA
   Conselho Federal de Medicina, 2016, NOT ENT CORT ORC SUS
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Campos GWD, 2016, CIENC SAUDE COLETIVA, V21, P2655, DOI 10.1590/1413-81232015219.18922016
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Gomez E. J., 2018, GEOPOLITICS HLTH CON
   Hennigan T., 2016, BMJ-BRIT MED J, V352, P1226
   IBGE, 2016, IND IBGE CONT NAC TI
   Malta M., 2018, GLOB PUBLIC HEALTH, P1
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Mendes A., 2013, SAUDE SOC, V22, P991
   Mendes A, 2013, SAUDE SOC-SAO PAULO, V22, P987, DOI 10.1590/S0104-12902013000400002
   Nunes A, 2001, ORG PAN AM SAUDE I P, V56, P82
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Henriques CMP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000100001, 10.5123/s1679-49742016000100001]
   Presidency of the Republic of Brazil-Casa Civi, 2016, ESTR RESP VIR ZIK CO
   Presidency of the Republic of Brazil-Portal Brasil, 2017, COMB INF AED TEM REF
   Prosecutor General of the Republic, 2016, 5592 ADI PROS GEN RE
   Reis AAC, 2016, SAUDE DEBATE, V40, P122
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Ventura Deisy F. L., 2016, CAD SAUDE PUBLICA, V32, P1
   Vieira FS, 2016, 28 IPEA
   WHO, 2016, ZIK RESP ACC WHO DIR
   World Health Organization, 2016, EM COMM ZIK VIR OBS
   World Health Organization, 2016, INT HLTH REG EM COMM
NR 35
TC 2
Z9 2
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD SEP
PY 2018
VL 3
IS 5
AR UNSP e000862
DI 10.1136/bmjgh-2018-000862
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA HK2CP
UT WOS:000457716300014
PM 30397514
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bartolone, SN
   Tree, MO
   Conway, MJ
   Chancellor, MB
   Lamb, LE
AF Bartolone, Sarah N.
   Tree, Maya O.
   Conway, Michael J.
   Chancellor, Michael B.
   Lamb, Laura E.
TI Reverse Transcription-Loop-mediated Isothermal Amplification (RT-LAMP)
   Assay for Zika Virus and Housekeeping Genes in Urine, Serum, and
   Mosquito Samples
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Genetics; Issue 139; Zika Virus; RT-LAMP; urine; serum; Aedes;
   point-of-care testing; field tools
ID PCR
AB Infection with Zika virus (ZIKV) can be asymptomatic in adults, however, infection during pregnancy can lead to miscarriage and severe neurological birth defects. The goal of this protocol is to quickly detect ZIKV in both human and mosquito samples. The current gold standard for ZIKV detection is quantitative reverse transcription PCR (qRT-PCR); reverse transcription loop-mediated isothermal amplification (RT-LAMP) may allow for a more efficient and low-cost testing without the need for expensive equipment. In this study, RT-LAMP is used for ZIKV detection in various biological samples within 30 min, without first isolating the RNA from the sample. This technique is demonstrated using ZIKV infected patient urine and serum, and infected mosquito samples. 18S ribosomal ribonucleic acid and actin are used as controls in human and mosquito samples, respectively.
C1 [Bartolone, Sarah N.; Chancellor, Michael B.; Lamb, Laura E.] Beaumont Hlth Syst, Dept Urol, Troy, MI 48085 USA.
   [Tree, Maya O.; Conway, Michael J.] Cent Michigan Univ, Coll Med, Fdn Sci, Mt Pleasant, MI 48859 USA.
   [Chancellor, Michael B.; Lamb, Laura E.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA.
RP Lamb, LE (corresponding author), Beaumont Hlth Syst, Dept Urol, Troy, MI 48085 USA.; Lamb, LE (corresponding author), Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA.
EM Laura.Lamb@beaumont.edu
FU Field Neurosciences Institute, St. Mary's of Michigan
FX This work was supported by the Maureen and Ronald Hirsch family
   philanthropic contribution and Field Neurosciences Institute, St. Mary's
   of Michigan. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. We
   also thank Dr. Bernadette Zwaans and Elijah Ward for their critical
   review of the manuscript.
CR Barkway C. P, 2015, J VISUALIZED EXPT
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x
   Gandasegui J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003963
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
NR 17
TC 1
Z9 1
U1 1
U2 3
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD SEP
PY 2018
IS 139
AR e58436
DI 10.3791/58436
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HI1MZ
UT WOS:000456210900112
PM 30272674
DA 2020-07-08
ER

PT J
AU Costa, AA
   Gonzalez, PV
   Harburguer, LV
   Masuh, HM
AF Costa, Agustin Alvarez
   Gonzalez, Paula V.
   Harburguer, Laura V.
   Masuh, Hector M.
TI Effects of Temephos, Permethrin, and Eucalyptus nitens Essential Oil on
   Survival and Swimming Behavior of Aedes aegypti and Anopheles
   pseudopunctipennis (Diptera: Culicidae) Larvae
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE sublethal effects; larvicides; larval behavior
ID CULEX-QUINQUEFASCIATUS; LARVICIDAL ACTIVITY; INSECTICIDES; ALBOPICTUS;
   VULNERABILITY; PESTICIDES; LOCOMOTION; REPELLENT; TOXICITY; RATS
AB An essential strategy to deal with mosquito-borne diseases is the control of larvae in their development sites. The mosquitoes Anopheles pseudopunctipennis (Theobald) (Diptera: Culicidae), a malaria vector, and Aedes aegypti( L.) (Diptera: Culicidae), vector of dengue, Zika, yellow fever, and chikungunya viruses, breed in very different habitats. Insecticide treatments of mosquito larvae focus mainly on their lethal effects. However, insecticide degradation or the poor dosage of larvicides will invariably lead to the sublethal exposure of a target (and nontarget) species, the nonlethal effects of these compounds may have important effects on vital insect activities, and therefore their evaluation is necessary. In this study, we assessed the survival and swimming behavior of larvae of Ae. aegypti and An. pseudopunctipennis exposed to increasing concentrations of three larvicides. We found that Ae. aegypti, was more sensitive to the larvicides than An, pseudopunctipennis, we also observed an overall decrease in the movement of those larvae of both species, which survive the treatments. This decrease might have ecological relevance in their natural habitats, increasing the chance to be predated and decreasing their ability to obtain food. Finally, this information will be valuable to assist authorities to make decisions in the implementation of further control programs.
C1 [Costa, Agustin Alvarez; Gonzalez, Paula V.; Harburguer, Laura V.; Masuh, Hector M.] UNIDEF, CONICET, CITEDEF, Ctr Invest Plagas & Insecticidas, Juan Bautista La Salle 4397,B1603ALO, Buenos Aires, DF, Argentina.
RP Masuh, HM (corresponding author), UNIDEF, CONICET, CITEDEF, Ctr Invest Plagas & Insecticidas, Juan Bautista La Salle 4397,B1603ALO, Buenos Aires, DF, Argentina.
EM hmasuh@gmail.com
RI Gonzalez, Paula/L-2041-2019; Costa, Agustin Alvarez/L-5040-2019
FU Agencia Nacional de Promocion Cientifica y Tecnologica
   (ANPCyT-Argentina)ANPCyT [PICT 2012-1857]; Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET)Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET)
FX This work was supported by project PICT 2012-1857 from the Agencia
   Nacional de Promocion Cientifica y Tecnologica (ANPCyT-Argentina) and
   Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). We
   are very grateful to Laci C., Laci E., and Carrizo of the National
   Coordination of Vector Control, Argentinean Ministry of Health, for
   their assistance with fieldwork. A.A.C., P.V.G., L.H., and H.M. are
   members of the CONICET. We thank two anonymous reviewers and editor for
   their valuable comments and suggestions, which helped improve the
   quality of this work. Finally, we thank T. Comber for the English
   writing corrections.
CR Abdel-Rahman A, 2001, EXP NEUROL, V172, P153, DOI 10.1006/exnr.2001.7807
   Costa AA, 2017, J MED ENTOMOL, V54, P670, DOI 10.1093/jme/tjw222
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   [Anonymous], 1992, World Health Organ Tech Rep Ser, V818, P1
   Arredondo-Jimenez JI, 2006, MED VET ENTOMOL, V20, P377, DOI 10.1111/j.1365-2915.2006.00656.x
   BANERJEE S, 1980, ENVIRON SCI TECHNOL, V14, P1227, DOI 10.1021/es60170a013
   Batish DR, 2008, FOREST ECOL MANAG, V256, P2166, DOI 10.1016/j.foreco.2008.08.008
   Brackenbury J, 2001, P ROY SOC B-BIOL SCI, V268, P101, DOI 10.1098/rspb.2000.1336
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   BRUCECHWATT LJ, 1985, ESSENTIAL MALARIOLOG
   BURESOVA O, 1986, BEHAV NEUROSCI, V100, P476, DOI 10.1037/0735-7044.100.4.476
   Campolo O, 2016, J ECON ENTOMOL, V109, P360, DOI 10.1093/jee/tov270
   Cantrell CL, 2012, J NAT PROD, V75, P1231, DOI 10.1021/np300024u
   Chavasse D. C., 1997, CHEM METHODS CONTROL
   Cohnstaedt LW, 2011, J VECTOR ECOL, V36, P395, DOI 10.1111/j.1948-7134.2011.00180.x
   DAMBOLENA JS, 2016, PSYCHE-CAMBRIDGE, V2016, DOI DOI 10.1155/2016/4595823
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Elumalai D, 2016, PARASITOL RES, V115, P1203, DOI 10.1007/s00436-015-4856-6
   FERNANDEZSALAS I, 1994, J AM MOSQUITO CONTR, V10, P477
   Gomez A, 2011, MEM I OSWALDO CRUZ, V106, P993, DOI 10.1590/S0074-02762011000800015
   Gonzalez PV, 2017, J MED ENTOMOL, V54, P793, DOI 10.1093/jme/tjw229
   GORCHEV HG, 1984, WHO CHRON, V38, P104
   Grieco F., 2010, ETHOVISION XT REFERE
   Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669
   Herrera J. V., 2003, REV PERU EPIDEMIOL, V11, P18
   Janssens L, 2012, AQUAT TOXICOL, V110, P91, DOI 10.1016/j.aquatox.2011.12.019
   Kembro J, 2009, PARASITOL RES, V104, P1119, DOI 10.1007/s00436-008-1296-6
   Kumar S, 2012, PARASITOL RES, V111, P173, DOI 10.1007/s00436-011-2814-5
   Lardeux F, 2007, CR BIOL, V330, P571, DOI 10.1016/j.crvi.2007.04.002
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   LITTLE EE, 1990, ENVIRON TOXICOL CHEM, V9, P13, DOI 10.1002/etc.5620090103
   Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467
   Lucia A, 2008, ENTOMOL EXP APPL, V129, P107, DOI 10.1111/j.1570-7458.2008.00757.x
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Manguin S, 1996, J AM MOSQUITO CONTR, V12, P619
   Marriel NB, 2016, ACTA TROP, V158, P88, DOI 10.1016/j.actatropica.2016.02.021
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Mileson BE, 1998, TOXICOL SCI, V41, P8
   Narahashi T, 1996, PHARMACOL TOXICOL, V79, P1, DOI 10.1111/j.1600-0773.1996.tb00234.x
   Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394
   Nwankwo A. E., 2013, INT J SCI NAT, V4, P214
   Ordonez Gonzalez J. G., 2008, FUNDAMENTOS METODOS
   Osimitz TG, 1997, J TOXICOL-CLIN TOXIC, V35, P435, DOI 10.3109/15563659709001224
   Park CG, 2017, MOLECULES, V22, DOI 10.3390/molecules22071050
   Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   R Core Team, 2016, R LANG ENV STAT COMP
   Ray DE, 2006, PHARMACOL THERAPEUT, V111, P174, DOI 10.1016/j.pharmthera.2005.10.003
   Reynaldi S, 2011, AQUAT TOXICOL, V104, P56, DOI 10.1016/j.aquatox.2011.03.017
   Schulz R, 2001, ENVIRON TOXICOL CHEM, V20, P2537, DOI [10.1897/1551-5028(2001)020&lt;2537:CEOPFA&gt;2.0.CO;2, 10.1002/etc.5620201120]
   Scott TW, 2000, J MED ENTOMOL, V37, P77, DOI 10.1603/0022-2585-37.1.77
   Senthilkumar A, 2013, PARASITOL RES, V112, P1337, DOI 10.1007/s00436-012-3188-z
   Shi XB, 2011, PEST MANAG SCI, V67, P1528, DOI 10.1002/ps.2207
   Spruijt B. M., 1998, P MEAS BEH 98 2 INT, P264
   TGSC T. G. S. C., 2018, FLAV PHYS PROPR
   Tome HW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-195
   Valenca MA, 2013, NEOTROP ENTOMOL, V42, P311, DOI 10.1007/s13744-013-0118-4
   WHO, 2018, CHEM CONTR PROGR DEN
   Ye YXH, 2016, EVOLUTION, V70, P2459, DOI 10.1111/evo.13039
NR 61
TC 1
Z9 1
U1 2
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2018
VL 55
IS 5
BP 1098
EP 1104
DI 10.1093/jme/tjy086
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0KQ
UT WOS:000456130900005
PM 29873741
DA 2020-07-08
ER

PT J
AU Muttis, E
   Balsalobre, A
   Chuchuy, A
   Mangudo, C
   Ciota, AT
   Kramer, LD
   Micieli, MV
AF Muttis, Evangelina
   Balsalobre, Agustin
   Chuchuy, Ailen
   Mangudo, Carolina
   Ciota, Alexander T.
   Kramer, Laura D.
   Micieli, Maria Victoria
TI Factors Related to Aedes aegypti (Diptera: Culicidae) Populations and
   Temperature Determine Differences on Life-History Traits With Regional
   Implications in Disease Transmission
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito; fitness; Argentina
ID L. DIPTERA; BIONOMICS
AB Aedes aegypti (L.) (Diptera: Culicidae) is a vector of many medically significant viruses in the Americas, including dengue virus, chikungunya virus, and Zika virus. Traits such as longevity, fecundity, and feeding behavior contribute to the ability of Ae. aegypti to serve as a vector of these pathogens. Both local environmental factors and population genetics could contribute to variability in these traits. We performed a comparative study of Ae. aegypti populations from four geographically and environmentally distinct collection sites in Argentina in which the cohorts from each population were held at temperature values simulating a daily cycle, with an average of 25 degrees C in order to identify the influence of population on life-history traits. In addition, we performed the study of the same populations held at a daily temperature cycle similar to that of the surveyed areas. According to the results, Aguaray is the most outstanding population, showing features that are important to achieve high fitness. Whereas La Plata gathers features consistent with low fitness. Iguazu was outstanding in blood-feeding rate while Posadas's population showed intermediate values. Our results also demonstrate that climate change could differentially affect unique populations, and that these differences have implications for the capacity for Ae. aegypti to act as vectors for medically important arboviruses.
C1 [Muttis, Evangelina; Balsalobre, Agustin; Chuchuy, Ailen; Micieli, Maria Victoria] UNLP, Ctr Estudios Parasitol Vectores CEPAVE, CONICET, CCT La Plata, Blvd 120 E-61 & 62, RA-1900 La Plata, Buenos Aires, Argentina.
   [Mangudo, Carolina] Univ Nacl Salta, Inst Invest Energia No Convenc INENCO, CONICET, UNSa, Ave Bolivia 5150,A4400FVY, Salta, Argentina.
   [Ciota, Alexander T.; Kramer, Laura D.] New York State Dept Hlth, Arbovirus Lab, Wadsworth Ctr, Slingerlands, NY USA.
   [Ciota, Alexander T.; Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA.
RP Micieli, MV (corresponding author), UNLP, Ctr Estudios Parasitol Vectores CEPAVE, CONICET, CCT La Plata, Blvd 120 E-61 & 62, RA-1900 La Plata, Buenos Aires, Argentina.
EM victoria@cepave.edu.ar
RI Ciota, Alexander/E-1634-2017
OI Ciota, Alexander/0000-0001-6589-4728; Micieli, Maria
   Victoria/0000-0003-0616-2214
FU Fulbright Visiting Scholar Program; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET)Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET)
FX We would like to thank Dr. Fabricio Tejerina and Neris Gauto for
   providing us with the populations of mosquitoes used for establishing
   the mosquito colonies from Misiones. We also want to thank Graciela
   Minardi for her assistance in statistical analysis. We appreciate the
   financial support of the Fulbright Visiting Scholar Program and Consejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET).
CR Llinas GA, 2011, J AM MOSQUITO CONTR, V27, P429, DOI 10.2987/11-6137.1
   Burkart R. N., 1999, ECOREGIONES ARGENTIA
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Christophers S., 1960, AEDES AEGYPTI L YELL
   De Majo MS, 2013, J MED ENTOMOL, V50, P543, DOI 10.1603/ME12211
   De Sousa GB, 2000, J AM MOSQUITO CONTR, V16, P206
   DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888
   Dominguez Martha C., 2000, Revista de la Sociedad Entomologica Argentina, V59, P41
   Rabinovich JE, 2011, J MED ENTOMOL, V48, P775, DOI 10.1603/ME10277
   Tejerina EF, 2009, ACTA TROP, V109, P45, DOI 10.1016/j.actatropica.2008.09.014
   Gerberg E., 1994, MANUAL MOSQUITO REAR
   Grech MG, 2010, J VECTOR ECOL, V35, P277, DOI 10.1111/j.1948-7134.2010.00083.x
   Grech M, 2012, REV SAUDE PUBL, V46, P387, DOI [10.1590/S0034-89102012005000007, 10.1590/s0034-89102012005000007]
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Micieli MV, 2003, MEM I OSWALDO CRUZ, V98, P659, DOI 10.1590/S0074-02762003000500013
   Mohammed A, 2011, ACTA TROP, V119, P38, DOI 10.1016/j.actatropica.2011.04.004
   Rodriguez-Morales AJ, 2015, IMEDPUB J ARCH MED, V11, P1
   Duenas JCR, 2009, J MED ENTOMOL, V46, P1344, DOI 10.1603/033.046.0613
NR 18
TC 5
Z9 5
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2018
VL 55
IS 5
BP 1105
EP 1112
DI 10.1093/jme/tjy057
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0KQ
UT WOS:000456130900006
PM 29659944
OA Green Published
DA 2020-07-08
ER

PT J
AU Marie, J
   Perera, D
   Garstang, H
   Bossin, HC
   Bourtzis, K
AF Marie, Jerome
   Perera, Devika
   Garstang, Helentina
   Bossin, Herve C.
   Bourtzis, Kostas
TI Exploring Mosquito Fauna of Majuro Atoll (Republic of Marshall Islands)
   in the Context of Zika Outbreak
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Aedes marshallensis; Culex
   annulirostris
ID ROSS RIVER VIRUS; FEDERATED STATES; DIPTERA-CULICIDAE; AEDES-AEGYPTI;
   YAP ISLAND; DISEASE
AB First autochthonous Zika clinical case was reported in the Republic of Marshall Islands (RMI) on Majuro Atoll in February 2016. An entomological survey of mosquito larvae and adult populations was carried out in four areas of Majuro, the most populated atoll of RMI encompassing different habitats (forest, rural, or urban) including some with confirmed clinical Zika cases to evaluate which mosquito species could be involved in the Zika transmission. A total of 2,367 immature and adult mosquito specimens were collected and identified to the species level. In total, five mosquito species were detected, Aedes aegypti (Linnaeus), Aedes albopictus (Skuse), Aedes marshallensis (Stone and Bohart), Culex quinquefasciatus (Say), and Culex annulirostris (Skuse) (Diptera: Culicidae), a first record for RMI. The most abundant species was Ae, aegypti presumed to be the main vector of Zika virus followed by Ae. albopictus. Improved management of breeding containers through better public awareness and community engagement, mosquito surveillance and innovative mosquito control strategies using the sterile insect technique (SIT) and/or the incompatible insect technique (IIT) could help prevent outbreaks of arboviruses in the RMI.
C1 [Marie, Jerome; Bossin, Herve C.] Inst Louis Malarde, Lab Entomol Med, BP 30, F-98713 Papeete, French Polynesi, France.
   [Marie, Jerome; Bossin, Herve C.] Aix Marseille Univ, IHU Mediterranee Infect, AP HM, IRD,SSA,VITROME, Marseille, France.
   [Perera, Devika] Anti Malaria Campaign, Kurunegala, Sri Lanka.
   [Garstang, Helentina] Minist Hlth, POB 16, Majuro 96960, Marshall Island.
   [Bourtzis, Kostas] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, POB 100, A-1400 Vienna, Austria.
RP Marie, J (corresponding author), Inst Louis Malarde, Lab Entomol Med, BP 30, F-98713 Papeete, French Polynesi, France.; Marie, J (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, AP HM, IRD,SSA,VITROME, Marseille, France.
EM jmarie@ilm.pf
FU International Atomic Energy AgencyInternational Atomic Energy Agency
   [MHL5001]
FX We are grateful to the owners of properties sampled on Majuro for
   providing access to live specimens at the start of the study, especially
   Bobson Soloman, Jackson Jacklik, and Leke Ankien who helped introducing
   our work to residents and assisted with the field missions. We thank our
   colleagues Darlene Korok, Paul Lalita, and Tom JACK from the Hospital
   (MoH) and Moriana Philipp and Aaron Lang from the EPA, the Environmental
   protection authority that provided assistance to the mosquito monitoring
   in private residences and homeowners. We thank also our colleagues
   Melissa Graham, Leon Hugo, and Gregor Devine from the Queensland
   Institute of Medical Research (QIMR) for their assistance in
   morphological and molecular analysis and Neal Evenhuis for the voucher
   record (Bernice Pauahi Bishop Museum). This study was supported by the
   International Atomic Energy Agency through technical cooperation expert
   mission in 2016 under project MHL5001.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI
   Bohart R. M., 1946, US NAVMED, V1055, P1
   Bohart R. M., 1957, DIPTERA CULICIDAE, V12, P1
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champion SR, 2014, ENVIRON HEALTH INSIG, V8, P35, DOI 10.4137/EHI.S16004
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Economic Policy Planning and Statistics Office (EPPSO), 2014, REP MARSH ISL NAT ST
   Ehlers G., 2011, COMMON MOSQUITOES N
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Leong Mark K. H., 2009, Proceedings of the Hawaiian Entomological Society, V41, P57
   Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Marie J, 2013, J MED ENTOMOL, V50, P37, DOI 10.1603/ME12170
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   National Institute of Communicable Diseases (NICD) / World Health Organization (WHO), 2006, GUID PREV CONTR DENG
   Noda Shinichi, 2013, Tropical Medicine and Health, V41, P157, DOI 10.2149/tmh.2013-08
   Nunn PV, 2011, J AM MOSQUITO CONTR, V27, P300, DOI 10.2987/11-6120.1
   PASHLEY D N, 1983, Mosquito Systematics, V15, P41
   Reuben R., 1994, Mosquito Systematics, V26, P75
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   Sharp TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108445
   Shinichi Noda, 2014, South Pacific Studies, V34, P117
   Stone Alan, 1944, PROC ENT SOC WASHINGTON, V46, P205
   SUGERMAN BB, 1972, P HAWAII ENTOMOL SOC, V21, P271
   Terry J., 2008, MARSHALL ISLANDS ENV, P1
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2013, LYMPH FIL MAN MORB P
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
NR 46
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2018
VL 55
IS 5
BP 1299
EP 1306
DI 10.1093/jme/tjy048
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0KQ
UT WOS:000456130900028
PM 29635382
DA 2020-07-08
ER

PT J
AU Zohdy, S
   Morse, WC
   Mathias, D
   Ashby, V
   Lessard, S
AF Zohdy, Sarah
   Morse, Wayde C.
   Mathias, Derrick
   Ashby, Victoria
   Lessard, Sarah
TI Detection of Aedes (Stegomyia) aegypti (Diptera: Culicidae) Populations
   in Southern Alabama Following a 26-yr Absence and Public Perceptions of
   the Threat of Zika Virus
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Gulf Coast; public health; vector-borne diseases; Zika virus
ID REPORTED DISTRIBUTION; UNITED-STATES; MOSQUITOS; ALBOPICTUS;
   REPLACEMENT; PREFERENCE; PATTERNS; FOCUS
AB With the establishment of Zika virus in the Americas, an accurate understanding of the geographic range of its primary vector, Aedes (Stegomyia) aegypti (L.) (Diptera: Culicidae), is vital to assessing transmission risk. In an article published in June 2016, Hahn and colleagues compiled county-level records in the United States for the presence of Ae. aegypti and Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) reported between January 1995 and March 2016. Despite ecological suitability for both mosquito species along the Gulf Coast, Ae. aegypti was not reported in Alabama during the time interval, a result consistent with research suggesting that interactions between these two species often result in displacement of Ae. aegypti. Herein, we report the detection of Ae, aegypti populations in Mobile, Alabama, after a 26-yr absence and present findings on human perceptions of Zika virus relevant to transmission. It is unclear whether the specimens (69 out of 1074) represent a recent re-introduction or belong to a previously undetected remnant population. Sequencing of mtDNA from identified Ae. aegypti matched closest to a specimen collected in Kerala, India. A survey of residents in the surveillance area suggests high encounter rates with mosquitoes in and around homes. Despite high self-reported knowledge about Zika virus, the survey revealed gaps in knowledge regarding its transmission cycle and relative degrees of vulnerability to serious illness among segments of the human population. These findings highlight the importance of continued surveillance, vector control, and public-health education in Gulf Coast states, as well as the potential threat of Ae. Aegypti-transmitted pathogens in southern Alabama.
C1 [Zohdy, Sarah; Morse, Wayde C.; Ashby, Victoria; Lessard, Sarah] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.
   [Zohdy, Sarah] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA.
   [Mathias, Derrick] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.
   [Mathias, Derrick] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL 32962 USA.
RP Zohdy, S (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.; Zohdy, S (corresponding author), Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA.
EM zohdy@auburn.edu
OI Zohdy, Sarah/0000-0001-5316-0567
FU Agriculture and Food Research Young Investigator Award from the USDA
   National Institute of Food and Agriculture;  [CDC-RFA-CK14-1401PPHF]
FX We would like to thank Marcus Williford and Kayla Krigger for field and
   laboratory assistance with entomological surveillance, and Kelly Stevens
   and the Alabama Department of Public Health, and Jerry Folse and the
   Mobile County Health Department Vector Control Program for logistical
   support, and four anonymous reviewers for their comments. This research
   was supported by Agriculture and Food Research Young Investigator Award
   from the USDA National Institute of Food and Agriculture, and
   CDC-RFA-CK14-1401PPHF.
CR Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Burkett-Cadena N. D, 2013, MOSQUITOES SE US
   Burkett-Cadena ND, 2008, J AM MOSQUITO CONTR, V24, P228, DOI 10.2987/5662.1
   Burkett-Cadena ND, 2014, J VECTOR ECOL, V39, P21, DOI 10.1111/j.1948-7134.2014.12066.x
   Burkett-Cadena ND, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00009.1
   Burkett-Cadena ND, 2011, J MED ENTOMOL, V48, P967, DOI 10.1603/ME10265
   Dillman D.A., 2009, INTERNET MAIL MIXED
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   Estep LK, 2011, AM J TROP MED HYG, V84, P718, DOI 10.4269/ajtmh.2011.10-0586
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   HOBBS JH, 1991, J AM MOSQUITO CONTR, V7, P488
   Jacob BG, 2011, ACTA TROP, V117, P61, DOI 10.1016/j.actatropica.2010.10.002
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2
   Lockaby G, 2016, J VECTOR ECOL, V41, P232, DOI 10.1111/jvec.12218
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Monaghan AJ, 2016, PLOS CURR, V16, P8
   Qualls WA, 2006, J AM MOSQUITO CONTR, V22, P601, DOI 10.2987/8756-971X(2006)22[601:LSOTMI]2.0.CO;2
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Rueda LM, 2004, PICTORIAL KEYS IDENT
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
NR 26
TC 2
Z9 2
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2018
VL 55
IS 5
BP 1319
EP 1324
DI 10.1093/jme/tjy050
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0KQ
UT WOS:000456130900030
PM 29659928
DA 2020-07-08
ER

PT J
AU Kovach, KB
   Smith, RC
AF Kovach, Kristofer B.
   Smith, Ryan C.
TI Surveillance of Mosquitoes (Diptera: Culicidae) in Southern Iowa, 2016
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito; medical entomology; surveillance; monitoring
ID AEDES STEGOMYIA ALBOPICTUS; REPORTED DISTRIBUTION; LARVAL COMPETITION;
   UNITED-STATES; JAPONICUS; AEGYPTI
AB The mosquito fauna of Iowa has been extensively investigated over several decades, providing a wealth of information regarding species distributions, relative abundance, temporal activity patterns, and identifying vectors of medical importance. However, these investigations have had unequal coverage, leaving the mosquito fauna in some parts of the state, including southern Iowa, largely uncharacterized. With the heightened public health threat of Zika virus in the summer of 2016, greater emphasis was placed on surveying for two potential Zika virus vectors: Aedes (Stegomyia) albopictus (Skuse) and Aedes (Stegomyia) aegypti (Linnaeus). Southern Iowa became an area of interest due to the range of Ae. Albopictus, potentially extending into this part of the state. Employing CO2-baited Centers for Disease Control and Prevention light traps and BG-Sentinel traps, our targeted trapping efforts in southern Iowa did not yield either Ae. albopictus or Ae. aegypti. However, the geographical expansion of our trapping efforts did lend valuable insights into the mosquito fauna of southern Iowa. Mosquito species such as Aedes atropalpus (Coquillett), Culex erraticus (Dyar and Knab), and several Psorophora species once presumed rare or uncommon in the state were found to be more prevalent in this ecologically diverse region, augmenting our understanding of mosquito distributions in the state. Moreover, these surveillance efforts established baseline data for continued monitoring of the potential introduction and spread of invasive mosquito species in Iowa as part of an integrated mosquito management program
C1 [Kovach, Kristofer B.; Smith, Ryan C.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.
RP Smith, RC (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.
EM smithr@iastate.edu
RI Smith, Ryan C./H-9360-2019
OI Smith, Ryan C./0000-0003-0245-2265
FU Iowa State University Agricultural Experiment Station, USDA National
   Institute of Food and Agriculture, Hatch Project [101071]; Midwest
   Center of Excellence for Vector-Borne Diseases, and Epidemiology and
   Laboratory Capacity for Infectious Diseases (ELC) Program Components
   [5887EL11]; Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [U01 CK000505]
FX We would like to thank the many people that contributed significant
   efforts toward making these mosquito surveillance efforts possible. This
   includes local public health partners from Fremont, Page, Ringgold,
   Decatur, Wayne, Appanoose, Davis, Van Buren, and Lee counties. This work
   would not have been possible without the help of B. Dunphy who was
   integral in identifying trapping locations and in performing mosquito
   identifications. We would also like to thank A. Garvey and J. Coughlin
   at the Iowa Department of Public Health, as well as L. Bartholomay for
   her past stewardship of the mosquito surveillance program from which the
   historical data used in this analysis were collected. This research was
   supported by the Iowa State University Agricultural Experiment Station,
   USDA National Institute of Food and Agriculture, Hatch Project 101071,
   The Midwest Center of Excellence for Vector-Borne Diseases, and
   Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)
   Program Components Contract #5887EL11. This publication was supported by
   Cooperative Agreement #U01 CK000505, funded by the Centers for Disease
   Control and Prevention. Its contents are solely the responsibility of
   the authors and do not necessarily represent the official views of the
   Centers of Disease Control and Prevention or the Department of Health
   and Human Services.
CR Alto BW, 2011, J MED ENTOMOL, V48, P232, DOI 10.1603/ME09252
   Armistead JS, 2008, J VECTOR ECOL, V33, P238, DOI 10.3376/1081-1710-33.2.238
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   DeGroote John P, 2008, Int J Health Geogr, V7, P19, DOI 10.1186/1476-072X-7-19
   Dunphy BM, 2014, J AM MOSQUITO CONTR, V30, P119, DOI 10.2987/13-6388.1
   Dunphy BM, 2009, J MED ENTOMOL, V46, P1282, DOI 10.1603/033.046.0605
   Estep LK, 2010, J MED ENTOMOL, V47, P977, DOI 10.1603/ME10056
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Larson SR, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11001
   Lee JH, 2000, J AM MOSQUITO CONTR, V16, P275
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Sucaet Y, 2008, J MED ENTOMOL, V45, P775, DOI 10.1603/0022-2585(2008)45[775:AWRDFM]2.0.CO;2
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 17
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2018
VL 55
IS 5
BP 1341
EP 1345
DI 10.1093/jme/tjy077
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA HI0KQ
UT WOS:000456130900035
PM 29788488
DA 2020-07-08
ER

PT J
AU Maciel-Lima, S
   Oliveira, FC
   Domingos, IM
AF Maciel-Lima, Sandra
   Oliveira, Francisco Cardozo
   Domingos, Isabela Moreira
TI Fundamental Health Rights: Microcefalia and Sanitary Policies to Combat
   the Zika Virus
SO REVISTA BRASILEIRA DE DIREITO
LA English
DT Article
DE Public Policies; Zika virus; Microcephaly; Basic sanitation
AB The present article portrays the Fundamental Right to Health and Basic Sanitation Policies as propelling mechanisms for human development. Based on the analysis of the National Combat Plan to Combat Zika Virus (ZIKV), we sought to address microcephaly as a global health emergency. To date, more than 48 countries have reported Zika virus transmission: North America; Central America; The Caribbean, and especially South America, with the highest incidence. This is why it requires the mobilization of public authorities and society through awareness-raising, investment in technology, research and basic infrastructure to eliminate the Aedes Aegypti vector in Brazilian territory.
C1 [Maciel-Lima, Sandra; Oliveira, Francisco Cardozo] UNICURITIBA, MSc Law, Curitiba, Parana, Brazil.
   [Domingos, Isabela Moreira] PUCPR, Law, Curitiba, Parana, Brazil.
RP Maciel-Lima, S (corresponding author), UNICURITIBA, MSc Law, Curitiba, Parana, Brazil.
EM maciellima.sandra@gmail.com; xikocardozo@msn.com; isabela.xr@hotmail.com
RI de Lima, Sandra Mara Maciel/I-9378-2018; Maciel-Lima, Sandra
   Mara/AAC-1631-2019
OI de Lima, Sandra Mara Maciel/0000-0002-5917-6540; Maciel-Lima, Sandra
   Mara/0000-0002-5917-6540
CR BRASIL, 2016, DENGUE CHIKUNGUNYA Z
   BRASIL. Portal da Saude, MIN SAUD CONF 1 616
   BRASIL. Secretaria da Saude, ZIKA MICR
   CANELA JUNIOR Osvaldo, 2011, CONTROLE JUDICIAL PO
   CYRINO Roberta Farias, 2016, REV JURIDICA, V2, P317
   d'Avila LS, 2017, REV DIREITO SANIT, V17, P15
   Dallari SG, 2008, REV DIREITO SANIT, V9, P9, DOI 10.11606/issn.2316-9044.v9i3p9-34
   DALLARI Sueli Gandolfi, 2017, REV DIREITO SANITARI, V17, P58
   de SOUZA Luiz Jose, 2016, DENGUE ZIKA CHIKUNGU
   DINIZ Claudio Smirne, 2016, MINISTERIO PUBLICO P
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   DOMINGOS Isabela Moreira, 2017, PARADIGMAS DIREITO C
   EBC, 2016, ENT DIF ENTR SINT ZI
   GRANZIERA Maria Luiza Machado, 2015, DIREITO AMBIENTAL
   GRINOVER Ada Pellegrini, 2013, CONTROLE JURISDICION
   MENDES Gilmar Ferreira, 2012, DIREITOS FUNDAMENTAI
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   ORGANIZACAO Mundial da Saude, SURT VIR ZIK CONT AN
   ORGANIZACAO Mundial da Saude, DOENC VIR ZIK
   PAHO, 2017, ZIKA AT EP
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   RAMOS Edith Maria Barbosa, 2017, REV JURIDICA UNICURI, V4, P304
   RODRIGUES Melissa Cachoni, 2016, REV JURIDICA MINISTE, P297
   RODRIGUES Thais Ferreira, 2016, CIDADANIA DESIGUALDA
   SALGE Ana Karina Marques, 2016, REV ELETRONICA ENFER, V18
   SARLET Ingo, 2015, CURSO DIREITO CONSTI
   TEIXEIRA Carmem, PRINCIPIOS SISTEMA U
   THE LANCET Infectious Diseases, 2017, LANCET INFECT DIS
   Wang DWL, 2009, REV DIREITO SANIT, V10, P308, DOI 10.11606/issn.2316-9044.v10i1p308-318
   WENTZEL Marina, 2016, ZIKA OMS DECLARA EME
   ZORZETTO Ricardo, ZIKA COLLABORATION C
NR 31
TC 0
Z9 0
U1 0
U2 0
PU FAC MERIDIONAL-IMED
PI PASSO FUNDO
PA R SEN PINHEIRO, 304-CRUZEIRO, PASSO FUNDO, RS 99070-220, BRAZIL
SN 1807-1228
EI 2238-0604
J9 REV BRAS DIREITO
JI Rev. Bras. Direito
PD SEP-DEC
PY 2018
VL 14
IS 3
BP 235
EP 248
DI 10.18256/2238-0604.2018.v14i3.2972
PG 14
WC Law
SC Government & Law
GA HF2LM
UT WOS:000454068000011
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Desjardins, MR
   Whiteman, A
   Casas, I
   Delmelle, E
AF Desjardins, M. R.
   Whiteman, A.
   Casas, I.
   Delmelle, E.
TI Space-time clusters and co-occurrence of chikungunya and dengue fever in
   Colombia from 2015 to 2016
SO ACTA TROPICA
LA English
DT Article
DE Space-time statistics; Vector-borne diseases; Clusters; GIS; Colombia
ID AEDES-AEGYPTI; CRIME PATTERNS; DISEASE; VIRUS; ZIKA; BURDEN; ANTIBODY;
   RISK; PREVENTION; PREDICTION
AB Vector-borne diseases (VBDs) infect over one billion people and are responsible for over one million deaths each year, globally. Chikungunya (CHIK) and Dengue Fever (DENF) are emerging VBDs due to overpopulation, increases in urbanization, climate change, and other factors. Colombia has recently experienced severe outbreaks of CHIK AND DENF. Both viruses are transmitted by the Aedes mosquitoes and are preventable with a variety of surveillance and vector control measures (e.g. insecticides, reduction of open containers, etc.). Spatiotemporal statistics can facilitate the surveillance of VBD outbreaks by informing public health officials where to allocate resources to mitigate future outbreaks. We utilize the univariate Kulldorff space-time scan statistic (STSS) to identify and compare statistically significant space-time clusters of CHIK and DENF in Colombia during the outbreaks of 2015 and 2016. We also utilize the multivariate STSS to examine co-occurrences (simultaneous excess incidences) of DENF and CHIK, which is critical to identify regions that may have experienced the greatest burden of VBDs. The relative risk of CHIK and DENF for each Colombian municipality belonging to a univariate and multivariate cluster is reported to facilitate targeted interventions. Finally, we visualize the results in a three-dimensional environment to examine the size and duration of the clusters. Our approach is the first of its kind to examine multiple VBDs in Colombia simultaneously, while the 3D visualizations are a novel way of illustrating the dynamics of space-time clusters of disease.
C1 [Desjardins, M. R.; Whiteman, A.; Delmelle, E.] Univ N Carolina, Dept Geog & Earth Sci, 2901 Univ City Blvd, Charlotte, NC 28223 USA.
   [Desjardins, M. R.; Whiteman, A.; Delmelle, E.] Univ N Carolina, Ctr Appl Geog Informat Sci, 2901 Univ City Blvd, Charlotte, NC 28223 USA.
   [Casas, I.] Louisiana Tech Univ, Sch Hist & Social Sci, 305 Wisteria St Ruston, Ruston, LA 71272 USA.
RP Delmelle, E (corresponding author), Univ N Carolina, Dept Geog & Earth Sci, 2901 Univ City Blvd, Charlotte, NC 28223 USA.; Delmelle, E (corresponding author), Univ N Carolina, Ctr Appl Geog Informat Sci, 2901 Univ City Blvd, Charlotte, NC 28223 USA.
EM eric.delmelle@uncc.edu
CR Alvis-Guzman N, 2017, REV MVZ CORDOBA, V22, P5994, DOI 10.21897/rmvz.1069
   Amin R, 2014, STAT PUBLIC POLICY, V1, P69, DOI 10.1080/2330443X.2014.928245
   Bailey T. C., 1995, INTERACTIVE SPATIAL, V413
   Banu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089440
   Banu S, 2012, TROP MED INT HEALTH, V17, P1086, DOI 10.1111/j.1365-3156.2012.03038.x
   Beckham JD, 2015, NEUROINFECT DIS, V21, P1599
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bloch D., 2016, COST BURDEN CHIKUNGU
   Brunsdon C, 2007, COMPUT ENVIRON URBAN, V31, P52, DOI 10.1016/j.compenvurbsys.2005.07.009
   Cali S., 2010, HIST DENGUE CALI END
   Chachareros, 2015, CERC 80000 CAS CHIK
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Cheng T, 2012, INT ARCH PHOTOGRAMM, V39-B2, P47
   Cheng T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097807
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delmelle E, 2013, INT J APPL GEOSPAT R, V4, P58, DOI 10.4018/jagr.2013100104
   Delmelle E, 2014, INT J GEOGR INF SCI, V28, P1107, DOI 10.1080/13658816.2013.871285
   Duczmal L, 2004, COMPUT STAT DATA AN, V45, P269, DOI 10.1016/S0167-9473(02)00302-X
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303
   Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847
   Eisen L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000411
   EPS C, 2015, B PRENS COOMEVA EPS
   Floore TG, 2006, J AM MOSQUITO CONTR, V22, P527, DOI 10.2987/8756-971X(2006)22[527:MLCPPA]2.0.CO;2
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Greene SK, 2012, FOODBORNE PATHOG DIS, V9, P431, DOI 10.1089/fpd.2011.1036
   Hanley KA, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P351, DOI 10.1016/B978-0-12-374153-0.00016-3
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250
   Hii Yien Ling, 2016, Curr Environ Health Rep, V3, P81, DOI 10.1007/s40572-016-0078-z
   Hohl A, 2016, SPAT SPATIO-TEMPORAL, V19, P10, DOI 10.1016/j.sste.2016.05.002
   INS, 2017, PROT VIG SAL PUBL CH
   INS, 2017, PROT VIL SAL PUBL DE
   INS, 2016, VIG RUT EV MUN
   JACQUEZ GM, 2005, J GEOGR SYST, V7, P7, DOI DOI 10.1007/S10109-005-0147-6
   Jonsson ME, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-48
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kitron U, 2000, PARASITOL TODAY, V16, P324, DOI 10.1016/S0169-4758(00)01708-7
   Kitron U, 1998, J MED ENTOMOL, V35, P435, DOI 10.1093/jmedent/35.4.435
   Kulldorff M, 1999, BIOMETRICS, V55, P544, DOI 10.1111/j.0006-341X.1999.00544.x
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Li J, 2014, AM J TROP MED HYG, V91, P1166, DOI 10.4269/ajtmh.13-0733
   Li ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-132
   Lian M, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-42
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   MANTEL N, 1967, CANCER RES, V27, P209
   Metras R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001808
   Mulatti P, 2015, EPIDEMIOL INFECT, V143, P202, DOI 10.1017/S0950268814000442
   Naish S, 2011, TROP MED INT HEALTH, V16, P884, DOI 10.1111/j.1365-3156.2011.02775.x
   Nakaya T, 2010, T GIS, V14, P223, DOI 10.1111/j.1467-9671.2010.01194.x
   Noticiascaracol, 2016, NOTICIASCARACOL
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003977
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   de Melo DPO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042125
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Perez A, 2011, SPAT SPATIO-TEMPORAL, V2, P135, DOI 10.1016/j.sste.2011.07.006
   Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1
   Pigott DM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003756
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rogerson P., 2008, STAT DETECTION SURVE
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Shepard D. S., 2010, DENGUE B, V34, P1
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Silverman Bernard W, 1986, DENSITY ESTIMATION S, V26
   Sivigila E., 2016, MANUAL USUARIO SISTE
   Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11
   Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018
   Theophilides CN, 2003, AM J EPIDEMIOL, V157, P843, DOI 10.1093/aje/kwg046
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Uittenbogaard A, 2012, REV EUR STUD, V4, P148, DOI DOI 10.5539/RES.V4N5P148
   Ullah S, 2017, GEOSPATIAL HEALTH, V12, P210, DOI 10.4081/gh.2017.567
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 86
TC 11
Z9 12
U1 2
U2 36
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2018
VL 185
BP 77
EP 85
DI 10.1016/j.actatropica.2018.04.023
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GO6ED
UT WOS:000440126000011
PM 29709630
DA 2020-07-08
ER

PT J
AU Scavuzzo, JM
   Trucco, F
   Espinosa, M
   Tauro, CB
   Abril, M
   Scavuzzo, CM
   Frery, AC
AF Scavuzzo, Juan M.
   Trucco, Francisco
   Espinosa, Manuel
   Tauro, Carolina B.
   Abril, Marcelo
   Scavuzzo, Carlos M.
   Frery, Alejandro C.
TI Modeling Dengue vector population using remotely sensed data and machine
   learning
SO ACTA TROPICA
LA English
DT Article
DE Remote sensing; Time series; Machine learning; Dengue population; Aedes
   irgypti (Linnaeus)
ID DIFFERENCE WATER INDEX; AEDES-AEGYPTI; NEURAL-NETWORKS; IMAGE
   CLASSIFICATION; CORDOBA CITY; EPIDEMIOLOGY; DYNAMICS; OUTBREAK;
   VALIDATION; PREDICTION
AB Mosquitoes are vectors of many human diseases. In particular, Aedes cegypti (Linnaeus) is the main vector for Chikungunya, Dengue, and Zika viruses in Latin America and it represents a global threat. Public health policies that aim at combating this vector require dependable and timely information, which is usually expensive to obtain with field campaigns. For this reason, several efforts have been done to use remote sensing due to its reduced cost. The present work includes the temporal modeling of the oviposition activity (measured weekly on 50 ovitraps in a north Argentinean city) of Aedes cegypti (Linnaeus), based on time series of data extracted from operational earth observation satellite images. We use are NDVI, NDWI, LST night, LST day and TRMM-GPM rain from 2012 to 2016 as predictive variables. In contrast to previous works which use linear models, we employ Machine Learning techniques using completely accessible open source toolkits. These models have the advantages of being non-parametric and capable of describing nonlinear relationships between variables. Specifically, in addition to two linear approaches, we assess a support vector machine, an artificial neural networks, a K-nearest neighbors and a decision tree regressor. Considerations are made on parameter tuning and the validation and training approach. The results are compared to linear models used in previous works with similar data sets for generating temporal predictive models. These new tools perform better than linear approaches, in particular nearest neighbor regression (KNNR) performs the best. These results provide better alternatives to be implemented operatively on the Argentine geospatial risk system that is running since 2012.
C1 [Scavuzzo, Juan M.; Trucco, Francisco] Univ Nacl Cordoba, Fac Maremat Atron Fis & Comp, Cordoba, Argentina.
   [Tauro, Carolina B.; Scavuzzo, Carlos M.] Univ Nacl Cordoba, Comis Nacl Actividades Espaciales, Inst Altos Estudios Espaciales Mario Gulich, Cordoba, Argentina.
   [Espinosa, Manuel; Abril, Marcelo] Fdn Mundo Sano, Buenos Aires, DF, Argentina.
   [Frery, Alejandro C.] Univ Fed Alagoas, Maceio, Brazil.
RP Scavuzzo, CM (corresponding author), Univ Nacl Cordoba, Comis Nacl Actividades Espaciales, Inst Altos Estudios Espaciales Mario Gulich, Cordoba, Argentina.
EM scavuzzocm@gmail.com
RI Frery, Alejandro C./A-8855-2008
OI Frery, Alejandro C./0000-0002-8002-5341
CR Andreo V, 2009, AUSTRAL ECOL, V34, P132, DOI 10.1111/j.1442-9993.2008.01889.x
   Arboleda S, 2012, J VECTOR ECOL, V37, P37, DOI 10.1111/j.1948-7134.2012.00198.x
   Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697218700
   Azamathulla HM, 2012, APPL SOFT COMPUT, V12, P1227, DOI 10.1016/j.asoc.2011.12.003
   Bose P, 2016, IEEE T GEOSCI REMOTE, V54, P6563, DOI 10.1109/TGRS.2016.2586602
   Bowman LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157971
   Brown ME, 2008, INT J REMOTE SENS, V29, P7141, DOI 10.1080/01431160802238435
   Buczak AL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-124
   Cramer S, 2017, EXPERT SYST APPL, V85, P169, DOI 10.1016/j.eswa.2017.05.029
   Espinosa M.O., 2018, GEOSPAT HLTH
   Espinosa M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004621
   Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Estallo EL, 2011, VECTOR-BORNE ZOONOT, V11, P543, DOI 10.1089/vbz.2009.0165
   Foody GM, 2004, INT J REMOTE SENS, V25, P3091, DOI 10.1080/01431160310001648019
   Fuller DO, 2010, INT J REMOTE SENS, V31, P3, DOI 10.1080/01431160902865756
   Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3
   Goldarag YJ, 2016, J INDIAN SOC REMOTE, V44, P885, DOI 10.1007/s12524-016-0557-6
   GOMES AC, 1998, INF EPIDEMIOL SUS, V7, P49
   Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125
   Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3
   Herbreteau V, 2007, HEALTH PLACE, V13, P400, DOI 10.1016/j.healthplace.2006.03.003
   Kalluri S., 2007, PLOS PATHOG, V3, P1
   Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2
   Lary DJ, 2009, IEEE GEOSCI REMOTE S, V6, P694, DOI 10.1109/LGRS.2009.2023605
   Lary DJ, 2016, GEOSCI FRONT, V7, P3, DOI 10.1016/j.gsf.2015.07.003
   Estallo EL, 2016, IEEE J-STARS, V9, P5461, DOI 10.1109/JSTARS.2016.2604577
   Estallo EL, 2012, INT J REMOTE SENS, V33, P4254, DOI 10.1080/01431161.2011.640962
   Lopez-Ibanez M, 2016, OPER RES PERSPECT, V3, P43, DOI 10.1016/j.orp.2016.09.002
   Madadi MR, 2015, EARTH SCI INFORM, V8, P627, DOI 10.1007/s12145-014-0197-8
   Moncayo A., 2004, EMERG INFECT DIS, V10
   Moreno-Madrinan MJ, 2014, ISPRS INT J GEO-INF, V3, P732, DOI 10.3390/ijgi3020732
   Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009
   PARRA-HENAO GABRIEL, 2010, CES Med., V24, P75
   Pavlovky E., 1966, NATURAL NIDALITY TRA
   Pena JM, 2014, REMOTE SENS-BASEL, V6, P5019, DOI 10.3390/rs6065019
   Peres LF, 2004, REMOTE SENS ENVIRON, V91, P377, DOI 10.1016/j.rse.2004.03.011
   PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403
   Porcasi X, 2012, GEOSPATIAL HEALTH, V6, pS31
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rai P.K, 2012, HLTH SCI J, V6, P731
   RITCHIE SA, 1984, MOSQ NEWS, V44, P77
   Rotela C, 2007, ACTA TROP, V103, P1, DOI 10.1016/j.actatropica.2007.05.003
   Rotela C, 2017, GEOSPATIAL HEALTH, V12, P226, DOI 10.4081/gh.2017.564
   Wan Z, 2004, INT J REMOTE SENS, V25, P261, DOI 10.1080/0143116031000116417
   WAN Z, 1999, MODIS LAND SURFACE T
   Wang DC, 2016, INT GEOSCI REMOTE SE, P5852, DOI 10.1109/IGARSS.2016.7730529
   WHO, 2016, ZIK VIR FACT SHEET J
   Yi JS, 1996, ENVIRON POLLUT, V92, P349, DOI 10.1016/0269-7491(95)00078-X
   Zahabiyoun B, 2013, CLEAN-SOIL AIR WATER, V41, P601, DOI 10.1002/clen.201100652
   Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037
NR 51
TC 12
Z9 12
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2018
VL 185
BP 167
EP 175
DI 10.1016/j.actatropica.2018.05.003
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GO6ED
UT WOS:000440126000023
PM 29777650
DA 2020-07-08
ER

PT J
AU Jiang, D
   Hao, MM
   Ding, FY
   Fu, JY
   Li, M
AF Jiang, Dong
   Hao, Mengmeng
   Ding, Fangyu
   Fu, Jingying
   Li, Meng
TI Mapping the transmission risk of Zika virus using machine learning
   models
SO ACTA TROPICA
LA English
DT Article
DE Zika virus; Transmission risk; Machine learning; Significant
   differences; Prediction uncertainty
ID AEDES-AEGYPTI DIPTERA; VECTOR-BORNE DISEASE; SPATIAL-DISTRIBUTION;
   OUTBREAK; HISTORY; ISOLATIONS; ALBOPICTUS; CULICIDAE; INFECTION;
   EPIDEMIC
AB Zika virus, which has been linked to severe congenital abnormalities, is exacerbating global public health problems with its rapid transnational expansion fueled by increased global travel and trade. Suitability mapping of the transmission risk of Zika virus is essential for drafting public health plans and disease control strategies, which are especially important in areas where medical resources are relatively scarce. Predicting the risk of Zika virus outbreak has been studied in recent years, but the published literature rarely includes multiple model comparisons or predictive uncertainty analysis. Here, three relatively popular machine learning models including backward propagation neural network (BPNN), gradient boosting machine (GBM) and random forest (RF) were adopted to map the probability of Zika epidemic outbreak at the global level, pairing high-dimensional multidisciplinary covariate layers with comprehensive location data on recorded Zika virus infection in humans. The results show that the predicted high-risk areas for Zika transmission are concentrated in four regions: Southeastern North America, Eastern South America, Central Africa and Eastern Asia. To evaluate the performance of machine learning models, the 50 modeling processes were conducted based on a training dataset. The BPNN model obtained the highest predictive accuracy with a 10-fold cross-validation area under the curve (AUC) of 0.966 [95% confidence interval (CI) 0.965-0.967], followed by the GBM model (10-fold cross-validation AUC = 0.964[0.963-0.965]) and the RF model (10-fold cross-validation AUC = 0.963[0.962-0.964]). Based on training samples, compared with the BPNN-based model, we find that significant differences (p = 0.0258* and p = 0.0001***, respectively) are observed for prediction accuracies achieved by the GBM and RF models. Importantly, the prediction uncertainty introduced by the selection of absence data was quantified and could provide more accurate fundamental and scientific information for further study on disease transmission prediction and risk assessment.
C1 [Jiang, Dong; Hao, Mengmeng; Ding, Fangyu; Fu, Jingying; Li, Meng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.
   [Jiang, Dong; Hao, Mengmeng; Ding, Fangyu; Fu, Jingying; Li, Meng] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing 100049, Peoples R China.
RP Ding, FY (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.
EM jiangd@igsnrr.ac.cn; haomm.16b@igsnrr.ac.cn; dingfy.17b@igsnrr.ac.cn;
   fujy@igsnrr.ac.cn; lim.17b@igsnrr.ac.cn
FU Ministry of Science and Technology of ChinaMinistry of Science and
   Technology, China [2016YFC1201300]
FX We thank Qiaoling Zhu for providing the valuable suggestions. This
   research was supported and funded by the Ministry of Science and
   Technology of China (2016YFC1201300).
CR Alaniz A.J., 2017, INT J EPIDEMIOL
   Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center for International Earth Science Information Network - CIESIN - Columbia University, 2016, GLOB SUMM LAND SURF
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Jane M., 2016, GLOBAL COMPENDIUM HU
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Pacheco O., 2016, NEW ENGL J MED
   Parra B., 2016, NEW ENGL J MED, V387, P1482
   Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ridgeway G., 2006, R PACKAGE VERSION, V1, P55
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2
   Roth A., 2014, EURO SURVEILL B EURO, V19
   RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Teng Y, 2017, J INFECTION, V74, P484, DOI 10.1016/j.jinf.2017.01.015
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2016, INT LEGAL MAT, V55, P1010
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 63
TC 9
Z9 9
U1 5
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2018
VL 185
BP 391
EP 399
DI 10.1016/j.actatropica.2018.06.021
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GO6ED
UT WOS:000440126000054
PM 29932934
DA 2020-07-08
ER

PT J
AU Chu, V
   Petersen, LR
   Moore, CA
   Meaney-Delman, D
   Nelson, G
   Sonne, DC
   Dodge, NN
   Glaser, C
   Rasmussen, SA
AF Chu, Victoria
   Petersen, Lyle R.
   Moore, Cynthia A.
   Meaney-Delman, Dana
   Nelson, Gregg
   Sonne, D. Christian
   Dodge, Nancy N.
   Glaser, Carol
   Rasmussen, Sonja A.
TI Possible Congenital Zika Syndrome in Older Children Due to Earlier
   Circulation of Zika Virus
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE congenital abnormalities; congenital defects; birth defect;
   microcephaly; Zika virus; zoonoses; flavivirus; TORCH
ID SUBEPENDYMAL CALCIFICATION; HEMORRHAGIC DESTRUCTION; INFECTION; INFANTS;
   BRAZIL; RUBELLA; ASSOCIATION; MUTATIONS; DIAGNOSIS; CAMBODIA
AB Congenital Zika syndrome (CZS) was identified following a large Zika virus (ZIKV) outbreak in Brazil in 2015. Two children with clinical presentations consistent with CZS, ages 7 and 8 years old, are described. Both mothers lived in Cambodia, a region with known ZIKV, during their pregnancies and reported fever and rash in the second trimester. The infants were born with severe microcephaly. Testing for congenital infection at birth and genetic testing were unremarkable. In 2017, serologic testing for both mothers were consistent with prior ZIKV infection. Review of infant neuroimaging demonstrated ventriculomegaly, severe cerebral atrophy, and subcortical calcifications consistent with CZS. Given the maternal symptoms suggesting ZIKV infection during pregnancy and the combination of clinical and radiological features unique to CZS, CZS is strongly suspected in these children, suggesting that CZS occurred before the 2013-2014 French Polynesia outbreak. As such, CZS should be considered in older children with congenital microcephaly of unknown etiology and a history consistent with possible ZIKV exposure.
C1 [Chu, Victoria; Sonne, D. Christian; Glaser, Carol] Kaiser Permanente, Oakland, CA 94611 USA.
   [Petersen, Lyle R.] Ctr Dis Control & Prevent, Ft Collins, CO USA.
   [Moore, Cynthia A.; Meaney-Delman, Dana; Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Nelson, Gregg] Kaiser Permanente, Roseville, CA USA.
   [Dodge, Nancy N.] Helen DeVos Childrens Hosp, Grand Rapids, MI USA.
RP Chu, V (corresponding author), Kaiser Permanente, Oakland, CA 94611 USA.
EM victoria.t.chu@gmail.com
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Akawi NA, 2013, HUM MUTAT, V34, P498, DOI 10.1002/humu.22263
   Alarcon A, 2013, J PEDIATR-US, V163, P828, DOI 10.1016/j.jpeds.2013.03.014
   Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003
   [Anonymous], 2016, ZIKA VIRUS EMERGENCY
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   COOPER LZ, 1971, AM J DIS CHILD, V122, P397, DOI 10.1001/archpedi.1971.02110050067006
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dontigny L, 2008, J OBSTET GYNAECOL CA, V30, P152, DOI 10.1016/S1701-2163(16)32740-2
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Edmunds WJ, 2000, EPIDEMIOL INFECT, V125, P113, DOI 10.1017/S0950268899004161
   Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ireton H., 1985, J PEDIATR PSYCHOL, V10, P288, DOI [10. 1093/jpepsy/10. 2. 288, DOI 10.1093/JPEPSY/10.2.288]
   Johnson AJ, 2007, CLIN VACCINE IMMUNOL, V14, P1084, DOI 10.1128/CVI.00115-07
   Kumar M., 2017, PLOS NEGLECT TROP D, V10, P1, DOI [10. 1371/journal, DOI 10.1371/JOURNAL]
   KUMAR ML, 1984, J PEDIATR-US, V104, P674, DOI 10.1016/S0022-3476(84)80942-7
   KUMAR ML, 1973, NEW ENGL J MED, V288, P1370, DOI 10.1056/NEJM197306282882603
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   MCAULEY J, 1994, CLIN INFECT DIS, V18, P38, DOI 10.1093/clinids/18.1.38
   Mochida GH, 2010, AM J HUM GENET, V87, P882, DOI 10.1016/j.ajhg.2010.10.026
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2017, LANCET INFECT DIS, V17, P782, DOI 10.1016/S1473-3099(17)30251-7
   Noyola DE, 2000, PEDIATR INFECT DIS J, V19, P505, DOI 10.1097/00006454-200006000-00003
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pond W., 1983, T R SOC TROP MED HYG, V57, P364
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smithburn K. C., 1953, J IMMUNOL, V72
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   THOMAS HIJ, 1993, J MED VIROL, V41, P196, DOI 10.1002/jmv.1890410305
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 49
TC 2
Z9 2
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD SEP
PY 2018
VL 176
IS 9
BP 1882
EP 1889
DI 10.1002/ajmg.a.40378
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA GU4RO
UT WOS:000445271900014
PM 30070773
OA Bronze
DA 2020-07-08
ER

PT J
AU de Mello, CPP
   Tao, X
   Kim, TH
   Vicchiarelli, M
   Bulitta, JB
   Kaushik, A
   Brown, AN
AF de Mello, Camilly P. Pires
   Tao, Xun
   Kim, Tae Hwan
   Vicchiarelli, Michael
   Bulitta, Juergen B.
   Kaushik, Ajeet
   Brown, Ashley N.
TI Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the
   Hollow-Fiber Infection Model
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE mathematical modeling; Zika virus; antiviral therapy; favipiravir;
   hollow-fiber infection model; pharmacodynamics; pharmacokinetics
ID IN-VIVO ACTIVITIES; POPULATION PHARMACOKINETICS; VITRO; SYSTEM;
   TRANSMISSION; T-705
AB Zika virus (ZIKV) infection is associated with serious, long-term neurological manifestations. There are currently no approved therapies for the treatment or prevention of ZIKV infection. Favipiravir (FAV) is a viral polymerase inhibitor with broad-spectrum activity. Our prior studies used static FAV concentrations and demonstrated promising activity. However, the anti-ZIKV activity of dynamic FAV concentrations has never been evaluated in a human cell line. Here we employed the hollow-fiber infection model (HFIM) to simulate the human pharmacokinetic (PK) profiles associated with the clinically utilized FAV dosage regimens against influenza and Ebola viruses and assessed the viral burden profiles. Clinically achievable FAV concentrations inhibited ZIKV replication in HUH-7 cells in a dose-dependent fashion (50% effective concentration = 236.5 mu M). The viral burden profiles under dynamic FAV concentrations were predicted by use of a mechanism-based mathematical model (MBM) and subsequently successfully validated in the HFIM. This validated, translational MBM can now be used to predict the anti-ZIKV activity of other FAV dosage regimens in the presence of between-patient variability in pharmacokinetics. This approach can be extended to rationally optimize FAV combination dosage regimens which hold promise to treat ZIKV infections in nonpregnant patients.
C1 [de Mello, Camilly P. Pires; Vicchiarelli, Michael; Brown, Ashley N.] Univ Florida, Coll Med, Dept Med, Inst Therapeut Innovat, Orlando, FL 32827 USA.
   [Tao, Xun; Kim, Tae Hwan; Bulitta, Juergen B.] Univ Florida, Coll Pharm, Dept Pharmaceut, Ctr Pharmacometr & Syst Pharmacol, Orlando, FL USA.
   [Kaushik, Ajeet] Florida Int Univ, Herbert Wertheim Coll Med, Inst Neuroimmune Pharmacol, Ctr Personalized Nanomed,Dept Immunol, Miami, FL 33199 USA.
RP Brown, AN (corresponding author), Univ Florida, Coll Med, Dept Med, Inst Therapeut Innovat, Orlando, FL 32827 USA.
EM Ashley.Brown@medicine.ufl.edu
RI Kaushik, Ajeet/K-1289-2018; Bulitta, Jurgen B/P-3355-2018
OI Kaushik, Ajeet/0000-0003-4206-1541; Bulitta, Jurgen
   B/0000-0001-7352-3097
FU Florida Department of Health Biomedical Research Program [7ZK30]
FX This work was supported by grant 7ZK30 from the Florida Department of
   Health Biomedical Research Program.
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bauer RJ, 2007, AAPS J, V9, pE60, DOI 10.1208/aapsj0901007
   Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260
   Brendel K, 2006, PHARM RES, V23, P2036, DOI 10.1007/s11095-006-9067-5
   Brown AN, 2015, ANTIMICROB AGENTS CH, V59, P3771, DOI 10.1128/AAC.00469-15
   Brown AN, 2011, ANTIMICROB AGENTS CH, V55, P1740, DOI 10.1128/AAC.01628-10
   Brown AN, 2011, ANTIMICROB AGENTS CH, V55, P1747, DOI 10.1128/AAC.01629-10
   Brown AN, 2010, ANTIMICROB AGENTS CH, V54, P3442, DOI 10.1128/AAC.01385-09
   Bulitta JB, 2013, ANTIMICROB AGENTS CH, V57, P498, DOI 10.1128/AAC.01354-12
   Bulitta JB, 2011, AAPS J, V13, P201, DOI 10.1208/s12248-011-9257-x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07
   Luma Henry Namme, 2016, Open AIDS J, V10, P199, DOI 10.2174/1874613601610010199
   Mendenhall M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001342
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nagata T, 2015, DISASTER MED PUBLIC, V9, P79, DOI 10.1017/dmp.2014.151
   Pharmaceuticals and Medical Devices Agency, 2014, REV REP
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Tanaka E, 1999, J CLIN PHARM THER, V24, P323, DOI 10.1046/j.1365-2710.1999.00236.x
   Nguyen THT, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005389
   Yano Y, 1998, J PHARM SCI, V87, P1177, DOI 10.1021/js9801337
NR 29
TC 3
Z9 3
U1 3
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2018
VL 62
IS 9
AR e00967-18
DI 10.1128/AAC.00967-18
PG 11
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA GR6NN
UT WOS:000442771200067
PM 29967017
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Meutiawati, F
   Bezemer, B
   Strating, JRPM
   Overheul, GJ
   Zusinaite, E
   van Kuppeveld, FJM
   van Cleef, KWR
   van Rij, RP
AF Meutiawati, Febrina
   Bezemer, Bodine
   Strating, Jeroen R. P. M.
   Overheul, Gijs J.
   Zusinaite, Eva
   van Kuppeveld, Frank J. M.
   van Cleef, Koen W. R.
   van Rij, Ronald P.
TI Posaconazole inhibits dengue virus replication by targeting
   oxysterol-binding protein
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Dengue virus; Zika virus; Posaconazole; Itraconazole; Antiviral drugs;
   Oxysterol-binding protein
ID OSBP-RELATED PROTEIN-2; CHOLESTEROL TRAFFICKING; ENTEROVIRUS
   REPLICATION; ANTIVIRAL ACTIVITY; REPLICON SYSTEM; RNA-SYNTHESIS;
   ITRACONAZOLE; ANTIFUNGAL; METABOLISM; COMPOUND
AB Dengue virus (DENV) is associated with an estimated 390 million infections per year, occurring across approximately 100 countries in tropical and sub-tropical regions. To date, there are no antiviral drugs or specific therapies to treat DENV infection. Posaconazole and itraconazole are potent antifungal drugs that inhibit ergosterol biosynthesis in fungal cells, but also target a number of human proteins. Here, we show that itraconazole and posaconazole have antiviral activity against DENV. Posaconazole inhibited replication of multiple serotypes of DENV and the related flavivirus Zika virus, and reduced viral RNA replication, but not translation of the viral genome. We used a combination of knockdown and drug sensitization assays to define the molecular target of posaconazole that mediates its antiviral activity. We found that knockdown of oxysterol-binding protein (OSBP) inhibited DENV replication. Moreover, knockdown of OSBP, but not other known targets of posaconazole, enhanced the inhibitory effect of posaconazole. Our findings imply OSBP as a potential target for the development of antiviral compounds against DENV.
C1 [Meutiawati, Febrina; Bezemer, Bodine; Overheul, Gijs J.; van Cleef, Koen W. R.; van Rij, Ronald P.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Med Microbiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.
   [Meutiawati, Febrina; Bezemer, Bodine; Overheul, Gijs J.; van Cleef, Koen W. R.; van Rij, Ronald P.] Radboud Univ Nijmegen, Radboudumc Ctr Infect Dis, Med Ctr, Nijmegen, Netherlands.
   [Strating, Jeroen R. P. M.; van Kuppeveld, Frank J. M.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands.
   [Zusinaite, Eva] Univ Tartu, Inst Technol, Tartu, Estonia.
   [van Cleef, Koen W. R.] MSD Anim Hlth, Boxmeer, Netherlands.
RP van Rij, RP (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Med Microbiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM ronald.vanrij@radboudumc.nl
RI Bezemer, Bodine/I-4509-2017; Strating, Jeroen/F-4399-2019; Van Rij,
   Ronald/I-7073-2012
OI Strating, Jeroen/0000-0003-2509-5213; Van Rij,
   Ronald/0000-0003-0221-4689; Overheul, Gijs/0000-0002-8356-8165
FU Indonesia Endowment Fund (LDPD); VICI grant from the Netherlands
   Organisation for Scientific Research [NWO-VICI-91812628,
   NWO-ECHO-711.017.002]; ECHO grant from the Netherlands Organisation for
   Scientific Research [NWO-VICI-91812628, NWO-ECHO-711.017.002]; Horizon
   Breakthrough fellowship from the Netherlands Genomics Initiative
   [93518028]; Radboud Institute for Molecular Life Science (RIMLS)
FX We thank Finny Varghese and other members of the Van Rij laboratory for
   fruitful discussions, Michael Thomassen for technical support during the
   initial stage of the project, and the Radboudumc Microscopic Imaging
   Center for support with fluorescence microscopy. This work was
   financially supported by a PhD fellowship from the Indonesia Endowment
   Fund (LDPD) to FM, by VICI and ECHO grants from the Netherlands
   Organisation for Scientific Research (project no. NWO-VICI-91812628 and
   NWO-ECHO-711.017.002) to FvK, and a Horizon Breakthrough fellowship from
   the Netherlands Genomics Initiative (project no. 93518028) and a PhD
   grant from the Radboud Institute for Molecular Life Science (RIMLS) to
   RvR. We thank Andres Merits (University of Tartu, Tartu, Estonia) for
   kindly providing the Zika virus replicon. We thank Claire Huang (Centers
   for Disease Control, Fort Collins, CO, USA) for providing DENV2 strain
   16681, Beate Kummerer (University of Bonn Medical Center, Germany) for
   providing DENV1 16007 and DENV4 H241, and Andrew Davidson (University of
   Bristol, UK) for providing the pRepDVPacLuc replicon plasmid. The NIH
   Clinical Collection was kindly provided through the National Institutes
   of Health Molecular Libraries Roadmap Initiative. We thank Paul Verweij
   (Radboud University Medical Center) for providing antifungal triazole
   drugs and Matthew Shair (Harvard University) for providing OSW-1.
CR Albulescu L, 2017, ANTIVIR RES, V140, P37, DOI 10.1016/j.antiviral.2017.01.008
   Albulescu L, 2015, ANTIVIR RES, V117, P110, DOI 10.1016/j.antiviral.2015.02.013
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09
   Arita M, 2015, MICROBIOL IMMUNOL, V59, P338, DOI 10.1111/1348-0421.12261
   Arita M, 2013, J VIROL, V87, P4252, DOI 10.1128/JVI.03546-12
   Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10
   Barajas D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004388
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625
   Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216
   Chen BZ, 2016, MOL CANCER THER, V15, P866, DOI 10.1158/1535-7163.MCT-15-0729-T
   Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899
   Chong CR, 2007, ACS CHEM BIOL, V2, P263, DOI 10.1021/cb600362d
   Chukkapalli V, 2012, CURR OPIN MICROBIOL, V15, P512, DOI 10.1016/j.mib.2012.05.013
   Das A, 2014, ELIFE, V3, DOI 10.7554/eLife.02882
   de Castro IF, 2017, J CELL SCI, V130, P260, DOI 10.1242/jcs.181586
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Head SA, 2017, ACS CHEM BIOL, V12, P174, DOI 10.1021/acschembio.6b00849
   Head SA, 2015, P NATL ACAD SCI USA, V112, pE7276, DOI 10.1073/pnas.1512867112
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Hynynen R, 2005, BIOCHEM J, V390, P273, DOI 10.1042/BJ20042082
   Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200
   Iaea DB, 2015, ESSAYS BIOCHEM, V57, P43, DOI [10.1042/bse0570043, 10.1042/BSE0570043]
   Ishikawa-Sasaki K, 2018, J VIROL, V92, DOI 10.1128/JVI.01952-17
   Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10
   Kato F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050122
   Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027
   Kim JH, 2014, MYCOPATHOLOGIA, V178, P259, DOI 10.1007/s11046-014-9792-y
   Laitinen S, 2002, J LIPID RES, V43, P245
   Lamb DC, 1999, YEAST, V15, P755, DOI 10.1002/(SICI)1097-0061(19990630)15:9&lt;755::AID-YEA417&gt;3.0.CO;2-8
   Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104
   Lee J, 2007, CHEMBIOCHEM, V8, P1916, DOI 10.1002/cbic.200700403
   Lehto M, 2001, J LIPID RES, V42, P1203
   Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lo MK, 2003, J VIROL, V77, P12901, DOI 10.1128/JVI.77.23.12901-12906.2003
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Park IW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075648
   Peyton LR, 2015, DRUG TODAY, V51, P705, DOI 10.1358/dot.2015.51.12.2421058
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Rhoden E, 2018, ANTIVIR RES, V149, P75, DOI 10.1016/j.antiviral.2017.11.011
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Roulin PS, 2014, CELL HOST MICROBE, V16, P677, DOI 10.1016/j.chom.2014.10.003
   Sabatelli F, 2006, ANTIMICROB AGENTS CH, V50, P2009, DOI 10.1128/AAC.00163-06
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40
   Simmons CP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001752
   Strating JRPM, 2017, CURR OPIN CELL BIOL, V47, P24, DOI 10.1016/j.ceb.2017.02.005
   Strating JRPM, 2015, CELL REP, V10, P600, DOI 10.1016/j.celrep.2014.12.054
   Te Helen S, 2007, Gastroenterol Hepatol (N Y), V3, P218
   Trinh MN, 2017, P NATL ACAD SCI USA, V114, P89, DOI 10.1073/pnas.1619571114
   van Cleef KWR, 2016, ANTIMICROB AGENTS CH, V60, P2554, DOI 10.1128/AAC.02462-15
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   VANDENBOSSCHE H, 1993, ANTIMICROB AGENTS CH, V37, P2101, DOI 10.1128/AAC.37.10.2101
   Wang HL, 2014, GASTROENTEROLOGY, V146, P1373, DOI 10.1053/j.gastro.2014.02.002
   Warnock DW, 1996, MYCOL RES, V100, P1153, DOI 10.1016/S0953-7562(96)80175-4
   Warrilow AG, 2013, ANTIMICROB AGENTS CH, V57, P1352, DOI 10.1128/AAC.02067-12
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xu J, 2010, P NATL ACAD SCI USA, V107, P4764, DOI 10.1073/pnas.0910872107
   Zhou Y, 2010, EXP CELL RES, V316, P3304, DOI 10.1016/j.yexcr.2010.06.008
NR 71
TC 7
Z9 8
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD SEP
PY 2018
VL 157
BP 68
EP 79
DI 10.1016/j.antiviral.2018.06.017
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GR5VF
UT WOS:000442709300008
PM 29981375
OA Other Gold
DA 2020-07-08
ER

PT J
AU Riva, L
   Petrini, C
AF Riva, Luciana
   Petrini, Carlo
TI Blood safety policy: should cautionary policies be adopted with caution?
SO BLOOD TRANSFUSION
LA English
DT Editorial Material
ID PRECAUTIONARY PRINCIPLE; EMERGING PATHOGENS; COST-EFFECTIVENESS;
   HEPATITIS-E; ZIKA VIRUS; TRANSFUSION; RISK; PREVALENCE; INFECTION;
   SYSTEM
C1 [Riva, Luciana; Petrini, Carlo] Italian Natl Inst Hlth, Bioeth Unit, Via Giano Bella 34, I-00162 Rome, Italy.
RP Riva, L (corresponding author), Italian Natl Inst Hlth, Bioeth Unit, Via Giano Bella 34, I-00162 Rome, Italy.
EM luciana.riva@iss.it
OI Petrini, Carlo/0000-0002-7895-4440
CR [Anonymous], 1992, UNITED NATIONS C ENV
   Bennett JL, 2011, TRANSFUS MED REV, V25, P267, DOI 10.1016/j.tmrv.2011.05.002
   Borkent-Raven BA, 2012, TRANSFUSION, V52, P478, DOI 10.1111/j.1537-2995.2011.03319.x
   Commission of the European Communities-Directorate General XXIV Consumer Policy and Consumer Health Protection, 1998, D98DG24 HBHB COMM EU
   Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15
   Grazzini G, 2008, BLOOD TRANSFUS-ITALY, V6, P235, DOI 10.2450/2008.0065-08
   Hergon E, 2005, TRANSFUS MED REV, V19, P273, DOI 10.1016/j.tmrv.2005.04.004
   JOHNSTON P, 1990, MAR POLLUT BULL, V21, P402, DOI 10.1016/0025-326X(90)90652-O
   Kramer K, 2017, AM J BIOETHICS, V17, P32, DOI 10.1080/15265161.2016.1276643
   Kumanan W., 2011, TRANSFUS MED REV, V3, P177
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marano G, 2015, BLOOD TRANSFUS-ITALY, V13, P6, DOI 10.2450/2014.0063-14
   Martuzzi M., 2004, PRECAUTIONARY PRINCI
   McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Spada E, 2018, BLOOD TRANSFUS-ITALY, V16, P413, DOI 10.2450/2018.0033-18
   Velati C, 2018, BLOOD TRANSFUS-ITALY, V16, P422, DOI 10.2450/2018.0069-18
   Verweij M, 2018, J MED ETHICS, V44, P187, DOI 10.1136/medethics-2015-103338
   Von Moltke K., 1988, 12 ROYAL COMM ENV PO
NR 21
TC 2
Z9 2
U1 0
U2 1
PU SIMTI SERVIZI SRL
PI MILAN
PA VIA DESIDERIO 21, MILAN, 20131, ITALY
SN 1723-2007
J9 BLOOD TRANSFUS-ITALY
JI Blood Transf.
PD SEP-OCT
PY 2018
VL 16
IS 5
BP 405
EP 407
DI 10.2450/2018.0135-18
PG 3
WC Hematology
SC Hematology
GA GS1RX
UT WOS:000443310300001
PM 30183614
DA 2020-07-08
ER

PT J
AU Sasmono, RT
   Dhenni, R
   Yohan, B
   Pronyk, P
   Hadinegoro, SR
   Soepardi, EJ
   Ma'roef, CN
   Satari, HI
   Menzies, H
   Hawley, WA
   Powers, AM
   Rosenberg, R
   Myint, KSA
   Soebandrio, A
AF Sasmono, R. Tedjo
   Dhenni, Rama
   Yohan, Benediktus
   Pronyk, Paul
   Hadinegoro, Sri Rezeki
   Soepardi, Elizabeth Jane
   Ma'roef, Chairin Nisa
   Satari, Hindra I.
   Menzies, Heather
   Hawley, William A.
   Powers, Ann M.
   Rosenberg, Ronald
   Myint, Khin Saw Aye
   Soebandrio, Amin
TI Zika Virus Seropositivity in 1-4-Year-Old Children, Indonesia, 2014
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFECTION; EPIDEMIC
AB We assessed Zika virus seroprevalence among healthy 1-4-year-old children using a serum sample collection assembled in 2014 representing 30 urban sites across Indonesia. Of 662 samples, 9.1% were Zika virus seropositive, suggesting widespread recent Zika virus transmission and immunity. Larger studies are needed to better determine endemicity in Indonesia.
C1 [Sasmono, R. Tedjo; Dhenni, Rama; Yohan, Benediktus; Ma'roef, Chairin Nisa; Myint, Khin Saw Aye; Soebandrio, Amin] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
   [Pronyk, Paul] UNICEF Indonesia, Jakarta, Indonesia.
   [Pronyk, Paul] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   [Hadinegoro, Sri Rezeki; Satari, Hindra I.] Univ Indonesia, Med Sch, Jakarta, Indonesia.
   [Hadinegoro, Sri Rezeki; Satari, Hindra I.] Cipto Mangunkusumo Hosp, Jakarta, Indonesia.
   [Soepardi, Elizabeth Jane] Minist Hlth Republ Indonesia, Jakarta, Indonesia.
   [Menzies, Heather; Hawley, William A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Powers, Ann M.; Rosenberg, Ronald] Ctr Dis Control & Prevent, Ft Collins, CO USA.
RP Sasmono, RT (corresponding author), Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
EM sasmono@eijkman.go.id
RI Yohan, Benediktus/J-9039-2019; Sasmono, Tedjo/H-5680-2016
OI Yohan, Benediktus/0000-0003-2378-2386; Sasmono,
   Tedjo/0000-0003-0986-2590; Dhenni, Rama/0000-0001-9782-6666
FU Ministry of Research, Technology, and Higher Education of the Republic
   of Indonesia; CDC, Atlanta, Georgia, USAUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   Office of Infectious Diseases, Bureau for Global Health, US Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID); CDCCentre National de la Recherche Scientifique
   (CNRS)United States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX This work was supported by the Ministry of Research, Technology, and
   Higher Education of the Republic of Indonesia and CDC, Atlanta, Georgia,
   USA. Funding for this work was also provided by the Office of Infectious
   Diseases, Bureau for Global Health, US Agency for International
   Development, under the terms of an interagency agreement with CDC.
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Prayitno A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005621
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
NR 13
TC 11
Z9 11
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2018
VL 24
IS 9
BP 1740
EP 1743
DI 10.3201/eid2409.180582
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GQ6YP
UT WOS:000441877400024
PM 30125240
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wongsurawat, T
   Athipanyasilp, N
   Jenjaroenpun, P
   Jun, SR
   Kaewnapan, B
   Wassenaar, TM
   Leelahakorn, N
   Angkasekwinai, N
   Kantakamalakul, W
   Ussery, DW
   Sutthent, R
   Nookaew, I
   Horthongkham, N
AF Wongsurawat, Thidathip
   Athipanyasilp, Niracha
   Jenjaroenpun, Piroon
   Jun, Se-Ran
   Kaewnapan, Bualan
   Wassenaar, Trudy M.
   Leelahakorn, Nattawat
   Angkasekwinai, Nasikarn
   Kantakamalakul, Wannee
   Ussery, David W.
   Sutthent, Ruengpung
   Nookaew, Intawat
   Horthongkham, Navin
TI Case of Microcephaly after Congenital Infection with Asian Lineage Zika
   Virus, Thailand
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID FETAL-BRAIN; PREGNANCY; COLOMBIA; UPDATE
AB We sequenced the virus genomes from 3 pregnant women in Thailand with Zika virus diagnoses. All had infections with the Asian lineage. The woman infected at gestational week 9, and not those infected at weeks 20 and 24, had a fetus with microcephaly. Asian lineage Zika viruses can cause microcephaly.
C1 [Wongsurawat, Thidathip; Jenjaroenpun, Piroon; Jun, Se-Ran; Ussery, David W.; Nookaew, Intawat] Univ Arkansas Med Sci, Little Rock, AR 72205 USA.
   [Athipanyasilp, Niracha; Kaewnapan, Bualan; Leelahakorn, Nattawat; Angkasekwinai, Nasikarn; Kantakamalakul, Wannee; Sutthent, Ruengpung; Horthongkham, Navin] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand.
   [Kaewnapan, Bualan; Wassenaar, Trudy M.] Mol Microbiol & Genom Consultants, Zotzenheim, Germany.
RP Nookaew, I (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Biomed Informat, Little Rock, AR 72205 USA.; Nookaew, I (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Physiol & Biophys, Little Rock, AR 72205 USA.; Horthongkham, N (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Wanglang Rd, Bangkok 10700, Thailand.
EM inookaew@uams.edu; navin.hor@mahidol.ac.th
RI Wongsurawat, Thidathip/K-5590-2019; Ussery, David/J-2026-2019;
   Angkasekwinai, Nasikarn/AAS-3199-2020
OI Ussery, David/0000-0003-3632-5512; 
FU Siriraj Research [RO16034012]; Helen Adams & Arkansas Research Alliance
   Endowed Chair; National Institute of General Medical Sciences of the
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P20GM125503]
FX This work was funded in part by Siriraj Research (grant no. RO16034012),
   the Helen Adams & Arkansas Research Alliance Endowed Chair, and the
   National Institute of General Medical Sciences of the National
   Institutes of Health (award no. P20GM125503).
CR de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sohan K, 2017, INT J GYNECOL OBSTET, V139, P278, DOI 10.1002/ijgo.12313
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 10
TC 24
Z9 24
U1 0
U2 11
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2018
VL 24
IS 9
BP 1758
EP 1761
DI 10.3201/eid2409.180416
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GQ6YP
UT WOS:000441877400032
PM 29985788
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Soriano-Panos, D
   Arias-Castro, H
   Naranjo-Mayorga, F
   Gomez-Gardenes, J
AF Soriano-Panos, D.
   Arias-Castro, H.
   Naranjo-Mayorga, F.
   Gomez-Gardenes, J.
TI Impact of human-human contagions in the spread of vector-borne diseases
SO EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS
LA English
DT Article; Proceedings Paper
CT International Conference on Dynamics Days Latin America and the
   Caribbean
CY OCT 24-NOV 01, 2016
CL Puebla, MEXICO
ID ZIKA VIRUS; CLIMATE-CHANGE
AB This article is aimed at proposing a generalization of the Ross-Macdonald model for the transmission of Vector-borne diseases in which human-to-human contagions are also considered. We first present this generalized model by formulating a mean field theory, checking its validity by comparing to numerical simulations. To make the premises of our model more realistic, we adapt the mean field equations to the case in which human contacts are described by a complex network. In this case we are also able to derive an analytical expression for the epidemic threshold. In both the mean-field and network-based models, we estimate the value of the epidemic threshold which corresponds to the boundary between the disease-free and epidemic regimes. The expression of this threshold allows us to discuss the impact that human-to-human contagions have on the spread of vector-borne diseases.
C1 [Soriano-Panos, D.; Gomez-Gardenes, J.] Univ Zaragoza, Dept Fis Mat Condensada, E-50009 Zaragoza, Spain.
   [Soriano-Panos, D.; Gomez-Gardenes, J.] Univ Zaragoza, GOTHAM Lab, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza 50018, Spain.
   [Arias-Castro, H.] Univ Valle, Dept Matemat, Santiago De Cali 25360, Colombia.
   [Naranjo-Mayorga, F.] Univ Pedag & Tecnol Colombia, Dept Fis, Tunja 150003, Colombia.
RP Gomez-Gardenes, J (corresponding author), Univ Zaragoza, Dept Fis Mat Condensada, E-50009 Zaragoza, Spain.; Gomez-Gardenes, J (corresponding author), Univ Zaragoza, GOTHAM Lab, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza 50018, Spain.
EM gardenes@gmail.com
RI Gomez-Gardenes, Jesus/B-5818-2009
OI Gomez-Gardenes, Jesus/0000-0001-5204-1937; SORIANO PANOS,
   DAVID/0000-0002-6388-4056
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Allard A, 2017, P NATL ACAD SCI USA, V114, P8969, DOI 10.1073/pnas.1703073114
   ANDERSON R M, 1991
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Bacaer N, 2011, SHORT HISTORY OF MATHEMATICAL POPULATION DYNAMICS, P1
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001
   Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Cho E, 2011, P 17 ACM SIGKDD INT, P1082, DOI DOI 10.1145/2020408.2020579
   Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   ECDPC, 2009, DEV AED ALB RISK MAP
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098
   Gomez S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38009
   Gomez S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036105
   Gomez-Gardenes J, 2018, NAT PHYS, V14, P391, DOI 10.1038/s41567-017-0022-7
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guerra B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.035101
   Keeling J. M., 2007, MODELING INFECT DIS
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Magori K, 2013, NATURE ED KNOWLEDGE, V4, P14
   Matamalas JT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0203
   Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133
   Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   O'Regan SM, 2016, THEOR ECOL-NETH, V9, P269, DOI 10.1007/s12080-015-0285-5
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Polwiang S, 2015, PEERJ, V3, DOI 10.7717/peerj.1069
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Ross Ronald, 1911, PREVENTION MALARIA
   Ruan SG, 2008, B MATH BIOL, V70, P1098, DOI 10.1007/s11538-007-9292-z
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
NR 42
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1951-6355
EI 1951-6401
J9 EUR PHYS J-SPEC TOP
JI Eur. Phys. J.-Spec. Top.
PD SEP
PY 2018
VL 227
IS 5-6
BP 661
EP 672
DI 10.1140/epjst/e2018-00099-3
PG 12
WC Physics, Multidisciplinary
SC Physics
GA HD5HN
UT WOS:000452559700016
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Best, K
   Perelson, AS
AF Best, Katharine
   Perelson, Alan S.
TI Mathematical modeling of within-host Zika virus dynamics
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review
DE mathematical modeling; viral dynamics; Zika virus
ID ANTIBODY-DEPENDENT ENHANCEMENT; B-CELL RESPONSES; VIRAL DYNAMICS; DENGUE
   VIRUS; IN-VIVO; INFECTED-CELLS; ECLIPSE PHASE; HIV; KINETICS; INTERFERON
AB Recent Zika virus outbreaks have been associated with severe outcomes, especially during pregnancy. A great deal of effort has been put toward understanding this virus, particularly the immune mechanisms responsible for rapid viral control in the majority of infections. Identifying and understanding the key mechanisms of immune control will provide the foundation for the development of effective vaccines and antiviral therapy. Here, we outline a mathematical modeling approach for analyzing the within-host dynamics of Zika virus, and we describe how these models can be used to understand key aspects of the viral life cycle and to predict antiviral efficacy.
C1 [Best, Katharine; Perelson, Alan S.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA.
RP Perelson, AS (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM 87545 USA.
EM asp@lanl.gov
RI Perelson, Alan S/Z-1959-2019
OI Perelson, Alan S/0000-0002-2455-0002
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01-AI028433,
   R01-AI078881, R01-OD0110955]
FX National Institutes of Health (NIH), Grant/Award Number: R01-AI028433,
   R01-AI078881 and R01-OD0110955
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05
   Bai F, 2019, J BIOL DYNAM, V13, P47, DOI 10.1080/17513758.2018.1498984
   Banerjee S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0479
   Banerjee S, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0130
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7
   Ben-Shachar R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0886
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Blackman MA, 2018, VIRAL IMMUNOL, V31, P117, DOI 10.1089/vim.2017.0145
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730
   Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Conway JM, 2015, P NATL ACAD SCI USA, V112, P5467, DOI 10.1073/pnas.1419162112
   Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006
   De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928
   De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001
   De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Di Mascio M, 2003, J VIROL, V77, P2271, DOI 10.1128/JVI.77.3.2271-2275.2003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dixit NM, 2004, NATURE, V432, P922, DOI 10.1038/nature03153
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Estes JD, 2018, NAT REV IMMUNOL, V18, P390, DOI 10.1038/s41577-018-0005-7
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Garcia-Sastre A, 1998, J VIROL, V72, P8550
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Gonzalez-Parra G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192645
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guedj J, 2007, B MATH BIOL, V69, P2493, DOI 10.1007/s11538-007-9228-7
   Guedj J, 2014, ANTIVIR THER, V19, P211, DOI 10.3851/IMP2733
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067
   Herz AVM, 1996, P NATL ACAD SCI USA, V93, P7247, DOI 10.1073/pnas.93.14.7247
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Holder BP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S10
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johnson PLF, 2011, J VIROL, V85, P5565, DOI 10.1128/JVI.00166-11
   Kakizoe Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep10371
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lavielle M, 2015, CHAPMAN HALL CRC BIO
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Li Y, 2014, J THEOR BIOL, V347, P63, DOI 10.1016/j.jtbi.2014.01.008
   Lim S-Y, BCX4430 BROAD SPECTR
   Madelain V, 2015, ANTIVIR RES, V123, P70, DOI 10.1016/j.antiviral.2015.08.015
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009
   Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10
   Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10
   Mittler JE, 1998, MATH BIOSCI, V152, P143, DOI 10.1016/S0025-5564(98)10027-5
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perelson AS, 2008, STAT MED, V27, P4647, DOI 10.1002/sim.3116
   Perelson AS, 2015, NAT REV GASTRO HEPAT, V12, P437, DOI 10.1038/nrgastro.2015.97
   Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   PERELSON AS, 1980, J MATH BIOL, V10, P209, DOI 10.1007/BF00276984
   Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700
   Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008
   Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746
   Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Smith AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38703
   Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238
   Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129
   Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001
   Snoeck E, 2010, CLIN PHARMACOL THER, V87, P706, DOI 10.1038/clpt.2010.35
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Talal AH, 2006, HEPATOLOGY, V43, P943, DOI 10.1002/hep.21136
   Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08
   Nguyen VK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167568
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wu HL, 2006, J PHARMACOKINET PHAR, V33, P399, DOI 10.1007/s10928-006-9006-4
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
NR 128
TC 8
Z9 8
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-2896
EI 1600-065X
J9 IMMUNOL REV
JI Immunol. Rev.
PD SEP
PY 2018
VL 285
IS 1
SI SI
BP 81
EP 96
DI 10.1111/imr.12687
PG 16
WC Immunology
SC Immunology
GA GQ0ER
UT WOS:000441290100007
PM 30129207
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Lima, AR
   Silva, CM
   Caires, CSA
   Prado, ED
   Rocha, LRP
   Cabrini, I
   Arruda, EJ
   Oliveira, SL
   Caires, ARL
AF Lima, Alessandra R.
   Silva, Cicera M.
   Caires, Cynthia S. A.
   Prado, Esmael D.
   Rocha, Luciana R. P.
   Cabrini, Isaias
   Arruda, Eduardo J.
   Oliveira, Samuel L.
   Caires, Anderson R. L.
TI Evaluation of Eosin-Methylene Blue as a Photosensitizer for Larval
   Control of Aedes aegypti by a Photodynamic Process
SO INSECTS
LA English
DT Article
DE Aedes aegypti; larval control; photodynamic process; eosin-methylene
   blue; sunlight
ID INACTIVATION; RESISTANT
AB Aedes aegypti (Ae. aegypti) is a competent vector for transmitting important viral diseases such as yellow fever, dengue, chikungunya, and Zika. Several strategies have been applied to avoid Ae. aegypti proliferation by using environmental management, biological, and chemical approaches. However, the development of new methods for effective control of the insect vector population is still needed. Photodynamic control is an alternative way to control the vector population by using a physical approach based on the larval phototoxicity of a photosensitizer. In this context, the present study evaluated the use of eosin-methylene blue (EMB) as a new photosensitizer for photodynamic control of Ae. aegypti larval populations. The photodynamic assays were performed submitting Ae. aegypti third-instar larvae to different EMB concentrations (0.0, 0.5, 1.0, 5.0, 10.0, 50.0, and 100.0 mu g mL(-1)) in combination of three different light doses (24.3, 48.6, and 97.2 J cm(-2)) under either white-light radiation from RGB LEDs or sunlight. The results demonstrated that EMB presented a rapid internalization into the larvae and was phototoxic. The photodynamic action induced 100% of larval mortality after about 40 min of sunlight irradiation even using low EMB concentration (0.5 mu g mL(-1)). The findings reveal EMB as an effective photoactive compound to control larval populations of Ae. aegypti by photodynamic process induced by either sunlight or white-light from RGB LEDs.
C1 [Lima, Alessandra R.; Silva, Cicera M.; Oliveira, Samuel L.; Caires, Anderson R. L.] Univ Fed Mato Grosso do Sul, Inst Fis, Grp Opt & Foton, CP 549, BR-79070900 Campo Grande, MS, Brazil.
   [Lima, Alessandra R.; Silva, Cicera M.; Prado, Esmael D.; Rocha, Luciana R. P.; Cabrini, Isaias; Arruda, Eduardo J.] Fundacao Univ Fed Grande Dourados, Fac Ciencias Exatas & Tecnol, CP 533, BR-79804970 Dourados, MS, Brazil.
   [Caires, Cynthia S. A.] Fac Med, Grp Espect & Bioinformat Aplicados Biodiversidade, CP 549, BR-79070900 Campo Grande, MS, Brazil.
RP Caires, ARL (corresponding author), Univ Fed Mato Grosso do Sul, Inst Fis, Grp Opt & Foton, CP 549, BR-79070900 Campo Grande, MS, Brazil.
EM ramos.alessandra.09@gmail.com; ciceraquimica@gmail.com;
   cynthiasuzyelen@yahoo.com.br; EsmaelPrado@ufgd.edu.br;
   LucianaPiovesan@ufgd.edu.br; isaias_c04@yahoo.com.br;
   ejarruda@gmail.com; samuel.oliveira@ufms.br; anderson.caires@ufms.br
RI Oliveira, Samuel L/A-9259-2008; de Arruda, Eduardo Jose/AAJ-9834-2020;
   Caires, Anderson Rodrigues Lima/M-2178-2013; AR, Lima/AAP-6642-2020
OI Oliveira, Samuel L/0000-0002-8616-772X; de Arruda, Eduardo
   Jose/0000-0002-9835-467X; Caires, Anderson Rodrigues
   Lima/0000-0002-2602-9480; AR, Lima/0000-0001-5810-5137; Caires,
   Cynthia/0000-0002-8025-8065
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [465360/2014-9, 440585/2016-3]; FUNDECTFundect [59/300.490/2016];
   CAPESCAPES; National Institute of Science and Technology in Basic Optics
   and Applied to Life Sciences
FX The authors are grateful to CNPq (grants: 465360/2014-9, and
   440585/2016-3), FUNDECT (grant: 59/300.490/2016), and CAPES, Brazilian
   funding agencies, for their financial support. The authors also
   acknowledge the financial support provided by the National Institute of
   Science and Technology in Basic Optics and Applied to Life Sciences.
CR AHMED YM, 1985, J ENVIRON SCI HEAL B, V20, P689, DOI 10.1080/03601238509372504
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arrivillaga J, 2004, J VECTOR ECOL, V29, P11
   Azizullah A, 2014, PARASITOL RES, V113, P4321, DOI 10.1007/s00436-014-4175-3
   BARBIERI Antonio, 1928, Rivista di Malariologia, V7, P456
   Barcia JJ, 2007, INT J SURG PATHOL, V15, P292, DOI 10.1177/1066896907302239
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Ben Amor T, 2000, INSECT BIOCHEM MOLEC, V30, P915, DOI 10.1016/S0965-1748(00)00072-2
   Boethling RS, 2007, CHEM REV, V107, P2207, DOI 10.1021/cr050952t
   Brammer Sandra Patussi, 2015, Arq. Inst. Biol., V82, P0, DOI 10.1590/1808-1657000192013
   Caires CSA, 2018, LASER PHYS LETT, V15, DOI 10.1088/1612-202X/aa86e0
   Caires C S A, 2017, PHOTODIAGN PHOTODYN, V17, pA41, DOI DOI 10.1016/j.pdpdt.2017.01.091
   Caires CSA, 2017, LASER MED SCI, V32, P1081, DOI 10.1007/s10103-017-2210-1
   Campos Jairo, 2002, Cad. Saúde Pública, V18, P661, DOI 10.1590/S0102-311X2002000300010
   Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022
   de Arruda EJ, 2010, BRAZ ARCH BIOL TECHN, V53, P335, DOI 10.1590/S1516-89132010000200012
   Dondji B, 2005, J MED ENTOMOL, V42, P652, DOI 10.1603/0022-2585(2005)042[0652:AOLAFA]2.0.CO;2
   Fleischer B, 2004, TROP MED INT HEALTH, V9, P755, DOI 10.1111/j.1365-3156.2004.01278.x
   Grinholc M, 2014, PHOTOMED LASER SURG, V32, P121, DOI 10.1089/pho.2013.3663
   Grzybowski A, 2013, PEST MANAG SCI, V69, P589, DOI 10.1002/ps.3409
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hamblin MR, 2016, CURR OPIN MICROBIOL, V33, P67, DOI 10.1016/j.mib.2016.06.008
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE
   Lima A.R., 2017, PHOTODIAGN PHOTODYN, V17, pA49, DOI [10.1016/j.pdpdt.2017.01.110, DOI 10.1016/J.PDPDT.2017.01.110]
   Lucantoni L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001434
   Ministerio da Saude (BR), 2009, DIR NAC PREV CONTR E
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Song RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42058
   Souza L.M., 2017, J LIFE SCI, V11, P78, DOI [10.17265/1934-7391/2017.02.003, DOI 10.17265/1934-7391/2017.02.003]
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 32
TC 3
Z9 3
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD SEP
PY 2018
VL 9
IS 3
AR 109
DI 10.3390/insects9030109
PG 8
WC Entomology
SC Entomology
GA GY1YY
UT WOS:000448335000037
PM 30200177
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lwin, MO
   Lu, JH
   Sheldenkar, A
   Schulz, PJ
AF Lwin, May O.
   Lu, Jiahui
   Sheldenkar, Anita
   Schulz, Peter J.
TI Strategic Uses of Facebook in Zika Outbreak Communication: Implications
   for the Crisis and Emergency Risk Communication Model
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Zika; CERC; Facebook; social media; outbreak communication; crisis
   communication; public health
ID SOCIAL MEDIA; TWITTER CONTENT; HEALTH; ORGANIZATIONS; INFORMATION;
   ENGAGEMENT; FRAMEWORK; EBOLA; AMPLIFICATION; SINGAPORE
AB While social media has been increasingly used for communication of infectious disease outbreaks, little is known about how social media can improve strategic communication across various stages of the health crisis. The Crisis and Emergency Risk Communication Model (Reynolds & Seeger, 2005; CERC) outlines strategies across different crisis phases and can guide crisis communication on social media. This research therefore investigates how social media can be utilized to implement and adapt the CERC model, by examining the strategic uses of Facebook in communicating the recent Zika epidemic by health authorities in Singapore. Zika-related Facebook posts of three main Singapore health agencies published within the one year period from January 2016 to December 2016 were thematically analysed. Results suggest that Facebook was used to communicate the crisis strategically, which supported and added to the CERC model. Novel uses of Facebook for outbreak communication were demonstrated, including promoting public common responsibility for disease prevention and expressing regards to the public for cooperation. Results also suggested that preparedness messages might be the most effective, as they produced a great level of public engagement. The adaptability of the CERC model in social media contexts to improve crisis communication is discussed.
C1 [Lwin, May O.; Lu, Jiahui; Sheldenkar, Anita] Nanyang Technol Univ, Wee Kim Wee Sch Commun & Informat, Singapore 637718, Singapore.
   [Lu, Jiahui] Nanyang Technol Univ, Div Psychol, Singapore 637332, Singapore.
   [Schulz, Peter J.] Univ Svizzera Italiana, Inst Commun & Hlth, CH-6900 Lugano, Switzerland.
RP Lu, JH (corresponding author), Nanyang Technol Univ, Wee Kim Wee Sch Commun & Informat, Singapore 637718, Singapore.; Lu, JH (corresponding author), Nanyang Technol Univ, Div Psychol, Singapore 637332, Singapore.
EM tmaylwin@ntu.edu.sg; jhlu@ntu.edu.sg; anitas@ntu.edu.sg;
   peter.schulz@usi.ch
RI Schulz, Peter/AAM-9816-2020
OI Schulz, Peter/0000-0003-4281-489X; Lu, Jiahui/0000-0003-2984-7435;
   Sheldenkar, Anita/0000-0002-5402-9269
FU Singapore Ministry of Health's National Medical Research CouncilNational
   Medical Research Council, Singapore [NMRC/ZRRF/0004/2016]
FX This research is supported by the Singapore Ministry of Health's
   National Medical Research Council under its NMRC/ZRRF/0004/2016.
CR Austin L, 2012, J APPL COMMUN RES, V40, P188, DOI 10.1080/00909882.2012.654498
   Biswas M., 2013, J NEW COMMUNICATIONS, V5, P46
   Chavez C., 2010, NEW WAY COMMUNICATE
   Cho M, 2014, PUBLIC RELAT REV, V40, P565, DOI 10.1016/j.pubrev.2014.01.008
   Covello VT, 2001, J URBAN HEALTH, V78, P382, DOI 10.1093/jurban/78.2.382
   Crowe Adam, 2011, J Bus Contin Emer Plan, V5, P409
   Ellison NB, 2011, NEW MEDIA SOC, V13, P873, DOI 10.1177/1461444810385389
   Freberg K, 2013, PUBLIC RELAT REV, V39, P185, DOI 10.1016/j.pubrev.2013.02.010
   Gearhart S., 2014, ELECT NEWS, V8, P243, DOI [10.1177/1931243114567565, DOI 10.1177/1931243114567565]
   Gittelman S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3970
   Guidry JPD, 2017, PUBLIC RELAT REV, V43, P477, DOI 10.1016/j.pubrev.2017.04.009
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   HELSON H, 1948, PSYCHOL REV, V55, P297, DOI 10.1037/h0056721
   Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092
   Hughes DJ, 2012, COMPUT HUM BEHAV, V28, P561, DOI 10.1016/j.chb.2011.11.001
   JIN Y, 2006, CPH J ASIAN STUD, V23, P81, DOI DOI 10.22439/CJAS.V23I1.693
   Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Keim Mark E, 2011, Am J Disaster Med, V6, P47
   Kim S, 2012, J PUBLIC RELAT RES, V24, P69, DOI 10.1080/1062726X.2012.626136
   Lachlan KA, 2016, COMPUT HUM BEHAV, V54, P647, DOI 10.1016/j.chb.2015.05.027
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Liu BF, 2011, PUBLIC RELAT REV, V37, P233, DOI 10.1016/j.pubrev.2011.03.005
   LOEWENSTEIN G, 1990, J RISK UNCERTAINTY, V3, P155, DOI 10.1007/BF00056370
   Lysaght T, 2016, SINGAP MED J, V57, P528, DOI 10.11622/smedj.2016161
   Menon KU, 2008, ANN ACAD MED SINGAP, V37, P525
   Panagiotopoulos P, 2016, TECHNOL FORECAST SOC, V111, P86, DOI 10.1016/j.techfore.2016.06.010
   Pidgeon N., 2003, SOCIAL AMPLIFICATION
   Priem J., 2012, ARXIV201212034745
   Procopio CH, 2007, J APPL COMMUN RES, V35, P67, DOI 10.1080/00909880601065722
   Radzikowski Jacek, 2016, JMIR Public Health Surveill, V2, pe1, DOI 10.2196/publichealth.5059
   Rastegar-Mojarad M, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3433
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Reynolds B, 2008, HEALTH PROMOT PRACT, V9, p13S, DOI 10.1177/1524839908325267
   Reynolds B, 2006, J APPL COMMUN RES, V34, P249, DOI 10.1080/00909880600771593
   SHOEMAKER PJ, 1991, JOURNALISM QUART, V68, P781, DOI 10.1177/107769909106800419
   Song M, 2015, INT J EMERG MANAG, V11, P224
   Spence PR, 2015, COMMUN Q, V63, P171, DOI 10.1080/01463373.2015.1012219
   Strauss A., 1990, BASICS QUALITATIVE R
   Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310
   Sutton Jeannette, 2008, P INF SYST CRIS RESP
   Swani K, 2013, J RES INTERACT MARK, V7, P269, DOI 10.1108/JRIM-05-2013-0026
   Thomas TL, 2016, J CONS HLTH INTERNET, V20, P19, DOI 10.1080/15398285.2016.1142927
   Veil S, 2008, HEALTH PROMOT PRACT, V9, p26S, DOI 10.1177/1524839908322113
   Veil SR, 2011, J CONTING CRISIS MAN, V19, P110, DOI 10.1111/j.1468-5973.2011.00639.x
   Vijaykumar S, 2017, J AM MED INFORM ASSN, V24, P1155, DOI 10.1093/jamia/ocx028
   Wong P.T., 2016, TODAY ONLINE
   Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342
NR 48
TC 4
Z9 4
U1 18
U2 22
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP
PY 2018
VL 15
IS 9
AR 1974
DI 10.3390/ijerph15091974
PG 19
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GV0PX
UT WOS:000445765600183
PM 30201929
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Siqueira, RMP
   Santos, MTBR
   Cabral, GMP
AF Pereira Siqueira, Rafaella Maximo
   Botti Rodrigues Santos, Maria Teresa
   Pimenta Cabral, Gloria Maria
TI Alterations in the primary teeth of children with microcephaly in
   Northeast Brazil: a comparative study
SO INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY
LA English
DT Article
ID ZIKA VIRUS; ERUPTION; CARE
AB Background. The outbreak of microcephaly between 2015 and 2017 in Brazil created an international public health emergency.
   Aim. This study sought to evaluate the chronology, sequence of eruption, and the presence of anomalies amongst children with microcephaly compared with normoreactive children.
   Design. A comparative study of 108 children aged 0-2 years attending public services was conducted. The microcephaly group (MG; n = 54) and the nonmicrocephaly group (NMG; n = 54) were matched by age, gender, and family income at a 1 : 1 ratio. Erupted teeth and the presence of anomalies were evaluated and compared. Chi-square tests, Pearson's correlations, Fisher's exact tests, and Student's t-tests were applied (alpha = 0.05).
   Results. No between-group differences were found with regard to gender (P = 0.560) or age (P = 0.529). The MG presented with a higher percentage of alterations in eruption sequence, opacity, self-injury, and delayed eruption compared with the NMG (P < 0.05). The MG was more likely to exhibit changes in tooth eruption sequence (OR = 12.23, 95% CIs = 3.25-46.03, P < 0.001), delayed eruption (OR = 23.12; 95% CIs = 7.0975.40, P < 0.001), and opacity (n = 12.19, 95% CIs = 1.44-103.28, P = 0.022) than the NMG.
   Conclusion. Children with microcephaly present with greater delays in chronology, alterations in eruption sequence, and enamel defects than normoreactive children.
C1 [Pereira Siqueira, Rafaella Maximo] Sch Dent Studies & Res, Dent Patients Special Needs, Joao Pessoa, Paraiba, Brazil.
   [Botti Rodrigues Santos, Maria Teresa] Cruzeiro do Sul Univ, Postgrad Program Dent, Sao Paulo, Brazil.
   [Pimenta Cabral, Gloria Maria] Higher Educ Inst Paraiba, Dent, Cabedelo, Brazil.
RP Siqueira, RMP (corresponding author), Rua Iole Eloi de Medeiros 307, Joao Pessoa, Paraiba, Brazil.
EM rafaellasiqueira@hotmail.com
RI Santos, Maria Teresa/B-9533-2011
OI Santos, Maria Teresa/0000-0002-1276-8012
CR [Anonymous], 1992, Int Dent J, V42, P411
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Santos MTBR, 2010, PHOTOMED LASER SURG, V28, P565, DOI 10.1089/pho.2009.2594
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   CDC, 2017, MICR OTH BIRTH DEF
   Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Haddad Anna Estela, 2005, J Clin Pediatr Dent, V29, P357
   Hair Jr JF, 2009, MULTIVARIATE DATA AN
   Kohli MV, 2014, J CLIN DIAGN RES, V8, P199, DOI 10.7860/JCDR/2014/6987.4161
   Larson R, 2016, ESTATISTICA APLICADA
   Leao JC, 2017, ORAL DIS, V23, P12, DOI 10.1111/odi.12512
   LUNT RC, 1974, J AM DENT ASSOC, V89, P872, DOI 10.14219/jada.archive.1974.0484
   Ministerio da Saude do Brasil. Secretaria de Atenca Saude, 2013, CAD SAUD CRIANC
   Ministerio da Saude do Brasil. Secretaria de Vigilancia em Saude/Secretaria de Atencao a Saude, 2016, ZIK AB CLIN AT BAS
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Neville BW, 2016, ORAL MAXILLOFACIAL P, P49
   Ortega AOL, 2007, J ORAL REHABIL, V34, P323, DOI 10.1111/j.1365-2842.2006.01703.x
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Portal Brasil, 2017, MIN SAUD DECL FIM EM
   Hoffmann RHS, 2007, CAD SAUDE PUBLICA, V23, P435, DOI 10.1590/S0102-311X2007000200020
   Secretaria de Estado de Saude da Paraiba, 2017, B CLASS FIN, P1
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   WHO, 2016, SCREEN ASS MAN NEON
NR 26
TC 1
Z9 1
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7439
EI 1365-263X
J9 INT J PAEDIATR DENT
JI Int. J. Paediatr. Dent.
PD SEP
PY 2018
VL 28
IS 5
BP 523
EP 532
DI 10.1111/ipd.12402
PG 10
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA GZ0UU
UT WOS:000449081800015
PM 29968396
OA Bronze
DA 2020-07-08
ER

PT J
AU Pandey, RK
   Ojha, R
   Mishra, A
   Prajapati, VK
AF Pandey, Rajan Kumar
   Ojha, Rupal
   Mishra, Amit
   Prajapati, Vijay Kumar
TI Designing B- and T-cell multi-epitope based subunit vaccine using
   immunoinformatics approach to control Zika virus infection
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE adjuvant; epitope; subunit vaccine; vaccine; Zika virus (ZKV)
ID TRYPANOTHIONE REDUCTASE; FEBRIFUGINE ANALOGS; MOLECULAR DOCKING;
   PROTEIN; SIMULATIONS; PREDICTION; INHIBITORS; ALPHA; ADMET; WEB
AB The Zika virus is a rapidly spreading Aedes mosquito-borne sickness, which creates an unanticipated linkage birth deformity and neurological turmoil. This study represents the use of the combinatorial immunoinformatics approach to develop a multiepitope subunit vaccine using the structural and nonstructural proteins of the Zika virus. The designed subunit vaccine consists of cytotoxic T-lymphocyteand helper T-lymphocyte epitopes accompanied by suitable adjuvant and linkers. The presence of humoral immune response specific B-cell epitopes was also confirmed by B-cell epitope mapping among vaccine protein. Further, the vaccine protein was characterized for its allergenicity, antigenicity, and physiochemical parameters and found to be safe and immunogenic. Molecular docking and molecular dynamics studies of the vaccine protein with the toll-like receptor-3 were performed to ensure the binding affinity and stability of their complex. Finally, in silico cloning was performed for the effective expression of vaccine construct in the microbial system (Escherichia coli K12 strain). Aforementioned approaches result in the multiepitope subunit vaccine which may have the ability to induce cellular as well as humoral immune response. Moreover, this study needs the experimental validation to prove the immunogenic and protective behavior of the developed subunit vaccine.
C1 [Pandey, Rajan Kumar; Ojha, Rupal; Prajapati, Vijay Kumar] Cent Univ Rajasthan, Sch Life Sci, Dept Biochem, Ajmer, Rajasthan, India.
   [Mishra, Amit] Indian Inst Technol Jodhpur, Cellular & Mol Neurobiol Unit, Jodhpur, Rajasthan, India.
RP Prajapati, VK (corresponding author), Cent Univ Rajasthan, Dept Biochem, NH-8, Ajmer 305817, Rajasthan, India.
EM vkprajapati@curaj.ac.in
RI Prajapati, Vijay K/M-8539-2013; Pandey, Rajan Kumar/AAP-1788-2020
OI Prajapati, Vijay K/0000-0001-6510-0596; Mishra, Amit/0000-0001-9401-4400
FU Department of Science and TechnologyDepartment of Science & Technology
   (India)
FX RK Pandey is thankful to the Department of Science and Technology for
   providing INSPIRE fellowship. VK Prajapati is thankful to the Central
   University of Rajasthan for providing computational facility.
CR Ahluwalia PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00107
   Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
   Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930
   Bergmann CC, 1996, J IMMUNOL, V157, P3242
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chander S, 2017, COMB CHEM HIGH T SCR, V20, P734, DOI 10.2174/1386207320666170615104703
   Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Gasteiger E., 2005, PROTEIN IDENTIFICATI
   GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155
   Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895
   Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085
   Khatoon N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08842-w
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liu HP, 2015, BIOCONJUGATE CHEM, V26, P791, DOI 10.1021/acs.bioconjchem.5b00103
   Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mohan T, 2014, IMMUNOL RES, V58, P139, DOI 10.1007/s12026-013-8428-5
   Mohan T, 2013, VACCINE, V31, P1707, DOI 10.1016/j.vaccine.2013.01.041
   Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238
   Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296
   Pandey RK, 2019, J CELL BIOCHEM, V120, P1141, DOI 10.1002/jcb.26719
   Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1
   Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P791, DOI 10.1080/07391102.2016.1161560
   Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P141, DOI 10.1080/07391102.2015.1135298
   Pandey RK, 2017, J RECEPT SIG TRANSD, V37, P60, DOI 10.3109/10799893.2016.1171344
   Pandey RK, 2016, COMB CHEM HIGH T SCR, V19, P813, DOI 10.2174/1386207319666160907100134
   Pandey RK, 2016, BIOMED PHARMACOTHER, V83, P141, DOI 10.1016/j.biopha.2016.06.010
   Pandey RK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00206
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   SHUKLA R, 2018, J BIOMOL STRUCT DYN, V36, P2147, DOI DOI 10.1080/07391102.2017.1344141
   Shukla R, 2018, J BIOMOL STRUCT DYN, V36, P2045, DOI 10.1080/07391102.2017.1341337
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilkins MR, 1999, METH MOL B, V112, P531
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 53
TC 10
Z9 10
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD SEP
PY 2018
VL 119
IS 9
BP 7631
EP 7642
DI 10.1002/jcb.27110
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GU3OB
UT WOS:000445187800049
PM 29900580
OA Bronze
DA 2020-07-08
ER

PT J
AU Huits, R
   Van Den Bossche, D
   Bottieau, E
   Van Esbroeck, M
AF Huits, Ralph
   Van Den Bossche, Dorien
   Bottieau, Emmanuel
   Van Esbroeck, Marjan
TI Re: Lack of Zika virus antibody response in confirmed patients in
   non-endemic countries
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Letter
C1 [Huits, Ralph; Van Den Bossche, Dorien; Bottieau, Emmanuel; Van Esbroeck, Marjan] Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.
RP Huits, R (corresponding author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.
EM rhuits@itg.be
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468; Van Esbroeck,
   Marjan/0000-0002-7294-6319
CR Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
NR 4
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2018
VL 106
BP 33
EP 33
DI 10.1016/j.jcv.2018.07.005
PG 1
WC Virology
SC Virology
GA GR2AR
UT WOS:000442361000008
PM 30031350
DA 2020-07-08
ER

PT J
AU Kayiwa, JT
   Nankya, AM
   Ataliba, IJ
   Mossel, EC
   Crabtree, MB
   Lutwama, JJ
AF Kayiwa, John Timothy
   Nankya, Annet Martha
   Ataliba, Irene Joyce
   Mossel, Eric C.
   Crabtree, Mary B.
   Lutwama, Julius Julian
TI Confirmation of Zika virus infection through hospital-based sentinel
   surveillance of acute febrile illness in Uganda, 2014-2017
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Arbovirus; Zika virus; hospital-based; sentinel surveillance; plaque
   reduction neutralization test; confirmation
ID WESTERN UGANDA; MOSQUITOS; NIGERIA; FEVER
AB Zika virus (ZIKV), transmitted by Aedes species mosquitoes, was first isolated in Uganda in 1947. From February 2014 to October 2017, the Uganda Virus Research Institute, in collaboration with the US Centers for Diseases Control and Prevention, conducted arbovirus surveillance in acute febrile illness (AFI) patients at St Francis hospital in Nkonkonjeru. Three hundred and eighty-four serum samples were collected and tested for IgM antibodies to yellow fever virus (YFV), West Nile virus (WNV), dengue virus (DENV), chikungunya virus (CHIKV) and ZIKV. Of the 384 samples, 5 were positive for ZIKV IgM. Of these five, three were confirmed by plaque reduction neutralization test (PRNT) to be ZIKV infections. Of the remaining two, one was determined to be a non-specific flavivirus infection and one was confirmed to be alphavirus-positive by reverse transcriptase polymerase chain reaction (RT-PCR). This study provides the first evidence of laboratory-confirmed ZIKV infection in Uganda in five decades, and emphasizes the need to enhance sentinel surveillance.
C1 [Kayiwa, John Timothy; Nankya, Annet Martha; Ataliba, Irene Joyce; Lutwama, Julius Julian] Uganda Virus Res Inst, Arbovirol Dept, Entebbe, Uganda.
   [Mossel, Eric C.; Crabtree, Mary B.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Kayiwa, JT (corresponding author), Uganda Virus Res Inst, Arbovirol Dept, Entebbe, Uganda.
EM jkayiwa@uvri.go.ug
FU Global Health Security Agenda
FX This study was funded in part by the Global Health Security Agenda
   through a cooperative agreement between the US Centers for Disease
   Control and the Uganda Virus Research Institute.
CR [Anonymous], 2016, ZIK VIR POT COMPL
   Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438
   BEATY BJ, 1995, DIAGNOSTIC PROCEDURE, P204
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, J GEN VIROL, V95, P1436, DOI 10.1099/vir.0.060764-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Mayanja Martin, 2014, Journal of Entomology and Zoology Studies, V2, P317
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Mossel EC, 2017, J MED ENTOMOL, V54, P1403, DOI 10.1093/jme/tjx120
   Mutebi JP, 2018, J MED ENTOMOL, V55, P587, DOI 10.1093/jme/tjx220
   Mutebi JP, 2012, J MED ENTOMOL, V49, P1289, DOI 10.1603/ME12111
   Nyakarahuka L, 2017, PLOS CURR, V9
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   ProMED-mail, 2015, UND ILLN BRAZ 02 ZIK
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
NR 29
TC 3
Z9 3
U1 0
U2 2
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD SEP
PY 2018
VL 99
IS 9
BP 1248
EP 1252
DI 10.1099/jgv.0.001113
PG 5
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GS2NX
UT WOS:000443388700010
PM 29975185
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Noor, R
   Ahmed, T
AF Noor, Rashed d
   Ahmed, Tasnia
TI Zika virus: Epidemiological study and its association with public health
   risk
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE Zika virus; Bangladesh; Microcephaly; Epidemic transmission; Public
   health risk
ID INFECTION; CHIKUNGUNYA; OUTBREAK; COINFECTION; DENGUE; STATES
AB Propagation of Zika virus has become an alarming global public health issue. The infection is spreading rapidly to different countries by several methods, especially by the transmission through traveling. Bangladesh is also at a risk to be affected with such newly viral infections. Though the virus initially appears to cause mild problems, the long term effects are more devastating to the next generation as seen in case of the delivery of the microcephalic babies. Current review discussed the epidemiologic era of the virus; i.e., the administration of Zika virus in the non-human mammals and finally to the human host across the world. Typical sign-symptoms which can often be considered as dengue or chikungunya for their similarities have been stated. The diagnosis of Zika virus, the protective measures taken by mass people as well as the actions that should be endorsed to prevent acquisition of the infection from travelers are discussed. (C) 2018 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Noor, Rashed d; Ahmed, Tasnia] Stamford Univ Bangladesh, Dept Microbiol, 51 Siddeswari Rd, Dhaka 1217, Bangladesh.
RP Noor, R (corresponding author), Stamford Univ Bangladesh, Dept Microbiol, 51 Siddeswari Rd, Dhaka 1217, Bangladesh.
EM rashednoor@stamforuniversity.edu.bd;
   tasniaahned@stamforduniversity.edu.bd
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Centers for Disease Control and Protection, 2016, DENG EP
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hassan Rashedul, 2014, J Med Case Rep, V8, P67, DOI 10.1186/1752-1947-8-67
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kleber de Oliveira W, 2015, MMWR-MORBID MORTAL W, V2016, P242
   Mallet HP., 2014, 15 JOURN NAT INF BOR, P28
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Matysiak A, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8947067
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, POTENTIAL ZIKA VIRUS
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Noor R, 2012, TZU CHI MED J, V24, P191, DOI 10.1016/j.tcmj.2012.09.001
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Silvia MR, 2017, ECON MICROBIOL, V11, P143
   Torres-Roman Jr Smith, 2017, Infez Med, V25, P193
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 39
TC 4
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD SEP-OCT
PY 2018
VL 11
IS 5
BP 611
EP 616
DI 10.1016/j.jiph.2018.04.007
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GR6QD
UT WOS:000442781000003
PM 29706319
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lum, FM
   Lye, DCB
   Tan, JJL
   Lee, B
   Chia, PY
   Chua, TK
   Amrun, SN
   Kam, YW
   Yee, WX
   Ling, WP
   Lim, VWX
   Pang, VJX
   Lee, LK
   Mok, EWH
   Chong, CY
   Leo, YS
   Ng, LFP
AF Lum, Fok-Moon
   Lye, David C. B.
   Tan, Jeslin J. L.
   Lee, Bernett
   Chia, Po-Ying
   Chua, Tze-Kwang
   Amrun, Siti N.
   Kam, Yiu-Wing
   Yee, Wearn-Xin
   Ling, Wei-Ping
   Lim, Vanessa W. X.
   Pang, Vincent J. X.
   Lee, Linda K.
   Mok, Esther W. H.
   Chong, Chia-Yin
   Leo, Yee-Sin
   Ng, Lisa F. P.
TI Longitudinal Study of Cellular and Systemic Cytokine Signatures to
   Define the Dynamics of a Balanced Immune Environment During Disease
   Manifestation in Zika Virus-Infected Patients
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; patient cohort; cytokines; immunophenotyping; viremia
ID T-CELLS; INTERFERON-GAMMA; GROWTH-FACTOR; BLOOD; OUTBREAK; TRANSMISSION;
   ASSOCIATION; MONOCYTES; EPIDEMIC; STRAINS
AB Background. Since its unexpected reemergence, Zika virus (ZIKV) has caused numerous outbreaks globally. This study characterized the host immune responses during ZIKV infection.
   Methods. Patient samples were collected longitudinally during the acute, convalescence and recovery phases of ZIKV infection over 6 months during the Singapore outbreak in late 2016. Plasma immune mediators were profiled via multiplex microbead assay, while changes in blood cell numbers were determined with immunophenotyping.
   Results. Data showed the involvement of various immune mediators during acute ZIKV infection accompanied by a general reduction in blood cell numbers for all immune subsets except CD14(+) monocytes. Importantly, viremic patients experiencing moderate symptoms had significantly higher quantities of interferon gamma-induced protein 10, monocyte chemotactic protein 1, interleukin 1 receptor antagonist, interleukin 8, and placental growth factor 1, accompanied by reduced numbers of peripheral CD8(+) T cells, CD4(+) T cells, and double-negative T cells. Levels of T-cell associated mediators, including interferon gamma-induced protein 10, interferon gamma, and interleukin 10, were high in recovery phases of ZIKV infection, suggesting a functional role for T cells. The identification of different markers at specific disease phases emphasizes the dynamics of a balanced cytokine environment in disease progression.
   Conclusions. This is the first comprehensive study that highlights specific cellular changes and immune signatures during ZIKV disease progression, and it provides valuable insights into ZIKV immunopathogenesis.
C1 [Lum, Fok-Moon; Tan, Jeslin J. L.; Lee, Bernett; Chua, Tze-Kwang; Amrun, Siti N.; Kam, Yiu-Wing; Yee, Wearn-Xin; Mok, Esther W. H.; Ng, Lisa F. P.] Agcy Sci Technol & Res, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
   [Lye, David C. B.; Chia, Po-Ying; Ling, Wei-Ping; Lim, Vanessa W. X.; Pang, Vincent J. X.; Lee, Linda K.; Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.
   [Lye, David C. B.; Leo, Yee-Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Lye, David C. B.; Leo, Yee-Sin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Chong, Chia-Yin] Natl Univ Singapore, KK Womens & Childrens Hosp, Singapore, Singapore.
   [Pang, Vincent J. X.; Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
   [Ng, Lisa F. P.] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Ng, LFP (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, 8A Biomed Grove,04-06 Immunos, Singapore 138648, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
RI Chia, Po Ying/AAN-9657-2020
OI Chia, Po Ying/0000-0002-8797-9527; Ng, Lisa/0000-0003-4071-5222; Lye,
   David/0000-0003-0324-0205
FU Singapore Biomedical Research Council (BMRC)Agency for Science
   Technology & Research (ASTAR); Singapore National Public Health
   Laboratory; University of Tartu; BMRC and Singapore Agency for Science,
   Technology, and Research-led Zika Virus Consortium Fund [15/1/82/27/001]
FX This work was supported by the Singapore Biomedical Research Council
   (BMRC; core research grants to the Singapore Immunology Network), the
   Singapore National Public Health Laboratory, the University of Tartu,
   and the BMRC and Singapore Agency for Science, Technology, and
   Research-led Zika Virus Consortium Fund (project 15/1/82/27/001).
CR Ben-Sasson S Z, 2013, Cold Spring Harb Symp Quant Biol, V78, P117, DOI 10.1101/sqb.2013.78.021246
   Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106
   Bristeau-Leprince A, 2008, J IMMUNOL, V181, P440, DOI 10.4049/jimmunol.181.1.440
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen WQ, 2015, J VIROL, V89, P581, DOI 10.1128/JVI.02034-14
   Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enghard P, 2006, SCAND J RHEUMATOL, V35, P209, DOI 10.1080/03009740500417791
   Enriquez-de-Salamanca A, 2008, CYTOKINE, V44, P160, DOI 10.1016/j.cyto.2008.07.007
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Freeman BE, 2012, P NATL ACAD SCI USA, V109, P9971, DOI 10.1073/pnas.1203543109
   Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Hess C, 2004, BLOOD, V104, P3463, DOI 10.1182/blood-2004-03-1067
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lohachanakul J, 2015, J MED VIROL, V87, P733, DOI 10.1002/jmv.24081
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Rojas JM, 2017, J IMMUNOL RES, DOI 10.1155/2017/6104054
   Roshan TM, 2009, INT J LAB HEMATOL, V31, P505, DOI 10.1111/j.1751-553X.2008.01068.x
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2
   Shadidi KR, 2003, SCAND J IMMUNOL, V57, P192, DOI 10.1046/j.1365-3083.2003.01214.x
   Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691
   Siveke JT, 1998, J IMMUNOL, V160, P550
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7
   Vrachnis N, 2013, J MATERN-FETAL NEO M, V26, P995, DOI 10.3109/14767058.2013.766694
   Yusa T, 2017, J INFECT CHEMOTHER, V23, P96, DOI 10.1016/j.jiac.2016.11.002
   Zhang H, 2014, BIOMED RES INT, DOI 10.1155/2014/359308
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
NR 50
TC 15
Z9 15
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD SEP 1
PY 2018
VL 218
IS 5
BP 814
EP 824
DI 10.1093/infdis/jiy225
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GQ6DC
UT WOS:000441791700018
PM 29672707
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Salazar, FV
   Chareonviriyaphap, T
   Grieco, JP
   Eisen, L
   Prabaripai, A
   Ojo, TA
   Gimutao, KA
   Polsomboon, S
   Bangs, MJ
   Achee, NL
AF Salazar, Ferdinand, V
   Chareonviriyaphap, Theeraphap
   Grieco, John P.
   Eisen, Lars
   Prabaripai, Atchariya
   Ojo, Tolulope A.
   Gimutao, Kaymart A.
   Polsomboon, Suppaluck
   Bangs, Michael J.
   Achee, Nicole L.
TI INFLUENCE OF LOCATION AND DISTANCE OF BIOGENTS SENTINEL (TM) TRAPS FROM
   HUMAN-OCCUPIED EXPERIMENTAL HUTS ON AEDES AEGYPTI RECAPTURE AND ENTRY
   INTO HUTS
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; BG-Sentinel (TM) trap; distance and position optimization
   trials; mark-release-recapture; push-pull strategy
ID MARK-RELEASE-RECAPTURE; BG-SENTINEL; DISPERSAL; EFFICACY; BEHAVIOR;
   DIPTERA
AB A mark-release-recapture study was conducted to refine the "push-pull'' strategy for controlling the dengue, chikungunya, and Zika virus vector Aedes aegypti in a peridomestic environment by determining optimal locations and distances from human-occupied experimental huts for placement of the "pull'' component (Biogents Sentinel (TM) [BGS] traps) to maximize the capture of mosquitoes. The BGS traps were placed at portals of entry (windows or doors) or corners of the experimental huts and at varying distances from the huts (0, 3, and 10 m). The location optimization trials revealed higher trap capture rates and reduction in entry of mosquitoes when the BGS traps were positioned nearer the experimental hut portals of entry than those placed in the corner of the huts. The trap capture rate at huts' portals of entry was 38.7% (116/300), while the corners recorded 23.7% (71/300). The percentage reduction in entry of mosquitoes into the huts was 69% and 31% at portals of entry and corners or vertices, respectively. In the distance optimization trials, the highest captures were recorded at 0 m (18.5%; 111/600) and 10 m (14.2%; 128/900) distances from the hut. Moreover, the highest percentage reduction in entry of mosquitoes into the huts occurred for traps set at 0 m (65.6%) compared with 3 m (17.2%) or 10 m (14.6%) distances from the huts.
C1 [Salazar, Ferdinand, V; Gimutao, Kaymart A.] Res Inst Trop Med, Dept Med Entomol, Dept Hlth, FCC, 9300 Res Dr, Muntinlupa, Philippines.
   [Chareonviriyaphap, Theeraphap; Polsomboon, Suppaluck; Bangs, Michael J.] Kasetsart Univ, Dept Entomol, Fac Agr, Bangkok 10900, Thailand.
   [Grieco, John P.; Ojo, Tolulope A.; Achee, Nicole L.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.
   [Eisen, Lars; Prabaripai, Atchariya] Kasetsart Univ, Dept Math Stat & Comp, Fac Liberal Arts & Sci, Kamphaengsean 73140, Nakhonpathom, Thailand.
   [Bangs, Michael J.] Int SOS, Publ Hlth & Malaria Control Dept, Jl Kertajasa, Kuala Kencana 99920, Papua, Indonesia.
RP Salazar, FV (corresponding author), Res Inst Trop Med, Dept Med Entomol, Dept Hlth, FCC, 9300 Res Dr, Muntinlupa, Philippines.
OI Chareonviriyaphap, Theeraphap/0000-0002-7362-5621
FU Armed Forces Development Command, Sai Yok District, Kanchanaburi
   Province, Thailand; Bill and Melinda Gates FoundationGates Foundation
   [48513]; Thailand Research FundThailand Research Fund (TRF) [RTA5280007]
FX We thank the Armed Forces Development Command, Sai Yok District,
   Kanchanaburi Province, Thailand, for support of the research program by
   providing land for the study site. Funding for this research was
   provided by the Bill and Melinda Gates Foundation (Grant 48513) and the
   Thailand Research Fund (RTA5280007).
CR Achee NL, 2005, J AM MOSQUITO CONTR, V21, P366, DOI 10.2987/8756-971X(2006)21[366:AMSUAN]2.0.CO;2
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1
   Chareonviriyaphap T, 2010, J VECTOR ECOL, V35, P428, DOI 10.1111/j.1948-7134.2010.00102.x
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Salazar FV, 2017, J AM MOSQUITO CONTR, V33, P293, DOI 10.2987/16-6552.1
   Salazar FV, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-145
   Salazar FV, 2012, J VECTOR ECOL, V37, P8, DOI 10.1111/j.1948-7134.2012.00195.x
   VANHANDEL E, 1994, J AM MOSQUITO CONTR, V10, P149
   Williams CR, 2006, J AM MOSQUITO CONTR, V22, P296, DOI 10.2987/8756-971X(2006)22[296:FEOTBC]2.0.CO;2
NR 15
TC 1
Z9 1
U1 0
U2 3
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2018
VL 34
IS 3
BP 201
EP 209
DI 10.2987/17-6713.1
PG 9
WC Entomology
SC Entomology
GA GZ0PJ
UT WOS:000449066500005
PM 31442172
OA Bronze
DA 2020-07-08
ER

PT J
AU Aller, S
   Scott, A
   Sarkar-Tyson, M
   Soyer, OS
AF Aller, Sean
   Scott, Andrew
   Sarkar-Tyson, Mitali
   Soyer, Orkun S.
TI Integrated human-virus metabolic stoichiometric modelling predicts
   host-based antiviral targets against Chikungunya, Dengue and Zika
   viruses
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE emerging viruses; antiviral targets; flux balance analysis; host-virus
   interactions; metabolic modelling
ID FLUX BALANCE ANALYSIS; GENE-EXPRESSION; SINGLE CELLS; INFECTION;
   REPLICATION; GROWTH; RECONSTRUCTION; ALPHAVIRUSES; INDUCTION; DATABASE
AB Current and reoccurring viral epidemic outbreaks such as those caused by the Zika virus illustrate the need for rapid development of antivirals. Such development would be facilitated by computational approaches that can provide experimentally testable predictions for possible antiviral strategies. To this end, we focus here on the fact that viruses are directly dependent on their host metabolism for reproduction. We develop a stoichiometric, genome-scale metabolic model that integrates human macrophage cell metabolism with the biochemical demands arising from virus production and use it to determine the virus impact on host metabolism and vice versa. While this approach applies to any host-virus pair, we first apply it to currently epidemic viruses Chikungunya, Dengue and Zika in this study. We find that each of these viruses causes specific alterations in the host metabolic flux towards fulfilling their biochemical demands as predicted by their genome and capsid structure. Subsequent analysis of this integrated model allows us to predict a set of host reactions, which, when constrained, inhibit virus production. We show that this prediction recovers known targets of existing antiviral drugs, specifically those targeting nucleotide production, while highlighting a set of hitherto unexplored reactions involving both amino acid and nucleotide metabolic pathways, with either broad or virus-specific antiviral potential. Thus, this computational approach allows rapid generation of experimentally testable hypotheses for novel antiviral targets within a host.
C1 [Aller, Sean; Soyer, Orkun S.] Univ Warwick, Sch Life Sci, Gibbet Hill Campus, Coventry CV4 7ES, W Midlands, England.
   [Scott, Andrew; Sarkar-Tyson, Mitali] Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England.
   [Sarkar-Tyson, Mitali] Univ Western Australia, Sch Biomed Sci, Marshall Ctr Infect Dis Res & Training, Perth, WA, Australia.
RP Soyer, OS (corresponding author), Univ Warwick, Sch Life Sci, Gibbet Hill Campus, Coventry CV4 7ES, W Midlands, England.
EM o.soyer@warwick.ac.uk
RI Soyer, Orkun/I-4863-2014
OI Soyer, Orkun/0000-0002-9504-3796
FU Defence Science and Technology Laboratory (DSTL)
FX This work was funded by the Defence Science and Technology Laboratory
   (DSTL). The funders did not have any influence in the design of
   experiments and analysis of the data.
CR Aurich MK, 2016, METHODS MOL BIOL, V1386, P253, DOI 10.1007/978-1-4939-3283-2_12
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Birch EW, 2014, J THEOR BIOL, V345, P12, DOI 10.1016/j.jtbi.2013.12.009
   Birch EW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002746
   Birungi G, 2010, J PROTEOME RES, V9, P6523, DOI 10.1021/pr100727m
   Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68
   Chindelevitch L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5893
   Chiu Hsuan-Chao, 2008, Genome Inform, V20, P171
   Delgado T, 2010, P NATL ACAD SCI USA, V107, P10696, DOI 10.1073/pnas.1004882107
   El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00
   Fox JM, 2015, CELL, V163, P1095, DOI 10.1016/j.cell.2015.10.050
   Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06
   Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858
   GOLLINS SW, 1985, J GEN VIROL, V66, P1969, DOI 10.1099/0022-1317-66-9-1969
   Guo WH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154188
   Haynie DT, 2009, BIOL THERMODYNAMICS
   Ikeda M, 2007, ADV DRUG DELIVER REV, V59, P1277, DOI 10.1016/j.addr.2007.03.021
   Jain R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-121
   Kelk SM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00580
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   Kotzamanis K, 2015, MED MICROBIOL IMMUN, V204, P395, DOI 10.1007/s00430-015-0402-5
   Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004
   Littler Eddy, 2005, Antiviral Chemistry & Chemotherapy, V16, P155
   Lundstrom JO, 1999, J VECTOR ECOL, V24, P1
   Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080
   Maynard ND, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001017
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1
   Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081
   Shrinet J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36833
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Tang BL, 2012, CELL MICROBIOL, V14, P1354, DOI 10.1111/j.1462-5822.2012.01825.x
   Terzer M, 2009, WIRES SYST BIOL MED, V1, P285, DOI 10.1002/wsbm.37
   Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488
   Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203
   Timm A, 2012, VIROLOGY, V424, P11, DOI 10.1016/j.virol.2011.12.005
   Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10
   Weisse AY, 2015, P NATL ACAD SCI USA, V112, pE1038, DOI 10.1073/pnas.1416533112
   Yu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064328
   Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002
   Zhu Y, 2009, VIROLOGY, V385, P39, DOI 10.1016/j.virol.2008.10.031
   Zielinski DC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8101
   Zomorrodi AR, 2016, J MOL BIOL, V428, P837, DOI 10.1016/j.jmb.2015.10.019
NR 52
TC 4
Z9 4
U1 0
U2 6
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD SEP
PY 2018
VL 15
IS 146
AR 20180125
DI 10.1098/rsif.2018.0125
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GV6VT
UT WOS:000446257100001
PM 30209043
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Chambers, MT
   Schwarz, MC
   Sourisseau, M
   Gray, ES
   Evans, MJ
AF Chambers, Matthew T.
   Schwarz, Megan C.
   Sourisseau, Marion
   Gray, Essanna S.
   Evans, Matthew J.
TI Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants
   Bearing Linear Epitope Insertions
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; antibody; glycoproteins; neutralization; structure
ID BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; DENGUE VIRUS; STRUCTURAL
   HETEROGENEITY; ANGSTROM RESOLUTION; CELL ENTRY; FLAVIVIRUSES; ANTIBODY;
   AMERICA; INFECTIVITY
AB Zika virus (ZIKV) glycoproteins are the primary target of the humoral immune response. In this study, we explored the capacity of these glycoproteins to tolerate insertion of linear epitope sequences and the potential of antibodies that bind these epitopes to inhibit infection. We first created a panel of ZIKV mutants with the FLAG epitope inserted in the premembrane (prM) and envelope (E) glycoprotein regions. The insertion locations were based on the results of our recent transposon insertional mutagenesis screen. Although FLAG insertions in prM greatly impaired viral fitness, this sequence was tolerated in numerous surface-exposed E protein sites. We observed that mutants bearing FLAG epitopes in E domains I and II and the E domain I-II hinge region were all neutralized by FLAG antibody; however, the neutralization sensitivity varied highly. We measured the antibody binding efficiency and found that this closely matched the pattern of neutralization sensitivity. We determined that E glycosylation did not affect antibody binding to a nearby epitope or its capacity to serve as a neutralization target. Although we could not generate infectious viruses with FLAG epitope insertions in a buried region of E protein domain III, we found that the V5 epitope could be inserted at this site without greatly impacting fitness. Furthermore, this virus was efficiently neutralized by V5 antibodies, highlighting that even buried epitopes can function as neutralization targets. Finally, we analyzed the timing of antibody neutralization activity during cell entry and found that all antibodies blocked a step after cell attachment.
   IMPORTANCE Zika virus (ZIKV) infections are associated with severe birth defects and neurological disease. The structure of the mature ZIKV particle reveals a virion surface covered by the envelope glycoprotein, which is the dominant target of the humoral immune response. It is unclear if all regions of the envelope protein surface or even buried epitopes can function as neutralization targets. To test this, we created a panel of ZIKV mutants with epitope insertions in different regions of the envelope protein. In characterizing these viruses, we found that the strength of antibody binding to an epitope is the major determinant of the neutralization potential of an antibody, that even a buried region of the envelope protein can be efficiently targeted, and that the sole potential envelope glycan does not impact nearby epitope antibody binding and neutralization. Furthermore, this work provides important insights into our understanding of how antibodies neutralize ZIKV.
C1 [Chambers, Matthew T.; Schwarz, Megan C.; Sourisseau, Marion; Gray, Essanna S.; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
RP Evans, MJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM matthew.evans@mssm.edu
FU Burroughs Wellcome FundBurroughs Wellcome Fund;  [NIDDK F30DK112514]; 
   [NIAID F31AI126863];  [NIH R01DK095125];  [R21AI133649]
FX This work was supported by the following grants: NIDDK F30DK112514 (to
   M.T.C.), NIAID F31AI126863 (to E.S.G.), NIH R01DK095125 (to M.J.E.), and
   R21AI133649 (to M.J.E.). M.J.E. holds an Investigators in Pathogenesis
   of Infectious Disease Award from the Burroughs Wellcome Fund.
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Gallichotte EN, 2017, J INFECT DIS, V216, P1196, DOI 10.1093/infdis/jix473
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HEINZ FX, 1986, J BIOL STAND, V14, P133, DOI 10.1016/0092-1157(86)90032-6
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067
   Michta ML, 2010, J VIROL, V84, P11696, DOI 10.1128/JVI.01555-10
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schrodinger Inc, 2015, PYMOL MOL GRAPH SYST
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   WHO, 2017, SIT REP
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 53
TC 3
Z9 3
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2018
VL 92
IS 18
AR e00505-18
DI 10.1128/JVI.00505-18
PG 17
WC Virology
SC Virology
GA GR8XN
UT WOS:000443019800011
PM 29976678
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Li, PH
   Ke, XL
   Wang, T
   Tan, ZY
   Luo, D
   Miao, YJ
   Sun, JH
   Zhang, Y
   Liu, Y
   Hu, QX
   Xu, FQ
   Wang, HZ
   Zheng, ZH
AF Li, Penghui
   Ke, Xianliang
   Wang, Ting
   Tan, Zhongyuan
   Luo, Dan
   Miao, Yuanjiu
   Sun, Jianhong
   Zhang, Yuan
   Liu, Yan
   Hu, Qinxue
   Xu, Fuqiang
   Wang, Hanzhong
   Zheng, Zhenhua
TI Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing
   Immunity in Mouse Models
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE codon pair bias; E protein; NS1 protein; Zika virus; deoptimization;
   vaccines
ID INFLUENZA-VIRUS; DINUCLEOTIDE BIAS; CAPSID REGION; VACCINE; GENOME; RNA;
   PROTEIN; PROTECTION; REDUCTION; CELLS
AB Zika virus (ZIKV) infection during the large epidemics in the Americas is related to congenital abnormities or fetal demise. To date, there is no vaccine, antiviral drug, or other modality available to prevent or treat Zika virus infection. Here we designed novel live attenuated ZIKV vaccine candidates using a codon pair deoptimization strategy. Three codon pair-deoptimized ZIKVs (Min E, Min NS1, and Min E + NS1) were de novo synthesized and recovered by reverse genetics and contained large amounts of underrepresented codon pairs in the E gene and/or NS1 gene. The amino acid sequence was 100% unchanged. The codon pair-deoptimized variants had decreased replication fitness in Vero cells (Min NS1 >> Min E > Min E + NS1), replicated more efficiently in insect cells than in mammalian cells, and demonstrated diminished virulence in a mouse model. In particular, Min E = NS1, the most restrictive variant, induced sterilizing immunity with a robust neutralizing antibody titer, and a single immunization achieved complete protection against lethal challenge and vertical ZIKV transmission during pregnancy. More importantly, due to the numerous synonymous substitutions in the codon pair-deoptimized strains, reversion to wild-type virulence through gradual nucleotide sequence mutations is unlikely. Our results collectively demonstrate that ZIKV can be effectively attenuated by codon pair deoptimization, highlighting the potential of Min E + NS1 as a safe vaccine candidate to prevent ZIKV infections.
   IMPORTANCE Due to unprecedented epidemics of Zika virus (ZIKV) across the Americas and the unexpected clinical symptoms, including Guillain-Barre syndrome, microcephaly, and other birth defects in humans, there is an urgent need for ZIKV vaccine development. Here we provided the first attenuated versions of ZIKV with two important genes (E and/or NS1) that were subjected to codon pair deoptimization. Compared to parental ZIKV, the codon pair-deoptimized ZIKVs were mammal attenuated and preferred insect to mammalian cells. Min E + NS1, the most restrictive variant, induced sterilizing immunity with a robust neutralizing antibody titer and achieved complete protection against lethal challenge and vertical virus transmission during pregnancy. More importantly, the massive synonymous mutational approach made it impossible for the variant to revert to wild-type virulence. Our results have proven the feasibility of codon pair deoptimization as a strategy to develop live attenuated vaccine candidates against flaviviruses such as ZIKV, Japanese encephalitis virus, and West Nile virus.
C1 [Li, Penghui; Ke, Xianliang; Wang, Ting; Tan, Zhongyuan; Luo, Dan; Miao, Yuanjiu; Sun, Jianhong; Zhang, Yuan; Liu, Yan; Wang, Hanzhong; Zheng, Zhenhua] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, CAS Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.
   [Li, Penghui] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Wang, Ting; Xu, Fuqiang] Chinese Acad Sci, Key Lab Magnet Resonance Biol Syst, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance,Wuhan Inst Phys & Math, Wuhan, Hubei, Peoples R China.
   [Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Hubei, Peoples R China.
RP Wang, HZ; Zheng, ZH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, CAS Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.
EM wanghz@wh.iov.cn; zhengzh@wh.iov.cn
RI xu, fuqiang/AAI-1571-2019
OI Hu, Qinxue/0000-0002-4594-9215
FU National Key R&D Program of China [2016YFD0500406]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [81471953]; Youth Innovation Promotion Association of CAS
   [2016302]
FX This work was supported by the National Key R&D Program of China
   (2016YFD0500406), the National Natural Science Foundation of China
   (NSFC) (no. 81471953), and the Youth Innovation Promotion Association of
   CAS (2016302). The funders had no role in study design, data collection
   and interpretation, or the decision to submit the work for publication.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Al-Saif M, 2012, MOL THER, V20, P954, DOI 10.1038/mt.2012.29
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Martinez MA, 2016, TRENDS MICROBIOL, V24, P134, DOI 10.1016/j.tim.2015.11.002
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Broadbent AJ, 2016, VACCINE, V34, P563, DOI 10.1016/j.vaccine.2015.11.054
   BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358
   Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Cheng BYH, 2015, J VIROL, V89, P3523, DOI 10.1128/JVI.03401-14
   Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fros JJ, 2017, ELIFE, V6, DOI 10.7554/eLife.29112
   Futcher B, 2015, P NATL ACAD SCI USA, V112, pE3635, DOI 10.1073/pnas.1507710112
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaunt E, 2016, ELIFE, V5, DOI 10.7554/eLife.12735
   GUTMAN GA, 1989, P NATL ACAD SCI USA, V86, P3699, DOI 10.1073/pnas.86.10.3699
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994
   Kunec D, 2016, CELL REP, V14, P55, DOI 10.1016/j.celrep.2015.12.011
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Le Nouen C, 2017, P NATL ACAD SCI USA, V114, pE386, DOI 10.1073/pnas.1619242114
   Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Meng J, 2014, MBIO, V5, DOI 10.1128/mBio.01704-14
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636
   Mueller S, 2009, CHEM BIOL, V16, P337, DOI 10.1016/j.chembiol.2009.03.002
   Ni YY, 2014, VIROLOGY, V450, P132, DOI 10.1016/j.virol.2013.12.009
   Nogales A, 2014, J VIROL, V88, P10525, DOI 10.1128/JVI.01565-14
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Segundo FDS, 2016, J VIROL, V90, P1298, DOI 10.1128/JVI.02167-15
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531
   Wang BY, 2015, MBIO, V6, DOI 10.1128/mBio.00237-15
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yang C, 2013, P NATL ACAD SCI USA, V110, P9481, DOI 10.1073/pnas.1307473110
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 67
TC 14
Z9 17
U1 4
U2 19
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2018
VL 92
IS 17
AR e00701-18
DI 10.1128/JVI.00701-18
PG 16
WC Virology
SC Virology
GA GR8VO
UT WOS:000443012300019
PM 29925661
OA Green Accepted, Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Parry, R
   Asgari, S
AF Parry, Rhys
   Asgari, Sassan
TI Aedes Anphevirus: an Insect-Specific Virus Distributed Worldwide in
   Aedes aegypti Mosquitoes That Has Complex Interplays with Wolbachia and
   Dengue Virus Infection in Cells
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Aedes aegypti; anphevirus; Mononegavirales; Wolbachia; insect viruses;
   mosquito; virome
ID STRAND RNA VIRUSES; FUSING AGENT VIRUS; VECTOR COMPETENCE;
   SUPERINFECTION EXCLUSION; FLAVIVIRUS INFECTION; HOST; TRANSMISSION;
   REPLICATION; EVOLUTION; LINES
AB Insect-specific viruses (ISVs) of the yellow fever mosquito Aedes aegypti have been demonstrated to modulate transmission of arboviruses such as dengue virus (DENV) and West Nile virus by the mosquito. The diversity and composition of the virome of A. aegypti, however, remains poorly understood. In this study, we characterized Aedes anphevirus (AeAV), a negative-sense RNA virus from the order Mononegavirales. AeAV identified from Aedes cell lines was infectious to both A. aegypti and Aedes albopictus cells but not to three mammalian cell lines. To understand the incidence and genetic diversity of AeAV, we assembled 17 coding-complete and two partial genomes of AeAV from available transcriptome sequencing (RNA-Seq) data. AeAV appears to transmit vertically and be present in laboratory colonies, wild-caught mosquitoes, and cell lines worldwide. Phylogenetic analysis of AeAV strains indicates that as the A. aegypti mosquito has expanded into the Americas and Asia-Pacific, AeAV has evolved into monophyletic African, American, and Asia-Pacific lineages. The endosymbiotic bacterium Wolbachia pipientis restricts positive-sense RNA viruses in A. aegypti. Reanalysis of a small RNA library of A. aegypti cells coinfected with AeAV and Wolbachia produces an abundant RNA interference (RNAi) response consistent with persistent virus replication. We found Wolbachia enhances replication of AeAV compared to a tetracycline-cleared cell line, and AeAV modestly reduces DENV replication in vitro. The results from our study improve understanding of the diversity and evolution of the virome of A. aegypti and adds to previous evidence that shows Wolbachia does not restrict a range of negative-strand RNA viruses.
   IMPORTANCE The mosquito Aedes aegypti transmits a number of arthropod-borne viruses (arboviruses), such as dengue virus and Zika virus. Mosquitoes also harbor insect-specific viruses that may affect replication of pathogenic arboviruses in their body. Currently, however, there are only a few insect-specific viruses described from A. aegypti in the literature. Here, we characterize a novel negative-strand virus, AeAV. Meta-analysis of A. aegypti samples showed that it is present in A. aegypti mosquitoes worldwide and is vertically transmitted. Wolbachia-transinfected mosquitoes are currently being used in biocontrol, as they effectively block transmission of several positive-sense RNA viruses in mosquitoes. Our results demonstrate that Wolbachia enhances the replication of AeAV and modestly reduces dengue virus replication in a cell line model. This study expands our understanding of the virome in A. aegypti as well as providing insight into the complexity of the Wolbachia virus restriction phenotype.
C1 [Parry, Rhys; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
RP Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
EM s.asgari@uq.edu.au
RI Parry, Rhys/L-5804-2019; Asgari, Sassan/G-2678-2011
OI Parry, Rhys/0000-0001-9238-1952; Asgari, Sassan/0000-0001-7885-6544
FU Australian Research Council grant (ARC)Australian Research Council
   [DP150101782]; University of Queensland scholarship
FX This project was funded by the Australian Research Council grant (ARC;
   DP150101782) to S.A. and University of Queensland scholarship to R.P..
CR Alfonso-Parra C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004451
   Amarasinghe GK, 2017, ARCH VIROL, V162, P2493, DOI 10.1007/s00705-017-3311-7
   Amuzu HE, 2018, ECOL EVOL, V8, P5441, DOI 10.1002/ece3.4066
   Asad S, 2018, INSECT BIOCHEM MOLEC, V92, P45, DOI 10.1016/j.ibmb.2017.11.008
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Baron OL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.4101
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Chandler JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00185
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Choi KH, 2012, ADV EXP MED BIOL, V726, P267, DOI 10.1007/978-1-4614-0980-9_12
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Darby AC, 2014, ISME J, V8, P925, DOI 10.1038/ismej.2013.192
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   Di Giallonardo F, 2018, J GEN VIROL, V99, P832, DOI 10.1099/jgv.0.001079
   Dietrich I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005272
   Dodson BL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006050
   Etebari K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15968
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Faucon F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005526
   Fauver JR, 2016, VIROLOGY, V498, P288, DOI 10.1016/j.virol.2016.07.031
   Ferron F, 2002, TRENDS BIOCHEM SCI, V27, P222, DOI 10.1016/S0968-0004(02)02091-1
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Green TJ, 2014, J VIROL, V88, P3766, DOI 10.1128/JVI.03483-13
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hornak KE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070194
   Hussain M, 2016, ADV INSECT PHYSIOL, V51, P189, DOI 10.1016/bs.aiip.2016.04.001
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kittayapong P, 1999, AM J TROP MED HYG, V61, P612, DOI 10.4269/ajtmh.1999.61.612
   KUNO G, 1983, IN VITRO CELL DEV B, V19, P707
   Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14
   Lee M, 2017, J GEN VIROL, V98, P1892, DOI 10.1099/jgv.0.000832
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lewis SH, 2018, NAT ECOL EVOL, V2, P174, DOI 10.1038/s41559-017-0403-4
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miller WA, 2010, NUCLEIC ACIDS MOL BI, V24, P193, DOI 10.1007/978-0-387-89382-2_9
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Parry R, 2018, BIORXIV, DOI [10.1101/335067, DOI 10.1101/335067]
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Pudney M., 1979, TCA (TISSUE CULTURE ASSOCIATION) MANUAL, V5, P997, DOI 10.1007/BF00919719
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Raymond DD, 2012, P NATL ACAD SCI USA, V109, P19208, DOI 10.1073/pnas.1213553109
   Rice DW, 2017, GENOME BIOL EVOL, V9, P1925, DOI 10.1093/gbe/evx139
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   Shriram AN, 2017, B ENTOMOL RES, V3, P166
   SINGH KRP, 1967, CURR SCI INDIA, V36, P506
   Sutton ER, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3280-3
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Walker PJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004664
   Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001
   Whitfield ZJ, 2017, CURR BIOL, V27, P3511, DOI 10.1016/j.cub.2017.09.067
   Woolfit M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118595
   Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
   Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007
NR 98
TC 16
Z9 16
U1 1
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2018
VL 92
IS 17
AR e00224-18
DI 10.1128/JVI.00224-18
PG 19
WC Virology
SC Virology
GA GR8VO
UT WOS:000443012300002
PM 29950416
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yan, DW
   Shi, Y
   Wang, HW
   Li, GX
   Li, XS
   Wang, BB
   Su, X
   Wang, JH
   Teng, QY
   Yang, JM
   Chen, HJ
   Liu, QF
   Ma, WJ
   Li, ZJ
AF Yan, Dawei
   Shi, Ying
   Wang, Haiwang
   Li, Guoxin
   Li, Xuesong
   Wang, Binbin
   Su, Xin
   Wang, Junheng
   Teng, Qiaoyang
   Yang, Jianmei
   Chen, Hongjun
   Liu, Qinfang
   Ma, Wenjun
   Li, Zejun
TI A Single Mutation at Position 156 in the Envelope Protein of Tembusu
   Virus Is Responsible for Virus Tissue Tropism and Transmissibility in
   Ducks
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Tembusu virus; flavivirus; envelope protein; mutation; replication;
   transmission
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; DENGUE VIRUS; MOUSE
   NEUROINVASIVENESS; JAPANESE ENCEPHALITIS; ZIKA VIRUS;
   INFECTIOUS-DISEASE; N-GLYCOSYLATION; MEMBRANE-FUSION; HOUSE SPARROWS
AB Duck Tembusu virus (TMUV), like other mosquito-borne flaviviruses, such as Japanese encephalitis virus, West Nile virus, and Bagaza virus, is able to transmit vector-independently. To date, why these flaviviruses can be transmitted without mosquito vectors remains poorly understood. To explore the key molecular basis of flavivirus transmissibility, we compared virus replication and transmissibility of an early and a recent TMUV in ducks. The recent TMUV strain FX2010 replicated systemically and transmitted efficiently in ducks, while the replication of early strain MM1775 was limited and did not transmit among ducks. The TMUV envelope protein and its domain I were responsible for tissue tropism and transmissibility. The mutation S156P in the domain I resulted in disruption of N-linked glycosylation at amino acid 154 of the E protein and changed the conformation of "150 loop" of the E protein, which reduced virus replication in lungs and abrogated transmission in ducks. These data indicate that the 156S in the envelope protein is critical for TMUV tissue tropism and transmissibility in ducks in the absence of mosquitos. Our findings provide novel insights on understanding TMUV transmission among ducks.
   IMPORTANCE Tembusu virus, similar to other mosquito-borne flaviviruses such as WNV, JEV, and BAGV, can be transmitted without the presence of mosquito vectors. We demonstrate that the envelope protein of TMUV and its amino acid (S) at position 156 is responsible for tissue tropism and transmission in ducks. The mutation S156P results in disruption of N-linked glycosylation at amino acid 154 of the E protein and changes the conformation of "150 loop" of the E protein, which induces limited virus replication in lungs and abrogates transmission between ducks. Our findings provide new knowledge about TMUV transmission among ducks.
C1 [Yan, Dawei; Shi, Ying; Wang, Haiwang; Li, Guoxin; Li, Xuesong; Wang, Binbin; Su, Xin; Wang, Junheng; Teng, Qiaoyang; Yang, Jianmei; Chen, Hongjun; Liu, Qinfang; Li, Zejun] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Avian Infect Dis, Shanghai, Peoples R China.
   [Yang, Jianmei; Li, Zejun] Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China.
   [Ma, Wenjun] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
RP Li, ZJ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Avian Infect Dis, Shanghai, Peoples R China.; Li, ZJ (corresponding author), Shanghai Key Lab Vet Biotechnol, Shanghai, Peoples R China.
EM lizejun@shvri.ac.cn
FU National Key Research and Development Program of China [2016YFD0500106];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31472205, 31702237]; Foundation of Shanghai Key
   Laboratory of Veterinary Biotechnology [klab201706]
FX This study was supported by the National Key Research and Development
   Program of China (2016YFD0500106), the National Natural Science
   Foundation of China (31472205 and 31702237), and the Foundation of
   Shanghai Key Laboratory of Veterinary Biotechnology (klab201706). This
   study was a collaborative research by the Shanghai Veterinary Research
   Institute, CAAS-Kansas State University Research Laboratory
   Collaboration for Animal influenza and Poultry Disease.
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Audsley M, 2011, VIROLOGY, V414, P63, DOI 10.1016/j.virol.2011.03.008
   Banet-Noach C, 2003, AVIAN PATHOL, V32, P489, DOI 10.1080/0307945031000154080
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890
   *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P1017
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hinton MG, 2015, J MED ENTOMOL, V52, P683, DOI 10.1093/jme/tjv040
   Holbrook MR, 2001, VIROLOGY, V286, P54, DOI 10.1006/viro.2001.0959
   Ip Hon S, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.b0f031fc8db2a827d9da0f30f0766871
   Ishak H, 2001, MICROBIOL IMMUNOL, V45, P327, DOI 10.1111/j.1348-0421.2001.tb02627.x
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kono Y, 2000, AM J TROP MED HYG, V63, P94, DOI 10.4269/ajtmh.2000.63.94
   LEAKE CJ, 1986, T ROY SOC TROP MED H, V80, P831, DOI 10.1016/0035-9203(86)90397-4
   Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Lei WW, 2017, VET MICROBIOL, V201, P32, DOI 10.1016/j.vetmic.2017.01.003
   Li GX, 2014, VIROLOGY, V450, P233, DOI 10.1016/j.virol.2013.12.028
   Li XS, 2015, J CLIN MICROBIOL, V53, P2734, DOI 10.1128/JCM.00770-15
   Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Llorente F, 2015, VET RES, V46, DOI 10.1186/s13567-015-0233-9
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   McMinn PC, 1996, J GEN VIROL, V77, P2085, DOI 10.1099/0022-1317-77-9-2085
   Mitzel DN, 2008, VIROLOGY, V381, P268, DOI 10.1016/j.virol.2008.08.030
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Moudy RM, 2011, AM J TROP MED HYG, V85, P374, DOI 10.4269/ajtmh.2011.10-0697
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Pandey Basu Dev, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P161
   PLATT GS, 1975, ANN TROP MED PARASIT, V69, P65, DOI 10.1080/00034983.1975.11686984
   Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Ruzek D, 2008, VIROLOGY, V374, P249, DOI 10.1016/j.virol.2008.01.010
   Scherret JH, 2001, ANN NY ACAD SCI, V951, P361, DOI 10.1111/j.1749-6632.2001.tb02719.x
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106
   Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P152, DOI 10.1111/j.1865-1682.2012.01328.x
   Thontiravong A, 2015, EMERG INFECT DIS, V21, P2164, DOI 10.3201/eid2112.150600
   Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Wang J, 2016, J IMMUNOL, V197, P4704, DOI 10.4049/jimmunol.1502317
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Wicker JA, 2012, VIROLOGY, V426, P22, DOI 10.1016/j.virol.2011.11.022
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   Wu XG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156579
   Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003
   Yu KX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071319
   Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064
   Zhang SL, 2006, VIROLOGY, V353, P35, DOI 10.1016/j.virol.2006.05.025
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhao DM, 2015, RES VET SCI, V98, P121, DOI [10.1, 10.1016/j.rvsc.2014.11.003]
NR 77
TC 10
Z9 11
U1 1
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD SEP
PY 2018
VL 92
IS 17
AR e00427-18
DI 10.1128/JVI.00427-18
PG 16
WC Virology
SC Virology
GA GR8VO
UT WOS:000443012300009
PM 29899104
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chen, Q
   Wu, J
   Ye, Q
   Ma, F
   Zhu, Q
   Wu, Y
   Shan, C
   Xie, XP
   Li, DP
   Zhan, XY
   Li, CF
   Li, XF
   Qin, XL
   Zhao, TY
   Wu, HT
   Shi, PY
   Man, JH
   Qin, CF
AF Chen, Qi
   Wu, Jin
   Ye, Qing
   Ma, Feng
   Zhu, Qian
   Wu, Yan
   Shan, Chao
   Xie, Xuping
   Li, Dapei
   Zhan, Xiaoyan
   Li, Chunfeng
   Li, Xiao-Feng
   Qin, Xiaoling
   Zhao, Tongyang
   Wu, Haitao
   Shi, Pei-Yong
   Man, Jianghong
   Qin, Cheng-Feng
TI Treatment of Human Glioblastoma with a Live Attenuated Zika Virus
   Vaccine Candidate
SO MBIO
LA English
DT Article
DE Zika virus; anticancer therapy; glioblastoma; vaccine
ID STEM-CELLS; ADJUVANT TEMOZOLOMIDE; RADIOTHERAPY; CONCOMITANT;
   CHALLENGES; PERICYTES; SURVIVAL; GROWTH
AB Glioblastoma (GBM) is the deadliest type of brain tumor, and glioma stem cells (GSCs) contribute to tumor recurrence and therapeutic resistance. Thus, an oncolytic virus targeting GSCs may be useful for improving GBM treatment. Because Zika virus (ZIKV) has an oncolytic tropism for infecting GSCs, we investigated the safety and efficacy of a live attenuated ZIKV vaccine candidate (ZIKV-LAV) for the treatment of human GBM in a GSC-derived orthotopic model. Intracerebral injection of ZIKV-LAV into mice caused no neurological symptoms or behavioral abnormalities. The neurovirulence of ZIKV-LAV was more attenuated than that of the licensed Japanese encephalitis virus LAV 14-14-2, underlining the superior safety of ZIKV-LAV for potential GBM treatment. Importantly, ZIKV-LAV significantly reduced intracerebral tumor growth and prolonged animal survival by selectively killing GSCs within the tumor. Mechanistically, ZIKV infection elicited antiviral immunity, inflammation, and GSC apoptosis. Together, these results further support the clinical development of ZIKV-LAV for GBM therapy.
   IMPORTANCE Glioblastoma (GBM), the deadliest type of brain tumor, is currently incurable because of its high recurrence rate after traditional treatments, including surgery to remove the main part of the tumor and radiation and chemotherapy to target residual tumor cells. These treatments fail mainly due to the presence of a cell subpopulation called glioma stem cells (GSCs), which are resistant to radiation and chemotherapy and capable of self-renewal and tumorigenicity. Because Zika virus (ZIKV) has an oncolytic tropism for infecting GSCs, we tested a live attenuated ZIKV vaccine candidate (ZIKV-LAV) for the treatment of human GBM in a human GSC-derived orthotopic model. Our results showed that ZIKV-LAV retained good efficacy against glioblastoma by selectively killing GSCs within the tumor. In addition, ZIKV-LAV exhibited an excellent safety profile upon intracerebral injection into the treated animals. The good balance between the safety of ZIKV-LAV and its efficacy against human GSCs suggests that it is a potential candidate for combination with the current treatment regimen for GBM therapy.
C1 [Chen, Qi; Ye, Qing; Li, Chunfeng; Li, Xiao-Feng; Qin, Xiaoling; Zhao, Tongyang; Qin, Cheng-Feng] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Wu, Jin; Zhan, Xiaoyan; Man, Jianghong] Natl Ctr Biomed Anal, State Key Lab Prote, Beijing, Peoples R China.
   [Ye, Qing] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Ma, Feng; Li, Dapei; Li, Chunfeng] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing, Peoples R China.
   [Ma, Feng; Li, Dapei; Li, Chunfeng] Peking Union Med Coll, Beijing, Peoples R China.
   [Ma, Feng; Li, Dapei; Li, Chunfeng] Suzhou Inst Syst Med, Suzhou, Peoples R China.
   [Zhu, Qian; Wu, Yan; Wu, Haitao] Beijing Inst Basic Med Sci, Dept Neurobiol, Beijing, Peoples R China.
   [Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Pharmacol & Toxicol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Wu, Jin] Acad Mil Med Sci, Tianjin Key Lab Risk Assessment & Control Technol, Inst Environm Med, Tianjin, Peoples R China.
RP Qin, CF (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Man, JH (corresponding author), Natl Ctr Biomed Anal, State Key Lab Prote, Beijing, Peoples R China.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Pharmacol & Toxicol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu; jhman@ncba.ac.cn; qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Xie, Xuping/AAD-7406-2019; Li,
   Chunfeng/S-3185-2019; Wu, Haitao/AAK-4389-2020
OI Qin, Cheng-Feng/0000-0002-0632-2807; Li, Chunfeng/0000-0001-8883-9078;
   Wu, Haitao/0000-0001-8437-3194; Shan, Chao/0000-0002-3953-3782
FU National Key Research and Development Project of China [2016YFD0500304];
   National Natural Science Foundation (NSFC) of ChinaNational Natural
   Science Foundation of China [31870912, 31770190, U170220023,
   81661148054, 81572889, 31522029, 31670883]; National Science and
   Technology Major Project of China [2018ZX09711003, 2017ZX10304402]; CAMS
   Initiative for Innovative Medicine [2016-I2M-1-005]; Beijing Municipal
   Science and Technology CommissionBeijing Municipal Science & Technology
   Commission [Z161100000216154]; Excellent Young Scientist Program
   [81522025]; NSFCNational Natural Science Foundation of China [81621005];
   U.K. Academy of Medical Sciences; University of Texas STARs Award; CDC
   grant for the Western Gulf Center of Excellence for Vector-Borne
   Diseases; Robert J. Kleberg Jr. and Helen C. Kleberg Foundation; UTMB
   CTSAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR-001439]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [AI127744]
FX This work was supported by the National Key Research and Development
   Project of China (no. 2016YFD0500304), the National Natural Science
   Foundation (NSFC) of China (no. 31870912, no. 31770190, U170220023, no.
   81661148054, no. 81572889, no. 31522029, and no. 31670883), the National
   Science and Technology Major Project of China (no. 2018ZX09711003 and
   no. 2017ZX10304402), the CAMS Initiative for Innovative Medicine (no.
   2016-I2M-1-005), and the Beijing Municipal Science and Technology
   Commission (Z161100000216154). The laboratory of C.-F.Q. was supported
   by the Excellent Young Scientist Program (no. 81522025), the Innovative
   Research Group (no. 81621005) from NSFC, and a Newton Advanced
   Fellowship from the U.K. Academy of Medical Sciences. The laboratory of
   P.-Y.S. was supported by the University of Texas STARs Award, a CDC
   grant for the Western Gulf Center of Excellence for Vector-Borne
   Diseases, the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation,
   UTMB CTSA UL1TR-001439, and NIH grant AI127744.
CR Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007
   Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287
   Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049
   Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435
   Enderlin M, 2009, CANCER GENE THER, V16, P149, DOI 10.1038/cgt.2008.62
   Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006
   Fang XG, 2017, J EXP MED, V214, P245, DOI 10.1084/jem.20151673
   Foreman PM, 2017, NEUROTHERAPEUTICS, V14, P333, DOI 10.1007/s13311-017-0516-0
   Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lu XL, 2008, VACCINE, V26, P5352, DOI 10.1016/j.vaccine.2008.08.012
   Man JH, 2018, CELL STEM CELL, V22, P104, DOI 10.1016/j.stem.2017.10.005
   Man JH, 2014, CELL REP, V9, P1812, DOI 10.1016/j.celrep.2014.10.055
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shergalis A, 2018, PHARMACOL REV, V70, P412, DOI 10.1124/pr.117.014944
   Singh S, 2004, J PHOTOCH PHOTOBIO B, V77, P45, DOI 10.1016/j.jphotobiol.2004.08.009
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Zhou WC, 2017, CELL STEM CELL, V21, P591, DOI 10.1016/j.stem.2017.10.002
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 35
TC 17
Z9 18
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2018
VL 9
IS 5
AR e01683-18
DI 10.1128/mBio.01683-18
PG 13
WC Microbiology
SC Microbiology
GA GZ5NY
UT WOS:000449472200069
PM 30228241
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Siramaneerat, I
AF Siramaneerat, Issara
TI Perception of the Zika virus infection and its influence on Zika
   prevention practices by pregnant women at the Region 5 Health Promotion
   Center in Thailand
SO MEDICAL JOURNAL OF INDONESIA
LA English
DT Article
DE perception; pregnant; Thailand; Zika
AB Background: The Zika virus (ZIKA) infection in pregnant women causes microcephaly, a brain disorder resulting in severe birth defects. The objective of this study was to identify the factors that influence Zika prevention practices by pregnant women at the Region 5 Health Promotion Center in Thailand.
   Methods: A cross-sectional study applied a survey method to collect data from pregnant women between 18 and 45 years of age. The sampling method used multistage random sampling. The data were analyzed using descriptive statistics and multiple linear regression analysis.
   Results: The findings indicated that 5 of 12 factors could significantly predict Zika prevention practices of pregnant women at the Health Promotion Center Region 5 in Thailand: education, smoking behavior, check-up status during pregnancy, perception of susceptibility, and perception of benefit.
   Conclusion: The results show a direct correlation between the perception of susceptibility and benefit and Zika prevention practices. Policies for promoting Zika knowledge and preventive behavior by providing information about Zika should focus on changing the thoughts, attitudes, and beliefs of pregnant women and their families.
C1 [Siramaneerat, Issara] Rajamangala Univ Technol Thanyaburi, Dept Social Sci, Fac Liberal Arts, Klongluang, Pathum Thani, Thailand.
RP Siramaneerat, I (corresponding author), Rajamangala Univ Technol Thanyaburi, Dept Social Sci, Fac Liberal Arts, Klongluang, Pathum Thani, Thailand.
EM issara_s@rmutt.ac.th
FU Kanchanabhishek Institute of Medical and Public Health Technology;
   Ministry of Public Health
FX This research was supported by the Kanchanabhishek Institute of Medical
   and Public Health Technology and the Ministry of Public Health. The
   author would like to thank Dr. Sawanya Siriphakhamongkhon, Ms. Wannisa
   Raksamart, Mr. Chanawee Surachatri, and Mrs. Sarinthorn Mungkhamanee for
   assisting with collecting data.
CR [Anonymous], 2015, KINGD THAIL HLTH SYS
   Besnard M, 2014, EURO SURVEILL, V19
   Binsaeed A A, 2016, J Egypt Soc Parasitol, V46, P571
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Bureau of Epidemiology Department of Disease Control Ministry of Public Health, 2017, REP MAJ DIS HLTH HAZ
   Busari O. A., 2010, Turk Silahli Kuvvetleri,  Koruyucu Hekimlik Bulteni, V9, P87
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   KREJCIE RV, 1970, EDUC PSYCHOL MEAS, V30, P607, DOI 10.1177/001316447003000308
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   . National Statistical Office Thailand, KEY FIND 2009 REPR H
   New Mexico Department of Health, 2016, ZIK PREP RESP PLAN
   PEARSON E, 2006, MEKONG CHALLENGE UND
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petrie KJ, 2012, CURR DIR PSYCHOL SCI, V21, P60, DOI 10.1177/0963721411429456
   Polwiang S, 2015, J TRAVEL MED, V22, P194, DOI 10.1111/jtm.12193
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203
   Saunders M, 2009, RES METHODS BUSINESS, P210
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stretcher V, 1997, HLTH BEHAV HLTH ED T, P31, DOI DOI 10.1111/J.1365-2648.2010.05450.X
   Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   World Desk Reference, 2017, WORLD DESK REFERENCE
   World Health Organization (WHO), 2017, ZIK STRAT RESP PLAN
NR 25
TC 1
Z9 1
U1 0
U2 2
PU UNIV INDONESIA, FAC MEDICINE
PI JAKARTA PUSAT
PA JALAN SALEMBA 6, JAKARTA PUSAT, 10430, INDONESIA
SN 0853-1773
EI 2252-8083
J9 MED J INDONES
JI Med. J. Indones.
PD SEP
PY 2018
VL 27
IS 3
BP 201
EP 208
DI 10.13181/mji.v27i3.2424
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA GW8CY
UT WOS:000447202100011
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wongsurawat, T
   Jenjaroenpun, P
   Athipanyasilp, N
   Kaewnapan, B
   Leelahakorn, N
   Angkasekwinai, N
   Kantakamalakul, W
   Sutthent, R
   Ussery, DW
   Horthongkham, N
   Nookaew, I
AF Wongsurawat, Thidathip
   Jenjaroenpun, Piroon
   Athipanyasilp, Niracha
   Kaewnapan, Bualan
   Leelahakorn, Nattawat
   Angkasekwinai, Nasikarn
   Kantakamalakul, Wannee
   Sutthent, Ruengpung
   Ussery, David W.
   Horthongkham, Navin
   Nookaew, Intawat
TI Genome Sequences of Zika Virus Strains Recovered from Amniotic Fluid,
   Placenta, and Fetal Brain of a Microcephaly Patient in Thailand, 2017
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
AB We present here the complete genome sequences of Zika virus strains isolated from aborted fetal tissue (brain and placenta) and amniotic fluid of a microcephaly patient in Thailand in 2017. The virus genomes that were sequenced have an average length of 10,807 nucleotides.
C1 [Wongsurawat, Thidathip; Jenjaroenpun, Piroon; Ussery, David W.; Nookaew, Intawat] Univ Arkansas Med Sci, Coll Med, Dept Biomed Informat, Little Rock, AR 72205 USA.
   [Athipanyasilp, Niracha; Kaewnapan, Bualan; Leelahakorn, Nattawat; Kantakamalakul, Wannee; Sutthent, Ruengpung; Horthongkham, Navin] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.
   [Angkasekwinai, Nasikarn] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Med, Bangkok, Thailand.
   [Ussery, David W.; Nookaew, Intawat] Univ Arkansas Med Sci, Coll Med, Dept Physiol & Biophys, Little Rock, AR 72205 USA.
RP Nookaew, I (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Biomed Informat, Little Rock, AR 72205 USA.; Horthongkham, N (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.; Nookaew, I (corresponding author), Univ Arkansas Med Sci, Coll Med, Dept Physiol & Biophys, Little Rock, AR 72205 USA.
EM navin.hor@mahidol.ac.th; inookaew@uams.edu
RI Ussery, David/J-2026-2019; Angkasekwinai, Nasikarn/AAS-3199-2020
OI Ussery, David/0000-0003-3632-5512; 
FU Siriraj research grant [RO16034012]; Helen Adams and Arkansas Research
   Alliance Endowed Chair; National Institute of General Medical Sciences
   of the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [P20GM125503]
FX This work was funded in part by Siriraj research grant RO16034012, the
   Helen Adams and Arkansas Research Alliance Endowed Chair, and the
   National Institute of General Medical Sciences of the National
   Institutes of Health (award P20GM125503).
CR Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
NR 6
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD SEP
PY 2018
VL 7
IS 11
AR UNSP e01020-18
DI 10.1128/MRA.01020-18
PG 2
WC Microbiology
SC Microbiology
GA HD3AD
UT WOS:000452383000008
PM 30533643
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lecuit, M
   Nguyen, L
AF Lecuit, Marc
   Nguyen, Laurent
TI Lessons learnt from the emergence of Zika virus
SO NATURE MICROBIOLOGY
LA English
DT Editorial Material
ID PROTEIN RESPONSE CONTRIBUTES; SEXUAL TRANSMISSION; CEREBRAL ORGANOIDS;
   INFECTION; WOMEN
AB Looking back at how Zika virus emergence was handled during and after the 2015-2016 outbreak will be important for assessing how well multiple relevant stakeholders were integrated to mount a response, and can provide the groundwork to better cope with emerging infections in the future.
C1 [Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France.
   [Lecuit, Marc] INSERM, U1117, Paris, France.
   [Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malad Univ Hosp, Inst Imagine, Dept Infect Dis & Trop Med, Paris, France.
   [Nguyen, Laurent] Univ Liege, CHU Sart Tilman, GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium.
RP Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, Paris, France.; Lecuit, M (corresponding author), INSERM, U1117, Paris, France.; Lecuit, M (corresponding author), Paris Descartes Univ, Necker Enfants Malad Univ Hosp, Inst Imagine, Dept Infect Dis & Trop Med, Paris, France.; Nguyen, L (corresponding author), Univ Liege, CHU Sart Tilman, GIGA Neurosci, Interdisciplinary Cluster Appl Genoprote GIGA R, Liege, Belgium.
EM marc.lecuit@pasteur.fr; lnguyen@uliege.be
RI Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013
OI Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance [734548]; F.R.S.-F.N.R.S.Fonds de la Recherche Scientifique
   - FNRS [J.0163.16, J.0028.18 - CDR]; Fonds Leon Fredericq; Fondation
   Medicale Reine Elisabeth; Fondation Simone et Pierre Clerdent; Belgian
   Science Policy (IAP-VII network) [P7/20]; ARCFondation ARC pour la
   Recherche sur le CancerAustralian Research Council [ARC11/16-01]; ERANET
   Neuron STEM-MCD; Institut Pasteur; InsermInstitut National de la Sante
   et de la Recherche Medicale (Inserm); LabEx IBEID
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement No. 734548
   (to L.N. and M.L.). L.N. is senior research associate from
   F.R.S-F.N.R.S. and his research is also supported by F.R.S.-F.N.R.S.
   (J.0163.16 and J.0028.18 - CDR), the Fonds Leon Fredericq, the Fondation
   Medicale Reine Elisabeth, the Fondation Simone et Pierre Clerdent, the
   Belgian Science Policy (IAP-VII network P7/20), the ARC (ARC11/16-01),
   and the ERANET Neuron STEM-MCD; M.L. is also funded by Institut Pasteur,
   Inserm and LabEx IBEID.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   [Anonymous], 2016, ZIK COMM ACT AR ZIK
   [Anonymous], ZIK CUM CAS
   Callender D. M., 2018, GLOB PUBLIC HLTH
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Subudhi BB, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050235
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 38
TC 1
Z9 1
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD SEP
PY 2018
VL 3
IS 9
BP 966
EP 968
DI 10.1038/s41564-018-0233-4
PG 3
WC Microbiology
SC Microbiology
GA GR6CC
UT WOS:000442731700002
PM 30143802
DA 2020-07-08
ER

PT J
AU Kalita, J
   Misra, UK
AF Kalita, Jayantee
   Misra, Usha K.
TI Zika virus and Guillain-Barre syndrome: Cause or association?
SO NEUROLOGY INDIA
LA English
DT Editorial Material
C1 [Kalita, Jayantee; Misra, Usha K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Neurol, Raebareli Rd, Lucknow 226014, Uttar Pradesh, India.
RP Kalita, J (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Neurol, Raebareli Rd, Lucknow 226014, Uttar Pradesh, India.
EM jayanteek@yahoo.com
RI Misra, Usha Kant/AAC-4818-2019
OI Misra, Usha Kant/0000-0002-7317-957X
CR Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Joob B, 2017, NEUROL INDIA, V65, P439, DOI 10.4103/neuroindia.NI_912_16
   Kalita J, 2005, Electromyogr Clin Neurophysiol, V45, P357
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Misra UK, 2012, INFECTION, V40, P125, DOI 10.1007/s15010-011-0203-8
   Misra UK, 1997, ACTA NEUROL SCAND, V96, P114
   PAHO WHO, 2016, ZIK CUM CAS 25 AUG 2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Umapathi T, 2018, J PERIPHER NERV SYST
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
NR 15
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD SEP-OCT
PY 2018
VL 66
IS 5
BP 1288
EP 1289
DI 10.4103/0028-3886.241382
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA GX3ES
UT WOS:000447605100009
PM 30232987
DA 2020-07-08
ER

PT J
AU Woollard, SM
   Olwenyi, OA
   Dutta, D
   Dave, RS
   Mathews, S
   Gorantla, S
   Johnson, N
   Giavedoni, L
   Norgren, RB
   Byrareddy, SN
AF Woollard, Shawna M.
   Olwenyi, Omalla A.
   Dutta, Debashis
   Dave, Rajnish S.
   Mathews, Saumi
   Gorantla, Santhi
   Johnson, Noel
   Giavedoni, Luis
   Norgren, Robert B., Jr.
   Byrareddy, Siddappa N.
TI Preliminary Studies on Immune Response and Viral Pathogenesis of Zika
   Virus in Rhesus Macaques
SO PATHOGENS
LA English
DT Article
DE Zika; Flaviviruses; rhesus macaque; intravaginal; sexual transmission;
   immunopathogenesis
ID MALE SEXUAL TRANSMISSION; CAUDATE-NUCLEUS; UNITED-STATES; INFECTION;
   BRAIN; CELLS; PERSISTENCE; PROLIFERATION; BLOCKADE
AB Zika Virus (ZIKV) is primarily transmitted through mosquito bites. It can also be transmitted during sexual intercourse and in utero from mother to fetus. To gain preliminary insight into ZIKV pathology and immune responses on route of transmission, rhesus macaques (RMs) were inoculated with ZIKV (PRVABC59) via intravaginal (IVAG) (n = 3) or subcutaneous (sub Q) (n = 2) routes. Systemic ZIKV infection was observed in all RMs, regardless of the route of inoculation. After 9 days postinfection (dpi), ZIKV was not detected in the plasma of IVAG- and sub-Q-inoculated RMs. Importantly, RMs harbored ZIKV up to 60 dpi in various anatomical locations. Of note, ZIKV was also present in several regions of the brain, including the caudate nucleus, parietal lobe, cortex, and amygdala. These observations appear to indicate that ZIKV infection may be systemic and persistent regardless of route of inoculation. In addition, we observed changes in key immune cell populations in response to ZIKV infection. Importantly, IVAG ZIKV infection of RMs is associated with increased depletion of CD11C hi myeloid cells, reduced PD-1 expression in NK cells, and elevated frequencies of Ki67(+) CD8(+) central memory cells as compared to sub Q ZIKV-infected RMs. These results need to interpreted with caution due to the small number of animals utilized in this study. Future studies involving large groups of animals that have been inoculated through both routes of transmission are needed to confirm our findings.
C1 [Woollard, Shawna M.; Dutta, Debashis; Dave, Rajnish S.; Mathews, Saumi; Gorantla, Santhi; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Olwenyi, Omalla A.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Johnson, Noel] Univ Nebraska Med Ctr, Dept Comparat Med, Omaha, NE 68198 USA.
   [Giavedoni, Luis] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78245 USA.
   [Norgren, Robert B., Jr.; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.
   [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
RP Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.
EM shawnamwoollard@gmail.com; omalla.olwenyi@unmc.edu;
   debashis.dutta@unmc.edu; raj.dave@unmc.edu; saumi.mathews@unmc.edu;
   sgorantla@unmc.edu; ndjohnso@unmc.edu; lgiavedoni@TxBiomed.org;
   rnorgren@unmc.edu; sid.byrareddy@unmc.edu
RI Dutta, Debashis/L-4685-2019
OI Norgren, Robert/0000-0002-0021-5875
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI113883, R21AI114415]; Nebraska
   Neuroscience Alliance Endowed Fund Award; University of Nebraska Food
   for Health Seed Grant Award
FX This research was partially supported by NIH R01AI113883, R21AI114415,
   Nebraska Neuroscience Alliance Endowed Fund Award to SNB and University
   of Nebraska Food for Health Seed Grant Award to SNB and RBN.
CR Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x
   Amancha PK, 2013, J IMMUNOL, V191, P6060, DOI 10.4049/jimmunol.1302044
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Caggiari L, 2001, CYTOMETRY, V46, P233, DOI 10.1002/cyto.1132
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Della Chiesa M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00351
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garber DA, 2004, J CLIN INVEST, V113, P836, DOI 10.1172/JCI200419442
   Geginat J, 2003, BLOOD, V101, P4260, DOI 10.1182/blood-2002-11-3577
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Gonzalez-Perez Oscar, 2012, Biol Biomed Rep, V2, P59
   Graff-Radford J, 2017, NEUROLOGY, V89, P2192, DOI 10.1212/WNL.0000000000004680
   Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira LE, 2009, CELL IMMUNOL, V259, P165, DOI 10.1016/j.cellimm.2009.06.012
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   SPENCER DD, 1992, NEW ENGL J MED, V327, P1541, DOI 10.1056/NEJM199211263272201
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 55
TC 4
Z9 4
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-0817
J9 PATHOGENS
JI Pathogens
PD SEP
PY 2018
VL 7
IS 3
AR 70
DI 10.3390/pathogens7030070
PG 12
WC Microbiology
SC Microbiology
GA GX7IP
UT WOS:000447941500014
PM 30127237
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hessert, M
   Wolf, KJ
   Schwetye, KE
   DiPaolo, RJ
   Brien, JD
   Pinto, AK
AF Hessert, Mariah
   Wolf, Kyle J.
   Schwetye, Katherine E.
   DiPaolo, Richard J.
   Brien, James D.
   Pinto, Amelia K.
TI CD4(+)T cells mediate protection against Zika associated severe disease
   in a mouse model of infection
SO PLOS PATHOGENS
LA English
DT Article
ID WEST-NILE-VIRUS; CD8(+) T-CELL; GUILLAIN-BARRE-SYNDROME; DENGUE VIRUS;
   ANTIBODY-RESPONSES; CROSS-REACTIVITY; REPERTOIRE; CLEARANCE; FEVER;
   ENCEPHALITIS
AB Zika virus (ZIKV) has gained worldwide attention since it emerged, and a global effort is underway to understand the correlates of protection and develop diagnostics to identify rates of infection. As new therapeutics and vaccine approaches are evaluated in clinical trials, additional effort is focused on identifying the adaptive immune correlates of protection against ZIKV disease. To aid in this endeavor we have begun to dissect the role of CD4(+)T cells in the protection against neuroinvasive ZIKV disease. We have identified an important role for CD4(+)T cells in protection, demonstrating that in the absence of CD4(+)T cells mice have more severe neurological sequela and significant increases in viral titers in the central nervous system (CNS). The transfer of CD4(+)T cells from ZIKV immune mice protect type I interferon receptor deficient animals from a lethal challenge; showing that the CD4(+)T cell response is necessary and sufficient for control of ZIKV disease. Using a peptide library spanning the complete ZIKV polyprotein, we identified both ZIKV-encoded CD4(+)T cell epitopes that initiate immune responses, and ZIKV specific CD4(+)T cell receptors that recognize these epitopes. Within the ZIKV antigen-specific TCR beta repertoire, we uncovered a high degree of diversity both in response to a single epitope and among different mice responding to a CD4(+)T cell epitope. Overall this study identifies a novel role for polyfunctional and polyclonal CD4(+)T cells in providing protection against ZIKV infection and highlights the need for vaccines to develop robust CD4(+)T cell responses to prevent ZIKV neuroinvasion and limit replication within the CNS.
C1 [Hessert, Mariah; Wolf, Kyle J.; DiPaolo, Richard J.; Brien, James D.; Pinto, Amelia K.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
   [Schwetye, Katherine E.] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA.
RP Pinto, AK (corresponding author), St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.
EM amelia.pinto@health.slu.edu
RI ; Pinto, Amelia/O-6658-2018
OI Brien, James/0000-0002-1670-8041; Hassert, Mariah/0000-0002-2141-3344;
   Pinto, Amelia/0000-0002-7147-3978; Wolf, Kyle/0000-0003-4874-2911
FU Saint Louis University School of Medicine; NIH NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K22AI104794]
FX AKP is funded by a seed grant from the Saint Louis University School of
   Medicine and startup funds from Saint Louis University School of
   Medicine. JDB is funded by a K22AI104794 early investigator award from
   the NIH NIAID as well a seed grant from the Saint Louis University
   School of Medicine and startup funds from Saint Louis University School
   of Medicine. RJP was funded by a seed grant from the Saint Louis
   University School of Medicine. For all funded individuals the funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barton MA, 2016, CAN MED ASSOC J, V188, pE118, DOI 10.1503/cmaj.160179
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196
   Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Charini WA, 2001, J IMMUNOL, V167, P4996, DOI 10.4049/jimmunol.167.9.4996
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodd KA, 2013, J VIROL, V87, P6161, DOI 10.1128/JVI.00337-13
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guimezanes A, 2003, EUR J IMMUNOL, V33, P3060, DOI 10.1002/eji.200324249
   Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Kedzierska K, 2005, P NATL ACAD SCI USA, V102, P11432, DOI 10.1073/pnas.0504851102
   Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001
   Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   MuraliKrishna K, 1996, J GEN VIROL, V77, P705, DOI 10.1099/0022-1317-77-4-705
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292
   Oehler E., 2014, EURO SURVEILLANCE B, V19
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Watson AM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040077
   Watson AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005786
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   Wolf KJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153705
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
NR 66
TC 23
Z9 24
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2018
VL 14
IS 9
AR e1007237
DI 10.1371/journal.ppat.1007237
PG 24
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GY9OA
UT WOS:000448975900013
PM 30212537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dias, JRD
   Ventura, CV
   Freitas, BD
   Prazeres, J
   Ventura, LO
   Bravo, V
   Aleman, T
   Ko, AI
   Zin, A
   Belfort, R
   Maia, M
AF de Oliveira Dias, Joao Rafael
   Ventura, Camila V.
   Freitas, Bruno de Paula
   Prazeres, Juliana
   Ventura, Liana O.
   Bravo-Filho, Vasco
   Aleman, Tomas
   Ko, Albert Icksang
   Zin, Andrea
   Belfort, Rubens, Jr.
   Maia, Mauricio
CA Zika Virus Study Grp
TI Zika and the Eye: Pieces of a Puzzle
SO PROGRESS IN RETINAL AND EYE RESEARCH
LA English
DT Review
ID WEST-NILE-VIRUS; OPTICAL COHERENCE TOMOGRAPHY; ASYMPTOMATIC
   BLOOD-DONORS; SEXUAL TRANSMISSION; YELLOW-FEVER; OPHTHALMIC
   MANIFESTATIONS; NEUTRALIZING ANTIBODIES; INVASIVE MOSQUITOS; INTERIM
   GUIDANCE; FRENCH-POLYNESIA
AB Zika virus (ZIKV) is an arbovirus mainly transmitted to humans by mosquitoes from Aedes genus. Other ways of transmission include the perinatal and sexual routes, blood transfusion, and laboratory exposure. Although the first human cases were registered in 1952 in African countries, outbreaks were only reported since 2007, when entire Pacific islands were affected. In March 2015, the first cases of ZIKV acute infection were notified in Brazil and, to date, 48 countries and territories in the Americas have confirmed local mosquito-borne transmission of ZIKV. Until 2015, ZIKV infection was thought to only cause asymptomatic or mild exanthematous febrile infections. However, after explosive ZIKV outbreaks in Polynesia and Latin American countries, it was confirmed that ZIKV could also lead to Guillain-Barre syndrome and congenital birth abnormalities. These abnormalities, which can include neurologic, ophthalmologic, audiologic, and skeletal findings, are now considered congenital Zika syndrome (CZS). Brain abnormalities in CZS include cerebral calcifications, malformations of cortical development, ventriculomegaly, lissencephaly, hypoplasia of the cerebellum and brainstem. The ocular findings, which are present in up to 70% of infants with CZS, include iris coloboma, lens subluxation, cataract, congenital glaucoma, and especially posterior segment findings. Loss of retinal pigment epithelium, the presence of a thin choroid, a perivascular choroidal inflammatory infiltrate, and atrophic changes within the optic nerve were seen in histologic analyses of eyes from deceased fetuses. To date, there is no ZIKV licensed vaccines or antiviral therapies are available for treatment. Preventive measures include individual protection from mosquito bites, control of mosquito populations and the use of barriers measures such as condoms during sexual intercourse or sexual abstinence for couples either at risk or after confirmed infection. A literature review based on studies that analyzed ocular findings in mothers and infants with CZS, with or without microcephaly, was conducted and a theoretical pathophysiologic explanation for ZIKV-ocular abnormalities was formulated.
C1 [de Oliveira Dias, Joao Rafael; Ventura, Camila V.; Freitas, Bruno de Paula; Prazeres, Juliana; Ventura, Liana O.; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Sao Paulo, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco] HOPE Eye Hosp, Recife, PE, Brazil.
   [Freitas, Bruno de Paula] Roberto Santos Gen Hosp, Dept Ophthalmol, Salvador, BA, Brazil.
   [Aleman, Tomas] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Ctr Adv Med,Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Zin, Andrea] Fundacao Oswaldo Cruz, Clin Res Unit, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Maia, Mauricio] Brazilian Inst Fight Blindness Assts & Presidente, Sao Paulo, Brazil.
RP Maia, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Pedro de Toledo St 781,2nd Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM mmaia@unifesp.br
RI Ventura, Camila V/N-2654-2018; Maia, Mauricio/I-5892-2015; Ko, Albert
   Icksang/P-2343-2015; Ventura, Liana Vieira O/N-6151-2018; Bravo-Filho,
   Vasco/N-6993-2018
OI Ventura, Camila V/0000-0002-2927-4684; Maia,
   Mauricio/0000-0002-7034-8091; Ko, Albert Icksang/0000-0001-9023-2339;
   Ventura, Liana Vieira O/0000-0001-6529-6883; Bravo-Filho,
   Vasco/0000-0003-4460-3236
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2016, EURO SURVEILL, V21
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Diasease Control and Prevention, 2017, MORB MORT WEEK REP M
   Centers for Disease Control and Prevention, 2014, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2016, CFDCAP ZIK VIR
   Centers for Disease Control and Prevention, 2018, ZIK CAS US
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   de Paula Freitas B., 2017, OPHTHALMOLOGY
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   European Centre for Disease Prevention and Control (ECDC), 2017, ZIK TRANSM
   European Centre for Disease Prevention and Control (ECDC), 2017, ZIK VIR TRANSM LIST
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Favoretto S., 2016, 1 DETECTION ZIKA VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez M. P., 2017, JAMA OPHTHALMOLOGY
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   FUNG JC, 1985, ANN CLIN LAB SCI, V15, P204
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   Gasperi G., 2014, PLOS NEGLECTED TROP, V6, pe1836
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Intergrowth-21st Fetal, 2017, PRETERM NEWBORN APPL
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   MacNamara F., 1952, ANN REPORT, P1951
   Mani RS, 2016, NATL MED J INDIA, V29, P339
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ministerio da Saude do Brasil, 2016, MIN SAUD BRAS B
   Ministerio da Saude do Brasil, 2017, MIN SAUD BRAS B EP, V48
   Ministerio da Saude do Brasil, 2016, NFORM EP 47 SEMANA E
   Mladinich M. C., 2017, ZIKA VIRUS PERSISTEN
   Mlalcar J., 2016, ENGL J MED, V374, P951
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Morris G., 2017, MOL NEUROBIOL
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan American Health Organization/World Health Organization, 2016, ZIK VIR INF STEP STE
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robin Y, 1978, B SOC PATHOL EXOT, V68, P249
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Roth A., 2014, EURO SURVEILL, V16
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Secretaria de Estado de Saude do Estado de Sao Paulo, 2016, DISTR CAS NOT CONF F
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Sun Lisa L, 2012, Digit J Ophthalmol, V18, P1, DOI 10.5693/djo.02.2012.04.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tognarelli J., 2015, ARCH VIROL, P665
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2014, ARQ BRAS OFTALMOL, V77, P300, DOI 10.5935/0004-2749.20140076
   Ventura L. O., 2017, J AAPOS
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO, 2017, ZIK SIT REP
   WHO, 2016, INT GUID
   WHO/Institut Pasteur/ISARIC/CONSISE, 2017, STAND PROT CROSS SEC
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2018, HIST ZIK VIR
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2017, INF TRAV VIS ZIK AFF
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 195
TC 8
Z9 8
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-9462
EI 1873-1635
J9 PROG RETIN EYE RES
JI Prog. Retin. Eye Res.
PD SEP
PY 2018
VL 66
BP 85
EP 106
DI 10.1016/j.preteyeres.2018.04.004
PG 22
WC Ophthalmology
SC Ophthalmology
GA GW6ZN
UT WOS:000447113700004
PM 29698814
DA 2020-07-08
ER

PT J
AU Chan, MPS
   Winneg, K
   Hawkins, L
   Farhadlooa, M
   Jamieson, KH
   Albarracin, D
AF Chan, Man-pui Sally
   Winneg, Kenneth
   Hawkins, Lauren
   Farhadlooa, Mohsen
   Jamieson, Kathleen Hall
   Albarracin, Dolores
TI Legacy and social media respectively influence risk perceptions and
   protective behaviors during emerging health threats: A multi-wave
   analysis of communications on Zika virus cases
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE USA; Risk perceptions; Legacy media; Social media; Communication;
   Protective behaviors; Zika
ID SOUTH-KOREA; OUTBREAK; FEAR; MESSAGES; EXPOSURE; COVERAGE; IMPACT;
   MODEL; SARS; FLU
AB Objective: Both legacy media, such as television and newspapers, and online social media are potentially important but incompletely understood sources of information in the face of emerging public health risks. This research aimed to understand media effects on risk perceptions and behaviors concerning the Zika virus in the United States.
   Methods: We analyzed a multi-wave nationally representative survey (N = 29,062) and the volume of communications in social and legacy media (i.e., legacy media data from news sources and databases, N = 2,660 and social media data from Twitter, N = 1,605,752) in the United States between April and October 2016, dates coinciding with the early cases of local transmission of Zika in the United States (i.e., 25 weeks). The present study conducted econometric analyses (i.e., Granger causality tests) to assess the associations of legacy and social media coverage with risk perceptions and protective behaviors in the total sample and specific groups separated by pregnancy status/intent, geographic region, income, education level, age, and ethnicity.
   Results: The results from the overall sample suggested that changes in the volume of information in legacy and social media (i.e., Twitter) were followed by different changes in community risk perceptions and protective behaviors. Specifically, social media coverage correlated with the level of risk perceptions, whereas the legacy media coverage correlated with the level of protective behaviors. Analyses across different subpopulations, including those of different pregnancy status/intent, geographic Zika risk, income, education level, age, and ethnicity, replicated the social media associations with risk perceptions in most cases. However, legacy media and protective behaviors were linked only in some vulnerable subpopulations (e.g., the less-educated populations).
   Conclusion: Understanding how media coverage relates to Zika risk perceptions and protective behaviors will help to facilitate effective risk communications by healthcare professionals and providers, particularly when a health risk emerges.
C1 [Chan, Man-pui Sally; Farhadlooa, Mohsen; Albarracin, Dolores] Univ Illinois, Dept Psychol, 603 E Daniel St, Champaign, IL 62810 USA.
   [Winneg, Kenneth; Hawkins, Lauren; Farhadlooa, Mohsen; Jamieson, Kathleen Hall] Univ Penn, Annenberg Publ Policy Ctr, 202 S 36th St, Philadelphia, PA 19104 USA.
RP Chan, MPS (corresponding author), Univ Illinois, Dept Psychol, 603 E Daniel St, Champaign, IL 62810 USA.
EM sallycmp@illinois.edu
OI Winneg, Kenneth/0000-0003-1871-3570; Chan, Man-pui
   Sally/0000-0003-2984-0487
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R56 AI114501]; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [R01 MH114847]
CR Albarracin D, 2017, HDB PERSONALITY SOCI
   Albarracin D, 2017, J EXP SOC PSYCHOL, V68, P171, DOI 10.1016/j.jesp.2016.06.009
   Bass SB, 2006, J HEALTH COMMUN, V11, P219, DOI 10.1080/10810730500526794
   BECKER MH, 1974, HEALTH EDUC QUART, V2, P409, DOI 10.1177/109019817400200407
   Brown VJ, 2014, ENVIRON HEALTH PERSP, V122, pA276, DOI 10.1289/ehp.122-A276
   CDC, 2017, CAS COUNTS US
   CDC, 2017, ADV PEOPL LIV TRAV S
   CDC, 2017, CERC CORN WHY WORK S
   CHAMPION VL, 2008, HLTH BEHAV HLTH ED T, V4, P45
   Chang CC, 2012, HEALTH COMMUN, V27, P111, DOI 10.1080/10410236.2011.569004
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Choi DH, 2017, COMPUT HUM BEHAV, V72, P422, DOI 10.1016/j.chb.2017.03.004
   Denecke K., 2016, PARTICIP HLTH SOC ME, P42, DOI DOI 10.1016/8978-0-12-809269-9.00004-9
   Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Earl A, 2009, J CONSULT CLIN PSYCH, V77, P668, DOI 10.1037/a0015763
   FISHBEIN M, 1995, J APPL SOC PSYCHOL, V25, P1, DOI 10.1111/j.1559-1816.1995.tb01580.x
   Fishbein M, 2006, J COMMUN, V56, pS1, DOI 10.1111/j.1460-2466.2006.00280.x
   Fox S, 2014, SOCIAL LIFE HLTH INF
   Fox S., 2011, SOCIAL LIFE HLTH INF
   Fung ICH, 2015, WEST PAC SURVEILL RE, V6, DOI [10.5365/wpsar.2015.6.1.019, 10.5365/WPSAR.2015.6.1.019]
   Hitlin P, 2015, METHODOLOGY CRIMSON
   Hon KLE, 2003, LANCET, V361, P1984, DOI 10.1016/S0140-6736(03)13556-8
   Hyndman R.J., 2007, INT J APPL FORECAST, V6, P12
   JOHNSON JD, 1993, HUM COMMUN RES, V19, P343, DOI 10.1111/j.1468-2958.1993.tb00305.x
   Jones NM, 2017, P NATL ACAD SCI USA, V114, P11663, DOI 10.1073/pnas.1708518114
   Karkowsky C. E, 2016, ITS OK BE WORRIED ZI
   Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035
   Knapton S., 2016, ZIKA OUTBREAK PUBLIC
   Kohut A., 2012, ASSESSING REPRESENTA
   Kousky C., 2010, IRRATIONAL EC MAKING
   Lopez M. H., 2013, GROWING SHARE LATINO
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i786
   Mendoza M., 2010, P 1 WORKSH SOC MED A, V10, P71, DOI DOI 10.1145/1964858.1964869
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750
   Petty R.E, 1986, ADV EXPT SOCIAL PSYC, P1, DOI [DOI 10.1016/S0065-2601(08)60214-2, 10.1007/978-1-4612-4964-1_1]
   Reynolds B, 2007, CRISIS EMERGENCY RIS
   Rimal RN, 2010, J APPL SOC PSYCHOL, V40, P287, DOI 10.1111/j.1559-1816.2009.00574.x
   ROGERS RW, 1975, J PERS SOC PSYCHOL, V32, P222, DOI 10.1037/0022-3514.32.2.222
   Rogers RW, 1983, SOCIAL PSYCHOPHYSIOL, P1, DOI DOI 10.1002/9780470479216.CORPSY0897
   Shearer E., 2017, NEWS USE SOCIAL MEDI
   Song J, 2017, CYBERPSYCH BEH SOC N, V20, P22, DOI 10.1089/cyber.2016.0126
   Srinivasan R, 2010, J ROY SOC MED, V103, P340, DOI 10.1258/jrsm.2010.100118
   Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729
   Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495
   WHO World Health Organization, 2016, MICR
   WITTE K, 2001, EFFECTIVE HLTH RISK
   World Health Organization, 2017, HIST ZIK VIR
   World Health Organization, 2008, WHO OUTBR COMM PLANN
NR 51
TC 7
Z9 7
U1 16
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD SEP
PY 2018
VL 212
BP 50
EP 59
DI 10.1016/j.socscimed.2018.07.007
PG 10
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA GQ8ZY
UT WOS:000442056900007
PM 30005224
OA Green Published
DA 2020-07-08
ER

PT J
AU Vanwalscappel, B
   Tada, T
   Landau, NR
AF Vanwalscappel, Benedicte
   Tada, Takuya
   Landau, Nathaniel R.
TI Toll-like receptor agonist R848 blocks Zika virus replication by
   inducing the antiviral protein viperin
SO VIROLOGY
LA English
DT Article
DE Monocytes; R848; RNA synthesis; Viperin; TLR7/8; ZIKV restriction
ID WEST NILE VIRUS; HIV-1 INFECTION; DENGUE VIRUS; CELLS; ENCEPHALITIS;
   ENTRY; TLR7
AB Zika virus (ZIKV) is an emerging pathogen linked to neurological disorders for which there is currently no targeted therapy. To identify host innate immune response proteins that restrict ZIKV replication, we treated monocytes and macrophages with toll-like receptor (TLR) agonists. Of those tested, the TLR7/8 agonist R848 (resiquimod) was the most potent inhibitor of ZIKV replication. RNA-seq analysis identified several genes strongly induced by R848 in monocytes. Testing of several of these for their ability to restrict ZIKV replication identified viperin, an interferon-induced gene active against several viruses. Transduction of microglial CHME3 cells with a viperin lentiviral expression vector rendered them resistant to ZIKV infection, preventing the synthesis of viral RNA and protein. CRISPR/Cas9 knock-out of viperin in macrophages relieved the block to infection, demonstrating that viperin is a major innate immune response protein able to block ZIKV replication. TLR agonists may be useful for the prophylactic or therapeutic treatment for ZIKV.
C1 [Vanwalscappel, Benedicte; Tada, Takuya; Landau, Nathaniel R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
RP Landau, NR (corresponding author), NYU, Sch Med, Rm 509,430 East 29th St, New York, NY 10016 USA.
EM Nathaniel.landau@med.nyu.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI122390, AI067059, AI058864]
FX We thank Andres Merits (University of Tartu, Estonia) for anti-NS5
   antibody, Adolfo Garcia-Sastre (Icahn School of Medicine at Mount Sinai)
   for ZIKV MR766, Philippe Despres (University of Reunion island) for
   ZIKV<INF>GFP</INF> and A549 cells, NYU Langone Medical Center Imaging
   Core and Paula Jauregui for helpful discussions. The work was supported
   by NIH grants AI122390, AI067059 and AI058864.
CR Alexopoulou L, 2012, M S-MED SCI, V28, P96, DOI 10.1051/medsci/2012281023
   Bobadilla S, 2013, GENE THER, V20, P514, DOI 10.1038/gt.2012.61
   Boivin N, 2008, J INFECT DIS, V198, P664, DOI 10.1086/590671
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Gotovtseva EP, 2008, SEX TRANSM DIS, V35, P346, DOI 10.1097/OLQ.0b013e31815ea8d1
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542
   Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106
   Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200
   Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941
   Hofmann H, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0316-3
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014
   Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003
   Mark KE, 2007, J INFECT DIS, V195, P1324, DOI 10.1086/513276
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395
   Panayiotou C., 2018, J VIROL
   Sariol CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019323
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Zhang X, 2009, MUCOSAL IMMUNOL, V2, P129, DOI 10.1038/mi.2008.81
NR 43
TC 14
Z9 16
U1 3
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2018
VL 522
BP 199
EP 208
DI 10.1016/j.virol.2018.07.014
PG 10
WC Virology
SC Virology
GA GQ9CE
UT WOS:000442062700021
PM 30036788
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Khachatoorian, R
   Cohn, W
   Buzzanco, A
   Riahi, R
   Arumugaswami, V
   Dasgupta, A
   Whitelegge, JP
   French, SW
AF Khachatoorian, Ronik
   Cohn, Whitaker
   Buzzanco, Anthony
   Riahi, Rana
   Arumugaswami, Vaithilingaraja
   Dasgupta, Asim
   Whitelegge, Julian P.
   French, Samuel W.
TI HSP70 Copurifies with Zika Virus Particles
SO VIROLOGY
LA English
DT Article
DE Heat shock proteins HSP70 HSC70 Zika virus
ID JAPANESE ENCEPHALITIS-VIRUS; COGNATE PROTEIN 70; HEAT-SHOCK-PROTEIN-70;
   INFECTION
AB Zika virus (ZIKV) has been identified as a cause of neurologic diseases in infants and Guillain-Barre Syndrome, and currently, no therapeutics or vaccines are approved. In this study, we sought to identify potential host proteins interacting with ZIKV particles to gain better insights into viral infectivity. Viral particles were purified through density-gradient centrifugation and subsequently, size-exclusion chromatography (SEC). Mass spectrometric analyses revealed viral envelope protein and HSP70 to comigrate in only one SEC fraction. Neither of these proteins were found in any other SEC fractions. We then performed neutralization assays and found that incubating viral particles with antibody against HSP70 indeed significantly reduced viral infectivity, while HSC70 antibody did not. Preincubating cells with recombinant HSP70 also decreased viral infectivity. Knockdown and inhibition of HSP70 also significantly diminished viral production. These results implicate HSP70 in the pathogenesis of ZIKV and identify HSP70 as a potential host therapeutic target against ZIKV infection.
C1 [Khachatoorian, Ronik; Buzzanco, Anthony; Riahi, Rana; French, Samuel W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.
   [Cohn, Whitaker; Whitelegge, Julian P.] UCLA, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Dasgupta, Asim] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Dasgupta, Asim; French, Samuel W.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.
   [Dasgupta, Asim; French, Samuel W.] Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Los Angeles, CA 90095 USA.
RP French, SW (corresponding author), UCLA, Ctr Hlth Sci, Dept Pathol & Lab Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
EM RnKhch@ucla.edu; WhitCohn@yahoo.com; ABuzzanco@gmail.com;
   RanaRiahi@mednet.ucla.edu; VArumugaswami@mednet.ucla.edu;
   Dasgupta@ucla.edu; JPW@chem.ucla.edu; SFrench@mednet.ucla.edu
OI Buzzanco, Anthony/0000-0002-6698-4060
FU UCLA Department of Pathology
FX UCLA Department of Pathology.
CR Badshah SL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010007
   Baronti C, 2014, GENOME ANNOUNC, V2
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chuang CK, 2015, J GEN VIROL, V96, P793, DOI 10.1099/jgv.0.000015
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Khachatoorian R, 2016, INT J ANTIMICROB AG, V47, P289, DOI 10.1016/j.ijantimicag.2016.01.012
   Khachatoorian R, 2016, WORLD J HEPATOL, V8, P9, DOI 10.4254/wjh.v8.i1.9
   Khachatoorian R, 2014, VIROLOGY, V454, P118, DOI 10.1016/j.virol.2014.02.016
   Khachatoorian R, 2012, HEPATOLOGY, V55, P1662, DOI 10.1002/hep.25533
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852
   Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tutiven JL, 2017, ANESTH ANALG, V124, P1918, DOI [10.1213/ANE.0000000000002047, 10.1213/ane.0000000000002047]
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   Zhang C, 2016, BIOCH BIOPHYS RES CO
   Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0
NR 30
TC 3
Z9 3
U1 2
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD SEP
PY 2018
VL 522
BP 228
EP 233
DI 10.1016/j.virol.2018.07.009
PG 6
WC Virology
SC Virology
GA GQ9CE
UT WOS:000442062700024
PM 30053656
OA Bronze
DA 2020-07-08
ER

PT J
AU Cui, YC
   Wu, Q
   Teh, SW
   Peli, A
   Bu, G
   Qiu, YS
   Benelli, G
   Kumar, SS
AF Cui, Yan Chao
   Wu, Qiong
   Teh, Seoh Wei
   Peli, Amira
   Bu, Gang
   Qiu, Yu Sheng
   Benelli, Giovanni
   Kumar, S. Suresh
TI Bone breaking infections - A focus on bacterial and mosquito-borne viral
   infections
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Arbovirus; Dengue; Chikungunya virus; Mosquito control; Ross river
   virus; Vector competence; Tuberculosis; Zika virus
ID OSTEOMYELITIS; NANOPARTICLES; OSTEOCLAST; OSTEOBLAST; MANAGEMENT;
   ARTHRITIS; TUBERCULOSIS; INFLAMMATION; MECHANISMS; DIAGNOSIS
AB The recent global resurgence of arthritogenic alphaviruses, including Ross River, chikungunya, and dengue, highlights an urgency for the development of therapeutic strategies. Currently, dengue represents the most rapidly transmitting mosquito-borne viral disease worldwide. By contracting bone breaking diseases, patients experience devastating clinical manifestations involving muscle pain and bone loss. The bone self-repair and regeneration mechanisms can be damaged by the presence of viruses and bacteria. The rapid establishment of dengue epidemic and the severity of bacterial and viral infections affecting the bone stress the urgent need of developing effective interventions. Herein, we review current knowledge on bone breaking infections, covering both bacterial and mosquito-borne viral ones. The mechanisms exploited by these diseases to significantly affect the bone, including interferences with self-repair and regeneration routes, were discussed. In the final section, challenges for future research aimed to treat and prevent bacterial and mosquito-borne bone-breaking infections have been outlined.
C1 [Cui, Yan Chao; Wu, Qiong; Bu, Gang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Rehabil Med, 277 Yantaxi Rd, Xian 710061, Shaanxi, Peoples R China.
   [Teh, Seoh Wei] Univ Putra Malaysia, Dept Biomed Sci, Upm Serdang 43400, Selangor, Malaysia.
   [Peli, Amira; Kumar, S. Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Upm Serdang 43400, Selangor, Malaysia.
   [Qiu, Yu Sheng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Orthoped, 277 Yantaxi Rd, Xian 710061, Shaanxi, Peoples R China.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
   [Kumar, S. Suresh] Univ Putra Malaysia, Genet & Regenerat Med Res Ctr, Upm Serdang 43400, Selangor, Malaysia.
   [Kumar, S. Suresh] Muthayammal Coll Arts & Sci, Muthayammal Ctr Adv Res, 25 Rasipuram, Namakkal 637408, Tamilnadu, India.
RP Teh, SW (corresponding author), Univ Putra Malaysia, Dept Biomed Sci, Upm Serdang 43400, Selangor, Malaysia.; Qiu, YS (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Orthoped, 277 Yantaxi Rd, Xian 710061, Shaanxi, Peoples R China.
EM seohwei1208@gmail.com; 276012035@qq.com
RI Kumar S, Suresh/J-2423-2017
OI Kumar S, Suresh/0000-0002-0505-7554
CR Al-Namnam NM, 2017, AUST DENT J, V62, P228, DOI 10.1111/adj.12472
   Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006
   Alikhani MI, 2003, J BIOL CHEM, V278, P52901, DOI 10.1074/jbc.M307638200
   Alla SAO, 2011, BEST PRACT RES CL RH, V25, P337, DOI 10.1016/j.berh.2011.03.005
   Amdekar S, 2017, VIRAL IMMUNOL, V30, P691, DOI 10.1089/vim.2017.0052
   [Anonymous], 2017, SCI REP, V7, pOF12
   Aragon-Sanchez J, 2010, DIABET FOOT ANKLE, V1, DOI 10.3402/dfa.v1i0.5418
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018
   Boyce BF, 2012, EUR J CLIN INVEST, V42, P1332, DOI 10.1111/j.1365-2362.2012.02717.x
   Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413
   Chen RM, 2005, ANN NY ACAD SCI, V1042, P448, DOI 10.1196/annals.1338.038
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chen WQ, 2015, TRENDS MICROBIOL, V23, P35, DOI 10.1016/j.tim.2014.09.005
   Chen WQ, 2015, J VIROL, V89, P581, DOI 10.1128/JVI.02034-14
   Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111
   Conrad DA, 2010, PEDIATR REV, V31, P464, DOI 10.1542/pir.31-11-464
   Dalrymple N. A., 2015, AM SOC MICROBIOL, V6
   Dapunt U, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1091-y
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477
   Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203
   FRASER JRE, 1986, CLIN RHEUM DIS, V12, P369
   Fritz JM, 2008, PHYSICIAN SPORTSMED, V36, P50, DOI 10.3810/psm.2008.12.11
   Galanakis N, 1997, J ANTIMICROB CHEMOTH, V39, P241, DOI 10.1093/jac/39.2.241
   Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023
   Graves DT, 2001, J DENT RES, V80, P1875, DOI 10.1177/00220345010800100301
   Guzman M. G., 2015, DENGUE, V385, P453
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hadid H, 2015, CASE REP INFECT DIS, DOI 10.1155/2015/347652
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027
   Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7
   Hirayama T, 2002, RHEUMATOLOGY, V41, P1232, DOI 10.1093/rheumatology/41.11.1232
   Hofbauer L. C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P268
   Huang YL, 2016, J MOL MED, V94, P1025, DOI 10.1007/s00109-016-1409-0
   Inui M, 2009, P NATL ACAD SCI USA, V106, P4816, DOI 10.1073/pnas.0900463106
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Josse J, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00085
   Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516
   Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682
   Kondekar S, 2006, J POSTGRAD MED, V52, P307
   Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P837, DOI 10.2106/JBJS.N.01350
   Larrieu S, 2010, J CLIN VIROL, V47, P85, DOI 10.1016/j.jcv.2009.11.014
   LOWE J, 1989, J BONE JOINT SURG BR, V71, P256
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Marriott I, 2004, IMMUNOL RES, V30, P291, DOI 10.1385/IR:30:3:291
   Matsushita T., 2012, PROTEIN KINASES, DOI [10.5772/38334, DOI 10.5772/38334]
   Meghji S, 1997, J EXP MED, V186, P1241, DOI 10.1084/jem.186.8.1241
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P318, DOI 10.1016/j.ecoenv.2016.06.021
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Mustafa M S, 2011, Med J Armed Forces India, V67, P192, DOI 10.1016/S0377-1237(11)60035-X
   Nagae M, 2006, BONE, V39, P1107, DOI 10.1016/j.bone.2006.04.033
   Nair SP, 1996, INFECT IMMUN, V64, P2371, DOI 10.1128/IAI.64.7.2371-2380.1996
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   Oishi Kazunori, 2007, Journal of Infection and Chemotherapy, V13, P125, DOI 10.1007/s10156-007-0516-9
   Patel A. A., 2015, ADV RADIOL, V2015
   Rao V. S., 2013, DYNAMIC MODELS INFEC
   Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84
   Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   Sanchez CJ, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-187
   Schell H, 2006, BONE, V38, P547, DOI 10.1016/j.bone.2005.09.018
   Schirmer P, 2010, INT J INFECT DIS, V14, pE659, DOI 10.1016/j.ijid.2009.11.009
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Stephens P, 2003, BRIT J DERMATOL, V148, P456, DOI 10.1046/j.1365-2133.2003.05232.x
   Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345
   Suresh U., 2017, PHYSL MOL PLANT PATH
   Teh SW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020558
   Teti A, 2013, BONEKEY REP, P2
   Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967
   Thomson CH, 2011, INT WOUND J, V8, P63, DOI 10.1111/j.1742-481X.2010.00749.x
   Watson AA, 2011, J BIOL CHEM, V286, P24208, DOI 10.1074/jbc.M111.226142
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Xiang Z, 2018, J CLUST SCI, V29, P1, DOI 10.1007/s10876-017-1311-0
   Yavropoulou M. P., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P204
NR 91
TC 4
Z9 4
U1 3
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD SEP
PY 2018
VL 122
BP 130
EP 136
DI 10.1016/j.micpath.2018.06.021
PG 7
WC Immunology; Microbiology
SC Immunology; Microbiology
GA HB7DV
UT WOS:000451238000020
PM 29909241
DA 2020-07-08
ER

PT J
AU Hussain, A
   Ali, F
   Latiwesh, OB
   Hussain, S
AF Hussain, Azhar
   Ali, Farwa
   Latiwesh, Omar B.
   Hussain, Sheharyar
TI A Comprehensive Review of the Manifestations and Pathogenesis of Zika
   Virus in Neonates and Adults
SO CUREUS
LA English
DT Review
DE zika virus; vertical transmission; microcephaly; lissencephaly;
   ventriculomegaly and cardiovascular anomalies; congenital glaucoma
ID GUILLAIN-BARRE-SYNDROME; PATHOPHYSIOLOGY; EPIDEMIOLOGY; TRANSMISSION;
   INFECTION
AB The Zika Virus (ZIKV) has been slowly becoming an epidemic in different parts of the world. Since its discovery in 1947, there have been numerous outbreaks affecting many different populations. Currently, there is an ongoing threat of ZIKV in Latin America and the United States of America. ZIKV is mainly spread by the Aedes aegypti mosquito and causes non-specific symptoms such as fever, myalgia, and generalized weakness. In addition to these symptoms, it has been noted the ZIKV is capable of causing associated conditions in adults, particularly in pregnant women as well as in newborns via vertical transmission. These manifestations include microcephaly, lissencephaly, ventriculomegaly, optic neuropathy, and congenital glaucoma, arthralgia, maculopapular rash, and cardiovascular anomalies such as atrial fibrillation. It is important to understand the reason for this specific set of associated conditions that emerge with ZIKV. This paper aims to identify the manifestations of ZIKV in adults and neonates in detail and attempts to understand the pathophysiology behind each one.
C1 [Hussain, Azhar] Xavier Univ, Med, Sch Med, Oranjestad, Aruba.
   [Ali, Farwa] Amer Univ Antigua, Med, Coll Med, New York, NY USA.
   [Latiwesh, Omar B.] Higher Inst Med Profess Benghazi, Med Lab, Benghazi, Libya.
   [Hussain, Sheharyar] Columbia Univ, Teachers Coll, Clin Psychol, New York, NY 10027 USA.
RP Hussain, A (corresponding author), Xavier Univ, Med, Sch Med, Oranjestad, Aruba.
EM azharhu786@gmail.com
CR Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049
   [Anonymous], 2016, LISS
   [Anonymous], 2016, HIST ZIKA VIRUS
   [Anonymous], 2017, VENTR SHUNT
   [Anonymous], 2018, FET CER VENTR
   [Anonymous], 2017, ZIK VIR CLIN PRES
   [Anonymous], 2017, ZIKA VIRUS MAY BE LI
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bordi L, 2017, ADV EXP MED BIOL, V972, P61, DOI 10.1007/5584_2016_187
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Calkins H, 2017, HEART RHYTHM, V14, pE275, DOI 10.1016/j.hrthm.2017.05.012
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, FACTS MICR
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Chu V, 2018, AM J MED GENET A, V176, P1882, DOI 10.1002/ajmg.a.40378
   Dantonio F, 2018, PAPAGEORGHIOU AT VEN, P230, DOI [10.1016/B978-0-323-44548-1.00043-7, DOI 10.1016/B978-0-323-44548-1.00043-7]
   De Moraes C Gustavo, 2018, JMM Case Rep, V5, pe005145, DOI 10.1099/jmmcr.0.005145
   Edupuganti S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx133
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ghai S, 2006, RADIOGRAPHICS, V26, P389, DOI 10.1148/rg.262055059
   Heikema AP, 2013, INFECT IMMUN, V81, P2095, DOI 10.1128/IAI.01437-12
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Irwin ML, 2015, J CLIN ONCOL, V33, P1104, DOI 10.1200/JCO.2014.57.1547
   January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuwabara S, 2004, DRUGS, V64, P597, DOI 10.2165/00003495-200464060-00003
   Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630
   Leeper C, 2018, PRIMARY CARE, V45, P567, DOI 10.1016/j.pop.2018.05.013
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   McAllister JP, 2012, SEMIN FETAL NEONAT M, V17, P285, DOI 10.1016/j.siny.2012.06.004
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Parikh Vevek, 2012, Int J Crit Illn Inj Sci, V2, P82, DOI 10.4103/2229-5151.97273
   Perrot S, 1996, REV RHUM, V63, P485
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tamaki K, 2018, CANCER RES, V78
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   WANG BX, 2017, NAT COMMUN, V8, DOI DOI 10.1038/NCOMMS.14765
   Wang KC, 2011, CHILD NERV SYST, V27, P1571, DOI 10.1007/s00381-011-1556-0
   Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192
   Yale University, 2016, YALENEWS
NR 49
TC 8
Z9 8
U1 1
U2 1
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
EI 2168-8184
J9 CUREUS
JI Cureus
PD SEP
PY 2018
VL 10
IS 9
AR UNSP e3290
DI 10.7759/cureus.3290
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA HB3IR
UT WOS:000450945000043
PM 30443460
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Nikitina, E
   Larionova, I
   Choinzonov, E
   Kzhyshkowska, J
AF Nikitina, Ekaterina
   Larionova, Irina
   Choinzonov, Evgeniy
   Kzhyshkowska, Julia
TI Monocytes and Macrophages as Viral Targets and Reservoirs
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE monocyte/macrophage; virus; persistence; reservoir; cell response;
   inflammation; cancer
ID SWINE-FEVER VIRUS; ROSS-RIVER-VIRUS; VESICULAR STOMATITIS-VIRUS;
   CENTRAL-NERVOUS-SYSTEM; HEPATITIS-C; JAPANESE ENCEPHALITIS;
   IMMUNE-RESPONSE; NEUTRALIZING ANTIBODY; INFLAMMATORY DISEASES; ALVEOLAR
   MACROPHAGES
AB Viruses manipulate cell biology to utilize monocytes/macrophages as vessels for dissemination, long-term persistence within tissues and virus replication. Viruses enter cells through endocytosis, phagocytosis, macropinocytosis or membrane fusion. These processes play important roles in the mechanisms contributing to the pathogenesis of these agents and in establishing viral genome persistence and latency. Upon viral infection, monocytes respond with an elevated expression of proinflammatory signalling molecules and antiviral responses, as is shown in the case of the influenza, Chikungunya, human herpes and Zika viruses. Human immunodeficiency virus initiates acute inflammation on site during the early stages of infection but there is a shift of M1 to M2 at the later stages of infection. Cytomegalovirus creates a balance between pro-and anti-inflammatory processes by inducing a specific phenotype within the M1/M2 continuum. Despite facilitating inflammation, infected macrophages generally display abolished apoptosis and restricted cytopathic effect, which sustains the virus production. The majority of viruses discussed in this review employ monocytes/macrophages as a repository but certain viruses use these cells for productive replication. This review focuses on viral adaptations to enter monocytes/macrophages, immune escape, reprogramming of infected cells and the response of the host cells.
C1 [Nikitina, Ekaterina] German Canc Res Ctr, Dept Episomal Persistent DNA Canc & Chron Dis, D-69120 Heidelberg, Germany.
   [Nikitina, Ekaterina] Russian Acad Sci, Tomsk Natl Res Med Ctr, Dept Oncovirol, Canc Res Inst, Tomsk 634050, Russia.
   [Nikitina, Ekaterina; Larionova, Irina; Kzhyshkowska, Julia] Tomsk State Univ, Dept Translat Cellular & Mol Biomed, Tomsk 634050, Russia.
   [Larionova, Irina] Russian Acad Sci, Tomsk Natl Res Med Ctr, Canc Res Inst, Dept Mol Oncol & Immunol, Tomsk 634050, Russia.
   [Choinzonov, Evgeniy] Russian Acad Sci, Tomsk Natl Res Med Ctr, Canc Res Inst, Head & Neck Dept, Tomsk 634050, Russia.
   [Kzhyshkowska, Julia] Heidelberg Univ, Med Fac Mannheim, Inst Transfus Med & Immunol, D-68167 Heidelberg, Germany.
RP Nikitina, E (corresponding author), German Canc Res Ctr, Dept Episomal Persistent DNA Canc & Chron Dis, D-69120 Heidelberg, Germany.; Nikitina, E (corresponding author), Russian Acad Sci, Tomsk Natl Res Med Ctr, Dept Oncovirol, Canc Res Inst, Tomsk 634050, Russia.; Nikitina, E (corresponding author), Tomsk State Univ, Dept Translat Cellular & Mol Biomed, Tomsk 634050, Russia.
EM e.nikitina@dkfz.de; mitrof_@mail.ru; choynzonov@tnimc.ru;
   Julia.kzhyshkowska@medma.uni-heidelberg.de
RI Choynzonov, Evgeny/P-1470-2014; Larionova, Irina V./L-9592-2018;
   Kzhyshkowska, Julia G./J-5835-2016; Larionova, Irina/R-2391-2017
OI Choynzonov, Evgeny/0000-0002-3651-0665; Larionova,
   Irina/0000-0001-5758-7330
FU ORYX Alpha, Munich; ERA Net RUS Plus S&T CHIT-ALPHA-THER grant; Russian
   Foundation for Basic ResearchRussian Foundation for Basic Research
   (RFBR) [16-54-76015]; Tomsk State University Competitiveness Improvement
   Program [8.1.23.2018]
FX This research was funded by ORYX Alpha, Munich, by the ERA Net RUS Plus
   S&T CHIT-ALPHA-THER grant, the Russian Foundation for Basic Research
   (project number 16-54-76015), and by the Tomsk State University
   Competitiveness Improvement Program (project number 8.1.23.2018).
CR Abbas W, 2015, VIRUSES-BASEL, V7, P1578, DOI 10.3390/v7041578
   Alidjinou EK, 2015, VIRUSES-BASEL, V7, P6067, DOI 10.3390/v7112924
   Aly AM, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0124-2
   Andrade V. M., 2018, J NEUROIMMUNE PHARM, P1
   Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245
   Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851
   Ashhurst TM, 2013, INDIAN J MED RES, V138, P632
   Assuncao-Miranda I, 2013, BIOMED RES INT, DOI 10.1155/2013/973516
   Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801
   Avalos CR, 2017, MBIO, V8, DOI 10.1128/mBio.01186-17
   Bajaj JS, 2016, ALIMENT PHARM THER, V44, P638, DOI 10.1111/apt.13732
   Ballon G, 2001, J INFECT DIS, V183, P417, DOI 10.1086/318072
   Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242
   Broer S, 2016, EXP NEUROL, V279, P57, DOI 10.1016/j.expneurol.2016.02.011
   Brown A, 2005, J LEUKOCYTE BIOL, V78, P675, DOI 10.1189/jlb.0505237
   Chan G, 2010, J IMMUNOL, V184, P3213, DOI 10.4049/jimmunol.0903025
   Cheevers WP, 1999, VIROLOGY, V258, P382, DOI 10.1006/viro.1999.9753
   Cipkova-Jarcuskova J, 2013, ACTA VIROL, V57, P105, DOI 10.4149/av_2013_02_105
   CLATCH RJ, 1990, VIROLOGY, V176, P244, DOI 10.1016/0042-6822(90)90249-Q
   Costers S, 2006, J GEN VIROL, V87, P2341, DOI 10.1099/vir.0.81808-0
   Couturier J, 2018, CURR HIV-AIDS REP, V15, P60, DOI 10.1007/s11904-018-0378-z
   Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   Donofrio G, 2001, J GEN VIROL, V82, P1181, DOI 10.1099/0022-1317-82-5-1181
   Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031
   Dutta K, 2010, IMMUNOBIOLOGY, V215, P884, DOI 10.1016/j.imbio.2009.12.003
   Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013
   Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239
   FRASER JRE, 1986, CLIN RHEUM DIS, V12, P369
   Fujimoto I, 2000, J VIROL, V74, P3399, DOI 10.1128/JVI.74.7.3399-3403.2000
   Gama L., 2018, CURRENT TOPICS MICRO
   GAZZOLO L, 1979, INFECT IMMUN, V23, P294, DOI 10.1128/IAI.23.2.294-297.1979
   Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111
   Ghazarian LN, 2013, DIABETES, V62, P3785, DOI 10.2337/db12-0958
   Gladkov S. A., 2015, Arkhiv Patologii, V77, P22, DOI 10.17116/patol201577222-27
   Glass WG, 2002, VIRAL IMMUNOL, V15, P261, DOI 10.1089/08828240260066215
   Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223
   Gowrishankar K, 2010, J VIROL, V84, P8861, DOI 10.1128/JVI.01020-10
   Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131
   Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293
   Henning JD, 2016, PROSTATE, V76, P735, DOI 10.1002/pros.23163
   Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33
   Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34
   Himeda T, 2010, J NEUROVIROL, V16, P219, DOI 10.3109/13550284.2010.484040
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hober D, 2012, CLIN EXP IMMUNOL, V168, P47, DOI 10.1111/j.1365-2249.2011.04559.x
   Inoue T, 2018, CLIN INFECT DIS, V67, P869, DOI 10.1093/cid/ciy205
   Jaffar-Bandjee MC, 2009, MICROBES INFECT, V11, P1206, DOI 10.1016/j.micinf.2009.10.001
   Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555
   Kang YB, 2018, CLIN RES HEPATOL GAS, V42, P110, DOI 10.1016/j.clinre.2017.09.006
   Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x
   Kipar A, 2010, J GEN VIROL, V91, P1698, DOI 10.1099/vir.0.020214-0
   Kondo K, 2002, J MED VIROL, V67, P364, DOI 10.1002/jmv.10082
   KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401
   Kumar S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-313
   Kundu K, 2013, CELL IMMUNOL, V285, P100, DOI 10.1016/j.cellimm.2013.09.005
   Kzhyshkowska J, 2016, TRANSFUS MED HEMOTH, V43, P66, DOI 10.1159/000444943
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9
   Lang JS, 2018, STEM CELL REP, V11, P348, DOI 10.1016/j.stemcr.2018.06.006
   Larrosa PNF, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-19
   Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32
   Lee WC, 1999, VET MICROBIOL, V67, P17, DOI 10.1016/S0378-1135(99)00029-2
   Liao HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7413
   Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003
   Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026
   Liu L, 2014, J MOL CELL CARDIOL, V76, P15, DOI 10.1016/j.yjmcc.2014.07.021
   Liu YL, 2000, J NEUROVIROL, V6, pS70
   Lund Laursen T., 2018, SCAND J GASTROENTERO, P1
   Lusso P, 2006, J CLIN VIROL, V37, pS4, DOI 10.1016/S1386-6532(06)70004-X
   Maginnis MS, 2018, J MOL BIOL, V430, P2590, DOI 10.1016/j.jmb.2018.06.024
   Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001
   MISTRIKOVA J, 1994, ACTA VIROL, V38, P151
   Munz C., 2015, EPSTEIN BARR VIRUS, V2
   Murakami M., 2012, MOL MECH CHRONIC INF
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Myint KSA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002980
   NAGRA RM, 1993, J NEUROPATH EXP NEUR, V52, P163, DOI 10.1097/00005072-199303000-00009
   Nakamura-Lopez Y, 2015, VIRUS RES, V204, P82, DOI 10.1016/j.virusres.2015.04.018
   Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024
   Nogalski MT, 2014, METHODS MOL BIOL, V1119, P15, DOI 10.1007/978-1-62703-788-4_2
   Noriega VM, 2014, J VIROL, V88, P9391, DOI 10.1128/JVI.00934-14
   Nowak P, 2015, AIDS, V29, P2409, DOI 10.1097/QAD.0000000000000869
   Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320
   Osman A, 2014, J IMMUNOL, V192, P5083, DOI 10.4049/jimmunol.1302732
   Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257
   Oura CAL, 1998, J VIROL METHODS, V72, P205, DOI 10.1016/S0166-0934(98)00029-9
   PANUSKA JR, 1990, J CLIN INVEST, V86, P113, DOI 10.1172/JCI114672
   Pawelek KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150568
   Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115
   Pleskov VM, 1996, VOP VIRUSOL+, V41, P53
   Psalla D, 2006, J COMP PATHOL, V135, P142, DOI 10.1016/j.jcpa.2006.04.003
   Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518
   Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741
   Revie D, 2014, WORLD J GASTROENTERO, V20, P2777, DOI 10.3748/wjg.v20.i11.2777
   Rivera-Toledo E, 2015, VIRUSES-BASEL, V7, P5361, DOI 10.3390/v7102879
   Robert J, 2007, J WILDLIFE DIS, V43, P645, DOI 10.7589/0090-3558-43.4.645
   Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044
   Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682
   Seitz S, 2018, J VIROL, V92, DOI [10.1128/JVI.00525-18, 10.1128/jvi.00525-18]
   Shaheen ZR, 2015, BIOMOLECULES, V5, P1938, DOI 10.3390/biom5031938
   Shimakage M, 2014, ONCOL REP, V32, P1763, DOI 10.3892/or.2014.3475
   Simon ID, 2010, J VIROL, V84, P3280, DOI 10.1128/JVI.02052-09
   Sintiprungrat K, 2010, J PROTEOMICS, V73, P602, DOI 10.1016/j.jprot.2009.08.001
   Smith A, 2003, BLOOD, V102, P2877, DOI 10.1182/blood-2002-10-3152
   Smith AJ, 2011, J IMMUNOL, V186, P6576, DOI 10.4049/jimmunol.1100277
   Smith MS, 2004, J LEUKOCYTE BIOL, V76, P65, DOI 10.1189/jlb.1203621
   Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x
   Soderberg-Naucler C, 2008, J CLIN VIROL, V41, P218, DOI 10.1016/j.jcv.2007.11.009
   Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003
   Stevenson EV, 2014, VIRUSES-BASEL, V6, P782, DOI 10.3390/v6020782
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244
   Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444
   Thormar H, 2005, AIDS REV, V7, P233
   Torre D, 2002, CLIN DIAGN LAB IMMUN, V9, P983, DOI 10.1128/CDLI.9.5.983-986.2002
   Traina-Dorge V, 2015, J VIROL, V89, P9817, DOI 10.1128/JVI.01324-15
   Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104
   Van Lent PLEM, 2001, AM J PATHOL, V159, P2309, DOI 10.1016/S0002-9440(10)63081-7
   Venzke Stephanie, 2006, Expert Rev Clin Immunol, V2, P613, DOI 10.1586/1744666X.2.4.613
   Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236
   WARDLEY RC, 1978, J GEN VIROL, V38, P183, DOI 10.1099/0022-1317-38-1-183
   Watson NB, 2015, J IMMUNOL, V194, P2796, DOI 10.4049/jimmunol.1402210
   Way SJR, 2002, VIROLOGY, V301, P281, DOI 10.1006/viro.2002.1587
   Wilkinson J, 2010, GUT, V59, P1394, DOI 10.1136/gut.2009.199356
   Zerboni L, 2014, NAT REV MICROBIOL, V12, P197, DOI 10.1038/nrmicro3215
NR 132
TC 15
Z9 15
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP
PY 2018
VL 19
IS 9
AR 2821
DI 10.3390/ijms19092821
PG 25
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HA1OU
UT WOS:000449988100357
PM 30231586
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Minto-Bain, C
   Jess, N
   Dickson, D
   Cnops, L
   Mankee-Sookram, S
   Arien, K
   Huits, R
   Ramsewak, S
AF Minto-Bain, C.
   Jess, N.
   Dickson, D.
   Cnops, L.
   Mankee-Sookram, S.
   Arien, K.
   Huits, R.
   Ramsewak, S.
TI EXPERIENCE WITH ZIKA VIRUS AND SEMEN PROCESSING.
SO FERTILITY AND STERILITY
LA English
DT Meeting Abstract
CT 74th Annual Scientific Meeting and Expo of the
   American-Society-for-Reproductive-Medicine (ASRM)
CY OCT 06-10, 2018
CL Denver, CO
SP Amer Soc Reprod Med
C1 [Minto-Bain, C.; Jess, N.; Dickson, D.; Mankee-Sookram, S.; Ramsewak, S.] Trinidad & Tobago IVF & Fertil Ctr, Maraval, Trinidad Tobago.
   [Cnops, L.; Huits, R.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.
   [Arien, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.
RI Huits, Ralph/I-8361-2019
OI Huits, Ralph/0000-0001-8803-9468
FU European Union's Horizon 2020 research and innovation programme under
   ZikaPLAN grant [734584]
FX Supported by: European Union's Horizon 2020 research and innovation
   programme under ZikaPLAN grant agreement No 734584
CR Franca GV, LANCET, V388, P891
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Nicastri E., 2016, EURO SURVEILL, V21
   SEMPRINI AE, 1992, LANCET, V340, P1317, DOI 10.1016/0140-6736(92)92495-2
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0015-0282
EI 1556-5653
J9 FERTIL STERIL
JI Fertil. Steril.
PD SEP
PY 2018
VL 110
IS 4
SU S
MA P-587
BP E343
EP E344
DI 10.1016/j.fertnstert.2018.07.960
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GY6PS
UT WOS:000448713601275
OA Bronze
DA 2020-07-08
ER

PT J
AU Herrera, BB
   Tsai, WY
   Brites, C
   Luz, E
   Pedroso, C
   Drexler, JF
   Wang, WK
   Kanki, PJ
AF Herrera, Bobby Brooke
   Tsai, Wen-Yang
   Brites, Carlos
   Luz, Estela
   Pedroso, Celia
   Drexler, Jan Felix
   Wang, Wei-Kung
   Kanki, Phyllis J.
TI T Cell Responses to Nonstructural Protein 3 Distinguish Infections by
   Dengue and Zika Viruses (vol 9, e00755-18, 2018)
SO MBIO
LA English
DT Correction
C1 [Herrera, Bobby Brooke; Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Tsai, Wen-Yang; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Brites, Carlos; Luz, Estela; Pedroso, Celia] Univ Fed Bahia, Sch Med, Lab Infect Res, Salvador, BA, Brazil.
   [Drexler, Jan Felix] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Inst Virol, Berlin Inst Hlth, Berlin, Germany.
   [Drexler, Jan Felix] German Ctr Infect Res, Bonn, Germany.
RP Herrera, BB (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
CR Herrera BB, 2018, MBIO, V9, DOI [10.1128/mBio.00755-18, 10.1128/mbio.00755-18]
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD SEP-OCT
PY 2018
VL 9
IS 5
AR e01995-18
DI 10.1128/mBio.01995-18
PG 1
WC Microbiology
SC Microbiology
GA GZ5NY
UT WOS:000449472200097
PM 30352936
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Delgado, FG
   Torres, KI
   Castellanos, JE
   Romero-Sanchez, C
   Simon-Loriere, E
   Sakuntabhai, A
   Roth, C
AF Delgado, Felix G.
   Torres, Karina, I
   Castellanos, Jaime E.
   Romero-Sanchez, Consuelo
   Simon-Loriere, Etienne
   Sakuntabhai, Anavaj
   Roth, Claude
TI Improved Immune Responses Against Zika Virus After Sequential Dengue and
   Zika Virus Infection in Humans
SO VIRUSES-BASEL
LA English
DT Article
DE dengue virus; zika virus; T-cell epitopes; cross-reactive T cells;
   immunodominance; neutralizing antibodies; antibody-dependent-enhancement
   (ADE)
ID ANTIBODY-DEPENDENT ENHANCEMENT; T-CELL RESPONSES; NEUTRALIZING
   ANTIBODIES; CROSS-NEUTRALIZATION; FLOW-CYTOMETRY; VACCINE; PREDICTION;
   EPITOPES; CD4(+); BRAZIL
AB The high levels of dengue-virus (DENV) seroprevalence in areas where the Zika virus (ZIKV) is circulating and the cross-reactivity between these two viruses have raised concerns on the risk of increased ZIKV disease severity for patients with a history of previous DENV infections. To determine the role of DENV preimmunity in ZIKV infection, we analyzed the T- and B-cell responses against ZIKV in donors with or without previous DENV infection. Using peripheral blood mononuclear cells (PBMCs) from donors living in an endemic area in Colombia, we have identified, by interferon (IFN)-gamma enzyme-linked immunospot (ELISPOT) assay, most of the immunodominant ZIKV T-cell epitopes in the nonstructural (NS) proteins NS1, NS3, and NS5. Analyses of the T- and B-cell responses in the same donors revealed a stronger T-cell response against peptides conserved between DENV and ZIKV, with a higher level of ZIKV-neutralizing antibodies in DENV-immune donors in comparison with DENV-naive donors. Strikingly, the potential for antibody-mediated enhancement of ZIKV infection was reduced in donors with sequential DENV and ZIKV infection in comparison with donors with DENV infection only. Altogether, these data suggest that individuals with DENV immunity present improved immune responses against ZIKV.
C1 [Delgado, Felix G.; Torres, Karina, I; Castellanos, Jaime E.] Univ El Bosque, Grp Virol, Bogota 110131, DC, Colombia.
   [Delgado, Felix G.; Simon-Loriere, Etienne; Sakuntabhai, Anavaj; Roth, Claude] Inst Pasteur, Funct Genet Infect Dis Unit, F-75015 Paris, France.
   [Romero-Sanchez, Consuelo] Univ El Bosque, Unidad Invest Basica Oral, Bogota 110131, DC, Colombia.
   [Simon-Loriere, Etienne; Sakuntabhai, Anavaj] Inst Pasteur, CNRS UMR Genom Evolut Modelisat & Sante 2000, F-75015 Paris, France.
RP Roth, C (corresponding author), Inst Pasteur, Funct Genet Infect Dis Unit, F-75015 Paris, France.
EM fdelgadot@unbosque.edu.co; karinatorrescaballero@gmail.com;
   castellanosjaime@unbosque.edu.co; spacolombia@gmail.com;
   etienne.simon-loriere@pasteur.fr; anavaj.sakuntabhai@pasteur.fr;
   claude.roth@pasteur.fr
RI Castellanos, Jaime/W-2635-2019
OI Castellanos, Jaime/0000-0003-1596-8383; Delgado,
   Felix/0000-0002-1734-6855; Roth, Claude/0000-0001-6360-4758;
   Romero-Sanchez, Consuelo/0000-0002-6973-7639
FU "Integrative Biology of Emerging Infectious Disease" Labex (Laboratoire
   d'excellence) [ANR-10-LABX-62-IBEID]; European CommissionEuropean
   Commission Joint Research Centre [282378]; Colombian Department of
   Sciences, Technology, and Innovation (COLCIENCIAS) [679]; Prix Duquesne
FX The research leading to these results has received funding from the
   "Integrative Biology of Emerging Infectious Disease" Labex (Laboratoire
   d'excellence) under Grant Agreement number ANR-10-LABX-62-IBEID (French
   Government's "Investissements d'Avenir" program), from the European
   Commission Seventh Framework Program [FP7/20072-013] for the DENFREE
   project under Grant Agreement no. 282378, and from the Prix Duquesne.
   F.G.D. is registered in the Ecole Doctorale BioSPC (Universite Paris
   Diderot) and has a PhD grant from the Colombian Department of Sciences,
   Technology, and Innovation (COLCIENCIAS) through the doctoral
   scholarship program number 679.
CR Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guy B, 2004, VACCINE, V22, P3563, DOI 10.1016/j.vaccine.2004.03.042
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   MORENS DM, 1990, J GEN VIROL, V71, P2909, DOI 10.1099/0022-1317-71-12-2909
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pacheco O, 2016, N ENGL J MED
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang SC, 2012, J IMMUNOL, V188, P5924, DOI 10.4049/jimmunol.1200219
NR 61
TC 10
Z9 11
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2018
VL 10
IS 9
AR 480
DI 10.3390/v10090480
PG 20
WC Virology
SC Virology
GA GZ3SA
UT WOS:000449305100034
PM 30205518
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mantke, OD
   McCulloch, E
   Wallace, PS
   Yue, C
   Baylis, SA
   Niedrig, M
AF Mantke, Oliver Donoso
   McCulloch, Elaine
   Wallace, Paul S.
   Yue, Constanze
   Baylis, Sally A.
   Niedrig, Matthias
TI External Quality Assessment (EQA) for Molecular Diagnostics of Zika
   Virus: Experiences from an International EQA Programme, 2016-2018
SO VIRUSES-BASEL
LA English
DT Review
DE Zika virus; mosquito-borne flavivirus; emerging arbovirus; outbreak
   control; molecular diagnostics; laboratory preparedness; assay
   standardization; external quality assessment; EQA; QCMD
ID INFECTION; BRAZIL; LABORATORIES; PREPAREDNESS; AMERICA
AB Quality Control for Molecular Diagnostics (QCMD), an international provider for External Quality Assessment (EQA) programmes, has introduced a programme for molecular diagnostics of Zika virus (ZIKV) in 2016, which has been continuously offered to interested laboratories since that time. The EQA schemes provided from 2016 to 2018 revealed that 86.7% (92/106), 82.4% (89/108), and 88.2% (90/102) of the participating laboratories reported correct results for all samples, respectively in 2016, 2017, and 2018. The review of results indicated a need for improvement concerning analytical sensitivity and specificity of the test methods. Comparison with the outcomes of other EQA initiatives briefly summarized here show that continuous quality assurance is important to improve laboratory performance and to increase preparedness with reliable diagnostic assays for effective patient management, infection and outbreak control.
C1 [Mantke, Oliver Donoso; McCulloch, Elaine; Wallace, Paul S.] QCMD, Unit 5,Technol Terrace,Todd Campus, Glasgow G20 0XA, Lanark, Scotland.
   [Yue, Constanze; Baylis, Sally A.] Fed Inst Vaccines & Biomed, PEI, Div Virol, D-63225 Langen, Germany.
   [Niedrig, Matthias] RKI, D-13353 Berlin, Germany.
RP Mantke, OD (corresponding author), QCMD, Unit 5,Technol Terrace,Todd Campus, Glasgow G20 0XA, Lanark, Scotland.
EM OliverDonoso@qcmd.org; ElaineMcCulloch@qcmd.org; PaulWallace@qcmd.org;
   Constanze.Yue@pei.de; Sally.Baylis@pei.de; niedrigm@rki.de
CR Abdad MY, 2017, WEST PAC SURVEILL RE, V8, DOI 10.5365/wpsar.2017.8.3.001
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baylis SA, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01997-17
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Corman V. M., 2016, CLIN COMP STANDARDIZ
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Escadafal C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3831-1
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   International Organization for Standardization (ISO), 2012, 151892012 ISO
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Pan American Health Organization (PAHO); World Health Organization (WHO), 2017, CUM CAS ZIK SUSP CON
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Squires RC, 2016, WEST PAC SURVEILL RE, V7, P44, DOI 10.5365/wpsar.2016.7.1.007
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Trosemeier J. H., 2016, GENOME ANNOUNC, V4, P00917
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
NR 28
TC 3
Z9 3
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2018
VL 10
IS 9
AR 491
DI 10.3390/v10090491
PG 7
WC Virology
SC Virology
GA GZ3SA
UT WOS:000449305100045
PM 30216988
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saiz, JC
   de Oya, NJ
   Blazquez, AB
   Escribano-Romero, E
   Martin-Acebes, MA
AF Saiz, Juan-Carlos
   Jimenez de Oya, Nereida
   Blazquez, Ana-Belen
   Escribano-Romero, Estela
   Martin-Acebes, Miguel A.
TI Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; Zika virus; therapy; host-directed antivirals
ID NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE; INHIBITS ZIKA; WEST NILE; DENGUE
   VIRUS; IN-VITRO; INFECTION; REPLICATION; DRUG; AXL
AB Zika virus (ZIKV), a mosquito-borne flavivirus, was an almost neglected pathogen until its introduction in the Americas in 2015, where it has been responsible for a threat to global health, causing a great social and sanitary alarm due to its increased virulence, rapid spread, and an association with severe neurological and ophthalmological complications. Currently, no specific antiviral therapy against ZIKV is available, and treatments are palliative and mainly directed toward the relief of symptoms, such as fever and rash, by administering antipyretics, anti-histamines, and fluids for dehydration. Nevertheless, lately, search for antivirals has been a major aim in ZIKV investigations. To do so, screening of libraries from different sources, testing of natural compounds, and repurposing of drugs with known antiviral activity have allowed the identification of several antiviral candidates directed to both viral (structural proteins and enzymes) and cellular elements. Here, we present an updated review of current knowledge about anti-ZIKV strategies, focusing on host-directed antivirals as a realistic alternative to combat ZIKV infection.
C1 [Saiz, Juan-Carlos; Jimenez de Oya, Nereida; Blazquez, Ana-Belen; Escribano-Romero, Estela; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
RP Saiz, JC; Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid 28040, Spain.
EM jcsaiz@inia.es; jdeoya@inia.es; blazquez@inia.es; eescribano@inia.es;
   martin.mangel@inia.es
RI de Oya, Nereida Jimenez/T-6449-2019; Martin-Acebes, Miguel
   A./L-2258-2014; Escribano-Romero, Estela/H-1495-2015; Blazquez,
   Ana/G-9791-2015
OI de Oya, Nereida Jimenez/0000-0003-3129-813X; Martin-Acebes, Miguel
   A./0000-0001-6015-3613; Escribano-Romero, Estela/0000-0002-5036-7607;
   Blazquez, Ana/0000-0002-0847-0977
FU Spanish Ministry of Economy and Competitiveness (MINECO) [RTA2015-00009,
   E-RTA2017-00003-C02, AGL2014-56518-JIN]
FX This study was funded by The Spanish Ministry of Economy and
   Competitiveness (MINECO) grant numbers RTA2015-00009 and
   E-RTA2017-00003-C02 (to J.-C.S.) and AGL2014-56518-JIN (to M.A.M.-A.).
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Arbuckle JH, 2017, MBIO, V8, DOI [10.1128/mBio.01141-17, 10.1128/mbio.01141-17]
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Lima G, 2017, EUR J MED CHEM, V127, P434, DOI 10.1016/j.ejmech.2017.01.007
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Chung DH, 2016, ANTIMICROB AGENTS CH, V60, P4552, DOI 10.1128/AAC.00282-16
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 2014, ANTIBODY FC: LINKING ADAPTIVE AND INNATE IMMUNITY, P333
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Khandia R, 2017, INT J PHARMACOL, V13, P370, DOI 10.3923/ijp.2017.370.377
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leonardi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep34475
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Menendez-Arias L, 2014, CURR OPIN VIROL, V8, pIV, DOI 10.1016/j.coviro.2014.08.002
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Opie LH, 2015, TRENDS CARDIOVAS MED, V25, P216, DOI 10.1016/j.tcm.2014.10.002
   Ortega-Prieto AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071039
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pitts JD, 2017, ANTIVIR RES, V147, P124, DOI 10.1016/j.antiviral.2017.10.014
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Pryke KM, 2017, MBIO, V8, DOI [10.1128/mBio.00452-17, 10.1128/mbio.00452-17]
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Raekiansyah M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0072-7
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Saiz J.C., 2017, ANTIMICROB AGENTS CH, P61
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarkey JP, 2007, J NEUROCHEM, V100, P1265, DOI 10.1111/j.1471-4159.2006.04309.x
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang HB, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0013-6
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, HIST ZIK VIR
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   World Health Organization, WHO VACC PIP TRACK
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 143
TC 12
Z9 13
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2018
VL 10
IS 9
AR 453
DI 10.3390/v10090453
PG 18
WC Virology
SC Virology
GA GZ3SA
UT WOS:000449305100007
PM 30149598
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, LM
   Alto, BW
   Shin, DY
   Yu, FH
AF Zhao, Liming
   Alto, Barry W.
   Shin, Dongyoung
   Yu, Fahong
TI The Effect of Permethrin Resistance on Aedes aegypti Transcriptome
   Following Ingestion of Zika Virus Infected Blood
SO VIRUSES-BASEL
LA English
DT Article
DE Aedes aegypti; RNA-seq; insecticide resistance; Zika virus;
   detoxification and immune system responses
ID CULEX-PIPIENS-PALLENS; INSECTICIDE RESISTANCE; ACTIN CYTOSKELETON;
   DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; DENGUE VIRUS; PUERTO-RICO;
   PROTEIN; HOST; DELTAMETHRIN
AB Aedes aegypti (L.) is the primary vector of many emerging arboviruses. Insecticide resistance among mosquito populations is a consequence of the application of insecticides for mosquito control. We used RNA-sequencing to compare transcriptomes between permethrin resistant and susceptible strains of Florida Ae. aegypti in response to Zika virus infection. A total of 2459 transcripts were expressed at significantly different levels between resistant and susceptible Ae. aegypti. Gene ontology analysis placed these genes into seven categories of biological processes. The 863 transcripts were expressed at significantly different levels between the two mosquito strains (up/down regulated) more than 2-fold. Quantitative real-time PCR analysis was used to validate the Zika-infection response. Our results suggested a highly overexpressed P450, with AAEL014617 and AAEL006798 as potential candidates for the molecular mechanism of permethrin resistance in Ae. aegypti. Our findings indicated that most detoxification enzymes and immune system enzymes altered their gene expression between the two strains of Ae. aegypti in response to Zika virus infection. Understanding the interactions of arboviruses with resistant mosquito vectors at the molecular level allows for the possible development of new approaches in mitigating arbovirus transmission. This information sheds light on Zika-induced changes in insecticide resistant Ae. aegypti with implications for mosquito control strategies.
C1 [Zhao, Liming; Alto, Barry W.; Shin, Dongyoung] Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
   [Yu, Fahong] Univ Florida, Interdisciplinary Ctr Biotechnol Res, 2033 Mowry Rd, Gainesville, FL 32611 USA.
RP Zhao, LM (corresponding author), Univ Florida, Florida Med Entomol Lab, 200 9th St South East, Vero Beach, FL 32962 USA.
EM lmzhao@ufl.edu; bwalto@ufl.edu; dshin@ufl.edu; fyu@ufl.edu
FU Florida Department of Agriculture and Consumer Services [024246, 023557,
   020180, 021803, 022399]
FX This research was funded by the Florida Department of Agriculture and
   Consumer Services: Contract Numbers 024246 and 023557 to Jorge Rey and
   Contract Number 020180 to Walter Tabachnick, Contract Numbers 021803 and
   022399 to Liming Zhao and Barry Alto.
CR Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Al Nazawi AM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2096-6
   Alemayehu E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2342-y
   Alout H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063849
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Antonio-Nkondjio C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2417-9
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Bonizzoni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1083-z
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044607
   Brice A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33493
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x
   Chang KS, 2017, J PEST SCI, V90, P759, DOI 10.1007/s10340-016-0820-1
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1
   Dang K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2232-3
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Etebari K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15968
   Faucon F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005526
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989
   Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673
   Ghosh A, 2009, INVEST OPHTH VIS SCI, V50, P4185, DOI 10.1167/iovs.08-3040
   Glinton K, 2017, J BIOL CHEM, V292, P6775, DOI 10.1074/jbc.M116.768937
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Gong YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00486-0
   Grigoraki L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005533
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Guo Q, 2017, INSECT BIOCHEM MOLEC, V84, P15, DOI 10.1016/j.ibmb.2017.03.006
   Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Ingham VA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4086-7
   Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707
   Itokawa K, 2013, HEREDITY, V111, P216, DOI 10.1038/hdy.2013.40
   Itokawa K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24652
   Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li Ting, 2017, Biochem Biophys Rep, V12, P12, DOI 10.1016/j.bbrep.2017.08.010
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Luftig Ronald B., 1994, Trends in Microbiology, V2, P178, DOI 10.1016/0966-842X(94)90669-6
   Lv Y, 2016, MOL GENET GENOMICS, V291, P309, DOI 10.1007/s00438-015-1109-4
   Mastrantonio V, 2017, ACTA TROP, V171, P37, DOI 10.1016/j.actatropica.2017.03.012
   McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671
   McCarroll L, 2002, INSECT BIOCHEM MOLEC, V32, P1345, DOI 10.1016/S0965-1748(02)00097-8
   Mondotte JA, 2018, ADV VIRUS RES, V100, P247, DOI 10.1016/bs.aivir.2017.10.006
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Oberhofer A, 2017, P NATL ACAD SCI USA, V114, pE4714, DOI 10.1073/pnas.1619473114
   Onomoto Koji, 2006, Nihon Rinsho, V64, P1236
   Pignatelli P, 2018, INSECT MOL BIOL, V27, P110, DOI 10.1111/imb.12351
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Reid WR, 2018, INSECT SCI, V25, P439, DOI 10.1111/1744-7917.12438
   Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sanders MC, 1996, TRENDS MICROBIOL, V4, P211, DOI 10.1016/0966-842X(96)30017-6
   Seixas G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005799
   Shin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-513
   Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200
   Shrinet J, 2017, BIOCHEM BIOPH RES CO, V492, P617, DOI 10.1016/j.bbrc.2017.01.162
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   Smith LB, 2018, PEST MANAG SCI, V74, P737, DOI 10.1002/ps.4771
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Sun XL, 2017, PARASITOL RES, V116, P2175, DOI 10.1007/s00436-017-5521-z
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   Wang HD, 2017, INSECT BIOCHEM MOLEC, V91, P10, DOI 10.1016/j.ibmb.2017.10.002
   Wu ZM, 2016, J AM MOSQUITO CONTR, V32, P144, DOI 10.2987/moco-32-02-144-151.1
   Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023
   Yan ZW, 2018, PEST MANAG SCI, V74, P1810, DOI 10.1002/ps.4879
   Yang G, 2012, GENE, V507, P139, DOI 10.1016/j.gene.2012.06.026
   Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418
   Yao JQ, 2011, BIOINFORMATION, V7, P44
   Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633
   Zhang J, 2016, SCI CHINA LIFE SCI, V59, P487, DOI 10.1007/s11427-016-5042-5
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055475
   Zhu GD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-448
   Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011
NR 92
TC 5
Z9 6
U1 3
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD SEP
PY 2018
VL 10
IS 9
AR 470
DI 10.3390/v10090470
PG 18
WC Virology
SC Virology
GA GZ3SA
UT WOS:000449305100024
PM 30200481
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saleh, F
   Kitau, J
   Konradsen, F
   Alifrangis, M
   Lin, CH
   Juma, S
   Mchenga, SS
   Saadaty, T
   Schioler, KL
AF Saleh, Fatma
   Kitau, Jovin
   Konradsen, Flemming
   Alifrangis, Michael
   Lin, Chia-Hsien
   Juma, Salim
   Mchenga, Salum Self
   Saadaty, Thabit
   Schioler, Karin Linda
TI HABITAT CHARACTERISTICS FOR IMMATURE STAGES OF AEDES AEGYPTI IN ZANZIBAR
   CITY, TANZANIA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes aegypti; habitat characteristics; Tanzania; Zanzibar
ID DENGUE VECTORS; CHIKUNGUNYA; VIRUS; FEVER
AB Aedes aegypti is the main vector for dengue, chikungunya, yellow fever, Zika, and other arboviruses of public health importance. The presence of Ae. aegypti has never been systematically assessed in Zanzibar, including its preferred larval habitats. In 2016 we conducted a cross-sectional entomological survey to describe the preferred larval habitats of Ae. aegypti in Zanzibar City, the main urban area of the Zanzibar archipelago. The surveys for container habitats were conducted for a 17-wk period beginning in January 2016. Immature stages (larvae and pupae) were collected, reared to adulthood, and identified to species. The positive and potential habitats were categorized on the basis of physical, biological, and chemical parameters. A total of 200 samples were collected, of which 124 (62.0%) were positive for immature stages of mosquitoes and 114 (92%) for Ae. aegypti larvae and pupae. Presence of vegetation (odds ratio [OR] = 2.11, 95% confidence interval [CI] = 1.193.74), organic matter (OR = 2.37, 95% CI = 1.21-4.60), inorganic matter (OR = 1.78, 95% CI = 1.01-3.13), and sun exposure (OR = 2.34, 95% CI = 1.24-4.36) were all significantly associated with the presence of immature stages of Ae. aegypti, suggesting that these conditions promote colonization of containers. Plastic containers supported 64% of the immature stages and produced approximately 50% of the pupae. Although immature counts were the highest in discarded artifacts, higher pupal counts were found in domestic water storage containers. Our observations suggest that effective control of Ae. aegypti in Zanzibar City must include improved solid waste management (collection and proper disposal of potential container habitats) and reliable supply of domestic water to minimize water-storing practices that provide larval habitats for Ae. aegypti.
C1 [Saleh, Fatma; Saadaty, Thabit] State Univ Zanzibar, Sch Hlth & Med Sci, Dept Allied Hlth Sci, POB 1898, Zanzibar, Tanzania.
   [Kitau, Jovin] Kilimanjaro Christian Med Univ Coll, Dept Parasitol, Moshi, Tanzania.
   [Konradsen, Flemming; Lin, Chia-Hsien; Schioler, Karin Linda] Univ Copenhagen, Dept Publ Hlth, Global Hlth Sect, Copenhagen, Denmark.
   [Alifrangis, Michael] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.
   [Juma, Salim] State Univ Zanzibar, Dept Nat Sci, Zanzibar, Tanzania.
   [Mchenga, Salum Self] State Univ Zanzibar, Dept Med Lab, Sch Hlth & Med Sci, Zanzibar, Tanzania.
RP Saleh, F (corresponding author), State Univ Zanzibar, Sch Hlth & Med Sci, Dept Allied Hlth Sci, POB 1898, Zanzibar, Tanzania.
RI lin, chia-hsien/O-2024-2019
OI lin, chia-hsien/0000-0001-8325-648X; Konradsen,
   Flemming/0000-0003-1036-6949; Alifrangis, Michael/0000-0002-3835-3333
FU DANIDA/Building Stronger Universities project (BSU II)
FX The authors express their sincere gratitude to DANIDA/Building Stronger
   Universities project (BSU II) for funding this work. We also thank
   Abdalla Ibrahim for his participation in entomological data collection
   and Juma Mcha (entomologists at Zanzibar Malaria Elimination Program)
   for sharing technical expertise and experience on entomological surveys
   and involvement in data collection.
CR Alvarado-Moreno MS, 2013, SOUTHWEST ENTOMOL, V38, P605, DOI 10.3958/059.038.0406
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P437
   Banerjee S, 2013, INDIAN J MED RES, V137, P549
   Chang MS, 2011, WEST PAC SURVEILL RE, V2, P9, DOI [10.5365/WPSAR.2010.1.1.012, 10.5365/wpsar.2010.1.1.012]
   Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584
   Haji KA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-82
   Harbach R., 2013, GENUS AEDES MEIGEN 1
   Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393
   Imam Hashmat, 2014, Trop Parasitol, V4, P53, DOI 10.4103/2229-5070.129167
   Kajeguka DC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1511-5
   Kenawy M. A., 2013, Journal of Entomological and Acarological Research, V45, P96, DOI 10.4081/jear.2013.e17
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Mathias L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0316-0
   Mboera LEG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004313
   Nguyen LAP, 2011, INT HEALTH, V3, P115, DOI 10.1016/j.inhe.2010.11.002
   Nyamah MA, 2010, TROP BIOMED, V27, P33
   Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168
   Philbert A, 2013, J ENV RES MANAG, V4, P344
   Piyaratne M. K., 2005, Journal of Vector Borne Diseases, V42, P61
   RAO TR, 1973, B WORLD HEALTH ORGAN, V48, P615
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   Teng Ang Kim, 2001, Dengue Bulletin, V25, P7
   TRPIS M, 1972, B WORLD HEALTH ORGAN, V47, P245
   TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P447
   United Republic of Tanzania, 2013, 2012 POP HOUS CENS P
   University of Florida Medical Entomology Laboratory, MOSQ ID GUID
   Vairo F, 2014, EMERG INFECT DIS, V20, P465, DOI 10.3201/eid2003.130150
   WHO, 2011, OP GUID ASS PROD AED
   WHO [World Health Organization], 2017, COUNTR RISK YELL FEV
   World Health Organization, 2014, DENG OUTBR UN REP TA
NR 32
TC 0
Z9 0
U1 0
U2 3
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2018
VL 34
IS 3
BP 190
EP 200
DI 10.2987/17-6709.1
PG 11
WC Entomology
SC Entomology
GA GZ0PJ
UT WOS:000449066500004
PM 31442169
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Felix, GE
   Barrera, R
   Vazquez, J
   Ryff, KR
   Munoz-Jordan, JL
   Matias, KY
   Hemme, RR
AF Felix, Gilberto E.
   Barrera, Roberto
   Vazquez, Jesus
   Ryff, Kyle R.
   Munoz-Jordan, Jorge L.
   Matias, Katia Y.
   Hemme, Ryan R.
TI ENTOMOLOGICAL INVESTIGATION OF AEDES AEGYPTI IN NEIGHBORHOODS WITH
   CONFIRMED HUMAN ARBOVIRUS INFECTION IN PUERTO RICO
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Autocidal gravid trap; Aedes aegypti; chikungunya virus; Puerto Rico;
   Zika virus
ID CHIKUNGUNYA VIRUS; ZIKA VIRUS; 1ST REPORT; TRANSMISSION; EPIDEMIC;
   OVITRAPS; AMERICA
AB The exotic arboviruses chikungunya (CHIKV) and Zika (ZIKV) recently caused large outbreaks and continue to circulate in Puerto Rico, prompting entomological investigations at 9 locations with confirmed CHIKV- or ZIKV-infected human cases. Adult mosquitoes were collected using the Centers for Disease Control and Prevention autocidal gravid ovitraps over a 14-day period at each site. Mean female Aedes aegypti captured per trapweek ranged from 13.47 per trap-week to 1.27 per trap-week. Arbovirus-positive pools were detected at 7 of the 9 sampling sites. We investigated vertical transmission by collecting Ae. aegypti eggs in a single location where ZIKV was found in adult mosquitoes. We discuss the relationship between vector density and infection rates and its implications for determining mosquito density thresholds of novel invasive arboviruses such as CHIKV and ZIKV.
C1 [Felix, Gilberto E.; Barrera, Roberto; Vazquez, Jesus; Ryff, Kyle R.; Munoz-Jordan, Jorge L.; Matias, Katia Y.; Hemme, Ryan R.] Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR 00921 USA.
RP Felix, GE (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, San Juan, PR 00921 USA.
FU Intramural CDC HHS [CC999999]
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Barrera R, 2017, J MED ENTOMOL, V54, P387, DOI 10.1093/jme/tjw187
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Biggerstaff B., 2016, POOLEDINFRATE VERSIO
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Dzul-Manzanilla F, 2015, J AM MOSQUITO CONTR, V31, P275, DOI 10.2987/moco-31-03-275-277.1
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   FDA [Food and Drug Administration], 2017, INT TRIOPL REAL TIM
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   PAHO [Pan American Health Organization], 2017, ZIK EP REP PUERT RIC
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Ritchie SA, 2004, J MED ENTOMOL, V41, P1, DOI 10.1603/0022-2585-41.1.1
   Sang RC, 2008, AM J TROP MED HYG, V78, P77
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P383, DOI 10.1089/vbz.2010.0022
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 21
TC 2
Z9 2
U1 0
U2 0
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2018
VL 34
IS 3
BP 233
EP 236
DI 10.2987/18-6741.1
PG 4
WC Entomology
SC Entomology
GA GZ0PJ
UT WOS:000449066500009
PM 31442166
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Unlu, I
   Baker, M
AF Unlu, Isik
   Baker, Mark
TI COMPARISON OF BG-SENTINEL PROTOTYPE, BG-SENTINEL-1, AND BG-SENTINEL-2:
   BETTER RESULTS WITH MODIFICATION OF EARLIER DESIGN
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes albopictus; BG-Sentinel; New Jersey; prototype
ID AEDES-ALBOPICTUS; TRAPPING PERFORMANCE; SURVEILLANCE; MOSQUITOS; TRAPS
AB The BG-Sentinel (R) (BGS) trap is considered "the gold standard'' for Aedes albopictus surveillance. With the risk of dengue, chikungunya, and Zika viruses in the USA, it is imperative our best surveillance asset is as dependable and cost-effective as possible. Biogents AG (Regensburg, Germany) in recent years has manufactured 3 generations of BGS traps in an effort to optimize trapping performance of invasive Aedes species. We evaluated the field efficacy of BG-Sentinel 2 prototype (BGS2P), BG-Sentinel (BGS1), and BG-Sentinel 2 (R) (BGS2). The field experiment was conducted between July 1 and September 21, 2016, on the outskirts of an abandoned industrial area in the city of Trenton, NJ (40 degrees 13'58.0"N, 74 degrees 44'21.6"W). All 3 traps were compared with 3-compound BG cartridge lures. There was no significant difference in total Ae. albopictus collections among BGS1 and BGS2. However, the number of Ae. albopictus collected from the BGS2P was significantly lower than BGS1 (P = 0.016) and BGS2 (P = 0.025). Our results indicate BGS2, encompassing the latest technology aimed with improved durability and efficacy, will yield the highest capture rates of adult Ae. albopictus mosquitoes.
C1 [Unlu, Isik] Rutgers State Univ, Ctr Vector Biol, Dept Entomol, New Brunswick, NJ 08901 USA.
   [Unlu, Isik] Mercer Cty Mosquito Control, 300 Scotch Rd, West Trenton, NJ 08628 USA.
   [Baker, Mark] PA Vector Control, 111 West Hunting Pk Ave, Philadelphia, PA 19140 USA.
RP Unlu, I (corresponding author), Rutgers State Univ, Ctr Vector Biol, Dept Entomol, New Brunswick, NJ 08901 USA.; Unlu, I (corresponding author), Mercer Cty Mosquito Control, 300 Scotch Rd, West Trenton, NJ 08628 USA.
CR Akaratovic KI, 2017, J AM MOSQUITO CONTR, V33, P108, DOI 10.2987/16-6596.1
   Arimoto H, 2015, J AM MOSQUITO CONTR, V31, P384, DOI 10.2987/moco-31-04-384-387.1
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1
   Crepeau TN, 2013, J AM MOSQUITO CONTR, V29, P177, DOI 10.2987/12-6277r.1
   HOLM S, 1979, SCAND J STAT, V6, P65
   Meeraus WH, 2008, J AM MOSQUITO CONTR, V24, P244, DOI 10.2987/5676.1
   Unlu I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172963
   Unlu I, 2014, ACTA TROP, V137, P201, DOI 10.1016/j.actatropica.2014.05.009
   Unlu I, 2014, J AM MOSQUITO CONTR, V30, P122, DOI 10.2987/14-6401.1
   Unlu I, 2012, J AM MOSQUITO CONTR, V28, P334, DOI 10.2987/12-6262R.1
   Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140
NR 11
TC 1
Z9 1
U1 0
U2 3
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD SEP
PY 2018
VL 34
IS 3
BP 237
EP 239
DI 10.2987/18-6753.1
PG 3
WC Entomology
SC Entomology
GA GZ0PJ
UT WOS:000449066500010
PM 31442174
OA Bronze
DA 2020-07-08
ER

PT J
AU Suzuki, T
   Okamoto, T
   Katoh, H
   Sugiyama, Y
   Kusakabe, S
   Tokunaga, M
   Hirano, J
   Miyata, Y
   Fukuhara, T
   Ikawa, M
   Satoh, T
   Yoshio, S
   Suzuki, R
   Saijo, M
   Huang, DCS
   Kantor, T
   Akira, S
   Matsuura, Y
AF Suzuki, Tatsuya
   Okamoto, Toru
   Katoh, Hiroshi
   Sugiyama, Yukari
   Kusakabe, Shinji
   Tokunaga, Makoto
   Hirano, Junki
   Miyata, Yuka
   Fukuhara, Takasuke
   Ikawa, Masahito
   Satoh, Takashi
   Yoshio, Sachiyo
   Suzuki, Ryosuke
   Saijo, Masayuki
   Huang, David C. S.
   Kantor, Tatsuya
   Akira, Shizuo
   Matsuura, Yoshiharu
TI Infection with flaviviruses requires BCLXL for cell survival
SO PLOS PATHOGENS
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; MCL-1; BCL-2; DEATH; APOPTOSIS; PROTEIN;
   REPLICATION; INHIBITOR; FAMILY; BAK
AB BCL2 family proteins including pro-survival proteins, BH3-only proteins and BAX/BAK proteins control mitochondria-mediated apoptosis to maintain cell homeostasis via the removal of damaged cells and pathogen-infected cells. In this study, we examined the roles of BCL2 proteins in the induction of apoptosis in cells upon infection with flaviviruses, such as Japanese encephalitis virus, Dengue virus and Zika virus. We showed that survival of the infected cells depends on BCLXL, a pro-survival BCL2 protein due to suppression of the expression of another pro-survival protein, MCL1. Treatment with BCLXL inhibitors, as well as deficient BCLXL gene expression, induced BAX/BAK-dependent apoptosis upon infection with flaviviruses. Flavivirus infection attenuates cellular protein synthesis, which confers reduction of short-half-life proteins like MCL1. Inhibition of BCLXL increased phagocytosis of virus-infected cells by macrophages, thereby suppressing viral dissemination and chemokine production. Furthermore, we examined the roles of BCLXL in the death of JEV-infected cells during in vivo infection. Haploinsufficiency of the BCLXL gene, as well as administration of BH3 mimetic compounds, increased survival rate after challenge of JEV infection and suppressed inflammation. These results suggest that BCLXL plays a crucial role in the survival of cells infected with flaviviruses, and that BCLXL may provide a novel antiviral target to suppress propagation of the family of Flaviviridae viruses.
C1 [Suzuki, Tatsuya; Okamoto, Toru; Katoh, Hiroshi; Sugiyama, Yukari; Kusakabe, Shinji; Tokunaga, Makoto; Hirano, Junki; Miyata, Yuka; Fukuhara, Takasuke; Matsuura, Yoshiharu] Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, Osaka, Japan.
   [Katoh, Hiroshi] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.
   [Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, Dept Expt Genome Res, Osaka, Japan.
   [Satoh, Takashi; Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Osaka, Japan.
   [Yoshio, Sachiyo; Kantor, Tatsuya] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan.
   [Suzuki, Ryosuke] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.
   [Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
   [Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.
   [Huang, David C. S.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.
RP Okamoto, T; Matsuura, Y (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, Osaka, Japan.
EM toru@biken.osaka-u.ac.jp; matsuura@biken.osaka-u.ac.jp
RI Yoshio, Sachiyo/K-8791-2019; ikawa, masahito/A-5315-2009; Huang, David
   C. S./C-7586-2013
OI Yoshio, Sachiyo/0000-0001-7860-6916; ikawa,
   masahito/0000-0001-9859-6217; Huang, David C. S./0000-0002-3101-4873;
   Saijo, Masayuki/0000-0001-5458-7298
FU Japan Agency for Medical Research and DevelopmentJapan Agency for
   Medical Research and Development (AMED) [JP18fk0108036h0002,
   JP18fk0210010h003]; Ministry of Education, Culture, Sports, Science, and
   TechnologyMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) [16H06432, 16H06429, 16K21723, 15H04736,
   16K19139]
FX This work was supported in part by Japan Agency for Medical Research and
   Development (JP18fk0108036h0002, JP18fk0210010h003,
   https://www.amed.go.jp/en/index.html) and the Ministry of Education,
   Culture, Sports, Science, and Technology (16H06432,16H06429, 16K21723,
   15H04736, 16K19139, http://www.mext.go.jp/en/). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379
   Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561
   Bonora M, 2015, ONCOGENE, V34, P1475, DOI 10.1038/onc.2014.96
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030
   CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997
   Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011
   Davis LE, 2006, ANN NEUROL, V60, P286, DOI 10.1002/ana.20959
   Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14
   Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957
   Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499
   Fujihara Y, 2014, METHOD ENZYMOL, V546, P319, DOI 10.1016/B978-0-12-801185-0.00015-5
   Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208
   Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530
   Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126
   Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732
   Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11
   Kebir El D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087006, DOI 10.1371/JOURNAL.PONE.0087006]
   King NJC, 2003, IMMUNOL CELL BIOL, V81, P207, DOI 10.1046/j.1440-1711.2003.01167.x
   Kodama T, 2012, CELL DEATH DIFFER, V19, P1856, DOI 10.1038/cdd.2012.88
   Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830
   Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642
   Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355
   Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009
   Michlmayr D, 2014, FRONT CELL NEUROSCI, V8, P8781, DOI [10.3389/fncel.2014.00264, 10.1084/jem.20042530, DOI 10.1084/JEM.20042530]
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mojsa B, 2014, CELLS-BASEL, V3, P418, DOI 10.3390/cells3020418
   Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07
   Morishima N, 2011, J BIOL CHEM, V286, P35227, DOI 10.1074/jbc.M111.233502
   MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nagata S, 2017, NAT REV IMMUNOL, V17, P333, DOI 10.1038/nri.2016.153
   Nakajima W, 2016, ONCOTARGET, V7, P36353, DOI 10.18632/oncotarget.9217
   NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
   Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424
   Roberts AW, 2017, CLIN PHARMACOL THER, V101, P89, DOI 10.1002/cpt.553
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Senft D, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.341
   Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048
   Speir M, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.34, 10.1038/nmicrobiol.2015.34]
   Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suzuki R, 2014, J GEN VIROL, V95, P60, DOI 10.1099/vir.0.058008-0
   Suzuki R, 2009, J VIROL, V83, P2389, DOI 10.1128/JVI.01690-08
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028
   Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108
   Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779
   Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105
   Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8
   Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yatim N, 2011, IMMUNITY, V35, P478, DOI 10.1016/j.immuni.2011.10.010
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081
   Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07
   Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009
NR 74
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2018
VL 14
IS 9
AR e1007299
DI 10.1371/journal.ppat.1007299
PG 28
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GY9OA
UT WOS:000448975900030
PM 30261081
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chowdhury, R
   Allan, MF
   Maranas, CD
AF Chowdhury, Ratul
   Allan, Matthew F.
   Maranas, Costas D.
TI OptMAVEn-2.0: De novo Design of Variable Antibody Regions against
   Targeted Antigen Epitopes
SO ANTIBODIES
LA English
DT Article
DE de novo antibody design; zika envelope protein; computational protein
   design; specific antigen epitope
ID MONOCLONAL-ANTIBODIES; MOLECULAR-DYNAMICS; DISTANCE GEOMETRY;
   OPTIMIZATION; AFFINITY; PROTEINS; BINDING; RECOGNITION; GENERATION;
   STABILITY
AB Monoclonal antibodies are becoming increasingly important therapeutic agents for the treatment of cancers, infectious diseases, and autoimmune disorders. However, laboratory-based methods of developing therapeutic monoclonal antibodies (e.g., immunized mice, hybridomas, and phage display) are time-consuming and are often unable to target a specific antigen epitope or reach (sub)nanomolar levels of affinity. To this end, we developed Optimal Method for Antibody Variable region Engineering (OptMAVEn) for de novo design of humanized monoclonal antibody variable regions targeting a specific antigen epitope. In this work, we introduce OptMAVEn-2.0, which improves upon OptMAVEn by (1) reducing computational resource requirements without compromising design quality; (2) clustering the designs to better identify high-affinity antibodies; and (3) eliminating intra-antibody steric clashes using an updated set of clashing parts from the Modular Antibody Parts (MAPs) database. Benchmarking on a set of 10 antigens revealed that OptMAVEn-2.0 uses an average of 74% less CPU time and 84% less disk storage relative to OptMAVEn. Testing on 54 additional antigens revealed that computational resource requirements of OptMAVEn-2.0 scale only sub-linearly with respect to antigen size. OptMAVEn-2.0 was used to design and rank variable antibody fragments targeting five epitopes of Zika envelope protein and three of hen egg white lysozyme. Among the top five ranked designs for each epitope, recovery of native residue identities is typically 45-65%. MD simulations of two designs targeting Zika suggest that at least one would bind with high affinity. OptMAVEn-2.0 can be downloaded from our GitHub repository and webpage as (links in Summary and Discussion section).
C1 [Chowdhury, Ratul; Allan, Matthew F.; Maranas, Costas D.] Penn State Univ, Dept Chem Engn, State Coll, PA 16802 USA.
   [Allan, Matthew F.] MIT, Computat & Syst Biol Initiat, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
RP Maranas, CD (corresponding author), Penn State Univ, Dept Chem Engn, State Coll, PA 16802 USA.
EM ratul@psu.edu; mfallan@mit.edu; costas@psu.edu
OI Allan, Matthew/0000-0001-8182-7402; Chowdhury, Ratul/0000-0003-4522-6911
CR Adolf-Bryfogle J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006112
   Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Byrne H, 2013, TRENDS BIOTECHNOL, V31, P621, DOI 10.1016/j.tibtech.2013.08.007
   Checa A, 1997, J MED CHEM, V40, P4136, DOI 10.1021/jm970245v
   Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106
   Choi H, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-8
   Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163
   Community N., 2011, NUMPY REF
   De Groot AS, 2008, CURR OPIN PHARMACOL, V8, P620, DOI 10.1016/j.coph.2008.08.002
   Der BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064363
   Duan LL, 2016, J AM CHEM SOC, V138, P5722, DOI 10.1021/jacs.6b02682
   Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042
   Entzminger KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10737-9
   Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005
   FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254
   HAVEL TF, 1983, B MATH BIOL, V45, P665
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Holmes MA, 1998, J EXP MED, V187, P479, DOI 10.1084/jem.187.4.479
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255
   Kumar S, 2011, PHARM RES-DORDR, V28, P949, DOI 10.1007/s11095-011-0414-9
   Lapidoth GD, 2015, PROTEINS, V83, P1385, DOI 10.1002/prot.24779
   Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029
   Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N
   Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269
   Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P633, DOI 10.1101/pdb.ip85
   Li T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105954
   Mahmuda A, 2017, TROP J PHARM RES, V16, P713, DOI 10.4314/tjpr.v16i3.29
   MARIMONT RB, 1979, J I MATH APPL, V24, P59
   Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018
   More JJ, 1999, J GLOBAL OPTIM, V15, P219, DOI 10.1023/A:1008380219900
   Mucherino A, 2010, LECT NOTES COMPUT SC, V6327, P186, DOI 10.1007/978-3-642-15582-6_34
   Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58
   Pantazes RJ, 2010, PROTEIN ENG DES SEL, V23, P849, DOI 10.1093/protein/gzq061
   Pantazes RJ, 2015, J COMPUT CHEM, V36, P251, DOI 10.1002/jcc.23796
   Pantazes RJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-168
   Pappu RV, 1998, J PHYS CHEM B, V102, P9725, DOI 10.1021/jp982255t
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Poosarla VG, 2017, BIOTECHNOL BIOENG, V114, P1331, DOI 10.1002/bit.26244
   Python Software Foundation, 2013, PYTH LANG REF VERS 2
   Ribeiro JV, 2016, SCI REP-UK, V6, DOI 10.1038/srep26536
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Rouet R, 2015, J BIOL CHEM, V290, P11905, DOI 10.1074/jbc.M114.614842
   Rudnick SI, 2009, CANCER BIOTHER RADIO, V24, P155, DOI 10.1089/cbr.2009.0627
   Saeed AFUH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00495
   Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770
   Schirrmann T, 2011, MOLECULES, V16, P412, DOI 10.3390/molecules16010412
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Shepard HM, 2017, CLIN MED, V17, P220, DOI 10.7861/clinmedicine.17-3-220
   Shriver Z, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00315
   Simpson EL, 2016, NEW ENGL J MED, V375, P2335, DOI 10.1056/NEJMoa1610020
   Soria-Guerra RE, 2015, J BIOMED INFORM, V53, P405, DOI 10.1016/j.jbi.2014.11.003
   Stojmirovic A., 2009, ARXIV09010287
   Stojmirovic A, 2004, TOPOL P, V28, P655
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930
   Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744
   Wensley B., STRUCTURE LYSOZYME A
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 60
TC 6
Z9 6
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4468
J9 ANTIBODIES
JI Antibodies
PD SEP
PY 2018
VL 7
IS 3
AR 23
DI 10.3390/antib7030023
PG 24
WC Immunology
SC Immunology
GA GY1XR
UT WOS:000448330700003
PM 31544875
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oliva, LO
   La Corte, R
   Santana, MO
   de Albuquerque, CMR
AF Oliva, Luciana O.
   La Corte, Roseli
   Santana, Marcelo O.
   de Albuquerque, Cleide M. R.
TI Quiescence in Aedes aegypti: Interpopulation Differences Contribute to
   Population Dynamics and Vectorial Capacity
SO INSECTS
LA English
DT Article
DE biological cycle; Culicidae; desiccation resistance; development; egg
   dormancy; fitness; mosquito; plasticity; reproduction
ID 1ST INSTAR QUIESCENCE; DIPTERA-CULICIDAE; DESICCATION RESISTANCE;
   CULEX-QUINQUEFASCIATUS; ANOPHELES-AQUASALIS; SKIP-OVIPOSITION;
   SURVIVAL-TIME; MOSQUITO EGGS; DENGUE; OXYGEN
AB The strategy of Aedes aegypti to prolong embryonic viability by quiescence has severe implications for geographic expansion and maintenance of mosquito populations in areas under control measures. We evaluated the effects of quiescence on biological parameters directly or indirectly associated with population dynamics and vectorial capacity in populations of this mosquito species from two Brazilian municipalities characterized as dengue, chikungunya, and Zika transmission areas. Egg viability, initial hatching time, post-embryonic development time, adult emergence rate, sexual proportion, adult size, fecundity, and fertility were analyzed using eggs stored for 10, 40, 70, 100, 130, and 160 d. Quiescence time reduced overall egg viability and post-embryonic development time in both municipalities but was more costly in Aracaju (100 d, 8 d) than in Recife (130 d, 7.5 d). Emergence rates increased in Recife when the eggs were older, but not in Aracaju. Significant deviations in sexual proportion, with male predominance, were observed in both populations. Initial hatch, fecundity, fertility, and adult size did not significantly influence egg quiescence time. These results indicate intrinsic and differential characteristics for each A. aegypti population, suggesting a differential cost of quiescence for population dynamics parameters that can indirectly affect vectorial capacity and control measures.
C1 [Oliva, Luciana O.; de Albuquerque, Cleide M. R.] Univ Fed Pernambuco UFPE, Dept Zool, Ctr Biociencias, BR-50670901 Recife, PE, Brazil.
   [Oliva, Luciana O.; La Corte, Roseli] Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Dept Morfol, BR-49100000 Sao Cristovao, Brazil.
   [Santana, Marcelo O.] UFS, Dept Educ Saude, BR-49400000 Lagarto, Brazil.
RP Oliva, LO; de Albuquerque, CMR (corresponding author), Univ Fed Pernambuco UFPE, Dept Zool, Ctr Biociencias, BR-50670901 Recife, PE, Brazil.; Oliva, LO (corresponding author), Univ Fed Sergipe, Ctr Ciencias Biol & Saude, Dept Morfol, BR-49100000 Sao Cristovao, Brazil.
EM oliva.luciana@gmail.com; rlacorte@ufs.br; mcelooliva@gmail.com;
   cleide.ufpe@gmail.com
RI Albuquerque, Cleide MR/I-2521-2012; Santos, Roseli LC/F-1735-2015
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE) [APQ 0153-2.04/16]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq) [307759/2015-6]
FX Grateful thanks to the Fundacao de Amparo a Ciencia e Tecnologia do
   Estado de Pernambuco (FACEPE) for the financial support (APQ
   0153-2.04/16) provided for this study. We are also very grateful to
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for
   a research productivity funding (Fellowship#307759/2015-6) to CMR
   Albuquerque.
CR Alaniz AJ, 2017, INT J EPIDEMIOL, V46, P966, DOI 10.1093/ije/dyw366
   Diniz DFA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2235-0
   Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5
   Ayres CFJ, 2004, J AM MOSQUITO CONTR, V20, P350
   Ayres M., 2014, BIOESTAT 5 3 APLICAC
   Banu S, 2016, NEGLECT TROP DIS, P237, DOI 10.1007/978-3-319-43148-2_9
   Capinha C, 2014, ECOHEALTH, V11, P420, DOI 10.1007/s10393-014-0918-y
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Colton YM, 2003, MED VET ENTOMOL, V17, P195, DOI 10.1046/j.1365-2915.2003.00424.x
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS, V11
   CRAIG GB, 1961, B WORLD HEALTH ORGAN, V24, P527
   da Silva Heloisa Helena Garcia, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P349, DOI 10.1590/S0037-86821999000400003
   Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Farnesi LC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006063
   Farnesi LC, 2015, J INSECT PHYSIOL, V83, P43, DOI 10.1016/j.jinsphys.2015.10.006
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Faull KJ, 2015, J VECTOR ECOL, V40, P292, DOI 10.1111/jvec.12167
   Gama RA, 2005, REV SOC BRAS MED TRO, V38, P64, DOI 10.1590/S0037-86822005000100014
   Gjullin CM, 1941, J CELL COMPAR PHYSL, V17, P193, DOI 10.1002/jcp.1030170205
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Harbach R.E., 1980, TAXONOMISTS GLOSSARY
   HICKEY WA, 1966, GENETICS, V53, P1177
   Jacobsen D, 2008, OECOLOGIA, V154, P795, DOI 10.1007/s00442-007-0877-x
   JUDSON CHARLES L., 1960, ANN ENT SOC AMER, V53, P688, DOI 10.1093/aesa/53.5.688
   JUDSON CL, 1967, ENTOMOL EXP APPL, V10, P181, DOI 10.1007/BF00302240
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   KBewer J. W., 1961, Annals of the Entomological Society of America, V54, P912
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krzywinska E, 2016, HEREDITY, V117, P408, DOI 10.1038/hdy.2016.57
   Mendonca J.A., 2016, QUIESCENCIA OVOS POP
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MOSS JI, 1991, J ECON ENTOMOL, V84, P537, DOI 10.1093/jee/84.2.537
   Mourya DT, 2001, ACTA VIROL, V45, P67
   Nsoesie EO, 2016, EUROPEAN COMMUNICABL, V21, P1, DOI DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Oliva LO, 2014, J INSECT BEHAV, V27, P81, DOI 10.1007/s10905-013-9407-3
   Peacock AJ, 1998, BRIT MED J, V317, P1063
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Perez MH, 2013, J INSECT PHYSIOL, V59, P318, DOI 10.1016/j.jinsphys.2012.12.007
   Perez MH, 2012, J INSECT PHYSIOL, V58, P824, DOI 10.1016/j.jinsphys.2012.03.005
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P942
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Satoto TBT, 2018, ENVIRON HEALTH PREV, V23, DOI 10.1186/s12199-018-0711-6
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Soares-Pinheiro VC, 2017, BRAZ J BIOL, V77, P396, DOI 10.1590/1519-6984.19815
   SOTA T, 1992, ENTOMOL EXP APPL, V63, P155, DOI 10.1007/BF00343575
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   Vargas HCM, 2014, J INSECT PHYSIOL, V62, P54, DOI 10.1016/j.jinsphys.2014.02.001
   Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
NR 59
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD SEP
PY 2018
VL 9
IS 3
AR 111
DI 10.3390/insects9030111
PG 14
WC Entomology
SC Entomology
GA GY1YY
UT WOS:000448335000039
PM 30200417
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Almeida, RD
   Racine, T
   Magalhaes, KG
   Kobinger, GP
AF Almeida, Raquel das Neves
   Racine, Trina
   Magalhaes, Kelly G.
   Kobinger, Gary P.
TI Zika Virus Vaccines: Challenges and Perspectives
SO VACCINES
LA English
DT Review
DE zika virus; flaviviruses; vaccines; animal models; immunopathology;
   immune responses; challenge; clinical trials
ID FLAVIVIRUS INFECTION ENHANCEMENT; ANTIBODY-DEPENDENT ENHANCEMENT;
   JAPANESE ENCEPHALITIS VACCINE; DENGUE VIRUS; DNA VACCINE; PROTEIN NS1;
   PHASE-III; IMMUNOGENICITY; SAFETY; PROTECTION
AB Zika virus is an arbovirus that has rapidly spread within the Americas since 2014, presenting a variety of clinical manifestations and neurological complications resulting in congenital malformation, microcephaly, and possibly, in male infertility. These significant clinical manifestations have led investigators to develop several candidate vaccines specific to Zika virus. In this review we describe relevant targets for the development of vaccines specific for Zika virus, the development status of various vaccine candidates and their different platforms, as well as their clinical progression.
C1 [Almeida, Raquel das Neves; Magalhaes, Kelly G.] Univ Brasilia, Lab Immunol & Inflammat, BR-70910900 Brasilia, DF, Brazil.
   [Racine, Trina; Kobinger, Gary P.] Univ Laval, CHU Quebec, Ctr Rech Infectiol, Quebec City, PQ G1V 4G2, Canada.
   [Racine, Trina; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.
   [Kobinger, Gary P.] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada.
   [Kobinger, Gary P.] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebc, PQ G1V 0A6, Canada.
   [Kobinger, Gary P.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Kobinger, GP (corresponding author), Univ Laval, CHU Quebec, Ctr Rech Infectiol, Quebec City, PQ G1V 4G2, Canada.; Kobinger, GP (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.; Kobinger, GP (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada.; Kobinger, GP (corresponding author), Univ Laval, Dept Microbiol Infectiol & Immunol, Quebc, PQ G1V 0A6, Canada.; Kobinger, GP (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
EM raquel.das-neves-almeida.1@ulaval.ca;
   trina.racine@crchudequebec.ulaval.ca; kellymagalhaes@gmail.com;
   Gary.Kobinger@crchudequebec.ulaval.ca
RI Magalhaes, Kelly Grace/L-6081-2019; Magalhaes, Kelly G/A-6966-2010
OI Magalhaes, Kelly Grace/0000-0002-7435-5272; Magalhaes, Kelly
   G/0000-0002-7435-5272; Racine, Trina/0000-0001-6370-8661
CR Agarwal A., 2016, SCIENCE, V353, P1
   Ahlers LRH, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00096
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Astill J, 2018, VACCINE, V36, P3908, DOI 10.1016/j.vaccine.2018.05.093
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Committee G. A. W, SAF IMM PREGN
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubaut JP, 2017, J ASSIST REPROD GEN, V34, P1237, DOI 10.1007/s10815-017-0988-1
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franco LD, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0395-z
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   GOLLINS SW, 1985, J GEN VIROL, V66, P1969, DOI 10.1099/0022-1317-66-9-1969
   GOLLINS SW, 1984, J GEN VIROL, V65, P1261, DOI 10.1099/0022-1317-65-8-1261
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hasson Sidgi Syed Anwer Abdo, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P344, DOI 10.1016/S2221-1691(15)30366-X
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KLIKS S, 1990, AIDS RES HUM RETROV, V6, P993, DOI 10.1089/aid.1990.6.993
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Lyons A, 2007, VACCINE, V25, P3445, DOI 10.1016/j.vaccine.2006.12.046
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Martins KAO, 2016, EBIOMEDICINE, V3, P67, DOI 10.1016/j.ebiom.2015.11.041
   Maslow JN, 2017, VACCINE, V35, P5437, DOI 10.1016/j.vaccine.2017.02.015
   Matsui K, 2010, J GEN VIROL, V91, P2249, DOI 10.1099/vir.0.021220-0
   Miyazaki C, 2014, CLIN VACCINE IMMUNOL, V21, P188, DOI 10.1128/CVI.00377-13
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Monath T.P., 2005, EXPERT REV VACCINES, DOI [10.1136/bmj.324.7335.439, DOI 10.1136/BMJ.324.7335.439]
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023
   Monath TP, 2002, VACCINE, V20, P1004, DOI 10.1016/S0264-410X(01)00457-1
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Mutebi JP, 2004, EMERG INFECT DIS, V10, P1657
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roehrig JT, 2013, VIROLOGY, V441, P114, DOI 10.1016/j.virol.2013.03.011
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
   Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Yang ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep43829
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou ZH, 2014, CURR OPIN VIROL, V5, P111, DOI 10.1016/j.coviro.2014.04.001
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 97
TC 8
Z9 8
U1 2
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD SEP
PY 2018
VL 6
IS 3
AR 62
DI 10.3390/vaccines6030062
PG 13
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GY1ZR
UT WOS:000448337100001
PM 30217027
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Knecht, H
   Richards, SL
   Balanay, JAG
   White, AV
AF Knecht, Heidi
   Richards, Stephanie L.
   Balanay, Jo Anne G.
   White, Avian V.
TI Impact of Mosquito Age and Insecticide Exposure on Susceptibility of
   Aedes albopictus (Diptera: Culicidae) to Infection with Zika Virus
SO PATHOGENS
LA English
DT Article
DE vector competence; mosquito age; Zika; insecticides
ID VECTOR COMPETENCE; WEST NILE; AEGYPTI; CULEX; BIOLOGY
AB Zika virus (ZIKV) is primarily transmitted to humans by Aedes aegypti and Ae. albopictus. Vector-virus interactions influencing vector competence vary and depend on biological and environmental factors. A mosquito's chronological age may impact its immune response against virus infection. Insecticides, source reduction, and/or public education are currently the best defense against mosquitoes that transmit ZIKV. This study assessed the effects of a mosquito's chronological age at time of infection on its response to ZIKV infection. We exposed young (6-7 d post-emergence) and old (11-12 d post-emergence) Ae. albopictus to a sublethal dose of bifenthrin prior to oral exposure to blood meals containing ZIKV (7-day incubation period). Old mosquitoes experienced a significantly (p < 0.01) higher rate of mortality than young mosquitoes. Significantly higher ZIKV body titers (p < 0.01) were observed in the old control group compared to the young control group. Significantly higher (p < 0.01) ZIKV dissemination rates and leg titers (p < 0.01) were observed in old bifenthrin-exposed mosquitoes compared to old control mosquitoes or young bifenthrin-exposed or control mosquitoes. Hence, bifenthrin exposure may increase the potential for virus transmission; however, the degree of these impacts varies with mosquito age. Impacts of insecticides should be considered in risk assessments of potential vector populations.
C1 [Knecht, Heidi; Richards, Stephanie L.; Balanay, Jo Anne G.; White, Avian V.] East Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Environm Hlth Sci Program, Greenville, NC 27858 USA.
RP Richards, SL (corresponding author), East Carolina Univ, Coll Hlth & Human Performance, Dept Hlth Educ & Promot, Environm Hlth Sci Program, Greenville, NC 27858 USA.
EM knechth16@students.ecu.edu; richardss@ecu.edu; balanayj@ecu.edu;
   whiteav15@ecu.edu
RI /AAD-1974-2020
OI /0000-0003-3173-3293
CR Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Boete C, 2003, TRENDS PARASITOL, V19, P32, DOI 10.1016/S1471-4922(02)00003-X
   Chan K.L., 1970, P STER PRINC INS CON
   CHEN WJ, 1993, J MED ENTOMOL, V30, P524, DOI 10.1093/jmedent/30.3.524
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6
   Glunt KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024968
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lee C.Y., 2000, J BIOSCIENCE, V11, P107
   Lee H. L., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P664
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL, V54, P251, DOI 10.1093/jme/tjw212
   PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009
   Richards S.L., 2005, AM J TROP MED HYG, V73, P543
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Richards SL, 2017, RES REP TROP MED, V8, P53, DOI 10.2147/RRTM.S133411
   Richards SL, 2017, J MED ENTOMOL, V54, P682, DOI 10.1093/jme/tjw231
   Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776
   Richards SL, 2009, AM J TROP MED HYG, V81, P264, DOI 10.4269/ajtmh.2009.81.264
   VanDusen AE, 2016, PEST MANAG SCI, V72, P1004, DOI 10.1002/ps.4081
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 30
TC 3
Z9 3
U1 3
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-0817
J9 PATHOGENS
JI Pathogens
PD SEP
PY 2018
VL 7
IS 3
AR 67
DI 10.3390/pathogens7030067
PG 9
WC Microbiology
SC Microbiology
GA GX7IP
UT WOS:000447941500011
PM 30103526
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sakkas, H
   Bozidis, P
   Giannakopoulos, X
   Sofikitis, N
   Papadopoulou, C
AF Sakkas, Hercules
   Bozidis, Petros
   Giannakopoulos, Xenofon
   Sofikitis, Nikolaos
   Papadopoulou, Chrissanthy
TI An Update on Sexual Transmission of Zika Virus
SO PATHOGENS
LA English
DT Review
DE Zika virus; flavivirus; Aedes; Host-virus interactions; testis; sexual
   transmission; epidemics
ID VECTOR-BORNE TRANSMISSION; DENGUE VIRUS; ENDOTHELIAL-CELLS; VIRAL LOAD;
   INFECTION; AXL; RECEPTORS; TARGETS; STATES; ADULT
AB Zika virus (ZIKV) is a single-stranded RNA virus belonging to the arthropod-borne flaviviruses (arboviruses) which are mainly transmitted by blood-sucking mosquitoes of the genus Aedes. ZIKV infection has been known to be rather asymptomatic or presented as febrile self-limited disease; however, during the last decade the manifestation of ZIKV infection has been associated with a variety of neuroimmunological disorders including Guillain-Barre syndrome, microcephaly and other central nervous system abnormalities. More recently, there is accumulating evidence about sexual transmission of ZIKV, a trait that has never been observed in any other mosquito-borne flavivirus before. This article reviews the latest information regarding the latter and emerging role of ZIKV, focusing on the consequences of ZIKV infection on the male reproductive system and the epidemiology of human-to-human sexual transmission.
C1 [Sakkas, Hercules; Bozidis, Petros; Papadopoulou, Chrissanthy] Univ Ioannina, Dept Microbiol, Fac Med, Sch Hlth Sci, GR-45110 Ioannina, Greece.
   [Giannakopoulos, Xenofon; Sofikitis, Nikolaos] Univ Ioannina, Dept Urol, Fac Med, Sch Hlth Sci, GR-45110 Ioannina, Greece.
RP Sakkas, H; Bozidis, P (corresponding author), Univ Ioannina, Dept Microbiol, Fac Med, Sch Hlth Sci, GR-45110 Ioannina, Greece.
EM isakkas@uoi.gr; pbozidis@cc.uoi.gr; xgiannakop@cc.uoi.gr;
   nsofikit@cc.uoi.gr; cpapadop@uoi.gr
RI Papadopoulou, Chrissanthy/AAC-2390-2019; Sakkas, Hercules/AAH-8344-2019;
   Bozidis, Petros/AAC-8283-2019
OI Papadopoulou, Chrissanthy/0000-0002-1628-1009; Sakkas,
   Hercules/0000-0002-2495-8374
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   [Anonymous], ZIK VIR 2017 CAS COU
   [Anonymous], ZIK VIR SEX TRANSM P
   [Anonymous], SEX TRANSM ZIK VIR C
   [Anonymous], 2017, SIT REP ZIKA VIR MIC
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carabali M, 2018, GLOB HEALTH RES POL, V3, DOI 10.1186/s41256-018-0069-8
   Chen Lin H, 2016, Trop Dis Travel Med Vaccines, V2, P15, DOI 10.1186/s40794-016-0032-y
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Depoux A, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0087-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Guerra-Reyes L, 2019, CULT HEALTH SEX, V21, P309, DOI 10.1080/13691058.2018.1469790
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Holtzman M, 2018, CLIN OBSTET GYNECOL, V61, P177, DOI 10.1097/GRF.0000000000000343
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li B, 2013, BIOCHEM J, V452, P139, DOI 10.1042/BJ20121671
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Shelby T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07620-y
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Urcuqui-Inchima S, 2017, ANTIVIR RES, V147, P47, DOI 10.1016/j.antiviral.2017.09.017
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, INT CLIN TRIALS REG
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang Y, 2012, CELL RES, V22, P773, DOI 10.1038/cr.2012.17
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 94
TC 11
Z9 12
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD SEP
PY 2018
VL 7
IS 3
AR 66
DI 10.3390/pathogens7030066
PG 14
WC Microbiology
SC Microbiology
GA GX7IP
UT WOS:000447941500010
PM 30081445
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chaikham, N
   Sawangtong, W
AF Chaikham, Nonthamon
   Sawangtong, Wannika
TI Sub-Optimal Control in the Zika Virus Epidemic Model Using Differential
   Evolution
SO AXIOMS
LA English
DT Article
DE Zika virus; sexual transmission; vertical transmission; sub-optimal
   control problem; differential evolution
ID SEXUAL TRANSMISSION; AEGYPTI; DISEASE
AB A dynamical model of Zika virus (ZIKV) epidemic with direct transmission, sexual transmission, and vertical transmission is developed. A sub-optimal control problem to counter against the disease is proposed including three controls: vector elimination, vector-to-human contact reduction, and sexual contact reduction. Each control variable is discretized into piece-wise constant intervals. The problem is solved by Differential Evolution (DE), which is one of the evolutionary algorithm developed for optimization. Two scenarios, namely four time horizons and eight time horizons, are compared and discussed. The simulations show that models with controls lead to decreasing the number of patients as well as epidemic period length. From the optimal solution, vector elimination is the prioritized strategy for disease control.
C1 [Chaikham, Nonthamon; Sawangtong, Wannika] Mahidol Univ, Fac Sci, Dept Math, Bangkok 10400, Thailand.
   [Chaikham, Nonthamon; Sawangtong, Wannika] Minist Educ, Commiss Higher Educ, Ctr Excellence Math, 328 Sri Ayuthaya Rd, Bangkok 10400, Thailand.
RP Sawangtong, W (corresponding author), Mahidol Univ, Fac Sci, Dept Math, Bangkok 10400, Thailand.; Sawangtong, W (corresponding author), Minist Educ, Commiss Higher Educ, Ctr Excellence Math, 328 Sri Ayuthaya Rd, Bangkok 10400, Thailand.
EM nonthamon.chi@student.mahidol.ac.th; wannika.saw@mahidol.ac.th
OI Sawangtong, Wannika/0000-0002-5363-0773
FU Centre of Excellence in Mathematics, PERDO, CHE, Thailand; Golden
   Jubilee Scholarship from Faculty of science, Mahidol university,
   Thailand
FX This research was supported by Centre of Excellence in Mathematics,
   PERDO, CHE, Thailand and Golden Jubilee Scholarship from Faculty of
   science, Mahidol university, Thailand.
CR Agusto F B, 2017, Infect Dis Model, V2, P244, DOI 10.1016/j.idm.2017.05.003
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bewick S., 2016, BIORXIV, DOI [10.1101/041897, DOI 10.1101/041897]
   Caetano MAL, 2001, OPTIM CONTR APPL MET, V22, P63, DOI 10.1002/oca.683
   Camacho E.F., 2007, MODEL PREDICTIVE CON, P1
   Carter M.T., 2013, MICROCEPHALY CAPILLA
   Centers for Disease Control and Prevention (CDC), 2016, UPD INT GUID PREV SE
   Chaikham N, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1220-4
   Chalishajar D., 2014, J ENG APPL SCI, V5, P36
   Chalishajar D., 2016, APPL MATH, V7, P1087, DOI [10.4236/am.2016.710097, DOI 10.4236/AM.2016.710097]
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   European Centre for Disease Prevention and Control, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grune L, 2009, SIAM J CONTROL OPTIM, V48, P1206, DOI 10.1137/070707853
   Herty M., 2015, ARXIV151108364
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lashari AA, 2012, NONLINEAR ANAL-REAL, V13, P203, DOI 10.1016/j.nonrwa.2011.07.026
   Lenhart S., 2007, OPTIMAL CONTROL APPL, P1
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Moulay D, 2012, MATH BIOSCI ENG, V9, P369, DOI 10.3934/mbe.2012.9.369
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Price K., 2005, DIFFERENTIAL EVOLUTI, P37
   Rodrigues HS, 2014, MATH BIOSCI, V247, P1, DOI 10.1016/j.mbs.2013.10.006
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Wikipedia, LIST SOV STAT DEP TE
   World Health Organization, MICR BRAZ DIS OUTBR
   World Health Organization, MOS CONTR CAN IT STO
   World Health Organization (WHO), ZIK SIT REP
   Yan X., 2007, WORLD J MODEL SIMUL, V3, P202
   Yan X, 2008, MATH COMPUT MODEL, V47, P235, DOI 10.1016/j.mcm.2007.04.003
NR 38
TC 1
Z9 1
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1680
J9 AXIOMS
JI Axioms
PD SEP
PY 2018
VL 7
IS 3
AR 61
DI 10.3390/axioms7030061
PG 14
WC Mathematics, Applied
SC Mathematics
GA GX6XZ
UT WOS:000447908400019
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Balaini, N
   Lal, V
AF Balaini, Neeraj
   Lal, Vivek
TI Zika virus: A wake up call
SO NEUROLOGY INDIA
LA English
DT Editorial Material
ID INFECTION
C1 [Balaini, Neeraj; Lal, Vivek] Post Grad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.
RP Lal, V (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurol, Chandigarh, India.
EM vivekl44@yahoo.com
CR Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Joob B, 2017, NEUROL INDIA, V65, P439, DOI 10.4103/neuroindia.NI_912_16
   Keane I, 2018, ZIKA VIRUS REV MAIN, V51, P261
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
NR 8
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD SEP-OCT
PY 2018
VL 66
IS 5
BP 1286
EP 1287
DI 10.4103/0028-3886.241374
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA GX3ES
UT WOS:000447605100008
PM 30232986
DA 2020-07-08
ER

PT J
AU Garg, RK
   Jain, A
   Rizvi, I
AF Garg, Ravindra Kumar
   Jain, Amita
   Rizvi, Imran
TI Guillain-Barre syndrome caused by Zika virus: A wake-up call for India
SO NEUROLOGY INDIA
LA English
DT Editorial Material
ID DISTRICT-OF-COLUMBIA; DENGUE VIRUS; INFECTION; COLOMBIA; STATES
C1 [Garg, Ravindra Kumar; Rizvi, Imran] King Georges Med Univ, Dept Neurol, Lucknow 226003, Uttar Pradesh, India.
   [Jain, Amita] King Georges Med Univ, Dept Microbiol, Lucknow, Uttar Pradesh, India.
RP Garg, RK (corresponding author), King Georges Med Univ, Dept Neurol, Lucknow 226003, Uttar Pradesh, India.
EM garg50@yahoo.com
CR Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Grill Marie F, 2018, Continuum (Minneap Minn), V24, P441, DOI 10.1212/CON.0000000000000597
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   Leonhard SE, 2018, PRACT NEUROL
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Long D, 2016, J EMERG MED, V50, P832, DOI 10.1016/j.jemermed.2016.03.033
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Raboni SM, 2017, TRANSPL INFECT DIS, P19
   Rockstroh A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.87
   Uncini A, 2018, EUR J NEUROL, V25, P644, DOI 10.1111/ene.13552
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   WHO, 2017, DIS OUTBREAK NE 0208
NR 18
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD SEP-OCT
PY 2018
VL 66
IS 5
BP 1290
EP 1292
DI 10.4103/0028-3886.241356
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA GX3ES
UT WOS:000447605100010
PM 30232988
DA 2020-07-08
ER

PT J
AU Baskar, D
   Amalnath, D
   Mandal, J
   Dhodapkar, R
   Vanathi, K
AF Baskar, Dipti
   Amalnath, Deepak
   Mandal, Jharna
   Dhodapkar, Rahul
   Vanathi, K.
TI Antibodies to Zika virus, Campylobacter jejuni and gangliosides in
   Guillain-Barre syndrome: A prospective single-center study from southern
   India
SO NEUROLOGY INDIA
LA English
DT Article
DE Anti-ganglioside antibodies; Campylobacter jejuni; Guillain-Barre
   syndrome; India; Zika virus
ID INFECTION
AB Background: The objective of this article was to study the presence of antibodies against Zika virus (ZIKV), Campylobacter jejuni, and gangliosides in patients with Guillain-Barre syndrome (GBS).
   Materials and Methods: Ninety consecutive patients (age more than 12 years) with GBS admitted to a tertiary care center in southern India were included in this study. Data on clinical manifestations, nerve conduction studies, and response to therapy were collected. The following tests were done in stored serum samples -anti-ZIKV (IgM) antibodies, anti-C. jejuni (IgG) antibodies, and anti-ganglioside antibodies (IgG). Those samples which were positive to anti-Zika antibodies were tested for conventional polymerase chain reaction for ZIKV and IgM antibodies against dengue, and Japanese encephalitis virus.
   Results: Of the 90 patients, 3 died and 8 had persistent weakness. Acute inflammatory demyelinating polyradiculoneuropathy was the most common type of GBS (56.7%). Anti-ganglioside antibodies were present in 62.2% patients with GT1b being the most common. Anti-C. jejuni antibodies were present in 46.6%. Anti-Zika antibodies (IgM) were present in 14 patients (15.5%). Four of these patients also had anti-dengue antibody (IgM) positivity.
   Conclusion: This is one of the largest studies on GBS from India and the first one to report on the presence of Zika virus antibodies from this geographical area. Our study had a high prevalence of anti-C. jejuni and anti-ganglioside antibodies. Evidence of recent ZIKV infection, as evidenced by anti-IgM antibodies, was present in 14 patients, with 4 of them being tested positive for anti-dengue IgM antibody. Whether this represents cross-reaction with dengue or prior/co-infection with dengue virus could not be addressed in this study.
C1 [Baskar, Dipti; Amalnath, Deepak] Jawaharlal Inst Postgrad Med Educ & Res, Dept Gen Med, Pondicherry, India.
   [Mandal, Jharna; Dhodapkar, Rahul; Vanathi, K.] Jawaharlal Inst Postgrad Med Educ & Res, Dept Microbiol, Pondicherry, India.
RP Baskar, D (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Gen Med, Pondicherry, India.
EM diptibaskar@gmail.com
RI Mandal, Jharna/AAF-5908-2020
CR ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Gorthi SP, 2006, NATL MED J INDIA, V19, P137
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hajra A, 2016, NEUROL INDIA, V64, P1102, DOI 10.4103/0028-3886.190249
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Joob B, 2017, NEUROL INDIA, V65, P439, DOI 10.4103/neuroindia.NI_912_16
   Kalra V, 2009, INDIAN J PEDIATR, V76, P795, DOI 10.1007/s12098-009-0125-y
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sharma A, 2011, Neurol India, V59, P717, DOI 10.4103/0028-3886.86547
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   Takahashi M, 2005, J CLIN MICROBIOL, V43, P335, DOI 10.1128/JCM.43.1.335-339.2005
   World Health Organization, ZIK VIR INF IND
NR 17
TC 8
Z9 8
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0028-3886
EI 1998-4022
J9 NEUROL INDIA
JI Neurol. India
PD SEP-OCT
PY 2018
VL 66
IS 5
BP 1324
EP 1331
DI 10.4103/0028-3886.241402
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA GX3ES
UT WOS:000447605100020
PM 30232998
DA 2020-07-08
ER

PT J
AU Batista, AC
   Pacheco, LGC
AF Batista, Angelo C.
   Pacheco, Luis G. C.
TI Detecting pathogens with Zinc-Finger, TALE and CRISPR- based
   programmable nucleic acid binding proteins
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Review
DE DNA binding proteins; Nucleic acid detection; Molecular diagnostics;
   CRISPR
ID DOUBLE-STRANDED DNA; ELECTROCHEMICAL DETECTION; DETECTION SYSTEM;
   DIAGNOSTICS; LUCIFERASE; BACTERIA; AMPLIFICATION; NUCLEASES; SEQUENCES;
   PLATFORM
AB The recent availability of highly adaptable engineered nucleic acid binding proteins has brought about a revolution in the genome-editing field. Now, several studies have harnessed these Zinc-Finger-based, Transcription Activator-like Effector (TALE)-based, and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based programmable DNA and RNA-binding proteins to develop very specific diagnostic platforms to detect pathogen's nucleic acids, with sensitivities that go down to single molecule resolution. Particularly, the very recent descriptions of novel CRISPR associated enzymes with different target specificities and activities, including Cas13a (C2c2), Cas12a (Cpf1) and Csm6, have subsided the development of methods such as the DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) and the Specific High-Sensitivity Enzymatic Reporter UnLOCKing (SHERLOCK). The reliabilities of these new diagnostic technologies have already been demonstrated for detection of nucleic acids from classical bacterial pathogens and also for emerging viral threats, including Zika virus. Besides, efficient genotyping capabilities have been reported for some technologies, that were shown, for instance, to be able to differentiate between human papillomavirus (HPV) types 16 and 18. Recent advancements that include improvements in multiplexing and quantitative capabilities, and instrument-free detection of results will potentially leverage the introduction of these new technologies to bacterial and viral detection at the point-of-care.
C1 [Batista, Angelo C.; Pacheco, Luis G. C.] Fed Univ Bahia UFBA, Postgrad Program Biotechnol, Inst Hlth Sci, Salvador, BA, Brazil.
   [Batista, Angelo C.] Natl Inst Agr Res INRA, Food & Digest Microbiol Human Hlth MICALIS, Jouy En Josas, France.
RP Pacheco, LGC (corresponding author), Fed Univ Bahia UFBA, Postgrad Program Biotechnol, Inst Hlth Sci, Salvador, BA, Brazil.
EM Angelo.CardosoBatista@inra.fr; luis.pacheco@ufba.br
RI Pacheco, Luis G C/K-3092-2012
OI Pacheco, Luis/0000-0003-2500-0800; Cardoso Batista,
   Angelo/0000-0003-0161-8462
FU FAPESB; CNPqNational Council for Scientific and Technological
   Development (CNPq) [FAPESB/CNPq 009/2014 - PRONEM]; CAPESCAPES
FX Work at our group is funded by FAPESB and CNPq (grant FAPESB/CNPq
   009/2014 - PRONEM). ACB was recipient of a scholarship from CAPES.
CR Abe K, 2012, ANAL CHEM, V84, P8028, DOI 10.1021/ac3018845
   Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245
   Chertow DS, 2018, SCIENCE, V360, P381, DOI 10.1126/science.aat4982
   Deiman B, 2002, MOL BIOTECHNOL, V20, P163, DOI 10.1385/MB:20:2:163
   Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Guk K, 2017, BIOSENS BIOELECTRON, V95, P67, DOI 10.1016/j.bios.2017.04.016
   Honarmand A, 2014, ACS SYNTH BIOL, V3, P953, DOI 10.1021/sb500045w
   Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686
   Kim JS, 2016, NAT PROTOC, V11, P1573, DOI 10.1038/nprot.2016.104
   Kim MS, 2016, ANAL METHODS-UK, V8, P6696, DOI [10.1039/c6ay02102f, 10.1039/C6AY02102F]
   Kim MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1214
   Lee J, 2017, BIOSENS BIOELECTRON, V93, P118, DOI 10.1016/j.bios.2016.09.060
   Lee J, 2014, ANAL METHODS-UK, V6, P4991, DOI 10.1039/c4ay00977k
   Li SY, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0028-z
   Murugan K, 2017, MOL CELL, V68, P15, DOI 10.1016/j.molcel.2017.09.007
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Nakade S, 2017, BIOENGINEERED, V8, P265, DOI 10.1080/21655979.2017.1282018
   Nayak S., 2016, ANAL CHEM ACS ANALCH, DOI [10.1021/acs.analchem.6604630, DOI 10.1021/ACS.ANALCHEM.6604630]
   Nerys A, 2018, GENET MOL BIOL, V41, P167, DOI [10.1590/1678-4685-GMB-2017-0065, 10.1590/1678-4685-gmb-2017-0065]
   Ooi AT, 2006, BIOCHEMISTRY-US, V45, P3620, DOI 10.1021/bi0517032
   Osawa Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn274
   Osawa Y, 2009, BIOTECHNOL LETT, V31, P725, DOI 10.1007/s10529-009-9927-2
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007
   Qiu XY, 2018, ACS SYNTH BIOL, V7, P807, DOI 10.1021/acssynbio.7b00446
   Shi C, 2017, J AGR FOOD CHEM, V65, P6674, DOI 10.1021/acs.jafc.7b02204
   Slomovic S, 2015, P NATL ACAD SCI USA, V112, P14429, DOI 10.1073/pnas.1508521112
   Stains CI, 2005, J AM CHEM SOC, V127, P10782, DOI 10.1021/ja051969w
   Strutt SC, 2018, ELIFE, V7, DOI 10.7554/eLife.32724
   Takano E, 2017, MICROCHIM ACTA, V184, P1595, DOI 10.1007/s00604-017-2152-0
   Wang Q, 2017, BIOMETALS, DOI [10.1101/236588, DOI 10.1101/236588]
   Waryah CB, 2018, METHODS MOL BIOL, V1767, P19, DOI 10.1007/978-1-4939-7774-1_2
   Wei TY, 2016, CELL CHEM BIOL, V23, P1056, DOI 10.1016/j.chembiol.2016.07.016
   Yin P, 2012, CELL REP, V2, P707, DOI 10.1016/j.celrep.2012.09.001
   Zhang BB, 2018, ANAL BIOANAL CHEM, V410, P2889, DOI 10.1007/s00216-018-0873-5
   Zhang YH, 2017, ACS SYNTH BIOL, V6, P211, DOI 10.1021/acssynbio.6b00215
   Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428
   Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003
   Zuo XL, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0091
NR 44
TC 6
Z9 6
U1 19
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD SEP
PY 2018
VL 152
BP 98
EP 104
DI 10.1016/j.mimet.2018.07.024
PG 7
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GW6ZM
UT WOS:000447113600017
PM 30076867
DA 2020-07-08
ER

PT J
AU Alves, LV
   Paredes, CE
   Silva, GC
   Mello, JG
   Alves, JG
AF Alves, Lucas V.
   Paredes, Camila E.
   Silva, Germanna C.
   Mello, Julia G.
   Alves, Joao G.
TI Neurodevelopment of 24 children born in Brazil with congenital Zika
   syndrome in 2015: a case series study
SO BMJ OPEN
LA English
DT Article
DE paediatric neurology
AB Objective To describe the neurodevelopment of children with congenital Zika syndrome during the second year of life.
   Design Case series study.
   Setting Instituto de Medicina Integral Professor Fernando Figueira (IMIP), Pernambuco, Brazil.
   Participants 24 children with congenital Zika syndrome born with microcephaly during the Zika outbreak in Brazil in 2015 and followed up at the IMIP during their second year of life.
   Main outcome measure Denver Developmental Screening Test II, head circumference and clinical neurological examination.
   Results All children presented neurodevelopmental delay: for an average chronological age of 19.9 months, language was equivalent to that of age 2.1 months, gross motor 2.7 months, fine motor/adaptive 3.1 months and personal/social 3.4 months. Head circumference remained below the third percentile for age and gender, and growth rate up to the second year of life was 10.3cm (expected growth 13cm). Muscle tone was increased in 23 (95.5%) of 24 children, musculotendinous reflexes were increased in the whole sample and clonus was present in 18 (77.3%) of 24 children. All children except one had epilepsy.
   Conclusion Children born with microcephaly associated with congenital Zika virus have a significant neurodevelopmental delay.
C1 [Alves, Lucas V.] Inst Med Integral Prof Fernando Figueira, Dept Paediat Neurol, Recife, PE, Brazil.
   [Paredes, Camila E.; Silva, Germanna C.] Fac Pernambucana Saude, Teaching Dept, Recife, PE, Brazil.
   [Mello, Julia G.; Alves, Joao G.] Inst Med Integral Prof Fernando Figueira, Dept Paediat, Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira, Dept Paediat, Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
FU Bill & Melinda Gates FoundationGates Foundation; CNPqNational Council
   for Scientific and Technological Development (CNPq) [439986/2016-8]
FX This research was supported by Bill & Melinda Gates Foundation and CNPq
   grant 439986/2016-8.
CR Abdel-Salam GMH, 2000, DEV MED CHILD NEUROL, V42, P760, DOI 10.1017/S0012162200001419
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   FRANKENBURG WK, 1992, PEDIATRICS, V89, P91
   Gordon-Lipkin E, 2017, J CHILD NEUROL, V32, P804, DOI 10.1177/0883073817707301
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oliver SE, 2009, J CLIN VIROL, V46, pS22, DOI 10.1016/j.jcv.2009.08.012
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pinto Fernanda Chequer de Alcântara, 2015, Rev. CEFAC, V17, P1262, DOI 10.1590/1982-0216201517418214
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Toizumi M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46483
   Triunfol M, 2016, LANCET INFECT DIS, V16, P527, DOI 10.1016/S1473-3099(16)30015-9
NR 13
TC 12
Z9 12
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD SEP
PY 2018
VL 8
IS 7
AR e021304
DI 10.1136/bmjopen-2017-021304
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA GV5YI
UT WOS:000446181900118
PM 30012787
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, DM
   Noh, BE
   Heo, J
   Lee, WG
   Yang, SC
   Lee, DK
AF Kim, Dong-Min
   Noh, Byung-Eon
   Heo, Jeonghoon
   Lee, Wook-Gyo
   Yang, Sung-Chan
   Lee, Dong-Kyu
TI Seasonal Prevalence of Mosquitoes Collected from Light Traps in
   Gyeongsangnam Province, Republic of Korea (2013-2014)
SO ENTOMOLOGICAL RESEARCH
LA English
DT Article
DE Korea; light trap; mosquito; seasonal prevalence; trap index
AB Adult mosquito surveillance was conducted from 2013 through 2014 at four cattle sheds, a wild bird refuge, and two residential areas located in Gyeongnam Province in the Republic of Korea. Adult mosquitoes were collected in black light traps from April 1, through November 30. Mosquito surveillance was conducted to figure out population densities of vector mosquitoes, possibly invaded mosquitoes and identify various virus infections at the selected sites. A total of 107,466 females comprising 14 species and 7 genera were collected from 2013 to 2014. The most common species collected were Culex tritaeniorhynchus Giles (63.8%), Anopheles sinensis s.l. (18.9%), Aedes vexans nipponii (Theobald) (7.7%), and Culex pipiens Coquillett (5.1%). Trap indices (TIs) varied widely for species over their range, due to geographical distribution and degree of association with rural and urban communities. The most collected An. sinensis s.l. and Cx. tritaeniorhynchus appeared at a cow shed in Hapcheon (TI 347.5) and a pigsty in Daejeo-1-dong, Busan (TI 1,040.8), respectively, due in part to their situation near breeding sites such as rice paddies. The bi-weekly population densities for mosquito species were variable for each of the years, apparently as a result of variable annual weather conditions. None of the mosquito species collected tested for the flavivirus including Japanese Encephalitis Virus, West Nile Virus, Dengue Virus, and Zika Virus infections by polymerase chain reaction (PCR) assay were positive.
C1 [Kim, Dong-Min; Noh, Byung-Eon; Lee, Dong-Kyu] Kosin Univ, Dept Hlth & Environm, Busan, South Korea.
   [Heo, Jeonghoon] Kosin Univ, Dept Mol Biol & Immunol, Busan, South Korea.
   [Lee, Wook-Gyo; Yang, Sung-Chan] Korea Ctr Dis Control & Prevent, Div Vectors & Parasit Dis, Osong, South Korea.
RP Lee, DK (corresponding author), Kosin Univ, Dept Hlth & Environm, Busan, South Korea.
EM leedk@kosin.ac.kr
FU Korea Centers for Disease Control and Prevention [2013-E5500200,
   2013-E5500201]
FX We sincerely thank the personnel of the Public Health Center of
   Gangseo-gu, Busan that offered mosquito control information. We also
   express our gratitude to the owners of cattle sheds allowing mosquito
   collections to conduct mosquito surveillance. This work was supported by
   the Research Program funded by the Korea Centers for Disease Control and
   Prevention (fund codes: #2013-E5500200 & #2013-E5500201).
CR Chai In-Ho, 1994, Korean Journal of Parasitology, V32, P195, DOI 10.3347/kjp.1994.32.3.195
   Gambel JM, 1998, J TRAVEL MED, V5, P217, DOI 10.1111/j.1708-8305.1998.tb00511.x
   Jeong Young-Seok, 2003, Korean Journal of Applied Entomology, V42, P125
   Kim H. C., 2004, Entomological Research, V34, P177, DOI 10.1111/j.1748-5967.2004.tb00111.x
   Kim Heung Chul, 2003, Korean Journal of Entomology, V33, P189
   Korea Centers for Disease Control & Prevention (KCDC), 2012, PUBL HLTH WEEKL REP, V5, P71
   Korea Centers for Disease Control & Prevention (KCDC), 2017, PUBL HLTH WEEKL REP, V10, P88
   Lee DK, 1999, KOSIN J HLTH SCI, V9, P79
   Lee Dong-Kyu, 2009, Entomological Research, V39, P257, DOI 10.1111/j.1748-5967.2009.00231.x
   Lee Dong-Kyu, 2001, Korean Journal of Entomology, V31, P183
   Lee Jong-Soo, 1998, Korean Journal of Parasitology, V36, P241, DOI 10.3347/kjp.1998.36.4.241
   Lee JS, 2002, AM J TROP MED HYG, V66, P13, DOI 10.4269/ajtmh.2002.66.13
   LEE KW, 1998, REVISION ILLUSTRATED
   LEE S-K, 1991, Korean Journal of Entomology, V21, P141
   Makiya K., 1973, Japanese J Sanit Zool, V24, P89
   Matsuzaki S., 1990, Japanese Journal of Sanitary Zoology, V41, P247
   MOGI M, 1978, Tropical Medicine, V20, P173
   Ree Han-Il, 1993, Korean Journal of Entomology, V23, P185
   Ree HI, 1973, SE ASIAN J TROPICAL, V4, P328
   Sohn Suck Rak, 1996, Korean Journal of Entomology, V26, P21
   Tanaka K, 1979, CONTRIBUTION AM ENTO, V16, P144
   Tsai TF, 2000, VACCINES, P671
   World Health Organization, 1981, WEEKLY EPIDEMIOL REC, V56, P145
NR 23
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1738-2297
EI 1748-5967
J9 ENTOMOL RES
JI Entomol. Res.
PD SEP
PY 2018
VL 48
IS 5
BP 437
EP 445
DI 10.1111/1748-5967.12314
PG 9
WC Entomology
SC Entomology
GA GV7AG
UT WOS:000446272700013
OA Bronze
DA 2020-07-08
ER

PT J
AU Burgos-Munoz, SJ
   Toro-Huamanchumo, CJ
AF Burgos-Munoz, Sara J.
   Toro-Huamanchumo, Carlos J.
TI Zika knowledge and preventive practices among reproductive-age women
   from Lambayeque, Peru
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Zika virus; Pregnancy; Fertile period; Health knowledge; Attitudes;
   Practice (source: MeSH-NLM)
ID DENGUE KNOWLEDGE; VIRUS-INFECTION; AEDES-AEGYPTI; FAMILY; IMPACT; RISK
AB Objective: To identify the knowledge and preventive practices on Zika among reproductive-age women in Lambayeque, Peru.
   Materials and methods: We conducted a cross-sectional study in three districts of Lambayeque, Peru. A representative sample of the reproductive-age women was obtained for each district by means of a multi-stage, stratified, conglomerate based sampling method. We applied a modified version of the World Health Organization (WHO) Questionnaire about Zika. The statistical package STATA v13.0 was used for the analysis.
   Results: We surveyed 388 reproductive-age women. The 88.4% recognized the mosquito as the main transmitting agent and more than 50% recognized fever, headache and arthralgia as the main symptoms. Similarly, the practices significantly more frequent were going to their antenatal-care and check-ups, the household use of temephos (Abate), the use of clothes that cover most of the body and the washing and covering the water containers.
   Conclusions: Although there is adequate knowledge, incorrect ideas still persist and more than half of the surveyed population reported not feeling sufficiently informed. Preventive practices, in general terms, are found in acceptable compliance percentages, but they should still be improved. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Burgos-Munoz, Sara J.] Univ San Martin de Porres, Fac Med Humana, Chiclayo, Peru.
   [Toro-Huamanchumo, Carlos J.] Univ San Ignacio de Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Ave Fontana 750, Lima 00012, Peru.
   [Toro-Huamanchumo, Carlos J.] ASME, Edinburgh, Midlothian, Scotland.
RP Toro-Huamanchumo, CJ (corresponding author), Univ San Ignacio de Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Ave Fontana 750, Lima 00012, Peru.
EM toro2993@hotmail.com
RI Huamanchumo, Carlos J Toro/E-6693-2017
OI Huamanchumo, Carlos J Toro/0000-0002-4664-2856
CR Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   [Anonymous], 2016, DIARIO CORREO
   [Anonymous], 2017, AM NOTICIAS
   Martinez-Vega RA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2055-4
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BeLue R, 2017, GLOB HEALTH PROMOT, V24, P71, DOI 10.1177/1757975915614190
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Bilal M, 2016, J CLIN DIAGN RES, V20, P8
   Carrera-Lasfuentes P, 2013, ATEN PRIM, V45, P528, DOI 10.1016/j.aprim.2013.05.006
   Centro Nacional de Epidemiologia, 2017, B EP PER
   Centro Nacional de Epidemiologia, 2017, SAL SIT AN SIT SAL
   Chandren JR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003954
   Cherry CC, 2016, TRAVEL MED INFECT DI, V14, P475, DOI 10.1016/j.tmaid.2016.08.011
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   Demir T, 2016, FOLIA MICROBIOL, V61, P523, DOI 10.1007/s12223-016-0467-6
   Direccion General de Epidemiologia, 2016, DOC TECN PLAN NAC PR
   Direccion Regional de Salud Lambayeque, 2017, SAL SIT LAMB
   Duvallet G, 2011, PARASITE, V18, P93
   Ellingson MK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1516-0
   Falcao MB, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0172-y
   Haenchen SD, 2016, AM J TROP MED HYG, V95, P945, DOI 10.4269/ajtmh.15-0732
   Hermoza-Moquillaza Rocío, 2016, Rev Med Hered, V27, P15
   Jennings C, 2017, EUR J PREV CARDIOL, V24, P77, DOI 10.1177/2047487317709118
   Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692
   Lugones Botell Miguel, 2016, Rev Cubana Obstet Ginecol, P398
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Marin Rodriguez Rodrigo, 2009, Revista Cubana de Medicina Tropical, V61, P1
   Mouchtouri VA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040367
   Mundial de Organizacion Salud la, 2016, ENC CON ACT PRACT EN
   Nalongsack S, 2009, NAGOYA J MED SCI, V71, P29
   Organizacion Panamericana de la Salud, 2016, GUIA VIG ENF VIR ZIK
   Osamor PE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005127
   Pacheco-Romero J, 2016, REV PERU GINECOL OBS, V62, P247
   Paz-Soldan VA, 2015, AM J TROP MED HYG, V93, P1330, DOI 10.4269/ajtmh.15-0096
   Pena-Sanchez ER, 2016, REV EXP MED, V2, P42
   Pengvanich Veerapong, 2011, Journal of the Medical Association of Thailand, V94, P235
   RIos-Gonzalez CM, 2016, MED UNIVER, V18, P134, DOI DOI 10.1016/J.RMU.2016.04.004
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Van Dijk JAW, 2011, JOGNN-J OBST GYN NEO, V40, P98, DOI 10.1111/j.1552-6909.2010.01206.x
   Vilcarromero Stalin, 2015, Rev. perú. med. exp. salud publica, V32, P172
   Villegas-Trejo A, 2011, SALUD PUBLICA MEXICO, V53, P141, DOI 10.1590/s0036-36342011000200007
   Wong LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122890
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zammarchi L, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.056
NR 48
TC 1
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD SEP
PY 2018
VL 228
BP 255
EP 260
DI 10.1016/j.ejogrb.2018.07.017
PG 6
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GV3KC
UT WOS:000445991800043
PM 30041146
DA 2020-07-08
ER

PT J
AU Yanagisawa, N
   Wada, K
   Spengler, JD
   Sanchez-Pina, R
AF Yanagisawa, Naoki
   Wada, Koji
   Spengler, John D.
   Sanchez-Pina, Ramon
TI Health preparedness plan for dengue detection during the 2020 summer
   Olympic and Paralympic games in Tokyo
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; MASS GATHERINGS; FAILURE MODE; JAPAN; PREVENTION;
   COMPETENCE; ALBOPICTUS; MEDICINE; SPREAD; BRAZIL
AB Background
   Participants in mass gathering events are at risk of acquiring imported and locally endemic infectious diseases. The 2014 dengue outbreak in Tokyo gathered attention since it was the first time in 70 years for Japan to experience an autochthonous transmission. Preparation for emerging infectious threats is essential even in places where these outbreaks have been largely unknown. The aim of this study is to identify strategies for early detection and prevention of dengue infection during the 2020 summer Olympics and Paralympics in Tokyo.
   Methodology/Principal findings
   We modified and adapted the failure mode and effect analysis (FMEA) methodology, generally used in industrial manufacturing, to examine the current controls for dengue detection and assessment. Information on existing controls were obtained from publicly available resources. Our analysis revealed that the national infectious disease control system to detect dengue in Japan is robust. However, in the case of large assemblies of international visitors for special events when the spread of communicable and vector-borne diseases increases, there are three main gaps that could be reinforced. First, cyclical training or a certification program on tropical disease management is warranted for physicians, especially those working in non-infectious disease-designated hospitals or clinics. Second, multi-language communication methods need to be strengthened especially in the health and hospitality sector. Third, owners of accommodations should consider incorporating a formal tropical disease-training program for their staff members and have a contingency plan for infectious disease-suspected travelers.
   Conclusions/Significance
   Our findings may facilitate physicians and public health officials where new controls would be beneficial for the 2020 summer Olympics and Paralympics. The FMEA framework has the potential to be applied to other infectious diseases, not just dengue.
C1 [Yanagisawa, Naoki; Spengler, John D.; Sanchez-Pina, Ramon] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   [Wada, Koji] Int Univ Hlth & Welf, Grad Sch Publ Hlth, Tokyo, Japan.
RP Yanagisawa, N (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
EM nay516@mail.harvard.edu
OI Yanagisawa, Naoki/0000-0001-9094-9663
FU Center for Climate, Health and the Global Environment at the Harvard
   T.H. Chan School of Public Health
FX We acknowledge our colleagues of the Center for Climate, Health and the
   Global Environment at the Harvard T.H. Chan School of Public Health for
   their support.
CR Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8
   Attaran A, COMMUNICATION
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Castro Marcia C, 2017, Lancet Infect Dis, V17, pe70, DOI 10.1016/S1473-3099(16)30545-X
   Castro MC, 2016, TRAVEL MED INFECT DI, V14, P384, DOI 10.1016/j.tmaid.2016.06.007
   Centers for Disease Control and Prevention, DENG VIR INF 2015 CA
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Fukusumi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004924
   Goodrum L, 2017, ISR J HEALTH POLICY, V6, DOI 10.1186/s13584-016-0131-2
   Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144, DOI 10.3201/eid1201.050645
   International Air Transport Association (IATA), IATA FORC PASS DEM D
   Japan National Tourism Organization, JAP OFF GUID
   Kutsuna S, 2018, JPN J INFECT DIS, V71, P62, DOI 10.7883/yoken.JJID.2016.508
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Lago P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001249
   Lewnard JA, 2016, ANN INTERN MED, V165, P286, DOI 10.7326/M16-1628
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lu Y, 2013, TRANSFUSION, V53, P3080, DOI 10.1111/trf.12174
   McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9
   Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1
   Ministry of Health Labor and Welfare, NAT ACT PLAN ANT RES
   Ministry of Health Labour and Welfare, 2016, 2016 SURV SUMM PHYS, DOI 10.7883/yoken.JJID.2016.508
   Ministry of Health Labour and Welfare, INF HOSP CLIN
   Mogi M, 2014, J MED ENTOMOL, V51, P572, DOI 10.1603/ME13178
   Nakamura S, 2018, TRAVEL MED INFECT DI, V22, P3, DOI 10.1016/j.tmaid.2018.01.005
   National Institute of Infectious Diseases, NOT TRENDS IMP DEG C
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   ProMED Mail, NOR S KOR GANGW WINT
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schenkel K, 2006, Euro Surveill, V11, P234
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   Society of Automotive Engineers, POT FAIL MOD EFF AN
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tatem AJ, 2017, LANCET INFECT DIS, V17, P98, DOI 10.1016/S1473-3099(16)30326-7
   *US DEP DEF, 1980, MILSTD1629A US DEP D
   Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9
   World Health Organization, DENG SEV DENG FACT S
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, WHO PUBL HLTH ADV RE
   World Travel and Tourism Council (WTTC), TRAV TOUR GLOB EC IM
NR 43
TC 5
Z9 5
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2018
VL 12
IS 9
AR e0006755
DI 10.1371/journal.pntd.0006755
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GV4FY
UT WOS:000446054600023
PM 30235211
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Franca, TLB
   Medeiros, WR
   de Souza, NL
   Longo, E
   Pereira, SA
   Franca, TBD
   Sousa, KG
AF Barbosa de Franca, Thais Lorena
   Medeiros, Wilton Rodrigues
   de Souza, Nilba Lima
   Longo, Egmar
   Pereira, Silvana Alves
   de Oliveira Franca, Thamyris Barbosa
   Sousa, Klayton Galante
TI Growth and Development of Children with Microcephaly Associated with
   Congenital Zika Virus Syndrome in Brazil
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE microcephaly; zika virus; child development; global health; public
   health; public health surveillance
AB The outbreak of Zika virus in Latin America in the period 2015-2016 has caused a sudden increase in the number of severe manifestations and reports of congenital changes in newborns in Brazil. This is the first study that evaluated and compared the growth and cognitive and motor development of children with microcephaly due to Congenital Zika Virus Syndrome (CZS) in relation to typical children. It was an observational, analytical, cross-sectional study with 8 children with CZS and 16 typical children, with a mean age of 20.5 months (+/- 2.1), in a region of northeastern Brazil. Considering the mean, children with CZS presented extremely low performance in the motor domain and in the cognitive development domain, whereas typical children presented average performance in the cognitive and motor development domains. Children with CZS presented a mean growth rate (head circumference and weight) lower than typical children. Therefore, children with CZS are at risk for growth retardation and development compared to typical children.
C1 [Barbosa de Franca, Thais Lorena; Medeiros, Wilton Rodrigues; Longo, Egmar; Pereira, Silvana Alves; Sousa, Klayton Galante] Univ Fed Rio Grande do Norte, Collect Hlth PostGrad Program, Fac Hlth Sci Trairi, BR-59200000 Santa Cruz, Brazil.
   [Barbosa de Franca, Thais Lorena; Medeiros, Wilton Rodrigues] Univ Fed Rio Grande do Norte, Ana Bezerra Univ Hosp, BR-59200000 Santa Cruz, Brazil.
   [de Souza, Nilba Lima] Univ Fed Rio Grande do Norte, Nursing Grad Program, BR-59072970 Natal, RN, Brazil.
   [Longo, Egmar; Pereira, Silvana Alves] Univ Fed Rio Grande do Norte, Rehabil Sci Postgrad Program, Fac Hlth Sci Trairi, BR-59200000 Santa Cruz, Brazil.
   [Pereira, Silvana Alves] Univ Fed Rio Grande do Norte, Dept Phys Therapy, BR-59072970 Natal, RN, Brazil.
   [de Oliveira Franca, Thamyris Barbosa] Primary Hlth Care, City Hall Touros, Dept Hlth, BR-59584000 Touros, Brazil.
RP Sousa, KG (corresponding author), Univ Fed Rio Grande do Norte, Collect Hlth PostGrad Program, Fac Hlth Sci Trairi, BR-59200000 Santa Cruz, Brazil.
EM thais-lorena@hotmail.com; wilton.medeiros@ebserh.gov.br;
   nilba.lima@hotmail.com; egmarlongo@yahoo.es; apsilvana@gmail.com;
   thamyris68@gmail.com; galante@facisa.ufrn.br
RI de Souza, Nilba Lima/R-3808-2019; Longo, Elson/B-9395-2012; Pereira,
   Silvana Alves/O-7243-2019; Sousa, Klayton/G-8547-2014
OI de Souza, Nilba Lima/0000-0002-3748-370X; Longo,
   Elson/0000-0001-8062-7791; Pereira, Silvana Alves/0000-0002-6226-2837;
   Rodrigues Medeiros, Wilton/0000-0002-9096-8108; Sousa,
   Klayton/0000-0002-7710-7522
CR Amir J, 2016, ARCH DIS CHILD-FETAL, V101, pF428, DOI 10.1136/archdischild-2015-308357
   AQUINO Leda A, 2011, REV PEDIAT SOPERJ, V12, P15
   Banks LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189996
   Bayley N, 2006, BAYLEY SCALES INFANT
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cieza A, 2018, BMC MED, V16, DOI 10.1186/s12916-017-1002-6
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Houwen S, 2016, RES DEV DISABIL, V53-54, P19, DOI 10.1016/j.ridd.2016.01.012
   Kuper H, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030514
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Madaschi V., 2016, J COMPUT HIGH ED
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Ministerio da Saude . Secretaria de AtencAo a Saude. Departamento de AtencAo Basica, 2012, SAUD CRIANC CRESC DE, P272
   Ministry of Health, 2015, PROT VIG RESP OC MIC, P55
   Oakland T, 2008, PRACT RESOUR MENT, P1
   Pan American Health Organization, 2016, REP INCR CONG MICR O
   Secretaria de Estado da Saude Publica, 2015, PAIN MON IND 2014, P32
   Sharp M, 2017, J DEV BEHAV PEDIATR, V38, P322, DOI 10.1097/DBP.0000000000000441
   Soni N. R., 2016, Asian Pacific Journal of Reproduction, V5, P179, DOI 10.1016/j.apjr.2016.04.014
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Weiss L.G., 2017, BAYLEY 3 USO CLIN IN, P208
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zonta Marise Bueno, 2009, Rev. paul. pediatr., V27, P416, DOI 10.1590/S0103-05822009000400011
NR 27
TC 5
Z9 5
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD SEP
PY 2018
VL 15
IS 9
AR 1990
DI 10.3390/ijerph15091990
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GV0PX
UT WOS:000445765600199
PM 30216976
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hill, ME
   Kumar, A
   Wells, JA
   Hobman, TC
   Julien, O
   Hardy, JA
AF Hill, Maureen E.
   Kumar, Anil
   Wells, James A.
   Hobman, Tom C.
   Julien, Olivier
   Hardy, Jeanne A.
TI The Unique Cofactor Region of Zika Virus NS2B-NS3 Protease Facilitates
   Cleavage of Key Host Proteins
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; STRESS GRANULE FORMATION; WEST-NILE-VIRUS;
   DENGUE-VIRUS; N-TERMINI; SUBSTRATE-SPECIFICITY; ANTIVIRAL ACTIVITY;
   COMPLEX; NS3; PROTEOLYSIS
AB Zika virus is an emerging mosquito-borne pathogen capable of severely damaging developing fetuses as well as causing neurological abnormalities in adults. The molecular details of how Zika virus causes pathologies that are unique among the flavivirus family remain poorly understood and have contributed to the lack of Zika antiviral therapies. To elucidate how Zika virus protease (ZVP) affects host cellular pathways and consequent pathologies, we used unbiased N-terminomics to identify 31 human proteins cleaved by the NS2B-NS3 protease. In particular, autophagy-related protein 16-1 (ATG16L1) and eukaryotic translation initiation factor 4 gamma 1 (eIF4G1) are dramatically depleted during Zika virus infection. ATG16L1 and eIF4G1 mediate type-II interferon production and host-cell translation, respectively, likely aiding immune system evasion and driving the Zika life cycle. Intriguingly, the NS2B cofactor region from Zika virus protease is essential for recognition of host cell substrates. Replacing the NS2B region in another flavivirus protease enabled recognition of novel Zika-specific substrates by hybrid proteases, suggesting that the cofactor is the principal determinant in ZVP substrate selection.
C1 [Hill, Maureen E.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.
   [Kumar, Anil; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada.
   [Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.
   [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.
   [Julien, Olivier] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.
RP Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.; Julien, O (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.
EM ojulien@ualberta.ca; hardy@chem.umass.edu
RI Julien, Olivier/N-9198-2019
OI Julien, Olivier/0000-0001-7068-7299; Kumar, Anil/0000-0002-6179-4516
FU NSFNational Science Foundation (NSF) [CBET 1511367]; Canadian Institutes
   of Health ResearchCanadian Institutes of Health Research (CIHR)
   [PJT-148699, ZV1-149782]; Alberta Innovates Health Solutions
FX This work was supported by NSF CBET 1511367 to J.A.H. Research in the
   laboratory of T.C.H. is supported by funding from the Canadian
   Institutes of Health Research (PJT-148699 and ZV1-149782). A.K. is
   supported by a postdoctoral fellowship from Alberta Innovates Health
   Solutions, and T.C.H. holds a Canada Research Chair in RNA virus host
   interactions.
CR Agard NJ, 2012, P NATL ACAD SCI USA, V109, P1913, DOI 10.1073/pnas.1117158109
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786
   Crawford ED, 2013, MOL CELL PROTEOMICS, V12, P813, DOI 10.1074/mcp.O112.024372
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Gevaert K, 2003, NAT BIOTECHNOL, V21, P566, DOI 10.1038/nbt810
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Hill ME, 2016, ACS CHEM BIOL, V11, P1603, DOI 10.1021/acschembio.5b00971
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hwang S, 2012, CELL HOST MICROBE, V11, P397, DOI 10.1016/j.chom.2012.03.002
   Ishida H, 2004, BIOCHEM BIOPH RES CO, V321, P722, DOI 10.1016/j.bbrc.2004.07.015
   Jagdeo JM, 2018, J VIROL, V92, DOI 10.1128/JVI.02211-17
   Julien O, 2016, P NATL ACAD SCI USA, V113, pE2001, DOI 10.1073/pnas.1524900113
   Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Ventoso I, 1998, FEBS LETT, V435, P79, DOI 10.1016/S0014-5793(98)01027-8
   Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003
   White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006
   White JP, 2011, J VIROL, V85, P12442, DOI 10.1128/JVI.05888-11
   Wiita AP, 2014, METHOD ENZYMOL, V544, P327, DOI 10.1016/B978-0-12-417158-9.00013-3
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Yoshihara HAI, 2008, BIOORG MED CHEM LETT, V18, P6000, DOI 10.1016/j.bmcl.2008.08.044
   Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8
NR 48
TC 9
Z9 9
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD SEP
PY 2018
VL 13
IS 9
BP 2398
EP 2405
DI 10.1021/acschembio.8b00508
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GU9YL
UT WOS:000445713100005
PM 30080377
DA 2020-07-08
ER

PT J
AU Dube, D
   Addy, TM
   Teixeira, MR
   Iadarola, LM
AF Dube, Derek
   Addy, Tracie M.
   Teixeira, Maria R.
   Iadarola, Linda M.
TI Enhancing Student Learning on Emerging Infectious Diseases: An Ebola
   Exemplar
SO AMERICAN BIOLOGY TEACHER
LA English
DT Article
DE Ebola virus; emerging infectious disease; virology; case study; student
   misconceptions
AB Throughout global history, various infectious diseases have emerged as particularly relevant within an era. Some examples include the Bubonic plague of the fourteenth century, the Spanish Influenza pandemic of 1918, the HIV epidemic of the 1980s, and the Zika virus outbreak in 2015-16. These instances of emerging infectious disease represent ideal opportunities for timely, relevant instruction in natural and health science courses through case studies. Such instructional approaches can promote student engagement in the material and encourage application and higher-order thinking. We describe here how the case study approach was utilized to teach students about emerging infectious diseases using the 2014-16 Ebola virus outbreak as the subject of instruction. Results suggest that students completing the case study not only had positive perceptions of the mode of instruction, but also realized learning gains and misconception resolution. These outcomes support the efficacy of case pedagogy as a useful teaching tool in emerging infectious diseases, and augment the paucity of literature examining Ebola virus knowledge and misconceptions among undergraduate students within United States institutions.
C1 [Dube, Derek] Univ St Joseph, Dept Biol, 1678 Asylum Ave, Hartford, CT 06117 USA.
   [Addy, Tracie M.] Lafayette Coll, Ctr Integrat Teaching Learning & Scholarship, Easton, PA 18042 USA.
   [Teixeira, Maria R.] Univ St Joseph, Hartford, CT USA.
   [Iadarola, Linda M.] Quinnipiac Univ, Dept Biol Sci, Hamden, CT USA.
RP Dube, D (corresponding author), Univ St Joseph, Dept Biol, 1678 Asylum Ave, Hartford, CT 06117 USA.
EM ddube@usj.edu
FU University of Saint Joseph; Office of Postsecondary Education, U.S.
   Department of Education [P031A140103]
FX The case study described in this article is currently published in the
   National Center for Case Study Teaching in Science Database and was
   presented as a Microbrew presentation at the 2016 conference hosted by
   the American Society for Microbiology Committee on Undergraduate
   Education. Support was provided by a University of Saint Joseph Student
   Research Award to Maria Teixeira (funded by institutional grant
   P031A140103 from the Office of Postsecondary Education, U.S. Department
   of Education.).
CR Addy T. M, 2016, EBOLA WARS GEN EDITI
   Bonney KM, 2015, J MICROBIOL BIOL EDU, V16, P21, DOI 10.1128/jmbe.v16i1.846
   Breslin M, 2008, DES ISSUES, V24, P36, DOI 10.1162/desi.2008.24.1.36
   Catholic Relief Services (CRS) Focus 1000 Unicef, 2014, STUD PUBL KNOWL ATT
   CDC, 2016, 2014 EB OUTBR W AFR
   Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111
   Herreid CF, 2013, START STORY CASE STU
   KRAIN M., 2016, J EXCELLENCE COLL TE, V27, P131
   Miller E., 2016, THESIS
   Shittu RO, 2015, J ANTIVIR ANTIRETROV, V7, P10
   White JM, 2012, NAT REV MICROBIOL, V10, P317, DOI 10.1038/nrmicro2764
NR 11
TC 0
Z9 0
U1 0
U2 2
PU NATL ASSOC BIOLOGY TEACHERS INC
PI RESTON
PA 12030 SUNRISE VALLEY DR, #110, RESTON, VA 20191 USA
SN 0002-7685
EI 1938-4211
J9 AM BIOL TEACH
JI Am. Biol. Teach.
PD SEP
PY 2018
VL 80
IS 7
BP 493
EP 500
DI 10.1525/abt.2018.80.7.493
PG 8
WC Biology; Education, Scientific Disciplines
SC Life Sciences & Biomedicine - Other Topics; Education & Educational
   Research
GA GV2CI
UT WOS:000445892400004
DA 2020-07-08
ER

PT J
AU Alvarado-Arnez, LE
   Escalera-Antezana, JP
AF Alvarado-Arnez, Lucia E.
   Pablo Escalera-Antezana, Juan
TI Zika infection in pregnancy: Follow up and outcomes, where are all the
   data?
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
DE Zika; Virus transmission; Travelers; Pregnancy; Latin America
ID DENGUE; CHIKUNGUNYA; COINFECTION; PATIENT
C1 [Alvarado-Arnez, Lucia E.; Pablo Escalera-Antezana, Juan] Univ Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
   [Pablo Escalera-Antezana, Juan] Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan, Hubei, Peoples R China.
   [Pablo Escalera-Antezana, Juan] Huazhong Univ Sci & Technol, Coll Med, Wuhan, Hubei, Peoples R China.
RP Alvarado-Arnez, LE (corresponding author), Univ Franz Tamayo UNIFRANZ, Cochabamba, Bolivia.
EM lucia.alvarado@unifranz.edu.bo
RI Escalera-Antezana, Juan Pablo/Q-6770-2019; Arnez, Lucia Elena
   Alvarado/D-4690-2016
OI Escalera-Antezana, Juan Pablo/0000-0003-1235-0019; Arnez, Lucia Elena
   Alvarado/0000-0002-3537-6361
CR Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Le Goff G, 2011, PARASITE, V18, P277, DOI 10.1051/parasite/2011183277
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Ministerio de Salud de Bolivia, 2018, SIST NACL INF SAL VI
   Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V25, P20, DOI 10.1016/j.tmaid.2018.06.006
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Villamil-Gomez WE, 2017, J INFECT PUBLIC HEAL, V10, P133, DOI 10.1016/j.jiph.2016.02.003
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 12
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2018
VL 25
BP 1
EP +
DI 10.1016/j.tmaid.2018.06.014
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GU6JB
UT WOS:000445417000001
PM 29958986
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Cardona-Ospina, JA
   Ramirez-Jaramillo, V
   Gaviria, JA
   Gonzalez-Moreno, GM
   Castrillon-Spitia, JD
   Lopez-Villegas, A
   Morales-Jimenez, E
   Ramirez-Zapata, V
   Rueda-Merchan, GE
   Trujillo, AM
   Tabares-Villa, FA
   Henao-Sanmartin, V
   Murillo-Garcia, DR
   Herrera-Soto, JA
   Buitrago-Canas, ML
   Collins, MH
   Sepulveda-Arias, JC
   Londono, JJ
   Bedoya-Rendon, HD
   Cardenas-Perez, JD
   Olaya, SX
   Lagos-Grisales, GJ
AF Rodriguez-Morales, Alfonso J.
   Cardona-Ospina, Jaime A.
   Ramirez-Jaramillo, Valeria
   Gaviria, Javier A.
   Maria Gonzalez-Moreno, Gloria
   Castrillon-Spitia, Juan D.
   Lopez-Villegas, Alejandra
   Morales-Jimenez, Estefania
   Ramirez-Zapata, Valentina
   Eduardo Rueda-Merchan, German
   Trujillo, Adriana M.
   Tabares-Villa, Fredy A.
   Henao-Sanmartin, Valentina
   Murillo-Garcia, David R.
   Andrea Herrera-Soto, Johana
   Liliana Buitrago-Canas, Marta
   Collins, Matthew H.
   Carlos Sepulveda-Arias, Juan
   Londono, Jose J.
   Bedoya-Rendon, Hector D.
   de Jesus Cardenas-Perez, Javier
   Olaya, Sandra X.
   Lagos-Grisales, Guillermo J.
TI Diagnosis and outcomes of pregnant women with Zika virus infection in
   two municipalities of Risaralda, Colombia: Second report of the
   ZIKERNCOL study
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika virus; Microcephaly; Congenital Zika syndrome; Complications;
   Pregnant; Colombia
ID PROLONGED DETECTION; PUBLIC-HEALTH; LATIN-AMERICA; UNITED-STATES;
   FOLLOW-UP; CHIKUNGUNYA; DENGUE; VENEZUELA; COINFECTION; TRANSMISSION
AB Background: Zika virus (ZIKV) infection has emerged as a significant threat for pregnant women and newborns in populations living in or visiting Latin America. We previously reported a preliminary analysis in Sucre, Colombia, as the first group of pregnant women with RT-PCR-confirmed ZIKV (ZIKa en Embarazadas y Recien Nacidos en COLombia, ZIKERNCOL).
   Methods: In this second report, findings of the first 86 pregnant women from La Virginia and Dosquebradas (municipalities), Risaralda, Colombia, with RT-PCR-confirmed ZIKV infection are reported. Clinical, demographical and obstetrical findings are described.
   Results: All women reported ZIKV symptoms during pregnancy: 79.1% rash, 55.8% fever, among others. In addition to ZIKV, RT-PCR was positive for dengue in 18.6%; 45.3% Dengue IgM +; 5.8% RT-PCR positive for chikungunya; 3.6% Chikungunya IgM +. STORCH screening in mother: 11.6% IgG + anti-Toxoplasma gondii, 6% IgG + anti-rubella, 4.7% IgG + CMV. The rest of STORCH tests were negative. Microcephaly was observed in 2.4% of the newborns. No calcifications or other CNS alterations were detected. One newborn had cleft palate and one had bilateral renal ectopy.
   Conclusions: The rate of microcephaly in our cohort was consistent with other studies. Pregnant women in endemic areas should be followed and tested according to standard protocols, and asymptomatic ZIKV infection should be considered. Long-term follow-up of children is required in the congenital Zika syndrome (CZS) assessment.
C1 [Rodriguez-Morales, Alfonso J.; Cardona-Ospina, Jaime A.; Ramirez-Jaramillo, Valeria; Castrillon-Spitia, Juan D.; Trujillo, Adriana M.; Henao-Sanmartin, Valentina; Murillo-Garcia, David R.; Olaya, Sandra X.; Lagos-Grisales, Guillermo J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.; Cardona-Ospina, Jaime A.; Maria Gonzalez-Moreno, Gloria; Castrillon-Spitia, Juan D.; Carlos Sepulveda-Arias, Juan; Olaya, Sandra X.; Lagos-Grisales, Guillermo J.] Colombian Collaborat Network Zika Chikungunya & O, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.; Cardona-Ospina, Jaime A.; Tabares-Villa, Fredy A.; Carlos Sepulveda-Arias, Juan] Univ Tecnol Pereira, Fac Hlth Sci, Infect & Immun Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Fac Hlth Sci, Med Sch, Cochabamba, Bolivia.
   [Gaviria, Javier A.; Maria Gonzalez-Moreno, Gloria] ESE Hosp Santa Monica, Dosquebradas, Risaralda, Colombia.
   [Castrillon-Spitia, Juan D.; Lopez-Villegas, Alejandra; Morales-Jimenez, Estefania; Ramirez-Zapata, Valentina; Eduardo Rueda-Merchan, German] Fdn Univ Autonoma Amer, Biomed, Pereira, Risaralda, Colombia.
   [Castrillon-Spitia, Juan D.; Andrea Herrera-Soto, Johana; Liliana Buitrago-Canas, Marta; Londono, Jose J.; Bedoya-Rendon, Hector D.; de Jesus Cardenas-Perez, Javier] ESE Hosp San Pedro y San Pablo, La Virginia, Risaralda, Colombia.
   [Collins, Matthew H.] Emory Univ, Atlanta, GA 30322 USA.
   [Olaya, Sandra X.] Univ San Jorge, ESE Hosp, Crit Care Obstet & Gynecol, Pereira, Risaralda, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI amsalu, ribka/G-8780-2019; AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
FU CDC/BAA: Zika Diagnostic Development [2017-N-108041, 7/2017-6/2022];
   Thrasher Early Career Development; Universidad Tecnologica de Pereira
   [5-18-3]
FX 2017-N-108041 CDC/BAA: Zika Diagnostic Development: 7/2017-6/2022
   (Serologic diagnosis of recent and remote Zika infections in
   flavirirus-endemic regions), Thrasher Early Career Development
   (Serologic risk for congenital Zika syndrome) and Universidad
   Tecnologica de Pereira (Proyecto de Investigacion: "Evaluacion de la
   funcion y el fenotipo de linfocitos T como indicador de exposicion a
   Zika in-utero", Codigo 5-18-3 [2018-2020]).
CR Alvarado-Socarras JL, 2016, ULTRASOUND OBST GYN, V47, P525, DOI 10.1002/uog.15885
   Alvarado-Socarras JL, 2018, TRAVEL MED INFECT DI, V23, P14, DOI 10.1016/j.tmaid.2018.02.002
   Alvarado-Socarras Jorge L, 2017, Rev. perú. med. exp. salud publica, V34, P332, DOI 10.17843/rpmesp.2017.342.2697
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Blohm GM, 2017, GENOME ANNOUNC, P5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burki T, 2015, LANCET INFECT DIS, V15, P641, DOI 10.1016/S1473-3099(15)00011-0
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Coronell-Rodriguez W, 2016, REV CHIL INFECTOL, V33, P665, DOI 10.4067/S0716-10182016000600009
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Carvalho FHC, 2017, PRENATAL DIAG, V37, P207, DOI 10.1002/pd.4985
   Counotte M, 2018, ZIKA VIRUS INFECT CA
   Daniels JP, 2018, LANCET INFECT DIS, V18, P257, DOI 10.1016/S1473-3099(18)30086-0
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   de Laval F, 2016, MED SANTE TROP, V26, P145, DOI 10.1684/mst.2016.0575
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Flamand C, 2017, EUROSURVEILLANCE, P22
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Grillet ME, 2018, SCIENCE, V359, P528, DOI 10.1126/science.aar5440
   Hancock WT, 2017, MMWR-MORBID MORTAL W, V66, P299, DOI 10.15585/mmwr.mm6611a5
   Haque U, 2016, ACTA TROP, V162, P5, DOI 10.1016/j.actatropica.2016.06.010
   Harapan H, 2018, J INFECT PUBLIC HEAL, V11, P99, DOI 10.1016/j.jiph.2017.06.013
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kanda Paulo Afonso Medeiros, 2018, Neurodiagn J, V58, P11, DOI 10.1080/21646821.2018.1428461
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Musso D, 2018, LANCET INFECT DIS, DOI [10.1016/S1473-3099(18), DOI 10.1016/S1473-3099(18)]
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Quintero-Herrera LL, 2015, J INFECT PUBLIC HEAL, V8, P291, DOI 10.1016/j.jiph.2014.11.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales AJ, 2017, RHEUMATOL INT, V37, P1757, DOI 10.1007/s00296-017-3795-1
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2017, INFECTION, V45, P93, DOI 10.1007/s15010-016-0948-1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P62, DOI 10.1016/j.tmaid.2015.06.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Rodriguez-Morales AJ, 2014, LANCET, V384, P663, DOI 10.1016/S0140-6736(14)61389-1
   Rodriguez-Morales AJ, 2012, INT J INFECT DIS, V16, pE704, DOI 10.1016/j.ijid.2012.04.011
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Saade GR, 2016, BJOG-INT J OBSTET GY, V123, P1272, DOI [10.1111/1471-0528.14068, 10.1111/1471-0528.14069]
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Sarmiento H, 2011, J INFECT DIS, V204, pS675, DOI 10.1093/infdis/jir444
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Torres-Duque CA, 2018, ARCH BRONCONEUMOL, V54, P7, DOI [10.1016/j.arbr.2017.11.012, 10.1016/j.arbres.2017.07.004]
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez WE, 2017, J CLIN VIROL, V95, P52, DOI 10.1016/j.jcv.2017.08.010
   Villamil-Gomez WE, 2017, J INFECT PUBLIC HEAL, V10, P133, DOI 10.1016/j.jiph.2016.02.003
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Weilg Claudia, 2018, BMC Res Notes, V11, P311, DOI 10.1186/s13104-018-3400-z
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 76
TC 5
Z9 5
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD SEP-OCT
PY 2018
VL 25
BP 20
EP 25
DI 10.1016/j.tmaid.2018.06.006
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GU6JB
UT WOS:000445417000010
PM 29894797
DA 2020-07-08
ER

PT J
AU Quintana-Domeque, C
   Carvalho, JR
   de Oliveira, VH
AF Quintana-Domeque, Climent
   Carvalho, Jose Raimundo
   de Oliveira, Victor Hugo
TI Zika virus incidence, preventive and reproductive behaviors: Correlates
   from new survey data
SO ECONOMICS & HUMAN BIOLOGY
LA English
DT Article
DE Zika; Education; Domestic violence; Information; Prevention; Survey data
ID INFECTION; BRAZIL; TRANSMISSION
AB During the outbreak of the Zika virus, Brazilian health authorities recommended that pregnant women take meticulous precaution to avoid mosquito bites and that women in general use contraceptive methods to postpone/delay pregnancies. In this article, we present new estimates on the Zika virus incidence, its correlates and preventive behaviors in the Northeast of Brazil, where the outbreak initiated, using survey data collected between March 30th and June 3rd of 2016. The target population were women aged 15-49 in the capital cities of the nine states of the Northeast region of Brazil. We find that more educated women were less likely to report suffering from Zika (or its symptoms) and more likely to report having taken precaution against Zika, such as having used long and light-colored clothes, having used mosquito repellent or insecticides, having used mosquito protective screens or kept windows closed, and having dumped standing water where mosquitoes can breed. In addition, more educated women were more likely to report being informed about the association between Zika and microcephaly and to avoid pregnancy in the last 12 months. Finally, we also find that women who reported experiencing sexual domestic violence in the last 12 months were more likely to report suffering from Zika. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Quintana-Domeque, Climent] Univ Oxford, Oxford, England.
   [Carvalho, Jose Raimundo] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [de Oliveira, Victor Hugo] Inst Pesquisa & Estrategia Econ Ceara, Fortaleza, Ceara, Brazil.
RP Quintana-Domeque, C (corresponding author), Univ Oxford, Dept Econ, Manor Rd Bldg,Manor Rd, Oxford OX1 3UQ, England.
EM climent.quintana-domeque@economics.ox.ac.uk
RI Quintana Domeque, Climent/N-9083-2016
OI Quintana Domeque, Climent/0000-0002-6626-6261; de Oliveira, Victor
   Hugo/0000-0002-4737-7062
FU Secretaria Especial de Politicas para as Mulheres - Ministerio da
   Justica, Brasil [06/2015]
FX We thank Diego Andre and Abel Brasil for providing excellent research
   assistance. We also thank Ines Lee, Sonia Oreffice and two anonymous
   referees for helpful comments and suggestions. The
   PCSVDF<SUP>mulher</SUP> survey was funded by the Secretaria Especial de
   Politicas para as Mulheres - Ministerio da Justica, Brasil (grant
   number: TED # 06/2015). The sponsors of the study had no role in study
   design, data collection, data analysis, data interpretation, or writing
   of this article. The authors of this article had full access to all data
   in the study and had final responsibility for the decision to submit for
   publication.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carvalho J. R., 2016, PESQUISA CONDICOES S
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Chiaravalloti Neto Francisco, 2006, Cad. Saúde Pública, V22, P987, DOI 10.1590/S0102-311X2006000500011
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galama T, 2018, OXF RES ENCY EC FINA
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   PAHO, 2017, REG ZIK EP UPD AM
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Possas C, 2016, EPIDEMIOL HLTH, V38
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rhee M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-35
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Venturi G, 2016, EUROSURVEILLANCE, V21
   World Health Organization, 2005, MULT STUD WOM HLTH D
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 31
TC 5
Z9 5
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-677X
EI 1873-6130
J9 ECON HUM BIOL
JI Econ. Hum. Biol.
PD SEP
PY 2018
VL 30
BP 14
EP 23
DI 10.1016/j.ehb.2018.04.003
PG 10
WC Economics; Public, Environmental & Occupational Health
SC Business & Economics; Public, Environmental & Occupational Health
GA GU5DG
UT WOS:000445305000002
PM 29772278
DA 2020-07-08
ER

PT J
AU Pawanis, Z
   Nasronudin
   Suharto
   Amin, M
   Rini, DP
   Romdhoni, AC
   Purwaningsih
   Hidayat, MS
AF Pawanis, Zulfayandi
   Nasronudin
   Suharto
   Amin, Muhammad
   Rini, Diah Puspita
   Romdhoni, Achmad Chusnu
   Purwaningsih
   Hidayat, Muhammad Syamsul
TI Gender Influence on Correlation Between Monocyte and Ratio of
   Thrombocyte to Hemoglobin-Hematocrit in Patients with Clinically
   Suspected Dengue Infection
SO ADVANCED SCIENCE LETTERS
LA English
DT Proceedings Paper
CT International Conference on Actual Economy - European Discourse on
   Global Challenges (ACE-EU)
CY NOV 27-29, 2017
CL Paris, FRANCE
DE Dengue; Monocyte; Thrombocyte; Haemoglobin; Haematocrit; Gender
ID FEVER
AB Introduction: Dengue remains the main public health concern for Indonesia with relatively high case fatality rate. Several factors associated with the pathogenesis of dengue have been investigated including its severity marker, routine laboratory test results and gender disparity. This study aimed to evaluate the gender influence on the correlation between monocyte and thrombocyte ratio in patients with clinically suspected dengue infection. Methods: This was a cross-sectional analysis study from Zika and Dengue surveillance data conducted by Airlangga Health Science Institute (AHSI) in 2016. Participants were recruited from four hospitals and eight public health centres in Surabaya using consecutive sampling method. Those with minimum age of 15 years and suspected to have dengue infection based on WHO guideline 1997 were approached. Thrombocyte to haemoglobin-haematocrit ratio was defined by thrombocyte count divided by the product of haemoglobin and haematocrit concentration. Result: There were 100 patients consented to the study between February and April 2016 with 46 males and 54 females. There was no difference in age between the gender (Female = 30.8 +/- 12.6; Male = 29.7 +/- 10.6; P = 0.653). Significant negative correlation was found between monocyte and ratio of thrombocyte to haemoglobin-haematocrit in female participants (Spearman's rho = -0.462; 95% CI -0.652, -0.163; **P < 0.001). On the other hand, no difference was seen in male participants (Spearman's rho = -0.182; 95% CI -0.469, +0.179; P = 0.227). Conclusion: Gender difference has an influence on the correlation between monocyte and ratio of thrombocyte to haemoglobin-haematocrit concentration.
C1 [Pawanis, Zulfayandi; Nasronudin; Suharto; Amin, Muhammad; Rini, Diah Puspita; Romdhoni, Achmad Chusnu; Purwaningsih; Hidayat, Muhammad Syamsul] Univ Airlangga Hosp, Surabaya, Indonesia.
   [Pawanis, Zulfayandi; Nasronudin; Suharto; Amin, Muhammad; Rini, Diah Puspita; Romdhoni, Achmad Chusnu; Purwaningsih; Hidayat, Muhammad Syamsul] Univ Airlangga, AHSI, Surabaya, Indonesia.
   [Nasronudin; Suharto; Amin, Muhammad; Rini, Diah Puspita; Romdhoni, Achmad Chusnu] Univ Airlangga, Fac Med, Surabaya, Indonesia.
   [Purwaningsih] Univ Airlangga, Fac Nursing, Surabaya, Indonesia.
RP Pawanis, Z (corresponding author), Univ Airlangga Hosp, Surabaya, Indonesia.; Pawanis, Z (corresponding author), Univ Airlangga, AHSI, Surabaya, Indonesia.
CR Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chunhakan S, 2015, INT J VASC MED, DOI 10.1155/2015/917143
   Hardhana B, 2017, DATA DAN INFORM PROF
   Hober D, 1996, IMMUNOL LETT, V53, P115, DOI 10.1016/S0165-2478(96)02620-X
   Kabra SK, 1999, T ROY SOC TROP MED H, V93, P294, DOI 10.1016/S0035-9203(99)90027-5
   KURANE I, 1988, J GEN VIROL, V69, P445, DOI 10.1099/0022-1317-69-2-445
   Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Orsi FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-350
   Prasith N, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2012.3.4.020, 10.5365/wpsar.2012.3.4.020]
   Prayitno A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005621
   Shahfiza N, 2015, ASIAN PAC J TROP MED, V8, P452, DOI [10.1016/S1995-7645(14)60359-X, 10.1016/j.apjtm.2015.05.012]
   Shekhar K C, 1992, Asia Pac J Public Health, V6, P15
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tsai J. J., 2017, BIOMEDICINE HUB, V2, P8
   Wong JGX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148579
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization, 2009, DENG HAEM FEV DIAGN
   Yacoub S., 2015, MED, V12, P147
NR 22
TC 0
Z9 0
U1 0
U2 1
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
EI 1936-7317
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD SEP
PY 2018
VL 24
IS 9
BP 6605
EP 6609
DI 10.1166/asl.2018.12793
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU2LJ
UT WOS:000445101000084
DA 2020-07-08
ER

PT J
AU Fernandes, A
   Agustina, A
   Nampira, CK
   Janu, I
   Afian, F
   Wibawanti, R
   Pakasi, TA
AF Fernandes, Albert
   Agustina, Amilya
   Nampira, Citra Kurnisari
   Janu, Irwan
   Afian, Ferdi
   Wibawanti, Retno
   Pakasi, Trevino A.
TI Prevention of Communicable Disease Spread in Soekarno-Hatta
   International Airport: An Evaluation Report in 2016
SO ADVANCED SCIENCE LETTERS
LA English
DT Proceedings Paper
CT International Conference on Actual Economy - European Discourse on
   Global Challenges (ACE-EU)
CY NOV 27-29, 2017
CL Paris, FRANCE
DE Communicable Disease; Thermoscanner; Airport
AB Introduction: Soekarno-Hatta International Airport has been following the International Health Regulation 2005 to prevent communicable diseases. On-board, each flight should make a report to the controller about health condition of the passengers, and the Health Port Office followed up the information. The Health Port Office used thermal scanner and prioritize the screening for the suspected endemic countries. The study aimed to evaluate the effectiveness of the program. Method: The evaluation started with reviewing report document and continued with interviewing the resource persons. At the end we observed directly the procedure how the Port Health screened for the suspected passengers. Result: In 2016 there were 39,088 international arrivals and 40,925 departures that carried 13,715,505 passengers to and from Indonesia. Among all arrivals, 3117 came from countries who applied meningitis and endemic of MERS-CoV, 983 flights were from endemic of H7N9, 9 flights were from MERS-CoV, and 3752 flights were Ebola endemic countries. The Port Health staffs used the thermal scanner to screen all passengers coming from the endemic countries and applied random checked from all other countries to find passengers with arising body temperature. The method was able to screen one passenger from MERS-CoV endemic countries, 2 passengers from Ebola endemic countries, and one from Zika endemic countries of total 1,510,632 passengers. Apart from the individual screening, several other related issues require consideration, including: transmission of disease on board aircraft; transmission of disease in airport terminal buildings; and contact tracing. Aircrew in each flight should also report when a passenger was sick on board. Conclusion: A major challenge is to ensure adequate resources are devoted to pandemic preparedness planning in the aviation sector, which may not be fully considered in a national preparedness plan.
C1 [Fernandes, Albert; Agustina, Amilya; Nampira, Citra Kurnisari; Janu, Irwan; Afian, Ferdi; Wibawanti, Retno; Pakasi, Trevino A.] Univ Indonesia, Sch Aviat Med, Dept Community Med, Fac Med, Jakarta, Indonesia.
RP Wibawanti, R (corresponding author), Univ Indonesia, Sch Aviat Med, Dept Community Med, Fac Med, Jakarta, Indonesia.
CR [Anonymous], 2016, PORT HLTH ANN REPORT
NR 1
TC 0
Z9 0
U1 2
U2 4
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
EI 1936-7317
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD SEP
PY 2018
VL 24
IS 9
BP 6821
EP 6823
DI 10.1166/asl.2018.12855
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU2LJ
UT WOS:000445101000135
DA 2020-07-08
ER

PT J
AU Lian, WL
   Jang, JB
   Potisopon, SPEE
   Li, PC
   Rahrneh, A
   Wang, JH
   Kwiatkowski, NP
   Gray, NS
   Yang, PL
AF Lian, Wenlong
   Jang, Jaebong
   Potisopon, Supanee
   Li, Pi-Chun
   Rahrneh, Arnal
   Wang, Jinhua
   Kwiatkowski, Nicholas P.
   Gray, Nathanael S.
   Yang, Priscilla L.
TI Discovery of Immunologically Inspired Small Molecules That Target the
   Viral Envelope Protein
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE antiviral; dengue antiviral; flavivirus antiviral; viral entry
   inhibitor; target-based HTS
ID TETRAVALENT DENGUE VACCINE; PROMISCUOUS INHIBITORS; DRUG DISCOVERY;
   VIRUS; ORGANIZATION; EFFICACY; DISEASE; FUSION; ENTRY
AB Dengue virus is a major human pathogen that infects over 390 million people annually leading to approximately 500 000 hospitalizations due to severe dengue. Since the only marketed vaccine, Dengvaxia, has recently been shown to increase disease severity in those lacking natural immunity, antivirals to prevent or treat dengue infection represent a large, unmet medical need. Small molecules that target the dengue virus envelope protein, E, on the surface of the virion could act analogously to antibodies by engaging E extracellularly to block infection; however, a shortage of target-based assays suitable for screening and medicinal chemistry studies has limited efforts in this area. Here we demonstrate that the dengue E protein offers a tractable drug target for preventing dengue infection by developing a target-based assay using a recombinantly expressed dengue serotype 2 E protein. We performed a high-throughput screen of similar to 20 000 compounds followed by secondary assays to confirm target-binding and antiviral activity and counter-screens to exclude compounds with nonspecific activities. These efforts yielded eight distinct chemical leads that inhibit dengue infection by binding to E and preventing E-mediated membrane fusion with potencies equal to or greater than previously described small molecule inhibitors of E. We show that a subset of these compounds inhibit viruses representative of the other three dengue serotypes and Zika virus. This work provides tools for discovery and optimization of direct-acting antivirals against dengue E and shows that this approach may be useful in developing antivirals with broad-spectrum activity against other flavivirus pathogens.
C1 [Lian, Wenlong; Potisopon, Supanee; Rahrneh, Arnal; Yang, Priscilla L.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Jang, Jaebong; Li, Pi-Chun; Wang, Jinhua; Kwiatkowski, Nicholas P.; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Jang, Jaebong; Li, Pi-Chun; Wang, Jinhua; Kwiatkowski, Nicholas P.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Potisopon, Supanee] Bioaster, 40 Ave Tony Gamier, F-69007 Lyon, France.
   [Rahrneh, Arnal] Amer Univ Beirut, Dept Biol, Beirut, Lebanon.
RP Yang, PL (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM priscilla_yang@hms.harvard.edu
OI Yang, Priscilla/0000-0001-7456-2557
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R56AI095499, R01AI095499,
   U19AI109740]; Harvard Clinical and Translational Science Center
   (National Center for Advancing Translational Sciences, National
   Institutes of Health) [UL1 TR001102]
FX Melissanne de Wispelaere, Jared Pitts, and other members of the Yang lab
   are thanked for scientific discussions. Stephen C. Harrison and Ian
   Walker are also thanked for technical assistance in expression of
   recombinant DENV proteins. We thank the following colleagues for sharing
   reagents: Didier Musso and Nathalie Pardigon for Zika PF13-251013-18;
   John Aaskov for the hybridoma cell line producing Mab 6F3.1; Lee Gehrke
   for DENV2 New Guinea C virus; Aravinda de Silva for DENV1, DENV3, and
   DENV4 strains; Sean Whelan for VSV-eGFP reporter virus; Eva Harris for
   BHK-21 cells; Stephen C. Harrison for the synthetic DENV2 sE gene and
   insect cell lines. Kelly Arnett and the Center for Macromolecular
   Interactions and Jennifer Smith and the ICCB-Longwood Screening Facility
   provided access to instruments and technical support. We thank Brian
   Shoichet for help with the PAINS assays utilizing MDH and AmpC. We also
   thank Liron David and Hao Wu for instruction and instrument access for
   the dynamic light scattering experiments. This work was supported by NIH
   awards R56AI095499, R01AI095499, and U19AI109740. Additional support was
   provided by The Harvard Clinical and Translational Science Center
   (National Center for Advancing Translational Sciences, National
   Institutes of Health Award UL1 TR001102).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   de Wispelaere M., 2018, CELL CHEM BIOL, DOI [10.1016/j.chem-bio1.2018.05.011, DOI 10.1016/J.CHEM-BIO1.2018.05.011]
   Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y
   Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
   Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
NR 32
TC 8
Z9 8
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD SEP
PY 2018
VL 4
IS 9
BP 1395
EP 1406
DI 10.1021/acsinfecdis.8b00127
PG 23
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA GU1UR
UT WOS:000445053200014
PM 30027735
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Rodriguez, Y
   Anaya, JM
AF Rodriguez, Yhojan
   Anaya, Juan-Manuel
TI Comment on: Zika virus and Guillain-Barre syndrome in Bangladesh
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Letter
C1 [Rodriguez, Yhojan; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 26 63-B-51, Bogota 110010, Colombia.
RP Rodriguez, Y (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Carrera 26 63-B-51, Bogota 110010, Colombia.
EM yhojan.rodriguez@urosario.edu.co
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Hardy TA, 2011, CURR ALLERGY ASTHM R, V11, P197, DOI 10.1007/s11882-011-0190-y
   Rodriguez Y, 2018, CLIN AUTON RES, V28, P211, DOI 10.1007/s10286-018-0515-1
NR 4
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD SEP
PY 2018
VL 5
IS 9
BP 1139
EP 1139
DI 10.1002/acn3.602
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GU0LL
UT WOS:000444941200012
PM 30250870
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU GeurtsvanKessel, CH
   Islam, Z
   Jacobs, BC
   Endtz, HP
AF GeurtsvanKessel, Corine H.
   Islam, Zhahirul
   Jacobs, Bart C.
   Endtz, Hubert P.
TI Reply to: Comment on: Zika virus and Guillain-Barre syndrome in
   Bangladesh
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Letter
C1 [GeurtsvanKessel, Corine H.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Islam, Zhahirul; Endtz, Hubert P.] Icddr B, Int Ctr Diarrhoeal Dis Res, Lab Sci & Serv Div, Dhaka, Bangladesh.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Endtz, Hubert P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Endtz, Hubert P.] Fdn Merieux, Lyon, France.
RP GeurtsvanKessel, CH; Islam, Z (corresponding author), Erasmus MC, Off Na 1018,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM c.geurtsvankessel@erasmusmc.nl; zislam@icddrb.org
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Muraduzzaman AKM, 2017, ASIAN PAC J TROP MED, V10, P925, DOI 10.1016/j.apjtm.2017.08.015
   Rodriguez Y, 2018, ANN CLIN TRANSL NEUR
NR 6
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD SEP
PY 2018
VL 5
IS 9
BP 1140
EP 1141
DI 10.1002/acn3.619
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GU0LL
UT WOS:000444941200013
PM 30250871
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Bandstra, ES
   Fernandez, MP
   Cooper, JM
   Saigal, GM
   Bauer, CR
   Hofheimer, JA
   Berkovits, MD
   Fifer, RC
   Pensirikul, AD
   Gonzalez, IA
   Curry, CL
   Andreansky, S
   Younis, RT
   Liu, XZ
   Banker, TP
   Dubovy, SR
   Langer, SM
   Berrocal, AM
AF Ventura, Camila V.
   Bandstra, Emmalee S.
   Fernandez, Maria P.
   Cooper, Joshua M.
   Saigal, Gaurav M.
   Bauer, Charles R.
   Hofheimer, Julie A.
   Berkovits, Michelle D.
   Fifer, Robert C.
   Pensirikul, Alyssa D.
   Gonzalez, Ivan A.
   Curry, Christine L.
   Andreansky, Samita
   Younis, Ramzi T.
   Liu, Xue Z.
   Banker, Tanuj P.
   Dubovy, Sander R.
   Langer, Samantha M.
   Berrocal, Audina M.
CA Univ Miami Pediat Zika Res
TI First Locally Acquired Congenital Zika Syndrome Case in the United
   States: Neonatal Clinical Manifestations
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID OPTICAL-COHERENCE-TOMOGRAPHY; INCONTINENTIA PIGMENTI; VIRUS; INFANTS;
   ATROPHY
AB In the spring of 2017, a full-term infant with microcephaly was delivered in South Florida. During first trimester, the mother presented with fever, nausea, and vomiting. She reported no foreign travel for herself or her partner. The infant's neurologic, ophthalmologic, neuroradiologic, and audiologic findings were highly suggestive of congenital Zika syndrome (CZS), confirmed by IgM antibodies and plaque reduction neutralization test. New observations, including peripheral temporal retinal avascularity and peripapillary retinal nerve fiber layer thinning, are presented from this first known case of non-travel-associated CZS in the United States.
C1 [Ventura, Camila V.; Fernandez, Maria P.; Banker, Tanuj P.; Dubovy, Sander R.; Berrocal, Audina M.] Univ Miami, Bascom Palmer Eye Inst, Dept Ophthalmol, Miller Sch Med, Miami, FL 33136 USA.
   [Ventura, Camila V.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Bandstra, Emmalee S.; Cooper, Joshua M.; Bauer, Charles R.; Berkovits, Michelle D.; Langer, Samantha M.] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Pediat,Div Neonatol, Miami, FL 33136 USA.
   [Saigal, Gaurav M.] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Radiol, Miami, FL 33136 USA.
   [Hofheimer, Julie A.] Univ N Carolina, Div Neonatal Perinatal Med, Dept Pediat, Chapel Hill, NC 27515 USA.
   [Fifer, Robert C.] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Pediat,Div Audiol & Speech Pathol, Miami, FL 33136 USA.
   [Pensirikul, Alyssa D.] Univ Miami, Miller Sch Med, Dept Neurol, Div Pediat Neurol, Miami, FL 33136 USA.
   [Gonzalez, Ivan A.] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Pediat,Div Pediat Infect Dis, Miami, FL 33136 USA.
   [Curry, Christine L.] Univ Miami, Miller Sch Med, Dept Obstet & Gynecol, Miami, FL 33136 USA.
   [Andreansky, Samita] Univ Miami, Miller Sch Med, Dept Pediat, Div Pediat Hematol & Oncol, Miami, FL 33136 USA.
   [Younis, Ramzi T.; Liu, Xue Z.] Univ Miami, Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.
RP Berrocal, AM (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.; Berrocal, AM (corresponding author), Bascom Palmer Eye Inst, 900 NW 17th Ave, Miami, FL 33136 USA.
EM aberrocal@med.miami.edu
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684
FU Florida Department of Health Biomedical Research Program, Zika Research
   Initiative Awards [7ZK08, 7ZK14, 7ZK20, 7ZK26]
FX This work was supported by the Florida Department of Health Biomedical
   Research Program, Zika Research Initiative Awards 7ZK08 (Bandstra),
   7ZK14 (Saigal), 7ZK20 (Younis), and 7ZK26 (Gonzalez).
CR Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027
   Centers for Disease Control and Prevention, OUTC PREGN LAB EV PO
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   John VJ, 2016, OSLI RETINA, V47, P14, DOI 10.3928/23258160-20151214-02
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Pan American Health Organization/ WHO, ZIK CAS CONG SYNDR A
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Tzu JH, 2013, OPHTHAL SURG LAS IM, V44, P91, DOI 10.3928/23258160-20121221-20
   Vajzovic L, 2012, AM J OPHTHALMOL, V154, P779, DOI 10.1016/j.ajo.2012.05.004
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WATZKE RC, 1976, ARCH OPHTHALMOL-CHIC, V94, P743
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 20
TC 2
Z9 2
U1 0
U2 3
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD SEP
PY 2018
VL 49
IS 9
BP E93
EP E98
DI 10.3928/23258160-20180907-14
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA GT9AI
UT WOS:000444831000014
PM 30222826
DA 2020-07-08
ER

PT J
AU Slavin, I
   Dea, S
   Montefusco, S
   Siqueira-Neto, JL
   Petcavich, R
   Zanella, F
   Carromeu, C
AF Slavin, Ileana
   Dea, Steven
   Montefusco, Sandro
   Siqueira-Neto, Jair L.
   Petcavich, Robert
   Zanella, Fabian
   Carromeu, Cassiano
TI Using hiPSC-derived neuronal cultures to assess the safety of
   pre-screened potential therapeutic compounds against Zika Virus
SO JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
LA English
DT Meeting Abstract
C1 [Slavin, Ileana; Dea, Steven; Petcavich, Robert; Zanella, Fabian; Carromeu, Cassiano] StemoniX, San Diego, CA USA.
   [Montefusco, Sandro; Siqueira-Neto, Jair L.] Univ Calif San Diego, San Diego, CA 92103 USA.
RI Siqueira-Neto, Jair L/D-6040-2012
OI Siqueira-Neto, Jair L/0000-0001-9574-8174; Carromeu,
   Cassiano/0000-0002-7570-2213
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1056-8719
EI 1873-488X
J9 J PHARMACOL TOX MET
JI J. Pharmacol. Toxicol. Methods
PD SEP-OCT
PY 2018
VL 93
SI SI
MA 087
BP 137
EP 137
DI 10.1016/j.vascn.2018.01.458
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA GT5CH
UT WOS:000444523000098
DA 2020-07-08
ER

PT J
AU Umapathi, T
   Kam, YW
   Ohnmar, O
   Ng, BCJ
   Ng, Y
   Premikha, M
   Leo, YS
   Ng, LFP
AF Umapathi, Thirugnanam
   Kam, Yiu-Wing
   Ohnmar, O.
   Ng, Brandon C. J.
   Ng, Yixiang
   Premikha, M.
   Leo, Yee-Sin
   Ng, Lisa F. P.
TI The 2016 Singapore Zika virus outbreak did not cause a surge in
   Guillain-Barre syndrome
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Article
DE dengue virus; Guillain-Barre syndrome; Zika virus
ID INFECTION; COLOMBIA
AB Although individuals with Zika virus (ZIKV) antibodies were reported in Malaya in mid-1950s, entomological and human surveillance in Singapore did not identify autochthonous transmission until the outbreak of August-November, 2016. A total of 455 cases from 15 separate clusters were identified. We asked if this ZIKV outbreak increased the incidence of Guillain-Barre syndrome (GBS) and aimed to characterize these cases. Eleven GBS cases, consecutively enrolled into our prospective GBS database from onset to 4weeks after outbreak, and six controls, comprising three GBS patients enrolled before outbreak and three non-GBS patients, were examined for evidence of recent ZIKV infection. We performed serum, urine ZIKV RT-PCR, ZIKV serology, and virus neutralization assays, accounting for cross-reaction and co-infection with dengue (DENV). We found five GBS cases with only serological evidence of recent ZIKV infection (including one ZIKV-DENV co-infection). A temporal relationship with ZIKV outbreak was unlikely as two cases were GBS controls enrolled 3 months before outbreak. None reported symptoms of ZIKV infection. In addition, compared to last 10 years the national number of GBS hospitalizations did not increase during and immediately after outbreak. We conclude the 2016 Singapore ZIKV outbreak did not cause a change in GBS epidemiology.
C1 [Umapathi, Thirugnanam; Ohnmar, O.; Ng, Brandon C. J.; Premikha, M.] Natl Neurosci Inst, Jalan Tan Tock Seng, Singapore 308433, Singapore.
   [Kam, Yiu-Wing; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Ng, Yixiang] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore.
   [Leo, Yee-Sin] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Communicable Dis Ctr, Singapore, Singapore.
   [Leo, Yee-Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
RP Umapathi, T (corresponding author), Natl Neurosci Inst, Jalan Tan Tock Seng, Singapore 308433, Singapore.
EM umapathi@nni.com.sg
OI Ng, Yixiang/0000-0003-4490-9374; Ng, Lisa/0000-0003-4071-5222
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR) [15/1/82/27/001]; BMRC-Agency for Science, Technology
   and Research (A*STAR), Singapore-led Zika Virus Consortium
FX Core grant to Singapore Immunology Network by the Biomedical Research
   Council (BMRC), Grant/Award Number: 15/1/82/27/001; BMRC-Agency for
   Science, Technology and Research (A*STAR), Singapore-led Zika Virus
   Consortium
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chia PY, 2017, J INFECTION, V74, P611, DOI 10.1016/j.jinf.2017.03.007
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Umapathi T, 2016, J PERIPHER NERV SYST, V21, P375, DOI 10.1111/jns.12190
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
NR 13
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2018
VL 23
IS 3
BP 197
EP 201
DI 10.1111/jns.12284
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GT3QY
UT WOS:000444419400007
PM 30070025
OA Bronze
DA 2020-07-08
ER

PT J
AU Fares-Gusmao, R
   Chancey, C
   Volkova, E
   Grinev, A
   Sippert, E
   Jiang, Z
   Rios, M
AF Fares-Gusmao, Rafaelle
   Chancey, Caren
   Volkova, Evgeniya
   Grinev, Andriyan
   Sippert, Emilia
   Jiang, Zhen
   Rios, Maria
TI Production and characterization of Zika virus RNA reference reagents as
   a response to a public health emergency
SO TRANSFUSION
LA English
DT Article
ID SEXUAL TRANSMISSION
AB BACKGROUNDThe emergence of Zika virus (ZIKV) in 2015 to 2016 created a global public health crisis and an urgent need for accurate detection assays. Nucleic acid testing (NAT) is the most specific and sensitive technology for early detection of ZIKV. Various NAT protocols have been created, but until recently, assessment of assay performance and comparative studies were hampered by the lack of available standards and reference reagents.
   STUDY DESIGN AND METHODSThe Center for Biologics Evaluation and Research/Food and Drug Administration responded to this crisis with the generation of two ZIKV-RNA reference reagents (ZIKV-RRs) for use in the development, validation, and assessment of performance of ZIKV-NAT assays. These reagents were produced from heat-inactivated (HI) ZIKV culture supernatant stock from two strains (PRVABC59 and FSS13025) diluted in dialyzed, defibrinated human plasma and lyophilized for evaluation in collaborative studies. The liquid, HI stock had been shared with the Paul-Ehrlich-Institute (Germany) and were included in the collaborative validation studies for the World Health Organization International Standard for ZIKV (WHO ZIKV IS).
   RESULTSNAT-detectable units (NDUs)/mL were determined in a collaborative study that led to the assignment of 5.77 log NDUs/mL for PRVABC59 and 5.54 log NDUs/mL for FSS13025 as the final concentrations of the FDA ZIKV-RRs.
   CONCLUSIONWe have established well-characterized reference reagents for ZIKV to facilitate evaluation of existing NAT assays and development of novel ZIKV assays which are correlated to that of the First WHO ZIKV IS. Vials of the ZIKV-RRs are available to qualified organizations upon request.
C1 [Fares-Gusmao, Rafaelle; Chancey, Caren; Volkova, Evgeniya; Grinev, Andriyan; Sippert, Emilia; Rios, Maria] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,Bldg 52-72 Room 5308, Silver Spring, MD 20993 USA.
   [Jiang, Zhen] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
RP Rios, M (corresponding author), US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave,Bldg 52-72 Room 5308, Silver Spring, MD 20993 USA.
EM maria.rios@fda.hhs.gov
RI Sippert, Emilia Angela/B-3033-2013
OI Sippert, Emilia Angela/0000-0002-6341-3879; Fares Gusmao,
   Rafaelle/0000-0002-2186-4145
FU FDA Medical Countermeasure initiative (MCMi)
FX We thank FDA Medical Countermeasure initiative (MCMi) for the financial
   support. This project was supported in part by an appointment to the
   Research Participation Program at the OBRR/ CBER, U.S. Food and Drug
   Administration, administered by the Oak Ridge Institute for Science and
   Education through an interagency agreement between the U.S. Department
   of Energy and FDA.
CR Anez G, 2015, VOX SANG, V109, P312, DOI 10.1111/vox.12297
   Anez G, 2017, TRANSFUSION, V57, P1977, DOI 10.1111/trf.14130
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Baylis SA, 2013, EMERG INFECT DIS, V19, P729, DOI 10.3201/eid1905.121845
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   COLLET D, 1991, MODELING BINARY DATA
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   R Development Core Team, 2010, R LANG ENV STAT COMP
   U.S. Food and Drug Administration, 2017, FDA APPR 1 TEST SCRE
   World Health Organization, 2017, VECT BORN DIS
NR 17
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD SEP
PY 2018
VL 58
IS 9
BP 2171
EP 2174
DI 10.1111/trf.14870
PG 4
WC Hematology
SC Hematology
GA GT1LV
UT WOS:000444232700015
PM 30178463
OA Bronze
DA 2020-07-08
ER

PT J
AU Findlater, A
   Bogoch, II
AF Findlater, Aidan
   Bogoch, Isaac I.
TI Human Mobility and the Global Spread of Infectious Diseases: A Focus on
   Air Travel
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID RESPIRATORY SYNDROME CORONAVIRUS; ZIKA VIRUS OUTBREAK; EBOLA-VIRUS;
   MATHEMATICAL-MODEL; AIRLINE TRAVEL; UNITED-STATES; HEALTH; DENGUE;
   SURVEILLANCE; CHIKUNGUNYA
AB Greater human mobility, largely driven by air travel, is leading to an increase in the frequency and reach of infectious disease epidemics. Air travel can rapidly connect any two points on the planet, and this has the potential to cause swift and broad dissemination of emerging and re-emerging infectious diseases that may pose a threat to global health security. Investments to strengthen surveillance, build robust early-warning systems, improve predictive models, and coordinate public health responses may help to prevent, detect, and respond to new infectious disease epidemics.
C1 [Findlater, Aidan; Bogoch, Isaac I.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Toronto Gen Hosp, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada.
RP Bogoch, II (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Bogoch, II (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Gen Internal Med, Toronto, ON, Canada.; Bogoch, II (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada.
EM isaac.bogoch@uhn.ca
RI Findlater, Aidan/K-8565-2019
OI Findlater, Aidan/0000-0003-4698-7536
CR Adeyi OOB, 2017, DRUG RESISTANT INFEC, V2
   Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208
   Alemnji GA, 2014, TROP MED INT HEALTH, V19, P450, DOI 10.1111/tmi.12269
   Angelini R., 2007, EUROSURVEILLANCE, V12, P12
   [Anonymous], 2014, CBC NEWS
   Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X
   Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591
   BBC News, 2014, BBC NEWS
   Bernasconi OJ, 2016, ANTIMICROB AGENTS CH, V60, P5080, DOI 10.1128/AAC.00731-16
   Berrazeg M., 2014, Eurosurveillance, V19, P20809, DOI 10.2807/1560-7917.ES2014.19.20.20809
   Bertoli G, 2016, J INFECT DEV COUNTR, V10, P537, DOI 10.3855/jidc.8203
   Boggild A K, 2016, Can Commun Dis Rep, V42, P12
   Boggild Andrea K, 2014, Open Med, V8, pe20
   Bogoch II, 2018, LANCET INFECT DIS, V18, P247, DOI 10.1016/S1473-3099(18)30077-X
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401
   Center for Disease Control and Prevention, 2015, CHIK 2014 FIN DAT US
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Chong KC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-309
   Christian MD, 2004, CLIN INFECT DIS, V38, P1420, DOI 10.1086/420743
   Cohen NJ, 2016, MMWR-MORBID MORTAL W, V65, P57, DOI 10.15585/mmwr.su6503a9
   Cosgrove SE, 2003, CLIN INFECT DIS, V36, P1433, DOI 10.1086/375081
   Cowling B.J., 2015, CURR OPIN INFECT DIS, V25, P458
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   Dion M, 2015, Can Commun Dis Rep, V41, P209
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Ellem JA, 2017, EMERG INFECT DIS, V23, P1160, DOI 10.3201/eid2307.161638
   Esposito DH, 2014, CLIN INFECT DIS, V59, P1401, DOI 10.1093/cid/ciu622
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fidler DP, 2006, J LAW MED ETHICS, V34, P85, DOI 10.1111/j.1748-720X.2006.00011.x
   FLAHAULT A, 1994, EUR J EPIDEMIOL, V10, P471, DOI 10.1007/BF01719679
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Gardner LM, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw063
   Gostic KM, 2015, ELIFE, V4, DOI 10.7554/eLife.05564
   Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853
   Harris M, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0102-3
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hotez PJ, 2016, ANNU REV MED, V67, P405, DOI 10.1146/annurev-med-051214-024241
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8
   Institute of Shipping Economics and Logistics, 2017, SHIPPING STAT MARKET, V61
   International Air Transport Association, 2017, IATA ANN REV 2017
   ISAACSON M, 1989, B WORLD HEALTH ORGAN, V67, P737
   Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559
   Khanal K., 2014, PLOS CURR OUTBREAKS, VI, P1
   Ki M, 2015, EPIDEMIOL HLTH, V2015, P37, DOI DOI 10.4178/EPIH/E2015033
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2015, EUROSURVEILLANCE, V20, P14, DOI 10.2807/1560-7917.ES2015.20.25.21167
   Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Lee SS, 2015, INT J INFECT DIS, V38, P65, DOI 10.1016/j.ijid.2015.07.014
   Leendertz SAJ, 2016, ECOHEALTH, V13, P18, DOI 10.1007/s10393-015-1053-0
   Lefebvre A, 2014, MED MALADIES INFECT, V44, P412, DOI 10.1016/j.medmal.2014.08.005
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7
   Lopaz MA, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.1.21003
   Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5
   Madoff LC, 2004, CLIN INFECT DIS, V39, P227, DOI 10.1086/422003
   McCarthy AE, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0638-y
   Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777
   Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Ouma John H., 2001, Trends in Parasitology, V17, P117, DOI 10.1016/S1471-4922(00)01877-8
   Pan American Health Organization, 2017, NUMB REP CAS CHIK FE
   Pattani R, 2015, CAN MED ASSOC J, V187, P166, DOI 10.1503/cmaj.141488
   Payne M, 2016, EMERG INFECT DIS, V22, P1673, DOI 10.3201/eid2209.160177
   PLOUGH HH, 1945, AM J CLIN PATHOL, V15, P446
   Pomares-Estran C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-202
   Ramalli L, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.4.18-00017
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regan JJ, 2015, MMWR-MORBID MORTAL W, V64, P63
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1
   Sante publique France, 2017, CHIK DENG ZIK DONN S
   Saywell T., 2003, DOW JONES FAR E EC R, V166, P12
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schwartz E., 2013, Eurosurveillance, V18, P20488
   Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274
   Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867
   Siedner MJ, 2018, LANCET PUBLIC HEALTH, V3, pE109, DOI 10.1016/S2468-2667(18)30029-X
   Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X
   Tatem AJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-57
   ten Bosch QA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006965
   Thomas L, 2014, AM J TROP MED HYG, V91, P138, DOI 10.4269/ajtmh.13-0595
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   United Nations Department of Economic and Social Affairs, 2017, INT MIGR REP HIGHL
   United Nations World Tourism Organization, 2017, UNWTO TOUR HIGHL 201
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Wang YA, 2017, ANN GLOB HEALTH, V83, P625, DOI 10.1016/j.aogh.2017.09.002
   Wertheim HFL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000231
   Wickremasinghe AR, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1763-6
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   World Bank, 2014, EC IMP 2014 EB EP SH
   World Health Organization, 2018, REV PLAG DET MAD YIE
   World Health Organization, 2015, GLOB ACT PLAN ANT RE
   World Health Organization (WHO), 2017, GLOB ANT RES SURV SY
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yang YM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10402-1
   Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09
   Zumla A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0686-3
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 120
TC 17
Z9 17
U1 14
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD SEP
PY 2018
VL 34
IS 9
BP 772
EP 783
DI 10.1016/j.pt.2018.07.004
PG 12
WC Parasitology
SC Parasitology
GA GT5DS
UT WOS:000444526700007
PM 30049602
OA Green Published
DA 2020-07-08
ER

PT J
AU Dirlikov, E
   Major, CG
   Medina, NA
   Lugo-Robles, R
   Matos, D
   Munoz-Jordan, JL
   Colon-Sanchez, C
   Garcia, M
   Olivero-Segarra, M
   Malave, G
   Rodriguez-Vega, GM
   Thomas, DL
   Waterman, SH
   Sejvar, JJ
   Luciano, CA
   Sharp, TM
   Rivera-Garcia, B
AF Dirlikov, Emilio
   Major, Chelsea G.
   Medina, Nicole A.
   Lugo-Robles, Roberta
   Matos, Desiree
   Munoz-Jordan, Jorge L.
   Colon-Sanchez, Candimar
   Garcia, Myriam
   Olivero-Segarra, Marangely
   Malave, Graciela
   Rodriguez-Vega, Gloria M.
   Thomas, Dana L.
   Waterman, Stephen H.
   Sejvar, James J.
   Luciano, Carlos A.
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Clinical Features of Guillain-Barre Syndrome With vs Without Zika Virus
   Infection, Puerto Rico, 2016
SO JAMA NEUROLOGY
LA English
DT Article
ID CASE SERIES; NOVEMBER 1; TRANSMISSION; COLOMBIA
AB IMPORTANCE The pathophysiologic mechanisms of Guillain-Barre syndrome (GBS) associated with Zika virus (ZIKV) infection may be indicated by differences in clinical features.
   OBJECTIVE To identify specific clinical features of GBS associated with ZIKV infection.
   DESIGN, SETTING, AND PARTICIPANTS During the ZIKV epidemic in Puerto Rico, prospective and retrospective strategies were used to identify patients with GBS who had neurologic illness onset in 2016 and were hospitalized at all 57 nonspecialized hospitals and 2 rehabilitation centers in Puerto Rico. Guillain-Barre syndrome diagnosis was confirmed via medical record review using the Brighton Collaboration criteria. Specimens (serum, urine, cerebrospinal fluid, and saliva) from patients with GBS were tested for evidence of ZIKV infection by real-time reverse transcriptase-polymerase chain reaction; serum and cerebrospinal fluid were also tested by IgM enzyme-linked immunosorbent assay. In this analysis of public health surveillance data, a total of 123 confirmed GBS cases were identified, of which 107 had specimens submitted for testing; there were 71 patients with and 36 patients without evidence of ZIKV infection. Follow-up telephone interviews with patients were conducted 6 months after neurologic illness onset; 60 patients with and 27 patients without evidence of ZIKV infection participated.
   MAIN OUTCOMES AND MEASURES Acute and long-term clinical characteristics of GBS associated with ZIKV infection.
   RESULTS Of 123 patients with confirmed GBS, the median age was 54 years (age range, 4-88 years), and 68 patients (55.3%) were male. The following clinical features were more frequent among patients with GBS and evidence of ZIKV infection compared with patients with GBS without evidence of ZIKV infection: facial weakness (44 [62.0%] vs 10 [27.8%]; P <.001), dysphagia (38 [53.5%] vs 9 [25.0%]; P =.005), shortness of breath ( 33 [46.5%] vs 9 [25.0%]; P =.03), facial paresthesia (13 [18.3%] vs 1 [2.8%]; P =.03), elevated levels of protein in cerebrospinal fluid (49 [94.2%] vs 23 [71.9%]; P =.008), admission to the intensive care unit (47 [66.2%] vs 16 [44.4%]; P =.03), and required mechanical ventilation (22 [31.0%] vs 4 [11.1%]; P =.02). Six months after neurologic illness onset, patients with GBS and evidence of ZIKV infection more frequently reported having excessive or inadequate tearing (30 [53.6%] vs 6 [26.1%]; P =.03), difficulty drinking from a cup (10 [17.9%] vs 0; P =.03), and self-reported substantial pain (15 [27.3%] vs 1 [4.3%]; P =.03).
   CONCLUSIONS AND RELEVANCE In this study, GBS associated with ZIKV infection was found to have higher morbidity during the acute phase and more frequent cranial neuropathy during acute neuropathy and 6 months afterward. Results indicate GBS pathophysiologic mechanisms that may be more common after ZIKV infection.
C1 [Dirlikov, Emilio; Lugo-Robles, Roberta; Waterman, Stephen H.; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
   [Dirlikov, Emilio] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, 2500 Century Pkwy NE,Mail Stop E-22, Atlanta, GA 30345 USA.
   [Major, Chelsea G.; Medina, Nicole A.; Matos, Desiree; Munoz-Jordan, Jorge L.; Colon-Sanchez, Candimar; Sharp, Tyler M.] US Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30345 USA.
   [Major, Chelsea G.] US Ctr Dis Control & Prevent, Off State Tribal Local & Terr Support, Atlanta, GA 30345 USA.
   [Garcia, Myriam; Olivero-Segarra, Marangely; Malave, Graciela] Puerto Rico Dept Hlth, Biol & Chem Emergencies Lab, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Garcia, Myriam; Olivero-Segarra, Marangely; Malave, Graciela] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
   [Rodriguez-Vega, Gloria M.] Hosp Interamer Med Avanzada San Pablo, Caguas, PR USA.
   [Thomas, Dana L.] US Ctr Dis Control & Prevent, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30345 USA.
   [Thomas, Dana L.; Waterman, Stephen H.; Sharp, Tyler M.] US PHS, Commissioned Corps, Rockville, MD USA.
   [Sejvar, James J.] US Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30345 USA.
   [Luciano, Carlos A.] Univ Puerto Rico, Sch Med, Neurol Sect, San Juan, PR 00936 USA.
RP Dirlikov, E (corresponding author), US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Sci Educ & Profess Dev, 2500 Century Pkwy NE,Mail Stop E-22, Atlanta, GA 30345 USA.
EM klt9@cdc.gov
OI Dirlikov, Emilio/0000-0003-4631-2643
FU National Institute on Minority Health and Health DisparitiesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Minority Health & Health
   Disparities (NIMHD); National Institute of Allergy and Infectious
   Diseases of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U54MD007587]
FX Dr Luciano received support from the National Institute on Minority
   Health and Health Disparities and the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health under award
   U54MD007587.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   HUND EF, 1993, CRIT CARE MED, V21, P433, DOI 10.1097/00003246-199303000-00023
   InBios International Inc, ANT VIR IMM IGM ANT
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lozier MJ, 2016, J INFECT DIS
   Major C, 2018, P R HLTH SCI J, V37
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   Merkies ISJ, 2002, J NEUROL NEUROSUR PS, V72, P596, DOI 10.1136/jnnp.72.5.596
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Salinas JL, 2017, J NEUROL SCI, V377, P102, DOI 10.1016/j.jns.2017.04.006
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   U. S. Food and Drug Administration, EM US AUTH ZIK VIR E
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   US Census Bureau, 2017, PUERT RIC COMM POP T
   VanSwearingen JM, 1996, PHYS THER, V76, P1288, DOI 10.1093/ptj/76.12.1288
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 37
TC 15
Z9 15
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD SEP
PY 2018
VL 75
IS 9
BP 1089
EP 1097
DI 10.1001/jamaneurol.2018.1058
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA GT1EJ
UT WOS:000444201900009
PM 29799940
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Robinson, N
   Galvan, EEM
   Trujillo, IGZ
   Zavala-Cerna, MG
AF Robinson, Nia
   Mayorquin Galvan, Evangelina E.
   Zavala Trujillo, Isidro G.
   Zavala-Cerna, Maria G.
TI Congenital Zika syndrome: Pitfalls in the placental barrier
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE antibody dependent enhancement; congenital Zika syndrome; microcephaly;
   sexual transmission; transplacental transmission; Zika virus; ZIKV
ID MALE SEXUAL TRANSMISSION; DENGUE VIRUS-INFECTION; 1ST TRIMESTER; CELLS;
   RESPONSES; MEMORY; RNA
AB Much progress with respect to congenital Zika virus (ZIKV) pathogenesis has been achieved after the 2015 outbreak in Brazil. It is now accepted that ZIKV is vertically transmitted, infects cells of the developing central nervous system and the placenta, yet it is unclear to what extent placental affection contributes to the development of congenital ZIKV. The association between fulminant villitis and severe fetal involvement emerges as a possibility. ZIKV is unique among the Flaviviruses in its ability to be sexually transmitted, possibly responsible for its teratogenicity. Furthermore, there is controversy over the participation of antibody dependent enhancement (ADE) in patients with non-neutralizing anti-Flavivirus antibodies, a phenomenon previously recognized in serious DENV infections. Our aim was to analyze information regarding the contribution of the placental barrier as an actual player in neonatal ZIKV. Therefore, we underwent a systematic review with keywords "Zika virus" and "ZIKV". Articles were screened for relevance concerning the topics of microcephaly, transplacental transmission, sexual transmission, and ADE. We identified variables that affect the severity of congenital Zika syndrome: age of gestation at maternal infection, the extent of placental disruption (villitis), sexual transmission, initial viral replication at the uterine wall, anti-DENV antibodies, and the possibility of antibody-mediated transcytosis of ZIKV through the placenta. These questions may not seem relevant when Zika becomes endemic, and we are no longer witness to the extreme clinical sequelae seen when the virus moves through an immunologically naive population; however, characterizing the pathogenesis of congenital Zika syndrome will continue to further our understanding.
C1 [Robinson, Nia] Univ Autonoma Guadalajara, Int Program Med, Zapopan, Mexico.
   [Mayorquin Galvan, Evangelina E.; Zavala-Cerna, Maria G.] Univ Autonoma Guadalajara, Int Program Med, Immunol Res Lab, Av Patria 1201, Zapopan, Jal, Mexico.
   [Zavala Trujillo, Isidro G.] Univ Autonoma Guadalajara, Hosp Dr Angel Leano, Infect Dis Div, Zapopan, Mexico.
RP Zavala-Cerna, MG (corresponding author), Univ Autonoma Guadalajara, Int Program Med, Immunol Res Lab, Av Patria 1201, Zapopan, Jal, Mexico.
EM g_zavala_78@hotmail.com
RI Zavala, Maria/AAQ-9569-2020; Zavala-Cerna, Maria Guadalupe/AAJ-7139-2020
OI Zavala-Cerna, Maria Guadalupe/0000-0001-6508-9657
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazilian Ministry of Health, 2016, MIN HLTH INV 3852 SU
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gnainsky Y, 2015, REPRODUCTION, V149, P75, DOI 10.1530/REP-14-0395
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pan American Health Organization, 2015, EP AL INCR MICR NE B
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang Y., 2010, VASCULAR BIOL PLACEN
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 52
TC 2
Z9 2
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD SEP
PY 2018
VL 28
IS 5
AR e1985
DI 10.1002/rmv.1985
PG 7
WC Virology
SC Virology
GA GS8GU
UT WOS:000443947600008
PM 29761581
OA Bronze
DA 2020-07-08
ER

PT J
AU Cathcart, LA
   Ramirez-Leon, G
   Orozco, YA
   Flanagan, EA
   Young, SE
   Garcia, RA
AF Cathcart, Laura A.
   Ramirez-Leon, Gabriela
   Orozco, Yamelith Aguilar
   Flanagan, Elizabeth A.
   Young, Stefanie E.
   Garcia, Robert A.
TI An Efficient Model for Designing Medical Countermeasure Just-in-Time
   Training During Public Health Emergencies
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
AB Rapidly training numerous staff and volunteers to distribute and dispense medical countermeasures is challenging because of limited resources and evolving information during public health emergencies.
   The Applied Learning and Development Team within the Division of State and Local Readiness at the Centers for Disease Control and Prevention (CDC) proposes just-in-time training (JITT) templates that can be rapidly customized and implemented early in any public health emergency. The proposed template model aligns with modular training design research to increase relevance and rapid deployment of training. Two case studies are described to demonstrate the potential for training templates to support medical countermeasure responses: (1) customization and implementation of a JITT to prepare staff to work on a CDC task force during the 2016-2017 Zika virus response and (2) a new modular, customizable course to teach the basics about working at a point-of-dispensing site.
   Flexible JITT templates in these cases reduce the burden on emergency planners and trainers, allowing for rapidly developed, customized training viable for all emergency responses.
C1 [Cathcart, Laura A.; Ramirez-Leon, Gabriela; Orozco, Yamelith Aguilar; Flanagan, Elizabeth A.; Young, Stefanie E.; Garcia, Robert A.] Ctr Dis Control & Prevent, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
RP Cathcart, LA (corresponding author), Ctr Dis Control & Prevent, Div State & Local Readiness, 1600 Clifton Rd,Mailstop D-29, Atlanta, GA 30329 USA.
EM ksr2@cdc.gov
FU ORISEUnited States Department of Energy (DOE)
FX Y. Aguilar Orozco, E.A. Flanagan, and S.E. Young are Oak Ridge Institute
   for Science and Education (ORISE) Fellows at Centers for Disease Control
   and Prevention funded by an interagency agreement with ORISE.
CR [Anonymous], 2007, T+D, P50
   Dana Ali, 2017, J Adv Med Educ Prof, V5, P134
   Institute of Medicine, 2008, RES PRIOR EM PREP RE
   Kalraiya A, 2015, ORTHOP REV, V7, P6, DOI 10.4081/or.2015.5750
   Karthikeyan Kaliaperumal, 2014, Indian Dermatol Online J, V5, P266, DOI 10.4103/2229-5178.137774
   National Association of County & City Health Officials, 2017, PUBL HLTH EM PREP LA
   Nistor N, 2010, STUD CONTIN EDUC, V32, P251, DOI 10.1080/0158037X.2010.517996
   Savoia E, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2017.304051
   Wang YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100892
NR 9
TC 0
Z9 0
U1 2
U2 7
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 2018
VL 108
SU 3
BP S212
EP S214
DI 10.2105/AJPH.2018.304599
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GS8JP
UT WOS:000443956400014
PM 30192673
OA Green Published
DA 2020-07-08
ER

PT J
AU Romero, L
   Koonin, LM
   Zapata, LB
   Hurst, S
   Mendoza, Z
   Lathrop, E
AF Romero, Lisa
   Koonin, Lisa M.
   Zapata, Lauren B.
   Hurst, Stacey
   Mendoza, Zipatly
   Lathrop, Eva
CA Z-CAN Program Dev Working Grp
TI Contraception as a Medical Countermeasure to Reduce Adverse Outcomes
   Associated With Zika Virus Infection in Puerto Rico: The Zika
   Contraception Access Network Program
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Editorial Material
ID INCREASING ACCESS; OUTBREAK
AB The Zika Contraception Access Network established a network of 153 physicians across Puerto Rico as a short-term emergency response during the 2016-2017 Zika virus outbreak to provide client-centered contraceptive counseling and same-day contraception services at no cost for women who chose to prevent pregnancy. Between May 2016 and August 2017, 21 124 women received services. Contraception was used as a medical countermeasure to reduce adverse Zika-related re-productive outcomes during the outbreak and may be considered a key strategy in other emergencies.
C1 [Romero, Lisa; Zapata, Lauren B.; Hurst, Stacey] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,MSF 74, Atlanta, GA 30341 USA.
   [Koonin, Lisa M.] Ctr Dis Control & Prevent, Influenza Coordinat Unit, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Mendoza, Zipatly] Natl Fdn Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Lathrop, Eva] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
RP Romero, L (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,MSF 74, Atlanta, GA 30341 USA.
EM eon1@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
FU National Foundation for the Centers for Disease Control and Prevention
   Inc. (CDC Foundation) by Bill & Melinda Gates Foundation; Bloomberg
   Philanthropies; William and Flora Hewlett Foundation; Pfizer Foundation;
   American College of Obstetricians and Gynecologists
FX Funding via the National Foundation for the Centers for Disease Control
   and Prevention Inc. (CDC Foundation) was made possible by the Bill &
   Melinda Gates Foundation, Bloomberg Philanthropies, the William and
   Flora Hewlett Foundation, The Pfizer Foundation, and the American
   College of Obstetricians and Gynecologists. The CDC Foundation also
   secured large-scale donations, offers of contraceptive products, support
   tools, and services from Bayer, Allergan, Medicines360, Americares and
   Janssen Pharmaceuticals Inc, Merck & Co Inc, Mylan, The Pfizer
   Foundation, Teva Pharmaceuticals, Church & Dwight Co Inc, RB, Power to
   Decide (formerly The National Campaign to Prevent Teen and Unplanned
   Pregnancy), Upstream USA, and Market Vision, Culture Inspired Marketing.
CR Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
NR 4
TC 2
Z9 2
U1 0
U2 1
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 2018
VL 108
SU 3
BP S227
EP S230
DI 10.2105/AJPH.2018.304558
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GS8JP
UT WOS:000443956400018
PM 30192658
OA Green Published
DA 2020-07-08
ER

PT J
AU Routhu, NK
   Xie, Y
   Dunworth, M
   Casero, RA
   Oupicky, D
   Byrareddy, SN
AF Routhu, Nanda Kishore
   Xie, Ying
   Dunworth, Matthew
   Casero, Robert A., Jr.
   Oupicky, David
   Byrareddy, Siddappa N.
TI Polymeric Prodrugs Targeting Polyamine Metabolism Inhibit Zika Virus
   Replication
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE Zika virus; virus replication; polyamines; bisethylnorspermine;
   prodrugs; polyamine metabolism; SMOX; SAT1
ID SEXUAL TRANSMISSION; IN-VITRO; INFECTION; SPERMINE; CELLS; DELIVERY;
   CANCER; FLAVIVIRUSES; PATHOGENESIS; TRANSLATION
AB The Zika virus (ZIKV) is primarily transmitted via an infected mosquito bite, during sexual intercourse, or in utero mother to child transmission. When a fetus is infected, both neurological malformations and deficits in brain development are frequently manifested. As such, there is a need for vaccines or drugs that may be used to cure ZIKV infections. Metabolic pathways play a crucial role in cell differentiation and development. More importantly, polyamines play a key role in replication and translation of several RNA viruses, including ZIKV, Dengue virus, and Chikungunya virus. Here, we present polyamine analogues (BENSpm and PG11047) and their corresponding polymer prodrug derivatives for inhibiting ZIKV infection by intersecting with polyamine catabolism pathways. We tested the compounds against ZIKV African (MR766) and Asian (PRVABC59) strains in human kidney epithelial (Vero) and glioblastoma derived (SNB-19) cell lines. Our results demonstrate potent inhibition of ZIKV viral replication in both cell lines tested. This antiviral effect was mediated by the upregulation of two polyamine catabolic enzymes, spermine oxidase, and spermidine (SMOX)/spermine N1-acetyltransferase (SAT1) as apparent reduction of the ZIKV infection following heterologous expression of SMOX and SAT1. On the basis of these observations, we infer potential use of these polyamine analogues to treat ZIKV infections.
C1 [Routhu, Nanda Kishore; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Xie, Ying; Oupicky, David] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Ctr Drug Delivery & Nanomed, Omaha, NE 68198 USA.
   [Dunworth, Matthew; Casero, Robert A., Jr.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.
RP Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Oupicky, D (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Ctr Drug Delivery & Nanomed, Omaha, NE 68198 USA.
EM david.oupicky@unmc.edu; sid.byrareddy@unmc.edu
RI Routhu, Nanda Kishore/U-4106-2019; Oupicky, David/C-7220-2009
OI Routhu, Nanda Kishore/0000-0003-2080-819X; Oupicky,
   David/0000-0003-4710-861X; Dunworth, Matthew/0000-0002-8852-169X;
   Casero, Robert/0000-0001-5653-3306
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI113883];
   Nebraska Neuroscience Alliance Endowed Fund
FX This work is supported in part by National Institutes of Health
   R01AI113883 and Nebraska Neuroscience Alliance Endowed Fund Award to
   S.N.B. We thank Dr. Dave for critical reading and Robin Taylor for
   editorial assistance. We thank Dr. Marton for providing PG11047. We
   thank Dr. Myung Hee Park (NIH/NIDCR) and Dr. Robert A. Casero, Jr.,
   (JHSM) for kindly providing pCMV7.1 3X FLAG/SAT 1 and phCMV3 HA
   c-terminal tagged SMOX vectors, respectively. We thank Dr. Gmeiner, Wake
   Forest School of Medicine, for providing SNB-19 cells.
CR Bearcroft WGC, 1956, T R SOC TROP MED HYG, V50, P438
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capone C, 2013, FREE RADICAL BIO MED, V63, P99, DOI 10.1016/j.freeradbiomed.2013.05.007
   Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243
   Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518
   Huang YL, 1998, J INTERF CYTOK RES, V18, P337, DOI 10.1089/jir.1998.18.337
   KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X
   Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mounce BC, 2017, J VIROL, V91, DOI [10.1128/JVI.00344-17, 10.1128/jvi.00344-17]
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Murray-Stewart T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175917
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Patkar C. G., 2008, NOVART FDN SYMP, V277, p[41, 71]
   Patkar C. G., 2008, NOVART FDN SYMP, V277, P71
   Patkar C. G., 2008, NOVART FDN SYMP, V277, P251
   Patkar C. G., 2008, NOVART FDN SYMP, V277, P52
   Pegg AE, 2008, AM J PHYSIOL-ENDOC M, V294, pE995, DOI 10.1152/ajpendo.90217.2008
   Reddy VK, 1998, J MED CHEM, V41, P4723, DOI 10.1021/jm980172v
   Roos WH, 2007, CELL MOL LIFE SCI, V64, P1484, DOI 10.1007/s00018-007-6451-1
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Wang QY, 2011, ANTIMICROB AGENTS CH, V55, P4072, DOI 10.1128/AAC.00620-11
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xie Y, 2017, J CONTROL RELEASE, V246, P110, DOI 10.1016/j.jconrel.2016.12.017
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhu Y, 2015, MOL PHARMACEUT, V12, P332, DOI 10.1021/mp500469n
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 63
TC 3
Z9 3
U1 1
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD SEP
PY 2018
VL 15
IS 9
BP 4284
EP 4295
DI 10.1021/acs.molpharmaceut.8b00068
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA GS7ZC
UT WOS:000443923800065
PM 30040423
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Moreira-Soto, A
   Torres, MC
   de Mendonca, MCL
   Mares-Guia, MA
   Rodrigues, CDD
   Fabri, AA
   dos Santos, CC
   Araujo, ESM
   Fischer, C
   Nogueira, RMR
   Drosten, C
   Sequeira, PC
   Drexler, JF
   de Filippis, AMB
AF Moreira-Soto, A.
   Torres, M. C.
   Lima de Mendonca, M. C.
   Mares-Guia, M. A.
   dos Santos Rodrigues, C. D.
   Fabri, A. A.
   dos Santos, C. C.
   Machado Araujo, E. S.
   Fischer, C.
   Ribeiro Nogueira, R. M.
   Drosten, C.
   Carvalho Sequeira, P.
   Drexler, J. F.
   Bispo de Filippis, A. M.
TI Evidence for multiple sylvatic transmission cycles during the 2016-2017
   yellow fever virus outbreak, Brazil
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Brazil; Flavivirus; Human; Nonhuman primates; Outbreak; Yellow fever
   virus
AB Objectives: Since December 2016, Brazil has experienced an unusually large outbreak of yellow fever (YF). Whether urban transmission may contribute to the extent of the outbreak is unclear. The objective of this study was to characterize YF virus (YFV) genomes and to identify spatial patterns to determine the distribution and origin of YF cases in Minas Gerais, Espirito Santo and Rio de Janeiro, the most affected Brazilian states during the current YFV outbreak.
   Methods: We characterized near-complete YFV genomes from 14 human cases and two nonhuman primates (NHP), sampled from February to April 2017, retrieved epidemiologic data of cases and used a geographic information system to investigate the geospatial spread of YFV.
   Results: All YFV strains were closely related. On the basis of signature mutations, we identified two cocirculating YFV clusters. One was restricted to the hinterland of Espirito Santo state, and another formed a coastal cluster encompassing several hundred kilometers. Both clusters comprised strains from humans living in rural areas and NHP. Another NHP lineage clustered in a basal relationship. No signs of adaptation of YFV strains to human hosts were detected.
   Conclusions: Our data suggest sylvatic transmission during the current outbreak. Additionally, cocirculation of two distinct YFV clades occurring in humans and NHP suggests the existence of multiple sylvatic transmission cycles. Increased detection of YFV might be facilitated by raised awareness for arbovirus-mediated disease after Zika and chikungunya virus outbreaks. Further surveillance is required, as reemergence of YFV from NHPs might continue and facilitate the appearance of urban transmission cycles. (C) 2018 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
C1 [Moreira-Soto, A.; Fischer, C.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Moreira-Soto, A.; Drosten, C.; Drexler, J. F.] Charite Univ Med Berlin, Berlin, Germany.
   [Moreira-Soto, A.; Drosten, C.; Drexler, J. F.] Free Univ Berlin, Berlin, Germany.
   [Moreira-Soto, A.; Drosten, C.; Drexler, J. F.] Humboldt Univ, Berlin, Germany.
   [Moreira-Soto, A.; Drosten, C.; Drexler, J. F.] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Torres, M. C.; Lima de Mendonca, M. C.; Mares-Guia, M. A.; dos Santos Rodrigues, C. D.; Fabri, A. A.; dos Santos, C. C.; Machado Araujo, E. S.; Ribeiro Nogueira, R. M.; Carvalho Sequeira, P.; Bispo de Filippis, A. M.] Fiocruz MS, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Drosten, C.; Drexler, J. F.] German Ctr Infect Res DZIF, Braunschweig, Germany.
RP Drexler, JF (corresponding author), Campus Charite Mitte, Inst Virol, Helmut Ruska Haus,Charitepl 1, D-10098 Berlin, Germany.
EM felix.drexler@charite.de
OI Moreira-Soto, Andres/0000-0002-9224-5157; Fischer,
   Carlo/0000-0001-9163-2406; Drexler, Jan Felix/0000-0002-3509-0232
FU European Union's Horizon 2020 research and innovation programme through
   the Horizon 2020 research and innovation program (ZIK Action project)
   [734857]; European Union's Horizon 2020 research and innovation
   programme through the Horizon 2020 research and innovation program (ZIK
   Alliance project) [734548]; Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-18/2015TXB]
FX Supported in part by the European Union's Horizon 2020 research and
   innovation programme through the Horizon 2020 research and innovation
   program (ZIK Action project, grant agreement 734857; ZIK Alliance
   project, grant agreement 734548), and by the Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ; grant E-18/2015TXB). All
   authors report no conflicts of interest relevant to this article.
CR Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Paploski IAD, 2018, ANN INTERN MED, V168, P301, DOI 10.7326/M17-1949
   Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Cavalcante KRLJ, 2017, EPIDEMIOL SERV SAUDE, V26, P617, DOI 10.5123/S1679-49742017000300018
   Cavalcante KRLJ, 2016, EPIDEMIOL SERV SAUDE, V25, P11, DOI [10.5123/S1679-49742016000100002, 10.5123/s1679-49742016000100002]
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, EM EP FEBR AM BRAS
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2
NR 15
TC 29
Z9 29
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD SEP
PY 2018
VL 24
IS 9
DI 10.1016/j.cmi.2018.01.026
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GQ6ZX
UT WOS:000441882800020
PM 29427798
OA Other Gold
DA 2020-07-08
ER

PT J
AU Sulczewski, FB
   Liszbinski, RB
   Romao, PRT
   Rodrigues, LC
AF Sulczewski, Fernando B.
   Liszbinski, Raquel B.
   Romao, Pedro R. T.
   Rodrigues Junior, Luiz Carlos
TI Nanoparticle vaccines against viral infections
SO ARCHIVES OF VIROLOGY
LA English
DT Review
ID VIRUS-LIKE PARTICLES; PATTERN-RECOGNITION RECEPTORS; SWINE
   INFLUENZA-VIRUS; IMMUNE-RESPONSES; DENDRITIC CELLS; INNATE IMMUNITY;
   DELIVERY; ANTIGEN; VACCINATION; IMMUNIZATION
AB Despite numerous efforts, we still do not have prophylactic vaccines for many clinically relevant viruses, such as HIV, hepatitis C virus, Zika virus, and respiratory syncytial virus. Several factors have contributed to the current lack of effective vaccines, including the high rate of viral mutation, low immunogenicity of recombinant viral antigens, instability of viral antigenic proteins administered in vivo, sophisticated mechanisms of viral immune evasion, and inefficient induction of mucosal immunity by vaccine models studied to date. Some of these obstacles could be partially overcome by the use of vaccine adjuvants. Nanoparticles have been intensively investigated as vaccine adjuvants because they possess chemical and structural properties that improve immunogenicity. The use of nanotechnology in the construction of immunization systems has developed into the field of viral nanovaccinology. The purpose of this paper is to review and correlate recent discoveries concerning nanoparticles and specific properties that contribute to the immunogenicity of viral nanoparticle vaccines, bio-nano interaction, design of nanoparticle vaccines for clinically relevant viruses, and future prospects for viral nanoparticle vaccination.
C1 [Sulczewski, Fernando B.; Liszbinski, Raquel B.; Romao, Pedro R. T.; Rodrigues Junior, Luiz Carlos] Fed Univ Hlth Sci Porto Alegre UFCSPA, Lab Cellular & Mol Immunol, Av Sarmento Leite 245, BR-90050170 Porto Alegre, RS, Brazil.
RP Rodrigues, LC (corresponding author), Fed Univ Hlth Sci Porto Alegre UFCSPA, Lab Cellular & Mol Immunol, Av Sarmento Leite 245, BR-90050170 Porto Alegre, RS, Brazil.
EM luizrdrgs@yahoo.com.br
RI Sulczewski, Fernando/G-1313-2018; Romao, Pedro/N-4826-2015
OI Sulczewski, Fernando/0000-0001-5611-6967; Romao,
   Pedro/0000-0002-1039-2509
CR Agarwal R, 2013, P NATL ACAD SCI USA, V110, P17247, DOI 10.1073/pnas.1305000110
   Ahmed Y, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0178-3
   Aikins ME, 2017, NANOMEDICINE-UK, V12, P673, DOI 10.2217/nnm-2016-0381
   Alberto J, 2015, EXPERT REV VACCINES, V14, P1197, DOI 10.1586/14760584.2015.1064772
   Amirnasr M, 2016, MICROB PATHOGENESIS, V97, P38, DOI 10.1016/j.micpath.2016.05.012
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P369
   Arama C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018319
   Avalos AM, 2014, FRONT IMMUNOL, P5
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Bale S, 2017, J VIROL, V91, DOI 10.1128/JVI.00443-17
   Barani H, 2008, J LIPOSOME RES, V18, P249, DOI [10.1080/08982100802354665, 10.1080/08982100802354665 ]
   Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359
   Benedicto I, 2015, J VIROL, V89, P4180, DOI 10.1128/JVI.03620-14
   Bernkop-Schnurch A., 2005, AM J DRUG DELIV, V3, P141, DOI DOI 10.2165/00137696-200503030-00001
   Bharali DJ, 2008, NANOMED-NANOTECHNOL, V4, P311, DOI 10.1016/j.nano.2008.05.006
   Binjawadagi B, 2016, ARCH VIROL, V161, P1579, DOI 10.1007/s00705-016-2812-0
   Bolhassani A, 2014, HUM VACC IMMUNOTHER, V10, P321, DOI 10.4161/hv.26796
   Brewer MG, 2017, VACCINE, V35, P774, DOI 10.1016/j.vaccine.2016.12.049
   Caskey M, 2016, NEW ENGL J MED, V375, P2019, DOI 10.1056/NEJMp1613362
   Chappuis F, 2017, VACCINE, V35, P1448, DOI 10.1016/j.vaccine.2017.01.031
   Chiang C, 2017, TRENDS IMMUNOL, V38, P39, DOI 10.1016/j.it.2016.10.008
   Chiara F, 2013, VACCINE, V32, P62, DOI 10.1016/j.vaccine.2013.10.074
   Chiu CC, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3276915
   Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]
   Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dehghan S, 2014, INT J PHARMACEUT, V475, P1, DOI 10.1016/j.ijpharm.2014.08.032
   Dhakal S, 2017, VACCINE, V35, P1124, DOI 10.1016/j.vaccine.2017.01.019
   Dhakal S, 2017, J CONTROL RELEASE, V247, P194, DOI 10.1016/j.jconrel.2016.12.039
   Dinda AK, 2016, VACCINE, V34, P3076, DOI 10.1016/j.vaccine.2016.04.084
   Ebensen T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01223
   Ebrahimian M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01077
   Ebrahimian M, 2016, INT J PHARMACEUT, V515, P708, DOI 10.1016/j.ijpharm.2016.10.065
   El-Serag HB, 2011, GASTROENTEROLOGY, V140, P386, DOI 10.1053/j.gastro.2010.12.019
   Gutjahr A, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040034
   He LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12041
   HogenEsch H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00406
   Hu CMJ, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-016-0321-6
   Hu Y, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-434
   Hunsawong T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003958
   Hunsawong T, 2015, VACCINE, V33, P1702, DOI 10.1016/j.vaccine.2015.02.016
   Jans J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0506-6
   Jeong H, 2017, J MICROBIOL, V55, P220, DOI 10.1007/s12275-017-7058-3
   Jesus S, 2017, NANOMEDICINE-UK, V12, P2335, DOI 10.2217/nnm-2017-0138
   Jesus S, 2016, INT J PHARMACEUT, V504, P59, DOI 10.1016/j.ijpharm.2016.03.013
   Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1321
   Karch CP, 2017, NANOMED-NANOTECHNOL, V13, P241, DOI 10.1016/j.nano.2016.08.030
   Kato H, 2017, J INTERF CYTOK RES, V37, P207, DOI 10.1089/jir.2016.0095
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kim SY, 2017, BIOMATERIALS, V130, P56, DOI 10.1016/j.biomaterials.2017.03.034
   Korber B, 2017, IMMUNOL REV, V275, P230, DOI 10.1111/imr.12516
   Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083
   Lee Young-Ran, 2013, Immune Netw, V13, P30, DOI 10.4110/in.2013.13.1.30
   Leleux JA, 2017, CELL REP, V18, P700, DOI 10.1016/j.celrep.2016.12.073
   Li AV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006516
   Lien G, 2013, INFECT DIS THER, V2, P167, DOI 10.1007/s40121-013-0014-6
   Liu TL, 2013, J COLLOID INTERF SCI, V400, P168, DOI 10.1016/j.jcis.2013.03.005
   Lv SJ, 2014, HEPATOLOGY, V59, P385, DOI 10.1002/hep.26654
   Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696
   Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55
   Mahony D, 2014, NANOSCALE, V6, P6617, DOI 10.1039/c4nr01202j
   Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071
   Mocan T, 2014, BIOTECHNOL MOL BIOL, V2, P13
   Mohsen MO, 2017, J CONTROL RELEASE, V251, P92, DOI 10.1016/j.jconrel.2017.02.031
   Molino NM, 2013, ACS NANO, V7, P9743, DOI 10.1021/nn403085w
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Mukai Y, 2011, J IMMUNOL, V187, P6249, DOI 10.4049/jimmunol.1001093
   Muszkat M, 2003, VACCINE, V21, P1180, DOI 10.1016/S0264-410X(02)00481-4
   Nandedkar TD, 2009, J BIOSCIENCES, V34, P995, DOI 10.1007/s12038-009-0114-3
   Nantachit N, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0598-z
   Ng S, 2017, VACCINE, V35, P6202, DOI 10.1016/j.vaccine.2017.09.036
   Nuismer SL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1903
   Paz-Zulueta M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4033-2
   Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017
   Pejawar-Gaddy S, 2014, BIOCONJUGATE CHEM, V25, P1470, DOI 10.1021/bc5002246
   Pezzotti P, 2018, VACCINE, V36, P4222, DOI 10.1016/j.vaccine.2018.06.002
   Piccini LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140824
   Pietrzak-Nguyen A, 2016, NANOMED-NANOTECHNOL, V12, P2383, DOI 10.1016/j.nano.2016.07.010
   Pileggi C, 2017, VACCINE, V35, P6302, DOI 10.1016/j.vaccine.2017.09.076
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Reikie BA, 2013, CLIN VACCINE IMMUNOL, V20, P33, DOI 10.1128/CVI.00557-12
   Rioux G, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-19
   ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111
   Ross KA, 2015, INT J NANOMED, V10, P229, DOI 10.2147/IJN.S72264
   Rostami H, 2017, IMMUNOL LETT, V187, P19, DOI 10.1016/j.imlet.2017.05.002
   Sahu KK, 2016, INT IMMUNOPHARMACOL, V39, P343, DOI 10.1016/j.intimp.2016.08.007
   Sanders MT, 2005, IMMUNOL CELL BIOL, V83, P119, DOI 10.1111/j.1440-1711.2005.01319.x
   Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223
   Cordeiro AS, 2015, BIOTECHNOL ADV, V33, P1279, DOI 10.1016/j.biotechadv.2015.05.010
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shaalan M, 2016, NANOMED-NANOTECHNOL, V12, P701, DOI 10.1016/j.nano.2015.11.005
   Shaw CA, 2013, IMMUNOL RES, V56, P304, DOI 10.1007/s12026-013-8403-1
   Silva AL, 2016, HUM VACC IMMUNOTHER, V12, P1056, DOI 10.1080/21645515.2015.1117714
   Singh SM, 2016, VIRAL IMMUNOL, V29, P269, DOI 10.1089/vim.2015.0144
   Sliepen K, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0210-4
   Somiya M, 2012, BIOORGAN MED CHEM, V20, P3873, DOI 10.1016/j.bmc.2012.04.031
   Su F, 2016, HUM VACC IMMUNOTHER, V12, P1070, DOI 10.1080/21645515.2015.1114195
   Suresh R, 2013, ADV PHYSIOL EDUC, V37, P284, DOI 10.1152/advan.00058.2013
   Tevi-Benissan MC, 2016, VACCINE, V34, P5193, DOI 10.1016/j.vaccine.2016.05.063
   Toda T, 2016, INT J IMMUNOPATH PH, V29, P408, DOI 10.1177/0394632016656192
   Tomljenovic L, 2012, LUPUS, V21, P223, DOI 10.1177/0961203311430221
   Trovato Maria, 2015, World J Virol, V4, P156, DOI 10.5501/wjv.v4.i3.156
   Turmagambetova AS, 2017, ARCH VIROL, V162, P3817, DOI 10.1007/s00705-017-3560-5
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Wadhwa S, 2012, EUR J PHARM BIOPHARM, V80, P315, DOI 10.1016/j.ejpb.2011.10.016
   Walczak AP, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3029-y
   Wang YR, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1554-y
   Weyland M, 2013, INT J PHARMACEUT, V454, P756, DOI 10.1016/j.ijpharm.2013.06.013
   Wu B, 2015, CLIN VACCINE IMMUNOL, V22, P883, DOI 10.1128/CVI.00170-15
   Xiang J, 2015, ACS NANO, V9, P6401, DOI 10.1021/acsnano.5b02014
   Zaric M, 2013, ACS NANO, V7, P2042, DOI 10.1021/nn304235j
   Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
   Zhao M, 2015, DRUG DELIV, P1, DOI DOI 10.3109/10717544.2015.1038856
   Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 119
TC 7
Z9 8
U1 4
U2 31
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD SEP
PY 2018
VL 163
IS 9
BP 2313
EP 2325
DI 10.1007/s00705-018-3856-0
PG 13
WC Virology
SC Virology
GA GS2YM
UT WOS:000443432000002
PM 29728911
DA 2020-07-08
ER

PT J
AU Bassi, MR
   Sempere, RN
   Meyn, P
   Polacek, C
   Arias, A
AF Bassi, Maria Rosaria
   Sempere, Raquel Navarro
   Meyn, Prashansa
   Polacek, Charlotta
   Arias, Armando
TI Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals
   Different Patterns of Sensitivity to Three Mutagenic Drugs
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE 5-fluorouracil; Usutu virus; Zika virus; error threshold; favipiravir;
   flavivirus; lethal mutagenesis; mutation frequency; ribavirin
ID MOUTH-DISEASE VIRUS; WEST-NILE-VIRUS; LYMPHOCYTIC CHORIOMENINGITIS
   VIRUS; SEXUAL TRANSMISSION; T-705 FAVIPIRAVIR; INFLUENZA-VIRUS;
   VIRAL-RNA; ERROR CATASTROPHE; MUTANT SPECTRUM; RIBAVIRIN
AB Flaviviruses constitute an increasing source of public health concern, with growing numbers of pathogens causing disease and geographic spread to temperate climates. Despite a large body of evidence supporting mutagenesis as a conceivable antiviral strategy, there are currently no data on the sensitivity to increased mutagenesis for Zika virus (ZIKV) and Usutu virus (USUV), two emerging flaviviral threats. In this study, we demonstrate that both viruses are sensitive to three ribo-nucleosides, favipiravir, ribavirin, and 5-fluorouracil, that have shown mutagenic activity against other RNA viruses while remaining unaffected by a mutagenic deoxyribonucleoside. Serial cell culture passages of ZIKV in the presence of these compounds resulted in the rapid extinction of infectivity, suggesting elevated sensitivity to mutagenesis. USUV extinction was achieved when a 10-fold dilution was applied between every passage, but not in experiments involving undiluted virus, indicating an overall lower susceptibility than ZIKV. Although the two viruses are inhibited by the same three drugs, ZIKV is relatively more susceptive to serial passage in the presence of purine analogues (favipiravir and ribavirin), while USUV replication is suppressed more efficiently by 5-fluorouracil. These differences in sensitivity typically correlate with the increases in the mutation frequencies observed in each nucleoside treatment. These results are relevant to the development of efficient therapies based on lethal mutagenesis and support the rational selection of different mutagenic nucleosides for each pathogen. We will discuss the implications of these results to the fidelity of flavivirus replication and the design of antiviral therapies based on lethal mutagenesis.
C1 [Bassi, Maria Rosaria; Sempere, Raquel Navarro; Meyn, Prashansa; Arias, Armando] Tech Univ Denmark, Natl Vet Inst DTU Vet, Lyngby, Denmark.
   [Polacek, Charlotta] Statens Serum Inst, Copenhagen, Denmark.
RP Arias, A (corresponding author), Tech Univ Denmark, Natl Vet Inst DTU Vet, Lyngby, Denmark.
EM arae@vet.dtu.dk
RI Arias, Armando/E-1393-2016
OI Arias, Armando/0000-0002-4138-4608
FU Independent Research Fund Denmark (Technology and Production Sciences,
   DFF-FTP) [6111-00104A]
FX This work is supported by funding procured by Independent Research Fund
   Denmark (Technology and Production Sciences, DFF-FTP) to A. A.,
   application number 6111-00104A. The funders had no role in the study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Agudo R, 2008, J MOL BIOL, V382, P652, DOI 10.1016/j.jmb.2008.07.033
   Agudo R, 2009, FUTURE MED CHEM, V1, P529, DOI 10.4155/FMC.09.26
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Airaksinen A, 2003, VIROLOGY, V311, P339, DOI 10.1016/S0042-6822(03)00144-2
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Arias A, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00279-16
   Arias A, 2014, ELIFE, V3, DOI 10.7554/eLife.03679
   Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Bakonyi T, 2017, EUROSURVEILLANCE, V22, DOI [10.2807/15607917.ES.2017.22.41.1700644, DOI 10.2807/15607917.ES.2017.22.41.1700644]
   Baranovich T, 2013, J VIROL, V87, P3741, DOI 10.1128/JVI.02346-12
   Beaucourt S, 2011, JOVE-J VIS EXP, DOI 10.3791/2953
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Biebricher CK, 2005, VIRUS RES, V107, P117, DOI 10.1016/j.virusres.2004.11.002
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Caroline AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002790
   Cavrini F, 2011, J CLIN VIROL, V50, P221, DOI 10.1016/j.jcv.2010.11.008
   Chung DH, 2013, J VIROL, V87, P10997, DOI 10.1128/JVI.01394-13
   Ciota AT, 2007, J GEN VIROL, V88, P865, DOI 10.1099/vir.0.82606-0
   Clouser Christine L, 2014, Antivir Chem Chemother, V23, P223, DOI 10.3851/IMP2682
   Crotty S, 2000, NAT MED, V6, P1375
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002
   de Avilla AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164691
   de Mello CPP, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01983-17
   Dietz J, 2013, J VIROL, V87, P6172, DOI 10.1128/JVI.02778-12
   Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Eigen M, 2002, P NATL ACAD SCI USA, V99, P13374, DOI 10.1073/pnas.212514799
   ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946
   Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01400-17, 10.1128/aac.01400-17]
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004
   Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07
   Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483
   Grande-Perez A, 2005, J VIROL, V79, P10451, DOI 10.1128/JVI.79.16.10451-10459.2005
   Grande-Perez A, 2002, P NATL ACAD SCI USA, V99, P12938, DOI 10.1073/pnas.182426999
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Griesemer SB, 2017, J GEN VIROL, V98, P201, DOI 10.1099/jgv.0.000682
   Grottola A, 2017, CLIN MICROBIOL INFEC, V23, P33, DOI 10.1016/j.cmi.2016.09.019
   Harris KS, 2005, ANTIVIR RES, V67, P1, DOI 10.1016/j.antiviral.2005.03.004
   Hierholzer J. C., 1996, P25, DOI 10.1016/B978-012465330-6/50003-8
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   de Avila AI, 2017, VIRUS RES, V233, P105, DOI 10.1016/j.virusres.2017.03.014
   Jin ZN, 2015, ANTIMICROB AGENTS CH, V59, P7504, DOI 10.1128/AAC.01391-15
   Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Levi LI, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001163
   Liu WJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189554
   Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Martin-Acebes MA, 2016, VACCINE, V34, P2066, DOI 10.1016/j.vaccine.2016.03.015
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804
   Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014
   Pauly MD, 2015, J VIROL, V89, P3584, DOI 10.1128/JVI.03483-14
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Perales C, 2016, CURR TOP MICROBIOL, V392, P323, DOI 10.1007/82_2015_459
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rawson JMO, 2015, ANTIMICROB AGENTS CH, V59, P6834, DOI 10.1128/AAC.01644-15
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Ruiz-Jarabo CM, 2003, VIROLOGY, V308, P37, DOI 10.1016/S0042-6822(02)00046-6
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Sanz-Ramos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039941
   Sejvar James J, 2003, Ochsner J, V5, P6
   Sierra M, 2007, J VIROL, V81, P2012, DOI 10.1128/JVI.01606-06
   Sierra S, 2000, J VIROL, V74, P8316, DOI 10.1128/JVI.74.18.8316-8323.2000
   Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967
   Smee DF, 2013, FUTURE VIROL, V8, P1085, DOI 10.2217/fvl.13.98
   Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565
   Snell N J, 2001, Expert Opin Pharmacother, V2, P1317, DOI 10.1517/14656566.2.8.1317
   Staples JE, 2014, AM J TROP MED HYG, V90, P402, DOI 10.4269/ajtmh.13-0206
   Tetro JA, 2017, MICROBES INFECT, V19, P380, DOI 10.1016/j.micinf.2017.05.004
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Van Slyke GA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005009
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Woodward J, 2017, CLIN EXP IMMUNOL, V188, P363, DOI 10.1111/cei.12884
   WRAY SK, 1985, ANTIVIR RES, V5, P29, DOI 10.1016/0166-3542(85)90012-9
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zaraska M., 2016, THE NEXT ZIKA
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 105
TC 10
Z9 10
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2018
VL 62
IS 9
AR e00380-18
DI 10.1128/AAC.00380-18
PG 15
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA GR6NN
UT WOS:000442771200014
PM 29914957
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Hansen, S
   Faye, O
   Sanabani, SS
   Faye, M
   Bohlken-Fascher, S
   Faye, O
   Sall, AA
   Bekaert, M
   Weidmann, M
   Czerny, CP
   Abd El Wahed, A
AF Hansen, Soeren
   Faye, Oumar
   Sanabani, Sabri S.
   Faye, Martin
   Boehlken-Fascher, Susanne
   Faye, Ousmane
   Sall, Amadou A.
   Bekaert, Michael
   Weidmann, Manfred
   Czerny, Claus-Peter
   Abd El Wahed, Ahmed
TI Combination random isothermal amplification and nanopore sequencing for
   rapid identification of the causative agent of an outbreak
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Nanopore sequencing; Random isothermal amplification; Point of need
   diagnostics; Zika virus
ID REAL-TIME; VIRUS; SURVEILLANCE; GENOMICS; ASSAY; ZIKA
AB Background: Outbreaks of fever of unknown origin start with nonspecific symptoms and case definition is only slowly developed and adapted, therefore, identifying the causative agent is crucial to ensure suitable treatment and control measures. As an alternative method for Polymerase Chain Reaction in molecular diagnostics diagnostic, metagenomics can be applied to identify the pathogen responsible for the outbreak through sequencing all nucleic acids present in a sample extract. Sequencing data obtained can identify new or variants of known agents.
   Objectives: To develop a rapid and field applicable protocol to allow the identification of the causative agent of an outbreak.
   Study design: We explored a sequencing protocol relying on multiple displacement isothermal amplification and nanopore sequencing in order to allow the identification of the causative agent in a sample. To develop the procedure, a mock sample consisting of supernatant from Zika virus tissue culture was used.
   Results: The procedure took under seven hours including sample preparation and data analysis using an offline BLAST search. In total, 63,678 sequence files covering around 10,000 bases were extracted. BLAST search revealed the presence of Zika virus.
   Conclusion: In conclusion, the protocol has potential for point of need sequencing to identify RNA viruses. The whole procedure was operated in a suitcase laboratory. However, the procedure is cooling chain dependent and the cost per sequencing run is still high.
C1 [Hansen, Soeren; Boehlken-Fascher, Susanne; Czerny, Claus-Peter; Abd El Wahed, Ahmed] Univ Goettingen, Div Microbiol & Anim Hyg, Burckhardtweg 2, D-37077 Gottingen, Germany.
   [Faye, Oumar; Faye, Martin; Faye, Ousmane; Sall, Amadou A.] Inst Pasteur, 43 Ave Pasteur,BP 220, Dakar, Senegal.
   [Sanabani, Sabri S.] Univ Sao Paulo, Sch Med, Dept Pathol, R Teodoro Sampaio 115, Sao Paulo, Brazil.
   [Bekaert, Michael; Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.
RP Abd El Wahed, A (corresponding author), Univ Goettingen, Div Microbiol & Anim Hyg, Burckhardtweg 2, D-37077 Gottingen, Germany.
EM abdelwahed@gwdg.de
RI Faye, Oumar/T-7168-2019; Weidmann, Manfred/G-1817-2015
OI Weidmann, Manfred/0000-0002-7063-7491; Bekaert,
   Michael/0000-0002-1206-7654
FU University of Goettingen, Germany [3,917,557]
FX The project was partially funded by the Start-up Funding Program of the
   University of Goettingen, Germany (ID: 3,917,557). The funder has no
   rule in study or the decision to submit the manuscript.
CR Abd El Wahed A, 2015, J CLIN VIROL, V69, P16, DOI 10.1016/j.jcv.2015.05.004
   Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147
   Croucher NJ, 2015, CURR OPIN MICROBIOL, V23, P62, DOI 10.1016/j.mib.2014.11.004
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faye O, 2015, EURO SURVEILL, V20
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522
   Kelly Heath, 2004, Aust Fam Physician, V33, P305
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Lu HY, 2016, GENOM PROTEOM BIOINF, V14, P265, DOI 10.1016/j.gpb.2016.05.004
   Mondal D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1572-8
   Ni PX, 2015, CHINESE MED J-PEKING, V128, P877, DOI 10.4103/0366-6999.154281
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440
   Urban J, 2015, BIORXIV
NR 21
TC 2
Z9 2
U1 2
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD SEP
PY 2018
VL 106
BP 23
EP 27
DI 10.1016/j.jcv.2018.07.001
PG 5
WC Virology
SC Virology
GA GR2AR
UT WOS:000442361000006
PM 30015285
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Coyne, CB
AF Coyne, Carolyn B.
TI STING'ing Zika virus in neurons
SO NATURE MICROBIOLOGY
LA English
DT Editorial Material
ID REVEALS
AB Studies in Drosophila reveal that the insect homologue of the stimulator of interferon genes (STING) exerts antiviral activity against Zika virus infection in the fly brain through the induction of autophagy, providing key insights into the possible evolutionary function of STING in antiviral defence.
C1 [Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.
   [Coyne, Carolyn B.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15260 USA.
   [Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.
   [Coyne, Carolyn B.] UPMC Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15260 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.; Coyne, CB (corresponding author), UPMC Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
EM coynec2@pitt.edu
CR Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004
   Martin M, 2018, CELL REP, V23, P3537, DOI 10.1016/j.celrep.2018.05.029
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004
NR 6
TC 1
Z9 1
U1 1
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD SEP
PY 2018
VL 3
IS 9
BP 975
EP 976
DI 10.1038/s41564-018-0232-5
PG 2
WC Microbiology
SC Microbiology
GA GR6CC
UT WOS:000442731700006
PM 30104582
DA 2020-07-08
ER

PT J
AU Bakhshi, H
   Failloux, AB
   Zakeri, S
   Raz, A
   Djadid, ND
AF Bakhshi, Hasan
   Failloux, Anna-Bella
   Zakeri, Sedigheh
   Raz, Abbasali
   Djadid, Navid Dinparast
TI Mosquito-borne viral diseases and potential transmission blocking
   vaccine candidates
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE Transmission blocking vaccine; Flaviviruses; Mosquito-borne viral
   diseases
ID WEST-NILE-VIRUS; RIFT-VALLEY FEVER; AEDES-AEGYPTI; JAPANESE
   ENCEPHALITIS; YELLOW-FEVER; ZIKA VIRUS; MOLECULAR CHARACTERIZATION;
   INSECTICIDE RESISTANCE; ANOPHELES-STEPHENSI; GENETIC DIVERSITY
AB Mosquito-borne viral diseases (MBVDs) have a complex biological cycle involving vectors and vertebrate hosts. These viruses are responsible for many deadly diseases worldwide. Although MBVDs threaten mostly developing countries, there is growing evidence indicating that they are also of concern in western countries where local transmission of arboviruses such as West Nile, Zika, Chikungunya and Dengue viruses have been recently reported. The rapid rise in human infections caused by these viruses is attributed to rapid climate change and travel facilities. Usually, the only way to control these diseases relies on the control of vectors in the absence of licensed vaccines and specific treatments. However, the overuse of insecticides has led to the emergence of insecticide resistance in vector populations, posing significant challenges for their control. An alternative method for reducing MBVDs can be the use of Transmission Blocking Vaccines (TBVs) that limits viral infection at the mosquito vector stage. Some successes have been obtained confirming the potential application of TBVs against viruses; however, this approach remains at the developmental stage and still needs improvements. The present review aims to give an update on MBVDs and to discuss the application as well as usage of potential TBVs for the control of mosquito-borne viral infections.
C1 [Bakhshi, Hasan; Zakeri, Sedigheh; Raz, Abbasali; Djadid, Navid Dinparast] PII, MVRG, BRC, POB 1316943551,Pasteur Ave, Tehran, Iran.
   [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
RP Djadid, ND (corresponding author), PII, MVRG, BRC, POB 1316943551,Pasteur Ave, Tehran, Iran.
EM navidmvrg@gmail.com
OI Bakhshi, Hasan/0000-0002-8819-4561
FU Institut Pasteur International Network (RIIP, MATI); Education Office,
   PII
FX The present article is a part of a project which has been supported
   through a grant from Institut Pasteur International Network (RIIP, MATI)
   to NDD and a scholarship from Education Office, PII to Hasan Bakhshi,
   Ph.D. student of Medical Biotechnology.
CR Esposito DLA, 2017, BRAZ J INFECT DIS, V21, P540, DOI 10.1016/j.bjid.2017.06.002
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   Arora AK, 2017, J INSECT PHYSIOL, V103, P10, DOI 10.1016/j.jinsphys.2017.09.011
   Atkinson SC, 2015, NAT STRUCT MOL BIOL, V22, P532, DOI 10.1038/nsmb.3048
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bennett N, 2008, VIC INFECT DIS B, V11, P94
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bokharaei Hanieh, 2012, Avicenna Journal of Medical Biotechnology, V4, P131
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brennan JDG, 2000, P NATL ACAD SCI USA, V97, P13859, DOI 10.1073/pnas.250472597
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   Busch M, 2015, JAAPA-J AM ACAD PHYS, V28, P54, DOI 10.1097/01.JAA.0000470441.99693.e1
   Caragata EP, 2016, FUTURE MICROBIOL, V11, P1499, DOI 10.2217/fmb-2016-0177
   Chaurio RA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004786
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Cheng JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-337
   Chu HL, 2017, VECTOR-BORNE ZOONOT, V17, P503, DOI 10.1089/vbz.2016.2086
   Chu JJH, 2005, VIROLOGY, V339, P249, DOI 10.1016/j.virol.2005.05.026
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Contigiani M.S, 2017, ARTHROPOD BORNE DIS, P61
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Coutinho-Abreu IV, 2010, MEM I OSWALDO CRUZ, V105, P1, DOI 10.1590/S0074-02762010000100001
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   Munoz MD, 2013, BIOMED RES INT, DOI 10.1155/2013/875958
   Dinglasan RR, 2005, INSECT BIOCHEM MOLEC, V35, P1, DOI 10.1016/j.ibmb.2004.09.005
   Dinglasan RR, 2003, INFECT IMMUN, V71, P6995, DOI 10.1128/IAI.71.12.6995-7001.2003
   Dohm DJ, 2000, J MED ENTOMOL, V37, P435, DOI 10.1603/0022-2585(2000)037[0435:LTORVF]2.0.CO;2
   Dragovic SM, 2018, CELL HOST MICROBE, V23, P523, DOI 10.1016/j.chom.2018.03.008
   ECDC: European Centre for Disease prevention and Control, 2014, DISTR W NIL FEV CASE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Fongsaran C, 2014, ARCH VIROL, V159, P3353, DOI 10.1007/s00705-014-2210-4
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500
   Gholizadeh S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-158
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   HUFF CLAY G., 1958, EXPTL PARASITOL, V7, P399, DOI 10.1016/0014-4894(58)90036-5
   Hwang J, 2016, CELL HOST MICROBE, V19, P583, DOI 10.1016/j.chom.2016.04.009
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Jones S, 2015, J INFECTION, V71, P117, DOI 10.1016/j.jinf.2015.03.007
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Khan SA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1948-9
   Kopp A, 2013, MBIO, V4, DOI 10.1128/mBio.00322-13
   Korochkina S, 2006, CELL MICROBIOL, V8, P163, DOI 10.1111/j.1462-5822.2005.00611.x
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lavazec C, 2007, INFECT IMMUN, V75, P1635, DOI 10.1128/IAI.00864-06
   Laveran A., 1880, B ACAD MED, VIX, P1235
   LEAKE CJ, 1986, T ROY SOC TROP MED H, V80, P831, DOI 10.1016/0035-9203(86)90397-4
   LINTHICUM KJ, 1989, AM J TROP MED HYG, V41, P491, DOI 10.4269/ajtmh.1989.41.491
   Liu K, 2017, J VIROL, V91
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu Y, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003931
   Londono-Renteria B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1802-0
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   malERA Refresh Consultative Panel on Tools for Malaria Elimination, 2017, PLOS MED, V30
   Manning JE, 2018, J INFECT DIS, V218, P7, DOI 10.1093/infdis/jiy179
   Maquart M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147589
   Markoff L, 2013, NEW ENGL J MED, V368, P689, DOI 10.1056/NEJMp1300772
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   Mehrizi AA, 2016, INFECT GENET EVOL, V43, P50, DOI 10.1016/j.meegid.2016.05.015
   Mehrizi AA, 2014, INFECT GENET EVOL, V22, P150, DOI 10.1016/j.meegid.2014.01.016
   Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85
   Monzavi-Karbassi B, 2003, VACCINE, V21, P753, DOI 10.1016/S0264-410X(02)00703-X
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mourya DT, 1998, INDIAN J MED RES, V107, P10
   Nchu F., 2013, African Journal of Microbiology Research, V7, P3891
   Neelakanta G, 2016, CURR OPIN INSECT SCI, V16, P44, DOI 10.1016/j.cois.2016.04.015
   Neelakanta G, 2015, ARCH IMMUNOL THER EX, V63, P169, DOI 10.1007/s00005-014-0324-8
   Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237
   Niu GD, 2017, J BIOL CHEM, V292, P11960, DOI [10.1074/jbc.M116.773564, 10.1074/jbc.m116.773564]
   Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373
   Okulate MA, 2007, INSECT MOL BIOL, V16, P711, DOI 10.1111/j.1365-2583.2007.00765.x
   Otranto D, 2016, HUMAN EMERGING AND RE-EMERGING INFECTIONS: VIRAL AND PARASITIC INFECTIONS, VOL 1, P505
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen Lyle R., 2007, P3, DOI 10.1007/978-0-387-32830-0_1
   Raz A, 2013, INFECT IMMUN, V81, P2206, DOI 10.1128/IAI.01331-12
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   RENER J, 1983, J EXP MED, V158, P976, DOI 10.1084/jem.158.3.976
   Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmidt CW, 2016, ENVIRON HEALTH PERSP, V124, pA157, DOI 10.1289/ehp.124-A157
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Seymour R, 2016, NEUROTROPIC VIRAL IN, P205
   Sinden RE, 2010, HUM VACCINES, V6, P3, DOI 10.4161/hv.6.1.9604
   Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Talaat KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163144
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Tham HW, 2015, J INFECT DEV COUNTR, V9, P1338, DOI 10.3855/jidc.6422
   Tham HW, 2014, VIRUSES-BASEL, V6, P5028, DOI 10.3390/v6125028
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vasilakis N, 2016, ARBOVIRUSES MOL BIOL
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   VenkatRao V, 2017, ACTA TROP, V168, P21, DOI 10.1016/j.actatropica.2016.12.035
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WHO, 2016, COMM
   WHO, 2012, WHOOR02
   World Health Organization, 2016, ZIK POT COMPL
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337
   Zakeri S, 2009, ACTA TROP, V109, P176, DOI 10.1016/j.actatropica.2008.09.012
NR 117
TC 1
Z9 1
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2018
VL 63
BP 195
EP 203
DI 10.1016/j.meegid.2018.05.023
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA GR0AH
UT WOS:000442167600025
PM 29842982
DA 2020-07-08
ER

PT J
AU Sookaromdee, P
   Wiwanitkit, V
AF Sookaromdee, Pathum
   Wiwanitkit, Viroj
TI Zika virus and HIV co-infection
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
C1 [Sookaromdee, Pathum] TWS Med Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Sookaromdee, P (corresponding author), TWS Med Ctr, Bangkok, Thailand.
EM pathumsook@gmail.com
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Villamil-Gomez WE, 2018, J FORMOS MED ASSOC, V117, P856, DOI 10.1016/j.jfma.2018.05.019
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, ANN TROP MED PUBLIC, V9, DOI 10.4103/1755-6783.190197
NR 4
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD SEP
PY 2018
VL 117
IS 9
BP 855
EP 855
DI 10.1016/j.jfma.2018.07.006
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GR3SV
UT WOS:000442516100013
PM 30033034
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Sanchez-Herrera, AR
   Hernandez-Prado, H
   Hernandez-Iriarte, J
   Diaz-Ricardo, K
   Vergara-Serpa, O
   Castellanos, J
   Portela-Gaviria, JE
   Patino-Valencia, S
   Vargas-Bedoya, DC
   Orozco-Villa, AF
   Reyes-Guerrero, SS
   Castrillon-Spitia, JD
   Murillo-Garcia, DR
   Henao-SanMartin, V
   Londono, JJ
   Bedoya-Rendon, H
   Cardenas-Perez, JDJ
   Cardona-Ospina, JA
   Lagos-Grisales, GJ
   Rodriguez-Morales, AJ
AF Villamil-Gomez, Wilmer E.
   Rosendo Sanchez-Herrera, Alvaro
   Hernandez-Prado, Hugo
   Hernandez-Iriarte, Jayder
   Diaz-Ricardo, Kelly
   Vergara-Serpa, Oscar
   Castellanos, Jaime
   Esteban Portela-Gaviria, Juan
   Patino-Valencia, Sarita
   Vargas-Bedoya, Dana C.
   Orozco-Villa, Andres F.
   Reyes-Guerrero, Sara S.
   Daniel Castrillon-Spitia, Juan
   Murillo-Garcia, David R.
   Henao-SanMartin, Valentina
   Londono, Jose J.
   Bedoya-Rendon, Hector
   de Jesus Cardenas-Perez, Javier
   Cardona-Ospina, Jaime A.
   Lagos-Grisales, Guillermo J.
   Rodriguez-Morales, Alfonso J.
TI Zika virus and HIV co-infection in five patients from two areas of
   Colombia
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Letter
ID INFECTION
C1 [Villamil-Gomez, Wilmer E.; Hernandez-Iriarte, Jayder; Diaz-Ricardo, Kelly; Vergara-Serpa, Oscar] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.; Rosendo Sanchez-Herrera, Alvaro; Hernandez-Prado, Hugo] Clin Santa Maria, Sincelejo, Sucre, Colombia.
   [Castellanos, Jaime] Univ El Bosque, Bogota, DC, Colombia.
   [Esteban Portela-Gaviria, Juan; Patino-Valencia, Sarita; Vargas-Bedoya, Dana C.; Orozco-Villa, Andres F.; Reyes-Guerrero, Sara S.; Daniel Castrillon-Spitia, Juan; Murillo-Garcia, David R.; Henao-SanMartin, Valentina; Cardona-Ospina, Jaime A.; Lagos-Grisales, Guillermo J.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Grp Res, Pereira, Risaralda, Colombia.
   [Daniel Castrillon-Spitia, Juan] Fdn Univ Autonoma Amer, Biomed, Pereira, Risaralda, Colombia.
   [Daniel Castrillon-Spitia, Juan; Londono, Jose J.; Bedoya-Rendon, Hector; de Jesus Cardenas-Perez, Javier] ESE Hosp San Pedro & San Pablo, La Virginia, Risaralda, Colombia.
   [Cardona-Ospina, Jaime A.; Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Infect & Immun Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] UniFranz, Fac Hlth Sci, Med Sch, Cochabamba, Bolivia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Grp Res, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI Castellanos, Jaime/W-2635-2019; AJ, Rodriguez-Morales/R-9765-2016
OI Castellanos, Jaime/0000-0003-1596-8383; AJ,
   Rodriguez-Morales/0000-0001-9773-2192
CR Barreiro P, 2016, AIDS REV, V18, P112
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Joob B, 2017, J FORMOS MED ASSOC, V116, P406, DOI 10.1016/j.jfma.2016.07.011
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
NR 6
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD SEP
PY 2018
VL 117
IS 9
BP 856
EP 858
DI 10.1016/j.jfma.2018.05.019
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA GR3SV
UT WOS:000442516100014
PM 29914733
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zatz, M
AF Zatz, Mayana
TI Helping our country as women scientists
SO NATURE CELL BIOLOGY
LA English
DT Editorial Material
AB Mayana Zatz is Professor of Genetics and Director of the Human Genome and Stem-Cell Research Center at the University of Sao Paulo, Brazil. She works on neuromuscular disorders, ageing and, more recently, Zika virus and cancer. She has a prolific publication record and is actively involved in ethical aspects of genetic research.
C1 [Zatz, Mayana] Univ Sao Paulo, Dept Genet & Evolutionary Biol, Human Genome & Stem Cell Res Ctr, Sao Paulo, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Dept Genet & Evolutionary Biol, Human Genome & Stem Cell Res Ctr, Sao Paulo, Brazil.
EM mayazatz@usp.br
RI Zatz, Mayana/M-5338-2015
OI Zatz, Mayana/0000-0003-3970-8025
NR 0
TC 0
Z9 0
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD SEP
PY 2018
VL 20
IS 9
BP 1012
EP 1012
DI 10.1038/s41556-018-0161-9
PG 1
WC Cell Biology
SC Cell Biology
GA GR7TD
UT WOS:000442896600017
PM 30154566
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Cerebral Infarction and Refractory Seizures in Zika Virus Infection
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Raymond A, 2018, PEDIATR INFECT DIS J, V37, pE112, DOI 10.1097/INF.0000000000001832
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2017, SEIZURE-EUR J EPILEP, V45, P1, DOI 10.1016/j.seizure.2016.11.004
NR 6
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD SEP
PY 2018
VL 37
IS 9
BP 960
EP 960
DI 10.1097/INF.0000000000001934
PG 1
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA GR3QK
UT WOS:000442508900028
PM 30102669
DA 2020-07-08
ER

PT J
AU Jazem, AM
   Khalid, MA
   Abdulaziz, BMB
AF Jazem, Mahyoub A.
   Khalid, Al-Ghamdi M.
   Abdulaziz, Barnawi B. M.
TI Toxicological and Histological Effects of Selected Bacterial
   Biopesticides on Aedes aegypti (L.), The Vector of Dengue in Saudi
   Arabia
SO RESEARCH JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Aedes aegypti; Spinosad; Bacillus thuringiensi; B. sphaericus; midgut;
   larvicidal; histological effects; mosquito-borne diseases
ID LISTON. DIPTERA-CULICIDAE; BACILLUS-SPHAERICUS; ANOPHELES-STEPHENSI;
   SILVER NANOPARTICLES; PUPICIDAL ACTIVITY; MOSQUITO; INSECTICIDE;
   EFFICIENCY; LARVICIDE; LARVAE
AB Mosquitoes are the carriers of severe well-known illnesses such as malaria, Japanese encephalitis, dengue fever, chikungunya fever, West Nile virus, yellow fever, lymphatic filariasis and zika virus. These diseases produce significant morbidity and mortalities in humans and livestock around the world. The present research investigated the toxicological and histological effects of three bacterial insecticide, Spinosad, Bacillus thuringiensis and B. sphaericus against the fourth-stage larvae of dengue and on zika virus vector, Aedes aegypti under laboratory as well as semi-field conditions. The lethal concentration to kill half (50%) of the population was found in Ae. aegypti fourth-instar larvae with LC50 0.005, 0.055, 0.414 ppm (laboratory conditions) and 0.007, 0.070, 0.563 ppm (semi-field conditions) respectively at 24 h.
   In laboratory conditions, the tested effect of bacteria against larvae were 1.26, 1.27 and 1.35 folds compared with semi-field conditions. Also, these results indicate that mosquito larvae of Ae. aegypti were more susceptible to Spinosad than B. thuringiensi and B. sphaericus by about 9.59 and 77.12 folds respectively. The histological changes in mosquitoes targeted with bacterial insecticide were studied by light microscopy, evaluating the impact on mid-gut epithelial cells following treatment with LC50 of bacterial insecticide and the results showed detectable alteration in Gastric Epithelial Tissue (GEC) and fatty body (F). Overall, this study highlighted that bacterial insecticides can be proposed as effective tools for eco-friendly control of the dengue and Zika virus vectors.
C1 [Jazem, Mahyoub A.; Khalid, Al-Ghamdi M.; Abdulaziz, Barnawi B. M.] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.
RP Jazem, AM (corresponding author), King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.
EM jazem2009@gmail.com
FU King Abdul Aziz University, Jeddah [G-320-130-38]; DSR
FX This project was funded by the Deanship of Scientific Research (DSR) at
   King Abdul Aziz University, Jeddah, under grant No. G-320-130-38. The
   authors, therefore, acknowledge with thanks DSR for technical and
   financial support.
CR Ahmed AM, 2014, PAK J ZOOL, V46, P191
   Al-Mehmadi R. M., 2010, Journal of King Saud University Science, V22, P77, DOI 10.1016/j.jksus.2010.02.004
   Alsobhi A. S., 2016, Asian Pacific Journal of Tropical Disease, V6, P533, DOI 10.1016/S2222-1808(16)61083-6
   BRET BL, 1997, DOWN EARTH, V52, P6
   Dambach P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1438-8
   DAVIDSON EW, 1987, J INVERTEBR PATHOL, V50, P213, DOI 10.1016/0022-2011(87)90085-1
   DEBARJAC H, 1988, ANN INST PASTEUR MIC, V139, P363, DOI 10.1016/0769-2609(88)90028-2
   Dias LD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173689
   Dua VK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-124
   FINNEY D, 1972, STAT METHOD BIOL ASS
   Hamed Ghramh A., 2017, J ASIA-PAC ENTOMOL, V21, P205
   Jai Gur, 1988, J INVERTEBR PATHOL, V52, P237
   Kalimuthu K, 2017, HYDROBIOLOGIA, V785, P359, DOI 10.1007/s10750-016-2943-z
   Kamal Hany A, 2013, J Egypt Soc Parasitol, V43, P115
   KELLEN WR, 1965, J INVERTEBR PATHOL, V7, P442, DOI 10.1016/0022-2011(65)90120-5
   Kong WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08377-0
   Kovendan K, 2012, PARASITOL RES, V111, P531, DOI 10.1007/s00436-012-2865-2
   Kovendan K, 2012, PARASITOL RES, V110, P195, DOI 10.1007/s00436-011-2469-2
   Kumar PM, 2013, PARASITOL RES, V112, P761, DOI 10.1007/s00436-012-3196-z
   Magana C, 2007, J ECON ENTOMOL, V100, P1836, DOI 10.1603/0022-0493(2007)100[1836:RTMIFP]2.0.CO;2
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Marina CF, 2011, PEST MANAG SCI, V67, P114, DOI [10.1002/ps.2043, 10.1002/pros.21278]
   Mittal P. K., 2003, Journal of Vector Borne Diseases, V40, P20
   Mizerakis P, 2017, ANN MICROBIOL, V67, P643, DOI 10.1007/s13213-017-1293-z
   Murugan K., 2015, PARASITOL RES, V114, P43
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6
   Panneerselvam C., 2013, ASIAN PACIFIC J TROP, V22, P412
   Poopathi S, 2010, J PHYSL PATHOPHYSIOL, V1, P22
   Singer S., 1997, DHEW PUBL, P3
   Slama G., 2007, DIABETOLOGIA, V49, P1711, DOI DOI 10.1007/S00125-007-0669-1
   TEHRI K, 2015, INT J MOSQ RES A, V2, P18
   Tjokropranoto R., 2016, ASIAN J PHARM CLI RE, V9, P281
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   Zyoud SH, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0534-2
NR 35
TC 1
Z9 1
U1 0
U2 4
PU RESEARCH JOURNAL BIOTECHNOLOGY
PI INDORE
PA SECTOR A-80, SCHEME NO 54, VIJAY NAGAR, A B ROAD, INDORE, 452 010 MP,
   INDIA
SN 2278-4535
J9 RES J BIOTECHNOL
JI Res. J. Biotechnol.
PD SEP
PY 2018
VL 13
IS 9
BP 1
EP 7
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GR3MM
UT WOS:000442495300001
DA 2020-07-08
ER

PT J
AU Audouze, K
   Taboureau, O
   Grandjean, P
AF Audouze, Karine
   Taboureau, Olivier
   Grandjean, Philippe
TI A systems biology approach to predictive developmental neurotoxicity of
   a larvicide used in the prevention of Zika virus transmission
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Computational biology; Developmental neurotoxicity; Pesticide;
   Pyriproxyfen; Predictive toxicology; Systems biology; Toxicity testing
ID COMPUTATIONAL APPROACH; TOXICOLOGY; EXPOSURE; MODELS; 21ST-CENTURY;
   PYRIPROXYFEN; CHEMICALS; PATHWAYS; OUTBREAK; NETWORK
AB The need to prevent developmental brain disorders has led to an increased interest in efficient neurotoxicity testing. When an epidemic of microcephaly occurred in Brazil, Zika virus infection was soon identified as the likely culprit. However, the pathogenesis appeared to be complex, and a larvicide used to control mosquitoes responsible for transmission of the virus was soon suggested as an important causative factor. Yet, it is challenging to identify relevant and efficient tests that are also in line with ethical research defined by the 3Rs rule (Replacement, Reduction and Refinement). Especially in an acute situation like the microcephaly epidemic, where little toxicity documentation is available, new and innovative alternative methods, whether in vitro or in silico, must be considered. We have developed a network-based model using an integrative systems biology approach to explore the potential developmental neurotoxicity, and we applied this method to examine the larvicide pyriproxyfen widely used in the prevention of Zika virus transmission. Our computational model covered a wide range of possible pathways providing mechanistic hypotheses between pyriproxyfen and neurological disorders via protein complexes, thus adding to the plausibility of pyriproxyfen neurotoxicity. Although providing only tentative evidence and comparisons with retinoic acid, our computational systems biology approach is rapid and inexpensive. The case study of pyriproxyfen illustrates its usefulness as an initial or screening step in the assessment of toxicity potentials of chemicals with incompletely known toxic properties.
C1 [Audouze, Karine; Taboureau, Olivier] INSERM, UMRS 973, F-75013 Paris, France.
   [Audouze, Karine; Taboureau, Olivier] Univ Paris Diderot, F-75013 Paris, France.
   [Grandjean, Philippe] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Grandjean, Philippe] Univ Southern Denmark, Odense, Denmark.
RP Grandjean, P (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 401 Pk Dr,4th Floor West, Boston, MA 02215 USA.
EM pgrand@hsph.harvard.edu
RI ; Grandjean, Philippe/I-2962-2014
OI Audouze, Karine/0000-0001-7525-4089; Grandjean,
   Philippe/0000-0003-4046-9658
FU National Institute of Environmental Health Sciences (National Institutes
   of Health)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [ES021477]
FX This work was supported by the National Institute of Environmental
   Health Sciences (National Institutes of Health) grant ES021477.
CR Adams Patricia F, 2013, Vital Health Stat 10, P1
   Audouze K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02712
   Audouze K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000788
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   Bellinger DC, 2009, NEUROTOXICOL TERATOL, V31, P267, DOI 10.1016/j.ntt.2009.06.006
   Benfenati E, 2013, ALTEX-ALTERN ANIM EX, V30, P19, DOI 10.14573/altex.2013.1.019
   Benford D, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3802
   BENKE PJ, 1984, JAMA-J AM MED ASSOC, V251, P3267, DOI 10.1001/jama.251.24.3267
   Bjorling-Poulsen M, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-50
   Boucher O, 2013, NEUROTOXICOLOGY, V35, P162, DOI 10.1016/j.neuro.2013.01.007
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Cassano A, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S4
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Crofton K, 2014, ALTEX-ALTERN ANIM EX, V31, P223, DOI 10.14573/altex.1402121
   Davis AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155530
   Fernandes TFD, 2014, J HEALTH POPUL NUTR, V32, P28
   Dzieciolowska S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40067
   Evans D., 2016, PEER J PREPR, V4
   Freire C, 2013, ENVIRON RES, V127, P7, DOI 10.1016/j.envres.2013.09.001
   Goeden N, 2016, J NEUROSCI, V36, P6041, DOI 10.1523/JNEUROSCI.2534-15.2016
   Gohlke JM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-46
   Gould E, 2009, ENVIRON HEALTH PERSP, V117, P1162, DOI 10.1289/ehp.0800408
   Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7
   Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3
   HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hou H, 2008, BIOCHEM BIOPH RES CO, V369, P641, DOI 10.1016/j.bbrc.2008.02.094
   Judson R, 2008, TOXICOL APPL PHARM, V233, P7, DOI 10.1016/j.taap.2007.12.037
   Kam RKT, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-11
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Kjaerulff SK, 2013, NUCLEIC ACIDS RES, V41, pD464, DOI 10.1093/nar/gks1166
   Knudsen Thomas, 2013, Methods Mol Biol, V947, P343, DOI 10.1007/978-1-62703-131-8_26
   Kongsbak K, 2014, ALTEX-ALTERN ANIM EX, V31, P11, DOI 10.14573/altex.1304241
   Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176
   Landrigan PJ, 2012, ENVIRON HEALTH PERSP, V120, pA258, DOI 10.1289/ehp.1104285
   Leung MCK, 2016, ENVIRON HEALTH PERSP, V124, P1050, DOI 10.1289/ehp.1510385
   McPartland J, 2017, SCI TOTAL ENVIRON, V593, P634, DOI [10.1016/j.scitotenv2017.03.024, 10.1016/j.scitotenv.2017.03.024]
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Nicolotti O, 2014, DRUG DISCOV TODAY, V19, P1757, DOI 10.1016/j.drudis.2014.06.027
   O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7
   Patlewicz G, 2008, SAR QSAR ENVIRON RES, V19, P397, DOI 10.1080/10629360802083848
   Pinero J, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav028
   Rao R, 2017, OBSTET GYNECOL, V129, P1098, DOI 10.1097/AOG.0000000000002049
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511
   Richard AM, 2016, CHEM RES TOXICOL, V29, P1225, DOI 10.1021/acs.chemrestox.6b00135
   Rizzati V, 2016, CHEM-BIOL INTERACT, V254, P231, DOI 10.1016/j.cbi.2016.06.003
   ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101
   Saegusa T., 1988, SUMILARY STUDY 5 311
   Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020
   Silva M, 2015, BIRTH DEFECTS RES B, V104, P71, DOI 10.1002/bdrb.21140
   Sipes NS, 2017, ENVIRON SCI TECHNOL, V51, P10786, DOI 10.1021/acs.est.7b00650
   Swedish Toxicology Sciences Research Center, 2016, PYRIPR MICR INV POT
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Taboureau O, 2017, ALTEX-ALTERN ANIM EX, V34, P289, DOI 10.14573/altex.1607201
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tice RR, 2013, ENVIRON HEALTH PERSP, V121, P756, DOI 10.1289/ehp.1205784
   Tohyama Chiharu, 2016, J Toxicol Sci, V41, pSP69, DOI 10.2131/jts.41.SP69
   Torres-Espinola FJ, 2015, EARLY HUM DEV, V91, P457, DOI 10.1016/j.earlhumdev.2015.05.001
   Vazquez M. A., 2016, RED U AMBIENTE SALUD
   Viel JF, 2015, ENVIRON INT, V82, P69, DOI 10.1016/j.envint.2015.05.009
   Wang Zichen, 2016, F1000Res, V5, P1574, DOI 10.12688/f1000research.9110.1
   World Health Organization, 2004, PUBL HLTH RESP BIOL, P13
   World Health Organization, 2016, DISP RUM ZIK COMPL
NR 64
TC 3
Z9 3
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD SEP 1
PY 2018
VL 354
SI SI
BP 56
EP 63
DI 10.1016/j.taap.2018.02.014
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA GR1TV
UT WOS:000442335500007
PM 29476864
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Porse, CC
   Messenger, S
   Vugia, DJ
   Jilek, W
   Salas, M
   Watt, J
   Kramer, V
AF Porse, Charsey Cole
   Messenger, Sharon
   Vugia, Duc J.
   Jilek, Wendy
   Salas, Maria
   Watt, James
   Kramer, Vicki
TI Travel-Associated Zika Cases and Threat of Local Transmission during
   Global Outbreak, California, USA
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID DIPTERA-CULICIDAE; INTERIM GUIDANCE; VIRUS; MICRONESIA; STATES; PCR
AB Zika and associated microcephaly among newborns were reported in Brazil during 2015. Zika has since spread across the Americas, and travel-associated cases were reported throughout the United States. We reviewed travel-associated Zika cases in California to assess the potential threat of local Zika virus transmission, given the regional spread of Aedes aegypti and Ae. albopictus mosquitoes. During November 2015-September 2017, a total of 588 travel-associated Zika cases were reported in California, including 139 infections in pregnant women, 10 congenital infections, and 8 sexually transmitted infections. Most case-patients reported travel to Mexico and Central America, and many returned during a period when they could have been viremic. By September 2017, Ae. aegypti mosquitoes had spread to 124 locations in California, and Ae. albopictus mosquitoes had spread to 53 locations. Continued human and mosquito surveillance and public health education are valuable tools in preventing and detecting Zika virus infections and local transmission in California.
C1 [Porse, Charsey Cole] Calif Dept Publ Hlth, Div Communicable Dis, Infect Dis Branch, Vector Borne Dis Sect, Sacramento, CA USA.
   [Jilek, Wendy; Kramer, Vicki] Calif Dept Publ Hlth, 1616 Capitol Ave,MS-7307, Sacramento, CA 95814 USA.
   [Messenger, Sharon; Vugia, Duc J.; Salas, Maria; Watt, James] Calif Dept Publ Hlth, Richmond, CA USA.
RP Porse, CC (corresponding author), Calif Dept Publ Hlth, 1616 Capitol Ave,MS-7307, Sacramento, CA 95814 USA.
EM charsey.porse@cdph.ca.gov
FU Epidemiology and Laboratory Capacity for Infectious Diseases from the
   Centers for Disease Control and Prevention [6 NU50CK000410]
FX This study was supported by the Epidemiology and Laboratory Capacity for
   Infectious Diseases Cooperative Agreement no. 6 NU50CK000410 from the
   Centers for Disease Control and Prevention.
CR Brault AC, 2015, J MED ENTOMOL, V52, P491, DOI 10.1093/jme/tjv021
   California Department of Public Health, ZIK WHAT CAL NEED KN
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Center for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS), 2016, CSTE POS STAT
   Centers for Disease Control and Prevention, 2017, TRIOPL REAL TIM RT P
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Florida Department of Public Health, ZIK VIR
   General Directorate of Epidemiology (DEG), 2017, NAT SYST EP SURV UN
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Metzger ME, 2017, J MED ENTOMOL, V54, P533, DOI 10.1093/jme/tjw237
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pan American Health Organization, GEOGR DISTR 2014 201
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Texas Department of State Health Services, ZIK IN TEX
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 17
TC 5
Z9 5
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2018
VL 24
IS 9
BP 1626
EP 1632
DI 10.3201/eid2409.180203
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GQ6YP
UT WOS:000441877400003
PM 30124194
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paixao, ES
   Teixeira, MG
   Costa, MDN
   Barreto, ML
   Rodrigues, LC
AF Paixao, Enny S.
   Teixeira, Maria Gloria
   Costa, Maria da Conceicao N.
   Barreto, Mauricio L.
   Rodrigues, Laura C.
TI Symptomatic Dengue during Pregnancy and Congenital Neurologic
   Malformations
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID VIRUS-INFECTION; ZIKA VIRUS; BRAZIL
AB Dengue virus infection during pregnancy increased the risk for any neurologic congenital anomaly in the infant by roughly 50% and for other congenital malformations of brain 4-fold. Our results show an association between dengue during pregnancy and congenital anomalies of the brain, suggesting that flaviviruses other than Zika virus are associated with such malformations.
C1 [Paixao, Enny S.; Rodrigues, Laura C.] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
   [Paixao, Enny S.; Teixeira, Maria Gloria; Costa, Maria da Conceicao N.; Barreto, Mauricio L.] Inst Saude Colet, Salvador, BA, Brazil.
   [Barreto, Mauricio L.; Rodrigues, Laura C.] Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
RP Paixao, ES (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.
EM enny.cruz@lshtm.ac.uk
RI Barreto, Mauricio L/B-1752-2008; Teixeira, Maria Gloria/G-4808-2012
OI Barreto, Mauricio L/0000-0002-0215-4930; Teixeira, Maria
   Gloria/0000-0003-3318-3408
FU National Council of Technological and Scientific Development (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); European UnionEuropean Union (EU) [734584]
FX E.S.P. is funded by the National Council of Technological and Scientific
   Development (CNPq), Brazil, and L.C.R. is partially funded by the
   European Union's Horizon 2020 research and innovation program under
   Zika-PLAN grant agreement No. 734584. The funders of this study had no
   role in study design, data collection, data analysis, data
   interpretation, or writing of the report.
CR Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Paixao ES, 2017, LANCET INFECT DIS, V17, P957, DOI 10.1016/S1473-3099(17)30366-3
   Paixao ES, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0506-5
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 10
TC 6
Z9 6
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2018
VL 24
IS 9
BP 1748
EP 1750
DI 10.3201/eid2409.170361
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GQ6YP
UT WOS:000441877400027
PM 30124410
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU White, SK
   Lednicky, JA
   Okech, BA
   Morris, JG
   Dunford, JC
AF White, Sarah K.
   Lednicky, John A.
   Okech, Bernard A.
   Morris, J. Glenn, Jr.
   Dunford, James C.
TI Spondweni Virus in Field-Caught Culex quinquefasciatus Mosquitoes,
   Haiti, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB Spondweni virus (SPONV) and Zika virus cause similar diseases in humans. We detected SPONV outside of Africa from a pool of Culex mosquitoes collected in Haiti in 2016. This finding raises questions about the role of SPONV as a human pathogen in Haiti and other Caribbean countries.
C1 [White, Sarah K.; Lednicky, John A.; Okech, Bernard A.; Morris, J. Glenn, Jr.] Univ Florida, Gainesville, FL USA.
   [Dunford, James C.] US Navy, Portsmouth, VA USA.
   [Dunford, James C.] Marine Corps Public Hlth Ctr, Portsmouth, VA USA.
   [White, Sarah K.] Brammer Bio, Assay Dev & Analyt, Alachua, FL USA.
   [White, Sarah K.] Brammer Bio, Small Scale Dev, Alachua, FL USA.
RP White, SK (corresponding author), Brammer Bio, 13859 Progress Blvd, Alachua, FL 32615 USA.
EM sek0005@tigermail.auburn.edu
RI Lednicky, John A/C-5678-2012
FU Armed Forces Health Surveillance Branch; Global Emerging Infections
   Surveillance Section; Proposal Management Information System (PROMIS)
   [P014517E2]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI26357-01S1]
FX This work was funded in part by the Armed Forces Health Surveillance
   Branch, Global Emerging Infections Surveillance Section, Proposal
   Management Information System (PROMIS) ID P014517E2, and a grant from
   the National Institutes of Health to J.G.M. (R01 AI26357-01S1).
CR Das B, 2012, TROP MED INT HEALTH, V17, P235, DOI 10.1111/j.1365-3156.2011.02899.x
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   Rueda L. M., 2004, ZOOTAXA, V589, P33
   Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339
   Unit WRB, CUL CUX QUINQ
   WOLFE MS, 1982, LANCET, V2, P1306
NR 9
TC 10
Z9 10
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2018
VL 24
IS 9
BP 1765
EP 1767
DI 10.3201/eid2409.171957
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GQ6YP
UT WOS:000441877400035
PM 30124422
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Misslin, R
   Vaguet, Y
   Vaguet, A
   Daude, E
AF Misslin, Renaud
   Vaguet, Yvette
   Vaguet, Alain
   Daude, Eric
TI Estimating air temperature using MODIS surface temperature images for
   assessing Aedes aegypti thermal niche in Bangkok, Thailand
SO ENVIRONMENTAL MONITORING AND ASSESSMENT
LA English
DT Article
DE MODIS; Air temperature; TVX algorithm; Aedes aegypti; Dengue; Zika
ID POPULATION-DYNAMICS; DENGUE; MAXIMUM; MINIMUM; VECTOR; MODEL
AB Dengue, the most widespread urban vector-borne disease, is transmitted to human by the mosquito Aedes aegypti. Its distribution in urban areas is heterogeneous over time and space. In time, it is linked to seasonal variations such as warm and cold seasons, as well as rainy and dry seasons. In space, it is linked to social and environmental conditions, which alternate between rich and deprived neighborhoods, vegetated and densely built areas. These variations in terms of land cover can affect surface and air temperature. As a result of its influence on the mosquito's life cycle, temperature plays a crucial part in dengue epidemics potential. Thus, deciphering the thermal variations effects within cities could lead to the identification of precise thermal comfort zones, favorable to the survival of mosquito populations during inter-epidemic periods. The maps that could be produced as a result would enable health authorities to target specific areas. Most cities are equipped with meteorological stations. However, the network is generally not dense enough to precisely identify thermal comfort zones. Remote sensing can be used as a tool to solve this issue. The methodological objective of this paper is to assess the potential of the TVX (Temperature-Vegetation indeX) approach applied to MODIS thermal images for the purpose of estimating daily minimum and maximum air temperatures in the city of Bangkok, Thailand. The TVX approach has been seldom used over urban areas due to the heterogeneous nature of cities in terms of land cover. However, our study shows that in vegetated cities such as Bangkok, the TVX method provides valuable results which can be used to assess thermal niche of A. aegypti.
C1 [Misslin, Renaud; Vaguet, Yvette; Vaguet, Alain; Daude, Eric] Univ Rouen, CNRS UMR IDEES 6266, Rouen, France.
   [Misslin, Renaud] Univ Lorraine, LAE, INRA, Colmar, France.
RP Misslin, R (corresponding author), Univ Lorraine, LAE, INRA, Colmar, France.
EM renaud.misslin@inra.fr; yvette.vaguet@univ-rouen.fr;
   alain.vaguet@univ-rouen.fr; eric.daude@cnrs.fr
RI Daude, Eric/P-4133-2014
OI Daude, Eric/0000-0001-8656-3346
FU European CommissionEuropean Commission Joint Research Centre [282 378]
FX The research leading to these results has received funding from the
   European Commission Seventh Framework Programme (FP7/2007-2013) for the
   DENFREE Project under Grant Agreement No. 282 378. The funding source
   had no role in study design, data collection, data analysis, data
   interpretation, or writing of the manuscript.
CR Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Azevedo T. S., 2018, GEOSPATIAL HEALTH, V13, P1
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Benali A, 2012, REMOTE SENS ENVIRON, V124, P108, DOI 10.1016/j.rse.2012.04.024
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Chen FG, 2015, INT J CLIMATOL, V35, P2131, DOI 10.1002/joc.4113
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Daude E., 2015, Natures Sciences Societes, V23, P331, DOI 10.1051/nss/2015058
   Dousset B., 1989, P IGARSS 91, V4, DOI [DOI 10.1109/IGARSS.1989.577798, 10.1109/IGARSS.1989.577798]
   Emamifar S, 2013, INT J CLIMATOL, V33, P3174, DOI 10.1002/joc.3655
   Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010
   Gill S.E., 2007, BUILT ENV, V33, P115, DOI DOI 10.2148/BENV.33.1.115
   Ho HC, 2014, REMOTE SENS ENVIRON, V154, P38, DOI 10.1016/j.rse.2014.08.012
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Kloog I, 2014, REMOTE SENS ENVIRON, V150, P132, DOI 10.1016/j.rse.2014.04.024
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Machault V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050674
   Maneerat S, 2016, ECOL MODEL, V333, P66, DOI 10.1016/j.ecolmodel.2016.04.012
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49
   Nieto H, 2011, REMOTE SENS ENVIRON, V115, P107, DOI 10.1016/j.rse.2010.08.010
   Oyler JW, 2015, INT J CLIMATOL, V35, P2258, DOI 10.1002/joc.4127
   Shah DB, 2012, J AGROMETEOROL, V14, P111
   Stisen S, 2007, REMOTE SENS ENVIRON, V110, P262, DOI 10.1016/j.rse.2007.02.025
   Sun YJ, 2005, THEOR APPL CLIMATOL, V80, P37, DOI 10.1007/s00704-004-0079-y
   Tsai PJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2606-6
   Tsunoda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095606
   TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0
   Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002
   Vezzani D, 2005, ACTA TROP, V95, P123, DOI 10.1016/j.actatropica.2005.03.010
   Voogt JA, 2003, REMOTE SENS ENVIRON, V86, P370, DOI 10.1016/S0034-4257(03)00079-8
   Weng QH, 2009, ISPRS J PHOTOGRAMM, V64, P335, DOI 10.1016/j.isprsjprs.2009.03.007
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Zhu WB, 2013, REMOTE SENS ENVIRON, V130, P62, DOI 10.1016/j.rse.2012.10.034
NR 37
TC 1
Z9 1
U1 2
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6369
EI 1573-2959
J9 ENVIRON MONIT ASSESS
JI Environ. Monit. Assess.
PD SEP
PY 2018
VL 190
IS 9
AR UNSP 537
DI 10.1007/s10661-018-6875-0
PG 17
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GR3GZ
UT WOS:000442479300001
PM 30132225
DA 2020-07-08
ER

PT J
AU Angulo, MT
   Velasco-Hernandez, JX
AF Tulio Angulo, Marco
   Velasco-Hernandez, Jorge X.
TI Robust qualitative estimation of time-varying contact rates in uncertain
   epidemics
SO EPIDEMICS
LA English
DT Article
DE Epidemic prediction; Inference; Contact rate
ID DYNAMICS; EVOLUTION; SMALLPOX; MODEL
AB We will inevitably face new epidemics where the lack of long time-series data and the uncertainty about the outbreak dynamics make difficult to obtain quantitative predictions. Here we present an algorithm to qualitatively infer time-varying contact rates from short time-series data, letting us predict the start, relative magnitude and decline of epidemic outbreaks. Using real time-series data of measles, dengue, and the current zika outbreak, we demonstrate our algorithm can outperform existing algorithms based on estimating reproductive numbers.
C1 [Tulio Angulo, Marco] UNAM, CONACyT Inst Math, Juriquilla 76230, Mexico.
   [Velasco-Hernandez, Jorge X.] UNAM, Inst Math, Juriquilla 76230, Mexico.
RP Angulo, MT (corresponding author), UNAM, CONACyT Inst Math, Juriquilla 76230, Mexico.
EM mangulo@im.unam.mx
RI Velasco-Hernandez, Jorge/A-5391-2008
OI Velasco-Hernandez, Jorge/0000-0002-5604-7719
FU CONACyT, MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT);
   PAPIIT (UNAM)Programa de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IN110917]
FX We thank the financial support of CONACyT, Mexico. J.X.V.H. acknowledges
   support from PAPIIT (UNAM) grant IN110917.
CR ANDERSON R M, 1991
   Astrom K. J., 2010, FEEDBACK SYSTEMS INT
   Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002
   Bliman P.-A., 2016, INTERVAL OBSERVER SI
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Capistran MA, 2012, MATH BIOSCI, V240, P250, DOI 10.1016/j.mbs.2012.08.005
   Carrillo-Valenzo E, 2010, ARCH VIROL, V155, P1401, DOI 10.1007/s00705-010-0721-1
   Chapman JD, 2009, BIOMED SIGNAL PROCES, V4, P278, DOI 10.1016/j.bspc.2009.02.003
   Chen J, 1996, INT J CONTROL, V63, P85, DOI 10.1080/00207179608921833
   Cintron-Arias A, 2009, MATH BIOSCI ENG, V6, P261, DOI 10.3934/mbe.2009.6.261
   Coelho FC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18455
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Dochain D, 2003, J PROCESS CONTR, V13, P801, DOI 10.1016/S0959-1524(03)00026-X
   DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014
   Elderd BD, 2006, P NATL ACAD SCI USA, V103, P15693, DOI 10.1073/pnas.0600816103
   Evans ND, 2005, MATH BIOSCI, V194, P175, DOI 10.1016/j.mbs.2004.10.011
   Ferguson N. M., 2016, SCIENCE
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Liu XZ, 2012, APPL MATH MODEL, V36, P1974, DOI 10.1016/j.apm.2011.08.019
   Lohmiller W, 1998, AUTOMATICA, V34, P683, DOI 10.1016/S0005-1098(98)00019-3
   McMichael A. J., 2003, CLIMATE CHANGE HUMAN
   Moreno JA, 2008, INT J CONTROL, V81, P1062, DOI 10.1080/00207170701636534
   Nishiura H., 2009, J ROYAL SOC INTERFAC
   Parham P. E., 2015, PHILOS T B, V370
   Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330
   Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638
   Teurlai M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001957
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   Walter E, 1997, IDENTIFICATION PARAM
   Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174
NR 34
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD SEP
PY 2018
VL 24
BP 98
EP 104
DI 10.1016/j.epidem.2018.03.001
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GR2RX
UT WOS:000442430000011
PM 29567063
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Jackman, JA
   Cho, NJ
AF Jackman, Joshua A.
   Cho, Nam-Joon
TI Targeting the Achilles Heel of Zika Virus and Other Emerging Viral
   Pathogens
SO ADVANCED THERAPEUTICS
LA English
DT Article
DE antiviral therapies; medical countermeasures; mosquito-borne viruses;
   nanomedicine; peptides
AB Viruses are a leading cause of infectious diseases and represent one of the world's biggest global health problems. The continual appearance of new and reemerging viruses exceeds our capacity to provide effective medical solutions, as highlighted by the recent Zika epidemic. Herein, the authors discuss how unconventional approaches might lead to innovations in antiviral drug development that would address this outstanding need. In particular, the case of Zika virus is analyzed and the authors suggest that a materials science and engineering perspective might revolutionize antiviral drug development. Zika virus and related viruses possess a lipid membrane envelope that is an Achilles heel because it is necessary for viral function and there is a high barrier for mutations to evolve there. The development of antiviral drugs, such as certain membrane-active peptides, to selectively target the lipid membrane envelope would represent an entirely new therapeutic approach. Such efforts could be aided by engineering approaches to design and characterize promising drug candidates that work against multiple viruses. Looking forward, there is excellent potential to develop new therapeutic strategies that target the Achilles heel of Zika virus and other emerging viral pathogens.
C1 [Jackman, Joshua A.; Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Cho, Nam-Joon] Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
RP Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.; Cho, NJ (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore.
EM njcho@ntu.edu.sg
RI Cho, Nam-Joon/J-7816-2012
OI Cho, Nam-Joon/0000-0002-8692-8955
FU National Research Foundation [NRF-NRFF2011-01]; Start-Up Grant (SUG)
   from Nanyang Technological UniversityNanyang Technological University
   [M4080751.070]
FX The authors gratefully acknowledge support from the National Research
   Foundation (NRF-NRFF2011-01) and a Start-Up Grant (SUG) from Nanyang
   Technological University (M4080751.070).
CR Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   Paploski IAD, 2018, ANN INTERN MED, V168, P301, DOI 10.7326/M17-1949
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003
   Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317
   Hong W, 2014, ANTIVIR RES, V102, P1, DOI 10.1016/j.antiviral.2013.11.013
   Jackman JA, 2016, SMALL, V12, P1133, DOI 10.1002/smll.201500854
   Jackman JA, 2016, J AM CHEM SOC, V138, P1406, DOI 10.1021/jacs.5b12491
   Jackman JA, 2015, SMALL, V11, P2372, DOI 10.1002/smll.201403638
   Jackman JA, 2013, J PHYS CHEM B, V117, P16117, DOI 10.1021/jp409716p
   Jackman JA, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0018-2
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montero A, 2011, CHEM BIOL, V18, P1453, DOI 10.1016/j.chembiol.2011.08.017
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Roberts MJ, 2012, ADV DRUG DELIVER REV, V64, P116, DOI 10.1016/j.addr.2012.09.025
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   World Health Organisation, 2018, RES DEV BLUEPR ACT P
   Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008
   Zhang JJ, 2015, BIOMATERIALS, V70, P37, DOI 10.1016/j.biomaterials.2015.08.014
   Zhang JJ, 2013, BIOMATERIALS, V34, P3846, DOI 10.1016/j.biomaterials.2013.01.026
NR 36
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2366-3987
J9 ADV THER-GERMANY
JI Adv. Therap.
PD SEP
PY 2018
VL 1
IS 5
AR UNSP 1800045
DI 10.1002/adtp.201800045
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA VI6NT
UT WOS:000506341200001
OA Bronze
DA 2020-07-08
ER

PT J
AU Soto-Garita, C
   Carrera, JP
   Lopez-Verges, S
   Corrales-Aguilar, E
AF Soto-Garita, Claudio
   Carrera, Jean-Paul
   Lopez-Verges, Sandra
   Corrales-Aguilar, Eugenia
TI Advances in Clinical Diagnosis and Management of Chikungunya Virus
   Infection
SO CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES
LA English
DT Article
DE Chikungunya virus; Chikungunya diagnosis; Chikungunya clinical
   management; Arbovirus differential diagnosis
AB Purpose of reviewIn this review, we attempt to give the reader an update on clinical diagnosis, management, and treatment of Chikungunya virus (CHIKV) infection regarding the course of the disease and the role of clinical laboratory. CHIKV infection evolves through three phases: acute, sub-acute, and chronic. Protocol for patient assessment and management should be in agreement with each phase requirements.Recent findingsDespite its benignity, CHIKV infection has shown an increase in severe cases during recent outbreaks. Among the most affected group are neonates, elderly population, and patients with co-morbidities. Furthermore, since CHIKV geographical distribution and clinical spectrum overlaps with other arboviruses, differential diagnosis becomes crucial for physicians to ensure good management and treatment for patients. In this review, we describe and compare the main symptoms, complications, and risk groups for CHIKV, Dengue (DENV), and Zika (ZIKV) infections, regarding key features will guide to an accurate diagnosis.SummaryCHIKV is an emergent and reemergent arbovirus that arrived in the Americas in 2014, causing thousands of infections. The acute febrile phase is similar to that of dengue but with a higher proportion of debilitating arthralgia that can persist for months or even years after infection. Severe forms of CHIKV infection can lead to chronic polyarthralgia, neurologic symptoms, or multiorgan failure. Treatment of CHIKV infection is mainly focused on supportive care, which includes the use of analgesic and anti-inflammatory medication, rehydration, and rest.
C1 [Soto-Garita, Claudio; Corrales-Aguilar, Eugenia] Univ Costa Rica, Fac Microbiol, Virol Res Ctr Trop Dis CIET, San Jose, Costa Rica.
   [Carrera, Jean-Paul; Lopez-Verges, Sandra] Gorgas Mem Inst Hlth Studies, Dept Res Virol, Panama City, Panama.
   [Carrera, Jean-Paul] Columbus Univ, Dept Preclin Med, Panama City, Panama.
RP Corrales-Aguilar, E (corresponding author), Univ Costa Rica, Fac Microbiol, Virol Res Ctr Trop Dis CIET, San Jose, Costa Rica.
EM eugenia.corrales@ucr.ac.cr
FU Vicerrectoria de Investigacion, Universidad de Costa Rica [803-B6-778]
FX SLV is a member of the Sistema Nacional de Investigacion of SENACYT,
   Panama. This work was supported by Vicerrectoria de Investigacion,
   Universidad de Costa Rica (803-B6-778) for the ARBORED.
CR [Anonymous], 2008, GUID CLIN MAN CHIK F, P18
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Busch M, 2015, JAAPA-J AM ACAD PHYS, V28, P54, DOI 10.1097/01.JAA.0000470441.99693.e1
   Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056
   Chen LH, 2010, CURR OPIN INFECT DIS, V23, P438, DOI 10.1097/QCO.0b013e32833c1d16
   Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300
   da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Datta Sibnarayan, 2015, World J Virol, V4, P265, DOI 10.5501/wjv.v4.i3.265
   Delogu I, 2011, J MED VIROL, V83, P1058, DOI 10.1002/jmv.22019
   Duncan R, 2016, EXPERT REV MOL DIAGN, V16, P83, DOI 10.1586/14737159.2016.1112272
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Farnon EC, 2008, CRIT CARE MED, V36, P2682, DOI 10.1097/CCM.0b013e3181843d94
   Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1019-1
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hassing RJ, 2010, EUROSURVEILLANCE, V15, P22
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Kashyap RS, 2010, CLIN VACCINE IMMUNOL, V17, P291, DOI 10.1128/CVI.00326-09
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Kuno G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004101
   Lam SK, 2001, J TROP MED PUBLIC HL, V32, P447
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   LEE VJ, 2012, PLOS NEGLECT TROP D, V6, DOI DOI 10.1371/JOURNAL.PNTD.00017863459852
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Mishra B, 2011, DIAGN MICR INFEC DIS, V71, P118, DOI 10.1016/j.diagmicrobio.2011.06.020
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517
   Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14
   OMS, 2016, OMS CHIK
   Parashar D, 2014, BIOMED RES INT, DOI 10.1155/2014/631642
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Puttamallesh Vinuth N, 2013, Clin Proteomics, V10, P14, DOI 10.1186/1559-0275-10-14
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Reddy V, 2012, J MED VIROL, V84, P1771, DOI 10.1002/jmv.23406
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Ritz N, 2015, PEDIATR INFECT DIS J, V34, P789, DOI 10.1097/INF.0000000000000716
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Seetharam KA, 2012, INDIAN PEDIATR, V49, P51, DOI 10.1007/s13312-012-0007-7
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Shukla J, 2009, DIAGN MICR INFEC DIS, V65, P142, DOI 10.1016/j.diagmicrobio.2009.06.017
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Waymouth HE, 2013, SEMIN ARTHRITIS RHEU, V43, P273, DOI 10.1016/j.semarthrit.2013.03.003
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wikan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031102
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 71
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 1534-6250
J9 CURR TREAT OPT INFEC
JI Curr. Treat. Option Infect. Dis
PD SEP
PY 2018
VL 10
IS 3
BP 397
EP 409
DI 10.1007/s40506-018-0172-x
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA VJ0UW
UT WOS:000529402700006
DA 2020-07-08
ER

PT J
AU Lee, H
   Halverson, S
   Ezinwa, N
AF Lee, Hobart
   Halverson, Sara
   Ezinwa, Ngozi
TI Mosquito-Borne Diseases
SO PRIMARY CARE
LA English
DT Review
DE Mosquitoes; Chikungunya; Dengue; Japanese encephalitis; Malaria; West
   Nile; Yellow fever; Zika
ID WEST-NILE-VIRUS; UNITED-STATES; ZIKA VIRUS; JAPANESE ENCEPHALITIS;
   CHIKUNGUNYA; INFECTION; SURVEILLANCE; INFANTS; UPDATE; DENGUE
AB Mosquito-borne diseases have become more common as previously geographically isolated diseases have spread globally. Chikungunya, dengue, Japanese encephalitis, malaria, West Nile, yellow fever, and Zika are a few of the common and emerging viral diseases spread by mosquitoes. A thorough patient history, physical, and knowledge of diagnostic testing based on symptom duration is important to make a quick and accurate diagnosis. Because the treatment for many of these diseases is supportive, the emphasis is on reducing risk and spread of infection.
C1 [Lee, Hobart; Halverson, Sara; Ezinwa, Ngozi] Loma Linda Univ, Sch Med, Dept Family Med, 1200 Calif St,Suite 240, Redlands, CA 92374 USA.
RP Lee, H (corresponding author), Loma Linda Univ, Sch Med, Dept Family Med, 1200 Calif St,Suite 240, Redlands, CA 92374 USA.
EM holee@llu.edu
CR Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2015, WNV ANT TEST
   [Anonymous], 2015, DIAGN TEST JAP ENC
   [Anonymous], 2018, TEST GUID ZIK VIR
   Arguin PM, 2017, MALARIA INFECT DIS R
   Bloch D., 2016, COST BURDEN CHIKUNGU
   Brent C, 2016, MMWR-MORBID MORTAL W, V65, P981, DOI 10.15585/mmwr.mm6536e4
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Center for Disease Control and Prevention, 2013, GUID TREATM MAL US
   Centers for Disease Control and Prevention, 2014, EPIDEMIOLOGY
   Centers for Disease Control and Prevention, DENG DENG HEM FEV IN
   Centers for Disease Control and Prevention, 2017, ZIK CAS US
   Centers for Disease Control and Prevention, 2018 NAT NOT COND
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Chan CK, 2006, OPHTHALMOLOGY, V113, P1539, DOI 10.1016/j.ophtha.2006.04.021
   Fischer Marc, 2008, V8, P93
   Fonseca K, 2005, EMERG INFECT DIS, V11, P1648, DOI 10.3201/eid1110.040212
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gershman MD, 2017, YELLOW FEVER INFECT
   Gunda R, 2017, COST EFFECT RESOUR A, V15, DOI 10.1186/s12962-017-0072-9
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Khetarpal N, 2016, J IMMUNOL RES, DOI 10.1155/2016/6803098
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Luce R., 2010, Morbidity and Mortality Weekly Report, V59, P715
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Schwameis M, 2016, HUM VACC IMMUNOTHER, V12, P716, DOI 10.1080/21645515.2015.1101197
   Simoes M, 2012, BIOLOGICALS, V40, P399, DOI 10.1016/j.biologicals.2012.09.005
   Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Verhagen LM, 2014, J INFECTION, V69, pS77, DOI 10.1016/j.jinf.2014.07.020
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2016, YELLOW FEVER
   WHO, 2015, JAPANESE ENCEPHALITI
   WHO, 2011, COMPR GUID PREV CONT
   World Health Organization, 2016, WORLD MALARIA REPORT
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2017, CHIK
   World Health Organization, 2017, VECT BORN DIS
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602
NR 56
TC 9
Z9 10
U1 0
U2 16
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0095-4543
EI 1558-299X
J9 PRIMARY CARE
JI Primary Care
PD SEP
PY 2018
VL 45
IS 3
BP 393
EP +
DI 10.1016/j.pop.2018.05.001
PG 16
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA GQ2RL
UT WOS:000441503900004
PM 30115330
DA 2020-07-08
ER

PT J
AU Leeper, C
   Lutzkanin, A
AF Leeper, Connie
   Lutzkanin, Andrew
TI Infections During Pregnancy
SO PRIMARY CARE
LA English
DT Review
DE Congenital infection; Pregnancy complications; Vertical transmission;
   Zika; TORCH
ID HERPES-SIMPLEX-VIRUS; HEPATITIS-C VIRUS; NEISSERIA-GONORRHOEAE
   INFECTION; DISEASES-TREATMENT-GUIDELINES; URINARY-TRACT-INFECTIONS;
   BIRTH-DEFECTS-PREVENTION; TO-INFANT TRANSMISSION; INFLUENZA-A H1N1; ZIKA
   VIRUS; UNITED-STATES
AB Several infections have unique consequences or considerations in pregnancy. Some common infections such as urinary tract infections, influenza, sexually transmitted diseases, and vaginitis affect pregnant women differently than the general population, can cause pregnancy complications, and require treatments that are safe in pregnancy. Infections such as hepatitis B and C and human immunodeficiency virus can be transmitted vertically, and therefore management focuses on decreasing perinatal transmission. Certain infections can be transmitted in utero and cause congenital infections. Classically, these were grouped together as the TORCH infections, although now several others, including varicella virus, parvovirus, and Zika virus, have also been recognized.
C1 [Leeper, Connie] Univ Alabama, Dept Family Internal & Rural Med, 850 Peter Bryce Blvd, Tuscaloosa, AL 35401 USA.
   [Lutzkanin, Andrew] Penn State Coll Med, Dept Family & Community Med, 500 Univ Dr, Hershey, PA 17033 USA.
RP Leeper, C (corresponding author), Univ Alabama, Dept Family Internal & Rural Med, 850 Peter Bryce Blvd, Tuscaloosa, AL 35401 USA.
EM ccleeper@ua.edu
CR ACOG, 2007, OBSTET GYNECOL, V109, P1489
   Ailes EC, 2016, BIRTH DEFECTS RES A, V106, P940, DOI 10.1002/bdra.23570
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   American College of Obstetricians and Gynecologists, 1998, INT J GYNECOL OBSTET, V61, P299
   American College of Obstetricians and Gynecologists Committee on Obstetric Practice, 2011, Obstet Gynecol, V117, P1019, DOI 10.1097/AOG.0b013e318219229b
   American College of Obstetrics and Gynecology Committee on Obstetric Practice, 2008, Obstet Gynecol, V112, P739, DOI 10.1097/AOG.0b013e318188d29c
   [Anonymous], 1999, Sex Transm Infect, V75 Suppl 1, pS21
   [Anonymous], 2016, 2015 STD TREATM GUID
   BALDWIN S, 1989, TERATOLOGY, V39, P1, DOI 10.1002/tera.1420390102
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Bar-Oz B, 2009, EUR J OBSTET GYN R B, V143, P75, DOI 10.1016/j.ejogrb.2008.12.007
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bialas KM, 2015, CLIN PERINATOL, V42, P61, DOI 10.1016/j.clp.2014.10.006
   Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458
   Brown RS, 2016, HEPATOLOGY, V63, P319, DOI 10.1002/hep.28302
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801
   Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70
   Carter JE, 2008, AM J TROP MED HYG, V78, P17, DOI 10.4269/ajtmh.2008.78.17
   CDC, 2018, ZIK CAS US
   Centers for Disease Control and Prevention, 2017, SYPH CDC FACT SHEET
   Centers for Disease Control and Prevention, 2018, ZIK PREGN TEST DIAGN
   Centers for Disease Control and Prevention, 2016, QUEST ANSW IMPL 2010
   Centers for Disease Control and Prevention, 2011, HIV SURV SUPPL REP 2, V16
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1106
   Centers for Disease Control and Prevention US Government, 2017, SEX TRANSM DIS SURV
   Centers for Disease Control Prevention, 2016, HIV SURV REP 2015, V27
   Chang MS, 2014, CAN J GASTROENTEROL, V28, P439, DOI 10.1155/2014/350179
   Chen HL, 2015, HEPATOLOGY, V62, P375, DOI 10.1002/hep.27837
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   COHLAN SQ, 1963, AM J DIS CHILD, V105, P453, DOI 10.1001/archpedi.1963.02080040455005
   Committee on Practice BulletinsObstetrics The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P964
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cotch MF, 1998, AM J OBSTET GYNECOL, V178, P374, DOI 10.1016/S0002-9378(98)80028-8
   Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008
   Cottrell EB, 2013, ANN INTERN MED, V158, P109, DOI 10.7326/0003-4819-158-2-201301150-00575
   Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947
   Crider KS, 2009, ARCH PEDIAT ADOL MED, V163, P978, DOI 10.1001/archpediatrics.2009.188
   del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590
   DONDERS GGG, 1993, GENITOURIN MED, V69, P98
   EPPS RE, 1995, SEMIN DERMATOL, V14, P179, DOI 10.1016/S1085-5629(05)80016-1
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feldman DM, 2016, CLIN LAB MED, V36, P407, DOI 10.1016/j.cll.2016.01.011
   FITZSIMMONS J, 1986, J REPROD MED, V31, P19
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gershon AA, 1987, INFECT DIS FETUS NEW
   Grangeot-Keros L, 1998, INTERVIROLOGY, V41, P158, DOI 10.1159/000024930
   Grohskopf LA, 2017, MMWR RECOMM REP, V66, P3, DOI 10.15585/mmwr.rr6602a1
   Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heumann CL, 2017, SEX TRANSM DIS, V44, P266, DOI [10.1097/OLQ.0000000000000592, 10.1097/olq.0000000000000592]
   Hoffman David J, 2003, J Perinatol, V23, P59, DOI 10.1038/sj.jp.7210819
   Hughes BL, 2017, AM J OBSTET GYNECOL, V217, pB2, DOI 10.1016/j.ajog.2017.07.039
   James SH, 2015, INFECT DIS CLIN N AM, V29, P391, DOI 10.1016/j.idc.2015.05.001
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2013, PEDIATRICS, V131, P383, DOI 10.1542/peds.2012-3217
   Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230
   Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223
   Kimberlin DW, 2015, RED BOOK 2015 REPORT, P288
   Kimberlin DW, 2015, RED BOOK 2015 REPORT, P972
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   Le J, 2004, ANN PHARMACOTHER, V38, P1692, DOI 10.1345/aph.1D630
   LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981
   Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005
   Liu B, 2013, SEX TRANSM INFECT, V89, P672, DOI 10.1136/sextrans-2013-051118
   Lopez-Rangel E, 2005, BIRTH DEFECTS RES A, V73, P919, DOI 10.1002/bdra.20189
   Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455
   Ly KN, 2017, ANN INTERN MED, V166, P775, DOI 10.7326/M16-2350
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Mann JR, 2009, AM J PERINAT, V26, P667, DOI 10.1055/s-0029-1220792
   Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701
   MAXWELL GL, 1992, AM J OBSTET GYNECOL, V166, P945, DOI 10.1016/0002-9378(92)91369-L
   McIntrye PG, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005546.pub2
   McNeil SA, 2011, AM J OBSTET GYNECOL, V204, pS54, DOI 10.1016/j.ajog.2011.04.031
   Mendez-Figueroa H, 2011, AM J OBSTET GYNECOL, V204, pS58, DOI 10.1016/j.ajog.2011.02.058
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Molgaard-Nielsen D, 2016, JAMA-J AM MED ASSOC, V315, P58, DOI 10.1001/jama.2015.17844
   Mosby LG, 2011, AM J OBSTET GYNECOL, V205, P10, DOI 10.1016/j.ajog.2010.12.033
   MUCH DH, 1991, PUBLIC HEALTH REP, V106, P490
   Murat JB, 2013, EXPERT REV ANTI-INFE, V11, P943, DOI 10.1586/14787210.2013.825441
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Newsome Kimberly, 2011, Morbidity and Mortality Weekly Report, V60, P1193
   Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Nunes MC, 2016, JAMA PEDIATR, V170, P840, DOI 10.1001/jamapediatrics.2016.0921
   Nygren P, 2008, ANN INTERN MED, V148, P220, DOI 10.7326/0003-4819-148-3-200802050-00008
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Okah E, 2018, SEX TRANSM DIS, V45, P177, DOI [10.1097/OLQ.0000000000000712, 10.1097/olq.0000000000000712]
   Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003
   Pergam SA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.052
   Pickering LK, 2012, RED BOOK 2012 REPORT
   Schlaudecker EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070867
   Shakib JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2360
   Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015
   Smith Lynne M, 2002, J Perinatol, V22, P502, DOI 10.1038/sj.jp.7210714
   Staras SAS, 2008, J CLIN VIROL, V43, P266, DOI 10.1016/j.jcv.2008.07.012
   Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643
   Temesvari P, 2002, J Matern Fetal Neonatal Med, V11, P347, DOI 10.1080/713605547
   Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156
   Thiebaut R, 2007, LANCET, V369, P115
   Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212
   US Food and Drug Administration, 2011, SAF COMM US LONG TER
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vennila Vijayasree, 2014, J Int Oral Health, V6, P115
   Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wang JS, 2002, CHINESE MED J-PEKING, V115, P1510
   Watts DH, 2003, AM J OBSTET GYNECOL, V188, P836, DOI 10.1067/mob.2003.185
   Whitmore SK, 2011, JAIDS-J ACQ IMM DEF, V57, P218, DOI 10.1097/QAI.0b013e3182167dec
   Wind CM, 2016, CLIN INFECT DIS, V62, P1348, DOI 10.1093/cid/ciw141
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Yang J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-100
NR 116
TC 5
Z9 6
U1 2
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0095-4543
EI 1558-299X
J9 PRIMARY CARE
JI Primary Care
PD SEP
PY 2018
VL 45
IS 3
BP 567
EP +
DI 10.1016/j.pop.2018.05.013
PG 21
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA GQ2RL
UT WOS:000441503900016
PM 30115342
DA 2020-07-08
ER

PT J
AU Waldorf, KMA
   Olson, EM
   Nelson, BR
   Little, MTE
   Rajagopal, L
AF Waldorf, Kristina M. Adams
   Olson, Erin M.
   Nelson, Branden R.
   Little, Marie-Terese E.
   Rajagopal, Lakshmi
TI The Aftermath of ZiKa: Need for Long-Term Monitoring of Exposed Children
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
ID PREGNANCY OUTCOMES; VIRUS-INFECTION; ADULT BRAIN; NEUROGENESIS;
   TERRITORIES
AB Pregnancy infections with Zika virus are associated with a spectrum of fetal brain injuries beyond microcephaly. Nonmicrocephalic children exposed to Zika virus in utero or early life should undergo neurodevelopmental testing to identify deficits and allow for early intervention. Additionally, long-term monitoring for higher order neurocognitive deficits should be implemented.
C1 [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
   [Olson, Erin M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.
   [Olson, Erin M.] Univ Washington, Sch Psychol Program, Dept Educ Psychol, Seattle, WA 98195 USA.
   [Nelson, Branden R.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.
   [Little, Marie-Terese E.] 4th Dimens Biomed Res Commun, Victoria, BC, Canada.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.
RP Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Rajagopal, L (corresponding author), Univ Washington, Dept Pediat, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Rajagopal, L (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.
EM adamsk@uw.edu; lakshmi.rajagopal@seattlechildrens.org
RI Adams Waldorf, Kristina/F-2608-2013
OI Adams Waldorf, Kristina/0000-0002-6939-7224
FU University of Washington Department of Obstetrics AMP; Gynecology,
   Seattle Children's Research Institute; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI100989, R01AI33976, R21OD023838]
FX We would like to acknowledge Jan Hamanishi for technical assistance with
   preparation of the figure. This work was supported by the University of
   Washington Department of Obstetrics & Gynecology, Seattle Children's
   Research Institute and the National Institutes of Health, Grant #
   R01AI100989 and R01AI33976 (LR and KAW) and R21OD023838 (BRN). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health or other funders. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
NR 15
TC 9
Z9 9
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD SEP
PY 2018
VL 26
IS 9
BP 729
EP 732
DI 10.1016/j.tim.2018.05.011
PG 4
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GQ1RR
UT WOS:000441415900001
PM 29960747
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Alves, LV
   Mello, MJG
   Bezerra, PG
   Alves, JGB
AF Alves, Lucas V.
   Mello, Maria J. G.
   Bezerra, Patricia G.
   Bezerra Alves, Joao Guilherme
TI Congenital Zika Syndrome and Infantile Spasms: Case Series Study
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Zika virus; congenital Zika syndrome; infantile spasms
ID VIRUS SYNDROME; INFECTION; BRAZIL
AB Recently described, the congenital Zika syndrome caused by the Zika virus has many features of other congenital infections. This case series study reports 22 infants with congenital Zika syndrome in Brazil who developed infantile spasms during their first year of life. The median age of infantile spasms onset was 4.3 (+/- 1.4) months and ranged from 1 to 7 months. Neurologic evaluation showed that all 22 children presented severe impairment of neuropsychomotor development. A total of 18 infants had an interictal hypsarrhythmia electroencephalogram (EEG) pattern. Vigabatrin was prescribed as first-line treatment; however, only 5 patients were controlled. Steroid regimes were started for children who did not respond to vigabatrin and they are being followed. In conclusion, congenital Zika syndrome may be considered as an etiological agent of infantile spasms.
C1 [Alves, Lucas V.; Mello, Maria J. G.; Bezerra, Patricia G.; Bezerra Alves, Joao Guilherme] Inst Med Integral Prof Fernando Figueira IMIP, Dept Paediat Neurol, Recife, PE, Brazil.
RP Alves, JGB (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Pediat, Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Alves, Joao G/J-6483-2013
OI Alves, Joao G/0000-0002-9170-0808
CR [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gordon-Lipkin E, 2017, J CHILD NEUROL, V32, P804, DOI 10.1177/0883073817707301
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   RIIKONEN R, 1993, NEUROPEDIATRICS, V24, P274, DOI 10.1055/s-2008-1071556
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Suzuki Y, 2008, BRAIN DEV-JPN, V30, P420, DOI 10.1016/j.braindev.2007.12.004
   Widjaja E, 2015, EPILEPSY RES, V109, P155, DOI 10.1016/j.eplepsyres.2014.11.012
   Xixis KL, 2017, SPASM INFANTILE W SY
NR 12
TC 5
Z9 5
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD SEP
PY 2018
VL 33
IS 10
BP 664
EP 666
DI 10.1177/0883073818780105
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GQ3UU
UT WOS:000441593400006
PM 29897010
DA 2020-07-08
ER

PT J
AU Lopez-Monroy, B
   Gutierrez-Rodriguez, SM
   Villanueva-Segura, OK
   Ponce-Garcia, G
   Morales-Forcada, F
   Alvarez, LC
   Flores, AE
AF Lopez-Monroy, Beatriz
   Gutierrez-Rodriguez, Selene M.
   Karina Villanueva-Segura, Olga
   Ponce-Garcia, Gustavo
   Morales-Forcada, Franco
   Alvarez, Leslie C.
   Flores, Adriana E.
TI Frequency and intensity of pyrethroid resistance through the CDC bottle
   bioassay and their association with the frequency of kdr mutations in
   Aedes aegypti (Diptera: Culicidae) from Mexico
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE pyrethroids; frequency of insecticide resistance; intensity of
   insecticide resistance; kdr; Aedes aegypti
ID SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; MECHANISMS; STATE
AB BACKGROUNDThe control of Aedes aegypti (L.), the main urban vector that causes arboviral diseases such as dengue, Chikungunya and Zika, has proved to be a challenge because of a rapid increase in insecticide resistance. Therefore, adequate monitoring of insecticide resistance is an essential element in the control of Ae. aegypti and the diseases it transmits. We estimated the frequency and intensity (Resistance Frequency Rapid Diagnostic Test [F-RDT] and Resistance Intensity Rapid Diagnostic Test [I-RDT]) of pyrethroid resistance in populations of Ae. aegypti from Mexico using the bottle bioassay and results were related to the frequencies of knockdown resistance (kdr) mutations V1016I and F1534C.
   RESULTSAll populations under study were resistant to the pyrethroids: bifenthrin (99%), d-(cis-trans)-phenothrin (6.3% cis, 91.7% trans) and permethrin (99.5%) according to F-RDT, and showed moderate to high-intensity resistance at 10x the diagnostic dose (DD) in I-RDT. Frequencies of the kdr mutation V1016I in Ae. aegypti populations were correlated with moderate permethrin resistance at 10x DD, whereas F1534C mutation frequencies were correlated with high bifenthrin resistance at 5x DD. Both I1016 and C1535 were highly correlated with high-intensity phenothrin resistance at 1x to 10x DD.
   CONCLUSIONSThis study showed that high frequencies of kdr mutations V1016I and F1534C are reflected in the results of F-RDT and I-RDT tests. Bioassays in conjunction with the characterization of genetic resistance mechanisms are indispensable in the strategic and rational management of resistance in mosquitoes. (c) 2018 Society of Chemical Industry
C1 [Lopez-Monroy, Beatriz; Gutierrez-Rodriguez, Selene M.; Karina Villanueva-Segura, Olga; Ponce-Garcia, Gustavo; Morales-Forcada, Franco; Flores, Adriana E.] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Dept Zool Invertebrados, San Nicolas De Los Garza 66455, NL, Mexico.
   [Alvarez, Leslie C.] Univ Andes, Nucleo Univ Rafael Rangel, Merida, Estado Trujillo, Venezuela.
RP Flores, AE (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Av Univ S-N,Ciudad Univ, San Nicolas De Los Garza 66455, NL, Mexico.
EM adriana.floressr@uanl.edu.mx
RI Villanueva-Segura, Olga Karina/AAF-2131-2020; Flores,
   Adriana/J-1820-2012; Lopez, Beatriz/G-2070-2019; Flores, Adriana
   E./AAM-4478-2020
OI Flores, Adriana/0000-0001-8554-8865; Lopez, Beatriz/0000-0003-3155-4244;
   Flores, Adriana E./0000-0001-8554-8865; Villanueva-Segura,
   Karina/0000-0002-1976-8277
CR Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Bagi J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0721-4
   Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159
   Brogdon WG, 2010, GUIDELINE EVALUATING
   COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X
   DOF, 2015, DIARIO OFICIAL FEDER, P1
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406
   Owusu HF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0971-6
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   WHO, 2012, GLOB PLAN INS RES MA
   World Health Organization, 2017, WORLD MALARIA REPORT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   World Health Organization, 2016, TEST PROC INREMO, P48
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 20
TC 5
Z9 5
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD SEP
PY 2018
VL 74
IS 9
BP 2176
EP 2184
DI 10.1002/ps.4916
PG 9
WC Agronomy; Entomology
SC Agriculture; Entomology
GA GP1EJ
UT WOS:000440556800022
PM 29575404
OA Bronze
DA 2020-07-08
ER

PT J
AU Goindin, D
   Cannet, A
   Delannay, C
   Ramdini, C
   Gustave, J
   Atyame, C
   Vega-Rua, A
AF Goindin, D.
   Cannet, A.
   Delannay, C.
   Ramdini, C.
   Gustave, J.
   Atyame, C.
   Vega-Rua, A.
TI Screening of natural Wolbachia infection in Aedes aegypti, Aedes
   taeniorhynchus and Culex quinquefasciatus from Guadeloupe (French West
   Indies)
SO ACTA TROPICA
LA English
DT Article
DE Wolbachia; Aedes aegypti; Aedes taeniorhynchus; Culex quinquefasciatus;
   Guadeloupe
ID PIPIENS; MOSQUITOS; ENDOBACTERIA; POPULATIONS; CULICIDAE; DIPTERA;
   COMPLEX; PCR
AB Guadeloupe islands are threatened by several mosquito-borne viruses such as Dengue, Chikungunya, Zika and West Nile virus. It appears essential to look for alternative mosquito control methods such as the incompatible insect technique (ITT) aiming at sterilizing wild females by inundative releases of incompatible males. Before considering the implementation of such a strategy, the characterization of genetic diversity of the endocellular bacterium Wolbachia regarding the local mosquito populations is a critical issue. Here, for the first time, we describe the prevalence and diversity of Wolbachia in natural populations of three mosquito species from Guadeloupe: Aedes aegypti, Aedes taeniorhynchus and Culex quinquefasciatus. The detection of Wolbachia in natural Ae. aegypti, Ae. taeniorhynchus and Cx. quinquefasciatus populations was conducted by studying Wolbachia 16S ribosomal RNA gene using a TaqMan quantitative real-time PCR and results were confirmed by conventional PCR and sequencing. In addition, molecular typing of wPip strains in Cx. quinquefasciatus was done by PCR-RFLP. We did not find Wolbachia infection in any of Ae. aegypti and Ae. taeniorhynchus studied populations. Natural Wolbachia infection was detected in Cx. quinquefasciatus with prevalence varying from 79.2% to 95.8%. In addition, no polymorphism was found between the Wolbachia strains infecting Cx. quinquefasciatus specimens, all carrying an infection from the same Wolbachia genetic wPip-I group. These results pave the way for the evaluation of the feasibility of IIT programs to fight against these medically-important mosquito species in Guadeloupe.
C1 [Goindin, D.; Delannay, C.; Vega-Rua, A.] Inst Pasteur Guadeloupe, Lab Med Entomol, Environm & Hlth Unit, F-97183 Les Abymes, Guadeloupe, France.
   [Cannet, A.] Ctr IRD France, Natl Ctr Expertise Vectors CNEV, Sud 911 Ave Agropolis BP 64501, F-34394 Montpellier 5, France.
   [Ramdini, C.; Gustave, J.] Reg Hlth Agcy, Vector Control Serv Guadeloupe, F-97139 Les Abymes, Guadeloupe, France.
   [Atyame, C.] Univ Reunion Isl, UMR PIMIT Proc Infect Milieu Insulaire Trop CNRS, INSERM U1187, IRD 249, St Clothilde, Reunion Isl, France.
RP Goindin, D (corresponding author), Inst Pasteur Guadeloupe, Lab Med Entomol, Environm & Hlth Unit, F-97183 Les Abymes, Guadeloupe, France.
EM daniella.goindin@gmail.com; ar.cannet@gmail.com;
   cdollin@pasteur-guadeloupe.fr; cedric.ramdini@ars.sante.fr;
   joel.gustave@ars.sante.fr; celestine.atyame-nten@univ-reunion.fr;
   anubis.vega-rua@pasteur.fr
FU Grand Port Maritime of Guadeloupe; FEDER - European UnionEuropean Union
   (EU); Guadeloupe Region (Programme Operationnel FEDER-Guadeloupe-Conseil
   Regional) [2015-FED-192]; FEDER RESMALIN2; National Center of Expertise
   on Vectors (Montpellier, France)
FX This work was supported by the Grand Port Maritime of Guadeloupe, by a
   FEDER grant, financed by the European Union and Guadeloupe Region
   (Programme Operationnel FEDER-Guadeloupe-Conseil Regional 2014-2020,
   Grant number 2015-FED-192), by FEDER RESMALIN2 and by the National
   Center of Expertise on Vectors (Montpellier, France).
CR Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Atyame C., 2011, MOL BIOL EVOL, V28
   Atyame CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087336
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Dumas E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-181
   Eastwood G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01519
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Guyane CIRE Antilie, 2016, SURVEILLANCE VIRUS Z, P1
   Guyane CIRE Antilles, 2014, CHIKUNGUNYA ANTILLES, P1
   Karami M, 2016, J ARTHROPOD-BORNE DI, V10, P349
   Lardeux F, 2008, T ROY SOC TROP MED H, V102, P485, DOI 10.1016/j.trstmh.2008.02.006
   Larrieu S, 2014, ACTA TROP, V131, P37, DOI 10.1016/j.actatropica.2013.11.023
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Lefrancois T, 2005, EMERG INFECT DIS, V11, P1100, DOI 10.3201/eid1107.050105
   Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Mee PT, 2015, APPL ENVIRON MICROB, V81, P6177, DOI 10.1128/AEM.01239-15
   Nugapola NWNP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2174-9
   Rao RU, 2006, AM J TROP MED HYG, V74, P826, DOI 10.4269/ajtmh.2006.74.826
   Rasgon JL, 2003, GENETICS, V165, P2029
   Rey JR, 2012, INT J ENV RES PUB HE, V9, P4537, DOI 10.3390/ijerph9124537
   Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562
   Richards SL, 2014, TROP MED INT HEALTH, V19, P610, DOI 10.1111/tmi.12277
   Rosine J., 1999, U PIERRE M CURIE, P51
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Slatko BE, 2014, MOL BIOCHEM PARASIT, V195, P88, DOI 10.1016/j.molbiopara.2014.07.004
   Tmimi FZ, 2017, J VECTOR ECOL, V42, P349, DOI 10.1111/jvec.12275
NR 28
TC 4
Z9 4
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2018
VL 185
BP 314
EP 317
DI 10.1016/j.actatropica.2018.06.011
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GO6ED
UT WOS:000440126000043
PM 29908171
OA Other Gold
DA 2020-07-08
ER

PT J
AU Momoh, AA
   Fugenschuh, A
AF Momoh, Abdulfatai A.
   Fuegenschuh, Armin
TI Optimal control of intervention strategies and cost effectiveness
   analysis for a Zika virus model
SO OPERATIONS RESEARCH FOR HEALTH CARE
LA English
DT Article
DE Vector-Borne disease; Zika virus; Optimal control; Cost effectiveness
   analysis; Reproduction number
ID TRANSMISSION; STATES
AB This paper presents an optimal control strategy and a cost effectiveness analysis for the Zika virus disease. A mathematical model for the transmission of the Zika virus is considered with four preventive measures as control, namely: the use of treated bednets, the use of condoms, a medical treatment of infected persons, and the use of indoor residual spray (IRS). We obtain the reproduction number R-0 for the disease and carry out a stability analysis. We observe that the disease's free equilibrium state is stable when R-0 < 1 but unstable when R-0 > 1, which leads to a spread of the disease. Weexamine the implementation of various combinations of the possible control strategies in order to determine the most cost- effective one. Based on the computational results, we conclude that a strategy that consists of treated bednets, treatment of symptomatic infected humans and indoor residual spray is the most cost effective strategy. (C) 2017 The Authors. Published by Elsevier
C1 [Momoh, Abdulfatai A.] Modibbo Adama Univ Technol, Yola, Adamawa State, Nigeria.
   [Fuegenschuh, Armin] Helmut Schmidt Univ, Hamburg, Germany.
RP Fugenschuh, A (corresponding author), Helmut Schmidt Univ, Hamburg, Germany.
EM fuegenschuh@hsu-hh.de
OI Fugenschuh, Armin/0000-0003-3637-4066; Momoh Atte,
   Abdulfatai/0000-0002-8077-2726
FU Helmut Schmidt University/University of the Federal Armed Forces Hamburg
FX Abdulfatai Momoh's research was supported by an internal research grant
   of the Helmut Schmidt University/University of the Federal Armed Forces
   Hamburg, which he gratefully acknowledges.
CR Adams BM, 2004, MATH BIOSCI ENG, V1, P223
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2016, NEW ENGLAND J MED
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Centre for Disease Control, 2016, CDC ADDS 2 DEST INT
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Daabo M. I., 2012, AFR J BIOTECHNOL, V11, P11287
   Dallas County Health and Human Services, 2016, DCHHS REP 1 ZIK VIR
   Dauzhou G., 2016, SCI REPORTS, V6, p[28070, 1]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Felippe de Souza J.A.M., 2000, P C DEC CONTR SYDN
   Fleming W. H., 1975, DETERMINISTIC STOCHA
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lakshmikantham V., 1989, STABILITY ANAL NONLI
   LENHART SM, 1995, NONLINEAR ANAL-THEOR, V25, P681, DOI 10.1016/0362-546X(94)00179-L
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Moore D. L., 1970, TROP MED PARASITOL, V69, P49
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Niger AM, 2008, DIFFER EQUAT DYN SYS, V16, P251, DOI 10.1007/s12591-008-0015-1
   Okosun KO, 2013, APPL MATH MODEL, V37, P3802, DOI 10.1016/j.apm.2012.08.004
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   Pontryagin L. S., 1962, MATH THEORY OPTIMAL
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Smith HL, 1995, THEORY CHEMOSTAT
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   WHO, 2016, ZIK VIR FACT SHEET
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 36
TC 8
Z9 7
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-6923
J9 OPER RES HEALTH CARE
JI OPER. RES. HEALTH CARE
PD SEP
PY 2018
VL 18
SI SI
BP 99
EP 111
DI 10.1016/j.orhc.2017.08.004
PG 13
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA GL1CR
UT WOS:000436834800010
OA Other Gold
DA 2020-07-08
ER

PT J
AU Masyeni, S
   Yohan, B
   Somia, IKA
   Myint, KSA
   Sasmono, RT
AF Masyeni, Sri
   Yohan, Benediktus
   Somia, I. Ketut Agus
   Myint, Khin S. A.
   Sasmono, R. Tedjo
TI Dengue infection in international travellers visiting Bali, Indonesia
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Dengue; serotype; genotype; travellers; Bali
ID MOLECULAR EVOLUTION; CHIKUNGUNYA FEVER; VIRUS-INFECTION; ZIKA VIRUS;
   AUSTRALIA; BURDEN
AB Background: Dengue, an acute febrile illness caused by infection with dengue virus (DENV), is endemic in Bali, Indonesia. As one of the world's most popular tourist destinations, Bali is regularly visited by domestic and international travellers, who are prone to infection by endemic pathogens, including DENV. Currently, limited data are available on the characteristics of dengue in travellers visiting Bali. Information on the epidemiology and virological aspects of dengue in these tourists is important to gain a better understanding of the dengue disease in international travellers.
   Methods: We performed a prospective cross-sectional dengue study involving foreign travellers visiting Bali, Indonesia in the period of 2015-17. Patients presenting at Kasih Ibu Hospital with fever and clinical symptoms of dengue were asked to participate in the study. Clinical and laboratory assessments were performed and sera were collected for molecular analysis, which included DENV serotyping, genome sequencing and phylogenetic analysis.
   Results: Among the 201 patients recruited, dengue was confirmed in 133 (66.2%) of them, based on detection of NS1 antigen and/or viral RNA. Of these, 115 (86.5%) manifested dengue fever (DF) and 18 (13.5%) dengue haemorrhagic fever (DHF). The temporal predominance of infecting DENV serotype was DENV-2 (48.7%), followed by DENV-3 (36.1%), DENV-1 (9.2%) and DENV-4 (3.4%). Phylogenetic analysis of DENV based on envelope gene sequences revealed that the source of DENVs was local endemic viruses.
   Conclusion: Our study confirms that dengue is one of the causes of fever in travellers visiting Bali. Although it is a cause of significant morbidity, the majority of patients only experienced mild DF, with only a small proportion developing DHF. We revealed that DENVs isolated were autochthonous. Accurate diagnosis, preventive measures and continuous disease surveillance will be useful for better management of dengue infection in travellers.
C1 [Masyeni, Sri] Warmadewa Univ, Dept Internal Med, Fac Med & Hlth Sci, Denpasar 80235, Bali, Indonesia.
   [Yohan, Benediktus; Myint, Khin S. A.; Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jakarta 10430, Indonesia.
   [Somia, I. Ketut Agus] Udayana Univ, Dept Internal Med, Fac Med & Hlth Sci, Denpasar 80232, Bali, Indonesia.
RP Sasmono, RT (corresponding author), Eijkman Inst Mol Biol, Jakarta 10430, Indonesia.
EM sasmono@eijkman.go.id
RI Sasmono, Tedjo/H-5680-2016
OI Sasmono, Tedjo/0000-0003-0986-2590
FU International Society for Travel Medicine Research Awards
FX This work was supported by grant from the International Society for
   Travel Medicine Research Awards to S.M. and R.T.S.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   de Jong W, 2018, CRIT REV MICROBIOL, V44, P487, DOI [10.1080/1040841X.2018.1438986, 10.1080/1040841x.2018.1438986]
   Ernst T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003442
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   Lestari CSW, 2017, VIRUS GENES, V53, P778, DOI 10.1007/s11262-017-1474-7
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Megawati D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005483
   Nusa R, 2014, J INFECT DEV COUNTR, V8, P733, DOI 10.3855/jidc.3959
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Ratnam I, 2013, J TRAVEL MED, V20, P384, DOI 10.1111/jtm.12052
   Sari K, 2017, T ROY SOC TROP MED H, V111, P325, DOI 10.1093/trstmh/trx054
   Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006
   Setiati T. E., 2006, Dengue Bulletin, V30, P1
   Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447
   Warrilow D, 2012, EMERG INFECT DIS, V18, P1850, DOI 10.3201/eid1811.120014
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   WHO-SEARO, 2011, REV EXP
   Wilder-Smith A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax027
   Wilder-Smith A, 2013, J TRAVEL MED, V20, P341, DOI 10.1111/jtm.12063
   Yoshikawa Minako Jen, 2013, Trop Med Health, V41, P67, DOI 10.2149/tmh.2011-05
NR 26
TC 22
Z9 22
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD AUG 31
PY 2018
VL 25
AR tay061
DI 10.1093/jtm/tay061
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0UB
UT WOS:000451513700001
PM 30113689
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pierson, TC
   Diamond, MS
AF Pierson, Theodore C.
   Diamond, Michael S.
TI The emergence of Zika virus and its new clinical syndromes
SO NATURE
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZING
   HUMAN-ANTIBODIES; DENGUE VIRUS; BIRTH-DEFECTS; SEXUAL TRANSMISSION;
   CROSS-REACTIVITY; STRUCTURAL BASIS; DNA VACCINE; MOUSE MODEL
AB Zika virus (ZIKV) is a mosquito-transmitted flavivirus that has emerged as a global health threat because of its potential to generate explosive epidemics and ability to cause congenital disease in the context of infection during pregnancy. Whereas much is known about the biology of related flaviviruses, the unique features of ZIKV pathogenesis, including infection of the fetus, persistence in immune-privileged sites and sexual transmission, have presented new challenges. The rapid development of cell culture and animal models has facilitated a new appreciation of ZIKV biology. This knowledge has created opportunities for the development of countermeasures, including multiple ZIKV vaccine candidates, which are advancing through clinical trials. Here we describe the recent advances that have led to a new understanding of the causes and consequences of the ZIKV epidemic.
C1 [Pierson, Theodore C.] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63130 USA.
EM piersontc@mail.nih.gov; diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Otero-Ojeda, Gloria Adelina/B-4024-2016
OI Diamond, Michael/0000-0002-8791-3165; Otero-Ojeda, Gloria
   Adelina/0000-0003-0548-1387
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972, U19
   AI083019, R01 HD091218]; Division of Intramural Research, National
   Institute of Allergy and Infectious Diseases, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
FX This work was supported by NIH grants (R01 AI073755, R01 AI104972, U19
   AI083019 and R01 HD091218) and by the Division of Intramural Research,
   National Institute of Allergy and Infectious Diseases, NIH. We thank E.
   Tyler (NIH) for assistance with figure preparation of virion models.
   This publication is the responsibility of the authors and does not
   necessarily represent the official view of the NIH.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2018, PLACENTA, V61, P33, DOI 10.1016/j.placenta.2017.11.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Dirlikov E, 2018, EMERG INFECT DIS, V24, P114, DOI 10.3201/eid2401.171331
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley D. M., 2018, NAT MED
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grifoni A., 2017, J VIROL
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 147
TC 81
Z9 81
U1 12
U2 52
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD AUG 30
PY 2018
VL 560
IS 7720
BP 573
EP 581
DI 10.1038/s41586-018-0446-y
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS0SZ
UT WOS:000443218600037
PM 30158602
DA 2020-07-08
ER

PT J
AU van der Linden, H
   Carvalho, MD
   van der Linden, V
   Lacerda, KM
   Pessoa, A
   Carneiro, ML
   Cordeiro, MT
   Valente, KD
AF van der Linden, Helio, Jr.
   Carvalho, Maria D.
   van der Linden, Vanessa
   Lacerda, Kalyne M.
   Pessoa, Andre
   Carneiro, Mara L.
   Cordeiro, Marli T.
   Valente, Kette D.
TI Epilepsy Profile in Infants with Congenital Zika Virus Infection
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID BRAZIL
C1 [van der Linden, Helio, Jr.; Carneiro, Mara L.] Dr Henrique Santillo Rehabil & Readaptat Ctr, Goiania, Go, Brazil.
   [Carvalho, Maria D.; Lacerda, Kalyne M.] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Cordeiro, Marli T.] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Valente, Kette D.] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil.
RP Valente, KD (corresponding author), Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil.
EM kette.valente@hc.fm.usp.br
OI VAN DER LINDEN JUNIOR, HELIO/0000-0002-3123-2264
CR Alves Lucas Victor, 2016, Rev. Bras. Saude Mater. Infant., V16, pS27, DOI 10.1590/1806-9304201600s100003
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 5
TC 7
Z9 7
U1 0
U2 2
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD AUG 30
PY 2018
VL 379
IS 9
BP 891
EP 892
DI 10.1056/NEJMc1716070
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GR9EA
UT WOS:000443047800017
PM 30157396
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Moore, SM
   ten Bosch, QA
   Siraj, AS
   Soda, KJ
   Espana, G
   Campo, A
   Gomez, S
   Salas, D
   Raybaud, B
   Wenger, E
   Welkhoff, P
   Perkins, TA
AF Moore, Sean M.
   ten Bosch, Quirine A.
   Siraj, Amir S.
   Soda, K. James
   Espana, Guido
   Campo, Alfonso
   Gomez, Sara
   Salas, Daniela
   Raybaud, Benoit
   Wenger, Edward
   Welkhoff, Philip
   Perkins, T. Alex
TI Local and regional dynamics of chikungunya virus transmission in
   Colombia: the role of mismatched spatial heterogeneity
SO BMC MEDICINE
LA English
DT Article
DE Aedes aegypti; Aggregation bias; Arbovirus; Chikungunya; Colombia;
   Epidemic; Mathematical model; Spatial scale; Transmission dynamics
ID AEDES-AEGYPTI; DENGUE VIRUS; SEROPREVALENCE SURVEY; HUMAN MOBILITY;
   WEST-AFRICA; ZIKA VIRUS; AMERICA; SPREAD; INFECTION; POPULATION
AB Background: Mathematical models of transmission dynamics are routinely fitted to epidemiological time series, which must inevitably be aggregated at some spatial scale. Weekly case reports of chikungunya have been made available nationally for numerous countries in the Western Hemisphere since late 2013, and numerous models have made use of this data set for forecasting and inferential purposes. Motivated by an abundance of literature suggesting that the transmission of this mosquito-borne pathogen is localized at scales much finer than nationally, we fitted models at three different spatial scales to weekly case reports from Colombia to explore limitations of analyses of nationally aggregated time series data.
   Methods: We adapted the recently developed Disease Transmission Kernel (DTK)-Dengue model for modeling chikungunya virus (CHIKV) transmission, given the numerous similarities of these viruses vectored by a common mosquito vector. We fitted versions of this model specified at different spatial scales to weekly case reports aggregated at different spatial scales: (1) single-patch national model fitted to national data; (2) single-patch departmental models fitted to departmental data; and (3) multi-patch departmental models fitted to departmental data, where the multiple patches refer to municipalities within a department We compared the consistency of simulations from fitted models with empirical data.
   Results: We found that model consistency with epidemic dynamics improved with increasing spatial granularity of the model. Specifically, the sum of single-patch departmental model fits better captured national-level temporal patterns than did a single-patch national model. Likewise, multi-patch departmental model fits better captured department-level temporal patterns than did single-patch departmental model fits. Furthermore, inferences about municipal-level incidence based on multi-patch departmental models fitted to department-level data were positively correlated with municipal-level data that were withheld from model fitting.
   Conclusions: Our model performed better when posed at finer spatial scales, due to better matching between human populations with locally relevant risk Confronting spatially aggregated models with spatially aggregated data imposes a serious structural constraint on model behavior by averaging over epidemiologically meaningful spatial variation in drivers of transmission, impairing the ability of models to reproduce empirical patterns.
C1 [Moore, Sean M.; ten Bosch, Quirine A.; Siraj, Amir S.; Soda, K. James; Espana, Guido; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Moore, Sean M.; ten Bosch, Quirine A.; Siraj, Amir S.; Soda, K. James; Espana, Guido; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [ten Bosch, Quirine A.] Inst Pasteur, Math Modelling Infect Dis Unit, F-75015 Paris, France.
   [ten Bosch, Quirine A.] Inst Pasteur, CNRS Genom Evolut Modelisat & Sante GEMS UMR2000, Paris, France.
   [ten Bosch, Quirine A.] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.
   [Campo, Alfonso] Inst Nacl Salud Colombia, Subdirecc Anal Riesgo & Respuesta Inmediata Salud, Bogota, Colombia.
   [Gomez, Sara; Salas, Daniela] Inst Nacl Salud Colombia, Grp Enfermedades Transmisibles, Bogota, Colombia.
   [Raybaud, Benoit; Wenger, Edward; Welkhoff, Philip] Inst Dis Modeling, Bellevue, WA USA.
RP Moore, SM; Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Moore, SM; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
EM smoore15@nd.edu; taperkins@nd.edu
OI SALAS BOTERO, DANIELA/0000-0002-8323-1888; Camargo Espana,
   guido/0000-0002-9915-8056
FU Young Faculty Award from the Defense Advanced Research Projects Agency
   [D16AP00114]; Intellectual Ventures
FX This research was supported by a Young Faculty Award from the Defense
   Advanced Research Projects Agency (D16AP00114) and by Intellectual
   Ventures.
CR Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   ARBIA G., 1986, METRON, V44, P391
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bloch D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005075
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Charu V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005382
   Chowell G, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0811-y
   Christofferson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110538
   Del Valle SY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3124-7
   Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303
   Escobar LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1403-y
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Gomez-Gardenes J, 2018, NAT PHYS, V14, P391, DOI 10.1038/s41567-017-0022-7
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hobbs N. T., 2015, BAYESIAN MODELS STAT
   Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001
   Imai N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004833
   Jeffery C, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-9
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0144-x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kumar NP, 2011, MEM I OSWALDO CRUZ, V106, P912, DOI 10.1590/S0074-02762011000800003
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Legros M, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1515
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Perkins T Alex, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3
   Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856
   Siraj AS, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.73
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Soda KJ, 2018, BIORXIV, DOI [10.1101/376533, DOI 10.1101/376533]
   Sorichetta A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.66
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19
   van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Wesolowski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052971
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 79
TC 3
Z9 3
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD AUG 30
PY 2018
VL 16
AR 152
DI 10.1186/s12916-018-1127-2
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA GR9RL
UT WOS:000443107900001
PM 30157921
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jimeaez-Silva, CL
   Carreno, MF
   Ortiz-Baez, AS
   Rey, LA
   Villabona-Arenas, CJ
   Ocazionez, RE
AF Jimeaez-Silva, Cinthy L.
   Fernanda Carreno, Maria
   Susana Ortiz-Baez, Ayda
   Aida Rey, Luz
   Villabona-Arenas, Christian Julian
   Ocazionez, Raquel E.
TI Evolutionary history and spatio-temporal dynamics of dengue virus
   serotypes in an endemic region of Colombia
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; MULTIPLE INTRODUCTIONS; AMERICA; EPIDEMIOLOGY;
   PHYLOGENETICS; SINGAPORE; AREA
AB Dengue is a prevalent disease in Colombia and all dengue virus serotypes (DENV-1 to -4) co-circulate in the country since 2001. However, the relative impact of gene flow and local diversification on epidemic dynamics is unknown due to heterogeneous sampling and lack of sufficient genetic data. The region of Santander is one of the areas with the highest incidence of dengue in Colombia. To provide a better understanding of the epidemiology of dengue, we inferred DENV population dynamics using samples collected between 1998 and 2015. We used Bayesian phylogenetic analysis and included 143 new envelope gene sequences from Colombia, mainly from the region of Santander, and 235 published sequences from representative countries in the Americas. We documented one single genotype for each serotype but multiple introductions. Whereas the majority of DENV-1, DENV-2, and DENV-4 strains fell into one single lineage, DENV-3 strains fell into two distinct lineages that co-circulated. The inferred times to the most recent common ancestors for the most recent clades of DENV-1, DENV-2, and DENV-4 fell between 1977 and 1987, and for DENV-3 was around 1995. Demographic reconstructions suggested a gradual increase in viral diversity over time. A phylogeographical analysis underscored that Colombia mainly receives viral lineages and a significant diffusion route between Colombia and Venezuela. Our findings contribute to a better understanding of the viral diversity and dengue epidemiology in Colombia.
C1 [Jimeaez-Silva, Cinthy L.; Fernanda Carreno, Maria; Susana Ortiz-Baez, Ayda; Ocazionez, Raquel E.] Univ Ind Santander, Lab Arbovirus, Ctr Invest Enfermedades Trop CINTROP, Bucaramanga, Colombia.
   [Aida Rey, Luz] Univ Ind Santander, Unidad Epidemiol Clin, Escuela Med, Bucaramanga, Colombia.
   [Villabona-Arenas, Christian Julian] Univ Montpellier, IRD, Lab TransVIHMI, Montpellier, France.
   [Villabona-Arenas, Christian Julian] Univ Montpellier, IBC, LIRMM, Montpellier, France.
RP Villabona-Arenas, CJ (corresponding author), Univ Montpellier, IRD, Lab TransVIHMI, Montpellier, France.; Villabona-Arenas, CJ (corresponding author), Univ Montpellier, IBC, LIRMM, Montpellier, France.
EM christian-julian.villabona-arenas@ird.fr
OI Carreno, Maria Fernanda/0000-0003-4294-1848; Villabona Arenas, Christian
   Julian/0000-0001-9928-3968
FU Colombian Government: Science, Technology and Innovation Fund of Sistema
   General de Regalias, Santander, Casanare, Valle del Cauca [BPIN
   2013000100011]
FX This study was supported by the Colombian Government: Science,
   Technology and Innovation Fund of Sistema General de Regalias,
   Santander, Casanare, Valle del Cauca (BPIN 2013000100011).
CR Afreen N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004511
   Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   Alvarez DP, 2012, DENGUE COLOMBIA EPID, P142
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005
   Baele G, 2013, BIOINFORMATICS, V29, P1970, DOI 10.1093/bioinformatics/btt340
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   (DANE) DAN de E, EST DEM POBL
   Departamento Nacional de Planeacion (DANE), AN MOV INT VIAJ COL
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Drumond BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059422
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gomez Rangel SY, 2008, DENGUE B, V32, P126
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Instituto Nacional de Salud, INSTR INT ACC VIG PR
   Villabona-Arenas CJ, 2009, TROP MED INT HEALTH, V14, P1241, DOI 10.1111/j.1365-3156.2009.02339.x
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Kotaki T, 2016, INFECT GENET EVOL, V37, P88, DOI 10.1016/j.meegid.2015.11.002
   Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012
   Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Manakkadan A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-37
   Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64
   Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226
   Mir D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098519
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004
   Ocazionez-Jimenez RE, 2013, BIOMEDICA, V33, P22, DOI 10.7705/biomedica.v33i0.717
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Ospina MC, 2010, AM J TROP MED HYG, V83, P672, DOI 10.4269/ajtmh.2010.09-0766
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Perez G, 2014, COLECCION EC REGIONA
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   R Core Team, 2015, R LANG ENV STAT COMP, V55, P275
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Ramirez Clemencia H., 2013, PERFIL MIGRATORIO CO
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   RODRIGUEZROCHE R, 2013, BIO MED RES INT, V2013, P20, DOI DOI 10.1155/2013/690835
   Santiago GA, 2012, J INFECT DIS, V206, P893, DOI 10.1093/infdis/jis426
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Sharp Tyler M, 2017, Curr Epidemiol Rep, V4, P11, DOI 10.1007/s40471-017-0095-y
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teoh BT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-213
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007
   Villabona-arenas CJ, 2016, PLOS NEGLECT TROP D, P5
   Villamor E, 2017, EPIDEMIOL INFECT, V145, P2961, DOI [10.1017/S0950268817002059, 10.1017/s0950268817002059]
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033
   Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005
NR 63
TC 4
Z9 4
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 29
PY 2018
VL 13
IS 8
AR e0203090
DI 10.1371/journal.pone.0203090
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR9JD
UT WOS:000443071400089
PM 30157270
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paul, AM
   Acharya, D
   Neupane, B
   Thompson, EA
   Gonzalez-Fernandez, G
   Copeland, KM
   Garrett, M
   Liu, HB
   Lopez, ME
   de Cruz, M
   Flynt, A
   Liao, J
   Guo, YL
   Gonzalez-Femandez, F
   Vig, PJS
   Bai, FW
AF Paul, Amber M.
   Acharya, Dhiraj
   Neupane, Biswas
   Thompson, E. Ashely
   Gonzalez-Fernandez, Gabriel
   Copeland, Katherine M.
   Garrett, Me'Lanae
   Liu, Haibei
   Lopez, Mariper E.
   de Cruz, Matthew
   Flynt, Alex
   Liao, Jun
   Guo, Yan-Lin
   Gonzalez-Femandez, Federico
   Vig, Parminder J. S.
   Bai, Fengwei
TI Congenital Zika Virus Infection in Immunocompetent Mice Causes Postnatal
   Growth Impediment and Neurobehavioral Deficits
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika; postnatal development; wild-type mice; neuron; behavior
ID MOUSE MODEL; VERTICAL TRANSMISSION; NEURAL PROGENITORS; BIRTH-DEFECTS;
   BRAIN; CELLS; NEUROGENESIS; HIPPOCAMPUS; ACTIVATION; ORGANOIDS
AB A small percentage of babies born to Zika virus (ZIKV)-infected mothers manifest severe defects at birth, including microcephaly. Among those who appeared healthy at birth, there are increasing reports of postnatal growth or developmental defects. However, the impact of congenital ZIKV infection in postnatal development is poorly understood. Here, we report that a mild congenital ZIKV-infection in pups born to immunocompetent pregnant mice did not display apparent defects at birth, but manifested postnatal growth impediments and neurobehavioral deficits, which include reduced locomotor and cognitive deficits that persisted into adulthood. We found that the brains of these pups were smaller, had a thinner cortical layer 1, displayed increased astrogliosis, decreased expression of microcephaly- and neuron development- related genes, and increased pathology as compared to mock-infected controls. In summary, our results showed that even a mild congenital ZIKV infection in immunocompetent mice could lead to postnatal deficits, providing definitive experimental evidence for a necessity to closely monitor postnatal growth and development of presumably healthy human infants, whose mothers were exposed to ZIKV infection during pregnancy.
C1 [Paul, Amber M.; Acharya, Dhiraj; Neupane, Biswas; Thompson, E. Ashely; Gonzalez-Fernandez, Gabriel; de Cruz, Matthew; Flynt, Alex; Guo, Yan-Lin; Bai, Fengwei] Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.
   [Copeland, Katherine M.; Garrett, Me'Lanae; Liao, Jun] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Liu, Haibei] Hattiesburg Clin, Hattiesburg, MS USA.
   [Lopez, Mariper E.; Vig, Parminder J. S.] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA.
   [Gonzalez-Femandez, Federico] GV Sonny Montgomery Vet Affairs Med Ctr, Med Res Serv, Jackson, MS USA.
   [Gonzalez-Femandez, Federico] Univ Mississippi, Med Ctr, Dept Ophthalmol & Pathol, Jackson, MS 39216 USA.
   [Gonzalez-Femandez, Federico] Pathrd Inc, Jackson, MS USA.
RP Bai, FW (corresponding author), Univ Southern Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.
EM fengwei.bai@usm.edu
OI Paul, Amber/0000-0002-1657-3618
FU University of Southern Mississippi Lucas Endowment for Faculty
   Excellence award; National Institute of Allergy and Infectious Diseases
   of the National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R15AI113706];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1EY09412]; Merit Review Award from
   the Biomedical Laboratory Research and Development Service of the
   Veterans Affairs Office of Research and Development [I01BX007080];
   Research Mississippi, Incorporation
FX This work was supported in part by The University of Southern
   Mississippi Lucas Endowment for Faculty Excellence award (FB) and
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health R15AI113706 (FB). FG-F is supported by NIH
   RO1EY09412, Merit Review Award I01BX007080 from the Biomedical
   Laboratory Research and Development Service of the Veterans Affairs
   Office of Research and Development, and Start-up Award from Research
   Mississippi, Incorporation.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Acharya D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004139
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408
   Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993
   Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cendelin Jan, 2014, Cerebellum Ataxias, V1, P4, DOI 10.1186/2053-8871-1-4
   Copp AJ, 1999, EPILEPSY RES, V36, P133, DOI 10.1016/S0920-1211(99)00047-9
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix A, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000009178, 10.1097/md.0000000000009178]
   Filges I, 2016, HUM MUTAT, V37, P359, DOI 10.1002/humu.22960
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Licon A., 2016, ZIKA SYNDROME HLTH P
   Lokensgard JR, 2015, GLIA, V63, P1982, DOI 10.1002/glia.22868
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   Mutnal MB, 2011, J NEUROVIROL, V17, P424, DOI 10.1007/s13365-011-0042-5
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Santos M, 2007, GENES BRAIN BEHAV, V6, P277, DOI 10.1111/j.1601-183X.2006.00258.x
   SEVER JL, 1985, REV INFECT DIS, V7, pS164
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Venere M, 2012, DEVELOPMENT, V139, P3938, DOI 10.1242/dev.081133
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vig PJS, 2012, CEREBELLUM, V11, P718, DOI 10.1007/s12311-011-0323-9
   Waters AM, 2015, J MED GENET, V52, P147, DOI 10.1136/jmedgenet-2014-102691
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 57
TC 8
Z9 8
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 29
PY 2018
VL 9
AR 2028
DI 10.3389/fmicb.2018.02028
PG 12
WC Microbiology
SC Microbiology
GA GR8WI
UT WOS:000443015300001
PM 30210488
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zanotto, PMD
   Leite, LCD
AF de Andrade Zanotto, Paolo Marinho
   de Cerqueira Leite, Luciana Cezar
TI The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE emerging infectious diseases; Dengue virus; Zika virus; Chikungunya
   virus; Brazil
ID VIRUS; PROTECTION; VACCINES; OUTBREAK; AMERICA; COST
AB Brazil has a well-established immunization program in which vaccines are provided through the Public Health System free of charge to the whole population, obtaining high coverage and reducing the incidence of important infectious diseases in children and adults. However, the environmental changes and high mobility rates of the population occurring in the last decades have triggered the sequential introduction of a series of vector-borne emerging infectious diseases, such as Dengue, Zika, and Chikungunya, that have imposed a considerable burden on the population, with yet unmet solutions. The first to be introduced in Brazil was the Dengue virus, reaching epidemic levels in 2010, with over 1 million cases annually, maintaining high infection rates until 2016. Brazil has invested in vaccine development. The Zika virus infection, initially assumed to have appeared during the World Cup in 2014, was later shown to have arrived earlier in 2013. Its emergence mobilized the Brazilian scientific community to de fine priorities and strategies, that rapidly investigated mechanisms of pathogenesis, differential diagnostics, and determined that Zika virus infection per se causes relatively mild symptoms, however, in pregnant women can cause microcephaly in the newborns. The diagnostics of Zika infection is confusing given its similar symptoms and cross-reactivity with Dengue, which also hindered the appraisal of the extent of the epidemics, which peaked in 2015 and finished in 2016. Another complicating factor was the overlap with Chikungunya virus infection, which arrived in Brazil in 2014, being prevalent in the same regions, with similar symptoms to both Dengue and Zika. Although Dengue infection can be fatal and Zika infection in pregnant woman can lead to newborns with microcephaly or an array of neurodegenerative manifestations, the Chikungunya infection is a debilitating disease leaving chronic sequelae, which unfortunately has received less attention. Precise differential diagnostics of Dengue, Zika, and Chikungunya will be necessary to evaluate the actual extent of each of these diseases during this overlapping period. Here we review the impact of these emerging infections on public health and how the scientific community was mobilized to deal with them in Brazil.
C1 [de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.
   [de Cerqueira Leite, Luciana Cezar] Inst Butantan, Lab Desenvolvimento Vacinas, Sao Paulo, Brazil.
RP Leite, LCD (corresponding author), Inst Butantan, Lab Desenvolvimento Vacinas, Sao Paulo, Brazil.
EM luciana.leite@butantan.gov.br
RI amsalu, ribka/G-8780-2019; de A. Zanotto, Paolo M./B-9286-2019; Leite,
   Luciana/D-1353-2012
OI de A. Zanotto, Paolo M./0000-0002-8167-0625; Leite,
   Luciana/0000-0003-0156-1312
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Azevedo AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058357
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CDC. Chikungunya Virus, 2015, CHIK VIR
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durham DP, 2013, VACCINE, V31, P3957, DOI 10.1016/j.vaccine.2013.06.036
   Dyer O, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j707
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garg H Sedano, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gould EA, 2004, FLAVIVIRUS STRUCTURE, P278
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Mahoney RT, 2012, VACCINE, V30, P4892, DOI 10.1016/j.vaccine.2012.02.064
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Perkel JM, 2016, NAT BIOTECHNOL, V34, P449, DOI 10.1038/nbt0516-449
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Strauss JH, 1994, MICROBIOL REV, V58, P71
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   van Panhuis WG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003063
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Vogel G., 2018, SCIENCE, DOI [10.1126/science.aat9362, DOI 10.1126/SCIENCE.AAT9362]
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 44
TC 12
Z9 14
U1 2
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 28
PY 2018
VL 9
AR 1964
DI 10.3389/fimmu.2018.01964
PG 6
WC Immunology
SC Immunology
GA GR8CS
UT WOS:000442936900001
PM 30210503
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abo-zeid, Y
   Urbanowicz, RA
   Thomson, BJ
   Irving, WL
   Tarr, AW
   Garnett, MC
AF Abo-zeid, Yasmin
   Urbanowicz, Richard A.
   Thomson, Brian J.
   Irving, William L.
   Tarr, Alexander W.
   Garnett, Martin C.
TI Enhanced nanoparticle uptake into virus infected cells: Could
   nanoparticles be useful in antiviral therapy?
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE HCV infection; Polymer nanoparticles; Poly(glycerol adipate); Huh7.5
   cells
ID POLY(GLYCEROL ADIPATE); IN-VITRO; COMBINATION; RIBAVIRIN; ACID; ZIKA
AB Virus infections cause diseases of different severity ranged from mild infection e.g. common cold into life threatening diseases e.g. Human Immunodeficiency virus (HIV), Hepatitis B. Virus infections represent 44% of newly emerging infections. Although there are many efficient antiviral agents, they still have drawbacks due to accumulation at off target organs and developing of virus resistance due to virus mutation. Therefore, developing a delivery system that can selectively target drug into affected organs and avoid off target accumulation would be a highly advantageous strategy to improve antiviral therapy. Nanoparticles (NP) can be effectively targeted to the liver, and therefore it could be used for improving therapy of hepatic virus infections including hepatitis B virus and hepatitis C virus (HCV). Many studies were performed to encapsulate antiviral agents into nano-delivery system to improve their pharmacokinetics parameters to have a better therapeutic efficacy with lower side effects. However, the effect of virus infection on the uptake of NP has not yet been studied in detail. The latter is a crucial area as modulation of endocytic uptake of nanoparticles could impact on reduce potential therapeutic usefulness of antiviral agents loaded into nano-delivery system. In this study, a fluorescently-labelled polymeric nanoparticle was prepared and used to track NP uptake into Huh7.5, human hepatoma cells transfected with replicating HCV genomes, compared with non-transfected cells as a model representing hepatocyte uptake. Confocal microscopy and flow cytometry of virus transfected Huh7.5 cells unexpectedly demonstrated two-fold increase in uptake of NP compared to non-transfected cells. Therefore, virus transfection enhanced NP uptake into Huh7.5 cells and NP could be considered as a promising delivery system for targeted treatment of hepatitis viruses.
C1 [Abo-zeid, Yasmin; Garnett, Martin C.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Urbanowicz, Richard A.; Thomson, Brian J.; Irving, William L.; Tarr, Alexander W.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham, England.
   [Urbanowicz, Richard A.; Thomson, Brian J.; Irving, William L.; Tarr, Alexander W.] Univ Nottingham, Nottingham, England.
   [Urbanowicz, Richard A.; Irving, William L.; Tarr, Alexander W.] Univ Nottingham, Fac Med & Hlth Sci, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England.
   [Abo-zeid, Yasmin] Helwan Univ, Sch Pharm, Cairo, Egypt.
RP Abo-zeid, Y (corresponding author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
EM Yasmin.Abozeid@nottingham.ac.uk; Richard.Urbanowicz@nottingham.ac.uk;
   Brian.thomson@nottingham.ac.uk; Will.Irving@nottingham.ac.uk;
   Alex.Tarr@nottingham.ac.uk; martin.garnett@nottingham.ac.uk
RI Tarr, Alexander W/B-7953-2008; Urbanowicz, Richard/M-3354-2019; Abozeid,
   Yasmin/AAB-6807-2019
OI Tarr, Alexander W/0000-0003-1009-0823; Urbanowicz,
   Richard/0000-0002-2461-4993; Abozeid, Yasmin/0000-0002-1651-7421;
   Thomson, Brian/0000-0001-8490-2332; Irving, William/0000-0002-7268-3168
FU Egyptian Culture Centre and Educational Bureau
FX Yasmin Abo-zeid was funded by a studentship from the Egyptian Culture
   Centre and Educational Bureau. Huh7.5 cells and the J6/JFH1 chimeric
   virus was a gift from Apath L.L.C.
CR Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14
   Buford M. C., 2007, COMP DISPERSING MEDI, V9, P1, DOI [10.1186/1743-8977-4-6, DOI 10.1186/1743-8977-4-6]
   Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t
   Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI DOI 10.1128/CMR.00102-15
   Deguchi S., 2007, STABILIZATION C 60 N, V60, P854
   Frohlich E., 2012, ROLE SURFACE CHARGE, P5577
   Garnett MC, 2006, OCCUP MED-OXFORD, V56, P307, DOI 10.1093/occmed/kql052
   Garnett M. C., 1986, ENDOCYTOSIS MONOCLON, V221, P214
   Gebauer J. S., 2012, IMPACT NANOPARTICLE
   Hutchison J. G. M. C., 2002, ADHERENCE COMBINATIO, P1061, DOI [10.1053/gast.2002.35950, DOI 10.1053/GAST.2002.35950]
   Kallinteri P., 2005, NOVEL FUNCTIONALIZED, P1885
   King A., 2012, VIRUS TAXONOMY
   Lanford RE, 2003, J VIROL, V77, P1092, DOI 10.1128/JVI.77.2.1092-1104.2003
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lembo D, 2018, EXPERT OPIN DRUG DEL, V15, P93, DOI 10.1080/17425247.2017.1360863
   Lindenbach B. D., 2005, CULTURE, P623
   Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8
   Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067
   Meng W, 2006, J CONTROL RELEASE, V116, P314, DOI 10.1016/j.jconrel.2006.09.014
   Montessori V, 2004, CAN MED ASSOC J, V170, P229
   Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240
   Navarro L, 2017, POLYM J, V49, P625, DOI 10.1038/pj.2017.30
   Nowacek A. S., 2012, NIH PUBLIC ACCESS, V150, P204, DOI [10.1016/j.jconrel.2010.11.019.Analyses, DOI 10.1016/J.JCONREL.2010.11.019.ANALYSES]
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Park J, 2011, J COLLOID INTERF SCI, V363, P105, DOI 10.1016/j.jcis.2011.07.006
   Rothan HA, 2016, ANTIVIR RES, V127, P50, DOI 10.1016/j.antiviral.2016.01.006
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160
   Tan M. J. A., 2017, COMPLEX RELATIONSHIP, P18
   Taresco V, 2016, POLYMER, V89, P41, DOI 10.1016/j.polymer.2016.02.036
   Taylor L. H., 2001, RISK FACTORS HUMAN D, DOI [10.1098/rstb.2001.0888, DOI 10.1098/RSTB.2001.0888]
   Wiwanitkit S., 2015, J TROP DIS, V3, P2, DOI [10.4172/2329-891X.1000160, DOI 10.4172/2329-891X.1000160]
   Yeo KL, 2015, ANTIMICROB AGENTS CH, V59, P2086, DOI 10.1128/AAC.04779-14
   Zhang T, 2014, POLYMER, V55, P5065, DOI 10.1016/j.polymer.2014.08.036
NR 34
TC 5
Z9 5
U1 3
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD AUG 25
PY 2018
VL 547
IS 1-2
BP 572
EP 581
DI 10.1016/j.ijpharm.2018.06.027
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GN5KF
UT WOS:000439096500057
PM 29908332
DA 2020-07-08
ER

PT J
AU Cox, F
   van der Fits, L
   Abbink, P
   Larocca, RA
   van Huizen, E
   Saeland, E
   Verhagen, J
   Peterson, R
   Tolboom, J
   Kaufmann, B
   Schuitemaker, H
   Barouch, DH
   Zahn, R
AF Cox, Freek
   van der Fits, Leslie
   Abbink, Peter
   Larocca, Rafael A.
   van Huizen, Ella
   Saeland, Eirikur
   Verhagen, Janneke
   Peterson, Rebecca
   Tolboom, Jeroen
   Kaufmann, Baerbel
   Schuitemaker, Hanneke
   Barouch, Dan H.
   Zahn, Roland
TI Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen
   induces humoral and cellular immune responses and protects mice and
   nonhuman primates against ZIKV challenge
SO PLOS ONE
LA English
DT Article
ID VACCINE PLATFORMS; IMMUNOGENICITY; INFECTION; SAFETY
AB In 2015, there was a large outbreak of Zika virus (ZIKV) in Brazil. Despite its relatively mild impact on healthy adults, ZIKV infection during pregnancy has been associated with severe birth defects. Currently, there is no ZIKV vaccine available, but several vaccine candidates based on the ZIKV membrane (M) and envelope (Env) structural proteins showed promising results in preclinical and clinical studies. Here, the immunogenicity and protective efficacy of a non-replicating adenoviral vector type 26 (Ad26) that encodes the ZIKV M-Env antigens (Ad26. ZIKV. M-Env) was evaluated in mice and non-human primates (NHP). Ad26. ZIKV. M-Env induced strong and durable cellular and humoral immune responses in preclinical models. Humoral responses were characterized by Env-binding and ZIKV neutralizing antibody responses while cellular responses were characterized by ZIKV reactive CD4(+) and CD8(+) T cells. Importantly, a single immunization with a very low dose of 4x10(7) vp of Ad26. ZIKV. M-Env protected mice from ZIKV challenge. In NHP, a single immunization with a typical human dose of 1x10(11) vp of Ad26. ZIKV. M-Env also induced Env-binding and ZIKV neutralizing antibodies and Env and M specific cellular immune responses that associated with complete protection against viremia from ZIKV challenge as measured in plasma and other body fluids. Together these data provide the rationale to progress the Ad26. ZIKV. M-Env candidate vaccine to clinical testing.
C1 [Cox, Freek; van der Fits, Leslie; van Huizen, Ella; Saeland, Eirikur; Verhagen, Janneke; Tolboom, Jeroen; Kaufmann, Baerbel; Schuitemaker, Hanneke; Zahn, Roland] Janssen Vaccines & Prevent BV, Leiden, Netherlands.
   [Abbink, Peter; Larocca, Rafael A.; Peterson, Rebecca; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
RP Zahn, R (corresponding author), Janssen Vaccines & Prevent BV, Leiden, Netherlands.
EM RZahn@its.jnj.com
RI Barouch, Dan/Y-3918-2019; Assumpcao Larocca, Rafael/H-1655-2015
OI Assumpcao Larocca, Rafael/0000-0002-9995-1804
FU Janssen Vaccines & Prevention B.V.
FX The authors received no specific funding for this work. Janssen Vaccines
   & Prevention B.V. provided support in the form of salaries for authors
   FC, LVDF, EVH, ES, JV, JT, BK, HS AND RZ, but did not have any
   additional role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. The specific
   roles of these authors are articulated in the 'author contributions'
   section.
CR Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Baden LR, 2016, ANN INTERN MED, V164, P313, DOI 10.7326/M15-0880
   Baden LR, 2013, J INFECT DIS, V207, P240, DOI 10.1093/infdis/jis670
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Gaudinski MR, 2017, LANCET
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Martinot AJ, 2018, CELL
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modjarrad K, 2017, LANCET
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Song G, 2018, MOL CELL PROTEOMICS, V17, P349, DOI 10.1074/mcp.RA117.000310
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tebas P, 2017, N ENGL J MED
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vellinga J, 2014, HUM GENE THER, V25, P318, DOI 10.1089/hum.2014.007
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Waldorf KMA, 2018, NAT MED
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 41
TC 11
Z9 11
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 24
PY 2018
VL 13
IS 8
AR e0202820
DI 10.1371/journal.pone.0202820
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR5ZQ
UT WOS:000442722500036
PM 30142207
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcez, PP
   Stolp, HB
   Sravanam, S
   Christoff, RR
   Ferreira, JCCG
   Dias, AA
   Pezzuto, P
   Higa, LM
   Barbeito-Andres, J
   Ferreira, RO
   Andrade, CBV
   Siqueira, M
   Santos, TMP
   Drumond, J
   Hoerder-Suabedissen, A
   de Lima, CVF
   Tovar-Moll, F
   Lopes, RT
   Fragel-Madeira, L
   Lent, R
   Ortiga-Carvalho, TM
   Stipursky, J
   Bellio, M
   Tanuri, A
   Molnar, Z
AF Garcez, P. P.
   Stolp, H. B.
   Sravanam, S.
   Christoff, R. R.
   Ferreira, J. C. C. G.
   Dias, A. A.
   Pezzuto, P.
   Higa, L. M.
   Barbeito-Andres, J.
   Ferreira, R. O.
   Andrade, C. B. V.
   Siqueira, M.
   Santos, T. M. P.
   Drumond, J.
   Hoerder-Suabedissen, A.
   de Lima, C. V. F.
   Tovar-Moll, F.
   Lopes, R. T.
   Fragel-Madeira, L.
   Lent, R.
   Ortiga-Carvalho, T. M.
   Stipursky, J.
   Bellio, M.
   Tanuri, A.
   Molnar, Z.
TI Zika virus impairs the development of blood vessels in a mouse model of
   congenital infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN NEUROSPHERES; BRAIN ORGANOIDS; VASCULAR NICHE; BIRTH-DEFECTS;
   STEM-CELLS; ANGIOGENESIS; NEUROGENESIS; GROWTH; MICE; CNS
AB Zika virus (ZIKV) is associated with brain development abnormalities such as primary microcephaly, a severe reduction in brain growth. Here we demonstrated in vivo the impact of congenital ZIKV infection in blood vessel development, a crucial step in organogenesis. ZIKV was injected intravenously in the pregnant type 2 interferon (IFN)-deficient mouse at embryonic day (E) 12.5. The embryos were collected at E15.5 and postnatal day (P) 2. Immunohistochemistry for cortical progenitors and neuronal markers at E15.5 showed the reduction of both populations as a result of ZIKV infection. Using confocal 3D imaging, we found that ZIKV infected brain sections displayed a reduction in the vasculature density and vessel branching compared to mocks at E15.5; altogether, cortical vessels presented a comparatively immature pattern in the infected tissue. These impaired vascular patterns were also apparent in the placenta and retina. Moreover, proteomic analysis has shown that angiogenesis proteins are deregulated in the infected brains compared to controls. At P2, the cortical size and brain weight were reduced in comparison to mock-infected animals. In sum, our results indicate that ZIKV impairs angiogenesis in addition to neurogenesis during development. The vasculature defects represent a limitation for general brain growth but also could regulate neurogenesis directly.
C1 [Garcez, P. P.; Christoff, R. R.; Ferreira, J. C. C. G.; Barbeito-Andres, J.; Ferreira, R. O.; Siqueira, M.; Drumond, J.; Tovar-Moll, F.; Lent, R.; Stipursky, J.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Garcez, P. P.; Stolp, H. B.; Sravanam, S.; Hoerder-Suabedissen, A.; Molnar, Z.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.
   [Stolp, H. B.] Kings Coll London, Ctr Dev Brain, Dept Perinatal Imaging & Hlth, London, England.
   [Dias, A. A.; Bellio, M.] Univ Fed Rio de Janeiro, Microbiol Inst Paulo Goes, Rio De Janeiro, Brazil.
   [Pezzuto, P.; Higa, L. M.; Tanuri, A.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil.
   [Andrade, C. B. V.; Ortiga-Carvalho, T. M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Santos, T. M. P.; Lopes, R. T.] Univ Fed Rio de Janeiro, Nucl Instrumentat Lab, Rio De Janeiro, Brazil.
   [de Lima, C. V. F.; Tovar-Moll, F.] DOr Inst Res & Educ IDOR, Rio De Janeiro, Brazil.
   [Fragel-Madeira, L.] Fluminense Fed Univ, Inst Biol, Dept Neurobiol, Niteroi, RJ, Brazil.
RP Garcez, PP (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Garcez, PP; Stolp, HB; Molnar, Z (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.; Stolp, HB (corresponding author), Kings Coll London, Ctr Dev Brain, Dept Perinatal Imaging & Hlth, London, England.
EM ppgarcez@gmail.com; hstolp@rvc.ac.uk; zoltan.molnar@dpag.ox.ac.uk
RI Fragel-Madeira, Lucianne/V-1665-2019; Molnar, Zoltan/J-7281-2012; Higa,
   Luiza/W-2698-2019; Garcez, Patricia/F-8026-2012; Hoerder-Suabedissen,
   Anna/G-7053-2011; Lopes, Ricardo T/O-8840-2014; Stipursky,
   Joice/Y-1961-2019; Ortiga-Carvalho, Tania/D-5093-2011; BELLIO,
   MARIA/N-8525-2018
OI Fragel-Madeira, Lucianne/0000-0001-6747-2828; Molnar,
   Zoltan/0000-0002-6852-6004; Garcez, Patricia/0000-0002-9107-1335; Lopes,
   Ricardo T/0000-0001-7250-824X; Ortiga-Carvalho,
   Tania/0000-0002-0225-1132; BELLIO, MARIA/0000-0002-3360-2740; Sravanam,
   Sanskrithi/0000-0003-2965-2400
CR Bookstein F L, 1997, Med Image Anal, V1, P225
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478
   Christensen BM, 2016, PLOS NEGL TROP DIS, V10
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106
   Dowall S. D, 2016, PLOS NEGL TROP DIS, V10
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148
   Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227
   Gonzalez PN, 2014, AM J PHYS ANTHROPOL, V154, P544, DOI 10.1002/ajpa.22545
   Javaherian A, 2009, CEREB CORTEX, V19, pI70, DOI 10.1093/cercor/bhp029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164
   Machado-Pereira M, 2017, J NEUROCHEM, V140, P692, DOI 10.1111/jnc.13914
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rounioja S, 2003, CARDIOVASC RES, V60, P156, DOI 10.1016/S0008-6363(03)00338-9
   Sagheer U, 2015, J DEV BIOL, V3, P112, DOI 10.3390/jdb3040112
   Salmaso N, 2014, CLIN PERINATOL, V41, P229, DOI 10.1016/j.clp.2013.10.007
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594
   Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074
   Vates GE, 2005, J NEUROSURG, V103, P136, DOI 10.3171/jns.2005.103.1.0136
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zou M, 2015, DEV DYNAM, V244, P86, DOI 10.1002/dvdy.24185
NR 44
TC 10
Z9 10
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 24
PY 2018
VL 8
AR 12774
DI 10.1038/s41598-018-31149-3
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR4SO
UT WOS:000442607800003
PM 30143723
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU O'Connor, MA
   Tisoncik-Go, J
   Lewis, TB
   Miller, CJ
   Bratt, D
   Moats, CR
   Edlefsen, PT
   Smedley, J
   Klatt, NR
   Gale, M
   Fuller, DH
AF O'Connor, Megan A.
   Tisoncik-Go, Jennifer
   Lewis, Thomas B.
   Miller, Charlene J.
   Bratt, Debra
   Moats, Cassie R.
   Edlefsen, Paul T.
   Smedley, Jeremy
   Klatt, Nichole R.
   Gale, Michael, Jr.
   Fuller, Deborah Heydenburg
TI Early cellular innate immune responses drive Zika viral persistence and
   tissue tropism in pigtail macaques
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; FEMALE GENITAL-TRACT; CENTRAL-NERVOUS-SYSTEM;
   VIRUS-INFECTION; RHESUS MACAQUES; SEXUAL TRANSMISSION; DENGUE PATIENTS;
   LYMPH-NODES; PUERTO-RICO; VACCINE
AB The immunological and virological events that contribute to the establishment of Zika virus (ZIKV) infection in humans are unclear. Here, we show that robust cellular innate immune responses arising early in the blood and tissues in response to ZIKV infection are significantly stronger in males and correlate with increased viral persistence. In particular, early peripheral blood recruitment of plasmacytoid dendritic cells and higher production of monocyte chemoattractant protein (MCP-1) correspond with greater viral persistence and tissue dissemination. We also identify non-classical monocytes as primary in vivo targets of ZIKV infection in the blood and peripheral lymph node. These results demonstrate the potential differences in ZIKV pathogenesis between males and females and a key role for early cellular innate immune responses in the blood in viral dissemination and ZIKV pathogenesis.
C1 [O'Connor, Megan A.; Lewis, Thomas B.; Fuller, Deborah Heydenburg] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.
   [O'Connor, Megan A.; Lewis, Thomas B.; Bratt, Debra; Moats, Cassie R.; Smedley, Jeremy; Klatt, Nichole R.; Fuller, Deborah Heydenburg] Washington Natl Primate Res Ctr, Seattle, WA 98121 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, CIIID, Seattle, WA 98109 USA.
   [Miller, Charlene J.; Klatt, Nichole R.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA.
   [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Miller, Charlene J.; Klatt, Nichole R.] Univ Miami, Dept Pediat, Miami, FL 33136 USA.
   [Moats, Cassie R.; Smedley, Jeremy] Oregon Natl Primate Res Ctr, Hillsboro, OR 97006 USA.
RP Fuller, DH (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Fuller, DH (corresponding author), Washington Natl Primate Res Ctr, Seattle, WA 98121 USA.
EM fullerdh@wanprc.org
RI Bratt, Debra/B-1106-2019
OI Smedley, Jeremy/0000-0003-3369-4662; Fuller,
   Deborah/0000-0001-7315-2441; Edlefsen, Paul/0000-0002-8393-8103;
   O'Connor, Megan/0000-0003-2127-5073
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51-OD010425];
   WaNPRC; UW;  [T32-AI007140]
FX We thank all members of the Fuller laboratory for their technical
   support and helpful discussion. We thank B. Agricola, S. Wangari, D.
   May, J. Ahrens, N. Iwayama, and J. Lane for their expert support in
   animal husbandry and care. We also thank T. Hensley-McBain and J.
   Manuzak for technical support in developing the flow cytometry panels.
   This work was supported in part by funds from the National Institute of
   Health (P51-OD010425) and in part by start-up funds from WaNPRC and UW
   to N.R.K. M.A.O. is supported by T32-AI007140.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hensley-McBain T, 2018, MUCOSAL IMMUNOL, V11, P1429, DOI 10.1038/s41385-018-0032-5
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kar M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx051
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Koday MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189780
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lugo-Roman LA, 2010, J MED PRIMATOL, V39, P41, DOI 10.1111/j.1600-0684.2009.00394.x
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oliveira Souto I., 2016, ENFERM INFEC MICR CL, V36, P21
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Patton DL, 2006, ANTIMICROB AGENTS CH, V50, P1696, DOI 10.1128/AAC.50.5.1696-1700.2006
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   R Core Team, 2016, R R PROJ STAT COMP
   Rossi SL, 2018, J INFECT DIS, V217, P1675, DOI 10.1093/infdis/jix631
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   't Hart BA, 2015, EUR J PHARMACOL, V759, P69, DOI 10.1016/j.ejphar.2015.03.023
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   'Thein TL, 2014, AM J TROP MED HYG, V90, P984, DOI 10.4269/ajtmh.14-0004
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhou Y, 2015, CURR OPIN IMMUNOL, V35, P131, DOI 10.1016/j.coi.2015.06.006
NR 70
TC 11
Z9 11
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 22
PY 2018
VL 9
AR 3371
DI 10.1038/s41467-018-05826-w
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR2ES
UT WOS:000442376200017
PM 30135445
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez-Valero, N
   Oroz, ML
   Sanchez, DC
   Vladimirov, A
   Espriu, M
   Vera, I
   Sanz, S
   Moreno, JLG
   Munoz, J
   Carbayo, MJL
AF Rodriguez-Valero, Natalia
   Luengo Oroz, Miguel
   Cuadrado Sanchez, Daniel
   Vladimirov, Alexander
   Espriu, Marina
   Vera, Isabel
   Sanz, Sergi
   Gonzalez Moreno, Jose Luis
   Munoz, Jose
   Ledesma Carbayo, Maria Jesus
TI Mobile based surveillance platform for detecting Zika virus among
   Spanish Delegates attending the Rio de Janeiro Olympic Games
SO PLOS ONE
LA English
DT Article
ID BRAZIL; OUTBREAK
AB Background
   Zika virus has created a major epidemic in Central and South America, especially in Brazil, during 2015-16. The infection is strongly associated with fetal malformations, mainly microcephaly, and neurological symptoms in adults. During the preparation of the Rio de Janeiro Olympic Games in 2016, members of Olympic Delegations worldwide expressed their concern about the health consequences of being infected with Zika virus. A major risk highlighted by the scientific community was the impact on the spreading of the virus into new territories immediately after the Games.
   Objectives
   To detect real-time incidence of symptoms compatible with arboviral diseases and other tropical imported diseases among the Spanish Olympic Delegation (SOD) attending the Rio Olympic Games in 2016.
   Methods
   We developed a surveillance platform based on a mobile application installed in participant's smartphones that monitored the health status of the SOD through a daily interactive check of the user health status including geo-localization data. The results were evaluated by a study physician on-call through a web-based platform monitoring system. Participants presenting severe symptoms or those compatible with Zika infection prompted an alarm in the system triggering specialized medical assistance and allowing early detection and control of the introduction of arboviral diseases in Spain.
   Summary of the results
   The system was downloaded by 189 participants and used by 143 of them (76%). Median age was 38 years (IQR 16), and 134 (71%) were male. Mean duration of travel was 19 days (+/-9SD). During the Games the highest accumulated incidence observed was for headache: 6.06% cough: 5.30% and conjunctivitis: 3.03%. The incidence rate of cough during the Olympic Games was 1.1% per day per person, followed by headache 0.8% and 0.4% conjunctivitis or diarrhea. In our cohort we observed that non-athletes experienced more incidence of symptoms, except for incidence of cough which was the same in the two groups (1.1%). No participants reported symptoms fulfilling Zika definition case.
   Conclusion
   Our system did not find cases fulfilling Zika definition amongst participants of the SOD during the Games, consistent with limited cases of Zika in Rio during the Games. The app showed good usability and the web based monitoring platform allowed to manage infectious cases in real-time. The overall system has proven to serve as a real-time surveillance platform for detecting symptoms that could be present in tropical imported diseases, especially arboviral diseases, contributing to the preparedness for the introduction of vector borne-diseases in non-endemic countries.
C1 [Rodriguez-Valero, Natalia; Espriu, Marina; Vera, Isabel; Sanz, Sergi; Munoz, Jose] Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin,Dept Int Hlth, Barcelona, Spain.
   [Luengo Oroz, Miguel; Cuadrado Sanchez, Daniel; Vladimirov, Alexander; Gonzalez Moreno, Jose Luis; Ledesma Carbayo, Maria Jesus] Univ Politecn Madrid, Biomed Image Technol, Elect Engn, Madrid, Spain.
   [Luengo Oroz, Miguel; Cuadrado Sanchez, Daniel; Vladimirov, Alexander; Gonzalez Moreno, Jose Luis; Ledesma Carbayo, Maria Jesus] CIBER BBN, Madrid, Spain.
RP Rodriguez-Valero, N (corresponding author), Univ Barcelona, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin,Dept Int Hlth, Barcelona, Spain.
EM natalia.rodriguez@isgloal.org
RI Gutierrez, Jose Munoz/AAH-6954-2020; Ledesma-Carbayo, Maria
   J/D-5529-2009; Rodriguez-Valero, Natalia/AAD-7083-2020; Gutierrez, Jose
   Munoz/X-5917-2018
OI Gutierrez, Jose Munoz/0000-0002-0945-1735; Ledesma-Carbayo, Maria
   J/0000-0001-6846-3923; Gutierrez, Jose Munoz/0000-0002-0945-1735;
   Luengo-Oroz, Miguel/0000-0002-8694-2001; Fernandez,
   Ivette/0000-0001-5179-0477
FU Fundacio La CaixaLa Caixa Foundation; Spanish Olympic Committe
FX The Project was financed by fundings from Fundacio La Caixa and Spanish
   Olympic Committe to develop it. The funders had no role in study design,
   data collection and analysis, decision to publish or preparation of the
   manuscript.
CR [Anonymous], 2016, WASHINGTON POST
   [Anonymous], 2016, RAP RISK ASS ZIK VIR
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Cao-Lormeau V, 2016, LANCET, V6736
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Control, 2016, CAS DEF ZIK VIR
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerrisi C, 2016, J INFECT DIS, V214, pS386, DOI 10.1093/infdis/jiw280
   Leal Neto Onicio, 2017, JMIR Public Health Surveill, V3, pe26, DOI 10.2196/publichealth.7313
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Mlakar J., 2016, NEW ENGL J MED
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pagliari C, 2016, PLOS NEGLECT TROP D, V10, P1
   Pan American Health Organization/World Health, ZIK EP REP BRAZ
   Rodriguez-Valero N, 2017, EMERG INFECT DIS, V23, P1426, DOI 10.3201/eid2308.170415
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2016, B EPIDEMIOLOGICO, V47
   Wojcik OP, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-7
NR 23
TC 1
Z9 1
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 22
PY 2018
VL 13
IS 8
AR e0201943
DI 10.1371/journal.pone.0201943
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR3NR
UT WOS:000442500400050
PM 30133492
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Chang, AY
   Lynch, R
   Martins, K
   Encinales, L
   Bonfanti, AAC
   Pacheco, N
   Reid, S
   Sarabia, OEL
   Torres, HJG
   Castillo, SM
   Taborda, OB
   Gomez, MA
   Duran, BG
   Giraldo, VM
   Ospino, AB
   Porras, A
   Mendoza, AR
   Mantus, G
   Li, GZ
   Peng, J
   Kamalapathy, P
   Echavez, LGA
   Dowd, KA
   Rengifo-Pardo, M
   Barraza, PP
   Hernandez, DJ
   Coba, AG
   Mendoza, KDLH
   Bethony, JM
   Simon, GL
AF Chang, Aileen Y.
   Lynch, Rebecca
   Martins, Karen
   Encinales, Liliana
   Cadena Bonfanti, Andres A.
   Pacheco, Nelly
   Reid, St. Patrick
   Sarabia, Osvaldo E. Lara
   Torres, Henry J. Gonzalez
   Castillo, Stella Mejia
   Taborda, Onaldo Barrios
   Gomez, Magda Alarcon
   Duran, Brenda Guerra
   Martinez Giraldo, Victor
   Benitez Ospino, Angelica
   Porras, Alexandra
   Mendoza, Alejandro R.
   Mantus, Grace
   Li, Guangzhao
   Peng, Jin
   Kamalapathy, Priyanka
   Echavez, Lil G. Avendano
   Dowd, Kimberly A.
   Rengifo-Pardo, Monica
   Pablo Barraza, Pedro
   Hernandez, Dennys Jimenez
   Coba, Andres Gonzalez
   Mendoza, Katya De la Hoz
   Bethony, Jeffrey M.
   Simon, Gary L.
TI Long-term clinical outcomes of Zika-associated Guillain-Barre syndrome
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID VIRUS-INFECTION; COLOMBIA; CUCUTA
C1 [Chang, Aileen Y.; Lynch, Rebecca; Mantus, Grace; Li, Guangzhao; Peng, Jin; Kamalapathy, Priyanka; Rengifo-Pardo, Monica; Bethony, Jeffrey M.; Simon, Gary L.] George Washington Univ, Washington, DC 20037 USA.
   [Martins, Karen; Encinales, Liliana] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.
   [Cadena Bonfanti, Andres A.; Sarabia, Osvaldo E. Lara; Torres, Henry J. Gonzalez; Castillo, Stella Mejia; Taborda, Onaldo Barrios; Gomez, Magda Alarcon; Duran, Brenda Guerra; Echavez, Lil G. Avendano] Univ Simon Bolivar, Barranquilla, Atlantico, Colombia.
   [Cadena Bonfanti, Andres A.; Sarabia, Osvaldo E. Lara; Martinez Giraldo, Victor; Benitez Ospino, Angelica; Hernandez, Dennys Jimenez; Coba, Andres Gonzalez; Mendoza, Katya De la Hoz] Clin La Costa Ltda, Barranquilla, Atlantico, Colombia.
   [Pacheco, Nelly; Pablo Barraza, Pedro] Allied Res Soc LLC, Barranquilla, Atlantico, Colombia.
   [Reid, St. Patrick] Univ Nebraska, Med Ctr, Omaha, NE 68182 USA.
   [Porras, Alexandra; Mendoza, Alejandro R.] Univ El Bosque, Bogota, Colombia.
   [Dowd, Kimberly A.] NIH, Bldg 10, Bethesda, MD 20892 USA.
RP Chang, AY (corresponding author), George Washington Univ, Washington, DC 20037 USA.
EM chang@email.gwu.edu
RI Gonzalez-Torres, Henry Joseth/N-1518-2014
OI Gonzalez-Torres, Henry Joseth/0000-0001-7434-4568; Porras-Ramirez,
   Alexandra/0000-0002-0800-1388; Lara-Sarabia,
   Osvaldo/0000-0002-7330-5871; Rengifo Pardo, Monica/0000-0002-3518-6867;
   Chang, Aileen/0000-0001-7410-9867; Cadena Bonfanti, Andres
   Angelo/0000-0003-3903-1915; Lara Sarabia, Osvaldo
   Elias/0000-0002-2129-5368
FU NIH National Center for Advancing Translational Sciences [UL1TR001876,
   KL2TR001877]
FX This publication was supported by Award UL1TR001876 and KL2TR001877 from
   the NIH National Center for Advancing Translational Sciences. Its
   contents are solely the responsibility of the authors and do not
   necessary represent the official views of the National Center for
   Advancing Translational Science or the National Institute of Health.
   Allied Research Society, Clinica de la Costa Ltda., Viviana Vitali
   Andrade, Camilo Fernandez Vega, Lorena Encinales, Mariana Encinales,
   Ariel Gonzalez, Martha Utrera, Lizneth Almendrales, and Marguieta Arroyo
   Wessel contributed critical logistical support to the study.
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Griffin JW, 1996, ANN NEUROL, V39, P17, DOI 10.1002/ana.410390105
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Islam B, 2018, EUR J CLIN MICROBIOL, V37, P511, DOI 10.1007/s10096-018-3199-5
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P3296, DOI 10.1002/art.20549
NR 13
TC 6
Z9 6
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD AUG 22
PY 2018
VL 7
AR 148
DI 10.1038/s41426-018-0151-9
PG 4
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GR2UB
UT WOS:000442438300002
PM 30131486
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gray, L
   Florez, SD
   Barreiro, AM
   Vadillo-Sanchez, J
   Gonzalez-Olvera, G
   Lenhart, A
   Manrique-Saide, P
   Vazquez-Prokopec, GM
AF Gray, Lyndsey
   Florez, Sergio Dzib
   Barreiro, Anuar Medina
   Vadillo-Sanchez, Jose
   Gonzalez-Olvera, Gabriela
   Lenhart, Audrey
   Manrique-Saide, Pablo
   Vazquez-Prokopec, Gonzalo M.
TI Experimental evaluation of the impact of household aerosolized
   insecticides on pyrethroid resistant Aedes aegypti
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SODIUM-CHANNELS; ESSENTIAL OIL; TREATED NETS; VECTORS; EFFICACY;
   MOSQUITOS; TANZANIA; DISEASE; MEXICO; SPRAY
AB The extensive reliance on insecticides to control Aedes aegypti mosquitoes and disrupt transmission of dengue, chikungunya and Zika has fueled the emergence of widespread resistance to insecticides. Mismatch between the frequency of pyrethroid resistance in mosquitoes and the occurrence of pyrethroid-based insecticide applications for vector control is often hypothesized to be due to household use of commercial insecticide products. We experimentally quantified phenotypic and genotypic responses of four Ae. aegypti strains (three field, pyrethroid resistant, and one laboratory, pyrethroid susceptible) after exposure to two commonly used household aerosol insecticide products (a space spray and a residual spray formulation) containing pyrethroid active ingredients. Experiments were performed within homes of Merida, Mexico. After exposure to the products, all three pyrethroid resistant field Ae. aegypti strains had significantly lower mortality rates (averaging 41% and 50% for the two products, respectively) than the controls (99%). Applying insecticides as surface sprays led to a significant increase in the frequency of I1016 kdr homozygotes in surviving Ae. aegypti, suggesting strong selection pressure for this allele. Given the large-scale use of household aerosol insecticide products in areas that are endemic for Ae. aegypti-transmitted diseases, their role as a pyrethroid resistance selection source, particularly when used as space sprays, should be taken into consideration when designing resistance management plans.
C1 [Gray, Lyndsey] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Florez, Sergio Dzib; Barreiro, Anuar Medina; Vadillo-Sanchez, Jose; Gonzalez-Olvera, Gabriela; Manrique-Saide, Pablo] Univ Autonoma Yucatan, Unidad Colaborat Bioensayos Entomol, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico.
   [Lenhart, Audrey] Ctr Dis Control & Prevent, Entomol Branch, Div Parasit Dis & Malaria, Atlanta, GA USA.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
RP Vazquez-Prokopec, GM (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
EM gmvazqu@emory.edu
OI Lenhart, Audrey/0000-0002-9156-4228
FU Emory Global Health Institute; Marcus Foundation [00052002]; Centers for
   Disease Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [CDC: OADS BAA
   2016-N-17844]; Mexico's CONACYTConsejo Nacional de Ciencia y Tecnologia
   (CONACyT) [000000000255141]; Office of Infectious Disease, Bureau for
   Global Health, U.S. Agency for International DevelopmentUnited States
   Agency for International Development (USAID)
FX We would like to thank the many staff members and students of UADY who
   were essential for this study's success: Carolina Carmona Carballo,
   Eduardo Jose Geded Moreno, Emilio Trujillo, and Azael Cohuo Rodriguez
   for their assistance in planning and conducting field surveys and
   Wilbert Bibiano Marin for his help in coordinating transportation to all
   field sites. Additionally, we would like to thank Lucrecia Vizcaino
   Cabarrus, Mariela Gonzalez Hernandez, Edgar Koyoc-Cardena, and Azael Che
   Mendoza for their technical assistance and laboratory training. This
   project received support from Emory Global Health Institute and Marcus
   Foundation (project #00052002), the Centers for Disease Control and
   Prevention (CDC: OADS BAA 2016-N-17844) and Mexico's CONACYT (Project
   #000000000255141). This research was made possible through support
   provided by the Office of Infectious Disease, Bureau for Global Health,
   U.S. Agency for International Development, under the terms of an
   Interagency Agreement with CDC. The opinions expressed herein are those
   of the author(s) and do not necessarily reflect the views of the U.S.
   Agency for International Development. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abu Bakar A, 2012, J ARTHROPOD-BORNE DI, V6, P28
   Lorono-Pino MA, 2014, TROP MED INT HEALTH, V19, P1267, DOI 10.1111/tmi.12364
   Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x
   Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335
   Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001
   Dada N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20367-4
   Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.1093/biomet/38.1-2.141
   Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158
   Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022
   Grossman MK, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2865-x
   Gurevitz JM, 2012, J MED ENTOMOL, V49, P1379, DOI 10.1603/ME11157
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Hien AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173098
   Kudom AA, 2013, ASIAN PAC J TROP MED, V6, P859, DOI 10.1016/S1995-7645(13)60153-4
   Kulkarni MA, 2007, TROP MED INT HEALTH, V12, P1061, DOI 10.1111/j.1365-3156.2007.01883.x
   Kuri-Morales PA, 2018, MED VET ENTOMOL, V32, P162, DOI 10.1111/mve.12281
   Kuri-Morales PA, 2018, J MED ENTOMOL, V55, P417, DOI 10.1093/jme/tjx212
   Lorono-Pino MA, 2004, AM J TROP MED HYG, V71, P485
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Marcombe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077857
   Matowo J, 2015, MED VET ENTOMOL, V29, P51, DOI 10.1111/mve.12090
   Misni N, 2011, TROP BIOMED, V28, P249
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631
   Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28
   O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Tsuji R, 2012, TOP CURR CHEM, V314, P83, DOI 10.1007/128_2011_269
   Vazquez-Prokopec GM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005656
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
NR 43
TC 8
Z9 9
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 22
PY 2018
VL 8
AR 12535
DI 10.1038/s41598-018-30968-8
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GR2HK
UT WOS:000442387500001
PM 30135460
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martins, AS
   Martins, IC
   Santos, NC
AF Martins, Ana S.
   Martins, Ivo C.
   Santos, Nuno C.
TI Methods for Lipid Droplet Biophysical Characterization in Flaviviridae
   Infections
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE lipid droplet; Flaviviridae; viral proteins; LDs-associated proteins;
   light scattering; microscopy
ID HEPATITIS-C VIRUS; ATOMIC-FORCE MICROSCOPY; DYNAMIC LIGHT-SCATTERING;
   WEST NILE VIRUS; FATTY-ACID SYNTHASE; CORE PROTEIN; DENGUE VIRUS; CAPSID
   PROTEIN; SIZE CHARACTERIZATION; VIRAL REPLICATION
AB Lipid droplets (LDs) are intracellular organelles for neutral lipid storage, originated from the endoplasmic reticulum. They play an essential role in lipid metabolism and cellular homeostasis. In fact, LDs are complex organelles, involved in many more cellular processes than those initially proposed. They have been extensively studied in the context of LD-associated pathologies. In particular, LDs have emerged as critical for virus replication and assembly. Viruses from the Flaviviridae family, namely dengue virus (DENV), hepatitis C virus (HCV), West Nile virus (WNV), and Zika virus (ZIKV), interact with LDs to usurp the host lipid metabolism for their own viral replication and pathogenesis. In general, during Flaviviridae infections it is observed an increasing number of host intracellular LDs. Several viral proteins interact with LDs during different steps of the viral life cycle. The HCV core protein and DENV capsid protein, extensively interact with LDs to regulate their replication and assembly. Detailed studies of LDs in viral infections may contribute for the development of possible inhibitors of key steps of viral replication. Here, we reviewed different techniques that can be used to characterize LDs isolated from infected or non-infected cells. Microscopy studies have been commonly used to observe LDs accumulation and localization in infected cell cultures. Fluorescent dyes, which may affect LDs directly, are widely used to probe LDs but there are also approaches that do not require the use of fluorescence, namely stimulated Raman scattering, electron and atomic force microscopy-based approaches. These three are powerful techniques to characterize LDs morphology. Raman scattering microscopy allows studying LDs in a single cell. Electron and atomic force microscopies enable a better characterization of LDs in terms of structure and interaction with other organelles. Other biophysical techniques, such as dynamic light scattering and zeta potential are also excellent to characterize LDs in terms of size in a simple and fast way and test possible LDs interaction with viral proteins. These methodologies are reviewed in detail, in the context of viral studies.
C1 [Martins, Ana S.; Martins, Ivo C.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.
RP Martins, IC; Santos, NC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.
EM ivomartins@fm.ul.pt; nsantos@fm.ul.pt
RI Martins, Ivo/G-2534-2013; Martins, Ana/M-1742-2014; Santos,
   Nuno/N-7248-2013
OI Martins, Ivo/0000-0002-9284-8599; Martins, Ana/0000-0002-4667-3716;
   Santos, Nuno/0000-0002-0580-0475
FU Fundacao para a Ciencia e a Tecnologia - Ministerio da Ciencia,
   Tecnologia e Ensino Superior (FCT-MCTES, Portugal)Portuguese Foundation
   for Science and Technology [PD/BD/113698/2015]; Program Investigador FCT
   [IF/00772/2013]; FEDER, through POR Lisboa 2020 - Programa Operacional
   Regional de Lisboa; FCT-MCTESPortuguese Foundation for Science and
   Technology; FEDER, through Portugal 2020;  [LISBOA01-0145-FEDER-007391]
FX This work was supported by Fundacao para a Ciencia e a Tecnologia -
   Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES,
   Portugal), including the fellowship PD/BD/113698/2015 and the Program
   Investigador FCT (research contract IF/00772/2013) to AM and IM,
   respectively. This work was also supported by LISBOA01-0145-FEDER-007391
   project, co-funded by FEDER, through POR Lisboa 2020 - Programa
   Operacional Regional de Lisboa, Portugal 2020, and FCT-MCTES.
CR Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111
   Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035
   Appelqvist H, 2017, BIOCONJUGATE CHEM, V28, P1363, DOI 10.1021/acs.bioconjchem.7b00048
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200
   Berne B. J, 1990, DYNAMIC LIGHT SCATTE, P4
   Bersuker K, 2018, DEV CELL, V44, P97, DOI 10.1016/j.devcel.2017.11.020
   Bersuker K, 2017, BBA-MOL CELL BIOL L, V1862, P1166, DOI 10.1016/j.bbalip.2017.06.006
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002
   Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005
   Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x
   Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0
   Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200
   Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200
   Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camus G, 2014, J BIOL CHEM, V289, P35770, DOI 10.1074/jbc.M114.587816
   Cao C, 2016, ANAL CHEM, V88, P4931, DOI 10.1021/acs.analchem.6b00862
   Carvalho FA, 2013, ARCH BIOCHEM BIOPHYS, V531, P116, DOI 10.1016/j.abb.2012.11.007
   Carvalho FA, 2012, IUBMB LIFE, V64, P465, DOI 10.1002/iub.1037
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Choudhary V, 2018, CURR BIOL, V28, P915, DOI 10.1016/j.cub.2018.02.020
   Cohen BC, 2017, J MAMMARY GLAND BIOL, V22, P235, DOI 10.1007/s10911-017-9386-7
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Dahlhoff M, 2015, EXP CELL RES, V332, P146, DOI 10.1016/j.yexcr.2014.12.004
   Dejgaard SY, 2014, J HISTOCHEM CYTOCHEM, V62, P889, DOI 10.1369/0022155414554835
   Deslandes F, 2017, BIOPHYS J, V113, P15, DOI 10.1016/j.bpj.2017.05.045
   DiDonato D, 2003, J HISTOCHEM CYTOCHEM, V51, P773, DOI 10.1177/002215540305100608
   Ding YF, 2013, NAT PROTOC, V8, P43, DOI 10.1038/nprot.2012.142
   Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Ferguson D, 2017, J LIPID RES, V58, P420, DOI 10.1194/jlr.M073734
   Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087
   Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7
   Gao Qiang, 2015, Front Cell Dev Biol, V3, P49, DOI 10.3389/fcell.2015.00049
   Goodman JM, 2018, DEV CELL, V44, P1, DOI 10.1016/j.devcel.2017.12.017
   Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069
   GREENBERG AS, 1991, J BIOL CHEM, V266, P11341
   Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6
   Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337
   Guedes AF, 2016, NAT NANOTECHNOL, V11, P687, DOI [10.1038/NNANO.2016.52, 10.1038/nnano.2016.52]
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025
   Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148
   Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238
   Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106
   Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582
   Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913
   Hussmann KL, 2014, J GEN VIROL, V95, P1991, DOI 10.1099/vir.0.065474-0
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Joshi AS, 2017, NAT CELL BIOL, V19, P876, DOI 10.1038/ncb3579
   Kaczocha M, 2010, J BIOL CHEM, V285, P2796, DOI 10.1074/jbc.M109.058461
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kirby BJ, 2004, ELECTROPHORESIS, V25, P187, DOI 10.1002/elps.200305754
   Kozusko K, 2015, DIABETES, V64, P299, DOI 10.2337/db14-0104
   Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671
   Krahmer N, 2009, CELL, V139, P1024, DOI 10.1016/j.cell.2009.11.023
   Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190
   Lin CC, 2014, J HEPATOL, V61, P984, DOI 10.1016/j.jhep.2014.06.026
   Lin PH, 2014, BBA-BIOMEMBRANES, V1838, P874, DOI 10.1016/j.bbamem.2013.12.003
   Lu FK, 2012, MOL PHYS, V110, P1927, DOI 10.1080/00268976.2012.695028
   Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106
   Martin A, 2003, P NATL ACAD SCI USA, V100, P9962, DOI 10.1073/pnas.1731505100
   Martin S, 2008, METHOD ENZYMOL, V438, P109, DOI 10.1016/S0076-6879(07)38008-7
   Martins A, 2017, PROTEIN SCI, V26, P150
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Matsumoto S, 2002, INSECT BIOCHEM MOLEC, V32, P1447, DOI 10.1016/S0965-1748(02)00065-6
   McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1
   McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2
   McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muratore KA, 2018, ANAL BIOANAL CHEM, V410, P3629, DOI 10.1007/s00216-018-1016-8
   Nevo-Yassaf I, 2017, METHODS, V127, P30, DOI 10.1016/j.ymeth.2017.05.010
   Ohsaki Y, 2005, HISTOCHEM CELL BIOL, V124, P445, DOI 10.1007/s00418-005-0061-5
   Peramuna A, 2014, ARCH MICROBIOL, V196, P881, DOI 10.1007/s00203-014-1027-6
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Pol A, 2014, J CELL BIOL, V204, P635, DOI 10.1083/jcb.201311051
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Prevost C, 2018, DEV CELL, V44, P73, DOI 10.1016/j.devcel.2017.12.011
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6
   Reddy SBG, 2018, BIOCHEM PHARMACOL, V154, P54, DOI 10.1016/j.bcp.2018.04.008
   Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0
   Rosch K, 2017, JOVE-J VIS EXP, DOI 10.3791/55585
   Roingeard P, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12688
   Rossi SL, 2010, CLIN LAB MED, V30, P47, DOI 10.1016/j.cll.2009.10.006
   Salloum S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003513
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Santos NC, 2004, BIOPHYS CHEM, V107, P133, DOI 10.1016/j.bpc.2003.09.001
   Santos NC, 1996, BIOPHYS J, V71, P1641, DOI 10.1016/S0006-3495(96)79369-4
   Schuldiner M, 2017, BBA-MOL CELL BIOL L, V1862, P1188, DOI 10.1016/j.bbalip.2017.06.005
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Sitar S, 2017, ANAL CHEM, V89, P11744, DOI 10.1021/acs.analchem.7b03251
   Skinner JR, 2009, J BIOL CHEM, V284, P30941, DOI 10.1074/jbc.M109.013995
   Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Thiam AR, 2017, J CELL SCI, V130, P315, DOI 10.1242/jcs.192021
   Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699
   Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x
   Uskokovic V, 2012, J DISPER SCI TECHNOL, V33, P1762, DOI 10.1080/01932691.2011.625523
   Vahabi S, 2013, IRAN J MED SCI, V38, P76
   Vanni Stefano, 2017, Lipid Insights, V10, p1178635317745518, DOI 10.1177/1178635317745518
   Vezocnik V, 2015, J CHROMATOGR A, V1418, P185, DOI 10.1016/j.chroma.2015.09.048
   Vogt DA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003302
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang CW, 2016, BBA-MOL CELL BIOL L, V1861, P793, DOI 10.1016/j.bbalip.2015.12.010
   Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004
   Whited AM, 2014, BBA-BIOMEMBRANES, V1838, P56, DOI 10.1016/j.bbamem.2013.04.011
   Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013
   Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
   Zhang JS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02286
NR 121
TC 8
Z9 9
U1 4
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 21
PY 2018
VL 9
AR 1951
DI 10.3389/fmicb.2018.01951
PG 20
WC Microbiology
SC Microbiology
GA GR0NE
UT WOS:000442213600002
PM 30186265
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaarj, K
   Akarapipad, P
   Yoon, JY
AF Kaarj, Kattika
   Akarapipad, Patarajarin
   Yoon, Jeong-Yeol
TI Simpler, Faster, and Sensitive Zika Virus Assay Using Smartphone
   Detection of Loop-mediated Isothermal Amplification on Paper
   Microfluidic Chips
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POINT-OF-CARE; CHIKUNGUNYA; DIAGNOSTICS; DENGUE
AB The recent Zika virus (ZIKV) outbreak has prompted the need for field-ready diagnostics that are rapid, easy-to-use, handheld, and disposable while providing extreme sensitivity and specificity. To meet this demand, we developed a wax-printed paper microfluidic chip utilizing reverse transcription loop-mediated isothermal amplification (RT-LAMP). The developed simple and sensitive ZIKV assay was demonstrated using undiluted tap water, human urine, and diluted (10%) human blood plasma. Paper type, pore size, and channel dimension of various paper microfluidic chips were investigated and optimized to ensure proper filtration of direct-use biological samples (tap water, urine, and plasma) during capillary action-driven flow. Once ZIKV RNA has flowed and reached to a detection area of the paper microfluidic chip, it was excised for the addition of an RT-LAMP mixture with a pH indicator, then placed on a hot plate at 68 degrees C. Visible color changes from successful amplification were observed in 15 minutes and quantified by smartphone imaging. The limit of detection was as low as 1 copy/mu L. The developed platform can also be used for identifying other flaviviruses, such as Chikungunya virus (CHIKV) and Dengue virus (DENV), and potentially other quickly transmitted virus pathogens, towards field-based diagnostics.
C1 [Kaarj, Kattika; Yoon, Jeong-Yeol] Univ Arizona, Dept Biosyst Engn, Tucson, AZ 85721 USA.
   [Akarapipad, Patarajarin; Yoon, Jeong-Yeol] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
RP Yoon, JY (corresponding author), Univ Arizona, Dept Biosyst Engn, Tucson, AZ 85721 USA.; Yoon, JY (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
EM jyyoon@email.arizona.edu
OI Akarapipad, Patarajarin/0000-0003-1991-2846; Kaarj,
   Kattika/0000-0002-0054-6519
FU Development and Promotion of Science and Technology Talents Project
   (DPST) of Thailand; One District One Scholarship (ODOS) of Thailand;
   BIO5 Institute at the University of Arizona
FX This work was supported by the student academic scholarships from the
   Development and Promotion of Science and Technology Talents Project
   (DPST) of Thailand, awarded to K.K., and One District One Scholarship
   (ODOS) of Thailand, awarded to P.A., as well as the pilot
   interdisciplinary grant from the BIO5 Institute at the University of
   Arizona, awarded to J.-Y.Y. The authors acknowledge Tiffany-Heather Ulep
   and Alana Gonzalez, both in the Department of Biomedical Engineering,
   the University of Arizona, for helpful discussion and proofreading the
   manuscript.
CR Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001
   Akyazi T, 2018, ANAL CHIM ACTA, V1001, P1, DOI 10.1016/j.aca.2017.11.010
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239
   Hedman Johannes, 2013, Methods Mol Biol, V943, P17, DOI 10.1007/978-1-60327-353-4_2
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Liger-Belair G, 2010, ADV FOOD NUTR RES, V61, P1, DOI [10.1016/S1043-4526(10)61001-7, 10.1016/B978-0-12-374468-5.00001-5]
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Patterson H. B. W., 2009, BLEACHING PURIFYING
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Sood YV, 2010, J SCI IND RES INDIA, V69, P300
   Tateishi-Karimata H, 2014, NUCLEIC ACIDS RES, V42, P8831, DOI 10.1093/nar/gku499
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   U. S. Centers for Disease Control and Prevention, 2018, ZIK VIR
   WHO, 2016, ZIK VIR FACT SHEET
   World Health Organization, 2017, ZIK VIR COMPL
   WU DY, 1991, DNA CELL BIOL, V10, P233, DOI 10.1089/dna.1991.10.233
   Yamada K, 2017, LAB CHIP, V17, P1206, DOI 10.1039/c6lc01577h
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Yoon J. - Y, 2016, INTRO BIOSENSORS ELE
NR 29
TC 24
Z9 25
U1 11
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 20
PY 2018
VL 8
AR 12438
DI 10.1038/s41598-018-30797-9
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ9TB
UT WOS:000442130900013
PM 30127503
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mottin, M
   Carvalho, A
   Melo, C
   Neves, B
   Braga, R
   Lima, C
   da Silva, S
   Shimizu, J
   Mesquita, N
   Regasini, L
   Jardim, A
   Muratov, E
   Oliva, G
   Perryman, A
   Ekins, S
   Andrade, C
AF Mottin, Melina
   Carvalho, Amanda
   Melo-Filho, Cleber
   Neves, Bruno
   Braga, Rodolpho
   Lima, Caroline
   da Silva, Suely
   Shimizu, Jacqueline
   Mesquita, Nathalya
   Regasini, Luis
   Jardim, Ana
   Muratov, Eupne
   Oliva, Glaucius
   Perryman, Alexander
   Ekins, Sean
   Andrade, Carolina
TI OpenZika: Discovery of new antiviral candidates against Zika virus
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 256th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nanoscience, Nanotechnology and Beyond
CY AUG 19-23, 2018
CL Boston, MA
SP Amer Chem Soc
C1 [Mottin, Melina; Carvalho, Amanda; Melo-Filho, Cleber; Neves, Bruno; Braga, Rodolpho; Andrade, Carolina] Univ Fed Goias, LabMol Lab Mol Modeling & Drug Design, Fac Pharm, Goiania, Go, Brazil.
   [Neves, Bruno] Univ Ctr Anapolis UniEVANGELICA, Lab Cheminformat, Anapolis, Go, Brazil.
   [Lima, Caroline; da Silva, Suely; Shimizu, Jacqueline; Regasini, Luis] Sao Paulo State Univ UNESP, Dept Chem & Environm Sci, Inst Biosci Humanities & Exact Sci, Sao Jose Do Rio Preto, SP, Brazil.
   [da Silva, Suely; Shimizu, Jacqueline; Jardim, Ana] Univ Fed Uberlandia, Virol Lab, Uberlandia, MG, Brazil.
   [Mesquita, Nathalya; Oliva, Glaucius] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Carlos, SP, Brazil.
   [Muratov, Eupne] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27515 USA.
   [Muratov, Eupne] Odessa Natl Polytech Univ, Dept Chem Technol, Odessa, Ukraine.
   [Perryman, Alexander] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA.
   [Ekins, Sean] Collaborat Pharmaceut, Fuquay Varina, NC USA.
EM melinamottin@gmail.com
RI Oliva, Glaucius/B-9059-2012; Mottin, Melina/D-8700-2016; Braga, Rodolpho
   C/A-9655-2011; Jardim, Ana Carolina Gomes/H-3615-2012; Neves,
   Bruno/R-7068-2019
OI Mottin, Melina/0000-0003-0878-9029; Braga, Rodolpho
   C/0000-0003-3814-3464; Jardim, Ana Carolina Gomes/0000-0002-6348-7923;
   Neves, Bruno/0000-0002-1309-8743
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2018
VL 256
MA 24
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX3CY
UT WOS:000447600003335
DA 2020-07-08
ER

PT J
AU Sanchez-Purra, M
   Carre-Camps, M
   de Puig, H
   Bosch, I
   Gehrke, L
   Hamad-Schifferli, K
AF Sanchez-Purra, Maria
   Carre-Camps, Marc
   de Puig, Helena
   Bosch, Irene
   Gehrke, Lee
   Hamad-Schifferli, Kimberly
TI Design of SERS nanotags for the multiplexed detection of dengue and zika
   in lateral flow assay
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 256th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nanoscience, Nanotechnology and Beyond
CY AUG 19-23, 2018
CL Boston, MA
SP Amer Chem Soc
C1 [Sanchez-Purra, Maria; Hamad-Schifferli, Kimberly] Univ Massachusetts, Engn, Boston, MA 02125 USA.
   [Carre-Camps, Marc] IQS Sch Engn, Biomat, Barcelona, Spain.
   [de Puig, Helena; Hamad-Schifferli, Kimberly] MIT, Mech Engn, Boston, MA USA.
   [Bosch, Irene] MIT, Inst Med Engn & Sci, Boston, MA USA.
   [Gehrke, Lee] Harvard Med Sch, Microbiol & Immunol, Boston, MA USA.
EM mariasanchezpurra@gmail.com
NR 0
TC 0
Z9 0
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2018
VL 256
MA 64
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX3CY
UT WOS:000447600000782
DA 2020-07-08
ER

PT J
AU Carraher, C
   Mosca, F
   Roner, M
   Miller, L
   Slawek, P
   Haky, J
AF Carraher, Charles
   Mosca, Francesca
   Roner, Michael
   Miller, Lindsey
   Slawek, Paul
   Haky, Jerome
TI Inhibition of the Zika virus by lamivudine-containing organotin polymers
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 256th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nanoscience, Nanotechnology and Beyond
CY AUG 19-23, 2018
CL Boston, MA
SP Amer Chem Soc
C1 [Carraher, Charles; Mosca, Francesca; Slawek, Paul; Haky, Jerome] Florida Atlantic Univ, Dept Chem & Biochem, Parkland, FL USA.
   [Roner, Michael; Miller, Lindsey] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.
EM carraher@fau.edu
RI Roner, Michael/Q-9253-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2018
VL 256
MA 445
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX3GB
UT WOS:000447609104635
DA 2020-07-08
ER

PT J
AU Dailey, G
AF Dailey, Gabrielle
TI Antisense-mediated knockdown of host selenoprotein expression in ZIKV
   infected cells via targeting of cellular mRNA by viral RNA
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 256th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nanoscience, Nanotechnology and Beyond
CY AUG 19-23, 2018
CL Boston, MA
SP Amer Chem Soc
C1 [Dailey, Gabrielle] Univ N Carolina, Chem & Biochem, Greensboro, NC USA.
EM gpdailey@uncg.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2018
VL 256
MA 68
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX3GB
UT WOS:000447609102052
DA 2020-07-08
ER

PT J
AU Surnar, B
   Dhar, S
AF Surnar, Bapurao
   Dhar, Shanta
TI Nanomedicine for trans-epithelial oral delivery of Ivermectin for Zika
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 256th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nanoscience, Nanotechnology and Beyond
CY AUG 19-23, 2018
CL Boston, MA
SP Amer Chem Soc
C1 [Surnar, Bapurao; Dhar, Shanta] Univ Miami, Biochem & Mol Bioli, Miami, FL USA.
EM bapusurnar@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2018
VL 256
MA 190-INOR
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX3GB
UT WOS:000447609101280
DA 2020-07-08
ER

PT J
AU Telehany, S
   Humby, M
   Mcgee, D
   Jacobs, A
   Rizzo, R
AF Telehany, Stephen
   Humby, Monica
   McGee, Dwight
   Jacobs, Amy
   Rizzo, Robert
TI Orthogonal approach to computational biomolecular screening: Application
   to glycoprotein E of Zika virus
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 256th National Meeting and Exposition of the American-Chemical-Society
   (ACS) - Nanoscience, Nanotechnology and Beyond
CY AUG 19-23, 2018
CL Boston, MA
SP Amer Chem Soc
C1 [Telehany, Stephen; Rizzo, Robert] SUNY Stony Brook, Chem, Stony Brook, NY 11794 USA.
   [Humby, Monica; Jacobs, Amy] Suny Buffalo, Jacobs Sch Med & Biomed Studies, Buffalo, NY USA.
   [McGee, Dwight; Rizzo, Robert] SUNY Stony Brook, Appl Math & Stat, Stony Brook, NY 11794 USA.
EM stephentelehany@mail.adelphi.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2018
VL 256
MA 370
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GX3CY
UT WOS:000447600004773
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika-associated health and development problems in children
SO LANCET
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD AUG 18
PY 2018
VL 392
IS 10147
BP 532
EP 532
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GQ8MN
UT WOS:000442009500003
DA 2020-07-08
ER

PT J
AU Stoney, RJ
   Esposito, DH
   Kozarsky, P
   Hamer, DH
   Grobusch, MP
   Gkrania-Klotsas, E
   Libman, M
   Gautret, P
   Lim, PL
   Leder, K
   Schwartz, E
   Sotir, MJ
   Licitra, C
AF Stoney, Rhett J.
   Esposito, Douglas H.
   Kozarsky, Phyllis
   Hamer, Davidson H.
   Grobusch, Martin P.
   Gkrania-Klotsas, Effrossyni
   Libman, Michael
   Gautret, Philippe
   Lim, Poh Lian
   Leder, Karin
   Schwartz, Eli
   Sotir, Mark J.
   Licitra, Carmelo
CA GeoSentinel Surveillance Network
TI Infectious diseases acquired by international travellers visiting the
   USA
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE International travellers; infectious diseases; USA; GeoSentinel; travel
   medicine; Lyme disease; coccidioidomycosis
ID UNITED-STATES; GEOSENTINEL SURVEILLANCE; COCCIDIOIDOMYCOSIS; ILLNESS;
   INCREASE
AB Background: Estimates of travel-related illness have focused predominantly on populations from highly developed countries visiting low-or middle-income countries, yet travel to and within high-income countries is very frequent. Despite being a top international tourist destination, few sources describe the spectrum of infectious diseases acquired among travellers to the USA.
   Methods: We performed a descriptive analysis summarizing demographic and travel characteristics, and clinical diagnoses among non-US-resident international travellers seen during or after travel to the USA at a GeoSentinel clinic from 1 January 1997 through 31 December 2016.
   Results: There were 1222 ill non-US-resident travellers with 1393 diagnoses recorded during the 20-year analysis period. Median age was 40 (range 0-86 years); 52% were female. Patients visited from 63 countries and territories, most commonly Canada (31%), Germany (14%), France (9%) and Japan (7%). Travellers presented with a range of illnesses; skin and soft tissue infections of unspecified aetiology were the most frequently reported during travel (29 diagnoses, 14% of during-travel diagnoses); arthropod bite/sting was the most frequently reported after travel (173 diagnoses, 15% after-travel diagnoses). Lyme disease was the most frequently reported arthropod-borne disease after travel (42, 4%). Nonspecific respiratory, gastrointestinal and systemic infections were also among the most frequently reported diagnoses overall. Low-frequency illnesses (<2% of cases) made up over half of diagnoses during travel and 41% of diagnoses after travel, including 13 cases of coccidioidomycosis and mosquito-borne infections like West Nile, dengue and Zika virus diseases.
   Conclusions: International travellers to the USA acquired a diverse array of mostly cosmopolitan infectious diseases, including nonspecific respiratory, gastrointestinal, dermatologic and systemic infections comparable to what has been reported among travellers to low-and middle-income countries. Clinicians should consider the specific health risks when preparing visitors to the USA and when evaluating and treating those who become ill.
C1 [Stoney, Rhett J.; Esposito, Douglas H.; Kozarsky, Phyllis; Sotir, Mark J.] Ctr Dis Control & Prevent CDC, Travelers Hlth Branch, Div Global Migrat & Quarantine, 1825 Century Blvd NE,MS E-28, Atlanta, GA 30345 USA.
   [Kozarsky, Phyllis] Emory Univ, Dept Med, Atlanta, GA 30322 USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.
   [Hamer, Davidson H.] Boston Med Ctr, Infect Dis Sect, Dept Med, Boston, MA USA.
   [Grobusch, Martin P.] Univ Amsterdam, Ctr Trop Med & Travel Med, Dept Infect Dis, Div Internal Med,Acad Med Ctr, Amsterdam, Netherlands.
   [Gkrania-Klotsas, Effrossyni] Cambridge Univ Hosp, Div Infect Dis, Cambridge, England.
   [Libman, Michael] McGill Univ, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada.
   [Gautret, Philippe] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Lim, Poh Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore.
   [Lim, Poh Lian] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Leder, Karin] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.
   [Leder, Karin] Royal Melbourne Hosp, Victorian Infect Dis Serv, Doherty Inst, Melbourne, Vic, Australia.
   [Schwartz, Eli] Sheba Med Ctr, Inst Geog Med & Trop Dis, Tel Hashomer, Israel.
   [Schwartz, Eli] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Licitra, Carmelo] Univ Cent Florida, Coll Med, Orlando Hlth Infect Dis, Orlando, FL 32816 USA.
RP Stoney, RJ (corresponding author), Ctr Dis Control & Prevent CDC, Travelers Hlth Branch, Div Global Migrat & Quarantine, 1825 Century Blvd NE,MS E-28, Atlanta, GA 30345 USA.
EM uyn2@cdc.gov
RI Leder, Karin/AAD-2388-2019; Hamer, Davidson/J-2020-2019; Wejse,
   Christian/C-8468-2014
OI Leder, Karin/0000-0003-1368-1039; Hamer, Davidson/0000-0002-4700-1495;
   Wejse, Christian/0000-0002-2534-2942; Mendelson,
   Marc/0000-0001-6668-3893; Gkrania-Klotsas,
   Effrossyni/0000-0002-0930-8330; Stoney, Rhett/0000-0002-4538-1463
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U50CK00189]; ISTM; Public Health Agency of Canada
FX GeoSentinel, the Global Surveillance Network of the International
   Society of Travel Medicine (ISTM), is supported by a cooperative
   agreement (U50CK00189) from the Centers for Disease Control and
   Prevention, ISTM and the Public Health Agency of Canada.
CR Angelo KM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax046
   Barbeau DN, 2017, CDC HLTH INFORM INT
   Centers for Disease Control and Prevention, DENG EP
   Chang DC, 2008, EMERG INFECT DIS, V14, P1053, DOI 10.3201/eid1407.070832
   Chen LH, 2016, TRAVEL MED INFECT DI, V14, P604, DOI 10.1016/j.tmaid.2016.09.009
   Cooksey GS, 2017, MMWR-MORBID MORTAL W, V66, P833, DOI 10.15585/mmwr.mm6631a4
   Drewett G, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw053
   Eisen RJ, 2017, ILAR J, V58, P319, DOI 10.1093/ilar/ilx005
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075
   Hochberg NS, 2013, MAYO CLIN PROC, V88, P1231, DOI 10.1016/j.mayocp.2013.07.018
   Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3
   Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005
   Metobi JP, 2017, CDC HLTH INFORM INT
   Paddock C. D., 2016, GLOBAL HLTH IMPACTS, P221
   Schwartz AM, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6622a1
   Siikamaki H, 2015, EUROSURVEILLANCE, V20, P15, DOI 10.2807/1560-7917.ES2015.20.19.21128
   Stevens AM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw099
   Tsang CA, 2013, MMWR-MORBID MORTAL W, V62, P217
   Vilkman K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1682-0
   Walker AT, 2017, CDC HLTH INFORM INT
   World Tourism Organization, 2016, UN WORLD TOUR OFF AN
NR 22
TC 0
Z9 0
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD AUG 17
PY 2018
VL 25
AR tay053
DI 10.1093/jtm/tay053
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0QJ
UT WOS:000451504000001
PM 30124885
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Huang, J
   Jia, RY
   Shen, HY
   Wang, MS
   Zhu, DK
   Chen, S
   Liu, MF
   Zhao, XX
   Wu, Y
   Yang, Q
   Yin, ZQ
   Cheng, AC
AF Huang, Juan
   Jia, Renyong
   Shen, Haoyue
   Wang, Mingshu
   Zhu, Dekang
   Chen, Shun
   Liu, Mafeng
   Zhao, Xinxin
   Wu, Ying
   Yang, Qiao
   Yin, Zhongqiong
   Cheng, Anchun
TI Oral Delivery of a DNA Vaccine Expressing the PrM and E Genes: A
   Promising Vaccine Strategy against Flavivirus in Ducks
SO SCIENTIFIC REPORTS
LA English
DT Article
ID COMPLETE GENOME SEQUENCE; WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS;
   TEMBUSU VIRUS; JAPANESE ENCEPHALITIS; SALMONELLA-TYPHIMURIUM;
   NEW-GENERATION; ZIKA VIRUS; E PROTEIN; IN-VITRO
AB A flavivirus, named duck tembusu virus (DTMUV), emerged in China in 2010. This virus has caused great economic losses in the poultry industry in China and may pose a threat to public health. As a safe, efficient and convenient vaccine development strategy, DNA-based vaccines have become a popular approach for both human and veterinary applications. Attenuated bacteria have been widely used as vehicles to deliver heterologous antigens to the immune system. Thus, an efficient and low-cost oral delivery DNA vaccine SL7207 (pVAX1-SME) based on envelope proteins (prM and E) of DTMUV and attenuated Salmonella typhimurium aroA-strain SL7207 was developed and evaluated in this study. The prM and E antigen proteins were successfully expressed from the vaccine SL7207 (pVAX1-SME) both in vitro and in vivo. High titers of the specific antibody against the DTMUV-E protein and the neutralizing antibody against the DTMUV virus were both detected after vaccination with SL7207 (pVAX1-SME). Ducks orally vaccinated with the SL7207 (pVAX-SME) vaccine were efficiently protected from lethal DTMUV infection in this study. Taken together, we demonstrated that prM and E proteins of DTMUV possess strong immunogenicity against the DTMUV infection. Moreover, an oral delivery of the DNA vaccine SL7207 (pVAX1-SME) utilizing Salmonella SL7207 was an efficient way to protect the ducks against DTMUV infection and provides an economic and fast vaccine delivery strategy for a large-scale clinical use.
C1 [Huang, Juan; Jia, Renyong; Shen, Haoyue; Wang, Mingshu; Zhu, Dekang; Chen, Shun; Liu, Mafeng; Zhao, Xinxin; Wu, Ying; Yang, Qiao; Cheng, Anchun] Sichuan Agr Univ, Avian Dis Res Ctr, Chengdu 611130, Sichuan, Peoples R China.
   [Huang, Juan; Jia, Renyong; Shen, Haoyue; Wang, Mingshu; Zhu, Dekang; Chen, Shun; Liu, Mafeng; Zhao, Xinxin; Wu, Ying; Yang, Qiao; Cheng, Anchun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China.
   [Huang, Juan; Jia, Renyong; Shen, Haoyue; Wang, Mingshu; Zhu, Dekang; Chen, Shun; Liu, Mafeng; Zhao, Xinxin; Wu, Ying; Yang, Qiao; Yin, Zhongqiong; Cheng, Anchun] Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China.
RP Cheng, AC (corresponding author), Sichuan Agr Univ, Avian Dis Res Ctr, Chengdu 611130, Sichuan, Peoples R China.; Cheng, AC (corresponding author), Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China.; Cheng, AC (corresponding author), Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu 611130, Sichuan, Peoples R China.
EM jiary@sicau.edu.cn; chenganchun@vip.163.com
RI Zhu, Dekang/A-2292-2014
OI Zhu, Dekang/0000-0002-7314-1088
FU National Key Research and Development Program of China [2017YFD0500800];
   China Agricultural Research System [CARS-42-17]; Sichuan Province
   Research Programs [2017JY0014/2017HH0026]
FX This work was supported by the National Key Research and Development
   Program of China (2017YFD0500800), China Agricultural Research System
   (CARS-42-17), and Sichuan Province Research Programs
   (2017JY0014/2017HH0026).
CR ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Ansari AR, 2015, VET IMMUNOL IMMUNOP, V166, P145, DOI 10.1016/j.vetimm.2015.05.004
   Ashraf S, 2011, VACCINE, V29, P3990, DOI 10.1016/j.vaccine.2011.03.066
   Baumler AJ, 1996, P NATL ACAD SCI USA, V93, P279, DOI 10.1073/pnas.93.1.279
   Chen PC, 2014, VACCINE, V32, P5271, DOI 10.1016/j.vaccine.2014.07.082
   da Silva WD, 2010, VET IMMUNOL IMMUNOP, V135, P173, DOI 10.1016/j.vetimm.2009.12.011
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   DEUBEL V, 1991, VIROLOGY, V180, P442, DOI 10.1016/0042-6822(91)90055-G
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041
   Huang J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040180
   JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kexiang Yu Z.-Z. S., 2013, PLOS ONE, V8
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   Konishi E, 1998, J VIROL, V72, P4925, DOI 10.1128/JVI.72.6.4925-4930.1998
   Konishi E, 1996, J MED VIROL, V48, P76, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;76::AID-JMV12&gt;3.0.CO;2-4
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Li GX, 2014, VIROLOGY, V450, P233, DOI 10.1016/j.virol.2013.12.028
   Li LL, 2012, VIRUS GENES, V45, P105, DOI 10.1007/s11262-012-0753-6
   Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106
   Liljebjelke KA, 2010, VACCINE, V28, P4430, DOI 10.1016/j.vaccine.2010.04.009
   Lin J, 2015, AVIAN DIS, V59, P244, DOI 10.1637/10960-101514-Reg
   Liu WQ, 2010, VIRUS GENES, V40, P53, DOI 10.1007/s11262-009-0418-2
   Ma TF, 2016, VACCINE, V34, P2157, DOI 10.1016/j.vaccine.2016.03.030
   Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]
   Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116
   Stachyra A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0599-y
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Tabrizi CA, 2004, CURR OPIN BIOTECH, V15, P530, DOI 10.1016/j.copbio.2004.10.004
   Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085
   Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P152, DOI 10.1111/j.1865-1682.2012.01328.x
   Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022
   Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865
   VENUGOPAL K, 1994, VACCINE, V12, P966, DOI 10.1016/0264-410X(94)90329-8
   Wan CH, 2012, J VIROL, V86, P10912, DOI 10.1128/JVI.01582-12
   Wang HJ, 2016, J GEN VIROL, V97, P1551, DOI 10.1099/jgv.0.000486
   Wen J, 2012, VACCINE, V30, P5733, DOI 10.1016/j.vaccine.2012.07.008
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003
   Yu X, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-56
   Yun T, 2012, VET MICROBIOL, V157, P311, DOI 10.1016/j.vetmic.2012.01.013
   Yun T, 2012, J VIROL, V86, P3406, DOI 10.1128/JVI.07132-11
   Zenglin Pei X. J., 2015, PLOS ONE, V10
   Zhang D, 2016, J VIROL METHODS, V227, P6, DOI 10.1016/j.jviromet.2015.08.011
   Zhang W, 2017, J GEN VIROL, V98, P2413, DOI 10.1099/jgv.0.000908
   Zhu KS, 2015, ARCH VIROL, V160, P2781, DOI 10.1007/s00705-015-2513-0
   Zhu WJ, 2012, J VIROL, V86, P13119, DOI 10.1128/JVI.02361-12
NR 58
TC 3
Z9 3
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 17
PY 2018
VL 8
AR 12360
DI 10.1038/s41598-018-30258-3
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ6YL
UT WOS:000441876700063
PM 30120326
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Wispelaere, M
   Lian, WL
   Potisopon, S
   Li, PC
   Jang, JB
   Ficarro, SB
   Clark, MJ
   Zhu, XL
   Kaplan, JB
   Pitts, JD
   Wales, TE
   Wang, JH
   Engen, JR
   Marto, JA
   Gray, NS
   Yang, PL
AF de Wispelaere, Melissanne
   Lian, Wenlong
   Potisopon, Supanee
   Li, Pi-Chun
   Jang, Jaebong
   Ficarro, Scott B.
   Clark, Margaret J.
   Zhu, Xuling
   Kaplan, Jenifer B.
   Pitts, Jared D.
   Wales, Thomas E.
   Wang, Jinhua
   Engen, John R.
   Marto, Jarrod A.
   Gray, Nathanael S.
   Yang, Priscilla L.
TI Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral
   Envelope Protein
SO CELL CHEMICAL BIOLOGY
LA English
DT Article
ID WEST-NILE-VIRUS; EXCHANGE-MASS-SPECTROMETRY; DENGUE-VIRUS;
   MEMBRANE-FUSION; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; GLYCOPROTEIN;
   ENTRY; LOCALIZATION; PEPTIDE
AB Viral envelope proteins are required for productive viral entry and initiation of infection. Although the humoral immune system provides ample evidence for targeting envelope proteins as an antiviral strategy, there are few pharmacological interventions that have this mode of action. In contrast to classical antiviral targets such as viral proteases and polymerases, viral envelope proteins as a class do not have a well-conserved active site that can be rationally targeted with small molecules. We previously identified compounds that inhibit dengue virus by binding to its envelope protein, E. Here, we show that these small molecules inhibit dengue virus fusion and map the binding site of these compounds to a specific pocket on E. We further demonstrate inhibition of Zika, West Nile, and Japanese encephalitis viruses by these compounds, providing pharmacological evidence for the pocket as a target for developing broad-spectrum antivirals against multiple, mosquito-borne flavivirus pathogens.
C1 [de Wispelaere, Melissanne; Lian, Wenlong; Potisopon, Supanee; Clark, Margaret J.; Zhu, Xuling; Kaplan, Jenifer B.; Pitts, Jared D.; Yang, Priscilla L.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA.
   [Li, Pi-Chun; Jang, Jaebong; Wang, Jinhua; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Li, Pi-Chun; Jang, Jaebong; Wang, Jinhua; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Ficarro, Scott B.; Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Dept Oncol Pathol, Dept Canc Biol, 360 Longwood Ave, Boston, MA 02215 USA.
   [Ficarro, Scott B.; Marto, Jarrod A.] Brigham & Womens Hosp, Dept Pathol, 45 Francis St, Boston, MA 02115 USA.
   [Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.
   [Potisopon, Supanee] Bioaster, F-69007 Lyon, France.
   [Zhu, Xuling] Elpidera Moderna Therapeut, Cambridge, MA 02139 USA.
   [Kaplan, Jenifer B.] Abbvie Biores Ctr, Worcester, MA USA.
RP Yang, PL (corresponding author), Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA.
EM priscilla_yang@hms.harvard.edu
RI de Wispelaere, Melissanne/S-3117-2019
OI de Wispelaere, Melissanne/0000-0002-0682-3054
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI095499, U19AI109740, U54AI057159,
   CA188881, GM101135, T32AI007245]; Waters Corp; Harvard Medical School
FX Stephen C. Harrison, Aaron Schmidt, Nicholas Kwiatkowski, and members of
   the Yang, Harrison, and Gray labs are thanked for scientific
   discussions. Stephen C. Harrison, Ian Walker, and Daryl Klein are also
   thanked for technical assistance in expression of recombinant sE
   proteins. We thank the following colleagues for sharing reagents:
   Gregory Gromowski for JEV SA14-14-2; Didier Musso and Nathalie Pardigon
   for ZIKV PF13-251013-18; John Aaskov for the hybridoma cell line
   producing Mab 6F3.1 against DENV core; Theodore Pierson for plasmids to
   produce DENV and WNV single-cycle reporter viruses; Lee Gehrke for DENV2
   New Guinea C virus; Eva Harris for BHK-21 cells; Stephen C. Harrison for
   the synthetic DENV2 sE gene and cell lines. Kelly Arnett and the Center
   for Macromolecular Interactions and Jennifer Smith and the ICCB-Longwood
   Screening Facility provided access to instruments and technical support.
   We thank Matthew Henn, Sinead Chapman, and the Viral Genomics Sequencing
   group at The Broad Institute of Harvard and MIT for sequencing of dengue
   virus quasispecies. The Nancy Lurie Marks Medicinal Chemistry Laboratory
   at the Dana-Farber Cancer Institute provided access to compounds. We
   thank Congressman Michael Capuano and his staff for assistance importing
   ZIKV PF13-251013-18 virus. We thank Wendy Jackelow for assistance with
   graphic art and figure preparation. This work was supported by NIH
   R01AI095499 (P.L.Y.), NIH U19AI109740, NIH U54AI057159, NIH CA188881
   (J.A.M.), NIH GM101135 (J.R.E.), and a research collaboration with the
   Waters Corp (J.R.E.). J.D.P. was supported by NIH T32AI007245. J.B.K.
   was supported by a Diversity Supplement to NIH R01AI095499 (P.L.Y.) and
   the Harvard Medical School Dean's Postdoctoral Fellowship.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760
   Alexander WM, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700091
   ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Butrapet S, 2011, VIROLOGY, V413, P118, DOI 10.1016/j.virol.2011.01.030
   Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   Ficarro SB, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5030020
   Gromowski GD, 2015, AM J TROP MED HYG, V92, P98, DOI 10.4269/ajtmh.14-0427
   Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kirschner AN, 2007, J VIROL, V81, P9216, DOI 10.1128/JVI.00575-07
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06
   RAPAPORT D, 1995, EMBO J, V14, P5524, DOI 10.1002/j.1460-2075.1995.tb00239.x
   Schmidt A. G., 2011, INHIBITION SMALL MOL
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064
   Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862
   Wang LT, 2002, MOL CELL PROTEOMICS, V1, P132, DOI 10.1074/mcp.M100009-MCP200
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
NR 40
TC 18
Z9 18
U1 1
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2451-9448
J9 CELL CHEM BIOL
JI Cell Chem. Biol.
PD AUG 16
PY 2018
VL 25
IS 8
BP 1006
EP +
DI 10.1016/j.chembiol.2018.05.011
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GQ6CZ
UT WOS:000441791200010
PM 29937406
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Montoya, M
   Collins, M
   Dejnirattisai, W
   Katzelnick, LC
   Puerta-Guardo, H
   Jadi, R
   Schildhauer, S
   Supasa, P
   Vasanawathana, S
   Malasit, P
   Mongkolsapaya, J
   de Silva, AD
   Tissera, H
   Balmaseda, A
   Screaton, G
   de Silva, AM
   Harris, E
AF Montoya, Magelda
   Collins, Matthew
   Dejnirattisai, Wanwisa
   Katzelnick, Leah C.
   Puerta-Guardo, Henry
   Jadi, Ramesh
   Schildhauer, Samuel
   Supasa, Piyada
   Vasanawathana, Sirijitt
   Malasit, Prida
   Mongkolsapaya, Juthathip
   de Silva, Aruna D.
   Tissera, Hasitha
   Balmaseda, Angel
   Screaton, Gavin
   de Silva, Aravinda M.
   Harris, Eva
TI Longitudinal Analysis of Antibody Cross-neutralization Following Zika
   Virus and Dengue Virus Infection in Asia and the Americas
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Zika virus; neutralizing antibodies; cross-reactivity;
   Latin America; Asia; flavivirus; longitudinal; Nicaragua
ID DEPENDENT ENHANCEMENT; PEDIATRIC COHORT; REACTIVITY; DISEASE; RESPONSES;
   VACCINE; HUMANS; BURDEN
AB Background. The 4 dengue virus serotypes (DENV1-4) and Zika virus (ZIKV) are related mosquito-borne flaviviruses of major importance globally. While monoclonal antibodies and plasma from DENV-immune donors can neutralize or enhance ZIKV in vitro and in small-animal models, and vice versa, the extent, duration, and significance of cross-reactivity in humans remains unknown, particularly in flavivirus-endemic regions.
   Methods. We studied neutralizing antibodies to ZIKV and DENV1-4 in longitudinal serologic specimens collected through 3 years after infection from people in Latin America and Asia with laboratory-confirmed DENV infections. We also evaluated neutralizing antibodies to ZIKV and DENV1-4 in patients with Zika through 6 months after infection.
   Results. In patients with Zika, the highest neutralizing antibody titers were to ZIKV, with low-level cross-reactivity to DENV1-4 that was greater in DENV-immune individuals. We found that, in primary and secondary DENV infections, neutralizing antibody titers to ZIKV were markedly lower than to the infecting DENV and heterologous DENV serotypes. Cross-neutralization was greatest in early convalescence, then ZIKV neutralization decreased, remaining at low levels over time.
   Conclusions. Patterns of antibody cross-neutralization suggest that ZIKV lies outside the DENV serocomplex. Neutralizing antibody titers can distinguish ZIKV from DENV infections when all viruses are analyzed simultaneously. These findings have implications for understanding natural immunity and vaccines.
C1 [Montoya, Magelda; Katzelnick, Leah C.; Puerta-Guardo, Henry; Schildhauer, Samuel; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Collins, Matthew; Jadi, Ramesh; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Dejnirattisai, Wanwisa; Supasa, Piyada; Mongkolsapaya, Juthathip; Screaton, Gavin] Imperial Coll London, Div Immunol & Inflammat, Dept Med, Hammersmith Campus, London, England.
   [Vasanawathana, Sirijitt] Khon Kaen Hosp, Pediat Dept, Khon Kaen, Thailand.
   [Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand.
   [Malasit, Prida] Natl Sci & Technol Dev Agcy, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand.
   [de Silva, Aruna D.] Minist Hlth, Genetech Res Inst, Colombo, Sri Lanka.
   [Tissera, Hasitha] Minist Hlth, Epidemiol Unit, Colombo, Sri Lanka.
   [Balmaseda, Angel] Minist Hlth, Lab Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [de Silva, Aruna D.; Screaton, Gavin] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford, England.
   [de Silva, Aruna D.] Kotelawala Def Univ, Fac Med, Ratmalana, Sri Lanka.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Li Ka Shing Ctr 185, 1951 Oxford St, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
RI Tissera, Hasitha/AAQ-2516-2020
OI Screaton, Gavin/0000-0002-3549-4309; Schildhauer,
   Samuel/0000-0001-7139-1086
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01AI106695,
   U19AI118610, R01AI099631, R21/R33AI100186]; Centers for Disease Control
   and PreventionUnited States Department of Health & Human ServicesCenters
   for Disease Control & Prevention - USA [00HVCLJB-2017-04191]; Wellcome
   TrustWellcome Trust; Newton Medical Research Council
FX This work was supported by the National Institutes of Health (grants
   P01AI106695 [to E. H. and A. D. d. S.], U19AI118610 [to E. H.],
   R01AI099631 [to A. B.], and R21/R33AI100186 [to A. B.]), the Centers for
   Disease Control and Prevention (contract 00HVCLJB-2017-04191 to A. D. d.
   S.), the Wellcome Trust (to G. S.), and the Newton Medical Research
   Council (J. M.).
CR ARBASPAETH GB, 2016, NATURE, V539
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Baronti C, 2014, GENOME ANNOUNC, V2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dyer O, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5577
   FERNANDEZ RJ, 1990, MEM I OSWALDO CRUZ, V85, P347, DOI 10.1590/S0074-02761990000300012
   Gutierrez G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002385
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead S.B., 2015, F1000RESEARCH, V4, pF1000, DOI DOI 10.12688/F1000RESEARCH.7024.1
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   PAHO WHO, DENGUE
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   SAGE, 2014, SAGE WORKING GROUP J
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tissera H, 2014, AM J TROP MED HYG, V91, P132, DOI 10.4269/ajtmh.13-0540
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yenchitsomanus Pa-Thai, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P228
NR 49
TC 41
Z9 41
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2018
VL 218
IS 4
BP 536
EP 545
DI 10.1093/infdis/jiy164
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GN6GQ
UT WOS:000439176000007
PM 29618091
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Tesla, B
   Demakovsky, LR
   Mordecai, EA
   Ryan, SJ
   Bonds, MH
   Ngonghala, CN
   Brindley, MA
   Murdock, CC
AF Tesla, Blanka
   Demakovsky, Leah R.
   Mordecai, Erin A.
   Ryan, Sadie J.
   Bonds, Matthew H.
   Ngonghala, Calistus N.
   Brindley, Melinda A.
   Murdock, Courtney C.
TI Temperature drives Zika virus transmission: evidence from empirical and
   mathematical models
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE mosquito; arbovirus; temperature; Aedes aegypti; Zika
ID VECTOR-BORNE DISEASES; MALARIA TRANSMISSION; DENGUE; INFECTION;
   EPIDEMIC; MOSQUITO; FLUCTUATIONS; HISTORY; CLIMATE; R-0
AB Temperature is a strong driver of vector-borne disease transmission. Yet, for emerging arboviruses we lack fundamental knowledge on the relationship between transmission and temperature. Current models rely on the untested assumption that Zika virus responds similarly to dengue virus, potentially limiting our ability to accurately predict the spread of Zika. We conducted experiments to estimate the thermal performance of Zika virus (ZIKV) in field-derived Aedes aegypti across eight constant temperatures. We observed strong, unimodal effects of temperature on vector competence, extrinsic incubation period and mosquito survival. We used thermal responses of these traits to update an existing temperature-dependent model to infer temperature effects on ZIKV transmission. ZIKV transmission was optimized at 29 degrees C, and had a thermal range of 22.7 degrees C-34.7 degrees C. Thus, as temperatures move towards the predicted thermal optimum (29 degrees C) owing to climate change, urbanization or seasonality, Zika could expand north and into longer seasons. By contrast, areas that are near the thermal optimum were predicted to experience a decrease in overall environmental suitability. We also demonstrate that the predicted thermal minimum for Zika transmission is 58 degrees C warmer than that of dengue, and current global estimates on the environmental suitability for Zika are greatly over-predicting its possible range.
C1 [Tesla, Blanka; Demakovsky, Leah R.; Brindley, Melinda A.; Murdock, Courtney C.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
   [Tesla, Blanka; Murdock, Courtney C.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Dept Populat Hlth, Athens, GA 30602 USA.
   [Brindley, Melinda A.; Murdock, Courtney C.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, River Basin Ctr, Athens, GA 30602 USA.
   [Mordecai, Erin A.] Stanford Univ, Biol Dept, Stanford, CA 94305 USA.
   [Ryan, Sadie J.] Univ Florida, Quantitat Dis Ecol & Conservat Lab, Dept Geog, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Ngonghala, Calistus N.] Univ Florida, Dept Math, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Coll Life Sci, Durban, South Africa.
   [Bonds, Matthew H.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.
RP Murdock, CC (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.; Murdock, CC (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.; Murdock, CC (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Murdock, CC (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.; Murdock, CC (corresponding author), Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.; Murdock, CC (corresponding author), Univ Georgia, River Basin Ctr, Athens, GA 30602 USA.
EM cmurdock@uga.edu
OI Mordecai, Erin/0000-0002-4402-5547; Ryan, Sadie/0000-0002-4308-6321
FU National Science FoundationNational Science Foundation (NSF); Grants for
   Rapid Response Research (NSF-RAPID) [1640780]; NSFNational Science
   Foundation (NSF) [DEB-1518681]; Stanford University Woods Institute for
   the Environment Environmental Ventures Program; CDCUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [1U01CK000510-01]; Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX This study was supported by the National Science Foundation, Grants for
   Rapid Response Research (NSF-RAPID) 1640780. E.A.M. and S.J.R. were
   supported by NSF DEB-1518681. E.A.M. was additionally supported by the
   Stanford University Woods Institute for the Environment Environmental
   Ventures Program. S.J.R. was additionally supported by the CDC grant no.
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: the Gateway Program, to S.J.R. This publication
   was supported by the Cooperative Agreement Number above from the Centers
   for Disease Control and Prevention.
CR Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9
   Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0
   Bacaer N, 2012, J MATH BIOL, V65, P601, DOI 10.1007/s00285-011-0479-4
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bivand R., 2017, RGDAL BINDINGS GEOSP
   Bivand R., 2017, MAPTOOLS TOOLS READI
   Brady OJ, 2015, INT HEALTH, V7, P121, DOI 10.1093/inthealth/ihv010
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2016, ENVIRON HEALTH INSIG, V10, P119, DOI [10.4137/EHI.S38345, 10.4137/ehi.s38345]
   Christofferson RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110538
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Dell AI, 2013, ECOLOGY, V94, P1205, DOI DOI 10.1890/12-2060.1
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   ESRI, 2015, ARCGIS DESKT
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   GADM, 2012, GADM DAT GLOB ADM AR
   Gloria-Soria A, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1506
   Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Hijmans R, 2016, RASTER GEOGRAPHIC DA
   HOUK EJ, 1979, ACTA TROP, V36, P39
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Johnson F., 1974, THEORY RATE PROCESSE
   Johnson LR, 2015, ECOLOGY, V96, P203, DOI 10.1890/13-1964.1
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Murdock CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27771
   Murdock CC, 2012, P ROY SOC B-BIOL SCI, V279, P3357, DOI 10.1098/rspb.2012.0638
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075
   Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   R Core Team, 2017, R LANG ENV STAT COMP
   Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, pe1918, DOI 10.1371/journal.pntd.0001918
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Shapiro LLM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003489
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325
   Siraj AS, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.73
   Siraj AS, 2018, DRYAD DATA REPOSITOR, DOI [10.5061/dryad.83nj1.2, DOI 10.5061/DRYAD.83NJ1.2]
   Tesla B, 2018, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.7hj6q4c, DOI 10.5061/DRYAD.7HJ6Q4C]
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 60
TC 20
Z9 20
U1 4
U2 31
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD AUG 15
PY 2018
VL 285
IS 1884
AR 20180795
DI 10.1098/rspb.2018.0795
PG 9
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA GQ5LT
UT WOS:000441725900004
PM 30111605
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Imran, M
   Usman, M
   Malik, T
   Ansari, AR
AF Imran, Mudassar
   Usman, Muhammad
   Malik, Tufail
   Ansari, Ali R.
TI Mathematical analysis of the role of hospitalization/isolation in
   controlling the spread of Zika fever
SO VIRUS RESEARCH
LA English
DT Article
DE Zika virus; Basic reproduction number; Steady states; Stability
   analysis; Optimal control
ID TRANSMISSION DYNAMICS; DENGUE-DISEASE; VIRUS DYNAMICS; PERSISTENCE;
   MODEL
AB The Zika virus is transmitted to humans primarily through Aedes mosquitoes and through sexual contact. It is documented that the virus can be transmitted to newborn babies from their mothers. We consider a deterministic model for the transmission dynamics of the Zika virus infectious disease that spreads in, both humans and vectors, through horizontal and vertical transmission. The total populations of both humans and mosquitoes are assumed to be constant. Our models consist of a system of eight differential equations describing the human and vector populations during the different stages of the disease. We have included the hospitalization/isolation class in our model to see the effect of the controlling strategy. We determine the expression for the basic reproductive number R-0 in terms of horizontal as well as vertical disease transmission rates.
   An in-depth stability analysis of the model is performed, and it is consequently shown, that the model has a globally asymptotically stable disease-free equilibrium when the basic reproduction number R-0 < 1. It is also shown that when R-0 > 1, there exists a unique endemic equilibrium. We showed that the endemic equilibrium point is globally asymptotically stable when it exists. We were able to prove this result in a reduced model. Furthermore, we conducted an uncertainty and sensitivity analysis to recognize the impact of crucial model parameters on R-0. The uncertainty analysis yields an estimated value of the basic reproductive number R-0 = 1.54. Assuming infection prevalence in the population under constant control, optimal control theory is used to devise an optimal hospitalization/isolation control strategy for the model. The impact of isolation on the number of infected individuals and the accumulated cost is assessed and compared with the constant control case.
C1 [Imran, Mudassar; Ansari, Ali R.] Gulf Univ Sci & Technol, Dept Math & Nat Sci, Int Ctr Appl Math & Computat Bioengn, Mishref, Kuwait.
   [Usman, Muhammad] Univ Dayton, Dept Math, Dayton, OH 45469 USA.
   [Malik, Tufail] Arizona State Univ, Dept Sci & Math, Mesa, AZ 85212 USA.
RP Imran, M (corresponding author), Gulf Univ Sci & Technol, Dept Math & Nat Sci, Int Ctr Appl Math & Computat Bioengn, Mishref, Kuwait.
EM mimran@asu.edu
RI Ansari, Ali R/B-5810-2011
OI Ansari, Ali R/0000-0001-5090-7813
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Anderson B., 2016, PRAIRIE RES, V29, P1
   Centers for Disease Control and Prevention (CDC), SEX TRANSM PREV
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Esteva L, 1999, J MATH BIOL, V38, P220, DOI 10.1007/s002850050147
   Esteva L, 1998, MATH BIOSCI, V150, P131, DOI 10.1016/S0025-5564(98)10003-2
   Esteva L, 2003, J MATH BIOL, V46, P31, DOI 10.1007/s00285-002-0168-4
   Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9
   European Centre for Disease prevention and Control (ECDC), MICR BRAZ POT LINK Z
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   Fleming W. H., 1975, DETERMINISTIC STOCHA
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Garba SM, 2010, INT J COMPUT MATH, V87, P2361, DOI 10.1080/00207160802660608
   Gumel A. B., 2003, P R SOC B, V271
   Hastings A., 2003, YALE J BIOL MED, V271
   Hayes E. B., 2009, ZIKA VIRUS OUTSIDE A, V15
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Imran M., 2013, J BIOL DYN, V7
   Imran M., 2017, DIFFER EQU DYN SYST, DOI [10.1007/s12591-017-0374-6, DOI 10.1007/S12591-017-0374-6]
   Kautner I., 1997, J PEDIAT, V131
   Khan A, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-12
   Kirschner D., 1997, MATH BIOL, V35
   Krow-Lucal E. R., 2017, CTR DIS CONTROL PREY, V23, P509
   Li M. Y., 2001, SIAM J APP MATH, V62
   Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616
   Lloyd-Smith J.O., 2003, P R SOC LOND B, V170
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Pan American Health Organization, 2018, ZIK CUM CAS
   Pontryagin L, 1980, MATH THEORY OPTIMAL
   Salceanu PL, 2011, MATH BIOSCI ENG, V8, P807, DOI 10.3934/mbe.2011.8.807
   Smith H. L., 2011, AM MATH SOC, V118
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   THIEME HR, 1992, J MATH BIOL, V30, P755
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Vivas-Barber A., 2015, BIOMATH, V3
   Wearing H. J., 2006, P NATL ACAD SCI, V103
   Wiratsudakul A., 2018, PEERJ, P1
NR 38
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 15
PY 2018
VL 255
BP 95
EP 104
DI 10.1016/j.virusres.2018.07.002
PG 10
WC Virology
SC Virology
GA GT2UX
UT WOS:000444356900012
PM 30003923
OA Green Published
DA 2020-07-08
ER

PT J
AU Giulietti, M
   Righetti, A
   Cianfruglia, L
   Sabanovic, B
   Armeni, T
   Principato, G
   Piva, F
AF Giulietti, M.
   Righetti, A.
   Cianfruglia, L.
   Sabanovic, B.
   Armeni, T.
   Principato, G.
   Piva, F.
TI To accelerate the Zika beat: Candidate design for RNA interference-based
   therapy
SO VIRUS RESEARCH
LA English
DT Article
DE RNA interference; siRNA design; Safety; Off-Target; Zika; Genome
   alignment
ID HUMAN SPLICING FACTORS; HEPATITIS-C VIRUS; GENE-EXPRESSION; ANTIVIRAL
   RNA; SIRNA DESIGN; DATABASE; REPLICATION; SPLICEAID; SELECTION;
   IDENTIFICATION
AB Zika virus infection is associated with the development of severe neurological disorders in adults and newborns, Although at the moment Zika virus outbreak is not threatening to become again an emergency, infection cases are still being sporadically reported and there is still no effective therapy available. A possible treatment to suppress Zika replication is represented by short interfering RNAs (siRNAs), since they have been successfully used even against Ebola, H5N1 and SARS viruses and clinical trials of siRNA-based drugs are ongoing. In order to speed up the time consuming experimental validation of effective siRNAs, we have performed a comprehensive bioinformatic analysis to design only a few promising siRNAs against Zika virus. Besides siRNA efficacy, we paid attention to broad-spectrum antiviral activity, obtained by analysing all known Zika genomes, and siRNA safety, by excluding siRNAs that could potentially provoke an immune response or interfere with host mRNAs, IncRNAs, circRNAs and RNA binding proteins. In Zika genome we identified several highly conserved regions targetable by only 20 siRNAs. In particular, only a few siRNAs survived highly stringent criteria for siRNA safety. Notably, two of our candidate siRNAs have been successfully used against other flaviviruses like Zika, both in in vitro and in vivo models. Since they were effective against two different flaviviruses, by targeting a highly conserved region, it is reasonable to hypothesize that they could be active also against Zika. Therefore, we encourage researchers to experimentally validate these promising siRNAs.
C1 [Giulietti, M.; Righetti, A.; Cianfruglia, L.; Armeni, T.; Principato, G.; Piva, F.] Polytech Univ Marche, Dept Specialist Clin & Odontostomatol Sci, Via Brecce Bianche, I-60131 Ancona, Italy.
   [Sabanovic, B.] Polytech Univ Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy.
RP Giulietti, M (corresponding author), Polytech Univ Marche, Dept Specialist Clin & Odontostomatol Sci, Via Brecce Bianche, I-60131 Ancona, Italy.
EM m.giulietti@univpm.it; righetti@pm.univpm.it; l.cianfruglia@univpm.it;
   sabanovic.b@gmail.com; t.armeni@univpm.it; g.b.principato@univpm.it;
   f.piva@univpm.it
RI Armeni, Tatiana/J-8228-2013
OI Armeni, Tatiana/0000-0003-0931-1342; Giulietti,
   Matteo/0000-0002-9871-265X
CR Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005
   Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157
   Angart P, 2013, PHARMACEUTICALS, V6, P440, DOI 10.3390/ph6040440
   Anthony KG, 2009, ANTIVIR RES, V82, P166, DOI 10.1016/j.antiviral.2008.12.007
   Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507
   Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103
   Bianchi F, 2011, FAM CANCER, V10, P27, DOI 10.1007/s10689-010-9371-4
   Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278
   Bobbin ML, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0174-y
   Boudreau RL, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks797
   Bowen J. R., 2017, VIRUS RES
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao YL, 2011, MOLECULES, V16, P1544, DOI 10.3390/molecules16021544
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069
   Cunha-Neto E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00640
   Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190
   Deng Y, 2014, GENE, V538, P217, DOI 10.1016/j.gene.2013.12.019
   Diosa-Toro M, 2013, ADV VIRUS RES, V85, P91, DOI 10.1016/B978-0-12-408116-1.00004-5
   Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111
   Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312
   Giulietti M, 2015, BIOINFORMATICS, V31, P246, DOI 10.1093/bioinformatics/btu620
   Giulietti M, 2013, NUCLEIC ACIDS RES, V41, pD125, DOI 10.1093/nar/gks997
   Goertz GP, 2017, VIRUS RES, V254, P41
   Gong WM, 2008, BIOINFORMATICS, V24, P2405, DOI 10.1093/bioinformatics/btn442
   Gredell JA, 2008, BIOTECHNOL BIOENG, V100, P744, DOI 10.1002/bit.21798
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480
   Hashem MA, 2017, J YOUNG PHARM, V9, P23, DOI 10.5530/jyp.2017.9.5
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835
   Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112
   Kakumani PK, 2015, BIOCHEM J, V471, P89, DOI 10.1042/BJ20150445
   Kalvari I, 2018, NUCLEIC ACIDS RES, V46, pD335, DOI 10.1093/nar/gkx1038
   Khantasup K, 2014, ANTIMICROB AGENTS CH, V58, P2816, DOI 10.1128/AAC.02768-13
   Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lam JKW, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.23
   Leonard JN, 2006, GENE THER, V13, P532, DOI 10.1038/sj.gt.3302645
   Liu YC, 2016, NUCLEIC ACIDS RES, V44, pD209, DOI 10.1093/nar/gkv940
   McCown M, 2003, VIROLOGY, V313, P514, DOI 10.1016/S0042-6822(03)00341-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372
   Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392
   Ong SP, 2006, ANTIVIR RES, V72, P216, DOI 10.1016/j.antiviral.2006.06.005
   Paul AM, 2014, J GEN VIROL, V95, P1712, DOI 10.1099/vir.0.066084-0
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Piva F, 2015, ONCOTARGET, V6, P32161, DOI 10.18632/oncotarget.5147
   Piva F, 2012, HUM MUTAT, V33, P81, DOI 10.1002/humu.21609
   Piva F, 2011, HUM PSYCHOPHARM CLIN, V26, P365, DOI 10.1002/hup.1214
   Piva F, 2010, HUM PSYCHOPHARM CLIN, V25, P153, DOI 10.1002/hup.1100
   Piva F, 2009, BIOINFORMATICS, V25, P1211, DOI 10.1093/bioinformatics/btp124
   Qureshi A, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1976
   Qureshi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-305
   Raheel U, 2015, VIRAL IMMUNOL, V28, P378, DOI 10.1089/vim.2015.0034
   Ren YL, 2009, NUCLEIC ACIDS RES, V37, pD146, DOI 10.1093/nar/gkn817
   Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936
   Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060
   Sagan SM, 2010, CHEM BIOL, V17, P515, DOI 10.1016/j.chembiol.2010.04.011
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scarola M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8631
   Shawan M. M. A. K., 2015, NAT SCI, V13, P37, DOI DOI 10.1017/CBO9781107415324.004
   Stein DA, 2011, J VIROL, V85, P10154, DOI 10.1128/JVI.05298-11
   Stojic L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10406
   Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08
   Sugiyama R, 2009, J BIOCHEM, V146, P481, DOI 10.1093/jb/mvp093
   Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tatiparti K, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040077
   Thakur N, 2012, NUCLEIC ACIDS RES, V40, pD230, DOI 10.1093/nar/gkr1147
   Thi EP, 2015, NATURE, V521, P362, DOI 10.1038/nature14442
   Tyagi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025917
   Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247
   Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
   von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wooddell CI, 2013, MOL THER, V21, P973, DOI 10.1038/mt.2013.31
   Wu XW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-270
   Wu ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026304
   Yang YB, 2008, J MED VIROL, V80, P930, DOI 10.1002/jmv.21164
   Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889
   Zhang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-118
   ZHANG W, 2004, GENET VACCINES THER, V2, P8, DOI DOI 10.1186/1479-0556-2-8
   Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252
NR 89
TC 4
Z9 4
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 15
PY 2018
VL 255
BP 133
EP 140
DI 10.1016/j.virusres.2018.07.010
PG 8
WC Virology
SC Virology
GA GT2UX
UT WOS:000444356900016
PM 30031046
DA 2020-07-08
ER

PT J
AU Sherman, KE
   Rouster, SD
   Kong, LX
   Shata, TM
   Archampong, T
   Kwara, A
   Aliota, MT
   Blackard, JT
AF Sherman, Kenneth E.
   Rouster, Susan D.
   Kong, Ling X.
   Shata, Tarek M.
   Archampong, Timothy
   Kwara, Awewura
   Aliota, Matthew T.
   Blackard, Jason T.
TI Zika Virus Exposure in an HIV-Infected Cohort in Ghana
SO JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
LA English
DT Letter
ID PATIENT
C1 [Sherman, Kenneth E.; Rouster, Susan D.; Kong, Ling X.; Shata, Tarek M.; Blackard, Jason T.] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45220 USA.
   [Archampong, Timothy] Univ Ghana, Sch Med & Dent, Coll Hlth Sci, Accra, Ghana.
   [Kwara, Awewura] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.
   [Kwara, Awewura] Univ Florida, Coll Med, Gainesville, FL USA.
   [Aliota, Matthew T.] Univ Wisconsin, Madison, WI USA.
RP Sherman, KE (corresponding author), Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45220 USA.
OI Aliota, Matthew/0000-0002-6902-9149
FU CFAR Grant [AI042853]; University of Cincinnati, Department of Medicine;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI132563, R56AI132563, R21AI131454]
FX Supported by funding from CFAR Grant AI042853 and by a Distinguished
   Investigator Award from the University of Cincinnati, Department of
   Medicine. M.T.A. received NIH funding from R01AI132563, R56AI132563, and
   R21AI131454.
CR Archampong TNA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1342-4
   Barreiro P, 2016, AIDS REV, V18, P112
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
NR 11
TC 4
Z9 4
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1525-4135
EI 1077-9450
J9 JAIDS-J ACQ IMM DEF
JI JAIDS
PD AUG 15
PY 2018
VL 78
IS 5
BP E35
EP E38
DI 10.1097/QAI.0000000000001718
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GT6PD
UT WOS:000444637400002
PM 29771784
OA Green Accepted
DA 2020-07-08
ER

PT J
AU To, ACY
   Chu, DHT
   Wang, AR
   Li, FCY
   Chiu, AWO
   Gao, DY
   Choi, CHJ
   Kong, SK
   Chan, TF
   Chan, KM
   Yip, KY
AF To, Andrew Ching-Yuet
   Chu, David Ho-Ting
   Wang, Angela Ruoning
   Li, Frances Cheuk-Yau
   Chiu, Alan Wai-On
   Gao, Daisy Yuwei
   Choi, Chung Hang Jonathan
   Kong, Siu-Kai
   Chan, Ting-Fung
   Chan, King-Ming
   Yip, Kevin Y.
TI A comprehensive web tool for toehold switch design
SO BIOINFORMATICS
LA English
DT Article
AB Motivation: Toehold switches are a class of RNAs with a hairpin loop that can be unfolded upon binding a trigger RNA, thereby exposing a ribosome binding site (RBS) and permitting translation of the reporter protein. They have been shown very useful in detecting a variety of targets including RNAs from Zika and Ebola viruses. The base complementation between the toehold switch and the trigger RNA also makes it sensitive to sequence variations. Design of toehold switches involves a series of considerations related to their sequence properties, structures and specificities.
   Results: Here we present the first comprehensive web tool for designing toehold switches. We also propose a score for predicting the efficacy of designed toehold switches based on properties learned from similar to 180 experimentally tested switches.
   Availability and implementation: The toehold switch web tool is available at https://yiplab.cse.cuhk.edu.hk/toehold/.
   Contact:kevinyip@cse.cuhk.edu.hk
C1 [To, Andrew Ching-Yuet; Chu, David Ho-Ting; Wang, Angela Ruoning; Kong, Siu-Kai; Chan, Ting-Fung; Chan, King-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.
   [Li, Frances Cheuk-Yau; Gao, Daisy Yuwei; Yip, Kevin Y.] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Shatin, Hong Kong, Peoples R China.
   [Chiu, Alan Wai-On; Gao, Daisy Yuwei; Choi, Chung Hang Jonathan; Yip, Kevin Y.] Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China.
RP Yip, KY (corresponding author), Chinese Univ Hong Kong, Dept Comp Sci & Engn, Shatin, Hong Kong, Peoples R China.; Yip, KY (corresponding author), Chinese Univ Hong Kong, Dept Biomed Engn, Shatin, Hong Kong, Peoples R China.
EM kevinyip@cse.cuhk.edu.hk
RI Chan, TingFung/A-6161-2013
OI Chan, TingFung/0000-0002-0489-3884; Chan, King Ming/0000-0003-4761-7844;
   Yip, Kevin/0000-0001-5516-9944; Choi, Chung Hang
   Jonathan/0000-0003-2935-7217
CR Green AA, 2017, NATURE, V548, P117, DOI 10.1038/nature23271
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   Hall M., 2009, SIGKDD EXPLORATIONS, V11, P1, DOI DOI 10.1145/1656274.1656278
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
NR 4
TC 3
Z9 3
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD AUG 15
PY 2018
VL 34
IS 16
BP 2862
EP 2864
DI 10.1093/bioinformatics/bty216
PG 3
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA GQ5NB
UT WOS:000441730900025
PM 29648573
OA Bronze
DA 2020-07-08
ER

PT J
AU Campos, MC
   Dombrowski, JG
   Phelan, J
   Marinho, CRF
   Hibberd, M
   Clark, TG
   Campino, S
AF Campos, Monica C.
   Dombrowski, Jamille G.
   Phelan, Jody
   Marinho, Claudio R. F.
   Hibberd, Martin
   Clark, Taane G.
   Campino, Susana
TI Zika might not be acting alone: Using an ecological study approach to
   investigate potential co-acting risk factors for an unusual pattern of
   microcephaly in Brazil
SO PLOS ONE
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; CHIKUNGUNYA VIRUS-INFECTION; AEDES-ALBOPICTUS;
   BIRTH-DEFECTS; TRANSMISSION; AEGYPTI; PREGNANCY; OUTBREAK; BAHIA;
   COLOMBIA
AB Zika virus infections can cause a range of neurologic disorders including congenital microcephaly. However, while Zika infections have been notified across all regions in Brazil, there has been an unusual number of congenital microcephaly case notifications concentrated in the Northeast of the country. To address this observation, we investigated epidemiological data (2014-2016) on arbovirus co-distribution, environmental and socio-economic factors for each region in Brazil. Data on arbovirus reported cases and microcephaly were collected from several Brazilian Ministry of Health databases for each Federal unit. These were complemented by environmental management, social economic and Aedes aegypti infestation index data, extracted from multiple databases. Spatial time "ecological" analysis on the number of arboviruses transmitted by Aedes mosquitoes in Brazil show that the distribution of dengue and Zika was widespread in the whole country, with higher incidence in the West-Central region. However, reported chikungunya cases were higher in the Northeast, the region also with the highest number of microcephaly cases registered. Social economic factors (human development index and poverty index) and environmental management (water supply/storage and solid waste management) pointed the Northeast as the less wealthy region. The Northeast is also the region with the highest risk of Aedes aegypti house infestation due to the man-made larval habitats. In summary, the results of our ecological analysis support the hypothesis that the unusual distribution of microcephaly might not be due to Zika infection alone and could be accentuated by poverty and previous or co-infection with other pathogens. Our study reinforces the link between poverty and the risk of disease and the need to understand the effect on pathogenesis of sequential exposure to arboviruses and co-viral infections. Comprehensive large-scale cohort studies are required to corroborate our findings. We recommend that the list of infectious diseases screened, particularly during pregnancy, be regularly updated to include and effectively differentiate all viruses from ongoing outbreaks.
C1 [Campos, Monica C.; Phelan, Jody; Hibberd, Martin; Clark, Taane G.; Campino, Susana] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
   [Dombrowski, Jamille G.; Marinho, Claudio R. F.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   [Clark, Taane G.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
RP Campos, MC (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.
EM monica.campos@lshtm.ac.uk
RI Clark, Taane G./AAM-2570-2020; Campino, Susana/AAM-2577-2020; Marinho,
   Claudio Romero Farias/F-7507-2012; Dombrowski, Jamille
   Gregorio/F-4758-2014
OI Clark, Taane G./0000-0001-8985-9265; Campino,
   Susana/0000-0003-1403-6138; Marinho, Claudio Romero
   Farias/0000-0002-1227-3845; Dombrowski, Jamille
   Gregorio/0000-0002-1863-1914; Phelan, Jody/0000-0001-8323-7019; Hibberd,
   Martin/0000-0001-8587-1849
FU Medical Research Council UKMedical Research Council UK (MRC)
   [MR/M01360X/1, MC_PC_15103, MR/K000551/1, MR/N010469/1]; Sao Paulo
   Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2016/07030-0]; FAPESPFundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP) [2012/04755-3]
FX MCC and SC are funded by the Medical Research Council UK (Grant no.
   MR/M01360X/1, MC_PC_15103). TGC is supported by the Medical Research
   Council UK (Grant no. MR/K000551/1, MR/M01360X/1, MR/N010469/1,
   MC_PC_15103). CRFM was primarily funded by grant from Sao Paulo Research
   Foundation (FAPESP) (2016/07030-0). JD was supported by FAPESP
   fellowships (2012/04755-3). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agarwal A, 2017, J NEUROVIROL, V23, P504, DOI 10.1007/s13365-017-0516-1
   Aguiar BS, INT J INFECT DIS, DOI [10.1016/j.ijid.2018.02.007, DOI 10.1016/602018.02.007]
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Malta JMAS, 2017, EPIDEMIOL SERV SAUDE, V26, P9, DOI [10.5123/S1679-49742017000100002, 10.5123/s1679-49742017000100002]
   [Anonymous], 2017, B EPIDEMIOLOGICO, V48, P6
   [Anonymous], 2017, B EPIDEMIOLOGICO, V48, P3
   [Anonymous], 2014, B EPIDEMIOLOGIQUE HE, V424
   [Anonymous], 2017, B EPIDEMIOLOGICO, V48, P9
   Arias-Goeta C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057548
   Bank AM, 2016, J NEUROVIROL, V22, P125, DOI 10.1007/s13365-015-0372-9
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho MS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005632
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   de Souza WV, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00017216
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gardner LM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006194
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Kraemer MU, 2015, ELIFE, V4, DOI [10.77554/eLite.08347, DOI 10.77554/ELITE.08347]
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pelizzo G, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-59
   Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Phongsamart W, 2008, PEDIATR INFECT DIS J, V27, P500, DOI 10.1097/INF.0b013e318167917a
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Sala de Apoio a Gestao Estrategica (SAGE), SAL AP GEST ESTR SAG
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Tsuzuki A, 2009, ACTA TROP, V111, P325, DOI 10.1016/j.actatropica.2009.05.010
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WHO, PAN AM REP 2016
   World Health Organisation (WHO), 2017, MICR DEF
   World Health Organisation (WHO), 2017, WHO REP 2017
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 74
TC 14
Z9 14
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 15
PY 2018
VL 13
IS 8
AR e0201452
DI 10.1371/journal.pone.0201452
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ5PD
UT WOS:000441738000031
PM 30110370
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Espana, G
   Grefenstette, J
   Perkins, A
   Torres, C
   Carey, AC
   Diaz, H
   de la Hoz, F
   Burke, DS
   van Panhuis, WG
AF Espana, Guido
   Grefenstette, John
   Perkins, Alex
   Torres, Claudia
   Campo Carey, Alfonso
   Diaz, Hernando
   de la Hoz, Fernando
   Burke, Donald S.
   van Panhuis, Willem G.
TI Exploring scenarios of chikungunya mitigation with a data-driven
   agent-based model of the 2014-2016 outbreak in Colombia
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS; INFECTIOUS-DISEASE; AEDES-AEGYPTI; DENGUE; TRANSMISSION;
   EPIDEMIC; LESSONS; EBOLA; INTERVENTIONS; STRATEGIES
AB New epidemics of infectious diseases can emerge any time, as illustrated by the emergence of chikungunya virus (CHIKV) and Zika virus (ZIKV) in Latin America. During new epidemics, public health officials face difficult decisions regarding spatial targeting of interventions to optimally allocate limited resources. We used a large-scale, data-driven, agent-based simulation model (ABM) to explore CHIKV mitigation strategies, including strategies based on previous DENV outbreaks. Our model represents CHIKV transmission in a realistic population of Colombia with 45 million individuals in 10.6 million households, schools, and workplaces. Our model uses high-resolution probability maps for the occurrence of the Ae. aegypti mosquito vector to estimate mosquito density in Colombia. We found that vector control in all 521 municipalities with mosquito populations led to 402,940 fewer clinical cases of CHIKV compared to a baseline scenario without intervention. We also explored using data about previous dengue virus (DENV) epidemics to inform CHIKV mitigation strategies. Compared to the baseline scenario, 314,437 fewer cases occurred when we simulated vector control only in 301 municipalities that had previously reported DENV, illustrating the value of available data from previous outbreaks. When varying the implementation parameters for vector control, we found that faster implementation and scale-up of vector control led to the greatest proportionate reduction in cases. Using available data for epidemic simulations can strengthen decision making against new epidemic threats.
C1 [Espana, Guido; Perkins, Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Espana, Guido; Perkins, Alex] Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Grefenstette, John] Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA USA.
   [Torres, Claudia; Diaz, Hernando] Univ Nacl Colombia, Dept Elect Engn, Bogota, Colombia.
   [Campo Carey, Alfonso] Colombia Inst Nacl Salud, Grp Gest Riesgo & Respuesta Inmediata, Bogota, Colombia.
   [de la Hoz, Fernando] Univ Nacl Colombia, Dept Publ Hlth, Bogota, Colombia.
   [Burke, Donald S.; van Panhuis, Willem G.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.
   [van Panhuis, Willem G.] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA.
RP Espana, G (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Espana, G (corresponding author), Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
EM guido.espana@nd.edu
RI Van Panhuis, Willem/S-5495-2019
OI Van Panhuis, Willem/0000-0002-7278-9982; /0000-0002-5704-8094; Camargo
   Espana, guido/0000-0002-9915-8056
FU Benter Foundation (Public Health Dynamics Fellows Program); Bill and
   Melinda Gates FoundationGates Foundation [49276]; US National Institute
   of General Medical SciencesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [5U54GM088491]; National Science
   FoundationNational Science Foundation (NSF) [DEB 1641130]
FX G.E. J.G., C.T., H.D., F.D. L.H., D.S.B. and W.G. V.P. would like to
   thank the Benter Foundation (Public Health Dynamics Fellows Program) for
   their support. D.S.B., J.G., and W.G. V.P. would like to thank the Bill
   and Melinda Gates Foundation (Grant 49276, Evaluation of Candidate
   Vaccine Technologies Using Computational Models) and the US National
   Institute of General Medical Sciences (Grant 5U54GM088491, Computational
   Models of Infectious Disease Threats) for their support. G.E. and T.A.P.
   would like to thank the National Science Foundation (DEB 1641130) for
   support. The authors would also like to thank the NIH Models of
   Infectious Disease Agents (MIDAS) Informatics Services Group (ISG) for
   computing support and Dr. Angel Paternina at the University of
   Pittsburgh for review of the manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Allenby B, 2005, SCIENCE, V309, P1034, DOI 10.1126/science.1111534
   [Anonymous], 2015, DISM CAS CHIK SANT M
   Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165
   Cajka James C, 2010, Methods Rep RTI Press, V19, P1
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876
   Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795
   Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918
   Grefenstette JJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-940
   Guevara-Souza M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0746-2
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X
   Karunaratne SHPP, 2013, PESTIC BIOCHEM PHYS, V107, P98, DOI 10.1016/j.pestbp.2013.05.011
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kruk ME, 2015, LANCET, V385, P1910, DOI 10.1016/S0140-6736(15)60755-3
   Lima EP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2199-y
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Ndeffo-Mbah ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep23997
   Ocampo CB, 2009, BIOMEDICA, V29, P282, DOI 10.7705/biomedica.v29i2.30
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   Pan American Health Organization, 2016, CHIK STAT DAT
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, CUM ZIK SUSP CONF CA
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Public Health Dynamics Laboratory, 2016, THE FRED REP
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Redaccion Nacional, 2015, EL ESPECTADOR
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Rodriguez-Barraquer I, 2016, BIORXIV, DOI [10.1101/041095, DOI 10.1101/041095]
   Siraj AS, 2017, PLOS NEGLECT TROP D, P1
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stettler K, 2016, SCIENCE, V374, P1552
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 42
TC 2
Z9 2
U1 3
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 15
PY 2018
VL 8
AR 12201
DI 10.1038/s41598-018-30647-8
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ4FQ
UT WOS:000441625500024
PM 30111778
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Blohm, GM
   Lednicky, JA
   White, SK
   Mavian, CN
   Marquez, MC
   Gonzalez-Garcia, KP
   Salemi, M
   Morris, JG
   Paniz-Mondolfi, AE
AF Blohm, Gabriela M.
   Lednicky, John A.
   White, Sarah K.
   Mavian, Carla N.
   Marquez, Marilianna C.
   Gonzalez-Garcia, Kellyh P.
   Salemi, Marco
   Morris, J. Glenn, Jr.
   Paniz-Mondolfi, Alberto E.
TI Madariaga Virus: Identification of a Lineage III Strain in a Venezuelan
   Child With Acute Undifferentiated Febrile Illness, in the Setting of a
   Possible Equine Epizootic
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE acute febrile illness; epizootic; Madariaga virus; Venezuela
ID ENCEPHALITIS
AB We report identification of Madariaga virus (MADV) in plasma and urine samples from a child with acute undifferentiated febrile illness in Venezuela. Our data document the occurrence of milder MADV infections (ie, without encephalitis), with a symptom complex that resembles that seen with other arboviral infections, including dengue and zika.
C1 [Blohm, Gabriela M.; Lednicky, John A.; White, Sarah K.; Mavian, Carla N.; Salemi, Marco; Morris, J. Glenn, Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Blohm, Gabriela M.; Lednicky, John A.; White, Sarah K.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA.
   [Blohm, Gabriela M.; Marquez, Marilianna C.; Paniz-Mondolfi, Alberto E.] IDB Hosp, Biomed Res Inst, IDB, Dept Infect Dis & Trop Med, Barquisimeto, Lara, Venezuela.
   [Blohm, Gabriela M.; Marquez, Marilianna C.; Paniz-Mondolfi, Alberto E.] Venezuelan Sci Res Incubator, Zoonosis & Emerging Pathogens Collaborat Network, Barquisimeto, Lara, Venezuela.
   [Mavian, Carla N.; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.
   [Marquez, Marilianna C.; Gonzalez-Garcia, Kellyh P.] Univ Ctr Occidental Lisandro Alvarado, Coll Med, Hlth Sci Dept, Barquisimeto, Lara, Venezuela.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32611 USA.
   [Paniz-Mondolfi, Alberto E.] IVSS, Dept Res & Acad Affairs, Directorate Hlth, Caracas, Venezuela.
RP Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM jgmorris@ufl.edu
RI Lednicky, John A/C-5678-2012; mavian, carla/H-3410-2019
OI mavian, carla/0000-0003-3819-5520
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI126357-01S1];
   National Science FoundationNational Science Foundation (NSF) [1515734]
FX Work was supported in part by the National Institutes of Health grant
   R01 AI126357-01S1, awarded to J. G. M. and by the National Science
   Foundation, grant 1515734.
CR Aguilar PV, 2007, AM J TROP MED HYG, V76, P293, DOI 10.4269/ajtmh.2007.76.293
   Arrigo NC, 2010, J VIROL, V84, P1014, DOI 10.1128/JVI.01586-09
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024
   Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Luciani K, 2015, AM J TROP MED HYG, V92, P1130, DOI 10.4269/ajtmh.14-0845
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256
   Vittor AY, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004554
NR 12
TC 8
Z9 8
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2018
VL 67
IS 4
BP 619
EP 621
DI 10.1093/cid/ciy224
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GP6OA
UT WOS:000441000000027
PM 29718127
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lozier, MJ
   Rosenberg, ES
   Doyle, K
   Adams, L
   Klein, L
   Munoz-Jordan, J
   Alvarado, LI
   Sharp, TM
   Paz-Bailey, G
AF Lozier, Matthew J.
   Rosenberg, Eli S.
   Doyle, Kate
   Adams, Laura
   Klein, Liore
   Munoz-Jordan, Jorge
   Alvarado, Luisa I.
   Sharp, Tyler M.
   Paz-Bailey, Gabriela
TI Prolonged Detection of Zika Virus Nucleic Acid Among Symptomatic
   Pregnant Women: A Cohort Study
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION; BRAIN; RNA
AB A prospective cohort of women with reverse transcription polymerase chain reaction (RT-PCR) confirmed Zika virus infection aged 18-39 years in Puerto Rico found that pregnant women have about a 3-fold longer estimated median detection of Zika virus RNA in serum, which can increase definitive diagnosis of infection and facilitate timely and appropriate clinical management.
C1 [Lozier, Matthew J.; Adams, Laura; Munoz-Jordan, Jorge; Sharp, Tyler M.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot & Infect Dis, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Rosenberg, Eli S.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.
   [Doyle, Kate] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis Sexually Transm, Atlanta, GA USA.
   [Klein, Liore] Caduceus Healthcare, Atlanta, GA USA.
   [Alvarado, Luisa I.] Ponce Univ, Sch Med, St Lukes Episcopal Hosp Consortium, Ponce, PR USA.
   [Rosenberg, Eli S.] SUNY Albany, Dept Epidemiol & Biostat, Albany, NY 12222 USA.
RP Lozier, MJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot & Infect Dis, 1324 Calle Canada, San Juan, PR 00920 USA.
EM mlozier@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA;
   Center for AIDS Research at Emory University [NIH P30AI050409]
FX This work was supported by the Centers for Disease Control and
   Prevention and the Center for AIDS Research at Emory University [NIH
   P30AI050409].
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Granovsky MO, 1998, PEDIATRICS, V102, P355, DOI 10.1542/peds.102.2.355
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 11
TC 8
Z9 8
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD AUG 15
PY 2018
VL 67
IS 4
BP 624
EP 627
DI 10.1093/cid/ciy209
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GP6OA
UT WOS:000441000000029
PM 29534160
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Farias, DS
   Novaes, MAC
   Santos, CS
   Azar, SR
   Vasilakis, N
   de Moura, DL
   Lima, FWD
   Alcantara, LC
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Santos, Cleiton Silva
   Azar, Sasha R.
   Vasilakis, Nikos
   de Moura, Daniel Lima
   Lima, Fernanda Washington de M.
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Reversible sensory polyneuropathy during an arboviral outbreak in
   Salvador, Bahia, Brazil
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Reversible sensory polyneuropathy; Zika virus; Chikungunya virus
ID NEUROLOGICAL MANIFESTATIONS; CHIKUNGUNYA
C1 [do Rosario, Mateus Santana; Santos, Cleiton Silva; Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Hosp Geral Roberto Santos, Secretaria Estadual Scude Bahia, Salvador, BA, Brazil.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Azar, Sasha R.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis,Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [de Moura, Daniel Lima; Lima, Fernanda Washington de M.] Univ Fed Bahia, Lab Imunol Doencas Infecciosas, Fac Farm, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Alcantara,
   Luiz/0000-0002-6769-9931; Jesus, Pedro Antonio/0000-0003-1211-2272; do
   Rosario, Mateus/0000-0001-7404-6392
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942, 1U01A1115577];
   MCTI/FINEP/FNDCT-Brazil grant [04160060-00/2016]
FX Zika work is supported in part by NIH grants R24AI120942 and
   1U01A1115577 (NV) and MCTI/FINEP/FNDCT-Brazil grant 04160060-00/2016
   (LCJA).
CR Acevedo N., 2017, FRONT MICROBIOL, V8, P1
   [Anonymous], 2016, PROC SER AD VIG FEBR
   CDC, ZIK MAC ELISA
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Mehta R., 2018, SPECTRUM NEUROLOGICA
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
NR 12
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD AUG 15
PY 2018
VL 391
BP 3
EP 4
DI 10.1016/j.jns.2018.05.009
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GO0YL
UT WOS:000439672500002
PM 30103966
DA 2020-07-08
ER

PT J
AU Anderson, KB
   Endy, TP
   Thomas, SJ
AF Anderson, Kathryn B.
   Endy, Timothy P.
   Thomas, Stephen J.
TI Finding the Signal in the Noise in the Serologic Diagnosis of Flavivirus
   Infections
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID ANTIBODY-DEPENDENT ENHANCEMENT; CONGENITAL ZIKA SYNDROME; PRIMARY-SCHOOL
   CHILDREN; DENGUE VIRUS-INFECTION; KAMPHAENG PHET; THAILAND;
   PATHOGENESIS; MICRONESIA; IMMUNITY; BURDEN
C1 [Anderson, Kathryn B.] Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA.
   [Endy, Timothy P.; Thomas, Stephen J.] SUNY Upstate Med Univ, Suite 311,725 Irving Ave, Syracuse, NY 13210 USA.
RP Thomas, SJ (corresponding author), SUNY Upstate Med Univ, Suite 311,725 Irving Ave, Syracuse, NY 13210 USA.
EM thomstep@upstate.edu
CR Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   [Anonymous], 2018, LANCET INFECT DIS, V18, P123, DOI DOI 10.1016/S1473-3099(18)30023-9
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Fernandes RCDC, 2016, LANCET INFECT DIS, V16, P772, DOI 10.1016/S1473-3099(16)30079-2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Gaibani P, 2017, MICROBES INFECT, V19, P382, DOI 10.1016/j.micinf.2017.05.003
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin-Acebes MA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00044
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
NR 25
TC 1
Z9 1
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2018
VL 218
IS 4
BP 516
EP 518
DI 10.1093/infdis/jiy166
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GN6GQ
UT WOS:000439176000003
PM 29618090
OA Bronze
DA 2020-07-08
ER

PT J
AU Chaves, BA
   Orfano, AS
   Nogueira, PM
   Rodrigues, NB
   Campolina, TB
   Nacif-Pimenta, R
   Pires, ACAM
   Vieira, AB
   Paz, AD
   Vaz, EBD
   Guerra, MDVB
   Silva, BM
   de Melo, FF
   Norris, DE
   de Lacerda, MVG
   Pimenta, PFP
   Secundino, NFC
AF Chaves, Barbara Aparecida
   Orfano, Alessandra Silva
   Nogueira, Paula Monalisa
   Rodrigues, Nilton Barnabe
   Campolina, Thais Bonifacio
   Nacif-Pimenta, Rafael
   Araujo Machado Pires, Ana Clara
   Vieira Junior, Ademir Bentes
   Paz, Andreia da Costa
   da Costa Vaz, Evelyn Beatriz
   Vale Barbosa Guerra, Maria das Gracas
   Silva, Breno Melo
   de Melo, Fabricio Freire
   Norris, Douglas Eric
   Guimaraes de lacerda, Marcus Vinicius
   Paolucci Pimenta, Paulo Filemon
   Costa Secundino, Nagila Francinete
TI Coinfection with Zika Virus (ZIKV) and Dengue Virus Results in
   Preferential ZIKV Transmission by Vector Bite to Vertebrate Host
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Coinfection; Aedes aegypti; Zika virus; dengue virus; preferential
   transmission; vector bite
ID CHIKUNGUNYA VIRUS; AEDES-AEGYPTI; CLINICAL PRESENTATION; INFECTION;
   EPIDEMIC; BRAZIL
AB Background. Several tropical cities are permissive to Aedes aegypti and dengue virus (DENV) endemicity and have allowed for invasion and circulation of Zika virus (ZIKV) in the same areas. People living in arbovirus-endemic regions have been simultaneously infected with >= 2 arboviruses.
   Methods. A. aegypti mosquitoes from Manaus, the capital city of Amazonas State in Brazil, were coinfected with circulating strains of DENV and ZIKV. The coinfected vectors were allowed to bite BALB/c mice.
   Results. A. aegypti from Manaus is highly permissive to monoinfection and coinfection with DENV and ZIKV and is capable of cotransmitting both pathogens by bite. Coinfection strongly influences vector competence, favoring transmission of ZIKV to the vertebrate host.
   Conclusions. This finding suggests that A. aegypti is an efficient vector of ZIKV and that ZIKV would be preferentially transmitted by coinfected A. aegypti. Coinfection in the vector population should be considered a new critical epidemiological factor and may represent a major public health challenge.
C1 [Chaves, Barbara Aparecida; Vieira Junior, Ademir Bentes; Paz, Andreia da Costa; da Costa Vaz, Evelyn Beatriz; Vale Barbosa Guerra, Maria das Gracas; Guimaraes de lacerda, Marcus Vinicius; Paolucci Pimenta, Paulo Filemon] Fundacao Med Trop Dr Heitor Vieira Dourado, Inst Pequisa Clin Carlos Borborema, Manaus, Amazonas, Brazil.
   [Chaves, Barbara Aparecida; da Costa Vaz, Evelyn Beatriz; Guimaraes de lacerda, Marcus Vinicius; Paolucci Pimenta, Paulo Filemon; Costa Secundino, Nagila Francinete] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.
   [Orfano, Alessandra Silva; Nogueira, Paula Monalisa; Rodrigues, Nilton Barnabe; Campolina, Thais Bonifacio; Nacif-Pimenta, Rafael; Araujo Machado Pires, Ana Clara; Paolucci Pimenta, Paulo Filemon; Costa Secundino, Nagila Francinete] Fundacao Oswaldo Cruz, Inst Rene Rachou, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
   [Silva, Breno Melo] Univ Fed Ouro Preto, Dept Ciencias Biol, Ouro Preto, MG, Brazil.
   [de Melo, Fabricio Freire] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, Brazil.
   [Norris, Douglas Eric] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Guimaraes de lacerda, Marcus Vinicius] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
RP Pimenta, PFP (corresponding author), Fundacao Oswaldo Cruz, Inst Rene Rachou, Av Augusto de Lima 1715, BR-30190002 Belo Horizonte, MG, Brazil.
EM pfppimenta@gmail.com
RI Secundino, Nagila/AAM-4553-2020; de Melo, Fabricio/AAN-5517-2020; silva,
   breno/W-5122-2018; Pimenta, Paulo/AAH-1502-2020
OI de Melo, Fabricio/0000-0002-5680-2753; silva, breno/0000-0003-2472-8111;
   Norris, Douglas/0000-0002-4631-2777
FU Oswaldo Cruz Foundation; Brazilian Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq); Instituto Nacional de Ciencia e
   Tecnologia (INCT)-Entomologia Molecular; Minas Gerais State Research
   Support Foundation (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG); Federal University of Bahia; Amazonas State Research Support
   Foundation (FAPEAM); Brazilian Comissao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Science Without Borders
FX This work was supported by the Oswaldo Cruz Foundation, the Brazilian
   Council for Scientific and Technological Development, Science Without
   Borders, the Instituto Nacional de Ciencia e Tecnologia
   (INCT)-Entomologia Molecular, the Minas Gerais State Research Support
   Foundation (FAPEMIG), the Federal University of Bahia Support Program
   for Young PhD Professors, the Amazonas State Research Support Foundation
   (FAPEAM), the Brazilian Comissao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) (support to B. A. C., T. B. C., and R. N.-P.), and the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (support to N. R. B., LV, A. S. O., N. F. C. S., M. V. G. d. L., and P.
   F. P. P.).
CR Esposito DLA, 2016, REV SOC BRAS MED TRO, V49, P535, DOI 10.1590/0037-8682-0428-2016
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brazilian Ministry of Health, 2017, MON CAS DENG FEBR CH, V2017, P1
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   HARDY JL, 1988, ARBOVIRUSES EPIDEMIO, V1, P87
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Martin S, 2013, EURO SURVEILL, V19
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   PAHO/ WHO, 2017, NUMB REP CAS DENG SE
   PAHO/ WHO, 2017, ZIK CAS CONG SYNDR A
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Rohani A, 2009, SE ASIAN J TROP MED, V40, P443
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   WHITE LA, 1987, J CLIN MICROBIOL, V25, P1221, DOI 10.1128/JCM.25.7.1221-1224.1987
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 36
TC 10
Z9 11
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2018
VL 218
IS 4
BP 563
EP 571
DI 10.1093/infdis/jiy196
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GN6GQ
UT WOS:000439176000010
PM 29659904
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cabral-Miranda, G
   Cardoso, AR
   Ferreira, LCS
   Sales, MGF
   Bachmann, MF
AF Cabral-Miranda, Gustavo
   Cardoso, Ana R.
   Ferreira, Luis C. S.
   Sales, M. Goreti F.
   Bachmann, Martin F.
TI Biosensor-based selective detection of Zika virus specific antibodies in
   infected individuals
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Biosensor; Antibody detection; Zika-specific; Dengue
ID DENGUE VIRUS
AB Zika virus (ZIKV) recently emerged as a global threat subsequent to its global spread because it induces microencephaly and other brain damages in infants born to infected mothers. Epidemiological monitoring of infection has been hampered by the absence of reliable serological tests capable to distinguish between ZIKV and other Flavivirus infections, in particular Dengue virus (DENV). As both viruses are transmitted by the same mosquito-species, their distributions largely overlap and reliable serological distinction between the viruses is essential. Here we develop a novel biosensor which is based on recombinant forms of ZIKV non-structural protein 1 (NS1) and the domain III of the envelope protein (EDIII). Using electrochemical impedance spectroscopy (EIS) and square wave voltammetry (SWV), we demonstrate that in addition to extremely sensitive detection of ZIKV-specific antibodies in serum and saliva, the biosensor promptly distinguished ZIKV and DENV-specific antibodies. Hence, this novel biosensor allows assessing ZIKV antibodies in blood and saliva and results are unaffected by presence of DENV virus-specific antibodies.
C1 [Cardoso, Ana R.; Sales, M. Goreti F.] Polytech Sch Porto, BioMark Ctr Biol Engn, Sch Engn, ISEP, Porto, Portugal.
   [Cabral-Miranda, Gustavo; Bachmann, Martin F.] Univ Oxford, CCMP, Jenner Inst, Oxford, England.
   [Bachmann, Martin F.] Univ Bern, Inselspital, RIA, Immunol, Bern, Switzerland.
   [Ferreira, Luis C. S.] Univ Sao Paulo, ICB USP, Inst Biomed Sci, Sao Paulo, Brazil.
RP Sales, MGF (corresponding author), Polytech Sch Porto, Sch Engn, R Dr Antonio Bernardino Almeida 431, P-4200072 Porto, Portugal.; Bachmann, MF (corresponding author), Henry Wellcome Bldg Mol Physiol, Roosevelt Dr, Oxford OX3 7BN, England.
EM mgf@isep.ipp.pt; martin.bachmann@dbmr.unibe.ch
RI de Miranda, Gustavo Cabral/AAH-5494-2019; Sales, Maria Goreti
   Ferreira/V-4408-2019; FSales, Goreti/K-9199-2013
OI Sales, Maria Goreti Ferreira/0000-0001-9936-7336; FSales,
   Goreti/0000-0001-9936-7336
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31003A_149925]; National Foundation for Science and Technology,
   I.P.; FEDER (European Funding or Regional Development)
   [PTDC/AAG-TEC/5400/2014, POCI-01-0145-FEDER-016637]
FX The Swiss National Science Foundation (Grant 31003A_149925) and the
   National Foundation for Science and Technology, I.P. with European
   funding to FEDER (European Funding or Regional Development), via
   COMPETE2020 - POCI (operational program for internationalization and
   competitiveness), through the project PTDC/AAG-TEC/5400/2014,
   POCI-01-0145-FEDER-016637) are acknowledged for the financial support.
   GCM acknowledges Robert Andreata-Santos and Monica Rodrigues for the
   technical support in the Laboratory of Vaccine Development, ICB-USP.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Ambrose JH, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8072491
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Cabral-Miranda G, 2014, J PARASITOL, V100, P73, DOI 10.1645/GE-3052.1
   Cabral-Miranda G, 2014, J MATER CHEM B, V2, P477, DOI 10.1039/c3tb21048k
   Cardoso AR, 2017, BIOSENS BIOELECTRON, V91, P833, DOI 10.1016/j.bios.2017.01.031
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   ECDC, 2016, STOCKHOLM, DOI [10.2900/376365X, DOI 10.2900/376365X]
   Fiorentino DG, 2016, CURR OBSTET GYNECOL, V5, P234, DOI 10.1007/s13669-016-0171-1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   Jiang KY, 2004, J MATER CHEM, V14, P37, DOI 10.1039/b310359e
   Johansson Michael A., 2009, NEW ENGL J MED, V361, P841, DOI [10.1056/NEJMp1415160, DOI 10.1056/NEJMP1415160]
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Seng P, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30149-9
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Turmel J. M., 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   WHO, 2018, ZIK VIR
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zanotto P., 2016, TEST DETECTS ANTIBOD
NR 26
TC 14
Z9 14
U1 4
U2 103
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD AUG 15
PY 2018
VL 113
BP 101
EP 107
DI 10.1016/j.bios.2018.04.058
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA GI8CT
UT WOS:000434750100014
PM 29751200
DA 2020-07-08
ER

PT J
AU Tsegaye, MM
   Beyene, B
   Ayele, W
   Abebe, A
   Tareke, I
   Sall, A
   Yactayo, S
   Shibeshi, ME
   Staples, E
   Belay, D
   Lilay, A
   Alemu, A
   Alemu, E
   Kume, A
   Mariam, AH
   Ronveaux, O
   Tefera, M
   Kassa, W
   Weyessa, AB
   Jima, D
   Kebede, A
   Tayachew, A
AF Tsegaye, Mesfin Mengesha
   Beyene, Berhane
   Ayele, Workenesh
   Abebe, Almaz
   Tareke, Israel
   Sall, Amadou
   Yactayo, Sergio
   Shibeshi, Messeret E.
   Staples, Erin
   Belay, Desalegn
   Lilay, Abrham
   Alemu, Abebe
   Alemu, Emana
   Kume, Adugna
   Mariam, Alemnesh H.
   Ronveaux, Olivier
   Tefera, Mesfin
   Kassa, Woubayehu
   Weyessa, Abyot Bekele
   Jima, Daddi
   Kebede, Amha
   Tayachew, Adamu
TI Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a
   public health perspective
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Yellow fever; Flaviviruses; Risk assessment; Ethiopia
ID RISK-ASSESSMENT; EPIDEMIOLOGY
AB Background: Yellow fever (YF) is a viral hemorrhagic fever, endemic in the tropical forests of Africa and Central and South America. The disease is transmitted by mosquitoes infected with the yellow fever virus (YFV). Ethiopia was affected by the largest YF outbreak since the vaccination era during 1960-1962. The recent YF outbreak occurred in 2013 in Southern part of the country. The current survey of was carried out to determine the YF seroprevalence so as to make recommendations from YF prevention and control in Ethiopia.
   Methodology: A multistage cluster design was utilized. Consequently, the country was divided into 5 ecological zones and two sampling towns were picked per zone randomly. A total of 1643 serum samples were collected from human participants. The serum samples were tested for IgG antibody against YFV using ELISA. Any serum sample testing positive by ELISA was confirmed by plaque reduction neutralization test (PRNT). In addition, differential testing was performed for other flaviviruses, namely dengue, Zika and West Nile viruses.
   Result: Of the total samples tested, 10 (0.61%) were confirmed to be IgG positive against YFV and confirmed with PRNT. Nine (0.5%) samples were antibody positive for dengue virus, 15(0.9%) forWest Nile virus and 7 (0.4%) for Zika virus by PRNT. Three out of the five ecological zones namely zones 1, 3 and 5 showed low levels (< 2%) of IgG positivity against YFV. A total of 41(2.5%) cases were confirmed to be positive for one of flaviviruses tested.
   Conclusion: Based on the seroprevalence data, the level of YFV activity and the risk of a YF epidemic in Ethiopia are low. However additional factors that could impact the likelihood of such an epidemic occurring should be considered before making final recommendations for YF prevention and control in Ethiopia. Based on the results of the serosurvey and other YF epidemic risk factors considered, a preventive mass vaccination campaign is not recommended, however the introduction of YF vaccine in routine EPI is proposed nationwide, along with strong laboratory based YF surveillance.
C1 [Tsegaye, Mesfin Mengesha; Beyene, Berhane; Ayele, Workenesh; Abebe, Almaz; Belay, Desalegn; Lilay, Abrham; Alemu, Abebe; Alemu, Emana; Kume, Adugna; Mariam, Alemnesh H.; Tefera, Mesfin; Kassa, Woubayehu; Weyessa, Abyot Bekele; Jima, Daddi; Kebede, Amha; Tayachew, Adamu] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.
   [Tareke, Israel] WHO, Country Off, Addis Ababa, Ethiopia.
   [Sall, Amadou] Inst Pasteur, Dakar, Senegal.
   [Yactayo, Sergio] WHO, Geneva, HQ, Switzerland.
   [Shibeshi, Messeret E.] WHO, IST, Harare, Zimbabwe.
   [Staples, Erin] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Ronveaux, Olivier] IST AFRO, Ouagadougou, Burkina Faso.
RP Tsegaye, MM (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.
EM mesfintiru@gmail.com
RI Woyessa, Abyot/X-7069-2018
OI Woyessa, Abyot/0000-0003-3585-1625
FU World Health OrganizationWorld Health Organization; Ethiopian Public
   Health Institute
FX This work was financially and technically supported by World Health
   Organization and Ethiopian Public Health Institute.
CR Abdelhalim KA, 2014, SUDAN AM J RES COMMU, V2, P81
   [Anonymous], 2016, WHO FACT SHEET YELLO
   ARDOIN P, 1976, TROP GEOGR MED, V28, P309
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   BONNEL P H, 1954, Bull World Health Organ, V11, P325
   Chabaud A, 1958, B WORLD HEALTH ORGAN, P19
   Ellis BR, 2008, REV MED VIROL, V18, P331, DOI 10.1002/rmv.584
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Lilay A, 2013, REEMERGENCE YELLOW F
   Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371
   NERI P, 1968, B WORLD HEALTH ORGAN, V38, P863
   SERIE C, 1968, B WORLD HEALTH ORGAN, V38, P879
   Staples JE, 2014, T ROY SOC TROP MED H, V108, P608, DOI 10.1093/trstmh/tru086
   *WHO, WHOEPIGEN9809
   Wood O L, 1975, Ethiop Med J, V13, P177
   World Health Organization, 2014, WORK DOC INF CONS EX
   World Health Organization, REP GLOB SURV EP INF
NR 18
TC 9
Z9 9
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD AUG 14
PY 2018
VL 18
AR 1011
DI 10.1186/s12889-018-5726-9
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GQ6YS
UT WOS:000441877700003
PM 30107830
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lang, JS
   Cheng, YC
   Rolfe, A
   Hammack, C
   Vera, D
   Kyle, K
   Wang, JY
   Meissner, TB
   Ren, Y
   Cowan, C
   Tang, HL
AF Lang, Jianshe
   Cheng, Yichen
   Rolfe, Alyssa
   Hammack, Christy
   Vera, Daniel
   Kyle, Kathleen
   Wang, Jingying
   Meissner, Torsten B.
   Ren, Yi
   Cowan, Chad
   Tang, Hengli
TI An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential
   Responses of Macrophages to ZIKV and DENY Infection
SO STEM CELL REPORTS
LA English
DT Article
ID MIGRATION INHIBITORY FACTOR; NF-KAPPA-B; VIRUS; CELLS; ACTIVATION;
   EXPRESSION; DISEASE; DENGUE; BLOOD; MICE
AB Zika virus (ZIKV) and dengue virus (DENV) are two closely related flaviviruses that lead to different clinical outcomes. The mechanism for the distinct pathogenesis of ZIKV and DENV is poorly understood. Here, we investigate ZIKV and DENV infection of macrophages using a human pluripotent stem cell (hPSC)-derived macrophage model and discover key virus-specific responses. ZIKV and DENV productively infect hPSC-derived macrophages. DENV, but not ZIKV, infection of macrophages strongly activates macrophage migration inhibitory factor (MIF) secretion and decreases macrophage migration. Neutralization of MIF leads to improved migratory ability of DENV-infected macrophages. In contrast, ZIKV-infected macrophages exhibit prolonged migration and express low levels of pro-inflammatory cytokines and chemokines. Mechanistically, ZIKV disrupts the nuclear factor kappa B (NF-kappa B)-MIF positive feedback loop by inhibiting the NF-kappa B signaling pathway. Our results demonstrate the utility of hPSC-derived macrophages in infectious disease modeling and suggest that the distinct impact of ZIKV and DENV on macrophage immune response may underlie different pathogenesis of Zika and dengue diseases.
C1 [Lang, Jianshe; Cheng, Yichen; Hammack, Christy; Tang, Hengli] Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.
   [Rolfe, Alyssa; Wang, Jingying; Ren, Yi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32304 USA.
   [Vera, Daniel; Kyle, Kathleen] Florida State Univ, Ctr Genom & Personalized Med, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Meissner, Torsten B.; Cowan, Chad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Meissner, Torsten B.; Cowan, Chad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
RP Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, 319 Stadium Dr, Tallahassee, FL 32306 USA.
EM tang@bio.fsu.edu
OI Rolfe, Alyssa/0000-0002-1427-549X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19 AI131130, R21 AI119530]; Florida
   State University
FX We would like to thank Li Sun, Sarah Ogden, Brian Washburn, Emily Lee,
   and Kristina Poduch for technical assistance. This study is supported in
   part by NIH grants U19 AI131130 and R21 AI119530 (to H.T.) and Zika seed
   funding from Florida State University (to H.T.).
CR Aflaki E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008659
   Arjona A, 2007, J CLIN INVEST, V117, P3059, DOI 10.1172/JCI32218
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Buchrieser J, 2017, STEM CELL REP, V8, P1
   CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   Cao WG, 2005, BIOL REPROD, V73, P565, DOI 10.1095/biolreprod.104.038331
   Chen L, 2015, J CLIN INVEST, V125, P2399, DOI 10.1172/JCI80467
   Chen LH, 2009, ATHEROSCLEROSIS, V207, P428, DOI 10.1016/j.atherosclerosis.2009.05.021
   Chuang YC, 2011, CYTOKINE, V54, P222, DOI 10.1016/j.cyto.2011.01.013
   Clarke D, 2000, ONCOGENE, V19, P3343, DOI 10.1038/sj.onc.1203661
   Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   FitzSimmons J, 2016, NEW ENGL J MED, V375, P293, DOI 10.1056/NEJMc1606769
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078
   Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Heikkinen J, 2003, CLIN EXP IMMUNOL, V131, P498, DOI 10.1046/j.1365-2249.2003.02092.x
   Hermanowski-Vosatka A, 1999, BIOCHEMISTRY-US, V38, P12841, DOI 10.1021/bi991352p
   Hernandez-Pigeon H, 2007, J BIOL CHEM, V282, P8157, DOI 10.1074/jbc.M607436200
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009
   Kasama T, 2010, ARTHRITIS, DOI 10.1155/2010/106202
   Kim JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06610-4
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lee SH, 2014, INT J MOL MED, V33, P919, DOI 10.3892/ijmm.2014.1645
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Lidstrom C, 2003, AM J REPROD IMMUNOL, V50, P444, DOI 10.1046/j.8755-8920.2003.00112.x
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Panicker LM, 2012, P NATL ACAD SCI USA, V109, P18054, DOI 10.1073/pnas.1207889109
   Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roney KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024795
   Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vanhee S, 2015, HAEMATOLOGICA, V100, P157, DOI 10.3324/haematol.2014.112144
   Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220
   Vereyken EJF, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522
   Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051
NR 58
TC 6
Z9 7
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2213-6711
J9 STEM CELL REP
JI Stem Cell Rep.
PD AUG 14
PY 2018
VL 11
IS 2
BP 348
EP 362
DI 10.1016/j.stemcr.2018.06.006
PG 15
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA GQ3RD
UT WOS:000441583100006
PM 29983385
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ho, NRY
   Lim, GS
   Sundah, NR
   Lim, DN
   Loh, TP
   Shao, HL
AF Ho, Nicholas R. Y.
   Lim, Geok Soon
   Sundah, Noah R.
   Lim, Diana
   Loh, Tze Ping
   Shao, Huilin
TI Visual and modular detection of pathogen nucleic acids with enzyme-DNA
   molecular complexes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CARCINOMA CELL-LINES; HUMAN-PAPILLOMAVIRUS; ISOTHERMAL AMPLIFICATION;
   CERVICAL-CANCER; ZIKA VIRUS; SEQUENCES; POINT; PCR
AB Rapid, visual detection of pathogen nucleic acids has broad applications in infection management. Here we present a modular detection platform, termed enzyme-assisted nanocomplexes for visual identification of nucleic acids (enVision). The system consists of an integrated circuit of enzyme-DNA nanostructures, which function as independent recognition and signaling elements, for direct and versatile detection of pathogen nucleic acids from infected cells. The built-in enzymatic cascades produce a rapid color readout for the naked eye; the assay is thus fast (<2 h), sensitive (<10 amol), and readily quantified with smart-phones. When implemented on a configurable microfluidic platform, the technology demonstrates superior programmability to perform versatile computations, for detecting diverse pathogen targets and their virus-host genome integration loci. We further design the enVision platform for molecular-typing of infections in patient endocervical samples. The technology not only improves the clinical inter-subtype differentiation, but also expands the intra-subtype coverage to identify previously undetectable infections.
C1 [Ho, Nicholas R. Y.; Lim, Geok Soon; Sundah, Noah R.; Loh, Tze Ping; Shao, Huilin] Natl Univ Singapore, Biomed Inst Global Hlth Res & Technol, Singapore 117599, Singapore.
   [Ho, Nicholas R. Y.; Lim, Geok Soon; Shao, Huilin] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore.
   [Sundah, Noah R.; Shao, Huilin] Natl Univ Singapore, Dept Biomed Engn, Fac Engn, Singapore 117583, Singapore.
   [Lim, Diana] Natl Univ Singapore Hosp, Dept Pathol, Singapore 119074, Singapore.
   [Loh, Tze Ping] Natl Univ Singapore Hosp, Dept Lab Med, Singapore 117599, Singapore.
   [Shao, Huilin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore.
RP Shao, HL (corresponding author), Natl Univ Singapore, Biomed Inst Global Hlth Res & Technol, Singapore 117599, Singapore.; Shao, HL (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138673, Singapore.; Shao, HL (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Fac Engn, Singapore 117583, Singapore.; Shao, HL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119228, Singapore.
EM huilin.shao@nus.edu.sg
OI Ho, Nicholas/0000-0002-9031-5633; Loh, Tze Ping/0000-0002-4272-0001
FU MOEMinistry of Education, SingaporeMinistry of Higher Education &
   Scientific Research (MHESR) [R-722-000-005-133]; NMRC
   [NMRC/TCR/016-NNI/2016]; A*STAR IMCB Independent Fellowship; NUS Early
   Career Research Award
FX We thank Luke P. Lee for helpful discussion, Carine Z. Lim for
   assistance with sample collection and Sree V. Sundararajan for device
   fabrication. This work was supported in part by funding from MOE
   (R-722-000-005-133), NMRC (NMRC/TCR/016-NNI/2016), A*STAR IMCB
   Independent Fellowship and NUS Early Career Research Award.
CR Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064
   Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8
   Cheung JLK, 2006, J INFECT DIS, V194, P1706, DOI 10.1086/509622
   Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7
   Cui M, 2014, J CLIN MICROBIOL, V52, P2210, DOI 10.1128/JCM.00883-14
   Dang C, 1996, J MOL BIOL, V264, P268, DOI 10.1006/jmbi.1996.0640
   Gardner SN, 2003, J CLIN MICROBIOL, V41, P2417, DOI 10.1128/JCM.41.6.2417-2427.2003
   Juskowiak B, 2011, ANAL BIOANAL CHEM, V399, P3157, DOI 10.1007/s00216-010-4304-5
   Laksanasopin T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0056
   Lee H, 2012, NAT NANOTECHNOL, V7, P389, DOI [10.1038/nnano.2012.73, 10.1038/NNANO.2012.73]
   Li J, 2017, NAT CHEM, V9, P1056, DOI 10.1038/nchem.2852
   McBride AA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006211
   Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725
   Nemiroski A, 2014, P NATL ACAD SCI USA, V111, P11984, DOI 10.1073/pnas.1405679111
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Nong RY, 2012, EXPERT REV PROTEOMIC, V9, P21, DOI [10.1586/EPR.11.78, 10.1586/epr.11.78]
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park KS, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600300
   Paterson AS, 2017, LAB CHIP, V17, P1051, DOI 10.1039/c6lc01167e
   Rao A, 2013, J CLIN MICROBIOL, V51, P1478, DOI 10.1128/JCM.03386-12
   Schiffman M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.86
   Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562
   Schotte L, 2015, ANTIMICROB AGENTS CH, V59, P4695, DOI 10.1128/AAC.00878-15
   Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Wang LY, 2017, NUCLEIC ACIDS RES, V45, P12090, DOI 10.1093/nar/gkx1045
   Williams VM, 2011, FUTURE VIROL, V6, P45, DOI 10.2217/FVL.10.73
   YEE C, 1985, AM J PATHOL, V119, P361
   Yeh EC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1501645
   Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428
   Zumla A, 2014, LANCET INFECT DIS, V14, P1123, DOI 10.1016/S1473-3099(14)70827-8
NR 35
TC 14
Z9 15
U1 10
U2 57
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 13
PY 2018
VL 9
AR 3238
DI 10.1038/s41467-018-05733-0
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GQ1IG
UT WOS:000441382000016
PM 30104566
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhu, XL
   Li, CF
   Afridi, SK
   Zu, SL
   Xu, JW
   Quanquin, N
   Yang, H
   Cheng, GH
   Xu, ZH
AF Zhu, Xingliang
   Li, Chunfeng
   Afridi, Shabbir Khan
   Zu, Shulong
   Xu, Jesse W.
   Quanquin, Natalie
   Yang, Heng
   Cheng, Genhong
   Xu, Zhiheng
TI E90 subunit vaccine protects mice from Zika virus infection and
   microcephaly
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE Zika virus; E90 vaccine; Protection; Microcephaly; Mouse model
ID PRENATAL VIRAL-INFECTION; MOUSE; IMMUNITY; AMERICA; STRAIN
AB Zika virus (ZIKV) became a global threat due to its unprecedented outbreak and its association with congenital malformations such as microcephaly in developing fetuses and neonates There are currently no effective vaccines or drugs available for the prevention or treatment of ZIKV infection. Although multiple vaccine platfoims have been established, their effectiveness in preventing congenital microcephaly has not been addressed. Herein, we tested a subunit vaccine containing the 450 amino acids at the N-terminus of the ZIKV envelope protein (E90) in mouse models for either in utero or neonatal ZIKV infection. In one model, embryos of vaccinated dams were challenged with a contempoiary ZIKV strain at embryonic day 13.5. The other model infects neonatal mice from vaccinated dams by direct injection of ZIKV into the developing brains. The vaccine led to a substantia ! reduction of ZIKV-infected cells measuied in the biains of fetal or suckling mice, and successfully prevented the onset of microcephaly compared to unvaccinated controls. Furthermore, E90 could protect mice from ZIKV infection even at 140 days post-immunization. This work directly demonstrates that immunization of pregnant mice piotects the developing brains of offspring both in utero and in the neonata ! period fiom subsequent ZIKV infection and miciocephaly. It also supports the further development of the E90 subunit vaccine towaids clinical trials.
C1 [Zhu, Xingliang; Afridi, Shabbir Khan; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
   [Zhu, Xingliang; Afridi, Shabbir Khan; Zu, Shulong; Xu, Zhiheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Li, Chunfeng; Yang, Heng; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Yang, Heng; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Zhu, Xingliang; Yang, Heng; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Li, Chunfeng; Xu, Jesse W.] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Zu, Shulong] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China.
   [Quanquin, Natalie; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing, Peoples R China.; Xu, ZH (corresponding author), Univ Chinese Acad Sci, Beijing 100101, Peoples R China.; Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM gcheng@mednet.ucla.edu; zhxu@genetics.ac.cn
RI Li, Chunfeng/S-3185-2019
OI Li, Chunfeng/0000-0001-8883-9078; Xu, Zhiheng/0000-0002-4809-2851; Zhu,
   Xingliang/0000-0003-3411-8712
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [NSFC 31730108/31430037]; Strategic Priority
   Research Program of the Chinese Academy of Science [XDBS1020100,
   QYZDJ-SSW-SMC007]; Shanghai Brain-Intelligence Project from the Shanghai
   Science and Technology Committee [STCSM 16JC1420500]; Beijing Brain
   Project [Z161100002616004]; MOST [2014CB942801]; CAMS Initiative for
   Innovative Medicine [2016-I2M-1-005]; National Science and Technology
   Major Project for "Significant New Drugs Innovation and Development"
   [2015ZX09102023]; NSFCNational Natural Science Foundation of China
   [91542201, 81590765, 31670883, 31500145]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AI069120, AI056154, AI078389]; PUMC Youth Fund [3332016125]; Natural
   Science Foundation of Jiangsu ProvinceJiangsu Planned Projects for
   Postdoctoral Research FundsNatural Science Foundation of Jiangsu
   Province [BK20170407, BK20161246, BK20151253]; Innovation Program of the
   Chinese Academy of ScienceKnowledge Innovation Program of the Chinese
   Academy of Sciences [XDBS1020100, QYZDJ-SSW-SMC007]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC 31730108/31430037), the Strategic Priority Research Program
   and Innovation Program of the Chinese Academy of Science (XDBS1020100
   and QYZDJ-SSW-SMC007), Shanghai Brain-Intelligence Project from the
   Shanghai Science and Technology Committee (STCSM 16JC1420500), Beijing
   Brain Project (Z161100002616004) and MOST (2014CB942801) grants to Z.X.;
   the CAMS Initiative for Innovative Medicine (No. 2016-I2M-1-005),
   National Science and Technology Major Project for "Significant New Drugs
   Innovation and Development" (2015ZX09102023), NSFC (91542201, 81590765,
   and 31670883), and NIH R01 (AI069120, AI056154 and AI078389) grants to
   G.C.; the PUMC Youth Fund (3332016125) and NSFC (31500145) grants to
   C.L.; and Natural Science Foundation of Jiangsu Province (BK20170407,
   BK20161246, BK20151253) to H.Y.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BROMLEY B, 1995, J ULTRAS MED, V14, P303
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fatemi SH, 2011, ADV NEUROBIOL, V2, P113, DOI 10.1007/978-1-4419-7197-5_4
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lin HH, 2017, J NURS RES, V25, P3, DOI 10.1097/jnr.0000000000000205
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Winter C, 2008, EUR NEUROPSYCHOPHARM, V18, P712, DOI 10.1016/j.euroneuro.2008.06.001
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 41
TC 6
Z9 7
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD AUG 10
PY 2018
VL 6
AR 77
DI 10.1186/s40478-018-0572-7
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA GQ0ME
UT WOS:000441312800001
PM 30097059
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brito, CAA
   Henriques-Souza, A
   Soares, CRP
   Castanha, PMS
   Machado, LC
   Pereira, MR
   Sobral, MCM
   Lucena-Araujo, AR
   Wallau, GL
   Franca, RFO
AF Brito, Carlos A. A.
   Henriques-Souza, Adelia
   Soares, Cynthia R. P.
   Castanha, Priscila M. S.
   Machado, Lais C.
   Pereira, Mylena R.
   Sobral, Mariana C. M.
   Lucena-Araujo, Antonio R.
   Wallau, Gabriel L.
   Franca, Rafael F. O.
TI Persistent detection of Zika virus RNA from an infant with severe
   microcephaly - a case report
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Neurological disease; Microcephaly; Virus persistence
ID INFECTION; BRAZIL; BRAIN
AB Background: Zika virus (ZIKV) is a recently emerged arbovirus, which infection during pregnancy is associated with a series of congenital malformations, collectively denominated Congenital Zika Syndrome (CZS). Following infection, ZIKV RNA has a median duration period of 10 days in plasma and up to 6 months in semen in immunocompetent adult individuals. Moreover, ZIKV is able to replicate and persist in fetal brains and placentas, consequently, infection is associated with pregnancy loss, albeit the pathogenic mechanisms are still unknown.
   Case presentation: Here we report a CZS case of an infant born during the ZIKV outbreak in northeast Brazil, the child presented recurrent episodes of seizures with prolonged presence of ZIKV RNA on the central nervous system (CNS) and blood. ZIKV RNA was identified and partially sequenced from a sample of cerebrospinal fluid (CSF) obtained from the infant with 6 months of life, and later from another sample after the infant completed 17 months of life. Commonly congenital infections were discarded based on STORCH (syphilis, toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus) negative laboratory results. Presence of specific ZIKV antibodies on both mother and children confirmed the association of severe microcephaly and ZIKV infection, diagnosed after birth.
   Conclusions: Altogether, our data raise the possibility that CZS cases may result in prolonged viral presence, these findings c ould be useful for therapy and diagnostic recommendations.
C1 [Brito, Carlos A. A.] Fed Univ Pernambuco UFPE, Dept Clin Med, BR-50670901 Recife, PE, Brazil.
   [Henriques-Souza, Adelia] Hosp Restauracao, Dept Pediat, BR-50110900 Recife, PE, Brazil.
   [Soares, Cynthia R. P.; Castanha, Priscila M. S.; Franca, Rafael F. O.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Dept Virol & Expt Therapy, Ave Prof Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
   [Machado, Lais C.; Sobral, Mariana C. M.; Wallau, Gabriel L.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Dept Entomol, BR-50740465 Recife, PE, Brazil.
   [Pereira, Mylena R.] Fed Rural Univ Pernambuco UFRPE, Dept Vet Med, BR-52171900 Recife, PE, Brazil.
   [Lucena-Araujo, Antonio R.] Fed Univ Pernambuco UFPE, Dept Biophys, BR-50670901 Recife, PE, Brazil.
RP Franca, RFO (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Dept Virol & Expt Therapy, Ave Prof Moraes Rego S-N, BR-50740465 Recife, PE, Brazil.
EM rafael.franca@cpqam.fiocruz.br
RI Wallau, Gabriel Luz/B-5911-2008; CASTANHA, PRISCILA/G-1785-2012
OI Wallau, Gabriel Luz/0000-0002-1419-5713; CASTANHA,
   PRISCILA/0000-0002-1220-5308
FU FACEPE - Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco
   [APQ-0055.2.11/16, APQ-0044.2.11/16]; CNPq - Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq) [439975/2016-6]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPES under RFOFCAPES
   [88887.116624/2016-01]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - CAPES under GLWCAPES [APQ-0078-2.02/16]
FX The research leading to these results received funding from the FACEPE -
   Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco, grant agreement
   nos. APQ-0055.2.11/16 and APQ-0044.2.11/16 and CNPq - Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico, grant agreement
   439975/2016-6, Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior - CAPES 88887.116624/2016-01 under RFOF coordination and
   responsibility and APQ-0078-2.02/16 under GLW coordination. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lozier MJ, 2018, CLIN INFECT DIS
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Singh Raj K, 2017, Front Microbiol, V8, P2677, DOI 10.3389/fmicb.2017.02677
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54
NR 28
TC 4
Z9 4
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD AUG 10
PY 2018
VL 18
AR 388
DI 10.1186/s12879-018-3313-4
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA GP9YG
UT WOS:000441271700003
PM 30097025
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ou, JW
   Wickramasinghe, NC
AF Ou, Jiangwen
   Wickramasinghe, N. Chandra
TI Weakened magnetic field, cosmic rays and Zika virus outbreak
SO CURRENT SCIENCE
LA English
DT Editorial Material
AB The Zika virus outbreak in 2015 posed a serious public health threat because of its association with congenital abnormalities. Research on the environmental factors underlying this outbreak epidemiology may provide useful insights into its occurrence. This study suggests that the localized lowering of the earth's magnetic,field intensity and a sudden increase of cosmic rays recorded in Mexico in 2015 were causally associated with the resurgence of the Zika virus outbreak in the Americas. Potential mechanisms by which a weakened magnetic field and enhanced cosmic ray activity may influence this outbreak in humans are discussed here. Current and facture surveillance efforts should be supported to construct a comprehensive early warning system involving monitoring of the earth's magnetic field, solar activity and cosmic ray intensity for predicting or detecting facture Zika virus outbreaks as early as possible.
C1 [Ou, Jiangwen] Tianjin Ctr Dis Control & Prevent, Dept Infect Dis Control, 6 Huayue Rd, Tianjin, Peoples R China.
   [Wickramasinghe, N. Chandra] Univ Buckingham, Buckingham Ctr Astrobiol, Hunter St, Buckingham MK18 1EG, England.
RP Wickramasinghe, NC (corresponding author), Univ Buckingham, Buckingham Ctr Astrobiol, Hunter St, Buckingham MK18 1EG, England.
EM ncwick@gmail.com
CR Christopher F., 2016, EARTH PLANETS SPACE, V68, P112
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Pan HJ, 2004, BIOELECTROMAGNETICS, V25, P84, DOI 10.1002/bem.10160
   Qu J., 2017, VIROL CURR RES, V1, P102
   Qu JW, 2016, REV MED VIROL, V26, P309, DOI 10.1002/rmv.1887
   Wickramasinghe N. C., 2017, ASTROBIOL OUTREACH, V5, P159
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 7
TC 0
Z9 0
U1 0
U2 0
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD AUG 10
PY 2018
VL 115
IS 3
BP 382
EP 383
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP6GV
UT WOS:000440977300015
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rice, ME
   Galang, RR
   Roth, NM
   Ellington, SR
   Moore, CA
   Valencia-Prado, M
   Ellis, EM
   Tufa, AJ
   Taulung, LA
   Alfred, JM
   Perez-Padilla, J
   Delgado-Lopez, CA
   Zaki, SR
   Reagan-Steiner, S
   Bhatnagar, J
   Nahabedian, JF
   Reynolds, MR
   Yeargin-Allsopp, M
   Viens, LJ
   Olson, SM
   Jones, AM
   Baez-Santiago, MA
   Oppong-Twene, P
   VanMaldeghem, K
   Simon, EL
   Moore, JT
   Polen, KD
   Hillman, B
   Ropeti, R
   Nieves-Ferrer, L
   Marcano-Huertas, M
   Masao, CA
   Anzures, EJ
   Hansen, RL
   Perez-Gonzalez, SI
   Espinet-Crespo, CP
   Luciano-Roman, M
   Shapiro-Mendoza, CK
   Gilboa, SM
   Honein, MA
AF Rice, Marion E.
   Galang, Romeo R.
   Roth, Nicole M.
   Ellington, Sascha R.
   Moore, Cynthia A.
   Valencia-Prado, Miguel
   Ellis, Esther M.
   Tufa, Aifili John
   Taulung, Livinson A.
   Alfred, Julia M.
   Perez-Padilla, Janice
   Delgado-Lopez, Camille A.
   Zaki, Sherif R.
   Reagan-Steiner, Sarah
   Bhatnagar, Julu
   Nahabedian, John F., III
   Reynolds, Megan R.
   Yeargin-Allsopp, Marshalyn
   Viens, Laura J.
   Olson, Samantha M.
   Jones, Abbey M.
   Baez-Santiago, Madelyn A.
   Oppong-Twene, Philip
   VanMaldeghem, Kelley
   Simon, Elizabeth L.
   Moore, Jazmyn T.
   Polen, Kara D.
   Hillman, Braeanna
   Ropeti, Ruta
   Nieves-Ferrer, Leishla
   Marcano-Huertas, Mariam
   Masao, Carolee A.
   Anzures, Edlen J.
   Hansen, Ransen L., Jr.
   Perez-Gonzalez, Stephany I.
   Espinet-Crespo, Carla P.
   Luciano-Roman, Mildred
   Shapiro-Mendoza, Carrie K.
   Gilboa, Suzanne M.
   Honein, Margaret A.
TI Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental
   Abnormalities Possibly Associated with Congenital Zika Virus Infection -
   US Territories and Freely Associated States, 2018
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UNITED-STATES; INFANTS; PREGNANCY; BRAZIL; CHILDREN; UPDATE
AB Introduction: Zika virus infection during pregnancy causes serious birth defects and might be associated with neurodevelopmental abnormalities in children. Early identification of and intervention for neurodevelopmental problems can improve cognitive, social, and behavioral functioning.
   Methods: Pregnancies with laboratory evidence of confirmed or possible Zika virus infection and infants resulting from these pregnancies are included in the U.S. Zika Pregnancy and Infant Registry (USZPIR) and followed through active surveillance methods. This report includes data on children aged >= 1 year born in U.S. territories and freely associated states. Receipt of reported follow-up care was assessed, and data were reviewed to identify Zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital Zika virus infection.
   Results: Among 1,450 children of mothers with laboratory evidence of confirmed or possible Zika virus infection during pregnancy and with reported follow-up care, 76% had developmental screening or evaluation, 60% had postnatal neuroimaging, 48% had automated auditory brainstem response-based hearing screen or evaluation, and 36% had an ophthalmologic evaluation. Among evaluated children, 6% had at least one Zika-associated birth defect identified, 9% had at least one neurodevelopmental abnormality possibly associated with congenital Zika virus infection identified, and 1% had both.
   Conclusion: One in seven evaluated children had a Zika-associated birth defect, a neurodevelopmental abnormality possibly associated with congenital Zika virus infection, or both reported to the USZPIR. Given that most children did not have evidence of all recommended evaluations, additional anomalies might not have been identified. Careful monitoring and evaluation of children born to mothers with evidence of Zika virus infection during pregnancy is essential for ensuring early detection of possible disabilities and early referral to intervention services.
C1 [Rice, Marion E.; Galang, Romeo R.; Roth, Nicole M.; Moore, Cynthia A.; Nahabedian, John F., III; Reynolds, Megan R.; Yeargin-Allsopp, Marshalyn; Viens, Laura J.; Olson, Samantha M.; Jones, Abbey M.; Baez-Santiago, Madelyn A.; Oppong-Twene, Philip; VanMaldeghem, Kelley; Simon, Elizabeth L.; Moore, Jazmyn T.; Polen, Kara D.; Gilboa, Suzanne M.; Honein, Margaret A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Rice, Marion E.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN 37830 USA.
   [Ellington, Sascha R.; Shapiro-Mendoza, Carrie K.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Valencia-Prado, Miguel; Delgado-Lopez, Camille A.; Nieves-Ferrer, Leishla; Marcano-Huertas, Mariam; Perez-Gonzalez, Stephany I.; Espinet-Crespo, Carla P.; Luciano-Roman, Mildred] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Ellis, Esther M.; Hillman, Braeanna] US Virgin Isl Dept Hlth, St Thomas, VI USA.
   [Tufa, Aifili John; Ropeti, Ruta] Amer Samoa Dept Hlth, Pago Pago, AS USA.
   [Alfred, Julia M.; Anzures, Edlen J.; Hansen, Ransen L., Jr.] Republ Marshall Isl Minist Hlth & Human Serv, Majuro, Marshall Island.
   [Perez-Padilla, Janice] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Zaki, Sherif R.; Reagan-Steiner, Sarah; Bhatnagar, Julu] CDC, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Honein, MA (corresponding author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM mrh7@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Hagan JF, 2007, BRIGHT FUTURES GUIDE
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Karoly L. A., 2005, PROVEN BENEFITS EARL
   Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/NEJMsa1803972, 10.1056/nejmsa1803972]
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SONKSEN PM, 1991, DEV MED CHILD NEUROL, V33, P320
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Yoshinaga-Itano C, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2964
NR 23
TC 57
Z9 57
U1 0
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 10
PY 2018
VL 67
IS 31
BP 858
EP 867
DI 10.15585/mmwr.mm6731e1
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP9XQ
UT WOS:000441270100004
PM 30091967
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Polen, KD
   Gilboa, SM
   Hills, S
   Oduyebo, T
   Kohl, KS
   Brooks, JT
   Adamski, A
   Simeone, RM
   Walker, AT
   Kissin, DM
   Petersen, LR
   Honein, MA
   Meaney-Delman, D
AF Polen, Kara D.
   Gilboa, Suzanne M.
   Hills, Susan
   Oduyebo, Titilope
   Kohl, Katrin S.
   Brooks, John T.
   Adamski, Alys
   Simeone, Regina M.
   Walker, Allison T.
   Kissin, Dmitry M.
   Petersen, Lyle R.
   Honein, Margaret A.
   Meaney-Delman, Dana
TI Update: Interim Guidance for Preconception Counseling and Prevention of
   Sexual Transmission of Zika Virus for Men with Possible Zika Virus
   Exposure - United States, August 2018
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID EPIDEMIC AREA; VIRAL LOAD; SEMEN; INFECTION; PERSISTENCE; DISEASE
C1 [Polen, Kara D.; Gilboa, Suzanne M.; Adamski, Alys; Simeone, Regina M.; Honein, Margaret A.; Meaney-Delman, Dana] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Hills, Susan; Petersen, Lyle R.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Oduyebo, Titilope; Kissin, Dmitry M.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Kohl, Katrin S.; Walker, Allison T.] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Brooks, John T.] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
RP Polen, KD (corresponding author), CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM kpolen@cdc.gov
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L., 2016, EURO SURVEILL, V21
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   ENDERS G, 1988, LANCET, V1, P1445
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Medina FA, 2019, J INFECT DIS, V219, P31, DOI 10.1093/infdis/jiy462
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nunoue T, 2002, PEDIATR INFECT DIS J, V21, P1133, DOI 10.1097/00006454-200212000-00009
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Revello MG, 2002, J INFECT DIS, V186, P553, DOI 10.1086/341831
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
NR 42
TC 25
Z9 25
U1 1
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD AUG 10
PY 2018
VL 67
IS 31
BP 868
EP 871
DI 10.15585/mmwr.mm6731e2
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GP9XQ
UT WOS:000441270100005
PM 30091965
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Mayor, S
AF Mayor, Susan
TI One in seven children born to mothers who had Zika infection has health
   problems
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Rice ME, 2018, VITAL SIGNS ZIKA ASS
NR 1
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD AUG 9
PY 2018
VL 362
AR k3477
DI 10.1136/bmj.k3477
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GU9UU
UT WOS:000445700300009
PM 30101745
DA 2020-07-08
ER

PT J
AU Lucas, CGO
   Kitoko, JZ
   Ferreira, FM
   Suzart, VG
   Papa, MP
   Coelho, SVA
   Cavazzoni, CB
   Paula-Neto, HA
   Olsen, PC
   Iwasaki, A
   Pereira, RM
   Pimentel-Coelho, PM
   Vale, AM
   de Arruda, LB
   Bozza, MT
AF Lucas, Carolina G. O.
   Kitoko, Jamil Z.
   Ferreira, Fabricio M.
   Suzart, Vinicius G.
   Papa, Michelle P.
   Coelho, Sharton V. A.
   Cavazzoni, Cecilia B.
   Paula-Neto, Heitor A.
   Olsen, Priscilla C.
   Iwasaki, Akiko
   Pereira, Renata M.
   Pimentel-Coelho, Pedro M.
   Vale, Andre M.
   de Arruda, Luciana B.
   Bozza, Marcelo T.
TI Critical role of CD4(+) T cells and IFN gamma signaling in
   antibody-mediated resistance to Zika virus infection
SO NATURE COMMUNICATIONS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; WEST-NILE-VIRUS; MOUSE MODEL; DENGUE;
   PROTECTION; VACCINE; RESPONSES; IMMUNITY; BRAIN; PATHOGENESIS
AB Protective adaptive immunity to Zika virus (ZIKV) has been mainly attributed to cytotoxic CD8(+) T cells and neutralizing antibodies, while the participation of CD4(+) T cells in resistance has remained largely uncharacterized. Here, we show a neutralizing antibody response, dependent on CD4(+) T cells and IFN gamma signaling, which we detected during the first week of infection and is associated with reduced viral load in the brain, prevention of rapid disease onset and survival. We demonstrate participation of these components in the resistance to ZIKV during primary infection and in murine adoptive transfer models of heterologous ZIKV infection in a background of IFNR deficiency. The protective effect of adoptively transferred CD4(+) T cells requires IFN gamma signaling, CD8(+) T cells and B lymphocytes in recipient mice. Together, this indicates the importance of CD4(+) T cell responses in future vaccine design for ZIKV.
C1 [Lucas, Carolina G. O.; Kitoko, Jamil Z.; Ferreira, Fabricio M.; Suzart, Vinicius G.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Imunol, Lab Inflamacao & Imunidade, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Kitoko, Jamil Z.; Olsen, Priscilla C.] Univ Fed Rio de Janeiro, Lab Bacteriol & Imunologia Clin, Fac Farm, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Papa, Michelle P.; Coelho, Sharton V. A.; de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Dept Virol, Lab Genet & Imunol Infeccoes Virais, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Cavazzoni, Cecilia B.; Vale, Andre M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Sinalizacao & Imunoreceptores, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Paula-Neto, Heitor A.] Univ Fed Rio de Janeiro, Dept Biotecnol Farmaceut, Lab Alvos Mol, Fac Farm, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA.
   [Pereira, Renata M.] Univ Fed Rio de Janeiro, Dept Imunol, Lab Imunol Mol, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Pimentel-Coelho, Pedro M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Neurobiol Celular & Mol, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Dept Imunol, Lab Inflamacao & Imunidade, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM mbozza@micro.ufrj.br
RI Pimentel-Coelho, Pedro Moreno/AAM-9106-2020; Iwasaki, Akiko/Z-1591-2019;
   Pereira, Renata/V-6194-2019; Olsen, Priscilla C/I-8994-2012;
   Pimentel-Coelho, Pedro M/K-1994-2015; Kitoko, JZ/D-1694-2016; Arruda,
   Luciana B/N-9086-2013
OI Pimentel-Coelho, Pedro Moreno/0000-0002-2414-3386; Iwasaki,
   Akiko/0000-0002-7824-9856; Olsen, Priscilla C/0000-0002-8795-037X;
   Pimentel-Coelho, Pedro M/0000-0002-2414-3386; Kitoko,
   JZ/0000-0003-0973-5460; 
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); CAPESCAPES; FINEPCiencia Tecnologia e
   Inovacao (FINEP); ICGEB [CRP/ BRA16-05-EC]
FX We thank Dr. Amilcar Tanuri and Dr. Ernesto T.A. Marques Jr. for kindly
   donating the ZIKV strain MR766 and PE243, respectively. Zika EDIII
   recombinant protein was kindly provided by Dr. Michel Nussenzweig. We
   acknowledge Leda R. Castilho, Matheus O. Souza, Renata G. F. Alvim, and
   Tulio M. Lima from Cell Culture Engineering Lab at COPPE/UFRJ for
   providing the purified VLPs used in the ELISA assays. We thank the
   members of the Bozza lab for helpful discussions and suggestions. This
   work was supported by grants from CNPq, FAPERJ, CAPES, FINEP (M.T.B) and
   ICGEB (CRP/ BRA16-05-EC; to R.M.P). C.G.O.L., J.Z.K., F.M.F., and
   V.G.S.S. are supported by fellowships from CAPES, M.P.P., and C.B.C. by
   CNPq and S.V.A.C. by FAPERJ.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Iijima N, 2016, NATURE, V533, P552, DOI 10.1038/nature17979
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   MuraliKrishna K, 1996, J GEN VIROL, V77, P705, DOI 10.1099/0022-1317-77-4-705
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
NR 63
TC 18
Z9 18
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 7
PY 2018
VL 9
AR 3136
DI 10.1038/s41467-018-05519-4
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP6IG
UT WOS:000440981600013
PM 30087337
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Qadir, A
   Riaz, M
   Saeed, M
   Shahzad-ul-Hussan, S
AF Qadir, Amina
   Riaz, Muhammad
   Saeed, Muhammad
   Shahzad-ul-Hussan, Syed
TI Potential targets for therapeutic intervention and structure based
   vaccine design against Zika virus
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Review
DE Zika virus; Therapeutic targets; Vaccine targets; Protease inhibitors;
   Lectins; Glycans; Entry inhibitor; Epitopes; Structure-based vaccine;
   Envelope proteins; NS5; NS1; CRISPR Cas9
ID WEST-NILE-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS;
   JAPANESE ENCEPHALITIS-VIRUS; N-LINKED GLYCOSYLATION; ENVELOPE PROTEIN
   GLYCOSYLATION; CROSS-REACTIVE ANTIBODIES; SMALL-MOLECULE INHIBITORS;
   HUMAN DENDRITIC CELLS; INFECTION IN-VITRO
AB Continuously increasing number of reports of Zika virus (ZIKV) infections and associated severe clinical manifestations, including autoimmune abnormalities and neurological disorders such as neonatal microcephaly and Guillain-Barre syndrome have created alarming situation in various countries. To date, no specific antiviral therapy or vaccine is available against ZIKV. This review provides a comprehensive insight into the potential therapeutic targets and describes viral epitopes of broadly neutralizing antibodies (bNAbs) in vaccine design perspective. Interactions between ZIKV envelope glycoprotein E and cellular receptors mediate the viral fusion and entry to the target cell. Blocking these interactions by targeting cellular receptors or viral structural proteins mediating these interactions or viral surface glycans can inhibit viral entry to the cell. Similarly, different non-structural proteins of ZIKV and untranslated regions (UTRs) of its RNA play essential roles in viral replication cycle and potentiate for therapeutic interventions. Structure based vaccine design requires identity and structural description of the epitopes of bNAbs. We have described different conserved bNAb epitopes present in the ZIKV envelope as potential targets for structure based vaccine design. This review also highlights successes, unanswered questions and future perspectives in relation to therapeutic and vaccine development against ZIKV. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Qadir, Amina; Shahzad-ul-Hussan, Syed] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore 54792, Pakistan.
   [Riaz, Muhammad] Univ Azad Jammu & Kashmir, Dept Chem, Muzaffarabad, Pakistan.
   [Saeed, Muhammad] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Chem & Chem Engn, Lahore 54792, Pakistan.
RP Shahzad-ul-Hussan, S (corresponding author), Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore 54792, Pakistan.; Saeed, M (corresponding author), Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Chem & Chem Engn, Lahore 54792, Pakistan.
EM muhammad.saeed@lums.edu.pk; shahzad.hussan@lums.edu.pk
OI Shahzad-ul-Hussan, Syed/0000-0001-7736-1072
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773
   Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288
   Andrabi R, 2017, IMMUNITY, V47, P524, DOI 10.1016/j.immuni.2017.08.006
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Balzarini J, 2006, ANTIVIR RES, V71, P237, DOI 10.1016/j.antiviral.2006.02.004
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0
   Bewley CA, 2013, BIOPOLYMERS, V99, P796, DOI 10.1002/bip.22329
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Brecher M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130062
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   BUCKLEY A, 1992, J GEN VIROL, V73, P1125, DOI 10.1099/0022-1317-73-5-1125
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Carvalho CAM, 2017, J GEN VIROL, V98, P1749, DOI 10.1099/jgv.0.000849
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Cervantes-Salazar M, 2015, VIROLOGY, V484, P113, DOI 10.1016/j.virol.2015.05.017
   Chakraborty C, 2017, MOL THER-NUCL ACIDS, V8, P132, DOI 10.1016/j.omtn.2017.06.005
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chien YJ, 2008, VIROLOGY, V379, P143, DOI 10.1016/j.virol.2008.06.017
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Contreras D., 2016, JOVE, V114
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fernandez-Leiro R, 2016, NATURE, V537, P339, DOI 10.1038/nature19948
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Gabius HJ, 2011, TRENDS BIOCHEM SCI, V36, P298, DOI 10.1016/j.tibs.2011.01.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   Gentile I, 2013, CURR MED CHEM, V20, P3733, DOI 10.2174/09298673113209990178
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Graham BS, 2013, IMMUNOL REV, V255, P230, DOI 10.1111/imr.12098
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Hajra A., 2017, AJRI AM J REPROD IMM, V1989, P77
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hannemann H, 2013, J BIOL CHEM, V288, P22621, DOI 10.1074/jbc.M113.481382
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hassan MZ, 2016, EUR J MED CHEM, V123, P236, DOI 10.1016/j.ejmech.2016.07.056
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   He LL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01025
   Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200
   Hemming A, 1996, ARCH VIROL, V141, P2139, DOI 10.1007/BF01718221
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   HORI H, 1990, J VIROL, V64, P4573, DOI 10.1128/JVI.64.9.4573-4577.1990
   Horiya S, 2014, J AM CHEM SOC, V136, P5407, DOI 10.1021/ja500678v
   Ishag HZA, 2016, VIRUS RES, V215, P50, DOI 10.1016/j.virusres.2016.01.016
   Ishag HZA, 2013, ARCH VIROL, V158, P349, DOI 10.1007/s00705-012-1489-2
   Jameson B, 2002, J VIROL, V76, P1866, DOI 10.1128/JVI.76.4.1866-1875.2002
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Johansson MA., 2016, BIORXIV
   JOHNSON LW, 1980, AM J PHYSIOL, V238, pC160
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342
   Kaminski R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22555
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuiper BD, 2017, BIOCHEM BIOPH RES CO, V492, P668, DOI 10.1016/j.bbrc.2017.03.108
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   LEONARD CK, 1990, J BIOL CHEM, V265, P10373
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Limjindaporn T, 2017, BIOCHEM BIOPH RES CO, V483, P58, DOI 10.1016/j.bbrc.2017.01.006
   Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200
   Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000
   Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Makhluf H., 2018, DEV ZIKA VIRUS VACCI, V6
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Mangia A, 2014, DIGEST LIVER DIS, V46, pS179, DOI 10.1016/j.dld.2014.09.026
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283
   McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meunier JC, 1999, J GEN VIROL, V80, P887, DOI 10.1099/0022-1317-80-4-887
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Mottin M., 2018, DRUG DISCOV TODAY, pS1359
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600
   Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819
   Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256
   Pejchal R, 2010, CURR PHARM DESIGN, V16, P3744, DOI 10.2174/138161210794079173
   Peplow M, 2017, NAT REV DRUG DISCOV, V16, P815, DOI 10.1038/nrd.2017.240
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Ramharack P, 2017, RSC ADV, V7, P22133, DOI 10.1039/c7ra01376k
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz J. C., 2017, AAC ANTIMICROB AGENT, V61
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scheepers C, 2017, AIDS, V31, P2199, DOI 10.1097/QAD.0000000000001643
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schuler-Faccini L, 2016, CLIN PHARMACOL THER, V100, P28, DOI 10.1002/cpt.386
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Shahzad-ul-Hussan S, 2011, J BIOL CHEM, V286, P20788, DOI 10.1074/jbc.M111.232678
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soilleux EJ, 2002, HUM PATHOL, V33, P652, DOI 10.1053/hupa.2002.124036
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015
   Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020
   Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998
   Sultana H, 2009, J IMMUNOL, V183, P650, DOI 10.4049/jimmunol.0900093
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tajima S, 2008, VIRUS GENES, V36, P323, DOI 10.1007/s11262-008-0211-7
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tatiparti K, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7040077
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Taylor ME, 2011, INTRO GLYCOBIOLOGY
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   Vanheule V, 2016, BIOCHEM PHARMACOL, V100, P73, DOI 10.1016/j.bcp.2015.11.001
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang XH, 2017, FRONT MED-PRC, V11, P449, DOI 10.1007/s11684-017-0589-5
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Woestenenk E, 2017, PROTEIN EXPRES PURIF, V140, P16, DOI 10.1016/j.pep.2017.07.002
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xie PW, 2013, NUCLEIC ACID THER, V23, P244, DOI 10.1089/nat.2012.0405
   Xie XP, 2017, J INFECT DIS, V216, pS945, DOI 10.1093/infdis/jix406
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Yusufzai SK, 2018, CHEM CENT J, V12, DOI 10.1186/s13065-018-0435-0
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-138
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 260
TC 6
Z9 7
U1 4
U2 13
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD AUG 5
PY 2018
VL 156
BP 444
EP 460
DI 10.1016/j.ejmech.2018.07.014
PG 17
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GS4YG
UT WOS:000443663200032
PM 30015077
DA 2020-07-08
ER

PT J
AU Li, AZ
   Yu, JY
   Lu, MJ
   Ma, YM
   Attia, Z
   Shan, C
   Xue, MG
   Liang, XY
   Craig, K
   Makadiya, N
   He, JJ
   Jennings, R
   Shi, PY
   Peeples, ME
   Liu, SL
   Boyaka, PN
   Li, JR
AF Li, Anzhong
   Yu, Jingyou
   Lu, Mijia
   Ma, Yuanmei
   Attia, Zayed
   Shan, Chao
   Xue, Miaoge
   Liang, Xueya
   Craig, Kelsey
   Makadiya, Nirajkumar
   He, Jennifer J.
   Jennings, Ryan
   Shi, Pei-Yong
   Peeples, Mark E.
   Liu, Shan-Lu
   Boyaka, Prosper N.
   Li, Jianrong
TI A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; ENCEPHALITIS-VIRUS; DENGUE VIRUS; DNA
   VACCINE; SEXUAL TRANSMISSION; PROTECTIVE EFFICACY; CANDIDATE VACCINE;
   CROSS-REACTIVITY; INFECTION; ANTIBODIES
AB Current efforts to develop Zika virus (ZIKV) subunit vaccines have been focused on premembrane (prM) and envelope (E) proteins, but the role of NS1 in ZIKV-specific immune response and protection is poorly understood. Here, we develop an attenuated recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing ZIKV prM-E-NS1 as a polyprotein. This vectored vaccine candidate is attenuated in mice, where a single immunization induces ZIKV-specific antibody and T cell immune responses that provide protection against ZIKV challenge. Co-expression of prM, E, and NS1 induces significantly higher levels of Th2 and Th17 cytokine responses than prM-E. In addition, NS1 alone is capable of conferring partial protection against ZIKV infection in mice even though it does not induce neutralizing antibodies. These results demonstrate that attenuated rVSV co-expressing prM, E, and NS1 is a promising vaccine candidate for protection against ZIKV infection and highlights an important role for NS1 in ZIKV-specific cellular immune responses.
C1 [Li, Anzhong; Yu, Jingyou; Lu, Mijia; Ma, Yuanmei; Attia, Zayed; Xue, Miaoge; Liang, Xueya; Craig, Kelsey; Makadiya, Nirajkumar; He, Jennifer J.; Jennings, Ryan; Liu, Shan-Lu; Boyaka, Prosper N.; Li, Jianrong] Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA.
   [Yu, Jingyou; Liu, Shan-Lu] Ohio State Univ, Ctr Retrovirus Res, 1925 Coffey Rd, Columbus, OH 43210 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Peeples, Mark E.] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, 700 Childrens Dr, Columbus, OH 43205 USA.
   [Peeples, Mark E.] Ohio State Univ, Dept Pediat, Coll Med, 370W 9th Ave, Columbus, OH 43210 USA.
   [Liu, Shan-Lu; Boyaka, Prosper N.; Li, Jianrong] Ohio State Univ, Infect Dis Inst, 1925 Coffey Rd, Columbus, OH 43210 USA.
   [Liu, Shan-Lu] Ohio State Univ, Dept Microbial Infect & Immun, 1925 Coffey Rd, Columbus, OH 43210 USA.
RP Li, JR (corresponding author), Ohio State Univ, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA.; Li, JR (corresponding author), Ohio State Univ, Infect Dis Inst, 1925 Coffey Rd, Columbus, OH 43210 USA.
EM li.926@osu.edu
RI Attia, Zayed/AAR-3340-2020
OI Shan, Chao/0000-0002-3953-3782
FU Ohio State UniversityOhio State University; Nationwide Children
   Hospital; NIH-NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01AI112524]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI112381, R21AI109464, AI127744]; University of Texas STARs
   Award; CDC grant for the Western Gulf Center of Excellence for
   Vector-Borne Diseases; Pan American Health Organization grant
   [SCON2016-01353]; Kleberg Foundation Award; UTMB CTSAUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR-001439]
FX This work was supported by internal funds from The Ohio State University
   (Jianrong Li and Prosper Boyaka) and Nationwide Children Hospital (Mark
   Peeples), and a grant from the NIH-NIAID (P01AI112524 supporting Mark
   Peeples and Jianrong Li). Work in Shan-Lu Liu's lab was supported by NIH
   grants R01AI112381 and R21AI109464. P.-Y.S. lab was supported by
   University of Texas STARs Award, CDC grant for the Western Gulf Center
   of Excellence for Vector-Borne Diseases, Pan American Health
   Organization grant SCON2016-01353, the Kleberg Foundation Award, UTMB
   CTSA UL1TR-001439, and NIH grant AI127744. We thank Gail Wertz for the
   VSV reverse genetics system and Sean Whelan for providing pVSV(+) GxxL
   plasmid. We thank Edward Calomeni at The Ohio State University for
   electron microscopy analysis.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Bukreyev A, 2006, J VIROL, V80, P10293, DOI 10.1128/JVI.00919-06
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chattopadhyay A, 2011, J VIROL, V85, P2004, DOI 10.1128/JVI.01852-10
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall RA, 1996, J GEN VIROL, V77, P1287, DOI 10.1099/0022-1317-77-6-1287
   HAMPTON T, 2016, JAMA J AM MED ASSOC, V316, P1755
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Huttner A, 2015, LANCET INFECT DIS, V15, P1156, DOI 10.1016/S1473-3099(15)00154-1
   Kapadia SU, 2005, VIROLOGY, V340, P174, DOI 10.1016/j.virol.2005.06.016
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kurup D, 2015, J VIROL, V89, P144, DOI 10.1128/JVI.02308-14
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li JR, 2006, P NATL ACAD SCI USA, V103, P8493, DOI 10.1073/pnas.0509821103
   Li JR, 2005, J VIROL, V79, P13373, DOI 10.1128/JVI.79.21.13373-13384.2005
   Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998
   Ma YM, 2014, J VIROL, V88, P2913, DOI 10.1128/JVI.03420-13
   Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Perlman S, 2016, INT J INFECT DIS, V47, P23, DOI 10.1016/j.ijid.2016.04.008
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999
   Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Safronetz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003736
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   STEINHOFF U, 1995, J VIROL, V69, P2153, DOI 10.1128/JVI.69.4.2153-2158.1995
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   vandenBroek MF, 1995, IMMUNOL REV, V148, P5
   Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61
   WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
NR 72
TC 15
Z9 16
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 3
PY 2018
VL 9
AR 3067
DI 10.1038/s41467-018-05276-4
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP2IO
UT WOS:000440653300003
PM 30076287
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mishra, PM
   Uversky, VN
   Giri, R
AF Mishra, Pushpendra Mani
   Uversky, Vladimir N.
   Giri, Rajanish
TI Molecular Recognition Features in Zika Virus Proteome
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Zika virus; intrinsically disorder protein; intrinsically disordered
   protein regions; molecular recognition features; Circular dichroism
   spectroscopy
ID WEST-NILE-VIRUS; DENGUE-VIRUS; CRYSTAL-STRUCTURE; NS2B-NS3 PROTEASE;
   MEMBRANE ASSOCIATION; INTRINSIC DISORDER; STRUCTURAL BASIS; BINDING
   REGIONS; NS3 HELICASE; KIX DOMAIN
AB Viruses have compact genomes that encode limited number of proteins in comparison to other biological entities. Interestingly, viral proteins have shown natural abundance of either completely disordered proteins that are recognized as intrinsically disorder proteins (IDPs) or partially disordered segments known as intrinsically disordered protein regions (IDPRs). IDPRs are involved in interactions with multiple binding partners to accomplish signaling, regulation, and control functions in cells. Tuning of IDPs and IDPRs are mediated through post-translational modification and alternative splicing. Often, the interactions of IDPRs with their binding protein partner(s) lead to transition from the state of disorder to ordered form. Such interaction-prone protein IDPRs are identified as molecular recognition features (MoRFs). Molecular recognition is an important initial step for the biomolecular interactions and their functional proceedings. Although previous studies have established occurrence of the IDPRs in Zika virus proteome, which provide the functional diversity and structural plasticity to viral proteins, the MoRF analysis has not been performed as of yet. Many computational methods have been developed for the identification of the MoRFs in protein sequences including ANCHOR, MoRFpred, DISOPRED3, and MoRFchibi_web server. In the current study, we have investigated the presence of MoRF regions in structural and non-structural proteins of Zika virus using an aforementioned set of computational techniques. Furthermore, we have experimentally validated the intrinsic disorderness of NS2B cofactor region of NS2B-NS3 protease. NS2B has one of the longest MoRF regions in Zika virus proteome. In future, this study may provide valuable information while investigating the virus host protein interaction networks. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Mishra, Pushpendra Mani; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175005, Himachal Prades, India.
   [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.
   [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA.
   [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino 142290, Moscow Region, Russia.
   [Giri, Rajanish] Indian Inst Technol Mandi, BioX Ctr, Mandi 175005, Himachal Prades, India.
RP Giri, R (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175005, Himachal Prades, India.; Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA.
EM vuversky@health.usf.edu; rajanishgiri@iitmandi.ac.in
RI Giri, Rajanish/Q-6530-2018; Uversky, Vladimir N./F-4515-2011
OI Giri, Rajanish/0000-0002-2046-836X; Uversky, Vladimir
   N./0000-0002-4037-5857; Mishra, Pushpendra/0000-0001-6674-6196
FU Department of Biotechnology, IndiaDepartment of Biotechnology (DBT)
   India [BT/PR15453/BRB/10/1460/2015]
FX The authors acknowledge the funding support of the Department of
   Biotechnology, India. The project number for the same is
   BT/PR15453/BRB/10/1460/2015. The authors also acknowledge IIT Mandi for
   providing host support and instruments.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Aguilera-Pesantes D, 2017, BIOCHEM BIOPH RES CO, V492, P659, DOI 10.1016/j.bbrc.2017.02.035
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Brunori M, 2012, BIOCHEM SOC T, V40, P429, DOI 10.1042/BST20110683
   CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   Daughdrill G. W., 2008, NATIVELY DISORDERED, P275, DOI [10.1002/9783527619498.ch41, DOI 10.1002/9783527619498.CH41]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209
   Dolan PT, 2015, PROTEIN SCI, V24, P221, DOI 10.1002/pro.2608
   Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518
   Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110
   Goh GKM, 2016, MOL BIOSYST, V12, P1881, DOI 10.1039/c6mb00228e
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   Khrustalev VV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00044
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malhis N, 2016, NUCLEIC ACIDS RES, V44, pW488, DOI 10.1093/nar/gkw409
   Malhis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141603
   Malhis N, 2015, BIOINFORMATICS, V31, P1738, DOI 10.1093/bioinformatics/btv060
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Meng FC, 2015, FEBS J, V282, P3368, DOI 10.1111/febs.13349
   Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750
   SAIZ JC, 2016, FRONT MICROBIOL, V7
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Shiryaev SA, 2009, J GEN VIROL, V90, P2081, DOI 10.1099/vir.0.012864-0
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Szilagyi A, 2008, BIOPHYS J, V95, P1612, DOI 10.1529/biophysj.108.131151
   Tay Y. F., 2014, C TERMINAL 50 AMINO, DOI [10.1074/jbc.M114.607341, DOI 10.1074/JBC.M114.607341]
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994
   Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Uversky V. N., 2012, INTRINSICALLY DISORD, P475
   Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411
   van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yan J, 2016, MOL BIOSYST, V12, P697, DOI 10.1039/c5mb00640f
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 108
TC 22
Z9 24
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 3
PY 2018
VL 430
IS 16
SI SI
BP 2372
EP 2388
DI 10.1016/j.jmb.2017.10.018
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GN8ID
UT WOS:000439402200009
PM 29080786
DA 2020-07-08
ER

PT J
AU Regla-Nava, JA
   Ngono, AE
   Viramontes, KM
   Huynh, AT
   Wang, YT
   Nguyen, AVT
   Salgado, R
   Mamidi, A
   Kim, K
   Diamond, MS
   Shresta, S
AF Regla-Nava, Jose Angel
   Ngono, Annie Elong
   Viramontes, Karla M.
   Huynh, Anh-Thy
   Wang, Ying-Ting
   Nguyen, Anh-Viet T.
   Salgado, Rebecca
   Mamidi, Anila
   Kim, Kenneth
   Diamond, Michael S.
   Shresta, Sujan
TI Cross-reactive Dengue virus-specific CD8(+) T cells protect against Zika
   virus during pregnancy
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; VERTICAL TRANSMISSION; IN-VIVO;
   INFECTION; RESPONSES; PATHOGENESIS; DISEASE; BRAIN; REPLICATION;
   MECHANISMS
AB As Zika virus (ZIKV) emerges into Dengue virus (DENV)-endemic areas, cases of ZIKV infection in DENV-immune pregnant women may rise. Here we show that prior DENV immunity affects maternal and fetal ZIKV infection in pregnancy using sequential DENV and ZIKV infection models. Fetuses in ZIKV-infected DENV-immune dams were normal sized, whereas fetal demise occurred in non-immune dams. Moreover, reduced ZIKV RNA is present in the placenta and fetuses of ZIKV-infected DENV-immune dams. DENV cross-reactive CD8(+) T cells expand in the maternal spleen and decidua of ZIKV-infected dams, their depletion increases ZIKV infection in the placenta and fetus, and results in fetal demise. The inducement of cross-reactive CD8(+) T cells via peptide immunization or adoptive transfer results in decreased ZIKV infection in the placenta. Prior DENV immunity can protect against ZIKV infection during pregnancy in mice, and CD8(+) T cells are sufficient for this cross-protection. This has implications for understanding the natural history of ZIKV in DENV-endemic areas and the development of optimal ZIKV vaccines.
C1 [Regla-Nava, Jose Angel; Ngono, Annie Elong; Viramontes, Karla M.; Huynh, Anh-Thy; Wang, Ying-Ting; Nguyen, Anh-Viet T.; Salgado, Rebecca; Mamidi, Anila; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med Mol Microbiol Pathol & Immunol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Shresta, Sujan] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Shresta, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.
EM sujan@lji.org
RI amsalu, ribka/G-8780-2019; Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Regla-Nava, Jose
   Angel/0000-0002-5438-1369
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI116813, R21 NS100477, P01
   AI106695, R01 AI073755, R01 AI127828]; Chiba-UCSD Center for Mucosal
   Immunology, Allergy and Vaccine Development
FX This research was funded by NIH grants (R01 AI116813 and R21 NS100477 to
   S.S. and P01 AI106695, R01 AI073755, and R01 AI127828 to M.S.D.) and the
   Chiba-UCSD Center for Mucosal Immunology, Allergy and Vaccine
   Development.
CR Anders AP, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12623
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Constantin CM, 2007, J IMMUNOL, V179, P4383, DOI 10.4049/jimmunol.179.7.4383
   Crespo AC, 2017, J REPROD IMMUNOL, V119, P85, DOI 10.1016/j.jri.2016.08.001
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Grifoni A., 2017, J VIROL
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   King NJC, 2017, TRENDS MICROBIOL, V25, P701, DOI 10.1016/j.tim.2017.05.005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lei J, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12798
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lissauer D, 2017, PLACENTA, V60, P140, DOI 10.1016/j.placenta.2017.09.003
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Munoz-Suano A, 2012, J AUTOIMMUN, V38, pJ103, DOI 10.1016/j.jaut.2011.09.007
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nancy P, 2014, INT J DEV BIOL, V58, P189, DOI 10.1387/ijdb.140054ae
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Nishiura H., 2008, Dengue Bulletin, V32, P55
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407
   Powell RM, 2017, J IMMUNOL, V199, P3406, DOI 10.4049/jimmunol.1700114
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Simon-Loriere E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5088
   Snow GE, 2014, AM J TROP MED HYG, V91, P1203, DOI 10.4269/ajtmh.14-0132
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tilburgs T, 2013, AM J REPROD IMMUNOL, V69, P395, DOI 10.1111/aji.12094
   van Egmond A, 2016, J REPROD IMMUNOL, V113, P1, DOI 10.1016/j.jri.2015.09.073
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
NR 74
TC 27
Z9 28
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD AUG 2
PY 2018
VL 9
AR 3042
DI 10.1038/s41467-018-05458-0
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GP1ZL
UT WOS:000440617500018
PM 30072692
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Andrade, DV
   Harris, E
AF Andrade, Daniela V.
   Harris, Eva
TI Recent advances in understanding the adaptive immune response to Zika
   virus and the effect of previous flavivirus exposure
SO VIRUS RESEARCH
LA English
DT Review
DE Zika virus; Dengue virus; Immunity; Flaviviruses; Neutralizing
   antibodies; Antibody-dependent enhancement; Cross-reactivity; Memory B
   cells; T cells; Envelope protein; Monoclonal antibody; Polyclonal
   antibody response; Structural immunology
ID ANTIBODY-DEPENDENT ENHANCEMENT; NEUTRALIZING HUMAN-ANTIBODIES;
   NONSTRUCTURAL PROTEIN NS1; T-CELL RESPONSES; DENGUE VIRUS;
   GUILLAIN-BARRE; HEMORRHAGIC-FEVER; CRYSTAL-STRUCTURE; CROSS-REACTIVITY;
   INFECTION
AB Zika virus (ZIKV) caused explosive epidemics across the Americas, starting in Brazil in 2015, and has been associated with severe manifestations such as microcephaly in babies born to infected mothers and Guillain-Barre syndrome in adults. As the underlying mechanisms of pathogenesis remain largely unknown, diverse investigations have focused on a potential role for flavivirus cross-reactive antibodies in enhancing ZIKV infection. Antibody-dependent enhancement is especially concerning due to structural similarities between ZIKV and other flaviviruses, especially dengue virus (DENY), that co-circulate in areas affected by ZIKV. Conversely, investigating cross-neutralizing antibodies is important for understanding protection among flaviviruses, including ZIKV. In this review, we discuss the latest findings regarding ZIKV-induced adaptive immunity, such as monoclonal and polyclonal antibody responses, structural immunology, and T cell-mediated responses. Much progress has been made in a short amount of time, but many questions remain. Fully understanding the specificity, magnitude, and kinetics of B cell/antibody and T cell responses in ZIKV-infected individuals with or without prior exposure to flaviviruses is of great relevance for diagnostics and vaccine development.
C1 [Andrade, Daniela V.; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01 AI106695]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX We thank Leah Katzelnick, Daniela Michlmayr and Paulina Andrade for
   helpful comments on the manuscript and Dustin Glasner for invaluable
   assistance with the figure. This work was supported by NIAID/NIH grant
   P01 AI106695 (to EH) and a Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) fellowship (to DVA).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abd El Wahed A., 2017, PLOS CURR, V25
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Besnard M, 2014, EURO SURVEILL, V19
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2016, CURR ZIK TRANSM
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1965, AM J PUBLIC HEALTH N, V55, P1386, DOI 10.2105/AJPH.55.9.1386
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Herriman R, 2015, OUTBREAK NEWS TODAY
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jampol L., 2016, JAMA OPHTHALMOL, V20, P1
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nishiura H., 2016, EMERG INFECT DIS, V20, P95
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shoenfeld Y, 1996, INT ARCH ALLERGY IMM, V109, P318, DOI 10.1159/000237258
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   World Health Organization (WHO), 2016, ZIK VIR COMPL 2016 P
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Zanluca C., 2015, MEM I O CUZ, V110, P659
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 95
TC 14
Z9 15
U1 1
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 27
EP 33
DI 10.1016/j.virusres.2017.06.019
PG 7
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500005
PM 28655548
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Goertz, GP
   Abbo, SR
   Fros, JJ
   Pijlman, GP
AF Goertz, Giel P.
   Abbo, Sandra R.
   Fros, Jelke J.
   Pijlman, Gorben P.
TI Functional RNA during Zika virus infection
SO VIRUS RESEARCH
LA English
DT Review
DE Zika virus; Virus-host interactions; RNA methylation; Codon usage bias;
   Dinucleotides; Nucleotide composition; G-quadruplex; 5' and 3'
   untranslated regions; Subgenomic flavivirus RNA
ID SUBGENOMIC FLAVIVIRUS RNA; CODON USAGE BIAS; MINUS-STRAND RNA;
   MESSENGER-RNA; DENGUE VIRUS; ENCEPHALITIS-VIRUS; CYCLIZATION SEQUENCES;
   ANTIVIRAL RESPONSES; ARBOVIRUS INFECTION; CRYSTAL-STRUCTURE
AB Zika virus (ZIKV; family Flaviviridae; genus Flavivirus) is a pathogenic mosquito-borne RNA virus that currently threatens human health in the Americas, large parts of Asia and occasionally elsewhere in the world. ZIKV infection is often asymptomatic but can cause severe symptoms including congenital microcephaly and Guillain-Barre syndrome. The positive single-stranded RNA genome of the mosquito-borne ZIKV requires effective replication in two evolutionary distinct hosts mosquitoes and primates. In addition to some of the viral proteins, the ZIKV genomic RNA and functional RNAs produced thereof aid in the establishment of productive infection and the evasion of host cell antiviral responses. ZIKV has evolved to contain a nucleotide composition and RNA modifications, such as methylation and the formation of G-quadruplexes that allow effective replication in both hosts. Furthermore, a number of host factors interact with the viral genome to modulate RNA replication. Importantly, the ZIKV genome produces non-coding subgenomic flavivirus RNA (sfRNA) due to stalling of host 5'-3' ribonucleases on viral RNA structures in the 3' untranslated region (UTR). This sfRNA (sfRNA) exerts important proviral functions such as antagonizing the innate interferon response and RNA interference. Here, we discuss the ZIKV genomic RNA and functional RNAs thereof to assess their significance during ZIKV infection. Understanding the details of the ZIKV infection cycle will aid in the development of effective antiviral strategies and safe vaccines.
C1 [Goertz, Giel P.; Abbo, Sandra R.; Fros, Jelke J.; Pijlman, Gorben P.] Wageningen Univ & Res, Lab Virol, Wageningen, Netherlands.
   [Fros, Jelke J.] Univ Oxford, Nuffield Dept Med, Peter Medawar Bldg Pathogen Res, Oxford, England.
RP Pijlman, GP (corresponding author), Wageningen Univ & Res, Lab Virol, Wageningen, Netherlands.
EM giel.goertz@wur.nl; sandra.abbo@wur.nl; jelke.fros@wur.nl;
   gorben.pijlman@wur.nl
RI Fros, Jelke/AAN-5110-2020
OI Fros, Jelke/0000-0002-3291-8401; Goertz, Giel/0000-0002-8194-3574
FU ZonMw project ZikaRisk "Risk of Zika virus introductions for the
   Netherlands" [522003001]
FX SRA was supported by the ZonMw project ZikaRisk "Risk of Zika virus
   introductions for the Netherlands", project number 522003001.
CR Adams RL, 2017, CURR OPIN VIROL, V24, P79, DOI 10.1016/j.coviro.2017.04.007
   Aguilar PV, 2008, J VIROL, V82, P4920, DOI 10.1128/JVI.02514-07
   Akiyama B. M., 2016, ZIKA VIRUS PRODUCES, P3963
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Martinez MA, 2016, TRENDS MICROBIOL, V24, P134, DOI 10.1016/j.tim.2015.11.002
   Atkins J. F., 2011, RNA WORLDS LIFES ORI
   Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075
   Bashkirov VI, 1997, J CELL BIOL, V136, P761, DOI 10.1083/jcb.136.4.761
   Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642
   BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Blaum BS, 2012, NUCLEIC ACIDS RES, V40, P3042, DOI 10.1093/nar/gkr1152
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020
   Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   de Fabritus L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004738
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626
   Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14
   Fernandez-Sanles A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00546
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaunt E, 2016, ELIFE, V5, DOI 10.7554/eLife.12735
   Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679
   Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Gortz GP, 2015, CELL HOST MICROBE, V18, P133, DOI 10.1016/j.chom.2015.07.009
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Haasnoot J, 2003, J BIOMED SCI, V10, P607, DOI 10.1007/BF02256311
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   HSUCHEN CC, 1977, NUCLEIC ACIDS RES, V4, P2671, DOI 10.1093/nar/4.8.2671
   Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6
   Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168
   Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109
   JOSSE J, 1961, J BIOL CHEM, V236, P864
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994
   Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115
   Khromykh AA, 2003, J VIROL, V77, P10623, DOI 10.1128/JVI.77.19.10623-10629.2003
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Khrustalev V. V., 2017, VIRUS LOCAL ADAR EDI, V7, P1, DOI DOI 10.3389/FCIMB.2017.00044
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Kunec D, 2016, CELL REP, V14, P55, DOI 10.1016/j.celrep.2015.12.011
   Li C, 2014, VIROLOGY, V449, P70, DOI 10.1016/j.virol.2013.11.008
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lindenbach BD, 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   Liu J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0630-y
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2
   LIU ZP, 1995, P NATL ACAD SCI USA, V92, P6002, DOI 10.1073/pnas.92.13.6002
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Markoff L, 2003, ADV VIRUS RES, V59
   McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306
   Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mongelli V, 2016, ANNU REV VIROL, V3, P573, DOI 10.1146/annurev-virology-110615-042447
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Piontkivska H, 2017, ECOL EVOL, V7, P4475, DOI 10.1002/ece3.3033
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rosato PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005028
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   RUSSELL GJ, 1976, J MOL BIOL, V108, P1, DOI 10.1016/S0022-2836(76)80090-3
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Shen W, 2011, J BIOL CHEM, V286, P29838, DOI 10.1074/jbc.M111.262352
   Shipley JG, 2012, VIROLOGY, V432, P232, DOI 10.1016/j.virol.2012.06.009
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Simmonds P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-610
   Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10
   Singh NK, 2017, ARCH VIROL, V162, P1963, DOI 10.1007/s00705-017-3324-2
   SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   STEVENS A, 1978, BIOCHEM BIOPH RES CO, V81, P656, DOI 10.1016/0006-291X(78)91586-3
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971
   Till DD, 1998, MECH DEVELOP, V79, P51, DOI 10.1016/S0925-4773(98)00173-7
   Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g
   Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Woo HM, 2013, ANTIVIR RES, V100, P337, DOI 10.1016/j.antiviral.2013.09.004
   Yuan Fan, 2015, J COMMUNICATIONS, V60, P2779, DOI DOI 10.1371/J0URNAL.P0NE.0166260
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 150
TC 27
Z9 28
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 41
EP 53
DI 10.1016/j.virusres.2017.08.015
PG 13
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500007
PM 28864425
OA Other Gold
DA 2020-07-08
ER

PT J
AU Magalhaes, T
   Foy, BD
   Marques, ETA
   Ebel, GD
   Weger-Lucarelli, J
AF Magalhaes, Tereza
   Foy, Brian D.
   Marques, Ernesto T. A.
   Ebel, Gregory D.
   Weger-Lucarelli, James
TI Mosquito-borne and sexual transmission of Zika virus: Recent
   developments and future directions
SO VIRUS RESEARCH
LA English
DT Review
DE Zika; Virus; Arbovirus; Mosquito; Sex; Sexual transmission
ID AEDES-AEGYPTI MOSQUITOS; FEMALE GENITAL-TRACT; YELLOW-FEVER VIRUS; WEST
   NILE VIRUS; UNITED-STATES; DENGUE VIRUS; VERTICAL TRANSMISSION;
   SOUTHEASTERN SENEGAL; FOREST MAMMALS; CULEX-PIPIENS
AB Zika virus (ZIKV; Genus Flavivirus, Family Flaviviridae) has recently emerged in Asia and the Americas to cause large outbreaks of human disease. The outbreak has been characterized by high attack rates, birth defects in infants and severe neurological complications in adults. ZIKV is transmitted to humans by Aedes mosquitoes, but recent evidence implicates sexual transmission as playing an important role as well. This review highlights the transmission of ZIKV in humans, with a focus on both mosquito and sexually-transmitted routes and their outcomes. We also discuss critical directions for future research.
C1 [Magalhaes, Tereza; Foy, Brian D.; Ebel, Gregory D.; Weger-Lucarelli, James] Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Lab Virol & Expt Therapeut, Recife, PE, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA 15261 USA.
RP Foy, BD (corresponding author), Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM brian.foy@colostate.edu
RI Magalhaes, Tereza/V-6632-2019; Marques, Ernesto T. A/L-4967-2013; Foy,
   Brian/E-6230-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Foy,
   Brian/0000-0002-9117-203X; Weger-Lucarelli, James/0000-0002-9483-1694
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI067380, R21AI125996,
   R21AI129464]
FX This publication was supported by the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health under award
   numbers R01AI067380, R21AI125996 and R21AI129464. The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amraoui F, 2016, EURO SURVEILL, V21
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B., 2016, GENOME ANNOUNC, V4
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bartellas E, 2000, BRIT J OBSTET GYNAEC, V107, P964, DOI 10.1111/j.1471-0528.2000.tb10397.x
   Barzon L., 2016, EURO SURVEILL, V21
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Berggren EK, 2011, SEX TRANSM DIS, V38, P172, DOI 10.1097/OLQ.0b013e3181f41b96
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Blohm G.M., 2017, GENOME ANNOUNC, V5
   Boccolini D, 2016, EURO SURVEILL, V21
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Davis NC, 1929, J EXP MED, V50, P81, DOI 10.1084/jem.50.1.81
   DAVIS NELSON C., 1930, JOUR EXP MED, V51, P703, DOI 10.1084/jem.51.5.703
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Di Luca M, 2016, EURO SURVEILL, V21
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Favoretto S., 2016, BIORXIV, P1
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EURO SURVEILL, V21
   Freour T., 2016, EURO SURVEILL, V21
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heitmann A, 2017, EURO SURVEILL, V22
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Johnson BJ, 2017, INSECTS, V8, DOI 10.3390/insects8010005
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Ladner J. T, 2016, GENOME ANNOUNC, V4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lee V. H., 1958, B WORLD HEALTH ORGAN, V46, P669
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lustig Y, 2016, EURO SURVEILL, V21
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mathers MJ, 2017, DTSCH ARZTEBL INT, V114, P186, DOI 10.3238/arztebl.2017.0186
   Mboera LEG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004313
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E., 2016, EURO SURVEILL, V21
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PAHO/WHO, 2016, ZIK EP UPD
   Pauleta JR, 2010, J SEX MED, V7, P136, DOI 10.1111/j.1743-6109.2009.01538.x
   Paz-Bailey G, 2017, N ENGL J MED
   Penot P, 2017, EURO SURVEILL, V22
   Pomar L, 2017, ULTRASOUND OBSTET GY
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   ROCHE JC, 1983, ANN INST PASTEUR VIR, V134, P233, DOI 10.1016/S0769-2617(83)80062-8
   Rosilainy Surubi Fernandes S. S. C., 2017, MEMCRIAS I O CRUZ, V112, P1
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   SALUZZO J-F, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P19
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Septfons A, 2016, EURO SURVEILL, V21
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Smartt C. T., 2017, J MED ENTOMOL
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   SMITHBURN KC, 1949, ANN TROP MED PARASIT, V43, P74, DOI 10.1080/00034983.1949.11685396
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Teasdale CA, 2017, ARCH SEX BEHAV, V46, P539, DOI 10.1007/s10508-016-0818-z
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   TraoreLamizana M, 1996, J MED ENTOMOL, V33, P760, DOI 10.1093/jmedent/33.5.760
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Waltz E, 2016, NAT BIOTECHNOL, V34, P221, DOI 10.1038/nbt0316-221
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, GLOB HLTH SECT STRAT
   WHO, 2016, PREV SEX TRANSM ZIK
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 157
TC 13
Z9 13
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 1
EP 9
DI 10.1016/j.virusres.2017.07.011
PG 9
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500001
PM 28705681
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Li, XD
   Ma, WQ
   Wong, G
   Ma, SQ
   Li, SH
   Bi, YH
   Gao, GF
AF Li, Xiangdong
   Ma, Wenqiang
   Wong, Gary
   Ma, Shuoqian
   Li, Shihua
   Bi, Yuhai
   Gao, George F.
TI A new threat to human reproduction system posed by Zika virus (ZIKV):
   From clinical investigations to experimental studies
SO VIRUS RESEARCH
LA English
DT Review
DE Zika virus; Reproductive system; Animal models
ID VECTOR-BORNE TRANSMISSION; MALE SEXUAL TRANSMISSION; VERTICAL
   TRANSMISSION; BARRE-SYNDROME; UNITED-STATES; MOUSE MODEL; INFECTION;
   OUTBREAK; GUILLAIN; AMERICA
AB Zika virus (ZIKV) was first isolated in 1947 from a rhesus monkey in the Zika forest of Uganda. ZIKV has since been silently circulating in a number of equatorial countries for over 50 years. The largest outbreak in humans occurred in Brazil in 2015-2016. Unlike its flavivirus relatives, sexual and post-transfusion transmissions of ZIKV have been reported. In addition, fetal infection can result in microcephaly and congenital Zikv syndrome has been reported in neonates. Moreover, ZIKV RNA can persist for at least 6 months in semen and 11 weeks in vaginal secretions after the infection, suggesting potential tropism for the male and female genital tracts. Accordingly, it is important to determine whether genital ZIKV infection could have deleterious effects on the male and female reproductive systems.
C1 [Li, Xiangdong; Ma, Wenqiang; Ma, Shuoqian] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.
   [Li, Xiangdong; Ma, Wenqiang; Ma, Shuoqian] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.
   [Wong, Gary; Li, Shihua; Bi, Yuhai; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Beijing, Peoples R China.
RP Li, XD (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
EM xiangdongli@cau.edu.cn; gaof@im.ac.cn
CR [Anonymous], 2016, EURO SURVEILLANCE B, V21, P32
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barzon L., 2016, EURO SURVEILL, V21
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   Baud D., 2017, J REPROD IMMUNOL, V77, P1107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   NAYAR JK, 1986, AM J TROP MED HYG, V35, P1296, DOI 10.4269/ajtmh.1986.35.1296
   Nelms BM, 2013, J MED ENTOMOL, V50, P371, DOI 10.1603/ME12264
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, ZIK VIR SIT REP
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 78
TC 2
Z9 2
U1 2
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 10
EP 14
DI 10.1016/j.virusres.2017.09.005
PG 5
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500002
PM 28893652
DA 2020-07-08
ER

PT J
AU Kublin, JL
   Whitney, JB
AF Kublin, Jessica L.
   Whitney, James B.
TI Zika virus research models
SO VIRUS RESEARCH
LA English
DT Review
DE Zika virus; Nonhuman primate models; Cell culture models; Vaccines;
   Therapeutics
ID SEXUAL TRANSMISSION; DENGUE VIRUS; CELL-CULTURE; MOUSE MODEL; INFECTION;
   BRAIN; VACCINE; SPECTRUM; LEADS; IDENTIFICATION
AB The 2015 Brazilian Zika virus outbreak sparked a rapid response to control the spread of the virus. What was first understood to be a mild self-resolving infection is now linked to significant neurological defects in both neonates and adults. The WHO declared the 2016 Zika epidemic a public health emergency and issued an unprecedented recommendation to women in affected regions to delay pregnancy until the risks surrounding Zika virus could be understood, or the epidemic contained. Since that time, considerable effort has been dedicated to understanding Zika transmission and pathogenesis to aid the development of drugs and vaccines. Several models have emerged to study numerous facets of Zika biology; this review details the various model systems.
C1 [Kublin, Jessica L.; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Whitney, James B.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Whitney, JB (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
EM jwhitne2@bidmc.harvard.edu
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI127089-02]
FX This work was supported in part by NIAID grant AI127089-02 awarded to
   J.B.W.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Arck PC, 2013, NAT MED, V19, P548, DOI 10.1038/nm.3160
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kuo SC, 2016, ANTIVIR RES, V134, P89, DOI 10.1016/j.antiviral.2016.07.025
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Meinhardt A, 2017, NAT REV UROL, V14, P135, DOI 10.1038/nrurol.2016.265
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oliveira Souto I., 2016, ENFERM INFECC MICROB
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Ren PJ, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.60
   Reusken C., 2016, EUR COMMUN DIS B, V21
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Soncin F, 2015, CELL MOL LIFE SCI, V72, P1291, DOI 10.1007/s00018-014-1794-x
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weisblum Y, 2017, J VIROL, V91, DOI [10.1128/jvi.01905-16, 10.1128/JVI.01905-16]
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 106
TC 2
Z9 3
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 15
EP 20
DI 10.1016/j.virusres.2017.07.025
PG 6
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500003
PM 28811170
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Bowen, JR
   Zimmerman, MG
   Suthar, MS
AF Bowen, James R.
   Zimmerman, Matthew G.
   Suthar, Mehul S.
TI Taking the defensive: Immune control of Zika virus infection
SO VIRUS RESEARCH
LA English
DT Review
DE Zika virus; Type I interferon; RIG-I; MDA5; RIG-I signaling; Flavivirus;
   Viral antagonism; Innate immunity; JAK/STAT signaling; Antibody; T cells
ID NF-KAPPA-B; RIG-I; CELLS; BRAIN; RESPONSES; STRAIN
AB ZIKV is a neurotropic mosquito-borne flavivirus that has recently emerged in the Americas and is a pathogen of significant public health concern across the world. ZIKV was first isolated in Uganda in 1947 and remained dormant in Africa and Asia for decades, with sporadic outbreaks characterized by a mild self-limiting disease in humans. The emergence of ZIKV in the Americas corresponded with enhanced disease severity and congenital Zika syndrome, a phenotype characterized by severe microcephaly, brain anomalies, ocular anomalies, congenital contractures and neurological impairments. In less than two years, a collective effort led by the scientific research community has uncovered many new facets to the once rarely discussed ZIKV. In this review, we highlight the known immune parameters that correlate with protective immunity to ZIKV infection, including pattern recognition receptors, interferons, humoral and cell-mediated responses, as well as countermeasures utilized by ZIKV to inhibit host antiviral immune responses.
C1 [Bowen, James R.; Zimmerman, Matthew G.; Suthar, Mehul S.] Emory Univ, Sch Med, Div Infect Dis, Dept Pediat, Atlanta, GA 30322 USA.
   [Bowen, James R.; Zimmerman, Matthew G.; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Bowen, James R.; Zimmerman, Matthew G.; Suthar, Mehul S.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.
RP Suthar, MS (corresponding author), Yerkes Natl Res Ctr, 954 Gatewood Rd,Off 2022, Atlanta, GA 30329 USA.
EM msuthar@emory.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI083019,
   R56AI110516, R21AI113485, 2U19AI090023, U01AI131566]; Emory University
   Department of Pediatrics Junior Faculty Focused Award; CCIV Pilot
   awards; Children's Healthcare of Atlanta; Emory Vaccine Center; Georgia
   Research Alliance
FX The Suthar laboratory is funded in part by National Institutes of Health
   grants U19AI083019, R56AI110516, R21AI113485, 2U19AI090023, U01AI131566,
   Emory University Department of Pediatrics Junior Faculty Focused Award,
   CCIV Pilot awards, Children's Healthcare of Atlanta, Emory Vaccine
   Center, and the Georgia Research Alliance. The author declares no
   commercial or financial conflict of interest.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Andrade DV, 2017, VIRUS RES
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106
   Dang J., 2016, CELL STEM CELL
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lim PY, 2011, J VIROL, V85, P5197, DOI 10.1128/JVI.02692-10
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2017, EUR J IMMUNOL, V47, P615, DOI 10.1002/eji.201646484
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rossi SL, 2016, AM J TROP MED HYG
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vazquez C, 2015, J VIROL, V89, P6974, DOI 10.1128/JVI.01918-14
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang JM, 2010, J IMMUNOL, V185, P1720, DOI 10.4049/jimmunol.1000114
   Weaver SC, 2016, ANTIVIRAL RES
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 62
TC 9
Z9 10
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 21
EP 26
DI 10.1016/j.virusres.2017.08.018
PG 6
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500004
PM 28867493
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Chiramel, AI
   Best, SM
AF Chiramel, Abhilash I.
   Best, Sonja M.
TI Role of autophagy in Zika virus infection and pathogenesis
SO VIRUS RESEARCH
LA English
DT Review
DE Zika virus; Autophagy; Er-phagy; FAM134B; Replication
ID ENDOPLASMIC-RETICULUM TURNOVER; DENGUE-VIRUS; SELECTIVE AUTOPHAGY; VIRAL
   REPLICATION; TAM RECEPTORS; CELLS; MEMBRANE; WEB; FLAVIVIRUSES;
   TRANSMISSION
AB Autophagy is an evolutionarily conserved cellular pathway that culminates in lysosomal degradation of selected substrates. Autophagy can serve dual roles in virus infection with either pro- or antiviral functions depending on the virus and the stage of the viral replication cycle. Recent studies have suggested a role for autophagy in Zika virus (ZIKV) replication by demonstrating the accumulation of autophagic vesicles following ZIKV infection in both in vitro and in vivo models. In human fetal neural stem cells, ZIKV inhibits Akt-mTOR signaling to induce autophagy, increase virus replication and impede neurogenesis. However, autophagy also has the potential to limit ZIKV replication, with separate studies demonstrating antiviral roles for autophagy at the maternal-placental-fetal interface, and more specifically, at the endoplasmic reticulum where virus replication is established in an infected cell. Interestingly, ZIKV (and related flaviviruses) has evolved specific mechanisms to overcome autophagy at the ER, thus demonstrating important roles for these autophagic pathways in virus replication and host response. This review summarizes the known roles of autophagy in ZIKV replication and how they might influence virus tissue tropism and disease.
C1 [Chiramel, Abhilash I.; Best, Sonja M.] NIAID, Lab Virol, Rocky Mt Labs, NIH, Hamilton, MT 20892 USA.
RP Best, SM (corresponding author), NIAID, Lab Virol, Rocky Mt Labs, NIH, Hamilton, MT 20892 USA.
EM abhilash.chiramel@nih.gov; sbest@niaid.nih.gov
FU Division of Intramural Research (DIR), National Institutes of Allergy
   and Infectious Diseases (NIAID), Natonal Institutes of Health (NIH)
FX We would like to thank Dr. Heinz Feldmann for critically reading the
   manuscript and for valuable suggestions in the preparation of the
   manuscript. Also, we would like to thank Mr. Ryan Kissinger for
   generating all illustrations used in this artile. This work was
   supported by the Division of Intramural Research (DIR), National
   Institutes of Allergy and Infectious Diseases (NIAID), Natonal
   Institutes of Health (NIH).
CR Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Best SM, 2013, CELL HOST MICROBE, V14, P117, DOI 10.1016/j.chom.2013.07.014
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128
   Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Chiramel AI, 2016, J INFECT DIS, V214, pS319, DOI 10.1093/infdis/jiw270
   Chiramel Abhilash I, 2013, Cells, V2, P83, DOI 10.3390/cells2010083
   Colucci F, 2011, PLACENTA, V32, P539, DOI 10.1016/j.placenta.2011.05.001
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147
   Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270
   Feng YC, 2015, TRENDS CELL BIOL, V25, P354, DOI 10.1016/j.tcb.2015.02.002
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaynor LM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00467
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022
   Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416
   Jordan TX, 2012, MICROBES INFECT, V14, P126, DOI 10.1016/j.micinf.2011.09.007
   Kaizuka T, 2016, MOL CELL BIOL, V36, P585, DOI 10.1128/MCB.01005-15
   Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260
   Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Kimura T, 2017, AUTOPHAGY, V13, P1084, DOI 10.1080/15548627.2017.1307486
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koyama-Honda I., 2017, AUTOPHAGY
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kumar S, 2017, ALIMENT PHARM THER, V45, P883, DOI 10.1111/apt.13963
   Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lippai M, 2017, CELL BIOL TOXICOL, V33, P145, DOI 10.1007/s10565-016-9374-5
   Lu Q, 2016, CELL HOST MICROBE, V19, P102, DOI 10.1016/j.chom.2015.12.011
   Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018
   Mauthe M, 2016, J CELL BIOL, V214, P619, DOI 10.1083/jcb.201602046
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522
   Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431
   Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul P, 2016, ADV VIRUS RES, V95, P149, DOI 10.1016/bs.aivir.2016.02.002
   Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984
   Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Tsuboyama K, 2016, SCIENCE, V354, P1036, DOI 10.1126/science.aaf6136
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Yamamoto H, 2016, DEV CELL, V38, P86, DOI 10.1016/j.devcel.2016.06.015
NR 69
TC 21
Z9 22
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD AUG 2
PY 2018
VL 254
SI SI
BP 34
EP 40
DI 10.1016/j.virusres.2017.09.006
PG 7
WC Virology
SC Virology
GA GQ9CW
UT WOS:000442064500006
PM 28899653
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Nambala, P
   Su, WC
AF Nambala, Peter
   Su, Wen-Chi
TI Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine
   Development
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE ZIKV; prM; viral pathogenicity; vaccine; epidemic
ID CLINICAL-TRIALS; BIOLOGY; INFECTION; IMMUNOGENICITY; PROTECTION;
   EPIDEMIC; PHASE-1; COMPLEX; SAFETY; STATES
AB Recent Zika virus (ZIKV) epidemics necessitate the urgent development of effective drugs and vaccines, which can be accelerated by an enhanced understanding of ZIKV biology. One of the ZIKV structural proteins, precursor membrane (prM), plays an important role in the assembly of mature virions through cleavage of prM into M protein. Recent studies have suggested that prM protein might be implicated in the neurovirulence of ZIKV. Most vaccines targeting ZIKV include prM as the immunogen. Here, we review progress in our understanding of ZIKV prM protein and its application in ZIKV vaccine development.
C1 [Nambala, Peter; Su, Wen-Chi] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.
   [Su, Wen-Chi] China Med Univ Hosp, Res Ctr Emerging Viruses, Taichung, Taiwan.
RP Su, WC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Su, WC (corresponding author), China Med Univ Hosp, Res Ctr Emerging Viruses, Taichung, Taiwan.
EM t23514@mail.cmuh.org.tw
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST 105-2628-B-039-006-MY3]
FX This work was supported by a grant (MOST 105-2628-B-039-006-MY3) from
   the Ministry of Science and Technology, Taiwan.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Counotte M, 2018, ZIKA VIRUS INFECT CA
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2014, RAP RISK ASS ZIK VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira ERA, 2017, J COMPUT AID MOL DES, V31, P1009, DOI 10.1007/s10822-017-0076-8
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Ramaiah A, 2017, INFECT GENET EVOL, V51, P74, DOI 10.1016/j.meegid.2017.03.012
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Vanlandingham DL, 2016, J MED ENTOMOL, V53, P1024, DOI 10.1093/jme/tjw025
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wetsman N, 2017, NAT MED, V23, P904, DOI 10.1038/nm0817-904
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2018, WHO VACC PIP TRACK
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yoshii K, 2012, J GEN VIROL, V93, P27, DOI 10.1099/vir.0.035964-0
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 55
TC 12
Z9 13
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD AUG 2
PY 2018
VL 9
AR 1797
DI 10.3389/fmicb.2018.01797
PG 6
WC Microbiology
SC Microbiology
GA GP1KN
UT WOS:000440574800001
PM 30116235
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carta, KG
   Mujica, IJM
   Britto, IJM
   Morr, IGOR
   Meza, Y
   Finizola, V
   Terzic, C
   Allison, T
   Martinez, N
   Marques, JUAN
AF Carta, K. Gonzalez
   Mujica, I. J. Mendoza
   Britto, I. J. Mendoza
   Morr, I. G. O. R.
   Meza, Y.
   Finizola, V.
   Terzic, C.
   Allison, T.
   Martinez, N.
   Marques, J. U. A. N.
TI Sudden cardiac death, heart failure and arrhythmias due to acute zika
   myocarditis
SO EUROPEAN HEART JOURNAL
LA English
DT Meeting Abstract
CT European-Society-of-Cardiology Congress
CY AUG 25-29, 2018
CL Munich, GERMANY
SP European Soc Cardiol
C1 [Carta, K. Gonzalez; Terzic, C.; Allison, T.] Mayo Clin, Cardiovasc Dis, Rochester, MN USA.
   [Mujica, I. J. Mendoza; Morr, I. G. O. R.; Meza, Y.; Martinez, N.; Marques, J. U. A. N.] Cent Univ Venezuela UCV, Trop Cardiol, Caracas, Venezuela.
   [Britto, I. J. Mendoza] Jackson Mem Hosp, Electrophysiol, Miami, FL 33136 USA.
   [Finizola, V.] ASCARDIO, Trop Med, Barquisimeto, Venezuela.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD AUG
PY 2018
VL 39
SU 1
MA P2923
BP 619
EP 619
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA HM9RZ
UT WOS:000459824001942
DA 2020-07-08
ER

PT J
AU Weaver, SC
AF Weaver, Scott C.
TI Prediction and prevention of urban arbovirus epidemics: A challenge for
   the global virology community
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID WEST NILE VIRUS; AEDES-AEGYPTI; ZIKA VIRUS; FEEDING-BEHAVIOR;
   YELLOW-FEVER; DENGUE; VECTOR; CHIKUNGUNYA; MOSQUITOS; PATTERNS
AB The recent emergence and rapid spread of Zika virus in tropical regions of the Western Hemisphere took arbovirologists and public health officials by surprise, and the earlier transfers of West Nile and chikungunya viruses from the Old to the New World were also unexpected.
   These pandemics underscore the increasing threat of zoonotic arboviruses, especially those that are capable of entering into human-amplified, urban transmission cycles transmitted by Aedes (Stegomyia) aegypti and sometimes other Aedes (Stegomyia) spp. mosquitoes. This review serves as an introduction to a World Health Organization-sponsored conference to be held on June 18-19, 2018 in Geneva, titled "From obscurity to urban epidemics: what are the next urban arboviruses?" It is intended to set the stage and fuel discussions of future urban arbovirus threats, how we can predict these risks from known and unknown viruses, and what factors may change these risks over time.
C1 [Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI121452, R24AI120942]
FX Scott Weaver's research related to this review is supported by NIH
   grants R01AI121452 and R24AI120942.
CR Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Cassadou S, 2014, EURO SURVEILL, V19
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guo XX, 2014, J AM MOSQUITO CONTR, V30, P309, DOI 10.2987/14-6439R.1
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Harrington LC, 2008, VECTOR-BORNE ZOONOT, V8, P415, DOI 10.1089/vbz.2007.0203
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Janssen N, 2015, TROP MED INT HEALTH, V20, P1488, DOI 10.1111/tmi.12587
   Kenawy MA, 2018, ACTA TROP, V181, P40, DOI 10.1016/j.actatropica.2018.01.015
   KOHN M, 1990, FOLIA PARASIT, V37, P165
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pearce JC, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay009
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   POWELL JR, 1980, SCIENCE, V208, P1385
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Weaver SC, 1996, LANCET, V348, P436, DOI 10.1016/S0140-6736(96)02275-1
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 43
TC 14
Z9 14
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD AUG
PY 2018
VL 156
BP 80
EP 84
DI 10.1016/j.antiviral.2018.06.009
PG 5
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GO0ZH
UT WOS:000439674700010
PM 29906475
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Gomez-Vargas, W
   Valencia-Jimenez, K
   Correa-Londono, G
   Jaramillo-Yepes, F
AF Gomez-Vargas, Wilber
   Valencia-Jimenez, Kelly
   Correa-Londono, Guillermo
   Jaramillo-Yepes, Faiber
TI Novel larvicide tablets of Bacillus thuringiensis var. israelensis:
   Assessment of larvicidal effect on Aedes aegypti (Diptera: Culicidae) in
   Colombia
SO BIOMEDICA
LA English
DT Article
DE Aedes; Bacillus thuringiensis; disease vectors; dengue; chikungunya
   virus; Zika virus; Colombia
ID ATLANTICO-COLOMBIA; MOSQUITO LARVAE; FIELD EFFICACY; DENGUE;
   FORMULATION; SUSCEPTIBILITY; PERSISTENCE; STRATEGIES; VECTORS; BTI
AB Introduction: Aedes (Stegomyia) aegypti is the vector for dengue, chikungunya, and Zika arboviruses. Bti-CECIF is a bioinsecticide designed and developed in the form of a solid tablet for the control of this vector. It contains Bacillus thuringiensis var. israelensis (Bti) serotype H-14.
   Objective: To evaluate under semi-field and field conditions the efficacy and residual activity of Bti-CECIF tablets on Aedes aegypti larvae in two Colombian municipalities.
   Materials and methods: We tested under semi-field conditions in plastic tanks (Rotoplast (TM)) four different Bti doses (0.13, 0.40, 0.66 and 0.93 mg/L) in the municipality of Apartado, department of Antioquia, to assess Bti-CECIF efficacy (percentage of reduction of larval density) and the residual activity in water tanks containing A. aegypti third-instar larvae. The efficacy and residuality of the most lethal dose were subsequently evaluated under field conditions in cement tanks in the municipality of San Carlos, department of Cordoba.
   Results: Under semi-field conditions, the highest tested dose exhibited the greatest residual activity (15 days) after which larval mortality was 80%. Under field conditions, the highest tested Bti-CECIF doses showed 100% mortality and exhibited a residual activity of seven days in 90% of the tanks.
   Conclusion: Bti-CECIF tablets effectively controlled A. aegypti larvae under field conditions for up to seven days post-treatment.
C1 [Gomez-Vargas, Wilber] Univ CES, Inst Colombiano Med Trop, Sabaneta, Colombia.
   [Valencia-Jimenez, Kelly; Jaramillo-Yepes, Faiber] Ctr Ciencia & Invest Farmaceut, Sabaneta, Colombia.
   [Correa-Londono, Guillermo] Univ Nacl Colombia, Fac Ciencias Agr, Medellin, Colombia.
RP Gomez-Vargas, W (corresponding author), Carrera 43A 52 Sur 99, Sabaneta, Antioquia, Colombia.
EM wgomez@ces.edu.co
OI Gomez, Wilber/0000-0001-9790-7415
FU Sistema Nacional de Ciencia y Tecnologia, Colciencias [381-2015]; CECIF;
   ICMT-Universidad CES
FX This work received the financial support of the Sistema Nacional de
   Ciencia y Tecnologia, Colciencias, grant No. 381-2015, and of CECIF and
   ICMT-Universidad CES.
CR Armengol G, 2006, J ECON ENTOMOL, V99, P1590, DOI 10.1603/0022-0493-99.5.1590
   Batra CP, 2000, J AM MOSQUITO CONTR, V16, P321
   BECKER N, 1992, J AM MOSQUITO CONTR, V8, P285
   BECKER N, 1991, Bulletin of the Society for Vector Ecology, V16, P176
   Ben-Dov E, 2003, J APPL ENTOMOL, V127, P146, DOI 10.1046/j.1439-0418.2003.00732.x
   Benjamin Seleena, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P879
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Cadavid JM, 2016, ESTRUCTURA GENETICA, P79
   Conde M, 2015, BIOMEDICA, V35, P43, DOI [10.7705/biomedica.v35i1.2367, 10.1590/S0120-41572015000100007]
   de Melo-Santos MAV, 2001, MEM I OSWALDO CRUZ, V96, P859, DOI 10.1590/S0074-02762001000600020
   DEBARJAC H, 1978, CR ACAD SCI D NAT, V286, P1629
   Departamento Administrativo Nacional de Estadistica, 2005, DOC ESQ ORD TERR
   GERBERG EJ, 1970, AMCA B, V5, P1
   Gurtler RE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000427
   Instituto Nacional de Salud, 2015, INF EV DENG
   Instituto Nacional de Salud, 2016, INF EV CHIK
   Instituto Nacional de Salud, 2015, INF EV CHIK
   Instituto Nacional de Salud, 2016, INF EV DENG
   Instituto Nacional de Salud, 2014, INF EV DENG
   Instituto Nacional de Salud, 2014, INF EP RED VIG RES I, P27
   Instituto Nacional de Salud, 2017, INF EV DENG
   Instituto Nacional de Salud, 2015, INF EV ZIK COL SEM E
   Instituto Nacional de Salud de Colombia, 2013, INF EV DENG
   Kroeger A, 1995, TROP MED PARASITOL, V46, P241
   Maestre R, 2010, REV COLOMB ENTOMOL, V36, P242
   Maestre R, 2009, REV COLOMB ENTOMOL, V35, P202
   Mahilum MM, 2005, J VECTOR ECOL, V30, P277
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Monnerat R., 2012, BIOASSAY, V7, P1, DOI DOI 10.14295/BA.V7.0.73
   Mulla MS, 2004, J AM MOSQUITO CONTR, V20, P64
   MULLA MS, 1971, J ECON ENTOMOL, V64, P300, DOI 10.1093/jee/64.1.300
   Musgrove P, 2000, HLTH SYSTEMS IMPROVI
   Ocampo CB, 2009, BIOMEDICA, V29, P282, DOI 10.7705/biomedica.v29i2.30
   Organizacion Panamerica de la Salud/Organizacion Mundial de la Salud, 2017, CAS REP DENG AM
   Organizacion Panamericana de la Salud/Organizacion Mundial de la Salud, 2017, ESTR GEST INT PREV C, P70
   Ortegon-Cardenas L, 2009, MOMENTOS CIENC, V6, P100
   Phan-Urai P, 1995, J TROP MED PARASITOL, V18, P106
   Ponce G, 2003, REV FAC SALUD PUBLIC, V4, P3
   Ponce G., 1999, THESIS
   Setha T, 2007, AM J TROP MED HYG, V77, P256
   Suarez M, 1987, BIOMEDICA, V7, P5, DOI [10.7705/biomedica.v7i1-2.1928, DOI 10.7705/BIOMEDICA.V7I1-2.1928]
   Tetreau G, 2012, APPL ENVIRON MICROB, V78, P5189, DOI 10.1128/AEM.00903-12
   Vilarinhos PTR, 2004, J AM MOSQUITO CONTR, V20, P311
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   World Health Organization, 2009, BAC THUR ISR BTI DRI
   World Health Organization, 2018, DENGUE
   ZEQUI JAC, 2015, INT J MOSQ RES A, V2, P5
NR 48
TC 0
Z9 0
U1 0
U2 2
PU INST NACIONAL SALUD
PI BOGOTA D C
PA AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C,
   00000, COLOMBIA
SN 0120-4157
J9 BIOMEDICA
JI Biomedica
PD AUG
PY 2018
VL 38
SU 2
BP 95
EP 105
DI 10.7705/biomedica.v38i0.3940
PG 11
WC Tropical Medicine
SC Tropical Medicine
GA GR1QW
UT WOS:000442324200013
PM 30184370
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Candelo, E
   Caicedo, G
   Feinstein, MM
   Pachajoa, H
AF Candelo, Estephania
   Caicedo, Gabriela
   Feinstein, Max M.
   Pachajoa, Harry
TI Microcephaly in Colombia before the Zika outbreak: A systematic
   literature review
SO BIOMEDICA
LA English
DT Review
DE Microcephaly; Zika virus infection; congenital abnormalities;
   prevalence; Colombia.
ID VIRUS-INFECTION; BIRTH-DEFECTS; HEAD; BRAZIL
AB Introduction: Microcephaly is characterized by a smaller than normal head circumference. Recently, Zika virus (ZV) has been associated with microcephaly.
   Objective: To describe the prevalence of microcephaly in Colombia taking as the baseline the information from the period before the Zika virus infection epidemics.
   Materials and methods: We reviewed Medline, Scopus, Scielo, Lilacs and annual reports of congenital malformation monitoring systems across Latin America, among others sources, for articles published before April, 2015, reporting the prevalence of microcephaly in Colombia between 1982 and 2013.
   Results: We identified 32 non-duplicate articles; we selected 25 articles for revision of which 12 met the criteria for inclusion in the systematic review, including 2,808,308 births.
   Conclusions: The prevalence of microcephaly in Colombia from 1982 to 2013, before the introduction of ZV, ranged from 0.3 to 3.1 per 10,000 births, with an average of 1.8 (95% CI 1.7- 1.8) per 10,000 births. These findings are important to determine if the prevalence after the introduction of the Zika virus infection registered significant changes.
C1 [Candelo, Estephania; Caicedo, Gabriela; Pachajoa, Harry] Univ ICESI, Ctr Invest Anomalias Congenitas & Enfermedades Ra, Calle 18 122-135, Cali, Colombia.
   [Candelo, Estephania] UCL, Biomat & Tissues Engn, London, England.
   [Feinstein, Max M.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA.
   [Pachajoa, Harry] Fdn Valle Lili, Dept Pediat, Cali, Colombia.
RP Pachajoa, H (corresponding author), Univ ICESI, Ctr Invest Anomalias Congenitas & Enfermedades Ra, Calle 18 122-135, Cali, Colombia.
EM hmpachajoa@icesi.edu.co
RI Feinstein, Max/AAC-3567-2019
OI Feinstein, Max/0000-0003-4436-1679
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Boom JA, MICROCEPHALY INFANTS
   Carmona RH, 2005, LANCET, V366, P1142, DOI 10.1016/S0140-6736(05)67459-4
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Estudio Colaborativo Latino Americano de Malformaciones Congenitas, 2015, MICR ECLAMC BRAS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Garcia Herbert, 2003, Biomedica, V23, P161
   Gonzalez Y, 2012, INFORME FINAL EVENTO
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   JAWORSKI M, 1986, PEDIATRICS, V78, P1064
   Kumar A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00403
   Mawson AR, 2016, BIORESEARCH OPEN ACC, V5, P171, DOI 10.1089/biores.2016.0004
   Medina MR, 1999, GEOGRAFIA MORTALIDAD
   Ministerio de Salud Instituto Nacional de Salud, 2014, PROT VIG SAL PUBL DE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Observatorio Nacional de Salud, 2014, 3 INF ONS MORT EV CO
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   Organizacion Mundial de la Salud, 2014, EST SAN MUND 2014, P13
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Porras-Hurtado GL, 2016, BIOMEDICA, V36, P556, DOI 10.7705/biomedica.v36i4.2771
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROCHE AF, 1987, PEDIATRICS, V79, P706
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   STEINLIN M, 1991, NEUROPEDIATRICS, V22, P184, DOI 10.1055/s-2008-1071438
   Stoll C, 2001, AM J MED GENET, V100, P110, DOI 10.1002/1096-8628(20010422)100:2<110::AID-AJMG1242>3.0.CO;2-I
   SUGIMOTO T, 1993, NEUROPEDIATRICS, V24, P4, DOI 10.1055/s-2008-1071504
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   WHO, 2016, SCREEN ASS MAN NEON
   World Health Organization, WEEKLY EPIDEMIOLOGIC
   World Health Organization, 2016, MICROCEPHALY BRAZIL, V91, P237
NR 33
TC 2
Z9 3
U1 3
U2 3
PU INST NACIONAL SALUD
PI BOGOTA D C
PA AVENIDA CALLE 26 NO 51-60, APARTADO AEREO 80334 Y 80080, BOGOTA D C,
   00000, COLOMBIA
SN 0120-4157
J9 BIOMEDICA
JI Biomedica
PD AUG
PY 2018
VL 38
SU 2
BP 127
EP 134
DI 10.7705/biomedica.v38i0.4413
PG 8
WC Tropical Medicine
SC Tropical Medicine
GA GR1QW
UT WOS:000442324200016
PM 30184373
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Moreira, J
   Bressan, CS
   Brasil, P
   Siqueira, AM
AF Moreira, J.
   Bressan, C. S.
   Brasil, P.
   Siqueira, A. M.
TI Epidemiology of acute febrile illness in Latin America
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Review
DE Acute febrile illness; Co-infection; Dengue; Fever; Latin America;
   Malaria
ID ENDEMIC SCRUB TYPHUS; HANTAVIRUS INFECTION; EMERGENCY-DEPARTMENT;
   CO-CIRCULATION; CHAGAS-DISEASE; SOUTH-AMERICA; FRENCH-GUIANA; DENGUE
   VIRUS; FEVER; COLOMBIA
AB Background: The causes of acute febrile illness (AFI) in Latin America are diverse and their complexity increases as the proportion of fever due to malaria decreases, as malaria control measures and new pathogens emerge in the region. In this context, it is important to shed light on the gaps in the epidemiological characteristics and the geographic range for many AFI aetiologies.
   Objectives: To review studies on community-acquired fever aetiology other than malaria in Latin America, and to highlight knowledge gaps and challenges needing further investigation. Sources: PubMed from 2012 to April 2018.
   Content: We found 17 eligible studies describing 13 539 patients. The median number of pathogens tested per individual was 3.5 (range 2-17). A causative pathogen could be determined for 6661 (49.2%) individuals. The most frequently reported pathogen during the study periods was dengue virus (DENV) (14 studies), followed by chikungunya virus (nine studies) and Zika virus (seven studies). Among the studies reporting concurrent infections, 296 individuals (2.2%) were found to have co-infections. Inhospital mortality was reported in eight (47%) studies, ranging between 0% and 18%.
   Implications: DENV fever is the febrile illness most frequently reported, reflecting its importance, while chikungunya and zika viruses present increasing trends since their emergence in the region. Studies with systematic and harmonized approaches for detection of multiple pathogens are needed and would probably reveal a higher burden of neglected pathogens such as Rickettsia spp. and arenaviruses. The lack of point-of-care tests and harmonized approach limits the care provided by health professionals and the efficacy of surveillance for AFI in the region. (c) 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Moreira, J.; Bressan, C. S.; Brasil, P.; Siqueira, A. M.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Moreira, J.; Bressan, C. S.; Brasil, P.; Siqueira, A. M.] Fundacao Oswaldo Cruz, Programa Posgrad Pesquisa Clin, Rio De Janeiro, Brazil.
RP Siqueira, AM (corresponding author), Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM andre.siqueira@ini.fiocruz.br
RI Siqueira, Andre M/G-1340-2010
OI Siqueira, Andre M/0000-0003-2208-0294
CR Abarca K, 2014, REV CHIL INFECTOL, V31, P569, DOI 10.4067/S0716-10182014000500009
   Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Anez N, 2016, INT J CLIN MED RES, V3, P29
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Arroyave E, 2013, BIOMEDICA, V33, P99, DOI 10.7705/biomedica.v33i0.734
   Azeredo EL, 2018, PLOS CURR, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Balcells ME, 2011, EMERG INFECT DIS, V17, P1659, DOI 10.3201/eid1709.100960
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054
   Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154
   Cifuentes SG, 2013, EMERG INFECT DIS, V19, P1642, DOI 10.3201/eid1910.130137
   Costa ED, 2017, INT J CARDIOL, V235, P176, DOI 10.1016/j.ijcard.2017.02.101
   Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P825, DOI 10.1590/0074-02760150153
   Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P277, DOI 10.1590/0074-0276140362
   De Cayenne CH, 2016, AIDS, V30, P167
   Epelboin L, 2012, CLIN INFECT DIS, V55, P67, DOI 10.1093/cid/cis288
   Faccini-Martinez AA, 2017, AM J TROP MED HYG, V97, P782, DOI 10.4269/ajtmh.16-0442
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   GRAY GC, 1990, AM J TROP MED HYG, V42, P215, DOI 10.4269/ajtmh.1990.42.215
   HOTEZ PJ, 2008, PLOS NEGLECT TROP D, V2
   Inst R, 2015, REV INST MED TROP SP, V57, P2015
   Kapasi AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160278
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kocher C, 2017, EMERG INFECT DIS, V23, P1389, DOI 10.3201/eid2308.170050
   Kocher C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004843
   Kumar A, 2016, J INFECT PUBLIC HEAL, V9, P81, DOI 10.1016/j.jiph.2015.06.004
   Lemos ERS, 2016, AM J TROP MED HYG, V94
   Limper M, 2012, W INDIAN MED J, V61, P76
   Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   Matheus S, 2006, EMERG INFECT DIS, V12, P1294, DOI 10.3201/eid1708.051619
   Mattar S, 2004, EMERG INFECT DIS, V10, P2263, DOI 10.3201/eid1012.040821
   Mattar S, 2017, J INFECT PUBLIC HEAL, V10, P507, DOI 10.1016/j.jiph.2016.09.014
   Mavian C, 2017, SCI REP, P1
   Minnick MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002919
   Figueiredo LTM, 2014, VIRUS RES, V187, P43, DOI 10.1016/j.virusres.2014.01.015
   Moreira-Soto A, 2016, TICKS TICK-BORNE DIS, V7, P748, DOI 10.1016/j.ttbdis.2016.03.007
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ore RMC, 2012, VECTOR-BORNE ZOONOT, V12, P683, DOI 10.1089/vbz.2011.0820
   Petrakovsky J, 2014, INT J ENV RES PUB HE, V11, P10770, DOI 10.3390/ijerph111010770
   Pini N, 2004, CURR OPIN INFECT DIS, V17, P427, DOI 10.1097/00001432-200410000-00007
   Recht J., 2017, MALARIA J, V16, P1
   Reller ME, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005185
   Reller ME, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005026
   Reller ME, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002941
   Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Sanchez-Carbonel Jose, 2018, BMC Res Notes, V11, P175, DOI 10.1186/s13104-018-3290-0
   Schoeler GB, 2005, EMERG INFECT DIS, V11, P622, DOI 10.3201/eid1104.040287
   Sifuentes-Osornio J, 2012, CURR FUNGAL INFECT R, V6, P23, DOI 10.1007/s12281-011-0081-7
   Tomashek KM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005859
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Vieira MACS, 2015, AM J TROP MED HYG, V93, P377, DOI 10.4269/ajtmh.15-0170
   Vitor-Silva S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1326-2
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weitzel T, 2016, NEW ENGL J MED, V375, P954, DOI 10.1056/NEJMoa1603657
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 62
TC 8
Z9 8
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD AUG
PY 2018
VL 24
IS 8
BP 827
EP 835
DI 10.1016/j.cmi.2018.05.001
PG 9
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GN8IU
UT WOS:000439403900009
PM 29777926
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Voris, DGD
   Dias, LD
   Lima, JA
   Lima, KDC
   Lima, JBP
   Lima, ALD
AF da Rocha Voris, Diego Gomes
   Dias, Luciana dos Santos
   Lima, Joselia Alencar
   Cople Lima, Keila Dos Santos
   Pereira Lima, Jose Bento
   dos Santos Lima, Antonio Luis
TI Evaluation of larvicidal, adulticidal, and anticholinesterase activities
   of essential oils of Illicium verum Hook. f., Pimenta dioica (L.) Merr.,
   and Myristica fragrans Houtt. against Zika virus vectors
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Aedes aegypti; Essential oils; Larvicide; Adulticide;
   Anticholinesterase; Bioinsecticide
ID PLANT ESSENTIAL OILS; AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS;
   INSECTICIDAL PROPERTIES; ANOPHELES-STEPHENSI; FOENICULUM-VULGARE;
   MOSQUITO VECTORS; TRANS-ANETHOLE; DIPTERA; POPULATIONS
AB Aedes aegypti is the vector responsible for transmitting pathogens that cause various infectious diseases, such as dengue, Zika, yellow fever, and chikungunya, worrying health authorities in the tropics. Due to resistance of mosquitoes to synthetic insecticides, the search for more effective insecticidal agents becomes crucial. The aim of this study was to verify the larvicidal, adulticidal, and anticholinesterase activities of the essential oils of the Illicium verum (EOIV), Pimenta dioica (EOPD), and Myristica fragrans (EOMF) against Ae. aegypti. The essential oils (EOs) were obtained by hydrodistillation and analyzed by gas chromatography-mass spectrometry (GC-MS). The larvicidal and adulticidal activities of EOs were evaluated against third instar larvae and Ae. aegypti adult females, respectively, using the procedures of the World Health Organization (WHO) and the anticholinesterase activity of the EOs by the modified Ellman method. The following major components were identified: (E)-anethole (90.1%) for EOIV, methyl eugenol (55.0%) for EOPD, and sabinene (52.1%) for EOMF. All EOs exhibited larvicidal and adulticidal activity against Ae. aegypti. The highest larval mortality was observed in EOMF with LC50 = 28.2 mu g mL(-1). Adult mortality was observed after 1 (knockdown) and 24 h exposure, with the highest potential established by the EOIV, KC50 = 7.3 mu g mg female(-1) and LC50 = 10.3 mu g mg female(-1). EOIV (IC50 = 4800 mu g mL(-1)), EOMF (IC50 = 4510 mu g mL(-1)), and EOPD (IC50 = 1320 mu g mL(-1)) inhibited AChE. EOMF (4130 mu g mL(-1)) and EOPD (IC50 = 3340 mu g mL(-1)) inhibited BChE whereas EOIV showed no inhibition. The EOs were toxic to larvae and adults of Ae. aegypti, as well as being less toxic to humans than the currently used insecticides, opening the possibility of elaboration of a natural, safe, and ecological bioinsecticide for vector control.
C1 [da Rocha Voris, Diego Gomes; Lima, Joselia Alencar; Cople Lima, Keila Dos Santos; dos Santos Lima, Antonio Luis] Mil Inst Engn, Sect Chem Engn, Chem & Biol Def Lab, BR-22291270 Rio De Janeiro, RJ, Brazil.
   [Dias, Luciana dos Santos; Pereira Lima, Jose Bento] Fiocruz MS, Oswaldo Cruz Inst, Lab Physiol & Control Vector Arthropods, Rio De Janeiro, RJ, Brazil.
   [Dias, Luciana dos Santos; Pereira Lima, Jose Bento] Inst Biol Army, Entomol Lab, BR-20911270 Rio De Janeiro, RJ, Brazil.
RP Voris, DGD (corresponding author), Mil Inst Engn, Sect Chem Engn, Chem & Biol Def Lab, BR-22291270 Rio De Janeiro, RJ, Brazil.
EM divoris@hotmail.com
RI Lima, Antonio/W-4670-2019; Lima, Joselia A/M-2720-2016
OI Lima, Joselia A/0000-0002-2076-1144; Lima, Antonio/0000-0001-6291-3049
FU Brazilian financial agency, CNPq; Brazilian financial agency,
   CAPESCAPES; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior) fellowshipCAPES
FX This study received financial support from the Brazilian financial
   agencies, CNPq and CAPES. JAL is the recipiente of a CAPES (Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior) fellowship.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   ABOUELNAGA ZS, 2014, J ENTOMOL ZOOL STU G, V2, P340
   Affonso RS, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4096
   Al-Malahmeh AJ, 2017, TOXICOL REP, V4, P1, DOI 10.1016/j.toxrep.2016.11.002
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   ATACK JR, 1989, J PHARMACOL EXP THER, V249, P194
   Babushok VI, 2011, J PHYS CHEM REF DATA, V40, DOI 10.1063/1.3653552
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Basile K, 2017, PATHOLOGY, V49, P698, DOI 10.1016/j.pathol.2017.08.002
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRAGA I. A., 2007, REV EPIDEMIOLOGIA SA, V16, P179, DOI DOI 10.5123/S1679-49742007000400006
   Brazil Ministry of Health, 2017, DENG CHIK ZIK PREV C
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chaiyasit D, 2006, PARASITOL RES, V99, P715, DOI 10.1007/s00436-006-0232-x
   Chang CL, 2009, J ECON ENTOMOL, V102, P203, DOI 10.1603/029.102.0129
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   Chung IM, 2011, IMMUNOPHARM IMMUNOT, V33, P450, DOI 10.3109/08923973.2010.532805
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   Corbel V, 2004, J MED ENTOMOL, V41, P712, DOI 10.1603/0022-2585-41.4.712
   Cavalcanti LPD, 2007, REV SAUDE PUBL, V41, P638, DOI 10.1590/s0034-89102006005000041
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards Falicia L, 2005, Int J Environ Res Public Health, V2, P430, DOI 10.3390/ijerph2005030007
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Fontoura NG, 2012, MEM I OSWALDO CRUZ, V107, P387, DOI 10.1590/S0074-02762012000300014
   Freire JM, 2008, THESIS
   Garcia-Fajardo J., 1997, Journal of Essential Oil Research, V9, P181
   Govindarajan M., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P43, DOI 10.1016/S2221-1691(11)60066-X
   Govindarajan M, 2018, ENVIRON SCI POLLUT R, V25, P1
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Hari I, 2018, ENVIRON SCI POLLUT R, V25, P9176, DOI 10.1007/s11356-018-1515-3
   Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004
   Hoeveler M, 2016, THESIS
   Huang Y, 2002, J STORED PROD RES, V38, P403, DOI 10.1016/S0022-474X(01)00042-X
   Jokanovic M, 2009, CURR MED CHEM, V16, P2177, DOI 10.2174/092986709788612729
   Kam YW, 2009, MICROBES INFECT, V11, P1186, DOI 10.1016/j.micinf.2009.09.003
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Lima JA, 2009, PHARMACOL BIOCHEM BE, V92, P508, DOI 10.1016/j.pbb.2009.01.024
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Norris EJ, 2015, J MED ENTOMOL, V52, P993, DOI 10.1093/jme/tjv090
   Pang EL, 2017, ASIAN PAC J TROP MED, V10, P209, DOI 10.1016/j.apjtm.2017.03.003
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10493, DOI 10.1007/s11356-017-0267-9
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, CURR ORG CHEM, V20, P2674, DOI 10.2174/1385272820666151026231851
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Perumalsamy H, 2009, J MED ENTOMOL, V46, P1420, DOI 10.1603/033.046.0624
   Rajkumar S, 2010, J ASIA-PAC ENTOMOL, V13, P107, DOI 10.1016/j.aspen.2010.02.001
   Rocha DK, 2015, NAT PROD COMMUN, V10, P677
   ROSA C.S., 2016, Rev. bras. plantas med., V18, P19, DOI 10.1590/1983-084X/15_006
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]
   Saavedra LM, 2018, SCI TOTAL ENVIRON, V610, P937, DOI 10.1016/j.scitotenv.2017.08.119
   Samarasekera R, 2005, J ESSENT OIL RES, V17, P301, DOI 10.1080/10412905.2005.9698909
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586
   Shaalan EAS, 2018, ENVIRON SCI POLLUT R, V25, P10207, DOI 10.1007/s11356-017-0408-1
   Siano F, 2003, FOOD CHEM, V81, P469, DOI 10.1016/S0308-8146(03)00004-9
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Valente VMM, 2005, THESIS
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   WHO G, 2005, GUID LAB FIELD TEST
   WHO G, 1996, REP WHO INF CONS EV
   Wiesner J, 2007, J ENZYM INHIB MED CH, V22, P417, DOI 10.1080/14756360701421294
   Yang SX, 2017, VACCINE, V35, P4851, DOI 10.1016/j.vaccine.2017.07.065
   Yang YoungCheol, 2004, Journal of Asia-Pacific Entomology, V7, P227, DOI 10.1016/S1226-8615(08)60220-4
   Yeom HJ, 2012, J AGR FOOD CHEM, V60, P7194, DOI 10.1021/jf302009w
NR 75
TC 9
Z9 9
U1 1
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD AUG
PY 2018
VL 25
IS 23
SI SI
BP 22541
EP 22551
DI 10.1007/s11356-018-2362-y
PG 11
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GP6QC
UT WOS:000441007000021
PM 29808407
DA 2020-07-08
ER

PT J
AU Milagres, F
   da Costa, AC
   Lima, RC
   Sabino, EC
   Segurado, A
AF Milagres, F.
   da Costa, A. C.
   Lima, R. C.
   Sabino, E. C.
   Segurado, A.
TI Outbreak of Zika Virus Infection an the Co-Circulation of Other
   Arboviruses in State of Tocantins, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Milagres, F.; Lima, R. C.] Hlth Tocantins, Palmas, Brazil.
   [Milagres, F.] Fed Univ Tocantins, Palmas, Brazil.
   [da Costa, A. C.; Sabino, E. C.; Segurado, A.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [da Costa, A. C.; Sabino, E. C.; Segurado, A.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
RI da-Costa, Antonio Charlys/G-1548-2010; milagres, flavio/Q-2403-2019;
   Sabino, Ester Cerdeira/F-7750-2010; Segurado, Aluisio C/K-2229-2012
OI da-Costa, Antonio Charlys/0000-0001-5516-5177; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Segurado, Aluisio C/0000-0002-6311-8036
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA Sat_Statio
BP 106
EP 106
DI 10.1016/j.ijid.2018.04.3661
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100227
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mendoza, JD
   Sanchez-Carbonel, J
   Tantalean-Yepez, D
   Luis, MAA
   Silva-Caso, W
   Weilg, P
   Vasquez-Achaya, F
   Costa, L
   Martin-Luna, J
   Palomares-Reyes, C
   Aquino-Orteaga, R
   Sandoval, I
AF del Valle Mendoza, J.
   Sanchez-Carbonel, J.
   Tantalean-Yepez, D.
   Aguilar Luis, M. A.
   Silva-Caso, W.
   Weilg, P.
   Vasquez-Achaya, F.
   Costa, L.
   Martin-Luna, J.
   Palomares-Reyes, C.
   Aquino-Orteaga, R.
   Sandoval, I.
TI Detection and molecular characterization of Chikungunya and Zika in a
   dengue endemic region of the Peruvian coast
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [del Valle Mendoza, J.; Sanchez-Carbonel, J.; Tantalean-Yepez, D.; Aguilar Luis, M. A.; Silva-Caso, W.; Weilg, P.; Vasquez-Achaya, F.; Martin-Luna, J.; Palomares-Reyes, C.; Aquino-Orteaga, R.] Univ Peruana Ciencias Aplicadas, Lima, Peru.
   [Costa, L.] Univ Vina del Mar, Vina Del Mar, Chile.
   [Sandoval, I.] DIRESA PIURA, Lima, Peru.
RI Caso, Wilmer Gianfranco Silva/D-2699-2018; del Valle Mendoza,
   Juana/C-9805-2018; Palomares Reyes, Carlos Cesar/Q-1255-2018;
   Aguilar-Luis, Miguel Angel/C-8686-2018; Vasquez Achaya,
   Fernando/I-6380-2017
OI Caso, Wilmer Gianfranco Silva/0000-0003-1086-8084; del Valle Mendoza,
   Juana/0000-0002-6011-5040; Palomares Reyes, Carlos
   Cesar/0000-0002-7027-1952; Aguilar-Luis, Miguel
   Angel/0000-0001-7023-3190; Vasquez Achaya, Fernando/0000-0003-3627-7688
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA Sat_Statio
BP 108
EP 108
DI 10.1016/j.ijid.2018.04.3664
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100230
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Terzian, ACB
   Estofolete, CF
   Nery, N
   Zini, N
   Da Silva, GCD
   Guimaraes, GF
   Rahal, P
   Costa, PF
   de Mattos, CCB
   de Mattos, LC
   Vasilakis, N
   Oliani, AH
   Oliani, DCMV
   Ko, AI
   Nogueira, ML
AF Bernardes Terzian, A. C.
   Estofolete, C. F.
   Nery-Junior, N.
   Zini, N.
   Celestino Dutra Da Silva, G.
   Guimaraes, G. F.
   Rahal, P.
   Fv Costa, P.
   Brandao de Mattos, C. C.
   de Mattos, L. C.
   Vasilakis, N.
   Helio Oliani, A.
   Mos Vaz Oliani, D. C.
   Ko, A. Icksang
   Lacerda Nogueira, M.
TI Newborn virological outcome after intrauterine ZIKV exposure
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Bernardes Terzian, A. C.; Estofolete, C. F.; Zini, N.; Celestino Dutra Da Silva, G.; Guimaraes, G. F.; Lacerda Nogueira, M.] FAMERP, DDDIP, Sao Jose Do Rio Preto, Brazil.
   [Nery-Junior, N.] Fiocruz MS, Salvador, BA, Brazil.
   [Rahal, P.] UNESP, Sao Jose Do Rio Preto, Brazil.
   [Fv Costa, P.] Inst Evandro Chagas, Ananindeua, Brazil.
   [Brandao de Mattos, C. C.; de Mattos, L. C.; Helio Oliani, A.; Mos Vaz Oliani, D. C.] FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Vasilakis, N.] UTMB, Pathol, Galveston, TX USA.
   [Ko, A. Icksang] Yale Univ, New Haven, CT USA.
RI Nogueira, Mauricio L/B-7599-2012; OLIANI, ANTONIO/O-1673-2019; Ko,
   Albert Icksang/P-2343-2015; Estofolete, Cassia/N-6673-2019; de Mattos,
   Luiz Carlos/P-3574-2019; Rahal, Paula/D-3871-2012
OI Nogueira, Mauricio L/0000-0003-1102-2419; Ko, Albert
   Icksang/0000-0001-9023-2339; Estofolete, Cassia/0000-0001-7324-1591;
   Rahal, Paula/0000-0001-5693-6148
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 779
BP 375
EP 375
DI 10.1016/j.ijid.2018.04.4262
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100828
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vincent, JL
   Marshall, JC
   Zimmerman, JL
AF Vincent, Jean-Louis
   Marshall, John C.
   Zimmerman, Janice L.
TI The changing face of critical care: Task force on tropical diseases
SO JOURNAL OF CRITICAL CARE
LA English
DT Editorial Material
DE Zika virus; Epidemiology; Clinical features; Neurological complications
AB Zika fever is an acute infectious disease caused by the Zika virus (ZIKV), an RNA virus belonging to the genus Flavivirus. ZIKV can be transmitted by bites from Aedes aegypti and Aedes albopictus species, sexual activity, blood transfusion and from mother to fetus during pregnancy and delivery. A total of 50 territories and countries in the Americas had reported ZIKV infections. For those with symptoms, the presentation is similar to dengue fever with body aches, joint pain, fatigue, malaise, fever and conjunctivitis lasting up to seven days. A maculopapular rash may also occur and is usually pruritic. Neurological complications are well documented and include Guillain-Barre Syndrome (GBS) and congenital ZIKV syndrome, and less frequently acute myelitis and meningoencephalitis. ZIKV infection usually causes a mild illness and most patients are managed conservatively. Currently, no antiviral therapy is available. The most appropriate therapy for ZIKV-associated GBS is yet unclear, however intravenous immunoglobulins have been used, as in conventional GBS. ZIKV infection can be prevented through the use of mosquito repellents, protection with long-sleeved clothing and trousers, and the use of clothes impregnated with permethrin. This review describes the current concepts regarding the epidemiology, diagnosis, clinical manifestations and neurological complications of ZIKV infection. (C) 2018 Published by Elsevier Inc.
C1 [Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium.
   [Marshall, John C.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada.
   [Marshall, John C.] St Michaels Hosp, Dept Crit Care Med, Toronto, ON, Canada.
   [Zimmerman, Janice L.] Houston Methodist Hosp, Div Crit Care, 6565 Fannin St, Houston, TX 77030 USA.
RP Vincent, JL (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.
EM jlvincent@intensive.org
OI Vincent, Jean-Louis/0000-0001-6011-6951
NR 0
TC 0
Z9 0
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD AUG
PY 2018
VL 46
BP 105
EP 105
DI 10.1016/j.jcrc.2017.12.019
PG 1
WC Critical Care Medicine
SC General & Internal Medicine
GA GK7YM
UT WOS:000436431000021
PM 29321100
DA 2020-07-08
ER

PT J
AU Campos, JLS
   Poggianella, M
   Burrone, OR
AF Campos, J. L. Slon
   Poggianella, M.
   Burrone, O. R.
TI Long-term stability of antibody responses elicited by Dengue virus
   envelope DIII-based DNA vaccines
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Dengue; Dengue virus; DNA vaccine; envelope protein; flaviviruses;
   genetic vaccines
ID PHASE-1 CLINICAL-TRIAL; ZIKA VIRUS; IMMUNE-RESPONSE; HEALTHY-ADULTS;
   DOMAIN-III; INFECTION; IMMUNOGENICITY; SAFETY; VACCINATION; CELLS
AB Dengue virus (DENV) is one the most important viral pathogens worldwide. Currently there is an imperative need for a reliable vaccine capable of inducing durable protection against all four serotypes. We have previously reported strongly neutralizing and highly specific antibody responses from all four serotypes to a DNA vaccine based on an engineered version of DENV E protein's domain III (DIII). Here, we show that monovalent and tetravalent immunizations with the DIII-based DNA vaccines are also capable of inducing highly stable antibody responses that remain strongly neutralizing over long periods of time. Our results demonstrate that DNA-vaccinated mice maintain a strong antibody response in terms of titre, avidity and virus-neutralizing capability 1 year after immunization.
C1 [Campos, J. L. Slon; Poggianella, M.; Burrone, O. R.] ICGEB, Mol Immunol Grp, Padriciano 99, I-34149 Trieste, Italy.
   [Campos, J. L. Slon] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Roosevelt Dr, Oxford OX3 7BN, England.
RP Campos, JLS; Burrone, OR (corresponding author), ICGEB, Mol Immunol Grp, Padriciano 99, I-34149 Trieste, Italy.; Campos, JLS (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Med, Roosevelt Dr, Oxford OX3 7BN, England.
EM jose.slon-campos@well.ox.ac.uk; burrone@icgeb.org
OI Slon Campos, Jose Luis/0000-0002-0012-5247
FU ICGEB Arturo Falaschi PhD and Postdoctoral fellowship
FX J. L. S. C. was supported by an ICGEB Arturo Falaschi PhD and
   Postdoctoral fellowship.
CR Arredondo-Garcia JL, 2018, CLIN MICROBIOL INFEC
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campos JLS, 2015, J GEN VIROL, V96, P3265, DOI 10.1099/jgv.0.000278
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Danko JR, 2018, AM J TROP MED HYG, V98, P849, DOI 10.4269/ajtmh.17-0416
   de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2018, HUM VACCIN IMMUNOTHE
   Hammarlund E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01901-w
   Hombach J, 2009, J CLIN VIROL, V46, pS7, DOI 10.1016/S1386-6532(09)70287-2
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Khan Kishwar Hayat, 2013, Germs, V3, P26, DOI 10.11599/germs.2013.1034
   LINDENBACH BD, 2007, FIELDS VIROLOGY
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Midgley CM, 2011, J VIROL, V85, P410, DOI 10.1128/JVI.01826-10
   Modis Y, 2014, CURR OPIN VIROL, V5, P34, DOI 10.1016/j.coviro.2014.01.009
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Porter KR, 2015, VACCINE, V33, P7135, DOI 10.1016/j.vaccine.2015.09.102
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Richner JM, 2017, CELL
   Sarwar UN, 2015, J INFECT DIS, V211, P549, DOI 10.1093/infdis/jiu511
   Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Toh YX, 2014, IMMUNOL MEM, V5, P1, DOI DOI 10.3389/FIMMU.2014.00388
   Torresi J, 2017, HUM VACC IMMUNOTHER, V13, P1059, DOI 10.1080/21645515.2016.1261770
   Tsen SWD, 2007, EXPERT REV VACCINES, V6, P227, DOI 10.1586/14760584.6.2.227
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wang G, 2011, HUM VACCINES, V7, P1271, DOI 10.4161/hv.7.12.17983
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 49
TC 2
Z9 2
U1 0
U2 4
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD AUG
PY 2018
VL 99
IS 8
BP 1078
EP 1085
DI 10.1099/jgv.0.001094
PG 8
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GO9XL
UT WOS:000440461400013
PM 29923817
OA Bronze
DA 2020-07-08
ER

PT J
AU Demers, J
   Bewick, S
   Calabrese, J
   Fagan, WF
AF Demers, Jeffery
   Bewick, Sharon
   Calabrese, Justin
   Fagan, William F.
TI Dynamic modelling of personal protection control strategies for
   vector-borne disease limits the role of diversity amplification
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE personal protection; diversity amplification; vector-borne disease;
   epidemiological control; insect repellent; bed nets
ID BED NETS; AEDES-AEGYPTI; TRANSMISSION; MALARIA; MOSQUITOS; PATHOGENS;
   HUMANS; PLUMES; IMPACT
AB Personal protection measures, such as bed nets and repellents, are important tools for the suppression of vector-borne diseases like malaria and Zika, and the ability of health agencies to distribute protection and encourage its use plays an important role in the efficacy of community-wide disease management strategies. Recent modelling studies have shown that a counterintuitive diversity-driven amplification in community-wide disease levels can result from a population's partial adoption of personal protection measures, potentially to the detriment of disease management efforts. This finding, however, may overestimate the negative impact of partial personal protection as a result of implicit restrictive model assumptions regarding host compliance, access to and longevity of protection measures. We establish a new modelling methodology for incorporating community-wide personal protection distribution programmes in vector-borne disease systems which flexibly accounts for compliance, access, longevity and control strategies by way of a flow between protected and unprotected populations. Our methodology yields large reductions in the severity and occurrence of amplification effects as compared to existing models.
C1 [Demers, Jeffery; Bewick, Sharon; Calabrese, Justin; Fagan, William F.] Univ Maryland Coll Pk, Dept Biol, College Pk, MD 20742 USA.
   [Demers, Jeffery; Calabrese, Justin] Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, 1500 Remount Rd, Front Royal, VA 22630 USA.
RP Demers, J (corresponding author), Univ Maryland Coll Pk, Dept Biol, College Pk, MD 20742 USA.; Demers, J (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, 1500 Remount Rd, Front Royal, VA 22630 USA.
EM jdemers@umd.edu
RI Calabrese, Justin/B-9131-2012
OI Calabrese, Justin/0000-0003-0575-6408
FU University of Maryland-Smithsonian Institution seed grant; DOD SERDP
   grant
FX This work was supported by a University of Maryland-Smithsonian
   Institution seed grant, and by a DOD SERDP grant.
CR Agusto F, 2013, J BIOL SYST, V21, DOI 10.1142/S0218339013400020
   Agusto FB, 2013, MATH POPUL STUD, V20, P82, DOI 10.1080/08898480.2013.777239
   Agusto FB, 2013, J THEOR BIOL, V320, P58, DOI 10.1016/j.jtbi.2012.12.007
   Agusto FB, 2012, ELECTRON J DIFFER EQ
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761
   Blayneh K, 2009, DISCRETE CONT DYN-B, V11, P587, DOI 10.3934/dcdsb.2009.11.587
   Bowman C, 2005, B MATH BIOL, V67, P1107, DOI 10.1016/j.bulm.2005.01.002
   Briet OJT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-20
   Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179
   Chiyaka C, 2008, APPL MATH COMPUT, V195, P641, DOI 10.1016/j.amc.2007.05.016
   DeGennaro M, 2015, FLY, V9, P45, DOI 10.1080/19336934.2015.1079360
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681
   Dushoff JG., 1997, THESIS
   Favier C, 2005, P ROY SOC B-BIOL SCI, V272, P1171, DOI 10.1098/rspb.2004.3020
   FOSTER WA, 1987, ANN ENTOMOL SOC AM, V80, P103, DOI 10.1093/aesa/80.2.103
   Gu WD, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-256
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Holling C. S., 1959, Canadian Entomologist, V91, P385
   HOLLING C. S., 1959, CANADIAN ENT, V91, P293
   HOLLING CS, 1966, MEM ENTOMOL SOC CAN, V48, P1, DOI DOI 10.4039/ENTM9848FV
   Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x
   Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575
   Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022
   Larson PS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-466
   Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006
   Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0727-y
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202
   McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9
   Miller E, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0666
   Miller E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080279
   Moore SJ, 2007, TROP MED INT HEALTH, V12, P532, DOI 10.1111/j.1365-3156.2006.01811.x
   Ngonghala CN, 2014, J THEOR BIOL, V363, P247, DOI 10.1016/j.jtbi.2014.08.018
   Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022
   Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005
   Raji JI, 2017, CURR OPIN INSECT SCI, V20, P34, DOI 10.1016/j.cois.2017.03.003
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0
   Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Spitzen J, 2017, ACTA TROP, V172, P180, DOI 10.1016/j.actatropica.2017.05.008
   Sutcliffe JF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-294
   van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   Yakob L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1762-4
NR 51
TC 0
Z9 0
U1 1
U2 7
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD AUG
PY 2018
VL 15
IS 145
AR 20180166
DI 10.1098/rsif.2018.0166
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS1YC
UT WOS:000443333600005
PM 30135260
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gurung, S
   Preno, AN
   Dubaut, JP
   Nadeau, H
   Hyatt, K
   Reuter, N
   Nehete, B
   Wolf, RF
   Nehete, P
   Dittmer, DP
   Myers, DA
   Papin, JF
AF Gurung, Sunam
   Preno, Alisha N.
   Dubaut, Jamie P.
   Nadeau, Hugh
   Hyatt, Kimberly
   Reuter, Nicole
   Nehete, Bharti
   Wolf, Roman F.
   Nehete, Pramod
   Dittmer, Dirk P.
   Myers, Dean A.
   Papin, James F.
TI Translational Model of Zika Virus Disease in Baboons
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE baboon; West Nile virus; ZIKV; Zika virus; flavivirus; nonhuman primate
ID PERIPHERAL-BLOOD LYMPHOCYTES; AEDES-AEGYPTI MOSQUITOS; WEST-NILE-VIRUS;
   SEXUAL TRANSMISSION; NONHUMAN PRIMATE; RHESUS MACAQUES; PATHOGENESIS;
   INFECTION; AGE; IMMUNIZATION
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus with devastating outcomes seen recently in the Americas due to the association of maternal ZIKV infection with fetal microcephaly and other fetal malformations not previously associated with flavivirus infections. Here, we have developed the olive baboon (Papio anubis) as a nonhuman primate (NHP) translational model for the study of ZIKV pathogenesis and associated disease outcomes to contrast and compare with humans and other major NHPs, such as macaques. Following subcutaneous inoculation of adult male and nonpregnant female baboons, viremia was detected at 3 and 4 days postinfection (dpi) with the concordant presentation of a visible rash and conjunctivitis, similar to human ZIKV infection. Furthermore, virus was detected in the mucosa and cerebrospinal fluid. A robust ZIKV-specific IgM and IgG antibody response was also observed in all the animals. These data show striking similarity between humans and the olive baboon following infection with ZIKV, suggesting our model is a suitable translational NHP model to study ZIKV pathogenesis and potential therapeutics.
   IMPORTANCE ZIKV was first identified in 1947 in a sentinel rhesus monkey in Uganda and subsequently spread to Southeast Asia. Until 2007, only a small number of cases were reported, and ZIKV infection was relatively minor until the South Pacific and Brazilian outbreaks, where more severe outcomes were reported. Here, we present the baboon as a nonhuman primate model for contrast and comparison with other published animal models of ZIKV, such as the mouse and macaque species. Baboons breed year round and are not currently a primary nonhuman primate species used in biomedical research, making them more readily available for studies other than human immunodeficiency virus studies, which many macaque species are designated for. This, taken together with the similarities baboons have with humans, such as immunology, reproduction, genetics, and size, makes the baboon an attractive NHP model for ZIKV studies in comparison to other nonhuman primates.
C1 [Gurung, Sunam; Dubaut, Jamie P.; Nadeau, Hugh; Hyatt, Kimberly; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA.
   [Preno, Alisha N.; Reuter, Nicole; Wolf, Roman F.; Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Div Comparat Med, Oklahoma City, OK USA.
   [Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.
   [Dittmer, Dirk P.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Nehete, Bharti; Nehete, Pramod] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA.
RP Papin, JF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Div Comparat Med, Oklahoma City, OK USA.; Papin, JF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.
EM james-papin@ouhsc.edu
OI dittmer, dirk/0000-0003-4968-5656; Nehete, Pramod/0000-0002-2815-2677;
   Peregrine, Jamie/0000-0001-6705-3957
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI129560, R21 NS103772, P40
   OD010988]; University of Oklahoma Health Sciences Center Vice President
   for Research
FX This study was supported by NIH R21 AI129560, NIH R21 NS103772, NIH P40
   OD010988, and funds from the University of Oklahoma Health Sciences
   Center Vice President for Research.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DAMIAN RT, 1971, J IMMUNOL, V106, P246
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Harewood WJ, 1999, J MED PRIMATOL, V28, P19, DOI 10.1111/j.1600-0684.1999.tb00085.x
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nehete PN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188694
   Nehete PN, 2017, J AM ASSOC LAB ANIM, V56, P509
   Nehete PN, 2017, COMPARATIVE MED, V67, P67
   Nehete PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079836
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Shearer MH, 1997, INFECT IMMUN, V65, P3267, DOI 10.1128/IAI.65.8.3267-3270.1997
   Shearer MH, 1999, CLIN DIAGN LAB IMMUN, V6, P953, DOI 10.1128/CDLI.6.6.953-958.1999
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Smith DG, 2005, COMPARATIVE MED, V55, P227
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Watts AM, 1999, NAT MED, V5, P427
   Wolf RF, 2006, VIROLOGY, V355, P44, DOI 10.1016/j.virol.2006.06.033
   World Health Organization, 2007, WHOIVB07
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 56
TC 8
Z9 8
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2018
VL 92
IS 16
AR e00186-18
DI 10.1128/JVI.00186-18
PG 17
WC Virology
SC Virology
GA GO7XD
UT WOS:000440292200006
PM 29875247
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Heitmann, A
   Jansen, S
   Luhken, R
   Leggewie, M
   Schmidt-Chanasit, J
   Tannich, E
AF Heitmann, Anna
   Jansen, Stephanie
   Luehken, Renke
   Leggewie, Mayke
   Schmidt-Chanasit, Jonas
   Tannich, Egbert
TI Forced Salivation As a Method to Analyze Vector Competence of Mosquitoes
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Biology; Issue 138; Vector competence; forced salivation; mosquito; Zika
   virus; Culex species; Aedes albopictus; Aedes aegypti; infection rate;
   transmission rate
ID TRANSMISSION
AB Vector competence is defined as the potential of a mosquito species to transmit a mosquito-borne virus (mobovirus) to a vertebrate host. Viable virus particles are transmitted during a blood meal via the saliva of an infected mosquito. Forced salivation assays allow determining the vector potential on the basis of single mosquitoes, avoiding the use of animal experiments. The method is suitable to analyze a large number of mosquitoes in one experiment within a short period of time. Forced salivation assays were used to analyze 856 individual mosquitoes trapped in Germany, including two different Culex pipiens pipiens biotypes, Culex torrentium as well as Aedes albopictus, which were experimentally infected with Zika virus (ZIKV) and incubated at 18 degrees C or 27 degrees C for two and three weeks. The results indicated the lack of vector competence of the different Culex taxa for ZIKV. In contrast, Aedes albopictus was susceptible to ZIKV, but only at 27 degrees C, with transmission rates similar to an Aedes aegypti laboratory colony tested in parallel.
C1 [Heitmann, Anna; Jansen, Stephanie; Luehken, Renke; Leggewie, Mayke; Schmidt-Chanasit, Jonas; Tannich, Egbert] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Jansen, Stephanie; Leggewie, Mayke; Schmidt-Chanasit, Jonas; Tannich, Egbert] German Ctr Infect Res DZIF, Braunschweig, Germany.
RP Heitmann, A (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.
EM heitmann@bnitm.de
RI Heitmann, Anna/K-4523-2019
OI Heitmann, Anna/0000-0002-9584-0947; Luhken, Renke/0000-0002-1984-839X
FU Leibniz Association [SAW-2014-SGN-3]
FX We thank Ella Weinert, Michelle Helms and Marlis Badusche for excellent
   technical assistance, Jessica Borstler for analyses of Culex mosquitoes,
   Norbert Becker and Bjorn Pluskota for providing Aedes albopictus eggs
   and Olli Vapalahti for providing the virus stock. ML was supported by
   the Leibniz Association; grant number SAW-2014-SGN-3.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Anderson SL, 2010, J AM MOSQUITO CONTR, V26, P108, DOI 10.2987/09-5935.1
   CORNEL AJ, 1989, J AM MOSQUITO CONTR, V5, P70
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Heitmann A., 2017, EUROVSURVEILLANCE, V22
   Hierholzer JCaK R. A., 1996, VIRUS ISOLATION QUAN
   Horzinek R.W., 2010, ZENTRALBLATT VETER A, V32, P480
   HURLBUT HS, 1966, AM J TROP MED HYG, V15, P989, DOI 10.4269/ajtmh.1966.15.989
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Richard V., 2016, PLOS NEGLECTED TROPI, V10
   Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 14
TC 3
Z9 3
U1 0
U2 0
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD AUG
PY 2018
IS 138
AR e57980
DI 10.3791/57980
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GU0BQ
UT WOS:000444913100081
PM 30148488
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Strugarek, M
   Vauchelet, N
   Zubelli, JP
AF Strugarek, Martin
   Vauchelet, Nicolas
   Zubelli, Jorge P.
TI QUANTIFYING THE SURVIVAL UNCERTAINTY OF WOLBACHIA-INFECTED MOSQUITOES IN
   A SPATIAL MODEL
SO MATHEMATICAL BIOSCIENCES AND ENGINEERING
LA English
DT Article
DE Reaction-diffusion equation; Wolbachia; uncertainty quantification;
   population replacement; mosquito release protocol
ID EXACT MULTIPLICITY; POSITIVE SOLUTIONS; GENETIC-CONTROL; AEDES-AEGYPTI;
   DENGUE; ESTABLISHMENT; SPECIATION; DISPERSAL; SPREAD
AB Artificial releases of Wolbachia-infected Aedes mosquitoes have been under study in the past years for fighting vector-borne diseases such as dengue, chikungunya and zika. Several strains of this bacterium cause cytoplasmic incompatibility (CI) and can also affect their host's fecundity or lifespan, while highly reducing vector competence for the main arboviruses.
   We consider and answer the following questions: 1) what should be the initial condition (i.e. size of the initial mosquito population) to have invasion with one mosquito release source? We note that it is hard to have an invasion in such case. 2) How many release points does one need to have sufficiently high probability of invasion? 3) What happens if one accounts for uncertainty in the release protocol (e.g. unequal spacing among release points)?
   We build a framework based on existing reaction-diffusion models for the uncertainty quantification in this context, obtain both theoretical and numerical lower bounds for the probability of release success and give new quantitative results on the one dimensional case.
C1 [Strugarek, Martin] AgroParisTech, 16 Rue Claude Bernard, F-75231 Paris 05, France.
   [Strugarek, Martin] Univ Paris Diderot, Sorbonne Univ, CNRS, INRIA,Lab Jacques Louis Lions,Equipe Mamba,SPC, F-75005 Paris, France.
   [Vauchelet, Nicolas] Univ Paris 13, Inst Galilee, LAGA, UMR 7539, 99 Ave Jean Baptiste Clement, F-93430 Villetaneuse, France.
   [Zubelli, Jorge P.] Estr Dona Castorina,110 Jardim Bot, BR-22460320 Rio De Janeiro, RJ, Brazil.
RP Strugarek, M (corresponding author), AgroParisTech, 16 Rue Claude Bernard, F-75231 Paris 05, France.; Strugarek, M (corresponding author), Univ Paris Diderot, Sorbonne Univ, CNRS, INRIA,Lab Jacques Louis Lions,Equipe Mamba,SPC, F-75005 Paris, France.
EM strugarek@ljll.math.upmc.fr; vauchelet@math.univ-paris13.fr;
   zubelli@impa.br
RI Zubelli, Jorge/B-6166-2008
OI Zubelli, Jorge/0000-0003-1581-9505
FU Programme Convergence Sorbonne Universites / FAPERJ Control and
   identification for mathematical models of Dengue epidemics;
   Capes-Cofecub projectCAPES [Ma-833 15]; ANR blanche project Kibord -
   French Ministry of ResearchFrench National Research Agency (ANR)
   [ANR-13-BS01-0004]; Emergence project from Mairie de Paris, Analysis and
   simulation of optimal shapes - application to life-sciences; Inria,
   France; CAPES, BrazilCAPES [99999.007551/2015-00]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [302161/2003-1,
   474085/2003-1]; FAPERJ through the programs Cientistas do Nosso Estado;
   Brazilian-French Network in Mathematics
FX The authors acknowledge partial support from the Programme Convergence
   Sorbonne Universites / FAPERJ Control and identification for
   mathematical models of Dengue epidemics and from the Capes-Cofecub
   project Ma-833 15 Modeling innovative control method for Dengue fever.
   MS and NV acknowledge partial funding from the ANR blanche project
   Kibord: ANR-13-BS01-0004 funded by the French Ministry of Research, from
   the Emergence project from Mairie de Paris, Analysis and simulation of
   optimal shapes - application to life-sciences and from Inria, France and
   CAPES, Brazil (processo 99999.007551/2015-00), in the framework of the
   STIC AmSud project MOSTICAW. JPZ was supported by CNPq grants
   302161/2003-1 and 474085/2003-1, by FAPERJ through the programs
   Cientistas do Nosso Estado, and by the Brazilian-French Network in
   Mathematics.
CR Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246
   BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0
   BARTON NH, 1991, EVOLUTION, V45, P499, DOI 10.1111/j.1558-5646.1991.tb04326.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Chan MHT, 2013, B MATH BIOL, V75, P1501, DOI 10.1007/s11538-013-9857-y
   Crain PR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-290
   Du YH, 2010, J EUR MATH SOC, V12, P279, DOI 10.4171/JEMS/198
   Erdos P., 1961, MAGYAR TUD AKAD MAT, P215
   Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247
   Hancock P. A., 2012, J ROYAL SOC INTERFAC, V9, P253
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Maciel-de-Freitas R, 2010, MED VET ENTOMOL, V24, P74, DOI 10.1111/j.1365-2915.2009.00851.x
   Matano H, 2016, COMMUN PART DIFF EQ, V41, P785, DOI 10.1080/03605302.2016.1156697
   Muratov CB, 2017, DISCRETE CONT DYN-A, V37, P915, DOI 10.3934/dcds.2017038
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Ouyang TC, 1999, J DIFFER EQUATIONS, V158, P94, DOI 10.1016/S0022-0396(99)80020-5
   Ouyang TC, 1998, J DIFFER EQUATIONS, V146, P121, DOI 10.1006/jdeq.1998.3414
   Polacik P, 2011, ARCH RATION MECH AN, V199, P69, DOI 10.1007/s00205-010-0316-8
   ROUHANI S, 1987, THEOR POPUL BIOL, V31, P465, DOI 10.1016/0040-5809(87)90016-5
   Strugarek M, 2016, SIAM J APPL MATH, V76, P2060, DOI 10.1137/16M1059217
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Vavre F, 2012, CURR OPIN MICROBIOL, V15, P263, DOI 10.1016/j.mib.2012.03.005
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yeap HL, 2016, HEREDITY, V116, P265, DOI 10.1038/hdy.2015.97
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zheng B, 2018, J MATH BIOL, V76, P235, DOI 10.1007/s00285-017-1142-5
   Zlatos A, 2006, J AM MATH SOC, V19, P251, DOI 10.1090/S0894-0347-05-00504-7
NR 39
TC 3
Z9 3
U1 0
U2 3
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1547-1063
EI 1551-0018
J9 MATH BIOSCI ENG
JI Math. Biosci. Eng.
PD AUG
PY 2018
VL 15
IS 4
BP 961
EP 991
DI 10.3934/mbe.2018043
PG 31
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GW6FI
UT WOS:000447046100007
PM 30380317
OA Other Gold
DA 2020-07-08
ER

PT J
AU Flores, HA
   O'Neill, SL
AF Flores, Heather A.
   O'Neill, Scott L.
TI Controlling vector-borne diseases by releasing modified mosquitoes
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID GENE DRIVE SYSTEM; LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI; HORIZONTAL
   TRANSMISSION; CHEMOSTERILIZED MALES; ANOPHELES-ALBIMANUS; DENGUE
   TRANSMISSION; DIPTERA-CULICIDAE; BLOCKS DENGUE; FIELD TRIALS
AB Aedes mosquito-transmitted diseases, such as dengue, Zika and chikungunya, are becoming major global health emergencies while old threats, such as yellow fever, are re-emerging. Traditional control methods, which have focused on reducing mosquito populations through the application of insecticides or preventing breeding through removal of larval habitat, are largely ineffective, as evidenced by the increasing global disease burden. Here, we review novel mosquito population reduction and population modification approaches with a focus on control methods based on the release of mosquitoes, including the release of Wolbachia-infected mosquitoes and strategies to genetically modify the vector, that are currently under development and have the potential to contribute to a reversal of the current alarming disease trends.
C1 [Flores, Heather A.; O'Neill, Scott L.] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
RP O'Neill, SL (corresponding author), Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
EM scott.oneill@monash.edu
RI O'Neill, Scott L/B-3568-2009; Flores, Heather/A-7403-2019; O'Neill,
   Scott/R-9560-2019
OI O'Neill, Scott L/0000-0002-4131-3615; Flores,
   Heather/0000-0001-5003-7547; O'Neill, Scott/0000-0002-4131-3615
FU Foundation for the National Institutes of Health through the
   Vector-Based Transmission of Control: Discovery Research (VCTR) program
   of the Grand Challenges in Global Health initiative of the Bill &
   Melinda Gates Foundation; Wellcome TrustWellcome Trust [102591]
FX The authors are grateful to M. Woolfit for reviewing the manuscript and
   acknowledge funding from The Foundation for the National Institutes of
   Health through the Vector-Based Transmission of Control: Discovery
   Research (VCTR) program of the Grand Challenges in Global Health
   initiative of the Bill & Melinda Gates Foundation and The Wellcome Trust
   Award No. 102591.
CR Ahmed MZ, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0660-x
   Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   [Anonymous], 2018, EL DENG OUR CHALL
   [Anonymous], 2018, DENGUE OUTBREAKS
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   BARGIELOWSKI I, 2011, PLOS ONE, V6
   Barton NH, 2011, AM NAT, V178, pE48, DOI 10.1086/661246
   Bellini R, 2013, J MED ENTOMOL, V50, P317, DOI 10.1603/ME12048
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Bellini R, 2010, J MED ENTOMOL, V47, P1082, DOI 10.1603/ME09154
   Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2011, TRENDS PARASITOL, V27, P362, DOI 10.1016/j.pt.2011.04.004
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bloss CS, 2017, JAMA-J AM MED ASSOC, V318, P662, DOI 10.1001/jama.2017.9285
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x
   Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271
   Chan YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074254
   Crawford J., 2017, DEBUG FRESNO OUR 1 U
   DAME DA, 1974, AM J TROP MED HYG, V23, P282, DOI 10.4269/ajtmh.1974.23.282
   De Barro PJ, 2011, J VERBRAUCH LEBENSM, V6, P33, DOI 10.1007/s00003-011-0671-x
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dorigatti I, 2018, TRENDS PARASITOL, V34, P102, DOI 10.1016/j.pt.2017.11.002
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107
   Galizi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31139
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gomes FM, 2017, P NATL ACAD SCI USA, V114, P12566, DOI 10.1073/pnas.1716181114
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P1
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Heinrich JC, 2000, P NATL ACAD SCI USA, V97, P8229, DOI 10.1073/pnas.140142697
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 2014, PLOS NEGLECT TROP D, V8
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hughes GL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004182
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hurst TP, 2012, J MED ENTOMOL, V49, P624, DOI 10.1603/ME11277
   International Atomic Energy Agency Office of Public Information and Communication, 2017, IAEA FACTSH ZIK VIR
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   Labbe GMC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001724
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Micieli MV, 2014, J MED ENTOMOL, V51, P189, DOI 10.1603/ME13152
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Murray JV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00043
   National Academies of Sciences Engineering and Medicine, 2016, GEN DRIV HOR ADV SCI
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Popovici J, 2010, MEM I OSWALDO CRUZ, V105, P957, DOI 10.1590/S0074-02762010000800002
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Reed FA, 2017, GENETICS, V205, P1037, DOI 10.1534/genetics.116.198887
   Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069
   Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988
   Roberts A, 2017, AM J TROP MED HYG, V96, P530, DOI 10.4269/ajtmh.16-0726
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Servick K, 2016, SCIENCE, V354, P164, DOI 10.1126/science.354.6309.164
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Traver BE, 2009, INSECT MOL BIOL, V18, P623, DOI 10.1111/j.1365-2583.2009.00905.x
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Unckless RL, 2017, GENETICS, V205, P827, DOI 10.1534/genetics.116.197285
   Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   WEIDHAAS DE, 1974, AM J TROP MED HYG, V23, P298, DOI 10.4269/ajtmh.1974.23.298
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
   Zwizwai R, 2017, LANCET INFECT DIS, V17, P270, DOI 10.1016/S1473-3099(17)30065-8
NR 112
TC 50
Z9 51
U1 16
U2 92
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD AUG
PY 2018
VL 16
IS 8
BP 508
EP 518
DI 10.1038/s41579-018-0025-0
PG 11
WC Microbiology
SC Microbiology
GA GN6JS
UT WOS:000439188500009
PM 29777177
DA 2020-07-08
ER

PT J
AU Conners, EE
   Lee, EH
   Thompson, CN
   McGibbon, E
   Rakeman, JL
   Iwamoto, M
   Cooper, H
   Vora, NM
   Limberger, RJ
   Fine, AD
   Liu, DK
   Slavinski, S
AF Conners, Erin E.
   Lee, Ellen H.
   Thompson, Corinne N.
   McGibbon, Emily
   Rakeman, Jennifer L.
   Iwamoto, Martha
   Cooper, Hannah
   Vora, Neil M.
   Limberger, Ronald J.
   Fine, Anne D.
   Liu, Dakai
   Slavinski, Sally
CA Zika Working Grp
TI Zika Virus Infection Among Pregnant Women and Their Neonates in New York
   City, January 2016-June 2017
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; US TERRITORIES; BIRTH-DEFECTS; UNITED-STATES;
   INFANTS; BRAZIL; ASSOCIATION; EPIDEMIC; EXPOSURE
AB OBJECTIVE: To describe and compare differences in the epidemiologic, clinical, and laboratory characteristics of pregnant women with confirmed or probable Zika virus infection and to compare the risk of having a neonate with laboratory evidence of Zika virus infection with that of having a neonate without evidence of Zika virus infection by maternal characteristics.
   METHODS: We conducted a retrospective cohort study of women with Zika virus infection who completed pregnancy in New York City from January 1, 2016 to June 30, 2017. Confirmed Zika virus infection was defined as 1) nucleic acid amplification test-detected Zika virus, or 2) a non-negative enzyme-linked immunosorbent assay test result and a plaque-reduction neutralization test result positive for Zika virus but negative for dengue virus, or 3) delivery of a neonate with laboratory evidence of Zika virus infection. Probable infection was defined as a nonnegative enzyme-linked immunosorbent assay test result and a positive plaque-reduction neutralization test result for Zika virus and dengue virus.
   RESULTS: We identified 390 women with confirmed (28%) or probable (72%) Zika virus infection. Fever, rash, arthralgia, or conjunctivitis was reported by 31% of women and were more common among women with confirmed than with probable infection (43% vs 26%, P5.001). Of 366 neonates born to these women, 295 (81%) were tested for Zika virus and 22 (7%) had laboratory-diagnosed congenital Zika virus infection. The relative risk (RR) for having a neonate with laboratory evidence of Zika virus infection was greater among women with fever (RR 4.8, 95% CI 2.1-10.7), tingling (RR 4.8, CI 1.7-13.7), or numbness (RR 6.9, CI 2.6-18.2) during pregnancy or the periconception period. However, the RR did not differ whether the mother had confirmed or probable Zika virus infection (RR 1.6, CI 0.7-4.1).
   CONCLUSION: In New York City, a greater proportion of women had probable Zika virus infection than confirmed infection. Women with some symptoms during pregnancy or periconceptionally were more likely to have a neonate with laboratory evidence of Zika virus infection. Neonates born to women with confirmed or probable Zika virus infection should be tested for Zika virus infection.
C1 New York City Dept Hlth & Mental Hyg, Div Dis Control, New York, NY USA.
   New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   Ctr Dis Control & Prevent, Career Epidemiol Field Officer Program, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
   New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
RP Slavinski, S (corresponding author), New York City Dept Hlth & Mental Hyg, Div Dis Control, 4209 28th St,CN 22A, Queens, NY 11101 USA.
EM sslavins@health.nyc.gov
RI amsalu, ribka/G-8780-2019
FU Public Health Emergency Preparedness Cooperative Agreement
   [NU90TP921856]; Epidemiology and Laboratory Capacity for Infectious
   Diseases from the Centers for Disease Control and Prevention (CDC)
   [NU50CK000407-03]
FX Supported by the Public Health Emergency Preparedness Cooperative
   Agreement (Grant Number: NU90TP921856) and by the Epidemiology and
   Laboratory Capacity for Infectious Diseases Cooperative Agreement (Grant
   Number: NU50CK000407-03) from the Centers for Disease Control and
   Prevention (CDC). Its contents are solely the responsibility of the
   authors and do not necessarily represent the official position of CDC.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, US ZIK PREGN INF REG
   Centers for Disease Control and Prevention, 2016 CAS COUNTS US 2
   Centers for Disease Control and Prevention, EXP TEST RISKS
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pacheco O, 2016, N ENGL J MED
   Paz-Bailey G, 2017, N ENGL J MED
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
NR 26
TC 5
Z9 5
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD AUG
PY 2018
VL 132
IS 2
BP 487
EP 495
DI 10.1097/AOG.0000000000002737
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3GB
UT WOS:000442476900035
PM 29995729
DA 2020-07-08
ER

PT J
AU Kao, JC
   HuangFu, WC
   Tsai, TT
   Ho, MR
   Jhan, MK
   Shen, TJ
   Tseng, PC
   Wang, YT
   Lin, CF
AF Kao, Jo-Chi
   HuangFu, Wei-Chun
   Tsai, Tsung-Ting
   Ho, Min-Ru
   Jhan, Ming-Kai
   Shen, Ting-Jing
   Tseng, Po-Chun
   Wang, Yung-Ting
   Lin, Chiou-Feng
TI The antiparasitic drug niclosamide inhibits dengue virus infection by
   interfering with endosomal acidification independent of mTOR
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; NS2B/NS3 PROTEASE; REPLICATION; IDENTIFICATION; PATHWAY;
   COMPLEX; RAPTOR; ENTRY
AB Background
   The antiparasitic agent niclosamide has been demonstrated to inhibit the arthropod-borne Zika virus. Here, we investigated the antiviral capacity of niclosamide against dengue virus (DENV) serotype 2 infection in vitro and in vivo.
   Principle finding
   Niclosamide effectively retarded DENV-induced infection in vitro in human adenocarcinoma cells (A549), mouse neuroblastoma cells (Neuro-2a), and baby hamster kidney fibroblasts (BHK-21). Treatment with niclosamide did not retard the endocytosis of DENV while niclosamide was unable to enhance the antiviral type I interferon response. Furthermore, niclosamide did not cause a direct effect on viral replicon-based expression. Niclosamide has been reported to competitively inhibit the mTOR (mammalian target of rapamycin), STAT3 (signal transducer and activator of transcription 3), and NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathways; however, selective inhibitors of those pathways did not reduce DENV infection. Similar to the vacuolar-type H+-ATPase inhibitor bafilomycin A1, both niclosamide and other protonophores, such as CCCP (carbonyl cyanide m-chlorophenyl hydrazone), and FCCP (carbonyl cyanide-p-trifluoromethoxyphenylhydrazone), effectively reduced endosomal acidification and viral dsRNA replication. Co-administration of a single dose of niclosamide partially decreased viral replication, viral encephalitis, and mortality in DENV-infected ICR suckling mice.
   Significance
   These results demonstrate that niclosamide diminishes viral infection by hindering endosomal acidification.
C1 [Kao, Jo-Chi; Tsai, Tsung-Ting; Ho, Min-Ru; Jhan, Ming-Kai; Shen, Ting-Jing; Tseng, Po-Chun; Wang, Yung-Ting; Lin, Chiou-Feng] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan.
   [Kao, Jo-Chi; Tsai, Tsung-Ting; Ho, Min-Ru; Jhan, Ming-Kai; Shen, Ting-Jing; Tseng, Po-Chun; Wang, Yung-Ting; Lin, Chiou-Feng] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.
   [HuangFu, Wei-Chun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Mol Biol & Drug Discovery, Taipei, Taiwan.
   [HuangFu, Wei-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.
RP Lin, CF (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan.; Lin, CF (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.
EM cflin2014@tmu.edu.tw
OI Shen, Ting-Jing/0000-0002-1714-0048
FU Ministry of Science and TechnologyMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)
   [MOST102-2628-B-038-011-MY3, 105-2321-B-038-002, 106-2321-B-038-002,
   107-2321-B-038-001]; Taipei, Taiwan [106TMU-CIT-01-2]
FX This study was supported by grants from the Ministry of Science and
   Technology (MOST102-2628-B-038-011-MY3, 105-2321-B-038-002,
   106-2321-B-038-002, and 107-2321-B-038-001) and the intramural funding
   106TMU-CIT-01-2, Taipei, Taiwan. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001
   Diehl N, 2013, VIRUSES-BASEL, V5, P3192, DOI 10.3390/v5123192
   Duan XQ, 2008, BIOCHEM BIOPH RES CO, V373, P319, DOI 10.1016/j.bbrc.2008.06.041
   Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Ho MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07023-z
   Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107
   Huang L, 2017, ANTIVIR RES, V138, P68, DOI 10.1016/j.antiviral.2016.12.002
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kato F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050122
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lin KH, 2017, J VIROL, V91, DOI 10.1128/JVI.00045-17
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x
   Rogers DM, 2015, BBA-BIOMEMBRANES, V1848, P1041, DOI 10.1016/j.bbamem.2014.12.018
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yacoub S, 2016, F1000RES, V5, DOI [10.1038/cr.2017.88, DOI 10.1038/CR.2017.88]
   Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13
   Zhang S, 2011, JOVE-J VIS EXP, DOI 10.3791/3168
NR 35
TC 11
Z9 11
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2018
VL 12
IS 8
AR e0006715
DI 10.1371/journal.pntd.0006715
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GS2LP
UT WOS:000443381000048
PM 30125275
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tesla, B
   Demakovsky, LR
   Packiam, HS
   Mordecai, EA
   Rodriguez, AD
   Bonds, MH
   Brindley, MA
   Murdock, CC
AF Tesla, Blanka
   Demakovsky, Leah R.
   Packiam, Hannah S.
   Mordecai, Erin A.
   Rodriguez, Americo D.
   Bonds, Matthew H.
   Brindley, Melinda A.
   Murdock, Courtney C.
TI Estimating the effects of variation in viremia on mosquito
   susceptibility, infectiousness, and R-0 of Zika in Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HERD-IMMUNITY; VIRUS; TRANSMISSION; IMMUNIZATION; COMPETENCE; MORTALITY;
   BARRIERS; SURVIVAL; IMPACT; BLOOD
AB Zika virus (ZIKV) is an arbovirus primarily transmitted by Aedes mosquitoes. Like most viral infections, ZIKV viremia varies over several orders of magnitude, with unknown consequences for transmission. To determine the effect of viral concentration on ZIKV transmission risk, we exposed field-derived Ae. aegypti mosquitoes to four doses (10(3), 10(4), 10(5), 10(6) PFU/mL) representative of potential variation in the field. We demonstrate that increasing ZIKV dose in the blood-meal significantly increases the probability of mosquitoes becoming infected, and consequently disseminating virus and becoming infectious. Additionally, we observed significant interactions between dose and days post-infection on dissemination and overall transmission efficiency, suggesting that variation in ZIKV dose affects the rates of midgut escape and salivary gland invasion. We did not find significant effects of dose on mosquito mortality. We also demonstrate that detecting virus using RT-qPCR approaches rather than plaque assays potentially over-estimates key transmission parameters, including the time at which mosquitoes become infectious and viral burden. Finally, using these data to parameterize an R-0 model, we showed that increasing viremia from 10(4) to 10(6) PFU/mL increased relative R-0 3.8-fold, demonstrating that variation in viremia substantially affects transmission risk.
C1 [Tesla, Blanka; Demakovsky, Leah R.; Packiam, Hannah S.; Brindley, Melinda A.; Murdock, Courtney C.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
   [Tesla, Blanka; Murdock, Courtney C.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.
   [Mordecai, Erin A.] Stanford Univ, Biol Dept, Stanford, CA 94305 USA.
   [Rodriguez, Americo D.] El Inst Nacl Salud Publ, Ctr Reg Invest & Salud Publ, Tapachula, Chiapas, Mexico.
   [Bonds, Matthew H.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.
   [Brindley, Melinda A.] Univ Georgia, Dept Populat Hlth, Athens, GA 30602 USA.
   [Brindley, Melinda A.; Murdock, Courtney C.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA USA.
   [Murdock, Courtney C.] Univ Georgia, River Basin Ctr, Athens, GA 30602 USA.
RP Tesla, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.; Tesla, B (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.
EM btesla@uga.edu
OI Mordecai, Erin/0000-0002-4402-5547
FU National Science Foundation, Grants for Rapid Response Research
   (NSF-RAPID) [1640780]; National Science Foundation, Division of
   Environmental BiologyNational Science Foundation (NSF) [1518681];
   Stanford University Woods Institute for the Environment Environmental
   Ventures Program
FX This study was supported by the National Science Foundation, Grants for
   Rapid Response Research (NSF-RAPID), award #1640780
   (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1640780) (CCM, MHB,
   EAM, MAB). EAM was supported by National Science Foundation, Division of
   Environmental Biology, award #1518681
   (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1518681&HistoricalAwar
   ds=false) and the Stanford University Woods Institute for the
   Environment Environmental Ventures Program. Any opinions, findings, and
   conclusions or recommendations expressed in this material are those of
   the author(s) and do not necessarily reflect the views of the National
   Science Foundation. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ANDERSON RM, 1992, VACCINE, V10, P928, DOI 10.1016/0264-410X(92)90327-G
   ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A
   ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0
   BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2017, ZIK SYMPT
   Centres for Disease Control and Prevention, 2017, WORLD MAP AR RISK ZI
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2016, ENVIRON HEALTH INSIG, V10, P119, DOI [10.4137/EHI.S38345, 10.4137/ehi.s38345]
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Da DF, 2015, EXP PARASITOL, V149, P74, DOI 10.1016/j.exppara.2014.12.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   GARRETTJ.C, 1964, B WORLD HEALTH ORGAN, V31, P71
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Jackson CH, 2016, J STAT SOFTW, V70, P1, DOI 10.18637/jss.v070.i08
   KRAMER LD, 1981, AM J TROP MED HYG, V30, P190, DOI 10.4269/ajtmh.1981.30.190
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Murdock CC, 2017, CURR OPIN INSECT SCI, V20, P28, DOI 10.1016/j.cois.2017.03.001
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nedelman J., 1990, ADV DIS VECTOR RES, P59
   Pakpour N, 2013, MICROBES INFECT, V15, P243, DOI 10.1016/j.micinf.2013.01.003
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   R Core Team, 2017, R LANG ENV STAT COMP
   Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shapiro LLM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0298
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Therneau T. M., 2015, COXME MIXED EFFECTS
   Vaidyanathan R, 2008, VECTOR-BORNE ZOONOT, V8, P727, DOI 10.1089/vbz.2007.0189
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078
NR 54
TC 9
Z9 9
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2018
VL 12
IS 8
AR e0006733
DI 10.1371/journal.pntd.0006733
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GS2LP
UT WOS:000443381000055
PM 30133450
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sookaromdee, P
   Wiwanitkit, V
AF Sookaromdee, Pathum
   Wiwanitkit, Viroj
TI Abortion and Zika Virus Congenital Infection
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
C1 [Sookaromdee, Pathum] TWS Med Ctr, Med Ctr, Bangkok 10130, Thailand.
   [Wiwanitkit, Viroj] DY Patil Univ, Dept Community Med, Fac Med, Pune, Maharashtra, India.
RP Sookaromdee, P (corresponding author), TWS Med Ctr, Med Ctr, Bangkok 10130, Thailand.
EM pathumsook@gmail.com
CR Mota VMR, 2018, REV BRAS GINECOL OBS, V40, P417, DOI 10.1055/s-0038-1648219
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 3
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD AUG
PY 2018
VL 40
IS 8
BP 497
EP 497
DI 10.1055/s-0038-1668531
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR5GJ
UT WOS:000442655200011
PM 30142669
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mota, VM
   Delfino, AD
   Lopes, TECF
   Pessoa, ALS
   Ribeiro, EM
   Cavalcanti, LPD
AF Ribeiro Mota, Vivian Maria
   Delfino, Alanna dos Santos
   Costa Figueiredo Lopes, Thayse Elaine
   Santos Pessoa, Andre Luiz
   Ribeiro, Erlane Marques
   de Goes Cavalcanti, Luciano Pamplona
TI Answer - Abortion and Zika Virus Congenital Infection
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
ID MISCARRIAGE
C1 [Ribeiro Mota, Vivian Maria] Univ Fortaleza, Rua Vasco de Ataide 895, Fortaleza, CE, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Fortaleza, CE, Brazil.
   [Delfino, Alanna dos Santos] Univ Estadual Ceara, Fortaleza, CE, Brazil.
   [Costa Figueiredo Lopes, Thayse Elaine; Ribeiro, Erlane Marques] Ctr Univ Christus, Fac Med, Fortaleza, CE, Brazil.
   [Santos Pessoa, Andre Luiz] Hosp Infantil Albert Sabin, Fortaleza, CE, Brazil.
RP Mota, VM (corresponding author), Univ Fortaleza, Rua Vasco de Ataide 895, Fortaleza, CE, Brazil.
EM vivianmariaribeiromota@gmail.com
RI Cavalcanti, Luciano/N-4391-2015
OI Cavalcanti, Luciano/0000-0002-3440-1182
CR Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Mota VMR, 2018, REV BRAS GINECOL OBS, V40, P417, DOI 10.1055/s-0038-1648219
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 5
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD AUG
PY 2018
VL 40
IS 8
BP 498
EP 498
DI 10.1055/s-0038-1668532
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR5GJ
UT WOS:000442655200012
PM 30142670
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rossi, G
   Karki, S
   Smith, RL
   Brown, WM
   Ruiz, MO
AF Rossi, Gianluigi
   Karki, Surendra
   Smith, Rebecca Lee
   Brown, William Marshall
   Ruiz, Marilyn O'Hara
TI The spread of mosquito-borne viruses in modern times: A spatio-temporal
   analysis of dengue and chikungunya
SO SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY
LA English
DT Article
DE Vector-borne diseases; Dengue virus; Chikungunya virus; Indian Ocean;
   Boosted regression trees
ID EMERGING INFECTIOUS-DISEASES; HEMORRHAGIC-FEVER; ZIKA VIRUS; EMERGENCE;
   ALBOPICTUS; HISTORY; TRANSMISSION; PROSPECTS; EPIDEMIC; OUTBREAK
AB Since the 1970s, mosquito-borne pathogens have spread to previously disease-free areas, as well as causing increased illness in endemic areas. In particular, dengue and chikungunya viruses, transmitted primarily by Aedes aegypti and secondarily by Aedes albopictus mosquitoes, represent a threat for up to a third of the world population, and are a growing public health concern.
   In this study, we assess the spatial and temporal factors related to the occurrences of historic dengue and chikungunya outbreaks in 76 nations focused geographically on the Indian Ocean, with outbreak data from 1959 to 2009. First, we describe the historical spatial and temporal patterns of outbreaks of dengue and chikungunya in the focal nations. Second, we use a boosted regression tree approach to assess the statistical relationships of nations' concurrent outbreak occurrences and annual occurrences with their spatial proximity to prior infections and climatic and socio-economic characteristics.
   We demonstrate that higher population density and shorter distances among nations with outbreaks are the dominant factors that characterize both dengue and chikungunya outbreaks. In conclusion, our analysis provides crucial insights, which can be applied to improve nations' surveillance and preparedness for future vector-borne disease epidemics. (c) 2018 Elsevier Ltd. All rights reserved.
C1 [Rossi, Gianluigi; Karki, Surendra; Smith, Rebecca Lee; Brown, William Marshall; Ruiz, Marilyn O'Hara] Univ Illinois, Coll Vet Med, Dept Pathobiol, 2001 S Lincoln Ave, Urbana, IL 61802 USA.
   [Rossi, Gianluigi] Univ Edinburgh, Royal Dick Sch Vet Med, Easter Bush Campus, Roslin EH25 9RG, Midlothian, Scotland.
RP Rossi, G (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, 2001 S Lincoln Ave, Urbana, IL 61802 USA.; Rossi, G (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Med, Easter Bush Campus, Roslin EH25 9RG, Midlothian, Scotland.
EM g.rossi@ed.ac.uk
OI Rossi, Gianluigi/0000-0002-6540-8467; Smith, Rebecca/0000-0002-8343-794X
CR Abel GJ, 2014, SCIENCE, V343, P1520, DOI 10.1126/science.1248676
   Abel GJ, 2013, DEMOGR RES, V28, P505, DOI 10.4054/DemRes.2013.28.18
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Esposito DLA, 2016, REV SOC BRAS MED TRO, V49, P535, DOI 10.1590/0037-8682-0428-2016
   Amraoui F, 2016, CURR OPIN VIROL, V21, P146, DOI 10.1016/j.coviro.2016.09.014
   Ashby J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9040328
   Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brown EBE, 2012, VECTOR-BORNE ZOONOT, V12, P310, DOI 10.1089/vbz.2010.0176
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Conley AK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-289
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/NCLIMATE2941, 10.1038/nclimate2941]
   Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gurugama Padmalal, 2010, Indian J Dermatol, V55, P68, DOI 10.4103/0019-5154.60357
   HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1
   Higgs S, 2006, VECTOR-BORNE ZOONOT, V6, P115, DOI 10.1089/vbz.2006.6.115
   Hijmans R.J., 2017, DISMO SPECIES DISTRI
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   Mayer T., 2011, 201125 CEPII, DOI [10.2139/ssrn.1994531, DOI 10.2139/SSRN.1994531]
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Moncayo AC, 2004, EMERG INFECT DIS, V10, P1790, DOI 10.3201/eid1010.030846
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL, V54, P251, DOI 10.1093/jme/tjw212
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   R Core Team, 2017, R LANG ENV STAT COMP
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Ruberto I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003511
   SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1
   Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wood CL, 2017, PHILOT ROYAL SOC B, V372
   World Health Organization, 2017, DENG SEV DENG FACT S
NR 56
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1877-5845
EI 1877-5853
J9 SPAT SPATIO-TEMPORAL
JI Spat. Spatio-Temporal Epidemiol.
PD AUG
PY 2018
VL 26
BP 113
EP 125
DI 10.1016/j.sste.2018.06.002
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GZ0AG
UT WOS:000449016400007
PM 30390927
DA 2020-07-08
ER

PT J
AU de Oliveira, EF
   Oliveira, RAS
   Ferreira, DRA
   Laroque, PO
   Pena, LJ
   Valenca-Montenegro, MM
   Mota, RA
   Gil, LHVG
AF de Oliveira-Filho, E. F.
   Oliveira, R. A. S.
   Ferreira, D. R. A.
   Laroque, P. O.
   Pena, L. J.
   Valenca-Montenegro, M. M.
   Mota, R. A.
   Gil, L. H. V. G.
TI Seroprevalence of selected flaviviruses in free-living and captive
   capuchin monkeys in the state of Pernambuco, Brazil
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE flavivirus; Sapajus flavius; Sapajus libidinosus; wild animals; zoonosis
ID YELLOW-FEVER VIRUS; NONHUMAN-PRIMATES; ANTIBODIES; HOWLER
AB Mosquito-borne diseases such as dengue, yellow fever and, more recently, Chikungunya virus (CHIKV) and Zika virus (ZIKV) have a great impact in the public health. In addition, the presence of such viruses might have an impact on wild animal conservation as well as their possible role as animal reservoir. Here, we performed a serological survey searching for antibodies against a panel of flaviviruses [ZIKV, Dengue virus (DENV), Yellow Fever virus (YFV), West Nile virus (WNV), Saint Louis Encephalitis virus (SLEV), Ilheus virus (ILHV) and Rocio virus (ROCV)] using plaque reduction neutralization test (PRNT90) in both free-ranging and captive capuchin monkeys (Sapajus flavius and Sapajus libidinosus). Captive and free-living monkeys were sampled between June 2015 and January 2016 in the state of Pernambuco, including in the border with State of Paraiba, the epicentre of the ZIKV epidemics in Brazil. We have found neutralizing antibodies for ZIKV, DENV-1, DENV-2, DENV-3, DENV-4, YFV, ILHV and SLEV in both S.flavius and S.libidinosus samples. No positives samples were found for ROCV and WNV. Our results suggest that these flaviviruses might be circulating in capuchin monkey in the studied region. The possible presence of these viruses represents a risk for public health, as well as for animal conservation, especially for S.flavius which is a critically endangered species, facing high risk of extinction.
C1 [de Oliveira-Filho, E. F.; Oliveira, R. A. S.; Pena, L. J.; Gil, L. H. V. G.] IAM Fiocruz, Dept Virol, Recife, PE, Brazil.
   [Ferreira, D. R. A.; Mota, R. A.] Fed Rural Univ Pernambuco UFRPE, Dept Vet Med, Recife, PE, Brazil.
   [Laroque, P. O.; Valenca-Montenegro, M. M.] Natl Ctr Res & Conservat Brazilian Primates, Inst Chico Mendes Conservacao Biodiversidade ICMB, Joao Pessoa, Paraiba, Brazil.
RP de Oliveira, EF (corresponding author), IAM Fiocruz, Dept Virol, Recife, PE, Brazil.
EM edmilsonz@gmail.com
RI Oliveira-Filho, Edmilson F/A-6305-2012; Oliveira, Renato/AAN-9394-2020;
   Oliveira, Renato/AAN-9879-2020
OI Oliveira-Filho, Edmilson F/0000-0002-3771-1565; Oliveira,
   Renato/0000-0002-4044-0794; Ferreira, Debora/0000-0001-5744-2473
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [DCR-0003-5.05/16, DCR-0032-05.05/12]; Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco [APQ-1380-5.05/15, APQ-2112-5.05/12]
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Grant/Award Number: DCR-0003-5.05/16, DCR-0032-05.05/12; Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco, Grant/Award
   Number: APQ-1380-5.05/15, APQ-2112-5.05/12
CR Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   de Thoisy B, 2001, AM J PRIMATOL, V54, P1, DOI 10.1002/ajp.1008
   de Thoisy B, 2004, T ROY SOC TROP MED H, V98, P409, DOI 10.1016/j.trstmh.2003.12.003
   Favoretto S., 2016, BIORXIV PREPRINT SER
   Ferreira DRA, 2015, AM J PRIMATOL, V77, P558, DOI 10.1002/ajp.22377
   Fialho Marcos de Souza, 2014, Neotropical Primates, V21, P214
   Gan VCH, 2014, ISBT SCI SER, V9, P262, DOI 10.1111/voxs.12083
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Laroque PO, 2014, PESQUI VET BRASIL, V34, P462, DOI 10.1590/S0100-736X2014000500013
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Martins A. B., 2016, M INT PRIM SOC AM SO
   Morales MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005351
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Tranquilin MV, 2013, REV SOC BRAS MED TRO, V46, P522, DOI 10.1590/0037-8682-0106-2013
   Vasilakis N, 2007, J VIROL, V81, P9591, DOI 10.1128/JVI.02776-06
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
NR 17
TC 6
Z9 6
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD AUG
PY 2018
VL 65
IS 4
BP 1094
EP 1097
DI 10.1111/tbed.12829
PG 4
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA GM0SK
UT WOS:000437765800021
PM 29424106
DA 2020-07-08
ER

PT J
AU Mani, S
   Tan, CW
   Wang, LF
   Anderson, DE
AF Mani, Shailendra
   Tan, Chee Wah
   Wang, Lin-Fa
   Anderson, Danielle E.
TI Serological Cross Reactivity between Zika and Dengue Viruses in
   Experimentally Infected Monkeys
SO VIROLOGICA SINICA
LA English
DT Letter
ID NEUTRALIZING ANTIBODIES; ENHANCEMENT; ASSAY
C1 [Mani, Shailendra; Tan, Chee Wah; Wang, Lin-Fa; Anderson, Danielle E.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
RP Wang, LF; Anderson, DE (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
EM linfa.wang@duke-nus.edu.sg; danielle.anderson@duke-nus.edu.sg
OI Anderson, Danielle/0000-0003-4791-5024; Mani,
   Shailendra/0000-0001-8541-8315
FU NMRC [ZRRF16006]; CD-PHRG [CDPHRG/0006/2014]
FX We thank Edgar Macabe Pena and his team, especially Ryan Cabo Maniquiz
   and Redmond Belen Cheng, for assistance with monkey infection studies.
   We thank Veronika von Messling for providing expertise and assistance in
   planning of the animal studies, and Eng Eong Ooi and his lab members,
   especially Eugenia Ong and Esther Gan, for providing DENV2 viruses. The
   project was funded in part by NMRC Grant ZRRF16006 and CD-PHRG Grant
   CDPHRG/0006/2014.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Jelsma T, 2017, J VIROL METHODS, V247, P114, DOI 10.1016/j.jviromet.2017.05.008
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Xu GJ, 2015, SCIENCE, V348, DOI 10.1126/science.aaa0698
NR 13
TC 0
Z9 0
U1 1
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD AUG
PY 2018
VL 33
IS 4
BP 378
EP 381
DI 10.1007/s12250-018-0048-8
PG 4
WC Virology
SC Virology
GA GS8YK
UT WOS:000444001200010
PM 30155852
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Weger-Lucarelli, J
   Garcia, SM
   Ruckert, C
   Byas, A
   O'Connor, SL
   Aliota, MT
   Friedrich, TC
   O'Connor, DH
   Ebel, GD
AF Weger-Lucarelli, James
   Garcia, Selene M.
   Ruckert, Claudia
   Byas, Alex
   O'Connor, Shelby L.
   Aliota, Matthew T.
   Friedrich, Thomas C.
   O'Connor, David H.
   Ebel, Gregory D.
TI Using barcoded Zika virus to assess virus population structure in vitro
   and in Aedes aegypti mosquitoes
SO VIROLOGY
LA English
DT Article
DE Zika virus; Flavivirus; Arbovirus; Virus evolution; Mosquito-borne virus
ID VERTICAL TRANSMISSION; ARBOVIRUS INFECTION; VECTOR COMPETENCE; CAPSID
   PROTEIN; SINDBIS-VIRUS; RNA-SYNTHESIS; HOST; REPLICATION; MICRONESIA;
   EVOLUTION
AB Arboviruses such as Zika virus (ZIKV, Flaviviridae; Flavivirus) must replicate in both mammalian and insect hosts possessing strong immune defenses. Accordingly, transmission between and replication within hosts involves genetic bottlenecks, during which viral population size and genetic diversity may be significantly reduced. To help quantify these bottlenecks and their effects, we constructed 4 "barcoded" ZIKV populations that theoretically contain thousands of barcodes each. After identifying the most diverse barcoded virus, we passaged this virus 3 times in 2 mammalian and mosquito cell lines and characterized the population using deep sequencing of the barcoded region of the genome. C6/36 maintain higher barcode diversity, even after 3 passages, than Vero. Additionally, field-caught mosquitoes exposed to the virus to assess bottlenecks in a natural host. A progressive reduction in barcode diversity occurred throughout systemic infection of these mosquitoes. Differences in bottlenecks during systemic spread were observed between different populations of Aedes aegypti.
C1 [Weger-Lucarelli, James; Garcia, Selene M.; Ruckert, Claudia; Byas, Alex; Ebel, Gregory D.] Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Aliota, Matthew T.; Friedrich, Thomas C.] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI USA.
   [O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
   [Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Weger-Lucarelli, James] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
RP Weger-Lucarelli, J; Ebel, GD (corresponding author), Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Weger-Lucarelli, J (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
EM weger@vt.edu; gregory.ebel@colostate.edu
OI Byas, Alexandria/0000-0002-0762-7389; Aliota,
   Matthew/0000-0002-6902-9149; Garcia-Luna, Selene M./0000-0001-8420-5078;
   Ruckert, Claudia/0000-0003-3732-6752; Weger-Lucarelli,
   James/0000-0002-9483-1694
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI067380, R01 AI132563, R01 AI125392,
   R56 AI132563, R21 AI125996, R21 AI131454]; NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [P51 OD011106]
CR Akiyama B. M., 2016, CRYSTAL STRUCTURE EX, DOI [10.2210/pdb5tpy/pdb, DOI 10.2210/PDB5TPY/PDB]
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Fennessey CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006359
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005
   Grubaugh ND, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew033
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Jerzak GVS, 2008, VIROLOGY, V374, P256, DOI 10.1016/j.virol.2008.02.032
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lauring AS, 2011, J VIROL, V85, P3780, DOI 10.1128/JVI.02217-10
   Linger BR, 2004, RNA, V10, P128, DOI 10.1261/rna.5127104
   Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560
   Lulla V, 2013, J VIROL, V87, P12003, DOI 10.1128/JVI.01960-13
   Miner JJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3438
   Monsion B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000174
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105
   Paterson A, 2005, VIROLOGY, V337, P253, DOI 10.1016/j.virol.2005.04.037
   Pfeiffer JK, 2006, P NATL ACAD SCI USA, V103, P5520, DOI 10.1073/pnas.0600834103
   Rand K., 1996, TECH TIPS ONLINE, V1, P23
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Stoltz M, 2010, J VIROL, V84, P9140, DOI 10.1128/JVI.00717-10
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wright S, 1931, GENETICS, V16, P0097
   You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
NR 50
TC 6
Z9 6
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD AUG
PY 2018
VL 521
BP 138
EP 148
DI 10.1016/j.virol.2018.06.004
PG 11
WC Virology
SC Virology
GA GO4EV
UT WOS:000439956400015
PM 29935423
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Lebov, JF
   Brown, LM
   MacDonald, PDM
   Robertson, K
   Bowman, NM
   Hooper, SR
   Becker-Dreps, S
AF Lebov, Jill F.
   Brown, Linda M.
   MacDonald, Pia D. M.
   Robertson, Kevin
   Bowman, Natalie M.
   Hooper, Stephen R.
   Becker-Dreps, Sylvia
TI Evidence of Neurological Sequelae in Children With Acquired Zika Virus
   Infection
SO PEDIATRIC NEUROLOGY
LA English
DT Review
DE Zika virus infection; Neurological sequelae; Malformations of cortical
   development; Child development; Flavivirus infections
ID GUILLAIN-BARRE-SYNDROME; PUERTO-RICO; ENCEPHALITIS; PERSISTENCE;
   DISEASE; BRAIN; MYELITIS; OUTBREAK; BIRTH
AB Limited information is available on health outcomes related to Zika virus infection acquired during childhood. Zika virus can cause severe central nervous system malformations in congenitally exposed fetuses and neonates. In vitro studies show the capacity of Zika virus to infect neural progenitor cells, induce central and peripheral neuronal cell deaths, and target different brain cells over the course of brain development. Studies of postnatally infected mice and nonhuman primates have detected degradation of neural cells and morphologic brain cell changes consistent with a broad neuroinflammatory response. In addition, case reports of central nervous system disease in adults and in adolescents secondary to Zika virus infection suggest that Zika virus may have a broader impact on neurological health beyond that observed in congenitally exposed newborns. Long-term neurological complications have been observed with other acquired flaviviral infections, with clinical symptoms manifesting for years after primary infection. The extent to which postnatal Zika virus infection in humans negatively affects the central and peripheral nervous systems and causes long-term neurological damage or cognitive effects is currently unknown. To better understand the potential for neurological sequelae associated with acquired Zika virus infection in children, we reviewed the biological, clinical, and epidemiologic literature and summarized the evidence for this link. First, we review biological mechanisms for neurological manifestations of Zika virus infection in experimental studies. Second, we review observational studies of congenital Zika virus infection and case studies and surveillance reports of neurological sequelae of Zika virus infection in adults and in children. Lastly, we discuss the challenges of conducting Zika virus-neurological sequoia studies and future directions for pediatric Zika virus research. (C) 2018 Published by Elsevier Inc.
C1 [Lebov, Jill F.] RTI Int, Ctr Appl Publ Hlth Res, Durham, NC 27709 USA.
   [Brown, Linda M.] RTI Int, Ctr Appl Publ Hlth Res, Rockville, MD USA.
   [MacDonald, Pia D. M.] RTI Int, Ctr Appl Publ Hlth Res, Berkeley, CA USA.
   [Robertson, Kevin] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA.
   [Bowman, Natalie M.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC 27515 USA.
   [Hooper, Stephen R.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27515 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Sch Med, Dept Family Med, Chapel Hill, NC 27515 USA.
RP Lebov, JF (corresponding author), RTI Int, Ctr Appl Publ Hlth Res, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Hooper, Stephen/X-8171-2019
FU RTI International
FX This work was supported by the Fellows Program of RTI International.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardosa Mary Jane, 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P272
   Carossino M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2852-4
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gonzalez-Perez Oscar, 2012, Biol Biomed Rep, V2, P59
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pardigon N, 2017, TRANSFUS CLIN BIOL, V24, P96, DOI 10.1016/j.tracli.2017.05.005
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   POGODINA VV, 1983, ARCH VIROL, V75, P71, DOI 10.1007/BF01314128
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   RAVI V, 1993, J MED VIROL, V40, P326, DOI 10.1002/jmv.1890400412
   Read JSRA, 2016, 2017 ANN M PED AC SO
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
NR 61
TC 3
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD AUG
PY 2018
VL 85
BP 16
EP 20
DI 10.1016/j.pediatrneurol.2018.03.001
PG 5
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA GZ5HK
UT WOS:000449449600004
PM 30343688
DA 2020-07-08
ER

PT J
AU Richner, JM
   Diamond, MS
AF Richner, Justin M.
   Diamond, Michael S.
TI Zika virus vaccines: immune response, current status, and future
   challenges
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID ANTIBODY-DEPENDENT ENHANCEMENT; CROSS-REACTIVITY; DENGUE VIRUS;
   INFECTION; PROTECTION; VACCINATION; EMERGENCE; PROSPECTS; DISEASE;
   RHESUS
AB Zika virus (ZIKV) is the most recent mosquito-transmitted virus to cause a global health crisis following its entrance into a naive population in the Western Hemisphere. Once the ZIKV outbreak began investigators rapidly established small and large animal models of pathogenesis, developed a number candidate vaccines using different platforms, and defined mechanisms of protection. In this review, we characterize the adaptive immune response elicited by ZIKV infections and vaccines, the status of ongoing clinical trials in humans, and discuss future challenges within the field.
C1 [Richner, Justin M.] IIT Res Inst, Dept Microbiol & Mol Biol, Chicago, IL 60616 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Richner,
   Justin/0000-0002-5344-118X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI127828, R01
   HD091218]
FX This work was supported by grants from the NIH (R01 AI073755, R01
   AI127828, and R01 HD091218).
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309
   [Anonymous], 2015, ZIK CAS CONG SYNDR A
   [Anonymous], 2017, ZIK EP UPD 25 AUG 20
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   GEORGE J, 2017, SCI REP, V7, DOI DOI 10.1038/S41598-017-10901-1.
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2018, HUM VACC IMMUNOTHER, DOI [10.1080/21645515.2018.1445448.0, DOI 10.1080/21645515.2018.1445448.0]
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kollaritsch H, 2012, EXPERT REV VACCINES, V11, P1103, DOI [10.1586/erv.12.86, 10.1586/ERV.12.86]
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 63
TC 21
Z9 22
U1 0
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
EI 1879-0372
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD AUG
PY 2018
VL 53
BP 130
EP 136
DI 10.1016/j.coi.2018.04.024
PG 7
WC Immunology
SC Immunology
GA GX9CR
UT WOS:000448096600021
PM 29753210
OA Green Accepted
DA 2020-07-08
ER

PT J
AU McQuade, L
   Rao, M
   Miller, R
   Zhou, WN
   Deol, R
   Sato, B
AF McQuade, Linda
   Rao, Mya
   Miller, Roger
   Zhou, Winnie
   Deol, Rinku
   Sato, Brian
TI Understanding Patterns of Socioeconomic and Demographic Factors Along
   With Health Services Provider Availability for Zika Outbreak in South
   Florida
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE Zika; Miami; Zika health services; provider availability; PCSA
AB In this study, we analyzed the patterns of socioeconomic and demographic factors along with health services provider availability for the current Zika outbreak in Miami-Dade County, South Florida. We used Center for Consumer Information & Insurance Oversight (CCIIO) Machine-Readable Public Use Files (MR-PUFs) to examine provider availability in combination with socioeconomic and demographic factors that could potentially lead to healthcare disparities between any underserved population of the Wynwood neighborhood and the broader population of Miami-Dade County. MR-PUFs contain public provider-level data from states that are participating in the Federally Facilitated Marketplace. According to CCIIO, an issuer of a Qualified Health Plan that uses a provider network must maintain a network that is sufficient in the number and types of providers, including providers that specialize in mental-health and substance-use disorder services, to assure that all services will be accessible to enrollees without unreasonable delay. (Disaster Med Public Health Preparedness. 2018;12:455-459)
C1 [McQuade, Linda; Rao, Mya; Miller, Roger; Zhou, Winnie; Deol, Rinku; Sato, Brian] Logist Management Inst, Hlth Div, 7940 Jones Branch Dr, Tysons, VA 22102 USA.
RP McQuade, L (corresponding author), Logist Management Inst, Hlth Div, 7940 Jones Branch Dr, Tysons, VA 22102 USA.
EM Lindaguo10@gmail.com
CR [Anonymous], CAS PREGN WOM ZIK AR
   [Anonymous], 2016, QUEST AN SUIT
   Artiga S., 2016, DISPARITIES HLTH HLT
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
NR 4
TC 0
Z9 0
U1 1
U2 2
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD AUG
PY 2018
VL 12
IS 4
BP 455
EP 459
DI 10.1017/dmp.2017.110
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GW3YH
UT WOS:000446845500009
PM 29041992
DA 2020-07-08
ER

PT J
AU Kotsakiozi, P
   Evans, BR
   Gloria-Soria, A
   Kamgang, B
   Mayanja, M
   Lutwama, J
   Le Goff, G
   Ayala, D
   Paupy, C
   Badolo, A
   Pinto, J
   Sousa, CA
   Troco, AD
   Powell, JR
AF Kotsakiozi, Panayiota
   Evans, Benjamin R.
   Gloria-Soria, Andrea
   Kamgang, Basile
   Mayanja, Martin
   Lutwama, Julius
   Le Goff, Gilbert
   Ayala, Diego
   Paupy, Christophe
   Badolo, Athanase
   Pinto, Joao
   Sousa, Carla A.
   Troco, Arlete D.
   Powell, Jeffrey R.
TI Population structure of a vector of human diseases: Aedes aegypti in its
   ancestral range, Africa
SO ECOLOGY AND EVOLUTION
LA English
DT Article
DE Aedes aegypti; Africa; genetics; migration; population structure;
   SNP-chip
ID YELLOW-FEVER VIRUS; R-PACKAGE; MOSQUITO; DENGUE; PHYLOGEOGRAPHY;
   COMPETENCE; CULICIDAE; EVOLUTION; GENETICS; GENOMICS
AB Aedes aegypti, the major vector of dengue, yellow fever, chikungunya, and Zika viruses, remains of great medical and public health concern. There is little doubt that the ancestral home of the species is Africa. This mosquito invaded the New World 400-500years ago and later, Asia. However, little is known about the genetic structure and history of Ae.aegypti across Africa, as well as the possible origin(s) of the New World invasion. Here, we use similar to 17,000 genome-wide single nucleotide polymorphisms (SNPs) to characterize a heretofore undocumented complex picture of this mosquito across its ancestral range in Africa. We find signatures of human-assisted migrations, connectivity across long distances in sylvan populations, and of local admixture between domestic and sylvan populations. Finally, through a phylogenetic analysis combined with the genetic structure analyses, we suggest West Africa and especially Angola as the source of the New World's invasion, a scenario that fits well with the historic record of 16th-century slave trade between Africa and Americas.
C1 [Kotsakiozi, Panayiota; Evans, Benjamin R.; Gloria-Soria, Andrea; Powell, Jeffrey R.] Yale Univ, New Haven, CT 06520 USA.
   [Kamgang, Basile] Ctr Res Infect Dis, POB 13591, Yaounde, Cameroon.
   [Mayanja, Martin; Lutwama, Julius] Uganda Virus Res Inst, Entebbe, Uganda.
   [Le Goff, Gilbert; Ayala, Diego; Paupy, Christophe] IRD, MIVEGEC Lab UMR IRD CNRS UM 224 5290, Montpellier, France.
   [Le Goff, Gilbert] IRD La Reunion GIP CYROI, St Clothilde, Reunion, France.
   [Ayala, Diego] CIRMF, Franceville, Gabon.
   [Badolo, Athanase] Univ Ouaga 1 Pr Joseph KI ZERBO, Lab Entomol Fondamentale & Appl, 03 BP 7021, Ouagadougou 03, Burkina Faso.
   [Pinto, Joao; Sousa, Carla A.] Univ Nova Lisboa, IHMT, GHTM, Lisbon, Portugal.
   [Troco, Arlete D.] Minist Saude, Direccao Nacl Saude Publ, Programa Nacl Controle Malaria, Luanda, Angola.
   [Gloria-Soria, Andrea] Connecticut Agr Expt Stn, New Haven, CT 06504 USA.
RP Powell, JR (corresponding author), Yale Univ, New Haven, CT 06520 USA.
EM jeffrey.powell@yale.edu
RI Gloria-Soria, Andrea/AAJ-3304-2020; Ayala, Diego/J-6788-2016; Paupy,
   Christophe/I-4847-2017; Pinto, Joao/C-2208-2012; Sousa,
   Carla/G-6531-2012
OI Gloria-Soria, Andrea/0000-0002-5401-3988; Ayala,
   Diego/0000-0003-4726-580X; Paupy, Christophe/0000-0002-7122-2079; Pinto,
   Joao/0000-0001-8572-7708; Sousa, Carla/0000-0002-2386-7577; Le Goff,
   Gilbert/0000-0001-9913-8736; Kamgang, Basile/0000-0002-8883-4557; Evans,
   Benjamin/0000-0003-2069-4938
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [RO1 AI101112]
FX National Institute of Allergy and Infectious Diseases, Grant/Award
   Number: RO1 AI101112
CR Bennett KL, 2016, MOL ECOL, V25, P4337, DOI 10.1111/mec.13762
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   Bosio CF, 2005, AM J TROP MED HYG, V72, P434, DOI 10.4269/ajtmh.2005.72.434
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   da Silva AG, 2012, EVOL APPL, V5, P664, DOI 10.1111/j.1752-4571.2012.00244.x
   Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   Eltis D., 2010, ATLAS TRANSATLANTIC
   Evans BR, 2015, G3-GENES GENOM GENET, V5, P711, DOI 10.1534/g3.114.016196
   EXCOFFIER L, 1992, GENETICS, V131, P479
   Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382
   Gloria-Soria A, 2018, AM J TROP MED HYG, V98, P445, DOI 10.4269/ajtmh.17-0676
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   HARTBERG W K, 1970, Evolution, V24, P692, DOI 10.1111/j.1558-5646.1970.tb01805.x
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   Luu K, 2017, MOL ECOL RESOUR, V17, P67, DOI 10.1111/1755-0998.12592
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   MCNEILL WH, 1976, PLAGUES PEOPLE
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Nazareno AG, 2017, MOL ECOL RESOUR, V17, P1136, DOI 10.1111/1755-0998.12654
   Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Powell JR, 2016, SCIENCE, V354, P971, DOI 10.1126/science.aal1717
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Puckett EE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1762
   Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   R Core Team, 2018, R LANG ENV STAT COMP
   Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Scarpassa VM, 2008, AM J TROP MED HYG, V78, P895, DOI 10.4269/ajtmh.2008.78.895
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982
   Wang JL, 2017, MOL ECOL RESOUR, V17, P981, DOI 10.1111/1755-0998.12650
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
NR 52
TC 4
Z9 4
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7758
J9 ECOL EVOL
JI Ecol. Evol.
PD AUG
PY 2018
VL 8
IS 16
BP 7835
EP 7848
DI 10.1002/ece3.4278
PG 14
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA GU0NC
UT WOS:000444946300009
PM 30250667
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fujita, R
   Kato, F
   Kobayashi, D
   Murota, K
   Takasaki, T
   Tajima, S
   Lim, CK
   Saijo, M
   Isawa, H
   Sawabe, K
AF Fujita, Ryosuke
   Kato, Fumihiro
   Kobayashi, Daisuke
   Murota, Katsunori
   Takasaki, Tomohiko
   Tajima, Shigeru
   Lim, Chang-Kweng
   Saijo, Masayuki
   Isawa, Haruhiko
   Sawabe, Kyoko
TI Persistent viruses in mosquito cultured cell line suppress
   multiplication of flaviviruses
SO HELIYON
LA English
DT Article
DE Virology; Molecular biology
ID WEST NILE; INFECTION; DENGUE; WOLBACHIA; TRANSMISSION; CHIKUNGUNYA;
   EXPOSURE
AB In the growth kinetics analysis of flaviviruses in Aedes albopictus C6/36 cell lines obtained from the Japanese Collection of Research Bioresources (JCRB) Cell Bank and the European Collection of Authenticated Cell Culture (ECACC), these two cells line showed different viral susceptibility for Zika virus (ZIKV), Dengue virus (DENV), and Japanese encephalitis virus (JEV). Next-generation sequencing (NGS) analysis revealed that the C6/36 JCRB strain was persistently infected with two viruses without showing any cytopathic effects. The complete sequence analysis demonstrated that the one virus was Menghai rhabdovirus (MERV), which has been found from Aedes albopictus mosquito. The other virus was a novel virus, designated as Shinobi tetravirus (SHTV). Interestingly, the viral susceptibility of these two strains was almost even for Sindbis virus and Getah virus. We cloned SHTV and MERV from JCRB C6/36 cell line and then re-infected them into another C6/36 cell line, resulting in the reproduction of persistent infection with each virus. ZIKV growth was suppressed in SHTV and/or MERV re-infected C6/36 cells also. To our knowledge, this is the first demonstration that persistent infection with rhabdovirus and/or permutotetravirus suppressed flavivirus replication in mosquito cells.
C1 [Fujita, Ryosuke; Kobayashi, Daisuke; Murota, Katsunori; Isawa, Haruhiko; Sawabe, Kyoko] Natl Inst Infect Dis, Dept Med Entomol, Tokyo, Japan.
   [Fujita, Ryosuke] Hokkaido Univ, Creat Res Inst, Isotope Imaging Lab, Sapporo, Hokkaido, Japan.
   [Fujita, Ryosuke; Kato, Fumihiro; Murota, Katsunori] Japan Agcy Med Res & Dev, Dept Res Promot, Tokyo, Japan.
   [Kato, Fumihiro; Takasaki, Tomohiko; Tajima, Shigeru; Lim, Chang-Kweng; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
   [Sawabe, Kyoko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.
RP Fujita, R (corresponding author), Natl Inst Infect Dis, Dept Med Entomol, Tokyo, Japan.; Fujita, R (corresponding author), Hokkaido Univ, Creat Res Inst, Isotope Imaging Lab, Sapporo, Hokkaido, Japan.; Fujita, R (corresponding author), Japan Agcy Med Res & Dev, Dept Res Promot, Tokyo, Japan.
EM r-fujita@cris.hokudai.ac.jp
RI Saijo, Masayuki/L-2697-2019
OI Saijo, Masayuki/0000-0001-5458-7298; Shigeru, Tajima/0000-0002-1981-9062
FU Research Program on Emerging and Re-emerging Infectious Diseases from
   Japan Agency for Medical Research and Development, AMEDJapan Agency for
   Medical Research and Development (AMED); JSPS KAKENHIMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [15H04614]
FX This work was supported by the Research Program on Emerging and
   Re-emerging Infectious Diseases from Japan Agency for Medical Research
   and Development, AMED, and JSPS KAKENHI 15H04614.
CR Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   BRACKNEY DE, 2010, PLOS NEGLECTED TROP, V4, P24
   Cholleti H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162751
   Duguma D, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00387-16, 10.1128/msphere.00387-16]
   Fujita R., 2016, ARCH VIROL, V162, P1
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hang J., 2016, GENOME ANNOUNC, V4, P1
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   MCota M.T. de O., 2016, J MICROBIOL, V47, P1
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Pesko K, 2009, VECTOR-BORNE ZOONOT, V9, P281, DOI 10.1089/vbz.2007.0281
   Prasad AN, 2013, VIRUSES-BASEL, V5, P3142, DOI 10.3390/v5123142
   ROZEBOOM LE, 1969, J MED ENTOMOL, V6, P407, DOI 10.1093/jmedent/6.4.407
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Shi CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129845
   Sun Q., 2016, ARCH VIROL
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   Zink SD, 2015, VIRUSES-BASEL, V7, P5619, DOI 10.3390/v7102886
NR 28
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2405-8440
J9 HELIYON
JI Heliyon
PD AUG
PY 2018
VL 4
IS 8
AR e00736
DI 10.1016/j.heliyon.2018.e00736
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS3MC
UT WOS:000443512800038
PM 30167494
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Karna, AK
   Azar, SR
   Plante, JA
   Yun, RM
   Vasilakis, N
   Weaver, SC
   Hansen, IA
   Hanley, KA
AF Karna, Ajit K.
   Azar, Sasha R.
   Plante, Jessica A.
   Yun, Rumei
   Vasilakis, Nikos
   Weaver, Scott C.
   Hansen, Immo A.
   Hanley, Kathryn A.
TI Colonized Sabethes cyaneus, a Sylvatic New World Mosquito Species, Shows
   a Low Vector Competence for Zika Virus Relative to Aedes aegypti
SO VIRUSES-BASEL
LA English
DT Article
DE Sabethes cyaneus; Zika virus; Aedes aegypti; sylvatic cycle; vector
   competence; Americas; spillback
ID YELLOW-FEVER VIRUS; DIPTERA-CULICIDAE; CHIKUNGUNYA VIRUS; DENGUE VIRUS;
   MATO-GROSSO; H-EQUINUS; HAEMAGOGUS; CHLOROPTERUS; INFECTION; STATE
AB The introduction of Zika virus (ZIKV) to the Americas raised concern that the virus would spill back from human transmission, perpetuated by Aedes aegypti, into a sylvatic cycle maintained in wildlife and forest-living mosquitoes. In the Americas, Sabethes species are vectors of sylvatic yellow fever virus (YFV) and are therefore candidate vectors of a sylvatic ZIKV cycle. To test the potential of Sabethes cyaneus to transmit ZIKV, Sa. cyaneus and Ae. aegypti were fed on A129 mice one or two days post-infection (dpi) with a ZIKV isolate from Mexico. Sa. cyaneus were sampled at 3, 4, 5, 7, 14, and 21 days post-feeding (dpf) and Ae. aegypti were sampled at 14 and 21 dpf. ZIKV was quantified in mosquito bodies, legs, and saliva to measure infection, dissemination, and potential transmission, respectively. Of 69 Sa. cyaneus that fed, ZIKV was detected in only one, in all body compartments, at 21 dpf. In contrast, at 14 dpf 100% of 20 Ae. aegypti that fed on mice at 2 dpi were infected and 70% had virus in saliva. These data demonstrate that Sa. cyaneus is a competent vector for ZIKV, albeit much less competent than Ae. aegypti.
C1 [Karna, Ajit K.; Hansen, Immo A.; Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Azar, Sasha R.; Plante, Jessica A.; Yun, Rumei; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Yun, Rumei; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Azar, Sasha R.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
RP Hanley, KA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
EM akarna@nmsu.edu; srazar@utmb.edu; japlante@utmb.edu; ruyun@utmb.edu;
   nivasila@utmb.edu; sweaver@utmb.edu; immoh@nmsu.edu; khanley@nmsu.edu
OI Karna, Ajit/0000-0002-5557-4402
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R15AI113628-01, R24AI120942]; NIH
   ICIDR [1U01AI115577-01]; NSFNational Science Foundation (NSF)
FX This research was funded by NIH 1R15AI113628-01, R24AI120942, and NIH
   ICIDR 1U01AI115577-01; the concept for this study was shaped by the
   NSF-funded Research Coordination Network Infectious Disease Evolution
   Across Scales.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Andrade CC, 2016, J EVOLUTION BIOL, V29, P2205, DOI 10.1111/jeb.12939
   ANTUNES P. C. A., 1937, American Journal of Tropical Medicine, V17, P825
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   BATES M, 1945, AM J TROP MED, V25, P203, DOI 10.4269/ajtmh.1945.s1-25.203
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Camargo-Neves Vera L. F. de, 2005, Cad. Saúde Pública, V21, P1278, DOI 10.1590/S0102-311X2005000400031
   CHADEE DD, 1990, J MED ENTOMOL, V27, P1041, DOI 10.1093/jmedent/27.6.1041
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Christofferson RC, 2016, J INFECT DIS, V214, pS466, DOI 10.1093/infdis/jiw283
   Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Degallier N, 1998, J MED ENTOMOL, V35, P931, DOI 10.1093/jmedent/35.6.931
   DERODANICHE E, 1957, AM J TROP MED HYG, V6, P681, DOI 10.4269/ajtmh.1957.6.681
   DERODANICHE E, 1957, AM J TROP MED HYG, V6, P686, DOI 10.4269/ajtmh.1957.6.686
   DERODANICHE E, 1957, AM J TROP MED HYG, V6, P232, DOI 10.4269/ajtmh.1957.6.232
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   GALINDO P, 1956, AM J TROP MED HYG, V5, P1022, DOI 10.4269/ajtmh.1956.5.1022
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Chaverri LG, 2018, J MED ENTOMOL, V55, P646, DOI 10.1093/jme/tjx254
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hanley Kathryn A., 2008, BMC Ecology, V8, P1, DOI 10.1186/1472-6785-8-1
   LORENZ L, 1984, AM J TROP MED HYG, V33, P690, DOI 10.4269/ajtmh.1984.33.690
   Mangudo C, 2018, B ENTOMOL RES, V108, P203, DOI 10.1017/S0007485317000700
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Mucci LF, 2016, J AM MOSQUITO CONTR, V32, P329, DOI 10.2987/16-6587.1
   Pinto CS, 2009, MEM I OSWALDO CRUZ, V104, P592, DOI 10.1590/S0074-02762009000400010
   RAWLINS SC, 1990, T ROY SOC TROP MED H, V84, P142, DOI 10.1016/0035-9203(90)90411-7
   Ribeiro ALM, 2012, J MED ENTOMOL, V49, P223, DOI 10.1603/ME11039
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva JD, 2010, MEM I OSWALDO CRUZ, V105, P155, DOI 10.1590/S0074-02762010000200008
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Tubaki RM, 2010, NEOTROP ENTOMOL, V39, P664, DOI 10.1590/S1519-566X2010000400030
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasconcelos PFC, 1997, AM J TROP MED HYG, V57, P132, DOI 10.4269/ajtmh.1997.57.132
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wanzeller ALM, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00454-14
   Weaver SC, 2005, ARCH VIROL, P33
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 49
TC 7
Z9 7
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2018
VL 10
IS 8
AR 434
DI 10.3390/v10080434
PG 9
WC Virology
SC Virology
GA GS4MO
UT WOS:000443619600045
PM 30115888
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yun, SI
   Song, BH
   Frank, JC
   Julander, JG
   Olsen, AL
   Polejaeva, IA
   Davies, CJ
   White, KL
   Lee, YM
AF Yun, Sang-Im
   Song, Byung-Hak
   Frank, Jordan C.
   Julander, Justin G.
   Olsen, Aaron L.
   Polejaeva, Irina A.
   Davies, Christopher J.
   White, Kenneth L.
   Lee, Young-Min
TI Functional Genomics and Immunologic Tools: The Impact of Viral and Host
   Genetic Variations on the Outcome of Zika Virus Infection
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; flavivirus; infectious cDNA; replication; gene expression;
   neuropathogenesis; viral genetic variation; host genetic variation
ID MEMBRANE ASSOCIATION; REVERSE GENETICS; ENCEPHALITIS; TRANSMISSION;
   ENTRY; REPLICATION; FLAVIVIRUSES; BIOGENESIS; EMERGENCE; ELEMENTS
AB Zika virus (ZIKV) causes no-to-mild symptoms or severe neurological disorders. To investigate the importance of viral and host genetic variations in determining ZIKV infection outcomes, we created three full-length infectious cDNA clones as bacterial artificial chromosomes for each of three spatiotemporally distinct and genetically divergent ZIKVs: MR-766 (Uganda, 1947), P6-740 (Malaysia, 1966), and PRVABC-59 (Puerto Rico, 2015). Using the three molecularly cloned ZIKVs, together with 13 ZIKV region-specific polyclonal antibodies covering nearly the entire viral protein-coding region, we made three conceptual advances: (i) We created a comprehensive genome-wide portrait of ZIKV gene products and their related species, with several previously undescribed gene products identified in the case of all three molecularly cloned ZIKVs. (ii) We found that ZIKV has a broad cell tropism in vitro, being capable of establishing productive infection in 16 of 17 animal cell lines from 12 different species, although its growth kinetics varied depending on both the specific virus strain and host cell line. More importantly, we identified one ZIKV-non-susceptible bovine cell line that has a block in viral entry but fully supports the subsequent post-entry steps. (iii) We showed that in mice, the three molecularly cloned ZIKVs differ in their neuropathogenicity, depending on the particular combination of viral and host genetic backgrounds, as well as in the presence or absence of type I/II interferon signaling. Overall, our findings demonstrate the impact of viral and host genetic variations on the replication kinetics and neuropathogenicity of ZIKV and provide multiple avenues for developing and testing medical countermeasures against ZIKV.
C1 [Yun, Sang-Im; Song, Byung-Hak; Frank, Jordan C.; Julander, Justin G.; Olsen, Aaron L.; Polejaeva, Irina A.; Davies, Christopher J.; White, Kenneth L.; Lee, Young-Min] Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, Logan, UT 84322 USA.
   [Julander, Justin G.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.
   [Polejaeva, Irina A.; Davies, Christopher J.; White, Kenneth L.; Lee, Young-Min] Utah State Univ, Utah Sci Technol & Res, Vet Diagnost & Infect Dis, Logan, UT 84341 USA.
RP Lee, YM (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Coll Agr & Appl Sci, Logan, UT 84322 USA.; Lee, YM (corresponding author), Utah State Univ, Utah Sci Technol & Res, Vet Diagnost & Infect Dis, Logan, UT 84341 USA.
EM sangim.yun@usu.edu; byunghak.song@aggiemail.usu.edu;
   jc.frank@aggiemail.usu.edu; justin.julander@usu.edu;
   aaron.olsen@usu.edu; irina.polejaeva@usu.edu; chris.davies@usu.edu;
   ken.white@usu.edu; youngmin.lee@usu.edu
OI Polejaeva, Irina/0000-0002-0858-5889; Julander,
   Justin/0000-0001-6888-7320
FU Utah Science Technology and Research [A34637, A36815]; American Board of
   Obstetrics and Gynecology; American College of Obstetricians and
   Gynecologists; American Society for Reproductive Medicine; Society for
   Reproductive Endocrinology and Infertility [200784-00001]; Utah
   Agricultural Experiment Station [UTA01345]
FX This work was funded in part by grants from the Utah Science Technology
   and Research (A34637 and A36815) and by a grant from the American Board
   of Obstetrics and Gynecology, the American College of Obstetricians and
   Gynecologists, the American Society for Reproductive Medicine, and the
   Society for Reproductive Endocrinology and Infertility (200784-00001).
   This research was also supported by the Utah Agricultural Experiment
   Station (UTA01345) and approved as journal paper number #8929.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Firth AE, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-14
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Kim JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124318
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lecot S, 2005, J VIROL, V79, P10826, DOI 10.1128/JVI.79.16.10826-10829.2005
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Methot PO, 2014, VIRULENCE, V5, P775, DOI 10.4161/21505594.2014.960726
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Paranjape SM, 2010, CURR TOP MICROBIOL, V338, P15, DOI 10.1007/978-3-642-02215-9_2
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sambrook J., 1989, MOL CLONING LAB MANU
   Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stobart CC, 2014, VIRUSES-BASEL, V6, P2531, DOI 10.3390/v6072531
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Yun SI, 2016, J GEN VIROL, V97, P2575, DOI 10.1099/jgv.0.000574
   Yun SI, 2015, JOVE-J VIS EXP, DOI 10.3791/53164
   Yun SI, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004290
   Yun SI, 2009, J VIROL, V83, P7909, DOI 10.1128/JVI.02541-08
   Yun SI, 2003, VIRUS RES, V96, P129, DOI 10.1016/S0168-1702(03)00181-3
   Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 89
TC 7
Z9 7
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD AUG
PY 2018
VL 10
IS 8
AR 422
DI 10.3390/v10080422
PG 28
WC Virology
SC Virology
GA GS4MO
UT WOS:000443619600033
PM 30103523
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brown, P
   Vega, CMV
   Murphy, CB
   Welton, M
   Torres, H
   Rosario, Z
   Alshawabkeh, A
   Cordero, JF
   Padilla, IY
   Meeker, JD
AF Brown, Phil
   Vega, Carmen M. Velez
   Murphy, Colleen B.
   Welton, Michael
   Torres, Hector
   Rosario, Zaira
   Alshawabkeh, Akram
   Cordero, Jose F.
   Padilla, Ingrid Y.
   Meeker, John D.
TI Hurricanes and the Environmental Justice Island: Irma and Maria in
   Puerto Rico
SO ENVIRONMENTAL JUSTICE
LA English
DT Article
DE Puerto Rico; Hurricane Maria; Superfund sites; contamination; disaster
   response
AB This article presents an overview of our research team's disaster response to the massive destruction of Hurricanes, Irma and Maria, in September 2017, in light of the 120-year colonial legacy and long-term, widespread environmental contamination in Puerto Rico. Both local and federal governmental responses have been extremely inadequate, especially in light of the long-standing issues of environmental contamination throughout the island. Community organizations in Puerto Rico have been fighting for environmental justice for decades, often succeeding, and always confronting government unwillingness to address environmental protection. Hurricanes Irma and Maria afforded attention to Puerto Rico through international news coverage and awareness of its colonial status, rundown infrastructures (especially the electric grid), indebtedness, and environmental hazards. Since the hurricanes, the research teams of the Puerto Rico Test Site to Explore Contamination Threats (PROTECT), the Center for Research on Early Childhood Exposure and Development (CRECE), and Zika in Infants and Pregnancy (ZIP) have worked tirelessly to address the needs of our research participants, partnering clinics, as well as the local team to ensure safety and wellness. We have been able to continue our environmental public health work with pregnant women and children. In response to the historical problems and current crisis, we offer a visionary rebuilding approach for remediation of the hurricanes' effects, and for a deeper solution to the environmental and other social injustices Puerto Rico has long faced.
C1 [Brown, Phil] Northeastern Univ, Sociol & Hlth Sci, Boston, MA 02115 USA.
   [Brown, Phil] Northeastern Univ, Social Sci Environm Hlth Res Inst, INV 318,360 Huntington Ave, Boston, MA 02115 USA.
   [Vega, Carmen M. Velez; Murphy, Colleen B.; Torres, Hector] Univ Puerto Rico, Sch Publ Hlth, Med Sci Campus, San Juan, PR 00936 USA.
   [Welton, Michael; Rosario, Zaira; Cordero, Jose F.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Alshawabkeh, Akram] Northeastern Univ, Dept Civil & Environm Engn, Engn, Boston, MA 02115 USA.
   [Cordero, Jose F.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Publ Hlth, Athens, GA 30602 USA.
   [Padilla, Ingrid Y.] Univ Puerto Rico, Dept Civil Engn & Surveying, Mayaguez, PR USA.
   [Meeker, John D.] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
RP Brown, P (corresponding author), Northeastern Univ, Social Sci Environm Hlth Res Inst, INV 318,360 Huntington Ave, Boston, MA 02115 USA.
EM p.brown@northeastern.edu
OI Meeker, John/0000-0001-8357-5085
FU NIEHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P50ES026049, P42 ES017198-04]
FX This article is based on work under NIEHS grants #P50ES026049 and P42
   ES017198-04. The authors thank Jennifer Ohayon for providing research
   assistance and Melanie Smith for editorial assistance.
CR [Anonymous], 2017, CBS             1205
   Barclay Eliza, 2017, VOX
   Caraballo Jose, 2017, RED ECONOLATIN
   Caraballo Jose, INFORM EC PUERTO RIC
   Chavez Aida, 2017, THE INTERCEPT
   ICADH (Caribbean Institute for Human Rights), PUERT RIC DEBT FISC
   Klinenberg E., 2002, HEAT WAVE SOCIAL AUT
   Klinenberg Eric, 2017, NY TIMES
   Lichtveld M, 2018, AM J PUBLIC HEALTH, V108, P28, DOI 10.2105/AJPH.2017.304193
   Pastor M., 2006, WAKE STORM ENV DISAS
   Robles F., 2017, NY TIMES
   Rodriguez-Diaz CE, 2018, AM J PUBLIC HEALTH, V108, P30, DOI 10.2105/AJPH.2017.304198
   Yeampierre E, 2017, THE INTERCEPT
   Yeampierre Elizabeth, IMAGINE PUERTO RICO
NR 14
TC 3
Z9 3
U1 1
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1939-4071
EI 1937-5174
J9 ENVIRON JUSTICE
JI Environ. Justice
PD AUG
PY 2018
VL 11
IS 4
BP 148
EP 153
DI 10.1089/env.2018.0003
PG 6
WC Environmental Studies
SC Environmental Sciences & Ecology
GA GQ7JZ
UT WOS:000441917700002
PM 31131071
OA Green Published
DA 2020-07-08
ER

PT J
AU Barbeito-Andres, J
   Schuler-Faccini, L
   Garcez, PP
AF Barbeito-Andres, Jimena
   Schuler-Faccini, Lavinia
   Garcez, Patricia Pestana
TI Why is congenital Zika syndrome asymmetrically distributed among human
   populations?
SO PLOS BIOLOGY
LA English
DT Article
ID LATIN-AMERICA; EXPERIMENTAL-MODELS; VIRUS PATHOGENESIS; HUMAN
   NEUROSPHERES; INFECTION; ENHANCEMENT; TRANSMISSION; SPECTRUM; DISEASE;
   ORIGIN
AB Zika virus (ZIKV) is a health burden due to the severe neurological abnormalities that arise after congenital infection. Although multiple experimental studies have linked ZIKV with neural birth defects, the scientific community has not been able to fully explain why Congenital Zika Syndrome (CZS) was only apparent after the virus entered the Americas and why these occurrences have an asymmetric geographic distribution. Here, we review the impact of ZIKV infection on human populations by exploring evolutionary changes in the virus' genome as well as examining the diverse genetic and environmental cofactors of the human hosts.
C1 [Barbeito-Andres, Jimena; Garcez, Patricia Pestana] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Barbeito-Andres, Jimena] Consejo Nacl Invest Cient & Tecn, ENyS, Inst Studies Neurosci & Complex Syst Studies, Buenos Aires, DF, Argentina.
   [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil.
   [Schuler-Faccini, Lavinia] Hosp Clin Porto Alegre, Med Genet Serv, Inst Nacl Genet Med Populac, Porto Alegre, RS, Brazil.
RP Garcez, PP (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
EM ppgarcez@icb.ufrj.br
RI Garcez, Patricia/F-8026-2012; SCHULER-FACCINI, LAVINIA/C-8309-2013
OI Garcez, Patricia/0000-0002-9107-1335; SCHULER-FACCINI,
   LAVINIA/0000-0002-2428-0460
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [203.291/2017]; Brazilian Ministry of
   Health-DECIT (CNPq) [440763/2016-9]; INAGEMP - National Institute of
   Population Medical Genetics (CNPq) [465549/2014-4]
FX FAPERJ (grant number 203.291/2017). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. Brazilian Ministry of Health-DECIT (grant
   number CNPq grant 440763/2016-9). The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. INAGEMP - National Institute of
   Population Medical Genetics (grant number CNPq 465549/2014-4). The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064
   [Anonymous], 2015, ATL DES HUM BRAS
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   CHANDRA RK, 1992, J NUTR, V122, P754, DOI 10.1093/jn/122.suppl_3.754
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duggal NK, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Instituto Brasileiro de Geografia e Estatistica, 2015, IND SOC POP BRAS
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Losada-Barragan M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45991
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001
   Osuna CE, 2016, NAT MED, P1, DOI [10.1038/nm.4033, DOI 10.1038/NM.4033]
   Priyamvada L, 2016, HUMAN ANTIBODY RESPO, V113, DOI [10.1073/pnas.1607931113, DOI 10.1073/PNAS.1607931113]
   Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044
   REVILLARD JP, 1990, FOOD ADDIT CONTAM, V7, pS82, DOI 10.1080/02652039009373853
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 56
TC 7
Z9 7
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD AUG
PY 2018
VL 16
IS 8
AR e2006592
DI 10.1371/journal.pbio.2006592
PG 11
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA GS2MH
UT WOS:000443383300037
PM 30142150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Almutairi, MM
   Alsalem, WS
   Hassanain, M
   Hotez, PJ
AF Almutairi, Mashal M.
   Alsalem, Waleed Saleh
   Hassanain, Mazen
   Hotez, Peter J.
TI Hajj, Umrah, and the neglected tropical diseases
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEMORRHAGIC-FEVER VIRUS; SAUDI-ARABIA; CUTANEOUS LEISHMANIASIS;
   YELLOW-FEVER; ZIKA VIRUS; DENGUE; SURVEILLANCE; OUTBREAK
C1 [Almutairi, Mashal M.] King Saud Univ, Prince Naif Hlth Res Ctr, Riyadh, Saudi Arabia.
   [Almutairi, Mashal M.] King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh, Saudi Arabia.
   [Almutairi, Mashal M.] King Saud Univ, Coll Pharm, Vaccines & Biol Res Unit, Riyadh, Saudi Arabia.
   [Almutairi, Mashal M.; Hassanain, Mazen; Hotez, Peter J.] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Almutairi, Mashal M.; Hassanain, Mazen; Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Almutairi, Mashal M.; Hassanain, Mazen; Hotez, Peter J.] Baylor Coll Med, Dept Microbiol, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Alsalem, Waleed Saleh] Saudi Minist Hlth, Natl Hlth Lab, Ctr Neglected Trop Dis, Riyadh, Saudi Arabia.
   [Hassanain, Mazen] King Saud Univ, Dept Surg, Coll Med, Riyadh, Saudi Arabia.
   [Hotez, Peter J.] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.
   [Hotez, Peter J.] Texas A&M Univ, Scowcroft Inst Int Affairs, Bush Sch Govt & Publ Policy, College Stn, TX 77843 USA.
   [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
RP Almutairi, MM (corresponding author), King Saud Univ, Prince Naif Hlth Res Ctr, Riyadh, Saudi Arabia.; Almutairi, MM (corresponding author), King Saud Univ, Dept Pharmacol & Toxicol, Coll Pharm, Riyadh, Saudi Arabia.; Almutairi, MM (corresponding author), King Saud Univ, Coll Pharm, Vaccines & Biol Res Unit, Riyadh, Saudi Arabia.; Almutairi, MM; Hotez, PJ (corresponding author), Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA.; Almutairi, MM; Hotez, PJ (corresponding author), Baylor Coll Med, Dept Mol Virol, Natl Sch Trop Med, Houston, TX 77030 USA.; Almutairi, MM; Hotez, PJ (corresponding author), Baylor Coll Med, Dept Microbiol, Natl Sch Trop Med, Houston, TX 77030 USA.; Hotez, PJ (corresponding author), Rice Univ, James A Baker III Inst Publ Policy, Houston, TX 77005 USA.; Hotez, PJ (corresponding author), Texas A&M Univ, Scowcroft Inst Int Affairs, Bush Sch Govt & Publ Policy, College Stn, TX 77843 USA.; Hotez, PJ (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.
EM mmalmutairi@ksu.edu.sa; hotez@bcm.edu
RI Hassanain, Mazen/C-7256-2011
OI Hassanain, Mazen/0000-0002-2441-5142
CR Abd El Ghany M, 2017, EMERG INFECT DIS, V23, P1640, DOI 10.3201/eid2310.161642
   Abuzaid AA, 2017, VECTOR-BORNE ZOONOT, V17, P673, DOI 10.1089/vbz.2017.2119
   Ahmed Q, 2016, FRONT MED-PRC, V10, P527, DOI 10.1007/s11684-016-0487-2
   Ahmed QA, 2016, AM J INFECT CONTROL, V44, P1449, DOI 10.1016/j.ajic.2016.09.002
   Al-Afaleq AI, 2011, VECTOR-BORNE ZOONOT, V11, P1513, DOI 10.1089/vbz.2010.0245
   Al-Saeed MS, 2017, J MED VIROL, V89, P1339, DOI 10.1002/jmv.24785
   Al-Tawfiq JA, 2017, TRAVEL MED INFECT DI, V19, P2, DOI 10.1016/j.tmaid.2017.10.005
   Al-Tawfiq JA, 2014, INT J INFECT DIS, V27, P26, DOI 10.1016/j.ijid.2014.07.001
   Amani S., 2015, VACCINE, V33, p6552 , DOI [10.1016/j.vaccine.2015.09.076, DOI 10.1016/J.VACCINE.2015.09.076]
   Bailey F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005739
   Bin Ghouth AS, 2012, AM J TROP MED HYG, V86, P1072, DOI 10.4269/ajtmh.2012.11-0723
   Charrel RN, 2005, EMERG INFECT DIS, V11, P683, DOI 10.3201/eid1105.041298
   Du R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004545
   El Hajj L, 2004, INT J DERMATOL, V43, P120, DOI 10.1111/j.1365-4632.2004.01991.x
   El-Kafrawy SA, 2016, VECTOR-BORNE ZOONOT, V16, P391, DOI 10.1089/vbz.2015.1911
   Elachola H, 2016, LANCET, V388, P1155, DOI 10.1016/S0140-6736(16)31546-X
   ElAzazy OME, 1997, T ROY SOC TROP MED H, V91, P275, DOI 10.1016/S0035-9203(97)90072-9
   Hassanein KM, 2000, ANN SAUDI MED, V20, P153, DOI 10.5144/0256-4947.2000.153
   Herricks JR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005424
   ILM Feed. ILMFeed. com, 2018, WHICH COUNTR HAV HIG
   Khan AS, 2002, J AYUB MED COLL ABBO, V14, P19
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Memish ZA, 2014, TRAVEL MED INFECT DI, V12, P415, DOI 10.1016/j.tmaid.2014.09.003
   Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0
   Memish ZA, 2014, ANN SAUDI MED, V34, P153, DOI 10.5144/0256-4947.2014.153
   Olaitan AO, 2015, INT J ANTIMICROB AG, V45, P600, DOI 10.1016/j.ijantimicag.2015.01.010
   Salam N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003208
   Salmon-Rousseau A, 2016, MED MALADIES INFECT, V46, P346, DOI 10.1016/j.medmal.2016.04.002
   Samy AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005226
   Shivanna V, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00926-16
   U. S. Department of State, 2018, TRAV STAT GOV HAJJ U
   WHO, 2018, WORLD MAL REP 2017
   Widagdo W, 2017, ONE HEALTH-AMSTERDAM, V3, P11, DOI 10.1016/j.onehlt.2016.12.001
   YUN T-Y, 1985, Korean Journal of Parasitology, V23, P327, DOI 10.3347/kjp.1985.23.2.327
   Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7
   Zhang M, 2016, AN BRAS DERMATOL, V91, P363, DOI 10.1590/abd1806-4841.20163820
   Zumla A, 2016, INT J INFECT DIS, V47, P1, DOI 10.1016/j.ijid.2016.06.010
   Zumla A, 2017, LANCET INFECT DIS, V17, P895, DOI 10.1016/S1473-3099(17)30454-1
NR 38
TC 2
Z9 2
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2018
VL 12
IS 8
AR e0006539
DI 10.1371/journal.pntd.0006539
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GS2LP
UT WOS:000443381000007
PM 30114210
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McDonald, EM
   Duggal, NK
   Ritter, JM
   Brault, AC
AF McDonald, Erin M.
   Duggal, Nisha K.
   Ritter, Jana M.
   Brault, Aaron C.
TI Infection of epididymal epithelial cells and leukocytes drives seminal
   shedding of Zika virus in a mouse model
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; VIRAL LOAD; SEMEN; SPERM;
   MEN; FERTILIZATION; PATHOLOGY; TYPE-1; TESTIS
AB While primarily a mosquito-borne virus, Zika virus (ZIKV; genus Flavivirus in the Flaviviridae family) is capable of being sexually transmitted. Thirty to fifty percent of men with confirmed ZIKV infection shed ZIKV RNA in their semen, and prolonged viral RNA shedding in semen can occur for more than 6 months. The cellular reservoir of ZIKV in semen is unknown, although spermatozoa have been shown to contain ZIKV RNA and antigen. Yet, spermatozoa are not a requisite for sexual transmission, as at least one case of ZIKV sexual transmission involved a vasectomized man. To determine the cellular reservoirs of ZIKV in semen, an established animal model of sexual transmission was used. The majority of virus detected in the seminal fluid of infected mice during the peak timing of sexual transmission was from the supernatant fraction, suggesting cell-free ZIKV may be largely responsible for sexual transmission. However, some ZIKV RNA was cell-associated. In the testes and epididymides of infected mice, intracellular staining of ZIKV RNA was more pronounced in spermatogenic precursors (spermatocytes and spermatogonia) than in spermatids. Visualization of intracellular negative strand ZIKV RNA demonstrated ZIKV replication intermediates in leukocytes, immature spermatids and epididymal epithelial cells in the male urogenital tract. Epididymal epithelial cells were the principal source of negative-strand ZIKV RNA during the peak timing of sexual transmission potential, indicating these cells may be the predominant source of infectious cell-free ZIKV in seminal fluid. These data promote a more complete understanding of sexual transmission of ZIKV and will inform further model development for future studies on persistent ZIKV RNA shedding.
C1 [McDonald, Erin M.; Duggal, Nisha K.; Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
   [Ritter, Jana M.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA.
RP Brault, AC (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.
EM abrault@cdc.gov
OI Brault, Aaron/0000-0001-5801-3021
FU Office of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID); CDCCentre National de la Recherche Scientifique
   (CNRS)United States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX This research was made possible through support provided by the Office
   of Infectious Disease, Bureau for Global Health, U.S. Agency for
   International Development, under the terms of an Interagency Agreement
   with CDC. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fukuda N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003858
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Hedger MP, 2011, J ANDROL, V32, P625, DOI 10.2164/jandrol.111.012989
   Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784
   Ho HC, 2010, J ANAT, V216, P525, DOI 10.1111/j.1469-7580.2009.01204.x
   Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328
   Zamora MJ, 2016, REPROD BIOMED ONLINE, V32, P584, DOI 10.1016/j.rbmo.2016.02.014
   Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654
   Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x
   Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mead PS, NEW ENGLAND J MED
   MILLER CJ, 1994, LAB INVEST, V70, P255
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Mullen TE, 2003, AIDS RES HUM RETROV, V19, P235, DOI 10.1089/088922203763315740
   PUDNEY J, 1991, AM J PATHOL, V139, P149
   Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132
   Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   World Health Organization, 2010, WHO LAB MAN EX PROC
   Zafer M, 2016, FERTIL STERIL, V105, P645, DOI 10.1016/j.fertnstert.2015.11.028
   Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996
   Zhu WW, 2015, J IMMUNOL, V194, P4825, DOI 10.4049/jimmunol.1402706
NR 30
TC 7
Z9 7
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD AUG
PY 2018
VL 12
IS 8
AR e0006691
DI 10.1371/journal.pntd.0006691
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GS2LP
UT WOS:000443381000036
PM 30070988
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arora, N
   Banerjee, AK
   Narasu, ML
AF Arora, Neelima
   Banerjee, Amit K.
   Narasu, Mangamoori L.
TI Zika outbreak aftermath: status, progress, concerns and new insights
SO FUTURE VIROLOGY
LA English
DT Review
DE Aedes aegypti; Aedes albopictus; economic burden; flavivirus;
   forecasting; mathematical model; mosquito-borne viral disease;
   transmission; Zika virus; Zika virus outbreak
ID VIRUS-INFECTION; INHIBITS ZIKA; CULEX-QUINQUEFASCIATUS; PUERTO-RICO;
   TRANSMISSION; IMPLEMENTATION; CONTRACEPTION; ALBOPICTUS; DYNAMICS;
   VECTORS
AB Zika, a neurotrophic virus belonging to Flaviviridae family of viruses and transmitted by vector mosquitoes of Aedes species, took the world by storm during its recent outbreak. Its spread to newer territories, unprecedented pace of transmission, lack of existing therapeutic agents and vaccines and an empty drug pipeline raised an alarm. Uncertainty about full spectrum of diseases and its long-term consequences, newly discovered modes of transmission and controversies over vector status of mosquito species like Culex quinquefasciatus led to layers of complexity and presented new hurdles and challenges in Zika virus research. This review summarizes the progress and updates of efforts, concerns, financial burden and available resources in light of newly acquired knowledge in Zika virus research.
C1 [Arora, Neelima; Narasu, Mangamoori L.] Jawaharlal Nehru Technol Univ Hyderabad, Ctr Biotechnol, Inst Sci & Technol Autonomous, Hyderabad 500085, Telangana, India.
   [Banerjee, Amit K.] Indian Inst Chem Technol, CSIR, Div Biol, Uppal Rd, Hyderabad 500007, Telangana, India.
RP Arora, N (corresponding author), Jawaharlal Nehru Technol Univ Hyderabad, Ctr Biotechnol, Inst Sci & Technol Autonomous, Hyderabad 500085, Telangana, India.
EM neelimaiict@gmail.com
RI Banerjee, Amit Kumar/A-1009-2009
OI Banerjee, Amit Kumar/0000-0002-2502-0521
FU University Grants CommissionUniversity Grants Commission, India
FX N Arora thanks University Grants Commission for Post Doctoral
   Fellowship.
CR Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Arora N, 2016, FUTURE VIROL, V11, P395, DOI 10.2217/fvl-2016-0048
   Asian Scientist, ASIAN SCI
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Belloto AC, 2017, NAT PROD RES, P1
   Blackman MA, 2018, VIRAL IMMUNOL, V31, P117, DOI 10.1089/vim.2017.0145
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, ZIK VIR
   Chowell G., 2016, PLOS CURR, V8
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dantas E, 2017, P SERIES BRAZIL SOC, V6
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Delaunay S, 2016, B WORLD HEALTH ORGAN, V94, P236, DOI 10.2471/BLT.16.172650
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Erbelding E, 2017, J INFECT DIS, V216, pS991, DOI 10.1093/infdis/jix492
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Freedman LP, 2016, LANCET, V388, P2068, DOI 10.1016/S0140-6736(16)31530-6
   Gluskin RT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002713
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Gurumayum S, 2018, VIROLOGY, V514, P203, DOI 10.1016/j.virol.2017.11.007
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hsieh YH, 2017, PEERJ, V5, DOI 10.7717/peerj.3015
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Kelvin AA, 2016, J INFECT DEV COUNTR, V10, P113, DOI 10.3855/jidc.8248
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kitson A, 2010, CAN MED ASSOC J, V182, pE73, DOI 10.1503/cmaj.081231
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lloyd AM, 2017, J AM MOSQUITO CONTR, V33, P151, DOI 10.2987/14-6459.1
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morain SR, 2017, NEW ENGL J MED, V377, P1505, DOI 10.1056/NEJMp1707273
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Parida MM, 2002, J ETHNOPHARMACOL, V79, P273, DOI 10.1016/S0378-8741(01)00395-6
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Poland GA, 2018, LANCET INFECT DIS, VS1473-S3099
   Pollett S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005871
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Osorio-De-Castro CGS, 2017, AM J PUBLIC HEALTH, V107, P960, DOI 10.2105/AJPH.2017.303705
   Shah SK, 2017, ETHICAL CONSIDERATIO
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Suroengrit A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14121-5
   Tambo E, 2017, J HLTH MED INFORM, V8, P254
   Tambo E, 2017, J PARASITE EPIDEMIOL, V2, P50
   Teng Y, 2017, J INFECTION, V74, P484, DOI 10.1016/j.jinf.2017.01.015
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, WHO DIR GEN SUMM OUT
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   Wong G, 2017, VIROL SIN, V32, P545, DOI 10.1007/s12250-017-4057-9
   World Health O, 2016, ZIK VIR RES AG
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 115
TC 0
Z9 0
U1 0
U2 2
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD AUG
PY 2018
VL 13
IS 8
BP 539
EP 556
DI 10.2217/fvl-2018-0040
PG 18
WC Virology
SC Virology
GA GS0FZ
UT WOS:000443165300004
DA 2020-07-08
ER

PT J
AU Quinn, C
   Poirot, E
   Kim, AS
   Viswanath, AL
   Patel, SN
   Abramson, DM
   Piltch-Loeb, R
AF Quinn, Celia
   Poirot, Eugenie
   Kim, Afua Sanders
   Viswanath, Aishwarya L.
   Patel, Sneha N.
   Abramson, David M.
   Piltch-Loeb, Rachael
TI VARIATIONS IN HEALTHCARE PROVIDER USE OF PUBLIC HEALTH AND OTHER
   INFORMATION SOURCES BY PROVIDER TYPE AND PRACTICE SETTING DURING NEW
   YORK CITY'S RESPONSE TO THE EMERGING THREAT OF ZIKA VIRUS DISEASE, 2016
SO HEALTH SECURITY
LA English
DT Article
DE Public health preparedness/response; Risk communication; Epidemic
   management/response; Hospital preparedness/response; Zika
AB The New York City (NYC) Department of Health and Mental Hygiene (DOHMH) used multiple methods to provide guidance to healthcare providers on the management and prevention of Zika virus disease during 2016. To better understand providers' use of information sources related to emerging disease threats, this article describes reported use of information sources by NYC providers to stay informed about Zika, and patterns observed by provider type and practice setting. We sent an electronic survey to all email addresses in the Provider Data Warehouse, a system used to maintain information from state and local health department sources on all prescribing healthcare providers in NYC. The survey asked providers about their use of information sources, including specific information products offered by the NYC DOHMH, to stay informed about Zika during 2016. Trends by provider type and practice setting were described using summary statistics. The survey was sent to 44,455 unique email addresses; nearly 20% (8,711) of the emails were undeliverable. Ultimately, 1,447 (5.8%) eligible providers completed the survey. Most respondents (79%) were physicians. Overall, the most frequently reported source of information from the NYC DOHMH was the NYC Health Alert Network (73%). Providers in private practice reported that they did not use any NYC DOHMH source of information about Zika more frequently than did those working in hospital settings (29% vs 23%); similarly, private practitioners reported that they did not use any other source of information about Zika more frequently than did those working in hospital settings (16% vs 8%). Maintaining timely and accurate databases of healthcare provider contact information is a challenge for local public health agencies. Effective strategies are needed to identify and engage independently practicing healthcare providers to improve communications with all healthcare providers during public health emergencies.
C1 [Quinn, Celia] Ctr Dis Control & Prevent CDC, Field Serv Branch, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA USA.
   [Quinn, Celia] New York City Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, 42-09 28th St, New York, NY 11101 USA.
   [Poirot, Eugenie] CDC, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.
   [Poirot, Eugenie] New York City Dept Hlth & Mental Hygiene, Div Epidemiol, New York, NY USA.
   [Kim, Afua Sanders] NYC Dept Hlth & Mental Hyg, IT Informat Informat Technol & Telecommun, New York, NY USA.
   [Viswanath, Aishwarya L.] NYC Dept Hlth & Mental Hyg, Bur Agcy Preparedness & Response, New York, NY USA.
   [Patel, Sneha N.] NYC Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, Bur Agcy Preparedness & Response, Evaluat, New York, NY USA.
   [Abramson, David M.; Piltch-Loeb, Rachael] NYU, Coll Global Publ Hlth, New York, NY USA.
RP Quinn, C (corresponding author), New York City Dept Hlth & Mental Hyg, Off Emergency Preparedness & Response, 42-09 28th St, New York, NY 11101 USA.
EM cquinnmd@health.nyc.gov
CR American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C
   Association of American Medical Colleges, 2014, 2014 PHYS SPEC DAT B
   Baseman J, 2016, DISASTER MED PUBLIC, V10, P98, DOI 10.1017/dmp.2015.139
   Gotham IJ, 2007, J PUBLIC HEALTH MAN, V13, P486
   Lee CT, 2017, J PUBLIC HLTH MANAG
   Lurio J, 2010, J AM MED INFORM ASSN, V17, P217, DOI 10.1136/jamia.2009.000539
   New York City Department of Health and Mental Hygiene, 2016, 2016 DOHMH ADV 1 MIC
   New York State Department of Health, 2018, DAT DICT PROV NETW D
   Revere D, 2014, PUBLIC HEALTH REP, V129, P67, DOI 10.1177/00333549141296S410
   Revere D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-337
NR 10
TC 1
Z9 1
U1 1
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD AUG
PY 2018
VL 16
IS 4
BP 252
EP 261
DI 10.1089/hs.2018.0026
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GR2GD
UT WOS:000442383100005
PM 30133373
DA 2020-07-08
ER

PT J
AU Shafit-Zagardo, B
   Gruber, RC
   DuBois, JC
AF Shafit-Zagardo, Bridget
   Gruber, Ross C.
   DuBois, Juwen C.
TI The role of TAM family receptors and ligands in the nervous system: From
   development to pathobiology
SO PHARMACOLOGY & THERAPEUTICS
LA English
DT Review
DE Tyro3; Axl and Mertk receptor tyrosine kinase family; Gas6; ProS1;
   Homeostasis in the nervous system; Myelination; Inflammation;
   Phagocytosis
ID PROTEIN-TYROSINE KINASE; BLOOD-BRAIN-BARRIER; SMALL-MOLECULE INHIBITOR;
   ZIKA VIRUS-INFECTION; OLIGODENDROCYTE PRECURSOR CELLS; CUPRIZONE-INDUCED
   DEMYELINATION; SUPERIOR CEREBELLAR PEDUNCLE; RETINAL DYSTROPHY
   PHENOTYPE; NEURAL PROGENITOR CELLS; INNATE IMMUNE-RESPONSES
AB Tyro3, Axl, and Mertk, referred to as the TAM family of receptor tyrosine kinases, are instrumental in maintaining cell survival and homeostasis in mammals. TAM receptors interact with multiple signaling molecules to regulate cell migration, survival, phagocytosis and clearance of metabolic products and cell debris called efferocytosis. The TAMs also function as rheostats to reduce the expression of proinflammatory molecules and prevent autoimmunity. All three TAM receptors are activated in a concentration-dependent manner by the vitamin K-dependent growth arrest-specific protein 6 (Gas6). Gas6 and the TAMs are abundantly expressed in the nervous system. Gas6, secreted by neurons and endothelial cells, is the sole ligand for Axl. ProteinS1 (ProS1), another vitamin K-dependent protein functions mainly as an anti-coagulant, and independent of this function can activate Tyro3 and Mertk, but not Axl. This review will focus on the role of the TAM receptors and their ligands in the nervous system. We highlight studies that explore the function of TAM signaling in myelination, the visual cortex, neural cancers, and multiple sclerosis (MS) using Gas6(-/-) and TAM mutant mice models. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Shafit-Zagardo, Bridget; DuBois, Juwen C.] Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   [Gruber, Ross C.] Sanofi, Neuroinflammat & MS Res, 49 New York Ave, Framingham, MA 01701 USA.
RP Shafit-Zagardo, B (corresponding author), Albert Einstein Coll Med, Dept Pathol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM bridget.shafit-zagardo@einstein.yu.edu
FU National Multiple Sclerosis SocietyNational Multiple Sclerosis Society
   [RG5351-A-10]; National Institues of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [NS093134]
FX We thank Ms. Hillary Guzik in the Analytical Imaging Facility for her
   help with images, Ms. Xheni Nishu for help with electron microscopy, Dr.
   Bryan Kaspar for AAV2/9 vectors, and Dr. Cedric Raine for his expert
   advice on electron microscopy. We are grateful to Dr. Pablo Garcia de
   Frutos for educating us on the functional differences between total and
   free ProS1, and guiding us toward appropriate references. We thank Ms.
   Kathleen O'Guin for her help in establishing the human co-cultures.
   Aspects of our research reported in this review were funded by the
   National Multiple Sclerosis Society (Grant # RG5351-A-10) and the
   National Institues of Health (Grant # NS093134).
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112
   Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343
   Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0
   Akalu YT, 2017, IMMUNOL REV, V276, P165, DOI 10.1111/imr.12522
   Akkermann R, 2017, GLIA, V65, P581, DOI 10.1002/glia.23113
   Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191
   Alvarez H, 2010, CANCER BIOL THER, V10, P1009, DOI 10.4161/cbt.10.10.13248
   Ammoun S, 2014, ONCOGENE, V33, P336, DOI 10.1038/onc.2012.587
   Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871
   Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079
   Angelillo-Scherrer A, 2008, J CLIN INVEST, V118, P583, DOI 10.1172/JCI30375
   Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842
   Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522
   Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738
   Avanzi GC, 1998, BLOOD, V91, P2334, DOI 10.1182/blood.V91.7.2334.2334_2334_2340
   Bellesi M, 2017, J NEUROSCI, V37, P5263, DOI 10.1523/JNEUROSCI.3981-16.2017
   Bellosta P, 1997, ONCOGENE, V15, P2387, DOI 10.1038/sj.onc.1201419
   Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Binder MD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005853
   Binder MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017727
   Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894
   BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4
   BLAKEMORE WF, 1973, J NEUROL SCI, V20, P73, DOI 10.1016/0022-510X(73)90119-6
   BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768
   Burstyn-Cohen T, 2017, INT J DEV BIOL, V61, P215, DOI 10.1387/ijdb.160285tb
   Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015
   Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325
   Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599
   Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955
   Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265
   Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008
   Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520
   Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113
   Carmeliet P, 2001, SCIENCE, V293, P1602, DOI 10.1126/science.1064981
   Cervellini Ilaria, 2013, Methods Mol Biol, V982, P163, DOI 10.1007/978-1-62703-308-4_10
   Chan MCW, 2000, J ANDROL, V21, P291
   Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x
   Cheng P, 2015, STEM CELL REP, V4, P899, DOI 10.1016/j.stemcr.2015.03.005
   Chien CW, 2016, ONCOGENE, V35, P5872, DOI 10.1038/onc.2016.120
   Cho EJ, 2012, KIDNEY RES CLIN PRAC, V31, P72, DOI 10.1016/j.krcp.2011.12.003
   Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776
   Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094
   Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7
   Crosier KE, 1997, PATHOLOGY, V29, P131, DOI 10.1080/00313029700169744
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Cummings CT, 2015, MOL CANCER THER, V14, P2014, DOI 10.1158/1535-7163.MCT-15-0116
   D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645
   de Castro GM, 2015, AM J PATHOL, V185, P2431, DOI 10.1016/j.ajpath.2015.05.011
   DE FRUTOS PG, 1994, BLOOD, V84, P815
   Debruyne DN, 2016, ONCOGENE, V35, P3681, DOI 10.1038/onc.2015.434
   Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dilokthornsakul P, 2016, NEUROLOGY, V86, P1014, DOI 10.1212/WNL.0000000000002469
   Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438
   El-Moslimany H, 2008, MULTIPLE SCLEROSIS C, P10
   FAIR DS, 1986, BLOOD, V67, P1168
   Fang ZQ, 1998, ENDOCRINOLOGY, V139, P3654, DOI 10.1210/en.139.8.3654
   Ferland G, 2012, BIOFACTORS, V38, P151, DOI 10.1002/biof.1004
   Foley JH, 2013, BLOOD, V121, P570, DOI 10.1182/blood-2012-11-468678
   Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630
   Fridell YWC, 1996, MOL CELL BIOL, V16, P135
   FUJIMOTO J, 1994, ONCOGENE, V9, P693
   Fukuda Y, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00481
   Funakoshi H, 2002, J NEUROSCI RES, V68, P150, DOI 10.1002/jnr.10211
   Gautam J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36450
   Gely-Pernot A, 2012, STEM CELLS, V30, P719, DOI 10.1002/stem.1045
   Geng K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01521
   Georgescu MM, 1999, MOL CELL BIOL, V19, P1171
   Ghosh AK, 2011, BLOOD, V117, P1928, DOI 10.1182/blood-2010-09-305649
   Giles KM, 2013, MOL CANCER THER, V12, P2541, DOI 10.1158/1535-7163.MCT-13-0170
   Gohlke PR, 2009, AUTOIMMUNITY, V42, P183, DOI 10.1080/08916930802668586
   Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019
   Goruppi S, 1999, ONCOGENE, V18, P4224, DOI 10.1038/sj.onc.1202788
   Goudarzi S, 2016, ASN NEURO, V8, DOI 10.1177/1759091416668430
   GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2
   Gruber RC, 2014, J NEUROSCI, V34, P16320, DOI 10.1523/JNEUROSCI.2449-14.2014
   Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje
   Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3
   Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han J, 2016, AUTOPHAGY, V12, P2326, DOI 10.1080/15548627.2016.1235124
   Hasanbasic I, 2005, J THROMB HAEMOST, V3, P2790, DOI 10.1111/j.1538-7836.2005.01662.x
   Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Healy LM, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000402
   Healy LM, 2016, J IMMUNOL, V196, P3375, DOI 10.4049/jimmunol.1502562
   Heeb MJ, 2008, J THROMB HAEMOST, V6, P1235, DOI 10.1111/j.1538-7836.2008.02994.x
   Heiring C, 2004, J BIOL CHEM, V279, P6952, DOI 10.1074/jbc.M311750200
   Hill JJ, 2009, PROTEOMICS, V9, P535, DOI 10.1002/pmic.200800257
   Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4
   Hoehn HJ, 2008, BRAIN RES, V1240, P1, DOI 10.1016/j.brainres.2008.08.076
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Huang HT, 2000, CANCER RES, V60, P6868
   Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971
   Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229
   Johansson G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115916
   Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x
   Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707
   Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018
   Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197
   Kim DY, 2017, DIS MODEL MECH, V10, P581, DOI 10.1242/dmm.027433
   Kleitman N, 1991, CULTURING NERVE CELL, P337
   Knubel KH, 2014, ONCOTARGET, V5, P1338, DOI 10.18632/oncotarget.1793
   Koh A, 2014, CELL SIGNAL, V26, P2470, DOI 10.1016/j.cellsig.2014.07.033
   Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008
   Krause S, 2015, BLOOD, V125, P820, DOI 10.1182/blood-2014-06-583062
   Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y
   LAI C, 1994, ONCOGENE, V9, P2567
   LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X
   Lassmann H, 2011, NEUROPATH APPL NEURO, V37, P698, DOI 10.1111/j.1365-2990.2011.01189.x
   Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x
   Lee-Sherick AB, 2015, ONCOTARGET, V6, P6722, DOI 10.18632/oncotarget.3156
   Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0
   Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385
   Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064812
   Li RH, 1996, J NEUROSCI, V16, P2012
   Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274
   Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212
   Li YX, 2015, BIOCHEM BIOPH RES CO, V457, P461, DOI 10.1016/j.bbrc.2015.01.017
   Lim CK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41473
   Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980
   Liu D, 2003, CIRCULATION, V107, P1791, DOI 10.1161/01.CIR.0000058460.34453.5A
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu X, 2015, HISTOL HISTOPATHOL, V30, P771, DOI 10.14670/HH-11-596
   Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x
   Ludwin S, 2008, MULTIPLE SCLEROSIS C, P151
   Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114
   Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002
   Ma G. Z. M., 2015, MULTIPLE SCLEROSIS J, V1
   Ma GZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016964
   Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200
   Marcus R, 2001, GOODMAN GILMANS PHAR, P1773
   MARK MR, 1994, J BIOL CHEM, V269, P10720
   MARLAR RA, 1990, SEMIN THROMB HEMOST, V16, P299, DOI 10.1055/s-2007-1002683
   Martinho O, 2015, EXP CELL RES, V332, P1, DOI 10.1016/j.yexcr.2015.01.009
   Mason JL, 2003, J NEUROSCI, V23, P7710
   Mat MFC, 2016, INT J ONCOL, V49, P2359, DOI 10.3892/ijo.2016.3755
   Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039
   Matsushima GK, 2001, BRAIN PATHOL, V11, P107
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melaragno MG, 1998, CIRC RES, V83, P697, DOI 10.1161/01.RES.83.7.697
   Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155
   Miller SD, 2010, CURR PROTOC IMMUNOL, V88, P1511
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Miyamoto Y, 2015, MOL BIOL CELL, V26, P3489, DOI 10.1091/mbc.E14-05-1020
   Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468
   Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Mun KC, 2000, BLOOD PURIFICAT, V18, P13, DOI 10.1159/000014403
   Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022
   Nakada M, 2013, ADV EXP MED BIOL, V986, P143, DOI 10.1007/978-94-007-4719-7_8
   Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411
   Nandrot E, 2000, NEUROBIOL DIS, V7, P586, DOI 10.1006/nbdi.2000.0328
   Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nyberg P, 1997, EUR J BIOCHEM, V246, P147, DOI 10.1111/j.1432-1033.1997.t01-2-00147.x
   O'Guin KN, 2014, ASN NEURO, V6, P29, DOI 10.1042/AN20130022
   OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551
   OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016
   OHASHI K, 1995, J BIOCHEM, V117, P1267, DOI 10.1093/oxfordjournals.jbchem.a124854
   OHASHI K, 1994, ONCOGENE, V9, P699
   Olivar R, 2013, J IMMUNOL, V190, P2857, DOI 10.4049/jimmunol.1200503
   Onken J, 2017, ONCOTARGET, V8, P50403, DOI 10.18632/oncotarget.18468
   Onken J, 2016, ONCOTARGET, V7, P9876, DOI 10.18632/oncotarget.7130
   Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209
   Ott M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047663
   Parinot C, 2016, ADV EXP MED BIOL, V854, P259, DOI 10.1007/978-3-319-17121-0_35
   Paty D, 1988, MULT SCLER, P48
   Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169
   Pierce A, 2011, MOL CELL ENDOCRINOL, V339, P151, DOI 10.1016/j.mce.2011.04.007
   Pierce AM, 2014, BRAIN RES, V1542, P206, DOI 10.1016/j.brainres.2013.10.049
   Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745
   Popova SN, 2014, HISTOPATHOLOGY, V64, P365, DOI 10.1111/his.12252
   Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011
   Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047
   Prieto AL, 2000, J COMP NEUROL, V425, P295
   PRINEAS JW, 1985, HDB CLIN NEUROLOGY R, V3, P213
   Raine CS, 2008, MULTIPLE SCLEROSIS C
   Ray AK, 2017, GLIA, V65, P2051, DOI 10.1002/glia.23214
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rettew AN, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.34
   Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957
   Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103
   Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001
   Rusielewicz T, 2014, GLIA, V62, P580, DOI 10.1002/glia.22627
   Sainaghi PP, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/406483
   Salian-Mehta S, 2014, MOL CELL ENDOCRINOL, V393, P164, DOI 10.1016/j.mce.2014.06.015
   Sasaki M, 1996, J BIOCHEM-TOKYO, V120, P264, DOI 10.1093/oxfordjournals.jbchem.a021408
   Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251
   Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389
   SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3
   Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603
   Scurlock B, 1999, J NEUROSCI RES, V55, P514, DOI 10.1002/(SICI)1097-4547(19990215)55:4<514::AID-JNR11>3.0.CO;2-V
   Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635
   Seitz HM, 2010, INT REV IMMUNOL, V29, P184, DOI 10.3109/08830181003602507
   Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006
   Shankar SL, 2003, J NEUROSCI, V23, P4208
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010
   Sixt M, 2001, J CELL BIOL, V153, P933, DOI 10.1083/jcb.153.5.933
   Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707
   Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206
   STERN D, 1986, J CELL BIOL, V102, P1971, DOI 10.1083/jcb.102.5.1971
   STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0
   Studer RA, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140121
   Suarez RM, 2013, EUR J MED CHEM, V61, P2, DOI 10.1016/j.ejmech.2012.06.005
   Sufit A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165107
   Suleiman L, 2013, CRIT REV ONCOL HEMAT, V88, P637, DOI 10.1016/j.critrevonc.2013.07.004
   Teunissen CE, 2015, NAT REV NEUROL, V11, P585, DOI 10.1038/nrneurol.2015.173
   Thomsen MS, 2017, J CEREBR BLOOD F MET, V37, P3300, DOI 10.1177/0271678X17722436
   Thomsen MS, 2017, J NEUROCHEM, V140, P741, DOI 10.1111/jnc.13747
   Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020
   Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200
   TOSHIMA J, 1995, BIOCHEM BIOPH RES CO, V209, P656, DOI 10.1006/bbrc.1995.1549
   Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189
   Tsiperson V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015748
   Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020
   Tufail Y, 2017, NEURON, V93, P574, DOI 10.1016/j.neuron.2016.12.021
   Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103
   van de Poel RHL, 1999, BLOOD CELL MOL DIS, V25, P279, DOI 10.1006/bcmd.1999.0255
   VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0
   Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116
   Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198
   von Massenhausen A, 2016, ONCOTARGET, V7, P32678, DOI 10.18632/oncotarget.8724
   Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66
   Vouri M, 2017, CANCER RES, V77, P2775, DOI 10.1158/0008-5472.CAN-16-2675
   Vouri M, 2015, ONCOTARGET, V6, P16183, DOI 10.18632/oncotarget.3952
   Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699
   Wang Y, 2013, ONCOGENE, V32, P872, DOI 10.1038/onc.2012.104
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Weinger JG, 2008, J NEUROCHEM, V106, P134, DOI 10.1111/j.1471-4159.2008.05343.x
   Weinger JG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-49
   Weinger JG, 2009, AM J PATHOL, V175, P283, DOI 10.2353/ajpath.2009.080807
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066
   Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105
   Wolswijk G, 2002, BRAIN, V125, P338, DOI 10.1093/brain/awf031
   Wolswijk G, 1997, MULT SCLER, V3, P168, DOI 10.1177/135245859700300221
   Wolswijk G, 1998, J NEUROSCI, V18, P601
   Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413
   Yen SY, 2016, ONCOGENE, V35, P2156, DOI 10.1038/onc.2015.277
   Yin ZR, 2017, NEUROBIOL AGING, V55, P115, DOI 10.1016/j.neurobiolaging.2017.03.021
   YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392
   Yuan RR, 2015, NEUROTHERAPEUTICS, V12, P850, DOI 10.1007/s13311-015-0379-1
   Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986
   Zelentsova K, 2017, STEM CELLS, V35, P679, DOI 10.1002/stem.2522
   Zelentsova-Levytskyi K, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00124
   Zhang J, 2005, BRAIN RES, V1034, P34, DOI 10.1016/j.brainres.2004.11.036
   Zhang WH, 2014, J MED CHEM, V57, P7031, DOI 10.1021/jm500749d
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
   Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]
   Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049
   Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386
   Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113
NR 273
TC 6
Z9 6
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7258
J9 PHARMACOL THERAPEUT
JI Pharmacol. Ther.
PD AUG
PY 2018
VL 188
BP 97
EP 117
DI 10.1016/j.pharmthera.2018.03.002
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GQ2ML
UT WOS:000441489000007
PM 29514053
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Mullerova, J
   Elsterova, J
   Cerny, J
   Ditrich, O
   Zarsky, J
   Culler, LE
   Kampen, H
   Walther, D
   Coulson, SJ
   Ruzek, D
   Grubhoffer, L
AF Mullerova, Jana
   Elsterova, Jana
   Cerny, Jiri
   Ditrich, Oleg
   Zarsky, Jakub
   Culler, Lauren E.
   Kampen, Helge
   Walther, Doreen
   Coulson, Stephen J.
   Ruzek, Daniel
   Grubhoffer, Libor
TI No indication of arthropod-vectored viruses in mosquitoes (Diptera:
   Culicidae) collected on Greenland and Svalbard
SO POLAR BIOLOGY
LA English
DT Article
DE Aedes nigripes; Mosquitoes; Arbovirus; Arctic; Svalbard; Greenland
ID CALIFORNIA SEROGROUP VIRUSES; ST-LOUIS ENCEPHALITIS; MACQUARIE ISLAND;
   UNITED-STATES; WILD ANIMALS; ARBOVIRUSES; ALASKA; INFECTIONS;
   BUNYAMWERA; BUNYAVIRUS
AB Viruses transmitted to vertebrates via arthropod vectors (so-called arboviruses) include many important pathogens such as dengue virus, Zika virus, and Sindbis virus. Mosquitoes represent the major vectors of many of these arboviruses and occur in all climatic zones, including the Arctic. The focal species, Aedes nigripes (Diptera: Culicidae), is the most widely distributed mosquito species in the Arctic. We screened over 11,000 specimens collected between 2012 and 2016 on Greenland (Kangerlussuaq) and Svalbard (Petuniabukta) for the presence of arboviruses which have previously been reported in latitudes up to 70A degrees N. Assays for arbovirus detection using RT-PCR with primers specific for the genera Alphavirus (family Togaviridae), Orthobunyavirus, Phlebovirus (Bunyaviridae), Flavivirus (Flaviviridae), and Orbivirus (Reoviridae) were negative for all specimens. Similar results were recently obtained in a screening focused on tick-borne pathogens on Svalbard. The findings suggest that the circulation of arboviruses at studied localities is currently negligible or nonexistent, possibly due to dispersal, climate, or biotic restrictions. However, global climate change could enhance vector abundance and activity, introduction of invasive host species, and increase in tourism which then could lead to emerging arbovirus outbreaks in the future, with considerable impact on local ecosystems.
C1 [Mullerova, Jana; Elsterova, Jana; Cerny, Jiri; Ruzek, Daniel; Grubhoffer, Libor] Czech Acad Sci, Biol Ctr, Inst Parasitol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.
   [Mullerova, Jana; Elsterova, Jana; Ditrich, Oleg; Grubhoffer, Libor] Univ South Bohemia Ceske Budejovice, Fac Sci, Ctr Polar Ecol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.
   [Elsterova, Jana; Cerny, Jiri; Ruzek, Daniel] Vet Res Inst, Hudcova 296-70, Brno 62100, Czech Republic.
   [Zarsky, Jakub] Charles Univ Prague, Dept Ecol, Vinicna 7, Prague 12842 2, Czech Republic.
   [Culler, Lauren E.] Dartmouth Coll, Inst Arctic Studies, Hanover, NH 03755 USA.
   [Culler, Lauren E.] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA.
   [Kampen, Helge] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Sudufer 10, D-17493 Uppsala, Germany.
   [Walther, Doreen] Leibniz Ctr Agr Landscape Res ZALF eV, Eberswalder Str 84, D-15374 Muncheberg, Germany.
   [Coulson, Stephen J.] Univ Ctr Svalbard, Dept Arctic Biol, POB 156, N-9171 Longyearbyen, Norway.
   [Coulson, Stephen J.] Swedish Univ Agr Sci, Swedish Species Informat Ctr, ArtDatabanken, POB 7007, S-75007 Uppsala, Sweden.
RP Cerny, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.; Cerny, J (corresponding author), Vet Res Inst, Hudcova 296-70, Brno 62100, Czech Republic.
EM cerny@paru.cas.cz
RI Zarsky, Jakub/D-1383-2013; Cerny, Jiri/Q-4140-2016; Culler, Lauren
   E/W-5244-2019; Ruzek, Daniel/G-9275-2014; Gribhoffer, Libor/G-9762-2014
OI Zarsky, Jakub/0000-0001-7072-0327; Cerny, Jiri/0000-0003-0891-0693;
   Ruzek, Daniel/0000-0003-4655-2380; 
FU CzechPolar2 - Czech Polar Research Infrastructure [LM2015078];
   ECOPOLARIS project by the Ministry of Education, Youth and Sports of the
   Czech Republic [CZ.02.1.01/0.0/0.0/16_013/0001708]; Czech Grant
   AgencyGrant Agency of the Czech Republic [GA15-03044S]; ECDC;
   Dartmouth's Biology Department (R. Melville Cramer Fund); NSF IGERT
   Fellowship (NSF) [0801490]; Czech Research Infrastructure for Systems
   Biology C4SYS [LM2015055]; EFSA; Centre of Polar Ecology at the Faculty
   of Science, University of South Bohemia
FX Our thanks belong to the whole team of the Centre of Polar Ecology at
   the Faculty of Science, University of South Bohemia, for their help and
   support during the field work, notably to Dr. Josef Elster for the
   possibility to participate in the field work on Svalbard, to Dr. Vaclav
   Pavel, Dr. Jan Kavan, Dr. Alexandra Bernardova, and Martin Lulak for
   logistic support, and to our laboratory technician Zuzana Vavruskova for
   her help with benchwork. Our thanks further belong to Dr. Daniel Ruzek
   for the methodological and theoretical guidance of our team. The project
   was supported by LM2015078 CzechPolar2 - Czech Polar Research
   Infrastructure and ECOPOLARIS project No.
   CZ.02.1.01/0.0/0.0/16_013/0001708 provided by the Ministry of Education,
   Youth and Sports of the Czech Republic. Further, the research was
   supported by the Czech Grant Agency (GA15-03044S to JM, JC, and LG) and
   by ECDC & EFSA (funding to HK and DW within the VectorNet project).
   Funding was provided by Dartmouth's Biology Department (R. Melville
   Cramer Fund) and a NSF IGERT Fellowship (NSF award 0801490) to LEC.
   Access to instruments and other facilities was supported by the Czech
   Research Infrastructure for Systems Biology C4SYS (project no
   LM2015055).
CR Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Bennike O., 1989, Polar Record, V25, P43
   Carson PK, 2017, J MED ENTOMOL, V54, P712, DOI 10.1093/jme/tjw219
   CORBET PS, 1966, ARCTIC, V19, P153
   Coulson SJ, 2004, CATALOGUE TERRESTRIA
   Culler LE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1549
   Deardorff ER, 2013, EMERG INFECT DIS, V19, P2012, DOI 10.3201/eid1912.130319
   Descamps S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065374
   DOHERTY RL, 1975, AM J TROP MED HYG, V24, P521, DOI 10.4269/ajtmh.1975.24.521
   Elsterova J, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.27466
   Hubalek Z, 2014, ADV VIRUS RES, V89, P201, DOI 10.1016/B978-0-12-800172-1.00005-7
   Jenkins DW, 1956, 10 INT C ENT MONTR A, P627
   Kuno G, 1996, J CLIN MICROBIOL, V34, P1184, DOI 10.1128/JCM.34.5.1184-1188.1996
   Linn ML, 2001, J VIROL, V75, P4103, DOI 10.1128/JVI.75.9.4103-4109.2001
   Lvov S.D., 1995, Voprosy Virusologii, V40, P170
   Major L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004375
   Markova E, 2016, ACTA ZOOL-STOCKHOLM, V97, P442, DOI 10.1111/azo.12138
   MCLEAN DM, 1977, J HYG-CAMBRIDGE, V79, P61, DOI 10.1017/S0022172400052852
   MCLEAN DM, 1978, ARCH VIROL, V57, P315, DOI 10.1007/BF01320071
   MCLEAN DM, 1975, MED BIOL, V53, P264
   MCLEAN DM, 1979, ARCH VIROL, V62, P313, DOI 10.1007/BF01318105
   MITCHELL CJ, 1993, AM J TROP MED HYG, V49, P53, DOI 10.4269/ajtmh.1993.49.53
   Overland JE, 2015, SURFACE AIR TEMPERAT
   Palacios G, 2011, J CLIN MICROBIOL, V49, P2314, DOI 10.1128/JCM.00337-11
   Pedersen K, 2016, AM J TROP MED HYG, V95, P206, DOI 10.4269/ajtmh.15-0840
   Putkuri N, 2016, EMERG INFECT DIS, V22, P810, DOI 10.3201/eid2205.151015
   Putkuri N, 2014, INFECT GENET EVOL, V22, P164, DOI 10.1016/j.meegid.2014.01.023
   Sahu SP, 2002, AM J TROP MED HYG, V67, P119, DOI 10.4269/ajtmh.2002.67.119
   Sanchez-Seco MP, 2003, J MED VIROL, V71, P140, DOI 10.1002/jmv.10465
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   STANSFIELD SK, 1988, CAN J MICROBIOL, V34, P1213, DOI 10.1139/m88-213
   STGEORGE TD, 1985, AM J TROP MED HYG, V34, P406
   Tingstrom O, 2016, VECTOR-BORNE ZOONOT, V16, P461, DOI 10.1089/vbz.2016.1940
   TRAAVIK T, 1978, ACTA PATH MICRO IM B, V86, P335
   Vanlandingham DL, 2002, AM J TROP MED HYG, V67, P306, DOI 10.4269/ajtmh.2002.67.306
   Walters LL, 1999, AM J TROP MED HYG, V60, P806, DOI 10.4269/ajtmh.1999.60.806
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Yoccoz Nigel G., 1999, Ecological Bulletins, V47, P137
   ZARNKE RL, 1983, J WILDLIFE DIS, V19, P175, DOI 10.7589/0090-3558-19.3.175
NR 41
TC 2
Z9 2
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0722-4060
EI 1432-2056
J9 POLAR BIOL
JI Polar Biol.
PD AUG
PY 2018
VL 41
IS 8
SI SI
BP 1581
EP 1586
DI 10.1007/s00300-017-2242-9
PG 6
WC Biodiversity Conservation; Ecology
SC Biodiversity & Conservation; Environmental Sciences & Ecology
GA GQ2UP
UT WOS:000441514400006
DA 2020-07-08
ER

PT J
AU Isaacs, D
AF Isaacs, David
TI Zika virus increased virulence due to single amino acid mutation
SO JOURNAL OF PAEDIATRICS AND CHILD HEALTH
LA English
DT Editorial Material
C1 [Isaacs, David] Childrens Hosp Westmead, Sydney, NSW, Australia.
RP Isaacs, D (corresponding author), Childrens Hosp Westmead, Sydney, NSW, Australia.
EM david.isaacs@health.nsw.gov.au
CR Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 1
TC 0
Z9 0
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1034-4810
EI 1440-1754
J9 J PAEDIATR CHILD H
JI J. Paediatr. Child Health
PD AUG
PY 2018
VL 54
IS 8
BP 926
EP 927
PG 2
WC Pediatrics
SC Pediatrics
GA GP9PL
UT WOS:000441248800026
PM 30133893
DA 2020-07-08
ER

PT J
AU Artegiani, B
   Clevers, H
AF Artegiani, Benedetta
   Clevers, Hans
TI Use and application of 3D-organoid technology
SO HUMAN MOLECULAR GENETICS
LA English
DT Review
ID ZIKA VIRUS-INFECTION; PLURIPOTENT STEM-CELLS; IN-VITRO EXPANSION; NEURAL
   PROGENITORS; CEREBRAL ORGANOIDS; HUMAN COLON; KIDNEY ORGANOIDS; SINGLE
   LGR5; GENOMIC DNA; DISEASE
AB The capacity of the 3D-organoid cultures to resemble a near-physiological tissue organization and to mimic - to a certain degree - organ functionality, make organoids an excellent model for applications spanning from basic developmental/stem cell research to personalized medicine. Here, we review key findings achieved through organoid technology, and we discuss applications such as disease - and tumour modelling, correction of genetic mutations and understanding gene - and cell functions. Finally, we discuss future developments in the field.
C1 [Artegiani, Benedetta; Clevers, Hans] Univ Med Ctr Utrecht, Hubrecht Inst, Royal Netherlands Acad Arts & Sci, Utrecht, Netherlands.
   [Artegiani, Benedetta; Clevers, Hans] Univ Utrecht, Utrecht, Netherlands.
   [Artegiani, Benedetta; Clevers, Hans] Oncode Inst, Utrecht, Netherlands.
RP Artegiani, B (corresponding author), Univ Med Ctr Utrecht, Hubrecht Inst, Royal Netherlands Acad Arts & Sci, Utrecht, Netherlands.; Artegiani, B (corresponding author), Univ Utrecht, Utrecht, Netherlands.
EM b.artegiani@hubrecht.eu; h.clevers@hubrecht.eu
FU FEBS_Long Term fellowship; NWO/VENINetherlands Organization for
   Scientific Research (NWO) [863.15.015]
FX BA was supported by a FEBS_Long Term fellowship and the NWO/VENI
   (863.15.015).
CR Andersson ER, 2018, GASTROENTEROLOGY, V154, P1080, DOI 10.1053/j.gastro.2017.11.002
   Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525
   Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013
   Bartfeld S, 2016, DEV BIOL, V420, P262, DOI 10.1016/j.ydbio.2016.09.014
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001
   Ben-David U, 2017, NAT GENET, V49, P1567, DOI 10.1038/ng.3967
   Bigorgne AE, 2014, J CLIN INVEST, V124, P328, DOI 10.1172/JCI71471
   Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021
   Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438
   Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Cruz NM, 2017, NAT MATER, V16, P1112, DOI [10.1038/nmat4994, 10.1038/NMAT4994]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dekkers JF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8278
   Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201
   Deng WL, 2018, STEM CELL REP, V10, P1267, DOI 10.1016/j.stemcr.2018.02.003
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6
   Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130
   Drost J, 2016, METHODS MOL BIOL, V1481, P141, DOI 10.1007/978-1-4939-6393-5_15
   Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415
   Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007
   Dye BR, 2015, ELIFE, V4, DOI 10.7554/eLife.05098
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937
   Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12
   Finnberg NK, 2017, ONCOTARGET, V8, P66747, DOI 10.18632/oncotarget.19965
   Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715
   Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003
   Fumagalli A, 2017, P NATL ACAD SCI USA, V114, pE2357, DOI 10.1073/pnas.1701219114
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644
   Guan Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94954
   Heo I., 2018, NATURE MICROBIOLOGY
   Ho BX, 2018, INT J MOL SCI, V19
   Huang JY, 2015, CELL HOST MICROBE, V18, P147, DOI 10.1016/j.chom.2015.07.002
   Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Huch M, 2015, DEVELOPMENT, V142, P3113, DOI 10.1242/dev.118570
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204
   Huch M, 2013, REGEN MED, V8, P385, DOI 10.2217/rme.13.39
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017
   Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989
   Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803
   Kim YK, 2017, STEM CELLS, V35, P2366, DOI 10.1002/stem.2707
   Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298
   Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee SH, 2018, CELL, V173, P515, DOI 10.1016/j.cell.2018.03.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Loomans CJM, 2018, STEM CELL REP, V10, P712, DOI 10.1016/j.stemcr.2018.02.005
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802
   McCauley HA, 2017, DEVELOPMENT, V144, P958, DOI 10.1242/dev.140731
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   Nie J, 2017, EMBO REP, V18, P367, DOI 10.15252/embr.201643732
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oost KC, 2018, CELL REP, V22, P1600, DOI 10.1016/j.celrep.2018.01.033
   Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111
   Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3
   Sachs N, 2018, CELL, V172, P373, DOI 10.1016/j.cell.2017.11.010
   Sachs N, 2014, CURR OPIN GENET DEV, V24, P68, DOI 10.1016/j.gde.2013.11.012
   Sasaki N, 2016, P NATL ACAD SCI USA, V113, pE5399, DOI 10.1073/pnas.1607327113
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Seino T, 2018, CELL STEM CELL, V22, P454, DOI 10.1016/j.stem.2017.12.009
   Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012
   Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894
   Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695
   Takata N, 2018, J HUM GENET, V63, P165, DOI 10.1038/s10038-017-0348-0
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001
   Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009
   Tsai S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4238-4
   van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053
   Verissimo CS, 2016, ELIFE, V5, DOI 10.7554/eLife.18489
   Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weeber F, 2015, P NATL ACAD SCI USA, V112, P13308, DOI 10.1073/pnas.1516689112
   Wiegerinck CL, 2014, GASTROENTEROLOGY, V147, P65, DOI 10.1053/j.gastro.2014.04.002
   Woo DH, 2016, CELL STEM CELL, V19, P397, DOI 10.1016/j.stem.2016.05.024
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin YB, 2015, ANTIVIR RES, V123, P120, DOI 10.1016/j.antiviral.2015.09.010
   Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 103
TC 19
Z9 18
U1 1
U2 29
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 1
PY 2018
VL 27
IS R2
BP R99
EP R107
DI 10.1093/hmg/ddy187
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA GP5WH
UT WOS:000440946500003
PM 29796608
OA Bronze
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
AF Mehrjardi, Mohammad Zare
TI Watch out for congenital Zika syndrome in non-endemic regions
SO JOURNAL OF PERINATAL MEDICINE
LA English
DT Editorial Material
DE Brain calcification; congenital Zika syndrome; CZS; microcephaly;
   non-endemic; prenatal diagnosis; screening; TORCH; ultrasound; Zika
   virus
ID VIRUS-INFECTION EMPHASIS; NEUROIMAGING FINDINGS; PICTORIAL ESSAY
AB Zika virus (ZIKV), first discovered in 1947, is the most recent member of the TORCH family. It usually causes an asymptomatic or mildly symptomatic disease in infected adults but can lead to severe brain abnormalities in fetuses who are infected in utero by vertical transmission of the virus through the placenta. The constellation of these fetal/neonatal abnormalities is named as congenital Zika syndrome (CZS). Although horizontal transmission of ZIKV is largely dependent on the presence of the vector (i.e. Aedes mosquitoes), women residing in non-endemic areas are still at risk of acquiring the infection once they travel to an endemic region or have unprotected sexual contact with an infected male. Therefore, it is important for physicians practicing in non-endemic regions to be familiar with the clinical and neuroimaging manifestations of CZS and to consider this diagnosis as a potential etiology for congenital microcephaly and other fetal central nervous system abnormalities.
C1 [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Sch Med, Dept Radiol, Shohada Tajrish Hosp, Tehran 1989934148, Iran.
   [Mehrjardi, Mohammad Zare] Climax Radiol Educ Fdn, Div Clin Res, Sect Fetal Imaging, Tehran, Iran.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Radiol, Shohada Tajrish Hosp, Tehran 1989934148, Iran.; Mehrjardi, MZ (corresponding author), Climax Radiol Educ Fdn, Div Clin Res, Sect Fetal Imaging, Tehran, Iran.
EM zare@sbmu.ac.ir
RI Zare Mehrjardi, Mohammad/G-8980-2017
OI Zare Mehrjardi, Mohammad/0000-0001-5793-5323
CR Kulkarni AM, 2010, AM J MED GENET A, V152A, P930, DOI 10.1002/ajmg.a.33358
   Mehrjardi Mohammad Zare, 2017, VirusDisease, V28, P247, DOI 10.1007/s13337-017-0399-z
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P87, DOI 10.1007/s11604-016-0605-8
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
NR 9
TC 2
Z9 2
U1 0
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0300-5577
EI 1619-3997
J9 J PERINAT MED
JI J. Perinat. Med.
PD AUG
PY 2018
VL 46
IS 6
BP 687
EP 690
DI 10.1515/jpm-2017-0191
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GP5RW
UT WOS:000440931900016
PM 29267173
DA 2020-07-08
ER

PT J
AU Dudley, DM
   Van Rompay, KK
   Coffey, LL
   Ardeshir, A
   Keesler, RI
   Bliss-Moreau, E
   Grigsby, PL
   Steinbach, RJ
   Hirschs, AJ
   MacAllister, RP
   Pecoraro, HL
   Colgin, LM
   Hodge, T
   Streblows, DN
   Tardif, S
   Patterson, JL
   Tamhankar, M
   Seferovic, M
   Aagaard, KM
   Sanchez-San Martin, C
   Chiu, CY
   Panganiban, AT
   Veazey, RS
   Wang, XL
   Manesss, NJ
   Gilbert, MH
   Bohm, RP
   Waldort, KMA
   Gale, M
   Rajagopal, L
   Hotchkiss, CE
   Mohr, EL
   Capuano, SV
   Simmons, HA
   Mejia, A
   Friedrich, TC
   Golos, TG
   O'Connor, DH
AF Dudley, Dawn M.
   Van Rompay, Koen K.
   Coffey, Lark L.
   Ardeshir, Amir
   Keesler, Rebekah, I
   Bliss-Moreau, Eliza
   Grigsby, Peta L.
   Steinbach, Rosemary J.
   Hirschs, Alec J.
   MacAllister, Rhonda P.
   Pecoraro, Heidi L.
   Colgin, Lois M.
   Hodge, Travis
   Streblows, Daniel N.
   Tardif, Suzette
   Patterson, Jean L.
   Tamhankar, Manasi
   Seferovic, Maxim
   Aagaard, Kjersti M.
   Sanchez-San Martin, Claudia
   Chiu, Charles Y.
   Panganiban, Antonito T.
   Veazey, Ronald S.
   Wang, Xiaolei
   Manesss, Nicholas J.
   Gilbert, Margaret H.
   Bohm, Rudolf P.
   Waldort, Kristina M. Adams
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Hotchkiss, Charlotte E.
   Mohr, Emma L.
   Capuano, Saverio V., III
   Simmons, Heather A.
   Mejia, Andres
   Friedrich, Thomas C.
   Golos, Thaddeus G.
   O'Connor, David H.
TI Miscarriage and stillbirth following maternal Zika virus infection in
   nonhuman primates
SO NATURE MEDICINE
LA English
DT Article
ID PREGNANCY OUTCOMES; TERRITORIES; BRAZIL; BRAIN; RATES
AB Zika virus (ZIKV) infection is associated with congenital defects and pregnancy loss. Here, we found that 26% of nonhuman primates infected with Asian/American ZIKV in early gestation experienced fetal demise later in pregnancy despite showing few clinical signs of infection. Pregnancy loss due to asymptomatic ZIKV infection may therefore be a common but under-recognized adverse outcome related to maternal ZIKV infection.
C1 [Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Van Rompay, Koen K.; Ardeshir, Amir; Keesler, Rebekah, I; Bliss-Moreau, Eliza] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Van Rompay, Koen K.; Coffey, Lark L.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Grigsby, Peta L.; Steinbach, Rosemary J.] Oregon Natl Primate Res Ctr, Dept Reprod & Dev Sci, Portland, OR USA.
   [Hirschs, Alec J.; Streblows, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.
   [Hirschs, Alec J.; Streblows, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Portland, OR 97006 USA.
   [MacAllister, Rhonda P.; Hodge, Travis] Oregon Natl Primate Res Ctr, Div Comparat Med, Portland, OR USA.
   [Pecoraro, Heidi L.; Colgin, Lois M.] Oregon Natl Primate Res Ctr, Pathol Serv Unit, Div Comparat Med, Portland, OR USA.
   [Tardif, Suzette] Southwest Fdn Biomed Res, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA.
   [Patterson, Jean L.; Tamhankar, Manasi] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX USA.
   [Seferovic, Maxim; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Sanchez-San Martin, Claudia; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA.
   [Panganiban, Antonito T.; Manesss, Nicholas J.] Tulane Natl Primate Res Ctr, Div Microbiol, New Orleans, LA 70130 USA.
   [Panganiban, Antonito T.] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA.
   [Veazey, Ronald S.; Wang, Xiaolei] Tulane Natl Primate Res Ctr, Div Comparat Pathol, New Orleans, LA USA.
   [Gilbert, Margaret H.; Bohm, Rudolf P.] Tulane Natl Primate Res Ctr, Div Vet Med, New Orleans, LA USA.
   [Waldort, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Ctr Global Infect Dis Res, Seattle Childrens Res Inst, Seattle, WA USA.
   [Hotchkiss, Charlotte E.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA.
   [Mohr, Emma L.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA.
   [Capuano, Saverio V., III; Simmons, Heather A.; Mejia, Andres; Friedrich, Thomas C.; Golos, Thaddeus G.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Golos, Thaddeus G.] Univ Wisconsin, Dept Comparat Biosci & Obstet & Gynecol, Madison, WI USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; Van Rompay, KK (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.; Van Rompay, KK (corresponding author), Univ Calif Davis, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.; Streblows, DN (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.; Streblows, DN (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Portland, OR 97006 USA.; Tardif, S (corresponding author), Southwest Fdn Biomed Res, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA.; Panganiban, AT (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, New Orleans, LA 70130 USA.; Panganiban, AT (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70118 USA.; Waldort, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
EM kkvanrompay@ucdavis.edu; streblow@ohsu.edu; stardif@txbiomed.org;
   apanagani@tulane.edu; adamsk@u.washington.edu; dhoconno@wisc.edu
RI Ardeshir, Amir/Q-1258-2017
OI Ardeshir, Amir/0000-0002-4330-4659; Steinbach,
   Rosemary/0000-0003-0257-7308
FU DHHS/PHS/NIH [R01Al116382-01A1]; Pediatric Infectious Diseases Society;
   Office of Research Infrastructure Programs/OD grant [P51OD011106];
   Research Facilities Improvement ProgramUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Research Resources (NCRR) [RR15459-01, RR020141-01];
   CNPRC pilot research grant [1R21AI129479-01]; Office of Research
   Infrastructure Programs/OD [P51OD011107]; FDA contract
   [HHSF223201610542P]; Pathology, Microbiology and Immunology Department;
   National Institutes of Health Office of Research Infrastructure Programs
   [P51OD011092]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI099795-05,
   R01HL105704, R21AI129455]; National Institutes of Health Office of
   Research Infrastructure Program [P51OD011104, P51 OD010425, P51
   ODOD011133]; University of Washington Department of Obstetrics
   Gynecology; Seattle Children's Research Institute; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI100989, AI083019, AI104002];
   Texas Biomedical Research Institute;  [R21HD091032]
FX We thank the Veterinary Services, Colony Management, Scientific Protocol
   Implementation, and Pathology Services staff at the WNPRC for their
   contribution to this study. We thank M. Harke, K. Brunner, T. Frost, M.
   Schotzko, W Newton, K. Antony, S. Kohn, C. Newman, L. Stewart, M.
   Koenig, M. Breitbach, and M. Mohns for technical assistance and for
   monitoring the ZIKV-infected pregnant animals at WNPRC. We thank J.
   Eickhoff for help with statistical analysis. We thank T. Morgan for help
   with interpreting pathology. Studies at WNPRC were supported by
   DHHS/PHS/NIH R01Al116382-01A1 to D.H.O. and by the Pediatric Infectious
   Diseases Society to E.L.M. We thank E. Kallas for providing information
   on 2016 live-birth rates in Brazil. This work was also supported in part
   by the Office of Research Infrastructure Programs/OD grant (P51OD011106)
   awarded to WNPRC, Madison-Wisconsin. This research was conducted in part
   at a facility constructed with support from Research Facilities
   Improvement Program grants RR15459-01 and RR020141-01. The studies at
   CNPRC were supported by a CNPRC pilot research grant, 1R21AI129479-01
   (K.K.V.R.), the Office of Research Infrastructure Programs/OD
   (P51OD011107) (CNPRC), FDA contract HHSF223201610542P (L.L.C.) and
   start-up funds from the Pathology, Microbiology and Immunology
   Department to L.L.C. We thank V. Bakula, I. Cazares, M. Christensen, C.
   Cruzen, A. Gibbons, D. Lemos, A. Singapuri, J. Usachenko, W von
   Morgenland, J. Watanabe, J. Yee, A. Murphy, and the staff of Clinical
   Labs, Veterinary and Colony Research Services for technical assistance.
   Work at the ONPRC was supported by the National Institutes of Health
   Office of Research Infrastructure Programs grant (P51OD011092) to ONPRC
   and R21HD091032 to D.N.S. We thank L. Drew Martin, B. Dozier and N.
   Sternberger for their veterinary expertise, and the dedicated staff in
   the ONPRC Department of Comparative Medicine for assistance with animal
   care. The studies at Tulane National Primate Research Center (TNPRC)
   were supported by NIH grant R01 AI099795-05 to X.W. and by the National
   Institutes of Health Office of Research Infrastructure Program grant
   (P51OD011104) to TNPRC. We thank F. Schiro, R. Blair, and P. Aye for
   technical assistance. At WaNPRC, the work was primarily supported by
   generous private philanthropic gifts, including those from five donors
   from Florida who wish to remain anonymous. Further support was obtained
   from the University of Washington Department of Obstetrics & Gynecology,
   the Seattle Children's Research Institute, and National Institutes of
   Health grants R01AI100989 (L.R. and K.A.W.), AI083019 (M.G.), and
   AI104002 (M.G.). The National Institutes of Health Office of Research
   Infrastructure Programs (P51 OD010425) also supported this project. We
   thank J. Ogle, W Lee, and J. Thiel for technical assistance in
   monitoring the animals. Work at SNPRC was supported by NIH grants
   R01HL105704 and R21AI129455 (C.Y.C.), National Institutes of Health
   Office of Research Infrastructure Programs grant P51 ODOD011133 to
   SNPRC, and the Texas Biomedical Research Institute. We thank D.
   Layne-Colon for marmoset pregnancy management, ultrasonography, and
   collection and processing of placental and fetal material. We also thank
   S. Davis for technical support; M. Suter for guidance in the placental
   studies and analysis; and X. de Lamballerie (European Virus Archive) and
   B. Russell (CDC) for providing ZIKV strains.
CR Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Esposito DL, 2017, AM J TROP MED HYG, V97, P610
   GOLUB MS, 1988, LAB ANIM SCI, V38, P435
   Heger W, 1988, NONHUMAN PRIMATES DE
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401
NR 26
TC 28
Z9 29
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2018
VL 24
IS 8
BP 1104
EP +
DI 10.1038/s41591-018-0088-5
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA GP5ZF
UT WOS:000440955500014
PM 29967348
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Luna, E
   Romano, C
   Araujo, E
   Felix, AC
   Nakasone, O
   Campos, S
   Fernandes, L
   Levi, JE
   Santiago, N
   Fernandes, J
   Fragoso, D
   Kallas, E
   Pannuti, C
AF Luna, E.
   Romano, C.
   Araujo, E.
   Felix, A. C.
   Nakasone, O.
   Campos, S.
   Fernandes, L.
   Levi, J. E.
   Santiago, N.
   Fernandes, J.
   Fragoso, D.
   Kallas, E.
   Pannuti, C.
TI Low prevalence after the first Zika virus epidemic wave in Southeastern
   Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Luna, E.; Romano, C.; Felix, A. C.; Campos, S.; Levi, J. E.; Santiago, N.; Kallas, E.; Pannuti, C.] Univ Sao Paulo, Sao Paulo, SP, Brazil.
   [Araujo, E.; Nakasone, O.; Fernandes, L.; Fernandes, J.; Fragoso, D.] Hosp Ana Costa, Santos, Brazil.
RI Luna, Expedito J A/B-7948-2012
OI Luna, Expedito J A/0000-0002-1145-9672
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016/16069-8]
FX Grant FAPESP no. 2016/16069-8
NR 0
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA SADI 12.00
BP 17
EP 17
DI 10.1016/j.ijid.2018.04.3464
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100030
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU van der Linden, V
AF van der Linden, V.
TI Long-term Zika complications
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 01.001
BP 30
EP 30
DI 10.1016/j.ijid.2018.04.3491
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100057
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cabral, J
   Faical, A
   Almeida, B
   Oliveira, JV
   Embirucu, E
   Ferreira, N
   Reis, L
   Salles, C
   Cabral, B
   Costa, B
   Francisco, MV
   Santos, C
   Alcantara, LC
   Acosta, A
   Siqueira, I
AF Cabral, J.
   Faical, A.
   Almeida, B.
   Oliveira, J. V.
   Embirucu, E.
   Ferreira, N.
   Reis, L.
   Salles, C.
   Cabral, B.
   Costa, B.
   Francisco, M. V.
   Santos, C.
   Alcantara, L. C.
   Acosta, A.
   Siqueira, I.
TI Neurodevelopmental delays arising from in utero exposure to Zika virus
   in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Cabral, J.; Almeida, B.; Costa, B.; Francisco, M. V.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Faical, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Oliveira, J. V.; Santos, C.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Embirucu, E.; Ferreira, N.; Reis, L.; Salles, C.; Cabral, B.; Acosta, A.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.002
BP 48
EP 49
DI 10.1016/j.ijid.2018.04.3533
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100099
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Saron, W
   Rathore, A
   St John, A
AF Saron, W.
   Rathore, A.
   St John, A.
TI Maternal immunity and antibodies to dengue can promote Zika
   virus-induced microcephaly in fetuses
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Saron, W.; St John, A.] Duke NUS Med Sch, Singapore, Singapore.
   [Rathore, A.] Duke Univ, Durham, NC 27706 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.001
BP 48
EP 48
DI 10.1016/j.ijid.2018.04.3532
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100098
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU do Rosario, M
   Jesus, P
   Farias, D
   Novaes, MA
   Moura, D
   Lima, F
   Santos, C
   Giovanetti, M
   Alcantara, LC
   Siqueira, I
AF do Rosario, M.
   Jesus, P.
   Farias, D.
   Novaes, M. A.
   Moura, D.
   Lima, F.
   Santos, C.
   Giovanetti, M.
   Alcantara, L. C.
   Siqueira, I.
TI Neurological complications associated with arboviruses during Zika
   outbreak in Salvador, Bahia-Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [do Rosario, M.; Santos, C.; Giovanetti, M.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Jesus, P.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Farias, D.] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Novaes, M. A.] Hosp Sao Rafael, Salvador, BA, Brazil.
   [Moura, D.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI Giovanetti, Marta/AAK-7408-2020; de Siqueira, Isadora
   Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.004
BP 49
EP 49
DI 10.1016/j.ijid.2018.04.3534
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100100
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU O'Reilly, K
   Brady, O
   Yakob, L
AF O'Reilly, K.
   Brady, O.
   Yakob, L.
TI Projecting the end of the Zika epidemic in Latin America: A modelling
   analysis
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [O'Reilly, K.; Brady, O.; Yakob, L.] LSHTM, London, England.
RI Yakob, Laith/AAD-4521-2019
OI Yakob, Laith/0000-0001-8639-4511
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.005
BP 49
EP 50
DI 10.1016/j.ijid.2018.04.3535
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100101
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fajardo, TCG
   Vedovello, D
   Botelho-Silva, AC
   Laranja, LR
   Mello, AS
   Melo, MC
   Duarte, SP
AF Fajardo, T. C. G.
   Vedovello, D.
   Botelho-Silva, A. C.
   Laranja, L. R.
   Mello, A. S.
   Melo, M. C.
   Duarte, S. P.
CA G Cohort Zika Virus Grp Study
TI Seroepidemiology of Arbovirus in pregnant women participating in Cohort
   study in Jundiai, SP, Brazil: Preliminaries results of Cohort Zika -
   Jundiai
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Fajardo, T. C. G.; Vedovello, D.; Botelho-Silva, A. C.; Laranja, L. R.; Mello, A. S.; Melo, M. C.; Duarte, S. P.; G Cohort Zika Virus Grp Study] Fac Med Jundiai, Jundiai, Brazil.
OI FAJARDO, THAMIRYS/0000-0003-1096-1078
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2016 / 08578-0]
FX FAPESP (2016 / 08578-0)
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 22.006
BP 50
EP 50
DI 10.1016/j.ijid.2018.04.3536
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100102
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Luz, KG
AF Luz, K. G.
TI Zika congenital syndorme: experience in Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Luz, K. G.] Hosp Giselda Trigueiro, Natal, RN, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 48.002
BP 70
EP 70
DI 10.1016/j.ijid.2018.04.3586
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100152
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Musso, D
AF Musso, D.
TI Neurological complications of Zika virus: Experience in French Polynesia
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Musso, D.] Inst Louis Malarde Tahiti, Tapeete Tahiti, France.
RI Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 48.001
BP 70
EP 70
DI 10.1016/j.ijid.2018.04.3585
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100151
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cardona-Ospina, J
AF Cardona-Ospina, J.
TI Risk factors, comorbidities and coinfections with Zika virus infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Cardona-Ospina, J.] Univ Tecnol Pereira, Pereira, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 48.004
BP 71
EP 71
DI 10.1016/j.ijid.2018.04.3588
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100154
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
AF Rodriguez-Morales, A. J.
TI Severe, atypical and fatal cases of Zika virus infection: Experience in
   Colombia
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Rodriguez-Morales, A. J.] Univ Cent Venezuela, Caracas, DC, Venezuela.
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 48.003
BP 71
EP 71
DI 10.1016/j.ijid.2018.04.3587
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100153
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Screaton, G
AF Screaton, G.
TI The human antibody response in Dengue and Zika virus infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Screaton, G.] Univ Oxford, Oxfprd, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA 55.001
BP 78
EP 78
DI 10.1016/j.ijid.2018.04.3604
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100170
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Almeida, B
   Cabral, J
   Faical, A
   Oliveira, JV
   Souza, M
   Salles, C
   Vianna, MI
   D'Agostino, E
   Ferreira, N
   Reis, L
   Embirucu, E
   Santos, C
   Duarte, A
   Acosta, A
   Siqueira, I
AF Almeida, B.
   Cabral, J.
   Faical, A.
   Oliveira, J. V.
   Souza, M.
   Salles, C.
   Vianna, M. I.
   D'Agostino, E.
   Ferreira, N.
   Reis, L.
   Embirucu, E.
   Santos, C.
   Duarte, A.
   Acosta, A.
   Siqueira, I.
TI Discordant congenital Zika virus infection in dizygotic twins: a case
   report
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Almeida, B.; Cabral, J.; Oliveira, J. V.; Santos, C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvador, BA, Brazil.
   [Faical, A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Souza, M.; Salles, C.; Vianna, M. I.; D'Agostino, E.; Ferreira, N.; Reis, L.; Embirucu, E.; Acosta, A.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Duarte, A.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
RI de Siqueira, Isadora Cristina/R-9953-2016
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA Sat_Statio
BP 107
EP 107
DI 10.1016/j.ijid.2018.04.3662
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100228
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Giavedoni, L
   Callery, J
   Hodara, V
   Parodi, L
   Glenn, J
   Obregon-Perko, V
   Patterson, J
   Frost, P
   Clemmons, E
   Cox, L
AF Giavedoni, L.
   Callery, J.
   Hodara, V.
   Parodi, L.
   Glenn, J.
   Obregon-Perko, V.
   Patterson, J.
   Frost, P.
   Clemmons, E.
   Cox, L.
TI The baboon as a nonhuman primate model for the study of natural Zika
   virus infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Giavedoni, L.] Texas Biomed Res Inst, Virol & Immunol, San Antonio, TX USA.
   [Callery, J.; Hodara, V.; Parodi, L.; Obregon-Perko, V.; Patterson, J.] Texas Biomed, V&I, San Antonio, TX USA.
   [Glenn, J.] Texas Biomed, Genet, San Antonio, TX USA.
   [Frost, P.; Clemmons, E.] Texas Biomed, SNPRC, San Antonio, TX USA.
   [Cox, L.] Wake Forest Univ, Bowman Gray Sch Med, Wiston Salem, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 007
BP 116
EP 116
DI 10.1016/j.ijid.2018.04.3681
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100247
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Yu, LS
   Yu, LS
   Moser, N
   Manzano, JR
   Wang, SF
   Chen, YH
   Holmes, AH
   Georgiou, P
AF Yu, L. -S.
   Yu, L. -S.
   Moser, N.
   Manzano, J. Rodriguez
   Wang, S. -F.
   Chen, Y. -H.
   Holmes, A. H.
   Georgiou, P.
TI Engineering rapid and sensitive electronic diagnostics for dengue and
   Zika viruses
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Yu, L. -S.; Moser, N.; Manzano, J. Rodriguez; Georgiou, P.] Imperial Coll London, Ctr Bioinspired Technol, Dept Elect & Elect Engn, London, England.
   [Yu, L. -S.; Wang, S. -F.; Chen, Y. -H.] Kaohsiung Med Univ, Kaohsiung, Taiwan.
   [Holmes, A. H.] Imperial Coll London, London, England.
   [Holmes, A. H.] Imperial Coll Healthcare NHS trust, Natl Ctr Infect Prevent & Management Med, London, England.
OI Georgiou, Pantelis/0000-0003-2476-3857
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 157
BP 166
EP 166
DI 10.1016/j.ijid.2018.04.3790
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100356
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Stukolova, O
   Karan, L
   Magassouba, NF
   Goptar, I
   Sudina, A
   Dedkov, V
   Dolgova, A
   Cherkashina, A
   Boiro, MY
   Shipulin, G
AF Stukolova, O.
   Karan, L.
   Magassouba, N. F.
   Goptar, I.
   Sudina, A.
   Dedkov, V.
   Dolgova, A.
   Cherkashina, A.
   Boiro, M. Y.
   Shipulin, G.
TI Detection of IgM and IgG in the sera samples from patients with
   unspecified fever collected in Republic of Guinea, using the developed
   microarray based on the recombinant antigens of arboviruses (ZIKV, DV,
   CHIKV, CCFV, RVFV)
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Stukolova, O.; Karan, L.; Goptar, I.; Sudina, A.; Dedkov, V.; Dolgova, A.; Shipulin, G.] Cent Res Inst Epidemiol, Mol Diagnost & Epidemiol, Moscow, Russia.
   [Magassouba, N. F.] Donka Natl Hosp, Lab Natl Fievres Hemorrag Guinee, Conakry, Guinea.
   [Cherkashina, A.] Izmerov Res Inst Occupat Hlth, Moscow, Russia.
   [Boiro, M. Y.] Inst Appl Biol Guinea, Kindia, Guinea.
RI Shipulin, German A/J-1167-2014; Dolgova, Anna S/G-7414-2017; Dedkov,
   Vladimir G/M-7010-2018
OI Shipulin, German A/0000-0002-3668-6601; Dolgova, Anna
   S/0000-0001-8730-4872; Dedkov, Vladimir G/0000-0002-5500-0169
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 161
BP 168
EP 168
DI 10.1016/j.ijid.2018.04.3794
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100360
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dolgova, A
   Stukolova, O
   Karan, L
   Grigoreva, I
   Shipulin, G
   Maleev, V
AF Dolgova, A.
   Stukolova, O.
   Karan, L.
   Grigoreva, I.
   Shipulin, G.
   Maleev, V.
TI Development of the microarray tecnology for investigation of antibody
   responses during Zika virus infection and of anti-Flaviviruses IgM/IgG
   cross-reactivity
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Dolgova, A.; Stukolova, O.; Karan, L.; Grigoreva, I.; Shipulin, G.; Maleev, V.] Cent Res Inst Epidemiol, Moscow, Russia.
RI Dolgova, Anna S/G-7414-2017; Shipulin, German A/J-1167-2014
OI Dolgova, Anna S/0000-0001-8730-4872; Shipulin, German
   A/0000-0002-3668-6601
FU Russian Scientific FundRussian Science Foundation (RSF) [17-75-10093]
FX This study was supported by the Russian Scientific Fund grant
   #17-75-10093.
NR 0
TC 0
Z9 0
U1 1
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 182
BP 174
EP 175
DI 10.1016/j.ijid.2018.04.3810
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100376
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Oliveira, JV
   Duarte, A
   Santos, C
   Pessoa, L
   Magalhaes, C
   Lima, J
   Carvalho, D
   Xavier, T
   Figueiredo, E
   Giovanetti, M
   Almeida, B
   Goes, J
   Lima, F
   Alcantara, LC
   Siqueira, I
AF Oliveira, J. V.
   Duarte, A.
   Santos, C.
   Pessoa, L.
   Magalhaes Filho, C.
   Lima, J.
   Carvalho, D.
   Xavier, T.
   Figueiredo, E.
   Giovanetti, M.
   Almeida, B.
   Goes, J.
   Lima, F.
   Alcantara, L. C.
   Siqueira, I.
TI Prevalence of Zika, dengue and Chikungunya virus infection in pregnant
   women and surveillance of congenital Zika infection in Salvador, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Oliveira, J. V.; Santos, C.; Pessoa, L.; Magalhaes Filho, C.; Lima, J.; Carvalho, D.; Giovanetti, M.; Almeida, B.; Goes, J.; Alcantara, L. C.; Siqueira, I.] Inst Goncalo Moniz Fiocruz, Salvdor, Brazil.
   [Duarte, A.; Lima, F.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Xavier, T.; Figueiredo, E.] Maternidade Referencia Prof Jose Maria Magalhaes, Salvador, BA, Brazil.
RI Giovanetti, Marta/AAK-7408-2020; de Siqueira, Isadora
   Cristina/R-9953-2016; amsalu, ribka/G-8780-2019
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; 
NR 0
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 202
BP 182
EP 182
DI 10.1016/j.ijid.2018.04.3826
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100392
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Francis, L
   Hunte, SA
   Valadere, AM
   Polson-Edwards, K
   Asin-Oostburg, V
   Hospedales, CJ
AF Francis, L.
   Hunte, S. -A.
   Valadere, A. M.
   Polson-Edwards, K.
   Asin-Oostburg, V.
   Hospedales, C. J.
TI Zika virus outbreak in 19 English- and Dutch-speaking Caribbean
   countries and territories, 2015-2016
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Francis, L.; Polson-Edwards, K.; Asin-Oostburg, V.; Hospedales, C. J.] Caribbean Publ Hlth Agcy, Surveillance Dis Prevent & Control, Port Of Spain, Trinidad Tobago.
   [Hunte, S. -A.] Caribbean Publ Hlth Agcy, Policy Planning & Res, Port Of Spain, Trinidad Tobago.
   [Valadere, A. M.] Caribbean Publ Hlth Agcy, Lab Serv, Port Of Spain, Trinidad Tobago.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 204
BP 183
EP 183
DI 10.1016/j.ijid.2018.04.3828
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100394
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Padilla-Ruiz, D
   Mendoza, A
   Alvarez, A
   Parra-Saad, EA
   Rodriguez-Morales, AJ
AF Villamil-Gomez, W. E.
   Padilla-Ruiz, D.
   Mendoza, A.
   Alvarez, A.
   Parra-Saad, E. A.
   Rodriguez-Morales, A. J.
TI Zika virus-associated urinary bladder agenesis, Colombia
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Villamil-Gomez, W. E.; Mendoza, A.; Alvarez, A.] Hosp Univ Sincelejo, Infect Dis & Infect Control Res Grp, Sucre, Sincelejo, Colombia.
   [Padilla-Ruiz, D.] Univ Metropolitana, Barranquilla, Colombia.
   [Parra-Saad, E. A.] Inst Nacl Salud, Pathol, Bogota, DC, Colombia.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Colombia.
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 213
BP 185
EP 186
DI 10.1016/j.ijid.2018.04.3834
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100400
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Zambrano, LI
   Vasquez-Bonilla, WO
   Fuentes-Barahona, IC
   Valle-Reconco, JA
   Da Silva, JC
   Rodriguez-Morales, AJ
AF Zambrano, L. I.
   Vasquez-Bonilla, W. O.
   Fuentes-Barahona, I. C.
   Valle-Reconco, J. A.
   Da Silva, J. C.
   Rodriguez-Morales, A. J.
TI Zika virus infection in Honduras: An analysis of the first 76
   epidemiological weeks, 2016-2017
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Zambrano, L. I.] Natl Autonomous Univ Honduras, Fac Med Sci, Dept Morphol Sci, Tegucigalpa, Honduras.
   [Zambrano, L. I.] Univ Fed, Escola Paulista Med UNIFESP EPM, Cardiovasc Div, Dept Physiol, Tegucigalpa, Honduras.
   [Vasquez-Bonilla, W. O.; Fuentes-Barahona, I. C.; Valle-Reconco, J. A.] Natl Autonomous Univ Honduras, Fac Med Sci, Tegucigalpa, Honduras.
   [Da Silva, J. C.] State Univ Hlth Sci Alagoas UNCISAL, Dept Human Physiol, Maceio, AL, Brazil.
   [Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Pereira, Colombia.
RI AJ, Rodriguez-Morales/R-9765-2016; da Silva, Jose Claudio/D-8731-2016;
   Zambrano, Lysien/N-8843-2015; Zambrano, Lysien/R-5628-2019
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; da Silva, Jose
   Claudio/0000-0003-3749-2822; Zambrano, Lysien/0000-0001-9002-5807;
   Zambrano, Lysien/0000-0001-9002-5807; Fuentes Barahona, Itzel
   Carolina/0000-0002-9995-2276
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 215
BP 186
EP 187
DI 10.1016/j.ijid.2018.04.3836
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100402
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Acevedo-Mendoza, WF
   Nasner-Posso, KM
   Martinez-Pulgarin, DF
   Restrepo-Lopez, A
   Cardona-Ospina, JA
AF Rodriguez-Morales, A. J.
   Acevedo-Mendoza, W. F.
   Nasner-Posso, K. M.
   Martinez-Pulgarin, D. F.
   Restrepo-Lopez, A.
   Cardona-Ospina, J. A.
TI Postnatal acquired fatal Zika Virus infection in the Americas: A
   systematic review
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Rodriguez-Morales, A. J.; Acevedo-Mendoza, W. F.; Nasner-Posso, K. M.; Restrepo-Lopez, A.; Cardona-Ospina, J. A.] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Martinez-Pulgarin, D. F.] Univ Nacl Colombia, Bogota, DC, Colombia.
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Martinez-Pulgarin, Dayron
   Fernando/0000-0002-9942-3868
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 239
BP 195
EP 195
DI 10.1016/j.ijid.2018.04.3856
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100422
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Bonica, MB
   Goenaga, S
   Martin, ML
   Feroci, M
   Luppo, V
   Fabbri, C
   Morales, MA
   Micieli, MV
   Enria, D
   Levis, S
AF Bonica, M. B.
   Goenaga, S.
   Martin, M. L.
   Feroci, M.
   Luppo, V.
   Fabbri, C.
   Morales, M. A.
   Micieli, M. V.
   Enria, D.
   Levis, S.
TI Vector competence of Argentinean Aedes aegypti population for different
   strains of Zika virus
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Bonica, M. B.; Micieli, M. V.] Ctr Estudios Parasitol & Vectores CEPAVE UNLP, La Plata, Buenos Aires, Argentina.
   [Goenaga, S.; Martin, M. L.; Feroci, M.; Luppo, V.; Fabbri, C.; Morales, M. A.; Enria, D.; Levis, S.] Inst Nacl Enfermedades Virales Humanas INEVH Dr J, Pergamino, Argentina.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 242
BP 196
EP 196
DI 10.1016/j.ijid.2018.04.3859
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100425
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cabral, G
   Ferreira, JLDP
   Souza, R
   Cunha, MS
   Luchs, A
   Figueiredo, CA
   Macedo, LFB
AF Cabral, G.
   Ferreira, J. L. D. P.
   Souza, R.
   Cunha, M. S.
   Luchs, A.
   Figueiredo, C. A.
   Brigido Macedo, L. F.
TI Simple Protocol for population (Sanger) sequencing for Zika virus
   genomic regions
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Cabral, G.; Ferreira, J. L. D. P.; Cunha, M. S.; Figueiredo, C. A.] Adolfo Lutz Inst, Sao Paulo, SP, Brazil.
   [Souza, R.] Inst Adolfo Lutz CCD, Estado Saude Sao Paulo, Sao Paulo, Brazil.
   [Luchs, A.] Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, SP, Brazil.
   [Brigido Macedo, L. F.] Inst Infect Dis Emilio Ribas, Ctr Estudos, Sao Paulo, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 241
BP 196
EP 196
DI 10.1016/j.ijid.2018.04.3858
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100424
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jeffree, SM
   Dony, JJF
   Ahmed, K
AF Jeffree, S. M.
   Dony, J. Julian Frederick
   Ahmed, K.
TI The first outbreak of autochthonous Zika virus in Sabah, Malaysian
   Borneo
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Jeffree, S. M.] Univ Malaysia Sabah, Fac Med & Hlth Sci, Kota Kinabalu Sabah, Malaysia.
   [Dony, J. Julian Frederick] MOH Malaysia, Sabah, Malaysia.
   [Ahmed, K.] Univ Malaysia Sabah, Sabah, Malaysia.
RI Giloi, Nelbon/AAI-6269-2020; Ahmed, Kamruddin/I-6423-2016; Jeffree,
   Saffree Mohammad/G-1156-2017; Jeffree, Mohammad Saffree/AAD-2765-2020
OI Ahmed, Kamruddin/0000-0002-1869-3701; Jeffree, Saffree
   Mohammad/0000-0002-0373-4451; Jeffree, Mohammad
   Saffree/0000-0002-0373-4451
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 297
BP 213
EP 213
DI 10.1016/j.ijid.2018.04.3899
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100465
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Foley, I
   Ryan, M
   Modi, S
   Bearman, G
   Stevens, MP
AF Foley, I.
   Ryan, M.
   Modi, S.
   Bearman, G.
   Stevens, M. P.
TI Perceptions and Risk Factors for Zika Virus Infection at Two Sites in
   the Dominican Republic
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Foley, I.] Virginia Commonwealth Univ Hlth Syst, Internal Med, Richmond, VA USA.
   [Ryan, M.] Virginia Commonwealth Univ Hosp Syst, Dept Family Med & Populat Hlth, Richmond, VA USA.
   [Modi, S.] VCU Med Ctr, Dept Internal Med, Richmond, VA USA.
   [Bearman, G.] Virginia Commonwealth Univ, North Hosp, VCUHS Epidemiol & Infect Control, Richmond, VA USA.
   [Stevens, M. P.] Virginia Commonwealth Univ, Richmond, VA USA.
NR 0
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 323
BP 223
EP 223
DI 10.1016/j.ijid.2018.04.3920
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100486
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Carabali, M
   Austin, N
   King, NB
   Kaufman, JS
AF Carabali, M.
   Austin, N.
   King, N. B.
   Kaufman, J. S.
TI The zika epidemic and abortion in Latin America: a scoping review
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Carabali, M.; Austin, N.; King, N. B.; Kaufman, J. S.] McGill Univ, Epidemiol, Montreal, PQ, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 553
BP 297
EP 297
DI 10.1016/j.ijid.2018.04.4091
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100657
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hurtado, M
   Collazos-Zapata, N
   Martinez-Hurtado, AF
   Cortes-Tabares, C
   Gualteros-Restrepo, DA
   Ramirez-Echeverri, M
   Cardona-Ospina, JA
   Rodriguez-Morales, AJ
AF Hurtado, M.
   Collazos-Zapata, N.
   Martinez-Hurtado, A. F.
   Cortes-Tabares, C.
   Gualteros-Restrepo, D. A.
   Ramirez-Echeverri, M.
   Cardona-Ospina, J. A.
   Rodriguez-Morales, A. J.
TI Estimating the burden of disease and the economic cost attributable to
   Zika, Colombia, 2016
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Hurtado, M.; Collazos-Zapata, N.; Martinez-Hurtado, A. F.; Cortes-Tabares, C.; Gualteros-Restrepo, D. A.; Ramirez-Echeverri, M.; Cardona-Ospina, J. A.; Rodriguez-Morales, A. J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 794
BP 380
EP 380
DI 10.1016/j.ijid.2018.04.4273
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100838
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Supramaniam, A
   Lui, H
   Bellette, BM
   Rudd, PA
   Herrero, LJ
AF Supramaniam, Aroon
   Lui, Hayman
   Bellette, Bernadette M.
   Rudd, Penny A.
   Herrero, Lara J.
TI How myeloid cells contribute to the pathogenesis of prominent emerging
   zoonotic diseases
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Review
DE host defense; emerging-viral pathogens; immunity; viral-disease
ID EBOLA HEMORRHAGIC-FEVER; CHIKUNGUNYA VIRUS-INFECTIONS; DENGUE VIRUS;
   ZIKA VIRUS; DENDRITIC CELLS; CYNOMOLGUS MACAQUES; MOUSE MODEL;
   INFLAMMATORY RESPONSES; NONHUMAN-PRIMATES; ZAIRE EBOLAVIRUS
AB Up to 75% of emerging human diseases are zoonoses, spread from animals to humans. Although bacteria, fungi and parasites can be causative agents, the majority of zoonotic infections are caused by viral pathogens. During the past 20 years many factors have converged to cause a dramatic resurgence or emergence of zoonotic diseases. Some of these factors include demographics, social changes, urban sprawl, changes in agricultural practices and global climate changes. In the period between 2014-2017 zoonotic viruses including ebola virus (EBOV), chikungunya virus (CHIKV), dengue virus (DENV) and zika virus (ZIKV), caused prominent outbreaks resulting in significant public health and economic burdens, especially in developing areas where these diseases are most prevalent. When a viral pathogen invades a new human host, it is the innate immune system that serves as the first line of defence. Myeloid cells are especially important to help fight viral infections, including those of zoonotic origins. However, viruses such as EBOV, CHIKV, DENV and ZIKV have evolved mechanisms that allow circumvention of the host's innate immune response, avoiding eradication and leading to severe clinical disease. Herein, the importance of myeloid cells in host defence is discussed and the mechanisms by which these viruses exploit myeloid cells are highlighted. The insights provided in this review will be invaluable for future studies looking to identify potential therapeutic targets towards the treatment of these emerging diseases.
C1 [Supramaniam, Aroon; Rudd, Penny A.; Herrero, Lara J.] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld, Australia.
   [Lui, Hayman; Bellette, Bernadette M.; Herrero, Lara J.] Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld, Australia.
RP Herrero, LJ (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld, Australia.; Herrero, LJ (corresponding author), Griffith Univ, Sch Med, Gold Coast Campus, Southport, Qld, Australia.
EM l.herrero@griffith.edu.au
RI Lui, Hayman/X-1784-2019
OI Lui, Hayman/0000-0001-6034-4823
FU NHMRCNational Health and Medical Research Council of Australia [1081954]
FX This study was supported by an NHMRC project grant number awarded to
   L.J.H. (ID: 1081954).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Agarwal A, 2016, INFECT GENET EVOL, V40, P126, DOI 10.1016/j.meegid.2016.02.033
   Alhoot MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001410
   Arock M, 2002, J LEUKOCYTE BIOL, V71, P557
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x
   BASKERVILLE A, 1985, J PATHOL, V147, P199, DOI 10.1002/path.1711470308
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black BO, 2015, OBSTET MED, V8, P108, DOI 10.1177/1753495X15597354
   Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025
   Bray M, 2003, J INFECT DIS, V188, P1613, DOI 10.1086/379727
   Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018
   Bullerdiek J, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0240-1
   Burrack K, 2014, J IMMUNOL, V192
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Centers for Disease Control, 2014, GUID SAF HANDL HUM R
   Centers for Disease Control, 2014, DENGUEEPIDEMIOLOGY
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493
   Chu YT, 2015, IMMUNOLOGY, V146, P163, DOI 10.1111/imm.12492
   Chuang YC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/547094
   Cilloniz C, 2011, J VIROL, V85, P9060, DOI 10.1128/JVI.00659-11
   Dahlmann F, 2015, J INFECT DIS, V212, pS247, DOI 10.1093/infdis/jiv140
   Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107
   Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805
   Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickinson D B, 1965, S Afr J Med Sci, V30, P11
   Dolnik O, 2004, EMBO J, V23, P2175, DOI 10.1038/sj.emboj.7600219
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Duran A, 2013, INVEST CLIN, V54, P299
   Ebihara H, 2013, J INFECT DIS, V207, P306, DOI 10.1093/infdis/jis626
   Ebihara H, 2011, J INFECT DIS, V204, pS991, DOI 10.1093/infdis/jir336
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Escudero-Perez B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004509
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Feldmann H, 1999, ARCH VIROL, P159
   Moron AF, 2017, BJOG-INT J OBSTET GY, V124, P549, DOI 10.1111/1471-0528.14387
   Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008
   Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389
   FISHERHOCH SP, 1992, J INFECT DIS, V166, P753, DOI 10.1093/infdis/166.4.753
   Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697
   Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724
   Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2
   Geisbert TW, 2003, AM J PATHOL, V163, P2371, DOI 10.1016/S0002-9440(10)63592-4
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Gupta M, 2001, VIROLOGY, V284, P20, DOI 10.1006/viro.2001.0836
   Gupta M, 2007, VIROLOGY, V364, P45, DOI 10.1016/j.virol.2007.02.017
   Gupta M, 2010, VIROLOGY, V402, P203, DOI 10.1016/j.virol.2010.03.024
   Haist KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006748
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He Li, 2012, Chinese Journal of Virology, V28, P652
   Hensley LE, 2002, IMMUNOL LETT, V80, P169, DOI 10.1016/S0165-2478(01)00327-3
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Herrero LJ, 2013, PHARMACOL THERAPEUT, V137, P266, DOI 10.1016/j.pharmthera.2012.10.007
   Hey YY, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00652
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Hottz ED, 2014, J IMMUNOL, V193, P1864, DOI 10.4049/jimmunol.1400091
   Hutchinson KL, 2001, J MED VIROL, V65, P561, DOI 10.1002/jmv.2073
   Ignatiev GM, 2000, IMMUNOL LETT, V71, P131, DOI 10.1016/S0165-2478(99)00169-8
   Iwamoto H, 2015, IMMUN INFLAMM DIS, V3, P280, DOI 10.1002/iid3.67
   Jahrling PB, 1996, ARCH VIROL, P115
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jin HL, 2010, J GEN VIROL, V91, P352, DOI 10.1099/vir.0.017343-0
   Johnson RF, 2011, VIROLOGY, V421, P129, DOI 10.1016/j.virol.2011.09.016
   Kelley JF, 2011, VIROLOGY, V418, P27, DOI 10.1016/j.virol.2011.07.006
   Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010
   Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299
   Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051
   Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178
   Kudoyarova-Zubavichene NM, 1999, J INFECT DIS, V179, pS218, DOI 10.1086/514294
   Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x
   Kumar S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-313
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lakschevitz FS, 2016, EXP CELL RES, V342, P200, DOI 10.1016/j.yexcr.2016.03.007
   Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444
   Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee JJ, 2012, J ALLERGY CLIN IMMUN, V130, P572, DOI 10.1016/j.jaci.2012.07.025
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Long KM, 2013, J VIROL, V87, P5697, DOI 10.1128/JVI.01611-12
   Lovera D, 2014, PEDIATR INFECT DIS J, V33, P933, DOI 10.1097/INF.0000000000000340
   Lubaki NM, 2013, J VIROL, V87, P7471, DOI 10.1128/JVI.03316-12
   Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X
   Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marinho CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102014
   Martines RB, 2015, J PATHOL, V235, P153, DOI 10.1002/path.4456
   Martinez O, 2013, J VIROL, V87, P3801, DOI 10.1128/JVI.02695-12
   Martins K, 2015, VIRAL IMMUNOL, V28, P32, DOI 10.1089/vim.2014.0085
   Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110
   Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192
   Melo RCN, 2016, EXP CELL RES, V347, P385, DOI 10.1016/j.yexcr.2016.08.016
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohamadzadeh M, 2006, J VIROL, V80, P7235, DOI 10.1128/JVI.00543-06
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakayama E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00267
   Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304
   Nkoghe D, 2012, INT J DERMATOL, V51, P1037, DOI 10.1111/j.1365-4632.2011.05379.x
   Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105
   Perry DL, 2012, VIRUSES-BASEL, V4, P2400, DOI 10.3390/v4102400
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Pothapregada S, 2016, INDIAN J PEDIATR, V83, P493, DOI 10.1007/s12098-015-1942-9
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puerta-Guardo H, 2013, J VIROL, V87, P7486, DOI 10.1128/JVI.00085-13
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605
   Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Reed DS, 2011, MICROBES INFECT, V13, P930, DOI 10.1016/j.micinf.2011.05.002
   Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613
   Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470
   Ryabchikova EI, 1999, J INFECT DIS, V179, pS199, DOI 10.1086/514293
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Samarasinghe AE, 2017, J IMMUNOL, V198, P3214, DOI 10.4049/jimmunol.1600787
   Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Schnittler HJ, 1998, CLIN INFECT DIS, V27, P404, DOI 10.1086/517704
   Singla M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004497
   Smith LM, 2013, J INFECT DIS, V208, P310, DOI 10.1093/infdis/jis921
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17
   Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447
   Sun PF, 2011, VIROLOGY, V421, P245, DOI 10.1016/j.virol.2011.08.026
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   Taniguchi S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-189
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Tsai CY, 2015, J IMMUNOL, V194, P3890, DOI 10.4049/jimmunol.1303343
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Twenhafel NA, 2013, VET PATHOL, V50, P514, DOI 10.1177/0300985812469636
   Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10
   Valero N, 2014, VIRAL IMMUNOL, V27, P151, DOI 10.1089/vim.2013.0123
   Venugopalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111305
   Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI.79.4.2413-2419.2005
   Wahl-Jensen V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001359
   Waschbisch A, 2016, J IMMUNOL, V196, P1558, DOI 10.4049/jimmunol.1501960
   Wong G, 2014, EXPERT REV CLIN IMMU, V10, P781, DOI 10.1586/1744666X.2014.908705
   Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435
   World Health Organization, 2016, ZIK VIR
   World Health Organization, 2015, IMP DENG
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
   Wyers M, 1999, J INFECT DIS, V179, pS54, DOI 10.1086/514300
   Yen B, 2014, J VIROL, V88, P12500, DOI 10.1128/JVI.02163-14
   Yen BC, 2016, J VIROL, V90, P5108, DOI 10.1128/JVI.00191-16
   Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97
   Zampieri CA, 2007, NAT IMMUNOL, V8, P1159, DOI 10.1038/ni1519
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
NR 177
TC 4
Z9 4
U1 0
U2 4
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD AUG
PY 2018
VL 99
IS 8
BP 953
EP 969
DI 10.1099/jgv.0.001024
PG 17
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GO9XL
UT WOS:000440461400002
PM 29939125
OA Bronze
DA 2020-07-08
ER

PT J
AU Wand, NIV
   Bonney, LC
   Watson, RJ
   Graham, V
   Hewson, R
AF Wand, Nadina I. Vasileva
   Bonney, Laura C.
   Watson, Robert J.
   Graham, Victoria
   Hewson, Roger
TI Point-of-care diagnostic assay for the detection of Zika virus using the
   recombinase polymerase amplification method
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Zika; RPA; recombinase polymerase amplification; isothermal;
   point-of-care; field-diagnostic; molecular detection
ID GUILLAIN-BARRE-SYNDROME; AEDES-AEGYPTI MOSQUITOS; SEXUAL TRANSMISSION;
   RAPID DETECTION; YELLOW-FEVER; OUTBREAK; INFECTION; DEVICES; PLATFORM;
   FUTURE
AB The sudden and explosive expansion of Zika virus (ZIKV) from the African continent through Oceania and culminating in the outbreak in South America has highlighted the importance of new rapid point-of-care diagnostic tools for the control and prevention of transmission. ZIKV infection has devastating consequences, such as neurological congenital malformations in infants born to infected mothers and Guillain-Barre syndrome in adults. Additionally, its potential for transmission through vector bites, as well as from person to person through blood transfusions and sexual contact, are important considerations for prompt diagnosis. Recombinase polymerase amplification (RPA), an isothermal method, was developed as an alternative field-applicable assay to PCR. Here we report the development of a novel ZIKV real-time reverse transcriptase RPA (RT-RPA) assay capable of detecting a range of different ZIKV strains from a variety of geographical locations. The ZIKV RT-RPA was shown to be highly sensitive, being capable of detecting as few as five copies of target nucleic acid per reaction, and suitable for use with a battery-operated portable device. The ZIKV RT-RPA demonstrated 100 % specificity and 83 % sensitivity in clinical samples. Furthermore, we determined that the ZIKV RT-RPA is a versatile assay that can be applied to crude samples, such as saliva and serum, and can be used as a vector surveillance tool on crude mosquito homogenates. Therefore, the developed ZIKV RT-RPA is a useful diagnostic tool that can be transferred to a resource-limited location, eliminating the need for a specialized and sophisticated laboratory environment and highly trained staff.
C1 [Wand, Nadina I. Vasileva; Bonney, Laura C.; Watson, Robert J.; Graham, Victoria; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Microbiol Serv Div, Salisbury SP4 0JG, Wilts, England.
RP Wand, NIV (corresponding author), Publ Hlth England, Natl Infect Serv, Microbiol Serv Div, Salisbury SP4 0JG, Wilts, England.
EM nadina.wand@phe.gov.uk
FU PHE Pipeline Fund [PLF1617]
FX This research was supported by the PHE Pipeline Fund (ID: PLF1617).
CR Abd El Wahed A, 2017, PLOS CURR, P9
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Anez G, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01583-15
   [Anonymous], 2017, DIAGNOSTIC TESTS ZIK
   [Anonymous], 2017, ZIKA VIRUS SAMPLE TE
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Azevedo RSS, 2016, GENOME SEQUENC UNPUB
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Centers for Disease Control and Prevention, 2017, PROT YOURS OTH ZIK
   Chang CC, 2012, SENSORS-BASEL, V12, P8319, DOI 10.3390/s120608319
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Craw P, 2015, SENSORS-BASEL, V15, P23418, DOI 10.3390/s150923418
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829
   de Oliveira Dias JR, 2017, RETIN CASES BRIEF RE
   Demidov Vadim V, 2002, Expert Rev Mol Diagn, V2, P542, DOI 10.1586/14737159.2.6.542
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Elston JWT, 2017, PUBLIC HEALTH, V143, P60, DOI 10.1016/j.puhe.2016.10.020
   Fakruddin M, 2013, J PHARM BIOALLIED SC, V5, P245, DOI 10.4103/0975-7406.120066
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Folkers KM, 2017, PUBLIC HEALTH, V148, P66, DOI 10.1016/j.puhe.2017.02.018
   Giuffrida MC, 2017, BIOSENS BIOELECTRON, V90, P174, DOI 10.1016/j.bios.2016.11.045
   Grard G, 2006, PHYLOGENY TICK UNPUB
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Hamon M, 2013, MOL CELLS, V36, P485, DOI 10.1007/s10059-013-0333-1
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Healy JM, 2016, MMWR-MORBID MORTAL W, V65, P1146, DOI 10.15585/mmwr.mm6541a4
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hughes MT, 2009, COMPLETE SEQUE UNPUB
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lewandowski K, 2016, DIRECT SUBMISSION ZI
   Li YM, 2017, MICROB PATHOGENESIS, V107, P54, DOI 10.1016/j.micpath.2017.03.016
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maffert P, 2017, EUR J CLIN MICROBIOL, V36, P1717, DOI 10.1007/s10096-017-3013-9
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miller E, 2017, J NEUROL SCI, V375, P367, DOI 10.1016/j.jns.2017.02.029
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Netto M, 2012, DIRECT SUBMISSION MA
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Sahiner F, 2017, PEDIATR INFECT DIS J, V36, pE341, DOI 10.1097/INF.0000000000001689
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Sharma S, 2015, BIOSENSORS-BASEL, V5, P577, DOI 10.3390/bios5030577
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Villamil-Gomez WE, 2017, TRAVEL MED INFECT DI, V16, P62, DOI 10.1016/j.tmaid.2017.03.012
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e
   Zika virus (ZIKV), 2017, ZIKA VIRUS ZIKV CLIN
NR 88
TC 9
Z9 9
U1 0
U2 9
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD AUG
PY 2018
VL 99
IS 8
BP 1012
EP 1026
DI 10.1099/jgv.0.001083
PG 15
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GO9XL
UT WOS:000440461400007
PM 29897329
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Stambaugh, A
   Parks, JW
   Stott, MA
   Meena, GG
   Hawkins, AR
   Schmidt, H
AF Stambaugh, Alexandra
   Parks, Joshua W.
   Stott, Matthew A.
   Meena, Gopikrishnan G.
   Hawkins, Aaron R.
   Schmidt, Holger
TI Optofluidic detection of Zika nucleic acid and protein biomarkers using
   multimode interference multiplexing
SO BIOMEDICAL OPTICS EXPRESS
LA English
DT Article
ID AMPLIFICATION-FREE; VIRUS; EBOLA; CHIP; INTEGRATION; INFECTION; EPIDEMIC
AB The recent massive Zika virus (ZIKV) outbreak illustrates the need for rapid and specific diagnostic techniques. Detecting ZIKV in biological samples poses unique problems: antibody detection of ZIKV is insufficient due to cross-reactivity of Zika antibodies with other flaviviruses, and nucleic acid and protein biomarkers for ZIKV are detectable at different stages of infection. Here, we describe a new optofluidic approach for the parallel detection of different molecular biomarkers using multimode interference (MMI) waveguides. We report differentiated, multiplex detection of both ZIKV biomarker types using multi-spot excitation at two visible wavelengths with over 98% fidelity by combining several analysis techniques. (C) 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement
C1 [Stambaugh, Alexandra; Parks, Joshua W.; Meena, Gopikrishnan G.; Schmidt, Holger] Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
   [Stott, Matthew A.; Hawkins, Aaron R.] Brigham Young Univ, ECEn Dept, 459 Clyde Bldg, Provo, UT 84602 USA.
RP Stambaugh, A (corresponding author), Univ Calif Santa Cruz, Sch Engn, 1156 High St, Santa Cruz, CA 95064 USA.
EM amstamba@ucsc.edu
FU W.M. Keck Center for Nanoscale Optofluidics at UC Santa Cruz; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [4R33AI100229]; National Science Foundation
   (NSF)National Science Foundation (NSF) [CBET-1159453, CBET-1159423]
FX W.M. Keck Center for Nanoscale Optofluidics at UC Santa Cruz; NIH
   (4R33AI100229); National Science Foundation (NSF) (CBET-1159453 and
   CBET-1159423).
CR Cai H, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4968033
   Cai H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14494
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chiavaioli F, 2018, ACS SENSORS, V3, P936, DOI 10.1021/acssensors.7b00918
   Du K, 2017, BIOSENS BIOELECTRON, V91, P489, DOI 10.1016/j.bios.2016.12.071
   Fan XD, 2011, NAT PHOTONICS, V5, P591, DOI [10.1038/NPHOTON.2011.206, 10.1038/nphoton.2011.206]
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu S, 2014, NANO LETT, V14, P4816, DOI 10.1021/nl502400x
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osterholm MT, 2016, SCIENCE, V353, P1073, DOI 10.1126/science.aai9078
   Ozcelik D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12487-0
   Ozcelik D, 2017, NANOPHOTONICS-BERLIN, V6, P647, DOI 10.1515/nanoph-2016-0156
   Ozcelik D, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2503321
   Ozcelik D, 2015, P NATL ACAD SCI USA, V112, P12933, DOI 10.1073/pnas.1511921112
   Parks JW, 2013, LAB CHIP, V13, P4118, DOI 10.1039/c3lc50818h
   Schmidt H, 2011, NAT PHOTONICS, V5, P598, DOI [10.1038/nphoton.2011.163, 10.1038/NPHOTON.2011.163]
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   SOLDANO LB, 1995, J LIGHTWAVE TECHNOL, V13, P615, DOI 10.1109/50.372474
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Watzinger F., 2006, Molecular Aspects of Medicine, V27, P254, DOI 10.1016/j.mam.2005.12.001
   WHO, WHO FAST TRACK AV DI
   Yin DL, 2007, LAB CHIP, V7, P1171, DOI 10.1039/b708861b
NR 27
TC 3
Z9 4
U1 0
U2 3
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 2156-7085
J9 BIOMED OPT EXPRESS
JI Biomed. Opt. Express
PD AUG 1
PY 2018
VL 9
IS 8
AR UNSP 330752
DI 10.1364/BOE.9.003725
PG 6
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA GP0HQ
UT WOS:000440490500018
PM 30338150
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sukla, S
   Ghosh, A
   Saha, R
   De, A
   Adhya, S
   Biswas, S
AF Sukla, Soumi
   Ghosh, Anisa
   Saha, Rajdeep
   De, Abhishek
   Adhya, Samit
   Biswas, Subhajit
TI In-depth molecular analysis of a small cohort of human and Aedes
   mosquito (adults and larvae) samples from Kolkata revealed absence of
   Zika but high prevalence of dengue virus
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE Dengue serotypes; Zika; Aedes mosquito; transovarial transmission;
   Kolkata
ID POLYMERASE-CHAIN-REACTION; AEGYPTI MOSQUITOS; INDIA; TRANSMISSION;
   OUTBREAK; DELHI; SEROTYPES; INFECTION
AB Purpose. Zika virus infections have recently been reported in many dengue-endemic areas globally. Both dengue (DENV) and Zika (ZIKV) virus are transmitted by Aedes mosquitoes, raising the possibility of mixed infections in both vector and host. We evaluated DENV and ZIKV prevalence in human and vector samples in Kolkata, a DENV-endemic city.
   Methodology. Blood samples were collected from 70 patients presenting dengue-like fever symptoms at a hospital in Kolkata during 2015-16. Serum was obtained and tested for DENV infection by DENV NS1-based ELISA. Adult (n= 8) and larval stages (n= 12) of Aedes were also collected. A RT-PCR-based screening of both viruses supplemented by amplicon sequencing was performed.
   Results. Of the 70 samples, 20 DENV NS1-positive serum samples were used for detailed molecular study for DENV infection. Eighteen of these (90 %) were positive by hemi-nested serotype-specific RT-PCR for DENV1/2/3, with four samples showing evidence of DENV2-3 or DENV1-3 mixed infection. None were ZIKV-positive using NS5 or ENV-based PCR, though weak amplification of a DENV1 NS5 sequence was detected in three serum samples indicating cross-reactivity of the primers. All mosquito samples were ZIKV-negative, whereas 5/8 (63 %) of adult mosquitoes and 11/12 (92 %) of larvae were DENV3-positive.
   Conclusion. Both host and vector samples showed absence of ZIKV but high prevalence of DENV. The high rate of infection of larvae with DENV is suggestive of trans-ovarial transmission that could contribute to the surge of human infections during each post-monsoon season. It would be important to guard against false positives using the available Zika-reporting primer sets.
C1 [Sukla, Soumi; Ghosh, Anisa; Adhya, Samit; Biswas, Subhajit] CSIR Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.
   [Saha, Rajdeep] Calcutta Natl Med Coll & Hosp, Dept Microbiol, Kolkata 700014, W Bengal, India.
   [De, Abhishek] Calcutta Natl Med Coll & Hosp, Dept Dermatol, Kolkata 700014, W Bengal, India.
RP Biswas, S (corresponding author), CSIR Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India.
EM subhajit.biswas@iicb.res.in
OI Biswas, Subhajit/0000-0002-9001-7150; Sukla, Soumi/0000-0003-2267-8595
FU CSIR-IICB, Kolkata
FX The project was funded by institutional grant from CSIR-IICB, Kolkata.
CR Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209
   Angel B, 2009, INDIAN J MED RES, V129, P665
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bandyopadhyay B, 2013, ISRN VIROLOGY, P1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007
   Chung SJ, 2015, AM J TROP MED HYG, V92, P367, DOI 10.4269/ajtmh.14-0247
   Doss CGP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0234-6
   Dutta P, 2015, J VECTOR DIS, V52, P293
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hati A K, 2006, J Commun Dis, V38, P124
   Hati AK, 2009, J VECTOR DIS, V46, P197
   Hoang LP, 2009, DIAGN MICR INFEC DIS, V63, P372, DOI 10.1016/j.diagmicrobio.2008.12.009
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Khan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147416
   Kumari R, 2011, TROP MED INT HEALTH, V16, P949, DOI 10.1111/j.1365-3156.2011.02789.x
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reddy MN, 2017, PEERJ, V5, DOI 10.7717/peerj.2970
   Rohani A, 2014, J VECTOR DIS, V51, P327
   Saha K, 2016, J MED VIROL, V88, P1697, DOI 10.1002/jmv.24529
   Sarkar A, 2012, J TROP MED, V2012, P1
   Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002
   Thielman AC, 2007, CANADIAN J ARTHROPOD
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Victor TJ, 2002, INDIAN J MED RES, V116, P133
   Vikram K, 2015, J VECTOR DIS, V52, P129
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization [WHO], 2017, ZIK VIR INF IND
NR 36
TC 0
Z9 0
U1 0
U2 2
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD AUG
PY 2018
VL 67
IS 8
BP 1109
EP 1119
DI 10.1099/jmm.0.000769
PG 11
WC Microbiology
SC Microbiology
GA GO9XV
UT WOS:000440462400014
PM 29897327
OA Bronze
DA 2020-07-08
ER

PT J
AU Brouillette, RB
   Phillips, EK
   Patel, R
   Mahauad-Fernandez, W
   Moller-Tank, S
   Rogers, KJ
   Dillard, JA
   Cooney, AL
   Martinez-Sobrido, L
   Okeoma, C
   Maury, W
AF Brouillette, Rachel B.
   Phillips, Elisabeth K.
   Patel, Radhika
   Mahauad-Fernandez, Wadie
   Moller-Tank, Sven
   Rogers, Kai J.
   Dillard, Jacob A.
   Cooney, Ashley L.
   Martinez-Sobrido, Luis
   Okeoma, Chioma
   Maury, Wendy
TI TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Lassa virus; TIM-1; arenavirus; phosphatidylserine; phosphatidylserine
   receptor; receptor; viral lipids; virus entry
ID LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-CELL IMMUNOGLOBULIN; RESIDENT
   PERITONEAL-MACROPHAGES; MUSCLE ALPHA-DYSTROGLYCAN; RECEPTOR TYROSINE
   KINASES; HUMAN DENDRITIC CELLS; NIEMANN-PICK C1; PHOSPHATIDYLSERINE
   RECEPTOR; APOPTOTIC CELLS; AIRWAY HYPERREACTIVITY
AB Lassa virus (LASV) is an Old World arenavirus responsible for hundreds of thousands of infections in West Africa every year. LASV entry into a variety of cell types is mediated by interactions with glycosyltransferase LARGE-modified O-linked glycans present on the ubiquitous receptor alpha-dystroglycan (alpha DG). However, cells lacking alpha DG are permissive to LASV infection, suggesting that alternative receptors exist. Previous studies demonstrated that the phosphatidylserine (PtdSer)-binding receptors Axl and Tyro3 along with C-type lectin receptors mediate alpha DG-independent entry. Here, we demonstrate that another PtdSer receptor, TIM-1, mediates LASV glycoprotein (GP)pseudotyped virion entry into alpha DG-knocked-out HEK 293T and wild-type (WT) Vero cells, which express alpha DG lacking appropriate glycosylation. To investigate the mechanism by which TIM-1 mediates enhancement of entry, we demonstrate that mutagenesis of the TIM-1 IgV domain PtdSer-binding pocket abrogated transduction. Furthermore, the human TIM-1 IgV domain-binding monoclonal antibody ARD5 blocked transduction of pseudovirions bearing LASV GP in a dose-dependent manner. Finally, as we showed previously for other viruses that use TIM-1 for entry, a chimeric TIM-1 protein that substitutes the proline-rich region (PRR) from murine leukemia virus envelope (Env) for the mucin-like domain served as a competent receptor. These studies provide evidence that, in the absence of a functional alpha DG, TIM-1 mediates the entry of LASV pseudoviral particles through interactions of virions with the IgV PtdSer-binding pocket of TIM-1.
   IMPORTANCE PtdSer receptors, such as TIM-1, are emerging as critical entry factors for many enveloped viruses. Most recently, hepatitis C virus and Zika virus have been added to a growing list. PtdSer receptors engage with enveloped viruses through the binding of PtdSer embedded in the viral envelope, defining them as GP-independent receptors. This GP-independent entry mechanism should effectively mediate the entry of all enveloped viruses, yet LASV GP-pseudotyped viruses were previously found to be unresponsive to PtdSer receptor enhancement in HEK 293T cells. Here, we demonstrate that LASV pseudovirions can utilize the PtdSer receptor TIM-1 but only in the absence of appropriately glycosylated alpha-dystroglycan (alpha DG), the high-affinity cell surface receptor for LASV. Our studies shed light on LASV receptor utilization and explain why previous studies performed with alpha-DG-expressing cells did not find that LASV pseudovirions utilize PtdSer receptors for virus uptake.
C1 [Brouillette, Rachel B.; Phillips, Elisabeth K.; Patel, Radhika; Mahauad-Fernandez, Wadie; Moller-Tank, Sven; Rogers, Kai J.; Dillard, Jacob A.; Cooney, Ashley L.; Okeoma, Chioma; Maury, Wendy] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.
   [Martinez-Sobrido, Luis] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA.
   [Okeoma, Chioma] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.
RP Maury, W (corresponding author), Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA.
EM wendy-maury@uiowa.edu
OI Cooney, Ashley/0000-0003-2717-9138; Mahauad Fernandez,
   Wadie/0000-0002-2203-8443; Maury, Wendy/0000-0002-9892-4484
FU NIH Regional Center of Excellence (RCE) [U54 AI1057156]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI077519, T32 AI007533, T32 GM067795]
FX The work was supported by a developmental award to W.M. from an NIH
   Regional Center of Excellence (RCE) grant (U54 AI1057156; principal
   investigator, David Walker) and by NIH grant R01 AI077519 (to W.M.).
   R.B.B. was supported by NIH training grant T32 AI007533. K.J.R. was
   supported by NIH training grant T32 GM067795.
CR Albacker LA, 2010, J IMMUNOL, V185, P6839, DOI 10.4049/jimmunol.1001360
   Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197
   Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814
   Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06
   BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M
   Brancaccio A, 1997, EUR J BIOCHEM, V246, P166, DOI 10.1111/j.1432-1033.1997.00166.x
   Briggs DC, 2016, NAT CHEM BIOL, V12, P810, DOI [10.1038/nchembio.2146, 10.1038/NCHEMBIO.2146]
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   BUCHMEIER MJ, 2001, FIELDS VIROLOGY, P1635
   Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Chiba A, 1997, J BIOL CHEM, V272, P2156
   Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380
   Das A, 2017, MBIO, V8, DOI 10.1128/mBio.00969-17
   DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059
   Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fedeli C, 2018, J VIROL, V92, DOI 10.1128/JVI.01613-17
   Feng ZD, 2015, J CLIN INVEST, V125, P169, DOI 10.1172/JCI77527
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123
   GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7
   Goncalves AR, 2013, J VIROL, V87, P11504, DOI 10.1128/JVI.01893-13
   Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108
   Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2
   Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9
   Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971
   IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651
   IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0
   Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487
   Imperiali M, 2008, J GEN VIROL, V89, P2713, DOI 10.1099/vir.0.2008/004721-0
   Jae LT, 2014, SCIENCE, V344, P1506, DOI 10.1126/science.1252480
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Kielian M, 2000, Subcell Biochem, V34, P409
   Kim HY, 2013, J ALLERGY CLIN IMMUN, V132, P414, DOI 10.1016/j.jaci.2013.03.025
   Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011
   Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108
   Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111
   Kunz S, 2005, J VIROL, V79, P14282, DOI 10.1128/JVI.79.22.14282-14296.2005
   Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005
   Kunz S, 2004, VIROLOGY, V325, P432, DOI 10.1016/j.virol.2004.05.009
   Lee HH, 2010, J IMMUNOL, V185, P5225, DOI 10.4049/jimmunol.1001116
   Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598
   Mahauad-Fernandez WD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0493-8
   Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101
   McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3
   McIntire JJ, 2001, NAT IMMUNOL, V2, P1109, DOI 10.1038/ni739
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307
   Mizui M, 2008, INT IMMUNOL, V20, P695, DOI 10.1093/intimm/dxn029
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Moller-Tank S, 2014, J VIROL, V88, P6702, DOI 10.1128/JVI.00300-14
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022
   Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13
   Nunberg JH, 2012, VIRUSES-BASEL, V4, P83, DOI 10.3390/v4010083
   Oppliger J, 2016, J VIROL, V90, P6412, DOI 10.1128/JVI.00257-16
   Pannetier D, 2011, J VIROL, V85, P8293, DOI 10.1128/JVI.02120-10
   Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376
   Reignier T, 2006, VIROLOGY, V353, P111, DOI 10.1016/j.virol.2006.05.018
   Rhein BA, 2016, J VIROL, V90, P6097, DOI 10.1128/JVI.00100-16
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rodrigo WWSI, 2011, J VIROL, V85, P1684, DOI 10.1128/JVI.02229-10
   Rodriguez-Manzanet R, 2010, P NATL ACAD SCI USA, V107, P8706, DOI 10.1073/pnas.0910359107
   Rojek JA, 2007, J VIROL, V81, P5685, DOI 10.1128/JVI.02574-06
   Rojek JM, 2012, CELL MICROBIOL, V14, P1122, DOI 10.1111/j.1462-5822.2012.01784.x
   Russier M, 2012, EUR J IMMUNOL, V42, P1822, DOI 10.1002/eji.201142099
   Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008
   Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7
   Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11
   Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002
   STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0
   Sullivan BM, 2013, J VIROL, V87, P4071, DOI 10.1128/JVI.03268-12
   Torriani G, 2017, J VIROL, V91, DOI [10.1128/JVI.01902-16, 10.1128/jvi.01902-16]
   Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107
   Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512
NR 78
TC 15
Z9 15
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD AUG
PY 2018
VL 92
IS 16
AR e00093-18
DI 10.1128/JVI.00093-18
PG 15
WC Virology
SC Virology
GA GO7XD
UT WOS:000440292200004
PM 29875238
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Suparit, P
   Wiratsudakul, A
   Modchang, C
AF Suparit, Parinya
   Wiratsudakul, Anuwat
   Modchang, Charin
TI A mathematical model for Zika virus transmission dynamics with a
   time-dependent mosquito biting rate
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Zika virus; Climatic factors; Brazil; Vector control; Mosquito biting
   rate
ID AEDES-ALBOPICTUS; CHIKUNGUNYA; AEGYPTI; DENGUE; BORNE; OUTBREAK; VECTOR
AB Background: Mathematical modeling has become a tool used to address many emerging diseases. One of the most basic and popular modeling frameworks is the compartmental model. Unfortunately, most of the available compartmental models developed for Zika virus (ZIKV) transmission were designed to describe and reconstruct only past, short-time ZIKV outbreaks in which the effects of seasonal change to entomological parameters can be ignored. To make an accurate long-term prediction of ZIKV transmission, the inclusion of seasonal effects into an epidemic model is unavoidable.
   Methods: We developed a vector-borne compartmental model to analyze the spread of the ZIKV during the 2015-2016 outbreaks in Bahia, Brazil and to investigate the impact of two vector control strategies, namely, reducing mosquito biting rates and reducing mosquito population size. The model considered the influences of seasonal change on the ZIKV transmission dynamics via the time-varying mosquito biting rate. The model was also validated by comparing the model prediction with reported data that were not used to calibrate the model.
   Results: We found that the model can give a very good fit between the simulation results and the reported Zika cases in Bahia (R-square = 0.9989). At the end of 2016, the total number of ZIKV infected people was predicted to be 1.2087 million. The model also predicted that there would not be a large outbreak from May 2016 to December 2016 due to the decrease of the susceptible pool. Implementing disease mitigation by reducing the mosquito biting rates was found to be more effective than reducing the mosquito population size. Finally, the correlation between the time series of estimated mosquito biting rates and the average temperature was also suggested.
   Conclusions: The proposed ZIKV transmission model together with the estimated weekly biting rates can reconstruct the past long-time multi-peak ZIKV outbreaks in Bahia.
C1 [Suparit, Parinya; Modchang, Charin] Mahidol Univ, Fac Sci, Dept Phys, Biophys Grp, Bangkok 10400, Thailand.
   [Wiratsudakul, Anuwat] Mahidol Univ, Fac Vet Sci, Dept Clin Sci & Publ Hlth, Phutthamonthon 73170, Nakhon Pathom, Thailand.
   [Wiratsudakul, Anuwat] Mahidol Univ, Fac Vet Sci, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Phutthamonthon 73170, Nakhon Pathom, Thailand.
   [Modchang, Charin] CHE, Ctr Excellence Math, Bangkok 10400, Thailand.
   [Modchang, Charin] CHE, Thailand Ctr Excellence Phys, 328 Si Ayutthaya Rd, Bangkok 10400, Thailand.
RP Modchang, C (corresponding author), Mahidol Univ, Fac Sci, Dept Phys, Biophys Grp, Bangkok 10400, Thailand.; Modchang, C (corresponding author), CHE, Ctr Excellence Math, Bangkok 10400, Thailand.
EM charin.mod@mahidol.edu
RI Wiratsudakul, Anuwat/V-2619-2019
OI Wiratsudakul, Anuwat/0000-0002-1112-3220; Modchang,
   Charin/0000-0002-0739-006X
FU National Science and Technology Development Agency, Thailand
   [P-16-50695]; Thailand Center of Excellence in Physics (ThEP); Centre of
   Excellence in Mathematics; Commission on Higher Education,
   ThailandOffice of Higher Education Commission (OHEC)
FX This project is financially supported by National Science and Technology
   Development Agency, Thailand (Project ID P-16-50695), the Thailand
   Center of Excellence in Physics (ThEP), and the Centre of Excellence in
   Mathematics, the Commission on Higher Education, Thailand.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Ferreira DAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2025-8
   de Souza DR, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012709
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ewing DA, 2016, J THEOR BIOL, V400, P65, DOI 10.1016/j.jtbi.2016.04.008
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goeijenbier M, 2016, NETH J MED, V74, P104
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lee HS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2326-8
   Huber JH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006451
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lee EK, 2016, COMPARTMENTAL MODEL
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Nugent EK, 2017, AM J MED SCI, V353, P466, DOI 10.1016/j.amjms.2016.12.018
   Organization P. A. H. O. W. H, 2017, ZIK EP REP BRAZ
   Chavez JP, 2017, MATH BIOSCI, V289, P29, DOI 10.1016/j.mbs.2017.04.005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Siraj AS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005797
   Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368
   Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038
   Wahid B, 2016, ASIAN PAC J TROP MED, V9, P723, DOI 10.1016/j.apjtm.2016.06.019
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006
   Wiratsudakul A, 2018, PEERJ, V6, DOI 10.7717/peerj.4526
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 46
TC 5
Z9 5
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD AUG 1
PY 2018
VL 15
AR 11
DI 10.1186/s12976-018-0083-z
PG 11
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA GO9TJ
UT WOS:000440450200001
PM 30064447
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wood, H
AF Wood, Heather
TI Targeting TNF to alleviate Zika virus complications
SO NATURE REVIEWS NEUROLOGY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-4758
EI 1759-4766
J9 NAT REV NEUROL
JI Nat. Rev. Neurol.
PD AUG
PY 2018
VL 14
IS 8
BP 450
EP 451
DI 10.1038/s41582-018-0035-6
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA GO5JQ
UT WOS:000440057300005
PM 29930323
DA 2020-07-08
ER

PT J
AU Walker, CL
   Merriam, AA
   Ohuma, EO
   Dighe, MK
   Gale, M
   Rajagopal, L
   Papageorghiou, AT
   Gyamfi-Bannerman, C
   Waldorf, KMA
AF Walker, Christie L.
   Merriam, Audrey A.
   Ohuma, Eric O.
   Dighe, Manjiri K.
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Papageorghiou, Aris T.
   Gyamfi-Bannerman, Cynthia
   Waldorf, Kristina M. Adams
TI Femur-sparing pattern of abnormal fetal growth in pregnant women from
   New York City after maternal Zika virus infection
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE biomarker; biometry; biparietal diameter; congenital Zika virus
   syndrome; femur length; fetal growth restriction; fetal infection;
   fetus; head circumference; INTERGROWTH-21st; intrauterine growth
   restriction; microcephaly; pregnancy; teratogenesis; ultrasound; virus;
   Zika
ID ULTRASOUND MEASUREMENTS; INTERIM GUIDANCE; INFANTS; OUTCOMES;
   CIRCUMFERENCE; RESTRICTION; TERRITORIES; PREDICTOR; STANDARDS; UPDATE
AB BACKGROUND: Zika virus is a mosquito-transmitted flavivirus, which can induce fetal brain injury and growth restriction following maternal infection during pregnancy. Prenatal diagnosis of Zika virus-associated fetal injury in the absence of microcephaly is challenging due to an incomplete understanding of how maternal Zika virus infection affects fetal growth and the use of different sonographic reference standards around the world. We hypothesized that skeletal growth is unaffected by Zika virus infection and that the femur length can represent an internal standard to detect growth deceleration of the fetal head and/or abdomen by ultrasound.
   OBJECTIVE: We sought to determine if maternal Zika virus infection is associated with a femur-sparing pattern of intrauterine growth restriction through analysis of fetal biometric measures and/or body ratios using the 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project and World Health Organization Fetal Growth Chart sonographic references.
   STUDY DESIGN: Pregnant women diagnosed with a possible recent Zika virus infection at Columbia University Medical Center after traveling to an endemic area were retrospectively identified and included if a fetal ultrasound was performed. Data were collected regarding Zika virus testing, fetal biometry, pregnancy, and neonatal outcomes. The 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project and World Health Organization Fetal Growth Chart sonographic standards were applied to obtain Z-scores and/or percentiles for fetal head circumference, abdominal circumference, and femur length specific for each gestational week. A novel 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project standard was also developed to generate Z-scores for fetal body ratios with respect to femur length (head circumference: femur length, abdominal circumference: femur length). Data were then grouped within clinically relevant gestational age strata (<24, 24-27 6/7, 28-33 6/7,>34 weeks) to analyze time-dependent effects of Zika virus infection on fetal size. Statistical analysis was performed using Wilcoxon signed-rank test on paired data, comparing either abdominal circumference or head circumference to femur length.
   RESULTS: A total of 56 pregnant women were included in the study with laboratory evidence of a confirmed or possible recent Zika virus infection. Based on the Centers for Disease Control and Prevention definition for microcephaly after congenital Zika virus exposure, microcephaly was diagnosed in 5% (3/56) by both the 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project and World Health Organization Fetal Growth Chart standards (head circumference Z-score <=-2 or <= 2.3%). Using 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project, intrauterine fetal growth restriction was diagnosed in 18% of pregnancies (10/56; abdominal circumference Z-score <=-1.3, < 10%). Analysis of fetal size using the last ultrasound scan for all subjects revealed a significantly abnormal skewing of fetal biometrics with a smaller abdominal circumference vs femur length by either 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project or World Health Organization Fetal Growth Chart (P <.001 for both). A difference in distribution of fetal abdominal circumference compared to femur length was first apparent in the 24-27 6/7 week strata (2014 International Fetal and Newborn Growth Consortium for the 21st Century Project, P =.002; World Health Organization Fetal Growth Chart, P =.001). A significantly smaller head circumference compared to femur length was also observed by 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project as early as the 28-33 6/7 week strata (2014 International Fetal and Newborn Growth Consortium for the 21st Century Project, P =.007). Overall, a femur-sparing pattern of growth restriction was detected in 52% of pregnancies with either head circumference: femur length or abdominal circumference: femur length fetal body ratio < 10th percentile (2014 International Fetal and Newborn Growth Consortium for the 21st Century Project Z-score <=-1.3).
   CONCLUSION: An unusual femur-sparing pattern of fetal growth restriction was detected in the majority of fetuses with congenital Zika virus exposure. Fetal body ratios may represent a more sensitive ultrasound biomarker to detect viral injury in nonmicrocephalic fetuses that could impart long-term risk for complications of congenital Zika virus infection.
C1 [Walker, Christie L.] Univ Washington, Div Maternal Fetal Med, Seattle, WA 98195 USA.
   [Walker, Christie L.; Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Dighe, Manjiri K.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.; Rajagopal, Lakshmi; Waldorf, Kristina M. Adams] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Merriam, Audrey A.; Gyamfi-Bannerman, Cynthia] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY USA.
   [Ohuma, Eric O.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [Ohuma, Eric O.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford, England.
   [Papageorghiou, Aris T.] Univ Oxford, Nuffield Dept Obstet & Gynecol, Oxford, England.
   [Papageorghiou, Aris T.] Univ Oxford, Green Templeton Coll, Oxford Maternal & Perinatal Hlth Inst, Oxford, England.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Waldorf, Kristina M. Adams] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
RP Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden.
EM adamsk@uw.edu
FU University of Washington Department of Obstetrics and Gynecology;
   Seattle Children's Research Institute; National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI100989, AI083019, AI104002]
FX This work was primarily supported by generous private philanthropic
   gifts mainly from 5 donors in Florida, who wish to remain anonymous.
   Further support was obtained from the University of Washington
   Department of Obstetrics and Gynecology; Seattle Children's Research
   Institute; and the National Institutes of Health (NIH), grants
   R01AI100989 (L.R. and K.M.A.W), AI083019 (M.G.), and AI104002 (M.G.).
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH or other funders.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Altman DG, 2013, BJOG-INT J OBSTET GY, V120, P71, DOI 10.1111/1471-0528.12031
   Anderson M. S., 1999, NEONATOLOGY PATHOPHY, P411
   ARAGAO MDV, 2016, BMJ BRIT MED J, V353
   Baschat AA, 2017, OBSTET NORMAL PROBLE, P737
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Centers for Disease Control and Prevention, CONG ZIK SYNDR OTH B
   Centers for Disease Control and Prevention, GUIDANCE FOR LABORAT
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Dashe JS, 2000, OBSTET GYNECOL, V96, P321, DOI 10.1016/S0029-7844(00)00943-1
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dissanayake HA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1971
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gordijn SJ, 2016, ULTRASOUND OBST GYN, V48, P333, DOI 10.1002/uog.15884
   HADLOCK FP, 1982, AM J ROENTGENOL, V139, P367, DOI 10.2214/ajr.139.2.367
   HADLOCK FP, 1982, AM J ROENTGENOL, V138, P649, DOI 10.2214/ajr.138.4.649
   HADLOCK FP, 1982, AM J ROENTGENOL, V138, P875, DOI 10.2214/ajr.138.5.875
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Pettker CM, 2017, OBSTET GYNECOL, V129, pE150, DOI 10.1097/AOG.0000000000002046
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sanders RC, 2006, CLINICAL SONOGRAPHY
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   VINTZILEOS AM, 1985, OBSTET GYNECOL, V66, P477
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   World Health Organization, 2016, WHOZIKVMOC163
   Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]
   WU YY, 2017, SCI REP, V7
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 46
TC 12
Z9 12
U1 0
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD AUG
PY 2018
VL 219
IS 2
AR 187.e1-e20
DI 10.1016/j.ajog.2018.04.047
PG 20
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GO2ZL
UT WOS:000439850300013
PM 29738748
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Rajapakse, NS
   Ellsworth, K
   Liesman, RM
   Ho, ML
   Henry, N
   Theel, ES
   Wallace, A
   Alvino, ACI
   de Mello, LM
   Meneses, J
AF Rajapakse, Nipunie S.
   Ellsworth, Kevin
   Liesman, Rachael M.
   Ho, Mai Lan
   Henry, Nancy
   Theel, Elitza S.
   Wallace, Adam
   Alvino, Ana Catarina Ishigami
   de Mello, Luisa Medeiros
   Meneses, Jucille
TI Unilateral Phrenic Nerve Palsy in Infants with Congenital Zika Syndrome
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS-INFECTION; DIAPHRAGMATIC PARALYSIS; SPINAL-CORD; TRANSMISSION;
   POSTMORTEM; EPIDEMIC; BRAZIL
AB Since the first identification of neonatal microcephaly cases associated with congenital Zika virus infection in Brazil in 2015, a distinctive constellation of clinical features of congenital Zika syndrome has been described. Fetal brain disruption sequence is hypothesized to underlie the devastating effects of the virus on the central nervous system. However, little is known about the effects of congenital Zika virus infection on the peripheral nervous system. We describe a series of 4 cases of right unilateral diaphragmatic paralysis in infants with congenital Zika syndrome suggesting peripheral nervous system involvement and Zika virus as a unique congenital infectious cause of this finding. All the patients described also had arthrogryposis (including talipes equinovarus) and died from complications related to progressive respiratory failure.
C1 [Rajapakse, Nipunie S.; Ellsworth, Kevin; Liesman, Rachael M.; Ho, Mai Lan; Henry, Nancy; Theel, Elitza S.; Wallace, Adam] Mayo Clin, Marian Hall 5,200 1st St SW, Rochester, MN 55905 USA.
   [Alvino, Ana Catarina Ishigami; de Mello, Luisa Medeiros; Meneses, Jucille] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
RP Rajapakse, NS (corresponding author), Mayo Clin, Div Pediat Infect Dis, Marian Hall 5,200 1st St SW, Rochester, MN 55905 USA.
EM rajapakse.nipunie@mayo.edu
OI Rajapakse, Nipunie/0000-0001-9286-2473
CR Adebanjo T, 2017, MMWR MORB MORTAL WKL
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Betensley AD, 2004, THORAX, V59, P268, DOI 10.1136/thorax.2003.009092
   Chien J, 2008, SINGAP MED J, V49, pE340
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Imai T, 2006, INTERNAL MED, V45, P563, DOI 10.2169/internalmedicine.45.1657
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Medina MT, 2016, J NEUROL SCI, V369, P271, DOI 10.1016/j.jns.2016.08.044
   Melero MJ, 2014, LUNG INDIA, V31, P149, DOI 10.4103/0970-2113.129846
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ramalho FS, 2017, CLIN INFECT DIS, V65, P687, DOI 10.1093/cid/cix374
   Ratnayake EC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-46
   Russell K, 2016, MMWR MORB MORTAL WKL
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Souza Alex Sandro Rolland, 2016, Rev. Bras. Saude Mater. Infant., V16, P467, DOI 10.1590/1806-93042016000400007
   STOWASSER M, 1990, MED J AUSTRALIA, V153, P555, DOI 10.5694/j.1326-5377.1990.tb126199.x
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 29
TC 2
Z9 2
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2018
VL 24
IS 8
BP 1422
EP 1427
DI 10.3201/eid2408.180057
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GN4ZI
UT WOS:000439050300004
PM 30016248
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yan, G
   Pang, L
   Cook, AR
   Ho, HJ
   Win, MS
   Khoo, AL
   Wong, JGX
   Lee, CK
   Yan, B
   Jureen, R
   Ho, SS
   Lye, DC
   Tambyah, PA
   Leo, YS
   Fisher, D
   Oon, J
   Bagdasarian, N
   Chow, A
   Smitasin, N
   Chai, LYA
AF Yan, Gabriel
   Pang, Long
   Cook, Alex R.
   Ho, Hanley J.
   Win, Mar Soe
   Khoo, Ai Leng
   Wong, Joshua G. X.
   Lee, Chun Kiat
   Yan, Benedict
   Jureen, Roland
   Ho, Siew Seen
   Lye, David C.
   Tambyah, Paul A.
   Leo, Yee Sin
   Fisher, Dale
   Oon, Jolene
   Bagdasarian, Natasha
   Chow, Angela
   Smitasin, Nares
   Chai, Louis Yi Ann
TI Distinguishing Zika and Dengue Viruses through Simple Clinical
   Assessment, Singapore
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB Dengue virus and Zika virus coexist in tropical regions in Asia where healthcare resources are limited; differentiating the 2 viruses is challenging. We showed in a case-control discovery cohort, and replicated in a validation cohort, that the diagnostic indices of conjunctivitis, platelet count, and monocyte count reliably distinguished between these viruses.
C1 [Yan, Gabriel; Pang, Long; Cook, Alex R.; Win, Mar Soe; Ho, Siew Seen; Tambyah, Paul A.; Fisher, Dale; Oon, Jolene; Bagdasarian, Natasha; Smitasin, Nares; Chai, Louis Yi Ann] Natl Univ Hlth Syst, Singapore, Singapore.
   [Pang, Long; Cook, Alex R.; Tambyah, Paul A.; Fisher, Dale; Bagdasarian, Natasha; Chai, Louis Yi Ann] Natl Univ Singapore, Singapore, Singapore.
   [Ho, Hanley J.; Wong, Joshua G. X.; Lye, David C.; Leo, Yee Sin; Chow, Angela] Tan Tock Seng Hosp, Singapore, Singapore.
   [Win, Mar Soe; Chai, Louis Yi Ann] Natl Univ, Inst Canc, Singapore, Singapore.
   [Khoo, Ai Leng] Natl Healthcare Grp, Singapore, Singapore.
   [Lee, Chun Kiat; Yan, Benedict; Jureen, Roland] Natl Univ Singapore Hosp, Singapore, Singapore.
   [Yan, Gabriel] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore.
RP Chai, LYA (corresponding author), Natl Univ Hlth Syst, Div Infect Dis, Univ Med Cluster, NUHS Tower Block,1E Kent Ridge Rd, Singapore 119228, Singapore.
EM chailouis@hotmail.com
RI Cook, Alex/S-3576-2019; Cook, Alex/B-5941-2011
OI Yan, Gabriel/0000-0003-3513-428X; Cook, Alex/0000-0002-6271-5832;
   Bagdasarian, Natasha/0000-0003-1133-8309; Lye,
   David/0000-0003-0324-0205; Wong, Joshua/0000-0001-8268-5610
FU Clinician Scientist Award (CSA); Individual Research Grant (IRG);
   Bedside & Bench (BB) grants; Centre Grant; Training Fellowship Award
   from National Medical Research Council (NMRC), Singapore; Aspiration
   Grant; Summit Research Program; Bench to Bedside Grant from National
   University Health System, Singapore; Synthetic Biology Research &
   Development Program of the National Research Foundation, Singapore
FX L.Y.A.C. has been supported by the Clinician Scientist Award (CSA),
   Individual Research Grant (IRG), Bedside & Bench (B&B) grants, Centre
   Grant, and the Training Fellowship Award from the National Medical
   Research Council (NMRC), Singapore. He also receives funding from the
   Aspiration Grant & Summit Research Program and Bench to Bedside Grant
   from the National University Health System, Singapore, as well as the
   Synthetic Biology Research & Development Program of the National
   Research Foundation, Singapore.
CR Centers for Disease Control and Prevention, ZIK VIR DIS ZIK VIR
   Fisher D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0737-9
   Ho HJ, 2017, EMERG INFECT DIS, V23, P2085, DOI 10.3201/eid2312.171224
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Pan American Health Organization/ World Health Organization, ZIK RES CAS DEF
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 10
TC 6
Z9 6
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD AUG
PY 2018
VL 24
IS 8
BP 1565
EP 1568
DI 10.3201/eid2408.171883
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GN4ZI
UT WOS:000439050300028
PM 30016242
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fister, KR
   McCarthy, ML
   Oppenheimer, SF
AF Fister, K. Renee
   McCarthy, Maeve L.
   Oppenheimer, Seth F.
TI Diffusing wild type and sterile mosquitoes in an optimal control setting
SO MATHEMATICAL BIOSCIENCES
LA English
DT Article
DE Partial differential equations; Optimal control; Sterile mosquitoes
ID INSECT RELEASE; AEDES-AEGYPTI; MATHEMATICAL-MODELS; INTERACTING WILD;
   POPULATIONS; ENVIRONMENT; EQUATIONS; DYNAMICS; SYSTEM
AB This paper develops an optimal control framework to investigate the introduction of sterile type mosquitoes to reduce the overal moquito population. As is well known, mosquitoes are vectors of disease. For instance the WHO lists, among other diseases, Malaria, Dengue Fever, Rift Valley Fever, Yellow Fever, Chikungunya Fever and Zika. [http://www.who.int/mediacentre/factsheets/fs387/en/ ] The goal is to establish the existence of a solution given an optimal sterilization protocol as well as to develop the corresponding optimal control representation to minimize the infiltrating mosquito population while minimizing fecundity and the number of sterile type mosquitoes introduced into the environment per unit time. This paper incorporates the diffusion of the mosquitoes into the controlled model and presents a number of numerical simulations.
C1 [Fister, K. Renee; McCarthy, Maeve L.] Murray State Univ, Dept Math & Stat, Murray, KY 42071 USA.
   [Oppenheimer, Seth F.] Mississippi State Univ, Dept Math & Stat, Starkville, MS USA.
RP McCarthy, ML (corresponding author), Murray State Univ, Dept Math & Stat, Murray, KY 42071 USA.
EM mmccarthy@murraystate.edu
FU National Science FoundationNational Science Foundation (NSF)
   [DUE-1028125]
FX We acknowledge that Fister and McCarthy's work on this project has been
   made possible through a grant from the National Science Foundation,
   DUE-1028125.we thank Jerome Goddard of the Department of Biochemistry,
   Molecular Biology, Entomology, and Plant Pathology of Mississippi State
   University for useful conversations.
CR Alford JG, 2015, COMMUN NONLINEAR SCI, V22, P175, DOI 10.1016/j.cnsns.2014.10.004
   Allen LJS, 2015, J BIOL DYNAM, V9, P1, DOI 10.1080/17513758.2015.1044185
   Alphey L., 2011, PLOS ONE, V6
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Barclay HJ, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P147, DOI 10.1007/1-4020-4051-2_6
   Bartlett A. C., 1990, HDB PEST MANAGEMENT, VII, P279
   Cai LM, 2014, SIAM J APPL MATH, V74, P1786, DOI 10.1137/13094102X
   Diaz H, 2011, J THEOR BIOL, V276, P57, DOI 10.1016/j.jtbi.2011.01.053
   Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6
   Esteva L, 2005, MATH BIOSCI, V198, P132, DOI 10.1016/j.mbs.2005.06.004
   Evans L. C., 1998, PARTIAL DIFFERENTIAL
   FAY R. W., 1963, MOSQUITO NEWS, V23, P210
   Fister KR, 2013, MATH BIOSCI, V244, P201, DOI 10.1016/j.mbs.2013.05.008
   Fister KR, 2003, Q APPL MATH, V61, P193, DOI 10.1090/qam/1976365
   Fister R, 1997, HOUSTON J MATH, V23, P341
   Gaff H, 2007, ELECTRON J DIFFER EQ, V115, P1, DOI DOI 10.1155/2012/138757
   HACKBUSCH W, 1978, COMPUTING, V20, P229, DOI 10.1007/BF02251947
   HOLLING C. S., 1959, CANADIAN ENT, V91, P293
   Holsetein MH, 1954, MONOGRAPH SERIES, V9
   KNIPLING E, 1979, AGR HDB, V512
   Knipling E. F., 1985, MISC PUBL ENTOMOL SO, V62, P1
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Ladyzhenskaya O. A., 1967, LINEAR QUASILINEAR E
   Lenhart S, 2007, OPTIMAL CONTROL APPL
   LEWIS MA, 1993, MATH BIOSCI, V116, P221, DOI 10.1016/0025-5564(93)90067-K
   Li J, 2004, MATH BIOSCI, V189, P39, DOI 10.1016/j.mbs.2004.01.001
   Li Jia, 2008, Journal of Biological Dynamics, V2, P241, DOI 10.1080/17513750701779633
   Li X., 1995, OPTIMAL CONTROL THEO
   Lions J. L., 1971, OPTIMAL CONTROL SYST
   Lutambi AM, 2013, MATH BIOSCI, V241, P198, DOI 10.1016/j.mbs.2012.11.013
   M. W. Service, 2012, MED ENTOMOLOGY STUDE
   Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011
   Midega J. T., 2007, J MED ENTOMOL, V6
   MORLAN HARVEY B., 1962, MOSQUITO NEWS, V22, P295
   Neitzel I., 2008, P COMSOL C HAN
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Pazy A., 1983, SEMIGROUPS LINEAR OP, DOI 10.1007/978-1-4612-5561-1
   PLANT RE, 1987, SIAM REV, V29, P235, DOI 10.1137/1029043
   Predescu M, 2007, APPL MATH LETT, V20, P919, DOI 10.1016/j.aml.2006.12.001
   Rafikov M, 2009, J THEOR BIOL, V258, P418, DOI 10.1016/j.jtbi.2008.08.006
   Rafikov M, 2010, J NONLINEAR SYST APP, V1, P27
   Showalter R.E., 2010, HILBERT SPACE METHOD
   Simon J., 1987, ANN MAT PUR APPL, V1, P65, DOI DOI 10.1007/BF01762360.MR916688
   SMITH CN, 1967, B WORLD HEALTH ORGAN, V36, P633
   Smith D., 2007, PLOS BIOL, V2, P1957
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   Wyse APP, 2007, ECOL MODEL, V206, P322, DOI 10.1016/j.ecolmodel.2007.03.038
   Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x
   Yilmaz F., 2009, P COMSOL C MIL
NR 50
TC 1
Z9 1
U1 1
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-5564
EI 1879-3134
J9 MATH BIOSCI
JI Math. Biosci.
PD AUG
PY 2018
VL 302
BP 100
EP 115
DI 10.1016/j.mbs.2018.05.015
PG 16
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA GO0YD
UT WOS:000439671700008
PM 29859194
DA 2020-07-08
ER

PT J
AU Mysorekar, IU
AF Mysorekar, I. U.
TI Mechanisms underlying Zika virus transplacental infection route during
   pregnancy
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Meeting Abstract
CT 15th Conference of the European-Society-for-Reproductive-Immunology
   (ESRI)
CY AUG 28-31, 2018
CL Aalborg, DENMARK
SP European Soc Reprod Immunol
C1 [Mysorekar, I. U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Mysorekar, I. U.] Washington Univ, Sch Med, Pathol & Immunol, St Louis, MO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
EI 1872-7603
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD AUG
PY 2018
VL 128
SI SI
MA IS16
BP 46
EP 46
DI 10.1016/j.jri.2018.06.017
PG 1
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA GQ9AW
UT WOS:000442059300022
DA 2020-07-08
ER

PT J
AU Guo, Q
   Chan, JFW
   Poon, VKM
   Wu, SP
   Chan, CCS
   Hou, LH
   Yip, CCY
   Ren, CP
   Cai, JP
   Zhao, MS
   Zhang, AJ
   Song, XH
   Chan, KH
   Wang, BS
   Kok, KH
   Wen, YB
   Yuen, KY
   Chen, W
AF Guo, Qiang
   Chan, Jasper Fuk-Woo
   Poon, Vincent Kwok-Man
   Wu, Shipo
   Chan, Chris Chung-Sing
   Hou, Lihua
   Yip, Cyril Chik-Yan
   Ren, Changpeng
   Cai, Jian-Piao
   Zhao, Mengsu
   Zhang, Anna Jinxia
   Song, Xiaohong
   Chan, Kwok-Hung
   Wang, Busen
   Kok, Kin-Hang
   Wen, Yanbo
   Yuen, Kwok-Yung
   Chen, Wei
TI Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine
   Expressing the Premembrane and Envelope Proteins of Zika Virus Provides
   Consistent and Sterilizing Protection in Multiple Immunocompetent and
   Immunocompromised Animal Models
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE adenovirus; envelope; premembrane; vaccine; Zika
ID DOUBLE-BLIND; HEALTHY-ADULTS; EBOLA VACCINE; DNA VACCINE; INFECTION;
   IMMUNOGENICITY; SAFETY; RNA; OUTBREAK; EFFICACY
AB Background. Zika virus (ZIKV) infection may be associated with severe complications and disseminated via both vector-borne and nonvector-borne routes. Adenovirus-vectored vaccines represent a favorable controlling measure for the ZIKV epidemic because they have been shown to be safe, immunogenic, and rapidly generable for other emerging viral infections. Evaluations of 2 previously reported adenovirus-vectored ZIKV vaccines were performed using nonlethal animal models and/or nonepidemic ZIKV strain.
   Methods. We constructed 2 novel human adenovirus 5 (Ad5)-vectored vaccines containing the ZIKV premembrane-envelope (Ad5-Sig-prM-Env) and envelope (Ad5-Env) proteins, respectively, and evaluated them in multiple nonlethal and lethal animal models using epidemic ZIKV strains.
   Results. Both vaccines elicited robust humoral and cellular immune responses in immunocompetent BALB/c mice. Dexamethasone-immunosuppressed mice vaccinated with either vaccine demonstrated robust and durable antibody responses and significantly lower blood and tissue viral loads than controls (P < .05). Similar findings were also observed in interferon-alpha/beta receptor-deficient A129 mice. In both of these immunocompromised animal models, Ad5-Sig-prM-Env-vaccinated mice had significantly (P < .05) higher titers of anti-ZIKV-specific neutralizing antibody titers and lower (undetectable) viral loads than Ad5-Env-vaccinated mice. The close correlation between the neutralizing antibody titer and viral load helped to explain the better protective effect of Ad5-Sig-prM-Env than Ad5-Env. Anamnestic response was absent in Ad5-Sig-prM-Env-vaccinated A129 mice.
   Conclusions. Ad5-Sig-prM-Env provided sterilizing protection against ZIKV infection in mice.
C1 [Guo, Qiang; Wu, Shipo; Hou, Lihua; Ren, Changpeng; Zhao, Mengsu; Song, Xiaohong; Wang, Busen; Wen, Yanbo; Chen, Wei] Beijing Inst Biotechnol, 20 Dongdajie St, Beijing 100071, Peoples R China.
   [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Poon, Vincent Kwok-Man; Chan, Chris Chung-Sing; Yip, Cyril Chik-Yan; Cai, Jian-Piao; Zhang, Anna Jinxia; Chan, Kwok-Hung; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Carol Yu Ctr Infect, Pokfulam, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Li Ka Shing Fac Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Pokfulam, Hong Kong, Peoples R China.
RP Chen, W (corresponding author), Beijing Inst Biotechnol, 20 Dongdajie St, Beijing 100071, Peoples R China.
EM cw0226@foxmail.com
RI Kok, Kin-Hang/C-4184-2009; Chan, Jasper F. W./D-8007-2013
OI Chan, Jasper F. W./0000-0001-6336-6657; wang, busen/0000-0001-9041-1919;
   Yuen, Kwok-yung/0000-0002-2083-1552; /0000-0003-3426-332X
FU Hong Kong Hainan Commercial Association South China Microbiology
   Research Fund; Chan Yin Chuen Memorial Charitable Foundation; Hui Hoy
   and Chow Sin Lan Charity Fund Limited; Zika Special Project of the MOST
   (Ministry of Science and Technology) Reform and Development Project of
   China; Collaborative Innovation Center for Diagnosis and Treatment of
   Infectious Diseases, the Ministry of Education of ChinaMinistry of
   Education, China
FX This work was partly funded by the donations of Michael Seak-Kan Tong,
   the Hong Kong Hainan Commercial Association South China Microbiology
   Research Fund, Chan Yin Chuen Memorial Charitable Foundation, Hui Ming,
   and the Hui Hoy and Chow Sin Lan Charity Fund Limited, funding from the
   Zika Special Project of the MOST (Ministry of Science and Technology)
   Reform and Development Project of China, and the Collaborative
   Innovation Center for Diagnosis and Treatment of Infectious Diseases,
   the Ministry of Education of China.
CR ABBINK P, 2017, SCI TRANSL MED, V9, DOI DOI 10.1126/SCI-TRANSLMED.AAO4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dolzhikova IV, 2017, HUM VACC IMMUNOTHER, V13, P613, DOI 10.1080/21645515.2016.1238535
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Green CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008748
   Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2010, VACCINE, V29, P304, DOI 10.1016/j.vaccine.2010.10.037
   Li JX, 2017, LANCET GLOB HEALTH, V5, pE324, DOI [10.1016/S2214-109X(16)30367-9, 10.1016/s2214-109x(16)30367-9]
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ng P, 1999, HUM GENE THER, V10, P2667, DOI 10.1089/10430349950016708
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   World Health Organization, INT TRAV HLTH YELL F
   Xinhua, CHIN APPR EB VACC
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   YANG M, 2017, SCI REP UK, V7
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhu FC, 2017, LANCET, V389, P621, DOI [10.1016/S0140-6736(16)32617-4, 10.1016/s0140-6736(16)32617-4]
   Zhu FC, 2015, LANCET, V385, P2272, DOI 10.1016/S0140-6736(15)60553-0
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 50
TC 11
Z9 11
U1 2
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 1
PY 2018
VL 218
IS 3
BP 365
EP 377
DI 10.1093/infdis/jiy187
PG 13
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GN6GH
UT WOS:000439174200005
PM 29617816
OA Bronze
DA 2020-07-08
ER

PT J
AU Arien, KK
   Wilder-Smith, A
AF Arien, Kevin K.
   Wilder-Smith, Annelies
TI Dengue vaccine: reliably determining previous exposure
SO LANCET GLOBAL HEALTH
LA English
DT Editorial Material
ID VIRUS-INFECTION; ZIKA VIRUS; ANTIBODIES
C1 [Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.
   [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London, England.
RP Arien, KK (corresponding author), Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.; Arien, KK (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
EM karien@itg.be
FU European Union's Horizon 2020 research and innovation programme, under
   the ZikaPLAN grant [734584.4]
FX We declare no competing interests. KKA serves as a consultant on
   diagnostics to WHO and AW-S as a consultant on arboviral diseases to
   WHO. KKA also serves as an expert for the Belgian Federal Agency for
   Medicines and Health Products. The views expressed in this manuscript do
   not necessarily represent the views of WHO or the Belgian Federal Agency
   for Medicines and Health Products. KKA is a member of ZikaPLAN and AWS
   is the coordinator of the ZikaPLAN consortium that received funding from
   the European Union's Horizon 2020 research and innovation programme,
   under the ZikaPLAN grant agreement 734584.4.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Rocha ESD, 2013, J VIROL METHODS, V187, P114, DOI 10.1016/j.jviromet.2012.09.012
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Sanchez-Vegas C, 2013, J TRAVEL MED, V20, P352, DOI 10.1111/jtm.12057
   Sanofi, 2017, SAN UPD INF DENG VAC
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   WHO, 2018, BACKGR PAP DNEG VACC
NR 11
TC 15
Z9 15
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD AUG
PY 2018
VL 6
IS 8
BP E830
EP E831
DI 10.1016/S2214-109X(18)30295-X
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GN2IM
UT WOS:000438821600011
PM 29941282
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Johnson-Mallard, V
   Curry, K
   Chandler, R
   Alexander, I
   Kostas-Polston, E
   Orsega, S
   Woods, NF
AF Johnson-Mallard, Versie
   Curry, Kim
   Chandler, Rasheeta
   Alexander, Ivy
   Kostas-Polston, Elizabeth
   Orsega, Susan
   Woods, Nancy Fugate
TI Managing sexually transmitted infections: Beyond the 2015 guidelines
SO NURSE PRACTITIONER
LA English
DT Article
DE men who have sex with men; MSM; prevention; reproductive health; sexual
   assault; sexually transmitted infections; STI; transgender
ID ZIKA VIRUS; VACCINATION RECOMMENDATIONS; PREEXPOSURE PROPHYLAXIS;
   ADVISORY-COMMITTEE; TRANSGENDER; RISK; CHLAMYDIA; BEHAVIOR; IMPACT; GAY
AB Guidelines for the prevention and management of sexually transmitted infections (STIs) are updated periodically while new science is continuously developed. Advanced practice registered nurses implement clinical decisions based on current guidelines and evidence. This article provides recent updates on managing STIs.
C1 [Johnson-Mallard, Versie] Univ Florida, Gainesville, FL 32611 USA.
   [Curry, Kim] Univ Florida, Coll Nursing, Gainesville, FL 32611 USA.
   [Chandler, Rasheeta] Emory Univ, Neill Hodgson Sch Nursing, Atlanta, GA 30322 USA.
   [Alexander, Ivy] Univ Connecticut, Sch Nursing, Storrs, CT USA.
   [Alexander, Ivy] Univ Connecticut, Sch Nursing, Adv Practice Programs, Storrs, CT USA.
   [Alexander, Ivy] Univ Connecticut, Sch Nursing, Adult Gerontol Primary Care Track, Storrs, CT USA.
   [Kostas-Polston, Elizabeth] Daniel K Inouye Grad Sch Nursing, Bethesda, MD USA.
   [Orsega, Susan] US PHS, Bethesda, MD USA.
   [Woods, Nancy Fugate] Univ Washington, Dept Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA.
RP Johnson-Mallard, V (corresponding author), Univ Florida, Gainesville, FL 32611 USA.
RI Kostas-Polston, Elizabeth A/K-2334-2018
CR Aggarwal A, 2017, TRAFFIC, V18, P392, DOI 10.1111/tra.12481
   [Anonymous], 2014, GUID CLIN PREV SERV
   Bluml BM, 2018, POPUL HEALTH MANAG, V21, P55, DOI 10.1089/pop.2017.0049
   Brener N, 2016, SEXUALLY TRANSMITTED
   Cantor AG, 2016, JAMA-J AM MED ASSOC, V315, P2328, DOI 10.1001/jama.2016.4114
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Dustin LB, 2016, CLIN MICROBIOL INFEC, V22, P826, DOI 10.1016/j.cmi.2016.08.025
   Falade-Nwulia O, 2018, J VIRAL HEPATITIS, V25, P220, DOI 10.1111/jvh.12859
   Falasinnu T, 2016, PREV MED, V89, P51, DOI 10.1016/j.ypmed.2016.04.001
   Falasinnu T, 2016, SEX TRANSM INFECT, V92, P12, DOI 10.1136/sextrans-2014-051992
   FDA, 2014, DEC 10 2014 APPR LET
   Frecker H, 2015, AM J OBSTET GYNECOL, V213, P886, DOI 10.1016/j.ajog.2015.09.016
   Guttmacher Institute, 2016, AB RAT
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1650, DOI 10.1111/jdv.13849
   Johnson BK, 2013, J GERONTOL NURS, V39, P53, DOI 10.3928/00989134-20130918-01
   Kojima N, 2018, AIDS, V32, P272, DOI 10.1097/QAD.0000000000001703
   LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981
   MacDonald J, 2016, J HEALTH PSYCHOL, V21, P2477, DOI 10.1177/1359105315580462
   Markowitz LE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1968
   Markowitz LE, 2014, MMWR RECOMM REP, V63, P1
   Marx GE, 2016, SEX TRANSM DIS, V43, P519, DOI 10.1097/OLQ.0000000000000477
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meites E, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14206
   Metsch LR, 2013, JAMA-J AM MED ASSOC, V310, P1701, DOI 10.1001/jama.2013.280034
   Miller SJ, 2017, PATIENT EDUC COUNS, V100, P190, DOI 10.1016/j.pec.2016.08.027
   Neumann MS, 2017, AM J PUBLIC HEALTH, V107, P207, DOI [10.2105/ajph.2016.303509, 10.2105/AJPH.2016.303509]
   Palmer C, 2017, LAW INEQUALITY J THE, V21, P219
   Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300
   Purcell DW, 2017, AIDS BEHAV, V21, P2835, DOI 10.1007/s10461-017-1800-z
   Raiford JL, 2016, AIDS BEHAV, V20, P2212, DOI 10.1007/s10461-016-1424-8
   Rasmussen CB, 2017, AM J EPIDEMIOL, V185, P8, DOI 10.1093/aje/kww161
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Scheim AI, 2017, JAIDS-J ACQ IMM DEF, V74, pE89, DOI [10.1097/QAI.0000000000001222, 10.1097/qai.0000000000001222]
   Schillie S, 2018, PREVENTION HEPATITIS
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Shepherd S, 2017, PELVIC INFLAMMATORY
   Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2
   Stanton MC, 2017, CULT HEALTH SEX, V19, P32, DOI 10.1080/13691058.2016.1189596
   Tuite AR, 2017, J INFECT DIS, V216, P1141, DOI [10.1093/inFdis/jix450, 10.1093/infdis/jix450]
   WHO, 2016, GLOB HLTH SECT STRAT
   WHO, 2016, WHO GUID TREATM NEIS
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   World Health Organization, 2016, GROW ANT RES FORC UP
   World Health Organization, 2016, WHO GUID TREATM CHLA
   Wuytack F, 2017, SEXUAL TRANSMISSION
NR 46
TC 0
Z9 0
U1 2
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0361-1817
EI 1538-8662
J9 NURSE PRACT
JI Nurse Pract.
PD AUG
PY 2018
VL 43
IS 8
BP 28
EP 34
DI 10.1097/01.NPR.0000541464.23795.5b
PG 7
WC Nursing
SC Nursing
GA GN7VD
UT WOS:000439355300004
PM 29985197
DA 2020-07-08
ER

PT J
AU Mathe, P
   Egah, DZ
   Muller, JA
   Shehu, NY
   Obishakin, ET
   Shwe, DD
   Pam, VC
   Okolo, MO
   Yilgwan, C
   Gomerep, SS
   Fuchs, J
   Abok, I
   Onyedibe, KI
   Olugbo, EJ
   Isa, SE
   Machunga-Mambula, SS
   Attah, CJ
   Munch, J
   Oguche, S
   Panning, M
AF Mathe, Philipp
   Egah, Daniel Z.
   Mueller, Janis A.
   Shehu, Nathan Y.
   Obishakin, Emmanuel T.
   Shwe, David D.
   Pam, Victor C.
   Okolo, Mark O.
   Yilgwan, Christopher
   Gomerep, Simji S.
   Fuchs, Jonas
   Abok, Ibrahim
   Onyedibe, Kenneth I.
   Olugbo, Ewa J.
   Isa, Samson E.
   Machunga-Mambula, Salamatu S.
   Attah, Caleb J.
   Muench, Jan
   Oguche, Stephen
   Panning, Marcus
TI Low Zika virus seroprevalence among pregnant women in North Central
   Nigeria, 2016
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Seroprevalence; NS1 ELISA; Neutralizing antibodies; Africa;
   Phylogeny
ID INFECTION; DISEASE; DENGUE
AB Background: Zika virus (ZIKV) has been known for decades in Africa but contemporary data is lacking at large.
   Objectives: To describe the seroepidemiology of ZIKV in North Central Nigeria.
   Study design: We performed a cross-sectional study at six health care facilities in North Central Nigeria from January to December 2016. Detection of ZIKV antibodies was done using an anti-ZIKV recombinant nonstructural protein 1 (NS1)-based ELISA. A colorimetric assay to detect ZIKV neutralizing antibodies was used on ELISA reactive and randomly selected ELISA non-reactive samples. ZIKV real-time RT-PCR was done on a subset of samples.
   Results: A total of 468 individual samples were included with almost 60% from pregnant women. Using NS1-based ELISA, an anti-ZIKV positive rate of 6% for IgM and 4% for IgG was found. Pregnant women showed anti-ZIKV positive rates of 4% for IgM and 3% for IgG. None of the ZIKV antibody positive samples tested ZIKV RTPCR positive. An association with male sex was found for anti-ZIKV IgG ELISA positivity (prevalence ratio 3.49; 95% confidence interval: 1.48-8.25; p=.004). No association with pregnancy, yellow fever vaccination or malaria was found for anti-ZIKV IgM or IgG positivity. ZIKV neutralizing antibodies were detected in 17/ 18 (94%) anti-ZIKV NS1 positive/borderline samples and in one sample without detectable ZIKV NS1 antibodies. Partial ZIKV E gene sequence was retrieved in one sample without ZIKV antibodies, which clustered within the West African ZIKV lineage.
   Conclusions: Our results show a largely ZIKV immunologically naive population and reinforce the importance of ZIKV surveillance in Africa.
C1 [Mathe, Philipp; Fuchs, Jonas; Panning, Marcus] Univ Freiburg, Fac Med, Med Ctr, Inst Virol, Freiburg, Germany.
   [Egah, Daniel Z.; Shehu, Nathan Y.; Okolo, Mark O.; Onyedibe, Kenneth I.] Jos Univ, Teaching Hosp, Dept Med Microbiol, Jos, Nigeria.
   [Mueller, Janis A.; Muench, Jan] Ulm Univ, Med Ctr, Inst Mol Virol, Ulm, Germany.
   [Obishakin, Emmanuel T.] Natl Inst Vet Res, Biotechnol Dept, Vom Jos, Nigeria.
   [Shwe, David D.] Jos Univ, Teaching Hosp, Dept Med, Jos, Nigeria.
   [Pam, Victor C.; Gomerep, Simji S.; Abok, Ibrahim; Isa, Samson E.; Oguche, Stephen] Jos Univ, Teaching Hosp, Dept Obstet & Gynaecol, Jos, Nigeria.
   [Yilgwan, Christopher] Jos Univ, Teaching Hosp, Dept Paediat, Jos, Nigeria.
   [Olugbo, Ewa J.] Univ Jos, Jos, Nigeria.
   [Machunga-Mambula, Salamatu S.] Univ Abuja, Abuja, Nigeria.
   [Attah, Caleb J.] Fed Med Ctr, Dept Paediat, Keffi, Nigeria.
RP Panning, M (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.
EM marcus.panning@uniklinik-freiburg.de
RI Panning, Marcus/I-7889-2016; amsalu, ribka/G-8780-2019
OI Jan, Munch/0000-0001-7316-7141; Shehu, Nathan/0000-0001-8802-4928
CR Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olaleye O D, 1988, Virologie, V39, P261
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Steinhagen K, 2016, EURO SURVEILL, V21
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
NR 25
TC 5
Z9 5
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD AUG
PY 2018
VL 105
BP 35
EP 40
DI 10.1016/j.jcv.2018.05.011
PG 6
WC Virology
SC Virology
GA GN3GN
UT WOS:000438892300006
PM 29885620
DA 2020-07-08
ER

PT J
AU Tuncer, N
   Marctheva, M
   LaBarre, B
   Payoute, S
AF Tuncer, Necibe
   Marctheva, Maia
   LaBarre, Brian
   Payoute, Sabrina
TI Structural and Practical Identifiability Analysis of Zika
   Epidemiological Models
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE Zika virus; Structural and practical identifiability analysis; Parameter
   estimation; Arbovirus diseases
ID VERTICAL TRANSMISSION; DYNAMICAL MODELS; DISEASE; BORNE
AB The Zika virus (ZIKV) epidemic has caused an ongoing threat to global health security and spurred new investigations of the virus. Use of epidemiological models for arbovirus diseases can be a powerful tool to assist in prevention and control of the emerging disease. In this article, we introduce six models of ZIKV, beginning with a general vector-borne model and gradually including different transmission routes of ZIKV. These epidemiological models use various combinations of disease transmission (vector and direct) and infectious classes (asymptomatic and pregnant), with addition to loss of immunity being included. The disease-induced death rate is omitted from the models. We test the structural and practical identifiability of the models to find whether unknown model parameters can uniquely be determined. The models were fit to obtain time-series data of cumulative incidences and pregnant infections from the Florida Department of Health Daily Zika Update Reports. The average relative estimation errors (AREs) were computed from the Monte Carlo simulations to further analyze the identifiability of the models. We show that direct transmission rates are not practically identifiable; however, fixed recovery rates improve identifiability overall. We found ARE is low for each model (only slightly higher for those that account for a pregnant class) and help to confirm a reproduction number greater than one at the start of the Florida epidemic. Basic reproduction number, , is an epidemiologically important threshold value which gives the number of secondary cases generated by one infected individual in a totally susceptible population in duration of infectiousness. Elasticity of the reproduction numbers suggests that the mosquito-to-human ratio, mosquito life span and biting rate have the greatest potential for reducing the reproduction number of Zika, and therefore, corresponding control measures need to be focused on.
C1 [Tuncer, Necibe; LaBarre, Brian; Payoute, Sabrina] Florida Atlantic Univ, Dept Math Sci, Sci Bldg,Room 234 777 Glades Rd, Boca Raton, FL 33431 USA.
   [Marctheva, Maia] Univ Florida, Dept Math, 358 Little Hall, Gainesville, FL 32611 USA.
RP Tuncer, N (corresponding author), Florida Atlantic Univ, Dept Math Sci, Sci Bldg,Room 234 777 Glades Rd, Boca Raton, FL 33431 USA.
EM ntuncer@fau.edu; maia@ufl.edu; blabarre2013@fau.edu; spayoute@my.fau.edu
CR Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Banks HT, 2014, MONOGR RES NOTES MAT, P1
   Bellu G, 2007, COMPUT METH PROG BIO, V88, P52, DOI 10.1016/j.cmpb.2007.07.002
   Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361
   CDC, 2016, EST AED ALB AED AEG
   Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755
   Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Dick GW, 1952, T R SOC TROP MED HYG, V46
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Karlson J, 2012, 16 IFAC S SYST ID IN
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd, DOI 10.1371/JOURNAL.PNTD]
   Lanciotti RS, 2016, EMERG INFECT DIS, V22
   Martcheva M, 2015, INTRO MATH EPIDEMIOL
   Meshkat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110261
   Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen EE, 2016, INTERIM GUIDELINES P
   Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stigter JD, 2015, AUTOMATICA, V58, P118, DOI 10.1016/j.automatica.2015.05.004
   Tuncer N, 2016, B MATH BIOL, V78, P1796, DOI 10.1007/s11538-016-0200-2
   VELASCOHERNANDEZ JX, 1994, THEOR POPUL BIOL, V46, P1, DOI 10.1006/tpbi.1994.1017
   Villaverde AF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005153
   Wei HM, 2008, J MATH ANAL APPL, V342, P895, DOI 10.1016/j.jmaa.2007.12.058
   WHO, ON YEAR ZIK OUTBR OB
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yang HZ, 2010, J SYST SCI COMPLEX, V23, P279, DOI 10.1007/s11424-010-8436-7
NR 34
TC 3
Z9 3
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD AUG
PY 2018
VL 80
IS 8
BP 2209
EP 2241
DI 10.1007/s11538-018-0453-z
PG 33
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA GM6PL
UT WOS:000438293400009
PM 29948883
DA 2020-07-08
ER

PT J
AU Rufener, R
   Ritler, D
   Zielinski, J
   Dick, L
   da Silva, ET
   Araujo, AD
   Joekel, DE
   Czock, D
   Goepfert, C
   Moraes, AM
   de Souza, MVN
   Muller, J
   Mevissen, M
   Hemphill, A
   Lundstrom-Stadelmann, B
AF Rufener, Reto
   Ritler, Dominic
   Zielinski, Jana
   Dick, Luca
   da Silva, Emerson Teixeira
   Araujo, Adriele da Silva
   Joekel, Deborah Elisabeth
   Czock, David
   Goepfert, Christine
   Moraes, Adriana Marques
   Nora de Souza, Marcus Vinicius
   Mueller, Joachim
   Mevissen, Meike
   Hemphill, Andrew
   Lundstroem-Stadelmann, Britta
TI Activity of mefloquine and mefloquine derivatives against Echinococcus
   multilocularis
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE
LA English
DT Article
DE Alveolar echinococcosis; Treatment; Anti-malaria; HPLC; Drug
   repurposing; Structure activity relationship
ID NEUROPSYCHIATRIC ADVERSE-REACTIONS; IN-VITRO; ALVEOLAR ECHINOCOCCOSIS;
   MYCOBACTERIUM-TUBERCULOSIS; SCHISTOSOMA-MANSONI; ANTIMALARIAL-DRUGS;
   CANCER-CELLS; ZIKA VIRUS; METACESTODES; IDENTIFICATION
AB The cestode E. multilocularis causes the disease alveolar echinococcosis (AE) in humans. The continuously proliferating metacestode (larval stage) of the parasite infects mostly the liver and exhibits tumor-like growth. Current chemotherapeutical treatment options rely on benzimidazoles, which are rarely curative and have to be applied daily and life-long. This can result in considerable hepatotoxicity and thus treatment discontinuation. Therefore, novel drugs against AE are urgently needed. The anti-malarial mefloquine was previously shown to be active against E. multilocularis metacestodes in vitro, and in mice infected by intraperitoneal inoculation of metacestodes when administered at 100 mg/kg by oral gavage twice a week for 12 weeks. In the present study, the same dosage regime was applied in mice infected via oral uptake of eggs representing the natural route of infection. After 12 weeks of treatment, the presence of parasite lesions was assessed in a liver squeeze chamber and by PCR, and a significantly reduced parasite load was found in mefloquine-treated animals. Assessment of mefloquine plasma concentrations by HPLC and modeling using a two-compartment pharmacokinetic model with first-order absorption showed that > 90% of the expected steady-state levels (C-min 1.15 mg/L, C-max 2.63 mg/L) were reached. These levels are close to concentrations achieved in humans during long-term weekly dosage of 250 mg (dose applied for malaria prophylaxis). In vitro structure-activity relationship analysis of mefloquine and ten derivatives revealed that none of the derivatives exhibited stronger activities than mefloquine. Activity was only observed, when the 2-piperidylmethanol group of mefloquine was replaced by an amino group-containing residue and when the trifluoromethyl residue on position 8 of the quinoline structure was present. This is in line with the anti-malarial activity of mefloquine and it implies that the mode of action in E. multilocularis might be similar to the one against malaria.
C1 [Rufener, Reto; Ritler, Dominic; Dick, Luca; Mueller, Joachim; Hemphill, Andrew; Lundstroem-Stadelmann, Britta] Univ Bern, Inst Parasitol, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Langgassstr 122, CH-3012 Bern, Switzerland.
   [Zielinski, Jana; Mevissen, Meike] Univ Bern, Div Pharmacol & Toxicol, Vetsuisse Fac, Langgassstr 124, CH-3012 Bern, Switzerland.
   [da Silva, Emerson Teixeira; Araujo, Adriele da Silva; Moraes, Adriana Marques; Nora de Souza, Marcus Vinicius] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos Far Manguinhos, BR-21041250 Rio De Janeiro, Brazil.
   [Joekel, Deborah Elisabeth] Univ Zurich, Inst Parasitol, Vetsuisse Fac, Winterthurerstr 266a, CH-8057 Zurich, Switzerland.
   [Czock, David] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
   [Goepfert, Christine] Univ Bern, Inst Anim Pathol COMPATH, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Langgassstr 122, Bern, Switzerland.
RP Lundstrom-Stadelmann, B (corresponding author), Univ Bern, Inst Parasitol, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Langgassstr 122, CH-3012 Bern, Switzerland.
EM britta.lundstroem@vetsuisse.unibe.ch
RI de Souza, Marcus/W-5002-2019; Ritler, Dominic/AAD-6733-2019;
   Lundstrom-Stadelmann, Britta/E-8042-2011
OI Ritler, Dominic/0000-0003-2046-4737; Mevissen,
   Meike/0000-0001-8766-9556; Rufener, Reto/0000-0001-5952-7585; Zielinski,
   Jana/0000-0001-6101-2716; Lundstrom-Stadelmann,
   Britta/0000-0003-2672-5766
FU European Cooperation in Science and Technology (COST)European
   Cooperation in Science and Technology (COST) [CM1307]; Fondation Sana,
   Switzerland; Swiss National Science Foundation (SNSF)Swiss National
   Science Foundation (SNSF) [160108, 179439]
FX This work was supported by the European Cooperation in Science and
   Technology (COST, CM1307); the Fondation Sana, Switzerland; and the
   Swiss National Science Foundation (SNSF, grant numbers 160108 and
   179439).
CR Ammann RW, 1996, GASTROENTEROL CLIN N, V25, P655, DOI 10.1016/S0889-8553(05)70268-5
   Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Brehm K, 2014, PARASITE, V21, DOI 10.1051/parasite/2014070
   Soares JBRC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000477
   Croft AM, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-6
   Croft AM, 2007, J ROY SOC MED, V100, P170, DOI 10.1258/jrsm.100.4.170
   Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101
   DEPLAZES P, 1988, SCHWEIZ ARCH TIERH, V130, P307
   Deplazes P, 2017, ADV PARASIT, V95, P315, DOI 10.1016/bs.apar.2016.11.001
   Deplazes P, 2001, VET PARASITOL, V98, P65, DOI 10.1016/S0304-4017(01)00424-1
   EGAN TJ, 1994, FEBS LETT, V352, P54, DOI 10.1016/0014-5793(94)00921-X
   Frey CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2369-0
   Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107
   GIMENEZ F, 1994, J PHARM SCI, V83, P824, DOI 10.1002/jps.2600830613
   Gorgas D, 2017, PARASITOLOGY, V144, P937, DOI 10.1017/S0031182017000051
   Grabias B, 2016, EXPERT OPIN DRUG SAF, V15, P903, DOI 10.1080/14740338.2016.1175428
   Gruner Beate, 2017, GMS Infect Dis, V5, pDoc01, DOI 10.3205/id000027
   Halby L, 2017, J MED CHEM, V60, P4665, DOI 10.1021/acs.jmedchem.7b00176
   Hofer S, 2000, PARASITOLOGY, V120, P135, DOI 10.1017/S0031182099005351
   Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430
   Ingram K, 2013, ANTIMICROB AGENTS CH, V57, P4506, DOI 10.1128/AAC.01129-13
   Keiser J, 2012, CURR PHARM DESIGN, V18, P3531
   Kern P, 2017, ADV PARASIT, V96, P259, DOI 10.1016/bs.apar.2016.09.006
   Kern P, 2008, AM J TROP MED HYG, V79, P119
   Klimpt A.D., 2011, SCI MICROBIAL PATHOG, P23
   Kuster T, 2014, INT J ANTIMICROB AG, V43, P40, DOI 10.1016/j.ijantimicag.2013.09.012
   Kuster T, 2011, ANTIMICROB AGENTS CH, V55, P713, DOI 10.1128/AAC.01392-10
   Kunin CM, 2000, ANTIMICROB AGENTS CH, V44, P848, DOI 10.1128/AAC.44.4.848-852.2000
   Kuster T, 2015, INT J ANTIMICROB AG, V46, P546, DOI 10.1016/j.ijantimicag.2015.07.016
   LACEY E, 1990, PARASITOL TODAY, V6, P112, DOI 10.1016/0169-4758(90)90227-U
   Lilienkampf A, 2009, J MED CHEM, V52, P2109, DOI 10.1021/jm900003c
   LIM LY, 1985, CLIN EXP PHARMACOL P, V12, P527, DOI 10.1111/j.1440-1681.1985.tb00904.x
   Liu YW, 2016, BIOCHEM BIOPH RES CO, V470, P350, DOI 10.1016/j.bbrc.2016.01.046
   LUBINSKY G, 1969, CAN J ZOOLOG, V47, P1001, DOI 10.1139/z69-161
   Manneck T, 2012, PARASITOLOGY, V139, P497, DOI 10.1017/S0031182011002204
   Mawson AR, 2013, MED SCI MONITOR, V19, P579, DOI 10.12659/MSM.889033
   McArdle JJ, 2005, NEUROPHARMACOLOGY, V49, P1132, DOI 10.1016/j.neuropharm.2005.06.011
   McCarthy JS, 2016, ANTIMICROB AGENTS CH, V60, P3669, DOI 10.1128/AAC.02883-15
   Milatovic D, 2011, NEUROTOXICOLOGY, V32, P578, DOI 10.1016/j.neuro.2011.01.001
   MIMICA I, 1983, CHEMOTHERAPY, V29, P184, DOI 10.1159/000238195
   Nevin RL, 2017, DRUGS R&D, V17, P199, DOI 10.1007/s40268-016-0167-3
   Nevin RL, 2016, NEUROL THER, V5, P69, DOI 10.1007/s40120-016-0045-5
   Panic G, 2014, INT J PARASITOL-DRUG, V4, P185, DOI 10.1016/j.ijpddr.2014.07.002
   PENNIE RA, 1993, T ROY SOC TROP MED H, V87, P459, DOI 10.1016/0035-9203(93)90036-P
   Reuter S, 2006, ANTIMICROB AGENTS CH, V50, P2966, DOI 10.1128/AAC.00476-06
   Ricken FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005636
   Rodrigues VS, 2016, INT J ANTIMICROB AG, V48, P203, DOI 10.1016/j.ijantimicag.2016.04.029
   Sharma N, 2012, CANCER LETT, V326, P143, DOI 10.1016/j.canlet.2012.07.029
   Spicher M, 2008, ANTIMICROB AGENTS CH, V52, P3447, DOI 10.1128/AAC.00553-08
   Stadelmann B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004535
   Stadelmann B, 2011, ANTIMICROB AGENTS CH, V55, P4866, DOI 10.1128/AAC.00478-11
   Stadelmann B, 2010, J ANTIMICROB CHEMOTH, V65, P512, DOI 10.1093/jac/dkp490
   STEIGER U, 1990, CLIN PHARMACOL THER, V47, P347, DOI 10.1038/clpt.1990.38
   Tappe D, 2009, ANN TROP MED PARASIT, V103, P177, DOI 10.1179/136485909X385036
   Thompson Andrew, 2017, Adv Parasitol, V95, pxiii, DOI 10.1016/S0065-308X(17)30009-X
   Tickell-Painter M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006491.pub4
   Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722
   Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235
   Trotz-Williams LA, 2017, ZOONOSES PUBLIC HLTH, V64, P460, DOI 10.1111/zph.12326
   Wong W, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.31
NR 62
TC 7
Z9 7
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2211-3207
J9 INT J PARASITOL-DRUG
JI Int. J. Parasitol.-Drugs Drug Resist.
PD AUG
PY 2018
VL 8
IS 2
BP 331
EP 340
DI 10.1016/j.ijpddr.2018.06.004
PG 10
WC Parasitology; Pharmacology & Pharmacy
SC Parasitology; Pharmacology & Pharmacy
GA GM4WD
UT WOS:000438125200021
PM 29933218
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Plaster, AN
   Painter, JE
   Tjersland, DH
   Jacobsen, KH
AF Plaster, Ashley N.
   Painter, Julia E.
   Tjersland, Dylan H.
   Jacobsen, Kathryn H.
TI University Students' Knowledge, Attitudes, and Sources of Information
   About Zika Virus
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Health knowledge; Attitudes; Practice; Health education; Student health
   services; Young adult; Zika virus infection
ID COLLEGE-STUDENTS; UNITED-STATES; PREVENTIVE BEHAVIORS; PREGNANT-WOMEN;
   SPRING BREAK; HEALTH; INFECTION; BRAZIL; SURVEILLANCE; TRANSMISSION
AB Colleges and universities are valuable partners for community health education outreach targeted to young adults. After the outbreak of Zika virus infection in the Americas was declared to be a Public Health Emergency of International Concern on February 1, 2016, postsecondary institutions played an important role in educating at-risk communities about health promotion and disease prevention strategies. In April 2016, we recruited 613 undergraduate students from a large public university to complete a survey about their Zika-related knowledge, attitudes, and information seeking behaviors. We standardized the results so that the participants' reports would be representative of the age, sex, major (course of study), and other characteristics of the university's student population. Most students knew that Zika virus is spread by mosquitoes (88.1%), but only about half knew that the virus could be transmitted through sexual intercourse (56.8%). Students perceived Zika to be a health risk for pregnant women in Zika-affected countries (83.0%), but did not personally feel at risk (12.1%). Many students (43.8%) reported not knowing where to get accurate information about Zika. Identifying gaps in scientific knowledge, misperceptions about personal susceptibility, and opportunities for behavioral risk reduction is an important foundation for designing community-based health interventions when future emerging infectious disease events occur.
C1 [Plaster, Ashley N.; Painter, Julia E.; Tjersland, Dylan H.; Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr 5B7, Fairfax, VA 22030 USA.
RP Painter, JE; Jacobsen, KH (corresponding author), George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr 5B7, Fairfax, VA 22030 USA.
EM aplaster@masonlive.gmu.edu; jpainte6@gmu.edu;
   dtjersla@masonlive.gmu.edu; kjacobse@gmu.edu
RI Jacobsen, Kathryn H./B-5857-2008
OI Jacobsen, Kathryn H./0000-0002-4198-6246
FU Department of Global & Community Health of George Mason University;
   College of Health & Human Services (CHHS) of George Mason University;
   Office of Student Scholarship, Creative Activities, and Research (OSCAR)
   of George Mason University
FX The authors are grateful for the support of the Department of Global &
   Community Health, the College of Health & Human Services (CHHS), and the
   Office of Student Scholarship, Creative Activities, and Research (OSCAR)
   of George Mason University.
CR American College Health Association (ACHA), 2016, UND STUD REF GROUP D
   Apostolopoulos Y, 2002, INT J STD AIDS, V13, P733, DOI 10.1258/095646202320753673
   Barnard M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182266
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chesser AK, 2016, DISASTER MED PUBLIC, V10, P641, DOI 10.1017/dmp.2016.61
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Hall NB, 2017, MMWR-MORBID MORTAL W, V66, P835, DOI 10.15585/mmwr.mm6631a5
   Hashmi S, 2016, J PUBLIC HEALTH-UK, V38, P739, DOI 10.1093/pubmed/fdv189
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Inungu Joseph, 2009, J Health Hum Serv Adm, V32, P259
   Kanadiya MK, 2011, J PUBLIC HEALTH-HEID, V19, P139, DOI 10.1007/s10389-010-0373-3
   Katz R, 2012, J AM COLL HEALTH, V60, P46, DOI 10.1080/07448481.2011.570398
   Kerr DCR, 2015, J STUD ALCOHOL DRUGS, V76, P733
   Koralek Thrissia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.f1f5c05c37a5ff8954f38646cfffc6a2
   Koralek T, 2015, AM J INFECT CONTROL, V43, P1143, DOI 10.1016/j.ajic.2015.06.012
   Koskan A, 2012, DISASTER PREV MANAG, V21, P418, DOI 10.1108/09653561211256134
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Marchand E, 2012, J COMMUN HEALTH, V37, P1136, DOI 10.1007/s10900-012-9572-x
   McCloskey B, 2017, PUBLIC HEALTH, V150, P87, DOI 10.1016/j.puhe.2017.05.008
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   National Center for Education Statistics Institute of Education Sciences, 2015, DIG ED STAT
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds M. R., 2016, MMWR-MORBID MORTAL W, V66, P366, DOI DOI 10.15585/MMWR.MM6613E1
   Serino L, 2011, J Prev Med Hyg, V52, P144
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sonmez S, 2006, ANN TOURISM RES, V33, P895, DOI 10.1016/j.annals.2006.06.005
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   U. S. Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV
   U. S. Centers for Disease Control and Prevention, 2017, ZIK CAS US 2016 CAS
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P157, DOI 10.1016/S1473-3099(16)00023-2
NR 37
TC 5
Z9 5
U1 5
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD AUG
PY 2018
VL 43
IS 4
BP 647
EP 655
DI 10.1007/s10900-017-0463-z
PG 9
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GL8FN
UT WOS:000437451400003
PM 29318503
DA 2020-07-08
ER

PT J
AU Thompson, EL
   Vamos, CA
   Jones, J
   Liggett, LG
   Griner, SB
   Logan, RG
   Daley, EM
AF Thompson, Erika L.
   Vamos, Cheryl A.
   Jones, Julianna
   Liggett, Langdon G.
   Griner, Stacey B.
   Logan, Rachel G.
   Daley, Ellen M.
TI Perceptions of Zika Virus Prevention Among College Students in Florida
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Zika virus; Birth control; Prevention; College
ID UNITED-STATES; UNINTENDED PREGNANCY; FEAR APPEALS; TRANSMISSION;
   INFECTION; EPIDEMIOLOGY; DISEASE; WOMEN
AB Zika virus in Florida prompted a strong public health response, due to its causal association with birth defects. While primarily spread by mosquitos, Zika can be transmitted sexually. The spread of Zika may influence reproductive behaviors among sexually active persons in Florida. This study examined factors associated with willingness to change birth control method use in response to Zika virus among college women and men in Florida. Women and men ages 18-44 at a Florida university (N = 328) were surveyed about Zika knowledge, beliefs about Zika, use of contraceptives and condoms, and socio-demographics between November 2016-April 2017. The outcome variable was willingness to change birth control method were Zika in their area. Logistic regression models in SAS 9.4 were used. Most participants were women (80%), and 47% were 20-22 years old. Only 27% of participants said they would change their birth control method if Zika were in their area. Participants who knew that Zika was sexually transmitted were more likely to be willing to change their birth control method (aOR = 1.71, 95%CI 1.01-2.91). Participants who agreed or strongly agreed that they were fearful of being infected with Zika virus were more likely to be willing to change their birth control methods (aOR = 1.98, 95%CI 1.07-3.67). This study found that, among Florida college students, Zika beliefs and knowledge were associated with a willingness to change birth control method in response to Zika. Understanding the factors that motivate individuals to change reproductive behaviors during an emerging health issue can help tailor preventative messages.
C1 [Thompson, Erika L.; Vamos, Cheryl A.; Liggett, Langdon G.; Griner, Stacey B.; Logan, Rachel G.; Daley, Ellen M.] Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.
   [Thompson, Erika L.] Univ North Texas, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Sch Publ Hlth, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.
   [Jones, Julianna] Univ S Florida, Dept Global Hlth, Coll Publ Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.
   [Jones, Julianna] Univ S Florida, Dept Epidemiol & Biostat, Coll Publ Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.
RP Thompson, EL (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA.; Thompson, EL (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Hlth Behav & Hlth Syst, Sch Publ Hlth, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.
EM Erika.Thompson@unthsc.edu; cvamos@health.usf.edu;
   jjones35@health.usf.edu; lgl@health.usf.edu;
   staceygriner@health.usf.edu; logan23@health.usf.edu;
   edaley@health.usf.edu
RI Griner, Stacey/D-6505-2016
OI Griner, Stacey/0000-0002-2774-5841
FU University of South Florida College of Public Health
FX This study was funded by the University of South Florida College of
   Public Health Interdisciplinary Research Grant Award.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Basch Corey H, 2017, J Prev Med Public Health, V50, P133, DOI 10.3961/jpmph.16.107
   Boulet SL, 2016, MMWR-MORBID MORTAL W, V65, P780, DOI 10.15585/mmwr.mm6530e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2017, ZIK CAS US
   Centers for Disease Control and Prevention, 2016, ZIK GUILL BARR SYNDR
   Centers for Disease Control and Prevention, 2017, 2017 CAS COUNTS US
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kost K., 2015, UNINTENDED PREGNANCY
   Nguyen KK, 2017, CLIN PEDIATR, V56, P213, DOI 10.1177/0009922816677039
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   The Henry J. Kaiser family foundation, 2016, WHAT DOES PUBL KNOW
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
NR 26
TC 0
Z9 0
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD AUG
PY 2018
VL 43
IS 4
BP 673
EP 679
DI 10.1007/s10900-018-0468-2
PG 7
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GL8FN
UT WOS:000437451400007
PM 29380211
DA 2020-07-08
ER

PT J
AU McDonald, JA
   Selchau, K
   Acquah-Baidoo, B
AF McDonald, Jill A.
   Selchau, Katherine
   Acquah-Baidoo, Bridget
TI Scope of Knowledge About Zika Among Women in US-Mexico Border
   Communities
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Zika; Education; Hispanic; Border; Pregnancy
AB Maternal Zika virus infection (ZIKV) has serious health consequences for unborn offspring. Knowledge about prevention is critical to reducing risk, yet what women in the high-risk US-Mexico border region know about protecting themselves and their babies from ZIKV is mostly unknown. This study aimed to assess knowledge of ZIKV among pregnant and inter-conception women and to identify sources of information that might address knowledge gaps. Clients in five federally-funded, border region Healthy Start programs (N = 326) were interviewed in late 2016 about their knowledge of ZIKV prevention methods and whether they believed themselves or their babies to be at risk. Sources of information about ZIKV and demographic characteristics were also measured. Chi square tests identified important associations between variables; adjusted odds ratios (AOR) and 95% confidence intervals for knowledge and beliefs were calculated. Among the 305 women aware of ZIKV, 69.5% could name two ways to prevent infection. Only 16.1% of women named using condoms or abstaining from sex as a prevention method. While 75.3% heard about ZIKV first from TV/radio, just 9.5% found the information helpful. Women who received helpful information from health care providers had greater odds of knowing two prevention methods (AOR = 2.0; 1.1-3.7), when to test for ZIKV (AOR = 5.2; 2.1-13.2), and how long to delay pregnancy after infection in a male partner (AOR = 1.9; 1.1-3.2). Those who said web-based and social media sources were helpful had greater odds of knowing when to test for ZIKV (AOR = 2.8; 1.3-6.3). Results can inform messaging for safe pregnancy and ZIKV prevention.
C1 [McDonald, Jill A.; Acquah-Baidoo, Bridget] New Mexico State Univ, Coll Hlth & Social Serv, Dept Publ Hlth Sci, POB 30001, Las Cruces, NM 88003 USA.
   [Selchau, Katherine] Project Concern Int, San Diego, CA 92105 USA.
RP McDonald, JA (corresponding author), New Mexico State Univ, Coll Hlth & Social Serv, Dept Publ Hlth Sci, POB 30001, Las Cruces, NM 88003 USA.
EM jillmcd@nmsu.edu
OI mcdonald, jill/0000-0003-1034-0677
CR Abramson D., 2016, US PUBLICS PERCEPTIO
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   California Department of Public Health, 2017, ZIK WHAT CAL NEED KN
   Centers for Disease Control and Prevention, 2017, PRAMS QUEST
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   D'Angelo DV, 2017, MMWR-MORBID MORTAL W, V66, P574, DOI 10.15585/mmwr.mm6622a2
   Guttmacher Institute, 2016, UN PREGN US
   Health Resources and Service Administration, 2018, HLTH START
   Healthy Start Border Alliance (HSBA), 2017, HLTH START BORD ALL
   Kaiser Family Foundation, 2016, KAIS HLTH TRACK POLL
   Lapeyrouse LM, 2012, J IMMIGR MINOR HEALT, V14, P264, DOI 10.1007/s10903-011-9453-x
   Lara-Valencia F., 2013, STATE BORDER REPORT, P20
   March of Dimes and Non-partisan and Objective Research Organi-zation (NORC) at the University of Chicago, 2016, ZIK VIR GAPS AM KNOW
   National Healthy Start Association, 2015, HLTH START RESC
   New Mexico Department of Health, 2017, ZIK VIR
   Pan American Health Organization, 2012, HLTH AM, P698
   Pan American Health Organization, 2016, ZIK VIR INF STEP STE
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Plaster AN, 2018, J COMMUN HEALTH, V43, P647, DOI 10.1007/s10900-017-0463-z
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shartzer A, 2016, WOMEN REPROD AGE LAC
   Texas Department of State Health Services, 2017, HLTH OFF FIND PROB L
   United States-Mexico Border Health Commission, 2010, BORD LIV HLTH STAT U
NR 23
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD AUG
PY 2018
VL 43
IS 4
BP 705
EP 716
DI 10.1007/s10900-018-0474-4
PG 12
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GL8FN
UT WOS:000437451400011
PM 29428987
DA 2020-07-08
ER

PT J
AU Silva, GS
   Richards, GA
   Baker, T
   Hidalgo, J
   Jimenez, JIS
   Amin, P
AF Silva, Gisele Sampaio
   Richards, Guy A.
   Baker, Tim
   Hidalgo, Jorge
   Silesky Jimenez, Juan Ignacio
   Amin, Pravin
CA Council World Federation Soc Inten
TI Zika virus: Report from the task force on tropical diseases by the world
   Federation of Societies of intensive and critical care medicine
SO JOURNAL OF CRITICAL CARE
LA English
DT Article
DE Zika virus; Epidemiology; Clinical features; Neurological complications
ID GUILLAIN-BARRE-SYNDROME; INFECTION; OUTBREAK; DISORDERS; BRAZIL
AB Zika fever is an acute infectious disease caused by the Zika virus (ZIKV), an RNA virus belonging to the genus Flavivirus. ZIKV can be transmitted by bites from Aedes aegypti and Aedes albopictus species, sexual activity, blood transfusion and from mother to fetus during pregnancy and delivery. A total of 50 territories and countries in the Americas had reported ZIKV infections. For those with symptoms, the presentation is similar to dengue fever with body aches, joint pain, fatigue, malaise, fever and conjunctivitis lasting up to seven days. A maculopapular rash may also occur and is usually pruritic. Neurological complications are well documented and include Guillain-Barre Syndrome (GBS) and congenital ZIKV syndrome, and less frequently acute myelitis and meningoencephalitis. ZIKV infection usually causes a mild illness and most patients are managed conservatively. Currently, no antiviral therapy is available. The most appropriate therapy for ZIKV-associated GBS is yet unclear, however intravenous immunoglobulins have been used, as in conventional GBS. ZIKV infection can be prevented through the use of mosquito repellents, protection with long-sleeved clothing and trousers, and the use of clothes impregnated with permethrin. This review describes the current concepts regarding the epidemiology, diagnosis, clinical manifestations and neurological complications of ZIKV infection. (C) 2018 Published by Elsevier Inc.
C1 [Silva, Gisele Sampaio] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Sao Paulo, Brazil.
   [Silva, Gisele Sampaio] Programa Integrado Neurol, Sao Paulo, Brazil.
   [Silva, Gisele Sampaio] Hosp Israelita Albert Einstein, Inst Ensino & Pesquisa, Sao Paulo, Brazil.
   [Richards, Guy A.] Univ Witwatersrand, Fac Hlth Sci, Charlotte Maxeke Hosp, Div Crit Care, Johannesburg, South Africa.
   [Baker, Tim] Queen Elizabeth Cent Hosp, Dept Anaesthesia & Intens Care, Blantyre, Malawi.
   [Baker, Tim] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth Hlth Syst & Policy, Stockholm, Sweden.
   [Hidalgo, Jorge] Karl Heusner Mem Hosp, Belize Healthcare Partners, Div Crit Care, Cent Amer, Belize.
   [Silesky Jimenez, Juan Ignacio] Hosp San Juan Dios, Crit Care Unit, San Jose, Costa Rica.
   [Silesky Jimenez, Juan Ignacio] Hosp CIMA, San Jose, Costa Rica.
   [Silesky Jimenez, Juan Ignacio] Univ Costa Rica, Crit Care, San Jose, Costa Rica.
   [Amin, Pravin] Bombay Hosp Inst Med Sci, Dept Crit Care Med, Bombay, Maharashtra, India.
RP Silva, GS (corresponding author), Univ Fed Sao Paulo, Neurol, Albert Einstein Hosp, Sao Paulo, Brazil.
EM gisele.sampaio@einstein.br
RI Silva, Gisele/H-3082-2013
OI Silva, Gisele/0000-0002-3247-3123
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   FitzSimmons J, 2016, NEW ENGL J MED, V375, P293, DOI 10.1056/NEJMc1606769
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Garza-Gonzlez E, 2017, BRAZ J INFECT DIS, V21, P554, DOI 10.1016/j.bjid.2017.04.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mejdoubi M, 2017, NEW ENGL J MED, V377, P1399, DOI 10.1056/NEJMc1612813
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pastula DM, 2017, NEUROCRIT CARE, V26, P457, DOI 10.1007/s12028-016-0333-z
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
NR 28
TC 6
Z9 6
U1 0
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0883-9441
EI 1557-8615
J9 J CRIT CARE
JI J. Crit. Care
PD AUG
PY 2018
VL 46
BP 106
EP 109
DI 10.1016/j.jcrc.2018.03.030
PG 4
WC Critical Care Medicine
SC General & Internal Medicine
GA GK7YM
UT WOS:000436431000022
PM 29779827
DA 2020-07-08
ER

PT J
AU Seruyange, E
   Gahutu, JB
   Muvunyi, CM
   Katare, S
   Ndahindwa, V
   Sibomana, H
   Nyamusore, J
   Rutagarama, F
   Hannoun, C
   Norder, H
   Bergstroem, T
AF Seruyange, Eric
   Gahutu, Jean-Bosco
   Muvunyi, Claude M.
   Katare, Swaibu
   Ndahindwa, Vedaste
   Sibomana, Hassan
   Nyamusore, Jose
   Rutagarama, Florent
   Hannoun, Charles
   Norder, Helene
   Bergstroem, Tomas
TI Seroprevalence of Zika virus and Rubella virus IgG among blood donors in
   Rwanda and in Sweden
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE ELISA; Rubella virus; Rwanda; seroprevalence; Zika virus
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; PREGNANT-WOMEN; COVERAGE; DENGUE
AB Seroprevalence studies provide information on the susceptibility to infection of certain populations, including women of childbearing age. Such data from Central Africa are scarce regarding two viruses that cause congenital infections: Zika virus (ZIKV), an emerging mosquito-borne infection, and Rubella virus (RuV), a vaccine-preventable infection. We report on the seroprevalence of both ZIKV and RuV from Rwanda, a country without any known cases of ZIKV, but bordering Uganda where this virus was isolated in 1947. Anti-ZIKV-specific and anti-RuV-specific immunoglobulin G (IgG) antibodies were analyzed by enzyme-linked immunosorbent assay (ELISA) in serum samples from 874 Rwandan and 215 Swedish blood donors. Samples positive for IgG antibodies against ZIKV were examined for viral RNA using real-time reverse transcription polymerase chain reaction (RT-qPCR). The seroprevalence of ZIKV IgG in Rwanda was 1.4% (12/874), of which the predominance of positive findings came from the Southeastern region. All anti-ZIKV IgG-positive samples were PCR-negative. Among 297 female blood donors of childbearing age, 295 (99.3%) were seronegative and thus susceptible to ZIKV. All Swedish blood donors were IgG-negative to ZIKV. In contrast, blood donors from both countries showed high seroprevalence of IgG to RuV: 91.2% for Rwandan and 92.1% for Swedish donors. Only 10.5% (31/294) of female donors of childbearing age from Rwanda were seronegative for RuV. In Rwanda, seroprevalence for ZIKV IgG antibodies was low, but high for RuV. Hence, women of childbearing age were susceptible to ZIKV. These data may be of value for decision-making regarding prophylactic measures.
C1 [Seruyange, Eric; Gahutu, Jean-Bosco; Muvunyi, Claude M.] Univ Rwanda, Coll Med & Hlth Sci, Fac Med & Pharm, Huye, Rwanda.
   [Seruyange, Eric; Rutagarama, Florent] Rwanda Mil Hosp, Kigali, Rwanda.
   [Seruyange, Eric; Hannoun, Charles; Norder, Helene; Bergstroem, Tomas] Univ Gothenburg, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden.
   [Katare, Swaibu] Rwanda Biomed Ctr, Natl Ctr Blood Transfus, Kigali, Rwanda.
   [Ndahindwa, Vedaste] Univ Rwanda, Sch Publ Hlth, Coll Med & Hlth Sci, Huye, Rwanda.
   [Sibomana, Hassan] Rwanda Biomed Ctr, Expanded Program Immunizat, Kigali, Rwanda.
   [Nyamusore, Jose] Rwanda Biomed Ctr, Div Epidem Surveillance & Response, Kigali, Rwanda.
RP Seruyange, E; Bergstroem, T (corresponding author), Univ Gothenburg, Dept Infect Dis, Guldhedsgatan 10B, S-41346 Gothenburg, Sweden.
EM ericseruyange@gmail.com; tomas.bergstrom@microbio.gu.se
RI amsalu, ribka/G-8780-2019
OI Seruyange, Eric/0000-0003-3817-9838
FU LUA-ALF foundation of Sahlgrenska University Hospital, Gothenburg,
   Sweden [ALF-Gbg 145-841]; Swedish International Development Cooperation
   Agency: University of Rwanda-Sweden Program for Research, Higher
   Education and Institutional Advancement
FX LUA-ALF foundation of Sahlgrenska University Hospital, Gothenburg,
   Sweden, Grant number: ALF-Gbg 145-841; The Swedish International
   Development Cooperation Agency: University of Rwanda-Sweden Program for
   Research, Higher Education and Institutional Advancement
CR Adam O, 2013, E MEDITERR HEALTH J, V19, P812
   Alleman MM, 2016, VACCINE, V34, P6502, DOI 10.1016/j.vaccine.2016.10.059
   [Anonymous], 2015, EPIDEMIOLOGY PREVENT, P325
   [Anonymous], 2017, MEASL RUB MON
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blacksell SD, 2012, AM J TROP MED HYG, V87, P573, DOI 10.4269/ajtmh.2012.12-0043
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caroca C, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4077-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2017, WORLD MAP AR RISK ZI
   Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Ganczak M, 2016, GINEKOL POL, V87, P538, DOI 10.5603/GP.2016.0040
   Gatera M, 2016, VACCINE, V34, P3420, DOI 10.1016/j.vaccine.2015.11.076
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Giambi C, 2017, EUR J PEDIATR, V176, P955, DOI 10.1007/s00431-017-2935-7
   GOMWALK NE, 1989, REV INFECT DIS, V11, P116
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Lahbil D, 2007, Bull Soc Belge Ophtalmol, P13
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lulandala L, 2017, J CLIN DIAGN RES, V11, pQC25, DOI 10.7860/JCDR/2017/22634.9544
   MOH, 2012, COMPR MULT PLAN 2013
   MOH, 2006, NAT POL BLOOD TRANSF
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seruyange E, 2016, INFECT DIS-NOR, V48, P800, DOI 10.1080/23744235.2016.1201720
   Squires RC, 2016, WEST PAC SURVEILL RE, V7, P44, DOI 10.5365/wpsar.2016.7.1.007
   Ward T, 2017, TROP MED INT HEALTH, V22, P960, DOI 10.1111/tmi.12903
   WHO, 2017, REP DIS INC TIM SER
   WHO, 2017, RUB FACT SHEET
   WHO, 2017, WHO STAT 1 M INT HLT
NR 39
TC 5
Z9 5
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2018
VL 90
IS 8
BP 1290
EP 1296
DI 10.1002/jmv.25198
PG 7
WC Virology
SC Virology
GA GK0JY
UT WOS:000435797200003
PM 29663453
DA 2020-07-08
ER

PT J
AU Sharma, R
   Santos, LC
   da Silva, RA
   Goncalves, CV
   Calado, SD
   Santos, DP
   de Melo, JPD
   Rampazzo, RDP
   Requiao, L
   Krieger, MA
   Barral-Netto, M
   de Oliveira, CI
AF Sharma, Rohit
   Santos, Larissa Costa
   da Silva, Robson A.
   Goncalves, Caroline V.
   Calado, Stefano de Melo
   Santos, Denisar P.
   de Andrade de Melo, Josana P.
   Pontello Rampazzo, Rita de Cassia
   Requiao, Luciana
   Krieger, Marco A.
   Barral-Netto, Manoel
   de Oliveira, Camila I.
TI Surveillance of donated blood during the 2016 arbovirus outbreak in
   Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE NAT; transfusion; ZIKV
ID ZIKA VIRUS; PUERTO-RICO; TRANSFUSION; TRANSMISSION; DONORS; STATES; RNA
AB Reports of arboviral transmission via blood transfusion may be a cause of concern among asymptomatic infected donors. This study evaluated the presence of arboviruses in donated blood products during the 2016 outbreak in Vitoria da Conquista (Bahia-Brazil). Serum samples (n=676) were screened for ZIKV, CHIKV, and the four DENV serotypes using a one-step reverse transcriptase-based Real-Time Polymerase Chain Reaction (RT-PCR). No samples tested positive for any of the targets, whereas positive controls performed as expected. The results suggest a low risk of arboviral transmission via transfusion of blood products in the endemic area studied during the 2016 outbreak.
C1 [Sharma, Rohit; Santos, Larissa Costa; Barral-Netto, Manoel; de Oliveira, Camila I.] Fiocruz MS, IGM, Salvador, BA, Brazil.
   [da Silva, Robson A.; Goncalves, Caroline V.; Calado, Stefano de Melo; Santos, Denisar P.] UFBA, IMS, Vitoria Da Conquista, BA, Brazil.
   [de Andrade de Melo, Josana P.] Serv Hemoterapia Sudoeste, Vitoria Da Conquista, PR, Brazil.
   [Pontello Rampazzo, Rita de Cassia; Requiao, Luciana; Krieger, Marco A.] IBMP, Curitiba, PR, Brazil.
   [Krieger, Marco A.] Fiocruz MS, ICC, Curitiba, PR, Brazil.
   [Barral-Netto, Manoel; de Oliveira, Camila I.] Inst Nacl Ciencia & Tecnol Invest Imunol, Sao Paulo, SP, Brazil.
RP de Oliveira, CI (corresponding author), Fiocruz MS, IGM, Rua Waldemar Falcao 121, BR-40196710 Candeal Salvador, BA, Brazil.
EM camila@bahia.fiocruz.br
RI Rampazzo, Rita/AAA-4590-2020; de Oliveira, Camila I/B-4358-2009; Silva,
   Robson A A/N-8801-2018; Krieger, Marco/AAE-8611-2020; Barral Netto,
   Manoel/B-3904-2009
OI Rampazzo, Rita/0000-0002-8367-999X; de Oliveira, Camila
   I/0000-0002-7868-5164; Goncalves, Caroline/0000-0003-0895-1583; Barral
   Netto, Manoel/0000-0002-5823-7903
FU CAPES FellowshipCAPES
FX CAPES Fellowship
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
NR 19
TC 1
Z9 1
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2018
VL 90
IS 8
BP 1406
EP 1410
DI 10.1002/jmv.25193
PG 5
WC Virology
SC Virology
GA GK0JY
UT WOS:000435797200020
PM 29667206
DA 2020-07-08
ER

PT J
AU Li, C
   Wang, Q
   Jiang, YS
   Ye, Q
   Xu, D
   Gao, F
   Xu, JW
   Wang, RK
   Zhu, XL
   Shi, L
   Yu, L
   Zhang, FC
   Guo, WX
   Zhang, LQ
   Qin, CF
   Xu, ZH
AF Li, Cui
   Wang, Qin
   Jiang, Yisheng
   Ye, Qing
   Xu, Dan
   Gao, Fei
   Xu, Jesse W.
   Wang, Ruoke
   Zhu, Xingliang
   Shi, Lei
   Yu, Lei
   Zhang, Fuchun
   Guo, Weixiang
   Zhang, Linqi
   Qin, Cheng-Feng
   Xu, Zhiheng
TI Disruption of glial cell development by Zika virus contributes to severe
   microcephalic newborn mice
SO CELL DISCOVERY
LA English
DT Article
ID NEURAL PROGENITORS; BRAIN; PROTECTION; ORGANOIDS; INFECTION; DISEASE;
   PROTEIN; STRAIN; MOUSE
AB The causal link between Zika virus (ZIKV) infection and microcephaly has raised alarm worldwide. Microglial hyperplasia, reactive gliosis, and myelination delay have been reported in ZIKV-infected microcephalic fetuses. However, whether and how ZIKV infection affects glial cell development remain unclear. Here we show that ZIKV infection of embryos at the later stage of development causes severe microcephaly after birth. ZIKV infects the glial progenitors during brain development. Specifically, ZIKV infection disturbs the proliferation and differentiation of the oligodendrocyte progenitor cells and leads to the abolishment of oligodendrocyte development. More importantly, a single intraperitoneal injection of pregnant mice with a human monoclonal neutralizing antibody provides full protection against ZIKV infection and its associated damages in the developing fetuses. Our results not only provide more insights into the pathogenesis of ZIKV infection, but also present a new model for the preclinical test of prophylactic and therapeutic agents against ZIKV infection.
C1 [Li, Cui; Wang, Qin; Jiang, Yisheng; Zhu, Xingliang; Shi, Lei; Guo, Weixiang; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100071, Peoples R China.
   [Li, Cui; Wang, Qin; Jiang, Yisheng; Zhu, Xingliang; Xu, Zhiheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Ye, Qing; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.
   [Xu, Dan] Fuzhou Univ, Inst Life Sci, Fuzhou 350116, Fujian, Peoples R China.
   [Gao, Fei; Wang, Ruoke] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Comprehens AIDS Res Ctr,Collaborat Innovat Ctr Di, Beijing 100084, Peoples R China.
   [Xu, Jesse W.; Zhang, Linqi] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Yu, Lei; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100071, Peoples R China.; Xu, ZH (corresponding author), Univ Chinese Acad Sci, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing 100071, Peoples R China.; Zhang, LQ (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM zhanglinqi@tsinghua.edu.cn; qincf@bmi.ac.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Wang, Qin/0000-0001-7447-1671; Xu,
   Zhiheng/0000-0002-4809-2851; Li, Cui/0000-0001-9777-9628; Zhu,
   Xingliang/0000-0003-3411-8712
FU National Natural Science Foundation (NSFC) of ChinaNational Natural
   Science Foundation of China [31730108, 31430037, 81522025, 81661130162];
   National Science and Technology Major Projects [2014CB942801,
   2017ZX10305501-003]; Innovation Program of the Chinese Academy of
   SciencesKnowledge Innovation Program of the Chinese Academy of Sciences
   [QYZDJ-SSWSMC007]; Shanghai brain-intelligence project from STCSM
   [16JC1420500]; Beijing brain project [Z161100002616004]; Newton Advanced
   Fellowship from UK Academy of Medical Sciences; Special Program of
   Guangdong Provincial Department of Science and Technology
   [2016A020248001]; Guangzhou Health Care and Cooperation Innovation Major
   grant [20174020229]
FX We thank Drs. Ye Zhang, Jianfeng Wang, and Xiu Jie Wang for valuable
   advice; Fu-Chun Zhang for the serum from ZIKV patient. This work was
   supported by grants from the National Natural Science Foundation (NSFC)
   of China (31730108/31430037/81522025/81661130162), the National Science
   and Technology Major Projects (2014CB942801/2017ZX10305501-003),
   Innovation Program of the Chinese Academy of Sciences (QYZDJ-SSWSMC007),
   Shanghai brain-intelligence project from STCSM (16JC1420500), Beijing
   brain project (Z161100002616004), the Newton Advanced Fellowship from
   the UK Academy of Medical Sciences to C.-F.Q., the Special Program of
   Guangdong Provincial Department of Science and Technology
   (2016A020248001), the Guangzhou Health Care and Cooperation Innovation
   Major grant (20174020229).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Domingues HS, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00071
   Fields RD, 2015, NEURON, V86, P374, DOI 10.1016/j.neuron.2015.01.014
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Ozkurt Z, 2017, EURASIAN J MED, V49, P142, DOI 10.5152/eurasianjmed.2017.17147
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479
   Steiner J, 2008, NEUROSCIENCE, V154, P496, DOI 10.1016/j.neuroscience.2008.03.060
   Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2
   Taverna Gianluigi, 2014, Curr Gerontol Geriatr Res, V2014, P478126, DOI 10.1155/2014/478126
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vives V, 2003, J COMP NEUROL, V457, P404, DOI 10.1002/cne.10552
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu D, 2014, CELL REP, V6, P104, DOI 10.1016/j.celrep.2013.12.016
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6815
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304
NR 49
TC 3
Z9 4
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD JUL 31
PY 2018
VL 4
AR UNSP 43
DI 10.1038/s41421-018-0042-1
PG 12
WC Cell Biology
SC Cell Biology
GA GO7LI
UT WOS:000440246500001
PM 30083387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Medigeshi, GR
   Fink, K
   Hegde, NR
AF Medigeshi, Guruprasad R.
   Fink, Katja
   Hegde, Nagendra R.
TI Position Paper on Road Map for RNA Virus Research in India
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE RNA virus; dengue virus; funding models; interdisciplinary; vaccines;
   clinical trials as topic
ID ROTAVIRUS VACCINE; SINGLE MUTATION; CLINICAL-TRIAL; EFFICACY;
   IMMUNOGENICITY; CHALLENGE; CHILDREN; INFANTS; MODEL
AB The Indian subcontinent with its population density, climatic conditions, means of subsistence, socioeconomic factors as well as travel and tourism presents a fertile ground for thriving of RNA viruses. Despite being pathogens of huge significance, there is very little focus on research into the biology and pathogenesis of RNA viruses in India. Studies on epidemiology and disease burden, risk factors, the immune response to RNA viruses, circulating virus strains and virus evolution, animal models of disease, antivirals and vaccines are strikingly absent. Emerging RNA viruses such as Zika virus, Nipah virus and Crimean-Congo haemorrhagic fever virus are a matter of grave concern to India. Here we summarize the outcome of the lndia|EMBO symposium on "RNA viruses: immunology, pathogenesis and translational opportunities" organized at Faridabad, National Capital Region, India, on March 28-30, 2018. The meeting focused on RNA viruses (non-HIV), and both national and international experts on RNA viruses covered topics ranging from epidemiology, immune response, virus evolution and vaccine trials concerning RNA viruses. The aim of the symposium was to create a road map for RNA virus research in India. Both concrete and tentative ideas pointing towards short-term and long-term goals were presented with recommendations for follow-up at government level.
C1 [Medigeshi, Guruprasad R.] Translat Hlth Sci & Technol Inst, Faridabad, India.
   [Fink, Katja] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore.
   [Hegde, Nagendra R.] Natl Inst Anim Biotechnol, Hyderabad, India.
RP Medigeshi, GR (corresponding author), Translat Hlth Sci & Technol Inst, Faridabad, India.
EM gmedtgeshi@thsti.res.in
RI Medigeshi, Guruprasad/V-1566-2019; Hegde, Nagendra R/H-3132-2019
OI Hegde, Nagendra R/0000-0001-5260-2159
FU EMBOEuropean Molecular Biology Organization (EMBO); India Alliance;
   Wellcome trust-DBT India AllianceWellcome Trust [IA/S/14/1/501291]
FX The India vertical bar EMBO Symposium was funded by the EMBO and the
   India Alliance. GM is funded by the intermediate fellowship from the
   Wellcome trust-DBT India Alliance (IA/S/14/1/501291).
CR Bhandari N, 2014, LANCET, V383, P2136, DOI 10.1016/S0140-6736(13)62630-6
   Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107
   Dubey AP, 2017, HUM VACC IMMUNOTHER, V13, P2032, DOI 10.1080/21645515.2017.1318236
   Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215
   Gordon Stephen B, 2017, Wellcome Open Res, V2, P70, DOI 10.12688/wellcomeopenres.12256.1
   Hasson Sidgi Syed Anwer Abdo, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P344, DOI 10.1016/S2221-1691(15)30366-X
   Jin C, 2017, LANCET, V390, P2472, DOI 10.1016/S0140-6736(17)32149-9
   Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143
   Kulkarni PS, 2017, VACCINE, V35, P6228, DOI 10.1016/j.vaccine.2017.09.014
   Kulkarni PS, 2017, EXPERT REV VACCINES, V16, P303, DOI 10.1080/14760584.2017.1294068
   Mallajosyula VVA, 2014, P NATL ACAD SCI USA, V111, pE2514, DOI 10.1073/pnas.1402766111
   Park JK, 2018, MBIO, V9, DOI [10.1128/mBio.02284-17, 10.1128/mbio.02284-17]
   Pollard AJ, 2012, LANCET INFECT DIS, V12, P903, DOI 10.1016/S1473-3099(12)70292-X
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Scorza F. B, 2018, VACCINES, V6, pE20, DOI [10.3390/vaccines6020020, DOI 10.3390/VACCINES]
   Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002
   Shi T, 2017, LANCET, V390, P946, DOI [10.1016/S0140-6736(17)30938-8, 10.1016/s0140-6736(17)30938-8]
   Singh A, 2015, J INFECT DIS, V212, P715, DOI 10.1093/infdis/jiv023
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Sutton TC, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0036-2
   Tsai WY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01372
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 24
TC 0
Z9 0
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 31
PY 2018
VL 9
AR 1753
DI 10.3389/fmicb.2018.01753
PG 6
WC Microbiology
SC Microbiology
GA GO8CX
UT WOS:000440312600001
PM 30131779
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ferguson, NM
AF Ferguson, Neil M.
TI Challenges and opportunities in controlling mosquito-borne infections
SO NATURE
LA English
DT Review
ID PLASMODIUM-FALCIPARUM MALARIA; ANTIBODY-DEPENDENT ENHANCEMENT;
   AEDES-AEGYPTI; GLOBAL DISTRIBUTION; DENGUE VACCINE; VECTOR CONTROL;
   TRANSMISSION; WOLBACHIA; ZIKA; CHIKUNGUNYA
AB Mosquito-borne diseases remain a major cause of morbidity and mortality across the tropical regions. Despite much progress in the control of malaria, malaria-associated morbidity remains high, whereas arboviruses-most notably dengue-are responsible for a rising burden of disease, even in middle-income countries that have almost completely eliminated malaria. Here I discuss how new interventions offer the promise of considerable future reductions in disease burden. However, I emphasize that intervention programmes need to be underpinned by rigorous trials and quantitative epidemiological analyses. Such analyses suggest that the long-term goal of elimination is more feasible for dengue than for malaria, even if malaria elimination would offer greater overall health benefit to the public.
C1 [Ferguson, Neil M.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Sch Publ Hlth, London, England.
RP Ferguson, NM (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, Sch Publ Hlth, London, England.
EM neil.ferguson@imperial.ac.uk
RI Ferguson, Neil/B-8578-2008
OI Ferguson, Neil/0000-0002-1154-8093
FU Medical Research CouncilMedical Research Council UK (MRC); National
   Institute of Health Research Health Protection Research Unit programme;
   National Institute of General Medical Sciences 'MIDAS' programme; Bill
   and Melinda Gates FoundationGates Foundation
FX I thank the Medical Research Council, the National Institute of Health
   Research Health Protection Research Unit programme, the National
   Institute of General Medical Sciences 'MIDAS' programme and the Bill and
   Melinda Gates Foundation for research funding. Among many others, A.
   Ghani, A. Burt and S. O'Neill have informed my understanding of this
   topic during many illuminating discussions.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adelman Z. N, 2015, GENETIC CONTROL MALA
   Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33
   Asher J, 2017, PRELIMINARY RESULTS
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrozo RB, 2004, BIOL RHYTHM RES, V35, P79, DOI 10.1080/09291010412331313250
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bigira V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001689
   Blackman MA, 2018, VIRAL IMMUNOL, V31, P117, DOI 10.1089/vim.2017.0145
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2017, LANCET GLOB HEALTH, V5, pE680, DOI [10.1016/S2214-109X(17)30220-6, 10.1016/s2214-109x(17)30220-6]
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8
   Clapham HE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005926
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563
   Department of Control of Neglected Tropical Diseases, 2017, WHOHTMNTDVEM201703
   Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108
   Dorigatti I, 2018, TRENDS PARASITOL, V34, P102, DOI 10.1016/j.pt.2017.11.002
   Eisele TP, 2016, J INFECT DIS, V214, P1831, DOI 10.1093/infdis/jiw416
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fiorenzano JM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040398
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   Griffi JT, 2016, LANCET INFECT DIS, V16, P465, DOI 10.1016/S1473-3099(15)00423-5
   Griffin JT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2657
   Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324
   GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kalayanarooj S, 2017, J INFECT DIS, V215, pS79, DOI 10.1093/infdis/jiw609
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lengeler C, 2004, COCHRANE DB SYST REV, P2, DOI [10.1002/14651858.CD000363.pub2, DOI 10.1002/14651858.CD000363.PUB2, 10.1002/14651858]
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Qualls WA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0819-8
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   Screaton G, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029520
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Slater HC, 2014, J INFECT DIS, V210, P1972, DOI 10.1093/infdis/jiu351
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133
   Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467
   West PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001630
   White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X
   White MT, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0117-2
   WHO, 2017, TABL MAL VACC PROJ G
   WHO, 2017, EFF TRIALS ZIKV VACC
   WHO, INT VECT MAN
   WHO, 2016, EST MAL DEATHS REG
   WHO, 2017, UPD QUEST ANSW REL I
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Winskill P, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000090
   Wolbers M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001937
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V30, P349
   World Health Organization, 2017, WORLD MAL REP 2017
NR 100
TC 27
Z9 27
U1 4
U2 49
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 26
PY 2018
VL 559
IS 7715
BP 490
EP 497
DI 10.1038/s41586-018-0318-5
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO2ZP
UT WOS:000439850800038
PM 30046071
DA 2020-07-08
ER

PT J
AU Petersen, MT
   da Silveira, ID
   Tatila-Ferreira, A
   David, MR
   Chouin-Carneiro, T
   Van den Wouwer, L
   Maes, L
   Maciel-De-Freitas, R
AF Petersen, Martha Thieme
   da Silveira, Isabella Dias
   Tatila-Ferreira, Aline
   David, Mariana Rocha
   Chouin-Carneiro, Thais
   Van den Wouwer, Liesbeth
   Maes, Louis
   Maciel-de-Freitas, Rafael
TI The impact of the age of first blood meal and Zika virus infection on
   Aedes aegypti egg production and longevity
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; DAILY SURVIVAL RATES; CONTAINER PRODUCTIVITY; BODY-SIZE;
   DIPTERA; DISPERSAL; FECUNDITY; TRANSMISSION; MOSQUITOS; PARASITE
AB The impact of senescence and pathogen infection on Aedes aegypti life-history traits remains poorly understood. This laboratory study focused on the impact of Zika virus (ZIKV) infection and the age of first blood intake on blood meal and clutch sizes, and more importantly on the egg production ratio per mu L of blood. Three groups of ZIKV-infected and uninfected Ae. aegypti females that received their first blood meal at 7 (young feeders), 14 (mature feeders) and 21 days old (old feeders) were monitored daily for survival and received a blood meal free of ZIKV once a week. The number of eggs laid per female were registered 3-4 days after blood feeding. Infection by ZIKV and age of feeding produced a strong negative impact on survival and oviposition success (e.g. likelihood of laying at least one egg per gonotrophic cycle). Interestingly, clutch size presented a dramatic reduction on uninfected mosquitoes, but raised from 36.5 in clutch1 to 55.1 eggs in clutch 3. Blood meal size remained stable in uninfected females, while a slight increase was observed for the infected counterparts. In uninfected Ae. aegypti, egg production was strongly affected by the age of feeding with younger females laying three times more eggs than when older. On the other hand, ZIKV-infected mosquitoes had a constant but low egg production. Overall, mosquito senescence and ZIKV infection had an impact on mosquito egg production by causing a sharp decrease in the number of eggs along the clutches for uninfected mosquitoes and a slight increase for infected mosquitoes. Despite some study limitations, our results contribute to a better understanding of the effects of mosquito aging and pathogen infection on the vectorial capacity of Ae. aegypti.
C1 [Petersen, Martha Thieme; da Silveira, Isabella Dias; Tatila-Ferreira, Aline; David, Mariana Rocha; Chouin-Carneiro, Thais; Maciel-de-Freitas, Rafael] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoa, Rio De Janeiro, RJ, Brazil.
   [Chouin-Carneiro, Thais] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, RJ, Brazil.
   [Van den Wouwer, Liesbeth; Maes, Louis] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium.
RP Maciel-De-Freitas, R (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Hematozoa, Rio De Janeiro, RJ, Brazil.
EM freitas@ioc.fiocruz.br
RI Maes, Louis JRM/A-2384-2017
OI Maes, Louis JRM/0000-0002-2324-9509; Maciel-de-Freitas,
   Rafael/0000-0002-2198-6492; Rocha David, Mariana/0000-0003-1241-3585
FU MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit [E14/2016 (440929/2016-4)];
   FaperjCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [Faperj]
FX This work was supported by the Brazilian Research Councils
   MCTIC/FNDCT-CNPq/ MEC-CAPES/ MS-Decit E14/2016 (440929/2016-4) and
   Faperj E18/2015. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   BRIEGEL H, 1980, EXPERIENTIA, V36, P1428, DOI 10.1007/BF01960142
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chahad-Ehlers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052559
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019
   Dickson LB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003153
   DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245
   DYE C, 1986, Parasitology Today, V2, P203
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Faria N Rodrigues, 2016, PLOS CURR, V8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   GARRETTJONES C, 1964, NATURE, V204, P1173, DOI 10.1038/2041173a0
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Harbach RE, 1980, TAXONOMISTS GLOSSARY, P1
   Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610
   Lucio PS, 2013, J VECTOR ECOL, V38, P20, DOI 10.1111/j.1948-7134.2013.12005.x
   Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x
   Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   McCann S, 2009, J VECTOR ECOL, V34, P174, DOI [10.1111/j.1948-7134.2009.00024.x, 10.3376/038.034.0202]
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339
   Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119
   ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364
   Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
NR 50
TC 2
Z9 2
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2018
VL 13
IS 7
AR e0200766
DI 10.1371/journal.pone.0200766
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4DQ
UT WOS:000439952400018
PM 30048481
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wheeler, AC
   Ventura, CV
   Ridenour, T
   Toth, D
   Nobrega, LALL
   Dantas, LCSD
   Rocha, C
   Bailey, DB
   Ventura, LO
AF Wheeler, Anne C.
   Ventura, Camila V.
   Ridenour, Ty
   Toth, Danielle
   Nobrega, Lucelia Lima
   Silva de Souza Dantas, Lana Claudia
   Rocha, Camilla
   Bailey, Donald B., Jr.
   Ventura, Liana O.
TI Skills attained by infants with congenital Zika syndrome: Pilot data
   from Brazil
SO PLOS ONE
LA English
DT Article
ID VIRUS; AGE; NORMS; SLEEP
AB The recent Zika outbreak and its link to microcephaly and other birth defects in infants exposed in utero have garnered widespread international attention. Based on the severity of birth defects the extent of impairment in these infants is expected to be profound; however, virtually nothing is known regarding the developmental and behavioral sequela of congenital Zika syndrome. This pilot study collected parent-reported patterns of development and sleep in 47 infants with confirmed congenital Zika syndrome who are being followed for clinical services at the Altino Ventura Foundation (FAV) in Recife, Brazil. With assistance from clinicians at FAV, caregivers completed Brazilian Portuguese versions of the Ages and Stages Questionnaire, 3 rd edition (ASQ-3) and the Brief Infant Sleep Questionnaire (BISQ). All infants were between 13-22 months of age at the time of the assessment. At 16 months of age, none of the children displayed age appropriate developmental skills. Most (similar to 75%) mastered some communication and gross motor skills at around a 6-8-month level. Communication and gross motor skills were relative strengths for the sample, while problem-solving and fine motor skills were relative weaknesses. Sleep was noted to be a problem for around 18% of the sample. In utero exposure to the Zika virus will have lifelong consequences for affected children and their families. Understanding the developmental and behavioral trajectories of affected infants will help identify appropriate family supports to improve quality of life.
C1 [Wheeler, Anne C.; Ridenour, Ty; Toth, Danielle; Bailey, Donald B., Jr.] RTI Int, RTI Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC USA.
   [Ventura, Camila V.; Nobrega, Lucelia Lima; Silva de Souza Dantas, Lana Claudia; Rocha, Camilla; Ventura, Liana O.] Altino Ventura Fdn FAV, Rehabil Ctr Menina dos Olhos, Recife, PE, Brazil.
RP Wheeler, AC (corresponding author), RTI Int, RTI Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC USA.
EM acwheeler@rti.org
RI Ventura, Liana Vieira O/N-6151-2018; Ventura, Camila/N-2654-2018
OI Ventura, Liana Vieira O/0000-0001-6529-6883; Ventura,
   Camila/0000-0002-2927-4684
FU NICHDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [1R01HD093572-01];
   RTI International
FX This work was supported by NICHD 1R01HD093572-01 to DB, CV, and AW; RTI
   International to DB and AW. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Center for the Developing Child, 2007, SCI EARL CHILDH DEV
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Filgueiras A, 2013, EARLY HUM DEV, V89, P561, DOI 10.1016/j.earlhumdev.2013.02.005
   Mindell JA, 2015, INFANT BEHAV DEV, V41, P102, DOI 10.1016/j.infbeh.2015.08.004
   Moore CA, 2016, JAMA PEDIAT
   Nunes ML, 2012, SLEEP SCI, V5, P89
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Salomao SR, 2008, ARQ BRAS OFTALMOL, V71, P475, DOI 10.1590/S0004-27492008000400002
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Squires J., 2009, AGES STAGES QUESTION
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
NR 14
TC 13
Z9 13
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2018
VL 13
IS 7
AR e0201495
DI 10.1371/journal.pone.0201495
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4DQ
UT WOS:000439952400096
PM 30048541
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Singh, PK
   Khatri, I
   Jha, A
   Pretto, CD
   Spindler, KR
   Arumugaswami, V
   Giri, S
   Kumar, A
   Bhasin, MK
AF Singh, Pawan Kumar
   Khatri, Indu
   Jha, Alokkumar
   Pretto, Carla D.
   Spindler, Katherine R.
   Arumugaswami, Vaithilingaraja
   Giri, Shailendra
   Kumar, Ashok
   Bhasin, Manoj K.
TI Determination of system level alterations in host transcriptome due to
   Zika virus (ZIKV) Infection in retinal pigment epithelium
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CHOLESTEROL EFFLUX; ENDOTHELIAL-CELLS; GENE-EXPRESSION; DIFFERENTIAL
   EXPRESSION; INTERACTION NETWORKS; DENGUE VIRUS; WEST NILE; ABCG1;
   PROTEIN; TRANSPORTERS
AB Previously, we reported that Zika virus (ZIKV) causes ocular complications such as chorioretinal atrophy, by infecting cells lining the blood-retinal barrier, including the retinal pigment epithelium (RPE). To understand the molecular basis of ZIKV-induced retinal pathology, we performed a meta-analysis of transcriptome profiles of ZIKV-infected human primary RPE and other cell types infected with either ZIKV or other related flaviviruses (Japanese encephalitis, West Nile, and Dengue). This led to identification of a unique ZIKV infection signature comprising 43 genes (35 upregulated and 8 downregulated). The major biological processes perturbed include SH3/SH2 adaptor activity, lipid and ceramide metabolism, and embryonic organ development. Further, a comparative analysis of some differentially regulated genes (ABCG1, SH2B3, SIX4, and TNFSF13B) revealed that ZIKV induced their expression relatively more than dengue virus did in RPE. Importantly, the pharmacological inhibition of ABCG1, a membrane transporter of cholesterol, resulted in reduced ZIKV infectivity. Interestingly, the ZIKV infection signature revealed the downregulation of ALDH5A1 and CHML, genes implicated in neurological (cognitive impairment, expressive language deficit, and mild ataxia) and ophthalmic (choroideremia) disorders, respectively. Collectively, our study revealed that ZIKV induces differential gene expression in RPE cells, and the identified genes/pathways (e.g., ABCG1) could potentially contribute to ZIKV-associated ocular pathologies.
C1 [Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48202 USA.
   [Khatri, Indu; Jha, Alokkumar; Bhasin, Manoj K.] Beth Israel Deaconess Med Ctr, Bioinformat & Syst Biol Ctr, BIDMC Genom, Boston, MA 02215 USA.
   [Khatri, Indu; Jha, Alokkumar; Bhasin, Manoj K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA.
   [Pretto, Carla D.; Spindler, Katherine R.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA.
   [Giri, Shailendra] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA.
   [Kumar, Ashok] Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI 48202 USA.
RP Kumar, A (corresponding author), Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48202 USA.; Bhasin, MK (corresponding author), Beth Israel Deaconess Med Ctr, Bioinformat & Syst Biol Ctr, BIDMC Genom, Boston, MA 02215 USA.; Bhasin, MK (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA.; Kumar, A (corresponding author), Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI 48202 USA.
EM akuma@med.wayne.edu; mbhasin@bidmc.harvard.edu
RI Khatri, Indu/Y-2429-2018; Jha, Alokkumar/AAB-7162-2019
OI Khatri, Indu/0000-0002-7993-1953; Jha, Alokkumar/0000-0002-8024-5854;
   Singh, Pawan Kumar/0000-0001-5517-1120; Pretto-Kernahan,
   Carla/0000-0002-2696-6802
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI135583,
   R01EY026964, R01 EY027381]; Research to Prevent Blindness Inc.Research
   to Prevent Blindness (RPB); NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [P30EY004068]
FX This study was supported in parts by grant from National Institute of
   Health (R21AI135583, R01EY026964, & R01 EY027381) and an unrestricted
   grant to the Department of Ophthalmology/Kresge Eye Institute (PI: Mark
   S. Juzych) from Research to Prevent Blindness Inc. The immunology
   resource core is supported by an NIH center grant P30EY004068 (PI: Linda
   D. Hazlett). The authors would like to thank other members of the lab
   for their helpful discussion and editing the final manuscript.
CR Abbasi Aziz-un-Nisa, 2016, J Ayub Med Coll Abbottabad, V28, P1
   Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x
   Ananth S, 2014, BBA-MOL BASIS DIS, V1842, P603, DOI 10.1016/j.bbadis.2014.01.010
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Andrews S, 2010, FASTQC QUALITY CONTR
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Barcelo-Coblijn G, 2007, BBA-MOL BASIS DIS, V1772, P556, DOI 10.1016/j.bbadis.2006.12.008
   Bhasin MK, 2016, ONCOTARGET, V7, P23263, DOI 10.18632/oncotarget.8139
   Bodaghi B, 1999, INVEST OPHTH VIS SCI, V40, P2598
   Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boulday G, 2002, TRANSPLANTATION, V74, P1352, DOI 10.1097/00007890-200211150-00026
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Deng Y, 2010, TRENDS CELL BIOL, V20, P371, DOI 10.1016/j.tcb.2010.04.001
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200
   Flister MJ, 2015, CIRC-CARDIOVASC GENE, V8, P294, DOI 10.1161/CIRCGENETICS.114.000527
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gordiyenko NV, 2010, INVEST OPHTH VIS SCI, V51, P1143, DOI 10.1167/iovs.09-4117
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   HSU HY, 1995, J BIOL CHEM, V270, P19630, DOI 10.1074/jbc.270.33.19630
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Keiser NW, 2005, MOL VIS, V11, P1052
   Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Lorizate M., 2011, COLD SPRING HARBOR P, V3
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Munoz-Erazo L, 2012, MOL VIS, V18, P730
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002
   Plomin R, 2004, MOL PSYCHIATR, V9, P582, DOI 10.1038/sj.mp.4001441
   Radziwon A, 2017, HUM MUTAT, V38, P704, DOI 10.1002/humu.23212
   Rajamani D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0282-3
   Rajamani D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21502
   Rao N A, 1998, Trans Am Ophthalmol Soc, V96, P111
   RAO NA, 1998, T AM OPHTHAL SOC, V96, P124
   Raof NA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2267-9
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254
   Seres L, 2008, BBA-BIOMEMBRANES, V1778, P2378, DOI 10.1016/j.bbamem.2008.06.010
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Storti F, 2017, EXP EYE RES, V165, P65, DOI 10.1016/j.exer.2017.09.008
   Takizawa H, 2008, EXP HEMATOL, V36, P897, DOI 10.1016/j.exphem.2008.02.004
   Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503
   Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001
   Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Vogel KR, 2018, TOXICOL IN VITRO, V46, P203, DOI 10.1016/j.tiv.2017.10.015
   Vogel KR, 2017, BBA-MOL BASIS DIS, V1863, P33, DOI 10.1016/j.bbadis.2016.10.009
   Whetzel AM, 2010, ARTERIOSCL THROM VAS, V30, P809, DOI 10.1161/ATVBAHA.109.199166
   Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 72
TC 10
Z9 12
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 25
PY 2018
VL 8
AR 11209
DI 10.1038/s41598-018-29329-2
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO1DB
UT WOS:000439686700032
PM 30046058
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, M
   Zhao, LZ
   Zhang, C
   Wang, X
   Hong, WX
   Sun, J
   Liu, R
   Yu, L
   Wang, JH
   Zhang, FC
   Jin, X
AF Li, Min
   Zhao, Lingzhai
   Zhang, Chao
   Wang, Xin
   Hong, Wenxin
   Sun, Jin
   Liu, Ran
   Yu, Lei
   Wang, Jianhua
   Zhang, Fuchun
   Jin, Xia
TI Dengue immune sera enhance Zika virus infection in human peripheral
   blood monocytes through Fc gamma receptors
SO PLOS ONE
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; PRINCIPAL TARGET-CELLS; IN-VITRO;
   MONONUCLEAR-CELLS; CROSS-REACTIVITY; T-CELLS; B-CELLS; TRANSMISSION;
   PATHOGENESIS; REPLICATION
AB Antibody dependent enhancement (ADE) has most often been associated with dengue virus (DENV). Studies using leukemia cell lines suggest that DENV specific antibodies can enhance Zika virus (ZIKV) infectivity, and vice versa. To examine the mechanisms of ADE of ZIKV infection in primary human cells, we assessed 40 serum samples obtained from convalescent DENV-1 or DENV-3 infected subjects. All sera tested exhibited high binding potency, while modest or none neutralization activities against ZIKV. Primary CD14+ monocytes, rather than B and T cells in peripheral blood mononuclear cells (PBMCs), were found to be the mediators of the enhancement of ZIKV infectivity by DENV immune sera. Monocyte-derived immature dendritic cells (DCs), but not mature DCs were highly permissive to ZIKV infection, whereas neither immature nor mature DCs could mediate enhanced ZIKV infection in the presence of DENV immune sera. In addition, antibody blocking of either Fc gamma RI (CD64), or Fc gamma RII (CD32), or Fc gamma RIII (CD16) resulted in diminished ADE of ZIKV infection. Our findings provide an improved understanding of the pathogenesis of ZIKV infection, and inform rational vaccine design.
C1 [Li, Min; Zhang, Chao; Wang, Xin; Sun, Jin; Liu, Ran; Wang, Jianhua; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
   [Li, Min; Zhang, Chao; Wang, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Zhao, Lingzhai; Hong, Wenxin; Yu, Lei; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Wang, Xin] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China.
RP Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.; Zhang, FC (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
EM gz8hzfc@126.com; xjin@ips.ac.cn
FU Chinese Ministry of Science and Technology (National Key Program Project
   Grant) [2016YFC1201000, 2016YFE0133500]; National Science Foundation of
   ChinaNational Natural Science Foundation of China [31670941, 31370870];
   Guangzhou Science and Technology Program for Public Wellbeing
   [2014Y2-00185, 2014Y2-00550, 201508020263]; Special Program of Guangdong
   Provincial Department of Science and Technology [2016A020248001,
   S201302001300]; Chinese Academy of Sciences (STS Grant) [KFJEWSTS098]
FX This project was supported by grants from Chinese Ministry of Science
   and Technology (National Key Program Project Grant, #2016YFC1201000 and
   #2016YFE0133500), National Science Foundation of China (General Grant,
   #31670941 and #31370870), Guangzhou Science and Technology Program for
   Public Wellbeing (#2014Y2-00185, #2014Y2-00550 and #201508020263), the
   Special Program of Guangdong Provincial Department of Science and
   Technology (#2016A020248001 and #S201302001300), and Chinese Academy of
   Sciences (STS Grant, #KFJEWSTS098).
CR Bardina SV, 2017, SCIENCE
   Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Charles AS, 2016, PLOS CURR
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Jin X, 2009, ANTIVIR THER, V14, P739, DOI 10.3851/IMP1288
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pan American Health Organization, 2016, NUMB REP CAS DENG SE
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   ROBINSON JE, 1990, J IMMUNOL METHODS, V132, P63, DOI 10.1016/0022-1759(90)90399-G
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wei HY, 2016, AM J TROP MED HYG, V95, P322, DOI 10.4269/ajtmh.15-0905
   WHO, 2017, ZIK VIR COMPL 2016 P
NR 46
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2018
VL 13
IS 7
AR e0200478
DI 10.1371/journal.pone.0200478
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4AN
UT WOS:000439942500055
PM 30044839
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mazar, J
   Li, YJ
   Rosado, A
   Phelan, P
   Kedarinath, K
   Parks, GD
   Alexander, KA
   Westmoreland, TJ
AF Mazar, Joseph
   Li, Yujia
   Rosado, Amy
   Phelan, Peter
   Kedarinath, Kritika
   Parks, Griffith D.
   Alexander, Kenneth A.
   Westmoreland, Tamarah J.
TI Zika virus as an oncolytic treatment of human neuroblastoma cells
   requires CD24
SO PLOS ONE
LA English
DT Article
ID RISK GROUP; INFECTION; SYSTEM; CANCER; ACTIVATION; HEPATITIS; CARCINOMA
AB Neuroblastoma is the second most common childhood tumor. Survival is poor even with intensive therapy. In a search for therapies to neuroblastoma, we assessed the oncolytic potential of Zika virus. Zika virus is an emerging mosquito-borne pathogen unique among flaviviruses because of its association with congenital defects. Recent studies have shown that neuronal progenitor cells are likely the human target of Zika virus. Neuroblastoma has been shown to be responsive to infection. In this study, we show that neuroblastoma cells are widely permissive to Zika infection, revealing extensive cytopathic effects (CPE) and producing high titers of virus. However, a single cell line appeared poorly responsive to infection, producing undetectable levels of non-structural protein 1 (NS1), limited CPE, and low virus titers. A comparison of these poorly permissive cells to highly permissive neuroblastoma cells revealed a dramatic loss in the expression of the cell surface glycoprotein CD24 in poorly permissive cells. Complementation of CD24 expression in these cells led to the production of detectable levels of NS1 expression after infection with Zika, as well as dramatic increases in viral titers and CPE. Complementary studies using the Zika virus index strain and a north African isolate confirmed these phenotypes. These results suggest a possible role for CD24 in host cell specificity by Zika virus and offer a potential therapeutic target for its treatment. In addition, Zika viral therapy can serve as an adjunctive treatment for neuroblastoma by targeting tumor cells that can lead to recurrent disease and treatment failure.
C1 [Mazar, Joseph; Rosado, Amy; Phelan, Peter; Alexander, Kenneth A.; Westmoreland, Tamarah J.] Nemours Childrens Hosp, Dept Biomed Res, Orlando, FL 32827 USA.
   [Li, Yujia; Kedarinath, Kritika; Parks, Griffith D.; Alexander, Kenneth A.; Westmoreland, Tamarah J.] Univ Cent Florida, Coll Med, Burnett Sch Biol Sci, Orlando, FL 32816 USA.
RP Mazar, J; Westmoreland, TJ (corresponding author), Nemours Childrens Hosp, Dept Biomed Res, Orlando, FL 32827 USA.; Westmoreland, TJ (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biol Sci, Orlando, FL 32816 USA.
EM jm0151@nemours.org; tamarah.westmoreland@nemours.org
RI Mazar, Joseph/AAQ-8199-2020
OI Mazar, Joseph/0000-0002-3713-4251
FU Nemours Foundation; Nemours Children's Hospital; Florida High Tech
   Corridor
FX The Nemours Foundation and Nemours Children's Hospital along with the
   regional economic development initiative of the Florida High Tech
   Corridor supported all funding for these studies. There was no
   additional external funding received for this study. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR [Anonymous], 2016, ZIK VIR SYMPT TEST T
   [Anonymous], 2016, ONCOTARGET, V8, P6589
   [Anonymous], 2017, ONCOTARGET, V8, P6589
   Aref S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100294
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014
   Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dingli D, 2004, BLOOD, V103, P1641, DOI 10.1182/blood-2003-07-2233
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fang XF, 2010, CELL MOL IMMUNOL, V7, P100, DOI 10.1038/cmi.2009.119
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GEORGIADES JERZY, 1959, BIUL INST MED MORSKIEJ W GDANSKU, V10, P49
   Gilliam DT, 2017, NEUROBIOL DIS, V99, P133, DOI 10.1016/j.nbd.2016.12.011
   Hadac EM, 2004, VIROLOGY, V329, P217, DOI 10.1016/j.virol.2004.08.036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HOSTER HA, 1949, CANCER RES, V9, P473
   HOUGH MR, 1994, GENOMICS, V22, P154, DOI 10.1006/geno.1994.1356
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Institute NC, 2017, NEUR TREATM PDQ PAT
   Kaid C, 2018, CANC RES
   Kristiansen G, 2004, J MOL HISTOL, V35, P255
   Lacroix J, 2010, INT J CANCER, V127, P1230, DOI 10.1002/ijc.25168
   Latchman DS, 2005, CURR OPIN MOL THER, V7, P415
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li DL, 2009, HEPATOLOGY, V50, P735, DOI 10.1002/hep.23047
   Li Y, 2013, J CANCER RES CLIN, V139, P933, DOI 10.1007/s00432-013-1406-4
   Lim SC, 2005, BIOMED PHARMACOTHER, V59, pS351, DOI 10.1016/S0753-3322(05)80076-9
   London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571
   Luplertlop N, 2017, J VECTOR DIS, V54, P207, DOI 10.4103/0972-9062.217611
   Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0
   Mazar J, 2017, ONCOTARGET, V8, P6589, DOI 10.18632/oncotarget.14244
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060
   Papaioannou Georgia, 2005, Cancer Imaging, V5, P116, DOI 10.1102/1470-7330.2005.0104
   Poncet C, 1996, ACTA NEUROPATHOL, V91, P400, DOI 10.1007/s004010050442
   Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015
   Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748
   SMITH RR, 1956, CANCER, V9, P1211, DOI 10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7
   SOUTHAM CM, 1952, CANCER, V5, P1025, DOI 10.1002/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TAYLOR AW, 1953, BRIT MED J, V1, P589, DOI 10.1136/bmj.1.4810.589
   Toyoda H, 2011, INT J ONCOL, V38, P81, DOI 10.3892/ijo_00000826
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Zhang SC, 2012, CANCER LETT, V325, P227, DOI 10.1016/j.canlet.2012.07.008
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 53
TC 5
Z9 5
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 25
PY 2018
VL 13
IS 7
AR e0200358
DI 10.1371/journal.pone.0200358
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO4AN
UT WOS:000439942500047
PM 30044847
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, XL
   Qu, LB
   Ye, XM
   Yi, CH
   Zheng, XH
   Hao, ML
   Su, W
   Yao, ZP
   Chen, PH
   Zhang, SN
   Feng, YP
   Wang, Q
   Yan, QH
   Li, PC
   Li, HY
   Li, F
   Pan, WQ
   Niu, XF
   Xu, RA
   Feng, LQ
   Chen, L
AF Liu, Xinglong
   Qu, Linbing
   Ye, Xianmiao
   Yi, Changhua
   Zheng, Xuehua
   Hao, Mingli
   Su, Wan
   Yao, Zhipeng
   Chen, Peihai
   Zhang, Shengnan
   Feng, Yupeng
   Wang, Qian
   Yan, Qihong
   Li, Pingchao
   Li, Heying
   Li, Feng
   Pan, Weiqi
   Niu, Xuefeng
   Xu, Ruian
   Feng, Liqiang
   Chen, Ling
TI Incorporation of NS1 and prM/M are important to confer effective
   protection of adenovirus-vectored Zika virus vaccine carrying E protein
SO NPJ VACCINES
LA English
DT Article
ID CD8(+) T-CELLS; DENGUE VIRUS; DNA VACCINE; JAPANESE ENCEPHALITIS;
   CLINICAL-TRIALS; INFECTED-CELLS; MICE; ANTIBODIES; CHALLENGE; EFFICACY
AB Current design of Zika virus (ZIKV) vaccine mainly considered envelope (E) as the major target antigen. Non-structural protein NS1 was seldom considered. Herein, we generated three adenovirus-vectored vaccines carrying E (Ad2-E), or premembrane/membrane (prM/M) with E (Ad2-prME), or NS1 in addition to prM/M with E (Ad2-prME-NS1). Ad2-prME induced higher neutralizing antibody response to ZIKV than Ad2-E, suggesting prM/M is important for the folding of immunogenic E. Most intriguingly, Ad2-prME-NS1 elicited the best viral inhibition when the immune sera were added to ZIKV-infected cells. In ZIKV-challenged neonatal mice born to maternally immunized dams, Ad2-prME-NS1 conferred the best protection in preventing weight loss, neurological disorders, and viral replication. Ad2-prME also conferred significant protection but was less effective than Ad2-prME-NS1, whereas Ad2-E only alleviated neurological symptoms but did not inhibit viral replication. Our study suggested that NS1 should be considered in the design of ZIKV vaccine in addition to prM/M and E.
C1 [Liu, Xinglong; Qu, Linbing; Ye, Xianmiao; Yi, Changhua; Zheng, Xuehua; Zhang, Shengnan; Feng, Yupeng; Wang, Qian; Yan, Qihong; Li, Pingchao; Li, Heying; Feng, Liqiang; Chen, Ling] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Labs Resp Dis, Guangzhou, Guangdong, Peoples R China.
   [Liu, Xinglong; Hao, Mingli; Su, Wan; Xu, Ruian; Chen, Ling] Huaqiao Univ, Sch Biomed Sci, Quanzhou, Peoples R China.
   [Ye, Xianmiao; Wang, Qian; Yan, Qihong] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Yao, Zhipeng; Chen, Peihai] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Anhui, Peoples R China.
   [Li, Feng; Pan, Weiqi; Niu, Xuefeng; Chen, Ling] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
RP Feng, LQ; Chen, L (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Labs Resp Dis, Guangzhou, Guangdong, Peoples R China.; Chen, L (corresponding author), Huaqiao Univ, Sch Biomed Sci, Quanzhou, Peoples R China.; Chen, L (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
EM feng_ligiang@gibh.ac.cn; chen_ling@gibh.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470892]; National Key Research and Development
   Project [2016YFC1200900]; National Science and Technology Major Projects
   of China [2017ZX10204401003]; Guangdong Science and Technology
   Department [2016A020250001]; Guangzhou Health Care and Cooperative
   Innovation Major Project [201704020229]; Pearl River S&T Nova Program of
   Guangzhou [201506010076]; CAS Youth Innovation Promotion Association
   [2014328]
FX The authors would like to thank Caixia Wu, Yichu Liu, Beiwu Zhang,
   Zhixia Li, Zheyu Cai for their technical support. This study was
   supported by the National Natural Science Foundation of China (No.
   31470892), National Key Research and Development Project (No.
   2016YFC1200900), National Science and Technology Major Projects of China
   (2017ZX10204401003), the grant from Guangdong Science and Technology
   Department (No. 2016A020250001), the Guangzhou Health Care and
   Cooperative Innovation Major Project (No. 201704020229), the Pearl River
   S&T Nova Program of Guangzhou (No. 201506010076), and CAS Youth
   Innovation Promotion Association (No. 2014328).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alayli F, 2016, VIROLOGY, V496, P227, DOI 10.1016/j.virol.2016.06.008
   Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Amorim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044984
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Baud D., 2017, LANCET, DOI [10.1016/S0140-6736(17)31450-2, DOI 10.1016/S0140-6736(17)31450-2[EPUBAHEADOFPRINT]]
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Ishikawa T, 2011, VACCINE, V29, P7444, DOI 10.1016/j.vaccine.2011.07.058
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lu H, 2013, MOL IMMUNOL, V54, P109, DOI 10.1016/j.molimm.2012.11.007
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Wan SW, 2017, J IMMUNOL, V199, P2834, DOI 10.4049/jimmunol.1601523
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
NR 55
TC 8
Z9 8
U1 2
U2 5
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD JUL 24
PY 2018
VL 3
AR 29
DI 10.1038/s41541-018-0072-6
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GP9XH
UT WOS:000441269200001
PM 30062066
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sebera, J
   Dubankova, A
   Sychrovsky, V
   Ruzek, D
   Boura, E
   Nencka, R
AF Sebera, Jakub
   Dubankova, Anna
   Sychrovsky, Vladimir
   Ruzek, Daniel
   Boura, Evzen
   Nencka, Radim
TI The structural model of Zika virus RNA-dependent RNA polymerase in
   complex with RNA for rational design of novel nucleotide inhibitors
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CRYSTAL-STRUCTURE; UCSF CHIMERA; DOCKING; METHYLTRANSFERASE; INSIGHTS;
   DOMAIN; PI4KB
AB Zika virus is a global health threat due to significantly elevated risk of fetus malformations in infected pregnant women. Currently, neither an effective therapy nor a prophylactic vaccination is available for clinical use, desperately necessitating novel therapeutics and approaches to obtain them. Here, we present a structural model of the Zika virus RNA-dependent RNA polymerase (ZIKV RdRp) in complex with template and nascent RNAs, Mg2+ ions and accessing nucleoside triphosphate. The model allowed for docking studies aimed at effective pre-screening of potential inhibitors of ZIKV RdRp. Applicability of the structural model for docking studies was illustrated with the NITD008 artificial nucleotide that is known to effectively inhibit the function of the ZIKV RdRp. The ZIKV RdRp - RNA structural model is provided for all possible variations of the nascent RNA bases pairs to enhance its general utility in docking and modelling experiments. The developed model makes the rational design of novel nucleosides and nucleotide analogues feasible and thus provides a solid platform for the development of advanced antiviral therapy.
C1 [Sebera, Jakub; Dubankova, Anna; Boura, Evzen; Nencka, Radim] Czech Acad Sci, Inst Organ Chem & Biochem, Gilead Sci Res Ctr, IOCB Prague, Prague, Czech Republic.
   [Sychrovsky, Vladimir] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic.
   [Ruzek, Daniel] Vet Res Inst, Hudcova 70, CZ-62100 Brno, Czech Republic.
   [Ruzek, Daniel] Czech Acad Sci, Inst Parasitol, Biol Ctr, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
RP Boura, E; Nencka, R (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Gilead Sci Res Ctr, IOCB Prague, Prague, Czech Republic.
EM boura@uochb.cas.cz; nencka@uochb.cas.cz
RI Sebera, Jakub/B-6112-2013; Ruzek, Daniel/G-9275-2014; amsalu,
   ribka/G-8780-2019; Dubankova, Anna/M-6168-2017
OI Sebera, Jakub/0000-0001-5671-5206; Ruzek, Daniel/0000-0003-4655-2380;
   Dubankova, Anna/0000-0002-1181-1867; Boura, Evzen/0000-0002-9652-4065
FU Czech Science FoundationGrant Agency of the Czech Republic [16-20054S];
   European Regional Development FundEuropean Union (EU); OP RDE; Project:
   "Chemical biology for drugging undruggable targets (ChemBioDrug)"
   [CZ.02.1.01/0.0/0.0/16_019/0000729]; Academy of Sciences Czech
   RepublicCzech Academy of SciencesCzech Republic Government [RVO:
   61388963]; Gilead Sciences, Inc.Gilead Sciences
FX We are grateful to Michael Downey for critical reading of the
   manuscript. The project was supported by the Czech Science Foundation
   (Registration No. 16-20054S) and also from European Regional Development
   Fund; OP RDE; Project: "Chemical biology for drugging undruggable
   targets (ChemBioDrug)" (No. CZ.02.1.01/0.0/0.0/16_019/0000729) and by
   the Academy of Sciences Czech Republic (RVO: 61388963). The work was
   also supported by Gilead Sciences, Inc.
CR [Anonymous], 2012, DESM MOL DYN SYST V
   [Anonymous], 2013, MAESTR V 9 3
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841
   BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bochevarov AD, 2013, INT J QUANTUM CHEM, V113, P2110, DOI 10.1002/qua.24481
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boura E, 2012, P NATL ACAD SCI USA, V109, P1901, DOI 10.1073/pnas.1117597109
   Caillet-Saguy C, 2014, ANTIVIR RES, V105, P8, DOI 10.1016/j.antiviral.2014.02.006
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Case D.A., 2016, AMBER
   Chen DL, 2007, PROTEINS, V67, P593, DOI 10.1002/prot.21249
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dubankova A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17621-6
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   FLAMAND A, 1978, J GEN VIROL, V40, P233, DOI 10.1099/0022-1317-40-1-233
   Frisch M. J., 2013, GAUSSIAN 09
   Genna V, 2016, J AM CHEM SOC, V138, P14592, DOI 10.1021/jacs.6b05475
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344
   HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485
   HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975
   HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030
   Jerabek P, 2014, BIOCHEMISTRY-US, V53, P6695, DOI 10.1021/bi500814t
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Klima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23641
   Klvana M, 2016, J PHYS CHEM B, V120, P13017, DOI 10.1021/acs.jpcb.6b08581
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lescar J, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P101
   Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mejdrova I, 2017, J MED CHEM, V60, P100, DOI 10.1021/acs.jmedchem.6b01465
   Mejdrova I, 2015, J MED CHEM, V58, P3767, DOI 10.1021/acs.jmedchem.5b00499
   Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   SCHLEGEL HB, 1984, THEOR CHIM ACTA, V66, P333
   Sholders AJ, 2014, J MOL BIOL, V426, P1407, DOI 10.1016/j.jmb.2013.12.031
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sychrovsky V, 2009, NUCLEIC ACIDS RES, V37, P7321, DOI 10.1093/nar/gkp783
   Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013
   Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zamyatkin DF, 2009, J MOL BIOL, V390, P10, DOI 10.1016/j.jmb.2009.04.069
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 74
TC 10
Z9 11
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 24
PY 2018
VL 8
AR 11132
DI 10.1038/s41598-018-29459-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN9TF
UT WOS:000439550200004
PM 30042483
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Emanuel, J
   Callison, J
   Dowd, KA
   Pierson, TC
   Feldmann, H
   Marzi, A
AF Emanuel, Jackson
   Callison, Julie
   Dowd, Kimberly A.
   Pierson, Theodore C.
   Feldmann, Heinz
   Marzi, Andrea
TI A VSV-based Zika virus vaccine protects mice from lethal challenge
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MOUSE MODEL; STRUCTURAL BASIS; INFLUENZA-VIRUS; DNA VACCINE; OPEN-LABEL;
   EBOLA; EFFICACY; VECTORS; TRANSMISSION; IMMUNIZATION
AB Infection with Zika virus (ZIKV) is commonly mild in humans but has been associated with alarming negative health outcomes including Guillain-Barre syndrome in adults and microcephaly in fetuses. As such, developing a vaccine for ZIKV is a global public health priority. Recombinant vesicular stomatitis virus (VSV) expressing the Ebola virus (EBOV) glycoprotein (GP) has been successfully used as a vaccine platform in the past. In this study, two novel VSV-ZIKV vaccines were generated utilizing the favorable immune targeting of the existing VSV-EBOV vector. In addition to the EBOV GP, these new vaccines express the full-length pre-membrane and envelope proteins or pre-membrane and truncated soluble envelope proteins as antigens. Efficacy testing of both of the VSV vectors against ZIKV was conducted in IFNAR(-/)-mice and resulted in uniform protection when a single dose was administered 28 days prior to lethal challenge. Furthermore, this vaccine is fast-acting and can uniformly protect mice from lethal disease when administered as late as 3 days prior to ZIKV challenge. Thus, VSV-ZIKV vectors are promising vaccine candidates and should move forward along the licensure pathway.
C1 [Emanuel, Jackson; Callison, Julie; Feldmann, Heinz; Marzi, Andrea] NIH, Natl Inst Allergy & Infect Dis, Lab Virol, Div Intramural Res, Hamilton, MT 20892 USA.
   [Dowd, Kimberly A.; Pierson, Theodore C.] NIH, Natl Inst Allergy & Infect Dis, Lab Viral Dis, Div Intramural Res, Bethesda, MD USA.
RP Marzi, A (corresponding author), NIH, Natl Inst Allergy & Infect Dis, Lab Virol, Div Intramural Res, Hamilton, MT 20892 USA.
EM marzia@niaid.nih.gov
RI Marzi, Andrea/AAF-4617-2020
OI Marzi, Andrea/0000-0003-0186-9587
FU Division of Intramural Research, NIAID, NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
FX We thank Elaine Haddock (Laboratory of Virology) and the animal care
   staff of the Rocky Mountain Veterinary Branch (National Institute of
   Allergy and Infectious Diseases (NIAID), NIH), especially Malea Higgins
   and Cammie Papineau, for their support of the animal experiments. This
   work was funded by the Division of Intramural Research, NIAID, NIH.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bray M, 1999, J INFECT DIS, V179, pS248, DOI 10.1086/514292
   Brown KS, 2011, J VIROL, V85, P12781, DOI 10.1128/JVI.00794-11
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DeBuysscher BL, 2014, VACCINE, V32, P2637, DOI 10.1016/j.vaccine.2014.02.087
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Haddock E., 2018, J INFECT DIS
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5
   Johnson JE, 2007, VIROLOGY, V360, P36, DOI 10.1016/j.virol.2006.10.026
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Jones SM, 2007, J INFECT DIS, V196, pS404, DOI 10.1086/520591
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Letchworth GJ, 1999, VET J, V157, P239, DOI 10.1053/tvjl.1998.0303
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998
   Marzi A., 2015, SCIENCE
   Marzi A., 2011, J BIOTERRORISM BIODE
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Marzi A, 2015, J INFECT DIS, V212, pS404, DOI 10.1093/infdis/jiv188
   Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110
   Mire CE, 2015, J INFECT DIS, V212, pS384, DOI 10.1093/infdis/jiv126
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Prescott J, 2015, VACCINE, V33, P2823, DOI 10.1016/j.vaccine.2015.03.089
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998
   Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2
   Shan C, 2017, NAT MED
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tsuda Y, 2011, J INFECT DIS, V204, pS1090, DOI 10.1093/infdis/jir379
   van den Pol AN, 2002, J VIROL, V76, P1309, DOI 10.1128/JVI.76.3.1309-1327.2002
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   WHO, 2017, ZIK CUM CAS
   Wong G, 2015, J INFECT DIS, V212, pS435, DOI 10.1093/infdis/jiv257
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 65
TC 18
Z9 18
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 23
PY 2018
VL 8
AR 11043
DI 10.1038/s41598-018-29401-x
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN8NP
UT WOS:000439421600011
PM 30038228
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gonzales, KK
   Rodriguez, SD
   Chung, HN
   Kowalski, M
   Vulcan, J
   Moore, EL
   Li, YY
   Willette, SM
   Kandel, Y
   Van Voorhies, WA
   Holguin, FO
   Hanley, KA
   Hansen, IA
AF Gonzales, Kristina K.
   Rodriguez, Stacy D.
   Chung, Hae-Na
   Kowalski, Margaret
   Vulcan, Julia
   Moore, Emily L.
   Li, Yiyi
   Willette, Stephanie M.
   Kandel, Yashoda
   Van Voorhies, Wayne A.
   Holguin, F. Omar
   Hanley, Kathryn A.
   Hansen, Immo A.
TI The Effect of SkitoSnack, an Artificial Blood Meal Replacement, on Aedes
   aegypti Life History Traits and Gut Microbiota
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ASIAN TIGER MOSQUITO; VECTOR COMPETENCE; PROTEIN MEAL; WOLBACHIA;
   DENGUE; CHIKUNGUNYA; POPULATION; TRANSMISSION; CHOLESTEROL; ERADICATION
AB Public health research and vector control frequently require the rearing of large numbers of vector mosquitoes. All target vector mosquito species are anautogenous, meaning that females require vertebrate blood for egg production. Vertebrate blood, however, is costly, with a short shelf life. To overcome these constraints, we have developed SkitoSnack, an artificial blood meal replacement for the mosquito Aedes aegypti, the vector of dengue, Zika and chikungunya virus. SkitoSnack contains bovine serum albumin and hemoglobin as protein source as well as egg yolk and a bicarbonate buffer. SkitoSnack-raised females had comparable life history traits as blood-raised females. Mosquitoes reared from SkitoSnack-fed females had similar levels of infection and dissemination when orally challenged with dengue virus type 2 (DENV-2) and significantly lower infection with DENV-4. When SkitoSnack was used as a vehicle for DENV-2 delivery, blood-raised and SkitoSnack-raised females were equally susceptible. The midgut microbiota differed significantly between mosquitoes fed on SkitoSnack and mosquitoes fed on blood. By rearing 20 generations of Aedes exclusively on SkitoSnack, we have proven that this artificial diet can replace blood in mosquito mass rearing.
C1 [Gonzales, Kristina K.; Rodriguez, Stacy D.; Chung, Hae-Na; Kowalski, Margaret; Vulcan, Julia; Moore, Emily L.; Kandel, Yashoda; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Hansen, Immo A.] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA.
   [Van Voorhies, Wayne A.; Holguin, F. Omar; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA.
   [Li, Yiyi] New Mexico State Univ, Dept Comp Sci, Las Cruces, NM 88003 USA.
   [Willette, Stephanie M.; Holguin, F. Omar] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.
RP Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.; Hansen, IA (corresponding author), New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA.; Hansen, IA (corresponding author), New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA.
EM immoh@nmsu.edu
FU NMSU RISE to the Post doctorate program (NIH NIGMS Grant) [R25GM061222];
   Bill & Melinda Gates FoundationGates Foundation
FX We would like to thank D. Nez for help with data collection, G. C.
   Lopez-Martinez for data analysis advice, B. Dungan for help with
   metabolomics protocol, and K. Young for help with virus titering. This
   research project is supported by NMSU RISE to the Post doctorate program
   (NIH NIGMS Grant # R25GM061222) and the Bill & Melinda Gates Foundation.
CR Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101
   ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Andrade CC, 2016, J EVOLUTION BIOL, V29, P2205, DOI 10.1111/jeb.12939
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Dutra HLC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16045-6
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   CDC, 2015, DENG CHIK OUR BACK P
   Center T. R., 2008, PHARM LETT PRESCRIBE, V24
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   CLAYTON RB, 1965, Q REV CHEM SOC, V19, P168, DOI 10.1039/qr9651900168
   Clements A. N., 1992, BIOL MOSQUITOES, V2
   Clements A.N., 1992, BIOL MOSQUITOES, V1
   Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Cosgrove JB, 1996, MED VET ENTOMOL, V10, P260, DOI 10.1111/j.1365-2915.1996.tb00740.x
   Costa-da-Silva A. L., 2014, J CLIN RES BIOETHICS, V5, P1
   DAY MF, 1954, AUST J BIOL SCI, V7, P515, DOI 10.1071/BI9540515
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Dyck VA, 2006, STERILE INSECT TECHN
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Farley Alistair, 2012, Nurs Stand, V27, P35
   Gaio AD, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-105
   GALUN R, 1967, B WORLD HEALTH ORGAN, V36, P590
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gary RE, 2001, J MED ENTOMOL, V38, P22, DOI 10.1603/0022-2585-38.1.22
   Gonzales KK, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121267
   Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938
   Graham P, 2014, HARMONISATION ADULT
   Gray EM, 2003, J MED ENTOMOL, V40, P903, DOI 10.1603/0022-2585-40.6.903
   Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hayes E., 1953, J EC ENTOMOLOGY, V46
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2
   Huang YJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182386
   Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pitts RJ, 2014, J INSECT PHYSIOL, V64, P1, DOI 10.1016/j.jinsphys.2014.02.012
   Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96
   Rather IA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00336
   ROSENFELD RS, 1954, J BIOL CHEM, V211, P301
   Rossi P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0888-0
   Semenza JC, 2017, FEMS MICROBIOL LETT, V365
   Shearer F. M., 2018, LANCET GLOBAL HLTH
   Talyuli OAC, 2015, J INSECT PHYSIOL, V83, P1, DOI 10.1016/j.jinsphys.2015.11.007
   USDA, 2016, 01125 USDA NAT AGR L
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x
   Xia J., 2016, CURRENT PROTOCOLS BI, V14, P91
   Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101
   Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009
NR 71
TC 3
Z9 3
U1 1
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 23
PY 2018
VL 8
AR 11023
DI 10.1038/s41598-018-29415-5
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN8NK
UT WOS:000439421000002
PM 30038361
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wewer, CR
   Khandelia, H
AF Wewer, Christian R.
   Khandelia, Himanshu
TI Different footprints of the Zika and dengue surface proteins on viral
   membranes
SO SOFT MATTER
LA English
DT Article
ID MOLECULAR-DYNAMICS; VIRUS-INFECTION; STRUCTURAL BASIS;
   PHOSPHATIDYLSERINE; GLYCOSYLATION; PARAMETERS; RECEPTORS; LIPIDS
AB The flavivirus Zika virus (ZV) became an international emergency within two years of its outbreak in the Americas. Dengue virus (DENV), which is also a flavivirus, causes significant clinical harm in equatorial regions. A common feature amongst flaviviruses like ZV and DENV is an icosahedral shell of exactly 180 copies of the envelope (E) and membrane (M) proteins anchored in a lipid membrane, which engulfs the viral RNA and capsid proteins. Host recognition by both ZV and DENV is linked to the presence of phosphatidylserine (PS) and phosphatidylethanolamine (PE) lipids in the viral lipidome. Glycosylation of Asn residues on the Zika E protein may be linked to ZV induced neuropathies. We carry out coarse grained molecular dynamics simulations of the E3M3 hexamer embedded in the ZV and DENV lipidomes, and we show that the proteins have a significantly different lipid footprint in the viral lipidome. PE lipids in DENV and PS lipids in ZV enrich near the protein hexamer. We attribute the difference to a higher number of cationic amino acids in the ZV M protein. We also show that the three glycosylation sites on ZV, but not on DENV, are conformationally variant. Our data shed new light on the lipid interactions, and thus the host recognition mechanisms of the two viruses, which may be molecular determinants of the neuropathies caused by the ZV.
C1 [Wewer, Christian R.; Khandelia, Himanshu] Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.
RP Khandelia, H (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.
EM hkhandel@sdu.dk
OI Khandelia, Himanshu/0000-0001-9913-6394
FU LundbeckfondenLundbeckfonden
FX HK is supported by Lundbeckfonden. The authors gratefully acknowledge Dr
   John H. Ipsen for useful discussions. We gratefully acknowledge Vikas
   Dubey for helping with the sequence alignment and Weria Pezeshkian for
   helping with the thickness and curvature calculations. Computations were
   performed at the Danish e-Infrastructure Cooperation (DeiC) National HPC
   Center by using ABACUS 2.0 and the Piz-Daint supercomputer in
   Switzerland under the PRACE 14th Call, proposal number 2016153468.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Apajalahti T, 2010, FARADAY DISCUSS, V144, P411, DOI 10.1039/b901487j
   Baker MK, 2014, J PHYS CHEM B, V118, P13590, DOI 10.1021/jp507027t
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Jong DH, 2016, COMPUT PHYS COMMUN, V199, P1, DOI 10.1016/j.cpc.2015.09.014
   de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Soares RDD, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa99c6
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Fuzo CA, 2013, J MOL MODEL, V19, P1369, DOI 10.1007/s00894-012-1687-6
   Gong D., 2018, SCIENCE, V1, P97
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Javanainen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187936
   Javanainen M, 2013, FARADAY DISCUSS, V161, P397, DOI 10.1039/c2fd20085f
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023
   Lopez CA, 2013, J CHEM THEORY COMPUT, V9, P1694, DOI 10.1021/ct3009655
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   PyMOL, PYMOL MOL GRAPH SYST
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wassenaar TA, 2015, J CHEM THEORY COMPUT, V11, P2144, DOI 10.1021/acs.jctc.5b00209
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 43
TC 3
Z9 3
U1 0
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PD JUL 21
PY 2018
VL 14
IS 27
BP 5615
EP 5621
DI 10.1039/c8sm00223a
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA GM7SW
UT WOS:000438395700009
PM 29932192
DA 2020-07-08
ER

PT J
AU Duman-Scheel, M
   Eggleson, KK
   Achee, NL
   Grieco, JP
   Hapairai, LK
AF Duman-Scheel, Molly
   Eggleson, Kathleen K.
   Achee, Nicole L.
   Grieco, John P.
   Hapairai, Limb K.
TI Mosquito control practices and perceptions: An analysis of economic
   stakeholders during the Zika epidemic in Belize, Central America
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI; WEST
AB The tourist-based economy of Belize, a tropical hub for eco-tourism, is at high risk to be disproportionately impacted by established and emerging mosquito-borne diseases such as Zika. An online survey was used to probe economic stakeholders working in the Belize tourism industry about their mosquito control practices and perceptions. Responses demonstrated that the respondents have good working knowledge of mosquitoes and mosquito-borne illnesses. Most businesses surveyed engage in some means of mosquito control, either through larval source reduction or use of insecticides on the premises. Larvicide use was significantly correlated with a general willingness to use insecticides, as well as belief that treatment of water will reduce mosquito densities and disease transmission. A majority of the respondents agreed that they would be interested in buying a new larvicide to be used on the business premises if it were shown to be safe and effective. The safety of mosquito control products for humans, animals, plants, and the environment in general, followed by product effectiveness, are the most critical determinants of mosquito control purchasing decisions. A majority of respondents agreed that control of mosquitoes and mosquito-borne illnesses is central to the success of their tourist-based industry. Respondents expressed significant concern that the Zika epidemic was over-sensationalized by the media, and that this negatively impacted their livelihoods. The respondents, many of whom are associated with eco/sustainable businesses, also voiced concerns that chemical pesticides could have a negative impact on human health and the environment and expressed a desire for balance between effective mosquito control and preservation of the rich biodiversity of Belize. This study provided a framework for further engagement activities in Belize and other Caribbean nations, uncovered both concerns and support for emerging mosquito control technologies, and revealed opportunities for further debate and educational outreach efforts.
C1 [Duman-Scheel, Molly; Hapairai, Limb K.] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.
   [Duman-Scheel, Molly; Eggleson, Kathleen K.; Achee, Nicole L.; Grieco, John P.; Hapairai, Limb K.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Duman-Scheel, Molly; Achee, Nicole L.; Grieco, John P.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Eggleson, Kathleen K.] Indiana Univ Sch Med, Dept Med, South Bend, IN USA.
RP Duman-Scheel, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46617 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
EM mscheel@nd.edu
OI Hapairai, Limb/0000-0002-2943-1061
FU United States Agency for International DevelopmentUnited States Agency
   for International Development (USAID) [AID-OAA-F-16-00097]
FX This study was funded by the United States Agency for International
   Development (https://www.usaid.gov/) award #AID-OAA-F-16-00097 to MDS.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Blamey RK, 2001, PRINCIPLES ECOTOURIS
   Blersch David M., 2013, Environment Development and Sustainability, V15, P67, DOI 10.1007/s10668-012-9374-4
   Brown DM, 2014, VECTOR-BORNE ZOONOT, V14, P291, DOI 10.1089/vbz.2013.1364
   CDC, 2018, TRAV HLTH
   CDC, 2018, NAT CTR EM ZOON INF
   CDC, 2018, DENGUE
   CDC, 2018, ZIK PREGN
   CDC, 2016, SURV CONTR AED AEG A
   CDC, 2018, ZIK VIR
   Ceballos-Lascurain H., 1987, MEXICO J, P13
   Chadee DD, 2007, ACTA TROP, V104, P1, DOI 10.1016/j.actatropica.2007.06.006
   Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1792
   Cruise complete, 2018, BEL CRUIS
   Despain D., 2015, AM ATTITUDES GMO FOO
   Destinations Belize, 2018, VAC PLANN PLAC PEN B
   Dusfour I, 2010, J PEST SCI, V83, P41, DOI 10.1007/s10340-009-0268-7
   Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035
   Finke MS, 2004, J AGROBIOTECHNOLOGY, V6, P7
   Funk C, PUBLIC OPINION FOOD
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hapairai LK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13566-y
   HONEY M, 1999, ECOTOURISM SUSTAINAB
   KUMAR A., 2013, MALARIA WORLD J, V4, P1, DOI DOI 10.1038/NC0MMS3618
   Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009
   Magnusson MK, 2002, APPETITE, V39, P9, DOI 10.1006/appe.2002.0486
   Moerbeek H., 2005, International Journal of Consumer Studies, V29, P308, DOI 10.1111/j.1470-6431.2005.00441.x
   Mysore K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2112-5
   Naturally Belize, 2018, BEL ECOT
   Oliva CF, 2014, ACTA TROP, V132, pS130, DOI 10.1016/j.actatropica.2013.11.019
   Online-Utility.org, 2018, TEXT AN
   PAHO, 2017, DENG FEV AM
   PAHO, 2017, ZIK EPID REP
   Sell TK, 2018, RISK ANAL, V38, P2514, DOI 10.1111/risa.12961
   Subramaniam TSS, 2012, BIOTECHNOL J, V7, P1323, DOI 10.1002/biot.201200282
   Van Ekert E, 2014, J INSECT PHYSIOL, V70, P143, DOI 10.1016/j.jinsphys.2014.08.001
   von Schomberg R., 2011, TECH NIKFOLGEN ABSCH
   Wagman J., 2014, SPATIAL REPELLENCY F
   WHO, 2018, ZIK VIR
   WHO, 2018, VECT SURV CONTR
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 42
TC 2
Z9 2
U1 1
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 19
PY 2018
VL 13
IS 7
AR e0201075
DI 10.1371/journal.pone.0201075
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN5RC
UT WOS:000439120000089
PM 30024951
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaptein, SJF
   Vincetti, P
   Crespan, E
   Rivera, JIA
   Costantino, G
   Maga, G
   Neyts, J
   Radi, M
AF Kaptein, Suzanne J. F.
   Vincetti, Paolo
   Crespan, Emmanuele
   Rivera, Jorge I. Armijos
   Costantino, Gabriele
   Maga, Giovanni
   Neyts, Johan
   Radi, Marco
TI Identification of Broad-Spectrum Dengue/Zika Virus Replication
   Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine
   Scaffolds
SO CHEMMEDCHEM
LA English
DT Article
DE 2,6-diaminopurines; broad-spectrum antivirals; co-infections; dengue;
   zika
ID KINASE INHIBITORS; CRYSTAL-STRUCTURE; DISEASES; ZIKA; DISCOVERY;
   ANTIVIRALS; INFECTION; AGENTS; ANALOG
AB Social and demographic changes across the world over the past 50 years have resulted in significant outbreaks of arboviruses such as dengue virus (DENV) and Zika virus (ZIKV). Despite the increased threat of infection, no approved drugs or fully protective vaccines are available to counteract the spread of DENV and ZIKV. The development of broad-spectrum antivirals (BSAs) that target common components of multiple viruses can be a more effective strategy to limit the rapid emergence of viral pathogens than the classic one-bug/one-drug approach. Starting from previously identified multitarget DENV inhibitors, herein we report the identification of novel 2,6-diaminopurine derivatives that are able to block the replication of both Zika virus and all serotypes of dengue virus (DENV 1-4) in infected cells.
C1 [Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, B-3000 Leuven, Belgium.
   [Vincetti, Paolo; Costantino, Gabriele; Radi, Marco] Univ Parma, Dipartimento Sci Alimenti & Farmaco, Viale Sci 27-A, I-43124 Parma, Italy.
   [Crespan, Emmanuele; Rivera, Jorge I. Armijos; Maga, Giovanni] CNR, Natl Res Council, Inst Mol Genet IGM, Via Abbiategrasso 207, I-27100 Pavia, Italy.
RP Radi, M (corresponding author), Univ Parma, Dipartimento Sci Alimenti & Farmaco, Viale Sci 27-A, I-43124 Parma, Italy.
EM marco.radi@unipr.it
RI Kaptein, Suzanne JF/O-8855-2018; Maga, Giovanni/C-5409-2009; Kaptein,
   Suzanne JF/O-4714-2019; Neyts, Johan/U-8267-2017; Crespan,
   Emmanuele/F-3899-2018; Radi, Marco/P-1457-2017
OI Kaptein, Suzanne JF/0000-0002-7935-0219; Maga,
   Giovanni/0000-0001-8092-1552; Kaptein, Suzanne JF/0000-0002-7935-0219;
   Neyts, Johan/0000-0002-0033-7514; Crespan,
   Emmanuele/0000-0003-0597-6929; Radi, Marco/0000-0002-0874-6697
FU University of Parma
FX This work was supported by the University of Parma (M.R.). We thank
   Charlotte Vanderheydt, Caroline Collard, Ruben Pholien, and Grazia
   Larosa for excellent technical assistance.
CR [Anonymous], 2013, PYMOL MOL GRAPHICS S
   Birger RB, 2015, TRENDS MICROBIOL, V23, P537, DOI 10.1016/j.tim.2015.05.002
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Botta L, 2018, FRONT BIOSCI-LANDMRK, V23, P997, DOI 10.2741/4630
   Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Freisz S., 2010, ANGEW CHEM, V122, P1849
   Freisz S, 2010, ANGEW CHEM INT EDIT, V49, P1805, DOI 10.1002/anie.200905651
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Jarvis L. M., 2017, CHEM ENG NEWS, V36, P10
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Maga G, 2011, CHEMMEDCHEM, V6, P1371, DOI 10.1002/cmdc.201100166
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Ojwang JO, 2005, ANTIVIR RES, V68, P49, DOI 10.1016/j.antiviral.2005.06.002
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Park H, 2012, BIOORG MED CHEM LETT, V22, P1027, DOI 10.1016/j.bmcl.2011.11.124
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Radi M, 2012, CHEMMEDCHEM, V7, P883, DOI 10.1002/cmdc.201200056
   Robinson ML, 2017, CURR OPIN INFECT DIS, V30, P449, DOI 10.1097/QCO.0000000000000394
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Stephen P, 2018, CHEM BIOL DRUG DES, V91, P322, DOI 10.1111/cbdd.13054
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tassini S, 2017, J MED CHEM, V60, P1400, DOI 10.1021/acs.jmedchem.6b01521
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Wispelaere M. D., 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 37
TC 4
Z9 4
U1 3
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-7179
EI 1860-7187
J9 CHEMMEDCHEM
JI ChemMedChem
PD JUL 18
PY 2018
VL 13
IS 14
BP 1371
EP 1376
DI 10.1002/cmdc.201800178
PG 6
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GO1YG
UT WOS:000439757200001
PM 29740962
DA 2020-07-08
ER

PT J
AU Clain, E
   Sinigaglia, L
   Koishi, AC
   Gorgette, O
   Gadea, G
   Viranaicken, W
   Krejbich-Trotot, P
   Mavingui, P
   Despres, P
   dos Santos, CND
   Guiraud, P
   Jouvenet, N
   El Kalamouni, C
AF Clain, Elodie
   Sinigaglia, Laura
   Koishi, Andrea Cristine
   Gorgette, Olivier
   Gadea, Gilles
   Viranaicken, Wildriss
   Krejbich-Trotot, Pascale
   Mavingui, Patrick
   Despres, Philippe
   Duarte dos Santos, Claudia Nunes
   Guiraud, Pascale
   Jouvenet, Nolwenn
   El Kalamouni, Chaker
TI Extract from Aphloia theiformis, an edible indigenous plant from Reunion
   Island, impairs Zika virus attachment to the host cell surface
SO SCIENTIFIC REPORTS
LA English
DT Article
ID EPIGALLOCATECHIN GALLATE; MEDICINAL-PLANTS; INHIBITS ZIKA; INFECTION;
   ENTRY; REPLICATION; EPIDEMIC; REMEDIES; BIOLOGY; BINDING
AB The mosquito-borne Zika virus (ZIKV) belongs to the flavivirus genus of the Flaviviridae family. Contemporary epidemic strains of ZIKV are associated with congenital malformations in infants, including microcephaly, as well as Guillain-Barre syndrome in adults. A risk of human-to-human transmission of ZIKV is also well documented. A worldwide research effort has been undertaken to identify safe and effective strategies to prevent or treat ZIKV infection. We show here that extract from Aphloia theiformis, an edible endemic plant from Indian Ocean islands, exerts a potent antiviral effect against ZIKV strains of African and Asian lineages, including epidemic strains. The antiviral effect of A. theiformis extract was extended to clinical isolates of dengue virus (DENV) of the four serotypes in human hepatocytes. A. theiformis inhibited virus entry in host cells by acting directly on viral particles, thus impairing their attachment to the cell surface. Electron microscopic observations revealed that organization of ZIKV particles was severely affected by A. theiformis. We propose a model of antiviral action for A. theiformis against flaviviruses that highlights the potential of medicinal plants as promising sources of naturally-derived antiviral compounds to prevent ZIKV and DENV infections.
C1 [Clain, Elodie; Gadea, Gilles; Viranaicken, Wildriss; Krejbich-Trotot, Pascale; Mavingui, Patrick; Despres, Philippe; Guiraud, Pascale; El Kalamouni, Chaker] Univ La Reunion, Proc Infect Insulaire Trop PIMIT UM134, Plateforme Technol CYROI, INSERM,U1187,CNRS,UMR 9192,IRD,UMR 249, F-97490 Sainte, Clotilde, France.
   [Sinigaglia, Laura; Jouvenet, Nolwenn] Pasteur Inst, Viral Genom & Vaccinat Unit, CNRS, UMR 3569, F-75724 Paris, France.
   [Koishi, Andrea Cristine; Duarte dos Santos, Claudia Nunes] FIOCRUZ PR, ICC, Lab Virol Mol, Curitiba, Parana, Brazil.
   [Gorgette, Olivier] Pasteur Inst, Ultrastruct BioImaging UTechsUBI, F-75724 Paris, France.
RP El Kalamouni, C (corresponding author), Univ La Reunion, Proc Infect Insulaire Trop PIMIT UM134, Plateforme Technol CYROI, INSERM,U1187,CNRS,UMR 9192,IRD,UMR 249, F-97490 Sainte, Clotilde, France.
EM chaker.el-kalamouni@univ-reunion.fr
RI jouvenet, nolwenn/K-2067-2019; Santos, Claudia Duarte dos/P-4868-2019;
   Gilles, Gadea/M-9966-2015
OI jouvenet, nolwenn/0000-0001-6103-6048; Santos, Claudia Duarte
   dos/0000-0001-8707-6638; Gilles, Gadea/0000-0001-6325-4866; Krejbich
   Trotot, Pascale/0000-0001-7329-1716; Koishi, Andrea/0000-0002-3542-1353;
   El Kalamouni, Chaker/0000-0003-4673-6614
FU Research Federation BioST; University of La Reunion; Centre National de
   la Recherche Scientifique (CNRS)Centre National de la Recherche
   Scientifique (CNRS); Institut Pasteur; CAPES-COFECUBCAPES [Me889/17];
   ZIKAlert project (European Union-Region Reunion programme) [SYNERGY:
   RE0001902]; Conseil Regional de La Reunion, France; Pasteur Paris
   University (PPU) International PhD program through an 'Institut Carnot
   Pasteur Maladies Infectieuses' grant
FX We are grateful to Claude Marrodon for helpful discussion on
   ethnopharmacological uses of plants. We thank Segolene Gracias for
   production of ZIKV-HD78 stocks as well as Marie Watson, Laurent Janci
   (Extraits De Bourbon) and Claire Desvignes for contribution in plant
   extracts preparation. This project was supported by Research Federation
   BioST, University of La Reunion, Centre National de la Recherche
   Scientifique (CNRS), Institut Pasteur, CAPES-COFECUB Me889/17 ZIKANET
   project and ZIKAlert project (European Union-Region Reunion programme
   under grant agreement no SYNERGY: RE0001902). E.C. is supported by a
   grant DIRED from the Conseil Regional de La Reunion, France and L.S. is
   supported by the Pasteur Paris University (PPU) International PhD
   program through an 'Institut Carnot Pasteur Maladies Infectieuses'
   grant.
CR Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Boulay K, 2014, NUCLEIC ACIDS RES, V42, P7867, DOI 10.1093/nar/gku506
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   CRUZ DJM, 2013, PLOS NEGLECT TROP D, V7
   de Boer HJ, 2005, J ETHNOPHARMACOL, V96, P461, DOI 10.1016/j.jep.2004.09.035
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gabaston J., 2018, J PEST SCI
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Galabov A. S., 2007, GMS KRANKENHAUSHYGIE, V2
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hsoidrou S., 2014, Phytotherapie (Paris), V12, P354, DOI 10.1007/s10298-014-0875-1
   Huang HC, 2014, ANTIVIR RES, V111, P100, DOI 10.1016/j.antiviral.2014.09.009
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Jonville MC, 2011, J ETHNOPHARMACOL, V136, P525, DOI 10.1016/j.jep.2010.06.013
   Jonville MC, 2008, J ETHNOPHARMACOL, V120, P382, DOI 10.1016/j.jep.2008.09.005
   Kim M, 2013, ANTIVIR RES, V100, P460, DOI 10.1016/j.antiviral.2013.08.002
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Marimoutou M, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0055-6
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mootoosamy A, 2014, J ETHNOPHARMACOL, V151, P413, DOI 10.1016/j.jep.2013.10.069
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Neergheen-Bhujun VS, 2014, J HERB MED, V4, P1, DOI 10.1016/j.hermed.2013.11.002
   Oo A, 2018, ANTIVIR RES, V150, P101, DOI 10.1016/j.antiviral.2017.12.012
   Picot MCN, 2017, PHARM BIOL, V55, P864, DOI 10.1080/13880209.2016.1277765
   Poullain C, 2004, J ETHNOPHARMACOL, V95, P19, DOI 10.1016/j.jep.2004.05.023
   Powers CN, 2016, COMB CHEM HIGH T SCR, V19, P516, DOI 10.2174/1386207319666160506123715
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Wang QY, 2015, ACS INFECT DIS, V1, P428, DOI 10.1021/acsinfecdis.5b00066
   ZANDI K, 2013, BMC COMPLEM ALTERN M, V13, P25003
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
NR 43
TC 8
Z9 8
U1 2
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 18
PY 2018
VL 8
AR 10856
DI 10.1038/s41598-018-29183-2
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN4TI
UT WOS:000439026000017
PM 30022045
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Beaver, JT
   Lelutiu, N
   Habib, R
   Skountzou, I
AF Beaver, Jacob T.
   Lelutiu, Nadia
   Habib, Rumi
   Skountzou, Ioanna
TI Evolution of Two Major Zika Virus Lineages: Implications for Pathology,
   Immune Response, and Vaccine Development
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE Zika virus; evolution; transmission; tissue tropism; phylogeny;
   immunology; vaccines
ID SEXUAL TRANSMISSION; UNITED-STATES; ANTIVIRAL RESPONSES; PROTECTIVE
   EFFICACY; OCULAR FINDINGS; SOUTH-PACIFIC; IN-VITRO; INFECTION; FETAL;
   BRAIN
AB Zika virus (ZIKV) became a public health emergency of global concern in 2015 due to its rapid expansion from French Polynesia to Brazil, spreading quickly throughout the Americas. Its unexpected correlation to neurological impairments and defects, now known as congenital Zika syndrome, brought on an urgency to characterize the pathology and develop safe, effective vaccines. ZIKV genetic analyses have identified two major lineages, Asian and African, which have undergone substantial changes during the past 50 years. Although ZIKV infections have been circulating throughout Africa and Asia for the later part of the 20th century, the symptoms were mild and not associated with serious pathology until now. ZIKV evolution also took the form of novel modes of transmission, including maternal-fetal transmission, sexual transmission, and transmission through the eye. The African and Asian lineages have demonstrated differential pathogenesis and molecular responses in vitro and in vivo. The limited number of human infections prior to the 21st century restricted ZIKV research to in vitro studies, but current animal studies utilize mice deficient in type I interferon (IFN) signaling in order to invoke enhanced viral pathogenesis. This review examines ZIKV strain differences from an evolutionary perspective, discussing how these differentially impact pathogenesis via host immune responses that modulate IFN signaling, and how these differential effects dictate the future of ZIKV vaccine candidates.
C1 [Beaver, Jacob T.; Lelutiu, Nadia; Habib, Rumi; Skountzou, Ioanna] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
RP Skountzou, I (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
EM iskount@emory.edu
OI Habib, Rumi/0000-0002-2812-8263
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5R01AI111557]
FX The work was supported by NIH grant 5R01AI111557.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cimini E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06536-x
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mbio.00741-17, 10.1128/mBio.00741-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dallas County Health Human Services (DCHHS), 2016, DCHHS REP 1 ZIK VIR
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   DOUAM F, 2017, MBIO, V8, DOI DOI 10.1128/MBI0.00819-17
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Durham DP, 2018, ANN INTERN MED, V168, P621, DOI 10.7326/M17-0641
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1307
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li JL, 2013, BLOOD, V121, P2934, DOI 10.1182/blood-2012-08-450353
   Li JL, 2011, GLIA, V59, P58, DOI 10.1002/glia.21076
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Lin SR, 2011, J VIROL, V85, P5159, DOI 10.1128/JVI.02099-10
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mattar S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2522-6
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, PAHO STAT ZIK VIR TR
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pradhan D, 2017, INTERDISCIP SCI, V9, P468, DOI 10.1007/s12539-017-0238-3
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Singh Mandeep S, 2018, Am J Ophthalmol Case Rep, V10, P6, DOI 10.1016/j.ajoc.2018.01.023
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Stauft CB, 2016, COMP AFRICAN ASIAN A
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tan JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08806-0
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 161
TC 30
Z9 32
U1 2
U2 25
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 18
PY 2018
VL 9
AR 1640
DI 10.3389/fimmu.2018.01640
PG 17
WC Immunology
SC Immunology
GA GN4ZU
UT WOS:000439052100001
PM 30072993
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wood, MJ
AF Wood, Michael J.
TI Propagating and Debunking Conspiracy Theories on Twitter During the
   2015-2016 Zika Virus Outbreak
SO CYBERPSYCHOLOGY BEHAVIOR AND SOCIAL NETWORKING
LA English
DT Article
DE conspiracy theories; rumor; social network analysis; Twitter; Zika virus
ID BELIEFS; RUMOR; AGREEMENT; ONLINE
AB The present study investigates the characteristics of discussion of conspiracy theories about the Zika virus outbreak of 2015-16 on Twitter. Content and social network analysis of a dataset of 25,162 original Tweets about Zika virus conspiracy theories showed that relative to debunking messages, conspiracy theories spread through a more decentralized network, are more likely to invoke supposedly knowledgeable authorities in making arguments, and ask more rhetorical questions. These trends can be understood in the context of previous work on conspiracy theories, including the just asking questions style of rhetoric, the importance of sourcing and authority, and the tendency to simultaneously consider many different potential conspiracies that might underlie an important topic or event.
C1 [Wood, Michael J.] Univ Winchester, Dept Psychol, Winchester, Hants, England.
RP Wood, MJ (corresponding author), Univ Winchester, Dept Psychol, Winchester, Hants, England.
EM michael.wood@winchester.ac.uk
OI Wood, Michael/0000-0002-9277-1878
FU British Academy/Leverhulme Trust Small Grants Scheme [SG161736]
FX This study was funded by the British Academy/Leverhulme Trust Small
   Grants Scheme, grant number SG161736. The author would like to thank
   Kiia Huttunen for her hard work on coding the data set.
CR Bordia P, 2004, SOC PSYCHOL QUART, V67, P33, DOI 10.1177/019027250406700105
   Butter M, 2016, DIOGENES, P1
   Byford J, 2011, CONSPIRACY THEORIES: A CRITICAL INTRODUCTION, P1, DOI 10.1057/9780230349216
   Centers for Disease Control, 2016, ZIK BAS VIR PROT IT
   Correa JC, 2017, CYBERPSYCH BEH SOC N, V20, P37, DOI 10.1089/cyber.2016.0402
   Csardi G., 2014, INT J COMPLEX SYST, DOI [10.3724/SP.J.1087.2009.02191., DOI 10.3724/SP.J.1087.2009.02191]
   DiFonzo N, 2007, DIOGENES, V54, P19, DOI 10.1177/0392192107073433
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Fellows I, 2015, PACKAGE WORDCLOUD
   Janson H, 2004, EDUC PSYCHOL MEAS, V64, P62, DOI 10.1177/0013164403260195
   Kou Y, 2017, PACM HUMAN COMPUTER, V61, P2
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Melley T, 2002, CONSPIRACY NATION PO, P57
   Mendoza M., 2010, P 1 WORKSH SOC MED A, V10, P71, DOI DOI 10.1145/1964858.1964869
   Miller JM, 2016, AM J POLIT SCI, V60, P824, DOI 10.1111/ajps.12234
   Oh O, 2013, MIS QUART, V37, P407, DOI 10.25300/MISQ/2013/37.2.05
   Parsons S, 1999, SOCIOL SPECTRUM, V19, P201, DOI 10.1080/027321799280235
   Porterfield A, ACTIVISTS ZIKA VIRUS
   Slim H, 2002, INT M GLOB TRENDS HU, P1
   Souza Mario, 2012, Computational Processing of the Portuguese Language. 10th International Conference, PROPOR 2012. Proceedings, P241, DOI 10.1007/978-3-642-28885-2_28
   Starbird K., 2017, P INT AAAI C WEB SOC, P230
   Starbird K, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P360, DOI 10.1145/2858036.2858551
   Swami V, 2016, PERS INDIV DIFFER, V99, P72, DOI 10.1016/j.paid.2016.04.084
   Uscinski JE, 2016, POLIT RES QUART, V69, P57, DOI 10.1177/1065912915621621
   van Prooijen JW, 2014, J EXP SOC PSYCHOL, V55, P63, DOI 10.1016/j.jesp.2014.06.006
   Wood MJ, 2017, BRIT J PSYCHOL, V108, P507, DOI 10.1111/bjop.12231
   Wood MJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00836
   Wood MJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00409
   Wood MJ, 2012, SOC PSYCHOL PERS SCI, V3, P767, DOI 10.1177/1948550611434786
NR 29
TC 6
Z9 6
U1 2
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-2715
EI 2152-2723
J9 CYBERPSYCH BEH SOC N
JI Cyberpsychology Behav. Soc. Netw.
PD AUG
PY 2018
VL 21
IS 8
BP 485
EP 490
DI 10.1089/cyber.2017.0669
EA JUL 2018
PG 6
WC Psychology, Social
SC Psychology
GA GQ5GV
UT WOS:000439547900001
PM 30020821
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Miglianico, M
   Eldering, M
   Slater, H
   Ferguson, N
   Ambrose, P
   Lees, RS
   Koolen, KMJ
   Pruzinova, K
   Jancarova, M
   Volf, P
   Koenraadt, CJM
   Duerr, HP
   Trevitt, G
   Yang, BY
   Chatterjee, AK
   Wisler, J
   Sturm, A
   Bousema, T
   Sauerwein, RW
   Schultz, PG
   Tremblay, MS
   Dechering, KJ
AF Miglianico, Marie
   Eldering, Maarten
   Slater, Hannah
   Ferguson, Neil
   Ambrose, Pauline
   Lees, Rosemary S.
   Koolen, Karin M. J.
   Pruzinova, Katerina
   Jancarova, Magdalena
   Volf, Petr
   Koenraadt, Constantianus J. M.
   Duerr, Hans-Peter
   Trevitt, Graham
   Yang, Baiyuan
   Chatterjee, Arnab K.
   Wisler, John
   Sturm, Angelika
   Bousema, Teun
   Sauerwein, Robert W.
   Schultz, Peter G.
   Tremblay, Matthew S.
   Dechering, Koen J.
TI Repurposing isoxazoline veterinary drugs for control of vector-borne
   human diseases
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE vector control; insecticide; malaria; zika fever; isoxazoline
ID PLASMODIUM-FALCIPARUM MALARIA; ANOPHELES-GAMBIAE; IVERMECTIN;
   TRANSMISSION; MOSQUITOS; DOGS; ECTOPARASITICIDE; INSECTICIDE;
   AFOXOLANER; RESISTANCE
AB Isoxazolines are oral insecticidal drugs currently licensed for ectoparasite control in companion animals. Here we propose their use in humans for the reduction of vector-borne disease incidence. Fluralaner and afoxolaner rapidly killed Anopheles, Aedes, and Culex mosquitoes and Phlebotomus sand flies after feeding on a drug-supplemented blood meal, with IC50 values ranging from 33 to 575 nM, and were fully active against strains with preexisting resistance to common insecticides. Based on allometric scaling of preclinical pharmacokinetics data, we predict that a single human median dose of 260 mg (IQR, 177-407 mg) for afoxolaner, or 410 mg (IQR, 278-648 mg) for fluralaner, could provide an insecticidal effect lasting 50-90 days against mosquitoes and Phlebotomus sand flies. Computational modeling showed that seasonal mass drug administration of such a single dose to a fraction of a regional population would dramatically reduce clinical cases of Zika and malaria in endemic settings. Isoxazolines therefore represent a promising new component of drug-based vector control.
C1 [Miglianico, Marie; Eldering, Maarten; Koolen, Karin M. J.; Sturm, Angelika; Sauerwein, Robert W.; Dechering, Koen J.] TropIQ Hlth Sci, NL-6534 Nijmegen, Netherlands.
   [Slater, Hannah; Ferguson, Neil] Imperial Coll London, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London SW7 2AZ, England.
   [Ambrose, Pauline; Lees, Rosemary S.] Univ Liverpool Liverpool Sch Trop Med, Liverpool Insect Testing Estab, Liverpool L3 5QA, Merseyside, England.
   [Pruzinova, Katerina; Jancarova, Magdalena; Volf, Petr] Charles Univ Prague, Fac Sci, Dept Parasitol, Prague 11636, Czech Republic.
   [Koenraadt, Constantianus J. M.] Wageningen Univ & Res, Entomol Lab, NL-6700 Wageningen, Netherlands.
   [Duerr, Hans-Peter] Numerus Ltd, RG40 2AY, Tubingen, Germany.
   [Trevitt, Graham] XenoGesis Ltd, Nottingham NG1 1GF, England.
   [Yang, Baiyuan; Chatterjee, Arnab K.; Wisler, John; Schultz, Peter G.; Tremblay, Matthew S.] Calif Inst Biomed Res, La Jolla, CA 92037 USA.
   [Bousema, Teun; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 Nijmegen, Netherlands.
RP Dechering, KJ (corresponding author), TropIQ Hlth Sci, NL-6534 Nijmegen, Netherlands.; Schultz, PG; Tremblay, MS (corresponding author), Calif Inst Biomed Res, La Jolla, CA 92037 USA.
EM schultz@calibr.org; mtremblay@calibr.org; k.dechering@tropiq.nl
RI Lees, Rosemary Susan/H-3425-2019; Bousema, Teun/N-3574-2014; Ferguson,
   Neil/B-8578-2008; Volf, Petr/C-4300-2012
OI Lees, Rosemary Susan/0000-0002-4232-9125; Bousema,
   Teun/0000-0003-2666-094X; Ferguson, Neil/0000-0002-1154-8093; Volf,
   Petr/0000-0003-1790-1123
FU UNCE [204072]; Infravec2 (H2020) Project; Infravec2 [731060]
FX We thank Geert-Jan van Gemert and Laura Pelser-Posthumus (Radboud
   University Medical Center) for their help with the A. stephensi
   experiments. We also thank David Malone from the Innovative Vector
   Control Consortium and Helen S. Williams and the other members of the
   Liverpool Insect Testing Establishment for help with mosquito
   experiments. Finally, we thank the DuPont Company for supporting the
   initiation of our research on isoxazolines. K.P., M.J., and P.V. were
   supported by the UNCE (204072) and Infravec2 (H2020 and 731060)
   Projects.
CR Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349
   Alout H, 2017, EXPERT REV ANTI-INFE, V15, P231, DOI 10.1080/14787210.2017.1271713
   Annis GD, 2009, E.I. Du Pont De Nemours and Company Patent Application, Patent No. [WO 2009126668, 2009126668]
   Bellinger AM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag2374
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Brady OJ, 2017, LANCET GLOB HEALTH, V5, pE680, DOI [10.1016/S2214-109X(17)30220-6, 10.1016/s2214-109x(17)30220-6]
   Burkot T, 2002, TRENDS PARASITOL, V18, P109, DOI 10.1016/S1471-4922(01)02221-8
   Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879
   Casida JE, 2015, PESTIC BIOCHEM PHYS, V121, P22, DOI 10.1016/j.pestbp.2014.11.006
   CHACCOUR C, 2017, MALARIA J, V16
   Cheah PY, 2016, INT HEALTH, V8, P235, DOI 10.1093/inthealth/ihw027
   Committee for Medicinal Products for Veterinary Use, 2013, EMEAVC0027290000 COM
   Derua YA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0735-3
   Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262
   European Medicines Agency Committee for Medicinal Products for Veterinary Use, 2016, CVMP ASS REP BRAV SP
   FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Foy BD, 2011, TRENDS PARASITOL, V27, P423, DOI 10.1016/j.pt.2011.05.007
   Franco AO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101699
   Garcia-Reynaga P, 2013, CHEM RES TOXICOL, V26, P514, DOI 10.1021/tx400055p
   Gassel M, 2014, INSECT BIOCHEM MOLEC, V45, P111, DOI 10.1016/j.ibmb.2013.11.009
   Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199
   Hamilton M, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1705-3
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Kilp S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-85
   Kobylinski KC, 2010, ACTA TROP, V116, P119, DOI 10.1016/j.actatropica.2010.06.001
   Letendre L, 2014, VET PARASITOL, V201, P190, DOI 10.1016/j.vetpar.2014.02.021
   Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x
   McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019
   Merial Australia Pty Ltd, 2014, SAF DAT SHEET NEXGAR
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ouedraogo AL, 2015, CLIN INFECT DIS, V60, P357, DOI 10.1093/cid/ciu797
   Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065
   Rizzoli A, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES2015.20.20.21135
   Shoop WL, 2014, VET PARASITOL, V201, P179, DOI 10.1016/j.vetpar.2014.02.020
   Slater HC, 2014, J INFECT DIS, V210, P1972, DOI 10.1093/infdis/jiu351
   U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2005, GUID IND EST MAX SAF
   U.S. Food and Drug Administration, 2014, 141406 NADA, P141
   U.S. Food and Drug Administration, 2014, CORR FREED INF SUMM, P141
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0
   Volf P, 2011, J VECTOR ECOL, V36, pS1, DOI 10.1111/j.1948-7134.2011.00106.x
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   Walther FM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1123-8
   WALTHER FM, 2014, PARASITE VECTOR, V7
   Weber T, 2016, CHEMMEDCHEM, V11, P270, DOI 10.1002/cmdc.201500516
   WHO, 1998, TEST PROC INS RES MO
   WHO, 2015, WORLD MALARIA REPORT
NR 51
TC 14
Z9 14
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 17
PY 2018
VL 115
IS 29
BP E6920
EP E6926
DI 10.1073/pnas.1801338115
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN3GQ
UT WOS:000438892600031
PM 29967151
OA Green Accepted, Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Chang, CR
   Leong, WY
AF Wilder-Smith, Annelies
   Chang, Chui Rhong
   Leong, Wei Yee
TI Zika in travellers 1947-2017: a systematic review
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Review
DE Zika; flavivirus; travellers; mobility patterns; GeoSentinel; sexual
   transmission
ID VIRUS-INFECTION; EMERGING INFECTIONS; SEXUAL TRANSMISSION; RETURNING
   TRAVELER; PREGNANCY OUTCOMES; DENGUE VIRUSES; BIRTH-DEFECTS;
   UNITED-STATES; JANUARY; DISEASE
AB Introduction: Travellers contributed substantially to the rapid spread of Zika virus (ZIKV). They act as sentinel and may unmask ongoing ZIKV transmission in countries where outbreaks have not yet been reported. Our objectives were to (i) describe the burden of ZIKV infections in international travellers over time; (ii) estimate the proportion of birth defects as a result of maternal ZIKV infection in travellers; (iii) track the extent of sexual transmission; (iv) summarize ZIKV infections in returning travellers as reported by the GeoSentinel network; and (v) identify countries without reports on local ZIKV transmission where travellers served as sentinel.
   Methods: We performed a systematic review from 1947 to April 2017 on travel-associated ZIKV infections. We also compared published reports on autochthonous ZIKV transmission in Asia with published reports on exportations from travellers in Asia.
   Results: Of 314 papers that fit the inclusion criteria, 61 were eligible for final analysis. There was an exponential increase in the number of reported ZIKV infected travellers from the years 2013 to 2016, which declined in 2017. Amongst pregnant women with ZIKV infection, (5%) resulted in a fetus or infant with ZIKV-associated birth defects. An estimated 1% of the total number of ZIKV cases reported in the USA and Europe were acquired through sexual transmission. Through the GeoSentinel network, five countries (Indonesia, Philippines, Thailand, Vietnam, Cameroon) were identified as sentinel markers where ZIKV was exported despite the absence of reported local transmission.
   Conclusions: Mobility patterns and travel volumes can help to identify the most likely origin of importation, and also in predicting further propagation. Studies on pregnant returning travellers have contributed to a better understanding of the risk estimates of congenital Zika syndrome/microcephaly as a result of maternal ZIKV infection, and the relative contribution of sexual transmisison.
C1 [Wilder-Smith, Annelies; Chang, Chui Rhong; Leong, Wei Yee] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, Annelies] Umea Univ, Dept Global Hlth & Epidemiol, Umea, Sweden.
   [Wilder-Smith, Annelies] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
RP Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Wilder-Smith, A (corresponding author), Umea Univ, Dept Global Hlth & Epidemiol, Umea, Sweden.; Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London, England.
EM anneliesws@gmail.com
RI amsalu, ribka/G-8780-2019
FU European Union through the ZikaPLAN consortium [734 584]; Lee Kong Chian
   School of Medicine, Singapore
FX This review was partially funded by the European Union's Horizon 2020
   research and innovation programme under (Grant Agreement No. 734 584)
   through the ZikaPLAN consortium, and partially funded through the Lee
   Kong Chian School of Medicine, Singapore.
CR Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Alejo-Cancho I, 2016, DIAGN MICR INFEC DIS, V86, P160, DOI 10.1016/j.diagmicrobio.2016.07.016
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2018, ZIK CAS COUNTS US
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bezerra TP, 2017, EMERG INF DIS, V23
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Calleri G, 2016, TRAVEL MED INFECT DI, V14, P506, DOI 10.1016/j.tmaid.2016.07.001
   Chen LH, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax001
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Diaz-Menendez M, 2016, ENFERM INFEC MICR CL, V36, P4
   Dong X J, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P597, DOI 10.3760/cma.j.issn.0254-6450.2016.05.002
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   ECDC, 2018, SURV ATL INF DIS
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V58, P519
   Freedman DO, 1999, J TRAVEL MED, V6, P94, DOI 10.1111/j.1708-8305.1999.tb00839.x
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Glaesser D, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax007
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   HUANG G, 1992, J MED ENTOMOL, V29, P911, DOI 10.1093/jmedent/29.6.911
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lalani T, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw043
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Meltzer E, 2016, AM J MED, V129, P1126, DOI 10.1016/j.amjmed.2016.04.034
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Ministry of Health and National Environment Agency, 2016, 1 CAS ZIK VIR INF SI
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1973-5
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Penot P, 2017, REV MED INTERNE, V38, P547, DOI 10.1016/j.revmed.2016.12.011
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Pro/MBDS, 2016, ZIK VIR CHIN HON KON
   Pyke A. T., 2016, PLOS CURR, V8
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rowe K, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax038
   Paiva MHS, 2017, GENET MOL BIOL, V40, P597, DOI [10.1590/1678-4685-GMB-2016-0312, 10.1590/1678-4685-gmb-2016-0312]
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Sokal A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/taw066
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Veletzky L, 2017, INT J INFECT DIS, V54, P13, DOI 10.1016/j.ijid.2016.11.004
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wang G, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay022
   WHO, 2016, WHO ZIK VIR RES AG
   WHO, 2016, ZIK VIR INF DIS OUTB
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax027
   Wong N, 2017, J INFECTION, V74, P616, DOI 10.1016/j.jinf.2017.03.004
   World Health Organization, 2016, ZIK SIT REP
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Ze-Ze L, 2016, IDCases, V4, P46, DOI 10.1016/j.idcr.2016.03.004
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 114
TC 20
Z9 20
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD JUL 17
PY 2018
VL 25
AR tay044
DI 10.1093/jtm/tay044
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0TA
UT WOS:000451511000001
PM 30016469
OA Bronze
DA 2020-07-08
ER

PT J
AU Tellechea, AL
   Luppo, V
   Morales, MA
   Groisman, B
   Baricalla, A
   Fabbri, C
   Sinchi, A
   Alonso, A
   Gonzalez, C
   Ledesma, B
   Masi, P
   Silva, M
   Israilev, A
   Rocha, M
   Quaglia, M
   Bidondo, MP
   Liascovich, R
   Barbero, P
AF Laura Tellechea, Ana
   Luppo, Victoria
   Alejandra Morales, Maria
   Groisman, Boris
   Baricalla, Agustin
   Fabbri, Cintia
   Sinchi, Anabel
   Alonso, Alicia
   Gonzalez, Cecilia
   Ledesma, Bibiana
   Masi, Patricia
   Silva, Maria
   Israilev, Adriana
   Rocha, Marcela
   Quaglia, Marcela
   Paz Bidondo, Maria
   Liascovich, Rosa
   Barbero, Pablo
CA RENAC Task Force
TI Surveillance of microcephaly and selected brain anomalies in Argentina:
   Relationship with Zika virus and other congenital infections
SO BIRTH DEFECTS RESEARCH
LA English
DT Article
DE Argentina; congenital anomalies; congenital infections; microcephaly;
   Zika virus
ID MICRONESIA; DIAGNOSIS; RUBELLA; STATES; WOMEN; AGE
AB Background: Zika virus (ZIKV) vertical transmission may lead to microcephaly and other congenital anomalies. In March and April 2016, the first outbreak of ZIKV occurred in Argentina. The objective was to describe the surveillance of newborns with microcephaly and other selected brain anomalies in Argentina, and evaluation different etiologies.
   Methods: Participants were enrolled between April 2016 and March 2017.
   Cases: newborns from the National Network of Congenital Abnormalities of Argentina (RENAC) with head circumference lower than the 3rd percentile according to gestational age and sex, or selected brain anomalies. Blood and urine samples from cases and their mothers were tested for ZIKV by real-time polymerase chain reaction (RT-PCR), antigen-specific Immunoglobulin M (MAC-ELISA) and plaque-reduction neutralization test (PRNT90). Toxoplasmosis, rubella, herpes simplex, syphilis, and cytomegalovirus (CMV) infection were also tested.
   Results: A total of 104 cases were reported, with a prevalence of 6.9 per 10,000 [95% confidence interval (CI): 5.7-8.4], a significant increase when compared with the data prior to 2016, Prevalence Rate Ratio 1.7 (95% CI 1.2-2.3). In five cases positive serology for ZIKV (IgM and IgG by PRNT) was detected. The five cases presented microcephaly with craniofacial disproportion. We detected four cases of CMV infection, three cases of congenital toxoplasmosis, two cases of herpes simplex infection, and one case of congenital syphilis.
   Conclusion: The prevalence of microcephaly was significantly higher when compared with the previous period. The system had the capacity to detect five cases with congenital ZIKV syndrome in a country with limited viral circulation.
C1 [Laura Tellechea, Ana; Groisman, Boris; Paz Bidondo, Maria; Liascovich, Rosa; Barbero, Pablo; RENAC Task Force] Natl Ctr Med Genet CENAGEM, Natl Network Congenital Abnormal Argentina RENAC, Buenos Aires, DF, Argentina.
   [Luppo, Victoria; Alejandra Morales, Maria; Baricalla, Agustin; Fabbri, Cintia; Sinchi, Anabel] Natl Inst Human Viral Dis Dr Julio I Maiztegui IN, Pergamino, Buenos Aires, Argentina.
   [Alonso, Alicia; Gonzalez, Cecilia; Ledesma, Bibiana] Natl Inst Infect Dis Dr Carlos Malbran INEI, Buenos Aires, DF, Argentina.
   [Masi, Patricia; Silva, Maria] Dalmacio Velez Sarsfield Hosp, Neonatol Serv, Buenos Aires, DF, Argentina.
   [Israilev, Adriana] Teodoro Alvarez Hosp, Neonatol Serv, Buenos Aires, DF, Argentina.
   [Rocha, Marcela] Inst Maternidad & Ginecol Nuestra Senora Mercedes, Dept Neonatol, San Miguel De Tucuman, Tucuman, Argentina.
   [Quaglia, Marcela] Materno Neonatal Hosp, Neonatol Serv, Cordoba, Argentina.
RP Groisman, B (corresponding author), Ctr Nacl Genet Med, Av Las Heras 2670,3er Piso, RA-1425 Buenos Aires, DF, Argentina.
EM bgroisman@gmail.com
OI Groisman, Boris/0000-0001-6263-2562
FU National Health Ministry of Argentina; Estudio multicentrico, becas
   salud investiga "Dr. Abraam Sonis" 2016; UNICEF Argentina; Program to
   improve the care newborns with microcephaly in Argentina
FX National Health Ministry of Argentina, Estudio multicentrico, becas
   salud investiga "Dr. Abraam Sonis" 2016. UNICEF Argentina, Program to
   improve the care newborns with microcephaly in Argentina
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Andrus JK, 2011, VACCINE, V29, pD91, DOI 10.1016/j.vaccine.2011.04.059
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CHEN R, 1987, STAT MED, V6, P517, DOI 10.1002/sim.4780060410
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fabbri C., 2016, ACTUALIZACIONES SIDA, V24, P111
   Groisman B., 2016, ARCH ARGENT PEDIATR, V114, P4
   Groisman B, 2013, ARCH ARGENT PEDIATR, V111, P484, DOI [10.1590/S0325-00752013000600006, 10.5546/aap.2013.484]
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McCarthy M., 2016, BMJ, V352
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Ministerio de Salud de la Nacion Argentina (MSNA, 2017, B INT VIG
   Ministerio de Salud de la Nacion Argentina (MSNA, 2016, B INT VIG
   Ministerio de Salud de la Nacion Argentina (MSNA, 2015, DIREPI ALERTA
   Ministerio de Salud de la Nacion Argentina (MSNA, 2016, GUIA VIG INT INF VIR
   Ministerio de Salud de la Nacion Argentina (MSNA, 2016, TUT VIG TRAV SIST NA
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PAHO, 2016, ZIK CUM CAS
   Pan American Health Organization (PAHO), 2016, GUIA VIG ENF VIR ZIK
   Pan American Health Organization (PAHO), 2016, MIN SAL INST SEDES C
   Pan American Health Organization (PAHO), 2017, ZIK ACT EP 25 AG 201
   Pandolfi E, 2017, EUR J PUBLIC HEALTH, V27, P530, DOI 10.1093/eurpub/ckw259
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RUSSELL PK, 1967, J IMMUNOL, V99, P285
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 2016, STAT 1 M INT HLTH RE
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization (WHO), 2016, STAT 3 M INT HLTH RE
NR 35
TC 6
Z9 6
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD JUL 17
PY 2018
VL 110
IS 12
BP 1016
EP 1026
DI 10.1002/bdr2.1347
PG 11
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GU8YT
UT WOS:000445630800006
PM 29921033
OA Bronze
DA 2020-07-08
ER

PT J
AU Yang, JC
   Carey, P
   Ren, F
   Mastro, MA
   Beers, K
   Pearton, SJ
   Kravchenko, II
AF Yang, Jiancheng
   Carey, Patrick
   Ren, Fan
   Mastro, Michael A.
   Beers, Kimberly
   Pearton, S. J.
   Kravchenko, Ivan I.
TI Zika virus detection using antibody-immobilized disposable cover glass
   and AIGaN/GaN high electron mobility transistors
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID FIELD-EFFECT TRANSISTOR; BIOSENSOR
AB Zika virus detection was demonstrated using antibody-functionalized cover glasses externally connected to the gate electrode of an AIGaN/GaN high electron mobility transistor (HEMT). A pulsed bias voltage of 0.5 V was applied to an electrode on the region of the cover glass region functionalized with antibody, and the resulting changes of drain current of the HEMT were employed to determine the presence of Zika virus antigen concentration ranging from 0.1 to 100 ng/ml. The dynamic and static drain current changes as a function of Zika virus concentration were modeled with a spring-like elastic relaxation model and the Langmuir extension model, respectively. Excellent fits to the data were found with relaxation time constants of antibody and antigen molecules in the range of 11 mu s and 0.66-24.4 mu s, respectively, for the concentration range investigated. The ratio of antibody bound with antigen to the total available antibody on the functionalized contact window was in the range of 0.013-0.84 for the Zika antigen concentration range of 0.1-100 ng/ml. Since the HEMT is not exposed to the bio-solution, it can be used repeatedly. The functionalized glass is the only disposable part in the detection system, showing the potential of this approach for hand-held, low cost sensor packages for point-of-care applications. Published by AIP Publishing.
C1 [Yang, Jiancheng; Carey, Patrick; Ren, Fan] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   [Mastro, Michael A.] US Naval Res Lab, Washington, DC 20375 USA.
   [Beers, Kimberly; Pearton, S. J.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
   [Kravchenko, Ivan I.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, POB 2009, Oak Ridge, TN 37830 USA.
RP Ren, F (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
EM fren@che.ufl.edu
RI Pearton, Stephen/AAS-5642-2020; Kravchenko, Ivan/K-3022-2015
OI Pearton, Stephen/0000-0001-6498-1256; Kravchenko,
   Ivan/0000-0003-4999-5822
FU Department of the Defense, Defense Threat Reduction AgencyUnited States
   Department of DefenseDefense Threat Reduction Agency [HDTRA1-17-1-1011];
   Office of Naval ResearchOffice of Naval Research
FX The work at UF was partially supported by a grant from the Department of
   the Defense, Defense Threat Reduction Agency, No. HDTRA1-17-1-1011. The
   work at NRL was partially supported by the Office of Naval Research.
   Part of this research was conducted at the Center for Nanophase
   Materials Sciences, which is a DOE Office of Science User Facility. The
   content of the information does not necessarily reflect the position or
   the policy of the federal government, and no official endorsement should
   be inferred.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Badshah SL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010007
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chaudhuri O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7365
   Chu CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05426-6
   FINE JD, 1985, J AM ACAD DERMATOL, V12, P697, DOI 10.1016/S0190-9622(85)70095-3
   Hamdi M, 2006, IEEE INT CONF ROBOT, P1794, DOI 10.1109/ROBOT.2006.1641966
   Hekstra DR, 2016, NATURE, V540, P400, DOI 10.1038/nature20571
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Hsu CP, 2017, ECS J SOLID STATE SC, V6, pQ63, DOI 10.1149/2.0281705jss
   Ierardi V, 2013, J PHYS CONF SER, V439, DOI 10.1088/1742-6596/439/1/012001
   Kang BS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354491
   Kang BS, 2008, J APPL PHYS, V104, DOI 10.1063/1.2959429
   Kang YW, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803916
   Law JKY, 2015, BIOSENS BIOELECTRON, V67, P170, DOI 10.1016/j.bios.2014.08.007
   Lee HH, 2016, SENSOR ACTUAT B-CHEM, V234, P316, DOI 10.1016/j.snb.2016.04.117
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Ren F, 2012, PHYS STATUS SOLIDI C, V9, DOI 10.1002/pssc.201100296
   Sarangadharan I, 2018, BIOSENS BIOELECTRON, V100, P282, DOI 10.1016/j.bios.2017.09.018
   Sarkar D, 2014, ACS NANO, V8, P3992, DOI 10.1021/nn5009148
   Saw WG, 2017, ANTIVIR RES, V141, P73, DOI 10.1016/j.antiviral.2017.02.005
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Wustoni S, 2015, BIOSENS BIOELECTRON, V67, P256, DOI 10.1016/j.bios.2014.08.028
   Yang JC, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.5011151
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 32
TC 3
Z9 3
U1 1
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD JUL 16
PY 2018
VL 113
IS 3
AR 032101
DI 10.1063/1.5029902
PG 5
WC Physics, Applied
SC Physics
GA GN8PP
UT WOS:000439429700022
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI "Breakthrough" in Mosquito-packed Drones to Combat Zika in Brazil
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2018
VL 67
IS 2
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GM8ST
UT WOS:000438504800004
DA 2020-07-08
ER

PT J
AU Lee, H
   Nguyen, MP
   Choi, Y
   Kim, YH
AF Lee, Hyeji
   Mai Phuong Nguyen
   Choi, Yunhee
   Kim, Yong-Hak
TI Minimum InDel pattern analysis of the Zika virus
SO BMC GENOMICS
LA English
DT Article
DE Zika virus; Minimum InDel; Polyprotein; Envelope protein; Virus typing
ID ADAPTIVE MOLECULAR EVOLUTION; DENGUE VIRUS; SPREAD; MUTATIONS; INFECTION
AB Background: The Zika virus (ZIKV) can cause microcephaly and congenital abnormalities in the foetus. Recent studies have provided insights into the evolution of ZIKV from the current and previous outbreaks, but the types have not been determined.
   Results: We analysed the insertions and deletions (InDels) in 212 ZIKV polyproteins and 5 Dengue virus (DENV) reference sequences. Spearman correlation tests for the minimum InDel (minlnDel) patterns were used to assess the type of polyprotein. Using the minlnDel frequencies calculated from polyproteins with 11 elements, likelihood estimation was conducted to correct the evolutionary distance. The minlnDel-corrected tree topology clearly distinguished between the ZIKV types (I and II) with a unique minlnDel character in the E protein. From the 10-year average genetic distance, the African and Asian lineages of ZIKV-II were estimated to have occurred similar to 270 years ago, which is unlikely for ZIKV-I.
   Conclusions: The minlnDl ! pattern analysis showed that the inmlnDli in the E protein is trigetalie for the rapid detection and determination of the virus types.
C1 [Lee, Hyeji; Mai Phuong Nguyen; Choi, Yunhee; Kim, Yong-Hak] Daegu Catholic Univ, Dept Microbiol, Sch Med, Daegu 42472, South Korea.
RP Kim, YH (corresponding author), Daegu Catholic Univ, Dept Microbiol, Sch Med, Daegu 42472, South Korea.
EM ykim@cu.ac.kr
FU National Research Foundation of KoreaNational Research Foundation of
   Korea [NRF-2016R1A2B2014493]
FX This study was supported by National Research Foundation of Korea
   (NRF-2016R1A2B2014493).
CR Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004
   Das S, 2008, J CLIN MICROBIOL, V46, P3276, DOI 10.1128/JCM.00163-08
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Liu H, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.109
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   McDonald J. H., 2015, HDB BIOL STAT
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ogurtsov AY, 2004, GENOME RES, V14, P1610, DOI 10.1101/gr.2450504
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Schenk MF, 2013, MOL BIOL EVOL, V30, P1779, DOI 10.1093/molbev/mst096
   Seo TK, 2004, MOL BIOL EVOL, V21, P1201, DOI 10.1093/molbev/msh088
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 44
TC 0
Z9 0
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD JUL 13
PY 2018
VL 19
AR 535
DI 10.1186/s12864-018-4935-z
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA GN1AG
UT WOS:000438713700006
PM 30005607
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kikuti, M
   Tauro, LB
   Moreira, PSS
   Campos, GS
   Paploski, IAD
   Weaver, SC
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Kikuti, Mariana
   Tauro, Laura B.
   Moreira, Patricia S. S.
   Campos, Gubio S.
   Paploski, Igor A. D.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI Diagnostic performance of commercial IgM and IgG enzyme- linked
   immunoassays ( ELISAs) for diagnosis of Zika virus infection
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika virus; Sensitivity and specificity; Enzyme-linked immunosorbent
   assay; Immunoglobulin M; Immunoglobulin G
ID RIO-DE-JANEIRO; CROSS-REACTIVITY; DENGUE VIRUSES; CHIKUNGUNYA; OUTBREAK;
   SAMPLES; ASSAY
AB Background: Serologic detection of Zika virus (ZIKV) infections is challenging because of antigenic similarities among flaviviruses.
   Objective: To evaluate the sensitivity and specificity of commercial ZIKV IgM and IgG enzyme-linked immunoassay (ELISA) kits.
   Methods: We used sera from febrile patients with RT-PCR-confirmed ZIKV infection to determine sensitivity and sera from RT-PCR-confirmed dengue cases and blood donors, both of which were collected before ZIKV epidemics in Brazil (2009-2011 and 2013, respectively) to determine specificity.
   Results: The ZIKV IgM-ELISA positivity among RT-PCR ZIKV confirmed cases was 0.0% (0/14) and 12.5% (1/8) for acute-and convalescent-phase sera, respectively, while its specificity was 100.0% (58/58) and 98.3% (58/59) for acute-and convalescent-phase sera of dengue patients, and 100.0% (23/23) for blood donors. The ZIKV IgG-ELISA sensitivity was 100.0% (6/6) on convalescent-phase sera from RT-PCR confirmed ZIKV patients, while its specificity was 27.3% (15/55) on convalescent-phase sera from dengue patients and 45.0% (9/20) on blood donors' sera. The ZIKV IgG-ELISA specificity among dengue confirmed cases was much greater among patients with primary dengue (92.3%; 12/13), compared to secondary dengue (7.1%; 3/42).
   Conclusions: In a setting of endemic dengue transmission, the ZIKV IgM-ELISA had high specificity, but poor sensitivity. In contrast, the ZIKV IgG-ELISA showed low specificity, particularly for patients previously exposed to dengue infections. This suggests that this ZIKV IgM-ELISA is not useful in confirming a diagnosis of ZIKV infection in suspected patients, whereas the IgG-ELISA is more suitable for ZIKV diagnosis among travelers, who reside in areas free of flavivirus transmission, rather than for serosurveys in dengue-endemic areas.
C1 [Kikuti, Mariana; Tauro, Laura B.; Moreira, Patricia S. S.; Paploski, Igor A. D.; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Kikuti, Mariana; Campos, Gubio S.; Paploski, Igor A. D.; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Moreira, Patricia S. S.] Consejo Nacl Invest Cient & Tecn, Inst Nacl Med Trop, Puerto Iguazu, Misiones, Argentina.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020;
   Paploski, Igor AD/D-7015-2014; Kikuti, Mariana/G-2313-2017
OI Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060; Paploski, Igor AD/0000-0002-3689-2042;
   Kikuti, Mariana/0000-0001-8119-7236
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [550160/2010-8, 400830/2013-2, 440891/2016-7]; Bahia Foundation
   [PNX0010/2011, PPP0055/2011, JCB0020/2013, PET0026/2013, APP0044/2016,
   PET0022/2016]; Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education [440891/2016-7]
FX This study was supported by the Brazilian National Council for
   Scientific and Technological Development (grant 550160/2010-8 to MGR,
   grants 400830/2013-2 and 440891/2016-7 to GSR; and scholarships to IADP,
   UK, MGR, and GSR); the Bahia Foundation for Research Support (grant
   PNX0010/2011 to MGR, grants PPP0055/2011, JCB0020/2013, PET0026/2013,
   APP0044/2016, and PET0022/2016 to GSR); and the Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education (grant 440891/2016-7 to GSR and scholarship to MK). The
   funding sources had no role in study design; in the collection, analysis
   and interpretation of data; in the writing of the paper; and in the
   decision to submit the article for publication.
CR [Anonymous], 2017, DENGUE NOTIFICACOES
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Passos SRL, 2017, EMERG INFECT DIS, V23, P2120, DOI 10.3201/eid2312.171375
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paploski IAD, 2016, EMERG INFECT DIS J, P22
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Teixeira  M G, 2001, Rev Soc Bras Med Trop, V34, P269
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
NR 25
TC 9
Z9 13
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD JUL 13
PY 2018
VL 15
AR 108
DI 10.1186/s12985-018-1015-6
PG 7
WC Virology
SC Virology
GA GM8WZ
UT WOS:000438520200001
PM 30005683
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kowalski, SC
   Morgan, RL
   Falavigna, M
   Florez, ID
   Etxeandia-Ikobaltzeta, I
   Wiercioch, W
   Zhang, Y
   Sakhia, F
   Ivanova, L
   Santesso, N
   Schunemann, HJ
AF Kowalski, Sergio C.
   Morgan, Rebecca L.
   Falavigna, Maicon
   Florez, Ivan D.
   Etxeandia-Ikobaltzeta, Itziar
   Wiercioch, Wojtek
   Zhang, Yuan
   Sakhia, Faria
   Ivanova, Liudmila
   Santesso, Nancy
   Schunemann, Holger J.
TI Development of rapid guidelines: 1. Systematic survey of current
   practices and methods
SO HEALTH RESEARCH POLICY AND SYSTEMS
LA English
DT Article
DE Guideline; Emergencies; Methodology; Rapid reviews; Guideline
   development; Clinical guidelines
ID INTERIM GUIDANCE; PREEXPOSURE PROPHYLAXIS; ZIKA VIRUS; HIV-INFECTION;
   PREVENTION; DIAGNOSIS; REVIEWS; CARE
AB Background: Guidelines in the healthcare field generally should contain evidence-based recommendations to inform healthcare decisions. Guidelines often require 2 years or more to develop, but certain circumstances necessitate the development of rapid guidelines (RGs) in a short period of time. Upholding methodological rigor while meeting the reduced development timeframe presents a challenge for developing RGs. Our objective was to review current practices and standards for the development of RGs. This is the first of a series of three articles addressing methodological issues around RGs.
   Methods: We conducted a systematic survey of methods manuals and published RGs to identify reasons for the development of RGs. Data sources included existing guideline manuals, published RGs, Trip Medical Database, MEDLINE, EMBASE and communication with guideline developers until February 2018.
   Results: We identified 46 guidelines that used a shortened timeframe for their development. Nomenclature describing RGs varied across organisations, wherein the United States Centers for Disease Control and Prevention produced 'Interim Guidelines', the National Institute for Health and Care Excellence in the United Kingdom developed 'Short Clinical Guidelines', and WHO provided 'Rapid Advice'. The rationale for RGs included response to emergencies, rapid increases in cases of a condition or disease severity, or new evidence regarding treatment. In general, the methods to assess the quality of evidence, the consensus process and the management of the conflict of interest were not always clear. While we identified another 11 RGs from other institutions, there was no reference to timeframe and reasons for conducting a RG. The three organisations mentioned above provide guidance for the development of RGs.
   Conclusions: There is a lack of standardised nomenclature and definitions regarding RGs and there is inconsistency in the methods described in manuals and in RG. It is therefore important that all RGs provide a detailed and transparent description of their methods in order for readers and end-users to be able to assess their quality and validate their findings.
C1 [Kowalski, Sergio C.; Morgan, Rebecca L.; Florez, Ivan D.; Etxeandia-Ikobaltzeta, Itziar; Wiercioch, Wojtek; Zhang, Yuan; Ivanova, Liudmila; Santesso, Nancy; Schunemann, Holger J.] McMaster Univ, Hlth Sci Ctr, Evidence & Impact & Mac GRADE Ctr, Dept Hlth Res Methods, Room 2C16,1280 Main St West, Hamilton, ON L8N 4K1, Canada.
   [Kowalski, Sergio C.] Univ Fed Parana, Div Rheumatol, Dept Internal Med, R Gen Carneiro 181, Curitiba, PR, Brazil.
   [Falavigna, Maicon] Hosp Moinhos Vento, Porto Alegre, RS, Brazil.
   [Falavigna, Maicon] Univ Fed Rio Grande do Sul, Natl Inst Sci & Technol Hlth Technol Assessment, Porto Alegre, RS, Brazil.
   [Florez, Ivan D.] Univ Antioquia, Dept Pediat, Cra 51D 62-29, Medellin 050001, Colombia.
   [Sakhia, Faria] McMaster Univ, Publ Hlth & Prevent Med Residency Program Includi, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.
   [Santesso, Nancy; Schunemann, Holger J.] McMaster Univ, Hlth Sci Ctr, Cochrane Canada Ctr, Room 2C14,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
   [Schunemann, Holger J.] McMaster Univ, Hlth Sci Ctr, Dept Med, Room 2C14,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
RP Schunemann, HJ (corresponding author), McMaster Univ, Hlth Sci Ctr, Evidence & Impact & Mac GRADE Ctr, Dept Hlth Res Methods, Room 2C16,1280 Main St West, Hamilton, ON L8N 4K1, Canada.; Schunemann, HJ (corresponding author), McMaster Univ, Hlth Sci Ctr, Cochrane Canada Ctr, Room 2C14,1280 Main St West, Hamilton, ON L8S 4K1, Canada.
EM schuneh@mcmaster.ca
RI Florez, Ivan D./K-3536-2015; Wiercioch, Wojtek/AAQ-8087-2020
OI Florez, Ivan D./0000-0002-0751-8932; Wiercioch,
   Wojtek/0000-0001-6576-1650; Etxeandia-Ikobaltzeta,
   Itziar/0000-0001-6606-649X; Morgan, Rebecca/0000-0002-1012-4897
FU McMaster University internal research funds
FX This research was supported by McMaster University internal research
   funds.
CR Amer Coll Med Toxicology, 2011, J MED TOXICOL, V7, P81, DOI 10.1007/s13181-010-0125-3
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   [Anonymous], 2012, WHO INT POS STAT ROL
   Bennett MI, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2806
   Bond S, 2016, J MIDW WOMENS HLTH, V61, P392
   Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449
   BUTLER G, 2005, QUICK NOT DIRTY RAPI
   Centers for Disease Control and Prevention, 2012, INT TREATM GUID CENT
   Centers for Disease Control and Prevention, 2013, INT GUID CAS DEF INV
   Centers for Disease Control and Prevention, 2012, SUPPL INT GUID SCH A
   Centers for Disease Control and Prevention, 2012, INT TREATM GUID OST
   Centers for Disease Control and Prevention, 2013, INT GUID INF CONTR H
   Centers for Disease Control and Prevention C, 2012, GUID REC CDC PRIM
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P154
   Centers for Disease Control and Prevention (CDC), 2014, MMWR Morb Mortal Wkly Rep, V63, P984
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P987
   Fleischer DM, 2016, PEDIATR DERMATOL, V33, P102, DOI 10.1111/pde.12685
   Florez ID, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0329-6
   GAGLIARDI AR, 2012, IMPLEMENT SCI, V7
   Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56
   Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240
   Harbour RT, 2008, SIGN 50 GUIDELINE DE, P1
   Health Protection Agency Group A Streptococcus Working Group, 2004, Commun Dis Public Health, V7, P354
   Morgan RL, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0330-0
   National Collaborating Centre for Cancer, 2012, OP PALL CAR SAF EFF
   National Institute for Health and Clinical Excellence, 2011, ORG DON TRANSPL IMPR
   National Institute for Health and Clinical Excellence, 2012, OST FRAG FRACT RISK
   National Institute for Health and Clinical Excellence, 2012, GUID MAN
   National Institute for Health and Clinical Excellence, 2011, KIDN DIS PER DIAL TR
   National Institute for Health and Clinical Excellence, 2011, COL SURV PREV COL CA
   National Institute for Health and Clinical-Excellence, 2011, TUB CLIN DIAGN MAN T
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Papanikolaou G N, 2001, BMC Med Res Methodol, V1, P3, DOI 10.1186/1471-2288-1-3
   Public Health Agency of Canada, 2003, MAN SERV AC RESP SYN
   Public Health Agency of Canada, 2016, INT SYPH TREATM GUID
   Public Health Agency of Canada, 2013, INT GUID INF H7N9 VI
   Rabar S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e3698
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Royal College of Ophthalmologists, 2010, INT GUID MAN RET VEI
   Schunemann HJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-4
   Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237
   Schunemann HJ, 2006, HEALTH RES POLICY SY, V4, P1, DOI DOI 10.1186/1478-4505-4-1
   Schunemann HJ, 2007, PLOS MED, V4, P786, DOI 10.1371/journal.pmed.0040119
   Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3
   SHEKELLE P, 2012, IMPLEMENT SCI, V7
   Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586
   Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65
   Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tan T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1280
   Thayer KA, 2016, ENVIRON INT, V92-93, P585, DOI 10.1016/j.envint.2016.03.027
   Wallace GS, 2014, MMWR-MORBID MORTAL W, V63, P591
   Walsh J, 2011, BRIT J GEN PRACT, V61, P473, DOI 10.3399/bjgp11X583498
   Watt A, 2008, INT J TECHNOL ASSESS, V24, P133, DOI 10.1017/S0266462308080185
   WHO, 2010, GUID HIV INF FEED 20
   *WHO, 2009, RAP ADV ANT THER HIV
   Woolf S, 2012, IMPLEMENT SCI, V7
   World Health Organization, 2016, INT GUID BREASTF CON
   World Health Organization, 2014, WHO HDB GUID DEV
   World Health Organization, 2017, WHO BEST PRACT STAT
   World Health Organization, 2010, RAP ADV TREATM TUB C
   World Health Organization, 2012, SAF EFF SINGL DOS PR
   World Health Organization, 2012, UPD WHO POL REC INT
   World Health Organization, 2011, RAP ADV DIAGN PREV M
   World Health Organization, 2009, REG M NAT TB PROGR M
   World Health Organization, 2014, INT GUID US BED TREA
NR 67
TC 2
Z9 3
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1478-4505
J9 HEALTH RES POLICY SY
JI Health Res. Policy Syst.
PD JUL 13
PY 2018
VL 16
AR 61
DI 10.1186/s12961-018-0327-8
PG 11
WC Health Policy & Services
SC Health Care Sciences & Services
GA GM8ZA
UT WOS:000438527400001
PM 30005712
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Valiant, WG
   Huang, YJS
   Vanlandingham, DL
   Higgs, S
   Lewis, MG
   Matrapallil, JJ
AF Valiant, William G.
   Huang, Yan-Jang S.
   Vanlandingham, Dana L.
   Higgs, Stephen
   Lewis, Mark G.
   Matrapallil, Joseph J.
TI Zika convalescent macaques display delayed induction of anmanestic
   cross-neutralizing antibody responses after dengue infection
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID VIRUS-INFECTION; DEPENDENT ENHANCEMENT; SUBCLASSES; DISEASE;
   MACROPHAGES; REACTIVITY; CORRELATE
AB Structural similarities between Zika (ZIKV) and dengue virus (DENV) leads to the induction of cross-reactive responses. We have previously demonstrated that ZIKV exposed macaques significantly enhance DENV viremia. Here we show that this enhancement of DENV infection occurred in the presence of high levels of DENV cross-reactive IgG1 subclass of binding antibodies (bAb) with low DENV neutralizing antibody (nAb) activity (<1:10). The DENV-2 nAb titres after ZIKV infection were, however, higher than those induced in DENV-2 only infected animals suggesting that ZIKV induced low titres of cross-nAb against DENV. Surprisingly, DENV-2 infection of animals previously infected with ZIKV was not accompanied by an anamnestic increase in cross-nAb titres till about 1 week after DENV-2 infection. This delay coincided with enhanced DENV-2 viremia indicating that high levels of cross-bAb in the absence of high nAb contributes to enhancement of DENV infection. Serum collected 8 weeks after DENV-2 infection had high levels of nAb and showed delayed antibody dependent enhancement (ADE) of infection (1:100 dilution) as compared with serum that was collected from ZIKV infected animals prior to DENV-2 infection (1:10 dilution). Examination of serum from macaques that were simultaneously infected with both ZIKV and DENV-2 showed high levels of nAb and delayed ADE responses raising the possibility that the low levels of cross-nAb induced by ZIKV infection could be overcome by co-immunization against ZIKV and DENV infection. Taken together, our results provide additional insights into the nature and kinetics of cross-reactive antibody responses and identify a critical correlate that could potentially prevent enhancement of DENV infection during ZIKV convalescence.
C1 [Valiant, William G.; Matrapallil, Joseph J.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.
   [Huang, Yan-Jang S.; Vanlandingham, Dana L.; Higgs, Stephen] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Lewis, Mark G.] Bioqual, Rockville, MD USA.
RP Matrapallil, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.
EM joseph.matrapallil@usuhs.edu
OI Mattapallil, Joseph/0000-0002-7412-9507
FU Uniformed Services University
FX The described project was supported by funds from the Uniformed Services
   University to JJM. The opinions or assertions contained herein are the
   private ones of the authors and are not to be construed as official or
   reflecting the views of the Department of Defense, the Uniformed
   Services University, or any other agency of the U.S. Government.
CR Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405
   Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mohanram V, 2016, J IMMUNOL, V197, P2316, DOI 10.4049/jimmunol.1600544
   Montoya M, 2018, J INFECT DIS, V164, DOI [10.1093/infdis/jiy, DOI 10.1093/INFDIS/JIY164(2018)]
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Posadas-Mondragon A, 2017, MICROBIOL IMMUNOL, V61, P433, DOI 10.1111/1348-0421.12536
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   THEIN S, 1993, J MED VIROL, V40, P102, DOI 10.1002/jmv.1890400205
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Valiant WG, 2018, JOVE-J VIS EXP, DOI 10.3791/57371
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028
NR 29
TC 8
Z9 8
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 13
PY 2018
VL 7
AR 130
DI 10.1038/s41426-018-0132-z
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GN1TW
UT WOS:000438778200001
PM 30006514
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Domingo, C
   Charrel, RN
   Schmidt-Chanasit, J
   Zeller, H
   Reusken, C
AF Domingo, Cristina
   Charrel, Remi N.
   Schmidt-Chanasit, Jonas
   Zeller, Herve
   Reusken, Chantal
TI Yellow fever in the diagnostics laboratory
SO EMERGING MICROBES & INFECTIONS
LA English
DT Review
ID LINKED IMMUNOSORBENT ASSAYS; REVERSE TRANSCRIPTION-PCR; VACCINE VIRUS;
   DENGUE VIRUS; MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; RAPID DETECTION;
   ZIKA VIRUS; BRAZIL; TRANSMISSION
AB Yellow fever (YF) remains a public health issue in endemic areas despite the availability of a safe and effective vaccine. In 2015-2016, urban outbreaks of YF were declared in Angola and the Democratic Republic of Congo, and a sylvatic outbreak has been ongoing in Brazil since December 2016. Of great concern is the risk of urban transmission cycles taking hold in Brazil and the possible spread to countries with susceptible populations and competent vectors. Vaccination remains the cornerstone of an outbreak response, but a low vaccine stockpile has forced a sparing-dose strategy, which has thus far been implemented in affected African countries and now in Brazil. Accurate laboratory confirmation of cases is critical for efficient outbreak control. A dearth of validated commercial assays for YF, however, and the shortcomings of serological methods make it challenging to implement YF diagnostics outside of reference laboratories. We examine the advantages and drawbacks of existing assays to identify the barriers to timely and efficient laboratory diagnosis. We stress the need to develop new diagnostic tools to meet current challenges in the fight against YF.
C1 [Domingo, Cristina] Robert Koch Inst, WHO Collaborating Ctr Emerging Infect & Biol Thre, Ctr Biol Threats & Special Pathogens, Highly Pathogen Viruses ZBS 1, D-13353 Berlin, Germany.
   [Charrel, Remi N.] Aix Marseille Univ, IRD 190, IHU Mediterranee Infect, Inserm 1207,UMR Unite Virus Emergents UVE, Marseille, France.
   [Charrel, Remi N.] Fac Med Marseille, F-13005 Marseille 05, France.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Trop Med, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, D-20359 Hamburg, Germany.
   [Zeller, Herve] European Ctr Dis Prevent & Control ECDC, S-17165 Solna, Sweden.
   [Reusken, Chantal] Erasmus MC, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Dept Virosci, NL-3000 CA Rotterdam, Netherlands.
   [Zeller, Herve] Inst Pasteur, Direct Int Affairs, F-75015 Paris, France.
RP Domingo, C (corresponding author), Robert Koch Inst, WHO Collaborating Ctr Emerging Infect & Biol Thre, Ctr Biol Threats & Special Pathogens, Highly Pathogen Viruses ZBS 1, D-13353 Berlin, Germany.
EM Domingo-CarrascoC@rki.de
OI Domingo Carrasco, Cristina/0000-0003-0957-3377
CR Adungo F, 2016, CLIN VACCINE IMMUNOL, V23, P689, DOI 10.1128/CVI.00209-16
   Almeida MAB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002741
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.39.30361
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P193
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   [Anonymous], 2017, NOTICIAS
   Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Basile AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075670
   Basile AJ, 2015, J VIROL METHODS, V225, P41, DOI 10.1016/j.jviromet.2015.08.025
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   BERRY G. P., 1931, American Journal of Tropical Medicine, V11, P365
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brinkmann A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006075
   Burke DS, 2001, FIELDS VIROLOGY, VI, P1043
   Cabezas C, 2013, APORTE TECNOLOGIAS D
   CAMMACK N, 1986, J VIROL METHODS, V13, P135, DOI 10.1016/0166-0934(86)90081-9
   Campi-Azevedo AC, 2016, HUM VACC IMMUNOTHER, V12, P491, DOI 10.1080/21645515.2015.1082693
   Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P324
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Cottin P, 2013, EXPERT REV VACCINES, V12, P1351, DOI 10.1586/14760584.2013.836320
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cui SJ, 2017, INT J INFECT DIS, V60, P93, DOI 10.1016/j.ijid.2017.05.001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dash PK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-27
   de Filippis AM, 2004, VACCINE, V22, P1073, DOI 10.1016/j.vaccine.2003.11.002
   de Filippis AMB, 2002, J MED VIROL, V68, P620, DOI 10.1002/jmv.10226
   de Souza RP, 2010, J MED VIROL, V82, P175, DOI 10.1002/jmv.21606
   DEUBEL V, 1983, AM J TROP MED HYG, V32, P565, DOI 10.4269/ajtmh.1983.32.565
   Deubel V, 1997, J MED VIROL, V53, P212, DOI 10.1002/(SICI)1096-9071(199711)53:3&lt;212::AID-JMV5&gt;3.0.CO;2-B
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Domingo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036291
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   European Centre for Disease Prevention and Control (ECDC), 2016, OUTBR YELL FEV ANG
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Gibney KB, 2012, AM J TROP MED HYG, V87, P1112, DOI 10.4269/ajtmh.2012.12-0182
   Gossner CM, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.11.18-00106
   GRAHAM JL, 1968, APPL MICROBIOL, V16, P177, DOI 10.1128/AEM.16.1.177-.1968
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Grobusch MP, 2013, CLIN MICROBIOL INFEC, V19, P885, DOI 10.1111/1469-0691.12332
   Hamrick PN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005897
   HANSON RP, 1967, SCIENCE, V158, P1283, DOI 10.1126/science.158.3806.1283
   Hindle E, 1930, LANCET, V2, P835
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Hughes HR, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00323-18, 10.1128/jcm.00323-18]
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal SG, 2016, REV SOC BRAS MED TRO, V49, P29, DOI 10.1590/0037-8682-0363-2015
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Low GC, 1931, BRIT MED J, V1931, P125, DOI 10.1136/bmj.1.3655.125
   Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   McFarland JM, 1997, CLIN INFECT DIS, V25, P1143, DOI 10.1086/516111
   McMullan LK, 2012, VIROLOGY, V422, P1, DOI 10.1016/j.virol.2011.08.024
   Mendez MC, 2013, BIOMEDICA, V33, P190, DOI [10.7705/biomedica.v33i0.706, 10.7705/biomedica.v33i0.1452]
   Ministerio da Saude do Brasil, 2005, SER NORM MAN TECN
   Ministerio da Saude do Brasil. Normas e Manuais Tecnicos, 2005, GUIA VIG EP PRIM NAO
   Ministerio da Saude (MS/SVS), 2017, COES FEBR AM INF
   Ministerio da Saude (MS/SVS), 2018, COMP VAC TER DOS FRA
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath T. P., 1985, ARBOVIRUSES EPIDEMIO, V5, P139
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   MONATH TP, 1984, AM J TROP MED HYG, V33, P151, DOI 10.4269/ajtmh.1984.33.151
   Mutebi JP, 2004, J VIROL, V78, P9652, DOI 10.1128/JVI.78.18.9652-9665.2004
   Mutebi JP, 2001, J VIROL, V75, P6999, DOI 10.1128/JVI.75.15.6999-7008.2001
   Nassar E da S, 1995, Rev Inst Med Trop Sao Paulo, V37, P337
   Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07
   Nigerian Centre for Disease Control (NCDC), 2018, SIT REP YELL FEV OUT
   Nunes MRT, 2015, J VIROL METHODS, V226, P40, DOI 10.1016/j.jviromet.2015.10.003
   PAHO/WHO, 2018, LAB DIAGN YELL FEV V
   PAHO/WHO, 2017, YELL FEV EP UPD
   PAHO/WHO, 2018, YELL FEV EP UPD
   Pang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095635
   Parra E. A, 2017, WORKSHEP UNASUR CPLP
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Reusken CBEM, 2017, J CLIN MICROBIOL, V55, P3294, DOI 10.1128/JCM.01113-17
   Ricciardi-Jorge T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16231-6
   Sariol CA, 1999, AM J TROP MED HYG, V61, P994, DOI 10.4269/ajtmh.1999.61.994
   SCHERER WF, 1980, AM J TROP MED HYG, V29, P1359
   Sonnenberg P, 2015, CLIN INFECT DIS, V60, P974, DOI 10.1093/cid/ciu981
   Teichmann D, 2003, SCAND J INFECT DIS, V35, P427, DOI 10.1080/00365540310009888
   Traiber C, 2011, J PEDIAT-BRAZIL, V87, P269, DOI [10.2223/JPED.2067, 10.1590/S0021-75572011000300015]
   TSAI TF, 1993, J INFECT DIS, V168, P1520, DOI 10.1093/infdis/168.6.1520
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Vazquez S, 2003, J VIROL METHODS, V110, P179, DOI 10.1016/S0166-0934(03)00128-9
   Weidmann M, 2010, J CLIN VIROL, V48, P187, DOI 10.1016/j.jcv.2010.04.013
   WHO, 2016, YELL FEV OUTBR ANG D
   WHO, 2016, INT GUID YELL FEV LA
   WHO/ AFRO, 2017, YELL FEV OUTBR ANG D
   World Health Organisation, 2016, YELL FEV SIT REP
   World Health Organization, 2016, YELL FEV STRAT RESP
   World Health Organization Media centre, 2016, YELL FEV FACT SHEET
   World Health Organization (WHO), 2018, DIS OUTBREAK NE 0208
   World Health Organization (WHO), 2004, LAB BIOS MAN
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
NR 108
TC 7
Z9 8
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD JUL 12
PY 2018
VL 7
AR 129
DI 10.1038/s41426-018-0128-8
PG 15
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GN1TQ
UT WOS:000438777500001
PM 30002363
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, FF
   Xu, YF
   Lavillette, D
   Zhong, J
   Zou, G
   Long, G
AF Zhao, Fanfan
   Xu, Yongfen
   Lavillette, Dimitri
   Zhong, Jin
   Zou, Gang
   Long, Gang
TI Negligible contribution of M2634V substitution to ZIKV pathogenesis in
   AG6 mice revealed by a bacterial promoter activity reduced infectious
   clone
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS; BIOLOGY; TRANSMISSION; NIGERIA; CELLS
AB ZIKV has emerged as a significant human pathogene for the severe neurological complications, including Guillain-Barre(GBS) syndrome in adults and a variety of fetal abnormalities such as microcephaly. A stable and efficient infectious clone of Brazilian ZIKV isolate is required to study pathogenesis of epidemic ZIKV and virus evolution impact on it. Here we successfully constructed infectious cDNA clone on an early Brazilian isolate by eliminating the activity of predicted bacterial promoter in 1-3000 nt of ZIKV genome, leading to a stable infectious cDNA clone (pZL1). pZL1 derived virus could infect different cell lines and cause lethal effect to AG6 mice. We further investigated the role of a recent emerged substitution in NS5 (M2634V). We found that a reverse mutation (V2634M) caused negligible effect on the ZIKV viral genome replication and infectious progeny production in multiple cell culture systems. Additionally, this mutation did not alter the pathogenesis feature and virulence of ZIKV in AG6 mice. In summary, our results present another robust infectious ZIKV clone from Brazilian isolate and provide evidences to support that M2634V single mutation did not alter virus life cycle in cell culture and pathogenesis in AG6 mouse model.
C1 [Zhao, Fanfan; Xu, Yongfen; Lavillette, Dimitri; Zhong, Jin; Zou, Gang; Long, Gang] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
RP Long, G (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China.
EM glong@ips.ac.cn
RI Zou, Gang/J-1833-2014
OI Zou, Gang/0000-0001-9607-7827; Lavillette, Dimitri/0000-0002-4706-1519
FU "100 talents program" from the Chinese Academy of Sciences; National
   Science and Technology Major Project of the Ministry of Science and
   Technology of China [2015CB554300, 2016YFC1200400]
FX We thank the Center for Emerging Infectious Diseases (Wuhan Institute of
   Virology, Chinese Academy of Sciences, Wuhan, China) for kindly provide
   the wild type ZIKV SZ-WIV01 strain. This work was supported by the "100
   talents program" from the Chinese Academy of Sciences and the National
   Science and Technology Major Project of the Ministry of Science and
   Technology of China (2015CB554300 and 2016YFC1200400).
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Harris E., 2006, NOVART FDN SYMP, V40, P251
   Harris E, 2006, NOVART FDN SYMP, V277, P251
   Harris E, 2006, NOVART FDN SYMP, V277, P40
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EURO SURVEILL, V19
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 53
TC 7
Z9 7
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 12
PY 2018
VL 8
AR 10491
DI 10.1038/s41598-018-28890-0
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM7ET
UT WOS:000438343600001
PM 30002446
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shan, C
   Xie, XP
   Shi, PY
AF Shan, Chao
   Xie, Xuping
   Shi, Pei-Yong
TI Zika Virus Vaccine: Progress and Challenges
SO CELL HOST & MICROBE
LA English
DT Review
ID ANTIBODY-DEPENDENT ENHANCEMENT; PROTECTIVE EFFICACY; DNA VACCINE;
   INFECTION; IMMUNITY; IMMUNOGENICITY; PATHOGENESIS; PHASE-1; SAFETY
AB The explosive emergence of Zika virus has inspired a global effort to develop vaccines. Zika virus, which is a flavivirus primarily transmitted by mosquitoes, can cause devastating congenital syndrome in fetuses of pregnant women, including microcephaly, craniofacial disproportion, spasticity, ocular abnormalities, and miscarriage. In adults, Zika infection has been linked to the autoimmune disorder Guillain-Barre syndrome. Thus, despite the current waning in newly reported Zika infections, an efficacious vaccine is urgently needed to help limit the emergence of another detrimental epidemic. Here we summarize the current status of the Zika vaccine pipeline and highlight the challenges for clinical efficacy trials.
C1 [Shan, Chao; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shan, Chao; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shan, Chao; Xie, Xuping; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019
FU University of Texas Medical Branch (UTMB) startup award; University of
   Texas STARs Award; UTMB Technology Commercialization Program Award; CDC
   grant for the Western Gulf Center of Excellence for Vector-Borne
   Diseases; Pan American Health Organization grant [SCON2016-01353];
   Kleberg Foundation Award; UTMB CTSAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR-001439]; NIH
   grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI127744]
FX We thank all members of the P.-Y.S. lab and the collaborators for their
   hard work and support. The P.-Y.S. lab was supported by a University of
   Texas Medical Branch (UTMB) startup award, University of Texas STARs
   Award, UTMB Technology Commercialization Program Award, CDC grant for
   the Western Gulf Center of Excellence for Vector-Borne Diseases, Pan
   American Health Organization grant SCON2016-01353, the Kleberg
   Foundation Award, UTMB CTSA UL1TR-001439, and NIH grant AI127744.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   To A, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00576-17
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Xia H., 2018, POTENTIAL MECH ENHAN
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
NR 35
TC 25
Z9 25
U1 1
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 11
PY 2018
VL 24
IS 1
BP 12
EP 17
DI 10.1016/j.chom.2018.05.021
PG 6
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7XD
UT WOS:000438410000006
PM 30008291
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Liu, Y
   Gordesky-Gold, B
   Leney-Greene, M
   Weinbren, NL
   Tudor, M
   Cherry, S
AF Liu, Yuan
   Gordesky-Gold, Beth
   Leney-Greene, Michael
   Weinbren, Nathan L.
   Tudor, Matthew
   Cherry, Sara
TI Inflammation-Induced, STING-Dependent Autophagy Restricts Zika Virus
   Infection in the Drosophila Brain
SO CELL HOST & MICROBE
LA English
DT Article
ID INNATE IMMUNE-RESPONSE; SINDBIS-VIRUS; HOST-DEFENSE; SELECTIVE
   AUTOPHAGY; ANTIVIRAL AUTOPHAGY; NEURAL PROGENITORS; STEM-CELLS; PATHWAY;
   NEURODEGENERATION; PATHOGENESIS
AB The emerging arthropod-borne flavivirus Zika virus (ZIKV) is associated with neurological complications. Innate immunity is essential for the control of virus infection, but the innate immune mechanisms that impact viral infection of neurons remain poorly defined. Using the genetically tractable Drosophila system, we show that ZIKV infection of the adult fly brain leads to NF-kB-dependent inflammatory signaling, which serves to limit infection. ZIKV-dependent NF-kappa B activation induces the expression of Drosophila stimulator of interferon genes (dSTING) in the brain. dSTING protects against ZIKV by inducing autophagy in the brain. Loss of autophagy leads to increased ZIKV infection of the brain and death of the infected fly, while pharmacological activation of autophagy is protective. These data suggest an essential role for an inflammation-dependent STING pathway in the control of neuronal infection and a conserved role for STING in antimicrobial autophagy, which may represent an ancestral function for this essential innate immune sensor.
C1 [Liu, Yuan; Gordesky-Gold, Beth; Leney-Greene, Michael; Weinbren, Nathan L.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Tudor, Matthew] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
RP Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
EM cherrys@pennmedicine.upenn.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI074951, 5R01AI122749]; Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease
   AwardBurroughs Wellcome Fund
FX We would like to thank the following for fly stocks: Bloomington, VDRC,
   NIG, BDGP, DRSC, Thomas Neufeld, Neal Silverman, Jun Hee Lee, Daniel J.
   Klionsky, and Margit Burmeister. We would like to thank M. Diamond for
   antibodies and ZIKV, R. Hardy for SINV, and P. Christian for DCV. We
   would like to thank Julie To for technical help with tittering, and the
   S.C. lab for helpful discussions and advice. This work was supported by
   NIH grants R01AI074951 and 5R01AI122749 to S.C. S.C. is a recipient of
   the Burroughs Wellcome Investigators in the Pathogenesis of Infectious
   Disease Award.
CR Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921
   Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763
   Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491
   Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429
   Burnham AJ, 2007, VIROLOGY, V367, P212, DOI 10.1016/j.virol.2007.05.008
   Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003
   Cantera R, 2015, J INNATE IMMUN, V7, P3, DOI 10.1159/000365195
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110
   Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250
   Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Choi J, 2014, IMMUNITY, V40, P924, DOI 10.1016/j.immuni.2014.05.006
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016
   Dong XN, 2013, J INNATE IMMUN, V5, P480, DOI 10.1159/000346388
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fields B. N., 2013, FIELDS VIROLOGY, V2
   Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Gammon DB, 2015, CURR OPIN INSECT SCI, V8, P111, DOI 10.1016/j.cois.2015.01.006
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106
   Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830
   Kim M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071596
   Kim M, 2016, ELIFE, V5, DOI 10.7554/eLife.12245
   Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014
   Kounatidis I, 2017, CELL REP, V19, P836, DOI 10.1016/j.celrep.2017.04.007
   Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022
   Lamiable O, 2014, CURR OPIN MICROBIOL, V20, P62, DOI 10.1016/j.mib.2014.05.006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Lennemann NJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004685
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Luo WY, 2012, CELL, V148, P765, DOI 10.1016/j.cell.2011.12.024
   Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004
   Martin-Acebes MA, 2015, AUTOPHAGY, V11, P861, DOI 10.1080/15548627.2015.1037062
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Morris O, 2016, CELL HOST MICROBE, V20, P283, DOI 10.1016/j.chom.2016.08.003
   Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966
   Nakamoto M, 2012, IMMUNITY, V36, P658, DOI 10.1016/j.immuni.2012.03.003
   Nezis Ioannis P, 2012, Int J Cell Biol, V2012, P146767, DOI 10.1155/2012/146767
   Nixon RA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008839
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Orvedahl A, 2008, CELL MICROBIOL, V10, P1747, DOI 10.1111/j.1462-5822.2008.01175.x
   Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007
   Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010
   Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009
   Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979
   Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281
   Sumpter R, 2010, SEMIN CELL DEV BIOL, V21, P699, DOI 10.1016/j.semcdb.2010.04.003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Watson RO, 2015, CELL HOST MICROBE, V17, P811, DOI 10.1016/j.chom.2015.05.004
   Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963
   Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002
   Xu J, 2012, CELL HOST MICROBE, V12, P531, DOI 10.1016/j.chom.2012.08.011
   Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013
   Yoshimori T, 2010, CELL HOST MICROBE, V7, P83, DOI 10.1016/j.chom.2010.02.003
   Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 102
TC 47
Z9 48
U1 2
U2 43
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 11
PY 2018
VL 24
IS 1
BP 57
EP +
DI 10.1016/j.chom.2018.05.022
PG 15
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7XD
UT WOS:000438410000011
PM 29934091
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Zitzmann, C
   Kaderali, L
AF Zitzmann, Carolin
   Kaderali, Lars
TI Mathematical Analysis of Viral Replication Dynamics and Antiviral
   Treatment Strategies: From Basic Models to Age-Based Multi-Scale
   Modeling
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE mathematical modeling; viral kinetics; viral replication; human
   immunodeficiency virus; Hepatitis C virus; Influenza A virus; antiviral
   therapy; immune response
ID CHRONIC HEPATITIS-C; INFLUENZA-VIRUS INFECTION; GENOTYPE 1 INFECTION;
   HIV-INFECTION; ZIKA VIRUS; IN-VIVO; A VIRUS; ANTIRETROVIRAL THERAPY;
   DRUG-RESISTANCE; INTRACELLULAR KINETICS
AB Viral infectious diseases are a global health concern, as is evident by recent outbreaks of the middle east respiratory syndrome, Ebola virus disease, and re-emerging zika, dengue, and chikungunya fevers. Viral epidemics are a socio-economic burden that causes short- and long-term costs for disease diagnosis and treatment as well as a loss in productivity by absenteeism. These outbreaks and their socio-economic costs underline the necessity for a precise analysis of virus-host interactions, which would help to understand disease mechanisms and to develop therapeutic interventions. The combination of quantitative measurements and dynamic mathematical modeling has increased our understanding of the within-host infection dynamics and has led to important insights into viral pathogenesis, transmission, and disease progression. Furthermore, virus-host models helped to identify drug targets, to predict the treatment duration to achieve cure, and to reduce treatment costs. In this article, we review important achievements made by mathematical modeling of viral kinetics on the extracellular, intracellular, and multi-scale level for Human Immunodeficiency Virus, Hepatitis C Virus, In fluenza A Virus, Ebola Virus, Dengue Virus, and Zika Virus. Herein, we focus on basic mathematical models on the population scale (so-called target cell-limited models), detailed models regarding the most important steps in the viral life cycle, and the combination of both. For this purpose, we review how mathematical modeling of viral dynamics helped to understand the virus-host interactions and disease progression or clearance. Additionally, we review different types and effects of therapeutic strategies and how mathematical modeling has been used to predict new treatment regimens.
C1 [Zitzmann, Carolin] Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany.
   Univ Med Greifswald, Ctr Funct Genom Microbes, Greifswald, Germany.
RP Zitzmann, C (corresponding author), Univ Med Greifswald, Inst Bioinformat, Greifswald, Germany.
EM carolin.zitzmann@uni-greifswald.de
FU BMBF through the ERASysAPP project SysVirDrug [031A602A]
FX LK received funding from the BMBF through the ERASysAPP project
   SysVirDrug (031A602A).
CR Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454
   Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alizon S, 2012, VIRUSES-BASEL, V4, P1984, DOI 10.3390/v4101984
   Andrade A, 2015, AIDS, V29, P2419, DOI 10.1097/QAD.0000000000000843
   Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286
   Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027
   Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05
   Ball CL, 2007, B MATH BIOL, V69, P2361, DOI 10.1007/s11538-007-9223-z
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Barton KM, 2013, CLIN PHARMACOL THER, V93, P46, DOI 10.1038/clpt.2012.202
   Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012
   Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031
   Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7
   Ben-Shachar R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005194
   Ben-Shachar R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0886
   Benzine T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006343
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561
   Boerma T., 2015, WHO HLTH 2015 MDGS S
   Boianelli A, 2015, VIRUSES-BASEL, V7, P5274, DOI 10.3390/v7102875
   Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971
   Braciale TJ, 2013, FIELDS VIROLOGY, P214
   BUCHHOLTZ F, 1987, BIOPHYS CHEM, V26, P171, DOI 10.1016/0301-4622(87)80020-0
   Canini L, 2014, J PHARMACOKINET PHAR, V41, P431, DOI 10.1007/s10928-014-9363-3
   Canini L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003568
   Cao PX, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00611
   Cardozo EF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006478
   Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972
   Ciupe Stanca M, 2017, Infect Dis Model, V2, P188, DOI 10.1016/j.idm.2017.04.002
   Clapham HE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004951
   Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094
   Clausznitzer D, 2016, VIRUS RES, V218, P96, DOI 10.1016/j.virusres.2015.09.011
   Conway JM, 2015, P NATL ACAD SCI USA, V112, P5467, DOI 10.1073/pnas.1419162112
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dahari H, 2005, GASTROENTEROLOGY, V128, P1056, DOI 10.1053/j.gastro.2005.01.049
   Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006
   Dahari H, 2007, HEPATOLOGY, V46, P16, DOI 10.1002/hep.21657
   Dahari H, 2007, J VIROL, V81, P750, DOI 10.1128/JVI.01304-06
   Dahari H, 2016, J HEPATOL, V64, P1232, DOI 10.1016/j.jhep.2016.02.022
   Dee KU, 1997, BIOTECHNOL BIOENG, V54, P468, DOI 10.1002/(SICI)1097-0290(19970605)54:5<468::AID-BIT7>3.0.CO;2-C
   DEE KU, 1995, BIOTECHNOL BIOENG, V46, P485, DOI 10.1002/bit.260460513
   EIGEN M, 1991, BIOCHEMISTRY-US, V30, P11005, DOI 10.1021/bi00110a001
   Endy D, 1997, BIOTECHNOL BIOENG, V55, P375, DOI 10.1002/(SICI)1097-0290(19970720)55:2<375::AID-BIT15>3.0.CO;2-G
   Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946
   Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960
   Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508
   Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105
   Goujard C, 2012, ANTIVIR THER, V17, P1001, DOI 10.3851/IMP2273
   Graw F, 2016, ANNU REV VIROL, V3, P555, DOI 10.1146/annurev-virology-110615-042249
   Gray GE, 2016, CURR OPIN VIROL, V17, P104, DOI 10.1016/j.coviro.2016.02.010
   Guedj J, 2010, J VIRAL HEPATITIS, V17, P825, DOI 10.1111/j.1365-2893.2010.01348.x
   Guedj J, 2014, ANTIVIR THER, V19, P211, DOI 10.3851/IMP2733
   Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110
   Guedj J, 2012, HEPATOLOGY, V55, P1030, DOI 10.1002/hep.24788
   Guedj J, 2011, HEPATOLOGY, V53, P1801, DOI 10.1002/hep.24272
   Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067
   Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463
   Heldt FS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003372
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hernandez-Vargas EA, 2014, J VIROL, V88, P4123, DOI 10.1128/JVI.03644-13
   Herrmann E, 2003, HEPATOLOGY, V37, P1351, DOI 10.1053/jhep.2003.50218
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0
   Ho DD, 1996, SCIENCE, V272, P1124, DOI 10.1126/science.272.5265.1124
   Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767
   HOLFORD NHG, 1982, PHARMACOL THERAPEUT, V16, P143, DOI 10.1016/0163-7258(82)90051-1
   Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227
   Hopkins S, 2012, J HEPATOL, V57, P47, DOI 10.1016/j.jhep.2012.02.024
   Iwasaki A, 2013, FIELDS VIROLOGY, P189
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912
   Kamal MA, 2015, ANTIMICROB AGENTS CH, V59, P5388, DOI 10.1128/AAC.00069-15
   Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916
   Ke RA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005237
   Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781
   Kim HJ, 2006, PLOS COMPUT BIOL, V2, P1232, DOI 10.1371/journal.pcbi.0020135
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355
   Kumberger P, 2016, FEBS LETT, V590, P1972, DOI 10.1002/1873-3468.12095
   Lawitz E, 2011, ANTIVIR RES, V89, P238, DOI 10.1016/j.antiviral.2011.01.003
   Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552
   Liu Z, 2009, J VIROL, V83, P6554, DOI 10.1128/JVI.02550-08
   Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1
   Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14
   Madelain V, 2015, ANTIVIR RES, V123, P70, DOI 10.1016/j.antiviral.2015.08.015
   Mailly L, 2015, NAT BIOTECHNOL, V33, P549, DOI 10.1038/nbt.3179
   Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239
   Manchanda H, 2014, BIOSYSTEMS, V118, P51, DOI 10.1016/j.biosystems.2014.02.004
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003
   Martyushev A, 2016, ANTIVIR RES, V135, P62, DOI 10.1016/j.antiviral.2016.10.004
   Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10
   Munier ML, 2007, IMMUNOL CELL BIOL, V85, P6, DOI 10.1038/sj.icb.7100015
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nelson PW, 2004, MATH BIOSCI ENG, V1, P267, DOI 10.3934/mbe.2004.1.267
   Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103
   Nowak M., 2001, VIRUS DYNAMICS MATH
   Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74
   Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398
   O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105
   Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588
   Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003
   Perelson AS, 2015, NAT REV GASTRO HEPAT, V12, P437, DOI 10.1038/nrgastro.2015.97
   Perelson AS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-96
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A
   Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700
   Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0
   Persaud D, 2011, AIDS, V25, P2227, DOI 10.1097/QAD.0b013e32834cdaba
   Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11
   Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015
   Quintela B. M., 2017, IFMBE P, P508, DOI DOI 10.1137/080714579
   Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8
   Reddy B, 1999, AIDS RES HUM RETROV, V15, P273, DOI 10.1089/088922299311457
   Ribeiro RM, 2000, P NATL ACAD SCI USA, V97, P7681, DOI 10.1073/pnas.97.14.7681
   Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10
   ROBERTS NJ, 1979, J IMMUNOL, V123, P365
   Rong LB, 2007, J THEOR BIOL, V247, P804, DOI 10.1016/j.jtbi.2007.04.014
   Rong LB, 2007, B MATH BIOL, V69, P2027, DOI 10.1007/s11538-007-9203-3
   Rong LB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002959
   Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011
   Ronsard L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01467
   Ronsard L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00706
   Ronsard L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085452
   Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09
   Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211
   Salgado M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-97
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248
   Schelker M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005075
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   SEDMAK JJ, 1973, J GEN VIROL, V21, P1, DOI 10.1099/0022-1317-21-1-1
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772
   Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076
   Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975
   Tamura SI, 2004, JPN J INFECT DIS, V57, P236
   Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395
   United Nations, 2017, SOC IMP ASS ZIK VIR
   Nguyen VK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00257
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014
   Wauquier N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000837
   WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0
   WHO, 2017, INFL SEAS
   WHO, 2017, EB VIR DIS
   Wodarz D, 2004, P ROY SOC B-BIOL SCI, V271, P1101, DOI 10.1098/rspb.2003.2664
   Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196
   World Health Organization, 2016, GUID SCREEN CAR TREA
   World Health Organization, 2017, HIV AIDS
   World Health Organization, 2017, ZIK VIR
   World Health Organization (WHO), 2016, DENG SEV DENG
   Wright PF, 2013, FIELDS VIROLOGY, P1186
   Xiao YN, 2013, ADV DRUG DELIVER REV, V65, P940, DOI 10.1016/j.addr.2013.04.005
   Zarnitsyna VI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00165
   Zeisel MB, 2013, J HEPATOL, V58, P375, DOI 10.1016/j.jhep.2012.09.022
NR 163
TC 7
Z9 7
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUL 11
PY 2018
VL 9
AR 1546
DI 10.3389/fmicb.2018.01546
PG 18
WC Microbiology
SC Microbiology
GA GM6HT
UT WOS:000438266100001
PM 30050523
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mysore, K
   Li, P
   Duman-Scheel, M
AF Mysore, Keshava
   Li, Ping
   Duman-Scheel, Molly
TI Identification of Aedes aegypti cis-regulatory elements that promote
   gene expression in olfactory receptor neurons of distantly related
   dipteran insects
SO PARASITES & VECTORS
LA English
DT Article
DE Mosquito; Sensory; Antenna; Neuron; Enhancer; FAIRE; Aedes aegypti;
   Drosophila melanogaster; Dengue; Zika
ID MALE COURTSHIP; ODORANT RECEPTOR; DROSOPHILA; SYSTEM; PATHWAYS;
   BEHAVIOR; FAIRE
AB Background: Sophisticated tools for manipulation of gene expression in select neurons, including neurons that regulate sexually dimorphic behaviors, are increasingly available for analysis of genetic model organisms. However, we lack comparable genetic tools for analysis of non-model organisms, including Aedes aegypti, a vector mosquito which displays sexually dimorphic behaviors that contribute to pathogen transmission. Formaldehyde-assisted isolation of regulatory elements followed by sequencing (FAIRE-seq) recently facilitated genome-wide discovery of putative A. aegypti cis-regulatory elements (CREs), many of which could be used to manipulate gene expression in mosquito neurons and other tissues. The goal of this investigation was to identify FAIRE DNA elements that promote gene expression in the olfactory system, a tissue of vector importance.
   Results: Eight A. aegypti CREs that promote gene expression in antennal olfactory receptor neurons (ORNs) were identified in a Drosophila melanogaster transgenic reporter screen. Four CREs identified in the screen were cloned upstream of GAL4 in a transgenic construct that is compatible with transformation of a variety of insect species. These constructs, which contained FAIRE DNA elements associated with the A. aegypti odorant coreceptor (orco), odorant receptor 1 (Or1), odorant receptor 8 (Or8) and fruitless (fru) genes, were used for transformation of A. aegypti. Six A. aegypti strains, including strains displaying transgene expression in all ORNs, subsets of these neurons, or in a sex-specific fashion, were isolated. The CREs drove transgene expression in A. aegypti that corresponded to endogenous gene expression patterns of the orco, Or1, Or8 and fru genes in the mosquito antenna. CRE activity in A. aegypti was found to be comparable to that observed in D. melanogaster reporter assays.
   Conclusions: These results provide further evidence that FAIRE-seq, which can be paired with D. melanogaster reporter screening to test FAIRE DNA element activity in select tissues, is a useful method for identification of mosquito cis-regulatory elements. These findings expand the genetic toolkit available for the study of Aedes neurobiology. Moreover, given that the CREs drive comparable olfactory neural expression in both A. aegypti and D. melanogaster, it is likely that they may function similarly in multiple dipteran insects, including other disease vector mosquito species.
C1 [Mysore, Keshava; Li, Ping; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, 1234 Notre Dame Ave,Raclin Carmichael Hall, South Bend, IN 46617 USA.
   [Mysore, Keshava; Li, Ping; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
RP Duman-Scheel, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, 1234 Notre Dame Ave,Raclin Carmichael Hall, South Bend, IN 46617 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; Duman-Scheel, M (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
EM mscheel@nd.edu
RI Mysore, Keshava/P-6248-2019
OI Mysore, Keshava/0000-0003-2794-7029
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI117145-01]
FX This work was funded by NIH/NIAID Award R21AI117145-01 to MDS. The
   funding source was not involved in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Anand A, 2001, GENETICS, V158, P1569
   Behura SK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2468-x
   Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006
   Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463
   Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x
   Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032
   Centers for Disease Control and Prevention, 2016, SURV CONTR AED AEG A
   Clemons A, 2010, COLD SPRING HARB PRO, V10
   Clemons A, 2010, COLD SPRING HARB PRO, V10
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027
   Duman-Scheel M, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00061
   Dweck HKM, 2015, P NATL ACAD SCI USA, V112, pE2829, DOI 10.1073/pnas.1504527112
   Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506
   Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003
   Goodwin SF, 2000, GENETICS, V154, P725
   Grosjean Y, 2011, NATURE, V478, P236, DOI 10.1038/nature10428
   Haugen M, 2010, COLD SPRING HARB PRO, V10
   Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206
   Hueston CE, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002443
   Jafari S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001280
   Kimura KI, 2011, DEV GROWTH DIFFER, V53, P236, DOI 10.1111/j.1440-169X.2010.01223.x
   Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004
   Kunzle H, 2001, NEUROSCI LETT, V303, P53, DOI 10.1016/S0304-3940(01)01714-1
   Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672
   Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859
   Mysore K, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-9
   O'Brochta DA, 2012, G3-GENES GENOM GENET, V2, P1305, DOI 10.1534/g3.112.003582
   Owald D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0211
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Patel Nipam H., 1996, P357
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003
   Sakurai A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2837
   Salvemini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048554
   Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444
   Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026
   Tabuchi K, 2000, J NEUROSCI RES, V59, P94, DOI 10.1002/(SICI)1097-4547(20000101)59:1<94::AID-JNR11>3.0.CO;2-Q
   Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021
   Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800
   Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567
   Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5
NR 42
TC 2
Z9 2
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 11
PY 2018
VL 11
AR 406
DI 10.1186/s13071-018-2982-6
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GM6VH
UT WOS:000438314700005
PM 29996889
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chazal, M
   Beauclair, G
   Gracias, S
   Najburg, V
   Simon-Loriere, E
   Tangy, F
   Komarova, AV
   Jouvenet, N
AF Chazal, Maxime
   Beauclair, Guillaume
   Gracias, Segolene
   Najburg, Valerie
   Simon-Loriere, Etienne
   Tangy, Frederic
   Komarova, Anastassia V.
   Jouvenet, Nolwenn
TI RIG-I Recognizes the 5 ' Region of Dengue and Zika Virus Genomes
SO CELL REPORTS
LA English
DT Article
ID RNA VIRUSES; MDA5; REPLICATION; ACTIVATION; ROLES; CELLS; PICORNAVIRUS;
   RECEPTORS; INFECTION; IMMUNITY
AB The flavivirus genus comprises major human pathogens, such as Dengue (DENV) and Zika (ZIKV) viruses. RIG-I and MDA5 are key cytoplasmic pathogen recognition receptors that are implicated in detecting viral RNAs. Here, we show that RNAs that co-purified with RIG-I during DENV infection are immuno-stimulatory, whereas RNAs bound to MDA5 are not. An affinity purification method combined with next-generation sequencing (NGS) revealed that the 5' region of the DENV genome is recognized by RIG-I. No DENV RNA was bound to MDA5. In vitro production of fragments of the DENV genome confirmed the NGS data and revealed that the 5' end of the genome, when bearing 5'-triphosphates, is the RIG-I ligand. The 5' region of the ZIKV genome is also a RIG-I agonist. We propose that RIG-I binds to the highly structured and conserved 5' region of flavivirus nascent transcripts before capping and that this mechanism leads to interferon secretion by infected cells.
C1 [Chazal, Maxime; Beauclair, Guillaume; Gracias, Segolene; Najburg, Valerie; Tangy, Frederic; Komarova, Anastassia V.; Jouvenet, Nolwenn] Inst Pasteur, Unite Genom Virale & Vaccinat, Dept Virol, CNRS,UMR 3569, F-75015 Paris, France.
   [Chazal, Maxime; Simon-Loriere, Etienne] Inst Pasteur, Unite Genet Fonct Malad Infect, F-75015 Paris, France.
   [Chazal, Maxime; Simon-Loriere, Etienne] Inst Pasteur, CNRS, UMR2000, Genom Evolut Modelisat & Sante, F-75015 Paris, France.
RP Komarova, AV; Jouvenet, N (corresponding author), Inst Pasteur, Unite Genom Virale & Vaccinat, Dept Virol, CNRS,UMR 3569, F-75015 Paris, France.
EM anastasia.komarova@pasteur.fr; nolwenn.jouvenet@pasteur.fr
RI jouvenet, nolwenn/K-2067-2019
OI jouvenet, nolwenn/0000-0001-6103-6048; Beauclair,
   Guillaume/0000-0001-5323-5987; CHAZAL, Maxime/0000-0002-3144-5032
FU European Commission program [H2020-SC1-2016-RTD, 732432]; Agence
   Nationale de la RechercheFrench National Research Agency (ANR)
   [ANR-16-CE15-0025-01]; Centre National de la Recherche Scientifique
   (CNRS)Centre National de la Recherche Scientifique (CNRS); Institut
   Pasteur
FX We thank Chantal Combredet for technical support; and Odile Sismeiro,
   Rachel Legendre, Hugo Varet, and Jean-Yves Coppee from Institut
   Pasteur's Plateforme "Transcriptome et Epigenome (PF2)" for their
   essential help in the RNA sequencing and data analysis. We are grateful
   to Lisset Hermida and Gerardo Enrique Guillen Nieto (CIGB, Havana, Cuba)
   for generously providing DENV-2 and DENV-4 isolates; to Nicolas Escriou
   (Institut Pasteur) for mengovirus C50UC10; to Ted Pierson (NIH,
   Bethesda, MD, USA) for the plasmid encoding the DENV-2 replicon; and to
   Olivier Schwartz (Institut Pasteur, Paris, France) for providing the
   Zika strain HD78788 and the plasmid encoding the full-length Zika MR766
   genome. We are also grateful to members of our laboratories for helpful
   discussions and technical advice. We thank the following funding
   agencies: European Commission program H2020-SC1-2016-RTD (Zikavax no.
   732432), Agence Nationale de la Recherche (ANR-16-CE15-0025-01), Centre
   National de la Recherche Scientifique (CNRS), and Institut Pasteur.
CR Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   da Conceicao TM, 2013, VIROLOGY, V435, P281, DOI 10.1016/j.virol.2012.09.038
   David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Feng Q, 2012, CELL REP, V2, P1187, DOI 10.1016/j.celrep.2012.10.005
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Lucas-Hourani M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003678
   Moresco EMY, 2010, P NATL ACAD SCI USA, V107, P1261, DOI 10.1073/pnas.0914011107
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09
   Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007
   Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sprokholt JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006738
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
NR 35
TC 21
Z9 22
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUL 10
PY 2018
VL 24
IS 2
BP 320
EP 328
DI 10.1016/j.celrep.2018.06.047
PG 9
WC Cell Biology
SC Cell Biology
GA GM8AF
UT WOS:000438422700007
PM 29996094
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Badawi, A
   Velummailum, R
   Ryoo, SG
   Senthinathan, A
   Yaghoubi, S
   Vasileva, D
   Ostermeier, E
   Plishka, M
   Soosaipillai, M
   Arora, P
AF Badawi, Alaa
   Velummailum, Russanthy
   Ryoo, Seung Gwan
   Senthinathan, Arrani
   Yaghoubi, Sahar
   Vasileva, Denitsa
   Ostermeier, Emma
   Plishka, Mikayla
   Soosaipillai, Marcel
   Arora, Paul
TI Prevalence of chronic comorbidities in dengue fever and West Nile virus:
   A systematic review and meta-analysis
SO PLOS ONE
LA English
DT Review
ID TYPE-2 DIABETES-MELLITUS; ACUTE KIDNEY INJURY; RISK-FACTORS;
   HEMORRHAGIC-FEVER; YELLOW-FEVER; CLINICAL-FEATURES; ADULT PATIENTS;
   NEUROINVASIVE DISEASE; JAPANESE ENCEPHALITIS; VASCULAR LEAKAGE
AB Background
   Flavivirus diseases such as dengue fever (DENV), West Nile virus (WNV), Zika and yellow fever represent a substantial global public health concern. Preexisting chronic conditions such as cardiovascular diseases, diabetes, obesity, and asthma were thought to predict risk of progression to severe infections.
   Objective
   We aimed to quantify the frequency of chronic comorbidities in flavivirus diseases to provide an estimate for their prevalence in severe and non-severe infections and examine whether chronic diseases contribute to the increased risk of severe viral expression.
   Methods
   We conducted a comprehensive search in PubMed, Ovid MEDLINE(R), Embase and Embase Classic and grey literature databases to identify studies reporting prevalence estimates of comorbidities in flavivirus diseases. Study quality was assessed with the risk of bias tool. Age-adjusted odds ratios (ORs) were estimated for severe infection in the presence of chronic comorbidities.
   Results
   We identified 65 studies as eligible for inclusion for DENV (47 studies) and WNV (18 studies). Obesity and overweight (i.e., BMI> 25 kg/m(2), prevalence: 24.5%, 95% CI: 18.6-31.6%), hypertension (17.1%, 13.3 - 21.8%) and diabetes (13.3%, 9.3 - 18.8%) were the most prevalent comorbidities in DENV. However, hypertension (45.0%, 39.1 - 51.0%), diabetes (24.7%, 20.2 - 29.8%) and heart diseases (25.6%, 19.5 - 32.7%) were the most prevalent in WNV.ORs of severe flavivirus diseases were about 2 to 4 in infected patients with comorbidities such as diabetes, hypertension and heart diseases. The small number of studies in JEV, YFV and Zika did not permit estimating the prevalence of comorbidities in these infections.
   Conclusion
   Higher prevalence of chronic comorbidities was found in severe cases of flavivirus diseases compared to non-severe cases. Findings of the present study may guide public health practitioners and clinicians to evaluate infection severity based on the presence of comorbidity, a critical public health measure that may avert severe disease outcome given the current dearth of clear prevention practices for some flavivirus diseases.
C1 [Badawi, Alaa] Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.
   [Badawi, Alaa; Velummailum, Russanthy] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
   [Ryoo, Seung Gwan; Vasileva, Denitsa; Ostermeier, Emma; Plishka, Mikayla] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada.
   [Senthinathan, Arrani] Mt Sinai Hlth Syst, Toronto, ON, Canada.
   [Yaghoubi, Sahar] Ryerson Univ, Fac Sci, Toronto, ON, Canada.
   [Soosaipillai, Marcel] Univ Waterloo, Fac Sci, Waterloo, ON, Canada.
   [Arora, Paul] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Natl Microbiol Lab, Toronto, ON, Canada.
RP Badawi, A (corresponding author), Publ Hlth Agcy Canada, Publ Hlth Risk Sci Div, Toronto, ON, Canada.; Badawi, A (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.
EM alaa.badawi@canada.ca
OI Velummailum, Russanthy/0000-0001-5958-1223
FU Public Health Agency of Canada
FX Public Health Agency of Canada (AB) is the funder of the study and had
   no role in study design, data collection, data analysis, data
   interpretation, or writing the report and the corresponding author had
   full access to all data in the study and had final responsibility for
   the decision to submit for publication.
CR Aamir M, 2015, PAK J MED HEALTH SCI, V9, P99
   Abroug F, 2006, MAYO CLIN PROC, V81, P12, DOI 10.4065/81.1.12
   Assir MZK, 2012, INT J INFECT DIS, V16, pE247, DOI 10.1016/j.ijid.2012.05.877
   Aubry C, 2012, TRAVEL MED INFECT DI, V10, P247, DOI 10.1016/j.tmaid.2012.09.004
   Badawi A, 2016, J PUBLIC HEALTH RES, V5, P130, DOI 10.4081/jphr.2016.733
   Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015
   Badawi A, 2010, DIABETES METAB SYNDR, V3, P173, DOI 10.2147/DMSO.S9089
   Benfield T, 2007, DIABETOLOGIA, V50, P549, DOI 10.1007/s00125-006-0570-3
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BISTRIAN BR, 1981, AM J CLIN NUTR, V34, P238
   Borenstein M, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, P193
   Bouzid M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-781
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Calvet GA, 2015, J CLIN VIROL, V74, DOI DOI 10.1016/J.JCV.2015.11
   Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832
   Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253
   CDC, 2016, AV ANN INC W NIL VIR
   Chamnanchanunt S, 2012, SE ASIAN J TROP MED, V43, P890
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x
   Chen CM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004376
   Chen CY, 2015, INT J MOL SCI, V16, P3820, DOI 10.3390/ijms16023820
   Choi BCK, 2001, DIABETOLOGIA, V44, P1221, DOI 10.1007/s001250100648
   Clayton D, 1993, STAT MODELS EPIDEMIO
   COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666
   Cogaltay N., 2015, LEADERSHIP ORG OUTCO, P19
   COHEN A, 1989, STAT MED, V8, P1485, DOI 10.1002/sim.4780081208
   Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717
   Craven RB, 2001, JAMA-J AM MED ASSOC, V286, P651, DOI 10.1001/jama.286.6.651
   Cunha RV, 1999, T ROY SOC TROP MED H, V93, P247, DOI 10.1016/S0035-9203(99)90008-1
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Dharmashankar K, 2010, CURR HYPERTENS REP, V12, P448, DOI 10.1007/s11906-010-0150-2
   Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8
   Douam F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14781
   Duderstadt SK, 2012, VACCINE, V30, P813, DOI 10.1016/j.vaccine.2011.10.087
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Fernandes-Charpiot I, 2014, TRANSPLANTATION, V98, P260
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699
   Fujimoto Denys Eiti, 2014, Rev. Bras. Hematol. Hemoter., V36, P115, DOI 10.5581/1516-8484.20140027
   Gotzsche PC, 2009, ANN INTERN MED, V151, P265
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hasanat M A, 2010, Mymensingh Med J, V19, P382
   Hasbun R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148898
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b
   Hayes EB, 2004, PEDIATRICS, V113, P1375, DOI 10.1542/peds.113.5.1375
   Higgins J, 2011, COCHRANE COLLAB, V5, P1, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Hoffman JE, 2013, J GERIATR PHYS THER, V36, P55, DOI 10.1519/JPT.0b013e318258bcba
   Hoffman KW, 2016, J INFECT DIS, V214, P634, DOI 10.1093/infdis/jiw179
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Htun NSN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003741
   Huang SY, 2015, AM J TROP MED HYG, V92, P75, DOI 10.4269/ajtmh.14-0343
   International Diabetes Federation, 2015, IDF DIABETES ATLAS, DOI DOI 10.1289/IMAGE.EHP.V119.I03
   Iqtadar S, 2014, INT J INFECT DIS, V21S
   Jaeger VK, 2015, J TRAVEL MED, V22, P161, DOI 10.1111/jtm.12184
   Jean CM, 2007, EMERG INFECT DIS, V13, P1918, DOI 10.3201/eid1312.061265
   Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378
   Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8
   Karunakaran A, 2014, J INFECT PUBLIC HEAL, V7, P114, DOI 10.1016/j.jiph.2013.09.006
   Kesavadev Jothydev, 2012, Indian J Endocrinol Metab, V16, P886, DOI 10.4103/2230-8210.102982
   Khairallah M, 2007, OCUL IMMUNOL INFLAMM, V15, P435, DOI 10.1080/09273940701798488
   Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3
   Kuo MC, 2008, CLIN J AM SOC NEPHRO, V3, P1350, DOI 10.2215/CJN.00020108
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Landis JR, 2014, MANTEL HAENSZEL METH, DOI DOI 10.1002/9781118445112.STAT04874
   Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008
   Lee CC, 2013, AM J EMERG MED, V31, P783, DOI 10.1016/j.ajem.2013.01.011
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lee IK, 2013, BIOMED RES INT, DOI 10.1155/2013/965853
   Lee IK, 2009, AM J TROP MED HYG, V80, P651, DOI 10.4269/ajtmh.2009.80.651
   Lee Min-Sheng, 2006, Journal of Microbiology Immunology and Infection, V39, P121
   Lee TH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004576
   Lenhard T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154143
   Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700
   Limonta D, 2008, DIABETES VASC DIS RE, V5, P213, DOI 10.3132/dvdr.2008.034
   Lin SZ, 2010, PERITON DIALYSIS INT, V30, P467, DOI 10.3747/pdi.2009.00028
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lindsey NP, 2012, AM J TROP MED HYG, V87, P179, DOI 10.4269/ajtmh.2012.12-0113
   Liu CC, 2008, AM J INFECT DIS, V4, P10, DOI 10.3844/ajidsp.2008.10.17
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191
   Lye DC, 2010, INT J INFECT DIS, V14, pE410, DOI 10.1016/j.ijid.2009.06.026
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mahmood S, 2013, ISRN TROP MED, V2013, DOI [10.1155/2013/673798, DOI 10.1155/2013/673798]
   Malavige GN, 2017, IMMUNOLOGY, V151, P261, DOI 10.1111/imm.12748
   Mallhi TH, 2016, POSTGRAD MED J, V92, P78, DOI 10.1136/postgradmedj-2015-133582
   Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3
   Mallhi TH, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0138465, DOI 10.1371/JOURNALPONE.0138465]
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Mirza AMB, 2016, J PAK MED ASSOC, V66, P1102
   Mohamed NA, 2013, EGYPT J CHEST DIS TU, V62, P319, DOI 10.1016/j.ejcdt.2013.03.002
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Mora A, 2013, CHEST, V144, DOI 10.1378/chest.1701609
   Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339
   Murray KO, 2009, ZOONOSES PUBLIC HLTH, V56, P370, DOI 10.1111/j.1863-2378.2008.01197.x
   Mutebi JP, 2002, MICROBES INFECT, V4, P1459, DOI 10.1016/S1286-4579(02)00028-X
   National Heart Lung and Blood Institute, 2014, QUAL ASS TOOL OBS CO
   Ng EL, 2014, INT J INFECT DIS, V21, P447, DOI 10.1016/j.ijid.2014.03.1342
   Pang JX, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0649-2
   Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641
   Pang VJ, 2013, AM J TROP MED HYG, V89
   Papa A, 2010, EUROSURVEILLANCE, V15
   Passos SRL, 2008, INFECTION, V36, P570, DOI 10.1007/s15010-008-7334-6
   Patgiri SJ, 2014, INDIAN J PATHOL MICR, V57, P400, DOI 10.4103/0377-4929.138732
   Pem-Novosel I, 2014, VECTOR-BORNE ZOONOT, V14, P82, DOI 10.1089/vbz.2012.1295
   Petersen LR, 2005, J TRAVEL MED, V12, pS3
   Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371
   Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613
   Prow NA, 2016, EMERG INFECT DIS, V22, P1353, DOI 10.3201/eid2208.151719
   Racsa L, 2014, DIAGN MICR INFEC DIS, V78, P132, DOI 10.1016/j.diagmicrobio.2013.11.006
   Ribeiro M, 2009, REV SOC BRAS MED TRO, V42, P523, DOI 10.1590/S0037-86822009000500009
   Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116
   Roehrig JT, 2001, ELS, DOI [10.1002/9780470015902.a0002233.pub3, DOI 10.1002/9780470015902.A0002233.PUB3]
   Rosenberger KD, 2016, TROP MED INT HEALTH, V21, P445, DOI 10.1111/tmi.12666
   Sakagianni K, 2013, INTENS CARE MED, V39, pS520
   Saqib Muhammad Arif Nadeem, 2014, BMC Res Notes, V7, P205, DOI 10.1186/1756-0500-7-205
   Sejvar JJ, 2011, VECTOR-BORNE ZOONOT, V11, P161, DOI 10.1089/vbz.2009.0086
   Shamliyan T, 2013, AM J PUBLIC HLTH RES, V1, P183
   Sierra B, 2010, CELL IMMUNOL, V262, P134, DOI 10.1016/j.cellimm.2010.02.005
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tedesco JM, 2016, FASEB J, V30
   ter Meulen J, 2004, J INFECT DIS, V190, P1821, DOI 10.1086/425016
   Thakare J. P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P801
   Thein TL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081060, DOI 10.1371/JOURNAL.PONE.0081060PMID:24278377]
   Thomas L, 2010, MED MALADIES INFECT, V40, P480, DOI 10.1016/j.medmal.2009.10.001
   Toledo J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004284
   Tomashek K, 2013, AM J TROP MED HYG S1, V89
   Tripepi G, 2010, NEPHRON CLIN PRACT, V116, pC317, DOI 10.1159/000319590
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Vrioni G, 2014, VECTOR-BORNE ZOONOT, V14, P52, DOI 10.1089/vbz.2013.1369
   Wang CC, 2007, AM J TROP MED HYG, V77, P151, DOI 10.4269/ajtmh.2007.77.151
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Wei HY, 2016, AM J TROP MED HYG, V95, P322, DOI 10.4269/ajtmh.15-0905
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Wong JGX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148579
   Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 153
TC 9
Z9 9
U1 3
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2018
VL 13
IS 7
AR e0200200
DI 10.1371/journal.pone.0200200
PG 27
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM5IS
UT WOS:000438170300032
PM 29990356
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dillard, JP
   Yang, C
   Li, RB
AF Dillard, James Price
   Yang, Chun
   Li, Ruobing
TI Self-regulation of emotional responses to Zika: Spiral of fear
SO PLOS ONE
LA English
DT Article
ID FIT INDEXES; TIME; DETERMINANTS; STRATEGIES; PHYSIOLOGY; ANXIETY; MODEL
AB Fear of infectious disease can create a variety of problems not the least of which is fear itself. An important question is how individuals attempt to manage their fear. The appearance of Zika in the U.S. presented an opportunity to examine this issue in a consequential natural context. Beginning nine days after the W.H.O. declared Zika a world health crisis, two-waves of survey data were collected from women ages 18-35 who were living in the Southern U.S. (N=561). Most respondents (71%) used one or more emotion regulation strategies and a plurality (41%) utilized multiple strategies. Fear of Zika showed no demonstrable effect on avoidance, reappraisal, or contesting and none of these three strategies were effective at down-regulating fear. Fear and suppression, however, showed a self-reinforcing cycle in which fear increased use of suppression and suppression increased intensity of the fear response. Although the observed associations were small, even modest effects can be consequential when cumulated over time or across large numbers of individuals.
C1 [Dillard, James Price] Penn State Univ, Dept Commun Arts & Sci, University Pk, PA 16802 USA.
   [Yang, Chun; Li, Ruobing] Louisiana State Univ, Manship Sch Mass Commun, Baton Rouge, LA 70803 USA.
RP Dillard, JP (corresponding author), Penn State Univ, Dept Commun Arts & Sci, University Pk, PA 16802 USA.
EM jpd16@psu.edu
OI Dillard, James/0000-0001-8109-1562
FU Communication Arts & Sciences Faculty grant at Penn State University
FX This research was supported by a Communication Arts & Sciences Faculty
   grant at Penn State University. JPD received this funding. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Barrett R, 2008, J INFECT DIS, V197, pS34, DOI 10.1086/524986
   Brans K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092410
   Brans K, 2013, EMOTION, V13, P926, DOI 10.1037/a0032400
   Campbell A, 2016, PERS INDIV DIFFER, V97, P210, DOI 10.1016/j.paid.2016.03.049
   Carmines E., 1981, SOCIAL MEASUREMENT C, P65, DOI DOI 10.1207/S15327965PLI0404_1
   Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136
   Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5
   Dillard JP, 2015, NAT COMM ASS LAS VEG
   Ekman P, 1989, HDB SOCIAL PSYCHOPHY, P143
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fransen ML, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01201
   Frijda N.H., 1986, EMOTIONS STUDIES EMO
   GOLLOB HF, 1987, CHILD DEV, V58, P80, DOI 10.1111/j.1467-8624.1987.tb03492.x
   Golman R, 2017, J ECON LIT, V55, P96, DOI 10.1257/jel.20151245
   GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970
   Gross JJ., 2013, HDB EMOTION REGULATI
   Heiy JE, 2014, EMOTION, V14, P878, DOI 10.1037/a0037231
   Hovland C. I, 1953, COMMUNICATION PERSUA
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424
   Jacks JZ, 2003, BASIC APPL SOC PSYCH, V25, P145, DOI 10.1207/S15324834BASP2502_5
   Knobloch-Westerwick S, 2009, COMMUN RES, V36, P426, DOI 10.1177/0093650209333030
   Lang PJ, 2016, PSYCHOPHYSIOLOGY, V53, P336, DOI 10.1111/psyp.12462
   Lederman SA, 2004, ENVIRON HEALTH PERSP, V112, P1772, DOI 10.1289/ehp.7348
   Lempel H, 2009, EC COST HLTH CARE WO, DOI [10.1371/currents.RRN1051, DOI 10.1371/CURRENTS.RRN1051]
   Little T. D., 2013, LONGITUDINAL STRUCTU
   MCCRAE RR, 1984, J PERS SOC PSYCHOL, V46, P919, DOI 10.1037/0022-3514.46.4.919
   McNeil Jr Donald G., 2016, NY TIMES
   McQueen A, 2013, HEALTH PSYCHOL, V32, P190, DOI 10.1037/a0027311
   Oatley K, 2014, TRENDS COGN SCI, V18, P134, DOI 10.1016/j.tics.2013.12.004
   Perez-Edgar Koraly E, 2014, Curr Behav Neurosci Rep, V1, P182
   Romero S, 2016, NY TIMES
   Segerstrom SC, 1998, J BEHAV MED, V21, P433, DOI 10.1023/A:1018732309353
   Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778
   Shultz JM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0741-y
   Silver RC, 2013, PSYCHOL SCI, V24, P1623, DOI 10.1177/0956797612460406
   Smits L, 2006, J PSYCHOSOM RES, V61, P715, DOI 10.1016/j.jpsychores.2006.04.020
   STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211
   Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260
   Tamir M, 2016, PERS SOC PSYCHOL REV, V20, P199, DOI 10.1177/1088868315586325
   Tavernise S, 2016, NY TIMES
   TOMARKEN AJ, 1995, J ABNORM PSYCHOL, V104, P312, DOI 10.1037/0021-843X.104.2.312
   Tooby J., 2008, HDB EMOTIONS, P114, DOI DOI 10.2307/2076468
   Van't Riet J, 2013, HEALTH PSYCHOL REV, V7, pS104, DOI 10.1080/17437199.2011.606782
   Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600
   WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34
   Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077
   Yang C, 2018, RISK ANAL, V38, P2535, DOI 10.1111/risa.12973
NR 48
TC 0
Z9 0
U1 4
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 10
PY 2018
VL 13
IS 7
AR e0199828
DI 10.1371/journal.pone.0199828
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM5IS
UT WOS:000438170300017
PM 29990349
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sheridan, MA
   Balaraman, V
   Schust, DJ
   Ezashi, T
   Roberts, RM
   Franz, AWE
AF Sheridan, Megan A.
   Balaraman, Velmurugan
   Schust, Danny J.
   Ezashi, Toshihiko
   Roberts, R. Michael
   Franz, Alexander W. E.
TI African and Asian strains of Zika virus differ in their ability to
   infect and lyse primitive human placental trophoblast
SO PLOS ONE
LA English
DT Article
ID EMBRYONIC STEM-CELLS; RUBELLA
AB Zika virus (ZIKV) drew worldwide attention when a recent epidemic was linked to fetal microcephaly. Here we used human embryonic stem cell derived trophoblasts as a model for primitive placental trophoblast to test the hypothesis that there are differences in how the two genetically distinct ZIKV lineages, African (AF) and Asian (AS), target the human placenta. Upon infection with three AF (ib-H30656, SEN/1984/41525-DAK, and MR-766) and three AS (FSS13025, Mexl-44, and PANcdc259249) ZIKV strains, we observed that severe placental cell lysis was only induced after infection with AF strains, while viral replication rates remained similar between both lineages. Differences in cytopathic effects (CPE) were not observed in Vero cells, indicating that the AF strains were not inherently superior at cell lysis. Taken together, we propose that infection with AF strains of ZIKV early in pregnancy would likely result in pregnancy loss, rather than allow further fetal development with accompanying brain damage. Our results also suggest that the long term laboratory-adapted MR766 strain does not behave aberrantly in cell culture relative to other AF lineage strains.
C1 [Sheridan, Megan A.; Ezashi, Toshihiko; Roberts, R. Michael] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.
   [Sheridan, Megan A.; Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.
   [Balaraman, Velmurugan; Franz, Alexander W. E.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Schust, Danny J.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO USA.
   [Ezashi, Toshihiko; Roberts, R. Michael] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
RP Roberts, RM (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.; Roberts, RM (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.; Franz, AWE (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Roberts, RM (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
EM RobertsRM@missouri.edu; FranzA@missouri.edu
OI Sheridan, Megan/0000-0002-6878-7976; Roberts, R.
   Michael/0000-0002-0008-6559
FU Eunice Kennedy Shriver Child Health and Human Development [HD R01
   077108, HD R01 067759]
FX This work was supported by the Eunice Kennedy Shriver Child Health and
   Human Development (https://www.nichd.nih.gov/) grant HD R01 077108 to TE
   and grant HD R01 067759 to RMR. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773
   Amita M, 2013, P NATL ACAD SCI USA, V110, pE1212, DOI 10.1073/pnas.1303094110
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010
   BAYER A, 2015, AM J OBSTET GYNECOL, V212, DOI DOI 10.1016/J.AJ0G.2014.07.060
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Carlson Amanda, 2010, Rev Obstet Gynecol, V3, P172
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gierman LM, 2015, PLACENTA, V36, P1246, DOI 10.1016/j.placenta.2015.09.004
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   HUSSA RO, 1977, IN VITRO CELL DEV B, V13, P443, DOI 10.1007/BF02615105
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jain A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17614-5
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nath B, 2017, MICROB PATHOGENESIS, V111, P187, DOI 10.1016/j.micpath.2017.08.046
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Osada N, 2014, DNA RES, V21, P673, DOI 10.1093/dnares/dsu029
   PATTILLO RA, 1971, IN VITRO CELL DEV B, V6, P398
   Roberts RM, 2018, BIOL REPROD, DOI [10.1093/biolre/05, DOI 10.1093/BIOLRE/05]
   Rothbauer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06364-z
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yabe S, 2016, P NATL ACAD SCI USA, V113, pE2598, DOI 10.1073/pnas.1601630113
   Yuan L, 2017, SCIENCE, DOI [10.1126/IJMS18081714, DOI 10.1126/IJMS18081714]
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 63
TC 13
Z9 13
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 9
PY 2018
VL 13
IS 7
AR e0200086
DI 10.1371/journal.pone.0200086
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM3UN
UT WOS:000438035500022
PM 29985932
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Draz, MS
   Venkataramani, M
   Lakshminarayanan, H
   Saygili, E
   Moazeni, M
   Vasan, A
   Li, YD
   Sun, XM
   Hua, S
   Yu, XG
   Shafiee, H
AF Draz, Mohamed Shehata
   Venkataramani, Manasa
   Lakshminarayanan, Harini
   Saygili, Ecem
   Moazeni, Maryam
   Vasan, Anish
   Li, Yudong
   Sun, Xiaoming
   Hua, Stephane
   Yu, Xu G.
   Shafiee, Hadi
TI Nanoparticle-enhanced electrical detection of Zika virus on paper
   microchips
SO NANOSCALE
LA English
DT Article
ID PROTEIN; ASSAY; DNA; IMMUNOASSAY; PCR
AB Zika virus (ZIKV) is a reemerging flavivirus causing an ongoing pandemic and public health emergency worldwide. There are currently no effective vaccines or specific therapy for Zika infection. Rapid, low-cost diagnostics for mass screening and early detection are of paramount importance in timely management of the infection at the point-of-care (POC). The current Zika diagnostics are laboratory-based and cannot be implemented at the POC particularly in resource-limited settings. Here, we develop a nanoparticle-enhanced viral lysate electrical sensing assay for Zika virus detection on paper microchips with printed electrodes. The virus is isolated from biological samples using antibodies and labeled with platinum nanoparticles (PtNPs) to enhance the electrical signal. The captured ZIKV-PtNP complexes are lysed using a detergent to release the electrically charged molecules associated with the intact virus and the PtNPs on the captured viruses. The released charged molecules and PtNPs change the electrical conductivity of the solution, which can be measured on a cellulose paper microchip with screen-printed microelectrodes. The results confirmed a highly specific detection of ZIKV in the presence of other non-targeted viruses, including closely related flaviviruses such as dengue virus-1 and dengue virus-2 with a detection limit down to 10(1) virus particles per l. The developed assay is simple, rapid, and cost-effective and has the potential for POC diagnosis of viral infections and treatment monitoring.
C1 [Draz, Mohamed Shehata; Venkataramani, Manasa; Lakshminarayanan, Harini; Saygili, Ecem; Moazeni, Maryam; Vasan, Anish; Li, Yudong; Shafiee, Hadi] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Engn Med, Boston, MA 02115 USA.
   [Draz, Mohamed Shehata; Shafiee, Hadi] Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
   [Draz, Mohamed Shehata] Tanta Univ, Fac Sci, Tanta 31527, Egypt.
   [Sun, Xiaoming; Hua, Stephane; Yu, Xu G.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02129 USA.
   [Sun, Xiaoming; Hua, Stephane; Yu, Xu G.] Harvard Univ, Boston, MA 02129 USA.
   [Yu, Xu G.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA.
RP Shafiee, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Engn Med, Boston, MA 02115 USA.; Shafiee, H (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
EM hshafiee@bwh.harvard.edu
OI Moazeni, Maryam/0000-0003-3956-042X
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI118502,
   R21HD092828, P30ES000002]; Harvard T.H. Chan School of Public Health,
   Harvard Center for Environmental Health through the Harvard NIEHS Grant;
   American Board of Obstetrics and Gynecology, American College of
   Obstetricians and Gynecologists, American Society for Reproductive
   Medicine, Society for Reproductive Endocrinology and Infertility through
   ASRM Award, Harvard University Center for AIDS Rese [5P30AI060354-14];
   Ragon Institute of MGH; MIT; Harvard University
FX Research reported in this publication was partially supported by the
   National Institute of Health under award numbers R01AI118502,
   R21HD092828, and P30ES000002; Harvard T.H. Chan School of Public Health,
   Harvard Center for Environmental Health through the Harvard NIEHS Grant;
   and the American Board of Obstetrics and Gynecology, American College of
   Obstetricians and Gynecologists, American Society for Reproductive
   Medicine, Society for Reproductive Endocrinology and Infertility through
   ASRM Award, Harvard University Center for AIDS Research (CFAR) under
   award number 5P30AI060354-14, and the Ragon Institute of MGH, MIT and
   Harvard University through their support to Dr Xu G. Yu.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Bigall NC, 2008, NANO LETT, V8, P4588, DOI 10.1021/nl802901t
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chang TL, 2007, BIOSENS BIOELECTRON, V22, P3139, DOI 10.1016/j.bios.2007.02.003
   Chen A, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4901348
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Das A, 2014, IMMUNOL LETT, V162, P132, DOI 10.1016/j.imlet.2014.08.004
   Draz MS, 2018, THERANOSTICS, V8, P1985, DOI 10.7150/thno.23856
   Draz MS, 2014, THERANOSTICS, V4, P872, DOI 10.7150/thno.9404
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Lan WJ, 2013, LAB CHIP, V13, P4103, DOI 10.1039/c3lc50771h
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Li X, 2015, ANAL CHEM, V87, P9009, DOI 10.1021/acs.analchem.5b02210
   Liana DD, 2012, SENSORS-BASEL, V12, P11505, DOI 10.3390/s120911505
   Liu XG, 2011, ELECTROCHIM ACTA, V56, P6266, DOI 10.1016/j.electacta.2011.05.055
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Mehrjardi MZ., 2017, VIROLOGY AUCKL, V8
   Mirabello V, 2015, J MATER CHEM B, V3, P5657, DOI 10.1039/c5tb00841g
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Reddy B, 2016, ANNU REV BIOMED ENG, V18, P329, DOI 10.1146/annurev-bioeng-071813-104643
   Rolim T, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-014-9911-z
   Routhu NK, 2017, J NEUROIMMUNE PHARM, V12, P219, DOI 10.1007/s11481-017-9736-7
   Safavieh M, 2017, NANOSCALE, V9, P1852, DOI 10.1039/c6nr06417e
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shafiee H., 2017, DIAGNOSTIC DEVICES M, P145
   Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep09919
   Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08719
   Shafiee H, 2013, SMALL, V9, P2553, DOI 10.1002/smll.201202195
   Sher M, 2017, EXPERT REV MOL DIAGN, V17, P351, DOI 10.1080/14737159.2017.1285228
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Sun XE, 2018, ANAL CHIM ACTA, V1007, P33, DOI 10.1016/j.aca.2017.12.005
   Tang CK, 2014, ANAL METHODS-UK, V6, P8878, DOI 10.1039/c4ay01962h
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wiwanitkit V, 2018, EUR J INTERN MED, V47, pE17, DOI 10.1016/j.ejim.2017.06.007
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Zayats M., 2010, BIOMOLECULE NANOPART
NR 43
TC 7
Z9 7
U1 10
U2 37
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2040-3364
EI 2040-3372
J9 NANOSCALE
JI Nanoscale
PD JUL 7
PY 2018
VL 10
IS 25
BP 11841
EP 11849
DI 10.1039/c8nr01646a
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA GM0QY
UT WOS:000437761500014
PM 29881853
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Joao, EAC
   Ferreira, OD
   Gouvea, MI
   Teixeira, MDB
   Tanuri, A
   Higa, LM
   Costa, DA
   Mohana-Borges, R
   Arruda, MB
   Matos, HJ
   Cruz, ML
   Mendes-Silva, W
   Read, JS
AF Joao, Esau A. C.
   Ferreira, Orlando da C., Jr.
   Gouvea, Maria Isabel
   Teixeira, Maria de Lourdes B.
   Tanuri, Amilcar
   Higa, Luiza M.
   Costa, Deise A.
   Mohana-Borges, Ronaldo
   Arruda, Monica B.
   Matos, Haroldo J.
   Cruz, Maria Leticia
   Mendes-Silva, Wallace
   Read, Jennifer S.
TI Pregnant women co-infected with HIV and Zika: Outcomes and birth defects
   in infants according to maternal symptomatology
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; VIRUS-INFECTION; BRAZIL
AB Background
   Zika virus (ZIKV) was first isolated in Uganda in 1947. In Brazil, the first reported case of ZIKV infection was in May 2015. Additionally, dengue (DENV) is endemic and there has been a recent outbreak of chikungunya (CHIKV). Since the clinical manifestations of different arboviral infections (AI) can be similar, definitive diagnosis requires laboratory testing.
   Objectives
   To determine the prevalence of ZIKV, DENV, and CHIKV infections in a Brazilian cohort of HIV-infected pregnant women, to assess clinical/immunological characteristics and pregnancy outcomes of women with evidence of recent AI.
   Study design
   Laboratory diagnosis of ZIKV, DENV and CHIKV infections utilized serological assays, RT-PCR and PRNT. The tests were performed at the first visit, 34-36 weeks of gestation and at any time if a woman had symptoms suggestive of AI. Mann-Whitney tests were used for comparison of medians, Chi-square or Fisher's to compare proportions; p<0.05 was considered statistically significant. Poisson regression was used to analyze risk factors for central nervous system (CNS) malformations in the infant according to maternal symptomatology.
   Results
   Of 219 HIV-infected pregnant women enrolled, 92% were DENV IgG+; 47(22%) had laboratory evidence of recent AI. Of these, 34 (72%) were ZIKV+, nine (19%) CHIKV+, and two (4%) DENV+. Symptoms consistent with AI were observed in 23 (10%) women, of whom 10 (43%) were ZIKV+, eight (35%) CHIKV+. No CNS abnormalities were observed among infants of DENV+ or CHIKV+ women; four infants with CNS abnormalities were born to ZIKV+ women (three symptomatic). Infants born to ZIKV+ women had a higher risk of CNS malformations if the mother was symptomatic (RR = 7.20), albeit not statistically significant (p = 0.066).
   Conclusions
   Among HIV-infected pregnant women with laboratory evidence of a recent AI, 72% were ZIKV-infected. In this cohort, CNS malformations occurred among infants born to both symptomatic and asymptomatic pregnant women with Zika infection.
C1 [Joao, Esau A. C.; Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.; Cruz, Maria Leticia] Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Orlando da C., Jr.; Tanuri, Amilcar; Higa, Luiza M.; Arruda, Monica B.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Biol Mol, Rio De Janeiro, RJ, Brazil.
   [Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Costa, Deise A.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [Matos, Haroldo J.] Inst Evandro Chagas, Dept Epidemiol, Belem, Para, Brazil.
   [Mendes-Silva, Wallace] Hosp Fed Servidores Estado, Maternal Fetal Unit, Rio De Janeiro, RJ, Brazil.
   [Read, Jennifer S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
RP Joao, EAC (corresponding author), Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, RJ, Brazil.
EM esaujoao@gmail.com
RI Cruz, Maria Leticia/Y-5632-2019; Borges, Ronaldo S Mohana/C-5575-2013;
   amsalu, ribka/G-8780-2019; Higa, Luiza/W-2698-2019
OI Joao, Esau/0000-0002-2412-0627; Mendes da Silva,
   Wallace/0000-0002-5195-4061
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Adams L, 2017, 2017 ANN M AM SOC TR
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2017, ZIK VIR GUID US LAB
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joao EC, 2012, INT J STD AIDS, V23, P44, DOI 10.1258/ijsa.2011.010545
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   SELVIN S, 1998, MODERN APPL BIOSTATI
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 25
TC 2
Z9 2
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2018
VL 13
IS 7
AR e0200168
DI 10.1371/journal.pone.0200168
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM1FJ
UT WOS:000437809500071
PM 29979796
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Atienza, BJP
   Jensen, LD
   Noton, SL
   Ansalem, AKV
   Hobman, T
   Fearns, R
   Marchant, DJ
   West, FG
AF Atienza, Bren Jordan P.
   Jensen, Lionel D.
   Noton, Sarah L.
   Ansalem, Anil Kumar Victoria
   Hobman, Tom
   Fearns, Rachel
   Marchant, David J.
   West, F. G.
TI Dual Catalytic Synthesis of Antiviral Compounds Based on
   Metallocarbene-Azide Cascade Chemistry
SO JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
ID VIRUS; INDOLE; (+)-ISATISINE; (-)-ISATISINE; REPLICATION; CARBENOIDS;
   INHIBITOR
AB Aryl azides trap ortho-metallocarbene intermediates to generate indolenones possessing a reactive C-acylimine moiety, which can react with added indole nucleophiles to afford the 2-(3-indolyl)indolin-3-one scaffold found in the antiviral natural product isatisine A. This overall process occurs through a dual catalytic sequence at room temperature. Redox activation of the Cu(OTf)(2) precatalyst by indole results in catalytically competent Cu(I) required for azide-metal-locarbene coupling. The Bronsted acid that is also formed from Cu(OTf)(2) reduction is responsible for catalysis of the C-C bond-forming indole addition step. This modular, procedurally simple method allows for rapid assembly of bis(indole) libraries, several of which proved to have anti-infective activity against respiratory syncytial virus and Zika virus.
C1 [Atienza, Bren Jordan P.; West, F. G.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.
   [Jensen, Lionel D.; Ansalem, Anil Kumar Victoria; Hobman, Tom; Marchant, David J.] Univ Alberta, Dept Med Microbiol & Immunol, Fac Med & Dent, Edmonton, AB T6G 2E1, Canada.
   [Noton, Sarah L.; Fearns, Rachel] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
RP West, FG (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.; Marchant, DJ (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Fac Med & Dent, Edmonton, AB T6G 2E1, Canada.
EM marchant@ualberta.ca; frederick.west@ualberta.ca
OI West, Frederick/0000-0001-7419-2314; Atienza, Bren
   Jordan/0000-0002-0150-3334
FU NSERC (Canada)Natural Sciences and Engineering Research Council of
   Canada; Li Ka Shing Institute of Virology
FX We thank Dr. Tina Bott, Dr. Angelina Moralez-Izquierdo, and Dr. Bob
   McDonald, Department of Chemistry, University of Alberta, for technical
   assistance. F.G.W. thanks NSERC (Canada), and D.J.M. thanks the Li Ka
   Shing Institute of Virology for support of this work.
CR Aburatani S, 2008, HETEROCYCLES, V75, P1407
   Bott TM, 2014, RSC ADV, V4, P31955, DOI 10.1039/c4ra06044j
   CANTER DM, 1993, VIROLOGY, V194, P518, DOI 10.1006/viro.1993.1290
   Chapman J, 2007, ANTIMICROB AGENTS CH, V51, P3346, DOI 10.1128/AAC.00211-07
   DOYLE MP, 1998, MODERN CATALYTIC MET
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guo T, 2016, TETRAHEDRON LETT, V57, P1097, DOI 10.1016/j.tetlet.2016.01.093
   Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000
   Jessing M, 2011, HETEROCYCLES, V82, P1739, DOI 10.3987/COM-10-S(E)127
   Karadeolian A, 2010, ANGEW CHEM INT EDIT, V49, P1133, DOI 10.1002/anie.200906632
   Karadeoltan A, 2010, J ORG CHEM, V75, P6830, DOI [10.1021/jo101209v, 10.1021/jo101209y]
   Lee J, 2015, J ORG CHEM, V80, P2959, DOI 10.1021/acs.joc.5b00051
   Lee J, 2011, ORG LETT, V13, P502, DOI 10.1021/ol102848w
   Liu JF, 2007, ORG LETT, V9, P4127, DOI 10.1021/ol701540y
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1
   Noton SL, 2015, J VIROL, V89, P7786, DOI 10.1128/JVI.00530-15
   Noton SL, 2015, VIROLOGY, V479, P545, DOI 10.1016/j.virol.2015.01.014
   PADWA A, 1991, CHEM REV, V91, P263, DOI 10.1021/cr00003a001
   Padwa A, 1996, CHEM REV, V96, P223, DOI 10.1021/cr950022h
   Patel P, 2012, J ORG CHEM, V77, P10509, DOI 10.1021/jo302198v
   Phipps RJ, 2008, J AM CHEM SOC, V130, P8172, DOI 10.1021/ja801767s
   Quartarone G, 2014, J PHYS ORG CHEM, V27, P680, DOI 10.1002/poc.3319
   Ribas X, 2002, ANGEW CHEM INT EDIT, V41, P2991, DOI 10.1002/1521-3773(20020816)41:16<2991::AID-ANIE2991>3.0.CO;2-6
   Rueping M, 2011, ADV SYNTH CATAL, V353, P563, DOI 10.1002/adsc.201000952
   SALOMON RG, 1973, J AM CHEM SOC, V95, P3300, DOI 10.1021/ja00791a038
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Suarez-Castillo OR, 2009, HETEROCYCLES, V78, P1463, DOI 10.3987/COM-08-11627
   Sun ZW, 2013, VIRUSES-BASEL, V5, P211, DOI 10.3390/v5010211
   Vanecko JA, 2006, TETRAHEDRON, V62, P1043, DOI 10.1016/j.tet.2005.09.123
   Wu W, 2012, ORG LETT, V14, P1624, DOI 10.1021/ol300379g
   Xiao MX, 2015, TETRAHEDRON, V71, P3705, DOI 10.1016/j.tet.2014.09.028
   Xu XH, 2011, ORG LETT, V13, P4854, DOI 10.1021/ol201931x
   Yin Q, 2011, CHEM SCI, V2, P1344, DOI 10.1039/c1sc00190f
   Zhang X, 2011, ANGEW CHEM INT EDIT, V50, P6164, DOI 10.1002/anie.201101621
NR 35
TC 5
Z9 5
U1 4
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-3263
J9 J ORG CHEM
JI J. Org. Chem.
PD JUL 6
PY 2018
VL 83
IS 13
BP 6829
EP 6842
DI 10.1021/acs.joc.8b00222
PG 14
WC Chemistry, Organic
SC Chemistry
GA GM8JF
UT WOS:000438471100003
PM 29663810
DA 2020-07-08
ER

PT J
AU Volpi, VG
   Pagani, I
   Ghezzi, S
   Iannacone, M
   D'Antonio, M
   Vicenzi, E
AF Volpi, Vera Giulia
   Pagani, Isabel
   Ghezzi, Silvia
   Iannacone, Matteo
   D'Antonio, Maurizio
   Vicenzi, Elisa
TI Zika Virus Replication in Dorsal Root Ganglia Explants from Interferon
   Receptor1 Knockout Mice Causes Myelin Degeneration
SO SCIENTIFIC REPORTS
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; GUILLAIN-BARRE-SYNDROME;
   ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; STEM-CELLS; WEST-NILE;
   INFECTION; DEMYELINATION; BRAZIL; MODEL
AB Zika virus (ZIKV) is a neurotropic agent that targets the developing fetal brain in women infected during pregnancy. In addition to the developing central nervous system, ZIKV has been recently shown to infect cells of the peripheral nervous system (PNS), highlighting its potential to cause acute peripheral neuropathies in adults, such as Guillain-Barre Syndrome (GBS). Here we show that myelinating dorsal root ganglia (DRG) explants obtained from interferon-alpha/beta receptor knock-out mice are productively infected by ZIKV. Virus replication is cytopathic in both peripheral neurons and myelinating Schwann cells leading to myelin disruption. These results confirm and extend previous observations suggesting that the PNS is indeed a potential site of ZIKV infection, replication and cytopathicity.
C1 [Volpi, Vera Giulia; D'Antonio, Maurizio] Ist Sci San Raffaele, Div Genet & Cell Biol, Myelin Biol Unit, Milan, Italy.
   [Pagani, Isabel; Ghezzi, Silvia; Vicenzi, Elisa] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Viral Pathogens & Biosafety Unit, Milan, Italy.
   [Iannacone, Matteo] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Dynam Immune Responses Unit, Milan, Italy.
RP Vicenzi, E (corresponding author), Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, Viral Pathogens & Biosafety Unit, Milan, Italy.
EM vicenzi.elisa@hsr.it
RI ghezzi, silvia/AAN-4092-2020; Pagani, Isabel/AAB-3301-2019; Vicenzi,
   Elisa/AAL-3980-2020
OI Pagani, Isabel/0000-0001-5396-0740; Ghezzi, Silvia/0000-0002-7586-663X
FU European Research Council Consolidator GrantEuropean Research Council
   (ERC) [725038]; Italian Association for Cancer ResearchAssociazione
   Italiana per la Ricerca sul Cancro (AIRC) [19891]; Fondazione Regionale
   per la Ricerca Biomedica Grant [2015-0010]; Italian Ministry of Health -
   Giovani Ricercatori Grant [GR-2011-02347925]; Career Development Award
   from the Armenise-Harvard Foundation
FX M.I. is supported by European Research Council Consolidator Grant
   725038, Italian Association for Cancer Research Grant 19891, Fondazione
   Regionale per la Ricerca Biomedica Grant 2015-0010, Italian Ministry of
   Health - Giovani Ricercatori Grant GR-2011-02347925 and a Career
   Development Award from the Armenise-Harvard Foundation. Imaging
   acquisition and analysis was carried out in ALEMBIC, an advanced
   microscopy laboratory established by the San Raffaele Scientific
   Institute. I. P. conducted this study as partial fulfilment of her Ph.D.
   in Molecular Medicine, Program in Basic and Applied Immunology,
   International Ph.D. School, Vita-Salute San Raffaele University, Milan,
   Italy. We thank Guido Poli for critical reading of the manuscript.
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mazzara PG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14088
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Nascimento OJM, 2017, CURR OPIN NEUROL, V30, P500, DOI 10.1097/WCO.0000000000000471
   Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sammicheli S, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6789
   Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Suwanmanee S, 2017, VIRAL IMMUNOL, V30, P13, DOI 10.1089/vim.2016.0092
   Swartwout BK, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040049
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017
   Wan GQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14487
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 47
TC 3
Z9 3
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 5
PY 2018
VL 8
AR 10166
DI 10.1038/s41598-018-28257-5
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL7VG
UT WOS:000437413200022
PM 29976926
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

EF